Citrus Sinensis ID: 006446

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640----
Protein Sequence
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHccccccEEEEcccccccccccEEEcccccccccEEEccccccccccccEEEEEEcccccccccccccccEEEEEEEEEEEccccccccEEEEEEccccccccccccccEEcccccccccccccEEEEEEccccccccccccccEEEEcccccccccEEcccccccccccEEEEEEEcccEEEEEEEccccccccccccccccccccEEEEEEcccccccccEEEEcccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccHHHcccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEcccEEEEEEcccccHHHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccHHEEEHHHcccccccccccccccccHHHHHHHHHHcccccHHccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccccccccEEcccccEccccEEEEccccccccHcccccccccccccEEEccccccEEEEEEEEEEEEEccccccccEEEEEEEcccccccccHHHHEEEEEccccccHHHccEEEEEEccccccccccccEEEEEEccccccEccccccEEEcccccEEEEEEEcccEEEEEEccccccEEEEEccHHHccccEEEEEEEEEccccccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccEEEEcEccccEEEEEEEcccccccHHHHHHHHHHHHHcHHHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHcEccccccccHHHEEEcccccEEEcccccccHccccccccccccEEEEcHccccHHHHHccccccccHHHHHHHEEHHHHcccccccccccccccEEEHHHHHHHHHccccHHcccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccHccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQnrnelsfdnstVAKSAIQVTYdvrgapitnqsgraIYKDQFQLwrdnknvkatFSTTFVLNILnqtaqpgegLAFVIAgnkdlpensegqWLGIVNGITNGTNQSQIVAIEFdtkksyeqdindnhvgldvnsvysirqvpltrvnlangtdikvqvrydGQNITVFVANmetpllsepidlseylpekvfvgfsastgddtqlncvkswafdgsdiggdsKAFRVLIAVLVPAVVLLAGVAFYCWRRYRareldddieglingtnlapkKFRLKELKKatgnfnpknklgkggfgtvykgIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYeympngsldkfifydetnsgpgevtlnwEKRLSVIHGTSQALdylhngsekrvlhrdikssnimldsefnarlgdfGLARTIQENLkthhstkeiagtpgymapesflvgratieTDIYAFGVLILEVAcgrkpgnqseqnsynNSIVHWLWELRRKGrildaadsrlggefseKEMECVLILGlacchpnphlrpsMKTVLQVLsgeadppvlpperpsfvwpamppsfvesdythtgsqldpfsdltgr
Flexible Loop (DISEMBL)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYdvrgapitnqsgrAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVpltrvnlangtdikvqvryDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRAReldddieglingtnlapkkfRLKELKKatgnfnpknklgkggfgtvykgiWRNKEIAVKRvsetsrqgkqefiaevttigslrhrNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKthhstkeiagtpgyMAPESFLVGRATIETDIYAFGVLILEVACGRkpgnqseqnsynNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESdythtgsqldpfsdltgr
Low Complexity Region (SEG)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRvliavlvpavvllagvaFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR
Disordered region (IsUnstruct)
*CFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS******KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR**********YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP*MKTVLQV***********************************************
Disordered Region (DISOPRED)
*CFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWR******ATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFD****G**SKAFRVLIAVLVPAVVLLAGVAFYCWRRYRAR************TNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSET****KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN****NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSF******************************
Disordered Region (DISEMBL)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVK********GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR
Disordered Region (DISPRO)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMP************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	644	2.2.26 [Sep-21-2011]
Q9FG33	652	Probable L-type lectin-do	yes	no	0.987	0.975	0.557	0.0
Q9FHG4	681	Probable L-type lectin-do	no	no	0.913	0.863	0.380	1e-110
O81291	669	L-type lectin-domain cont	no	no	0.813	0.783	0.406	1e-106
O80939	675	L-type lectin-domain cont	no	no	0.822	0.785	0.393	1e-105
Q9FJI4	675	Putative L-type lectin-do	no	no	0.815	0.777	0.383	1e-100
O81292	674	L-type lectin-domain cont	no	no	0.880	0.841	0.376	1e-100
Q9M345	677	L-type lectin-domain cont	no	no	0.815	0.775	0.382	2e-99
Q9M3D8	664	L-type lectin-domain cont	no	no	0.815	0.790	0.379	2e-99
Q9LYX1	711	L-type lectin-domain cont	no	no	0.822	0.745	0.372	1e-98
Q9LXA5	651	L-type lectin-domain cont	no	no	0.881	0.872	0.372	1e-98

>sp|Q9FG33|LRKS5_ARATH Probable L-type lectin-domain containing receptor kinase S.5 OS=Arabidopsis thaliana GN=LECRKS5 PE=2 SV=1

 Score =  736 bits (1900), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/660 (55%), Positives = 477/660 (72%), Gaps = 24/660 (3%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
           M FSL  K L L  ++      QV  L F+F  F   N  EL  DNS +   AIQVT DV
Sbjct: 1   MRFSLAWKLLFL--ILTCKIETQVKCLKFDFPGFNVSNELELIRDNSYIVFGAIQVTPDV 58

Query: 61  RGAP---ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN 117
            G P   I NQ+GRA+YK  F+LW  +K+  ATF+TTFV+NI N+T   GEGLAFV+   
Sbjct: 59  TGGPGGTIANQAGRALYKKPFRLWSKHKS--ATFNTTFVINISNKTDPGGEGLAFVLTPE 116

Query: 118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQV 177
           +  P+NS G WLG+VN  TN  N+S+IV++EFDT+KS+  D++ NHV L+VN++ S+ Q 
Sbjct: 117 ETAPQNSSGMWLGMVNERTNRNNESRIVSVEFDTRKSHSDDLDGNHVALNVNNINSVVQE 176

Query: 178 PLTR--VNLANGTDIKVQVRYDGQNITVFVA------NMETPLLSEPIDLSEYLPEKVFV 229
            L+   + + +G D+   VRYDG+N++V+V+           + S  IDLS YLPE V+V
Sbjct: 177 SLSGRGIKIDSGLDLTAHVRYDGKNLSVYVSRNLDVFEQRNLVFSRAIDLSAYLPETVYV 236

Query: 230 GFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGV--AFYCWRRYR 287
           GF+AST + T+LNCV+SW+F+G  I GD     + I + +  +V +     A Y   R +
Sbjct: 237 GFTASTSNFTELNCVRSWSFEGLKIDGDGNMLWLWITIPIVFIVGIGAFLGALYLRSRSK 296

Query: 288 ARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAV 347
           A E + DIE  ++     P+KF+L+ELK+ATGNF  +NKLG+GGFG V+KG W+ ++IAV
Sbjct: 297 AGETNPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRDIAV 356

Query: 348 KRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           KRVSE S QGKQEFIAE+TTIG+L HRNLVKL+GWCYER ++LLVYEYMPNGSLDK++F 
Sbjct: 357 KRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFL 416

Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
           ++ +       L WE R ++I G SQAL+YLHNG EKR+LHRDIK+SN+MLDS+FNA+LG
Sbjct: 417 EDKSRS----NLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLG 472

Query: 468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           DFGLAR IQ++  THHSTKEIAGTPGYMAPE+FL GRAT+ETD+YAFGVL+LEV  G+KP
Sbjct: 473 DFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP 532

Query: 528 GN---QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
                +  QN+YNNSIV+WLWEL R G I DAAD  +G  F ++EM+ VL+LGLACCHPN
Sbjct: 533 SYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPN 592

Query: 585 PHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           P+ RPSMKTVL+VL+GE  PP +P ERP+FVWPAMPPSF + DY+ TGSQ++  ++LTGR
Sbjct: 593 PNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDIDYSLTGSQINSLTELTGR 652

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  398 bits (1023), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 250/657 (38%), Positives = 386/657 (58%), Gaps = 69/657 (10%)

Query: 11  ILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSG 70
           I A+ M     +   +++F F+SFT +N   L   +S +    + +T ++ G P T+ SG
Sbjct: 15  ITALSMSKPIFVSSDNMNFTFKSFTIRNLTFLG--DSHLRNGVVGLTREL-GVPDTS-SG 70

Query: 71  RAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQP---GEGLAFVIAGNKDLPENSEGQ 127
             IY +  + +  + N  A+FST F   + N    P   G+GLAF ++ + D    S G 
Sbjct: 71  TVIYNNPIRFYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDND-TLGSPGG 129

Query: 128 WLGIVNGITNGTNQSQIVAIEFDTK-KSYEQDINDNHVGLDVNSVYSIRQV-PL--TRVN 183
           +LG+VN  ++   +++ VAIEFDTK   +  D N NH+GLDV+S+ SI    PL  ++++
Sbjct: 130 YLGLVN--SSQPMKNRFVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSDPLLSSQID 187

Query: 184 LANGTDIKVQVRY--DGQNITVFVANM---------ETPLLSEPIDLSEYLPEKVFVGFS 232
           L +G  I   + Y  D + + VF++           E PLLS  IDLS +L  +++VGFS
Sbjct: 188 LKSGKSITSWIDYKNDLRLLNVFLSYTDPVTTTKKPEKPLLSVNIDLSPFLNGEMYVGFS 247

Query: 233 ASTGDDTQLNCVKSWAF-------------------DGSDIGGD-----SKAFR------ 262
            ST   T+++ +++W+F                   D S +  D     SK  R      
Sbjct: 248 GSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSKKRRHRHNLA 307

Query: 263 VLIAVLVPAVVLLAGVAF--YCWRRYRARELDDDIEG-LINGTNLAPKKFRLKELKKATG 319
           + + +  P ++ LA   F  +  +++++ + + +++  LI G     ++F  KEL  AT 
Sbjct: 308 IGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELKTELITGL----REFSYKELYTATK 363

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
            F+    +G+G FG VY+ ++ +     AVKR    S +GK EF+AE++ I  LRH+NLV
Sbjct: 364 GFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLV 423

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L GWC E+ + LLVYE+MPNGSLDK I Y E+ +G   V L+W  RL++  G + AL Y
Sbjct: 424 QLQGWCNEKGELLLVYEFMPNGSLDK-ILYQESQTG--AVALDWSHRLNIAIGLASALSY 480

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH+  E++V+HRDIK+SNIMLD  FNARLGDFGLAR + E+ K+  ST   AGT GY+AP
Sbjct: 481 LHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLAR-LTEHDKSPVSTL-TAGTMGYLAP 538

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E    G AT +TD +++GV+ILEVACGR+P ++  ++    ++V W+W L  +GR+L+A 
Sbjct: 539 EYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAV 598

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSF 614
           D RL GEF E+ M+ +L++GL C HP+ + RPSM+ VLQ+L+ E +P  +P  +P+ 
Sbjct: 599 DERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPTL 655

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 238/586 (40%), Positives = 327/586 (55%), Gaps = 62/586 (10%)

Query: 69  SGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQW 128
           +G A Y    +         ++FSTTFV  I +Q      G+AFVIA N  LP  S  Q+
Sbjct: 64  TGHAFYTKPIRFKDSPNGTVSSFSTTFVFAIHSQIPI-AHGMAFVIAPNPRLPFGSPLQY 122

Query: 129 LGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVP--------- 178
           LG+ N   NG  ++ + A+E DT  + E  D N+NHVG+D+NS+ S++  P         
Sbjct: 123 LGLFNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQ 182

Query: 179 LTRVNLANGTDIKVQVRYDGQN--ITVFVANM-----ETPLLSEPIDLSEYLPEKVFVGF 231
              + L +   ++V V +DG    I V +A         PL+S   DLS  L + +FVGF
Sbjct: 183 FHNLTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGF 242

Query: 232 SASTGDDTQLNCVKSWAFDGSDIGGD------SKAFRVLIAVLVPAVVL----------- 274
           S++TG+      V  W+F    + G+      SK  R+ +  L P  V            
Sbjct: 243 SSATGNIVSEIFVLGWSFG---VNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLIS 299

Query: 275 ---------LAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKN 325
                    +  V F   RR +  E  +D E     T     + R K+L  AT  F  KN
Sbjct: 300 LLLIPFLLIIFLVRFIMKRRRKFAEEVEDWE-----TEFGKNRLRFKDLYYATKGFKDKN 354

Query: 326 KLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            LG GGFG+VYKGI     KEIAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C
Sbjct: 355 ILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYC 414

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
             R + LLVY+YMPNGSLDK+++     + P EVTL+W++R  VI+G + AL YLH   E
Sbjct: 415 RRRDELLLVYDYMPNGSLDKYLY-----NSP-EVTLDWKQRFKVINGVASALFYLHEEWE 468

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRD+K+SN++LD+E N RLGDFGLA+       +   T  + GT GY+AP+    G
Sbjct: 469 QVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHG--SDPQTTRVVGTWGYLAPDHIRTG 526

Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG 563
           RAT  TD++AFGVL+LEVACGR+P   + Q+     +V W++    +  ILDA D  LG 
Sbjct: 527 RATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGS 586

Query: 564 EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
           E+ +KE+E VL LGL C H +P  RP+M+ VLQ L G+A  P L P
Sbjct: 587 EYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDAMLPDLSP 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  384 bits (986), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 228/580 (39%), Positives = 321/580 (55%), Gaps = 50/580 (8%)

Query: 68  QSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTA-QPGEGLAFVIAGNKDLPENSEG 126
           ++G A Y    +         ++FST+FV  I +Q A   G G+AFV+A N  LP  +  
Sbjct: 62  KTGHAFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPS 121

Query: 127 QWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVP------- 178
           Q++G+ N   NG   + + A+E DT  S E  D NDNHVG+D+NS+ S++  P       
Sbjct: 122 QYIGLFNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEK 181

Query: 179 --LTRVNLANGTDIKVQVRYDGQ----NITVFVANMET---PLLSEPIDLSEYLPEKVFV 229
                + L +   ++V V YDG+    ++T+   N +    PL++   DLS  L + ++V
Sbjct: 182 GQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYV 241

Query: 230 GFSASTGDDTQLNCVKSWAFDGSDIGG-------------DSKAFRVLIAVLVPAVVLLA 276
           GFS++TG     + +  W+F  ++                + K       + +P + L  
Sbjct: 242 GFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFL 301

Query: 277 GVAF-----YCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGG 331
             +F     Y  RR R    + +      G N    +FR K+L  AT  F  K  LG GG
Sbjct: 302 IFSFIFLVCYIVRRRRKFAEELEEWEKEFGKN----RFRFKDLYYATKGFKEKGLLGTGG 357

Query: 332 FGTVYKGIWRNK--EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF 389
           FG+VYKG+      EIAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C  R + 
Sbjct: 358 FGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGEL 417

Query: 390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHR 449
           LLVY+YMPNGSLDK+++         EVTLNW++R+ VI G +  L YLH   E+ V+HR
Sbjct: 418 LLVYDYMPNGSLDKYLYNTP------EVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHR 471

Query: 450 DIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET 509
           D+K+SN++LD E N RLGDFGLAR       +   T  + GT GY+APE    GRAT+ T
Sbjct: 472 DVKASNVLLDGELNGRLGDFGLARLYDHG--SDPQTTHVVGTLGYLAPEHTRTGRATMAT 529

Query: 510 DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKE 569
           D++AFG  +LEVACGR+P    ++      +V W++ L  KG IL A D  +G E  EKE
Sbjct: 530 DVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKE 589

Query: 570 MECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
           +E VL LGL C H +P  RPSM+ VL  L G+A  P L P
Sbjct: 590 VEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPELSP 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FJI4|LK111_ARATH Putative L-type lectin-domain containing receptor kinase I.11 OS=Arabidopsis thaliana GN=LECRK111 PE=3 SV=1

 Score =  367 bits (942), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 224/584 (38%), Positives = 329/584 (56%), Gaps = 59/584 (10%)

Query: 66  TNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQT-AQPGEGLAFVIAGNKDLPENS 124
           T Q G A +K  F+   D+   K +FST FV  ++ +  A  G G+AFV++ + D  +  
Sbjct: 63  TQQMGHAFFKKPFKF--DSYEKKLSFSTHFVCALVPKPGADGGHGIAFVVSSSIDFTQAD 120

Query: 125 EGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLT--- 180
             Q+LG++N  TNG+  SQ++AIE DT +S E  DI+ NHVG+D+ S+ S+     +   
Sbjct: 121 PTQYLGLLNISTNGSPSSQLLAIELDTVESAEFDDIDKNHVGIDIKSLNSVESASASYFS 180

Query: 181 -------RVNLANGTDIKVQVRYDGQNITVFVANMET-----PLLSEPIDLSEYLPE-KV 227
                   + L +G  I++ V Y+G  + V VA +       PLLS  I+L++  P+ K+
Sbjct: 181 NAKGKNQSIKLLSGDPIQIWVDYEGALLNVTVAPLSIQKPNHPLLSRSINLTDIFPDRKL 240

Query: 228 FVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAV--------------- 272
           F GFSA+TG       +  W+F  S +   S  F  L  +  P                 
Sbjct: 241 FFGFSAATGTLVSYQYILGWSFSRSRMLLQSLDFSKLPQIPHPKAKQEQTSPLLIVLLML 300

Query: 273 ------VLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNK 326
                  +L G+  Y +RR +  E+ +  E        +P +F  K L KAT  F+   +
Sbjct: 301 LVLIMLAVLGGI--YLYRRKKYAEVREVWE-----KEYSPHRFSYKSLYKATNRFDKDGR 353

Query: 327 LGKGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           LGKGGFG VY+G +    +IAVKRV   ++QG ++F+AEV T+GSL+HRNLV L+G+C  
Sbjct: 354 LGKGGFGEVYRGNLPHVGDIAVKRVCHDAKQGMKQFVAEVVTMGSLKHRNLVPLLGYCRR 413

Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
           + + LLV EYM NGSLD+++F+ E      +  L+W +RL ++   + AL YLH G+ + 
Sbjct: 414 KGELLLVSEYMSNGSLDQYLFHRE------KPALSWSQRLVILKDIASALSYLHTGANQV 467

Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA 505
           VLHRDIK+SN+MLDSEFN RLGDFG+AR   E+           GT GYMAPE   +G +
Sbjct: 468 VLHRDIKASNVMLDSEFNGRLGDFGMARF--EDYGDSVPVTAAVGTMGYMAPELTTMGTS 525

Query: 506 TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEF 565
           T  TD+YAFGVL+LEV CGR+P +  +  S    ++ W+ +  R+  I+DA D+RLGG++
Sbjct: 526 T-RTDVYAFGVLMLEVTCGRRPLD-PKIPSEKRHLIKWVCDCWRRDSIVDAIDTRLGGQY 583

Query: 566 SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
           S +E   VL LGL C +     RP+M+ V+Q ++     P   P
Sbjct: 584 SVEETVMVLKLGLICTNIVAESRPTMEQVIQYINQNLPLPNFSP 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  367 bits (941), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 237/629 (37%), Positives = 338/629 (53%), Gaps = 62/629 (9%)

Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           SL+F + SF     N      +TV  + I    D         +G A Y +  +      
Sbjct: 26  SLNFTYNSFHRPPTNISIQGIATVTSNGILKLTD----KTVISTGHAFYTEPIRFKDSPN 81

Query: 86  NVKATFSTTFVLNILNQTAQ-PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQI 144
           +  ++FSTTFV+ I +      G G+AF IA N  L      Q+LG+ +   NG + + I
Sbjct: 82  DTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNNGNDTNHI 141

Query: 145 VAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQV---------PLTRVNLANGTDIKVQV 194
           +A+EFDT  + E  D NDNHVG+++NS+ S++               + L +   ++V V
Sbjct: 142 LAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWV 201

Query: 195 RYDGQN--ITVFVANM-----ETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSW 247
            YD +   I V +A          L+S   DLS    + +++GFSA+TG     + V  W
Sbjct: 202 DYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGW 261

Query: 248 AF----------------DGSDIGGDS---------KAFRVLIAVLVPAVVLLAGVAFYC 282
           +F                    +G  S           F +L+  ++  V L+  V F  
Sbjct: 262 SFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIV 321

Query: 283 WRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW-- 340
            RR +  E  +D E     T     + R K+L  AT  F  K+ LG GGFG VY+G+   
Sbjct: 322 RRRRKFAEEFEDWE-----TEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPT 376

Query: 341 RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS 400
             KEIAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C  R + LLVY+YMPNGS
Sbjct: 377 TKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGS 436

Query: 401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS 460
           LDK++ YD       EVTL+W++R +VI G +  L YLH   E+ V+HRDIK+SN++LD+
Sbjct: 437 LDKYL-YDCP-----EVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDA 490

Query: 461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE 520
           E+N RLGDFGLAR       +   T  + GT GY+AP+    GRAT  TD++AFGVL+LE
Sbjct: 491 EYNGRLGDFGLARLCDHG--SDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLE 548

Query: 521 VACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLAC 580
           VACGR+P     ++  +  +V  ++    +G ILDA D  LG  + ++E+E VL LGL C
Sbjct: 549 VACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLC 608

Query: 581 CHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
            H +P +RP+M+ VLQ L G+A  P L P
Sbjct: 609 SHSDPQVRPTMRQVLQYLRGDATLPDLSP 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  363 bits (933), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 224/586 (38%), Positives = 333/586 (56%), Gaps = 61/586 (10%)

Query: 68  QSGRAIYKDQFQLWRDNKNVK-ATFSTTFVLNILNQTAQ-PGEGLAFVIAGNKDLPENSE 125
           ++G A   ++ + ++D++N   ++FSTTFV  I +Q     G G+AFV+A    LP    
Sbjct: 62  KTGHAFCTERIR-FKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALP 120

Query: 126 GQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSV---------YSIR 175
            Q++G+ N   NG + + I A+EFDT +S E  D NDNHVG+D+N +         Y   
Sbjct: 121 SQYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDD 180

Query: 176 QVPLTRVNLANGTDIKVQVRYDGQN--ITVFVANMET-----PLLSEPIDLSEYLPEKVF 228
                 ++L +   I+V + YD ++  I V VA  ++     PL+S   DLS  L E ++
Sbjct: 181 HDKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMY 240

Query: 229 VGFSASTGDDTQLNCVKSWAFDGSDIGGD--------------------SKAFRVLIAVL 268
           VGFS++TG     + +  W+F    + G+                    S+ +++ + ++
Sbjct: 241 VGFSSATGSVLSEHFLVGWSFR---LNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLI 297

Query: 269 VPAVVL-LAGVAFYCWRRYRARELD-DDIEGLINGTNLAPKKFRLKELKKATGNFNPKNK 326
             +++  +  +AFY  RR +  E + DD E     T     +FR KEL  AT  F  K+ 
Sbjct: 298 SLSLIFSIIFLAFYIVRRKKKYEEELDDWE-----TEFGKNRFRFKELYHATKGFKEKDL 352

Query: 327 LGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LG GGFG VY+GI      E+AVKRVS  S+QG +EF+AE+ +IG + HRNLV L+G+C 
Sbjct: 353 LGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCR 412

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            R + LLVY+YMPNGSLDK+++ +       E TL+W++R ++I G +  L YLH   E+
Sbjct: 413 RRGELLLVYDYMPNGSLDKYLYNNP------ETTLDWKQRSTIIKGVASGLFYLHEEWEQ 466

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR 504
            V+HRD+K+SN++LD++FN RLGDFGLAR       +   T  + GT GY+APE    GR
Sbjct: 467 VVIHRDVKASNVLLDADFNGRLGDFGLARLYDHG--SDPQTTHVVGTLGYLAPEHSRTGR 524

Query: 505 ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGE 564
           AT  TD+YAFG  +LEV  GR+P      +     +V W++ L  +G I++A D +LG  
Sbjct: 525 ATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSS 584

Query: 565 -FSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
            +  +E+E VL LGL C H +P  RPSM+ VLQ L G+   P L P
Sbjct: 585 GYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPELTP 630

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M3D8|LRK13_ARATH L-type lectin-domain containing receptor kinase I.3 OS=Arabidopsis thaliana GN=LECRK13 PE=1 SV=1

 Score =  363 bits (933), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 222/585 (37%), Positives = 327/585 (55%), Gaps = 60/585 (10%)

Query: 68  QSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQT--AQPGEGLAFVIAGNKDLPENSE 125
           Q G A +K  F     + +   +F T FV  ++     A  G G+ FV++ + DL     
Sbjct: 60  QMGHAFFKKPFDF---DPSSSLSFYTHFVCALVPPKLGADGGHGIVFVVSPSIDLSHAYA 116

Query: 126 GQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLT---- 180
            Q+LG+ + +TNGT+ S ++AIE DT K+ E  ++   HVG+D+NS  S+     +    
Sbjct: 117 TQYLGVFSNLTNGTSSSHLLAIELDTVKTVEFNELEKPHVGIDLNSPISVESALPSYFSN 176

Query: 181 ------RVNLANGTDIKVQVRYDGQNITVFVANMET-----PLLSEPIDLSEYLPEKVFV 229
                  +NL +G  I+V V YDG  + V +A +E      PL+S  I+LSE   EK++V
Sbjct: 177 ALGKNISINLLSGEPIQVWVDYDGSFLNVTLAPIEIKKPNQPLISRAINLSEIFQEKMYV 236

Query: 230 GFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLV-------------------- 269
           GFS+STG+    + +  W+F        S     L  V +                    
Sbjct: 237 GFSSSTGNLLSNHYILGWSFSRRKEQLQSLNLSTLPRVPLPKEEKKKLSPLLIGLVILLV 296

Query: 270 -PAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLG 328
            P V++L GV  Y +RR +  E+ +  E         P +F  K L KAT  F    ++G
Sbjct: 297 IPVVMVLGGV--YWYRRKKYAEVKEWWE-----KEYGPHRFSYKSLYKATNGFRKDCRVG 349

Query: 329 KGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH 387
           KGGFG VYKG +   + IAVKR+S  + QG ++F+AEV T+G+L+HRNLV L+G+C  + 
Sbjct: 350 KGGFGEVYKGTLPGGRHIAVKRLSHDAEQGMKQFVAEVVTMGNLQHRNLVPLLGYCRRKC 409

Query: 388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVL 447
           + LLV EYMPNGSLD+++F+ E N  P     +W +R+S++   + AL YLH G+++ VL
Sbjct: 410 ELLLVSEYMPNGSLDQYLFH-EGNPSP-----SWYQRISILKDIASALSYLHTGTKQVVL 463

Query: 448 HRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI 507
           HRDIK+SN+MLDSEFN RLGDFG+A+    +  T+ S     GT GYMAPE   +G  ++
Sbjct: 464 HRDIKASNVMLDSEFNGRLGDFGMAKF--HDRGTNLSATAAVGTIGYMAPELITMG-TSM 520

Query: 508 ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSE 567
           +TD+YAFG  +LEV CGR+P  + E       +V W++E  ++  +    D RLG EF  
Sbjct: 521 KTDVYAFGAFLLEVICGRRP-VEPELPVGKQYLVKWVYECWKEACLFKTRDPRLGVEFLP 579

Query: 568 KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERP 612
           +E+E VL LGL C +  P  RP+M+ V+Q L+ +   P+  P  P
Sbjct: 580 EEVEMVLKLGLLCTNAMPESRPAMEQVVQYLNQDLPLPIFSPSTP 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1

 Score =  361 bits (927), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 227/609 (37%), Positives = 338/609 (55%), Gaps = 79/609 (12%)

Query: 66  TNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENS 124
           T+ +G+A+Y    +         A+F+T F  ++ N   +  G GLAFVI+ ++D    S
Sbjct: 70  TSTAGKALYGKPVKFRHPETKSPASFTTYFSFSVTNLNPSSIGGGLAFVISPDEDY-LGS 128

Query: 125 EGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVN 183
            G +LG+     +G   S  VA+EFDT    + +D+N NHVGLD+N+V S     L  V+
Sbjct: 129 TGGFLGLTEETGSG---SGFVAVEFDTLMDVQFKDVNGNHVGLDLNAVVSAAVADLGNVD 185

Query: 184 --LANGTDIKVQVRYDGQN--ITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSAST 235
             L +G  +   + YDG    +TV+V+      ++P+LS P+DL  Y+ + +FVGFS ST
Sbjct: 186 IDLKSGNAVNSWITYDGSGRVLTVYVSYSNLKPKSPILSVPLDLDRYVSDSMFVGFSGST 245

Query: 236 GDDTQLNCVKSWAFDGS---------------------------------DIGGDSKAFR 262
              T+++ V  W+F  S                                      S + R
Sbjct: 246 QGSTEIHSVDWWSFSSSFEESSESPPPMPNSPPPSSPSSSITPSLSTVRRKTADPSSSCR 305

Query: 263 VLIAVLVPAVV------------LLAGVAFYCWRRYRARELDDDIEGLINGTNLAPKKFR 310
             +    PA V            L AGV    W   +  +     E L +    +P++F 
Sbjct: 306 NKLCKKSPAAVAGVVTAGAFFLALFAGVII--WVYSKKIKYTRKSESLASEIMKSPREFT 363

Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTI 368
            KELK AT  F+    +G G FGTVYKGI ++    IA+KR S  S QG  EF++E++ I
Sbjct: 364 YKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHIS-QGNTEFLSELSLI 422

Query: 369 GSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           G+LRHRNL++L G+C E+ + LL+Y+ MPNGSLDK ++   T       TL W  R  ++
Sbjct: 423 GTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPT-------TLPWPHRRKIL 475

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
            G + AL YLH   E +++HRD+K+SNIMLD+ FN +LGDFGLAR  + + K+  +T   
Sbjct: 476 LGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHD-KSPDATAA- 533

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE-----QNSYNNSIVHW 543
           AGT GY+APE  L GRAT +TD++++G ++LEV  GR+P  + E     +    +S+V W
Sbjct: 534 AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVDW 593

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD 603
           +W L R+G++L A D RL  EF+ +EM  V+++GLAC  P+P  RP+M++V+Q+L GEAD
Sbjct: 594 VWGLYREGKLLTAVDERL-SEFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEAD 652

Query: 604 PPVLPPERP 612
            P +P  +P
Sbjct: 653 VPEVPIAKP 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  361 bits (926), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 233/626 (37%), Positives = 346/626 (55%), Gaps = 58/626 (9%)

Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           V S+ FN   F   + +E+++     A  A+++T        T ++G A Y  Q  LW  
Sbjct: 17  VCSVQFNISRFG-SDVSEIAYQGDARANGAVELT----NIDYTCRAGWATYGKQVPLWNP 71

Query: 84  NKNVKATFSTTFVLNILNQT---AQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGT 139
             +  + FST F   I  +       G G AF +A  +  LP NS G +LG+ NG  N +
Sbjct: 72  GTSKPSDFSTRFSFRIDTRNVGYGNYGHGFAFFLAPARIQLPPNSAGGFLGLFNGTNNQS 131

Query: 140 NQSQIVAIEFDTKKSYEQDIND--NHVGLDVNSVYSIRQVPLTRVNLANGTDI-KVQVRY 196
           +   +V +EFDT  + E D  D  +HVG++ NS+ S           ++  DI +V + Y
Sbjct: 132 SAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNYTSWNAT--SHNQDIGRVLIFY 189

Query: 197 DGQNITVFVA--------NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWA 248
           D     + V+         +E   LS  IDLS+ LP +V +GFSA++G  T+ N + SW 
Sbjct: 190 DSARRNLSVSWTYDLTSDPLENSSLSYIIDLSKVLPSEVTIGFSATSGGVTEGNRLLSWE 249

Query: 249 FDGS----DIG---GDSKAFRVLIAV--LVPAVVLLAGVAFYCWRRYRARE--------- 290
           F  S    DI     D K   + I+V   V     +  +  +  R+ + ++         
Sbjct: 250 FSSSLELIDIKKSQNDKKGMIIGISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTS 309

Query: 291 LDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVK 348
           +++D+E         P+KF  K+L  A  NF    KLG+GGFG VY+G   + +  +A+K
Sbjct: 310 INEDLE-----RGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVYRGYLNSLDMMVAIK 364

Query: 349 RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYD 408
           + +  S+QGK+EF+ EV  I SLRHRNLV+LIGWC+E+ +FL++YE+MPNGSLD  +F  
Sbjct: 365 KFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGK 424

Query: 409 ETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD 468
           + +       L W  R  +  G + AL YLH   E+ V+HRDIK+SN+MLDS FNA+LGD
Sbjct: 425 KPH-------LAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGD 477

Query: 469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG 528
           FGLAR +   L     T  +AGT GYMAPE    GRA+ E+D+Y+FGV+ LE+  GRK  
Sbjct: 478 FGLARLMDHELGPQ--TTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLEIVTGRKSV 535

Query: 529 NQSE-QNSYNNSIVHWLWELRRKGRILDAADSRLG-GEFSEKEMECVLILGLACCHPNPH 586
           ++ + +     ++V  +W+L  KG ++ A D +L  G F EK+ EC++I+GL C HP+ +
Sbjct: 536 DRRQGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVN 595

Query: 587 LRPSMKTVLQVLSGEADPPVLPPERP 612
            RPS+K  +QVL+ EA  P LP + P
Sbjct: 596 TRPSIKQAIQVLNLEAPVPHLPTKMP 621

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	644
255579755	652	ATP binding protein, putative [Ricinus c	0.993	0.981	0.603	0.0
255579759	653	ATP binding protein, putative [Ricinus c	0.995	0.981	0.586	0.0
147783760	654	hypothetical protein VITISV_011879 [Viti	0.956	0.941	0.591	0.0
359493418	796	PREDICTED: probable L-type lectin-domain	0.970	0.785	0.586	0.0
359493420	603	PREDICTED: probable L-type lectin-domain	0.920	0.983	0.608	0.0
297822473	649	predicted protein [Arabidopsis lyrata su	0.984	0.976	0.555	0.0
297806691	654	predicted protein [Arabidopsis lyrata su	0.990	0.975	0.562	0.0
225460332	603	PREDICTED: probable L-type lectin-domain	0.920	0.983	0.605	0.0
15240142	652	concanavalin A-like lectin kinase-like p	0.987	0.975	0.557	0.0
356498420	668	PREDICTED: probable L-type lectin-domain	0.998	0.962	0.559	0.0

>gi|255579755|ref|XP_002530716.1| ATP binding protein, putative [Ricinus communis] gi|223529730|gb|EEF31670.1| ATP binding protein, putative [Ricinus communis]

 Score =  783 bits (2021), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/656 (60%), Positives = 504/656 (76%), Gaps = 16/656 (2%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYD 59
           M FS+  K  ILA L+      QV SL+FN+  F + +R++  F  N+ +   AIQVT D
Sbjct: 1   MLFSVTVKLSILATLLWVGLTTQVESLNFNYTKFQDSDRDQFIFSSNARLFLDAIQVTPD 60

Query: 60  VRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKD 119
           V GA + ++SGR +YK  F+LW ++K++ ++F+TTFVLNILNQT   GEGLAF++A + +
Sbjct: 61  VNGASMADRSGRVVYKKPFKLW-NSKSIHSSFNTTFVLNILNQTNPGGEGLAFILAADSN 119

Query: 120 LPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           +P +SEG WLGIVN   NGT+Q++IVAIEFDT+KSY  D++DNHVGLDVNSVYS RQ  +
Sbjct: 120 VPADSEGAWLGIVNSKLNGTSQAKIVAIEFDTRKSYTDDLDDNHVGLDVNSVYSRRQFSM 179

Query: 180 TR--VNLANGT--DIKVQVRYD--GQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSA 233
           T   V +++G   +I   V+YD  G+ +T+FV +ME P+ SE +DLS YLP +++VGFS 
Sbjct: 180 TSRGVKISDGAKENITALVQYDSEGKILTLFVEDMEEPVFSENLDLSLYLPGEIYVGFSG 239

Query: 234 STGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYC-WRRYRARELD 292
           ST  +TQLNCV SW F+G +I  D K   V I V V  ++LLAG+AF   W+R   RE  
Sbjct: 240 STSSETQLNCVVSWEFNGVEIDDDDKLIWVWIVVPVVGMLLLAGIAFLVYWKRKSDREKL 299

Query: 293 DD----IEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVK 348
           +D    IE  I G++ AP+KF+LKEL+KATGNF+PKNKLGKGGFGTVYKG+  NKE+AVK
Sbjct: 300 EDAYPSIEEAIKGSSTAPRKFKLKELRKATGNFSPKNKLGKGGFGTVYKGVIGNKEMAVK 359

Query: 349 RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYD 408
           +VS+ S QGK EFIAEVTTIG+L HRNLVKLIGWCYER +FLLVYEY+PNGSLDK++FYD
Sbjct: 360 KVSKKSTQGKTEFIAEVTTIGNLHHRNLVKLIGWCYERREFLLVYEYLPNGSLDKYVFYD 419

Query: 409 ETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD 468
           +  S   E+TL+W  RL+VI G +QALDYLHNG E+ VLHRDIK+SNIMLDS +N +LGD
Sbjct: 420 K-KSEMQELTLSWGTRLTVISGAAQALDYLHNGCEETVLHRDIKASNIMLDSVYNPKLGD 478

Query: 469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG 528
           FGLARTI+ + +THHSTKE+AGTPGYMAPES L GR T+ETD+YAFGVLILEVACGRKPG
Sbjct: 479 FGLARTIKLSDQTHHSTKELAGTPGYMAPESILTGRFTVETDVYAFGVLILEVACGRKPG 538

Query: 529 NQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR 588
           +Q EQN Y+ +IVHW+WEL +KGR+LDAAD RL  +F   +M+C+L+LGLACCHPNP+ R
Sbjct: 539 SQHEQNDYSCNIVHWVWELHKKGRVLDAADPRLNEDFEPVDMQCLLVLGLACCHPNPNKR 598

Query: 589 PSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           PSMK VLQVL GEA PP +P E+P+F+WP +PPSF E D +    Q+ PFS++ GR
Sbjct: 599 PSMKIVLQVLKGEAPPPPVPNEKPAFMWPPLPPSFKELDISL--GQISPFSEINGR 652

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255579759|ref|XP_002530718.1| ATP binding protein, putative [Ricinus communis] gi|223529732|gb|EEF31672.1| ATP binding protein, putative [Ricinus communis]

 Score =  768 bits (1984), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/656 (58%), Positives = 485/656 (73%), Gaps = 15/656 (2%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
           M  S   KF +   L+GSA  I V  L F +  F  +N  +L   NS +  +AIQVT DV
Sbjct: 1   MYCSWAIKFFLKIALLGSAV-ISVECLSFTYPKFETENETDLIRHNSYIVLNAIQVTPDV 59

Query: 61  RGAPITNQSGRAIYKDQFQLWRDNKN----VKATFSTTFVLNILNQTAQPGEGLAFVIAG 116
            G  ITN SGRA+YK+ F+LW  +K      +A+F++TFVLNI  +T   GEG+AF++  
Sbjct: 60  SGGSITNLSGRALYKEPFKLWGKSKKGISRTRASFNSTFVLNISPRTNPGGEGVAFILTE 119

Query: 117 NKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQ 176
           + DLPENS+GQWLGIVN  TNG +Q++I+ IEFDT+KS+ +D++DNHVGLDVNS+YSIRQ
Sbjct: 120 DSDLPENSQGQWLGIVNENTNGNSQAKIIGIEFDTRKSFPRDVDDNHVGLDVNSIYSIRQ 179

Query: 177 VPL--TRVNLANGTDIKVQVRYDGQNITVFVANMETPLL-SEPIDLSEYLPEKVFVGFSA 233
            PL    V+L+ G D+ VQ++YDG+ + + +   E   L S PIDLS YLPE+VFVGFS 
Sbjct: 180 EPLGIHGVDLSAGIDVMVQIQYDGETLILSIGQQEKNFLFSVPIDLSAYLPEEVFVGFSG 239

Query: 234 STGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARE--- 290
           ST + T+LNCV+SW F  S I  +S    V I   + A  LL G+ FY  RR++A +   
Sbjct: 240 STSNYTELNCVRSWEFYSSVIKEESSLLWVKIVAPIGAA-LLIGITFYICRRWKAEKHRP 298

Query: 291 --LDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVK 348
              D  IE  ING+++AP+KF  KEL+KAT  FN +N +GKGGFG VYKGI  N+E+AVK
Sbjct: 299 VVADPSIEEEINGSSMAPRKFTFKELEKATAKFNSQNMIGKGGFGAVYKGILNNEEVAVK 358

Query: 349 RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYD 408
           R+S  S QGKQEFIAEVTTIG+  H+NLVKLIGWCYER++FLLVYEYMPNGSLDK IF +
Sbjct: 359 RISRESTQGKQEFIAEVTTIGNFHHKNLVKLIGWCYERNEFLLVYEYMPNGSLDKLIFRE 418

Query: 409 ETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD 468
           +T +   E TL+W KR+++I G +QALDYLHNG EKRVLHRDIK+SNIMLDSEFNA+LGD
Sbjct: 419 DT-AEEQEKTLDWGKRINIILGIAQALDYLHNGCEKRVLHRDIKTSNIMLDSEFNAKLGD 477

Query: 469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG 528
           FGLAR +++  +THH+T+E+AGT GYMAPE F   RAT+ETD+YAFGVL+LEV CG+KPG
Sbjct: 478 FGLARMVKQREQTHHTTRELAGTHGYMAPECFFTARATVETDVYAFGVLLLEVVCGKKPG 537

Query: 529 NQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR 588
           NQ+EQ+ YN+ IV W+WEL R GRILDAAD +  G  S++EMECVLILGLACC+ N   R
Sbjct: 538 NQNEQSDYNSRIVCWVWELYRLGRILDAADRKSIGVRSDEEMECVLILGLACCNTNQEQR 597

Query: 589 PSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           PSMK VLQVL+GEA  P++PPE P+FVW   PP   ESD + TGSQL PFS++TGR
Sbjct: 598 PSMKIVLQVLTGEAPLPIVPPEMPAFVWQTTPPPIKESDCSLTGSQLTPFSEITGR 653

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147783760|emb|CAN63688.1| hypothetical protein VITISV_011879 [Vitis vinifera]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/629 (59%), Positives = 471/629 (74%), Gaps = 13/629 (2%)

Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           V   HF +Q F +   N+    +S + + AIQVTYDV G PITN SG+A+YK  F+LW +
Sbjct: 31  VECFHFKYQFFNDSTENDFLLTDSQITQDAIQVTYDVSGNPITNLSGQALYKRPFKLWSE 90

Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
           +K   A+F+TTFVL I  +T   GEGL F++ G    PENSEG+WLGIVN  TNG+ Q+Q
Sbjct: 91  SKGT-ASFNTTFVLRITPRTDPGGEGLVFILTGRATRPENSEGKWLGIVNASTNGSAQNQ 149

Query: 144 IVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITV 203
           IVA+EFDT+KSY +D+++NH+G++VNSVYSI+Q  L+ +NL++GTDI V+++YDG+N++ 
Sbjct: 150 IVAVEFDTRKSYMEDLSNNHIGVNVNSVYSIKQANLS-INLSSGTDITVKIQYDGKNLSA 208

Query: 204 FVA-NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFR 262
           FV   M+ P ++ PI+LS++LP+ VFVGFSASTG+ TQLNCV+SW F GS +  D     
Sbjct: 209 FVGTQMKAPAIALPINLSDHLPQNVFVGFSASTGNHTQLNCVRSWEFSGSSVDEDPDLLW 268

Query: 263 VLIAVLVPAVVLLAGVAFYC---WRRYRARELDDD--IEGLINGTNLAPKKFRLKELKKA 317
           V I  +VP  VL++GVAFY    W+  +  E +DD  +E  I G++ AP+KFRLKELK A
Sbjct: 269 VWI--MVPVTVLVSGVAFYFSWKWKCGKQEEEEDDPRVEQQIQGSSTAPRKFRLKELKAA 326

Query: 318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           T NFN KN+LGKGGFGTVYKG  +NKE+AVKR S  S Q  Q+FIAEVTTI +L H+NLV
Sbjct: 327 TENFNSKNELGKGGFGTVYKGFLKNKEVAVKRFSMNSHQSNQDFIAEVTTISNLHHKNLV 386

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           KL+GWCYE+ + L++YE+MPN SLDK IF  +++     +TLNWE R  +I G +QALDY
Sbjct: 387 KLVGWCYEKRELLIIYEFMPNTSLDKLIFCKKSDV-ENPITLNWETRYGIICGVAQALDY 445

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LHNG EKRVLHRDIK+SNIMLDS+FNARLGDFGLAR IQ N +THHSTKEIAGTPGYMAP
Sbjct: 446 LHNGCEKRVLHRDIKASNIMLDSDFNARLGDFGLARIIQLNDQTHHSTKEIAGTPGYMAP 505

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           ESF  GRA +ETD+YAFGVL+LEV CGRKPG+QS  N YNN IV W+WE  R+ RILD  
Sbjct: 506 ESFHTGRAAVETDVYAFGVLVLEVVCGRKPGDQSVNNKYNNGIVDWVWEYYRRQRILDVV 565

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWP 617
           D RL G F +++ E  L+L L+CCHPNP+ RPSM+  L+VL+GE DPPV+P E+P FVWP
Sbjct: 566 DLRLNGVFHKEQTEYALMLALSCCHPNPYQRPSMRIALRVLTGEVDPPVIPIEKPPFVWP 625

Query: 618 AMPP-SFVES-DYTHTGSQLDPFSDLTGR 644
           A PP SF E  +Y  T   L P S+L GR
Sbjct: 626 ATPPVSFREDLEYPPTEGLLSPPSELIGR 654

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493418|ref|XP_002280278.2| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5 [Vitis vinifera]

 Score =  759 bits (1960), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/638 (58%), Positives = 473/638 (74%), Gaps = 13/638 (2%)

Query: 15  LMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIY 74
           L  S     V   HF +Q F +   N+    +S + + AIQVTYDV G PITN SG+A+Y
Sbjct: 164 LRNSPPDSPVECFHFKYQFFNDSTENDFLLTDSQITQDAIQVTYDVSGNPITNLSGQALY 223

Query: 75  KDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNG 134
           K  F+LW ++K   A+F+TTFVL I  +T   GEGL F++ G    PENSEG+WLGIVN 
Sbjct: 224 KRPFKLWSESKGT-ASFNTTFVLRITPRTDPGGEGLVFILTGRATRPENSEGKWLGIVNA 282

Query: 135 ITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQV 194
            TNG+ Q+QIVA+EFDT+KSY +D+++NH+G++VNSVYSI+Q  L+ +NL++GTDI V++
Sbjct: 283 STNGSAQNQIVAVEFDTRKSYMEDLSNNHIGVNVNSVYSIKQANLS-INLSSGTDITVKI 341

Query: 195 RYDGQNITVFVA-NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD 253
           +YDG+N++ FV   M+ P ++ PI+LS++LP+ VFVGFSASTG+ TQLNCV+SW F GS 
Sbjct: 342 QYDGKNLSAFVGTQMKAPAIALPINLSDHLPQNVFVGFSASTGNHTQLNCVRSWEFSGSS 401

Query: 254 IGGDSKAFRVLIAVLVPAVVLLAGVAFYC---WRRYRARELDDD--IEGLINGTNLAPKK 308
           +  D     V I  +VP  VL++GVAFY    W+  +  E +DD  +E  I G++ AP+K
Sbjct: 402 VDEDPDLLWVWI--MVPVTVLVSGVAFYFSWKWKCGKQEEEEDDPRVEQQIQGSSTAPRK 459

Query: 309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTI 368
           FRLKELK AT NFN KN+LGKGGFGTVYKG  +NKE+AVKR S  S Q  Q+FIAEVTTI
Sbjct: 460 FRLKELKAATENFNSKNELGKGGFGTVYKGFLKNKEVAVKRFSMNSHQSNQDFIAEVTTI 519

Query: 369 GSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
            +L H+NLVKL+GWCYE+ + L++YE+MPN SLDK IF  +++     +TLNWE R  +I
Sbjct: 520 SNLHHKNLVKLVGWCYEKRELLIIYEFMPNTSLDKLIFCKKSDV-ENPITLNWETRYGII 578

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
            G +QALDYLHNG EKRVLHRDIK+SNIMLDS+FNARLGDFGLAR IQ N +THHSTKEI
Sbjct: 579 CGVAQALDYLHNGCEKRVLHRDIKASNIMLDSDFNARLGDFGLARIIQLNDQTHHSTKEI 638

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
           AGTPGYMAPESF  GRA +ETD+YAFGVL+LEV CGRKPG+QS  N YNN IV W+WE  
Sbjct: 639 AGTPGYMAPESFHTGRAAVETDVYAFGVLVLEVVCGRKPGDQSVNNKYNNGIVDWVWEYY 698

Query: 549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLP 608
           R+ RILD  D RL G F +++ E  L+L L+CCHPNP+ RPSM+  L+VL+GE DPPV+P
Sbjct: 699 RRQRILDVVDLRLNGVFHKEQTEYALMLALSCCHPNPYQRPSMRIALRVLTGEVDPPVIP 758

Query: 609 PERPSFVWPAMPP-SFVES-DYTHTGSQLDPFSDLTGR 644
            E+P FVWPA PP SF E  +Y  T   L P S+L GR
Sbjct: 759 IEKPPFVWPATPPVSFREDLEYPPTEGLLSPPSELIGR 796

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493420|ref|XP_002280307.2| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5-like [Vitis vinifera]

 Score =  745 bits (1924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/606 (60%), Positives = 464/606 (76%), Gaps = 13/606 (2%)

Query: 47  STVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQP 106
           S +A +AIQVT+DV G+PITN SG+A+YK  F+LW ++K   A+F+TTFV  I  +T   
Sbjct: 3   SEIAVNAIQVTHDVSGSPITNLSGQALYKRPFKLWSESKGT-ASFNTTFVFRITPRTDPG 61

Query: 107 GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGL 166
           GEGLAF++ G+   PENSEG+WLGIVN  TNG+ Q+QIVA+EFDT+KSY +D+++NH+G+
Sbjct: 62  GEGLAFILTGHATRPENSEGKWLGIVNASTNGSAQNQIVAVEFDTRKSYMEDLSNNHIGV 121

Query: 167 DVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVA-NMETPLLSEPIDLSEYLPE 225
           +VNSVYSI+Q  L+ +NL++GTDI V+V+YDG+ ++ FV   M+ P ++ PI+L E+LP+
Sbjct: 122 NVNSVYSIKQANLS-INLSSGTDITVKVQYDGKILSAFVGTQMKAPAIALPINLPEHLPQ 180

Query: 226 KVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFY-CWR 284
           KVFVGFSASTG+ TQLNCV SW F G  +  D     V I  +VP  VL++GVAFY  W+
Sbjct: 181 KVFVGFSASTGNHTQLNCVSSWEFSGLSVDEDPDLLWVWI--MVPVTVLVSGVAFYFSWK 238

Query: 285 RYRAR--ELDDD--IEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW 340
              A+  E +DD  +E  I G++ AP+KFRLKELK AT NFN KN+LGKGGFG VYKG  
Sbjct: 239 CKCAKQEEEEDDPWVEQQIQGSSTAPRKFRLKELKTATENFNSKNELGKGGFGRVYKGFL 298

Query: 341 RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS 400
           +NKE+AVKR S  S Q KQ+FIAEVTTI +L H+NLVKL+GWCYE+ + LL+YE+MPN S
Sbjct: 299 KNKEVAVKRFSRNSHQSKQDFIAEVTTISNLHHKNLVKLVGWCYEKRELLLIYEFMPNTS 358

Query: 401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS 460
           LDK IFY +++     +TLNWE R  +I G +QALDYLHNG EKRVLHRDIK+SNIMLDS
Sbjct: 359 LDKLIFYKKSDE-ENPITLNWETRYGIICGVAQALDYLHNGCEKRVLHRDIKASNIMLDS 417

Query: 461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE 520
           +FNARLGDFGLAR IQ++  THHSTKEIAGTPGYMAPESF  GRA +ETD+YAFGVL+LE
Sbjct: 418 DFNARLGDFGLARIIQQSDYTHHSTKEIAGTPGYMAPESFHTGRAAVETDVYAFGVLVLE 477

Query: 521 VACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLAC 580
           V CGRKPG+QS  N YNN IV W+WE  R+ RILD  D RL G F +++ E  L+L L+C
Sbjct: 478 VVCGRKPGDQSVNNKYNNGIVDWVWEYYRRQRILDVVDLRLNGVFRKEQTEYALMLALSC 537

Query: 581 CHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPP-SFVES-DYTHTGSQLDPF 638
           CHPNP+ RPSM+  L+VL+GE DPPV+P E+P FVWPA PP SF E  +Y  TG  L P 
Sbjct: 538 CHPNPYQRPSMRISLRVLTGEVDPPVIPIEKPPFVWPATPPVSFREDLEYPPTGGLLSPP 597

Query: 639 SDLTGR 644
           S+L GR
Sbjct: 598 SELIGR 603

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297822473|ref|XP_002879119.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297324958|gb|EFH55378.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/659 (55%), Positives = 479/659 (72%), Gaps = 25/659 (3%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
           M +S   K L L + +      QV  + FNF  F     + L  + S +A  A+QVT + 
Sbjct: 1   MKYSPACKLLFLILTITCKIETQVKCMKFNFSKF--NGDSNLYLNYSDIAFEALQVTPEA 58

Query: 61  RGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDL 120
           RGAPITN SGR +YKD+F+LWR  K  K+TF+TTFV+NI NQT   GEGLAFV+   K++
Sbjct: 59  RGAPITNLSGRTVYKDRFRLWRKGK--KSTFNTTFVINIKNQTEFGGEGLAFVLTPEKNV 116

Query: 121 PENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT 180
           P+NS G WLG++N  TNGT +S+IVA+EFDT+K++  D++ NHV L+VN++ S+ Q  L+
Sbjct: 117 PQNSSGMWLGLMNERTNGTRESRIVAVEFDTRKNHPDDLDGNHVALNVNNINSVVQESLS 176

Query: 181 R--VNLANGTDIKVQVRYDGQNITVFVA------NMETPLLSEPIDLSEYLPEKVFVGFS 232
              + + +  D    VRYDG+N++V+V+      +    + S PIDLS YLPE V++GF+
Sbjct: 177 SRGITINSSIDFTAHVRYDGKNLSVYVSRNPEVHDQRNLVFSWPIDLSAYLPENVYIGFT 236

Query: 233 ASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRAR--- 289
           AST D TQLNCVKSW+F+G ++ GD   +   + ++ P V  +   AF C    R+R   
Sbjct: 237 ASTSDFTQLNCVKSWSFEGLEVDGDRNIWLWSLWIITPTVCAVVIGAFLCGLYLRSRSKA 296

Query: 290 -ELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVK 348
            E + DIE  ++     P+KF+L+ELK+ATGNF+ +NKLG+GGFG V+KG W  ++IAVK
Sbjct: 297 GETNPDIEAELDNCGAHPQKFKLRELKRATGNFSGENKLGQGGFGMVFKGKWEGRDIAVK 356

Query: 349 RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYD 408
           RVSE SRQGKQEFI+E+ TIG+L HRNLVKL+GWCYER +FLLVYEYMPNGSLD+++F +
Sbjct: 357 RVSEKSRQGKQEFISEIKTIGNLNHRNLVKLLGWCYERKEFLLVYEYMPNGSLDRYVFVE 416

Query: 409 ETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD 468
           + +S      L WE R  +I G SQAL+YLHNG EKR+LHRDIK+SN+MLDS+FNA+LGD
Sbjct: 417 DKSSS----NLKWETRKHIIRGISQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLGD 472

Query: 469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG 528
           FGLAR IQ++  THHST EIAGTPGYMAPE+FL GRAT+ETD+YAFGVL+LEV  G+KP 
Sbjct: 473 FGLARMIQQSEMTHHSTNEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKPS 532

Query: 529 N---QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNP 585
               +  +++Y NSIV+WLWEL R G I+DAAD R+G  F E+EM+ VL+LGLACCHPNP
Sbjct: 533 YVLVKENESNYKNSIVNWLWELYRNGTIMDAADPRMGSLFDEEEMKSVLLLGLACCHPNP 592

Query: 586 HLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           +LRPSMKTVL+VL+GE  PP +P ERP+FVWP MPPSF   DY+ TGSQ    ++LTGR
Sbjct: 593 NLRPSMKTVLKVLTGETSPPNVPTERPAFVWPVMPPSFGVVDYSLTGSQ--DITELTGR 649

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297806691|ref|XP_002871229.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297317066|gb|EFH47488.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/660 (56%), Positives = 479/660 (72%), Gaps = 22/660 (3%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
           M FSL  K L L + +      QV  L FNF  F   N  +L  DNS +   AIQVT DV
Sbjct: 1   MRFSLAWKLLFLILTIACKLETQVKCLEFNFPGFNVSNDLDLIRDNSYIVLGAIQVTPDV 60

Query: 61  RGAP---ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN 117
            G P   I NQ+GRA+Y   F+LW  +KN  ATF+TTFV+NI N+T   GEGLAFV+   
Sbjct: 61  SGGPGGSIANQAGRALYNKPFRLWSKDKN--ATFNTTFVINISNKTDPGGEGLAFVLTPE 118

Query: 118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQV 177
           K  P+NS G WLG+VN  TN T +S+IV++EFDT+KS+  DI+ NHV L+VN++ S+ Q 
Sbjct: 119 KTAPQNSSGMWLGLVNERTNMTLESRIVSVEFDTRKSHPDDIDGNHVALNVNNINSVVQE 178

Query: 178 PLTR--VNLANGTDIKVQVRYDGQNITVFVA-NMET-----PLLSEPIDLSEYLPEKVFV 229
            L+   + + +G D+   VRYDG+N++V+V+ N+E       + S  IDL  YLPE V+V
Sbjct: 179 SLSGRGIKIDSGVDLTAHVRYDGKNLSVYVSRNLEVFEQRNLVFSRAIDLLAYLPETVYV 238

Query: 230 GFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGV--AFYCWRRYR 287
           GF+AST + T+LNCV+SW F+GS+I GD     + I + +  VV++     A Y   R +
Sbjct: 239 GFTASTSNFTELNCVRSWRFEGSEIDGDGNMLWLWITIPIVFVVVIGAFLGALYLRSRSK 298

Query: 288 ARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAV 347
           A E + DIE  ++     P+KF+L+ELK+ATGNF  +NKLG+GGFG V+KG W+ ++IAV
Sbjct: 299 AGETNPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRDIAV 358

Query: 348 KRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           KRVSE S QGKQEFIAE+TTIG+L HRNLVKL+GWCYER ++LLVYEYMPNGSLDK++F 
Sbjct: 359 KRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFL 418

Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
           +  +       L WE R ++I G SQAL+YLHNG EKR+LHRDIK+SN+MLDS+FNA+LG
Sbjct: 419 ENKSRS----NLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLG 474

Query: 468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           DFGLAR IQ++  THHSTKEIAGTPGYMAPE+FL GRAT+ETD+YAFGVL+LEV  G+KP
Sbjct: 475 DFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP 534

Query: 528 GN---QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
                +  Q++YNNSIV+WLWEL R   I+DAAD  +G  F ++EM+ VL+LGLACCHPN
Sbjct: 535 CYVLVKENQSNYNNSIVNWLWELYRNETIMDAADPGMGSLFDKEEMKSVLLLGLACCHPN 594

Query: 585 PHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           P+ RPSMKTVL+VL+GE  PP +P ERP+FVWPAMPPSF + DY+ TGSQ++  ++LTGR
Sbjct: 595 PNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDIDYSLTGSQINSLTELTGR 654

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225460332|ref|XP_002280222.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5-like [Vitis vinifera]

 Score =  740 bits (1911), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/606 (60%), Positives = 460/606 (75%), Gaps = 13/606 (2%)

Query: 47  STVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQP 106
           S +A  AI VT D  G+PITN SG+A+YK  F+LW ++K   A+F+TTFVL I  +T   
Sbjct: 3   SEIAVDAIHVTPDFSGSPITNFSGQALYKRSFKLWSESKGT-ASFNTTFVLRITPRTDPG 61

Query: 107 GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGL 166
           GEGLAF++ G   LPENSEG+WLGIVN  TNG+ ++QIVA+EFDT+KSY +D+++NH+G+
Sbjct: 62  GEGLAFILTGRATLPENSEGKWLGIVNASTNGSAENQIVAVEFDTRKSYMEDLSNNHIGV 121

Query: 167 DVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVA-NMETPLLSEPIDLSEYLPE 225
           +VNSVYSI+Q  L+ +NL++GT I V+V+YDG+ +  FV   M+ P ++ PI+LS++LP+
Sbjct: 122 NVNSVYSIKQANLS-INLSSGTAITVKVQYDGKILRAFVGTQMKAPAIALPINLSDHLPQ 180

Query: 226 KVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYC--- 282
           KVFVGFSASTG+ TQLNCV+SW F GS +  D     V I  +VP  VL++GVAFY    
Sbjct: 181 KVFVGFSASTGNHTQLNCVRSWEFSGSSVDEDPDLLWVWI--MVPVTVLVSGVAFYFSWK 238

Query: 283 WRRYRARELDDD--IEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW 340
           W   +  E +DD  +E  I G++ AP+KFRLKELK AT NFN KN+LGKGGFGTVYKG  
Sbjct: 239 WNCGKQEEEEDDPRVEQQIQGSSTAPRKFRLKELKAATENFNSKNELGKGGFGTVYKGFL 298

Query: 341 RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS 400
           +NKE+AVKR S  S Q KQ+FIAEVTTI +L H+NLVKL+GWCYE+ + LL+YE+MPN S
Sbjct: 299 KNKEVAVKRFSRNSHQSKQDFIAEVTTISNLHHKNLVKLVGWCYEKRELLLIYEFMPNTS 358

Query: 401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS 460
           LDK IF  E++     +TLNWE R  +I G +QALDYLHNG EKRVLHRDIK+SNIMLDS
Sbjct: 359 LDKLIFCKESDV-ENRITLNWETRYLIICGVAQALDYLHNGCEKRVLHRDIKASNIMLDS 417

Query: 461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE 520
           +FNARLGDFGLAR IQ + +THHSTKEIAGTPGYMAPESF  GRA +ETD+YAFG+L+LE
Sbjct: 418 DFNARLGDFGLARIIQLSDQTHHSTKEIAGTPGYMAPESFHTGRAAVETDVYAFGILVLE 477

Query: 521 VACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLAC 580
           V CGRKPG+QS  N YNN IV W+WE  R+ RILD  D RL G F +++ E  L+L L+C
Sbjct: 478 VVCGRKPGDQSLNNKYNNGIVDWVWEYYRRQRILDVLDLRLNGVFHKEQTEYALMLALSC 537

Query: 581 CHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPP-SFVES-DYTHTGSQLDPF 638
           CHPNP+ RPSM+  L+VL+GE DPPV+P E+P FVWPA PP SF E  +Y  TG  L P 
Sbjct: 538 CHPNPYQRPSMRIALRVLTGEVDPPVIPIEKPPFVWPATPPDSFREDLEYPPTGGLLSPP 597

Query: 639 SDLTGR 644
           S+L GR
Sbjct: 598 SELIGR 603

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240142|ref|NP_196292.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana] gi|75333788|sp|Q9FG33.1|LRKS5_ARATH RecName: Full=Probable L-type lectin-domain containing receptor kinase S.5; Short=LecRK-S.5; Flags: Precursor gi|9759302|dbj|BAB09808.1| lectin-like protein kinase [Arabidopsis thaliana] gi|332003674|gb|AED91057.1| concanavalin A-like lectin kinase-like protein [Arabidopsis thaliana]

 Score =  736 bits (1900), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/660 (55%), Positives = 477/660 (72%), Gaps = 24/660 (3%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
           M FSL  K L L  ++      QV  L F+F  F   N  EL  DNS +   AIQVT DV
Sbjct: 1   MRFSLAWKLLFL--ILTCKIETQVKCLKFDFPGFNVSNELELIRDNSYIVFGAIQVTPDV 58

Query: 61  RGAP---ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN 117
            G P   I NQ+GRA+YK  F+LW  +K+  ATF+TTFV+NI N+T   GEGLAFV+   
Sbjct: 59  TGGPGGTIANQAGRALYKKPFRLWSKHKS--ATFNTTFVINISNKTDPGGEGLAFVLTPE 116

Query: 118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQV 177
           +  P+NS G WLG+VN  TN  N+S+IV++EFDT+KS+  D++ NHV L+VN++ S+ Q 
Sbjct: 117 ETAPQNSSGMWLGMVNERTNRNNESRIVSVEFDTRKSHSDDLDGNHVALNVNNINSVVQE 176

Query: 178 PLTR--VNLANGTDIKVQVRYDGQNITVFVA------NMETPLLSEPIDLSEYLPEKVFV 229
            L+   + + +G D+   VRYDG+N++V+V+           + S  IDLS YLPE V+V
Sbjct: 177 SLSGRGIKIDSGLDLTAHVRYDGKNLSVYVSRNLDVFEQRNLVFSRAIDLSAYLPETVYV 236

Query: 230 GFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGV--AFYCWRRYR 287
           GF+AST + T+LNCV+SW+F+G  I GD     + I + +  +V +     A Y   R +
Sbjct: 237 GFTASTSNFTELNCVRSWSFEGLKIDGDGNMLWLWITIPIVFIVGIGAFLGALYLRSRSK 296

Query: 288 ARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAV 347
           A E + DIE  ++     P+KF+L+ELK+ATGNF  +NKLG+GGFG V+KG W+ ++IAV
Sbjct: 297 AGETNPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRDIAV 356

Query: 348 KRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           KRVSE S QGKQEFIAE+TTIG+L HRNLVKL+GWCYER ++LLVYEYMPNGSLDK++F 
Sbjct: 357 KRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFL 416

Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
           ++ +       L WE R ++I G SQAL+YLHNG EKR+LHRDIK+SN+MLDS+FNA+LG
Sbjct: 417 EDKSRS----NLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLG 472

Query: 468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           DFGLAR IQ++  THHSTKEIAGTPGYMAPE+FL GRAT+ETD+YAFGVL+LEV  G+KP
Sbjct: 473 DFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP 532

Query: 528 GN---QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
                +  QN+YNNSIV+WLWEL R G I DAAD  +G  F ++EM+ VL+LGLACCHPN
Sbjct: 533 SYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPN 592

Query: 585 PHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
           P+ RPSMKTVL+VL+GE  PP +P ERP+FVWPAMPPSF + DY+ TGSQ++  ++LTGR
Sbjct: 593 PNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDIDYSLTGSQINSLTELTGR 652

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498420|ref|XP_003518050.1| PREDICTED: probable L-type lectin-domain containing receptor kinase S.5-like [Glycine max]

 Score =  731 bits (1887), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/669 (55%), Positives = 490/669 (73%), Gaps = 26/669 (3%)

Query: 1   MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYD 59
           M    + K+ + + +       +V+  +FNF +F + N +EL    NS +   AIQVT D
Sbjct: 1   MHLPWLVKYQLASTIFIIITLTKVTCFYFNFPTFQKDNESELLLSKNSQIYFDAIQVTPD 60

Query: 60  VRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKD 119
           +RG PI + SGRA YK  ++LW   KN  A+F+TTFVLNI  +T   GEGLAF++  +  
Sbjct: 61  IRG-PIQDYSGRAFYKKPYKLWNKKKNQIASFNTTFVLNIKPETTPGGEGLAFILTSDTT 119

Query: 120 LPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           LP+NS G+WLGIVN  +NGT+Q+ I+A+EFDT+KS+ QD  DNHVG+++NS+ SI+QVPL
Sbjct: 120 LPQNSSGEWLGIVNATSNGTSQAGILAVEFDTRKSFSQDGPDNHVGVNINSINSIQQVPL 179

Query: 180 --TRVNLANGTDIKVQVRYDGQNITVFVA------NMETPLLSEPIDLSEYLPEKVFVGF 231
             T VN+++G ++  +++Y    ITVF +      +MET L+S P++LS YL E V++GF
Sbjct: 180 INTGVNVSSGINVTFKIQYLNDTITVFGSMTGFEESMETLLVSPPLNLSSYLHEVVYLGF 239

Query: 232 SASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVA-----FYCWRRY 286
           SAST + T+LNCV+SW F G DI  D     + + + VP V+++  +        CW+R 
Sbjct: 240 SASTSNYTELNCVRSWEFSGVDIADDDNKSLLWVYITVPIVIVIVIIGGMVIFLLCWQRK 299

Query: 287 RARELDDD----IEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN 342
           R  E  +D    IE  I  +++APKKF+L+E+ KATG F+P+NKLG+GGFGTVYKG+  N
Sbjct: 300 RHMERPEDAYPRIEDQIQYSSMAPKKFKLREITKATGGFSPQNKLGEGGFGTVYKGLLEN 359

Query: 343 KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD 402
           KE+AVKRVS+ SRQGKQEF+AEVTTIGSL HRNLVKL GWCYE+ + LLVYE+MP GSLD
Sbjct: 360 KEVAVKRVSKNSRQGKQEFVAEVTTIGSLHHRNLVKLTGWCYEKRELLLVYEFMPKGSLD 419

Query: 403 KFIFYDE-----TNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM 457
           K++F D+     T      +TLNWE R SVIHG +QALDYLHNG EKRVLHRDIK+SNIM
Sbjct: 420 KYLFGDKNFGNNTLEEGYSLTLNWETRHSVIHGVAQALDYLHNGCEKRVLHRDIKASNIM 479

Query: 458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
           LDS++NA+LGDFGLARTIQ+  +THHSTKEIAGTPGYMAPE+FL GRAT+ETD+YAFGVL
Sbjct: 480 LDSDYNAKLGDFGLARTIQQRNETHHSTKEIAGTPGYMAPETFLTGRATVETDVYAFGVL 539

Query: 518 ILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS-RLGGEFSEKEMECVLIL 576
           +LEV CGR+PG+   Q+ Y NSIV+W+W+L  KG+++ A D+     E  E+E+ECVL+L
Sbjct: 540 VLEVVCGRRPGSVYAQDDYKNSIVYWVWDLYGKGKVVGAVDAKLKKEEIKEEEVECVLVL 599

Query: 577 GLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVES-DYTHTGSQL 635
           GLACCHPNPH RPSM+TVLQVL+GEA PP +P ERP F+WPAMPPSF E+ D +     L
Sbjct: 600 GLACCHPNPHHRPSMRTVLQVLNGEATPPEVPKERPVFMWPAMPPSFKEAEDSSLVQGTL 659

Query: 636 DPFSDLTGR 644
            PF+++TGR
Sbjct: 660 APFTEITGR 668

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	644
TAIR|locus:2170224	652	AT5G06740 [Arabidopsis thalian	0.987	0.975	0.554	1.1e-190
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.495	0.468	0.473	1.7e-105
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.465	0.419	0.503	2.5e-104
TAIR|locus:2142499	651	AT5G10530 [Arabidopsis thalian	0.613	0.606	0.420	5.9e-101
TAIR|locus:2143528	711	AT5G03140 [Arabidopsis thalian	0.476	0.431	0.458	1.2e-98
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.486	0.467	0.495	1.4e-95
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.493	0.471	0.481	6.1e-95
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.537	0.513	0.459	1.3e-94
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.472	0.444	0.476	1.3e-94
TAIR|locus:2078337	664	AT3G45410 [Arabidopsis thalian	0.475	0.460	0.452	4.8e-93

TAIR|locus:2170224 AT5G06740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1848 (655.6 bits), Expect = 1.1e-190, P = 1.1e-190
 Identities = 366/660 (55%), Positives = 472/660 (71%)

Query:     1 MCFSLMAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDV 60
             M FSL  K L L  ++      QV  L F+F  F   N  EL  DNS +   AIQVT DV
Sbjct:     1 MRFSLAWKLLFL--ILTCKIETQVKCLKFDFPGFNVSNELELIRDNSYIVFGAIQVTPDV 58

Query:    61 RGAP---ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN 117
              G P   I NQ+GRA+YK  F+LW  +K+  ATF+TTFV+NI N+T   GEGLAFV+   
Sbjct:    59 TGGPGGTIANQAGRALYKKPFRLWSKHKS--ATFNTTFVINISNKTDPGGEGLAFVLTPE 116

Query:   118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQV 177
             +  P+NS G WLG+VN  TN  N+S+IV++EFDT+KS+  D++ NHV L+VN++ S+ Q 
Sbjct:   117 ETAPQNSSGMWLGMVNERTNRNNESRIVSVEFDTRKSHSDDLDGNHVALNVNNINSVVQE 176

Query:   178 PLTR--VNLANGTDIKVQVRYDGQNITVFVA-NMET-----PLLSEPIDLSEYLPEKVFV 229
              L+   + + +G D+   VRYDG+N++V+V+ N++       + S  IDLS YLPE V+V
Sbjct:   177 SLSGRGIKIDSGLDLTAHVRYDGKNLSVYVSRNLDVFEQRNLVFSRAIDLSAYLPETVYV 236

Query:   230 GFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRXXXXX--XXXXXXXXXXXXFYCWRRYR 287
             GF+AST + T+LNCV+SW+F+G  I GD                         Y   R +
Sbjct:   237 GFTASTSNFTELNCVRSWSFEGLKIDGDGNMLWLWITIPIVFIVGIGAFLGALYLRSRSK 296

Query:   288 ARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAV 347
             A E + DIE  ++     P+KF+L+ELK+ATGNF  +NKLG+GGFG V+KG W+ ++IAV
Sbjct:   297 AGETNPDIEAELDNCAANPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKWQGRDIAV 356

Query:   348 KRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
             KRVSE S QGKQEFIAE+TTIG+L HRNLVKL+GWCYER ++LLVYEYMPNGSLDK++F 
Sbjct:   357 KRVSEKSHQGKQEFIAEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFL 416

Query:   408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
             ++ +       L WE R ++I G SQAL+YLHNG EKR+LHRDIK+SN+MLDS+FNA+LG
Sbjct:   417 EDKSRS----NLTWETRKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLG 472

Query:   468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             DFGLAR IQ++  THHSTKEIAGTPGYMAPE+FL GRAT+ETD+YAFGVL+LEV  G+KP
Sbjct:   473 DFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLNGRATVETDVYAFGVLMLEVVSGKKP 532

Query:   528 GN---QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
                  +  QN+YNNSIV+WLWEL R G I DAAD  +G  F ++EM+ VL+LGLACCHPN
Sbjct:   533 SYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGNLFDKEEMKSVLLLGLACCHPN 592

Query:   585 PHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDLTGR 644
             P+ RPSMKTVL+VL+GE  PP +P ERP+FVWPAMPPSF + DY+ TGSQ++  ++LTGR
Sbjct:   593 PNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAMPPSFSDIDYSLTGSQINSLTELTGR 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 761 (272.9 bits), Expect = 1.7e-105, Sum P(2) = 1.7e-105
 Identities = 158/334 (47%), Positives = 225/334 (67%)

Query:   283 WRRYRA-RELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR 341
             W+  +A +EL  +   LI G     ++F  KEL  AT  F+    +G+G FG VY+ ++ 
Sbjct:   333 WKSVKAEKELKTE---LITGL----REFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFV 385

Query:   342 NKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG 399
             +     AVKR    S +GK EF+AE++ I  LRH+NLV+L GWC E+ + LLVYE+MPNG
Sbjct:   386 SSGTISAVKRSRHNSTEGKTEFLAELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNG 445

Query:   400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
             SLDK I Y E+ +G   V L+W  RL++  G + AL YLH+  E++V+HRDIK+SNIMLD
Sbjct:   446 SLDK-ILYQESQTGA--VALDWSHRLNIAIGLASALSYLHHECEQQVVHRDIKTSNIMLD 502

Query:   460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLIL 519
               FNARLGDFGLAR + E+ K+  ST   AGT GY+APE    G AT +TD +++GV+IL
Sbjct:   503 INFNARLGDFGLAR-LTEHDKSPVSTLT-AGTMGYLAPEYLQYGTATEKTDAFSYGVVIL 560

Query:   520 EVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLA 579
             EVACGR+P ++  ++    ++V W+W L  +GR+L+A D RL GEF E+ M+ +L++GL 
Sbjct:   561 EVACGRRPIDKEPESQKTVNLVDWVWRLHSEGRVLEAVDERLKGEFDEEMMKKLLLVGLK 620

Query:   580 CCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPS 613
             C HP+ + RPSM+ VLQ+L+ E +P  +P  +P+
Sbjct:   621 CAHPDSNERPSMRRVLQILNNEIEPSPVPKMKPT 654

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 2.5e-104, Sum P(2) = 2.5e-104
 Identities = 159/316 (50%), Positives = 215/316 (68%)

Query:   305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFI 362
             APK+F  KELK  T NFN    +G G FG VY+GI       +AVKR S +S+  K EF+
Sbjct:   360 APKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFL 419

Query:   363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
             +E++ IGSLRHRNLV+L GWC+E+ + LLVY+ MPNGSLDK +F           TL W+
Sbjct:   420 SELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF-------ESRFTLPWD 472

Query:   423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              R  ++ G + AL YLH   E +V+HRD+KSSNIMLD  FNA+LGDFGLAR I+ + K+ 
Sbjct:   473 HRKKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHD-KSP 531

Query:   483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG----NQSEQN-SYN 537
              +T   AGT GY+APE  L GRA+ +TD++++G ++LEV  GR+P     N    N   N
Sbjct:   532 EATVA-AGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVN 590

Query:   538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
              ++V W+W L ++G++  AADSRL G+F E EM  VL++GLAC HP+P  RP+M++V+Q+
Sbjct:   591 PNLVEWVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQM 650

Query:   598 LSGEADPPVLPPERPS 613
             L GEAD PV+P  RP+
Sbjct:   651 LIGEADVPVVPKSRPT 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)]

 Score = 775 (277.9 bits), Expect = 5.9e-101, Sum P(2) = 5.9e-101
 Identities = 178/423 (42%), Positives = 248/423 (58%)

Query:   208 METPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS----DIG---GDSKA 260
             +E   LS  IDLS+ LP +V +GFSA++G  T+ N + SW F  S    DI     D K 
Sbjct:   209 LENSSLSYIIDLSKVLPSEVTIGFSATSGGVTEGNRLLSWEFSSSLELIDIKKSQNDKKG 268

Query:   261 FRXXXXXXXXXXXXXXXXXFYCW-RRYRARELDDDIEGL--INGT---NLAPKKFRLKEL 314
                                   + +R + ++  ++ E L  IN        P+KF  K+L
Sbjct:   269 MIIGISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPRKFTYKDL 328

Query:   315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLR 372
               A  NF    KLG+GGFG VY+G   + +  +A+K+ +  S+QGK+EF+ EV  I SLR
Sbjct:   329 ASAANNFADDRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLR 388

Query:   373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
             HRNLV+LIGWC+E+ +FL++YE+MPNGSLD  +F  + +       L W  R  +  G +
Sbjct:   389 HRNLVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPH-------LAWHVRCKITLGLA 441

Query:   433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
              AL YLH   E+ V+HRDIK+SN+MLDS FNA+LGDFGLAR +   L     T  +AGT 
Sbjct:   442 SALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELGPQ--TTGLAGTF 499

Query:   493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN--QSEQNSYNNSIVHWLWELRRK 550
             GYMAPE    GRA+ E+D+Y+FGV+ LE+  GRK  +  Q       N +V  +W+L  K
Sbjct:   500 GYMAPEYISTGRASKESDVYSFGVVTLEIVTGRKSVDRRQGRVEPVTN-LVEKMWDLYGK 558

Query:   551 GRILDAADSRLG-GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
             G ++ A D +L  G F EK+ EC++I+GL C HP+ + RPS+K  +QVL+ EA  P LP 
Sbjct:   559 GEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPT 618

Query:   610 ERP 612
             + P
Sbjct:   619 KMP 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 1.2e-98, Sum P(2) = 1.2e-98
 Identities = 149/325 (45%), Positives = 215/325 (66%)

Query:   296 EGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSET 353
             E L +    +P++F  KELK AT  F+    +G G FGTVYKGI ++    IA+KR S  
Sbjct:   349 ESLASEIMKSPREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHI 408

Query:   354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
             S QG  EF++E++ IG+LRHRNL++L G+C E+ + LL+Y+ MPNGSLDK ++   T   
Sbjct:   409 S-QGNTEFLSELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPT--- 464

Query:   414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
                 TL W  R  ++ G + AL YLH   E +++HRD+K+SNIMLD+ FN +LGDFGLAR
Sbjct:   465 ----TLPWPHRRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLAR 520

Query:   474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
               + + K+  +T   AGT GY+APE  L GRAT +TD++++G ++LEV  GR+P  + E 
Sbjct:   521 QTEHD-KSPDATAA-AGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEP 578

Query:   534 N-----SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR 588
                      +S+V W+W L R+G++L A D RL  EF+ +EM  V+++GLAC  P+P  R
Sbjct:   579 EPGLRPGLRSSLVDWVWGLYREGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTR 637

Query:   589 PSMKTVLQVLSGEADPPVLPPERPS 613
             P+M++V+Q+L GEAD P +P  +PS
Sbjct:   638 PTMRSVVQILVGEADVPEVPIAKPS 662

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 1.4e-95, Sum P(2) = 1.4e-95
 Identities = 161/325 (49%), Positives = 214/325 (65%)

Query:   287 RARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKE 344
             R R+  +++E     T     + R K+L  AT  F  KN LG GGFG+VYKGI     KE
Sbjct:   318 RRRKFAEEVEDW--ETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKE 375

Query:   345 IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF 404
             IAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C  R + LLVY+YMPNGSLDK+
Sbjct:   376 IAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKY 435

Query:   405 IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA 464
             ++    NS P EVTL+W++R  VI+G + AL YLH   E+ V+HRD+K+SN++LD+E N 
Sbjct:   436 LY----NS-P-EVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNG 489

Query:   465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
             RLGDFGLA+       +   T  + GT GY+AP+    GRAT  TD++AFGVL+LEVACG
Sbjct:   490 RLGDFGLAQLCDHG--SDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACG 547

Query:   525 RKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
             R+P   + Q+     +V W++    +  ILDA D  LG E+ +KE+E VL LGL C H +
Sbjct:   548 RRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSD 607

Query:   585 PHLRPSMKTVLQVLSGEADPPVLPP 609
             P  RP+M+ VLQ L G+A  P L P
Sbjct:   608 PLARPTMRQVLQYLRGDAMLPDLSP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 6.1e-95, Sum P(2) = 6.1e-95
 Identities = 159/330 (48%), Positives = 209/330 (63%)

Query:   282 CWRRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR 341
             C+   R R+  +++E           +FR K+L  AT  F  K  LG GGFG+VYKG+  
Sbjct:   310 CYIVRRRRKFAEELEEWEK--EFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMP 367

Query:   342 NK--EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG 399
                 EIAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C  R + LLVY+YMPNG
Sbjct:   368 GTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNG 427

Query:   400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
             SLDK+++    N+ P EVTLNW++R+ VI G +  L YLH   E+ V+HRD+K+SN++LD
Sbjct:   428 SLDKYLY----NT-P-EVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLD 481

Query:   460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLIL 519
              E N RLGDFGLAR       +   T  + GT GY+APE    GRAT+ TD++AFG  +L
Sbjct:   482 GELNGRLGDFGLARLYDHG--SDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLL 539

Query:   520 EVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLA 579
             EVACGR+P    ++      +V W++ L  KG IL A D  +G E  EKE+E VL LGL 
Sbjct:   540 EVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLL 599

Query:   580 CCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
             C H +P  RPSM+ VL  L G+A  P L P
Sbjct:   600 CSHSDPRARPSMRQVLHYLRGDAKLPELSP 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
 Identities = 166/361 (45%), Positives = 226/361 (62%)

Query:   287 RARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKE 344
             R R+  ++ E     T     + R K+L  AT  F  K+ LG GGFG VY+G+     KE
Sbjct:   323 RRRKFAEEFEDW--ETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKE 380

Query:   345 IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF 404
             IAVKRVS  SRQG +EF+AE+ +IG + HRNLV L+G+C  R + LLVY+YMPNGSLDK+
Sbjct:   381 IAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKY 440

Query:   405 IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA 464
             + YD     P EVTL+W++R +VI G +  L YLH   E+ V+HRDIK+SN++LD+E+N 
Sbjct:   441 L-YD----CP-EVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNG 494

Query:   465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
             RLGDFGLAR       +   T  + GT GY+AP+    GRAT  TD++AFGVL+LEVACG
Sbjct:   495 RLGDFGLARLCDHG--SDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACG 552

Query:   525 RKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
             R+P     ++  +  +V  ++    +G ILDA D  LG  + ++E+E VL LGL C H +
Sbjct:   553 RRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSD 612

Query:   585 PHLRPSMKTVLQVLSGEADPPVLPPE--RPSFVWPAMPPSFVESDYTHTGSQLDPFSDLT 642
             P +RP+M+ VLQ L G+A  P L P   R S     M   F ES    +GS +  +S ++
Sbjct:   613 PQVRPTMRQVLQYLRGDATLPDLSPLDFRGSGKMLGMNHRFSESCTFSSGSSI-AYSIVS 671

Query:   643 G 643
             G
Sbjct:   672 G 672

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
 Identities = 150/315 (47%), Positives = 205/315 (65%)

Query:   303 NLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQE 360
             +  P +F  +ELKKAT  F  K  LG GGFG VYKG     +  +AVKR+S  SRQG +E
Sbjct:   328 DFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVRE 387

Query:   361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
             F++EV++IG LRHRNLV+L+GWC  R D LLVY++MPNGSLD ++F DE    P EV L 
Sbjct:   388 FMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLF-DEN---P-EVILT 442

Query:   421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
             W++R  +I G +  L YLH G E+ V+HRDIK++N++LDSE N R+GDFGLA+ + E+  
Sbjct:   443 WKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAK-LYEHGS 501

Query:   481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
                +T+ + GT GY+APE    G+ T  TD+YAFG ++LEVACGR+P   S        +
Sbjct:   502 DPGATR-VVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPE-ELVM 559

Query:   541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             V W+W   + G I D  D RL GEF E+E+  V+ LGL C + +P +RP+M+ V+  L  
Sbjct:   560 VDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEK 619

Query:   601 EADPPVLPPERPSFV 615
             +   P + P  P F+
Sbjct:   620 QFPSPEVVPA-PDFL 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078337 AT3G45410 [Arabidopsis thaliana (taxid:3702)]

 Score = 686 (246.5 bits), Expect = 4.8e-93, Sum P(2) = 4.8e-93
 Identities = 144/318 (45%), Positives = 203/318 (63%)

Query:   306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQEFIAE 364
             P +F  K L KAT  F    ++GKGGFG VYKG +   + IAVKR+S  + QG ++F+AE
Sbjct:   327 PHRFSYKSLYKATNGFRKDCRVGKGGFGEVYKGTLPGGRHIAVKRLSHDAEQGMKQFVAE 386

Query:   365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
             V T+G+L+HRNLV L+G+C  + + LLV EYMPNGSLD+++F+ E N  P     +W +R
Sbjct:   387 VVTMGNLQHRNLVPLLGYCRRKCELLLVSEYMPNGSLDQYLFH-EGNPSP-----SWYQR 440

Query:   425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +S++   + AL YLH G+++ VLHRDIK+SN+MLDSEFN RLGDFG+A+       T+ S
Sbjct:   441 ISILKDIASALSYLHTGTKQVVLHRDIKASNVMLDSEFNGRLGDFGMAKFHDRG--TNLS 498

Query:   485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
                  GT GYMAPE   +G  +++TD+YAFG  +LEV CGR+P  + E       +V W+
Sbjct:   499 ATAAVGTIGYMAPELITMG-TSMKTDVYAFGAFLLEVICGRRPV-EPELPVGKQYLVKWV 556

Query:   545 WELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             +E  ++  +    D RLG EF  +E+E VL LGL C +  P  RP+M+ V+Q L+ +   
Sbjct:   557 YECWKEACLFKTRDPRLGVEFLPEEVEMVLKLGLLCTNAMPESRPAMEQVVQYLNQDLPL 616

Query:   605 PVLPPERPSFVWPAMPPS 622
             P+  P  P  +   MP S
Sbjct:   617 PIFSPSTPG-IGAFMPVS 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0071369 "cellular response to ethylene stimulus" evidence=IEP

GO:0071472 "cellular response to salt stress" evidence=IEP

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010043 "response to zinc ion" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FG33	LRKS5_ARATH	2, ., 7, ., 1, 1, ., 1	0.5575	0.9875	0.9754	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	644
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	5e-76
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	9e-64
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-47
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-41
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-33
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-28
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-27
cd01951	223	cd01951, lectin_L-type, legume lectins	3e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-22
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd07308	218	cd07308, lectin_leg-like, legume-like lectins: ERG	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.003

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  242 bits (620), Expect = 5e-76
 Identities = 88/236 (37%), Positives = 133/236 (56%), Gaps = 17/236 (7%)

Query: 27  LHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           L FNF  F+    N L+   ++T+ +  A+Q+T         +  GRA+Y    +LW   
Sbjct: 1   LSFNFNGFSSDQSN-LTLQGDATISSNGALQLT---NDTSPASSVGRALYSKPVRLWDST 56

Query: 85  KNVKATFSTTFVLNILNQTAQ-PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
               A+FST+F  +I        G+GLAF +A    LP  S G +LG+ N   NG + + 
Sbjct: 57  TGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNH 116

Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVN--LANGTDIKVQVRYDG-- 198
           IVA+EFDT ++ E  D +DNHVG+DVNS+ S++          L +G  ++  + YD   
Sbjct: 117 IVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSS 176

Query: 199 QNITVFVA-----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++V +A       + PLLS P+DLS+ LPE+V+VGFSASTG  T+L+ + SW+F
Sbjct: 177 KRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSF 232

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  210 bits (536), Expect = 9e-64
 Identities = 91/237 (38%), Positives = 137/237 (57%), Gaps = 19/237 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
           S++ FN+  F   N + L+   ++TV  +  +Q+T         N +GRA+Y    +LW 
Sbjct: 1   STVSFNYNGF--SNVSNLTLQGDATVLPNGLLQLTNVT-----NNSAGRALYSKPIRLWD 53

Query: 83  DNKNVKATFSTTFVLNI--LNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
            +    A+FST+FV  I  + ++   G+GLAF +A +   P  S G +LG+ N   NG +
Sbjct: 54  SSTGKVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNS 113

Query: 141 QSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPL--TRVNLANGTDIKVQVRYD 197
            + IVA+EFDT  + E  DI+DNHVG+DVNS+ S+         ++L +G  I+V + YD
Sbjct: 114 SNHIVAVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESASFVPLDLNSGKPIQVWIDYD 173

Query: 198 G--QNITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           G  + ++V +A    P   LLS  +DLS  LPE V+VGFSASTG  T+ + V SW+F
Sbjct: 174 GSSKRLSVTLAYPNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSF 230

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  180 bits (460), Expect = 2e-52
 Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 32/277 (11%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           KLG G FGTVYK   +   K +AVK +       +  Q    E+  +  L H N+V+LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              ++    LV EY   G L  ++             L+ ++   +     + L+YLH  
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR--------GGPLSEDEAKKIALQILRGLEYLH-- 115

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
               ++HRD+K  NI+LD     ++ DFGLA+ +   LK+  S     GTP YMAPE  L
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMAPEVLL 171

Query: 502 VGR-ATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDAADS 559
            G     + D+++ GV++ E+  G+ P   ++  +         L  +RR        D 
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ--------LQLIRRILGPPLEFDE 223

Query: 560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
                 SE   E   ++   C + +P  RP+ + +LQ
Sbjct: 224 PKWSSGSE---EAKDLIK-KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (449), Expect = 8e-51
 Identities = 82/289 (28%), Positives = 135/289 (46%), Gaps = 52/289 (17%)

Query: 326 KLGKGGFGTVYKGIWRNK------EIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           KLG+G FG VYKG  + K      E+AVK +  + S Q  +EF+ E   +  L H N+VK
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L+G C E    ++V EYMP G L  ++             L+    LS     ++ ++YL
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYL------RKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAP 497
                K  +HRD+ + N ++      ++ DFGL+R + ++        ++   P  +MAP
Sbjct: 120 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---PIRWMAP 173

Query: 498 ESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGR 552
           ES   G+ T ++D+++FGVL+ E+   G +P        Y    N  ++ +L    +KG 
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--------YPGMSNAEVLEYL----KKGY 221

Query: 553 ILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            L             K   C   +  L L C   +P  RP+   ++++L
Sbjct: 222 RL------------PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (442), Expect = 2e-50
 Identities = 68/199 (34%), Positives = 107/199 (53%), Gaps = 18/199 (9%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           LG+GGFGTVY    +   K++A+K +  E S    +E + E+  +  L H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            + +   LV EY   GSL   +   + N G     L+ ++ L ++    + L+YLH    
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGK----LSEDEILRILLQILEGLEYLH---S 110

Query: 444 KRVLHRDIKSSNIMLDS-EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL- 501
             ++HRD+K  NI+LDS     +L DFGL++ +  +     +   I GTP YMAPE  L 
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT---IVGTPAYMAPEVLLG 167

Query: 502 VGRATIETDIYAFGVLILE 520
            G  + ++DI++ GV++ E
Sbjct: 168 KGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  174 bits (445), Expect = 3e-50
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 50/288 (17%)

Query: 326 KLGKGGFGTVYKGIWR------NKEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVK 378
           KLG+G FG VYKG  +        ++AVK + E  S + ++EF+ E + +  L H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L+G C +     +V EYMP G L  F+     +       L  +  L +    ++ ++YL
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEK----LTLKDLLQMALQIAKGMEYL 118

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ--ENLKTHHSTKE-IAGTPGYM 495
                K  +HRD+ + N ++      ++ DFGL+R I   +  +     K  I     +M
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WM 171

Query: 496 APESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSY----NNSIVHWLWELRRK 550
           APES   G+ T ++D+++FGVL+ E+   G +P        Y    N  ++  L      
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEEVLELL----ED 219

Query: 551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           G  L   ++         E+  ++   L C   +P  RP+   +++ L
Sbjct: 220 GYRLPRPEN------CPDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  174 bits (443), Expect = 5e-50
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 57/293 (19%)

Query: 324 KNKLGKGGFGTVYKGIWRNK------EIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNL 376
             KLG+G FG VYKG  + K      E+AVK +  + S Q  +EF+ E   +  L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           VKL+G C E     +V EYM  G L  ++     N       L+    LS     ++ ++
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRP----KLSLSDLLSFALQIARGME 116

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--- 493
           YL     K  +HRD+ + N ++      ++ DFGL+R +              G      
Sbjct: 117 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIR 168

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELR 548
           +MAPES   G+ T ++D+++FGVL+ E+   G +P        Y    N  ++ +L    
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEEVLEYL---- 216

Query: 549 RKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           + G  L             +   C   +  L L C   +P  RP+   ++++L
Sbjct: 217 KNGYRL------------PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  172 bits (438), Expect = 2e-49
 Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 48/287 (16%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +    KLG+G FG VY    +   K +A+K +  +  ++ ++  + E+  +  L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +L     +     LV EY   G L   +       E            ++    +     
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE------------DEARFYLRQILS 108

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL+YLH    K ++HRD+K  NI+LD + + +L DFGLAR +    K         GTP 
Sbjct: 109 ALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT----FVGTPE 161

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWELRRKG 551
           YMAPE  L        DI++ GV++ E+  G+ P  G+      +   I           
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK-IGKPKPPFPPPE 220

Query: 552 RIL--DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             +  +A D               LI        +P  R + +  LQ
Sbjct: 221 WDISPEAKD---------------LIRK--LLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (427), Expect = 1e-47
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 35/285 (12%)

Query: 325 NKLGKGGFGTVYKGIWRNK-----EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVK 378
            KLG+G FG VYKG  + K     E+AVK + E  S + +++F+ E   +  L H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           L+G C E     LV EYM  G L  ++         P + TL+ +  LS     ++ ++Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE---IAGTPGY 494
           L     K+ +HRD+ + N ++  +   ++ DFGL+R + ++      T     I     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           MAPES   G  T ++D+++FGVL+ E+   G  P        Y       + E  RKG  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------YPGLSNEEVLEYLRKGYR 225

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           L   +        ++    +  L L+C   +P  RP+   +++ L
Sbjct: 226 LPKPEY-----CPDE----LYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  154 bits (391), Expect = 9e-43
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 30/216 (13%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           F    K+GKGGFG VYK   +   KE+A+K +   S++ K++ I E+  +   +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 379 LIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGT 431
             G  Y + D L +V E+   GSL              ++  +  + L+      V    
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLK-------------DLLKSTNQTLTESQIAYVCKEL 107

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
            + L+YLH+     ++HRDIK++NI+L S+   +L DFGL+  + +    +     + GT
Sbjct: 108 LKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGT 160

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           P +MAPE         + DI++ G+  +E+A G+ P
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (379), Expect = 5e-41
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 22/211 (10%)

Query: 325 NKLGKGGFGTVYKGIWRN--KEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
             LG+G FG+VY  + ++  + +AVK   +S  S +  +    E+  + SL+H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 381 GWCYER-HDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS--VIHGTSQALD 436
           G   +   + L ++ EY+  GSL   +   +      E  +   ++ +  ++ G    L 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVI---RKYTRQILEG----LA 115

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH      ++HRDIK +NI++DS+   +L DFG A+ + +   T   T  + GTP +MA
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE-TGEGTGSVRGTPYWMA 171

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE           DI++ G  ++E+A G+ P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 2e-34
 Identities = 69/216 (31%), Positives = 113/216 (52%), Gaps = 26/216 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQ--EFIAEVTTIGSLRH 373
           N+   + +G+G FG VYKG+  N E    +A+K++S    + +     + E+  + +L+H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGL--NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH 58

Query: 374 RNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV-IHGT 431
            N+VK IG   E  D L ++ EY  NGSL + I       GP       E  ++V ++  
Sbjct: 59  PNIVKYIG-SIETSDSLYIILEYAENGSLRQII----KKFGP----FP-ESLVAVYVYQV 108

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
            Q L YLH   E+ V+HRDIK++NI+   +   +L DFG+A  + +          + GT
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV---SKDDASVVGT 162

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           P +MAPE   +  A+  +DI++ G  ++E+  G  P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (330), Expect = 2e-33
 Identities = 78/288 (27%), Positives = 129/288 (44%), Gaps = 25/288 (8%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRH-RN 375
           ++    KLG+G FG VY      K +A+K ++   E+  +  + F+ E+  + SL H  N
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +VKL  +  +     LV EY+  GSL+  +          +  L+  + L ++     AL
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLL-----KKIGRKGPLSESEALFILAQILSAL 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHS---TKEIAGT 491
           +YLH    K ++HRDIK  NI+LD +    +L DFGLA+ + +   T           GT
Sbjct: 115 EYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 492 PGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
           PGYMAPE  L   +  A+  +DI++ G+ + E+  G  P    + +S  +  +  + EL 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
               +            S+   +    L       +P  R S  + L 
Sbjct: 232 TP-SLASPLSPSNPELISKAASD----LLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  128 bits (323), Expect = 3e-33
 Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 34/281 (12%)

Query: 325 NKLGKGGFGTVYKGIWRN--KEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
             +GKG FGTV K   ++  K +  K +     + + KQ+ ++EV  +  L+H N+V+  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 381 GWCYER--HDFLLVYEYMPNGSLDKFI-FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
               +R      +V EY   G L + I    +      E     E    ++     AL  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE-----EFIWRILTQLLLALYE 120

Query: 438 LHNGSEK--RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            HN S+    VLHRD+K +NI LD+  N +LGDFGLA+ +  +       K   GTP YM
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYVGTPYYM 177

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PE         ++DI++ G LI E+     P     Q            +L  K  I +
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----------QLASK--IKE 224

Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
               R+   +S    E   ++  +  + +P  RPS + +LQ
Sbjct: 225 GKFRRIPYRYSS---ELNEVIK-SMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (321), Expect = 4e-33
 Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLV 377
             ++GKG FG VY    R K       +K +  S  S + +++ + EV  +  L H N++
Sbjct: 5   IKQIGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 378 KLIGWCYERHDFLL-VYEYMPNGSLDKFIFYDETNSG----PGEVTLNWEKRLSVIHGTS 432
           K     +E    L  V EY   G L + I   +        P E  L+W  +L +     
Sbjct: 63  KYYE-SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCL----- 114

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            AL YLH    +++LHRDIK  NI L S    +LGDFG+++ +   +      K + GTP
Sbjct: 115 -ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGTP 167

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
            Y++PE         ++DI++ G ++ E+   + P                  EL  K  
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----------ELALK-- 214

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           IL      +  ++S  E+   L+        +P  RPS+  +LQ
Sbjct: 215 ILKGQYPPIPSQYS-SELRN-LVSS--LLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  127 bits (321), Expect = 6e-33
 Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 37/284 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNL 376
           +      LG+G  G VYK       K  A+K++      + +++ + E+ T+ S     +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ--- 433
           VK  G  Y+  +  +V EYM  GSL   +                E  L+ I    Q   
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP---------EPVLAYI--ARQILK 110

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            LDYLH   ++ ++HRDIK SN++++S+   ++ DFG+++ ++  L   ++     GT  
Sbjct: 111 GLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT---FVGTVT 165

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           YM+PE       +   DI++ G+ +LE A G+ P     Q S+        +EL +   I
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--------FELMQA--I 215

Query: 554 LDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            D     L   EFS  E    +    AC   +P  RPS   +LQ
Sbjct: 216 CDGPPPSLPAEEFSP-EFRDFIS---ACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  124 bits (314), Expect = 8e-32
 Identities = 70/209 (33%), Positives = 108/209 (51%), Gaps = 26/209 (12%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G VYK   R   KE+A+K++     Q K+  I E+  +   +H N+V      
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD-S 83

Query: 384 YERHDFL-LVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLS-VIHGTSQALDYLHN 440
           Y   D L +V EYM  GSL D              V +N E +++ V     Q L+YLH+
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQNF--------VRMN-EPQIAYVCREVLQGLEYLHS 134

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              + V+HRDIKS NI+L  + + +L DFG A  + +     +S   + GTP +MAPE  
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS---VVGTPYWMAPE-- 186

Query: 501 LVGRA--TIETDIYAFGVLILEVACGRKP 527
           ++ R     + DI++ G++ +E+A G  P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 2e-30
 Identities = 71/281 (25%), Positives = 131/281 (46%), Gaps = 42/281 (14%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
              +GKG FG V  G +R +++AVK + + S    Q F+AE + + +LRH NLV+L+G  
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            + +   +V EYM  GSL   + Y  +    G   +   ++L       + ++YL    E
Sbjct: 70  LQGNPLYIVTEYMAKGSL---VDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---E 120

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLV 502
           K  +HRD+ + N+++  +  A++ DFGLA+   +         +    P  + APE+   
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-------DSGKLPVKWTAPEALRE 173

Query: 503 GRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL 561
            + + ++D+++FG+L+ E+ + GR P  +         +         KG  ++A +   
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE--------KGYRMEAPEG-- 223

Query: 562 GGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                     C   V  +   C   +P  RP+ K + + L+
Sbjct: 224 ----------CPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 9e-30
 Identities = 65/211 (30%), Positives = 115/211 (54%), Gaps = 24/211 (11%)

Query: 327 LGKGGFGTVYKGIWR-----NK-EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTVYKG+W       K  +A+K + E TS +  +E + E   + S+ H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 380 IGWCY-ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           +G C   +    L+ + MP G L  ++   + N G  +  LNW  +++      + + YL
Sbjct: 75  LGICLSSQV--QLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQIA------KGMSYL 125

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAP 497
               EKR++HRD+ + N+++ +  + ++ DFGLA+ +  + K +H+       P  +MA 
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG--GKVPIKWMAL 180

Query: 498 ESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           ES L    T ++D++++GV + E+   G KP
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 3e-29
 Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 22/208 (10%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQG---KQEFIAEVTTIGSLRHRNLVKLIG 381
           KLG G FG V+ G W    ++AVK    T + G    + F+ E   +  LRH  LV+L  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVK----TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C E     +V EYM  GSL  F+      SG G   L   + + +    ++ + YL   
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFL-----KSGEG-KKLRLPQLVDMAAQIAEGMAYLE-- 120

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
             +  +HRD+ + NI++      ++ DFGLAR I+++    ++ +E A  P  + APE+ 
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAA 176

Query: 501 LVGRATIETDIYAFGVLILE-VACGRKP 527
             GR TI++D+++FG+L+ E V  GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  115 bits (289), Expect = 1e-28
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 19/210 (9%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           F+   KLG+G +G+VYK I +   + +A+K V        QE I E++ +       +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDY 437
             G  ++  D  +V EY   GS+   +    TN      TL  E+ ++ I + T + L+Y
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNK-----TLT-EEEIAAILYQTLKGLEY 114

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH+    + +HRDIK+ NI+L+ E  A+L DFG++  + +   T      + GTP +MAP
Sbjct: 115 LHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTVIGTPFWMAP 168

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKP 527
           E         + DI++ G+  +E+A G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  114 bits (287), Expect = 2e-28
 Identities = 81/287 (28%), Positives = 135/287 (47%), Gaps = 33/287 (11%)

Query: 318 TGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
            GNF  + K+GKG F  VYK I     + +A+K+V        + +Q+ + E+  +  L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGP-GEVTLNWEKRLSVIHGT 431
           H N++K +    E ++  +V E    G L + I + +       E T+ W+  + +    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQL---- 115

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL+++H    KR++HRDIK +N+ + +    +LGD GL R         HS   + GT
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGT 169

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YM+PE         ++DI++ G L+ E+A  + P    + N         L+ L +K 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCKK- 219

Query: 552 RILDAADSRLGGE-FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
            I       L  + +SE+  + V      C +P+P  RP +  VLQV
Sbjct: 220 -IEKCDYPPLPADHYSEELRDLVSR----CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 325 NKLGKGGFGTVYKGIWRN------KEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
            +LG+G FG V    +        +++AVK ++     Q + +F  E+  + +L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 378 KLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           K  G C +       L+ EY+P+GSL  ++             +N ++ L       + +
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-------INLKRLLLFSSQICKGM 122

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG-Y 494
           DYL +   +R +HRD+ + NI+++SE   ++ DFGLA+ + E+ K ++  KE   +P  +
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYYYVKEPGESPIFW 178

Query: 495 MAPESFLVGRATIETDIYAFGVLILE 520
            APE     + +  +D+++FGV + E
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  113 bits (285), Expect = 3e-28
 Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 16/202 (7%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+  +  +AVK + E + + + EF+ E   +  ++H NLV+L+G
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++           V L    ++      S A++YL   
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYLE-- 121

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+    A  P  + APES 
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 177

Query: 501 LVGRATIETDIYAFGVLILEVA 522
              + +I++D++AFGVL+ E+A
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  113 bits (284), Expect = 4e-28
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           F  + KLG G FG V++G+W+N+  +A+K +       +Q+F  EV  +  LRH++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
              C       ++ E M  GSL  F+      S  G+V L     + +    ++ + YL 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFL-----RSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E+  +HRD+ + NI++  +   ++ DFGLAR I+E++      K     P  + APE
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK----IPYKWTAPE 174

Query: 499 SFLVGRATIETDIYAFGVLILEV 521
           +   G  + ++D+++FG+L+ E+
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  111 bits (280), Expect = 2e-27
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 30/276 (10%)

Query: 325 NKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
            +LG G  G V K       K +AVK +     +  Q+ I  E+  +       +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             Y   D  +  EYM  GSLDK     E      E  L    +++V     + L YLH  
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERIL---GKIAV--AVLKGLTYLH-- 117

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            + +++HRD+K SNI+++S    +L DFG++  +  +L      K   GT  YMAPE   
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSSYMAPERIQ 172

Query: 502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL 561
               ++++DI++ G+ ++E+A GR P        Y                I++    RL
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFP--------YPPENDPPDGIFELLQYIVNEPPPRL 224

Query: 562 -GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             G+FS    + V      C   +P  RPS K +L+
Sbjct: 225 PSGKFSPDFQDFV----NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  112 bits (281), Expect = 2e-27
 Identities = 78/304 (25%), Positives = 142/304 (46%), Gaps = 64/304 (21%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
           K +LG+G FG V+ G   + E       +AVK + E  S   +++F  E   + + +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI--------FYDETNSGPGEVTLNWEKRLSV 427
           +VK  G C E    ++V+EYM +G L+KF+        F    +S  GE+TL+      +
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS-----QL 124

Query: 428 IHGTSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +    Q    + YL   + +  +HRD+ + N ++  +   ++GDFG++R +       ++
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-------YT 174

Query: 485 TK--EIAGTP----GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYN 537
           T    + G       +M PES +  + T E+D+++FGV++ E+   G++P         +
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-----LS 229

Query: 538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTV 594
           N  V    E   +GR+L            ++   C   V  + L C   +P  R ++K +
Sbjct: 230 NEEV---IECITQGRLL------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274

Query: 595 LQVL 598
            + L
Sbjct: 275 HERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score =  109 bits (275), Expect = 3e-27
 Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 36/239 (15%)

Query: 29  FNFQSFTEQNRNELSFDNS---TVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNK 85
            NF +F+  N++    + S   T     +++T D       NQ+G A YK    L +D  
Sbjct: 3   LNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPD-----TGNQAGSAWYKTPIDLSKD-- 55

Query: 86  NVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKD--LPENSEGQWLGIVNGITNGTNQSQ 143
                F+TTF   +  +     +G+AFV+  +    L     G  LG   GI N      
Sbjct: 56  -----FTTTFKFYLGTKGTNGADGIAFVLQNDPAGALGGGGGGGGLGY-GGIGNS----- 104

Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVY--SIRQVPLTRVNLANGTDI----KVQVRY 196
            VA+EFDT K+ +  D N NH+ +DVN     +     L   +L NGT +     V++ Y
Sbjct: 105 -VAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITY 163

Query: 197 DG--QNITVFVANMETPL---LSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFD 250
           D     +TV++ N  T     ++ P+DL +  P K + GF+ASTG  T L+ + +W+F 
Sbjct: 164 DPTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFT 222

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  110 bits (277), Expect = 4e-27
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 325 NKLGKGGFGTVYKGIW--RNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
             +G G    VY  I    N+++A+KR+  E  +    E   EV  +    H N+VK   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-N 440
                 +  LV  Y+  GSL   +       G  E  +      +V+    + L+YLH N
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII-----ATVLKEVLKGLEYLHSN 121

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL-KTHHSTKEIAGTPGYMAPES 499
           G     +HRDIK+ NI+L  + + ++ DFG++ ++ +   +T    K   GTP +MAPE 
Sbjct: 122 GQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 500 FLVGRA-TIETDIYAFGVLILEVACGRKPG 528
                    + DI++FG+  +E+A G  P 
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (276), Expect = 5e-27
 Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 43/280 (15%)

Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVS-----ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FG+VY+G+  +     AVK VS     +T ++  ++   E+  +  L+H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G   E  +  +  E +P GSL K     +  S P  V   + +++ +       L+YLH
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKL--LKKYGSFPEPVIRLYTRQILL------GLEYLH 119

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +   +  +HRDIK +NI++D+    +L DFG+A+ + E        K   G+P +MAPE 
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF----SFAKSFKGSPYWMAPEV 172

Query: 500 FL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
               G   +  DI++ G  +LE+A G+ P +Q E        V  ++++ R   +    D
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPD 225

Query: 559 --SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             S    +F  K           C   +P LRP+   +L+
Sbjct: 226 HLSDEAKDFILK-----------CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 34/275 (12%)

Query: 327 LGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           LG G FG V+ G WR K ++A+K + E +   + +FI E   +  L H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
           +    +V EYM NG L  ++       G     L  E  L +     +A++YL       
Sbjct: 71  QRPIFIVTEYMANGCLLNYL---RERKG----KLGTEWLLDMCSDVCEAMEYLE---SNG 120

Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N ++  +   ++ DFGLAR +   L   +++ +    P  +  PE F   R
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSR 177

Query: 505 ATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG 563
            + ++D+++FGVL+ EV + G+ P     +   N+ +V    E    G  L         
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMP----YERFSNSEVV----ESVSAGYRLYRPKL---- 225

Query: 564 EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                  E   I+   C H  P  RP+ K +L  L
Sbjct: 226 ----APTEVYTIMYS-CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 3e-26
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 23/212 (10%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRNL 376
           +    KLG+G +G VYK   +   + +A+K++  +   +G     + E++ +  L+H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS--VIHGTSQA 434
           VKL+   +      LV+EY     L K++   +   GP  ++ N  K +   ++ G    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGP--LSPNLIKSIMYQLLRG---- 110

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L Y H     R+LHRD+K  NI+++ +   +L DFGLAR     L+T+  T E+  T  Y
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVV-TLWY 164

Query: 495 MAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
            APE  L  +  +   DI++ G +  E+  G+
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  108 bits (271), Expect = 3e-26
 Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 54/296 (18%)

Query: 325 NKLGKGGFGTVYKGIWRNK-------EIAVKRVSETSRQGKQE-FIAEVTTIGSLRHRNL 376
             LG G FG VY+G++R +       ++AVK + E+  +  +  F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNWEKRLSVIHGTSQAL 435
           V+LIG  +ER    ++ E M  G L  F+   E    P   + L  +  L      ++  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNAR---LGDFGLARTI------QENLKTHHSTK 486
            YL    E   +HRDI + N +L  +   R   + DFG+AR I      ++  +     K
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +M PE+FL G  T +TD+++FGVL+ E+ + G  P        Y         
Sbjct: 187 -------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--------YPG------- 224

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
             R    +++      GG   +    C   V  +   C    P  RP+  T+L+ +
Sbjct: 225 --RTNQEVMEFVTG--GGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (270), Expect = 5e-26
 Identities = 78/292 (26%), Positives = 138/292 (47%), Gaps = 55/292 (18%)

Query: 327 LGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 381 GWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL---SVIHGTSQ-- 433
           G CY   R +  LV EY+P GSL  ++                 +RL    ++   SQ  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL-------------QKHRERLDHRKLLLYASQIC 118

Query: 434 -ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             ++YL     KR +HRD+ + NI+++SE   ++GDFGL + + ++ K ++  +E   +P
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESP 174

Query: 493 GY-MAPESFLVGRATIETDIYAFGVLILEV--ACGRKPGNQSE------QNSYNNSIVHW 543
            +  APES    + ++ +D+++FGV++ E+     +     +E       +     IV+ 
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMK 592
           L EL +    L A               C   +  +   C + +P  RPS  
Sbjct: 235 LIELLKNNGRLPAPPG------------CPAEIYAIMKECWNNDPSQRPSFS 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (268), Expect = 6e-26
 Identities = 71/225 (31%), Positives = 108/225 (48%), Gaps = 33/225 (14%)

Query: 325 NKLGKGGFGTVYKGIW--RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           NK+G G FG VY  +     + +AVK  R+ +   +  +E   E+  +  L+H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFY----DETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           G    R    +  EY   G+L++ + +    DE       V   +  +L         L 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE------HVIRVYTLQLLE------GLA 113

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST-KEIAGTPGYM 495
           YLH      ++HRDIK +NI LD     +LGDFG A  ++ N  T     + +AGTP YM
Sbjct: 114 YLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 496 APESFLV------GRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
           APE          GRA    DI++ G ++LE+A G++P ++ +  
Sbjct: 171 APEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 1e-25
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 53/223 (23%)

Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LGKG FG V              K +   K+  +K      R+  +  + E   +  + H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL--KKKKIIK------RKEVEHTLTERNILSRINH 52

Query: 374 RNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
             +VKL  + ++  + L LV EY P G L   +                 K        +
Sbjct: 53  PFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL----------------SKEGRFSEERA 95

Query: 433 Q--------ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +        AL+YLH+     +++RD+K  NI+LD++ + +L DFGLA+   E       
Sbjct: 96  RFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSR 149

Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           T    GTP Y+APE  L        D ++ GVL+ E+  G+ P
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 2e-25
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 29/215 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNK-----EIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVK 378
            +LG G FG+V KG++  K     E+AVK +  E    GK+EF+ E + +  L H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           LIG C +    +LV E  P G L K++             L       + H  +  + YL
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIP---VSDL-----KELAHQVAMGMAYL 111

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG----- 493
                K  +HRD+ + N++L +   A++ DFG++R +        S    A T G     
Sbjct: 112 E---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-----SDYYRATTAGRWPLK 163

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           + APE    G+ + ++D++++GV + E  + G KP
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (260), Expect = 1e-24
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 327 LGKGGFGTVYKG--IWRNKE-----IAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVK 378
           LG+G FG VYKG     N+      +A+K + E    + +QEF  E   +  L+H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVIHG 430
           L+G C +     +++EY+ +G L +F+  +  +S  G  +        L+    L +   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            +  ++YL   S    +HRD+ + N ++      ++ DFGL+R I     +    +  + 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY----SADYYRVQSK 185

Query: 491 TP---GYMAPESFLVGRATIETDIYAFGVLILEV 521
           +     +M PE+ L G+ T E+DI++FGV++ E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  103 bits (258), Expect = 1e-24
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 49/290 (16%)

Query: 320 NFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRN 375
           +F    KLGKG +G+VYK   +  N+  A+K V     S++ +++ + E+  + S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 376 LVKLIGWCYERHD-FLL------VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           ++      Y   + FL       V EY P G L K I   +           W   + ++
Sbjct: 61  II-----SY--KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
            G    L  LH   E+++LHRD+KS+NI+L +    ++GD G+++ +++N+      K  
Sbjct: 114 RG----LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-----AKTQ 161

Query: 489 AGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
            GTP YMAPE +  GR  + ++DI++ G L+ E+A    P                + +L
Sbjct: 162 IGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----------MQDL 209

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
           R K  +       +   +S+     +     +     P LRP+   +L  
Sbjct: 210 RYK--VQRGKYPPIPPIYSQDLQNFI----RSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 65/216 (30%), Positives = 118/216 (54%), Gaps = 21/216 (9%)

Query: 327 LGKGGFGTVYKGIWR---NKEI--AVKRVSETSRQGKQ--EFIAEVTTIGSLRHRNLVKL 379
           +G G FG V +G  +    KEI  A+K +   S   KQ  +F+ E + +G   H N+++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ EYM NGSLDKF+  ++     G+ T    + + ++ G +  + YL 
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFT--VGQLVGMLRGIASGMKYL- 122

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SE   +HRD+ + NI+++S    ++ DFGL+R + E+ +  ++TK       + APE+
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRWTAPEA 179

Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP-GNQSEQ 533
               + T  +D+++FG+++ EV + G +P  + S Q
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (259), Expect = 2e-24
 Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 46/237 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIA-EVTTIGSL-RH 373
           +F     +G+G F TV     +  NKE A+K + +    ++ K +++  E   +  L  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI---HG 430
             ++KL     +  +   V EY PNG L ++I                   L        
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--------------RKYGSLDEKCTRFY 107

Query: 431 TSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            ++   AL+YLH+   K ++HRD+K  NI+LD + + ++ DFG A+ +  N     +  +
Sbjct: 108 AAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 488 IA-----------------GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                              GT  Y++PE      A   +D++A G +I ++  G+ P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  102 bits (255), Expect = 2e-24
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 36/274 (13%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V  G WR + ++A+K + E S   + EFI E   +  L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           ++    +V EYM NG L  ++   E         L     L +     + + YL +   K
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQL-----LEMCKDVCEGMAYLES---K 119

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
           + +HRD+ + N ++D +   ++ DFGL+R +   L   +++   +  P  +  PE  L  
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYS 176

Query: 504 RATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNS-IVHWLWELRRKGRILDAADSRL 561
           + + ++D++AFGVL+ EV + G+ P        +NNS  V  + +  R  R   A++   
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMP-----YERFNNSETVEKVSQGLRLYRPHLASEK-- 229

Query: 562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
                      V  +  +C H     RP+ + +L
Sbjct: 230 -----------VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (255), Expect = 3e-24
 Identities = 63/212 (29%), Positives = 112/212 (52%), Gaps = 16/212 (7%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEI-AVKRV--SETSRQGKQEFIAEVTTIGSLRHRN 375
           +F   NK+GKG FG V+K + + +K + A+K++  S+ +R+ ++E I E   +  L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +++      ++    +V EY  NG L K +        P +    W   + ++ G    L
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPED--QVWRFFIQILLG----L 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            +LH+   K++LHRDIKS N+ LD+  N ++GD G+A+ + +N    +    I GTP Y+
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYL 168

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +PE         ++D++A GV++ E   G+ P
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  102 bits (254), Expect = 4e-24
 Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 31/284 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHR 374
           NF  + K+G+G F  VY+   +   K +A+K+V        + +Q+ + E+  +  L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N++K +    E ++  +V E    G L + I Y +           W+  + +      A
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL----CSA 118

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           ++++H+   +RV+HRDIK +N+ + +    +LGD GL R         HS   + GTP Y
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGTPYY 172

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           M+PE         ++DI++ G L+ E+A  + P    + N +  S+           +I 
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--SLCQ---------KIE 221

Query: 555 DAADSRLGGE-FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
                 L  E +SEK  E V +    C +P+P  RP +  V Q+
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSM----CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (254), Expect = 4e-24
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)

Query: 326 KLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           KLG G FG V+ G +    ++A+K + + S    + F+AE   +  L+H  LV+L     
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA-VV 70

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+   +T  G   + L   K + +    ++ + ++     K
Sbjct: 71  TQEPIYIITEYMENGSLVDFL---KTPEG---IKLTINKLIDMAAQIAEGMAFIE---RK 121

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++      ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 178

Query: 504 RATIETDIYAFGVLILE-VACGRKP 527
             TI++D+++FG+L+ E V  GR P
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 6e-24
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+GKG FG VYKG+ +   E+AVK    T     K++F+ E   +    H N+VKLIG C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    +V E +P GSL  F+   +       +T+   K L +    +  ++YL +   
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK-----NRLTVK--KLLQMSLDAAAGMEYLES--- 111

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLV 502
           K  +HRD+ + N ++      ++ DFG++R  +E    +  +  +   P  + APE+   
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 503 GRATIETDIYAFGVLILEV 521
           GR T E+D++++G+L+ E 
Sbjct: 170 GRYTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  101 bits (253), Expect = 7e-24
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 28/216 (12%)

Query: 323 PKNKLGKGGFGTVYKGIWRNKE-----IAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNL 376
               +G+G FG VY+G++ + E     +AVK   + TS   +++F+ E   +    H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ--- 433
           VKLIG   E   ++ V E  P G L  ++   + N              S+I  + Q   
Sbjct: 70  VKLIGVITENPVWI-VMELAPLGELRSYL---QVNK-------YSLDLASLILYSYQLST 118

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP- 492
           AL YL +   KR +HRDI + N+++ S    +LGDFGL+R +++      S  ++   P 
Sbjct: 119 ALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL---PI 172

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
            +MAPES    R T  +D++ FGV + E+   G KP
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 327 LGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LG G FG VYK   +   +  A K +   S +  ++F+ E+  +   +H N+V L    +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
             +   ++ E+   G+LD  +   E   G  E  + +     V     +AL++LH+    
Sbjct: 73  YENKLWILIEFCDGGALDSIM--LELERGLTEPQIRY-----VCRQMLEALNFLHS---H 122

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR 504
           +V+HRD+K+ NI+L  + + +L DFG++   +  L+   +     GTP +MAPE  +V  
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPE--VVAC 177

Query: 505 ATIE-------TDIYAFGVLILEVACGRKP 527
            T +        DI++ G+ ++E+A    P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.9 bits (246), Expect = 4e-23
 Identities = 62/220 (28%), Positives = 112/220 (50%), Gaps = 23/220 (10%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           ++G G FG V+ G W  K ++A+K + E +   +++FI E   +  L H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           ER    LV+E+M +G L  ++       G      + E  L +     + + YL + +  
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL---RAQRG----KFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT-HHSTKEIAGTP-GYMAPESFLV 502
            V+HRD+ + N ++      ++ DFG+ R + ++  T    TK     P  + +PE F  
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK----FPVKWSSPEVFSF 175

Query: 503 GRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIV 541
            + + ++D+++FGVL+ EV + G+ P     +N  N+ +V
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTP----YENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.8 bits (246), Expect = 5e-23
 Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 21/213 (9%)

Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVS------ETSRQGKQEFIAEVTTIGSLRHRNLV 377
             LGKG +GTVY G+    + IAVK+V         + +  ++   EV  + SL+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           + +G C + +   +  E++P GS+   +  +     P  V   + K+  ++ G +    Y
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQ--ILDGVA----Y 117

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLKTHHST--KEIAGTPGY 494
           LHN     V+HRDIK +N+ML      +L DFG AR +    L   HS   K + GTP +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           MAPE         ++DI++ G  + E+A G+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 36/220 (16%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEF----IAEVTTIGSLR 372
           +    ++G+G +G VYK   RNK+    +A+K++       K+ F    I E+  +  LR
Sbjct: 1   YEKIAQIGEGTYGQVYKA--RNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLR 56

Query: 373 HRNLVKLIGWCYERH--DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           H N+V+L      +      +V+EYM +  L   +   E      ++     K       
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI-----KCY----- 105

Query: 431 TSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
             Q    L YLH+     +LHRDIK SNI+++++   +L DFGLAR   +     ++ + 
Sbjct: 106 MKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162

Query: 488 IAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGR 525
           I  T  Y  PE  L+G  R   E D+++ G ++ E+  G+
Sbjct: 163 I--TLWYRPPE-LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 46/280 (16%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
            +GKG FG VYK I +  N+ +A+K +  E +    ++   E+  +   R   + K  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHNG 441
             +     ++ EY   GS       D    G  +     E  ++ I       L+YLH  
Sbjct: 68  FLKGSKLWIIMEYCGGGSC-----LDLLKPGKLD-----ETYIAFILREVLLGLEYLH-- 115

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            E+  +HRDIK++NI+L  E + +L DFG++  +   +   ++     GTP +MAPE   
Sbjct: 116 -EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIK 171

Query: 502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL-----DA 556
                 + DI++ G+  +E+A G  P           S +H +       R+L     + 
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP----------LSDLHPM-------RVLFLIPKNN 214

Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             S  G +FS+   + V      C + +P  RPS K +L+
Sbjct: 215 PPSLEGNKFSKPFKDFV----SLCLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 16/207 (7%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
             KLG G FG V++G+W N   +AVK +   +   K +F+AE   +  LRH  L++L   
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAV 69

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C       +V E M  GSL +++             L   + + +    +  + YL    
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGR------ALKLPQLIDMAAQVASGMAYLE--- 120

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
            +  +HRD+ + N+++      ++ DFGLAR I+E++   +  +E A  P  + APE+ L
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAAL 177

Query: 502 VGRATIETDIYAFGVLILE-VACGRKP 527
             R +I++D+++FG+L+ E V  GR P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 327 LGKGGFGTVYKGIWRNKE-----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG+G FG+V +G     +     +AVK  ++   +    +EF++E   +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 380 IGWCYERHDF------LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           IG C+E          +++  +M +G L  F+ Y      P ++ L  +  L  +   + 
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIAL 124

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP- 492
            ++YL   S +  +HRD+ + N ML  +    + DFGL++ I      ++    IA  P 
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIAKMPV 179

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVA 522
            ++A ES      T ++D++AFGV + E+A
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 56/209 (26%), Positives = 116/209 (55%), Gaps = 19/209 (9%)

Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V++GI +    KE+AV     +   T +Q +Q+F++E + +G   H N+++L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNIIRL 71

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ EYM NG+LDK++   +      ++       + ++ G +  + YL 
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-------VGMLRGIAAGMKYL- 123

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T        + APE+
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181

Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D+++FG+++ EV + G +P
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)

Query: 309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEF 361
            +  EL+K          LG G FGTV+KGIW  +       +A+K + + + RQ  QE 
Sbjct: 4   LKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
              +  +GSL H  +V+L+G C       LV +  P GSL   +     +  P +  LNW
Sbjct: 57  TDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNW 114

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
             +++      + + YL    E R++HR++ + NI+L S+   ++ DFG+A  +  + K 
Sbjct: 115 CVQIA------KGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
           +  + E      +MA ES L GR T ++D++++GV + E+
Sbjct: 166 YFYS-EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 82/309 (26%), Positives = 146/309 (47%), Gaps = 56/309 (18%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-------EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + + S   +++F  E   + +L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKRLSVI 428
           VK  G C E    ++V+EYM +G L+KF        +   E N  P E+T +  + L + 
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR-PAELTQS--QMLHIA 126

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH---HST 485
              +  + YL   + +  +HRD+ + N ++      ++GDFG++R +          H+ 
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWL 544
             I     +M PES +  + T E+D+++ GV++ E+   G++P  Q      NN ++   
Sbjct: 184 LPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVI--- 232

Query: 545 WELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMK---TVLQVL 598
            E   +GR+L            ++   C   V  L L C    PH+R ++K   ++LQ L
Sbjct: 233 -ECITQGRVL------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Query: 599 SGEADPPVL 607
           + +A P  L
Sbjct: 280 A-KASPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 82/285 (28%), Positives = 131/285 (45%), Gaps = 52/285 (18%)

Query: 327 LGKGGFGTVYKGIW-----RNKEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +GKG FG VY G       +    AVK ++  T  +  ++F+ E   +    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 381 GWCYERHDF-LLVYEYMPNGSLDKFIFYDETNS------GPGEVTLNWEKRLSVIHGTSQ 433
           G C       L+V  YM +G L  FI  +  N       G G         L V  G   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG---------LQVAKG--- 110

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP- 492
            ++YL   + K+ +HRD+ + N MLD  F  ++ DFGLAR I +  K ++S     G   
Sbjct: 111 -MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGAKL 164

Query: 493 --GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR 549
              +MA ES    + T ++D+++FGVL+ E+   G  P    + +S++  I  +L + RR
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVDSFD--ITVYLLQGRR 220

Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV 594
                      L  E+    +  V+   L+C HP P +RP+   +
Sbjct: 221 ----------LLQPEYCPDPLYEVM---LSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 325 NKLGKGGFGTVYKGIWR-NKEI-AVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           ++LG+G  G+V K   +    I A+K ++       +++ + E+    S +   +VK  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 382 WCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL-SVIHGTSQALDYL 438
              +       +  EY   GSLD    Y +     G +    EK L  +     + L YL
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSI--YKKVKKRGGRIG---EKVLGKIAESVLKGLSYL 121

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H    ++++HRDIK SNI+L  +   +L DFG++  +  +L          GT  YMAPE
Sbjct: 122 H---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGTSFYMAPE 173

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKP 527
                  +I +D+++ G+ +LEVA  R P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.5 bits (237), Expect = 6e-22
 Identities = 61/198 (30%), Positives = 107/198 (54%), Gaps = 15/198 (7%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           KLG G FG V+ G + N  ++AVK +   +    Q F+ E   + +L+H  LV+L     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           +     ++ EYM  GSL  F+  DE     G+V L   K +      ++ + Y+     K
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEG----GKVLL--PKLIDFSAQIAEGMAYIE---RK 122

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++N+++      ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFG 179

Query: 504 RATIETDIYAFGVLILEV 521
             TI++D+++FG+L+ E+
Sbjct: 180 SFTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 96.3 bits (239), Expect = 7e-22
 Identities = 66/210 (31%), Positives = 118/210 (56%), Gaps = 22/210 (10%)

Query: 327 LGKGGFGTVYKGIWRNK------EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTVYKGIW  +       +A+K ++ET+  +   EF+ E   + S+ H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G C       LV + MP+G L  ++   + N G  ++ LNW  +++      + + YL 
Sbjct: 75  LGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIG-SQLLLNWCVQIA------KGMMYLE 126

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E+R++HRD+ + N+++ S  + ++ DFGLAR ++ + K +++  +    P  +MA E
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALE 181

Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKP 527
                + T ++D++++GV I E+   G KP
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 47/279 (16%)

Query: 326 KLGKGGFGTVYKGIWRNK-----EIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKL 379
           KLG G FG V +G W         +AVK +          +F+ E   + SL H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDE-TNSGPGEVTLN--WEKRLSVIHGTSQALD 436
            G     H  ++V E  P GSL      D       G   ++   +  + +    +  + 
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSL-----LDRLRKDALGHFLISTLCDYAVQI----ANGMR 111

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL     KR +HRD+ + NI+L S+   ++GDFGL R + +N + H+  +E    P  + 
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN-EDHYVMEEHLKVPFAWC 167

Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           APES      +  +D++ FGV + E+   G +P                 W      +IL
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-----------------WAGLSGSQIL 210

Query: 555 DAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPS 590
              D    GE  E+   C   +  + L C   NP  RP+
Sbjct: 211 KKIDKE--GERLERPEACPQDIYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 95.5 bits (237), Expect = 8e-22
 Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 30/280 (10%)

Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+GI +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P +   + +K + +    +  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL   +  + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 133 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 188

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIA---TLAEQPYQGMSNEQVLRFVME----GGLLD 241

Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
             D+     F    M         C   NP +RPS   ++
Sbjct: 242 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           KLG+G FG V+ G W     +A+K +   +    + F+ E   +  LRH  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           E   ++ V EYM  GSL  F+       G     L   + + +    +  + Y+      
Sbjct: 72  EEPIYI-VTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 121

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L G
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYG 178

Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
           R TI++D+++FG+L+ E+   GR P
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 94.7 bits (236), Expect = 9e-22
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 34/212 (16%)

Query: 328 GKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           GKG FG V     R   K  A+K +++     +   +  + E   +  L H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--- 65

Query: 383 CYE---RHDFLLVYEYMPNGSL----DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
            Y      +  LV + +  G L     + + + E      E    W   + +      AL
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE------EQVKFWICEIVL------AL 113

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           +YLH    K ++HRDIK  NI+LD + +  + DF +A      +     T   +GTPGYM
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIAT----KVTPDTLTTSTSGTPGYM 166

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP 527
           APE       ++  D ++ GV   E   G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEV-TTIGSLRHRNLVKLIGW 382
           +G+G FGTV K + +     +AVKR+  T  + +Q   + ++   + S     +VK  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 383 CYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
            +   D  +  E M + SLDKF    Y+   S   E  L       +   T +AL+YL  
Sbjct: 72  LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL-KTHHSTKEIAGTPGYMAPES 499
             E +++HRD+K SNI+LD   N +L DFG++  + +++ KT       AG   YMAPE 
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPER 178

Query: 500 FLVGRAT---IETDIYAFGVLILEVACGRKP 527
                     + +D+++ G+ + EVA G+ P
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)

Query: 321 FNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +    ++G G +G VYK   I   + +A+K +        +    E++ +   RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 379 LIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS-VIHGTSQALD 436
             G  Y R D L +V EY   GSL     Y  T  GP       E +++ V   T + L 
Sbjct: 65  YFG-SYLRRDKLWIVMEYCGGGSLQDI--YQVTR-GPLS-----ELQIAYVCRETLKGLA 115

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH   E   +HRDIK +NI+L  + + +L DFG++  +   +    S     GTP +MA
Sbjct: 116 YLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMA 169

Query: 497 PESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           PE   V   G    + DI+A G+  +E+A  + P
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 67/205 (32%), Positives = 107/205 (52%), Gaps = 17/205 (8%)

Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           KLG G FG V+ G W  N ++AVK +   +    + F+ E   +  LRH  LV+L     
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           E   ++ V EYM  GSL  F+       G G   L     + +    +  + Y+      
Sbjct: 72  EEPIYI-VTEYMSKGSLLDFL-----KDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RM 121

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++S+NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L G
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYG 178

Query: 504 RATIETDIYAFGVLILE-VACGRKP 527
           R TI++D+++FG+L+ E V  GR P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 24/206 (11%)

Query: 326 KLGKGGFGTVYKGIWRNKE---IAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +LG G FG VYK   +NKE   +A  +V ET S +  ++++ E+  + +  H  +VKL+G
Sbjct: 19  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             Y      ++ E+ P G++D  +   E + G  E  +       +     +AL YLH+ 
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQ-----VICRQMLEALQYLHS- 128

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
              +++HRD+K+ N++L  + + +L DFG++    +N+KT        GTP +MAPE  +
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 502 VGRAT-----IETDIYAFGVLILEVA 522
                      + DI++ G+ ++E+A
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 22/213 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHR 374
           NF    KLG+G + TVYKG  RN+     +A+K +   + +G     I E++ +  L+H 
Sbjct: 1   NFKQLEKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+V+L    +  +  +LV+EYM +  L K++   +T+   G +  N  K  S  +   + 
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVK--SFTYQLLKG 112

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + + H   E RVLHRD+K  N++++     +L DFGLAR     + T  +  E+  T  Y
Sbjct: 113 IAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN--EVV-TLWY 166

Query: 495 MAPESFLVGRATIET--DIYAFGVLILEVACGR 525
            AP+  L+G  T  T  DI++ G ++ E+  GR
Sbjct: 167 RAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 44/227 (19%)

Query: 327 LGKGGFGTVYKGIWRNKEI--AVKRVSETS--RQGKQEFI-AEVTTIGSLRHRNLVKLIG 381
           LG GGFG V     ++K    A+K V +      G+QE I +E   +    H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 382 WCYERHDFLLVYEYMP----------NGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIH 429
              ++    ++ EY             G  D++   FY         V L          
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY------IACVVL---------- 104

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
               A +YLHN   + +++RD+K  N++LDS    +L DFG A+ ++   KT        
Sbjct: 105 ----AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFC 153

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSY 536
           GTP Y+APE  L        D ++ G+L+ E+  GR P  + +++  
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)

Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G   E 
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 71

Query: 387 HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              L +V EYM  GSL  ++         G   L  +  L       +A++YL   +   
Sbjct: 72  KGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122

Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N+++  +  A++ DFGL        K   ST++    P  + APE+    +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKK 175

Query: 505 ATIETDIYAFGVLILEV-ACGRKP 527
            + ++D+++FG+L+ E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 43/296 (14%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE-------IAVKRVSETSRQGKQ-EFIAEVTTIGSL 371
           N      LG+G FG V+    +  E       + VK + +T  +  Q EF  E+     L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIF----YDETNSGPGEVTLNWEKRLSV 427
            H+N+V+L+G C E     ++ EY   G L +F+      DE    P    L+ ++++++
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP---PLSTKQKVAL 122

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
               +  +D+L N    R +HRD+ + N ++ S+   ++    L++ +  +         
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 488 IAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSY---NNSIVHW 543
           I   P  ++APE+      + ++D+++FGVL+ EV        Q E   Y   +  +++ 
Sbjct: 180 I---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF------TQGELPFYGLSDEEVLNR 230

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           L   + +  + +   SRL      K M         C   NP  RPS   ++  L 
Sbjct: 231 LQAGKLELPVPEGCPSRL-----YKLM-------TRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 36/279 (12%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           ++G+G FG V+ G  R  N  +AVK   ET     K +F+ E   +    H N+V+LIG 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C ++    +V E +  G    F+       GP    L  ++ + ++   +  ++YL +  
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL----RTEGP---RLKVKELIQMVENAAAGMEYLES-- 112

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
            K  +HRD+ + N ++  +   ++ DFG++R  +E    + ST  +   P  + APE+  
Sbjct: 113 -KHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDAADS 559
            GR + E+D+++FG+L+ E  + G  P  N S Q +          E   +G        
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR---------EAIEQG-------V 213

Query: 560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           RL     E   + V  L   C   +P  RPS  TV Q L
Sbjct: 214 RL--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)

Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           LGKG +G VY    R+      IA+K + E   +  Q    E+     L+HRN+V+ +G 
Sbjct: 16  LGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGP---GEVTLNWEKRLSVIHGTSQALDYLH 439
             E   F +  E +P GSL   +    +  GP    E T+ +  +  ++ G    L YLH
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTK-QILEG----LKYLH 125

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
              + +++HRDIK  N+++++     ++ DFG ++ +      +  T+   GT  YMAPE
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA---GINPCTETFTGTLQYMAPE 179

Query: 499 SFLVGRATI--ETDIYAFGVLILEVACGRKP 527
               G        DI++ G  I+E+A G+ P
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 35/279 (12%)

Query: 321 FNPKNKLGKGGFGTVYKGIW-RNKEI-AVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    ++GKG FG VYKGI  R KE+ A+K +  E +    ++   E+T +       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +  G   +     ++ EY+  GS       D    GP E T       +++    + LDY
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA-----LDLLKPGPLEETY----IATILREILKGLDY 116

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH+   +R +HRDIK++N++L  + + +L DFG+A  + +   T        GTP +MAP
Sbjct: 117 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 170

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P          NS +H    +R    I   +
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPP----------NSDLH---PMRVLFLIPKNS 217

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G++S+   E V     AC + +P  RP+ K +L+
Sbjct: 218 PPTLEGQYSKPFKEFV----EACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 73/289 (25%), Positives = 136/289 (47%), Gaps = 30/289 (10%)

Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL   + K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +      M
Sbjct: 133 AYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW-M 188

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 241

Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+        + +  ++ +   C   NP +RP+   ++ +L  +  P
Sbjct: 242 QPDN------CPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.7 bits (227), Expect = 1e-20
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV L     E
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              ++ V E+M  GSL  F+       G G+    + K   ++   +Q  D +       
Sbjct: 73  EPIYI-VTEFMGKGSLLDFL-----KEGDGK----YLKLPQLVDMAAQIADGMAYIERMN 122

Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 179

Query: 505 ATIETDIYAFGVLILE-VACGRKP 527
            TI++D+++FG+L+ E V  GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 67/230 (29%), Positives = 115/230 (50%), Gaps = 35/230 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + E S   +Q+F  E   +  L+H+++
Sbjct: 10  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF---------IFYDETNSGPGEVTLNWEKRLSV 427
           V+  G C E    L+V+EYM +G L++F         I     +  PG++TL   + L++
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG--QMLAI 127

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK- 486
               +  + YL   +    +HRD+ + N ++      ++GDFG++R I       +ST  
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-------YSTDY 177

Query: 487 -EIAGTP----GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQ 530
             + G       +M PES L  + T E+DI++FGV++ E+   G++P  Q
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 79/306 (25%), Positives = 145/306 (47%), Gaps = 47/306 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + + +   +++F  E   + +L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTL--------NWEKRLS-V 427
           VK  G C +    ++V+EYM +G L+KF+       GP  + L          E  LS +
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFL----RAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH---HS 484
           +H  SQ    +   + +  +HRD+ + N ++ +    ++GDFG++R +          H+
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHW 543
              I     +M PES +  + T E+D+++FGV++ E+   G++P  Q      +N+ V  
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-----LSNTEV-- 234

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS--GE 601
             E   +GR+L+            KE+  ++   L C    P  R ++K + ++L   G+
Sbjct: 235 -IECITQGRVLERP------RVCPKEVYDIM---LGCWQREPQQRLNIKEIYKILHALGK 284

Query: 602 ADPPVL 607
           A P  L
Sbjct: 285 ATPIYL 290

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 60/205 (29%), Positives = 115/205 (56%), Gaps = 17/205 (8%)

Query: 326 KLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           KLG G FG V+   + ++ ++AVK +   S    + F+AE   + +L+H  LVKL     
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ E+M  GSL  F+  DE +  P    +++  +++      + + ++    ++
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA------EGMAFIE---QR 121

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++ +    ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFG 178

Query: 504 RATIETDIYAFGVLILE-VACGRKP 527
             TI++D+++FG+L++E V  GR P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 38/282 (13%)

Query: 327 LGKGGFGTVYKGIWRNKE----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LG+G FG+V +G     +    +AVK  +++  +R   ++F++E   +    H N+++LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 381 GWCY---ERHDF---LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           G C    E   +   +++  +M +G L  F+ Y      P    L  +  +  +   +  
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMTDIASG 124

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-G 493
           ++YL   S K  +HRD+ + N ML+   N  + DFGL++ I      ++    IA  P  
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRIAKMPVK 179

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
           ++A ES      T ++D+++FGV + E+A  G+ P    E    N+ I  +   LR+  R
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----NSEIYDY---LRQGNR 232

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV 594
           +    D           ++ +  L  +C   NP  RPS +T+
Sbjct: 233 LKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 71/277 (25%), Positives = 130/277 (46%), Gaps = 34/277 (12%)

Query: 326 KLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G WR + ++A+K ++E +   +++FI E   +  L H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           ++    +V E+M NG L  ++       G     L+ +  LS+     + ++YL   S  
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL---RQRQG----KLSKDMLLSMCQDVCEGMEYLERNS-- 120

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD+ + N ++ S    ++ DFG+ R +   L   +++   A  P  +  PE F   
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 504 RATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLG 562
           + + ++D+++FGVL+ EV   G+ P     +   N  +V  +    R  R       +L 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPF----EKKSNYEVVEMISRGFRLYR------PKLA 226

Query: 563 GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                + M        +C H  P  RP+   +L+ ++
Sbjct: 227 SMTVYEVM-------YSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.7 bits (227), Expect = 3e-20
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 29/216 (13%)

Query: 321 FNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRN 375
           F+   ++G G FG VY  + +  ++ +A+K++S + +Q     Q+ I EV  +  LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 376 LVKLIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            ++  G CY R H   LV EY    + D      E +  P    L   +  +V HG  Q 
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLL----EVHKKP----LQEVEIAAVTHGALQG 127

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L YLH+     ++HRD+K+ NI+L      +LGDFG A  +              GTP +
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANXFVGTPYW 177

Query: 495 MAPESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           MAPE  L    G+   + D+++ G+  +E+A  RKP
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV------SETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           LG+G FG VY    +   +E+AVK+V       ET ++       E+  + +L+H  +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKNLQHERIVQ 68

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
             G   +     +  EYMP GS+   +       G    T+  +    ++ G      YL
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVE----YL 120

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H+     ++HRDIK +NI+ DS  N +LGDFG ++ +Q    +    K + GTP +M+PE
Sbjct: 121 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 499 SFL---VGRATIETDIYAFGVLILEVACGRKPGNQSE 532
                  GR   + D+++ G  ++E+   + P  + E
Sbjct: 178 VISGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 30/214 (14%)

Query: 327 LGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVK 378
           LG+G FG VY+G+ +          +A+K V+E +   ++ EF+ E + +      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFY----DETNSGPGEVTL----NWEKRLSVIHG 430
           L+G        L+V E M  G L  ++       E N G G  TL         ++    
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA---- 129

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
               + YL     K+ +HRD+ + N M+  +   ++GDFG+ R I E   T +  K   G
Sbjct: 130 --DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE---TDYYRKGGKG 181

Query: 491 T-P-GYMAPESFLVGRATIETDIYAFGVLILEVA 522
             P  +MAPES   G  T ++D+++FGV++ E+A
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 24/218 (11%)

Query: 327 LGKGGFGTVYKGIWRN--------KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLV 377
           LG G FG VY+G   +          +AVK + + +  Q K+EF+ E   + +  H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           KL+G C       ++ E M  G L  ++           + L  ++ L +    ++   Y
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLDVAKGCVY 121

Query: 438 LHNGSEKRVLHRDIKSSNIML-----DSEFNARLGDFGLARTIQENLKTHHSTKEIAG-- 490
           L    +   +HRD+ + N ++     D++   ++GDFGLAR I    K+ +  KE  G  
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEGEGLL 175

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              +MAPES L G+ T ++D+++FGVL+ E+   G++P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 62/210 (29%), Positives = 115/210 (54%), Gaps = 22/210 (10%)

Query: 327 LGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ + ++ +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G C       L+ + MP G L  ++   + N G  +  LNW  +++      + ++YL 
Sbjct: 75  LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIA------KGMNYLE 126

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E+R++HRD+ + N+++ +  + ++ DFGLA+ +  + K +H+  E    P  +MA E
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIKWMALE 181

Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           S L    T ++D++++GV + E+   G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 89.9 bits (223), Expect = 6e-20
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 25/228 (10%)

Query: 327 LGKGGFGTVYK-------GIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V          ++  K++  KR+ +  R+G +  + E   +  +  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 + D  LV   M  G L   I+  DE N G  E              T+Q +  L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP--------RACFYTAQIISGL 110

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
            +  ++R+++RD+K  N++LD++ N R+ D GLA  +++       TK  AGTPG+MAPE
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTKGYAGTPGFMAPE 167

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKP----GNQSEQNSYNNSIVH 542
                      D +A GV + E+   R P    G + E       I++
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 21/206 (10%)

Query: 326 KLGKGGFGTVYKGIWRNK----EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G  G V   I R K    ++AVK +    +Q ++    EV  +   +H+N+V++  
Sbjct: 28  KIGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +  ++ E++  G+L   +          +  LN E+  +V     QAL YLH+ 
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIV---------SQTRLNEEQIATVCESVLQALCYLHS- 135

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             + V+HRDIKS +I+L  +   +L DFG    I +++      K + GTP +MAPE   
Sbjct: 136 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVIS 190

Query: 502 VGRATIETDIYAFGVLILEVACGRKP 527
                 E DI++ G++++E+  G  P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 9e-20
 Identities = 77/298 (25%), Positives = 124/298 (41%), Gaps = 36/298 (12%)

Query: 327 LGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V     +        K++  KR+ +  R+G+Q  + E   +  +  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSL 58

Query: 380 IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ---AL 435
             + +E  D L LV   M  G L K+  Y+    G  E           I   +Q    L
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDL-KYHIYNVGEPGFPEA--------RAIFYAAQIICGL 108

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           ++LH    +R+++RD+K  N++LD   N R+ D GLA  ++   K        AGTPGYM
Sbjct: 109 EHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYM 161

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK--GRI 553
           APE           D +A G  + E+  GR P  Q ++      +     E+  +   + 
Sbjct: 162 APEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF 221

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV--LQVLSGEADPPVLPP 609
              A         +   + +   G +      H  P  K +   ++ +G  +PP +P 
Sbjct: 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH--PLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 36/212 (16%)

Query: 326 KLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +LG G FG VYK   +NKE     A K +   S +  ++++ E+  + S  H N+VKL+ 
Sbjct: 12  ELGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGTSQAL 435
             Y  ++  ++ E+   G++D              V L  E+ L+      V   T +AL
Sbjct: 70  AFYYENNLWILIEFCAGGAVDA-------------VMLELERPLTEPQIRVVCKQTLEAL 116

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           +YLH   E +++HRD+K+ NI+   + + +L DFG++    +N +T        GTP +M
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWM 170

Query: 496 APESFLVGRAT-----IETDIYAFGVLILEVA 522
           APE  +   +       + D+++ G+ ++E+A
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 33/286 (11%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRH 373
            NF  + K+G+G F  VY+   +     +A+K+V        + + + I E+  +  L H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGT 431
            N++K      E ++  +V E    G L + I  F  +    P +    +  +L      
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----- 116

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL+++H+   +RV+HRDIK +N+ + +    +LGD GL R         HS   + GT
Sbjct: 117 -SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGT 169

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YM+PE         ++DI++ G L+ E+A  + P    + N         L+ L +K 
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCKKI 220

Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
              D     L  +   +E+  ++ +   C +P+P  RP +  V  V
Sbjct: 221 EQCDYPP--LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 17/204 (8%)

Query: 326 KLGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  GTVY  I     +E+A+K+++   +  K+  I E+  +   +H N+V  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V EY+  GSL   +   ET    G++        +V     QAL++LH+   
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA-------AVCRECLQALEFLHS--- 133

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
            +V+HRDIKS NI+L  + + +L DFG    I    ++  ST  + GTP +MAPE     
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST--MVGTPYWMAPEVVTRK 190

Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               + DI++ G++ +E+  G  P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 24/219 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 1   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+  D +      + L   K  S +    Q
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASP--LSGIPLPLIK--SYLFQLLQ 111

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 112 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 165

Query: 494 YMAPESFLVGR-ATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L  +  +   DI++ G +  E+   R   PG+
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 44/281 (15%)

Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
            +G+G FG V +G +  +++AVK +        Q F+ E   +  L H+NLV+L+G    
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL- 69

Query: 386 RHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            H+ L +V E M  G+L  F+         G   ++  + L      ++ ++YL +   K
Sbjct: 70  -HNGLYIVMELMSKGNLVNFL------RTRGRALVSVIQLLQFSLDVAEGMEYLES---K 119

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR 504
           +++HRD+ + NI++  +  A++ DFGLAR     +       +      + APE+    +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKK 173

Query: 505 ATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG 563
            + ++D++++GVL+ EV + GR P        Y    +  + E   KG  ++  +     
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP--------YPKMSLKEVKECVEKGYRMEPPE----- 220

Query: 564 EFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGE 601
                   C   V +L  +C    P  RPS   + + L  E
Sbjct: 221 -------GCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 30/218 (13%)

Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRH---RNLVKLI 380
           +G+G +G VY+G  +   + +A+K ++ +T      +   EV  +  LR     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 381 GWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYL 438
           G  Y +   L ++ EY   GS+        T    G +    EK +SVI      AL Y+
Sbjct: 69  G-SYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIA---EKYISVIIREVLVALKYI 117

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI--AGTPGYMA 496
           H      V+HRDIK++NI++ +  N +L DFG+A  + +N     S+K     GTP +MA
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-----SSKRSTFVGTPYWMA 169

Query: 497 PESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQ 533
           PE    G+    + DI++ G+ I E+A G  P +  + 
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 57/211 (27%), Positives = 112/211 (53%), Gaps = 21/211 (9%)

Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V +G  +    +EI V     +   T +Q +++F++E + +G   H N++ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIHL 70

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ E+M NG+LD F+     N G   V     + + ++ G +  + YL 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVI----QLVGMLRGIAAGMKYL- 122

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT-P-GYMAP 497
             SE   +HRD+ + NI+++S    ++ DFGL+R ++++      T  + G  P  + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 498 ESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           E+    + T  +D++++G+++ EV + G +P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 70/226 (30%), Positives = 103/226 (45%), Gaps = 48/226 (21%)

Query: 320 NFNPKNKLGKGGFGTV----YKGIWRNKEIAVKRVS--ETSRQGKQE--FIAEVTTIGSL 371
           +F     LG G FG V    +KG    K  A+K +S  +  +  KQ    + E   + S+
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKL-KQVEHVLNEKRILQSI 58

Query: 372 RHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           RH  LV L G  ++    L LV EY+P G L    F            L    R      
Sbjct: 59  RHPFLVNLYG-SFQDDSNLYLVMEYVPGGEL----FS----------HLRKSGRFPEPVA 103

Query: 431 ---TSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
               +Q   AL+YLH+     +++RD+K  N++LDS+   ++ DFG A+ ++        
Sbjct: 104 RFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154

Query: 485 TKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           T  + GTP Y+APE  L    G+A    D +A G+LI E+  G  P
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 34/228 (14%)

Query: 323 PKNK------LGKGGFGTVYK----GIWRNKE---IAVKRVSE-TSRQGKQEFIAEVTTI 368
           P+N       +G+G FG V++    G+   +    +AVK + E  S   + +F  E   +
Sbjct: 3   PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 62

Query: 369 GSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI--------------FYDETNSGP 414
               H N+VKL+G C       L++EYM  G L++F+                     G 
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
             + L+  ++L +    +  + YL   SE++ +HRD+ + N ++      ++ DFGL+R 
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 475 IQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           I      ++   E    P  +M PES    R T E+D++A+GV++ E+
Sbjct: 180 IY--SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 35/279 (12%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    ++GKG FG V+KGI    +  +A+K +  E +    ++   E+T +       + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D   +GP     +  +  +++    + LDY
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA-----LDLLRAGP----FDEFQIATMLKEILKGLDY 116

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L  + + +L DFG+A  + +   T        GTP +MAP
Sbjct: 117 LH--SEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 170

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P          NS +H    +R    I    
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP----------NSDMH---PMRVLFLIPKNN 217

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L GEFS+   E +     AC + +P  RP+ K +L+
Sbjct: 218 PPTLTGEFSKPFKEFI----DACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 14/196 (7%)

Query: 327 LGKGGFGTVYKGIWRNK-EIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LGKG FG V+KG  ++K  +AVK   E   Q  K +F++E   +    H N+VKLIG C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           +R    +V E +P G    F+          E+      + ++    +  + YL +   K
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFAL--DAAAGMAYLES---K 112

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR 504
             +HRD+ + N ++      ++ DFG++R   + + +    K+I     + APE+   GR
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGR 170

Query: 505 ATIETDIYAFGVLILE 520
            + E+D++++G+L+ E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 70/211 (33%), Positives = 105/211 (49%), Gaps = 29/211 (13%)

Query: 326 KLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRNLVKLI 380
           ++G G FG VY  + +  N+ +A+K++S + +Q     Q+ I EV  +  LRH N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 381 GWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G CY R H   LV EY    + D      E +  P    L   +  ++ HG  Q L YLH
Sbjct: 82  G-CYLREHTAWLVMEYCLGSASDIL----EVHKKP----LQEVEIAAICHGALQGLAYLH 132

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S +R+ HRDIK+ NI+L      +L DFG A  +              GTP +MAPE 
Sbjct: 133 --SHERI-HRDIKAGNILLTEPGTVKLADFGSASLVS-------PANSFVGTPYWMAPEV 182

Query: 500 FLV---GRATIETDIYAFGVLILEVACGRKP 527
            L    G+   + D+++ G+  +E+A  RKP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 64/216 (29%), Positives = 116/216 (53%), Gaps = 27/216 (12%)

Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRV-----SETSRQGKQEFIA----EVTTIGSLRHRN 375
           +G G FG+VY G+     + +AVK+V     S +S+  K+  +     E+  +  L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 376 LVKLIGWCYERHDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +V+ +G      D L ++ EY+P GS+   +     N G  E TL      + +    + 
Sbjct: 68  IVQYLG-SSLDADHLNIFLEYVPGGSVAALL----NNYGAFEETL----VRNFVRQILKG 118

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL---KTHHSTKEIAGT 491
           L+YLHN   + ++HRDIK +NI++D++   ++ DFG+++ ++ N    KT+ +   + G+
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             +MAPE       T + DI++ G L++E+  G+ P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 325 NKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
            K+G+G  G V         +++AVK++    +Q ++    EV  +   +H N+V++   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
                +  +V E++  G+L   +             +N E+  +V     +AL +LH   
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIV---------THTRMNEEQIATVCLAVLKALSFLHA-- 133

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
            + V+HRDIKS +I+L S+   +L DFG    + + +      K + GTP +MAPE  ++
Sbjct: 134 -QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPE--VI 187

Query: 503 GRAT--IETDIYAFGVLILEVACGRKP 527
            R     E DI++ G++++E+  G  P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 31/221 (14%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVS----ETSRQGK--QEFIAEVTTIGSLRHRNLVK 378
           LG G F + Y  + +     +AVK+V+     +S Q +  +    E+  +  L H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE--VTLNWEKRLSVIHGTSQALD 436
           ++G   E   F L  E+M  GS+   +    +  G  +  V +N+           + L 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINY------TEQLLRGLS 117

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENL-KTHHSTKEIAGTPGY 494
           YLH   E +++HRD+K +N+++DS     R+ DFG A  +            ++ GT  +
Sbjct: 118 YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174

Query: 495 MAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSE 532
           MAPE       GR+    D+++ G +I+E+A  + P N  +
Sbjct: 175 MAPEVLRGEQYGRS---CDVWSVGCVIIEMATAKPPWNAEK 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.6 bits (218), Expect = 5e-19
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 35/222 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-----EVTTIGSLR 372
            +    KLG+G +  VYK   +   + +A+K++    R+  ++ I      E+  +  L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 373 HRNLVKLIGWCYERHDFL-LVYEYMPNGSL-----DKFIFYDETNSGPGEVTLNWEKRLS 426
           H N++ L+   +     + LV+E+M    L     DK I        P ++        S
Sbjct: 61  HPNIIGLLD-VFGHKSNINLVFEFME-TDLEKVIKDKSIVL-----TPADIK-------S 106

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
            +  T + L+YLH+     +LHRD+K +N+++ S+   +L DFGLAR+   +     + +
Sbjct: 107 YMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQ 162

Query: 487 EIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
            +  T  Y APE     R   +  D+++ G +  E+   R P
Sbjct: 163 VV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAEL-LLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 326 KLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  GTV+    +   +E+A+K+++   +  K+  I E+  +  L++ N+V  +   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V EY+  GSL   +          E  ++  +  +V     QAL++LH    
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV---------TETCMDEAQIAAVCRECLQALEFLH---A 133

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
            +V+HRDIKS N++L  + + +L DFG    I    ++  ST  + GTP +MAPE     
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRST--MVGTPYWMAPEVVTRK 190

Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               + DI++ G++ +E+  G  P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 23/225 (10%)

Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    I   +E+A+K+++   +  K+  I
Sbjct: 5   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 65  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 118

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QALD+LH+    +V+HRDIKS NI+L  + + +L DFG    I    ++ 
Sbjct: 119 ---AVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK 171

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            ST  + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 172 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 26/218 (11%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV------SETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           LG+G FG VY        +E+AVK+V       ETS++       E+  + +LRH  +V+
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 379 LIGWCYERHD---FLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
             G C    +     +  EYMP GS+ D+   Y       G +T N  +R +      Q 
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAY-------GALTENVTRRYT--RQILQG 118

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + YLH+     ++HRDIK +NI+ DS  N +LGDFG ++ IQ    +    K + GTP +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
           M+PE         + D+++    ++E+   + P  + E
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)

Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D    GP    L+  +  +++    + LDY
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGP----LDETQIATILREILKGLDY 116

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L      +L DFG+A  + +   T        GTP +MAP
Sbjct: 117 LH--SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 170

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P ++             L  ++    I    
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-------------LHPMKVLFLIPKNN 217

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 218 PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 46/231 (19%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR-NKEI-AVKRVSETSRQGKQEF--IAEVTT---IGSLR- 372
           +    +LG G FG+VY    +   E+ A+K++       K++F    E      + SLR 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRK 53

Query: 373 ---HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
              H N+VKL     E  +   V+EYM  G+L + +   +       V  +       I+
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSI------IY 106

Query: 430 GTSQALDYLH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHHSTK 486
              Q L ++H +G      HRD+K  N+++      ++ DFGLAR I+       + ST+
Sbjct: 107 QILQGLAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR 162

Query: 487 EIAGTPGYMAPESFLVGRATIET---DIYAFGVLILEVACGRK--PGNQSE 532
                  Y APE  L  R+T  +   DI+A G ++ E+   R   PG+ SE
Sbjct: 163 ------WYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRPLFPGS-SE 204

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 2e-18
 Identities = 80/336 (23%), Positives = 141/336 (41%), Gaps = 37/336 (11%)

Query: 272 VVLLAGVAFYCWRRYRAREL-----DDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNK 326
           V+ L    F   R     EL     +D    L    +   K   + ++  +      +N 
Sbjct: 641 VLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL---KEENV 697

Query: 327 LGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           + +G  G  YKG      +   VK +++ +       IA+   +G L+H N+VKLIG C 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-PSSEIAD---MGKLQHPNIVKLIGLCR 753

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
                 L++EY+   +L + +             L+WE+R  +  G ++AL +LH     
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVL-----------RNLSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR 504
            V+  ++    I++D +    L    L   +  + K   S+        Y+APE+     
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-------AYVAPETRETKD 854

Query: 505 ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGE 564
            T ++DIY FG++++E+  G+ P +   +   + SIV W         +    D  + G+
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADA--EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912

Query: 565 FSEKEMECVLILGLA--CCHPNPHLRPSMKTVLQVL 598
            S  + E V ++ LA  C   +P  RP    VL+ L
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 22/209 (10%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKL 379
           K+G+G +G VYKG  RNK+    +A+K++  E+  +G     I E++ +  L+H N+V L
Sbjct: 7   KIGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
                +     L++E++   S+D   + D     P    ++ E   S ++   Q + + H
Sbjct: 65  QDVLMQESRLYLIFEFL---SMDLKKYLDSL---PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
               +RVLHRD+K  N+++D++   +L DFGLAR     ++ +  T E+  T  Y APE 
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY--THEVV-TLWYRAPEV 172

Query: 500 FLVG-RATIETDIYAFGVLILEVACGRKP 527
            L   R +   DI++ G +  E+A  +KP
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)

Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     ++  K++AVK++    +Q ++    EV  +    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +   N          E+  +V     +AL YLHN   
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNE---------EQIATVCLSVLRALSYLHN--- 136

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L S+   +L DFG    + + +      K + GTP +MAPE     
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL 193

Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               E DI++ G++++E+  G  P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 60/236 (25%), Positives = 108/236 (45%), Gaps = 26/236 (11%)

Query: 320 NFNPKNKLGKGGFG--TVYKG-------IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS 370
           ++ P   LGKG FG  T+Y+        +W  KE+ + R+SE  R+       E+  +  
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVW--KEVNLTRLSEKERRDALN---EIVILSL 55

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           L+H N++       + +  L+  EY   G+L   I   +      E+ L W      +  
Sbjct: 56  LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL-W-----YLFQ 109

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
              A+ Y+H      +LHRDIK+ NI L      +LGDFG+++ +    +   + + + G
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMA-ETVVG 163

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE 546
           TP YM+PE     +   ++DI+A G ++ E+   ++  + +   +    IV   + 
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 19/221 (8%)

Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRN 375
            +    K+G+G FG +Y  K    ++   +K +  T    + K+    EV  +  ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +V       E     +V EY   G L K I          +  L+W  ++S+       L
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            ++H   ++++LHRDIKS NI L      A+LGDFG+AR + ++++  ++     GTP Y
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYY 168

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQ 533
           ++PE         +TDI++ G ++ E+   + P  GN   Q
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 84.3 bits (208), Expect = 5e-18
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 22/210 (10%)

Query: 327 LGKGGFGTVYKGIW----RNKEI--AVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTVYKGIW     N +I  A+K + E TS +  +E + E   +  +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G C       LV + MP G L  ++  ++   G  ++ LNW  +++      + + YL 
Sbjct: 75  LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIA------KGMSYLE 126

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E R++HRD+ + N+++ S  + ++ DFGLAR +  +   +H+  +    P  +MA E
Sbjct: 127 ---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA--DGGKVPIKWMALE 181

Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           S L  R T ++D++++GV + E+   G KP
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 321 FNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRN 375
           F    ++G G FG VY  + +  N+ +A+K++S + +Q     Q+ I EV  +  ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 376 LVKLIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            ++  G CY R H   LV EY    + D      E +  P    L   +  ++ HG  Q 
Sbjct: 87  SIEYKG-CYLREHTAWLVMEYCLGSASDLL----EVHKKP----LQEVEIAAITHGALQG 137

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L YLH+ +   ++HRDIK+ NI+L      +L DFG A                 GTP +
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-------PANSFVGTPYW 187

Query: 495 MAPESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           MAPE  L    G+   + D+++ G+  +E+A  RKP
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 47/295 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLV 377
           ++ +G+G FG V K   +      + A+KR+ E  S+   ++F  E+  +  L  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYD---ETN-----SGPGEVTLNWEKRLSVIH 429
            L+G C  R    L  EY P+G+L  F+      ET+     +     TL+ ++ L    
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++ +DYL   S+K+ +HRD+ + NI++   + A++ DFGL+R  +  +K     K + 
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMG 183

Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWEL 547
             P  +MA ES      T  +D++++GVL+ E V+ G  P        Y       L+E 
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELYEK 235

Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             +G  L            EK + C   V  L   C    P+ RPS   +L  L+
Sbjct: 236 LPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 56/209 (26%), Positives = 112/209 (53%), Gaps = 19/209 (9%)

Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G  +    +EI V     +   T +Q +++F++E + +G   H N++ L
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHL 70

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    ++V EYM NGSLD F+     + G   V     + + ++ G +  + YL 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVI----QLVGMLRGIASGMKYL- 122

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+       + APE+
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D++++G+++ EV + G +P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 55/222 (24%), Positives = 110/222 (49%), Gaps = 28/222 (12%)

Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRV------SETSRQGKQEFI----AEVTTIGSLRHR 374
           +GKG +G VY  +     + +AVK+V      +      +++ +    +E+ T+  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 375 NLVKLIGWCYERHDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           N+V+ +G      ++L ++ EY+P GS+   +       G  E  L             +
Sbjct: 69  NIVQYLG-FETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLV----RFFTEQVLE 119

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L YLH+   K +LHRD+K+ N+++D++   ++ DFG+++   +++  +     + G+  
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVF 175

Query: 494 YMAPESFLVGRA--TIETDIYAFGVLILEVACGRKPGNQSEQ 533
           +MAPE         + + DI++ G ++LE+  GR+P +  E 
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 27/211 (12%)

Query: 325 NKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRNLVKL 379
           +++G G FG VY       N+ +AVK++S + +Q     Q+ I EV  +  L+H N ++ 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   + H   LV EY    + D      E +  P    L   +  ++ HG  Q L YLH
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLL----EVHKKP----LQEVEIAAITHGALQGLAYLH 138

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           + +   ++HRDIK+ NI+L      +L DFG A                 GTP +MAPE 
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-------PANSFVGTPYWMAPEV 188

Query: 500 FLV---GRATIETDIYAFGVLILEVACGRKP 527
            L    G+   + D+++ G+  +E+A  RKP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 23/225 (10%)

Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    +   +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 119

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I       
Sbjct: 120 ---AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
            +G+G +G V K   RNK     +A+K  + SE     K+  + EV  +  LRH N+V L
Sbjct: 8   VVGEGAYGVVLKC--RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
                 +    LV+EY+    L+     + +  G     L  +   S I    QA+ Y H
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELL---EASPGG-----LPPDAVRSYIWQLLQAIAYCH 117

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
                 ++HRDIK  NI++      +L DFG AR ++        T  +A T  Y APE 
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVA-TRWYRAPE- 171

Query: 500 FLVGRATI--ETDIYAFGVLILEVACGR 525
            LVG        D++A G ++ E+  G 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 327 LGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G+G FG V+    +        K+I V+++++  R   Q    E   +  L H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIEY 64

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
                E    ++V EY P G+L ++I     NS   E T        ++H   Q L  LH
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDT--------ILHFFVQILLALH 115

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           +   K +LHRD+K+ NI+LD      ++GDFG    I + L +      + GTP Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFG----ISKILSSKSKAYTVVGTPCYISPE 171

Query: 499 SFLVGRATIETDIYAFGVLILEVA 522
                    ++DI+A G ++ E+A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 327 LGKGGFGTV--YKGIWRNKE----IAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG+G FG V  Y     N      +AVK +  E  +Q    +  E+  + +L H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 380 IGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G C E+      L+ EY+P GSL  ++        P    LN  + L       + + Y
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKH-KLNLAQLLLFAQQICEGMAY 122

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           LH+   +  +HRD+ + N++LD++   ++GDFGLA+ + E    ++  +E   +P +  A
Sbjct: 123 LHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRVREDGDSPVFWYA 178

Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
            E     + +  +D+++FGV + E+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 58/205 (28%), Positives = 110/205 (53%), Gaps = 21/205 (10%)

Query: 327 LGKGGFGTVY------KGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL 379
           LG+G FG V       +G    +++AVK +   S      +   E+  + +L H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 380 IGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G C E       L+ E++P+GSL +++  ++         +N +++L       + +DY
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-------INLKQQLKYAVQICKGMDY 124

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L  GS + V HRD+ + N++++SE   ++GDFGL + I+ + K +++ K+   +P +  A
Sbjct: 125 L--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEYYTVKDDLDSPVFWYA 180

Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PE  +  +  I +D+++FGV + E+
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 25/268 (9%)

Query: 327 LGKGGFGTVYK--GIWRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           LG G  G+V K   I     +A K V        +++ + E+  +   R   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
              ++  +  E+M  GSLD+   Y +   GP  V +  +  ++V+ G    L YL+N   
Sbjct: 73  LNENNICMCMEFMDCGSLDRI--YKK--GGPIPVEILGKIAVAVVEG----LTYLYN--V 122

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
            R++HRDIK SNI+++S    +L DFG++  +  ++          GT  YM+PE    G
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTSTYMSPERIQGG 177

Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL-G 562
           + T+++D+++ G+ I+E+A G+ P   S  +         + +L +  +I+     RL  
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ--QIVQEPPPRLPS 235

Query: 563 GEFSEKEMECVLILGLACCHPNPHLRPS 590
            +F E   +    +  AC   +P  RP+
Sbjct: 236 SDFPE---DLRDFVD-ACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVS------ETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           LG+G FG VY    +   +E+A K+V       ETS++       E+  + +L+H  +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE-VSALECEIQLLKNLQHERIVQ 68

Query: 379 LIGWCYERHD--FLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
             G   +R +    +  EYMP GS+ D+   Y         VT  + ++  ++ G S   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQ--ILEGMS--- 120

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YLH+     ++HRDIK +NI+ DS  N +LGDFG ++ +Q    +    + + GTP +M
Sbjct: 121 -YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
           +PE         + D+++ G  ++E+   + P  + E
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 31/210 (14%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKL 379
            +G+G +G V K   ++KE    +A+K+  E+      + IA  E+  +  LRH NLV L
Sbjct: 8   LVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           I     +    LV+E++ +  LD    Y      P  +  +  ++   +    + +++ H
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKY------PNGLDESRVRK--YLFQILRGIEFCH 117

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           + +   ++HRDIK  NI++      +L DFG ART+    + +  T  +A T  Y APE 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVA-TRWYRAPE- 170

Query: 500 FLV-----GRATIETDIYAFGVLILEVACG 524
            LV     GRA    DI+A G L+ E+  G
Sbjct: 171 LLVGDTKYGRA---VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKL 379
           K+G+G +G VYK   R+K     +A+K++            A  E+  +  L H N++KL
Sbjct: 6   KIGEGTYGVVYKA--RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +     + D  LV+E+M +  L K I   +         L      S ++   Q L + H
Sbjct: 64  LDVFRHKGDLYLVFEFM-DTDLYKLI---KDRQRG----LPESLIKSYLYQLLQGLAFCH 115

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
                 +LHRD+K  N+++++E   +L DFGLAR+    ++ +  T  +  T  Y APE 
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVV-TRWYRAPEL 169

Query: 500 FLVGRA-TIETDIYAFGVLILEVACGR 525
            L  +  +   DI++ G +  E+   R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 30/207 (14%)

Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           K+G+G FG       +        KEI + ++S   R+   E   EV  + +++H N+V+
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 E  +  +V +Y   G L K I        P +  L+W  ++ +      AL ++
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHV 117

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA----GTPGY 494
           H   ++++LHRDIKS NI L  +   +LGDFG+AR +       +ST E+A    GTP Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELARTCIGTPYY 167

Query: 495 MAPESFLVGRATIETDIYAFGVLILEV 521
           ++PE         ++DI+A G ++ E+
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 57/231 (24%), Positives = 114/231 (49%), Gaps = 35/231 (15%)

Query: 324 KNKLGKGGFGTV----------YKGIWRNKE------IAVKRV-SETSRQGKQEFIAEVT 366
           K KLG+G FG V          + G    +       +AVK + ++ ++  + +F+ E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE-------TNSGPGEVTL 419
            +  L++ N+++L+G C       ++ EYM NG L++F+   E        N+ P   ++
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP---SV 126

Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +    L +    +  + YL   +    +HRD+ + N ++ + +  ++ DFG++R +    
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG- 182

Query: 480 KTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV--ACGRKP 527
             ++  +  A  P  +MA ES L+G+ T  +D++AFGV + E+   C  +P
Sbjct: 183 -DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 43/237 (18%)

Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGI-WRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR 372
           L   TG F     +G+G +G VYK    +  ++   ++ +     ++E   E      LR
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI---LR 57

Query: 373 ----HRNLVKLIGWCYER-----HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
               H N+    G   ++      D L LV E    GS+   +          +      
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----------KGLRKKG 107

Query: 423 KRLS------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
           KRL       ++  T + L YLH   E +V+HRDIK  NI+L      +L DFG++  + 
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164

Query: 477 -ENLKTHHSTKEIAGTPGYMAPESFLVG---RATIE--TDIYAFGVLILEVACGRKP 527
               + +       GTP +MAPE         A+ +  +D+++ G+  +E+A G+ P
Sbjct: 165 STLGRRNTFI----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 28/219 (12%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVS------ETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           LG+G FG VY        +E+AVK+V       ETS++       E+  + +L H  +V+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68

Query: 379 LIGWCYERHDFLL--VYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLS--VIHGTSQ 433
             G   +  +  L    E+MP GS+ D+   Y       G +T N  ++ +  ++ G S 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVS- 120

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
              YLH+     ++HRDIK +NI+ DS  N +LGDFG ++ +Q    +    K + GTP 
Sbjct: 121 ---YLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
           +M+PE         + DI++ G  ++E+   + P  + E
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 5e-17
 Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 67/239 (28%)

Query: 324 KNKLGKGGFGTVYKGI-WRNKEI-AVKRVSETSR--QGKQEFIAEVTTIGSLR-HRNLVK 378
             KLGKG +G V+K I  R KE+ A+K++ +  R     Q    E+  +  L  H N+VK
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71

Query: 379 LIGWCYERH------DFLLVYEYMPN--------GSLD----KFIFYDETNSGPGEVTLN 420
           L+             D  LV+EYM            L+    ++I Y             
Sbjct: 72  LL----NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY------------- 114

Query: 421 WEKRLSVIHGTSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
                       Q   AL Y+H+G    V+HRD+K SNI+L+S+   +L DFGLAR++ E
Sbjct: 115 ------------QLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 478 NLKTHHS---TKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGRK--PGN 529
             +   +   T  +A T  Y APE  L+G  R T   D+++ G ++ E+  G+   PG 
Sbjct: 160 LEENPENPVLTDYVA-TRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 53/209 (25%), Positives = 110/209 (52%), Gaps = 19/209 (9%)

Query: 326 KLGKGGFGTVYKGIWRNK----EIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +LG G FG V KG+++ +    ++A+K + +E  +  + E + E   +  L +  +V++I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G C E    +LV E    G L+KF+     +    E+T+     + ++H  S  + YL  
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITV--SNVVELMHQVSMGMKYLE- 112

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
              K  +HRD+ + N++L ++  A++ DFGL++ +  +  +++  +     P  + APE 
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPEC 169

Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + +  +D++++G+ + E  + G+KP
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 26/216 (12%)

Query: 327 LGKGGFGTVYK-------GIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V          ++  K++  KR+ +  R+G+   + E   +  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSL 65

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ--ALDY 437
             + YE  D L +   + NG   KF  Y    +G       +E+  +V +       L+ 
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-------FEEGRAVFYAAEICCGLED 117

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH   ++R+++RD+K  NI+LD   + R+ D GLA  + E      + K   GT GYMAP
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----QTIKGRVGTVGYMAP 170

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           E     R T   D +A G L+ E+  G+ P  Q ++
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 54/241 (22%)

Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEF----IAEVTTIG 369
              ++    KLG+G FG VYK       + +A+K++     + G   F    + E+  + 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62

Query: 370 SLRHRNLVKLIGWCYERHD--------FLLVYEYMP---NGSLDKFIFYDETNSGPGEVT 418
            L+H N+V LI    ER D          +V  YM    +G L       E  S    V 
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-------ENPS----VK 111

Query: 419 LNWEK----RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
           L   +     L ++ G +    YLH   E  +LHRDIK++NI++D++   ++ DFGLAR 
Sbjct: 112 LTESQIKCYMLQLLEGIN----YLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 475 IQENLKT-----HHSTKEIAG---TPGYMAPESFLVG--RATIETDIYAFGVLILEVACG 524
                          T++      T  Y  PE  L+G  R T   DI+  G +  E+   
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE-LLLGERRYTTAVDIWGIGCVFAEMFTR 223

Query: 525 R 525
           R
Sbjct: 224 R 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 7e-17
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 25/210 (11%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKL 379
           K+G+G +G VYK   R+K     +A+K++  ET  +G     I E++ +  L H N+V+L
Sbjct: 6   KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +   +  +   LV+E++ +  L K++     +S P    L+     S ++   Q + Y H
Sbjct: 64  LDVVHSENKLYLVFEFL-DLDLKKYM-----DSSP-LTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +    RVLHRD+K  N+++D E   +L DFGLAR     ++T+  T E+  T  Y APE 
Sbjct: 117 S---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVV-TLWYRAPE- 169

Query: 500 FLVGRATIET--DIYAFGVLILEVACGRKP 527
            L+G     T  DI++ G +  E+   R+P
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEM-VNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.1 bits (200), Expect = 8e-17
 Identities = 62/252 (24%), Positives = 115/252 (45%), Gaps = 43/252 (17%)

Query: 324 KNKLGKGGFGTVY--------------------KGIWRNKEIAVKRV-SETSRQGKQEFI 362
           K KLG+G FG V+                    KG  R   +AVK +  + ++  + +F+
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFL 67

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY-----DETNSGPGE- 416
            EV  +  L+  N+++L+G C +     ++ EYM NG L++F+        E N      
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 417 -----VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL 471
                  +++   L V    +  + YL   S    +HRD+ + N ++      ++ DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 472 ARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV--ACGRKP- 527
           +R +      ++  +  A  P  +MA E  L+G+ T  +D++AFGV + E+   C  +P 
Sbjct: 185 SRNLYAG--DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 528 GNQSEQNSYNNS 539
           G  +++    N+
Sbjct: 243 GELTDEQVIENA 254

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     ++  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +   N          E+  +V     +AL  LH    
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNE---------EQIAAVCLAVLKALSVLH---A 134

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPE--LIS 189

Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 21/205 (10%)

Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQG-KQEFIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ ++    ++AVK +  T+    ++  ++E+  +  L  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L+G C      L++ EY   G L  F+          E  L  E  LS  +  ++ + +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKR------ESFLTLEDLLSFSYQVAKGMAF 156

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L   + K  +HRD+ + N++L      ++ DFGLAR I  +  +++  K  A  P  +MA
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND--SNYVVKGNARLPVKWMA 211

Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES      T E+D++++G+L+ E+
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 66/244 (27%), Positives = 94/244 (38%), Gaps = 65/244 (26%)

Query: 327 LGKGGFGTV----YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           LG+G FG V    YK     +  A+K +       K+  I     + SL     +     
Sbjct: 7   LGRGHFGKVLLAEYKK--TGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETAN 57

Query: 383 CYERHDFLL--------------VYEYMPNGSL------DKF-----IFYDETNSGPGEV 417
             ERH FL+              V EY   G L      D F     +FY         V
Sbjct: 58  S-ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACV 110

Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            L               L YLH   E ++++RD+K  N++LD+E   ++ DFGL +   E
Sbjct: 111 VL--------------GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---E 150

Query: 478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN 537
            +     T    GTP ++APE       T   D +  GVLI E+  G  P    ++    
Sbjct: 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210

Query: 538 NSIV 541
           +SIV
Sbjct: 211 DSIV 214

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 56/232 (24%), Positives = 115/232 (49%), Gaps = 30/232 (12%)

Query: 324 KNKLGKGGFGTVY----KGIWRNKE--------------IAVKRV-SETSRQGKQEFIAE 364
           K KLG+G FG V+    +G+ +  +              +AVK +  + ++  + +F+ E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE---VTLNW 421
           +  +  L+  N+++L+  C       ++ EYM NG L++F+   E      +   VT+++
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
              + +    +  + YL   S    +HRD+ + N ++   +  ++ DFG++R +      
Sbjct: 130 STLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG--D 184

Query: 482 HHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVA--CGRKPGNQ 530
           ++  +  A  P  +M+ ES L+G+ T  +D++AFGV + E+   C  +P +Q
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 24/207 (11%)

Query: 329 KGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFI---AEVTTIGSLRHRNLVKLIGWC 383
           KG FG+VY  K        A+K + ++    K +     AE   +        V  + + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 384 YERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           ++  D+L LV EY+  G     I         G +  +W K+   I      ++ LH   
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQY--IAEVVLGVEDLH--- 114

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
           ++ ++HRDIK  N+++D   + +L DFGL+R   EN       K+  GTP Y+APE+ L 
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETILG 167

Query: 503 GRATIETDIYAFGVLILEVACGRKPGN 529
                 +D ++ G +I E   G  P +
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 62/211 (29%), Positives = 114/211 (54%), Gaps = 23/211 (10%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQG--KQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG+++ K+    +AVK +   +     K E + E   +  L +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS-VIHGTSQALDYL 438
           IG C E   ++LV E    G L+KF+  ++       VT   EK ++ ++H  S  + YL
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNK------HVT---EKNITELVHQVSMGMKYL 111

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAP 497
               E   +HRD+ + N++L ++  A++ DFGL++ +  + + ++  K     P  + AP
Sbjct: 112 E---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAP 167

Query: 498 ESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           E     + + ++D+++FGVL+ E  + G+KP
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 76/304 (25%), Positives = 134/304 (44%), Gaps = 67/304 (22%)

Query: 327 LGKGGFGTV----YKGIWRNKE---IAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLV 377
           LG+G FG V      G+    E   +AVK + +  + +   + ++E+  +  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-----VTLNWEKRLSVIHGTS 432
            L+G C +     +V EY  +G+L  F+        PGE          E+ L+     S
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFL---RARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 433 ------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN---LKTHH 483
                 + +++L   + K+ +HRD+ + N+++  +   ++ DFGLAR I       KT  
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191

Query: 484 STKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYN 537
                  T G     +MAPE+      T ++D+++FGVL+ E    G  P        Y 
Sbjct: 192 -------TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP--------YP 236

Query: 538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTV 594
              V  L++L ++G        R+     EK   C   +  L   C H  P  RP+ K +
Sbjct: 237 GIPVEELFKLLKEGY-------RM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284

Query: 595 LQVL 598
           ++ L
Sbjct: 285 VEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 48/294 (16%)

Query: 327 LGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVK 378
           LG+G FG V K              +AVK + E +   + ++ ++E   +  + H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFI----------------FYDETNSGPGEVTLNWE 422
           L G C +    LL+ EY   GSL  F+                        P E  L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLKT 481
             +S     S+ + YL   +E +++HRD+ + N+++      ++ DFGL+R + +E+   
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSI 540
             S   I     +MA ES      T ++D+++FGVL+ E V  G  P        Y    
Sbjct: 185 KRSKGRIPVK--WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--------YPGIA 234

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV 594
              L+ L + G  ++  ++           E +  L L C    P  RP+   +
Sbjct: 235 PERLFNLLKTGYRMERPENC---------SEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 24/215 (11%)

Query: 327 LGKGGFGTVYK-------GIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V          ++  K++  KR+ +  R+G+   + E   +  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSL 65

Query: 380 IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
             + YE  D L LV   M  G L KF  Y+  N G       +++  +V +         
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDL-KFHIYNMGNPG-------FDEERAVFYAAEITCGLE 116

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
               E R+++RD+K  NI+LD   + R+ D GLA  I E      + +   GT GYMAPE
Sbjct: 117 DLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----ETIRGRVGTVGYMAPE 171

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
                R T   D +  G LI E+  G+ P  Q ++
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 64/244 (26%)

Query: 327 LGKGGFGTV----YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSL----------- 371
           LGKG FG V     KG   ++  AVK +       K++ I +   +              
Sbjct: 3   LGKGSFGKVLLAELKG--TDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53

Query: 372 RHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPGEVT 418
           +H  L +L   C++  D L  V EY+  G L        +F      FY        E+ 
Sbjct: 54  KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIV 106

Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L               L +LH   E+ +++RD+K  N++LDSE + ++ DFG+ +   E 
Sbjct: 107 L--------------GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EG 146

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN 538
           +    +T    GTP Y+APE           D +A GVL+ E+  G+ P    +++    
Sbjct: 147 ILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206

Query: 539 SIVH 542
           SI+ 
Sbjct: 207 SILE 210

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 5e-16
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG---KQEFIAEVTTIGSLRHRNLVKLI 380
            +GKGG G VY       ++ +A+K++ E   +    K+ F+ E      L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 381 GWCYERHDFLLVYEYMP--NG----SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
             C +      VY  MP   G    SL K ++  E+ S       +    LS+ H     
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ-------------ENLKT 481
           ++Y+H+   K VLHRD+K  NI+L       + D+G A   +              N+  
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 482 HHSTK--EIAGTPGYMAPESFLVGRATIETDIYAFGVLI 518
              T   +I GTP YMAPE  L   A+  TDIYA GV++
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 47/233 (20%)

Query: 325 NKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGSLRHRN 375
            ++G+G +G VYK   R+K+    +A+K+V  +  ++G   F    I E+  +  L HRN
Sbjct: 13  GQIGEGTYGQVYKA--RDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRN 67

Query: 376 LVKLIGWCYERHD----------FLLVYEYMPN---GSLDKFIFYDETNSGPGEVTLNWE 422
           +V L     ++ D          F LV+EYM +   G L+            G V  + +
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----------GLVHFSED 116

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              S +    + L+Y H    K  LHRDIK SNI+L+++   +L DFGLAR         
Sbjct: 117 HIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 483 HSTKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           ++ K I  T  Y  PE  L+G  R     D+++ G ++ E+   +KP  Q+ Q
Sbjct: 174 YTNKVI--TLWYRPPE-LLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 75/303 (24%), Positives = 141/303 (46%), Gaps = 63/303 (20%)

Query: 327 LGKGGFGTVY--KGIWRNKE-------IAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V   + I  +KE       +AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------EVTLNWEKR 424
           ++ L+G C +     ++ EY   G+L +++        PG           E  L+++  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I      HH 
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI------HHI 193

Query: 485 TKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNN 538
                 T G     +MAPE+      T ++D+++FGVL+ E+   G  P        Y  
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPG 245

Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVL 595
             V  L++L ++G  +D            K   C   + ++   C H  P  RP+ K ++
Sbjct: 246 VPVEELFKLLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293

Query: 596 QVL 598
           + L
Sbjct: 294 EDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 48/222 (21%)

Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           N++G G  GTVYK I R   +  A+K +        +  I  E+  +  + H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 382 WCYERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            C++  D      ++ E+M  GSL+     DE       +     + LS I        Y
Sbjct: 137 -CHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-----QFLADVARQILSGIA-------Y 183

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    + ++HRDIK SN++++S  N ++ DFG++R + + +   +S+    GT  YM+P
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSP 237

Query: 498 ESFLVGRATIET------------DIYAFGVLILEVACGRKP 527
           E        I T            DI++ GV ILE   GR P
Sbjct: 238 ER-------INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 18/206 (8%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGFG V     R   K  A KR+ +     R+G+   + E   +  +  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
           + YE  D L +   + NG   KF  Y+  N G  E     E+ L         L+ LH  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-----ERALFYAAEILCGLEDLH-- 119

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             +  ++RD+K  NI+LD   + R+ D GLA  I E      S +   GT GYMAPE   
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----ESIRGRVGTVGYMAPEVLN 174

Query: 502 VGRATIETDIYAFGVLILEVACGRKP 527
             R T+  D +  G LI E+  G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 26/235 (11%)

Query: 327 LGKGGFGTVYKGIWRN---KEIAVKRVSETS---RQGKQE-------FIAEVTTIG-SLR 372
           LG G FG VYK   +N     +A+K ++  +    + K+E        ++EVT I   LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           H N+V+      E     +V + +    L + F    E      E  + W   + ++   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL YLH   EKR++HRD+  +NIML  +    + DFGLA+  Q   K       + GT
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----LTSVVGT 176

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE 546
             Y  PE         + D++AFG ++ ++   + P   +   S    IV  ++E
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 66/298 (22%)

Query: 327 LGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGK---------QEFIAEVTTIGSLRHRN 375
           LG+G F  +YKG+ R +     V    E S   K           F    + +  L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           LVKL G C  R + ++V EY+  G LD F+     +     V+L+W  +L V    + AL
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASAL 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIML----DSEFN---ARLGDFGLARTIQENLKTHHSTKEI 488
            YL    +K+++H ++   NI++     +E      +L D G+  T+         ++E 
Sbjct: 115 HYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--------LSREE 163

Query: 489 AGTPG-YMAPESFLVGRA--TIETDIYAFGVLILEVAC-GRKPGN---QSEQNSYNNSIV 541
                 ++APE    G+A  TI  D ++FG  +LE+   G +P +    SE+        
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------- 216

Query: 542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                  +    L   D     E +    +C           +P  RPS + +L+ L+
Sbjct: 217 ----RFYQDQHRLPMPDC---AELANLINQCW--------TYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRNLVKLIG 381
           + KG +G V+  K        A+K + +     K    + + E   +   +   +VKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 382 WCYE-RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH- 439
           + ++ + +  LV EY+P G L   +  +   S   +V   +      I     AL+YLH 
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIY------IAEIVLALEYLHS 111

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA------RTIQENLKTHHSTKEIAGTPG 493
           NG    ++HRD+K  NI++DS  + +L DFGL+      R I  N       K I GTP 
Sbjct: 112 NG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPD 166

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE  L    +   D ++ G ++ E   G  P
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 39/277 (14%)

Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIG 381
           ++LGKG +G+VYK + R     +A+K +     + K  + I E+  +       +V   G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS--VIHGTSQALDYLH 439
             +      +  EYM  GSLDK   Y    +  G +  +  +R++  V+ G  + L   H
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKL--YAGGVATEG-IPEDVLRRITYAVVKGL-KFLKEEH 122

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           N     ++HRD+K +N++++     +L DFG++  +  +L      K   G   YMAPE 
Sbjct: 123 N-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-----AKTNIGCQSYMAPER 172

Query: 500 FLVGRA------TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
              G        T+++D+++ G+ ILE+A GR P       +Y N I   L        I
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYAN-IFAQL------SAI 222

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS 590
           +D     L   +S+   + V      C +  P+ RP+
Sbjct: 223 VDGDPPTLPSGYSDDAQDFV----AKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)

Query: 327 LGKGGFGTV-------YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V          ++  K++  KR+ +  R+G+   + E   +  +  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSL 65

Query: 380 IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
             + YE  D L LV   M  G L KF  Y+  N G       ++++ ++ +        L
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDL-KFHIYNMGNPG-------FDEQRAIFYAAELCCG-L 115

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
            +   +R+++RD+K  NI+LD   + R+ D GLA  I E      + +   GT GYMAPE
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRVGTVGYMAPE 171

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKP 527
                + T   D +  G LI E+  G+ P
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 69/276 (25%), Positives = 128/276 (46%), Gaps = 34/276 (12%)

Query: 324 KNKLGKGGFGTVYKGIW--RNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +  LG G  GTVYK       + +AVK +  + + + +++ ++E+  +       ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G  +  +   +  E+M  GSLD +    E   G          R++V     + L YL +
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAV--AVVKGLTYLWS 113

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               ++LHRD+K SN+++++    +L DFG++  +  ++      K   GT  YMAPE  
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----AKTYVGTNAYMAPERI 165

Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
              +  I +D+++ G+  +E+A GR P  Q ++N  +      L  L+    I+D     
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS------LMPLQLLQCIVDEDPPV 219

Query: 561 LG-GEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
           L  G+FSEK +  +      C    P  RP+ + ++
Sbjct: 220 LPVGQFSEKFVHFI----TQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 48/246 (19%)

Query: 316 KATGNFNPKNKLGKGGFGTVY------------KGIWRNKE------IAVK--RVSETSR 355
                 N   KLG+G FG V+            K    N        +AVK  R   +  
Sbjct: 2   FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD- 60

Query: 356 QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY--DETNSG 413
             +++F+ EV  +  L   N+ +L+G C       ++ EYM NG L++F+     ET+  
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 414 PGEVTLNWEKRLSV---IHGTSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
                    K LS    ++  +Q    + YL        +HRD+ + N ++   +  ++ 
Sbjct: 121 ACNS-----KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIA 172

Query: 468 DFGLARTIQENLKTHHSTKEIAGTP----GYMAPESFLVGRATIETDIYAFGVLILEVA- 522
           DFG++R    NL +    + + G       +MA ES L+G+ T ++D++AFGV + E+  
Sbjct: 173 DFGMSR----NLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Query: 523 -CGRKP 527
            C  +P
Sbjct: 228 LCREQP 233

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKL 379
           K+G+G +G V+K   RN+E    +A+K+  E+      + IA  E+  +  L+H NLV L
Sbjct: 8   KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           I     +    LV+EY  +  L++    ++   G  E  +       +I  T QA+++ H
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIK-----KIIWQTLQAVNFCH 117

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              +   +HRD+K  NI++  +   +L DFG AR +         T  +A T  Y APE 
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVA-TRWYRAPE- 170

Query: 500 FLVGRATIET--DIYAFGVLILEVACG 524
            LVG        D++A G +  E+  G
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 25/205 (12%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G +G VYK   R  N+ IA+K++  E   +G     I E++ +  ++H N+V+L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL--SVIHGTSQALDYLH 439
             +      LV+EY+    LD     D +             RL  + ++   + + Y H
Sbjct: 69  VVHSEKRLYLVFEYL---DLDLKKHMDSSPD------FAKNPRLIKTYLYQILRGIAYCH 119

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           +    RVLHRD+K  N+++D   NA +L DFGLAR     ++T   T E+  T  Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVV-TLWYRAPE 173

Query: 499 SFLVGRATIET--DIYAFGVLILEV 521
             L+G     T  DI++ G +  E+
Sbjct: 174 -ILLGSRHYSTPVDIWSVGCIFAEM 197

Length = 294

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 34/212 (16%)

Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG 381
           +G G FG V+    R  E    + V  + E  R  +++ +  E   +  + H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS--QALDYL 438
           W      FL ++ EY+P G L  ++     NSG       +     + + +    AL+YL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYL----RNSG------RFSNSTGLFYASEIVCALEYL 117

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H+   K +++RD+K  NI+LD E + +L DFG A+      K    T  + GTP Y+APE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPE 168

Query: 499 SFLV---GRATIETDIYAFGVLILEVACGRKP 527
                   +A    D +A G+LI E+  G  P
Sbjct: 169 VIQSKGHNKA---VDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 71/212 (33%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 327 LGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGKQEF---IAEVTTIGSLRHRNLVKLIG 381
           LGKG FG V   K     +  A+K + +     K E    + E   + + RH  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61

Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS--QALDYL 438
           + ++ HD L  V EY   G L   +  +   S         E R +  +G     ALDYL
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFS---------EDR-ARFYGAEIVSALDYL 111

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H  SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPE 166

Query: 499 SFL---VGRATIETDIYAFGVLILEVACGRKP 527
                  GRA    D +  GV++ E+ CGR P
Sbjct: 167 VLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 71/292 (24%), Positives = 139/292 (47%), Gaps = 41/292 (14%)

Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V +    GI +++      +AVK + +  + +   + I+E+  +  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY------DETNSGP--GEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +F+        D T       E  L+++  +S 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL +   +R +HRD+ + N+++  +   ++ DFGLAR + + +  +  T  
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD-IDYYKKTSN 195

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FG+L+ E+   G  P        Y    V  L++
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP--------YPGIPVEELFK 247

Query: 547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           L R+G  +D   S    E      E        C H  P  RP+ K +++ L
Sbjct: 248 LLREGHRMDKP-SNCTHELYMLMRE--------CWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 51/213 (23%), Positives = 107/213 (50%), Gaps = 22/213 (10%)

Query: 326 KLGKGGFGTVYKG------IWRNKEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +LG+  FG +YKG      +   + +A+K + +  + Q   EF  E + +  L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG---------EVTLNWEKRLSVIH 429
           L+G   +     +++EY+  G L +F+     +S  G         + +L+    L +  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             +  ++YL   S    +H+D+ + NI++  + + ++ D GL+R I      ++  +  +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA--DYYRVQPKS 186

Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             P  +M PE+ + G+ + ++DI++FGV++ E+
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 48/202 (23%), Positives = 95/202 (47%), Gaps = 14/202 (6%)

Query: 330 GGFGTVYKGIWRN------KEIAVKRVSETSRQGKQE-FIAEVTTIGSLRHRNLVKLIGW 382
           G FG ++ GI  +      +E+ VK V + + + +    + E   +  L H+N++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 383 CYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
           C E  +   V Y YM  G+L  F+             L+ ++ + +    +  + YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
             + V+H+DI + N ++D E   ++ D  L+R +      +H   +    P  +MA ES 
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM--DYHCLGDNENRPVKWMALESL 191

Query: 501 LVGRATIETDIYAFGVLILEVA 522
           +    +  +D+++FGVL+ E+ 
Sbjct: 192 VNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 8e-15
 Identities = 68/296 (22%), Positives = 138/296 (46%), Gaps = 53/296 (17%)

Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------EVTLNWEKR 424
           ++ L+G C +     ++ EY   G+L +++        PG           E  L ++  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYL---RARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + ++ +HRD+ + N+++  +   ++ DFGLAR +  N+  +  
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH-NIDYYKK 192

Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHW 543
           T        +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP--------YPGIPVEE 244

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQ 596
           L++L ++G  +D            K   C   + ++   C H  P  RP+ K +++
Sbjct: 245 LFKLLKEGHRMD------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 45/290 (15%)

Query: 327 LGKGGFGTVYKGIWRNKE-----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKG FG+V +   ++++     +AVK  +    S    +EF+ E   +    H N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 380 IGWCYERHDF------LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           IG              +++  +M +G L  F+        P   TL  +  +  +   + 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP--FTLPLQTLVRFMIDIAS 124

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP- 492
            ++YL   S K  +HRD+ + N ML+      + DFGL++ I      ++     +  P 
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG--DYYRQGCASKLPV 179

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            ++A ES      T  +D++AFGV + E+   G+ P    E    N+ I ++L       
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE----NSEIYNYL------- 228

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
                    + G   ++  +C   V  L   C  P P  RPS + +   L
Sbjct: 229 ---------IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 30/220 (13%)

Query: 327 LGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLVKLI 380
           +G+G FG V + + +        A+K + E  S    ++F  E+  +  L  H N++ L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFI-----------FYDETNSGPGEVTLNWEKRLSVIH 429
           G C  R    +  EY P G+L  F+           F  E  +     TL  ++ L    
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS---TLTSQQLLQFAS 126

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             +  + YL   SEK+ +HRD+ + N+++     +++ DFGL+R  +  +K     K + 
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-----KTMG 178

Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILE-VACGRKP 527
             P  +MA ES      T ++D+++FGVL+ E V+ G  P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 29/213 (13%)

Query: 327 LGKGGFGTVYKGIWRNKEI----AVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLVKLI 380
           +G+G FG V K   +   +    A+KR+ E  S+   ++F  E+  +  L  H N++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFI-----------FYDETNSGPGEVTLNWEKRLSVIH 429
           G C  R    L  EY P+G+L  F+           F    ++     TL+ ++ L    
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS---TLSSQQLLHFAA 119

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++ +DYL   S+K+ +HRD+ + NI++   + A++ DFGL+R  +  +K     K + 
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMG 171

Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             P  +MA ES      T  +D++++GVL+ E+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 67/290 (23%), Positives = 132/290 (45%), Gaps = 46/290 (15%)

Query: 326 KLGKGGFGTVYKGIW-------RNKEIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLV 377
           +LG+  FG VYKG         + + +A+K + + +    ++EF  E      L+H N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV--------TLNWEKRLSVIH 429
            L+G   +     +++ Y  +  L +F+     +S  G          TL     + ++ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             +  +++L   S   V+H+D+ + N+++  + N ++ D GL R +      ++     +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA--ADYYKLMGNS 186

Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWEL 547
             P  +M+PE+ + G+ +I++DI+++GV++ EV + G +P        Y+N  V    E+
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----YCGYSNQDV---IEM 238

Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTV 594
            R  ++L   D            +C   V  L L C +  P  RP  K +
Sbjct: 239 IRNRQVLPCPD------------DCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)

Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLI-G 381
           +GKG +G V     R   K+  +K+++    SR+ ++    E   +  L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
           W  E     +V  +   G L   +   +    P    + W  ++++      AL YLH  
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM------ALQYLH-- 119

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            EK +LHRD+K+ N+ L      ++GD G+AR + EN     ST  + GTP YM+PE F 
Sbjct: 120 -EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST--LIGTPYYMSPELFS 175

Query: 502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL 561
                 ++D++A G  + E+A  +   N  +     NS+V+         RI++     +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVY---------RIIEGKLPPM 222

Query: 562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             ++S +  E  LI  +      P  RPS+K++L+
Sbjct: 223 PKDYSPELGE--LIATMLS--KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 51/209 (24%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 327 LGKGGFGTVYKGIW-----RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FG + +G       R   +A+   R   + +Q ++ F+AE  T+G   H N+V+L
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVRL 71

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G     +  ++V EYM NG+LD F+   E     G++     + + ++ G +  + YL 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHE-----GQLVAG--QLMGMLPGLASGMKYL- 123

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SE   +H+ + +  ++++S+   ++  F   R  ++  +  ++T        + APE+
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
                 +  +D+++FG+++ EV + G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 67/296 (22%), Positives = 139/296 (46%), Gaps = 49/296 (16%)

Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRVSETSRQGK-QEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + + + +    + ++E+  +  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  +    P E  + ++  +S
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE-QMTFKDLVS 141

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR +  N+  +  T 
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN-NIDYYKKTT 197

Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 249

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 250 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 18/200 (9%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRNLVKLIG 381
           ++G+G  G V+K   R   + +A+K+V+    +G    + + E+  + + +H  +VKL+ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                  F+LV EYMP   L + +  +E      +V     K         + + Y+H  
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV-----KSYM--RMLLKGVAYMH-- 116

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
               ++HRD+K +N+++ ++   ++ DFGLAR +    +    + ++A T  Y APE   
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVA-TRWYRAPELLY 173

Query: 502 VGRA-TIETDIYAFGVLILE 520
             R      D++A G +  E
Sbjct: 174 GARKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 19/154 (12%)

Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF-IAEVTTIGSLRHRNLVKL 379
           K+G+G +GTV+K   +N+E    +A+KRV  +   +G     + E+  +  L+H+N+V+L
Sbjct: 7   KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
               +      LV+EY  +  L K+  +D  N   G++     K  S +    + L + H
Sbjct: 65  YDVLHSDKKLTLVFEYC-DQDLKKY--FDSCN---GDIDPEIVK--SFMFQLLKGLAFCH 116

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
                 VLHRD+K  N++++     +L DFGLAR
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 324 KNKLGKGGFGTVY----KGIWRNKEIAVKR---VSETSRQGKQEFIAEVTTIGSLRHRNL 376
           + +LGKG FGTVY    K     + + V +   V E +     +   E   +  L H  +
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLD-KFIFYDETNSG-PGEVTLNWEKRLSVIHGTSQA 434
           VK      ER  F ++ EY     LD K      T           W  +L +       
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE--NLKTHHSTKEIAGTP 492
           + Y+H   ++R+LHRD+K+ NI L +    ++GDFG++R +    +L T        GTP
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLAT-----TFTGTP 169

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVAC 523
            YM+PE+        ++DI++ G ++ E+ C
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 327 LGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LGKGGFG V     +N       K++  KR+ + S  G++  + E   +  +    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS--GEKMALLEKEILEKVNSPFIVNL 58

Query: 380 IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ---AL 435
             + +E    L LV   M  G L   I+        GE  L  E+   VIH ++Q    +
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYN------VGERGLEMER---VIHYSAQITCGI 108

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            +LH      +++RD+K  N++LD + N RL D GLA  +++      +  + AGT GYM
Sbjct: 109 LHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQRAGTNGYM 161

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP 527
           APE       +   D +A G  I E+  GR P
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V K   +   + + R     E     + + I E+  +       +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +   E    P E+    +  ++V+ G    L 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEIL--GKVSIAVLRG----LA 117

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 118 YLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 170

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 325 NKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQG-KQEFIAEVTTIGSLR---HRN 375
            ++G+G +GTVYK   R+      +A+K+V    S +G     + E+  +  L    H N
Sbjct: 5   AEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 376 LVKLI----GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           +V+L+    G   +R     LV+E++ +  L  ++        PG   L  E    ++  
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL---SKCPKPG---LPPETIKDLMRQ 115

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
             + +D+LH+    R++HRD+K  NI++ S+   ++ DFGLAR     +    +   +  
Sbjct: 116 LLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM----ALTSVVV 168

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVAC 523
           T  Y APE  L          YA  V +  V C
Sbjct: 169 TLWYRAPEVLL-------QSSYATPVDMWSVGC 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 35/217 (16%)

Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           LG+G +G V K         +AVKR+  T  S++ K+  +    ++ S+     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            +   D  +  E M + SLDKF  Y +       +  +   +++V     +AL+YLH  S
Sbjct: 69  LFREGDVWICMEVM-DTSLDKF--YKKVYDKGLTIPEDILGKIAV--SIVKALEYLH--S 121

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFG--------LARTIQENLKTHHSTKEIAGTPGY 494
           +  V+HRD+K SN++++     +L DFG        +A+TI             AG   Y
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID------------AGCKPY 169

Query: 495 MAPESFLVGRAT----IETDIYAFGVLILEVACGRKP 527
           MAPE            +++D+++ G+ ++E+A GR P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 26/218 (11%)

Query: 325 NKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIG 381
           +KLG+G + TVYKG  +  +  +A+K +     +G     I EV+ +  L+H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 382 WCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
             +      LV+EY     LDK +  + D+  +     ++N       +    + L+Y H
Sbjct: 72  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCH 121

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
               ++VLHRD+K  N++++     +L DFGLAR   +++ T   + E+  T  Y  P+ 
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVV-TLWYRPPD- 174

Query: 500 FLVGRATIET--DIYAFGVLILEVACGRK--PGNQSEQ 533
            L+G     T  D++  G +  E++ GR   PG+  E+
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 326 KLGKGGFGTVYKGIWRN---KEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           ++G G +G VYK   RN    E+A  ++ +         I  E+  +   +H N+V   G
Sbjct: 16  RVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGP-GEVTLNWEKRLSVIHGTSQALDYLHN 440
               R    +  EY   GSL     Y  T  GP  E+ + +     V   T Q L YLH+
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDI--YHVT--GPLSELQIAY-----VCRETLQGLAYLHS 124

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              K  +HRDIK +NI+L    + +L DFG+A  I   +      K   GTP +MAPE  
Sbjct: 125 ---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVA 178

Query: 501 LV---GRATIETDIYAFGVLILEVA 522
            V   G      DI+A G+  +E+A
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 29/208 (13%)

Query: 326 KLGKGGFGTVYKGIW----RNKEIAVKRVSETSRQG---KQEFIAEVTTIGSLRHRNLVK 378
            +G+G +G VYK         KE A+K+      Q     Q    E+  +  L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 379 LIGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSG---PGEV-TLNWEKRLSVIHGTS 432
           L+    E  D    L+++Y  +       F+ +       P  V +L W+    +++G  
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----ILNG-- 120

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR----LGDFGLARTIQENLKTHHSTKEI 488
             + YLH      VLHRD+K +NI++  E   R    +GD GLAR     LK       +
Sbjct: 121 --VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 489 AGTPGYMAPESFLVGRA-TIETDIYAFG 515
             T  Y APE  L  R  T   DI+A G
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 36/241 (14%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGI-WRNKEIAVKRVSETSRQGKQEFIAE 364
                L+ L   T  +     +GKG +G VYK    ++  +A  ++ +      +E  AE
Sbjct: 9   SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE 68

Query: 365 VTTIGSL-RHRNLVKLIGWCYERHDFL-----LVYEYMPNGSLDKFIFYDETNSGPGEVT 418
              + SL  H N+VK  G  Y+    +     LV E    GS+ + +          +  
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----------KGL 118

Query: 419 LNWEKRLS------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL- 471
           L   +RL       +++G    L +LHN    R++HRD+K +NI+L +E   +L DFG+ 
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-----TIETDIYAFGVLILEVACGRK 526
           A+     L+ + S     GTP +MAPE     +          D+++ G+  +E+  G  
Sbjct: 176 AQLTSTRLRRNTSV----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 527 P 527
           P
Sbjct: 232 P 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           S AL+YLH   E+ +++RD+K  N++LDSE + +L D+G+ +   E L+   +T    GT
Sbjct: 106 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGT 159

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP------GNQSEQNSYNNSIVHWLW 545
           P Y+APE           D +A GVL+ E+  GR P       +  +QN+ +      L 
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219

Query: 546 ELRRKGRILDAADSRLGGEFSEKE----MECVLILGLACCHPNPHLRPSMKTVLQVLSGE 601
           +  R  R L    + +   F  K+    + C    G A    +P  R     +++     
Sbjct: 220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLME----- 274

Query: 602 ADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSD 640
               V+PP +P+        +F ++ +T+   QL P  D
Sbjct: 275 -QKQVVPPFKPNISGEFGLDNF-DAQFTNEPVQLTPDDD 311

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 3e-13
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 37/224 (16%)

Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRN 375
           +     +G G +G V   +     +++A+K++S         K+    E+  +  LRH N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60

Query: 376 LVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           ++ L+         + +D  +V E M    L K I      S          + L+  H 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI-----KSP---------QPLTDDHI 105

Query: 431 ---TSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
                Q    L YLH+ +   V+HRD+K SNI+++S  + ++ DFGLAR +  +      
Sbjct: 106 QYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 485 TKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKP 527
             E   T  Y APE  L   R T   DI++ G +  E+   RKP
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 38/241 (15%)

Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRV--------SETSRQGKQEFIAEVTTIGSLRHRNL 376
           +G+G FG   + + +  +++ A+K +         E SR+       E   +  ++H N+
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-------EAVLLAKMKHPNI 60

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V             +V EY   G L + I        P +  L W  ++ +       + 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQ 114

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           ++H   EKRVLHRDIKS NI L      +LGDFG AR +  +   +  T    GTP Y+ 
Sbjct: 115 HIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACT--YVGTPYYVP 168

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE---------QNSYNNSIVHWLWEL 547
           PE +       ++DI++ G ++ E+   + P   +          Q SY     H+ +EL
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYEL 228

Query: 548 R 548
           R
Sbjct: 229 R 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN---KEIAVKRVSETSRQGKQEFIA---EVTTIGSLRH 373
           +F    ++G G +G VYK   RN    E+A  +V +   +  ++F     E+  +   +H
Sbjct: 10  DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKH 65

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+V   G    R    +  E+   GSL     Y  T  GP    L+  +   V   T Q
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDI--YHVT--GP----LSESQIAYVSRETLQ 117

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L YLH+   K  +HRDIK +NI+L    + +L DFG++  I   +      K   GTP 
Sbjct: 118 GLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPY 171

Query: 494 YMAPESFLVGRA---TIETDIYAFGVLILEVA 522
           +MAPE   V R        DI+A G+  +E+A
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 325 NKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIG 381
            KLG+G + TV+KG  +  E  +A+K +     +G     I EV+ +  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 382 WCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
             +      LV+EY     LDK +  + D+  +      ++       ++   + L Y H
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCH 121

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
               ++VLHRD+K  N++++     +L DFGLAR      KT+  + E+  T  Y  P+ 
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVV-TLWYRPPDV 175

Query: 500 FL-VGRATIETDIYAFGVLILEVACGRK--PGNQSE 532
            L     + + D++  G +  E+A GR   PG+  E
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 39/216 (18%)

Query: 327 LGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGKQEF---IAEVTTIGSLRHRNLVKLIG 381
           LGKG FG V   +     K  A+K + +     K E    + E   + + RH  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 382 WCYERHDFL-LVYEYMPNGSL------DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           + ++  D L  V EY+  G L      ++    D T     E+                A
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV--------------SA 107

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           LDYLH+G   ++++RD+K  N+MLD + + ++ DFGL +   E +    + K   GTP Y
Sbjct: 108 LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEY 161

Query: 495 MAPESFL---VGRATIETDIYAFGVLILEVACGRKP 527
           +APE       GRA    D +  GV++ E+ CGR P
Sbjct: 162 LAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 12/110 (10%)

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           S AL++LH   E+ +++RD+K  N++LD+E + +L D+G+ +   E ++   +T    GT
Sbjct: 106 SLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGT 159

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP------GNQSEQNS 535
           P Y+APE           D +A GVL+ E+  GR P       +  +QN+
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 66/292 (22%), Positives = 130/292 (44%), Gaps = 41/292 (14%)

Query: 325 NKLGKGGFGTVYKG----IWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKL 379
           +++G G FG V  G          + VK +  ++   +Q  F+ EV     L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL--SVIHGTSQALDY 437
           +G C E   +LLV E+ P G L  ++      S  G V    +K +   +    +  L +
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYL-----RSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           LH   +   +H D+   N  L ++ + ++GD+GLA  +++  + ++ TK+    P  ++A
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLA 170

Query: 497 PE-------SFLVGRATIETDIYAFGVLILEV--ACGRKPGNQSEQNSYNNSIVHWLWEL 547
           PE         L    T +++I++ GV + E+  A  +   + S++      +       
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV------- 223

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           R +   L      L  ++S++  E +       C  +P  RP+ + V ++L+
Sbjct: 224 REQDIKLPKPQLDL--KYSDRWYEVMQF-----CWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEF---IAEVTTIGSLRHRNLVKLIG 381
           LGKG FG V   +     K  A+K + +     K E    + E   + + RH  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61

Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS--QALDYL 438
           + ++ HD L  V EY   G L   +  +   S         E R +  +G     AL YL
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFS---------EDR-ARFYGAEIVSALGYL 111

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H      V++RD+K  N+MLD + + ++ DFGL +   E +    + K   GTP Y+APE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165

Query: 499 SFL---VGRATIETDIYAFGVLILEVACGRKP 527
                  GRA    D +  GV++ E+ CGR P
Sbjct: 166 VLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 117

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 118 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 170

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 29/211 (13%)

Query: 327 LGKGGFGTVY------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LGKG FG V        G +   +I  K V   ++      + E   + + RH  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTAL- 60

Query: 381 GWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            + ++ HD L  V EY   G L    F+  +     E     E+          AL+YLH
Sbjct: 61  KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARFYGAEIVSALEYLH 112

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K   GTP Y+APE 
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166

Query: 500 FL---VGRATIETDIYAFGVLILEVACGRKP 527
                 GRA    D +  GV++ E+ CGR P
Sbjct: 167 LEDNDYGRA---VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 26/215 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F    +LG G  G V K + R   + + R     E     + + I E+  +       +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGP----GEVTLNWEKRLSVIHGTS 432
           V   G  Y   +  +  E+M  GSLD+ +   +    P    G++++      +V+ G  
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISI------AVLRG-- 111

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             L YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT 
Sbjct: 112 --LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTR 162

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            YM+PE       T+++DI++ G+ ++E+A GR P
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 74/270 (27%), Positives = 112/270 (41%), Gaps = 64/270 (23%)

Query: 383 CYERHDFLL-VYEYMPNGSL----DKFIFYDETNSG--PGEVTLNWEKRLSVIHGTSQAL 435
           C++  D L  V EY+  G L     +   +DE  S     EVTL              AL
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL--------------AL 109

Query: 436 DYLH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +LH +G    V++RD+K  NI+LD+E + +L DFG+ +   E +    +T    GTP Y
Sbjct: 110 MFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH-----WLWELRR 549
           +APE           D +A GVL+ E+  G+ P     ++    SI+H      +W  + 
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKE 222

Query: 550 KGRILDA-----ADSRLGGEFSEKEMECVLILGLACCHP---------------NPHLRP 589
              IL A      + RLG   S+   + +        HP                P  +P
Sbjct: 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ------HPFFKEIDWVLLEQRKIKPPFKP 276

Query: 590 SMKTVLQVLSGEAD----PPVLPPERPSFV 615
            +KT   V + + D     PVL P  P+ +
Sbjct: 277 KIKTKRDVNNFDQDFTKEEPVLTPVDPAVI 306

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIGW 382
           KLG+G + TVYKG  +   + +A+K +     +G     I E + +  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIHGTSQALDYLHN 440
            + +    LV+EY+ +  L +++  D+   G     V L   + L       + L Y H 
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQYM--DDCGGGLSMHNVRLFLFQLL-------RGLAYCH- 120

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++RVLHRD+K  N+++      +L DFGLAR   +++ +   + E+  T  Y  P+  
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVV-TLWYRPPDVL 175

Query: 501 LVGRA-TIETDIYAFGVLILEVACGRK--PG 528
           L     +   D++  G +  E+A GR   PG
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK-------- 378
           +GKG FG VY+   R K+   +R+       K+E +A+     ++  RN++         
Sbjct: 1   IGKGTFGQVYQ--VRKKD--TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 379 -LIGWCYERH---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV-IHGTSQ 433
            ++G  +      D  LV +YM  G L    F+     G        E R    I     
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFS-----EDRAKFYIAELVL 107

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL++LH   +  +++RD+K  NI+LD+  +  L DFGL++    NL  + +T    GT  
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKA---NLTDNKTTNTFCGTTE 161

Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           Y+APE  L  +  T   D ++ GVL+ E+ CG  P
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 36/219 (16%)

Query: 325 NKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIG 381
           +KLG+G + TV+KG  +  E  +A+K +     +G     I EV+ + +L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS-------QA 434
             +      LV+EY+ +  L +++     N G           L  +H          + 
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYL----DNCG----------NLMSMHNVKIFMFQLLRG 115

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L Y H   ++++LHRD+K  N++++ +   +L DFGLAR      KT+  + E+  T  Y
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVV-TLWY 169

Query: 495 MAPESFLVGRATIET--DIYAFGVLILEVACGRK--PGN 529
             P+  L+G     T  D++  G ++ E+A GR   PG+
Sbjct: 170 RPPD-VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 60/271 (22%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWRN--KEI-AVKRVS-ETSRQGKQE--FIAEVTTIGSLR 372
            +F     +G+G FG V+  +      ++ A+K +      +  Q     AE   +    
Sbjct: 1   DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59

Query: 373 HRNLVKLIGWCYERHDFL-LVYEYMPNGSL-----DKFIFYDETNSGPG-EVTLNWEKRL 425
              +VKL  + ++  + L LV EYMP G L      K +F +ET      E+ L      
Sbjct: 60  SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL------ 112

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI---------- 475
                   ALD +H       +HRDIK  NI++D++ + +L DFGL + +          
Sbjct: 113 --------ALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 476 --------QENLKTHHSTKE--------IAGTPGYMAPESFLVGRATIETDIYAFGVLIL 519
                   ++N+       +          GTP Y+APE        +E D ++ GV++ 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221

Query: 520 EVACGRKP-GNQSEQNSYNNSIVHWLWELRR 549
           E+  G  P  + + Q +YN  I++W   LR 
Sbjct: 222 EMLYGFPPFYSDTLQETYNK-IINWKESLRF 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 47/222 (21%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGS 370
            +   N++ +G +G VY+   R+K+    +A+K++  E  ++G   F    + E+  +  
Sbjct: 6   EYEKLNRIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLK 60

Query: 371 LRHRNLVKL----IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGP---GEVTLNWE 422
           L+H N+V +    +G      D + +V EY+ +  L   +   ET   P    EV     
Sbjct: 61  LQHPNIVTVKEVVVG---SNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEV----- 108

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           K L  +      + +LH   +  +LHRD+K+SN++L++    ++ DFGLAR     LK +
Sbjct: 109 KCL--MLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 483 HSTKEIAGTPGYMAPESFL-VGRATIETDIYA----FGVLIL 519
             T+ +  T  Y APE  L     +   D+++    F  L+ 
Sbjct: 164 --TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 6/106 (5%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L +LH+   K +++RD+K  N+MLD+E + ++ DFG+ +   EN+    +T+   GTP Y
Sbjct: 114 LFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDY 167

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           +APE           D +AFGVL+ E+  G+ P +  +++    SI
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 6/108 (5%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L +LH+   K +++RD+K  N+MLDSE + ++ DFG+ +   EN+    +TK   GTP 
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPD 166

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           Y+APE           D +AFGVL+ E+  G+ P    +++    SI+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE---IAVKRVSETS--RQGKQEFI-AEV 365
           ++ K    +FN    LG G FG V    ++N++   +A+KR  ++   +Q + + + +E 
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
             +  + H   V L G   +     LV E++  G    F F       P +V   +  ++
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQI 140

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +I    Q+L+         +++RD+K  N++LD +   ++ DFG A+ +         T
Sbjct: 141 VLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------T 185

Query: 486 KEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
             + GTP Y+APE  L VG      D +  G+ I E+  G  P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGK-AADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G +G V K   R+KE    +A+K+   SE + + K+  + E+  + +L+  N+V+L 
Sbjct: 9   VGEGAYGVVLK--CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
                R    LV+EY+    L+  +  +  N  P E      K  S I+   +A+ + H 
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE------KVRSYIYQLIKAIHWCH- 117

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             +  ++HRDIK  N+++      +L DFG AR + E    +++  E   T  Y +PE  
Sbjct: 118 --KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT--EYVATRWYRSPELL 173

Query: 501 LVGRATIETDIYAFGVLILEVACGR 525
           L        D+++ G ++ E++ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIGW 382
           KLG+G + TVYKGI R   + +A+K +S  + +G     I E + +  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            + +     V+EYM +  L +++        P  V L   + L       + L Y+H   
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG-- 121

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL- 501
            + +LHRD+K  N+++      +L DFGLAR      +T+ S  E+  T  Y  P+  L 
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS--EVV-TLWYRPPDVLLG 177

Query: 502 VGRATIETDIYAFGVLILEVACGR 525
               +   DI+  G + +E+  G+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 38/217 (17%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHR--NLVKLIGW 382
           +G G  G VYK  ++     +AVK++  T  + + + I     +    H    +VK  G+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGP------GEVTLNWEKRLSVIHGTSQALD 436
                D  +  E M    LDK +   +   GP      G++T+      +++    +AL 
Sbjct: 83  FITDSDVFICMELMST-CLDKLL---KRIQGPIPEDILGKMTV------AIV----KALH 128

Query: 437 YLHNGSEKR-VLHRDIKSSNIMLDSEFNARLGDFGLA-RTIQENLKTHHSTKEIAGTPGY 494
           YL    EK  V+HRD+K SNI+LD+  N +L DFG++ R +    KT       AG   Y
Sbjct: 129 YL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-----AGCAAY 180

Query: 495 MAPE----SFLVGRATIETDIYAFGVLILEVACGRKP 527
           MAPE         +  I  D+++ G+ ++E+A G+ P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 38/197 (19%)

Query: 325 NKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEF----IAEVTTIGSLRHRNL 376
            K+G+G FG V+K   R+K+    +A+K+V   +   K+ F    + E+  +  L+H N+
Sbjct: 18  AKIGQGTFGEVFKA--RHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENV 73

Query: 377 VKLIGWCYE--------RHDFLLVYEYMPNGSLDKFIFYDETN--SGPGEVTLNWEKRLS 426
           V LI  C          +  F LV+E         F  +D     S    V     +   
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFE---------FCEHDLAGLLSNK-NVKFTLSEIKK 123

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART--IQENLKTHHS 484
           V+      L Y+H     ++LHRD+K++NI++  +   +L DFGLAR   + +N K +  
Sbjct: 124 VMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 485 TKEIAGTPGYMAPESFL 501
           T  +  T  Y  PE  L
Sbjct: 181 TNRVV-TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 8e-12
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIGW 382
           KLG+G + TVYKG  +   K +A+K +     +G     I E + +  L+H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIHGTSQALDYLHN 440
            + +    LV+EY+     D   + D+   G  P  V L   + L       + L Y+H 
Sbjct: 72  IHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIH- 120

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++ +LHRD+K  N+++      +L DFGLAR   +++ +H  + E+     +  P   
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTL--WYRPPDV 174

Query: 501 LVGRATIET--DIYAFGVLILEVACG 524
           L+G     T  D++  G + +E+  G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 8e-12
 Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 32/198 (16%)

Query: 344 EIAVKRVSETSRQGKQE---FIAEVTTIGSLRHRNLVKLIGWCYERHDFLL-VYEYMPNG 399
           E+A+K +   + + + +   F  E      L H N+V L+         L  V+EY+P  
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64

Query: 400 SLDKFIFYDETNSGPGEVTLNWEKRLSVI---HGTSQALDYLHNGSEKRVLHRDIKSSNI 456
           +L + +       G           L          Q LD L     + ++HRD+K  NI
Sbjct: 65  TLREVL----AADGA----------LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 457 ML---DSEFNARLGDFGL------ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI 507
           M+       +A++ DFG+       R       T   T E+ GTP Y APE       T 
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT--RTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 508 ETDIYAFGVLILEVACGR 525
            +D+YA+G++ LE   G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 30/192 (15%)

Query: 342 NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL---LVYEYMPN 398
            K++ VK V+     G+     E+  + ++ HR ++ LI      H +     V   MP 
Sbjct: 119 RKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINLI------HAYRWKSTVCMVMPK 167

Query: 399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML 458
              D F + D +   P E  +  ++RL       +AL YLH    + ++HRD+K+ NI L
Sbjct: 168 YKCDLFTYVDRSGPLPLEQAITIQRRLL------EALAYLH---GRGIIHRDVKTENIFL 218

Query: 459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM---APESFLVGRATIETDIYAFG 515
           D   NA LGDFG A      L  H  T +  G  G +   +PE   +     +TDI++ G
Sbjct: 219 DEPENAVLGDFGAAC----KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG 274

Query: 516 VLILEVACGRKP 527
           +++ E++     
Sbjct: 275 LVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 6/110 (5%)

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           S  L +LH    + +++RD+K  N+MLDSE + ++ DFG+ +   E++    +T+   GT
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGT 164

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           P Y+APE           D +A+GVL+ E+  G+ P +  +++    SI+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 28/239 (11%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWRN-KEI-AVKRVSETSRQGKQE---FIAEVTTIGSLRH 373
            +F    ++G+GG+G V+    ++  EI A+KR+ ++      E    + E   + + + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 374 RNLVKLIGWCYERHDFLLVY---EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
             LVKL+   Y   D   +Y   EY+P G     +     N G     L+ +     +  
Sbjct: 61  EWLVKLL---YAFQDDEYLYLAMEYVPGGDFRTLL----NNLG----VLSEDHARFYMAE 109

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
             +A+D LH   E   +HRD+K  N ++D+  + +L DFGL++ I   +   +S   + G
Sbjct: 110 MFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS---VVG 160

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           +P YMAPE           D ++ G ++ E  CG  P + S  N    ++ +W   L+R
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVS-ETSRQGKQ-EFIAEVTTI---GS 370
           +    ++G+G +G V+K   R+     + +A+KRV  +T  +G     I EV  +    +
Sbjct: 3   YECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 371 LRHRNLVKLIGWC-YERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
             H N+V+L   C   R D      LV+E++          Y +    PG  T   E   
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPT---ETIK 113

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            ++    + LD+LH+    RV+HRD+K  NI++ S    +L DFGLAR     +    + 
Sbjct: 114 DMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----AL 166

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 25/227 (11%)

Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIGSL- 371
           L+   G F     +G G +G VYKG   +  ++A  +V + +   ++E   E+  +    
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 372 RHRNLVKLIGWCYERH------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
            HRN+    G   +++         LV E+   GS+   I   + N      TL  E   
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEEWIA 114

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +     + L +LH   + +V+HRDIK  N++L      +L DFG++  +   +   ++ 
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 170

Query: 486 KEIAGTPGYMAPESFLVGR---AT--IETDIYAFGVLILEVACGRKP 527
               GTP +MAPE         AT   ++D+++ G+  +E+A G  P
Sbjct: 171 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 32/218 (14%)

Query: 320 NFNPKNKLGKGGFGTV----YKGIWRNKEIAVK--RVSETSRQGKQEFI-AEVTTIGSLR 372
           +F     LG G FG V    +KG    +  A+K  +  E  +  + + +  E + +  L 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H  +V ++    + +    + E++  G L  F    +    P +V   +   L +     
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVL----- 129

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            A +YLH+   K +++RD+K  N++LD++ + ++ DFG A+ + +       T  + GTP
Sbjct: 130 -AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------TFTLCGTP 179

Query: 493 GYMAPE---SFLVGRATIETDIYAFGVLILEVACGRKP 527
            Y+APE   S   G+A    D +  GVL+ E   G  P
Sbjct: 180 EYLAPEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 6/106 (5%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L +LH+   K +++RD+K  NI+LD++ + ++ DFG+ +   EN+     T    GTP Y
Sbjct: 109 LQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDY 162

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           +APE  L  +     D ++FGVL+ E+  G+ P +  ++     SI
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL +LH   +K +++RD+K  N++LD E + +L DFG+ +   E +    +T    GTP 
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPD 161

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE           D +A GVL+ E+ CG  P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 32/109 (29%), Positives = 60/109 (55%), Gaps = 6/109 (5%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L +LH    K +++RD+K  N++LD + + ++ DFG+ +   EN+          GTP 
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTPD 161

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
           Y+APE     +     D ++FGVL+ E+  G+ P +  +++   +SI++
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 6/94 (6%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL++LH   E+ +++RD+K  N++LD++ + +L D+G+ +   E L    +T    GTP 
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPN 161

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE           D +A GVL+ E+  GR P
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 6/106 (5%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L +LH+   K +++RD+K  N+MLD + + ++ DFG+ +   EN+   +      GTP Y
Sbjct: 109 LQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDY 162

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           +APE     + T   D ++FGVL+ E+  G+ P +  +++    SI
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 62/284 (21%), Positives = 116/284 (40%), Gaps = 84/284 (29%)

Query: 323 PKNKL------GKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTI 368
           P++ L      G G FG V +    G+ +      +AVK +  ++   ++E  ++E+  +
Sbjct: 36  PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKIL 95

Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEY--------------------------MPNGSL 401
             L +H+N+V L+G C      L++ EY                          +   S 
Sbjct: 96  SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSS 155

Query: 402 D--------KFIFYD----------------------------ETNSGPGEVTLNWEKRL 425
           D        K+I  D                            +         L+ +  L
Sbjct: 156 DYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLL 215

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 +Q +D+L   + K  +HRD+ + N++L     A++ DFGLAR I  +  +++  
Sbjct: 216 RFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVV 270

Query: 486 KEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           K  A  P  +MAPES      T+++D++++G+L+ E+ + G+ P
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 31/213 (14%)

Query: 320 NFNPKNKLGKGGFGTVYKG-IWRNKEI-AVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRN 375
            F   N++G+G +G VY+     + EI A+K+V  +  R G     + E+T + +LRH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 376 LVKLIGWCYERH--DFLLVYEYMPN--GSLDKFIFYDETNSGPGEVTLNWEKRLS--VIH 429
           +V+L      +H     LV EY      SL         ++ P   + +  K L   ++ 
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASL--------LDNMPTPFSESQVKCLMLQLLR 119

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
           G    L YLH   E  ++HRD+K SN++L  +   ++ DFGLART    L     T ++ 
Sbjct: 120 G----LQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVV 170

Query: 490 GTPGYMAPESFLVGRATIET--DIYAFGVLILE 520
            T  Y APE  L+G  T  T  D++A G ++ E
Sbjct: 171 -TLWYRAPE-LLLGCTTYTTAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 29/232 (12%)

Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIG 369
           L  L+   G F     +G G +G VYKG   +  ++A  +V + +   ++E   E+  + 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67

Query: 370 SL-RHRNLVKLIGWCYER----HD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
               HRN+    G   ++    HD    LV E+   GS+   +   + N+    +  +W 
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA----LKEDWI 123

Query: 423 KRLS--VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
             +   ++ G    L +LH     +V+HRDIK  N++L      +L DFG++  +   + 
Sbjct: 124 AYICREILRG----LAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176

Query: 481 THHSTKEIAGTPGYMAPESFLVGR---ATIE--TDIYAFGVLILEVACGRKP 527
             ++     GTP +MAPE         AT +  +DI++ G+  +E+A G  P
Sbjct: 177 RRNT---FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVS-ETSRQG-KQEFIAEVTTIGSLR---H 373
           + P  ++G G +GTVYK    +    +A+K V  +T+  G     + EV  +  L    H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 374 RNLVKLIGWCYE-RHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
            N+V+L+  C   R D      LV+E++          Y +    PG   L  E    ++
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQ----DLRTYLDKVPPPG---LPAETIKDLM 114

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
               + LD+LH      ++HRD+K  NI++ S    +L DFGLAR          +   +
Sbjct: 115 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPV 167

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 71/254 (27%), Positives = 108/254 (42%), Gaps = 44/254 (17%)

Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQE---FIAEVTTIGSLRHRN-LVK 378
           +GKG FG V     ++K      AVK + + +   K+E    +AE         RN L+K
Sbjct: 3   IGKGSFGKVLLA--KHKADGKFYAVKVLQKKAILKKKEQKHIMAE---------RNVLLK 51

Query: 379 LIGWCYERHDFL--LVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHG----- 430
            +     +H FL  L Y +    + DK  F  D  N G     L  E+            
Sbjct: 52  NV-----KHPFLVGLHYSFQ---TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA 103

Query: 431 -TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             + AL YLH      +++RD+K  NI+LDS+ +  L DFGL +   E ++   +T    
Sbjct: 104 EIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFC 157

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GTP Y+APE           D +  G ++ E+  G  P    +     ++I++    LR 
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPLRL 215

Query: 550 KGRILDAADSRLGG 563
           K  I  +A   L G
Sbjct: 216 KPNISVSARHLLEG 229

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 18/163 (11%)

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           Q L  +H+   K ++HRDIKS+NI+L S    +LGDFG ++ +     +    +   GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGTP 209

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
            Y+APE +     + + D+++ GVL+ E+   ++P        ++   +  +      GR
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP--------FDGENMEEVMHKTLAGR 261

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
                 S         EM+ ++   L+    +P  RPS   +L
Sbjct: 262 YDPLPPS------ISPEMQEIVTALLS---SDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 318 TGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLR 372
           T  +     +G G FG V   +     + +A+K++ +   T    K+ +  E+  +  LR
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67

Query: 373 HRNLVKLIG-WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           H N++ L   +     D   V E +    L + +      S P E          ++ G 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRG- 120

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
              L Y+H+     V+HRD+K SNI+++   + ++ DFGLAR IQ+       T  ++ T
Sbjct: 121 ---LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-IQD----PQMTGYVS-T 168

Query: 492 PGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKP 527
             Y APE  L   +  +E DI++ G +  E+  G KP
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 42/223 (18%)

Query: 326 KLGKGGFGTV----YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR--------- 372
           +LG+G +G V           + +A+K+++         F  ++    +LR         
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59

Query: 373 -HRNLVKL----IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
            H+N+  L    I +     + L +YE +    L + I      SG     L      S 
Sbjct: 60  GHKNITCLYDMDIVF-PGNFNELYLYEELMEADLHQII-----RSG---QPLTDAHFQSF 110

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK--THHST 485
           I+     L Y+H+ +   VLHRD+K  N++++++   ++ DFGLAR   EN        T
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           + +A T  Y APE  L  ++ T   D+++ G ++ E+  GRKP
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 37/217 (17%)

Query: 327 LGKGGFGTVYK-----GIWRNKEIAVKRVSE----TSRQGKQEFIAEVTTIGSLRHRNLV 377
           LGKGG+G V++     G    K  A+K + +     +++      AE   + +++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 378 KLIGWCYERHDFLLVYEYMPNGSL-----DKFIFYDETNS-GPGEVTLNWEKRLSVIHGT 431
            LI          L+ EY+  G L      + IF ++T      E++L            
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL------------ 111

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR-TIQENLKTHHSTKEIAG 490
             AL++LH   ++ +++RD+K  NI+LD++ + +L DFGL + +I E   TH       G
Sbjct: 112 --ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCG 162

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           T  YMAPE  +        D ++ G L+ ++  G  P
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)

Query: 327 LGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCY 384
           +GKG +G V+K + + N   A  ++ +      +E  AE   + +L  H N+VK  G  Y
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT------LNWEKRLS------VIHGTS 432
           ++         + NG  D+     E  +G G VT      L   +R+       ++H   
Sbjct: 86  KKD--------VKNG--DQLWLVLELCNG-GSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             L +LH     + +HRD+K +NI+L +E   +L DFG++  +     T        GTP
Sbjct: 135 MGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS---TRLRRNTSVGTP 188

Query: 493 GYMAPESFLVGRATIET-----DIYAFGVLILEVACGRKP 527
            +MAPE     +    T     D+++ G+  +E+  G  P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL+ LH   +  V++RD+K  NI+LD + +  L DFGL +    N+K    T    GTP 
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPE 158

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE  L    T   D +  GVL+ E+  G  P
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 39/218 (17%)

Query: 327 LGKGGFGTVYKGIWRN---------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           LG+G F  ++KGI R           E+ +K + ++ R   + F    + +  L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              G C    + ++V EY+  GSLD ++           + ++W  +L V    + AL +
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-----KKNKNLINISW--KLEVAKQLAWALHF 115

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNA--------RLGDFGLARTIQENLKTHHSTKEI- 488
           L    +K + H ++ + N++L  E +         +L D G++ T+          KEI 
Sbjct: 116 LE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL--------PKEIL 164

Query: 489 -AGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACG 524
               P ++ PE     +  ++  D ++FG  + E+  G
Sbjct: 165 LERIP-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 42/240 (17%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRV--SETSRQGKQEFIAEVTTIGSLRH 373
           +F+ K+ +G+G FG V   + R K      A+K +  S    Q    F  E   I S+ +
Sbjct: 2   DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 374 RNLVKLIGWCYE-RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
              +  + + ++ + +  LV EY P G L                 L+   R        
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------------LSLLNRYEDQFDED 102

Query: 433 QALDYL-------HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            A  YL       H+  +   +HRDIK  N+++D   + +L DFG A  +  N K  +S 
Sbjct: 103 MAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSK 161

Query: 486 KEIAGTPGYMAPESFLV----GRAT--IETDIYAFGVLILEVACGRKPGNQ-SEQNSYNN 538
             + GTP Y+APE        G+ T  +E D ++ GV+  E+  GR P ++ +   +YNN
Sbjct: 162 LPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 10/96 (10%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           ALD+LH+     +++RD+K  NI+LD E + +L DFGL++   E++          GT  
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVE 163

Query: 494 YMAPESFLVGRA--TIETDIYAFGVLILEVACGRKP 527
           YMAPE  +V R   T   D ++FGVL+ E+  G  P
Sbjct: 164 YMAPE--VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 47/185 (25%), Positives = 94/185 (50%), Gaps = 23/185 (12%)

Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
           E+ L+ E  LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264

Query: 476 QENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQ 533
           + +  +++  K  A  P  +MAPES      T E+D++++G+L+ E+ + G  P      
Sbjct: 265 RND--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322

Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
           +S         +++ ++G  + +       E +  EM  ++    +C   +P  RP+ K 
Sbjct: 323 DSK-------FYKMIKEGYRMLSP------ECAPSEMYDIM---KSCWDADPLKRPTFKQ 366

Query: 594 VLQVL 598
           ++Q++
Sbjct: 367 IVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 69/271 (25%), Positives = 103/271 (38%), Gaps = 66/271 (24%)

Query: 291 LDDDIEGLINGTNL-------APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK 343
            D DI  L    N+            ++ +L+    +F+    +G+G FG V   + R+K
Sbjct: 8   YDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHK 65

Query: 344 E----IAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD---FLLVYE 394
                 A+K +S  E  ++    F  E   I  + H N   ++   Y   D     +V E
Sbjct: 66  SSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQLHYAFQDDKYLYMVME 123

Query: 395 YMPNGSL-----------DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
           YMP G L               FY        EV L              ALD +H+   
Sbjct: 124 YMPGGDLVNLMSNYDIPEKWARFY------TAEVVL--------------ALDAIHSMG- 162

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-- 501
              +HRD+K  N++LD   + +L DFG    +  N      T    GTP Y++PE     
Sbjct: 163 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQ 218

Query: 502 -----VGRATIETDIYAFGVLILEVACGRKP 527
                 GR   E D ++ GV + E+  G  P
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 2e-09
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 39/219 (17%)

Query: 331 GFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL------IGWCY 384
           G  +  +G  + + +  KRV   SR   Q    E+  +G L H N++K+          Y
Sbjct: 181 GVNSTNQGKPKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKIEEILRSEANTY 239

Query: 385 ---ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +++DF L Y +M + + D   + D          L  + R +++     A++Y+H+ 
Sbjct: 240 MITQKYDFDL-YSFMYDEAFD---WKDRP--------LLKQTR-AIMKQLLCAVEYIHD- 285

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             K+++HRDIK  NI L+ +    LGDFG A    E  +       + GT    +PE  L
Sbjct: 286 --KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWV-GTVATNSPE-IL 340

Query: 502 VGRATIE-TDIYAFGVLILEVAC---------GRKPGNQ 530
            G    E TDI++ G+++L++           G KPG Q
Sbjct: 341 AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379

Length = 501

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.9 bits (147), Expect = 2e-09
 Identities = 65/256 (25%), Positives = 111/256 (43%), Gaps = 49/256 (19%)

Query: 326 KLGKGGFGTVY-------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           K+G G FG V+       +  +  K I+ + + E   + K + + EV  +  L+H+N+V+
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVIEVNVMRELKHKNIVR 76

Query: 379 LIGWCYER--HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
            I     +      ++ E+   G L + I       G  E     +    ++H    AL 
Sbjct: 77  YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH----ALA 132

Query: 437 YLHNGSE----KRVLHRDIKSSNIMLDSEFN-----------------ARLGDFGLARTI 475
           Y HN  +    +RVLHRD+K  NI L +                    A++GDFGL++ I
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIE--TDIYAFGVLILEVACGRKPGNQSEQ 533
                 H       GTP Y +PE  L    + +  +D++A G +I E+  G+ P +++  
Sbjct: 193 GIESMAH----SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-- 246

Query: 534 NSYNNSIVHWLWELRR 549
               N+    + EL+R
Sbjct: 247 ----NNFSQLISELKR 258

Length = 1021

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 326 KLGKGGFGTVYKGIWRN----KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL-- 379
           K+G+G +G VYK   ++    KE A+K++  T          E+  +  L+H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65

Query: 380 IGWCYERHDFLLVYEYMPNG--SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +   +      L+++Y  +    + KF    + N  P ++  +  K L       Q LD 
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL-----LYQILDG 120

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNAR----LGDFGLARTIQENLKTHHSTKEIAGTPG 493
           +H      VLHRD+K +NI++  E   R    + D G AR     LK       +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEV 521
           Y APE  L  R  T   DI+A G +  E+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 4e-09
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 8/165 (4%)

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
           +E+  + +  H  +VK           LL+ EY   G L+K I        P +    +E
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYE 170

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
             L + +    ALD +H+   ++++HRD+KS+NI L      +LGDFG ++   +++   
Sbjct: 171 VGL-LFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            ++    GTP Y+APE +   R + + D+++ GV++ E+    +P
Sbjct: 227 VAS-SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 41/213 (19%)

Query: 325 NKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEF--IAEVTT---IGSLR----H 373
            K+G+G F  V K       K  A+K +       K+ F  + +V     I +LR    H
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPH 57

Query: 374 RNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL-SVIHG 430
            N+++LI   ++R      LV+E M + +L + I         G      EKR+ S ++ 
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELM-DMNLYELI--------KGRKRPLPEKRVKSYMYQ 108

Query: 431 TSQALDYLH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++LD++H NG    + HRDIK  NI++  +   +L DFG  R I     +     E  
Sbjct: 109 LLKSLDHMHRNG----IFHRDIKPENILIKDD-ILKLADFGSCRGIY----SKPPYTEYI 159

Query: 490 GTPGYMAPESFLV-GRATIETDIYAFGVLILEV 521
            T  Y APE  L  G    + DI+A G +  E+
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 326 KLGKGGFGTVYKGI----WRNKEIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           ++G G FG V  G     +   ++ VK +    S Q + +F+ E     SL+H NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDET--NSGPGEVTLN---WEKRLSVIHGTSQAL 435
           G C E   +LLV E+ P G L  ++          P   TL     E  L ++H      
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH------ 115

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GY 494
             LH   +   +H D+   N +L ++   ++GD+GL+    +  + ++ T +    P  +
Sbjct: 116 --LH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK--EDYYVTPDQLWVPLRW 168

Query: 495 MAPE-------SFLVGRATIETDIYAFGVLILEV 521
           +APE       + LV   T E+++++ GV I E+
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL----- 379
           LG G  G V+  +    +K +AVK++  T  Q  +  + E+  I  L H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 380 ---------IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-VTLNWEKRLSVIH 429
                    +G   E +   +V EYM    L   +   E      E   L   + L    
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQLL---- 124

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTK-- 486
              + L Y+H+ +   VLHRD+K +N+ +++E    ++GDFGLAR     +  H+S K  
Sbjct: 125 ---RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI----VDPHYSHKGY 174

Query: 487 --EIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
             E   T  Y +P   L     T   D++A G +  E+  G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 27/246 (10%)

Query: 292 DDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKR 349
           + +I+  +N      +K R  ++K    +++    +G+G FG V   +     K  A+K 
Sbjct: 18  NKNIDNFLNRYEKIVRKIRKLQMKAE--DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75

Query: 350 VS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIF 406
           +S  E  ++    F  E   I +  +   V  +   ++   +L +V EYMP G L   + 
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135

Query: 407 -YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR 465
            YD        V   W K  +       ALD +H+     ++HRD+K  N++LD   + +
Sbjct: 136 NYD--------VPEKWAKFYTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLK 182

Query: 466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEV 521
           L DFG    + E       T    GTP Y++PE        G    E D ++ GV + E+
Sbjct: 183 LADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Query: 522 ACGRKP 527
             G  P
Sbjct: 241 LVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.0 bits (137), Expect = 9e-09
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 326 KLGKGGFGTVYKGIWRN----KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL-- 379
           K+G+G +G VYK   ++    ++ A+K++  T          E+  +  L+H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65

Query: 380 IGWCYERHDFLLVYEYMPNG--SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +   +      L+++Y  +    + KF    + N  P ++     K L       Q LD 
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL-----LYQILDG 120

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNAR----LGDFGLARTIQENLKTHHSTKEIAGTPG 493
           +H      VLHRD+K +NI++  E   R    + D G AR     LK       +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEV 521
           Y APE  L  R  T   DI+A G +  E+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 26/163 (15%)

Query: 442 SEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
           + ++ +HRD+ + NI+L SE N  ++ DFGLAR I ++    +  K  A  P  +MAPES
Sbjct: 190 ASRKCIHRDLAARNILL-SENNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPES 246

Query: 500 FLVGRATIETDIYAFGVLILEV---ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
                 T ++D+++FGVL+ E+        PG Q ++             L+   R+   
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR--------RLKEGTRMRAP 298

Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                  E++  E+  ++   L C H NP  RP+   ++++L 
Sbjct: 299 -------EYATPEIYSIM---LDCWHNNPEDRPTFSELVEILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 330 GGFGTVYKGIWRNKE----IAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           G +G VY  + R+KE     A+K++++ +   R   Q+   E   +    +  +V +   
Sbjct: 12  GAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS 69

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
              +    +V EY+  G     +     N G   V +    R+     T  AL+YLHN  
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLL----KNIGALPVDM---ARMYFAE-TVLALEYLHNYG 121

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLAR----TIQENLKTHH--------STKEIAG 490
              ++HRD+K  N+++ S  + +L DFGL++    ++  NL   H          K++ G
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           TP Y+APE  L        D +A G+++ E   G  P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S     GT G
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV----GTHG 160

Query: 494 YMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQ 530
           YMAPE    G A   + D ++ G ++ ++  G  P  Q
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 32/228 (14%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQE---FIAEVTTIGSLRHRN-LVKLI 380
           +GKG FG V   K        AVK + + +   K+E    +AE         RN L+K +
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE---------RNVLLKNL 53

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG------TSQA 434
                +H FL+   Y    +   +   D  N G     L  E+              + A
Sbjct: 54  -----KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + YLH+     +++RD+K  NI+LDS+ +  L DFGL +   E ++   +T    GTP Y
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEY 162

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
           +APE           D +  G ++ E+  G  P    + +   ++I+H
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 327 LGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQE---FIAEVTTI-GSLRHRNLVKLI 380
           +GKG FG V     + +E   AVK + + +   K+E    ++E   +  +++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 381 GWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            + ++  D L  V +Y+  G L    FY           L    R       S AL YLH
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL----FYHLQRE---RCFLEPRARFYAAEIAS-ALGYLH 113

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +     +++RD+K  NI+LDS+ +  L DFGL +   EN++ + +T    GTP Y+APE 
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEV 167

Query: 500 FLVGRATIETDIYAFGVLILEVACGRKP 527
                     D +  G ++ E+  G  P
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S     GT GY
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV----GTHGY 161

Query: 495 MAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYN 537
           MAPE    G A   + D ++ G ++ ++  G  P  Q +    +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 36/227 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNL 376
            +   + +G+G +G V     +    ++A+K++S    Q   Q  + E+  +   +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 377 VK----LIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS----- 426
           +     +    +E  +D  +V E M    L K I                 + LS     
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK---------------TQHLSNDHIQ 109

Query: 427 -VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
             ++   + L Y+H+ +   VLHRD+K SN++L++  + ++ DFGLAR            
Sbjct: 110 YFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRK--PGN 529
            E   T  Y APE  L  +  T   DI++ G ++ E+   R   PG 
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 8/93 (8%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L YLH+     +LHRDIK  N++++S    ++ DFGLAR  +E  ++ H T+E+  T  Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVV-TQYY 170

Query: 495 MAPESFLVG--RATIETDIYAFGVLILEVACGR 525
            APE  L+G    T   DI++ G +  E+   R
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 45/201 (22%)

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +VK+     ++ +  L+ E++P G +   +   +T        L  E+    I  T  A+
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--------LTEEETQFYIAETVLAI 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT------HHS----- 484
           D +H   +   +HRDIK  N++LDS+ + +L DFGL   +++  +T      +HS     
Sbjct: 115 DSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 485 -----------------TKEIA----GTPGYMAPESFLVGRATIETDIYAFGVLILEVAC 523
                             +++A    GTP Y+APE F+        D ++ GV++ E+  
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 524 GRKP-GNQSEQNSYNNSIVHW 543
           G  P  +++ Q +Y   +++W
Sbjct: 232 GYPPFCSETPQETYKK-VMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)

Query: 323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVK 378
           P   +G+G +G V        N+++A+K+++    +R   +  + E+  +  L H N++ 
Sbjct: 9   PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 379 LIGWCYERH-----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +       H     D  +VYE M +  L + I   +T        L+ +     ++   +
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQT--------LSDDHCQYFLYQLLR 119

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L Y+H+ +   VLHRD+K SN++L++  + ++ DFGLART     +      E   T  
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRW 173

Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
           Y APE  L     T   D+++ G +  E+  GRKP
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 36/230 (15%)

Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRN-LVKLI 380
           +GKG FG V   K     K  AVK + +    +R+ ++  +AE         RN L+K +
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE---------RNVLLKNV 53

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV--------IHGTS 432
                +H FL+   Y    + +K  F  +  +G GE+  + ++  S             +
Sbjct: 54  -----KHPFLVGLHYSFQ-TTEKLYFVLDFVNG-GELFFHLQRERSFPEPRARFYAAEIA 106

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            AL YLH+     +++RD+K  NI+LDS+ +  L DFGL +   E +    +T    GTP
Sbjct: 107 SALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTP 160

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
            Y+APE           D +  G ++ E+  G  P    +     ++I+H
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 25/228 (10%)

Query: 310 RLKELKKATGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVS--ETSRQGKQEFIAEV 365
           ++++L+    ++     +G+G FG V   +     K  A+K +S  E  ++    F  E 
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEK 423
             I +  +   V  + + ++   +L +V EYMP G L   +  YD        V   W +
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--------VPEKWAR 145

Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
             +       ALD +H+      +HRD+K  N++LD   + +L DFG    + +      
Sbjct: 146 FYTA--EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200

Query: 484 STKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVACGRKP 527
            T    GTP Y++PE        G    E D ++ GV + E+  G  P
Sbjct: 201 DTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 41/116 (35%), Positives = 61/116 (52%), Gaps = 13/116 (11%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART-IQENLKTHHSTKEIAGTP 492
           ALD+LH   +  +++RDIK  NI+LDSE +  L DFGL++  + E  +  +S     GT 
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS---FCGTI 170

Query: 493 GYMAPESFLVGRATIE--TDIYAFGVLILEVACGRKP----GNQSEQNSYNNSIVH 542
            YMAPE    G    +   D ++ GVL  E+  G  P    G Q+ Q+  +  I+ 
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK 226

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 47/202 (23%)

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +VK+     ++ +  L+ E++P G +   +   +T        L+ E     I  T  A+
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--------LSEEATQFYIAETVLAI 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE--------NLKTHHSTKE 487
           D +H   +   +HRDIK  N++LD++ + +L DFGL   +++        NL TH+   +
Sbjct: 115 DAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL-THNPPSD 170

Query: 488 IA-------------------------GTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
            +                         GTP Y+APE F+        D ++ GV++ E+ 
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 523 CGRKP-GNQSEQNSYNNSIVHW 543
            G  P  +++ Q +Y   +++W
Sbjct: 231 IGYPPFCSETPQETYRK-VMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 49/219 (22%)

Query: 327 LGKGGFGTVYKGI-WRNKE-IAVKRVSETSRQGKQEFIA-----EVTTIGSLRHRNLVKL 379
           +G G +G+V   I  R  E +A+K++S   R  + E  A     E+T +  ++H N+   
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENV--- 76

Query: 380 IGWC---------YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           IG            E  DF LV  YM    L K + +           L+ +K   +++ 
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP----------LSEDKVQYLVYQ 125

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
               L Y+H+     ++HRD+K  N+ ++ +   ++ DFGLAR         H+  E+ G
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTG 173

Query: 491 ---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
              T  Y APE  L      +T DI++ G ++ E+  G+
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 55/275 (20%), Positives = 114/275 (41%), Gaps = 43/275 (15%)

Query: 335 VYKGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL- 390
           +YKGI+ NKE+ ++   +  +  K        E+  +  +   N++K+ G+  +  D L 
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 391 ---LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVL 447
              L+ EY   G L + +          E  L+++ +L +     + L  L+  + K   
Sbjct: 96  RLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-- 145

Query: 448 HRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL--VGRA 505
           ++++ S + ++   +  ++   GL     E + +    K +     Y + +         
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNV-NFMVYFSYKMLNDIFSEY 199

Query: 506 TIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGE 564
           TI+ DIY+ GV++ E+  G+ P  N + +  Y+  I       +     L          
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII------NKNNSLKLPLDCPL---- 249

Query: 565 FSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
               E++C++    AC   +   RP++K +L  LS
Sbjct: 250 ----EIKCIVE---ACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 325 NKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           N +G G FG VY+ I    ++++A+K+V +  +   +E +     + +L H N++ L  +
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127

Query: 383 CY-------ERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            Y       E++ FL +V E++P  ++ K++ +   N+    + L   K  S  +   +A
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL--VKLYS--YQLCRA 182

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           L Y+H+   K + HRD+K  N+++D   +  +L DFG A+ +   L    S   I  +  
Sbjct: 183 LAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVSYIC-SRF 235

Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACG 524
           Y APE  L     T   D+++ G +I E+  G
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 28/212 (13%)

Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRN-LVKLI 380
           K+G+G +G VYK   +N  K +A+K+   E   +G     + E++ +  L     +V+L+
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 381 GWCYERHD-------FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
               E  +         LV+EY+ +  L KF+  D    GPG   L  +   S ++   +
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM--DSNGRGPGR-PLPAKTIKSFMYQLLK 121

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTP 492
            + + H   +  V+HRD+K  N+++D +    ++ D GL R     +K++  T EI  T 
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIV-TL 175

Query: 493 GYMAPESFLVGRATIET--DIYAFGVLILEVA 522
            Y APE  L+G     T  DI++ G +  E++
Sbjct: 176 WYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 8/96 (8%)

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH--HSTKEIAGTP 492
           L Y+H+ +   V+HRD+K SN++++ +   R+GDFG+AR +  +   H    T+ +A T 
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TR 175

Query: 493 GYMAPESFLV-GRATIETDIYAFGVLILEVACGRKP 527
            Y APE  L     T   D+++ G +  E+  GR+ 
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 62/262 (23%), Positives = 115/262 (43%), Gaps = 69/262 (26%)

Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGK-QEFIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   + +  ++E+  +  +  H N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 378 KLIGWCYERHDFLLV-YEYMPNGSL--------DKFIFYD-------ETNSGPGEVTLNW 421
            L+G C +    L+V  E+   G+L         +F+ Y        +  SG G+++ + 
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 422 EKRLSVI--HGTSQALDYLHNGS------------------------------------- 442
           ++RL  I    +S +  ++   S                                     
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 443 --EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
              ++ +HRD+ + NI+L      ++ DFGLAR I ++    +  K  A  P  +MAPE+
Sbjct: 195 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPET 252

Query: 500 FLVGRATIETDIYAFGVLILEV 521
                 TI++D+++FGVL+ E+
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 9/105 (8%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL++LH   +  +++RDIK  NI+LDSE +  L DFGL++      K    T    GT  
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFCGTIE 171

Query: 494 YMAPESFL--VGRATIETDIYAFGVLILEVACGRKPGN-QSEQNS 535
           YMAPE      G      D ++ G+LI E+  G  P   + E+N+
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNT 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 24/161 (14%)

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
           + ++ +HRD+ + NI+L      ++ DFGLAR I ++    +  K  A  P  +MAPES 
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGSARLPLKWMAPESI 248

Query: 501 LVGRATIETDIYAFGVLILEV---ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
                T ++D+++FGVL+ E+        PG Q  +                  R+ D  
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ--------------RLKDGT 294

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
             R   E +  E+  ++   LAC   +P  RP+   ++++L
Sbjct: 295 RMR-APENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 29/218 (13%)

Query: 326 KLGK----GGFGTVYKGIWRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
            +GK         + K    N  +AVK+++    S++  +    E+ T   L+H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 380 IGWCYERHDFLLVYEYMPNGS---LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +       +  +V   M  GS   L K  F      G  E+ + +     ++     ALD
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHF----PEGLPELAIAF-----ILKDVLNALD 115

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI----QENLKTHHSTKEIAGTP 492
           Y+H+   K  +HR +K+S+I+L  +    L     + ++    +     H   K      
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172

Query: 493 GYMAPESF---LVGRATIETDIYAFGVLILEVACGRKP 527
            +++PE     L G    ++DIY+ G+   E+A G  P
Sbjct: 173 PWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 43/177 (24%)

Query: 321 FNPKNK-LGKGGFGTVYKGIWRN--KEIAVKRVS----ETSRQGKQEFIAEV----TTIG 369
           +  K   LG+G +G V K       K +A+K+V            ++ +       TT+ 
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 370 SLR------HRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            L+      H N++ L+   Y   DF+ LV + M    L K +              + +
Sbjct: 70  ELKIMNEIKHENIMGLVD-VYVEGDFINLVMDIM-ASDLKKVV--------------DRK 113

Query: 423 KRLSVIHGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
            RL+              L+ LH       +HRD+  +NI ++S+   ++ DFGLAR
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 64/252 (25%), Positives = 108/252 (42%), Gaps = 59/252 (23%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVK--RVSETSRQGKQEFI-AEVTTIGSLR 372
           +F     +G+G FG V   + + K+     A+K  R SE   + +   + AE   +    
Sbjct: 2   DFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59

Query: 373 HRNLVKLIGWCYERHDFL-LVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           +  +VKL  + ++  ++L L+ EY+P G +    +  D         T   E+    I  
Sbjct: 60  NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAE 109

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH------- 483
           T  A+D +H       +HRDIK  N++LD++ + +L DFGL   ++++ +T         
Sbjct: 110 TILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 484 -------------STKEIA---------------GTPGYMAPESFLVGRATIETDIYAFG 515
                        S+K  A               GTP Y+APE FL      E D ++ G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 516 VLILEVACGRKP 527
           V++ E+  G  P
Sbjct: 227 VIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           A+D +H   +   +HRDIK  NI++D   + RL DFG    + E+     S     GTP 
Sbjct: 114 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPD 168

Query: 494 YMAPESFLV-----GRATIETDIYAFGVLILEVACGRKP 527
           Y++PE         G+   E D ++ GV + E+  G  P
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 46/237 (19%)

Query: 327 LGKGGFGTVYKGIWRN--KEIAVKR-------VSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +GKG +G V   I  +  +++A+K+       VS+ +R      + E+  +  LRH ++V
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62

Query: 378 --KLIGWCYERHDF---LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
             K I     R +F    +V+E M    L + I  ++         L  E     ++   
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--------LTPEHHQFFLYQLL 113

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           +AL Y+H  +   V HRD+K  NI+ +++   ++ DFGLAR    +  T     +   T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 493 GYMAPE---SFLVGRATIETDIYAFGVLILEVACGRK--PGNQSEQNSYNNSIVHWL 544
            Y APE   SF   + T   DI++ G +  EV  G+   PG          ++VH L
Sbjct: 171 WYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPG---------KNVVHQL 217

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 8/91 (8%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT--HHSTKEIAGT 491
           A+DY+H    + ++HRDIK+ N++++   +  LGDFG A   + +  T  H+    IAGT
Sbjct: 272 AIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG---IAGT 325

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               APE       T   DI++ G++I E A
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 7/95 (7%)

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+  +   +HRDIK  N++LD   + RL DFG    + ++     S     GTP Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172

Query: 498 ESFL-----VGRATIETDIYAFGVLILEVACGRKP 527
           E        +G+   E D ++ GV + E+  G  P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 345 IAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNLVKLIG------WCYERHDFLLVYEY 395
           +AVK++S   +     K+ +  E+  +  + H+N++ L+          E  D  LV E 
Sbjct: 49  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN 455
           M + +L + I  +          L+ E+   +++     + +LH+     ++HRD+K SN
Sbjct: 108 M-DANLCQVIHME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 153

Query: 456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFG 515
           I++ S+   ++ DFGLART   N      T  +  T  Y APE  L        DI++ G
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMM---TPYVV-TRYYRAPEVILGMGYKENVDIWSVG 209

Query: 516 VLILEVACG 524
            ++ E+  G
Sbjct: 210 CIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 8/105 (7%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL++LH   +  +++RDIK  NI+LDS  +  L DFGL++   E+           GT  
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVERAYSFCGTIE 171

Query: 494 YMAPESFLVGRATIE--TDIYAFGVLILEVACGRKPGN-QSEQNS 535
           YMAP+    G    +   D ++ GVL+ E+  G  P     E+NS
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 25/217 (11%)

Query: 326 KLGKGGFGTVYKG-IWRNKEIAVKRVSE----TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           ++G G FG V    I+ +  +A   V E     S + + EF+ +      L+H N+++ +
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G C E   +LLV+EY   G L  ++  ++ +    ++ L       +  G    + ++H 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG----VTHMH- 116

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH-STKEIAGTP-GYMAPE 498
             +   LH D+   N  L S+   ++GD+G+  +     K  +  T++    P  ++APE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS---RYKEDYIETEDDKCVPLRWLAPE 171

Query: 499 ---SFLVGRATIE----TDIYAFGVLILEV-ACGRKP 527
               F  G  T E    ++++A GV + E+     +P
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 320 NFNPKNKLGKGGFGTV---YKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRH 373
           N  P   +G G  G V   Y  I   + +A+K++S   +     K+ +  E+  +  + H
Sbjct: 28  NLKP---IGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82

Query: 374 RNLVKLIG------WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
           +N++ L+          E  D  +V E M + +L + I          ++ L+ E+   +
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----------QMELDHERMSYL 131

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           ++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART   +      T  
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPY 185

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
           +  T  Y APE  L        DI++ G ++ E+  G 
Sbjct: 186 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 42/216 (19%)

Query: 327 LGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGKQEFIA-----EVTTIGSLRHRNLVKL 379
           +G G +GTV   + R    ++A+K++    R  + E  A     E+  +  ++H N++ L
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY---RPFQSELFAKRAYRELRLLKHMKHENVIGL 79

Query: 380 IGWCY------ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +            HDF LV  +M    L K + +++         L+ ++   +++   +
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---------LSEDRIQFLVYQMLK 129

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG--- 490
            L Y+H      ++HRD+K  N+ ++ +   ++ DFGLAR          +  E+ G   
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---------QTDSEMTGYVV 177

Query: 491 TPGYMAPESFLVG-RATIETDIYAFGVLILEVACGR 525
           T  Y APE  L     T   DI++ G ++ E+  G+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 10/99 (10%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           A+D +H   +   +HRDIK  N++LD   + RL DFG    +  +     +     GTP 
Sbjct: 114 AIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPD 168

Query: 494 YMAPESFLV-----GRATIETDIYAFGVLILEVACGRKP 527
           Y++PE         GR   E D ++ GV + E+  G  P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 28/98 (28%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           LS  +  ++ +++L   + K  +HRD+ + N++L      ++ DFGLAR I  +  +++ 
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD--SNYV 294

Query: 485 TKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           +K     P  +MAPES      T  +D++++G+L+ E+
Sbjct: 295 SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 38/219 (17%)

Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +G G +G+V   Y    R K +AVK++S    S    +    E+  +  ++H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 382 WCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLS------VIHGTSQ 433
                        + P  S++ F  ++      G     +   ++LS      +I+   +
Sbjct: 82  ------------VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L Y+H+     ++HRD+K SN+ ++ +   R+ DFGLAR   + +  + +T+       
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR------W 180

Query: 494 YMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
           Y APE  L      +T DI++ G ++ E+  G+   PGN
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 329 KGGFGTVYKGIWRN--KEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G FG VY G  +N  K  AVK V +     K    +  AE   +   +   +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 384 YERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
              ++  LV EY+  G +   +    ++DE            E  +  I   + ALDYLH
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDE------------EMAVKYISEVALALDYLH 121

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
                 ++HRD+K  N+++ +E + +L DFGL++
Sbjct: 122 RHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 7e-06
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 29/211 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + H+N+
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNI 78

Query: 377 VKLIG------WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           + L+          E  D  LV E M + +L + I          ++ L+ E+   +++ 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSYLLYQ 127

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
               + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T         
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVV 180

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEV 521
           T  Y APE  L        DI++ G ++ E+
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.1 bits (115), Expect = 8e-06
 Identities = 51/232 (21%), Positives = 100/232 (43%), Gaps = 52/232 (22%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRN 375
           +   + +G G +G V         +++A+K++S   +++   K+ +  E+  +  + H N
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHEN 75

Query: 376 LVKLIGWCY----ERHDFLLVYEYMP--NGSLDKFIFYDETNSGPGEVTLNWEKRLS--- 426
           ++ L+   +       DF  VY         L+  +                 ++LS   
Sbjct: 76  VIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIV---------------KCQKLSDDH 119

Query: 427 ---VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
              +++   + L Y+H+     ++HRD+K SNI ++ +   ++ DFGLAR         H
Sbjct: 120 IQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---------H 167

Query: 484 STKEIAG---TPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRK--PGN 529
           +  E+ G   T  Y APE  L         DI++ G ++ E+  G+   PG+
Sbjct: 168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 15/113 (13%)

Query: 411 NSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG 470
            S P    L  ++ L +     + L YLH    +R++HRD+K+ NI ++      +GD G
Sbjct: 150 RSRP----LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG 202

Query: 471 LAR--TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
            A+   +            +AGT    APE     +   + DI++ G+++ E+
Sbjct: 203 AAQFPVVAPAFLG------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA-RTIQENLKTHH 483
           L++     +A+ YLH     R++HRDIK+ NI ++   +  LGDFG A   +  N   ++
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                AGT    APE           DI++ G+++ E+A   
Sbjct: 242 GW---AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 18/108 (16%)

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR         H+  
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDD 172

Query: 487 EIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PG 528
           E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 3e-05
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 31/162 (19%)

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------ 426
           + N +KL          +L+ +Y+ +G L     +D          L  E +LS      
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL-----FD---------LLKKEGKLSEAEVKK 113

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHST 485
           +I    +AL+ LH      ++H DIK  N++ D ++    L D+GL + I     + +  
Sbjct: 114 IIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GTPSCYD- 167

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
               GT  Y +PE        +  D +A GVL  E+  G+ P
Sbjct: 168 ----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 60/261 (22%), Positives = 87/261 (33%), Gaps = 86/261 (32%)

Query: 321 FNPKNKLGKGGFGTVY----KGIWRNKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRH 373
           F     LGKG  G V+    KG    K  A+K + +     R   +  + E   + +L H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 374 RNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPG-------------EVTL 419
             L  L    ++   +L LV +Y P G       +      PG             EV L
Sbjct: 61  PFLPTLY-ASFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA------- 472
                         AL+YLH      +++RD+K  NI+L    +  L DF L+       
Sbjct: 115 --------------ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157

Query: 473 -----------RTIQENLKTHHSTKEIA--------GTPGYMAPE-------SFLVGRAT 506
                      R    N     +  E          GT  Y+APE          V    
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV---- 213

Query: 507 IETDIYAFGVLILEVACGRKP 527
              D +  G+L+ E+  G  P
Sbjct: 214 ---DWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 25/81 (30%), Positives = 47/81 (58%), Gaps = 3/81 (3%)

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
           + K  +HRD+ + N+++      ++ DFGLAR I  +  +++ +K     P  +MAPES 
Sbjct: 256 ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD--SNYISKGSTFLPLKWMAPESI 313

Query: 501 LVGRATIETDIYAFGVLILEV 521
                T  +D+++FG+L+ E+
Sbjct: 314 FNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 79/367 (21%), Positives = 131/367 (35%), Gaps = 100/367 (27%)

Query: 270 PAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAP--KKFRLKELKKATGNFNPKNKL 327
           P   L    A Y W             G ++   LAP    FR    KK   +F    KL
Sbjct: 90  PGAALALLAATYLWATPGV------APGFVDMFVLAPLEGLFR-PSFKKD--DFVLGKKL 140

Query: 328 GKGGFGTVYKGIWRNK------EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           G+G FG VYK    NK      +  +K+ +E           E+     +R         
Sbjct: 141 GEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------VEIWMNERVRRACPNSCAD 193

Query: 382 WCY---------ERHDFLLVYEYMPNGSL-------------DKFIFYDETNSGPGEVTL 419
           + Y         +  ++ LV+ Y    +L             + ++     +   G   L
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG---L 250

Query: 420 NWEKRL--SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQ 476
             E ++  +++     ALD LH+     ++HRD+K  NI+      + ++ D G A  ++
Sbjct: 251 ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR 307

Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIET----------------------DIYAF 514
             +  ++  KE    P Y APE +++   T                         DIY+ 
Sbjct: 308 VGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365

Query: 515 GVLILEVACGRKPGNQSEQN--SYN-------NSIVHWL--------WELRRKGRILDAA 557
           G++ L++A    P  +S+ N   +N         +V W          +LRR   +LD  
Sbjct: 366 GLIFLQMAF---PNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD-L 421

Query: 558 DSRLGGE 564
           D   G E
Sbjct: 422 DGGAGWE 428

Length = 566

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 40/174 (22%), Positives = 65/174 (37%), Gaps = 59/174 (33%)

Query: 447 LHRDIKSSNIMLDSEFNARLGDFGLA-------------RTIQENLKTHHSTK------- 486
           +HRDIK  NI++D   + +L DFGL+             + +Q     +           
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 487 ----------EIA--------------GTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
                     +IA              GTP Y+APE FL      E D ++ G ++ E  
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 523 CGRKP-GNQSEQNSYNNSIVHWLWELRRKG-------------RILDAADSRLG 562
            G  P  +++   +Y   I++W   L                 R++  A++RLG
Sbjct: 243 IGWPPFCSENSHETYRK-IINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLG 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 43/134 (32%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL---------ARTIQEN------ 478
           A++ +H       +HRDIK  NI++D + + +L DFGL         ++  Q+       
Sbjct: 113 AIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169

Query: 479 ------------------LKTHHSTKE-------IAGTPGYMAPESFLVGRATIETDIYA 513
                             L+     +        + GTP Y+APE  L    T   D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229

Query: 514 FGVLILEVACGRKP 527
            GV++ E+  G+ P
Sbjct: 230 VGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 7/92 (7%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            + +LH+     ++HRD+K SNI++ S+   ++ DFGLART   +      T  +  T  
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVV-TRY 182

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGR 525
           Y APE  L        DI++ G ++ E+  G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 30/125 (24%), Positives = 48/125 (38%), Gaps = 44/125 (35%)

Query: 447 LHRDIKSSNIMLDSEFNARLGDFGLA---------------------------------- 472
           +HRDIK  NI++D + + +L DFGL                                   
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 473 -------RTIQENLKTHHS---TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
                  +T+++     H       + GTP Y+APE  L    T   D ++ GV++ E+ 
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 523 CGRKP 527
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173892 cd07308, lectin_leg-like, legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 40/213 (18%), Positives = 66/213 (30%), Gaps = 49/213 (23%)

Query: 49  VAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGE 108
           + K+ I++T       + +QSG         LW         F      +I   +   G+
Sbjct: 30  ITKNYIRLT-----PDVPSQSG--------SLWSRVPIPAKDFEIEVEFSIHGGSGLGGD 76

Query: 109 GLAFVIAGNKDLPENSEG---QWLGIVNGIT------NGTNQSQIVAIEFDTKKSY--EQ 157
           G AF             G   ++ G+   I       +G     I     D  KSY  E 
Sbjct: 77  GFAFWYTEEPGSDGPLFGGPDKFKGL--AIFFDTYDNDGKGFPSISVFLNDGTKSYDYET 134

Query: 158 DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANMETP------ 211
           D     +              L   N    T +++   Y    + V +   E        
Sbjct: 135 DGEKLELA----------SCSLKFRNSNAPTTLRIS--YLNNTLKVDITYSEGNNWKECF 182

Query: 212 LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCV 244
            + + I  S+      + GFSA TGD +  + +
Sbjct: 183 TVEDVILPSQG-----YFGFSAQTGDLSDNHDI 210

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 218

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 24/115 (20%)

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA----------------RLGDFG 470
           +I  T  ALDY H  +E  ++H D+K  NI++++                    R+ D G
Sbjct: 236 IIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                       HS   I  T  Y +PE  L       TD+++ G +I E+  G+
Sbjct: 294 GC------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 39/217 (17%)

Query: 327 LGKGGFGTVYKGIWR------------NKEIAV--KRVSETSRQGKQEFIAEVTTIGSLR 372
           LG+G    +Y GI               KEI V  K +  + R     F    + +  + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H+++V L G C    + ++V E++  G LD F+           +T  W  +  V    +
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-----VLTTPW--KFKVAKQLA 115

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIML-----DSEFNA--RLGDFGLARTIQENLKTHHST 485
            AL YL    +K ++H ++ + NI+L     D E     +L D G+  T+        S 
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL-------SR 165

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEV 521
           +E      ++APE     +  +I  D ++FG  + E+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	644
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK10345	210	hypothetical protein; Provisional	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
smart00090	237	RIO RIO-like kinase.	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.97
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	98.95
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	98.94
KOG3087	229	consensus Serine/threonine protein kinase [General	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
COG4248	637	Uncharacterized protein with protein kinase and he	98.72
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.58
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
PRK09902	216	hypothetical protein; Provisional	98.46
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.41
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	98.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.22
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.19
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	98.13
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
PF01636	239	APH: Phosphotransferase enzyme family This family	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
KOG3839	351	consensus Lectin VIP36, involved in the transport	97.93
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.86
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.82
PLN02876	822	acyl-CoA dehydrogenase	97.81
PRK10593	297	hypothetical protein; Provisional	97.78
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.71
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.69
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.68
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.56
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.54
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.53
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.52
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.36
PRK05231	319	homoserine kinase; Provisional	97.34
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.24
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.09
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.05
PLN02236	344	choline kinase	96.55
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.28
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.18
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.08
COG2334	331	Putative homoserine kinase type II (protein kinase	95.83
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.83
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.82
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.65
PLN02756	418	S-methyl-5-thioribose kinase	95.61
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.59
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=483.31  Aligned_cols=290  Identities=45%  Similarity=0.783  Sum_probs=255.6

Q ss_pred             CCcccCHHHHHHHhCCCCCCCcccccCcEEEEEeeecC-ceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeee
Q 006446          305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC  383 (644)
Q Consensus       305 ~~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~  383 (644)
                      ..+.|++.++..||++|...++||+|+||.||+|.+.+ ..||||++.....+..++|..|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999996 78999988765543156699999999999999999999999


Q ss_pred             eecc-ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          384 YERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       384 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      .+.+ +.+||||||++|||.++|+.....      .|+|.+|++|+.++|+||+|||+.+..+|+||||||+|||||+++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            9999 499999999999999999865432      489999999999999999999999888999999999999999999


Q ss_pred             cEEEeccCCccccccccccccccccc-ccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEI-AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      ++||+|||+|+..... ...  .... .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+ .....++
T Consensus       215 ~aKlsDFGLa~~~~~~-~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~  290 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEG-DTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLV  290 (361)
T ss_pred             CEEccCccCcccCCcc-ccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHH
Confidence            9999999999765421 111  1112 899999999999999999999999999999999999998876442 2223499


Q ss_pred             HHHHHHHhcCchhhhhhcccC-CCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          542 HWLWELRRKGRILDAADSRLG-GEFSE-KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      +|++.....+++.+++|+++. +++.. +++.++..++.+|++++|++||+|.||+++|+.....
T Consensus       291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            999999999999999999997 66765 7899999999999999999999999999999665443

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=4.2e-51  Score=409.09  Aligned_cols=222  Identities=40%  Similarity=0.688  Sum_probs=198.5

Q ss_pred             eeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-CC
Q 006446           27 LHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QT  103 (644)
Q Consensus        27 ~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~~  103 (644)
                      ++|+|++|... ..+|.++ +|.+. ++.|+||++..   ...++|||+|++||+||+..+++++||+|+|+|.|.+ ..
T Consensus         1 ~~f~f~~f~~~-~~~l~l~G~A~~~~~~~i~LT~~~~---~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~   76 (236)
T cd06899           1 LSFNFNGFSSD-QSNLTLQGDATISSNGALQLTNDTS---PASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNP   76 (236)
T ss_pred             CceecCCCCCC-CCCEEEecceEcCCCCeEEecCCCC---CCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCC
Confidence            47999999874 4589999 99998 89999998862   1278999999999999999999999999999999997 45


Q ss_pred             CCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCc--
Q 006446          104 AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLT--  180 (644)
Q Consensus       104 ~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~--  180 (644)
                      ..+||||||+|+|....+.++.|++|||++.++++.+.+++|||||||++|.++ ||++||||||+|++.|..+..+.  
T Consensus        77 ~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~  156 (236)
T cd06899          77 SLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDD  156 (236)
T ss_pred             CCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeeccccc
Confidence            678999999999976666678999999999887777889999999999999887 99999999999999988877764  


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe-----cCCCCCcccccCccCcCCCceeeeecccCCCcccccccccccccCC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA-----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS  252 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~-----~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss  252 (644)
                      ..++.+|+.++|||+||+  ++|.|++.     +|..|+|++.+||+.+|+++|||||||+||...+.|+|++|+|+++
T Consensus       157 ~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~  235 (236)
T cd06899         157 GGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN  235 (236)
T ss_pred             cccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence            344789999999999997  88899884     4667899999999999999999999999999999999999999875

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=1.2e-48  Score=392.54  Aligned_cols=219  Identities=40%  Similarity=0.698  Sum_probs=192.1

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-cccc-cCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec--
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN--  101 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~-~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~--  101 (644)
                      +++|+|++|..  ..++.+. +|.+ .+|.|+||++..    .+++|||+|++||+|||..+++++||+|+|+|.|..  
T Consensus         1 ~~~F~~~~F~~--~~~~~l~G~A~~~~~~~l~LT~~~~----~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~   74 (236)
T PF00139_consen    1 SVSFSFPSFSN--SSNLTLNGDASISSNGSLQLTPDST----NNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGP   74 (236)
T ss_dssp             EEEEEESSBTT--GTTEEEEETEEEETTSEEESSTBET----SSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESS
T ss_pred             CceEEcCCCCC--CCceEEEeeEEeccCCeEEcCCCCC----CCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccC
Confidence            36899999922  3689999 9998 799999997754    379999999999999999999999999999999963  


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecC
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                       ....+||||||||+|....+.++.|++||+++..+++.+.++.|||||||++|.++ ||++||||||+|++.|..+.++
T Consensus        75 ~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~  154 (236)
T PF00139_consen   75 GSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASA  154 (236)
T ss_dssp             SSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE-
T ss_pred             CCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccc
Confidence             45678999999999987778888999999999887777788999999999999887 9999999999999999887543


Q ss_pred             c-----ccccCCCceEEEEEEEcC--ceEEEEEec----CCCCCcccccCccCcCCCceeeeecccCCCccccccccccc
Q 006446          180 T-----RVNLANGTDIKVQVRYDG--QNITVFVAN----METPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWA  248 (644)
Q Consensus       180 ~-----~~~l~~g~~~~~~I~Y~~--~~l~v~~~~----~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~ws  248 (644)
                      .     ..++.+|+.++|||+||+  ++|.|++..    |..|+|+..+||+.+++++||||||||||...+.|.|++|+
T Consensus       155 ~~~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~  234 (236)
T PF00139_consen  155 GYYSSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNSSKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWS  234 (236)
T ss_dssp             ---EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETTTTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEE
T ss_pred             cccccccccccCCcEEEEEEEEcCCccEEEEEEecccCCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEE
Confidence            2     678899999999999999  889999853    45679999999999999999999999999999999999999


Q ss_pred             cc
Q 006446          249 FD  250 (644)
Q Consensus       249 f~  250 (644)
                      |+
T Consensus       235 F~  236 (236)
T PF00139_consen  235 FS  236 (236)
T ss_dssp             EE
T ss_pred             eC
Confidence            85

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=403.41  Aligned_cols=251  Identities=30%  Similarity=0.516  Sum_probs=210.7

Q ss_pred             CCCcccccCcEEEEEeeecCce-EEEEEeecccchh--hHHHHHHHHHHhccCCCceeeEeeeeeecc-ceEEEEeccCC
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQG--KQEFIAEVTTIGSLRHRNLVKLIGWCYERH-DFLLVYEYMPN  398 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~-vavK~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~  398 (644)
                      ..+.||+|+||+||+|.+++.. ||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3566999999999999999988 9999997654332  568999999999999999999999999887 79999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC-eEeCCCCCCCEEEcCCC-cEEEeccCCccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR-VLHRDIKSSNIMLDSEF-NARLGDFGLARTIQ  476 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDlkp~NILld~~~-~vkL~DFGla~~~~  476 (644)
                      |+|.++++....      ..++|..+++++.|||+||.|||+   .+ ||||||||+||||+.++ ++||+|||+++...
T Consensus       125 GsL~~~l~~~~~------~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  125 GSLSVLLHKKRK------RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             CcHHHHHhhccc------CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            999999987411      149999999999999999999999   66 99999999999999997 99999999998765


Q ss_pred             ccccccccccccccCCCccCccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL--VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~--~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ...   ...+...||+.|||||++.  ...++.|+|||||||+||||+||+.||......    .+...+          
T Consensus       196 ~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v----------  258 (362)
T KOG0192|consen  196 ISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAV----------  258 (362)
T ss_pred             ccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHH----------
Confidence            321   2234578999999999999  569999999999999999999999999876531    121111          


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        +....+..++......+..|+.+||+.||+.||++.+++..|+..
T Consensus       259 --~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  259 --VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             --HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence              112233444445667788899999999999999999999999854

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-46  Score=390.81  Aligned_cols=251  Identities=31%  Similarity=0.527  Sum_probs=211.0

Q ss_pred             CCCcccccCcEEEEEeeecCc-eEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          323 PKNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~-~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ..+.||+|.||.||.|.+++. .||+|.++... ...+.|.+|+.+|++|+|+|||+++|+|..++.++||+|||++|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            378899999999999999965 99999998753 3457899999999999999999999999998899999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+||......      .+...+.+.++.|||+|++||++   +++|||||.++||||+++..+||+||||||...+... 
T Consensus       289 l~yLr~~~~~------~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-  358 (468)
T KOG0197|consen  289 LDYLRTREGG------LLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-  358 (468)
T ss_pred             HHHhhhcCCC------ccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce-
Confidence            9999762222      48889999999999999999999   9999999999999999999999999999996543222 


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR  560 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  560 (644)
                       .......-+..|.|||.+..++++.|||||||||+||||+| |+.|+......+        +.+...+|         
T Consensus       359 -~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~G---------  420 (468)
T KOG0197|consen  359 -TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERG---------  420 (468)
T ss_pred             -eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhcc---------
Confidence             22334445779999999999999999999999999999999 888887654321        12222333         


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       561 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .+-..++.+...+.+|+..||+.+|++|||++.+...|+...
T Consensus       421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            333445556778889999999999999999999999988754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=364.12  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=208.9

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      .++.+++.       .+.||+|..|+|||++++  +.-+|+|.+... .....++..+|++++++.+||+||.++|.|..
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            45555554       788999999999999998  678999999544 34456889999999999999999999999999


Q ss_pred             cc-ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          386 RH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       386 ~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      .+ +..++||||.+|||+.++....        .++....-+|+.+|++||.|||+  +.+||||||||+|||++..|.+
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g--------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVG--------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCE
Confidence            99 4999999999999999986442        27888899999999999999996  3899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc-cchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN-SYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~-~~~~~l~~~  543 (644)
                      ||||||.++.+...     .....+||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+. ...-.++.+
T Consensus       219 KicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  219 KICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA  293 (364)
T ss_pred             EeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence            99999999987643     245678999999999999999999999999999999999999998765221 111222222


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +         ..-..+++...   .....+..++..|++.||.+||+++|+++.
T Consensus       294 I---------v~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  294 I---------VDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             H---------hcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1         11122344433   133456677889999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-44  Score=398.18  Aligned_cols=265  Identities=28%  Similarity=0.485  Sum_probs=221.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      ..+....+.||+|+||+||+|...+       ..||||.++..... ..++|.+|++++..|+|||||+|+|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3455668899999999999998752       45999999887655 788999999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCC------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNS------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      ++|+|||..|+|.+||.......      .+....|+..+.+.|+.|||.|++||-+   +.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence            99999999999999997543211      1113459999999999999999999998   99999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~  542 (644)
                      |||+||||+|.....+.... .....-+.+||+||.+..+++|.+||||||||+||||++ |+.|+.+...++       
T Consensus       642 VKIsDfGLsRdiYssDYYk~-~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKV-RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             EEecccccchhhhhhhhhcc-cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            99999999998764433222 223345789999999999999999999999999999999 999988754322       


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                       |.+..+.|++++         .++..+..+..|++.||+.+|++||+++||-..|+.-..
T Consensus       714 -VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 -VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             334555666533         445667789999999999999999999999999987543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=361.38  Aligned_cols=201  Identities=26%  Similarity=0.537  Sum_probs=181.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ..+|...+.||+|+||+||+|+++  +..||||++.+.  .+...+.+..||.+|++++|||||++++++...+.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888889999999999999997  678999999766  5556677889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC------CcEEEe
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE------FNARLG  467 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~------~~vkL~  467 (644)
                      |||.+|+|.+|++...        .++......++.|+|.||++||+   ++||||||||.||||+..      -.+||+
T Consensus        89 EyC~gGDLs~yi~~~~--------~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--------RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             EeCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            9999999999998665        38899999999999999999999   999999999999999765      458999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      |||+||.+.+..    .....+|++-|||||++..++|+.|+|+||.|++|||+++|+.||+....
T Consensus       158 DFGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  158 DFGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             ccchhhhCCchh----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            999999887432    24567999999999999999999999999999999999999999986543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-44  Score=378.07  Aligned_cols=246  Identities=27%  Similarity=0.448  Sum_probs=208.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+|...+.||+|||++||+++..  +..||+|++.+.   .....+...+||++.++|+|||||++++++++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            57888999999999999999983  889999999763   3445678889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |+|++++|.+++...+        .++..+...++.||+.||.|||+   .+|+|||||..|+||++++++||+|||||.
T Consensus        98 ELC~~~sL~el~Krrk--------~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK--------PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EecCCccHHHHHHhcC--------CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceee
Confidence            9999999999987433        38999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+.....   .....+||+.|.|||++.....+..+||||+||+||-|++|++||+.....+....+.        ..  
T Consensus       167 ~le~~~E---rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--------~~--  233 (592)
T KOG0575|consen  167 QLEYDGE---RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--------LN--  233 (592)
T ss_pred             eecCccc---ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--------hc--
Confidence            8864322   2456899999999999999899999999999999999999999998754322221111        11  


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +    -.++........+|+.+++++||.+|||+++|+.
T Consensus       234 ----~----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ----E----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----C----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                1    1122233344567888999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=394.29  Aligned_cols=273  Identities=21%  Similarity=0.429  Sum_probs=226.0

Q ss_pred             cccCHHHHHHHhCC---------CCCCCcccccCcEEEEEeeec--C---ceEEEEEeeccc-chhhHHHHHHHHHHhcc
Q 006446          307 KKFRLKELKKATGN---------FNPKNKLGKGGFGTVYKGIWR--N---KEIAVKRVSETS-RQGKQEFIAEVTTIGSL  371 (644)
Q Consensus       307 ~~~~~~~l~~a~~~---------f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l  371 (644)
                      ..++|++-..|...         ..+.++||.|.||+||+|+++  +   ..||||.++... ...+.+|+.|..||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            45666665554433         355789999999999999997  3   469999998764 34567899999999999


Q ss_pred             CCCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC
Q 006446          372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI  451 (644)
Q Consensus       372 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl  451 (644)
                      .||||++|.|+......+++|.|||+||+|+.||..++.+       +.|.+...++.+||.|++||-+   .++|||||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-------ftviQLVgMLrGIAsGMkYLsd---m~YVHRDL  757 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-------FTVIQLVGMLRGIASGMKYLSD---MNYVHRDL  757 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-------eEeehHHHHHHHHHHHhHHHhh---cCchhhhh
Confidence            9999999999999999999999999999999999887754       8999999999999999999998   99999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 006446          452 KSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQ  530 (644)
Q Consensus       452 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~  530 (644)
                      .++|||++.+..+|++|||++|.+.+.......+..-.-+.+|.|||.+...++|.+|||||||++|||+++ |.+||-+
T Consensus       758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd  837 (996)
T KOG0196|consen  758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  837 (996)
T ss_pred             hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence            999999999999999999999988654322222222233579999999999999999999999999999887 9999755


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCC
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPV  606 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  606 (644)
                      ....                 ++..+++..++-.-+.++...+.+|++.|||.|-.+||.+.|++..|+.....|.
T Consensus       838 mSNQ-----------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  838 MSNQ-----------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             cchH-----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            4321                 2233344444444556778889999999999999999999999999988654443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-44  Score=345.43  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=205.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeee-eeeccc-eEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGW-CYERHD-FLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~-~~~~~~-~~lV~  393 (644)
                      +|++.++||+|.||+|||+...  +..+|.|.++-.  +.+..++..+|+.+|++|+|||||++++| +.+.++ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4556889999999999999875  788999998743  44567789999999999999999999995 444445 89999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||..|+|...+..-+...    ..++....++++.|++.||..+|+.+.. -|+||||||.||+|+.+|.+||+||||+
T Consensus       100 E~c~~GDLsqmIk~~K~qk----r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQK----RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HhhcccCHHHHHHHHHhcc----ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999987544332    2488889999999999999999985532 4999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.+....   ..+...+||+.||+||.+...+|+.||||||+||++|||+.-++||.+..       +.+ +.+...+|+
T Consensus       176 r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~-L~~KI~qgd  244 (375)
T KOG0591|consen  176 RFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLS-LCKKIEQGD  244 (375)
T ss_pred             hHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------HHH-HHHHHHcCC
Confidence            9986432   22456899999999999999999999999999999999999999998752       222 122233333


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ...     ++   ++.-.+.+..|+..|+..||+.||+.-.+++.+..
T Consensus       245 ~~~-----~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 YPP-----LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCC-----Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            211     11   13345667788999999999999995555555444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-43  Score=354.05  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      +.|-..+.||+|+||.|-+|..+  ++.||||.+++...       .......+|+++|++|+|||||++.+++......
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45667899999999999999876  78999999975421       1223457999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---CcEEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FNARL  466 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL  466 (644)
                      |||+|||++|.|.+++-.+..        +.......+++|++.|+.|||+   ++|+||||||+|||+..+   ..+||
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~--------l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY--------LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc--------cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence            999999999999999976653        5566667899999999999999   999999999999999766   77999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCC---CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA---TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~  543 (644)
                      +|||+|+...+.    ......+||+.|.|||++.+...   ..+.|+||+||+||-++||.+||.....+..   +   
T Consensus       321 tDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l---  390 (475)
T KOG0615|consen  321 TDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---L---  390 (475)
T ss_pred             cccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---H---
Confidence            999999987522    22567899999999999986643   4588999999999999999999987654331   1   


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       .+...+|++..      ......+..++..+|+.+|+..||++|||+.|+++
T Consensus       391 -~eQI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 -KEQILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -HHHHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             12222333211      11223345677888999999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=344.78  Aligned_cols=241  Identities=27%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ..+|+..++||+|+||+||.++..  ++.+|+|++++.   .....+...+|..+|.+++||.||+++-.+++.+++|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999876  678999999764   233466788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+.||.|..+|.+...        ++.....-++.+|+.||.|||+   .+||||||||+|||||.+|+++|+||||+
T Consensus       104 ld~~~GGeLf~hL~~eg~--------F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR--------FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             EeccCCccHHHHHHhcCC--------cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccc
Confidence            999999999999975543        7778788899999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +..-...   ..+...+||+.|||||++....++..+|+||+|+++|||++|.+||...+.....+.+        .+++
T Consensus       173 k~~~~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--------~~~k  241 (357)
T KOG0598|consen  173 KEDLKDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--------LKGK  241 (357)
T ss_pred             hhcccCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--------hcCc
Confidence            8643221   2245579999999999999999999999999999999999999999876543222221        1122


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                      +      .....+   ......+++.+.++.||++|.
T Consensus       242 ~------~~~p~~---ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 L------PLPPGY---LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C------CCCCcc---CCHHHHHHHHHHhccCHHHhc
Confidence            0      111221   223445567788999999996

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=356.67  Aligned_cols=264  Identities=27%  Similarity=0.436  Sum_probs=213.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-ceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ......++||+|-||+|.++...+ ..||||.++..... ..++|.+||++|.+|+|||||+++|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            445668899999999999999986 89999999877554 4589999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+|+..+...      .+.-.....|+.|||+||+||.+   .++|||||.++|+|+|.++++||+|||++|-+.
T Consensus       618 EnGDLnqFl~aheap------t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELP------TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             hcCcHHHHHHhccCc------ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence            999999999776432      24455667899999999999999   999999999999999999999999999999766


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHH--cCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA--CGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~--tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ... ........+-+.+|||||.+..++++.++|||+||++|||++  |..+||.....    +.+++-...+.+.+.. 
T Consensus       689 sg~-yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~-  762 (807)
T KOG1094|consen  689 SGD-YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGR-  762 (807)
T ss_pred             cCC-ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCc-
Confidence            332 222234556788999999999999999999999999999974  67889876543    2233322222221111 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                           ..-...+......+.+++++||..|.++||+++++...|...+
T Consensus       763 -----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  763 -----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             -----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                 1111123344566789999999999999999999999987654

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-40  Score=344.09  Aligned_cols=258  Identities=17%  Similarity=0.275  Sum_probs=204.9

Q ss_pred             cccCHHHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchh---hHHHHHHHHHHhccCCCceeeEeeee
Q 006446          307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQG---KQEFIAEVTTIGSLRHRNLVKLIGWC  383 (644)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~  383 (644)
                      +.+.++++     +......||+|++|.||+|.++++.||||+++......   .+.|.+|+.+|++++||||++++|++
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            44455555     22334679999999999999999999999997653332   46788999999999999999999998


Q ss_pred             ee----ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          384 YE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       384 ~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      .+    ...+++||||+++|+|.+++....        .++|..+++++.+++.||.|||+  ..+++||||||+|||++
T Consensus        88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--------~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~  157 (283)
T PHA02988         88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK--------DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVT  157 (283)
T ss_pred             EecccCCCceEEEEEeCCCCcHHHHHhhCC--------CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEEC
Confidence            77    346899999999999999996532        38899999999999999999997  13788999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccch
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN  537 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~  537 (644)
                      +++.+||+|||+++.....      .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......   
T Consensus       158 ~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---  228 (283)
T PHA02988        158 ENYKLKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---  228 (283)
T ss_pred             CCCcEEEcccchHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---
Confidence            9999999999999865422      123467899999999876  68999999999999999999999999764321   


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       .+...+.   ..+.         ....+......+.+++.+||+.||++||+++++++.|+..
T Consensus       229 -~~~~~i~---~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        229 -EIYDLII---NKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             -HHHHHHH---hcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence             1222111   1111         1112222345678899999999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=379.37  Aligned_cols=261  Identities=29%  Similarity=0.465  Sum_probs=213.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---Cc----eEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---NK----EIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      .+.+..+.||+|+||.||+|...   +.    .||+|.+++. +.+...+|++|..+|+.++|||||+++|+|.+.+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            45566788999999999999986   22    4899998765 5567789999999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +++|||++|+|..||...+..... ...|.....+.++.|||+|+.||++   +++|||||.++|+||+....|||+|||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~-~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQ-PSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCC-CCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999876443222 3459999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +||.+........ .....-..+|||||.+..+.++.|+|||||||+||||++ |..||......+   .+..+    ..
T Consensus       848 lArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~~----~~  919 (1025)
T KOG1095|consen  848 LARDIYDKDYYRK-HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLDV----LE  919 (1025)
T ss_pred             hhHhhhhchheec-cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHHH----Hh
Confidence            9996653322111 112234579999999999999999999999999999999 888987654321   11111    12


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .|        ||  +.+..+.+.+.+|+..||+.+|++||+++.+++.+...
T Consensus       920 gg--------RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  920 GG--------RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             CC--------cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            22        22  33445667888999999999999999999999988764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=342.75  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=204.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc--ceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--DFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E  394 (644)
                      .++...+.||+|+||.||++...  +...|||.+........+.+.+|+.+|++++|||||+++|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999987  5889999987654333667899999999999999999999755444  6999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~  473 (644)
                      |+++|||.+++.....       .|+......+..||++||+|||+   ++|+||||||+||||+. ++.+||+|||+++
T Consensus        97 y~~~GsL~~~~~~~g~-------~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-------KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             ccCCCcHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence            9999999999976543       28899999999999999999998   99999999999999999 7999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ................||+.|||||++..+. ...++||||+||++.||+||++||....      ....++......+.
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~  240 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDS  240 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCC
Confidence            7763122222244678999999999998643 3459999999999999999999987630      11222222222221


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .         ..++........+.+.+|++.||++|||++++++.---
T Consensus       241 ~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  241 L---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             C---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            1         13333344556677889999999999999999986433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-40  Score=352.24  Aligned_cols=264  Identities=23%  Similarity=0.410  Sum_probs=203.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc-
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH-  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~-  387 (644)
                      .++|+..++||+|+||.||+|.+.       +..||+|+++.... ...+.+..|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            357888999999999999999752       35799999875432 3356789999999999 8999999999987644 


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCC------------------------------------------------------
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSG------------------------------------------------------  413 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~------------------------------------------------------  413 (644)
                      .+++||||+++|+|.+++........                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            58999999999999999865321000                                                      


Q ss_pred             CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCC
Q 006446          414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG  493 (644)
Q Consensus       414 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~  493 (644)
                      .....+++...+.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....... ........++..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~  241 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLK  241 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCcc
Confidence            001248899999999999999999999   8999999999999999999999999999986542211 111223456788


Q ss_pred             ccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHH
Q 006446          494 YMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC  572 (644)
Q Consensus       494 y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  572 (644)
                      |+|||++.+..++.++|||||||++|||++ |+.||.......   .+    ......+..     .+.    +......
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~-----~~~----~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EF----CQRLKDGTR-----MRA----PENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HH----HHHHhcCCC-----CCC----CCCCCHH
Confidence            999999998899999999999999999997 999987643221   11    111111211     111    1122345


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          573 VLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       573 l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +.+|+.+||+.||++||++.++++.|+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            77899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=359.93  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=211.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--C---ce-EEEEEeec---ccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--N---KE-IAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      +....++||+|+||+||+|++.  +   .. ||+|..+.   ..+....+|+.|.++|++++|||||+++|++..+..++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            4445689999999999999987  1   13 89999874   34667789999999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|||+|+||+|++||.+...       .++..+++.++.+.|.||+|||.   ++++||||.++|+|++.++.+||+|||
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-------~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-------SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence            99999999999999987664       38999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++....   .........-+.+|+|||.+..+.++.++|||||||++||+.+ |..||.+....    .+..++.    
T Consensus       308 Ls~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~----  376 (474)
T KOG0194|consen  308 LSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIV----  376 (474)
T ss_pred             cccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHH----
Confidence            9886431   1110112235689999999999999999999999999999998 88898765432    2222221    


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVL  607 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~  607 (644)
                              ....+-..+......+..+..+||..+|++||+|.++.+.|+........
T Consensus       377 --------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 --------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             --------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                    11122233335556677778899999999999999999999887655443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.2e-40  Score=344.17  Aligned_cols=268  Identities=23%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------------------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------------------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKL  379 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l  379 (644)
                      ++|...++||+|+||.||++.+.                  +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            46788899999999999999753                  2359999987643 3345679999999999999999999


Q ss_pred             eeeeeeccceEEEEeccCCCccchhhhccCCCC-----------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEe
Q 006446          380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS-----------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLH  448 (644)
Q Consensus       380 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~-----------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH  448 (644)
                      ++++.+.+..++||||+++|+|.+++.......           ......++|...++++.|++.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            999999999999999999999999986432211           1112347899999999999999999999   89999


Q ss_pred             CCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc--CCC
Q 006446          449 RDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC--GRK  526 (644)
Q Consensus       449 rDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t--G~~  526 (644)
                      |||||+|||++.++.+||+|||+++....... ........++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999986542211 111233456789999999998899999999999999999986  556


Q ss_pred             CCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          527 PGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       527 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ||......    .+...+..........      .....+......+.+++.+||+.||++||++.+|.+.|++
T Consensus       241 p~~~~~~~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDE----QVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHH----HHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            77654321    2222222222111100      0001111233567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-39  Score=391.28  Aligned_cols=260  Identities=26%  Similarity=0.471  Sum_probs=215.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ..|+..+.||+|+||.||+|+..  +..||||++......    ...|++.+++++|||||+++|+|.+.+..++|||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            46778899999999999999974  788999998654322    235688999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.++++           .++|.++.+|+.|+|+||+|||+.+..+|+||||||+||+++.++.+++. ||......
T Consensus       766 ~~g~L~~~l~-----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        766 EGKNLSEVLR-----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             CCCcHHHHHh-----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            9999999984           28999999999999999999997666899999999999999999988876 66554322


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      .       .....+|..|+|||++.+..++.++|||||||++|||++|+.||+....  ....+.+|+............
T Consensus       834 ~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        834 T-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             c-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhhe
Confidence            1       1223688999999999999999999999999999999999999854322  234577787766555555566


Q ss_pred             hhcccCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          557 ADSRLGG--EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       557 ~d~~l~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      +|+.+..  ..+.++...+.+++.+||+.||++||+|+||++.|+....
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            6776644  3456677788999999999999999999999999997643

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=350.36  Aligned_cols=240  Identities=25%  Similarity=0.484  Sum_probs=203.9

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccch
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDK  403 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  403 (644)
                      .+.||.|+.|.||+|++.++.||||+++...       ..+|+-|++|+|+||+.+.|+|.....+|||||||+.|-|..
T Consensus       129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            6789999999999999999999999985432       257888999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccc
Q 006446          404 FIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH  483 (644)
Q Consensus       404 ~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~  483 (644)
                      .|...+        .+.-.....+.++||.|+.|||.   +.|||||||.-||||..+..+||+|||-++...+.    .
T Consensus       202 VLka~~--------~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----S  266 (904)
T KOG4721|consen  202 VLKAGR--------PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK----S  266 (904)
T ss_pred             HHhccC--------ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh----h
Confidence            997554        36777888999999999999999   99999999999999999999999999999876532    1


Q ss_pred             cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCC
Q 006446          484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG  563 (644)
Q Consensus       484 ~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  563 (644)
                      .....+||..|||||++.+.+.++|+||||||||||||+||..||.+-+....       +|..   |      ...|.-
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGV---G------sNsL~L  330 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGV---G------SNSLHL  330 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEec---c------CCcccc
Confidence            23467899999999999999999999999999999999999999876543211       1211   1      111223


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          564 EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       564 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..+....+-+..|+.+||+..|..||+++|+++.|+-.
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            44556667788899999999999999999999999755

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-40  Score=340.77  Aligned_cols=260  Identities=24%  Similarity=0.311  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  393 (644)
                      .|+..++||+|.||.||+|+..  ++.||+|+++...  ........+||.+|++|.||||++|.+...++  +.+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            4666788999999999999986  7789999998654  22334567899999999999999999998877  6899999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++ +|..++.....       .++..++..+++|+++||+|+|.   ++|+|||||.+|||||.+|.+||+|||||+
T Consensus       198 eYMdh-DL~GLl~~p~v-------kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSSPGV-------KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             ecccc-hhhhhhcCCCc-------ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEecccccee
Confidence            99954 78777754333       38899999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc--
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK--  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~--  550 (644)
                      .+.....  ...+..+-|..|.|||++.+. .|+.+.|+||.||||.||+.|++.+.+..+-+....|.    ++...  
T Consensus       267 ~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf----klcGSP~  340 (560)
T KOG0600|consen  267 FYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF----KLCGSPT  340 (560)
T ss_pred             eccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH----HHhCCCC
Confidence            8864332  225667889999999998865 69999999999999999999999998866543333332    22211  


Q ss_pred             ------CchhhhhhcccCCCCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 ------GRILDAADSRLGGEFSE-------KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ------~~~~~~~d~~l~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            .++....--+-...+..       ......++|+..+|..||.+|.|+.++++
T Consensus       341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                  11110000000011111       12234567888999999999999999985

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-41  Score=326.63  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .|+...++|+|+||.|||++.+  |+.||||++....  ..-.+-.++||++|++|+|+|+|.++.+|..+..++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            5777889999999999999987  7889999997643  33456678999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |+.--|++ |......       ++.....+++.|++.|+.|+|+   +++|||||||+||||+.++.+||||||.||.+
T Consensus        83 ~dhTvL~e-Le~~p~G-------~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   83 CDHTVLHE-LERYPNG-------VPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             cchHHHHH-HHhccCC-------CCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            96654444 4333332       7888999999999999999999   99999999999999999999999999999988


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ...+.   ..+..+.|..|.|||++.+ .+|....|||+.||++.||++|.+-|.+..+   .+++......+   |.+.
T Consensus       152 ~~pgd---~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD---iDQLy~I~ktL---G~L~  222 (396)
T KOG0593|consen  152 SAPGD---NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD---IDQLYLIRKTL---GNLI  222 (396)
T ss_pred             cCCcc---hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch---HHHHHHHHHHH---cccC
Confidence            64322   2567889999999999887 6899999999999999999999988866432   22222211111   1111


Q ss_pred             hhhhc-----------ccC---------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADS-----------RLG---------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~-----------~l~---------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..-..           +++         ..++ .....+++++..|++.||.+|++-+|++.
T Consensus       223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11000           000         0111 22336789999999999999999999873

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=352.91  Aligned_cols=266  Identities=26%  Similarity=0.478  Sum_probs=210.8

Q ss_pred             HHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      ++.....+.+.....||+|.||+||+|++-| .||||++...  ..+..+.|..|+..+++-||.||+-+.|||.+.+. 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            3444445667778999999999999999965 6999999765  33467889999999999999999999999998766 


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      .+|.-+|++.+|+.+|+..+..       ++..+.+.|+.|||+|+.|||.   ++|||||||..||+|.++++|||+||
T Consensus       463 AIiTqwCeGsSLY~hlHv~etk-------fdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETK-------FDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             eeeehhccCchhhhhccchhhh-------hhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecc
Confidence            9999999999999999876653       8999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      ||+..-..- ..........|...|||||++..   .+|+..+||||||+++|||+||..||.....+.    ++   |.
T Consensus       533 GLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Ii---fm  604 (678)
T KOG0193|consen  533 GLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----II---FM  604 (678)
T ss_pred             cceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eE---EE
Confidence            999754321 11122344567889999999864   468999999999999999999999998433221    11   11


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                       ...|.+..  |.   ........+.+.+|+..||..++++||.+.+++..|+...+
T Consensus       605 -VGrG~l~p--d~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  605 -VGRGYLMP--DL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             -ecccccCc--cc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence             12222111  10   01122344567778889999999999999999998887643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=335.24  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=208.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .+.|+..+.||.|..+.||+|+..  +..||||++..+. ......+.+|+..|+.++||||++++..|..+.++|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            467888999999999999999986  7889999997543 3346888999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ||.+||+.+.++..-..      .++...+..|+++++.||.|||+   ++.||||||+.||||+.+|.|||+|||.+..
T Consensus       105 fMa~GS~ldIik~~~~~------Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD------GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             hhcCCcHHHHHHHHccc------cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999754332      28888999999999999999999   9999999999999999999999999999887


Q ss_pred             ccccccccccc-cccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          475 IQENLKTHHST-KEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       475 ~~~~~~~~~~~-~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +..++...... ...+||+.|||||++..  ..|+.|+||||||++.+||++|..||....+..   .+   ...+.  +
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vL---l~tLq--n  247 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VL---LLTLQ--N  247 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HH---HHHhc--C
Confidence            76555332222 45689999999999543  469999999999999999999999998765421   11   11221  1


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ......-..+..+-.......+.+++..|++.||++|||++++++
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111111111122335677888999999999999999984

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=337.92  Aligned_cols=276  Identities=23%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHh--ccCCCceeeEeeeeeecc----ceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIG--SLRHRNLVKLIGWCYERH----DFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~H~nIv~l~g~~~~~~----~~~lV  392 (644)
                      ...+..++||+|.||.||||.+.++.||||++....   ++.|.+|-.|.+  .++|+||+++++.-....    +++||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            345567889999999999999999999999996543   456666655554  568999999999877655    89999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC------CCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS------EKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      +||.++|||.+||..+         +++|....+|+..+++||+|||++.      +.+|+|||||++||||..|+++.|
T Consensus       287 t~fh~kGsL~dyL~~n---------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN---------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             eeeccCCcHHHHHHhc---------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            9999999999999654         4899999999999999999999863      468999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCC------CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR------ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~------~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +|||+|..+.. ......+-..+||.+|||||++.+..      .-.+.||||+|.+||||++...-++.....++....
T Consensus       358 aDFGLAl~~~p-~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  358 ADFGLALRLEP-GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eccceeEEecC-CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            99999998873 33333355689999999999986542      234799999999999999876544321111111111


Q ss_pred             HHHHHHHHhcCchhh-hhhcccCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 006446          541 VHWLWELRRKGRILD-AADSRLGGEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVL  607 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~-~~d~~l~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~  607 (644)
                      -.-+.....-+++.+ ++..+.+..++.     .-+..+.+.+..||..||+.|.|+.=|.+++.....+.+.
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            100000000000000 111222222222     3466788899999999999999999999888877655443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=347.80  Aligned_cols=248  Identities=26%  Similarity=0.417  Sum_probs=208.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ..|....+||+|+.|.||.++..  +..||||++.......++-.++|+.+|+..+|+|||++++.+..++++|.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            35667789999999999999876  6789999998877776777899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+.+...         .++..++..|+.++++||+|||.   ++|+|||||.+|||++.++.+||+|||+|..+.
T Consensus       353 ~ggsLTDvVt~~---------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  353 EGGSLTDVVTKT---------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             CCCchhhhhhcc---------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            999999998543         38899999999999999999999   999999999999999999999999999998876


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   .....+||+.|||||++....|.+|.||||||++++||+-|.+||-.+.+-.       -++-....|.    
T Consensus       421 ~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~----  486 (550)
T KOG0578|consen  421 EEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGT----  486 (550)
T ss_pred             cccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCC----
Confidence            4322   2456899999999999999999999999999999999999999987644311       1111222222    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        +.+  ...+.....+.+++.+||+.|+++||++.|+|+
T Consensus       487 --P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 --PKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --CCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              111  122333445677888999999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=340.91  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=206.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  390 (644)
                      ...+|..++.||+|+|++|++|+..  ++++|||++.+.-   ....+-...|-.+|.+| .||.|++|+-.+++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3467888999999999999999887  7899999986531   12223456788888888 8999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|+||+++|+|.++|.+..        .++......++.+|+.||+|||+   .+||||||||+|||||+|+++||+|||
T Consensus       151 FvLe~A~nGdll~~i~K~G--------sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG--------SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC--------cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999997654        38888889999999999999999   999999999999999999999999999


Q ss_pred             Ccccccccccc------c----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          471 LARTIQENLKT------H----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       471 la~~~~~~~~~------~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      .|+.+.+....      .    ......+||..|.+||++..+..+..+|+|+|||+||.|+.|.+||....+--..+.+
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            99988643222      1    0013478999999999999999999999999999999999999999876542222222


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ++              ++-    +|++...+.+.+|+.+.+..||.+|++.+|+.+.
T Consensus       300 ~~--------------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  300 QA--------------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HH--------------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            21              122    3333334567778888999999999999988765

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.5e-40  Score=335.52  Aligned_cols=249  Identities=34%  Similarity=0.630  Sum_probs=194.3

Q ss_pred             CCCcccccCcEEEEEeeec------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          323 PKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+.||.|.||.||+|.+.      +..|+||.++... ....++|.+|+..+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999988      5679999996543 33478899999999999999999999999988889999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.++|......      .+++..++.|+.||++||.|||+   .+++|+||+++||++++++.+||+|||+++..
T Consensus        83 ~~~g~L~~~L~~~~~~------~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKE------PLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             -TTEBHHHHHHHTCTT------TSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccc------ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            9999999999876211      38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ...... ...........|+|||.+....++.++||||||+++|||++ |+.|+.....    ..+..   .. ..+.. 
T Consensus       154 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~---~~-~~~~~-  223 (259)
T PF07714_consen  154 SEKSKY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIE---KL-KQGQR-  223 (259)
T ss_dssp             TTSSSE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHH---HH-HTTEE-
T ss_pred             cccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc---cc-ccccc-
Confidence            322111 11233456789999999999999999999999999999999 6788765422    11211   11 22221 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                              ...+......+..++.+||+.||++||+++++++.|
T Consensus       224 --------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                    112222345577899999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-39  Score=335.31  Aligned_cols=249  Identities=27%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      |+..+.||+|+||.||++...  +..||+|.+....   ......+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667889999999999999875  7889999986542   22345678999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|..++.....      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        82 ~~~g~L~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          82 MNGGDLKFHIYNMGN------PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             cCCCcHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999888754321      138899999999999999999999   99999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....    ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+..    .....    
T Consensus       153 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~----  220 (285)
T cd05631         153 PEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----RVKED----  220 (285)
T ss_pred             CCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----Hhhcc----
Confidence            3211    12345789999999999999999999999999999999999999976543221111111    11000    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                            ...+.......+.+|+.+||+.||++||+     ++++++
T Consensus       221 ------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 ------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  11122223346778899999999999997     778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=341.36  Aligned_cols=264  Identities=23%  Similarity=0.318  Sum_probs=206.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhH-HHHHHHHHHhccC-CCceeeEeeeeeecc-ceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLR-HRNLVKLIGWCYERH-DFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~-~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~  393 (644)
                      ++|...++||.|.||.||+|+-.  +..||||+++..-....+ .=++|++.|++|+ |||||+|.+++.+.. .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            46777899999999999999876  788999999765433222 2368999999998 999999999999988 999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||| ..+|.+.+...+.       .++...+..|+.||.+||+|+|.   +|+.|||+||+|||+..+..+||+|||+||
T Consensus        90 E~M-d~NLYqLmK~R~r-------~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDRNR-------LFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             Hhh-hhhHHHHHhhcCC-------cCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence            999 6799999976533       49999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH----HHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL----WELR  548 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~----~~~~  548 (644)
                      .....    ...+..+.|..|.|||++. .+-|+.+.|+|++||+++||.+-++-|.+..+-+..-.+.+-+    ++-+
T Consensus       159 ev~Sk----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  159 EVRSK----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             ccccC----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            77532    2367889999999999875 5678999999999999999999998887755432222222111    0001


Q ss_pred             hcC-chhhhhhcccCC-------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          549 RKG-RILDAADSRLGG-------EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       549 ~~~-~~~~~~d~~l~~-------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..| .+...+.-++..       ..-.......++|+.+|+.+||.+|||+.|++++
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111 111111111111       0111255677889999999999999999999985

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-39  Score=348.40  Aligned_cols=264  Identities=24%  Similarity=0.395  Sum_probs=204.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      .++|+..++||+|+||.||+|++.       +..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            347888999999999999999742       3579999986543 33456788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCC--------------------------------------------------------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS--------------------------------------------------------  412 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~--------------------------------------------------------  412 (644)
                      .++||||+++|+|.+++.......                                                        
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432100                                                        


Q ss_pred             -----------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          413 -----------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       413 -----------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                                 ......++|..+++++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                       0012248899999999999999999999   89999999999999999999999999999866432211


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR  560 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  560 (644)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   ..+..++    ..+.        
T Consensus       271 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~----~~~~--------  334 (375)
T cd05104         271 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMI----KEGY--------  334 (375)
T ss_pred             -cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHH----HhCc--------
Confidence             11222345678999999999999999999999999999998 88888654321   1122211    1111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       561 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       ....+......+.+|+.+|+++||++||++.+|++.|+..
T Consensus       335 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 -RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             0011111234577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-39  Score=331.36  Aligned_cols=254  Identities=21%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|.+.     +..||+|.++... ......|.+|+.++++++||||++++|++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999764     4579999987653 23346789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|++++.....       .++|..++.++.|++.||+|||+   ++++||||||+|||++.++.+|++|||.+
T Consensus        85 ~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          85 TEYMSNGALDSFLRKHEG-------QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EEeCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            999999999999865432       38999999999999999999998   89999999999999999999999999987


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ........  .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......    .+.+.    ...+
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~----~~~~  224 (266)
T cd05064         155 QEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKA----VEDG  224 (266)
T ss_pred             ccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HHCC
Confidence            65421111  11122345678999999999999999999999999999775 99998754321    12211    1111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..         ...+......+.+++.+||+++|.+||+++++++.|+..
T Consensus       225 ~~---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 FR---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11         111223345677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-39  Score=340.32  Aligned_cols=240  Identities=24%  Similarity=0.319  Sum_probs=195.1

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||+++..  ++.||+|+++...   ......+..|+.++++++||||+++++++...+.+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999876  6789999987542   234456788999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|.+++....        .+++.+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~--------~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          81 ELFFHLSRER--------VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             cHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            9999886543        38899999999999999999999   899999999999999999999999999997532111


Q ss_pred             cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    ..+.      .
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~----~~~~------~  212 (323)
T cd05571         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI----LMEE------I  212 (323)
T ss_pred             ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHH----HcCC------C
Confidence               1133457999999999999999999999999999999999999999754321    121111    1111      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                      .+..    .....+.+++.+|++.||++||     ++.++++
T Consensus       213 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCC----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1222    2334567889999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=340.43  Aligned_cols=250  Identities=25%  Similarity=0.433  Sum_probs=203.6

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc----cc-hhhHHHHHHHHHHhccC-CCceeeEeeeeeecc
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET----SR-QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERH  387 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~  387 (644)
                      ...++|...+.||+|.||+|++|...  +..||+|.+...    .. ...+...+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999886  789999976553    11 23445667999999999 999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEE
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARL  466 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL  466 (644)
                      .+++||||+.+|+|.+++... .       .+...+..+++.|+++|++|||+   .+|+||||||+|||+|.+ +++||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~-g-------~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl  162 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK-G-------RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKL  162 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc-C-------CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEE
Confidence            999999999999999999762 2       27778999999999999999999   999999999999999999 99999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCC-CC-CccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR-AT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      +|||++....   .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....    .+..  
T Consensus       163 ~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~--  233 (370)
T KOG0583|consen  163 SDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYR--  233 (370)
T ss_pred             eccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHH--
Confidence            9999999773   1112256679999999999999877 75 8899999999999999999999873321    1111  


Q ss_pred             HHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 WELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       . ...+.+      .++..+.   ...+..|+.+|+.+||.+|+++.++++
T Consensus       234 -k-i~~~~~------~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  234 -K-IRKGEF------KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -H-HhcCCc------cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             1 112211      1111221   456778999999999999999999983

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.8e-39  Score=347.08  Aligned_cols=263  Identities=24%  Similarity=0.420  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      ++|+..+.||+|+||.||+++..       ...||+|+++... ....+.+.+|+.+++.+ +|+||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47888999999999999998853       2479999997543 33356788999999999 899999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCC----------------------------------------------------------
Q 006446          390 LLVYEYMPNGSLDKFIFYDETN----------------------------------------------------------  411 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~----------------------------------------------------------  411 (644)
                      ++||||+++|+|.+++......                                                          
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999998643210                                                          


Q ss_pred             ----CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccc
Q 006446          412 ----SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE  487 (644)
Q Consensus       412 ----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  487 (644)
                          .......+++.+.++++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++....... ......
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~  273 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGN  273 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccC
Confidence                00112347899999999999999999999   8999999999999999999999999999986542211 111222


Q ss_pred             cccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCC
Q 006446          488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFS  566 (644)
Q Consensus       488 ~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  566 (644)
                      ..++..|+|||++....++.++|||||||++|||++ |+.||.......   .+    ......+         .....+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~----~~~~~~~---------~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KF----YKMVKRG---------YQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HH----HHHHHcc---------cCccCC
Confidence            345678999999998899999999999999999997 999987543221   11    1111111         011111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          567 EKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       567 ~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ......+.+++.+||+.||++||++.+|++.|+..
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11234577889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=345.52  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=213.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+....++||-|.||.||.|+|+  .-.||||.++++.. ..++|++|..+|+.++|||+|+|+|+|..+..+|||.||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            346677899999999999999998  56899999976543 478999999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |.+|+|.+||......      .++--..+.++.||++|++||..   +++|||||.++|+|+.++..||++||||+|++
T Consensus       345 M~yGNLLdYLRecnr~------ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRS------EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             ccCccHHHHHHHhchh------hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999876543      26667788999999999999998   99999999999999999999999999999998


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .......  .....-...|.|||-+....++.|+|||+|||+||||+| |..||.+.+.        .-+.++.++|.  
T Consensus       416 tgDTYTA--HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgy--  483 (1157)
T KOG4278|consen  416 TGDTYTA--HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGY--  483 (1157)
T ss_pred             cCCceec--ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhccc--
Confidence            6433222  222334678999999999999999999999999999998 8889876432        11344444443  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                             +-+-++.+...+.+|++.||+++|.+||+++|+-|.++.
T Consensus       484 -------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  484 -------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             -------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence                   333455667789999999999999999999999887753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-39  Score=310.10  Aligned_cols=274  Identities=23%  Similarity=0.338  Sum_probs=208.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-h-hHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-G-KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .+|...++||+|.||.||+|++.  ++.||+|+++..... + ....++||+.|++++|+||+.+++++...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            36777889999999999999987  789999999865332 2 3457899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      || ..+|+..+..+..       .+.-.+...++.++.+||+|||.   +.|+||||||.|+|+++++.+||+|||+|+.
T Consensus        82 fm-~tdLe~vIkd~~i-------~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNI-------ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             ec-cccHHHHhccccc-------ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhc
Confidence            99 5689888865543       48889999999999999999999   8999999999999999999999999999999


Q ss_pred             ccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC--
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG--  551 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--  551 (644)
                      +......   .+..+-|..|.|||++.+. .|+...|+||.||++.||+-|.+-|.+..+-   +++.. +.......  
T Consensus       151 f~~p~~~---~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi---dQL~~-If~~LGTP~~  223 (318)
T KOG0659|consen  151 FGSPNRI---QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI---DQLSK-IFRALGTPTP  223 (318)
T ss_pred             cCCCCcc---cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH---HHHHH-HHHHcCCCCc
Confidence            8744322   2334789999999988754 6899999999999999999887666553321   22211 11111110  


Q ss_pred             -------chhhhh------hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCCCCCCCCCCC
Q 006446          552 -------RILDAA------DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEADPPVLPPERP  612 (644)
Q Consensus       552 -------~~~~~~------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~p~~~p  612 (644)
                             .+.+..      .+.++. .-.......++|+..++..||.+|++++|++++  +.. .|.|..|.+-|
T Consensus       224 ~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~~lp  297 (318)
T KOG0659|consen  224 DQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPSKLP  297 (318)
T ss_pred             ccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChhhCc
Confidence                   011111      111111 222334455889999999999999999999875  222 44555444433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=336.02  Aligned_cols=244  Identities=25%  Similarity=0.323  Sum_probs=199.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||++...  ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999987  7889999986532   233466889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          81 EYVPGGELFSYLRNSG--------RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             eCCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence            9999999999986443        37889999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..    ....+. 
T Consensus       150 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~----~i~~~~-  214 (291)
T cd05612         150 KLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYE----KILAGK-  214 (291)
T ss_pred             hccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhCC-
Confidence            65421      233568999999999998889999999999999999999999997643211    111    111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~~  597 (644)
                           .    .++......+.+++.+|++.||.+||+     ++++++.
T Consensus       215 -----~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 -----L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 1    112222345778999999999999995     7777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.7e-39  Score=330.09  Aligned_cols=260  Identities=26%  Similarity=0.474  Sum_probs=206.9

Q ss_pred             CCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      +|+..+.||+|+||.||+|...+       ..|++|.+.... ......|.+|+.++++++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            57778999999999999998752       469999986543 3345678999999999999999999999999899999


Q ss_pred             EEeccCCCccchhhhccCCCCC--------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          392 VYEYMPNGSLDKFIFYDETNSG--------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      +|||+++|+|.+++........        .....+++...+.++.|++.||.|||+   .+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            9999999999999965422111        011358899999999999999999999   89999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~  542 (644)
                      +||+|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......    .+..
T Consensus       163 ~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIE  237 (283)
T ss_pred             EEECCCcceeeccccccc-cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence            999999999865422211 11334456889999999998899999999999999999998 99998764321    1222


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .    ...+..         ...+......+.+|+.+||+.||.+||++++|++.|+.
T Consensus       238 ~----i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 M----IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1    111111         11223344678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-39  Score=340.36  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=198.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888999999999999999986  6789999987542   233467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        98 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--------RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             cCCCCChHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999999986533        27788888999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......    .+.    +....+..
T Consensus       167 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~----~~i~~~~~  232 (329)
T PTZ00263        167 KVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY----EKILAGRL  232 (329)
T ss_pred             EcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH----HHHhcCCc
Confidence            65421      22357899999999999988999999999999999999999999754321    111    11111111


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                            .+...+    ...+.+++.+||+.||.+||+     ++++++
T Consensus       233 ------~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 ------KFPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ------CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  111112    245678999999999999996     677764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-38  Score=324.38  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||++.+. +..+|+|.+.... ....++..|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            35777889999999999999887 4589999876433 335678899999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....       .++|..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          83 NGCLLNYLRQRQG-------KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             CCcHHHHHHhCcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999864332       38899999999999999999999   8999999999999999999999999999986532


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||.+....++.++||||||+++|||++ |+.||......    .+...+.    .+..   
T Consensus       153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~----~~~~---  219 (256)
T cd05114         153 DEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMIS----RGFR---  219 (256)
T ss_pred             Cce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH----CCCC---
Confidence            211  11223345678999999988889999999999999999999 89998654321    1222211    1110   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                            ...+......+.+++.+||+++|++||++.++++.|.
T Consensus       220 ------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0111112346788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=340.28  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||+|+..  +..||+|+++...   ....+.+..|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999986  6789999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 e~~~g~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--------VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             eCCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            9999999999986432        37889999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|.       ..
T Consensus       150 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------~~  216 (333)
T cd05600         150 GIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------ET  216 (333)
T ss_pred             cccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-------cc
Confidence            6542      1345679999999999998899999999999999999999999997654322211121110       00


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..  .+.. ..........+.+++.+|++.+|.+||+++++++.
T Consensus       217 ~~--~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         217 LQ--RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cc--CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00  0000 00001223456778889999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-38  Score=337.42  Aligned_cols=241  Identities=24%  Similarity=0.346  Sum_probs=195.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||++...  +..||+|++...   .......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999876  678999999754   2334567889999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|..++....        .+++.+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          81 ELFFHLSRER--------VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            9998885432        38899999999999999999999   899999999999999999999999999987542111


Q ss_pred             cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    ....+      +.
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~----~~~~~------~~  212 (328)
T cd05593         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE----LILME------DI  212 (328)
T ss_pred             ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHH----HhccC------Cc
Confidence               1123457999999999999889999999999999999999999999754321    1111    11011      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                      .+...+    ...+.+++.+|++.||++||     ++.++++.
T Consensus       213 ~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 KFPRTL----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             cCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            122223    34567788999999999997     88988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-38  Score=327.43  Aligned_cols=263  Identities=24%  Similarity=0.477  Sum_probs=205.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      .+++|+..+.||+|+||.||+|.+.       +..||+|++.... .....++.+|+.+++.++|+||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998764       3569999886432 2345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCC--CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS--GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      .++||||+++|+|.+++.......  ......++|..++.++.|++.||.|||+   .+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532211  1112347899999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++........ .......++..|+|||.+..+.++.++|||||||++|||++ |..||......    .....+ 
T Consensus       161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~-  234 (277)
T cd05062         161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFV-  234 (277)
T ss_pred             CCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH-
Confidence            999999865422111 11122345778999999998889999999999999999999 68888654321    122111 


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                         ..+...         ..+......+.+++.+|++.||++||++.++++.|++
T Consensus       235 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 ---MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence               111111         1122233567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.5e-38  Score=334.17  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=191.6

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHH---hccCCCceeeEeeeeeeccceEEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTI---GSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      |+..+.||+|+||.||++...  ++.||||+++...   ....+.+..|+.++   ++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556789999999999999886  6789999997542   22344566665554   567899999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|..++...         .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~E~~~~~~L~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EcCCCCCcHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence            9999999998887432         38999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......   .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..   .. ..+.
T Consensus       149 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~~---~i-~~~~  217 (324)
T cd05589         149 KEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VFD---SI-VNDE  217 (324)
T ss_pred             ccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HHH---HH-HhCC
Confidence            7532111   11334679999999999999899999999999999999999999997643211    111   11 1111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                            ......+    ...+.+++.+|++.||.+||     ++.++++
T Consensus       218 ------~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 ------VRYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------CCCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                  1112222    34567789999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-38  Score=335.14  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|+..+.||+|+||.||+|++.  +.    .||+|+++... ....+++..|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999874  22    48999987543 34457889999999999999999999999864 5789


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ++||+++|+|.+++.....       .+++...+.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+
T Consensus        86 v~e~~~~g~l~~~l~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD-------NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeecCCCCCHHHHHHhccc-------cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccc
Confidence            9999999999999975433       38899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........++..|+|||++....++.++|||||||++|||++ |+.||......    .+..    ....
T Consensus       156 a~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~----~~~~  226 (316)
T cd05108         156 AKLLGADEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS----ILEK  226 (316)
T ss_pred             cccccCCCc-ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----HHhC
Confidence            987653221 111222334678999999999999999999999999999997 99998754321    1111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      +..       +  ..+......+.+++.+||+.+|.+||++.++++.|.....
T Consensus       227 ~~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         227 GER-------L--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCC-------C--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            111       0  1111223457789999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=323.58  Aligned_cols=255  Identities=24%  Similarity=0.465  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|.+.     ...||+|.++... .....+|.+|+.++++++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999885     2469999887543 33456789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++++|.+++.....       .+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        84 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          84 TEYMENGSLDKFLRENDG-------KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEcCCCCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchh
Confidence            999999999999865432       38999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....    ..+.+.+    ..+
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~----~~~  224 (266)
T cd05033         154 RRLEDSEA-TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAV----EDG  224 (266)
T ss_pred             hccccccc-ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHHH----HcC
Confidence            87752111 111223345678999999998899999999999999999998 9999865332    1122211    111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .         ....+....+.+.+++.+|++.+|++||++++|++.|+..
T Consensus       225 ~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 Y---------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1         0111122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=337.47  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=192.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +|+..++||+|+||.||++++.  ++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455788999999999999886  68899999865432 34567899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|....            ...+.....++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       155 ~~~~L~~~~------------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        155 DGGSLEGTH------------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             CCCcccccc------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999986543            24567778899999999999999   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ....   ......||..|+|||.+..     ...+.++|||||||++|||++|+.||........ ..+..   .. ...
T Consensus       220 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~---~~-~~~  291 (353)
T PLN00034        220 QTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASLMC---AI-CMS  291 (353)
T ss_pred             cccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHH---HH-hcc
Confidence            2211   1234578999999998743     2245689999999999999999999974332211 11111   00 000


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                               ............+.+++.+||+.||++||++.|+++.
T Consensus       292 ---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ---------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0111122233457789999999999999999999974

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-38  Score=335.72  Aligned_cols=199  Identities=26%  Similarity=0.416  Sum_probs=174.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||+|+||.||+++..  +..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67888999999999999999987  6779999887543 23456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++....        .+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          85 MDGGSLDQVLKEAK--------RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             CCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999986433        37889999999999999999997  236999999999999999999999999999765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      ....     .....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         155 IDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             cccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4221     234568999999999998899999999999999999999999996543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.7e-38  Score=335.22  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||+++..  +..||+|+++..   .......+..|+.++++++||||+++++++...+.+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875  678999999754   2334556788999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|..++....        .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          81 ELFFHLSRER--------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             cHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            9988885433        38899999999999999999999   899999999999999999999999999987532111


Q ss_pred             cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                         .......||+.|+|||++.++.++.++|||||||++|||++|+.||.......    +..    ....+.      .
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~----~~~~~~------~  212 (323)
T cd05595         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFE----LILMEE------I  212 (323)
T ss_pred             ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----HHH----HHhcCC------C
Confidence               11234579999999999999999999999999999999999999997543211    111    110111      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                      .+...+    ...+.+++.+|++.||++||     ++.++++
T Consensus       213 ~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCC----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            122223    34567888999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2e-38  Score=323.44  Aligned_cols=253  Identities=25%  Similarity=0.457  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||+|... +..||+|.+.... ...+.+..|+.++++++|+||+++++.+...+..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            46788899999999999999876 5679999876533 245788999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++......      .+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          85 KGSLLDFLKSDEGG------KVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCcHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999998654221      37899999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||++..+.++.++|||||||++|||++ |+.||......    .+...+    ..+..   
T Consensus       156 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~----~~~~~---  222 (261)
T cd05072         156 NEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSAL----QRGYR---  222 (261)
T ss_pred             Cce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHH----HcCCC---
Confidence            211  11223346778999999988889999999999999999998 99998653321    122211    11110   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                            ..........+.+++.+|++++|++||+++++++.|+.
T Consensus       223 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 ------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                  01111223457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-38  Score=323.69  Aligned_cols=253  Identities=30%  Similarity=0.504  Sum_probs=204.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .+|+..++||+|+||.||+|...  ++.+++|++.... ....++.+|+.++++++|+||++++++|...+.++++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777899999999999999886  6789999986543 34567899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....      ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        85 ~~~~L~~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          85 TYGNLLDYLRECNR------QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCcHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            99999999864332      148999999999999999999998   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....  .......++..|+|||.+.+..++.++|||||||++|||++ |..|+......    .+    +.....+    
T Consensus       156 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~----~~~~~~~----  221 (263)
T cd05052         156 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QV----YELLEKG----  221 (263)
T ss_pred             ccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HH----HHHHHCC----
Confidence            3211  11122334678999999998899999999999999999998 88898654321    11    1111111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           ...+.+......+.+++.+|++.||++||++.++++.|+.
T Consensus       222 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         222 -----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence                 1112222234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-39  Score=337.05  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=205.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|...+.||+|.||+||||+.+  .+.||+|.+.+..+  ...+.+.+|++++++++|||||.+++|+....++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777789999999999999887  56799999976543  345678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+.+ +|..+|.++..        ++.+....|+.++.+||.|||+   .+|+|||+||.|||++.++.+|+||||+|+.
T Consensus        82 ~a~g-~L~~il~~d~~--------lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK--------LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             hhhh-hHHHHHHhccC--------CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhh
Confidence            9955 99999976653        8999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      +..+.   ...+.+.||+-|||||++.++.|+..+|.||+||++||+.+|++||...       .+.+.+.......   
T Consensus       150 m~~~t---~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~---  216 (808)
T KOG0597|consen  150 MSTNT---SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDP---  216 (808)
T ss_pred             cccCc---eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCC---
Confidence            76421   2246788999999999999999999999999999999999999998652       3444333332211   


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .    ..+......+..++...+..||..|.+..++++
T Consensus       217 ----v----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 ----V----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----C----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                1    122234445666777889999999999999875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-38  Score=326.65  Aligned_cols=267  Identities=22%  Similarity=0.398  Sum_probs=202.1

Q ss_pred             CCCCCcccccCcEEEEEeeec------CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLL  391 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  391 (644)
                      |+..+.||+|+||+||++...      +..||+|.++.... .....+.+|+.++++++||||++++++|...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            377899999999999886532      56799999875432 3456788999999999999999999998764  35899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      +|||+++++|.+++...         .+++.++..++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+
T Consensus        86 v~e~~~~~~l~~~~~~~---------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EecCCCCCCHHHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccc
Confidence            99999999999998542         28999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++................++..|+|||.+....++.++||||||+++|||++|+.|+.......  ..+..+........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~  231 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVV  231 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchh
Confidence            9876432211111122345667999999988889999999999999999999999976533211  11111111000011


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.+..+.......+......+.+++.+|++++|++||+++++++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11122222222222333446788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-38  Score=326.71  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=199.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||++++.  +..+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999987  6789999987542  2335678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++++.+..+... ..       .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~~~~l~~~~~~-~~-------~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          81 YVEKNMLELLEEM-PN-------GVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             cCCCCHHHHHHhc-CC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            9998877654422 11       38889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH--------HHH
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW--------LWE  546 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~--------~~~  546 (644)
                      ......  .......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...        ...
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07848         150 LSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL  227 (287)
T ss_pred             cccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence            642211  1123457899999999999888999999999999999999999999764322111111100        000


Q ss_pred             HHhcCchhhhhhcccCC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRILDAADSRLGG------EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ............+....      .+.......+.+++.+|++.||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000000000      001112345788999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-39  Score=335.45  Aligned_cols=241  Identities=24%  Similarity=0.313  Sum_probs=192.8

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||.||+++..  +..||+|++...   .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999986  678999998753   234456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        81 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--  147 (312)
T cd05585          81 FHHLQREG--------RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--  147 (312)
T ss_pred             HHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--
Confidence            99986532        38899999999999999999999   999999999999999999999999999998643211  


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +.   .... .+.      .  
T Consensus       148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~---~~~~-~~~------~--  210 (312)
T cd05585         148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MY---RKIL-QEP------L--  210 (312)
T ss_pred             -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HH---HHHH-cCC------C--
Confidence             11344579999999999999899999999999999999999999997543211    11   1111 111      1  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                        .++......+.+++.+|++.||++||++..+.+.|+
T Consensus       211 --~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 --RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence              112222345678889999999999986544444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.9e-39  Score=335.59  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=208.6

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      +...++|+....||+|+||.||+++.+  |..+|+|++++..   ....+..++|-.+|....+|.||+|+-.+.+...+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345678999999999999999999876  7889999998764   34456788999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ||||||+|||++..+|....        +|+......++.+++.|+.-||+   .++|||||||+|+|||..|++||+||
T Consensus       217 YLiMEylPGGD~mTLL~~~~--------~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD--------TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC--------cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccc
Confidence            99999999999999997655        38888888999999999999999   99999999999999999999999999


Q ss_pred             CCcccccccc---------------------ccc-----cc------------------ccccccCCCccCccccccCCC
Q 006446          470 GLARTIQENL---------------------KTH-----HS------------------TKEIAGTPGYMAPESFLVGRA  505 (644)
Q Consensus       470 Gla~~~~~~~---------------------~~~-----~~------------------~~~~~gt~~y~APE~~~~~~~  505 (644)
                      ||+.-+....                     ...     ..                  ....+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            9995432100                     000     00                  012579999999999999999


Q ss_pred             CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCC
Q 006446          506 TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNP  585 (644)
Q Consensus       506 t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP  585 (644)
                      +..+|+||+|||+|||+.|.+||...++.+....++.|...+.....              ........+|+.+|+. ||
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CH
Confidence            99999999999999999999999999988888889888644422211              1112456678888888 99


Q ss_pred             CCCCC
Q 006446          586 HLRPS  590 (644)
Q Consensus       586 ~~RPs  590 (644)
                      ++|..
T Consensus       431 ~~RLG  435 (550)
T KOG0605|consen  431 ENRLG  435 (550)
T ss_pred             HHhcC
Confidence            99976

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-38  Score=319.94  Aligned_cols=248  Identities=26%  Similarity=0.457  Sum_probs=196.8

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ++||+|+||.||+|++.  ++.+|+|.+.... ......+.+|+.++++++||||++++++|......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999885  7789999876443 34456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++.....       .+++..++.++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          81 LTFLRTEGP-------RLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             HHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            999864322       38899999999999999999998   89999999999999999999999999999865421111


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR  560 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  560 (644)
                       ........+..|+|||.+.++.++.++|||||||++|||++ |..||......    ....    ....         .
T Consensus       151 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~----~~~~---------~  212 (252)
T cd05084         151 -STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTRE----AIEQ---------G  212 (252)
T ss_pred             -ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHH----HHHc---------C
Confidence             10111223567999999999999999999999999999998 88887643221    1111    1111         1


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       561 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1112222334567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.4e-38  Score=328.73  Aligned_cols=264  Identities=24%  Similarity=0.466  Sum_probs=209.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|...+.||+|+||.||++...       ...+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777899999999999999753       34589999877666666789999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCC--------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          392 VYEYMPNGSLDKFIFYDETN--------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      ||||+++++|.+++......        .......++|..+++++.|++.||+|||+   .+++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            99999999999999654311        00112248999999999999999999999   99999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~  542 (644)
                      +||+|||+++....... ........++..|+|||.+....++.++|||||||++|||++ |+.||......    ...+
T Consensus       162 ~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIE  236 (291)
T ss_pred             EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence            99999999976542211 111234456788999999998899999999999999999998 99998654321    1111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                          ....+...         .........+.+++.+|++++|++||++++|+++|+....
T Consensus       237 ----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 ----CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ----HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                11222211         1111234567889999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-38  Score=342.47  Aligned_cols=264  Identities=25%  Similarity=0.394  Sum_probs=206.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhccC-CCceeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  388 (644)
                      .++|...++||+|+||.||+|++.       ...||||++..... ...+.+..|+.+++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888999999999999999864       23699999975433 33567899999999996 9999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCC--------------------------------------------------------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS--------------------------------------------------------  412 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~--------------------------------------------------------  412 (644)
                      .+||||||++|+|.++|.......                                                        
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999986532100                                                        


Q ss_pred             --------------------------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          413 --------------------------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       413 --------------------------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                                                      ......+++..++.++.|+++||+|||+   .+|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                            0011247899999999999999999999   89999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhh
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNS  539 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~  539 (644)
                      ++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   .
T Consensus       273 ~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---T  348 (400)
T ss_pred             CCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---H
Confidence            99999999999986542211 111233457788999999998899999999999999999997 889986543211   1


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +    ......+.         ....+......+.+++.+||+.||++||++.+|.++|+..
T Consensus       349 ~----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 F----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             H----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            1    11111111         1111223345678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-38  Score=324.02  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=208.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ..+|+..++||+|+||.||+|... +..+++|.+.........++..|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            346778899999999999999987 6789999988766656778999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++......      .+++.+++.++.+++.||.|||+   .+++||||||+||++++++.+||+|||.+....
T Consensus        85 ~~~~L~~~~~~~~~~------~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          85 EKGSLLAFLRSPEGQ------VLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             ccCCHHHHHhcCCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999653321      48999999999999999999998   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   .....++..|+|||.+..+.++.++||||||+++|||++ |+.||......    .+.....    .+    
T Consensus       156 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~----~~----  220 (261)
T cd05148         156 EDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQIT----AG----  220 (261)
T ss_pred             Ccccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHH----hC----
Confidence            22111   223346778999999988899999999999999999998 89998654321    1222111    11    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           .....+......+.+++.+|++.||++||+++++++.|+.
T Consensus       221 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         221 -----YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                 1111222334567789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=321.30  Aligned_cols=254  Identities=25%  Similarity=0.462  Sum_probs=204.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .++|+..+.||+|++|.||+|... ++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            356888999999999999999876 5679999986543 23567899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....      ..++|..+..++.+++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 ~~~~L~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          84 KYGSLLEYLQGGAG------RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             cCCcHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            99999999865431      148999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....  ........+..|+|||.+....++.++||||||+++|||++ |+.||......    .+..    ....+    
T Consensus       155 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~----~~~~~----  220 (261)
T cd05068         155 EDIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQ----QVDQG----  220 (261)
T ss_pred             CCcc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHHcC----
Confidence            2211  11122233468999999998899999999999999999999 99898654321    1111    11111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           .....+....+.+.+++.+|++.+|++||++.++++.|+.
T Consensus       221 -----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 -----YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                 1111222334668889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.9e-38  Score=325.59  Aligned_cols=261  Identities=24%  Similarity=0.450  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|+..++||+|+||.||+|...      +..+++|.+.... .+...++.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            35677899999999999999852      4679999987533 3344678899999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCC---------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          392 VYEYMPNGSLDKFIFYDETN---------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~---------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      ||||+++++|.+++......         .......+++.+.+.++.|++.||+|||+   ++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            99999999999998543211         01112348899999999999999999999   8999999999999999999


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHH
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~  541 (644)
                      .+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....    ..+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVI  236 (283)
T ss_pred             cEEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence            9999999999876422211 11233445778999999988889999999999999999998 8889865332    1122


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      +    ....+...         ..+......+.+++.+|+++||++||++.++++.|+.
T Consensus       237 ~----~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 E----MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            2    11111111         1111223457778899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-38  Score=334.85  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HDFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~  390 (644)
                      +|+..++||+|+||.||+|+..  +..||+|++...  .......+.+|+.++++++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999876  688999998643  223345788999999999999999999988643     2489


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||| +++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        81 lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND--------DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc--------cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCc
Confidence            999999 478888885432        38899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      +++................||..|+|||++.+  ..++.++|||||||++|||++|+.||.......    ....+....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~----~~~~~~~~~  224 (338)
T cd07859         149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLITDLL  224 (338)
T ss_pred             cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHHh
Confidence            99865322211111234679999999999865  678999999999999999999999997643211    111111110


Q ss_pred             h-----------cC---chhhhhhcccCCCCCH---HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          549 R-----------KG---RILDAADSRLGGEFSE---KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       549 ~-----------~~---~~~~~~d~~l~~~~~~---~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .           ..   .....+.+.....+..   .....+.+++.+|++.||++||+++++++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0           00   0011111111111100   112346789999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-38  Score=328.60  Aligned_cols=263  Identities=24%  Similarity=0.305  Sum_probs=193.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---CceEEEEEeecccc--hhhHHHHHHHHHHhcc---CCCceeeEeeeeee-----
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL---RHRNLVKLIGWCYE-----  385 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~-----  385 (644)
                      ++|+..+.||+|+||.||+|+..   +..||+|+++....  .....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999873   46799998865332  2234566677776665   69999999999852     


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      ...+++|+||++ ++|.+++......      .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~k  150 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP------GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIK  150 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEE
Confidence            346899999995 7899888643321      38899999999999999999999   9999999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+|||+++.....    .......||..|+|||.+....++.++|||||||++|||++|+.||......+....+.+...
T Consensus       151 l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~  226 (290)
T cd07862         151 LADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  226 (290)
T ss_pred             EccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            9999999865422    113455789999999999888999999999999999999999999986543222222221110


Q ss_pred             HHHhcCchh---hhhhcccC---C----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRIL---DAADSRLG---G----EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~~---~~~d~~l~---~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      . .......   ......+.   .    .........+.+++.+|++.||++||++.++++
T Consensus       227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 L-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             C-CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0 0000000   00000000   0    000112345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=310.63  Aligned_cols=235  Identities=25%  Similarity=0.353  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+|+..+.||.|+||+|.+.+.+  +.-+|+|++++..-   ...+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            36777899999999999999887  67899999976532   23456778999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||.++|-|..+|++...        ++......++.+|+.||+|||+   ..|++|||||+|||||.+|.+||.|||.|+
T Consensus       124 eyv~GGElFS~Lrk~~r--------F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR--------FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             eccCCccHHHHHHhcCC--------CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceE
Confidence            99999999999976553        7888889999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      +-..+||+.|+|||.++...+..++|.|||||++|||++|.+||....+....+.+        -.+++
T Consensus       193 ~v~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--------~~~~v  258 (355)
T KOG0616|consen  193 RVSGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--------LEGKV  258 (355)
T ss_pred             EecCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--------HhCcc
Confidence            77532      55689999999999999999999999999999999999999999876542211111        12221


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR  588 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R  588 (644)
                                .++.-....+.+|+...++.|-.+|
T Consensus       259 ----------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ----------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                      1222223345556667777777777

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-38  Score=322.19  Aligned_cols=256  Identities=23%  Similarity=0.477  Sum_probs=203.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--C---ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--N---KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .+|+..+.||+|+||.||+|+..  +   ..+++|++.... ....+++..|++++++++|+||+++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999875  2   268999886543 33456789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++++|.+++.....       .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        85 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          85 TEYMENGALDKYLRDHDG-------EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             EEcCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccc
Confidence            999999999999865332       38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ..................+..|+|||++....++.++|||||||++|||++ |+.||......    .+..   .. ..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~---~i-~~~  226 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMK---AI-NDG  226 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHH---HH-hcC
Confidence            866432211111112233567999999988889999999999999999997 99998654321    1111   11 111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .         ......+....+.+++.+|++.+|++||++.+|++.|++.
T Consensus       227 ~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 F---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0         1111122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-38  Score=328.98  Aligned_cols=264  Identities=22%  Similarity=0.280  Sum_probs=197.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||+|+..  +..||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999876  67899999865432 2345678999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ |+|.+++.....       .+++.....++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~-~~l~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          85 LD-SDLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CC-cCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            96 589888854332       37889999999999999999999   99999999999999999999999999999765


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH----HHHhc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----ELRRK  550 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~----~~~~~  550 (644)
                      ....   .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.....    +.+..
T Consensus       154 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         154 SVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             cCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence            3211   11234568999999998865 5689999999999999999999999976543222111111000    00000


Q ss_pred             ----CchhhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 ----GRILDAADSRLGGEF----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ----~~~~~~~d~~l~~~~----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          ........+......    .........+++.+|++.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                000000000000000    0011234678999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4e-38  Score=324.42  Aligned_cols=261  Identities=25%  Similarity=0.475  Sum_probs=207.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|...+.||+|+||.||+|+..       +..||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777899999999999999864       357999998765444 4678999999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCC------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNS------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      +||||+++++|.+++.......      ......+++.....++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999996543210      1123348899999999999999999999   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......    .+.+.
T Consensus       162 kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC  236 (280)
T ss_pred             EECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence            99999999765322111 11233456788999999999999999999999999999998 99998654321    12221


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      +    ..+...         ..+......+.+++.+||+.||++||++.||++.|+.
T Consensus       237 ~----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 I----TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H----HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1    122211         1112234567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8e-38  Score=329.15  Aligned_cols=239  Identities=21%  Similarity=0.331  Sum_probs=188.3

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhc-cCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGS-LRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+|+..  +..||+|+++...   ....+.+..|..++.. .+||||+++++++..++.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986  5679999987542   2334455667777665 4899999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .++......++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          81 GDLMFHIQSSG--------RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            99998886432        27888899999999999999999   99999999999999999999999999999764321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..   ... ..      .
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~~---~i~-~~------~  212 (316)
T cd05592         150 E---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LFD---SIL-ND------R  212 (316)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HHH---HHH-cC------C
Confidence            1   11344579999999999998899999999999999999999999997643211    111   111 10      0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK-TVL  595 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl  595 (644)
                          ..++......+.+++.+|++.||++||++. +++
T Consensus       213 ----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 ----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                111222234566788999999999999876 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.5e-38  Score=324.14  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=200.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|+||.||+|++.  +.    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35677899999999999999874  33    47888875433 2334678889999999999999999998864 56789


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ++||+++|+|.+++.....       .++|..++.++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+
T Consensus        86 i~e~~~~gsL~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD-------SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCcc
Confidence            9999999999999975433       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........++..|+|||.+.++.++.++|||||||++|||++ |+.||......    .+.+    ....
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~----~~~~  226 (279)
T cd05111         156 ADLLYPDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPD----LLEK  226 (279)
T ss_pred             ceeccCCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----HHHC
Confidence            987643221 111334567789999999998899999999999999999998 99998754321    1222    1122


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      +....  .+   .    .....+..++.+||+.||++||++.++++.|....
T Consensus       227 ~~~~~--~~---~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         227 GERLA--QP---Q----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCcCC--CC---C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            22111  01   1    11234567888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.5e-38  Score=325.79  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             CCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      +|+..+.||+|+||.||+|+...       ..+++|.+..... ...+++..|+.++++++||||+++++.|..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778999999999999998642       4688888865432 345678899999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCC----------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNS----------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N  455 (644)
                      ++||+++|+|.+++.......                ......+++...+.++.|++.||.|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            999999999999986432110                1122358899999999999999999998   999999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccc
Q 006446          456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQN  534 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~  534 (644)
                      ||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            99999999999999999865422211 11223345678999999988889999999999999999998 9999865432 


Q ss_pred             cchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                         ..+.    .....+.         ....+......+.+++.+|++++|++||++.++++.|+...
T Consensus       236 ---~~~~----~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ---ERLF----NLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ---HHHH----HHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence               1122    2221111         11112223346778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-38  Score=326.22  Aligned_cols=272  Identities=23%  Similarity=0.385  Sum_probs=201.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  390 (644)
                      ++|+..+.||+|+||.||++...      +..||+|++........+.+.+|+.++++++||||+++++++...  ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46778899999999999998752      568999999877666677899999999999999999999987543  4689


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|+||+++|+|.+++.....       .++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE-------RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc-------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCc
Confidence            99999999999999864432       38999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++................++..|+|||++.+..++.++|||||||++|||++|..|+...... ....+..........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIV  232 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccch
Confidence            9987643221111111223445699999998888999999999999999999988775432210 000000000000000


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..+.+.+...............+.+++.+||+++|++|||++++++.|+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000111111111111222345688899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-38  Score=338.24  Aligned_cols=244  Identities=23%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC---ceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN---KEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~---~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|.+.+   ..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999998652   579999986532   23456788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||++
T Consensus       110 ~Ey~~~g~L~~~i~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK--------RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             EeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            99999999999986543        38889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +    ......+.
T Consensus       179 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~----~~~i~~~~  244 (340)
T PTZ00426        179 KVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I----YQKILEGI  244 (340)
T ss_pred             eecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H----HHHHhcCC
Confidence            865421      234578999999999998889999999999999999999999997643211    1    11111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                      .      .+...+    ...+.+++.+|++.||++|+     +++++++.
T Consensus       245 ~------~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 I------YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C------CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0      111222    23467789999999999995     88888764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-38  Score=319.41  Aligned_cols=246  Identities=26%  Similarity=0.434  Sum_probs=195.0

Q ss_pred             cccccCcEEEEEeeec----CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          326 KLGKGGFGTVYKGIWR----NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      .||+|+||.||+|.+.    +..+|+|+++...  ....+++..|+.++++++|+||+++++++. ....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999763    5679999986543  234567899999999999999999999985 45679999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|.+++....        .+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          81 PLNKFLQKNK--------HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             cHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999985432        37899999999999999999998   899999999999999999999999999998764322


Q ss_pred             cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      ..........++..|+|||.+....++.++|||||||++|||++ |+.||......    .+.+.    ...+..     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~----i~~~~~-----  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQM----IESGER-----  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHCCCC-----
Confidence            21111222344678999999988889999999999999999998 99998754321    12211    122211     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          ...+......+.+++.+||++||++||++.+|.+.|++
T Consensus       217 ----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 ----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                11222233457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.2e-38  Score=325.19  Aligned_cols=263  Identities=27%  Similarity=0.489  Sum_probs=207.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|...+.||+|+||.||++...       +..+|+|.+........+.+..|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999752       34589999877666667789999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCC-----CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          392 VYEYMPNGSLDKFIFYDETN-----SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      |+||+++++|.+++......     .......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            99999999999998643210     11122348999999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......    .+..   
T Consensus       162 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~---  233 (288)
T cd05093         162 GDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIE---  233 (288)
T ss_pred             ccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---
Confidence            99999986542211 111223445788999999998889999999999999999998 89898654321    1111   


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                       ....+....     ....    ....+.+++.+|+++||.+||+++++++.|+...
T Consensus       234 -~i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         234 -CITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -HHHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             111222111     1112    2345788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.7e-38  Score=334.68  Aligned_cols=264  Identities=23%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec-cc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER-HD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  388 (644)
                      ++|+..+.||+|+||.||+|...       ++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46888999999999999999753       2579999987543 23345678899999999 899999999988754 56


Q ss_pred             eEEEEeccCCCccchhhhccCCCCC-----------------------------------------------------CC
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSG-----------------------------------------------------PG  415 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~-----------------------------------------------------~~  415 (644)
                      +++++||+++++|.+++........                                                     ..
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8899999999999999864321000                                                     00


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCcc
Q 006446          416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM  495 (644)
Q Consensus       416 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~  495 (644)
                      ...++|..+.+++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+..... ........++..|+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~y~  242 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWM  242 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCcccc
Confidence            1258999999999999999999998   8999999999999999999999999999987642221 11123345677899


Q ss_pred             CccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHH
Q 006446          496 APESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVL  574 (644)
Q Consensus       496 APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  574 (644)
                      |||++.+..++.++|||||||++|||++ |+.||......+   .+    ......+..         ...+......+.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF----CRRLKEGTR---------MRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH----HHHHhccCC---------CCCCccCCHHHH
Confidence            9999999999999999999999999998 999986533221   11    111111111         111222335678


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          575 ILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       575 ~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      +++.+|++.+|++||++.++++.|+...
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            8999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.5e-38  Score=319.90  Aligned_cols=251  Identities=27%  Similarity=0.470  Sum_probs=201.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-ceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||+|...+ ..+|+|.+..... ...++.+|+.++++++||||++++++|.+....+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            356778899999999999998874 4699999875432 34678999999999999999999999999989999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....       .+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~l~~~i~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          83 NGCLLNYLREHGK-------RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             CCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999865332       38999999999999999999999   8999999999999999999999999999986542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|++||.+....++.++|||||||++|||++ |+.||......    .+...+    ..+..   
T Consensus       153 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~---  219 (256)
T cd05113         153 DEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKV----SQGLR---  219 (256)
T ss_pred             Cce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----hcCCC---
Confidence            211  11222345678999999988889999999999999999998 99998654321    111111    11110   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                            ........+.+.+++.+||+++|.+||++.++++.|+
T Consensus       220 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                  0111122456788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-38  Score=331.11  Aligned_cols=240  Identities=24%  Similarity=0.332  Sum_probs=192.4

Q ss_pred             CcccccCcEEEEEeeec-----CceEEEEEeeccc----chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          325 NKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++||+|+||.||+++..     ++.||+|.++...    ......+..|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999998753     5789999987532    22345678899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++....        .+.+.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          82 LSGGELFMHLEREG--------IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCchHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999886433        26788888899999999999999   99999999999999999999999999998754


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..   ... ..+.   
T Consensus       151 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~---~~~-~~~~---  216 (323)
T cd05584         151 IHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TI---DKI-LKGK---  216 (323)
T ss_pred             ccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HH---HHH-HcCC---
Confidence            3211   11334579999999999998889999999999999999999999997643211    11   111 1111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                         .    .++......+.+++.+|++.||++||     +++++++
T Consensus       217 ---~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 ---L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               1    11122234567889999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.9e-38  Score=332.27  Aligned_cols=251  Identities=23%  Similarity=0.268  Sum_probs=196.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc----chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS----RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      +|+..++||+|+||.||+++..     +..||+|++....    ....+.+..|+.++.++ +|+||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998763     5789999986532    22345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||+++|+|.+++....        .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--------NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999986433        38889999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++.......  .......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+..    ..
T Consensus       150 G~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~  223 (332)
T cd05614         150 GLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RI  223 (332)
T ss_pred             cCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HH
Confidence            99986532211  112345799999999998765 478899999999999999999999975432221111111    11


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                      ..      .++.+...+    ...+.+++.+|++.||++||     +++++++.
T Consensus       224 ~~------~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 LK------CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             hc------CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00      112222222    34567788999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-38  Score=349.09  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec---CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .|...+.||+|+||.||++...   +..||+|.+..........+..|+.+++.++|||||++++++...+.++|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4788899999999999999765   4578888876655555567888999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++......    ...+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~gg~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        148 SGGDLNKQIKQRLKE----HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCHHHHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999988643221    1247889999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      .... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   .. ..+...  
T Consensus       221 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~---~~-~~~~~~--  289 (478)
T PTZ00267        221 DSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQ---QV-LYGKYD--  289 (478)
T ss_pred             Cccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-HhCCCC--
Confidence            3221 11134457999999999999999999999999999999999999998654321    1111   11 111110  


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                             .++......+.+++.+|++.||++||+++++++
T Consensus       290 -------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                   111122345778899999999999999999864

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.5e-38  Score=322.15  Aligned_cols=260  Identities=27%  Similarity=0.462  Sum_probs=203.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      +++|...+.||+|++|.||+|.+.+       ..|++|.+.... ......|..|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999998853       568889876543 33456789999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARL  466 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL  466 (644)
                      ++||||+++++|.+++........ ....++|..++.++.||+.||+|||+   .+++||||||+||+++.++   .+||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPE-RPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999976542211 12358999999999999999999999   8999999999999998764   5999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||......    .+.+.  
T Consensus       161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~--  233 (277)
T cd05036         161 ADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEF--  233 (277)
T ss_pred             ccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH--
Confidence            999999876322111 11122234568999999998999999999999999999997 99998754321    11111  


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                        ....         .....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       234 --~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 --VTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              1111         111122223356778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-38  Score=334.10  Aligned_cols=251  Identities=23%  Similarity=0.297  Sum_probs=198.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|+++...   ....+.+..|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999876  7789999997542   234566889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          81 EYQPGGDLLSLLNRYED-------QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             CCCCCCCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCe
Confidence            99999999999965432       38899999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccc------cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL------VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      .......  .......||+.|+|||++.      ...++.++|||||||++|||++|+.||........       ....
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i  221 (330)
T cd05601         151 RLTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNI  221 (330)
T ss_pred             ECCCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHH
Confidence            7643211  1123457899999999986      45678999999999999999999999976432111       1111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ........     ...  .......+.+|+.+|++ +|.+||+++++++
T Consensus       222 ~~~~~~~~-----~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         222 MNFQRFLK-----FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HcCCCccC-----CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111110     000  01123446678888998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-38  Score=318.04  Aligned_cols=250  Identities=28%  Similarity=0.498  Sum_probs=200.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +|+..+.||+|+||.||++.+. +..+|+|.+..... ...++.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5777899999999999999886 45799998864432 345788999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++.....       .++|..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        84 ~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          84 GCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             CCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            999999865432       38999999999999999999999   89999999999999999999999999999865422


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+    +..   .. ..+      
T Consensus       154 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~---~~-~~~------  217 (256)
T cd05059         154 QY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVE---SV-SAG------  217 (256)
T ss_pred             cc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH----HHH---HH-HcC------
Confidence            11  11122234568999999998899999999999999999999 788886543211    111   11 111      


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                         .+...+......+.+++.+|++.+|++||++.++++.|.
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence               111112223456888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-37  Score=317.45  Aligned_cols=248  Identities=22%  Similarity=0.415  Sum_probs=195.9

Q ss_pred             cccccCcEEEEEeeec----CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          326 KLGKGGFGTVYKGIWR----NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      .||+|+||.||+|++.    +..||+|.+..... ...+.+.+|+.++++++|+||++++++|. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999875    34699999876532 33567899999999999999999999985 457899999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK  480 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~  480 (644)
                      |.+++.....       .+++..+++++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          81 LNKFLSGKKD-------EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             HHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            9999864332       38999999999999999999999   8999999999999999999999999999986543222


Q ss_pred             ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       481 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                      .........++..|+|||.+....++.++|||||||++||+++ |+.||......    .+..    ....+.       
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~~-------  215 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMS----FIEQGK-------  215 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH----HHHCCC-------
Confidence            1111222234678999999988889999999999999999996 99998764321    1111    111221       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        ....+....+.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus       216 --~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 --RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              1122233445677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=324.65  Aligned_cols=268  Identities=22%  Similarity=0.381  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC----------------ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN----------------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG  381 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g  381 (644)
                      ++|+..++||+|+||.||+++..+                ..||+|.++.. .......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987642                24899998754 2334567899999999999999999999


Q ss_pred             eeeeccceEEEEeccCCCccchhhhccCCCC----CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEE
Q 006446          382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNS----GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM  457 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NIL  457 (644)
                      ++...+..++||||+++++|.+++.......    ......++|..++.++.|++.||+|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            9999999999999999999999986432111    1112247899999999999999999999   89999999999999


Q ss_pred             EcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc--CCCCCCCCcccc
Q 006446          458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC--GRKPGNQSEQNS  535 (644)
Q Consensus       458 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t--G~~P~~~~~~~~  535 (644)
                      +++++.+||+|||+++....... ........++..|+|||.+..+.++.++|||||||++|||++  |..||...... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            99999999999999986542211 111223345778999999998899999999999999999988  55676543321 


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                         .+.....+......      .......+......+.+|+.+|++.||++||++.+|++.|+.
T Consensus       240 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 ---QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ---HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence               12221111111100      000011111223578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=316.16  Aligned_cols=249  Identities=26%  Similarity=0.471  Sum_probs=198.7

Q ss_pred             CcccccCcEEEEEeeec--C---ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--N---KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||+|++.  +   ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999875  2   5799999876543 34567899999999999999999999876 4568999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKKRR--------EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999996543        38899999999999999999998   89999999999999999999999999999876533


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...........++..|+|||.+....++.++|||||||++|||++ |+.||.....    ..+..++.    .+..    
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~----~~~~----  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLE----SGER----  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH----cCCc----
Confidence            221111122234568999999998899999999999999999998 9999875432    12222221    1111    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                           ...+......+.+++.+|++++|++||++.++++.|++..
T Consensus       217 -----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 -----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                 0111222356778999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-38  Score=323.85  Aligned_cols=251  Identities=28%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      +|+..++||+|+||.||++...  ++.||+|++....   ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4677899999999999999875  6789999986532   2223557889999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++|+|.+++.....      ..+++.....++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++.
T Consensus        81 ~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          81 LMNGGDLKFHIYNMGN------PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             ccCCCcHHHHHHhcCc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            9999999988864321      138899999999999999999999   8999999999999999999999999999986


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......    .....|+..|+|||.+.+..++.++||||+||++|||++|+.||...........+    ......    
T Consensus       152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~~~~~----  219 (285)
T cd05605         152 IPEGET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKE----  219 (285)
T ss_pred             cCCCCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HHHhhh----
Confidence            542211    23346899999999999888999999999999999999999999764322111111    111110    


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                            ....++......+.+|+.+|++.||.+||     ++.++++.
T Consensus       220 ------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 ------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                  11122233445677899999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-37  Score=324.90  Aligned_cols=262  Identities=22%  Similarity=0.287  Sum_probs=196.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..++||+|+||.||+|+..  ++.||+|++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999986  67899999875432 233467889999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ ++|.+++.....       .++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          84 YVH-TDLCQYMDKHPG-------GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             CCC-cCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence            994 678777754432       27888899999999999999999   9999999999999999999999999999975


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....   .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......  .. ....+.........
T Consensus       153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~-~~~~~~~~~~~~~~  226 (303)
T cd07869         153 KSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QD-QLERIFLVLGTPNE  226 (303)
T ss_pred             ccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HH-HHHHHHHHhCCCCh
Confidence            43211   11234568999999998865 45788999999999999999999999764321  11 11111111100000


Q ss_pred             ------h--hhhh-cccCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 ------L--DAAD-SRLGGEFSE---------KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ------~--~~~d-~~l~~~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            .  ...+ .++....+.         .....+.+++.+|++.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                  0  0000 000000000         01134668999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=316.24  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=206.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++|+..+.||+|+||.||++...++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            4678889999999999999999999999999976654 567899999999999999999999999998999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++......      .++|..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.++.....
T Consensus        85 ~~L~~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          85 GSLVDYLRSRGRA------VITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             CcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            9999998654321      38999999999999999999999   99999999999999999999999999999876321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                            ......+..|+|||.+..+.++.++||||||+++||+++ |+.||......    .+..    ....+      
T Consensus       156 ------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~~~~~------  215 (256)
T cd05039         156 ------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVP----HVEKG------  215 (256)
T ss_pred             ------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHhcC------
Confidence                  112334678999999998899999999999999999997 99998654321    1211    11111      


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                         .....+......+.+++.+|++.+|++||++++++++|+.
T Consensus       216 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         216 ---YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               1111122234567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=317.81  Aligned_cols=258  Identities=26%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             CCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc-----
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD-----  388 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----  388 (644)
                      |+..+.||+|+||.||+|.+.     +..||+|+++...  ......+.+|+..+++++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            466889999999999999875     2569999987542  3345678999999999999999999999876554     


Q ss_pred             -eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          389 -FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       389 -~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                       .++++||+++|+|..++.......  ....+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGG--LPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccC--CcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEEC
Confidence             799999999999999986543221  12248999999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++........ .......++..|+|||.+....++.++|||||||++|||++ |..||.....    ..+.+++. 
T Consensus       156 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~-  229 (273)
T cd05035         156 DFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLR-  229 (273)
T ss_pred             Cccceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH-
Confidence            99999876432211 11222345678999999988889999999999999999999 8888865332    12222221 


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                         .+..         ...+......+.+++.+|++.||++||++.++++.|+..
T Consensus       230 ---~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 ---HGNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---cCCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               1111         111223345678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.3e-38  Score=323.37  Aligned_cols=259  Identities=22%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             CCCCCcccccCcEEEEEeeec-------CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      |+..+.||+|+||.||+|...       +..||+|+++..... ..+.+..|+.++++++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            555788999999999999864       357999999755433 346688999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCC--------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          393 YEYMPNGSLDKFIFYDETN--------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      +||+++++|.+++......        .......+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence            9999999999998532110        01112348899999999999999999998   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++........ .......+++.|+|||.+..+.++.++|||||||++|||++ |..||......    .+.+ 
T Consensus       164 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~-  237 (283)
T cd05091         164 KISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVIE-  237 (283)
T ss_pred             Eecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH-
Confidence            99999999866432211 11233456789999999988889999999999999999998 88887654321    1221 


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                         ....+..         ..++......+.+++.+|++.+|.+||+++++++.|+.
T Consensus       238 ---~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 ---MIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               1111111         11222334557789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.1e-38  Score=330.49  Aligned_cols=236  Identities=24%  Similarity=0.324  Sum_probs=187.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHH-HHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVT-TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||+||+|+..  ++.||+|++....   ....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999986  7789999987542   222344555554 56789999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++.....++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          81 GELFFHLQRER--------SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            99999886433        37888999999999999999999   89999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +.   ... ..+.      
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~---~~i-~~~~------  212 (323)
T cd05575         150 S---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MY---DNI-LNKP------  212 (323)
T ss_pred             C---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HH---HHH-HcCC------
Confidence            1   11345579999999999999999999999999999999999999997643211    11   111 1111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK  592 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  592 (644)
                      ..+....    ...+.+++.+|++.||.+||+++
T Consensus       213 ~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 LRLKPNI----SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence            1122222    34567888999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-37  Score=323.52  Aligned_cols=269  Identities=22%  Similarity=0.367  Sum_probs=206.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecC------------------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceee
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRN------------------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVK  378 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~------------------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~  378 (644)
                      .++|+..+.||+|+||.||+++...                  ..||+|++.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987652                  358999987553 344678899999999999999999


Q ss_pred             EeeeeeeccceEEEEeccCCCccchhhhccCCCCC---CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCC
Q 006446          379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       379 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N  455 (644)
                      ++++|..++..++++||+++++|.+++........   .....+++..++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            99999999999999999999999999865432110   112248999999999999999999998   899999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc--CCCCCCCCcc
Q 006446          456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC--GRKPGNQSEQ  533 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t--G~~P~~~~~~  533 (644)
                      |+++.++.++|+|||+++....... ........++..|+|||.+..+.++.++|||||||++|||++  |..|+.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999986542221 111234456789999999988889999999999999999998  6677754332


Q ss_pred             ccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       534 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          ..+...+..........      ............+.+++.+|++.||++||+++++++.|+.
T Consensus       240 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 ----QQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ----HHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                12222222221111110      0011111223568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-37  Score=329.31  Aligned_cols=198  Identities=25%  Similarity=0.423  Sum_probs=173.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||++.+.  +..+|+|.+.... ......+.+|++++++++|+||++++++|.+++.+++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            68889999999999999999987  6678999887543 23456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++....        .+++.....++.+++.||.|||+  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          85 MDGGSLDQVLKKAG--------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             CCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            99999999986432        37888889999999999999997  247999999999999999999999999999765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      ....     .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         155 IDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            3211     23356899999999999888999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-37  Score=336.33  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=194.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..+.||+|+||+||+|+..  +..||+|++....   ....+.+..|+.++++++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999886  6789999997542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~--------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME--------VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999986543        37888888999999999999999   9999999999999999999999999999864


Q ss_pred             ccccccc--------------------------------------------cccccccccCCCccCccccccCCCCCccc
Q 006446          475 IQENLKT--------------------------------------------HHSTKEIAGTPGYMAPESFLVGRATIETD  510 (644)
Q Consensus       475 ~~~~~~~--------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~~sD  510 (644)
                      .......                                            ........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            3210000                                            00012347999999999999888999999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHH--hcCCCCCCC
Q 006446          511 IYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLA--CCHPNPHLR  588 (644)
Q Consensus       511 VwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~--Cl~~dP~~R  588 (644)
                      ||||||++|||++|+.||...........+..|      ... ....   ....++.+    +.+++.+  |+.++|..|
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~-~~~~---~~~~~s~~----~~dli~~ll~~~~~~~~R  296 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINW------ENT-LHIP---PQVKLSPE----AVDLITKLCCSAEERLGR  296 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc-cCCC---CCCCCCHH----HHHHHHHHccCcccccCC
Confidence            999999999999999999765432211111111      000 0000   00123333    3344444  667777789


Q ss_pred             CCHHHHHHH
Q 006446          589 PSMKTVLQV  597 (644)
Q Consensus       589 Ps~~evl~~  597 (644)
                      |+++++++.
T Consensus       297 ~~~~~~l~h  305 (381)
T cd05626         297 NGADDIKAH  305 (381)
T ss_pred             CCHHHHhcC
Confidence            999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-37  Score=317.66  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=199.7

Q ss_pred             CCCCCcccccCcEEEEEeeecC----ceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------cc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------HD  388 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~  388 (644)
                      |...++||+|+||.||+|.+..    ..+|+|.++..  .....+.+..|+.++++++|+||+++++.|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3457899999999999999862    25899988653  344467889999999999999999999988542      24


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++++||+++|+|.+++......  .....+++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG--DCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc--CCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECC
Confidence            68999999999999988543321  112248999999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+++........ .......++..|+|||.+....++.++|||||||++|||++ |+.||......    .+.    +.
T Consensus       156 fg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~----~~  226 (272)
T cd05075         156 FGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIY----DY  226 (272)
T ss_pred             CCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHH----HH
Confidence            9999876432211 11223346778999999999899999999999999999999 78888653221    111    11


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...+...         .........+.+++.+||++||++||++.++++.|+..
T Consensus       227 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2222111         11112334578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-37  Score=320.88  Aligned_cols=261  Identities=26%  Similarity=0.443  Sum_probs=205.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      +++...++||+|+||.||++...       +..+++|.+........+.+.+|+.++++++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999642       45789999877666667889999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCC-------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          392 VYEYMPNGSLDKFIFYDETN-------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      ++||+++++|.+++......       .......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            99999999999998654211       01112348999999999999999999998   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......    ....
T Consensus       162 kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----AIEC  236 (280)
T ss_pred             EECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----HHHH
Confidence            9999999976542211 111223345788999999998899999999999999999998 899986543211    1111


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          ...+.         ....+......+.+++.+||+.||++||++++|++.|+.
T Consensus       237 ----~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ----ITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ----HHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                11111         011111223457789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=328.74  Aligned_cols=247  Identities=28%  Similarity=0.462  Sum_probs=205.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..|+..++||+|.||.||||.+.  ++.||+|.+..+ .....++..+|+.++.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35667789999999999999987  678999999754 445678889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |.+|++.+.|.....        ++.....-|+.++..||.|||.   .+.+|||||+.|||+..+|.+||+|||++-.+
T Consensus        93 ~~gGsv~~lL~~~~~--------~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI--------LDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             hcCcchhhhhccCCC--------CccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeee
Confidence            999999999965443        3455556688899999999999   89999999999999999999999999999877


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   .....+||+.|||||++....|+.|+||||||++.+||++|.+|+....+.....             -+.+
T Consensus       162 ~~~~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk  225 (467)
T KOG0201|consen  162 TNTVK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPK  225 (467)
T ss_pred             echhh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccC
Confidence            64322   1356799999999999998899999999999999999999999987765422110             1222


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...|.+.+.+..    .+.+++..|++.||+.||++.++++
T Consensus       226 ~~PP~L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  226 SAPPRLDGDFSP----PFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCccccccCH----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence            334455554443    4666778999999999999999984

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.1e-38  Score=335.53  Aligned_cols=203  Identities=26%  Similarity=0.420  Sum_probs=174.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||++...  ++.||+|+++...   ......+..|+.++.+++|+||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999876  6789999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          81 EFLPGGDMMTLLMKKD--------TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             cCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            9999999999986543        38899999999999999999999   999999999999999999999999999997


Q ss_pred             cccccccc--------------------------------cccccccccCCCccCccccccCCCCCccchHHHHHHHHHH
Q 006446          474 TIQENLKT--------------------------------HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV  521 (644)
Q Consensus       474 ~~~~~~~~--------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el  521 (644)
                      ........                                .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            64321100                                0001235799999999999999999999999999999999


Q ss_pred             HcCCCCCCCCc
Q 006446          522 ACGRKPGNQSE  532 (644)
Q Consensus       522 ~tG~~P~~~~~  532 (644)
                      ++|+.||....
T Consensus       230 l~G~~Pf~~~~  240 (363)
T cd05628         230 LIGYPPFCSET  240 (363)
T ss_pred             HhCCCCCCCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-37  Score=315.74  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=206.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|+..  +..||+|+++..   .......+.+|+.++++++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999875  789999987642   2334467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++......    ...++......++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        82 e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ----KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EecCCCcHHHHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999999888532211    1137888999999999999999998   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......++..|+|||.+.+..++.++||||||+++|||++|+.||......     ..++.... .... 
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~-~~~~-  224 (267)
T cd08228         155 FFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKI-EQCD-  224 (267)
T ss_pred             eccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHH-hcCC-
Confidence            7643211   122346888999999998888999999999999999999999998654321     11111111 1111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                             ............+.+++.+||+.+|++||++.+|++.|++.
T Consensus       225 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 -------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                   11111223345678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9e-38  Score=324.34  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=206.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ..++|+..+.||+|+||.||++...+       ..+|+|.+.... .....++.+|+.++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888999999999999998752       568999887542 33456788999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCC--------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETN--------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      .++++|||+++|+|.+++......        .......+++..+++++.|++.||.|||+   .+|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence            999999999999999998643210        00123358999999999999999999998   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  242 (293)
T ss_pred             CCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence            999999999999987653211 111222345678999999988899999999999999999998 888886543211   


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       +.+    ....+.         ....+......+.+|+.+|+++||++|||+.++++.|+..
T Consensus       243 -~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 -LFK----LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -HHH----HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence             111    111111         1112223345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=337.62  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|+++...   ......+..|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999987  7889999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 e~~~~~~L~~~l~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          81 EYMPGGDLMNLLIRKD--------VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             cCCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            9999999999996542        38889999999999999999999   999999999999999999999999999998


Q ss_pred             cccccc--------------------------cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 006446          474 TIQENL--------------------------KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP  527 (644)
Q Consensus       474 ~~~~~~--------------------------~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P  527 (644)
                      ......                          ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            664322                          000112345799999999999999999999999999999999999999


Q ss_pred             CCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 006446          528 GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-MKTVLQV  597 (644)
Q Consensus       528 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~  597 (644)
                      |...........+..|.      ...      .+...  ......+.+++.+|++ ||.+||+ ++++++.
T Consensus       230 f~~~~~~~~~~~i~~~~------~~~------~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         230 FYSDTLQETYNKIINWK------ESL------RFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCHHHHHHHHhccC------Ccc------cCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            97654322111111110      000      01010  0123456678889997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-38  Score=332.29  Aligned_cols=237  Identities=24%  Similarity=0.298  Sum_probs=190.4

Q ss_pred             CcccccCcEEEEEeee-----cCceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      +.||+|+||.||+++.     .+..+|+|++.....  .....+..|+.++++++||||+++++++...+.+++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875     267899999975432  234567789999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++....        .+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          82 GGDLFTRLSKEV--------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999985432        38899999999999999999999   8999999999999999999999999999986542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ..   .......||..|+|||.+....++.++|||||||++|||++|+.||......    ....   ... ...     
T Consensus       151 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~---~i~-~~~-----  214 (318)
T cd05582         151 HE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMT---MIL-KAK-----  214 (318)
T ss_pred             CC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHH---HHH-cCC-----
Confidence            21   1133457899999999999888999999999999999999999999754321    1111   111 111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT  593 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  593 (644)
                           ..++......+.+++.+|++.||++||++.+
T Consensus       215 -----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 -----LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 0112222345677889999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-37  Score=322.61  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC----ceEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|+...    ..+++|.++.. .....+.+..|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998762    24788888743 334456789999999999 799999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          393 YEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      +||+++|+|.+++.......        ......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999996543211        0112348899999999999999999998   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||++........    ......+..|+|||.+....++.++|||||||++|||++ |+.||.......    +.. 
T Consensus       159 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~~~-  229 (297)
T cd05089         159 KIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----LYE-  229 (297)
T ss_pred             EECCcCCCccccceec----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH-
Confidence            9999999874321110    111233567999999988889999999999999999997 999986543211    111 


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                         ....+         .....+......+.+++.+|++.+|.+||+++++++.|+...
T Consensus       230 ---~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         230 ---KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             ---HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11111         111112223345778999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-37  Score=317.86  Aligned_cols=256  Identities=22%  Similarity=0.453  Sum_probs=203.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .+|+..+.||+|+||.||+|++.     +..+|+|.++... ....+.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999874     2369999886543 23456789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++++|.+++.....       .+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        84 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG-------QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999965432       38899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +................++..|+|||.+.+..++.++||||||+++||+++ |+.||......    .+...+    ..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~  225 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAI----EEG  225 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHH----hCC
Confidence            876532211111122234568999999998899999999999999999886 99998654321    122211    111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .         +..........+.+++.+|++.+|.+||+|.++++.|+..
T Consensus       226 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 Y---------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C---------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0         0111112234677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=319.43  Aligned_cols=261  Identities=26%  Similarity=0.478  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+|...+       ..||+|.+.... ......+.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            467888999999999999998752       579999986543 234567889999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCC--CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +||||+++|+|.+++........  .....++|..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence            99999999999999865332111  112247899999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+++........ .......++..|+|||.+..+.++.++|||||||++||+++ |+.||......    .+..+.   
T Consensus       163 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~~---  234 (277)
T cd05032         163 FGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----EVLKFV---  234 (277)
T ss_pred             cccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----HHHHHH---
Confidence            9999866432211 11233456789999999988889999999999999999998 88898654321    222211   


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                       ..+...         ..+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       235 -~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 -IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             111111         1112224567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-38  Score=345.63  Aligned_cols=258  Identities=24%  Similarity=0.307  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-C-ceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeee-eee------ccc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-N-KEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGW-CYE------RHD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~-~~~------~~~  388 (644)
                      -++++.+.|.+|||+.||.+... + .++|+|++-..++...+...+||.+|++|+ |+|||.+++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            35567889999999999999987 3 799999998888888899999999999997 9999999993 221      237


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      ++|.||||++|+|-+++......      .|+..+.++|+.++++|+++||. +..+|||||||-+||||+.+++.||||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~------~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT------RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc------cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence            89999999999999999755433      38999999999999999999998 457899999999999999999999999


Q ss_pred             cCCcccccccccccccc------cccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          469 FGLARTIQENLKTHHST------KEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~------~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                      ||.|.-.-.........      -...-|+.|+|||++.   +..+++|+|||+|||+||-|+....||+......    
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----  265 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----  265 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----
Confidence            99997533221111100      1234689999999874   6678999999999999999999999998753211    


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                                      ++.....-.-......++..||..||++||.+||++-||+..+-..+.
T Consensus       266 ----------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 ----------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                            111111111123567789999999999999999999999988866543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=332.55  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC------ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ......++||.|-||.||+|++..      -.||||..+.+ ..+..+.|+.|..+|++++|||||+|+|+|.+. ..|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            345667899999999999998862      24899998874 455678999999999999999999999999764 7999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |||.++-|-|..||..++..       |+......++.||..||+|||+   .++|||||..+|||+.....|||+|||+
T Consensus       468 vmEL~~~GELr~yLq~nk~s-------L~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDS-------LPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             EEecccchhHHHHHHhcccc-------chHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccch
Confidence            99999999999999877653       8888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +|.++......  .+...-+..|||||.+.-.+++.+||||-|||++|||+. |..||.+-...+...        ..++
T Consensus       538 SR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------~iEn  607 (974)
T KOG4257|consen  538 SRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------HIEN  607 (974)
T ss_pred             hhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------EecC
Confidence            99987543322  234445778999999999999999999999999999987 999998754332211        1122


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      |.         +...++.+...+..|+.+||..+|.+||.+.++...|..
T Consensus       608 Ge---------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  608 GE---------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CC---------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            22         234455666788899999999999999999998877643

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.8e-37  Score=311.79  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=197.4

Q ss_pred             CcccccCcEEEEEeeec-CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccc
Q 006446          325 NKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD  402 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  402 (644)
                      ++||+|+||.||+|... +..+|+|++..... .....+.+|+.++++++||||++++++|...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46999999999999876 67899999876543 33457889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccccc
Q 006446          403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH  482 (644)
Q Consensus       403 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~  482 (644)
                      +++.....       .+++..++.++.+++.||.|||+   .+++||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  148 (250)
T cd05085          81 SFLRKKKD-------ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--  148 (250)
T ss_pred             HHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc--
Confidence            99864332       37899999999999999999998   8999999999999999999999999999976432211  


Q ss_pred             ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       483 ~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                      .......++..|+|||++..+.++.++||||||+++||+++ |..||......    ....    ....+.         
T Consensus       149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~----~~~~~~---------  211 (250)
T cd05085         149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QARE----QVEKGY---------  211 (250)
T ss_pred             ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH----HHHcCC---------
Confidence            11122344678999999998899999999999999999998 99998654321    1111    111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ....+......+.+++.+|++.+|++||++.++++.|.
T Consensus       212 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11122223456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-37  Score=321.19  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=205.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeee--ccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~  389 (644)
                      +.|+..+.||+|+||.||++++.      +..+|+|+++..... ..+.|..|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35667789999999999999864      468999998765443 46789999999999999999999999987  5578


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++++|.+++.....       .++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD-------QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc-------ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccc
Confidence            999999999999999965442       38999999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccch-------hhHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-------NSIVH  542 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-------~~l~~  542 (644)
                      |++.................++..|++||.+.+..++.++||||||+++|||++|+.|+.........       .....
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            99987652222111122234566799999998889999999999999999999999997653221100       00011


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...+.         +........+......+.+++.+|++++|++||++.+|+++|+..
T Consensus       234 ~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLEL---------LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHH---------HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111         111111111222335688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.2e-37  Score=312.99  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=203.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|++|.||+++..  +..|++|.+...  .....+.+..|++++++++||||+++++.+.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999886  688999998643  344567889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....      ..+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~L~~~l~~~~~------~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          81 AENGDLHKLLKMQRG------RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             CCCCcHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            999999999875422      148899999999999999999998   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   ......|+..|+|||++.+..++.++|||||||++|||++|+.||......    .....    ...+.   
T Consensus       152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~---  217 (256)
T cd08529         152 SDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILK----IIRGV---  217 (256)
T ss_pred             cCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHcCC---
Confidence            53221   123346888999999999989999999999999999999999998754321    11111    11111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ...........+.+++.+|++.+|++||++.++++.
T Consensus       218 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  111222334567889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.4e-37  Score=324.37  Aligned_cols=239  Identities=21%  Similarity=0.304  Sum_probs=189.5

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||+++..  +..||+|+++...   ....+.+..|..++..+ +||||+++++++.+++.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999986  6789999997542   23345567788887754 899999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++.+...++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~i~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          81 GDLMFHIQDKG--------RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            99998886432        27888999999999999999999   99999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||......    .+.+    ....+      .
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~----~~~~~------~  212 (316)
T cd05620         150 D---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFE----SIRVD------T  212 (316)
T ss_pred             C---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhC------C
Confidence            1   1134467899999999999999999999999999999999999999754321    1111    11111      1


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK-TVL  595 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl  595 (644)
                      +.+...    ....+.+++.+|++.||++||++. +++
T Consensus       213 ~~~~~~----~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 PHYPRW----ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCC----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111112    233566788999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=336.68  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=196.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||||++....   ......+..|+.++.+++||||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999986  6789999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~~g~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--------TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             CCCCCcHHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccce
Confidence            9999999999986533        38899999999999999999999   899999999999999999999999999987


Q ss_pred             ccccccccc-----------------------------------ccccccccCCCccCccccccCCCCCccchHHHHHHH
Q 006446          474 TIQENLKTH-----------------------------------HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLI  518 (644)
Q Consensus       474 ~~~~~~~~~-----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl  518 (644)
                      .+.......                                   .......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            543211000                                   001124699999999999998999999999999999


Q ss_pred             HHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---HHHHH
Q 006446          519 LEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS---MKTVL  595 (644)
Q Consensus       519 ~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs---~~evl  595 (644)
                      |||++|+.||...........+..|       ....     ......  .....+.+++.+|+. +|.+|++   +++++
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~-------~~~~-----~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll  294 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINW-------KETL-----QFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIK  294 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcC-------CCcc-----CCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence            9999999999765432111111111       0000     001110  112345567778886 9999998   88887


Q ss_pred             H
Q 006446          596 Q  596 (644)
Q Consensus       596 ~  596 (644)
                      +
T Consensus       295 ~  295 (364)
T cd05599         295 S  295 (364)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-37  Score=327.15  Aligned_cols=240  Identities=22%  Similarity=0.321  Sum_probs=193.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||++++.  +..||+|+++...   ......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986  5789999997542   23445677888998887 699999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++.+...++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~~L~~~~~~~~--------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          81 GDLMFHIQRSG--------RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            99998886442        38899999999999999999999   99999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......|+..|+|||++.+..++.++|||||||++|||++|+.||......    .+..    ....+.      
T Consensus       150 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~----~i~~~~------  212 (318)
T cd05570         150 G---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQ----SILEDE------  212 (318)
T ss_pred             C---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHH----HHHcCC------
Confidence            1   1133456899999999999999999999999999999999999999754321    1111    111111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSM-----KTVLQ  596 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~  596 (644)
                      .    .++......+.+++.+||+.||.+||++     .++++
T Consensus       213 ~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1    1112223457789999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-37  Score=319.86  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=193.7

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||+||++...  ++.+|+|++.....   ...+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999876  67899999865422   2345678899999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      ..++......    ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          81 RYHIYNVDEE----NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             HHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9887542211    1248999999999999999999999   8999999999999999999999999999976542211 


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..   .. ..+          
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~-~~~----------  216 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RI-LND----------  216 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hh-ccc----------
Confidence              12345789999999999999999999999999999999999999976432211111111   00 000          


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                      ...++......+.+++.+|++.||++||     +++++++
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            0112223345677888999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.8e-37  Score=328.41  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=191.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+++..  +..+|+|.++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999886  678999999754   223345677899888877 799999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          81 GDLMFHMQRQR--------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            99988875432        38899999999999999999999   89999999999999999999999999999753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccc-hhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSY-NNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ......++.+....+..    
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  222 (329)
T cd05618         150 G---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  222 (329)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----
Confidence            1   113345789999999999999999999999999999999999999964221111 11122333332222211    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                            .++......+.+++.+|++.||++||+.
T Consensus       223 ------~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 ------RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                  1222233456789999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=313.73  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-----chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|++|.||++...  +..+++|.+....     ....+.+.+|+.++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999875  6889999886432     1234568889999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++++|.+++....        .+++.....++.+++.||.|||+   .+++||||||+||+++++++++|+|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--------ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999886432        37888899999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++................++..|+|||.+.+..++.++||||||+++|||++|+.||.......    ..   ...... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~---~~~~~~-  222 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AI---FKIATQ-  222 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HH---HHHhcc-
Confidence            9865432111111134567889999999999889999999999999999999999986542211    11   111100 


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                              .....++......+.+++.+|++.+|.+||+++++++.
T Consensus       223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 --------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    11112223334567789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3e-37  Score=314.07  Aligned_cols=248  Identities=27%  Similarity=0.450  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeee-eccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY-ERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||++...+..+++|.++...  ..+.+.+|+.++++++|+|++++++++. .++..++++||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            367788999999999999999999999999986543  3467899999999999999999999765 4457899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....      ..+++..++.++.+++.||+|||+   ++++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          84 KGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCcHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            9999999865432      138899999999999999999998   8999999999999999999999999999876432


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      .      .....++..|+|||++....++.++|||||||++|||++ |+.||.....    ..+...+    ..+     
T Consensus       155 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~----~~~-----  215 (256)
T cd05082         155 T------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV----EKG-----  215 (256)
T ss_pred             c------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----hcC-----
Confidence            1      122344678999999988889999999999999999997 9988864322    1122211    111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          ............+.+++.+|++.+|++||++.++++.|+.
T Consensus       216 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         216 ----YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                1111222334567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.6e-37  Score=314.16  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=200.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||++... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46778899999999999999876 56799999875433 3467899999999999999999999885 456899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....      ..+++..++.++.+++.||.|||+   .+++||||||+||++++++.++|+|||++.....
T Consensus        84 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          84 KGSLLDFLKDGEG------RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CCcHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999865322      138899999999999999999999   8999999999999999999999999999986543


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....  ......++..|+|||.+....++.++||||||+++|||++ |+.||.....    ..+.+..    ..+     
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~----~~~-----  219 (260)
T cd05070         155 NEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQV----ERG-----  219 (260)
T ss_pred             cccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----HcC-----
Confidence            2111  1122345678999999988889999999999999999999 8888865332    1122211    111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          .....+......+.+++.+|++++|++|||++++.+.|+.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 ----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                1111222334568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-37  Score=319.34  Aligned_cols=263  Identities=22%  Similarity=0.363  Sum_probs=206.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecC------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeee-ccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~  389 (644)
                      .++|+..+.||+|+||.||+|.+..      ..|++|++.... ....+.+..|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999998764      678999886543 3345678899999999999999999999876 4678


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++|+|.+++.............+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999865433221222358999999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++.+..... ........++..|+|||++.+..++.++|||||||++||+++ |+.||.....    ..+..++.   
T Consensus       162 g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~---  233 (280)
T cd05043         162 ALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLK---  233 (280)
T ss_pred             CCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHH---
Confidence            99986642211 111223456778999999988889999999999999999998 9999875432    11222111   


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       .+.         ...........+.+++.+|++.||++||++.++++.|+..
T Consensus       234 -~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         234 -DGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             -cCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             111         0011112234678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-37  Score=315.19  Aligned_cols=253  Identities=26%  Similarity=0.460  Sum_probs=201.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||+|++. +..||+|+++... ...+++.+|+.++++++|+||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56888999999999999999886 4579999987533 23467899999999999999999999875 456899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....      ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||.++....
T Consensus        84 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          84 KGSLLDFLKGEMG------KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             CCcHHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            9999999964322      137899999999999999999999   8999999999999999999999999999986643


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||+.....++.++|||||||++|||++ |+.||......    .+..    ....+     
T Consensus       155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~-----  219 (262)
T cd05071         155 NEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERG-----  219 (262)
T ss_pred             ccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcC-----
Confidence            221  11223456778999999988899999999999999999999 78888654321    1111    11111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          .......+....+.+++.+|++.+|++||++.++++.|+..
T Consensus       220 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 ----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                01112233455678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-37  Score=315.92  Aligned_cols=239  Identities=23%  Similarity=0.393  Sum_probs=189.6

Q ss_pred             CcccccCcEEEEEeeecC--------------ceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          325 NKLGKGGFGTVYKGIWRN--------------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~--------------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      +.||+|+||.||+|+...              ..|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998541              258889877655555678889999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc-------
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-------  463 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-------  463 (644)
                      +||||+++|+|+.++.....       .+++..+++++.||++||+|||+   .+|+||||||+|||++.++.       
T Consensus        81 lv~e~~~~~~l~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD-------VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCce
Confidence            99999999999988864332       38899999999999999999998   99999999999999987664       


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHH-cCCCCCCCCccccchhhHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~-tG~~P~~~~~~~~~~~~l~  541 (644)
                      +|++|||++.....       .....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+......+.     
T Consensus       151 ~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----  218 (262)
T cd05077         151 IKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----  218 (262)
T ss_pred             eEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----
Confidence            89999999875431       22345788999999886 456899999999999999998 58888754322110     


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      .   ... .+..      ....    .....+.+|+.+||+.||++||++.++++.|+
T Consensus       219 ~---~~~-~~~~------~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 E---RFY-EGQC------MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             H---HHH-hcCc------cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0   011 1110      0111    12345778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-37  Score=334.86  Aligned_cols=264  Identities=22%  Similarity=0.384  Sum_probs=205.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhccC-CCceeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  388 (644)
                      .++|...++||+|+||.||+|++.       +..||+|+++.... ...+.+..|+.++.++. ||||+++++.|...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            346777899999999999999864       35799999976533 23457889999999997 9999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCC--------------------------------------------------------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS--------------------------------------------------------  412 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~--------------------------------------------------------  412 (644)
                      .++|+||+++|+|.++++......                                                        
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999997543100                                                        


Q ss_pred             ----------------------------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          413 ----------------------------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       413 ----------------------------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                                                        ......++|...++++.|++.||+|||+   .+++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence                                              0112347888999999999999999998   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      ++++.+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++ |+.||......+  
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--  349 (401)
T ss_pred             eCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence            99999999999999865322111 11223457889999999998889999999999999999998 888986543211  


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       .+    ......+.         ....+......+.+++.+||+.+|.+||+++++++.|+..
T Consensus       350 -~~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 -QF----YNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -HH----HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             11    11111111         1111122235678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-37  Score=327.95  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=195.2

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+++..  +..||+|+++...   ....+.+..|..++.++ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999986  6789999997542   23345678899999998 799999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          81 GDLMFHMQRQR--------KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            99988885432        38999999999999999999999   99999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc-chhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS-YNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......++..+....+.     
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  221 (329)
T cd05588         150 G---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-----  221 (329)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-----
Confidence            1   11334579999999999999999999999999999999999999996432211 01112233333222221     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPS------MKTVLQ  596 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs------~~evl~  596 (644)
                       ..+...+    ...+.+++.+|++.||.+||+      ++++++
T Consensus       222 -~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 -IRIPRSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             1122222    345678899999999999997      567664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-37  Score=328.32  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||+|+..  +..||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999886  5689999987542   23445677888888866 799999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          81 GDLMFQIQRSR--------KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            99998886443        37889999999999999999999   89999999999999999999999999998754321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||.......    +...   . ..+.      
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~---i-~~~~------  212 (321)
T cd05591         150 G---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFES---I-LHDD------  212 (321)
T ss_pred             C---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----HHHH---H-HcCC------
Confidence            1   11334578999999999998899999999999999999999999997654221    1111   1 1111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRP-------SMKTVLQV  597 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-------s~~evl~~  597 (644)
                      .......    ...+.+++.+|++.||++||       +++++++.
T Consensus       213 ~~~p~~~----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 VLYPVWL----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCC----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0111112    24567788999999999999       77777743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.2e-37  Score=320.20  Aligned_cols=268  Identities=23%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------------------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------------------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKL  379 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l  379 (644)
                      ++|+..++||+|+||.||++...                  ...+|+|++.... .....++..|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998542                  2358999987543 3445789999999999999999999


Q ss_pred             eeeeeeccceEEEEeccCCCccchhhhccCCCC---CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCE
Q 006446          380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS---GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI  456 (644)
Q Consensus       380 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI  456 (644)
                      ++++...+..++||||+++|+|.+++.......   ......+++.+.+.++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            999999999999999999999999987543221   1122348899999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc--CCCCCCCCccc
Q 006446          457 MLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC--GRKPGNQSEQN  534 (644)
Q Consensus       457 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t--G~~P~~~~~~~  534 (644)
                      |++.++.+||+|||+++.+..... ........++..|++||....+.++.++|||||||++|||++  |..||......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999986542211 111222345678999999888899999999999999999998  66787654322


Q ss_pred             cchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .    +...............      ....+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus       241 ~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q----VIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H----HHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1    1111111111110000      001111233567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-37  Score=318.44  Aligned_cols=238  Identities=23%  Similarity=0.367  Sum_probs=188.3

Q ss_pred             cccccCcEEEEEeeec--------------------------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeE
Q 006446          326 KLGKGGFGTVYKGIWR--------------------------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL  379 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~--------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l  379 (644)
                      +||+|+||.||+|++.                          ...|++|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999752                          13488998876555556778899999999999999999


Q ss_pred             eeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       380 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      +++|.+....++||||+++|+|+.++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~  151 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-------RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLA  151 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEe
Confidence            9999999999999999999999999865332       37899999999999999999998   8999999999999998


Q ss_pred             CCC-------cEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHH-cCCCCCCC
Q 006446          460 SEF-------NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVA-CGRKPGNQ  530 (644)
Q Consensus       460 ~~~-------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~-tG~~P~~~  530 (644)
                      +.+       .+|++|||++.....       .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             ccCcccCccceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            654       389999999864321       122357788999998865 56899999999999999995 68998875


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      .....    ...+    ....       ..+....    ...+.+++.+||+.+|++||++.++++.|+
T Consensus       225 ~~~~~----~~~~----~~~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         225 RTPSE----KERF----YEKK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             cChHH----HHHH----HHhc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            43221    1111    1100       0111111    235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-38  Score=330.88  Aligned_cols=242  Identities=25%  Similarity=0.342  Sum_probs=194.1

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||++...  +..||+|.+...   .......+..|+.++..++||||+++++++...+.+++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875  678999999754   2234466788999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|..++....        .+++.....++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          81 ELFFHLSRER--------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             cHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            9998885432        38899999999999999999995  2689999999999999999999999999987543111


Q ss_pred             cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    ..+.      .
T Consensus       151 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i----~~~~------~  213 (325)
T cd05594         151 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI----LMEE------I  213 (325)
T ss_pred             ---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHH----hcCC------C
Confidence               1123457999999999999989999999999999999999999999754321    111111    1111      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                      .+...+    ...+.+++.+|++.||++|+     +++++++.
T Consensus       214 ~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            122223    34567788999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.5e-37  Score=317.81  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=203.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|+..++||+|+||.||+|++.  +.    .||+|.++... ....+++..|+.++..++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56788899999999999999864  33    48999987543 3345678899999999999999999999975 45789


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ++||+++|+|.+++.....       .+++..++.++.|+++||+|||+   ++++||||||+|||+++++.+||+|||+
T Consensus        86 ~~~~~~~g~l~~~l~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKD-------RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             EEEcCCCCCHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCc
Confidence            9999999999999865432       38899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....    ..+..++    ..
T Consensus       156 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~----~~  226 (279)
T cd05109         156 ARLLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLL----EK  226 (279)
T ss_pred             eeecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----HC
Confidence            9876532111 11222345678999999998899999999999999999998 8889865432    1222221    11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP  605 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  605 (644)
                      +...         ..+......+.+++.+||+.||++||++.++++.|+.....|
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         227 GERL---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCcC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            1110         111123345778999999999999999999999998765444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-37  Score=325.20  Aligned_cols=236  Identities=23%  Similarity=0.322  Sum_probs=185.9

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHH-HHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVT-TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||+++..  +..||+|++....   .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986  6789999987532   222344555554 67889999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+.......++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          81 GELFFHLQRER--------CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            99988875432        27778888899999999999999   89999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                         ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..    .+.+.+    ..+.      
T Consensus       150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i----~~~~------  212 (321)
T cd05603         150 ---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNI----LHKP------  212 (321)
T ss_pred             ---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHH----hcCC------
Confidence               11134457899999999999889999999999999999999999999764321    111111    1111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK  592 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  592 (644)
                          ..++......+.+++.+|++.||.+||+..
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ----LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                112222334577889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=345.81  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc----
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----  387 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----  387 (644)
                      ...++|...++||+|+||.||+++..  +..||||++...  .......+.+|+.++..++|+||+++.+.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34578999999999999999999875  789999998654  3344567889999999999999999988765432    


Q ss_pred             ----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          388 ----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       388 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                          .+++||||+++|+|.+++......    ...+++.....++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~----~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKT----NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence                368999999999999998643221    1248889999999999999999999   89999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~  543 (644)
                      +||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......       +.
T Consensus       182 vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~  253 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EV  253 (496)
T ss_pred             EEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HH
Confidence            99999999987643211 11134467999999999999999999999999999999999999999754321       11


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +.. ...+..         ...+......+.+++.+||+.||.+||++.++++.
T Consensus       254 ~~~-~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MHK-TLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHH-HhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111 111111         11122233457788999999999999999999863

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-37  Score=328.02  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=191.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCC-ceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHR-NLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~  393 (644)
                      +|+..+.||+|+||.||+|+..  ++.||+|++....   ....+.+..|..++..++|+ +|+++++++.+.+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777899999999999999887  5689999987542   23456778899999999765 5888999999889999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~~g~L~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--------KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             cCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            9999999999886432        27889999999999999999999   899999999999999999999999999987


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+.    ... 
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~----~~~-  217 (324)
T cd05587         150 ENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIM----EHN-  217 (324)
T ss_pred             ecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----cCC-
Confidence            532111   1133457999999999999999999999999999999999999999764321    1111111    111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                               ..++......+.+++.+|++.||.+||+.
T Consensus       218 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ---------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     11122223456788899999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-38  Score=300.83  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=205.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+.++.||+|-||.||.|+.+  +--||+|++.+..   .+..+++.+|+++-+.|+||||+++++|+.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            57889999999999999999987  4579999986542   334578899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||.++|.|...|...+..      .++......++.|+|.||.|+|.   ++|+||||||+|+|++..+..||+|||-+.
T Consensus       102 Eya~~gel~k~L~~~~~~------~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMK------RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             EecCCchHHHHHHhcccc------cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            999999999999744332      25556667899999999999999   999999999999999999999999999987


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ... .    ......+||..|.+||...+...+...|+|++|++.||++.|.+||+.....+....+..           
T Consensus       173 ~~p-~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-----------  236 (281)
T KOG0580|consen  173 HAP-S----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-----------  236 (281)
T ss_pred             ecC-C----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-----------
Confidence            543 1    224567999999999999999999999999999999999999999987553322222211           


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                         +|-    .++........+++.+|+..+|.+|.+..|+++.
T Consensus       237 ---~~~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 ---VDL----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---ccc----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               111    2223344567789999999999999999999863

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-37  Score=332.76  Aligned_cols=258  Identities=20%  Similarity=0.229  Sum_probs=194.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .+|+..++||+|+||.||++...  ++.||+|...      ...+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999886  6789999753      245678999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                       .++|..++....        .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       166 -~~~L~~~l~~~~--------~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        166 -KTDLYCYLAAKR--------NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             -CCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence             578888875432        37899999999999999999999   899999999999999999999999999997543


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccc---hhhHHHHHHHHHhc---
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSY---NNSIVHWLWELRRK---  550 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~---~~~l~~~~~~~~~~---  550 (644)
                      ...  ........||+.|+|||++....++.++|||||||++|||++|+.|+........   .......+......   
T Consensus       234 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        234 DIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             ccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            211  1113345799999999999998999999999999999999999988654321100   00111111110000   


Q ss_pred             -------Cchhh----hhh--cccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 -------GRILD----AAD--SRLGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 -------~~~~~----~~d--~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                             ..+..    ...  .......+     ......+.+|+.+|++.||++|||++|+++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   00000    000  00000000     112346778999999999999999999985

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-37  Score=322.30  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      ++|...+.||+|+||.||++...       +..+|+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            46888999999999999999752       3479999987543 23346789999999999 799999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++|+|.+++......      .+++.++..++.+++.||+|||+   .+++|+||||+|||++.++.+||+||
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRES------FLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCC
Confidence            9999999999999998643321      28999999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++........ .......++..|+|||.+..+.++.++|||||||++|||++ |+.||.......   .+...    .
T Consensus       186 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~----~  257 (302)
T cd05055         186 GLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKL----I  257 (302)
T ss_pred             cccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHH----H
Confidence            999865422111 11223346788999999998899999999999999999998 999987543321   11111    1


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ..+.         ....+......+.+++.+|++++|++||++.++++.|+.
T Consensus       258 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         258 KEGY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HcCC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            1111         111111223467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.6e-37  Score=323.58  Aligned_cols=262  Identities=23%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC---------ceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN---------KEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ++|...+.||+|+||.||++...+         ..+|+|.+.... .....++..|+.++.++ +|+||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468889999999999999997632         369999987542 34456788999999999 7999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      ..++|+||+++|+|.+++.......        ......++|.++++++.|++.||+|||+   .+++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence            9999999999999999997543211        0122358999999999999999999998   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......    
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             CCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            9999999999999765421111 11122234578999999988889999999999999999998 88888643221    


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+..    ....+.         ..+.+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus       250 ~~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         250 ELFK----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHH----HHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1111    111111         1122223345677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-37  Score=322.51  Aligned_cols=264  Identities=21%  Similarity=0.398  Sum_probs=205.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~  386 (644)
                      ..+|...+.||+|+||.||+++..         +..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356778899999999999999752         2368999886542 34457789999999999 899999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCC--------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSG--------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      ...++||||+++|+|.+++........        .....++|.+++.++.|+++||.|||+   .+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            999999999999999999975432110        112358899999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      +.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  246 (304)
T ss_pred             cCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence            99999999999999876432211 11223345678999999988889999999999999999998 77887543211   


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                       .+..    ....+..         ...+......+.+++.+||+++|++||++.++++.|++..
T Consensus       247 -~~~~----~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         247 -ELFK----LLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             -HHHH----HHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence             1111    1111111         1112233456778899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.3e-37  Score=319.43  Aligned_cols=262  Identities=25%  Similarity=0.460  Sum_probs=205.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      .++|+..+.||+|+||.||++...       +..+|+|++.... ....+++..|+.++++++||||++++++|..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357888999999999999999863       4679999987543 34456789999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCC--------------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCC
Q 006446          390 LLVYEYMPNGSLDKFIFYDETN--------------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N  455 (644)
                      ++++||+++|+|.+++......              .......+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            9999999999999999643211              00112348899999999999999999998   899999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccc
Q 006446          456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQN  534 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~  534 (644)
                      ||+++++.+||+|||+++....... .........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999876542211 111222345678999999988899999999999999999998 88888653321


Q ss_pred             cchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          .+..    ....+....         .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus       240 ----~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIY----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                1111    111222111         111233567889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-37  Score=327.72  Aligned_cols=235  Identities=24%  Similarity=0.340  Sum_probs=189.4

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+++..  ++.||+|++....   ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986  6789999987532   23445677888888876 699999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~i~~~~--------~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          81 GDLMFHIQKSR--------RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             chHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            99999886543        28889999999999999999999   99999999999999999999999999998754321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...    ...+..     
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~----i~~~~~-----  213 (320)
T cd05590         150 G---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEA----ILNDEV-----  213 (320)
T ss_pred             C---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHH----HhcCCC-----
Confidence            1   1133457999999999999889999999999999999999999999764422    11111    111111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                           .++......+.+++.+|++.||++||++
T Consensus       214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                 1111223456788899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-37  Score=335.10  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=193.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      +|+..+.||+|+||.||+++..  ++.||+|++....   ......+.+|+.++++++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999876  6789999986532   2234567899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++|+|.+++....        .++......++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~~g~L~~~i~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          82 YIPGGDMMSLLIRLG--------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999986532        27778888899999999999999   9999999999999999999999999999853


Q ss_pred             ccccc----------------------------------------cccccccccccCCCccCccccccCCCCCccchHHH
Q 006446          475 IQENL----------------------------------------KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAF  514 (644)
Q Consensus       475 ~~~~~----------------------------------------~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSf  514 (644)
                      +....                                        ..........||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                        00000123479999999999999899999999999


Q ss_pred             HHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC---CH
Q 006446          515 GVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP---SM  591 (644)
Q Consensus       515 Gvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP---s~  591 (644)
                      ||++|||++|+.||...........+..|.       .....  + ....++.    .+.+++.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~-------~~~~~--~-~~~~~s~----~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWE-------TTLHI--P-SQAKLSR----EASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccC-------ccccC--C-CCCCCCH----HHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999997654322111111110       00000  0 0112333    3444555555 4999999   88


Q ss_pred             HHHHHH
Q 006446          592 KTVLQV  597 (644)
Q Consensus       592 ~evl~~  597 (644)
                      .++++.
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=333.05  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||++...  ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999875  7789999986532   234467888999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          81 EFLPGGDLMTMLIKYD--------TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             eCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999999986432        37888888999999999999999   999999999999999999999999999996


Q ss_pred             cccccccc-----------c---------------------------------ccccccccCCCccCccccccCCCCCcc
Q 006446          474 TIQENLKT-----------H---------------------------------HSTKEIAGTPGYMAPESFLVGRATIET  509 (644)
Q Consensus       474 ~~~~~~~~-----------~---------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~s  509 (644)
                      .+......           .                                 .......||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            43210000           0                                 000124699999999999988999999


Q ss_pred             chHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC-
Q 006446          510 DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR-  588 (644)
Q Consensus       510 DVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-  588 (644)
                      |||||||++|||++|+.||...........+..|       .....     +...  ......+.+++.+|++ +|.+| 
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------~~~~~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW-------RETLY-----FPDD--IHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHcc-------CCccC-----CCCC--CCCCHHHHHHHHHHhc-CHhhcC
Confidence            9999999999999999999764432211111111       00000     1110  0112346677888887 66665 


Q ss_pred             --CCHHHHHHH
Q 006446          589 --PSMKTVLQV  597 (644)
Q Consensus       589 --Ps~~evl~~  597 (644)
                        +++.++++.
T Consensus       295 ~r~~~~~~l~h  305 (377)
T cd05629         295 GRGGAHEIKSH  305 (377)
T ss_pred             CCCCHHHHhcC
Confidence              699998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-37  Score=319.18  Aligned_cols=265  Identities=25%  Similarity=0.466  Sum_probs=205.7

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      ..++|+..++||+|+||.||+|...       +..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3467888999999999999999754       3479999886543 2334568889999999999999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCC--CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETN--SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      .++||||+++|+|.+++......  .......+.+....+++.|++.||.|||+   ++|+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            99999999999999999653221  11122346788889999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..||......    .+.+.+ 
T Consensus       161 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~~~~-  234 (288)
T cd05061         161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLKFV-  234 (288)
T ss_pred             CcCCccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH-
Confidence            999999865422111 11222345678999999998899999999999999999998 78888653321    122211 


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                         ..+..         ...+......+.+++.+|++.||++||++.++++.|+...
T Consensus       235 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 ---MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ---HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence               11111         0112223457888999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.5e-37  Score=326.35  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +|+..+.||+|+||.||+|+..  +..||+|.+....   ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777899999999999999887  5689999987542   22334567788888777 5899999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~~g~L~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--------RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             cCCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence            9999999998885432        37889999999999999999999   899999999999999999999999999997


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......   .......||+.|+|||++....++.++|||||||++|||++|+.||......    .+...+.    ... 
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~----~~~-  217 (323)
T cd05616         150 ENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIM----EHN-  217 (323)
T ss_pred             ecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCC-
Confidence            543111   1134567999999999999999999999999999999999999999764322    1221111    111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                               ..++......+.+++.+|++.||++|++.
T Consensus       218 ---------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                     11222233456788999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-36  Score=310.60  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=207.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|...  +..+++|.++..   .....+.+..|++++++++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999986  788999988642   2233567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++......    ...+++.+++.++.++++||.|||+   .+++||||||+||+++.++.++|+|||+++
T Consensus        82 e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQ----KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             ecCCCCCHHHHHHHhccc----CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999988643211    1248899999999999999999999   899999999999999999999999999988


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......++..|+|||.+.+..++.++|||||||++|||++|+.||......     +.+... ....+. 
T Consensus       155 ~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~~-  224 (267)
T cd08224         155 FFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCK-KIEKCD-  224 (267)
T ss_pred             eccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHHh-hhhcCC-
Confidence            6542211   123346888999999998888999999999999999999999998654321     111111 111111 


Q ss_pred             hhhhhcccCCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          554 LDAADSRLGGEFSE-KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                              ....+. .....+.+++.+|++++|++||++.+++++|+..
T Consensus       225 --------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 --------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                    111112 3345678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-37  Score=316.01  Aligned_cols=255  Identities=21%  Similarity=0.436  Sum_probs=202.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec--C---ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--N---KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .|+..+.||+|+||.||+|.+.  +   ..||+|.+... .....++|..|+.++++++||||+++.+++.++...++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4667899999999999999886  2   25999998754 3445678999999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        85 e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          85 EFMENGALDSFLRQNDG-------QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             ecCCCCcHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccc
Confidence            99999999999865432       38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccc--cCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKTHHSTKEIA--GTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ................  .+..|+|||.+....++.++|||||||++||+++ |..||.....    ..+..++.    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~----~  226 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIE----Q  226 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHH----c
Confidence            6643221111111111  2457999999998999999999999999999886 9999865432    12222221    1


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..         ......+....+.+++.+|++.+|.+||+++++++.|+..
T Consensus       227 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 DY---------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10         0011122334577899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-37  Score=313.95  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++.++.++.....||+|+||.||+|++.  +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3456677777889999999999999876  56799999877666667789999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFG  470 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFG  470 (644)
                      |+||+++++|.+++......     ...++..+..++.|++.||+|||+   .+|+||||||+||+++. ++.+||+|||
T Consensus        83 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGP-----LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEecCCCCCHHHHHHHhccc-----CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999998654221     012778888999999999999998   89999999999999986 6799999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ++........   ......++..|+|||++....  ++.++||||||+++|||++|+.||.......    ...+.....
T Consensus       155 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~  227 (268)
T cd06624         155 TSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMF  227 (268)
T ss_pred             hheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhh
Confidence            9976542111   123346889999999986644  7889999999999999999999986532211    111110000


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                                 +....++....+.+.+++.+|++.+|++||++.++++
T Consensus       228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                       0111223333456778899999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-37  Score=324.38  Aligned_cols=240  Identities=23%  Similarity=0.349  Sum_probs=190.4

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhc-cCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGS-LRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||+||+|+..  +..||+|+++...   ....+.+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999986  5689999987542   2334556678888876 4899999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~l~~~~--------~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          81 GDLMFHIQSCH--------KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            99999986432        37889999999999999999999   89999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    ..+      .
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i----~~~------~  212 (316)
T cd05619         150 D---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSI----RMD------N  212 (316)
T ss_pred             C---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhC------C
Confidence            1   1133457899999999999889999999999999999999999999764321    121111    111      1


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK-TVLQ  596 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  596 (644)
                      +.+...    ....+.+++.+|++.||++||++. ++.+
T Consensus       213 ~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PCYPRW----LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCCcc----CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111112    224467788999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-37  Score=319.66  Aligned_cols=263  Identities=23%  Similarity=0.408  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  390 (644)
                      -|+..+.||+|+||.||++.+.      +..||+|.++... ......+.+|+.++++++||||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4677899999999999998742      5679999987543 33456789999999999999999999999875  5689


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++++|.+++.....       .++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus        85 lv~e~~~g~~L~~~l~~~~~-------~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN-------KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCc
Confidence            99999999999999864332       38999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc-------chhhHHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS-------YNNSIVHW  543 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~-------~~~~l~~~  543 (644)
                      +++................++..|+|||.+.+..++.++|||||||++|||++++.|........       ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            99876532221111234556778999999988889999999999999999999887643211100       00000011


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .......+.         ...........+.+++.+|++.+|++||++.++++.|+..
T Consensus       235 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111111         1111222345788899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=318.56  Aligned_cols=256  Identities=22%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--------------hhhHHHHHHHHHHhccCCCceeeE
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--------------QGKQEFIAEVTTIGSLRHRNLVKL  379 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~nIv~l  379 (644)
                      +..++|+..+.||+|.||.|-+|+..  ++.||+|++.+...              ...+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999987  78899999864311              113578899999999999999999


Q ss_pred             eeeeeec--cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEE
Q 006446          380 IGWCYER--HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM  457 (644)
Q Consensus       380 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NIL  457 (644)
                      +.+..+.  ..+|||+|||..|.+...--.        ...|+..+..+++.++..||+|||.   ++||||||||+|+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d--------~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLL  242 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD--------KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLL  242 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC--------cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheE
Confidence            9998764  579999999998887543211        1128899999999999999999999   99999999999999


Q ss_pred             EcCCCcEEEeccCCccccccccc--ccccccccccCCCccCccccccCC----CCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          458 LDSEFNARLGDFGLARTIQENLK--THHSTKEIAGTPGYMAPESFLVGR----ATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       458 ld~~~~vkL~DFGla~~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      |++++++||+|||.+........  ........+||+.|+|||+..++.    .+.+.||||+||+||.|+.|+.||...
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999986632110  111124578999999999987743    367899999999999999999999764


Q ss_pred             ccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          532 EQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       532 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                      ..-+...                .++...|.-....++-+.+.+|++++++.||+.|.++.+|....
T Consensus       323 ~~~~l~~----------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FELELFD----------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hHHHHHH----------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            3211111                11122222122234677888999999999999999999997664

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.9e-37  Score=316.80  Aligned_cols=249  Identities=24%  Similarity=0.313  Sum_probs=194.0

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||.||++...  ++.+|+|++....   ....+.+..|+.++++++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999876  7889999986432   12234556799999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      ..++.....      ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          81 KYHIYNVGE------RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             HHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            988854332      138899999999999999999999   999999999999999999999999999998654221  


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+   ..... ....    .. .
T Consensus       150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~~-~~~~----~~-~  218 (277)
T cd05607         150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTL-EDEV----KF-E  218 (277)
T ss_pred             --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHhh-cccc----cc-c
Confidence              123456899999999999888999999999999999999999998754322111111   11110 0000    00 0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...+    ...+.+|+.+|++.||++||+++|+++.+...
T Consensus       219 ~~~~----~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h  254 (277)
T cd05607         219 HQNF----TEESKDICRLFLAKKPEDRLGSREKNDDPRKH  254 (277)
T ss_pred             cccC----CHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence            0112    33467899999999999999998877554443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-36  Score=311.84  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             CcccccCcEEEEEeeec----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||+|...    ...+++|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36999999999999865    3469999887543 234457889999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|.+++......   .....++..+..++.|++.||+|||+   .+++||||||+||+++.++++||+|||+++......
T Consensus        81 ~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          81 DLKGYLRSCRKA---ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             cHHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            999999654321   11236788888999999999999999   899999999999999999999999999997543221


Q ss_pred             cccccccccccCCCccCccccccC-------CCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVG-------RATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~-------~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      . ........++..|+|||++...       .++.++||||||+++|||++ |+.||.......    ......    .+
T Consensus       155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~~~~----~~  225 (269)
T cd05087         155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----VLTYTV----RE  225 (269)
T ss_pred             e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----HHHHHh----hc
Confidence            1 1112334578899999988642       35789999999999999996 999986543211    111111    11


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ......++.+...    ..+.+.+++.+|+ .+|++||++++|++.|+
T Consensus       226 ~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111122222211    2234666888998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.8e-37  Score=311.47  Aligned_cols=252  Identities=26%  Similarity=0.464  Sum_probs=200.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|...++||+|++|.||++.+. +..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            45777889999999999999887 4579999876543 23567889999999999999999999875 456899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....      ..++|..+..++.+++.||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          84 KGSLLDFLKEGDG------KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            9999999965322      137899999999999999999998   8999999999999999999999999999986642


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||......++.++||||||+++|||++ |+.||......    ....+.    ..+.    
T Consensus       155 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~~----  220 (260)
T cd05069         155 NEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQV----ERGY----  220 (260)
T ss_pred             Ccc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCC----
Confidence            211  11223346778999999988899999999999999999999 88898754321    121111    1110    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           ....+......+.+++.+|++.||++||+++++++.|+.
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -----RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 111222334567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.6e-37  Score=318.57  Aligned_cols=248  Identities=26%  Similarity=0.407  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||+|+..  +..+++|.+........+.+..|+.++++++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999875  6789999998766556678899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++...         .+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       100 ~~~~L~~~~~~~---------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654         100 AGGSLTDVVTET---------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             CCCCHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999998532         27889999999999999999999   899999999999999999999999999988654


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......   .+..    ....+.    
T Consensus       168 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~----~~~~~~----  233 (296)
T cd06654         168 PEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYL----IATNGT----  233 (296)
T ss_pred             cccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHH----HhcCCC----
Confidence            2211   1233468899999999998889999999999999999999999997543211   1111    111110    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        +.+  ..+......+.+++.+|+..+|++||++.++++
T Consensus       234 --~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 --PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence              000  112223345778899999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-37  Score=305.66  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-h-hHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-G-KQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  392 (644)
                      +.|+..++|++|.||.||+|+++  ++.||+|+++..... + --.-++||.+|.+.+|||||.+-.+....  +.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46778999999999999999987  678999999865422 1 12357999999999999999998887643  479999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      ||||+ -+|...+.....       .+...+...++.|+++|++|||.   ..|+|||||++|+|++..|.+||+|||+|
T Consensus       156 Me~~E-hDLksl~d~m~q-------~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMKQ-------PFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             HHHHH-hhHHHHHHhccC-------CCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchh
Confidence            99995 588888865543       37788888999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH----HH
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----EL  547 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~----~~  547 (644)
                      |.+.....   ..+..+-|..|.|||++.+. .|+...|+||+||++.|++++++-|.+..+-...+.+...+-    ..
T Consensus       225 R~ygsp~k---~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  225 REYGSPLK---PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             hhhcCCcc---cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence            99875432   25677889999999998865 589999999999999999999998877554333233322110    00


Q ss_pred             HhcCchhhhh---------hcccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGRILDAA---------DSRLGGEFSEK-EMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~~~~~~---------d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      |..-..+..+         -..++..|... ..+.-.+|+...+..||.+|.|+.|.++.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            0000011111         01111222222 23455678888999999999999998863

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.6e-37  Score=310.47  Aligned_cols=249  Identities=28%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             CcccccCcEEEEEeeecC-----ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWRN-----KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|++|.||+|.+..     ..||+|.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998752     2589999987665 567789999999999999999999999988 889999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++.....      ..++|.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        80 ~~L~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          80 GSLLDRLRKDAL------GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CcHHHHHHhccc------ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccc
Confidence            999999875432      148999999999999999999999   89999999999999999999999999999877532


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...........++..|+|||++....++.++|||||||++|||++ |+.||......    .+.....   ..+..    
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~---~~~~~----  219 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKID---KEGER----  219 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH---hcCCc----
Confidence            221111223457789999999998899999999999999999998 99998654321    1211111   11110    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                           ...+......+.+++.+|++.+|++||++.++++.|.
T Consensus       220 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 -----LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 0111223456788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-37  Score=334.98  Aligned_cols=202  Identities=24%  Similarity=0.366  Sum_probs=171.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..++||+|+||.||+|+..  +..+|+|++....   ....+.+.+|+.++++++|+||+++++.+.+++.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999886  6789999987542   2335678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++|+|.+++....        .++......++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~--------~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG--------IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999986432        27788888999999999999999   8999999999999999999999999999853


Q ss_pred             cccccc--------------------------------------------ccccccccccCCCccCccccccCCCCCccc
Q 006446          475 IQENLK--------------------------------------------THHSTKEIAGTPGYMAPESFLVGRATIETD  510 (644)
Q Consensus       475 ~~~~~~--------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~t~~sD  510 (644)
                      +.....                                            .........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            310000                                            000012346999999999999989999999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCc
Q 006446          511 IYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       511 VwSfGvvl~el~tG~~P~~~~~  532 (644)
                      ||||||++|||++|+.||....
T Consensus       231 iwSlGvil~elltG~~Pf~~~~  252 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCC
Confidence            9999999999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-37  Score=309.61  Aligned_cols=254  Identities=30%  Similarity=0.517  Sum_probs=203.2

Q ss_pred             CcccccCcEEEEEeeec-----CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR-----NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||++...     +..+++|.+...... ..+.+.+|+..+.+++|+||+++++++......++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            47999999999999887     568999998765443 367889999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCC-CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          399 GSLDKFIFYDETNS-GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       399 gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      ++|.+++....... ......+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997642110 0001248999999999999999999999   9999999999999999999999999999987753


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ... ........++..|+|||.+....++.++||||+|+++|||++ |+.||......    .+.+.    ...+.    
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----~~~~~----  224 (262)
T cd00192         158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEY----LRKGY----  224 (262)
T ss_pred             ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH----HHcCC----
Confidence            321 111334567889999999988889999999999999999999 69998765321    12111    11111    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                           ....+......+.+++.+|++.+|++||++.++++.|+
T Consensus       225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 11122223456788999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.5e-37  Score=311.42  Aligned_cols=252  Identities=27%  Similarity=0.476  Sum_probs=201.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||+|... ++.+|+|.+..... ...++.+|+.++++++|+||+++++++. .+..++++||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            46788899999999999999876 67899999875443 3567899999999999999999999874 457899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++......      .+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.....
T Consensus        84 ~~~L~~~~~~~~~~------~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          84 NGSLVDFLKTPEGI------KLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CCCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999998653321      48899999999999999999998   8999999999999999999999999999976642


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||.+....++.++||||||+++|||++ |+.||......    .+....    ..+.    
T Consensus       155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~~~----  220 (260)
T cd05067         155 NEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNL----ERGY----  220 (260)
T ss_pred             CCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH----HcCC----
Confidence            111  11223346778999999998889999999999999999999 99998754321    121111    1111    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           ...........+.+++.+|++.+|++||+++++++.|+.
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 -----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 111112223468889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-37  Score=325.65  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=189.7

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHH-HHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVT-TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||+||+++..  +..+|+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999876  678999998653   2233345555654 56779999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~l~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          81 GELFFHLQRER--------SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            99988885432        38899999999999999999999   89999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|+.||.......    +.+   .. ..+.      
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~---~~-~~~~------  212 (325)
T cd05604         150 S---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MYD---NI-LHKP------  212 (325)
T ss_pred             C---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HHH---HH-HcCC------
Confidence            1   11345579999999999999999999999999999999999999997643211    111   11 1111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                      ..+...    ....+.+++.+|++.+|++||++++.++.+
T Consensus       213 ~~~~~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         213 LVLRPG----ASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             ccCCCC----CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            011122    234566788999999999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=7.7e-37  Score=311.75  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=192.4

Q ss_pred             CcccccCcEEEEEeeec-----CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEEEEeccC
Q 006446          325 NKLGKGGFGTVYKGIWR-----NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVYEYMP  397 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~  397 (644)
                      +.||+|+||.||+|.+.     ...+|+|++... .....+.+..|+.+++.++||||++++++|.. ++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999864     246999988543 33446788899999999999999999998764 456899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....       .+.+..++.++.|+++||.|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        81 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          81 HGDLRNFIRSETH-------NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999965432       26788889999999999999998   8999999999999999999999999999986542


Q ss_pred             cccc-cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          478 NLKT-HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR-KPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       478 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~-~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .... ........++..|+|||.+....++.++|||||||++|||++|. .|+.....    ..+...+   . .+..  
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~---~-~~~~--  220 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYL---L-QGRR--  220 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH---h-cCCC--
Confidence            2111 11112345677899999998889999999999999999999954 55543221    1122211   1 1110  


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                             ...+......+.+++.+||+++|++||++.++++.|+..
T Consensus       221 -------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 -------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   011112234677899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-36  Score=313.16  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=197.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||+|+..  +..||+|++... .....+++..|+.++++++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35777899999999999999875  678999998654 333456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|..+.            .+++.....++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          81 MDGGSLDVYR------------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             CCCCChHHhh------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            9999997653            26788888999999999999999   99999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ...     ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..............+. ......    
T Consensus       146 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~----  215 (279)
T cd06619         146 VNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDE----  215 (279)
T ss_pred             ccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhcc----
Confidence            422     1334578999999999998899999999999999999999999986533221111111111 000000    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       ..+.+..   ......+.+++.+|++.+|++||+++++++.
T Consensus       216 -~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         216 -DPPVLPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCCCCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             0111111   1122456788999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-37  Score=316.55  Aligned_cols=239  Identities=23%  Similarity=0.428  Sum_probs=190.4

Q ss_pred             CcccccCcEEEEEeeec---------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          325 NKLGKGGFGTVYKGIWR---------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +.||+|+||.||+|...         ...+++|.+........+.+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999874         234888888665555567889999999999999999999999998999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc--------EEEe
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN--------ARLG  467 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--------vkL~  467 (644)
                      +++|+|.+++.....       .+++..+++++.||+.||+|||+   .+|+||||||+||+++.++.        ++++
T Consensus        81 ~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          81 VKFGSLDTYLKKNKN-------LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             CCCCcHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEec
Confidence            999999999975433       38899999999999999999999   99999999999999988765        6999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCC-CCCCCCccccchhhHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGR-KPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~-~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |||++.....       .....++..|+|||++.+. .++.++|||||||++|||++|. .|+.......    ...   
T Consensus       151 d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~---  216 (258)
T cd05078         151 DPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQ---  216 (258)
T ss_pred             ccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHH---
Confidence            9998865432       2234678899999999864 5799999999999999999985 5544322110    000   


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                       ....           ...++......+.+++.+||+.||++||+++++++.|+
T Consensus       217 -~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 -FYED-----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -HHHc-----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             1110           01112222345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-38  Score=316.83  Aligned_cols=245  Identities=23%  Similarity=0.373  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      -+|+..+.||+|.||+|-+++..  ++.||||.+++..   +++.-...+||+||+.|+||||++++.++.+++.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            36777889999999999999874  8999999998754   444556788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||..+|.|.+|+.....        |+..+...++.||.+|+.|+|.   ++++|||||.+|||||.++++||+|||++.
T Consensus       133 EYaS~GeLYDYiSer~~--------LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS--------LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             EecCCccHHHHHHHhcc--------ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhh
Confidence            99999999999976553        8999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ++.....    .+..+|.+-|.+||++.+.+| .+..|-||+||+||-|+.|..||++.+..    .++    .....|.
T Consensus       202 ly~~~kf----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lv----rQIs~Ga  269 (668)
T KOG0611|consen  202 LYADKKF----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLV----RQISRGA  269 (668)
T ss_pred             hhccccH----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHH----HHhhccc
Confidence            8763321    456799999999999999888 58999999999999999999999876532    121    1222333


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..+           .+.......|+.||+..||++|-|+.+|...
T Consensus       270 YrE-----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 YRE-----------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ccC-----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            222           1223344568899999999999999999865

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5e-37  Score=321.06  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc--eEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK--EIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|.+.  +.  .+++|+++.. .......+.+|+.++.++ +|+||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46778899999999999999875  33  4677777643 334556788999999999 899999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCC--------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          393 YEYMPNGSLDKFIFYDETNSG--------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      +||+++|+|.+++........        .....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            999999999999975432110        112358999999999999999999998   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++......    ......++..|+|||.+....++.++|||||||++|||++ |..||......+    ... 
T Consensus       164 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~-  234 (303)
T cd05088         164 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE-  234 (303)
T ss_pred             EeCccccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----HHH-
Confidence            999999986432111    0112234678999999988889999999999999999998 999986543211    111 


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        .. ..+         ...+........+.+|+.+|++.+|++||++.++++.|+..
T Consensus       235 --~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 --KL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             --HH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              11 111         11111112234577899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-38  Score=328.27  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=208.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc-eEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD-FLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~  393 (644)
                      ++|...+++|+|+||.++..+++  ++.+++|++...  .....+....|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46778899999999999988776  678999998654  33344567899999999999999999999999988 99999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      +|++||+|.+.+...+..      -++.+...+++.|++.|+.|||+   ..|+|||||+.|||++.+..+||+|||+|+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~------~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGV------LFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             eecCCCCHHHHHHHHhhc------cccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhh
Confidence            999999999999765522      37888899999999999999998   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+....   ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+...    ++.   +..+    
T Consensus       155 ~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----Li~---ki~~----  220 (426)
T KOG0589|consen  155 ILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----LIL---KINR----  220 (426)
T ss_pred             hcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----HHH---HHhh----
Confidence            987543   12566899999999999999999999999999999999999999998765432    211   1111    


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ......+......+..|+..|++.+|+.||++.+++..
T Consensus       221 ------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 ------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                  01122333444567778889999999999999999865

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.1e-37  Score=324.29  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=188.6

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHH-HHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEV-TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+++..  +..+|+|++....   .....++..|. .+++.++|+||+++++++...+.+++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999886  5679999987532   12233444444 456788999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+.......++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          81 GELFYHLQRER--------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            99999886533        26677888899999999999999   99999999999999999999999999999754321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +.+.+   . ...      
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i---~-~~~------  212 (325)
T cd05602         150 N---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNI---L-NKP------  212 (325)
T ss_pred             C---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHH---H-hCC------
Confidence            1   11345579999999999999999999999999999999999999997543221    11111   1 110      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ..+...    ....+.+++.+|++.||.+||++.+.++.+.
T Consensus       213 ~~~~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         213 LQLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             cCCCCC----CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            011122    2345677889999999999999875444333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.5e-37  Score=312.32  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=204.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+|+..+.||+|+||.||++...  +..++||.+...   ......++..|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            36777899999999999999974  788999987653   2234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++......    ...+++.....++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++.
T Consensus        82 e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQ----KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EecCCCCHHHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999988642211    1248999999999999999999999   999999999999999999999999999988


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......++..|+|||.+.+..++.++||||||+++|||++|..||.......  ..+..   . ...   
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~---~-~~~---  222 (267)
T cd08229         155 FFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCK---K-IEQ---  222 (267)
T ss_pred             ccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhh---h-hhc---
Confidence            6642211   1233468899999999988889999999999999999999999986533211  11111   0 000   


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                        ...+   ........+.+.+++.+|++.||++||+|.+|++.++.
T Consensus       223 --~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         223 --CDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             --CCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence              0011   11112234567888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=329.44  Aligned_cols=246  Identities=29%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccc
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD  402 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  402 (644)
                      -+||+|.||+||.|++.  ..++|||.+.....+..+-+.+||.+-++|+|+|||+++|.|.+++.+-+.||.+|+|||.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999999987  4578999998777777788999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCcccccccccc
Q 006446          403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       403 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~~~  481 (644)
                      ..|...-...+.     +....-.+.+||++||.|||+   +.|||||||-+|||++. .|.+||+|||-++.+..  ..
T Consensus       661 sLLrskWGPlKD-----NEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--in  730 (1226)
T KOG4279|consen  661 SLLRSKWGPLKD-----NESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--IN  730 (1226)
T ss_pred             HHHHhccCCCcc-----chhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc--CC
Confidence            999765443221     445556788999999999999   99999999999999965 68899999999988752  22


Q ss_pred             cccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                      .. +....||..|||||++..++  |..++|||||||++.||+|||+||.........    .     .+-|-      -
T Consensus       731 P~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----M-----FkVGm------y  794 (1226)
T KOG4279|consen  731 PC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----M-----FKVGM------Y  794 (1226)
T ss_pred             cc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----h-----hhhcc------e
Confidence            22 55678999999999998764  889999999999999999999999765432211    1     11111      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +....++++........+++|+.+||.+||+++++++
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            1235677777788888999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=316.78  Aligned_cols=272  Identities=25%  Similarity=0.371  Sum_probs=205.4

Q ss_pred             CHHHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHH--HHHHHhccCCCceeeEeeeeeecc
Q 006446          310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKLIGWCYERH  387 (644)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~--Ei~~l~~l~H~nIv~l~g~~~~~~  387 (644)
                      ++--.+...++....+.||+|.||+||+|.++|+.||||++...++   +.+.+  ||..-..|||+||+.+++.-..+.
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            3333445567888899999999999999999999999999965432   33334  555555679999999998754432


Q ss_pred             ----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC-----CCCCeEeCCCCCCCEEE
Q 006446          388 ----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG-----SEKRVLHRDIKSSNIML  458 (644)
Q Consensus       388 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlkp~NILl  458 (644)
                          +++||.+|.++|||.+||...         +++-...++++..+|+||++||.+     ....|.|||||+.|||+
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~---------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV  349 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRN---------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  349 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhc---------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence                689999999999999999653         488999999999999999999974     45789999999999999


Q ss_pred             cCCCcEEEeccCCccccccc-ccccccccccccCCCccCccccccCC------CCCccchHHHHHHHHHHHcCC------
Q 006446          459 DSEFNARLGDFGLARTIQEN-LKTHHSTKEIAGTPGYMAPESFLVGR------ATIETDIYAFGVLILEVACGR------  525 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~-~~~~~~~~~~~gt~~y~APE~~~~~~------~t~~sDVwSfGvvl~el~tG~------  525 (644)
                      .+++.+.|+|+|||...... ..........+||.+|||||++....      .-..+||||||.++||++...      
T Consensus       350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~  429 (513)
T KOG2052|consen  350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV  429 (513)
T ss_pred             ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence            99999999999999876533 22223345678999999999986432      234699999999999997532      


Q ss_pred             ----CCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          526 ----KPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGE-----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       526 ----~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .||.+.-+.+..  .-+ +.      ++  +...++++.     .+.+.+..+.+|+..||+.+|..|-|+-.+-+
T Consensus       430 eey~~Pyyd~Vp~DPs--~ee-Mr------kV--VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  430 EEYQLPYYDVVPSDPS--FEE-MR------KV--VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             hhhcCCcccCCCCCCC--HHH-Hh------cc--eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                455543322111  100 00      00  112233332     33467888999999999999999999999998


Q ss_pred             HHhCCCCC
Q 006446          597 VLSGEADP  604 (644)
Q Consensus       597 ~L~~~~~~  604 (644)
                      .|.+....
T Consensus       499 tl~~l~~~  506 (513)
T KOG2052|consen  499 TLAKLSNS  506 (513)
T ss_pred             HHHHHhcC
Confidence            88776543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-37  Score=329.37  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=208.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +-|+.++-||.|+.|.|-+|++.  |+..|||.+.+..   ........+||.+|+-+.|||++++++++.++.++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45777899999999999999987  8899999997652   223455778999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|-|.++|..+..        +...+..+++.||..|+.|+|.   .+|+||||||+|+|||..+++||+|||+|.
T Consensus        92 Eyv~gGELFdylv~kG~--------l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP--------LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             EecCCchhHHHHHhhCC--------CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceee
Confidence            99999999999976543        8888999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +..+...    ....+|.+.|.|||++.+.+| ..++||||+||+||.|++|+.||++...    ..++.    ..+.|.
T Consensus       161 Le~~gkl----LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----r~LLl----KV~~G~  228 (786)
T KOG0588|consen  161 LEVPGKL----LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----RVLLL----KVQRGV  228 (786)
T ss_pred             cccCCcc----ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----HHHHH----HHHcCc
Confidence            7653221    455789999999999999998 5799999999999999999999985332    22222    122232


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEADP  604 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~~  604 (644)
                      .          +++......+.+|+.+|+..||++|.|++||++.  |.+-..+
T Consensus       229 f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  229 F----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             c----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            1          2233344456778899999999999999999985  4554333

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-36  Score=326.29  Aligned_cols=191  Identities=19%  Similarity=0.280  Sum_probs=164.0

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ...+|+..+.||+|+||.||+|+..  +..||+|.....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999987  467999975332      23568999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+ .++|.+++.....       .++|..+..|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       138 ~~-~~~l~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        138 HY-SSDLYTYLTKRSR-------PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             cc-CCcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            99 5788888864332       38999999999999999999999   8999999999999999999999999999975


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      ....    .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       207 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        207 PVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            3311    1123457899999999999999999999999999999999966554

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.8e-37  Score=312.80  Aligned_cols=253  Identities=27%  Similarity=0.359  Sum_probs=200.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||+|+..  +..||+|++..........+..|+.++++++||||+++++++..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            47888999999999999999975  6789999987655455567889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus        89 ~~~~L~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          89 GGGSLQDIYHVTG--------PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999885432        37889999999999999999999   899999999999999999999999999998664


Q ss_pred             ccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ....   ......++..|+|||.+.   ...++.++|||||||++|||++|+.|+........   ...+     .....
T Consensus       158 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~-----~~~~~  226 (267)
T cd06646         158 ATIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM-----SKSNF  226 (267)
T ss_pred             cccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee-----ecCCC
Confidence            2211   123356889999999874   44578899999999999999999999864332111   0000     00000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                         ..+....  .......+.+++.+|++.+|++||+++++++.|
T Consensus       227 ---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 ---QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               0011110  112235677899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-37  Score=333.40  Aligned_cols=253  Identities=21%  Similarity=0.254  Sum_probs=197.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ..++|+..++||+|+||.||+++..  +..||+|++...   .......+..|+.+++.++||||+++++++.+...+++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467888999999999999999886  678999998653   22334557889999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++...         .++......++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       121 v~Ey~~gg~L~~~l~~~---------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999988542         26677788899999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccC----CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVG----RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ++.......  .......||+.|+|||.+...    .++.++|||||||++|||++|+.||.......    ...   ..
T Consensus       189 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~---~i  259 (370)
T cd05596         189 CMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYS---KI  259 (370)
T ss_pred             eeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHH---HH
Confidence            987642211  112345799999999998643    47899999999999999999999997643211    111   11


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~  597 (644)
                      ......     ..+..  .......+.+++.+|++.+|.+  ||++.++++.
T Consensus       260 ~~~~~~-----~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 MDHKNS-----LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HcCCCc-----CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            110000     00111  0112345677889999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=312.49  Aligned_cols=253  Identities=27%  Similarity=0.434  Sum_probs=196.5

Q ss_pred             CcccccCcEEEEEeeecC--c--eEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWRN--K--EIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~--~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+|++.+  .  .+++|.++.. .....+.+..|+.++.++ +||||++++++|...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999862  2  4788888753 334556889999999999 799999999999999999999999999


Q ss_pred             CccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          399 GSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       399 gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      |+|.+++.......        ......+++.++..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986543211        1112348899999999999999999998   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++.......    ......+..|+|||++....++.++|||||||++|||++ |+.||......    .+..    ...
T Consensus       158 l~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~----~~~  225 (270)
T cd05047         158 LSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE----KLP  225 (270)
T ss_pred             Cccccchhhh----ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHH----HHh
Confidence            9864321100    112234567999999988889999999999999999997 99998653321    1111    111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.         ..+........+.+++.+|++.+|.+||++.++++.|+..
T Consensus       226 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         226 QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCC---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            111         1111112234577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-36  Score=324.80  Aligned_cols=263  Identities=22%  Similarity=0.268  Sum_probs=195.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----  387 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----  387 (644)
                      ..++|+..+.||+|+||.||+++..  +..||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999876  678999998643  2334567889999999999999999999986543     


Q ss_pred             -ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          388 -DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       388 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                       .+++||||++ ++|.+.+..          .+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc----------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEE
Confidence             4799999995 456665531          27788889999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH-----
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV-----  541 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~-----  541 (644)
                      +|||+++.....    .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.     
T Consensus       165 ~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  240 (359)
T cd07876         165 LDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT  240 (359)
T ss_pred             ecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999764321    11334578999999999999999999999999999999999999997653211100000     


Q ss_pred             ----------HHHHHHHhcC-ch-----hhhhhccc-C--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          542 ----------HWLWELRRKG-RI-----LDAADSRL-G--GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       542 ----------~~~~~~~~~~-~~-----~~~~d~~l-~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                ..+....... ..     .+...... .  ..........+.+|+.+|++.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                      0000000000 00     00000000 0  00111123457789999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=331.27  Aligned_cols=242  Identities=25%  Similarity=0.392  Sum_probs=201.0

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  390 (644)
                      ..++|...++||+|.||+|+++.++  ++.+|||.+++..   ++..+..+.|-+++... +||.|++++..+..+.+++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468999999999999999999987  5689999998763   45566677888877776 5999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      .||||+.+|++..+.+..         .++.....-++..|+.||.|||+   ++||+||||.+|||||.+|.+||+|||
T Consensus       446 fvmey~~Ggdm~~~~~~~---------~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD---------VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEEecCCCcEEEEEecc---------cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccc
Confidence            999999999955444322         38888889999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++..-.   ....+...+||+.|||||++.+..|+.+.|.|||||+||||+.|..||.+.++++..+.|+.        
T Consensus       514 lcKe~m~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------  582 (694)
T KOG0694|consen  514 LCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------  582 (694)
T ss_pred             cccccCC---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------
Confidence            9986421   22236778999999999999999999999999999999999999999998776554333322        


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                            .|+.    ++.......+.|+.+.+..+|++|..+
T Consensus       583 ------d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 ------DEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------CCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence                  1122    333344556678889999999999877

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.9e-37  Score=329.92  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----ceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----DFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  390 (644)
                      +|+..++||+|+||.||++...  ++.||+|++...  .....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999875  788999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|+||+. ++|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        81 lv~e~~~-~~l~~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ--------PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccc
Confidence            9999995 67777774332        38899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++.......  .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+    ...
T Consensus       149 ~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~g  222 (372)
T cd07853         149 LARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD----LLG  222 (372)
T ss_pred             ceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----HcC
Confidence            9986542211  112344678999999998764 478999999999999999999999976543221111111    000


Q ss_pred             cCch----------hhhhhcc-c-CC------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          550 KGRI----------LDAADSR-L-GG------EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       550 ~~~~----------~~~~d~~-l-~~------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ....          ...+... . ..      .......+.+.+++.+|++.||++||++.|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000          0000000 0 00      1111223457789999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.3e-37  Score=321.34  Aligned_cols=263  Identities=23%  Similarity=0.430  Sum_probs=204.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      .+|...++||+|+||.||+++..         ...+|+|+++... .....++..|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46778999999999999999752         3468999887543 33456788999999999 6999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      ..++++||+++|+|.+++.......        ......++|.+++.++.|++.||.|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            9999999999999999996543210        1122358999999999999999999998   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++.......... .....++..|+|||.+.++.++.++|||||||++|||++ |+.||......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----  243 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKK-TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----  243 (314)
T ss_pred             CCCcEEEccccccccccccccccc-cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            999999999999986642211111 112234567999999988889999999999999999999 88888654321    


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .+..    ....+..         .+.+......+.+++.+|++.+|++||++.++++.|+...
T Consensus       244 ~~~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 ELFK----LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HHHH----HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111    1111111         1112222345678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=309.79  Aligned_cols=254  Identities=28%  Similarity=0.501  Sum_probs=204.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .++|...++||+|+||.||++... +..+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            357888999999999999999877 5679999887543 34567899999999999999999999999888999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....      ..+++..+..++.+++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 ~~~~L~~~i~~~~~------~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          84 SKGSLLDFLKSGEG------KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             CCCCHHHHHhcccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999965432      148999999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....  .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....    ....+..    ..+    
T Consensus       155 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~----~~~----  220 (261)
T cd05034         155 DDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQV----ERG----  220 (261)
T ss_pred             chhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HcC----
Confidence            3211  11122334678999999998889999999999999999998 9999865332    1111111    111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           .....+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       221 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 -----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 1111112224567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-36  Score=334.57  Aligned_cols=262  Identities=21%  Similarity=0.240  Sum_probs=195.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+|...+.||+|+||.||++++.  +..||||...      ...+.+|+.++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457888999999999999999987  5789999642      23457899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      + .++|.+++.....       .++|.+++.|+.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       242 ~-~~~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        242 Y-RSDLYTYLGARLR-------PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             c-CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            9 5788888854332       38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc----cchhhHHHHHHHHHhc-
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN----SYNNSIVHWLWELRRK-  550 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~----~~~~~l~~~~~~~~~~-  550 (644)
                      ...... .......||..|+|||++.+..++.++|||||||++|||++|..|+......    .....+...+...... 
T Consensus       311 ~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~  389 (461)
T PHA03211        311 RGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV  389 (461)
T ss_pred             cccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence            432111 1123457999999999999999999999999999999999988764332211    1111222221111000 


Q ss_pred             Cch--------hhhhh----cccCCCCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRI--------LDAAD----SRLGGEFSE-------KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~--------~~~~d----~~l~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...        .....    .........       .....+.+|+.+|++.||.+|||+.|+++.
T Consensus       390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000        00000    000000000       111246779999999999999999999874

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-36  Score=322.25  Aligned_cols=263  Identities=22%  Similarity=0.405  Sum_probs=205.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      .+|+..+.||+|+||.||++...         ...||+|.++... ....+++.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            36788999999999999999753         1368999887543 33457889999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      ..++++||+++|+|.+++.......        ......++|..++.++.|++.||+|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            9999999999999999997532110        1123358999999999999999999999   9999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++....... ........++..|+|||.+....++.++|||||||++|||++ |..||......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  243 (334)
T ss_pred             CCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence            999999999999986643211 111222344578999999999999999999999999999998 88888654321    


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .+..    ....+.         ..+.+......+.+++.+|++.+|++||++.++++.|+...
T Consensus       244 ~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         244 ELFK----LLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHH----HHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            1111    111111         11112223346778999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-37  Score=331.14  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=196.1

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ...++|+..++||+|+||.||+++..  ++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+++.++
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999986  678999998642   2233456788999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++|+|.+++...         .++......++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||
T Consensus       120 lv~Ey~~gg~L~~~l~~~---------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY---------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999998532         26778888999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC----CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG----RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +++.......  .......||+.|+|||++...    .++.++||||+||++|||++|+.||.......    ..   ..
T Consensus       188 ~a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~---~~  258 (370)
T cd05621         188 TCMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TY---SK  258 (370)
T ss_pred             cceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HH---HH
Confidence            9987642211  112345799999999998653    37889999999999999999999997643211    11   11


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQV  597 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~  597 (644)
                      ........     .+..  .......+.+++..|++.++.+  ||++.++++.
T Consensus       259 i~~~~~~~-----~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 IMDHKNSL-----NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHhCCccc-----CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11110000     0111  1122344566777888755543  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.5e-37  Score=309.97  Aligned_cols=248  Identities=27%  Similarity=0.451  Sum_probs=200.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++|+..+.||+|+||.||++...+..+|+|.++...  ..+.+.+|+.++++++|||++++++++... ..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            357788999999999999999889999999986543  346788999999999999999999998764 57999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++.....      ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~L~~~l~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          83 GNLVNFLRTRGR------ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             CCHHHHHHhcCc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            999999965432      137899999999999999999998   89999999999999999999999999998764321


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                            ......+..|+|||.+.++.++.++|||||||++|||++ |+.||.......    +.    .....+.     
T Consensus       154 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~----~~~~~~~-----  214 (254)
T cd05083         154 ------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VK----ECVEKGY-----  214 (254)
T ss_pred             ------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HH----HHHhCCC-----
Confidence                  122334578999999988899999999999999999998 999986543211    11    1111111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          ...........+.+++.+|++.+|++||++.++++.|+.+
T Consensus       215 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         215 ----RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE  254 (254)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence                1111122335677899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.4e-37  Score=313.23  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=197.4

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeec------
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER------  386 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~------  386 (644)
                      .+++.|+..+.||+|+||.||+|...  +..+|+|++.... ....++..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678888999999999999999886  6789999986543 3356788999999998 799999999998753      


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ...+++|||+++++|.+++.....      ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG------NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEE
Confidence            358999999999999999865332      148899999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      +|||+++......   .......|+..|+|||++.     ...++.++|||||||++|||++|+.||.......      
T Consensus       153 ~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------  223 (272)
T cd06637         153 VDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------  223 (272)
T ss_pred             ccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------
Confidence            9999998654221   1123456889999999986     3357889999999999999999999986533211      


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ... .... ..     ...+   ........+.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~-~~~~-~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         224 ALF-LIPR-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHH-HHhc-CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            100 0000 00     0111   11112345778999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-36  Score=311.44  Aligned_cols=254  Identities=28%  Similarity=0.469  Sum_probs=198.9

Q ss_pred             CcccccCcEEEEEeeecC--------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          325 NKLGKGGFGTVYKGIWRN--------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~--------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +.||+|+||.||+|+...        ..+++|.+.... ......+.+|+.++++++||||++++++|......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998752        468999886543 23466889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-----cEEEeccC
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-----NARLGDFG  470 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-----~vkL~DFG  470 (644)
                      +++++|.+++........ ....++|.+++.++.|++.||.|||+   .+++|+||||+||+++.+.     .+||+|||
T Consensus        81 ~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERF-GPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhccc-CCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999975432211 22348899999999999999999998   8999999999999999887     89999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++....... ........++..|+|||.+.++.++.++|||||||++|||++ |+.||.....    ......+    .
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~----~  227 (269)
T cd05044         157 LARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHV----T  227 (269)
T ss_pred             cccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHH----h
Confidence            9976542211 111223345778999999999999999999999999999998 9999864322    1111111    1


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .+.         ...........+.+++.+||+++|++||++.++++.|+.
T Consensus       228 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111         011122234567889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=306.10  Aligned_cols=248  Identities=29%  Similarity=0.472  Sum_probs=198.8

Q ss_pred             CcccccCcEEEEEeeec-CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccc
Q 006446          325 NKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD  402 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  402 (644)
                      ++||+|+||.||++.+. ++.|++|++...... ....+..|+.++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987 788999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccccc
Q 006446          403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH  482 (644)
Q Consensus       403 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~  482 (644)
                      +++.....       .+++..++.++.+++.||.|||+   ++++||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~~l~~~~~-------~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  149 (251)
T cd05041          81 TFLRKKKN-------RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-T  149 (251)
T ss_pred             HHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-e
Confidence            99865432       37899999999999999999998   8999999999999999999999999999986542111 1


Q ss_pred             ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       483 ~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                      ........+..|+|||.+.++.++.++|||||||++|||++ |..||.......    ....    ...+         .
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~----~~~~---------~  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRER----IESG---------Y  212 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHH----HhcC---------C
Confidence            11112234667999999988899999999999999999999 888886543211    1111    1111         0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ....+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            111122334568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-36  Score=309.53  Aligned_cols=237  Identities=26%  Similarity=0.476  Sum_probs=190.0

Q ss_pred             CcccccCcEEEEEeeecCc------------eEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          325 NKLGKGGFGTVYKGIWRNK------------EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~------------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +.||+|+||.||+|.+.+.            .+++|.+...... ...|.+|+.++++++||||++++++|.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999998732            3788877654433 6788999999999999999999999988 788999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-------cEE
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-------NAR  465 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-------~vk  465 (644)
                      +||+++|+|.+++.....       .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++       .+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-------NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEE
Confidence            999999999999975442       38899999999999999999998   9999999999999999888       799


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccC--CCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~  542 (644)
                      |+|||+++....       .....++..|+|||++...  .++.++|||||||++|||++ |..|+.......    ...
T Consensus       149 l~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~  217 (259)
T cd05037         149 LSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KER  217 (259)
T ss_pred             eCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHH
Confidence            999999986542       2233566789999998876  78999999999999999999 567765543211    111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      +    +....           ..+......+.+++.+|++.+|.+||++.++++.|+
T Consensus       218 ~----~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 F----YQDQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             H----HhcCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1    11100           001111166788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-36  Score=314.70  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      |+..+.||+|+||.||++...  ++.+|+|.+.....   .....+..|+.++++++|+|++++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999887  67899999865422   2234577899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++......      .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++...
T Consensus        82 ~~g~~L~~~l~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          82 MNGGDLKFHIYHMGEA------GFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             cCCCcHHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9999999988543221      38899999999999999999998   99999999999999999999999999998765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....    .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..................         
T Consensus       153 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------  219 (285)
T cd05630         153 PEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------  219 (285)
T ss_pred             CCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------
Confidence            32211    23347899999999999989999999999999999999999999764322111111110000         


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                       ........+    ...+.+|+.+|++.||++||+     ++|+++
T Consensus       220 -~~~~~~~~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 -VQEEYSEKF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhhhcCccC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             001111222    334678899999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.9e-37  Score=310.26  Aligned_cols=251  Identities=32%  Similarity=0.514  Sum_probs=198.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhh--HHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |+..+.||+|+||+||+++..  ++.+|+|++........  .....|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            345789999999999999998  45799999987654333  23456999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++....        .+++..+..++.|+++||.|||+   .+++||||||+||+++++++++|+|||.+....
T Consensus        81 ~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   81 PGGSLQDYLQKNK--------PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             TTEBHHHHHHHHS--------SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccc--------ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999997322        38999999999999999999999   899999999999999999999999999997541


Q ss_pred             ccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ..   ........++..|+|||.+. ...++.++||||+|+++|+|++|+.||...........+..    .. ......
T Consensus       150 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~----~~-~~~~~~  221 (260)
T PF00069_consen  150 EN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK----IL-KRPLPS  221 (260)
T ss_dssp             ST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH----HH-HTHHHH
T ss_pred             cc---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh----cc-cccccc
Confidence            11   11244567899999999998 78899999999999999999999999886521111111111    00 000000


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         . .  .........+.+++.+|++.||++||++.++++
T Consensus       222 ---~-~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 ---S-S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---H-T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---c-c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0 0  000011267888999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8e-37  Score=316.26  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=192.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhcc---CCCceeeEeeeeeec-----c
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL---RHRNLVKLIGWCYER-----H  387 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~-----~  387 (644)
                      +|+..+.||+|+||.||+|+..  ++.||+|.++....  .....+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999886  67899999875322  1233456677776665   799999999988642     3


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++++||++ ++|.+++......      .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~  150 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPP------GLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLA  150 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEC
Confidence            5899999996 5888887543221      38899999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++......    ......||..|+|||++.+..++.++|||||||++|||++|++||...........+..+....
T Consensus       151 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07863         151 DFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  226 (288)
T ss_pred             ccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence            999998764221    1234578999999999998899999999999999999999999987644322111121111000


Q ss_pred             Hhc--CchhhhhhcccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 RRK--GRILDAADSRLG-------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~--~~~~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...  ..........+.       ........+.+.+++.+|++.||++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000  000000000000       0011122345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-36  Score=309.08  Aligned_cols=250  Identities=25%  Similarity=0.409  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-----chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  389 (644)
                      .+|+..+.||+|+||.||++...  +..|++|++....     .+..+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999875  6789999886432     22345688999999999999999999988753  568


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++++|.+++....        .+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--------ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence            89999999999999986432        27889999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++................++..|+|||.+.+..++.++|||||||++|||++|+.||.......   .+    .....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~----~~~~~  223 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AI----FKIAT  223 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HH----HHHhc
Confidence            999865422111111233568899999999998889999999999999999999999987542211   11    11110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..         ....++....+.+..++ +||..+|++||+++||++
T Consensus       224 ~~---------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 QP---------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC---------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00         11222222233444454 799999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.1e-36  Score=312.47  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=197.1

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      |+..+.||+|+||.||+|...  +..+++|.+........+.+..|+.+++.++||||+++++.+..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            345678999999999999987  567889988766656677889999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|..++.....       .+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        87 ~~l~~~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          87 GAVDAVMLELER-------PLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             CcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999988764322       38999999999999999999999   89999999999999999999999999998765322


Q ss_pred             ccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .   .......++..|+|||++.     ...++.++|||||||++|||++|+.||.......   ....    ... ...
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~----~~~-~~~  225 (282)
T cd06643         157 I---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VLLK----IAK-SEP  225 (282)
T ss_pred             c---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HHHH----Hhh-cCC
Confidence            1   1123456899999999874     3457889999999999999999999986543211   1111    100 000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           +.+  ..+......+.+++.+||+.||.+||++.++++.
T Consensus       226 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         226 -----PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000  0111123457788999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-36  Score=324.20  Aligned_cols=263  Identities=21%  Similarity=0.261  Sum_probs=196.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec------
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------  386 (644)
                      ..++|+..+.||+|+||.||++...  +..||+|++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999875  7789999987542  23456778899999999999999999988643      


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ...++||||++ ++|.+.+..          .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEE
Confidence            35799999995 566666531          27888899999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH----
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH----  542 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~----  542 (644)
                      +|||+++......    ......||..|+|||++.+..++.++|||||||++|||++|+.||..............    
T Consensus       161 ~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (355)
T cd07874         161 LDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_pred             eeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999998654221    12345789999999999988999999999999999999999999976432111111100    


Q ss_pred             -----------HHHHHHhc-Cchhhhhhcc------cC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 -----------WLWELRRK-GRILDAADSR------LG--GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 -----------~~~~~~~~-~~~~~~~d~~------l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                 .+...... ........+.      ..  ..........+.+++.+|++.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       00000000 0000000000      00  01111223467889999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-36  Score=307.98  Aligned_cols=251  Identities=26%  Similarity=0.496  Sum_probs=201.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .+|+..+.||+|+||.||++.+. +..+++|.+..... ...+|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35677899999999999999886 77899998865432 34678999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....       .+++..+..++.+++.||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQRG-------KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhCcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            9999999865432       37899999999999999999999   8999999999999999999999999999986542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++.+|+|||.+.++.++.++||||||+++|||++ |+.||......    .+.+   .. ..+.    
T Consensus       153 ~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~---~~-~~~~----  218 (256)
T cd05112         153 DQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVE---TI-NAGF----  218 (256)
T ss_pred             Ccc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHH---HH-hCCC----
Confidence            211  11122345678999999998889999999999999999998 89998654321    1111   11 1110    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                           ....+....+.+.+++.+|++.+|++||++.++++.|.
T Consensus       219 -----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 -----RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 00111112356888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-36  Score=321.70  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=191.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +|+..+.||+|+||.||++...  ++.||+|++....   ....+.+..|..++..+. |++|+++.+++...+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999876  6789999987542   233456778888988885 577888999999888999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~i~~~~--------~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--------KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             cCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEecccccc
Confidence            9999999999885432        38899999999999999999999   899999999999999999999999999987


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+.    .+. 
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~----~~~-  217 (323)
T cd05615         150 EHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIM----EHN-  217 (323)
T ss_pred             ccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCC-
Confidence            543211   1133456899999999999888999999999999999999999999764321    1221111    111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                           .    .++......+.+++.+|++.+|.+|++.
T Consensus       218 -----~----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -----V----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----C----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 0    1112223456778899999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.7e-36  Score=322.76  Aligned_cols=263  Identities=21%  Similarity=0.274  Sum_probs=196.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------  386 (644)
                      ..++|+..+.||+|+||.||+++..  ++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999876  678999998753  233456788999999999999999999987643      


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ...++||||++ ++|.+++..          .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL  167 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI  167 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh----------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEE
Confidence            35799999995 567666631          27788899999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH----
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH----  542 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~----  542 (644)
                      +|||+++......    ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+.......+..    
T Consensus       168 ~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  243 (364)
T cd07875         168 LDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT  243 (364)
T ss_pred             EeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999998654221    12345789999999999999999999999999999999999999976543211111110    


Q ss_pred             ----HH-------HHHHh-cCchh----hhhhccc----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 ----WL-------WELRR-KGRIL----DAADSRL----GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ----~~-------~~~~~-~~~~~----~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                          +.       ..... .....    +...+..    ..+........+.+++.+|++.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                00       00000 00000    0000000    001111123467789999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-36  Score=316.43  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|...++||+|+||.||+|+..  +..||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999876  67899999875432 2345678899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....       .+++.....++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          86 LD-KDLKQYMDDCGN-------IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceec
Confidence            96 588887754332       37889999999999999999999   89999999999999999999999999999764


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-------HHHH
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-------LWEL  547 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-------~~~~  547 (644)
                      .....   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...       .|..
T Consensus       155 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         155 SVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             CCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence            32211   1233467899999998865 46889999999999999999999999765432221111110       0000


Q ss_pred             HhcC-chhhhhhcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 RRKG-RILDAADSRLGGE----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~~-~~~~~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .... .......+.....    ........+.+++.+|++.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 0000000000000    00012234668999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=312.13  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=202.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--C----ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--N----KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|+..+.||+|+||.||+|.+.  +    ..+|+|...... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46777899999999999999875  2    258999886554 3345778999999999999999999999987 78999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++|+|.+++.....       .+++...+.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        86 v~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD-------NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEecCCCCcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcc
Confidence            9999999999999965433       28899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........++..|+|||.+....++.++||||||+++||+++ |+.||......    .+.+.+    ..
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~  226 (279)
T cd05057         156 AKLLDVDEK-EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----EIPDLL----EK  226 (279)
T ss_pred             cccccCccc-ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHH----hC
Confidence            987653221 111122334678999999988889999999999999999998 99998764321    122211    11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      +..         ...+......+.+++.+||..+|.+||++.++++.|+...
T Consensus       227 ~~~---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         227 GER---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111         0111112245678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2e-36  Score=310.28  Aligned_cols=255  Identities=21%  Similarity=0.358  Sum_probs=189.8

Q ss_pred             CcccccCcEEEEEeeec----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||+|...    ...+++|.+.... ......+.+|+.+++.++|+||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36999999999999754    2468888876443 334567889999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|.+++.......   ....++...+.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~L~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          81 DLKNYLRSNRGMV---AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             cHHHHHHhccccc---cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9999996543211   1235678889999999999999999   899999999999999999999999999987543221


Q ss_pred             cccccccccccCCCccCcccccc-------CCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLV-------GRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~-------~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      .. .......++..|+|||++..       ..++.++|||||||++|||++ |+.||......    ....   .....+
T Consensus       155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~---~~~~~~  226 (269)
T cd05042         155 YY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLK---QVVREQ  226 (269)
T ss_pred             he-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHH---HHhhcc
Confidence            11 11233456778999998743       356889999999999999999 77887654321    1111   111111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                       .....++.+...    ....+.+++..|+ .||++||++++|++.|.
T Consensus       227 -~~~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 -DIKLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             -CccCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence             111222222222    2344556777888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-36  Score=320.63  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=190.8

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||++...  +..+|+|+++...   ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999886  5789999997642   23345678899999888 699999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|..++....        .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~L~~~~~~~~--------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          81 GDLMFHMQRQR--------KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            99998885432        38999999999999999999999   89999999999999999999999999998753211


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...++.........      
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~------  219 (327)
T cd05617         150 G---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKP------  219 (327)
T ss_pred             C---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCC------
Confidence            1   1133457999999999999999999999999999999999999999653322111 11222222221111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                      ..+....    ...+.+++.+|++.||++||++
T Consensus       220 ~~~p~~~----~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 IRIPRFL----SVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCC----CHHHHHHHHHHhccCHHHcCCC
Confidence            1112222    3446678899999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-36  Score=322.54  Aligned_cols=263  Identities=22%  Similarity=0.393  Sum_probs=200.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec-cc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER-HD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  388 (644)
                      ++|+..++||+|+||.||+|++.       ++.||||+++... ......+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            47888999999999999999742       4679999997543 23346788999999999 689999999988754 46


Q ss_pred             eEEEEeccCCCccchhhhccCCCCC-------------------------------------------------------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSG-------------------------------------------------------  413 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~-------------------------------------------------------  413 (644)
                      .++++||+++|+|.+++........                                                       
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7999999999999999865321000                                                       


Q ss_pred             ----CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccc
Q 006446          414 ----PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA  489 (644)
Q Consensus       414 ----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~  489 (644)
                          .....++|..+..++.|+++||+|||+   .+|+||||||+|||++.++++||+|||+++....... ........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~  242 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDAR  242 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCC
Confidence                001247899999999999999999998   9999999999999999999999999999986532211 11122334


Q ss_pred             cCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHH
Q 006446          490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEK  568 (644)
Q Consensus       490 gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  568 (644)
                      ++..|+|||.+....++.++||||||+++|||++ |..||.......   .+    ......+...     ......   
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~-----~~~~~~---  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF----CRRLKEGTRM-----RAPDYT---  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HH----HHHHhccCCC-----CCCCCC---
Confidence            5678999999988899999999999999999997 888986533211   11    1111111111     111111   


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          569 EMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       569 ~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       ...+.+++.+||+.||++||++.++++.|+..
T Consensus       308 -~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         308 -TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             -CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             23577889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.9e-37  Score=336.74  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=189.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec--------c
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--------H  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--------~  387 (644)
                      .++|+..++||+|+||.||+|+..  +..||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999885  6789999885432    2335799999999999999999876432        2


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEE
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARL  466 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL  466 (644)
                      .+++||||++ ++|.+++......    ...+++.....++.|++.||+|||+   .+|+||||||+|||++.++ .+||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARN----NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence            3679999996 5677666432111    1248899999999999999999999   9999999999999999665 6999


Q ss_pred             eccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++.......    .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...........+.....
T Consensus       213 ~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        213 CDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999987642211    234578999999998865 4689999999999999999999999976543221111111000


Q ss_pred             ----HHHh--cCchhhh-----hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ----ELRR--KGRILDA-----ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ----~~~~--~~~~~~~-----~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +...  .....+.     ....+...++......+.+|+.+||+.||.+|||+.|+++
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                0000  0000000     0000001111122346778999999999999999999984

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.5e-36  Score=316.53  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||++...  +..+|+|.+.... .....++.+|++++++++||||+++++.+..++.+++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999886  5678888886543 23346688999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++....        .+++.....++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          81 MDGGSLDQVLKKAG--------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             cCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            99999999996542        37889999999999999999997  248999999999999999999999999998765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc---
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR---  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~---  552 (644)
                      ....     .....++..|+|||.+.+..++.++|||||||++|||++|+.||.......    +..+.........   
T Consensus       151 ~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~  221 (308)
T cd06615         151 IDSM-----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKE  221 (308)
T ss_pred             cccc-----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccC
Confidence            3211     234568899999999988889999999999999999999999986533211    1111000000000   


Q ss_pred             -----------------hhhhhhccc---CCCCCH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 -----------------ILDAADSRL---GGEFSE-KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 -----------------~~~~~d~~l---~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                       ..+..+...   ....+. .....+.+++.+|++.+|++||+++++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             000000000   000000 123357789999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.9e-36  Score=307.65  Aligned_cols=252  Identities=26%  Similarity=0.477  Sum_probs=201.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||++.+. +..+++|.+.... ...+.+.+|+.++++++|+||+++.+.+.+ ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            57888999999999999999876 5679999886543 345678999999999999999999999887 77899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....      ..+++..++.++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          84 KGSLLDFLKSDEG------SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCcHHHHHHhCCc------cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999865322      137899999999999999999998   8999999999999999999999999999976542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||++..+.++.++|+|||||++||+++ |+.||.....    ..+..+.    ..+..   
T Consensus       155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~----~~~~~---  221 (260)
T cd05073         155 NEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRAL----ERGYR---  221 (260)
T ss_pred             CCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----hCCCC---
Confidence            211  11223345678999999988889999999999999999999 8989865432    1122211    11111   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                            ..........+.+++.+|++++|++||++.++++.|+.
T Consensus       222 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  11112233457788999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.7e-36  Score=312.41  Aligned_cols=250  Identities=24%  Similarity=0.413  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +.|+..++||+|+||.||+|...  +..+++|.+........+.+..|+.++++++|+||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46778899999999999999886  6789999998776666788999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|..++.....       .+++..+..++.|++.+|+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        92 ~~~~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          92 PGGAVDAIMLELDR-------GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCcHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999888754332       38999999999999999999998   899999999999999999999999999987643


Q ss_pred             ccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ...   .......++..|+|||++.     ...++.++|||||||++|||++|+.||.......   ..    .... ..
T Consensus       162 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~----~~~~-~~  230 (292)
T cd06644         162 KTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VL----LKIA-KS  230 (292)
T ss_pred             ccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---HH----HHHh-cC
Confidence            211   1123456888999999884     3456889999999999999999999986533211   11    1111 11


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .     .+..  ..+......+.+++.+||+.+|++||+++++++
T Consensus       231 ~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 E-----PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             C-----CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0     0000  111122345778899999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-36  Score=306.05  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=202.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..++||+|+||.||+|+..  +..+++|.+.....  .+++.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            57888999999999999999987  57899999865433  678999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....       .+++.....++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~~~~L~~~l~~~~~-------~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          81 GAGSVSDIMKITNK-------TLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCCcHHHHHHhCcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999864332       38999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......++..|+|||.+.+..++.++||||||+++|||++|+.||........   ...     ....     
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~-----~~~~-----  214 (256)
T cd06612         151 DTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFM-----IPNK-----  214 (256)
T ss_pred             cCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhh-----hccC-----
Confidence            3211   12334578899999999888999999999999999999999999875432111   000     0000     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+.  ...+......+.+++.+|++.||++||++.++++
T Consensus       215 ~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0000  0111222346788899999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-36  Score=313.52  Aligned_cols=249  Identities=27%  Similarity=0.334  Sum_probs=196.6

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      |+..++||+|+||+||++...  ++.+|+|.+....   ......+..|+.++++++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999886  6789999986542   22234578899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++......      .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++...
T Consensus        82 ~~~~~L~~~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          82 MNGGDLKFHIYNMGNP------GFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             ccCccHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9999999888643221      38999999999999999999999   89999999999999999999999999999765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....    ......|+..|+|||++.+..++.++|+|||||++|||++|+.||.........   .. +......+    
T Consensus       153 ~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~-~~~~~~~~----  220 (285)
T cd05632         153 PEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EE-VDRRVLET----  220 (285)
T ss_pred             CCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HH-HHHhhhcc----
Confidence            3211    123457899999999999889999999999999999999999999754321111   11 11111110    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                        .    ..+.......+.+|+.+|++.||++||+     +.++++
T Consensus       221 --~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 --E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --c----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              0    1112222345678889999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-36  Score=307.19  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=200.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +|+..++||+|+||.||++...  +..+|+|.++.. .....+.+..|+.++++++|+||+++++.+..++.+++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999876  678999998653 2334567889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++......      .++....+.++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++...
T Consensus        81 ~~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          81 DGGDLMQKIKLQRGK------LFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            999999988543221      37888999999999999999999   999999999999999999999999999998664


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......    ..   .... ..+...  
T Consensus       152 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~---~~~~-~~~~~~--  218 (255)
T cd08219         152 SPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NL---ILKV-CQGSYK--  218 (255)
T ss_pred             cccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HH---HHHH-hcCCCC--
Confidence            2211   123456889999999998888999999999999999999999999754321    11   1111 111111  


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                             ..+......+.+++.+||+.||++||++.+++..
T Consensus       219 -------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   1112223456788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-36  Score=314.18  Aligned_cols=203  Identities=26%  Similarity=0.380  Sum_probs=162.2

Q ss_pred             CCcccccCcEEEEEeeec----CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEEEeccC
Q 006446          324 KNKLGKGGFGTVYKGIWR----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLVYEYMP  397 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  397 (644)
                      ..+||+|+||.||+|+..    +..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865    3679999886543  23467889999999999999999999854  457899999985


Q ss_pred             CCccchhhhccCCC-CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----cCCCcEEEeccCCc
Q 006446          398 NGSLDKFIFYDETN-SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDFGLA  472 (644)
Q Consensus       398 ~gsL~~~l~~~~~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla  472 (644)
                       ++|.+++...... .......+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5777776532211 11122348899999999999999999999   899999999999999    56678999999999


Q ss_pred             ccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      +................||..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            876533222222345578999999999876 457999999999999999999999987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.2e-36  Score=313.94  Aligned_cols=203  Identities=25%  Similarity=0.383  Sum_probs=162.3

Q ss_pred             CCcccccCcEEEEEeeec----CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEEEeccC
Q 006446          324 KNKLGKGGFGTVYKGIWR----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLVYEYMP  397 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~  397 (644)
                      .++||+|+||.||+|+..    +..+|+|.+....  ....+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            568999999999999864    4679999986542  23457789999999999999999998864  346899999984


Q ss_pred             CCccchhhhccCCCC-CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----cCCCcEEEeccCCc
Q 006446          398 NGSLDKFIFYDETNS-GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDFGLA  472 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DFGla  472 (644)
                       ++|.+++....... ......+++.....++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             68877775332211 1122348899999999999999999999   899999999999999    45678999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      +................||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            8765332222223456789999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.5e-36  Score=313.70  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=202.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|.+........+.+..|+.+++.++|+||+++++++......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57888999999999999999874  7899999997765556677889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++...         .+++.++..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus        99 ~~~~L~~~~~~~---------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          99 AGGSLTDVVTET---------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             CCCCHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999998532         27889999999999999999999   899999999999999999999999999997654


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........   +.. .   ...+     
T Consensus       167 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~-~---~~~~-----  231 (297)
T cd06656         167 PEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL-I---ATNG-----  231 (297)
T ss_pred             CCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eee-e---ccCC-----
Confidence            2211   12334688899999999988899999999999999999999999965432111   000 0   0000     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       .+.  ...+......+.+++.+|++.+|++||+++++++
T Consensus       232 -~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 -TPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000  0111223345677889999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-36  Score=306.72  Aligned_cols=249  Identities=24%  Similarity=0.425  Sum_probs=198.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch---------hhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      +|.....||+|++|.||+|...  +..+|+|.+......         ..+.+..|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999875  678999988654221         22567889999999999999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++++||+++++|.+++....        .+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG--------AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc--------CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecc
Confidence            999999999999999995432        37888999999999999999998   8999999999999999999999999


Q ss_pred             cCCcccccccccccc---cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          469 FGLARTIQENLKTHH---STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       469 FGla~~~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      ||+++..........   ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......   ..+.    
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~----  222 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIF----  222 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHH----
Confidence            999987652211110   012345788999999999888999999999999999999999999754221   1111    


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...      ...    ....+....+.+.+++.+||++||.+||++.++++
T Consensus       223 ~~~------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 KIG------ENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHh------ccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            100      011    11222233456778889999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.1e-36  Score=314.00  Aligned_cols=248  Identities=26%  Similarity=0.425  Sum_probs=201.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||.|++|.||+|+..  ++.|++|.+........+.+.+|+.+++.++|+||+++++++.....+++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999864  7889999997665555678899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++...         .+++.++..++.+++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        99 ~~~~L~~~~~~~---------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          99 AGGSLTDVVTET---------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             CCCcHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            999999988532         27899999999999999999999   899999999999999999999999999988654


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......   .+. ..   ...+ .   
T Consensus       167 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~-~~---~~~~-~---  232 (296)
T cd06655         167 PEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALY-LI---ATNG-T---  232 (296)
T ss_pred             cccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-HH---HhcC-C---
Confidence            2211   1233468889999999998889999999999999999999999997644211   111 01   0000 0   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        +.+  ..+......+.+++.+||+.||++||++.++++
T Consensus       233 --~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 --PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              001  011122335667889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-36  Score=327.39  Aligned_cols=260  Identities=21%  Similarity=0.262  Sum_probs=199.4

Q ss_pred             HHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      +.++....++|+..+.||+|+||.||+++..  +..+|+|++...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455556689999999999999999999987  678999998642   22334567889999999999999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      ++.+++||||+++|+|.+++...         .++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEE
Confidence            99999999999999999988532         26777888899999999999999   9999999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccC----CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG----RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      |+|||+++.......  .......||+.|+|||++...    .++.++|||||||++|||++|+.||.......    ..
T Consensus       183 L~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~  256 (371)
T cd05622         183 LADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TY  256 (371)
T ss_pred             EEeCCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----HH
Confidence            999999987642211  112346799999999998653    37899999999999999999999997643211    11


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQVL  598 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~L  598 (644)
                         ............     .  ........+.+++.+|+..++.+  ||+++++++..
T Consensus       257 ---~~i~~~~~~~~~-----~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 ---SKIMNHKNSLTF-----P--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---HHHHcCCCcccC-----C--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               111111110110     0  01122345667788899844433  78999888753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-36  Score=326.83  Aligned_cols=261  Identities=22%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec----CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ..+|...+.||+|+||.||++...    +..|++|.+...     +.+.+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357889999999999999998764    457899987543     24568999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |++ .++|.+++....        .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       166 e~~-~~~l~~~l~~~~--------~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        166 PKY-KCDLFTYVDRSG--------PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             hhc-CCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            999 478888883222        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc-
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR-  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~-  552 (644)
                      ........ .......||..|+|||++....++.++|||||||++|||++|+.||...........+..-+. ..+... 
T Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~  311 (392)
T PHA03207        234 KLDAHPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPL  311 (392)
T ss_pred             ccCccccc-ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCcc
Confidence            66533221 112346799999999999999999999999999999999999999876543322222221111 110000 


Q ss_pred             ---------hhhh---hhcccCCCCCH-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ---------ILDA---ADSRLGGEFSE-------KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ---------~~~~---~d~~l~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                               +...   .....+..+..       .....+.+++.+|++.||++||++.++++.
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     0000   00000111100       112345678899999999999999999875

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-36  Score=308.64  Aligned_cols=253  Identities=28%  Similarity=0.448  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|...++||+|+||.||+|.+.+     ..|++|...... ....+.+.+|+.++++++||||++++++|.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998752     368999887654 4456789999999999999999999999875 467899


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++.....       .+++..++.++.+++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        85 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          85 MELAPLGELRSYLQVNKY-------SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCcee
Confidence            999999999999965432       38999999999999999999998   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +....... .. .....++..|+|||.+....++.++||||||+++||+++ |+.||......    ....+.    ..+
T Consensus       155 ~~~~~~~~-~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~----~~~  224 (270)
T cd05056         155 RYLEDESY-YK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRI----ENG  224 (270)
T ss_pred             eecccccc-ee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH----HcC
Confidence            86643211 11 122344568999999988889999999999999999986 99998754322    111111    111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...         .........+.+++.+|+.++|.+||++.++++.|+..
T Consensus       225 ~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         225 ERL---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            110         11122234677889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=329.00  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=207.5

Q ss_pred             CCCCCcccccCcEEEEEeeec---C--ceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR---N--KEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~---~--~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ....++||+|.||.|++|.|+   +  -.||||+++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ..+.||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            445788999999999999997   2  25999999876543 67899999999999999999999999988 68999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      .++.|||.+.|++....      .+-......++.|||.||.||..   +++|||||..+|+||-....+||+||||.|.
T Consensus       191 LaplGSLldrLrka~~~------~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKA------ILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hcccchHHHHHhhcccc------ceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceec
Confidence            99999999999763322      37777888999999999999999   9999999999999999999999999999998


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      +..+...........-...|.|||.+...+++.++|||+|||++|||++ |..||.+....    .             +
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----q-------------I  324 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----Q-------------I  324 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----H-------------H
Confidence            8755443332333445678999999999999999999999999999999 78898764321    1             2


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ++.+|.+-+-.-+..+.+.+.++++.||.++|++||++..+.+
T Consensus       325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            2333333333445667889999999999999999999999973

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-36  Score=320.86  Aligned_cols=254  Identities=20%  Similarity=0.243  Sum_probs=194.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999886  578999998653   2233455788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 Ey~~gg~L~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          81 DYYVGGDLLTLLSKFED-------RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             eCCCCCcHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEecccee
Confidence            99999999999975332       27888999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      .......  .......||+.|+|||++..     +.++.++|||||||++|||++|+.||........       .....
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~  221 (331)
T cd05624         151 KMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIM  221 (331)
T ss_pred             eccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-------HHHHH
Confidence            6643211  11233569999999999875     5678999999999999999999999975432111       11111


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQV  597 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~  597 (644)
                      ......     .+.... ....+.+.+++.+|++.++++  |++++++++.
T Consensus       222 ~~~~~~-----~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         222 NHEERF-----QFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCCcc-----cCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            111000     011111 112345667777888765544  5688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.5e-37  Score=327.64  Aligned_cols=204  Identities=25%  Similarity=0.421  Sum_probs=174.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||++...  +..||+|++....   ......+..|+.++.+++|+||+++++.+.+++.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36788899999999999999886  6789999987532   233567788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .++......++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 E~~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          81 EFLPGGDMMTLLMKKD--------TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             eCCCCccHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            9999999999986433        37888999999999999999999   999999999999999999999999999987


Q ss_pred             cccccccc--------------------------------cccccccccCCCccCccccccCCCCCccchHHHHHHHHHH
Q 006446          474 TIQENLKT--------------------------------HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV  521 (644)
Q Consensus       474 ~~~~~~~~--------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el  521 (644)
                      ........                                ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            54321100                                0001234799999999999999999999999999999999


Q ss_pred             HcCCCCCCCCcc
Q 006446          522 ACGRKPGNQSEQ  533 (644)
Q Consensus       522 ~tG~~P~~~~~~  533 (644)
                      ++|+.||.....
T Consensus       230 ~tG~~Pf~~~~~  241 (360)
T cd05627         230 LIGYPPFCSETP  241 (360)
T ss_pred             ccCCCCCCCCCH
Confidence            999999976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=311.11  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=201.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||.||++...  +..+|+|.+........+.+..|+.++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888899999999999999986  678999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....       .+++.....++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++...
T Consensus        84 ~~~~~L~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          84 CDGGALDSIMLELER-------GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             cCCCcHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999865432       38899999999999999999999   89999999999999999999999999998765


Q ss_pred             cccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      .....   ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......   ..+..    . ..
T Consensus       154 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~----~-~~  222 (280)
T cd06611         154 KSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLK----I-LK  222 (280)
T ss_pred             ccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHH----H-hc
Confidence            32111   123456889999999875     344678999999999999999999998754321   11111    1 11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +..     +.+  ..+......+.+++.+|++.+|.+||++.++++.
T Consensus       223 ~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 SEP-----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCC-----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            110     011  1111223456788999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-36  Score=315.41  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=199.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|+||.||+|++.  +.    .+|+|.+..... ....++.+|+.++++++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46777899999999999999874  33    478888865432 3345788999999999999999999999754 5679


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ++||+++|+|.+++.....       .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        86 v~e~~~~g~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD-------NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eehhcCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccc
Confidence            9999999999999865432       37899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........++..|+|||.+.+..++.++|||||||++|||++ |+.||.....    ..+.++    ...
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~----~~~  226 (303)
T cd05110         156 ARLLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDL----LEK  226 (303)
T ss_pred             cccccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH----HHC
Confidence            987642211 111223446778999999988899999999999999999997 8899865432    112222    111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      +...         .........+.+++.+||..+|++||+++++++.|+...
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         227 GERL---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111         011112345778899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=307.90  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=201.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||.|++|.||+|+..  +..+++|.+.... ......+.+|+.+++.++|+||+++.+.+.+...+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778899999999999999986  6789999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++...         .+++.....++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++..
T Consensus        81 ~~~~~L~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          81 CGGGSCLDLLKPG---------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             eCCCcHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999998643         38899999999999999999999   89999999999999999999999999999877


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....   .......++..|+|||.+.+..++.++|||||||++|||++|+.||.......    .   ... ...+.   
T Consensus       149 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~---~~~-~~~~~---  214 (274)
T cd06609         149 TSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----V---LFL-IPKNN---  214 (274)
T ss_pred             cccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----H---HHH-hhhcC---
Confidence            5321   11234568889999999998889999999999999999999999986543211    1   111 11111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        .+.+...   .....+.+++.+|++.+|++||+++++++
T Consensus       215 --~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 --PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              1111111   02345777889999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=317.60  Aligned_cols=201  Identities=25%  Similarity=0.352  Sum_probs=171.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999986  678999998752   2233456888999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .++......++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        81 e~~~g~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          81 DYYVGGDLLTLLSKFED-------RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             ecCCCCcHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence            99999999999864322       37888899999999999999999   999999999999999999999999999997


Q ss_pred             cccccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      .......  .......||+.|+|||++..     +.++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         151 RLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            6542211  11223469999999999863     45788999999999999999999999754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=305.71  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeec--ccchhhHHHHHHHHHHhccCCCceeeEeeeeee-----c
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-----R  386 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~  386 (644)
                      .....|...+.||+|+||.|+.++..  +..||+|++..  ...-..++-.+|+++|+.++|+||+.+.++...     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456666789999999999999887  78999999973  344456778899999999999999999998875     3


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      +.+|+|+|+| +-+|.+.++.+.        .|+......++.|++.||.|+|+   .+|+||||||+|+|++.+..+||
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~--------~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ--------DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc--------cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEe
Confidence            4689999999 778988886544        38888889999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-  544 (644)
                      +|||+||..... ......+..+-|..|.|||++. ...|+.+.||||.||++.||++|++-|.+.+.-.....+.+.+ 
T Consensus       167 ~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  167 CDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG  245 (359)
T ss_pred             ccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence            999999988654 2222247788999999999875 4579999999999999999999999887765433222222110 


Q ss_pred             ------HHHHhcCchhhhhh---cccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 ------WELRRKGRILDAAD---SRLGGE----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 ------~~~~~~~~~~~~~d---~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ............+.   ..-+..    ++ ......++|+.+|+..||.+|+|++|+++.
T Consensus       246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  01111001111110   000011    11 122345678899999999999999999863

>cd01951 lectin_L-type legume lectins

Probab=100.00  E-value=5.5e-36  Score=298.83  Aligned_cols=193  Identities=30%  Similarity=0.483  Sum_probs=162.5

Q ss_pred             CCCeEEe-ccccc--CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEe
Q 006446           39 RNELSFD-NSTVA--KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIA  115 (644)
Q Consensus        39 ~~~l~~~-~a~~~--~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~  115 (644)
                      ..++.+. +|.+.  ++.|+||++..     +++|+++|++||++|       ++|+|+|+|.|.+....+||||||+|+
T Consensus        13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~-----~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~~~~gdG~aF~l~   80 (223)
T cd01951          13 QSNWQLNGSATLTTDSGVLRLTPDTG-----NQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKGTNGADGIAFVLQ   80 (223)
T ss_pred             hhhcEEcccEEecCCCCEEEECCCCC-----CcEEEEEECCcEecc-------CCEEEEEEEEEeCCCCCCCCcEEEEEe
Confidence            3478898 99998  89999998765     799999999999998       789999999999755678999999999


Q ss_pred             cCCCCCCCCCC--cccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccce-------eeecCcccccC
Q 006446          116 GNKDLPENSEG--QWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSI-------RQVPLTRVNLA  185 (644)
Q Consensus       116 ~~~~~~~~~~g--~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~-------~~~~~~~~~l~  185 (644)
                      |....+.+..|  ++||.       ...++.+||||||++|.++ ||+.||||||+|+..+.       .+..+ +....
T Consensus        81 ~~~~~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~~-~~~~~  152 (223)
T cd01951          81 NDPAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASL-PNGTG  152 (223)
T ss_pred             cCCCCccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceeeC-CCccC
Confidence            96655555555  88886       3456889999999999875 99999999999998753       23333 22233


Q ss_pred             CCceEEEEEEEcC--ceEEEEEecC---CCCCcccccCccCcCCCceeeeecccCCCcccccccccccccC
Q 006446          186 NGTDIKVQVRYDG--QNITVFVANM---ETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDG  251 (644)
Q Consensus       186 ~g~~~~~~I~Y~~--~~l~v~~~~~---~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~s  251 (644)
                      +|+.++|||+|++  +.|+|++...   ..+.++.++||+..++++||||||||||...+.|+|++|+|..
T Consensus       153 ~g~~~~v~I~Y~~~~~~L~v~l~~~~~~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~  223 (223)
T cd01951         153 LGNEHTVRITYDPTTNTLTVYLDNGSTLTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS  223 (223)
T ss_pred             CCCEEEEEEEEeCCCCEEEEEECCCCccccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence            4999999999996  8899998643   4579999999999999999999999999999999999999963

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.8e-36  Score=305.19  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=195.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-----chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  389 (644)
                      .+|+..++||+|+||.||+|...  +..|++|++....     ....+.+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999876  6789999885321     22345788899999999999999999988763  457


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++++|.+++....        .+++...++++.|++.||+|||+   .+++|+||||+||+++.++.+||+||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--------ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcC
Confidence            89999999999999986432        27788889999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++................++..|+|||.+.+..++.++|||||||++|||++|+.||......   ..+.    ....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~----~~~~  223 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIF----KIAT  223 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHH----HHhc
Confidence            99986542211111123456889999999998888999999999999999999999998653211   1111    1100


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .         ......+......+.+++.+|+. +|++||+++++++
T Consensus       224 ~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 Q---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0         01122333444566778888885 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-36  Score=310.11  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .+|+..+.||+|+||+||++...  +..+|+|++.... ....+.+.+|+++++.++||||+++++.+.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            35667889999999999999886  7789999886543 34457889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++....        .+++.....++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++...
T Consensus        85 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          85 MDCGSLDRIYKKGG--------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             CCCCCHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            99999999885432        38899999999999999999996  247999999999999999999999999998754


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc----chhhHHHHHHHHHhcC
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS----YNNSIVHWLWELRRKG  551 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~----~~~~l~~~~~~~~~~~  551 (644)
                      ....     .....|+..|+|||.+.++.++.++|||||||++||+++|+.||.......    ....+.++........
T Consensus       155 ~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         155 INSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             hhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence            3211     234578999999999988889999999999999999999999997644321    1112222222221110


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                            .+.+..   ......+.+++.+|+++||++||++.|+++..
T Consensus       230 ------~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ------PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ------CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                  111111   11334577899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-36  Score=310.89  Aligned_cols=245  Identities=25%  Similarity=0.443  Sum_probs=198.3

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      |+..+.||+|+||.||+|.+.  +..||+|.+.... ....+.+..|+.++++++||||+++++++..+...++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445678999999999999875  6789999887443 3445678899999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++...         .+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        86 ~~~L~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          86 GGSALDLLKPG---------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCcHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999988432         37899999999999999999998   8999999999999999999999999999986542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...   ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......    ...   . ...+      
T Consensus       154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~---~-~~~~------  216 (277)
T cd06642         154 TQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VLF---L-IPKN------  216 (277)
T ss_pred             cch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HHh---h-hhcC------
Confidence            211   1223467889999999998889999999999999999999999986533211    111   0 0111      


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                         ............+.+++.+|++.+|.+||++.++++.
T Consensus       217 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 ---SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               1112222334567889999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-36  Score=344.98  Aligned_cols=264  Identities=24%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||+|+..  ++.||+|++....   ....++|.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999886  6889999987532   223567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCC---CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNS---GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ||+++|+|.+++.......   ......+++..+++++.||++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986422111   1112346788899999999999999999   899999999999999999999999999


Q ss_pred             Ccccccccccc---------------cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          471 LARTIQENLKT---------------HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       471 la~~~~~~~~~---------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      +++........               ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99866211000               000123569999999999999999999999999999999999999997532211


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhC
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-SMKTVLQVLSG  600 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~  600 (644)
                          +..   .    ........  . .. ..+....+.+++.+|++.||++|| +++++++.|+.
T Consensus       239 ----i~~---~----~~i~~P~~--~-~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ----ISY---R----DVILSPIE--V-AP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             ----hhh---h----hhccChhh--c-cc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                110   0    00000000  0 00 012234567788999999999996 56667766654

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5e-36  Score=308.19  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=204.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+|+..       ...+++|.+...... ..+++..|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46888899999999999999864       356899988654433 4577999999999999999999999999989999


Q ss_pred             EEEeccCCCccchhhhccCCCCC-CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSG-PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      +||||+++|+|.+++........ .....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999975442111 112248999999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++.......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....    ..+..    ..
T Consensus       162 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~----~~  231 (275)
T cd05046         162 SLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLN----RL  231 (275)
T ss_pred             ccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHH----HH
Confidence            99875432111  11233456778999999988889999999999999999999 7788864322    11111    11


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ..+...        ..........+.+++.+|++.+|++||++.++++.|..
T Consensus       232 ~~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QAGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HcCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111111        11112233568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=303.09  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||++...  ++.+++|.+........+.+..|+.++++++||||+++++.+..+..++++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999885  5789999998765556788999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....       .++..+...++.|++.||.|||+   .+++||||||+||++++++.+||+|||++....
T Consensus        83 ~~~~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          83 GGGSLQDIYQVTRG-------PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             CCCcHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999998865422       38889999999999999999998   899999999999999999999999999998654


Q ss_pred             ccccccccccccccCCCccCccccccC---CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVG---RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ....   ......++..|+|||.+...   .++.++|||||||++|||++|+.|+.......   ....    . .....
T Consensus       153 ~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~----~-~~~~~  221 (262)
T cd06613         153 ATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFL----I-SKSNF  221 (262)
T ss_pred             hhhh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----H-HhccC
Confidence            3211   12345688899999998776   78999999999999999999999987543211   1111    0 01100


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         ....+  .........+.+++.+|++.+|.+||++.++++
T Consensus       222 ---~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 ---PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               00001  112233456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=292.04  Aligned_cols=265  Identities=24%  Similarity=0.277  Sum_probs=208.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeee--cCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----ce
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----DF  389 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~  389 (644)
                      ..++|.+.++||+|||+-||.++.  .++.+|+|++...+.++.+..++|++.-++++|||++++++++..+.     +.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346888899999999999999874  37789999999888888899999999999999999999999887544     48


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ||+++|...|||.+.+......    ...++..+.++|+.++.+||++||+. ..+..||||||.|||+.+++.++|.||
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~k----g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIK----GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhc----CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence            9999999999999998654332    22489999999999999999999983 246999999999999999999999999


Q ss_pred             CCcccccccccccc------cccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          470 GLARTIQENLKTHH------STKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       470 Gla~~~~~~~~~~~------~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      |.++...-......      .-.....|..|.|||++..   ...++++|||||||+||+|+.|..||+...+..     
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-----  248 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-----  248 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence            99986542211111      0122356899999999864   456899999999999999999999997543211     


Q ss_pred             HHHHHHHHhcCchhhhhh-cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          541 VHWLWELRRKGRILDAAD-SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                                |.+.-++. ..+.-.-...-.+.+.+++.+|++.||.+||++.+++..++..
T Consensus       249 ----------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  249 ----------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                      11111111 1111111112456788899999999999999999999988653

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-35  Score=305.75  Aligned_cols=246  Identities=24%  Similarity=0.430  Sum_probs=201.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .|+..++||+|+||.||+|...  +..||+|.+.... ......+..|+.++++++|+||+++++.+.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999875  6789999987543 345677889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++...         .+++.+...++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~~~~L~~~i~~~---------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          85 GGGSALDLLRAG---------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCcHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999988532         27888899999999999999998   899999999999999999999999999997664


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......++..|+|||.+.+..++.++|||||||++|||++|..|+.......    ..   . ..        
T Consensus       153 ~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~---~-~~--------  213 (277)
T cd06640         153 DTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL---F-LI--------  213 (277)
T ss_pred             CCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh---h-hh--------
Confidence            3211   1233467889999999988889999999999999999999999987543211    11   0 00        


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       ...............+.+++.+||+.+|++||++.++++.
T Consensus       214 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             1111123334455678899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9e-36  Score=304.58  Aligned_cols=251  Identities=28%  Similarity=0.425  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeeccc------chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETS------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +|+..+.||+|+||.||+|... +..+|+|.+....      ....+.+.+|+.++++++|+||++++++|.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677899999999999999875 6789999886432      12235688899999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+++++|.+++....        .+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++
T Consensus        81 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          81 MEFVPGGSISSILNRFG--------PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             EecCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999999986432        27889999999999999999998   89999999999999999999999999999


Q ss_pred             cccccccc---ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          473 RTIQENLK---THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       473 ~~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +.......   .........++..|+|||.+.+..++.++|||||||++|||++|+.||.......   ....   ....
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~  223 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFY---IGAH  223 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHH---hhhc
Confidence            86532111   1111234568899999999998889999999999999999999999996543211   0100   0000


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+.     .+.+    +......+.+++.+|++++|.+||++.++++
T Consensus       224 ~~~-----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 RGL-----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cCC-----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000     1112    2223345678899999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-36  Score=317.25  Aligned_cols=254  Identities=21%  Similarity=0.249  Sum_probs=192.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||+++..  +..+|+|++.+..   ......+..|+.++..++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999987  5679999986432   223445788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ey~~~g~L~~~l~~~~~-------~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          81 DYYVGGDLLTLLSKFED-------RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             eccCCCcHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence            99999999999965332       38888999999999999999999   999999999999999999999999999997


Q ss_pred             cccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      .......  .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||.......       ......
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~  221 (332)
T cd05623         151 KLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIM  221 (332)
T ss_pred             ecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------HHHHHh
Confidence            6532211  1123457999999999986     3467899999999999999999999997543211       111111


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHP--NPHLRPSMKTVLQV  597 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~--dP~~RPs~~evl~~  597 (644)
                      ......     ..... .......+.+++.+|+..  ++..|++++++++.
T Consensus       222 ~~~~~~-----~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKERF-----QFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccc-----cCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111000     01110 011233455666676654  44447899998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-35  Score=302.15  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E  394 (644)
                      +|+..+.||+|++|.||+++..  ++.+++|++....  ....+.+..|+.++++++|+|++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999876  5789999986542  3445678899999999999999999998764 446799999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++.....      ..+++.++..++.+++.||+|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~~l~~~l~~~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~  151 (257)
T cd08223          81 FCEGGDLYHKLKEQKG------KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV  151 (257)
T ss_pred             ccCCCcHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEE
Confidence            9999999999865322      138899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......   ......+++.|+|||.+.+..++.++||||||++++||++|+.||...+..       ...... ..+.. 
T Consensus       152 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~-  219 (257)
T cd08223         152 LENQCD---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRI-IEGKL-  219 (257)
T ss_pred             ecccCC---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHH-HhcCC-
Confidence            642211   123456889999999999989999999999999999999999998753321       111111 11111 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                              ...+......+.+++.+|++++|++||++.++++.
T Consensus       220 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 --------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    11222334567889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-35  Score=302.40  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=201.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|+||.||.++..  +..+++|.+...  .....+++.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999998888765  678999988653  344567789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....      ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        81 ~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          81 ANGGTLYDKIVRQKG------QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             cCCCcHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            999999999865421      148899999999999999999998   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+       ..... ..+... 
T Consensus       152 ~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~-~~~~~~-  219 (256)
T cd08221         152 GSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVVKI-VQGNYT-  219 (256)
T ss_pred             ccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH-HcCCCC-
Confidence            43221   1234568999999999988888999999999999999999999986543211       11111 111111 


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                              .........+.+++.+|++.+|.+||++.++++.
T Consensus       220 --------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 --------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                    1112233457788999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.9e-36  Score=309.07  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=198.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|++|.||+|++.  ++.||+|++....  ....+.+.+|+.++++++|+|++++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788899999999999999986  6789999986542  2234568899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|..++....        .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          81 YCDHTVLNELEKNPR--------GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             ccCccHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECcccccee
Confidence            999988887764322        38999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH-------
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE-------  546 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~-------  546 (644)
                      ......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......       
T Consensus       150 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07847         150 LTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  226 (286)
T ss_pred             cCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            653221   1233457889999999875 45789999999999999999999999764432111111110000       


Q ss_pred             HHhcCchh-hhhhcccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRIL-DAADSRLGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~-~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ........ ....+......+     ......+.+++.+|++++|++||++.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000000 000000000000     112355778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=334.47  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=192.2

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCC------CceeeEeeeeee
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH------RNLVKLIGWCYE  385 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~g~~~~  385 (644)
                      +...+++|+..++||+|+||+||+|.+.  +..||||+++.... ..+++..|+.++++++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999886  67899999865332 23455667777777654      458889998876


Q ss_pred             c-cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC--
Q 006446          386 R-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF--  462 (644)
Q Consensus       386 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~--  462 (644)
                      . ..+++|||++ +++|.+++....        .+++..+..|+.||+.||.|||+  +.+|+||||||+|||++.++  
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~--------~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG--------PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcc
Confidence            4 4789999998 788888886432        38899999999999999999996  14899999999999998765  


Q ss_pred             --------------cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          463 --------------NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       463 --------------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                                    .+||+|||.+.....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                          499999998864321      134568999999999999999999999999999999999999999


Q ss_pred             CCCccccchhhHHH--------HHHH--------HHh-cCchhhhhhcc-----cCCC--CCHHHHHHHHHHHHHhcCCC
Q 006446          529 NQSEQNSYNNSIVH--------WLWE--------LRR-KGRILDAADSR-----LGGE--FSEKEMECVLILGLACCHPN  584 (644)
Q Consensus       529 ~~~~~~~~~~~l~~--------~~~~--------~~~-~~~~~~~~d~~-----l~~~--~~~~~~~~l~~L~~~Cl~~d  584 (644)
                      ......+....+..        |...        +.. .+.+....++.     ....  ........+.+|+.+||+.|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            76543221111111        1000        000 00000000000     0000  00012345778999999999


Q ss_pred             CCCCCCHHHHHH
Q 006446          585 PHLRPSMKTVLQ  596 (644)
Q Consensus       585 P~~RPs~~evl~  596 (644)
                      |++|||++|+++
T Consensus       426 P~~R~ta~e~L~  437 (467)
T PTZ00284        426 RQKRLNARQMTT  437 (467)
T ss_pred             hhhCCCHHHHhc
Confidence            999999999997

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-35  Score=303.67  Aligned_cols=254  Identities=19%  Similarity=0.344  Sum_probs=188.9

Q ss_pred             CcccccCcEEEEEeeec-C---ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          325 NKLGKGGFGTVYKGIWR-N---KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      +.||+|+||.||+|... +   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999754 2   246677765443 334578999999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      +|.+++......    ...+.+.....++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~L~~~l~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          81 DLKSYLSQEQWH----RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             cHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            999999754321    1136677788999999999999998   899999999999999999999999999986432111


Q ss_pred             cccccccccccCCCccCcccccc-------CCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLV-------GRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~-------~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      . ........++..|+|||++..       ..++.++|||||||++|||++ |..||......    ....   .... +
T Consensus       154 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~---~~~~-~  224 (268)
T cd05086         154 Y-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----EVLN---HVIK-D  224 (268)
T ss_pred             h-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HHHh-h
Confidence            1 111234567889999998753       245789999999999999997 56677543321    1111   1111 1


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ......++.+...++    +.+.+++..|| .+|++||++++|++.|.
T Consensus       225 ~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 QQVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            112223333333333    34566778899 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.8e-36  Score=309.77  Aligned_cols=265  Identities=25%  Similarity=0.308  Sum_probs=195.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|++|.||+|+..  +..||+|+++...  ....+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999986  6789999986532  22346788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....     ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          81 LS-MDLKKYLDSLPK-----GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             CC-CCHHHHHhcCCC-----CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            96 788888754322     1248899999999999999999999   89999999999999999999999999999765


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH----HHHhc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----ELRRK  550 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~----~~~~~  550 (644)
                      ....   .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.................    ..+..
T Consensus       152 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         152 GIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             CCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence            4221   112334578899999987654 578999999999999999999999976432211111110000    00000


Q ss_pred             CchhhhhhcccC----CC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLG----GE---FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~----~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ............    ..   ........+.+++.+|++.||++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000    00   00012235568999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-36  Score=318.70  Aligned_cols=261  Identities=20%  Similarity=0.270  Sum_probs=194.4

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec-----
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----  386 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----  386 (644)
                      ...++|+..+.||+|+||.||++...  +..||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578899999999999999999875  6789999986532  22345677899999999999999999987543     


Q ss_pred             -cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          387 -HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       387 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                       ...++++|++ +++|.+++...         .+++..+..++.|+++||.|||+   .+|+||||||+|||+++++.+|
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ---------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEE
Confidence             3579999998 88998877421         38899999999999999999999   9999999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      |+|||+++.....      .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       159 l~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07878         159 ILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV  232 (343)
T ss_pred             EcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999865421      234578999999999876 568999999999999999999999997543211111111100


Q ss_pred             -------HHHHhcCchhhhhhcccCCCCCH--------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 -------WELRRKGRILDAADSRLGGEFSE--------KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 -------~~~~~~~~~~~~~d~~l~~~~~~--------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                             ............ ...+. ..+.        .....+.+++.+|++.||.+|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         233 GTPSPEVLKKISSEHARKY-IQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCCHHHHHhcchhhHHHH-hhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   000000000000 00000 0000        012246789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=332.86  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=209.1

Q ss_pred             CCCCCcccccCcEEEEEeeec------CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ....++||+|+||+||||.+-      +-+||+|++... ..+...++++|+.+|.+++|||+++|+|+|.... +.||.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445789999999999999884      346999998654 4556789999999999999999999999998765 89999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      +|||.|+|.+|++.++..       +.-...+.+..|||+||.|||+   ++++||||.++||||.+-..+|+.|||+++
T Consensus       777 q~mP~G~LlDyvr~hr~~-------igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDN-------IGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             HhcccchHHHHHHHhhcc-------ccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhh
Confidence            999999999999877654       7778889999999999999998   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .+...... .......-.+.|||-|.+....++.++|||||||++||++| |..|++.....+.        -++.+.|.
T Consensus       847 ll~~d~~e-y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------~dlle~ge  917 (1177)
T KOG1025|consen  847 LLAPDEKE-YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------PDLLEKGE  917 (1177)
T ss_pred             ccCccccc-ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------hHHHhccc
Confidence            88744332 22444455778999999999999999999999999999999 9999887654322        22223332


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                             ||  .-++.....+..++.+||..|+..||+++++.....+-+
T Consensus       918 -------RL--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 -------RL--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             -------cC--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                   12  223344456777889999999999999999988876643

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-36  Score=313.37  Aligned_cols=264  Identities=25%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|.+.  ++.+|+|++....  ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36778899999999999999986  6789999876432  2235678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|..+.....        .++|.+++.++.|+++||+|||+   .+++||||+|+||++++++.+||+|||++..
T Consensus        81 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          81 FVDHTVLDDLEKYPN--------GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             cCCccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            999999988764322        28999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC-c
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG-R  552 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-~  552 (644)
                      ......   ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+....+..+........ .
T Consensus       150 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (286)
T cd07846         150 LAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE  226 (286)
T ss_pred             ccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence            643221   1234567899999998865 4578899999999999999999999865432111111111110000000 0


Q ss_pred             hh---hhhhcccCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 IL---DAADSRLGGEF---------SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~---~~~d~~l~~~~---------~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..   ...+.....+.         .......+.+++.+|++.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00   00000000000         0122456888999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.5e-36  Score=306.51  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=198.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||+|+..  +..||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            35667788999999999999875  6789999987665555567889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++....        .+++.+...++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        89 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          89 GGGSLQDIYHVTG--------PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999885432        38899999999999999999999   899999999999999999999999999987654


Q ss_pred             ccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ...   .......|+..|+|||.+.   .+.++.++|||||||++|||++|+.||....+...   +    ... .....
T Consensus       158 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~----~~~-~~~~~  226 (267)
T cd06645         158 ATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---L----FLM-TKSNF  226 (267)
T ss_pred             Ccc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---H----Hhh-hccCC
Confidence            221   1133457899999999874   45688999999999999999999999865432111   1    000 01110


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .   .+.+....  ...+.+.+++.+|++.+|++||+++++++
T Consensus       227 ~---~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 Q---PPKLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             C---CCcccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   01111100  11234678899999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-35  Score=301.63  Aligned_cols=250  Identities=30%  Similarity=0.538  Sum_probs=201.0

Q ss_pred             CCCCCcccccCcEEEEEeeecC------ceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      |+..+.||.|+||.||+++...      ..||+|++...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999874      67999999765433 5678999999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++......      .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++
T Consensus        81 e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK------ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             eccCCCCHHHHHHhhhhc------cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCce
Confidence            999999999998654321      18899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ........ . .....++..|+|||.+....++.++||||+|++++||++ |+.||.....    ..+.+.+    ..+.
T Consensus       152 ~~~~~~~~-~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~----~~~~  221 (258)
T smart00219      152 DLYDDDYY-K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYL----KKGY  221 (258)
T ss_pred             eccccccc-c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----hcCC
Confidence            76532111 1 112347789999999988889999999999999999998 7888765322    1122211    1111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                      .         ..........+.+++.+|++.||++|||+.++++.|
T Consensus       222 ~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 R---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1         111112345677899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=311.83  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=199.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|++|.||++...  +..+|+|.+.....   ...+.+..|+.++++++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999886  68899999876432   24567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++.....      ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        81 e~~~~~~L~~~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          81 DYCPGGELFRLLQRQPG------KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             EecCCCCHHHHHHhCCC------CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence            99999999999864322      148899999999999999999999   899999999999999999999999999987


Q ss_pred             ccccccccc--------------------------ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 006446          474 TIQENLKTH--------------------------HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP  527 (644)
Q Consensus       474 ~~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P  527 (644)
                      .........                          .......|+..|+|||++.+..++.++||||||+++|||++|+.|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            653211000                          001234688999999999988899999999999999999999999


Q ss_pred             CCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 006446          528 GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS----MKTVLQ  596 (644)
Q Consensus       528 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs----~~evl~  596 (644)
                      |.......   .+..    .         .+..............+.+++.+|++.||++||+    ++++++
T Consensus       232 f~~~~~~~---~~~~----~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         232 FKGSNRDE---TFSN----I---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCchHH---HHHH----H---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            87543221   1110    0         1111111111114567888999999999999999    555555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.3e-36  Score=313.39  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|...++||+|+||.||+|+..  +..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999886  6789999987543 22345678899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....       .+++.....++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        86 ~~-~~l~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          86 LD-KDLKQYLDDCGN-------SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             cc-cCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            96 689888864432       37889999999999999999999   99999999999999999999999999999764


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-------HHHH
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-------LWEL  547 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-------~~~~  547 (644)
                      .....   ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+...       .|..
T Consensus       155 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         155 SIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             CCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence            32111   12334578899999987654 5788999999999999999999999765432111111110       0000


Q ss_pred             H-hcCchhhhhhcccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 R-RKGRILDAADSRLGGEF----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~-~~~~~~~~~d~~l~~~~----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      . ..........+......    .......+.+|+.+|++.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0 00000000000000000    0112234678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.5e-36  Score=302.64  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..++||+|+||.||+++..  ++.+++|++...  .....+++..|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999875  678999998653  233456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++......      .+++.+++.++.|++.||.|||+   .+++|+||+|+|||++.++.++|+|||++...
T Consensus        81 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          81 CEGGDLYKKINAQRGV------LFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            9999999988643221      37889999999999999999998   89999999999999999999999999999866


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ......   .....|+..|+|||++.+..++.++|||||||+++||++|+.||......       +.+... ..+..  
T Consensus       152 ~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~--  218 (256)
T cd08218         152 NSTVEL---ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------NLVLKI-IRGSY--  218 (256)
T ss_pred             Ccchhh---hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------HHHHHH-hcCCC--
Confidence            432111   22346888999999999888999999999999999999999998654321       111111 11111  


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                             ...+......+.+++.+|++.+|.+||++++|++
T Consensus       219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 -------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                   1122223445788999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-36  Score=302.13  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=200.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCc-eeeEeeeeeecc------c
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRN-LVKLIGWCYERH------D  388 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------~  388 (644)
                      .|+..++||+|+||+||+|+..  +..||+|+++....+  .-....+|+.++++|+|+| ||++.+++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4555778999999999999887  778999999866442  2345689999999999999 999999999877      7


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++|+||+ .-+|..++.......    ..++-.....++.|++.||+|||+   ++|+||||||.||||+++|.+||+|
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~----~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKP----QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeec
Confidence            89999999 779999996544211    236668889999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+|+...-...   ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+   .+. -+.+.
T Consensus       164 FGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~-~If~~  236 (323)
T KOG0594|consen  164 FGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLF-RIFRL  236 (323)
T ss_pred             cchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHH-HHHHH
Confidence            999997652222   14567889999999998876 68999999999999999999888887654321   121 12222


Q ss_pred             HhcCc------hhhhhhcc--cC-----CCCCHHHH---HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGR------ILDAADSR--LG-----GEFSEKEM---ECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~------~~~~~d~~--l~-----~~~~~~~~---~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .....      +....+-+  .+     ..+...+.   ....+++.+|++.+|.+|.|++.++++
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22110      00001100  00     01111111   357789999999999999999999985

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-35  Score=306.83  Aligned_cols=264  Identities=23%  Similarity=0.288  Sum_probs=197.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-----hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-----GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +|+..+.||+|++|.||+|...  ++.|++|++......     ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999976  679999999765322     234567899999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+ +|+|.+++.....       .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        81 ~e~~-~~~L~~~i~~~~~-------~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSI-------VLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             Eccc-CCCHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceee
Confidence            9999 9999999864431       38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH----HH
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----EL  547 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~----~~  547 (644)
                      +.......   ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...........+.....    ..
T Consensus       150 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         150 RSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             eeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence            87643211   1233456788999998854 4578999999999999999999877765432111111111000    00


Q ss_pred             H-hcCchhhhhhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 R-RKGRILDAADSRLGGEF-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~-~~~~~~~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      + .................     .......+.+++.+|+++||++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0 00000000000000111     11224567889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-35  Score=306.82  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +|+..+.||+|+||.||++...  +..+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5777899999999999999986  788999988654 3334567889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|..++.....     ...+++..+..++.++++||.|||+  ..+++||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          82 DAGSLDKLYAGGVA-----TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CCCCHHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999998864311     1138999999999999999999996  2589999999999999999999999999997653


Q ss_pred             ccccccccccccccCCCccCccccccCC------CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGR------ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~------~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ...     .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||.......    ...-... ...
T Consensus       155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~-~~~  224 (286)
T cd06622         155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSA-IVD  224 (286)
T ss_pred             CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHH-Hhh
Confidence            211     23346788999999985543      4889999999999999999999996543211    1110000 001


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.         ....+......+.+++.+|++.+|++||+++++++
T Consensus       225 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 GD---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cC---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11         11223334456778999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.3e-36  Score=315.21  Aligned_cols=200  Identities=19%  Similarity=0.280  Sum_probs=164.9

Q ss_pred             CCCccccc--CcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          323 PKNKLGKG--GFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       323 ~~~~LG~G--~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ..++||+|  +|++||+++..  +..||+|++....  ....+.+.+|+.+++.++||||++++++|..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  78999999886  6789999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++......      .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.+....
T Consensus        82 ~~~~l~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          82 AYGSAKDLICTHFMD------GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             CCCcHHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            999999998643221      38899999999999999999999   899999999999999999999999998765432


Q ss_pred             ccccccc----cccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          477 ENLKTHH----STKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       477 ~~~~~~~----~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      .......    ......++..|+|||++..  ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            1111100    0122356778999999875  45889999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-35  Score=300.38  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=199.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|++|.||++...  +..+|+|++...  .....+.+..|+.++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999998875  678999998654  233457788999999999999999999999988999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEeccCCccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLART  474 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~  474 (644)
                      +++++|.+++.....      ..+++..+..++.+++.+|.|||+   ++++||||||+||+++.+ +.+||+|||++..
T Consensus        81 ~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          81 APGGTLAEYIQKRCN------SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             CCCCCHHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            999999999965332      137899999999999999999999   899999999999999865 4689999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......    .....++..|+|||.+....++.++||||||+++|||++|+.||......    .....   ... +.  
T Consensus       152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~---~~~-~~--  217 (256)
T cd08220         152 LSSKSK----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLK---IMS-GT--  217 (256)
T ss_pred             cCCCcc----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHH---HHh-cC--
Confidence            643211    23356888999999999888999999999999999999999998664321    11111   110 11  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                             ...........+.+++.+|++++|.+||+++++++.
T Consensus       218 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 -------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   011112233457788999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-35  Score=302.97  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec---CceEEEEEeecc----------cchhhHHHHHHHHHHhc-cCCCceeeEeeeeee
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSET----------SRQGKQEFIAEVTTIGS-LRHRNLVKLIGWCYE  385 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~  385 (644)
                      +|+..+.||+|+||.||+|.+.   +..+|+|++...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4777889999999999999986   467999987532          22234567789988875 799999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      ++..+++|||+++++|.+++......    ...+++..+++++.|++.||.|||+  ..+++||||||+||+++.++.+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK----KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEE
Confidence            99999999999999999987532211    1238899999999999999999995  26799999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+|||++.......    ......|+..|+|||.+.++.++.++||||||+++|||++|+.||......    ....   
T Consensus       155 l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~---  223 (269)
T cd08528         155 ITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLAT---  223 (269)
T ss_pred             Eecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHH---
Confidence            99999998764322    134456889999999999888999999999999999999999998653321    1111   


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      .. ..+....        .........+.+++.+|++.||++||++.|+..+|+
T Consensus       224 ~~-~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KI-VEAVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HH-hhccCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11 1111110        001112345778899999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-35  Score=303.68  Aligned_cols=258  Identities=27%  Similarity=0.435  Sum_probs=198.9

Q ss_pred             CCCCCcccccCcEEEEEeeec-----CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      |...+.||+|+||.||+|.+.     +..+|+|++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999864     467999998654  2334567889999999999999999999886532      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++++||+++|+|..++.......  ....+++...++++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGE--EPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEEC
Confidence            2478999999999998875432211  12248899999999999999999998   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++........ .......++..|++||.+....++.++|||||||++|||++ |+.||.....    ..+..+.. 
T Consensus       156 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~-  229 (273)
T cd05074         156 DFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLI-  229 (273)
T ss_pred             cccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHH-
Confidence            99999866422111 11223345678999999988889999999999999999999 8888865432    12222211 


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                         .+..       +  ..+......+.+++.+|++.+|++||++.++++.|++.
T Consensus       230 ---~~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 ---KGNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---cCCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               1110       0  01112335788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.3e-36  Score=308.33  Aligned_cols=263  Identities=22%  Similarity=0.341  Sum_probs=201.0

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeee-
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCY-  384 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~-  384 (644)
                      +.+..+..+.++|+..+.||+|+||.||+++..  ++.+|+|++.... ....++.+|+.+++++ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556667889999999999999999999886  6789999876532 2245678899999999 6999999999884 


Q ss_pred             ----eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          385 ----ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       385 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                          .++..++||||+++++|.+++......    ...+++..+..++.|+++||.|||+   .+++||||||+||++++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~  159 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR----GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTT  159 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhcc----CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECC
Confidence                335689999999999999987532111    1247889999999999999999999   89999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      ++.+||+|||+++.......   ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.......
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~  236 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR  236 (286)
T ss_pred             CCCEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence            99999999999986642211   1234568999999998753     447889999999999999999999987543211


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                         .+..    . ..+.     .+.+.  .+......+..++.+|++.||++||++.++++.
T Consensus       237 ---~~~~----~-~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 ---ALFK----I-PRNP-----PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---HHhh----c-cccC-----CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               1111    0 0000     00000  011112357788999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=309.59  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+|...  +..|++|+++..  .....+.+.+|++++++++|+||+++++.+..++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999986  678999988653  23345778999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++++.+..+.....        .+++.+...++.+++.||.|||+   .+++||||||+||++++++.+||+|||++..
T Consensus        81 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          81 YVERTLLELLEASPG--------GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             cCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            998877766553221        27899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh----
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR----  549 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~----  549 (644)
                      ......  .......++..|+|||++... .++.++||||||+++|||++|+.||...........+.........    
T Consensus       150 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         150 LRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             cCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence            653321  113345678899999999887 7899999999999999999999998754322111111110000000    


Q ss_pred             ----cCchh-----hhhhcc-cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 ----KGRIL-----DAADSR-LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ----~~~~~-----~~~d~~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .....     +..++. +...++......+.+++.+|++.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                00000     000000 000111122466888999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-35  Score=300.52  Aligned_cols=246  Identities=28%  Similarity=0.472  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-----chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +|+..+.||+|++|.||+|...  +..|++|.+....     .+..+.+..|+.++++++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677899999999999999986  6789999886543     23456788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+++++|.+++....        .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--------SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEecCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999986432        37899999999999999999999   89999999999999999999999999998


Q ss_pred             ccccccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      .......    ......++..|++||.+.... ++.++|+|||||++|||++|+.||......       ..........
T Consensus       150 ~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~  218 (258)
T cd06632         150 KQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSK  218 (258)
T ss_pred             eeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcc
Confidence            8654221    123456889999999987766 899999999999999999999998754311       1111111111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..         ..++......+.+++.+|++.+|.+||++.++++
T Consensus       219 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 EL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11         1122223355677889999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-35  Score=308.17  Aligned_cols=263  Identities=26%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeee
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE  385 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~  385 (644)
                      +.+.++..++++|+..+.||+|+||.||++...  ++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445566667889999999999999999999885  6789999986532 2345677899999998 89999999999875


Q ss_pred             c-----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          386 R-----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       386 ~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                      .     +..++|+||+++++|.+++......    ...+++..+..++.|++.||.|||+   .+++||||||+||+++.
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~  163 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC----GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTT  163 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcC
Confidence            4     3589999999999999988542211    1138899999999999999999998   89999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCccccccCC-----CCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR-----ATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      ++.+||+|||+++........   .....|+..|+|||.+....     ++.++|||||||++|||++|+.||.......
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             CCCEEEeecccchhccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            999999999999865422111   22346889999999876443     6899999999999999999999987543211


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                         .+..    .. .+..     +.+  .........+.+++.+|++.+|++||++.++++.
T Consensus       241 ---~~~~----~~-~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 ---TLFK----IP-RNPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ---HHHH----Hh-cCCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               1111    11 1111     011  0111223457889999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5e-36  Score=311.86  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             CCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      ....||+|+||.||++...  +..||+|++........+.+..|+.++++++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            3467999999999999875  67899999876665666778999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK  480 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~  480 (644)
                      |.+++...         .+++.+...++.||+.||.|||+   .+++||||||+||++++++.+||+|||++....... 
T Consensus       106 L~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-  172 (292)
T cd06658         106 LTDIVTHT---------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-  172 (292)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence            99987432         27889999999999999999999   899999999999999999999999999997653221 


Q ss_pred             ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcc
Q 006446          481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR  560 (644)
Q Consensus       481 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  560 (644)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......    ...   ...      ....+.
T Consensus       173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~---~~~------~~~~~~  237 (292)
T cd06658         173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ----AMR---RIR------DNLPPR  237 (292)
T ss_pred             --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---HHH------hcCCCc
Confidence              11234568899999999988889999999999999999999999987543211    111   000      011111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       561 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +..  .......+..++.+|++.||++||+++++++.
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  11123356678889999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-35  Score=303.69  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc----------hhhHHHHHHHHHHhccCCCceeeEeeeeeecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR----------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH  387 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~  387 (644)
                      +|...+.||+|+||.||+|...  +..+|+|.++....          ...+.+..|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999875  67899998754211          11246788999999999999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++|+||+++++|.+++....        .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG--------RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEe
Confidence            9999999999999999986542        38889999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |||+++..... ..........++..|+|||.+....  ++.++||||||+++||+++|+.||......       ....
T Consensus       151 d~~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~  222 (272)
T cd06629         151 DFGISKKSDDI-YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMF  222 (272)
T ss_pred             ecccccccccc-ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHH
Confidence            99999865421 1111123456889999999987654  789999999999999999999998643221       1111


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +....... .    .+...........+.+++.+|++++|++||++.+|++.
T Consensus       223 ~~~~~~~~-~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         223 KLGNKRSA-P----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             HhhccccC-C----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111110 0    11111112234567788899999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-35  Score=300.57  Aligned_cols=253  Identities=22%  Similarity=0.398  Sum_probs=200.6

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc------chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      +|+..+.||+|++|.||++...  +..+|+|.+....      ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999874  7889999986432      1234678899999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFG  470 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFG  470 (644)
                      |+||+++++|.+++....        .+++.....++.|++.||.|||+   .+++||||||+||+++.++ .+||+|||
T Consensus        81 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--------AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence            999999999999986432        37889999999999999999999   8999999999999998775 59999999


Q ss_pred             Cccccccccccc-ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTH-HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      ++.......... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||........    .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~  225 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIAS  225 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhc
Confidence            998765321111 112234688999999999888899999999999999999999999865432111    111111110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               .....+.+......+.+++.+|++.+|.+||++.++++
T Consensus       226 ---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ---------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                     01112333444566778999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-35  Score=300.52  Aligned_cols=254  Identities=28%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  393 (644)
                      +|+..+.||.|+||.||++...  +..+++|++...  .....+.+..|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999876  678999988643  23345678899999999999999999998764  34689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC--CCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS--EKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||+++++|.+++......    ...+++...+.++.+++.||.|||..+  ..+++||||||+||+++.++.+||+|||+
T Consensus        81 e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKE----RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             hhccCCCHHHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence            999999999998653211    124899999999999999999999332  38999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +........   ......++..|+|||.+....++.++||||||+++|+|++|+.||.....    ..+.+.    ...+
T Consensus       157 ~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~----~~~~  225 (265)
T cd08217         157 AKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASK----IKEG  225 (265)
T ss_pred             cccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHH----HhcC
Confidence            987653221   02234689999999999988899999999999999999999999876432    112211    1111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .         ...++......+.+++.+|++.+|++||++++|++.
T Consensus       226 ~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 K---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             C---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1         112233344677889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-35  Score=300.55  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=199.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|+||.||+|...  +..+++|.++....  ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999875  67899999876543  3567889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++....        .+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        81 ~~~~~L~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          81 CSGGTLEELLEHGR--------ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             CCCCcHHHHHhhcC--------CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999999986432        27888999999999999999999   89999999999999999999999999999876


Q ss_pred             ccccccccc-ccccccCCCccCccccccCC---CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          476 QENLKTHHS-TKEIAGTPGYMAPESFLVGR---ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       476 ~~~~~~~~~-~~~~~gt~~y~APE~~~~~~---~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ......... .....++..|+|||++....   .+.++||||||+++||+++|+.||......   ....   ..... +
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~---~~~~~-~  222 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIM---FHVGA-G  222 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHH---HHHhc-C
Confidence            533221111 12356788999999998766   889999999999999999999999754311   1111   11100 1


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ..+.+....  .....+.+++.+|++.+|++||++.++++
T Consensus       223 -----~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 -----HKPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----CCCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 011111111  11345678889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-35  Score=305.87  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=202.0

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeee
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE  385 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~  385 (644)
                      .++.++..+.+.|+..+.||+|+||.||+|...  +..+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466677777889999999999999999999985  6789999886543 3345688899999998 69999999999853


Q ss_pred             ------ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          386 ------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       386 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                            ....+++|||+++|+|.+++......      .+++..+..++.|++.||.|||+   .+++||||||+||+++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~  155 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN------ALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLT  155 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEC
Confidence                  35689999999999999998653321      37788889999999999999999   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                      +++.++|+|||++........   ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||......
T Consensus       156 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~  232 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM  232 (282)
T ss_pred             CCCCEEEeeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence            999999999999886542211   123456889999999875     345788999999999999999999998654321


Q ss_pred             cchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .   .+.    ....      ...+.+   ........+.+++.+||+.||.+||++.|+++
T Consensus       233 ~---~~~----~~~~------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 R---ALF----LIPR------NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h---hhh----hHhh------CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1   110    0000      001111   11122346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-35  Score=307.22  Aligned_cols=264  Identities=20%  Similarity=0.277  Sum_probs=199.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|...  +..+++|.++.....  ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999986  678999998754322  234567899999999999999999998877  789999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||++ ++|.+++.....       .+++...+.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        85 ~e~~~-~~L~~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~  153 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ-------PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLA  153 (293)
T ss_pred             ehhcC-cCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCce
Confidence            99996 589888865432       38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-------
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-------  544 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-------  544 (644)
                      +.......   ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+....       
T Consensus       154 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         154 REYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence            87653211   12344678899999988754 46899999999999999999999997654322211121110       


Q ss_pred             HHHHhc------CchhhhhhcccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 WELRRK------GRILDAADSRLGGEFSEK-EMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 ~~~~~~------~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      |.....      ..........+...+... ..+.+.+++.+|++.||++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            100000      000001111111222222 3456778999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.6e-36  Score=307.52  Aligned_cols=260  Identities=23%  Similarity=0.320  Sum_probs=194.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..++||+|+||.||+++..  +..+++|+++....  .....+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999986  77899999865422  2235678899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....       .+++.....++.||++||.|||+   .+++||||||+||+++.++++||+|||+++..
T Consensus        81 ~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          81 CD-QDLKKYFDSCNG-------DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             CC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            96 578777754322       38999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc--
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR--  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~--  552 (644)
                      .....   ......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.......   .....+........  
T Consensus       150 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~  223 (284)
T cd07839         150 GIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEE  223 (284)
T ss_pred             CCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH---HHHHHHHHHhCCCChH
Confidence            42211   12334678899999988764 46899999999999999999999865432211   11111111100000  


Q ss_pred             ----hhhhhhcc----cCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ----ILDAADSR----LGGE-----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ----~~~~~d~~----l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          ..+..+..    ....     ........+.+++.+|++.||.+|||++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                00000000    0000     01112345678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-36  Score=291.43  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--------hhhHHHHHHHHHHhcc-CCCceeeEeeeeeec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--------QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~  386 (644)
                      ...|...+.||.|..+.|-++.++  +++.|+|++.....        .-.+.-..|+.+|+++ .||+|+++.+++...
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            457888999999999999998876  78899999864321        1223456799999998 699999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ..+++|+|.|+.|-|.++|...-        +++..+..+|+.|+.+|+.|||.   .+||||||||+|||+|++.++||
T Consensus        96 sF~FlVFdl~prGELFDyLts~V--------tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~i  164 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV--------TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKI  164 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe--------eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEE
Confidence            99999999999999999995443        58999999999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccC------CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG------RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +|||.++.+.+..+    ....+||++|+|||.+...      .|+...|.|++||+||-|+.|.+||-...      ++
T Consensus       165 sDFGFa~~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qm  234 (411)
T KOG0599|consen  165 SDFGFACQLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QM  234 (411)
T ss_pred             eccceeeccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HH
Confidence            99999998874432    4678999999999988643      47889999999999999999999986432      12


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.  ..+..+|+..      +..+-=.+....+.+|+.+|++.||++|.|++|+++
T Consensus       235 lM--LR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  235 LM--LRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HH--HHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            21  2222333320      011111133455778999999999999999999974

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-35  Score=306.60  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=200.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|++|.||+|+..  +..|++|++....  ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677899999999999999975  6789999987654  33456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      + +++|.+++.....       .+++.++..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~-~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          81 M-PSDLSEVLRDEER-------PLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             c-CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            9 9999999865432       38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch-
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI-  553 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-  553 (644)
                      .....  .......++..|+|||.+.+. .++.++||||+||++|||++|++||.......    ...++......... 
T Consensus       150 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~  223 (286)
T cd07832         150 SEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEE  223 (286)
T ss_pred             cCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChH
Confidence            53221  113345689999999998654 46899999999999999999987776543211    11111111110000 


Q ss_pred             --------h---hhhhcccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 --------L---DAADSRLG----GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 --------~---~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                              .   ....+.-.    .+...+....+.+++.+|++++|++||+++++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    0   00000000    00011223677889999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=306.65  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=194.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|++|.||+|+..  +..||+|.+...... ....+.+|+.++++++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999886  678999998754322 234567899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....       .+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~-~~L~~~~~~~~~-------~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LD-TDLKQYMDDCGG-------GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CC-CCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECcccccccc
Confidence            97 589988865432       37889999999999999999999   89999999999999999999999999998754


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc--
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR--  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~--  552 (644)
                      .....   ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......  . ...-.+.......  
T Consensus       154 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~-~~~~~~~~~~~~~~~  227 (291)
T cd07844         154 SVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--D-QLHKIFRVLGTPTEE  227 (291)
T ss_pred             CCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--H-HHHHHHHhcCCCChh
Confidence            32111   1122346889999998865 457899999999999999999999986543111  1 1111111110000  


Q ss_pred             h-hhh------hh--------cccCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 I-LDA------AD--------SRLGGEFS-EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~-~~~------~d--------~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      . ...      ..        ..+..... ......+.+++.+|++++|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0 000      00        00000000 001245678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-35  Score=305.77  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|...+.||+|+||.||++...  +..+++|.+........+.+..|+.++++++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888999999999999999864  6789999987655555678899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++...         .+++.++..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        99 ~~~~L~~~~~~~---------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          99 AGGSLTDVVTET---------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CCCcHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999998532         27889999999999999999999   899999999999999999999999999987654


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   ......++..|+|||.+..+.++.++|||||||++||+++|+.||........   +.    .....+.    
T Consensus       167 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~----~~~~~~~----  232 (293)
T cd06647         167 PEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LY----LIATNGT----  232 (293)
T ss_pred             cccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---ee----ehhcCCC----
Confidence            3211   12334688899999999888899999999999999999999999976433211   00    0000000    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                        +.  ..........+.+++.+||+.+|++||++.++++.
T Consensus       233 --~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 --PE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00  01112233457789999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-35  Score=309.33  Aligned_cols=244  Identities=26%  Similarity=0.406  Sum_probs=196.3

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ...||+|+||.||++...  +..||+|++........+.+.+|+.+++.++||||+++++.+..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            457999999999999875  788999998765555567788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      ..++...         .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........ 
T Consensus       106 ~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-  172 (297)
T cd06659         106 TDIVSQT---------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-  172 (297)
T ss_pred             HHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence            9877431         27899999999999999999998   8999999999999999999999999999876542211 


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......    ...   .. ....     ....
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~---~~-~~~~-----~~~~  237 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMK---RL-RDSP-----PPKL  237 (297)
T ss_pred             --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---HH-hccC-----CCCc
Confidence              1234568899999999998889999999999999999999999987543211    111   11 0100     0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                        .........+.+++.+|++.+|++||++.++++.
T Consensus       238 --~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 --KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0011122456778899999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3e-35  Score=307.68  Aligned_cols=257  Identities=22%  Similarity=0.290  Sum_probs=201.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||++...  ++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999887  5789999987653   233467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++.....++.++++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        81 e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          81 EYVEGGDCATLLKNIG--------ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             ecCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            9999999999995432        37899999999999999999999   899999999999999999999999999987


Q ss_pred             ccccccc------------ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          474 TIQENLK------------THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       474 ~~~~~~~------------~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      .......            .........++..|+|||.+....++.++|+|||||++|||++|+.||......    .+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~  225 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELF  225 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH
Confidence            4211100            000112345788999999998888999999999999999999999998653321    111


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                         .. ...+..   ..+....    .....+.+++.+|++.||++||+..++.+.|+..
T Consensus       226 ---~~-~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 ---GQ-VISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             ---HH-HHhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence               11 111110   0111111    1234567899999999999999988788877764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.9e-35  Score=305.79  Aligned_cols=245  Identities=29%  Similarity=0.443  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||+|++....   ....+++.+|+.++++++||||+++.++|...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999875  7889999986433   233457889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||++ |+|.+++.....       .+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++.
T Consensus        95 e~~~-g~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          95 EYCL-GSASDILEVHKK-------PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             HhhC-CCHHHHHHHccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcce
Confidence            9996 677776643322       38999999999999999999998   899999999999999999999999999987


Q ss_pred             cccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ....       .....++..|+|||.+.   .+.++.++||||||+++|||++|+.||.......    .   ...... 
T Consensus       164 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~---~~~~~~-  228 (307)
T cd06607         164 LVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A---LYHIAQ-  228 (307)
T ss_pred             ecCC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----H---HHHHhc-
Confidence            6532       22346788999999874   4568899999999999999999999986543211    1   111110 


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...     +.+   ........+.+++.+||+.+|++||+++++++.
T Consensus       229 ~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 NDS-----PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC-----CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000     001   112234568889999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-35  Score=305.68  Aligned_cols=264  Identities=26%  Similarity=0.338  Sum_probs=195.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||.|++|.||+|+..  +..|++|++....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999885  6789999886543  22345788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +. ++|.+++......      .+++.....++.|++.||+|||+   .+++||||+|+||++++++.+||+|||+++..
T Consensus        81 ~~-~~l~~~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          81 LH-QDLKKFMDASPLS------GIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             cc-cCHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            95 6888888643321      48999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-------HHH
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-------WEL  547 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-------~~~  547 (644)
                      .....   ......++..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+..+.       |..
T Consensus       151 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         151 GVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             ccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            42211   123345688999999887644 6889999999999999999999987643221111111100       000


Q ss_pred             Hhc-CchhhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 RRK-GRILDAADSRLGGEF---SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~-~~~~~~~d~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ... ..............+   .......+.+++.+|++.||++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000 000000000000000   0011234567899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=317.07  Aligned_cols=239  Identities=25%  Similarity=0.334  Sum_probs=184.4

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhcc---CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSL---RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ||+|+||+||+|+..  +..||+|++.....   .....+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999886  68899999865321   2233455677777665   699999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+++.....++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 g~L~~~l~~~~--------~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          81 GELFWHLQKEG--------RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             ChHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            99998886432        38889999999999999999999   89999999999999999999999999998754321


Q ss_pred             ccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      .   .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......    +    ......+.     
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~----~~~i~~~~-----  213 (330)
T cd05586         150 N---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----M----YRNIAFGK-----  213 (330)
T ss_pred             C---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----H----HHHHHcCC-----
Confidence            1   113345799999999998755 47999999999999999999999997643211    1    11111111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPS----MKTVLQ  596 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs----~~evl~  596 (644)
                       .++...   .....+.+++.+|++.||.+||+    +.++++
T Consensus       214 -~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 -VRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             111111   12234567889999999999995    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-35  Score=338.97  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=199.1

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec--cce
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDF  389 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  389 (644)
                      ...++|...++||+|+||.||++.+.  +..+|+|.+...  .......|..|+.++.+|+|||||++++++...  ..+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34468999999999999999999987  567899988643  233456789999999999999999999988653  468


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC----CCCeEeCCCCCCCEEEcCC----
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS----EKRVLHRDIKSSNIMLDSE----  461 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----~~~ivHrDlkp~NILld~~----  461 (644)
                      +|||||+++|+|.++|......    ...+++...+.|+.||+.||.|||+..    ..+|+||||||+||||+.+    
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKM----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            9999999999999998643211    113899999999999999999999832    1459999999999999643    


Q ss_pred             -------------CcEEEeccCCcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCC
Q 006446          462 -------------FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRK  526 (644)
Q Consensus       462 -------------~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~  526 (644)
                                   ..+||+|||+++......    ......||+.|+|||++..  ..++.++|||||||+||||++|+.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                         348999999998664221    1234579999999999854  458899999999999999999999


Q ss_pred             CCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhCC
Q 006446          527 PGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL--QVLSGE  601 (644)
Q Consensus       527 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl--~~L~~~  601 (644)
                      ||.....      ....+..+ ..+.       .+..   ......+.+|+..||+.+|.+||++.|++  +.+...
T Consensus       242 PF~~~~~------~~qli~~l-k~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        242 PFHKANN------FSQLISEL-KRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCCcCCc------HHHHHHHH-hcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            9965332      11111111 1111       1110   01124577889999999999999999998  455544

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.1e-35  Score=302.45  Aligned_cols=263  Identities=22%  Similarity=0.282  Sum_probs=195.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++++|...+.||+|+||.||+|...  ++.+++|++...... ....+.+|+.++++++|+||+++.+++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578889999999999999999875  789999998754332 2346788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+. ++|.+++.....       .+.+.....++.|++.||.|||+   .+++||||||+|||++.++++||+|||+++
T Consensus        83 e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG-------GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             eccc-CCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEecccccc
Confidence            9995 777777654322       27788888999999999999999   899999999999999999999999999997


Q ss_pred             cccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC-
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG-  551 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~-  551 (644)
                      .......   ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......  ...+.+ .+...... 
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~-~~~~~~~~~  225 (291)
T cd07870         152 AKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEK-IWTVLGVPT  225 (291)
T ss_pred             ccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHH-HHHHcCCCC
Confidence            6432111   12334578899999998754 5788999999999999999999999754321  111111 11111000 


Q ss_pred             -----------chhhhhhc-ccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 -----------RILDAADS-RLGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 -----------~~~~~~d~-~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                                 ...+.... .......     ......+.+++.+|++.||++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                       00000000 0000000     011345678899999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-36  Score=303.36  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=190.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----ceEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----DFLLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV  392 (644)
                      .|...+++|.|.||.||+|++.  ++.||||++..+.+.    --+|+.+|+++.|||||+|+-++....     .+.||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566889999999999999997  578999998655432    236899999999999999998876532     35789


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEeccCC
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGL  471 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGl  471 (644)
                      ||||| .+|.+++.......    ..++.....-+..||.+||.|||+   .+|+||||||.|+|+|.+ +.+||||||.
T Consensus       101 leymP-~tL~~~~r~~~~~~----~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRAN----QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcC----CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence            99996 48888886421110    125555666789999999999999   999999999999999987 8999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      |+.+.....    ......|..|.|||++.+. .|+.+.||||.||++.||+-|++-|.+....   +++...+ +....
T Consensus       173 AK~L~~~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIi-k~lG~  244 (364)
T KOG0658|consen  173 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEII-KVLGT  244 (364)
T ss_pred             ceeeccCCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHH-HHhCC
Confidence            998864322    2345678899999998765 6999999999999999999999988774432   3333322 11111


Q ss_pred             C----------chhhhhhcccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 G----------RILDAADSRLGGE-----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~----------~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .          ...+.-.+.+...     +........++++.+|++.+|.+|.++.|++.
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1          1111111111110     22233446778899999999999999999985

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.7e-35  Score=297.22  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=203.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||.|+||+||+|...  +..+++|++.... ....+.+.+|+.+++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999875  6789999986532 33567889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++......     ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++...
T Consensus        81 ~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          81 LSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             cCCCcHHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            9999999998653221     138899999999999999999998   99999999999999999999999999999876


Q ss_pred             ccccccc-ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          476 QENLKTH-HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       476 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ....... .......|+..|+|||.+... .++.++|||||||++|||++|+.||.......   .+.+    ....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~----~~~~---  222 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLML----TLQN---  222 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHH----HhcC---
Confidence            5332211 112344688999999998877 78999999999999999999999987543221   1111    1111   


Q ss_pred             hhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEF-SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         ..+.+.... .......+.+++.+|++.||++||+++++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               011111111 1123456778999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.6e-35  Score=300.60  Aligned_cols=245  Identities=25%  Similarity=0.451  Sum_probs=197.9

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      |+..++||+|+||.||+|...  +..+|+|.+.... ....+.+.+|+.++++++||||+++++.+..+...++|+||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            556788999999999999875  6789999876432 3345678899999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++...         .+++.....++.+++.|+.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        86 ~~~l~~~i~~~---------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          86 GGSALDLLEPG---------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCcHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999988532         37899999999999999999998   9999999999999999999999999999876543


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...   ......++..|+|||.+.+..++.++|||||||++|||++|..|+......    ...   ... ..+.     
T Consensus       154 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~---~~~-~~~~-----  217 (277)
T cd06641         154 TQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KVL---FLI-PKNN-----  217 (277)
T ss_pred             chh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HHH---HHH-hcCC-----
Confidence            211   122346788999999998888999999999999999999999998653221    111   111 1111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                          ...........+.+++.+|++.+|.+||++.++++.
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                111222234557788999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-35  Score=306.49  Aligned_cols=269  Identities=23%  Similarity=0.304  Sum_probs=197.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec----CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR----NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  390 (644)
                      +|+..++||+|+||.||+|+..    +..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999984    5789999987633   33446778899999999999999999999988  7899


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC----CCcEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~----~~~vkL  466 (644)
                      +||||++ ++|.+++.......   ...++......++.|++.||.|||+   .+++||||||+|||++.    ++.+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAK---RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCC---CcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            9999996 46666664322211   1247888999999999999999999   89999999999999999    999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccc------hhh
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSY------NNS  539 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~------~~~  539 (644)
                      +|||+++................++..|+|||.+.+. .++.++|||||||++|||++|+.||........      ...
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            9999998765332212223445788999999987664 578999999999999999999999976543320      011


Q ss_pred             HHHHHHHHHh------------cCchhhhhhcccCCCCC----H-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          540 IVHWLWELRR------------KGRILDAADSRLGGEFS----E-------KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       540 l~~~~~~~~~------------~~~~~~~~d~~l~~~~~----~-------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +...+ ....            ........+......++    .       .....+.+++.+|+++||++|||+.|+++
T Consensus       234 ~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         234 LERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111 1100            00000100000011111    0       22345788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=300.42  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=198.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc------
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH------  387 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~------  387 (644)
                      ++++|+..+.||+|++|.||+|...  +..+++|.+..... ..+.+..|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5678999999999999999999986  57899998875543 356789999999999 6999999999997654      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      .+++||||+++++|.+++......    ...+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKK----GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEEC
Confidence            489999999999999988643211    1248899999999999999999998   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      |||++........   ......++..|+|||.+..     ..++.++|||||||++|||++|+.||......   ..+..
T Consensus       156 d~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~  229 (275)
T cd06608         156 DFGVSAQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK  229 (275)
T ss_pred             CCccceecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH
Confidence            9999876542211   1234568899999998753     34678999999999999999999998643221   11111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .. .+.     .+.+  .......+.+.+++.+|+..||++|||+.++++
T Consensus       230 ----~~-~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 ----IP-RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----hh-ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                10 010     0111  111223456778999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.2e-35  Score=301.49  Aligned_cols=246  Identities=24%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      |...++||+|++|.||++...  +..+++|++........+.+.+|+.++++++|+||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444679999999999999875  678999998766555567788999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++...         .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||.+......
T Consensus       101 ~~L~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648         101 GALTDIVTHT---------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             CCHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999998641         27899999999999999999999   89999999999999999999999999988765422


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      ..   ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......       ...... ..+.     .
T Consensus       169 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~-~~~~-----~  232 (285)
T cd06648         169 VP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRI-RDNL-----P  232 (285)
T ss_pred             Cc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHH-HhcC-----C
Confidence            11   123346889999999998888999999999999999999999998654321       111111 1110     0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.+..  .......+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         233 PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11110  1112346788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=311.03  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch---hhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l  391 (644)
                      ...|+..+.||+|.||.||+++.+  ++.+|+|.+.+....   ..+.+.+|+.+|+++. |||||++.+++.....+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457888899999999999999987  778999999765433   3468899999999998 9999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC----CcEEEe
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNARLG  467 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vkL~  467 (644)
                      |||++.+|.|.+.+...         .++......++.|++.++.|||+   .+|+||||||+|+|+...    +.+|++
T Consensus       114 vmEL~~GGeLfd~i~~~---------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEecCCchHHHHHHHc---------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEe
Confidence            99999999999998654         17888999999999999999999   999999999999999543    479999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||++.....    .......+||+.|+|||.+....|+.++||||.||++|.|++|..||..........        .
T Consensus       182 DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~  249 (382)
T KOG0032|consen  182 DFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------A  249 (382)
T ss_pred             eCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------H
Confidence            9999998764    122567899999999999999999999999999999999999999998765432221        1


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...++.      .+..+.-....+...+++..|+..||.+|+++.++++.
T Consensus       250 i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  250 ILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            112221      11222222335667788999999999999999999993

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-35  Score=303.62  Aligned_cols=243  Identities=27%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||++...  ++.+|+|++....   ....+.+..|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999886  6889999986532   233567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .++...+..++.|+++||.|||+   .+++||||+|+|||++.++.+||+|||+++
T Consensus        81 e~~~~~~L~~~~~~~~--------~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          81 EYVPGGELFSHLRKSG--------RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             ecCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            9999999999986542        38899999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....+++.|+|||.+.+...+.++||||||+++|||++|+.||......    ...    .....+. 
T Consensus       150 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~----~~~~~~~-  214 (290)
T cd05580         150 RVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIY----EKILEGK-  214 (290)
T ss_pred             ccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHH----HHHhcCC-
Confidence            76422      23446889999999998888999999999999999999999998754311    111    1111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                           .    .++......+.+++.+|++.||.+||     +++++++
T Consensus       215 -----~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 -----V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 1    11222235667888999999999999     6676664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.6e-35  Score=300.50  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=191.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHH-HhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTT-IGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|+++... .....++..|+.+ ++.++||||+++++++..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999986  7889999987543 2334455666665 566789999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |++ |+|.+++......    ...+++...+.++.|++.||+|||+   . +++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~-~~l~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          81 VMD-TSLDKFYKKVYDK----GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhc-ccHHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            995 7888887543221    1248999999999999999999998   5 89999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCcccccc----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      ......    ......++..|+|||.+..    ..++.++|+|||||++|||++|+.||......  ...+..    ...
T Consensus       153 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~----~~~  222 (283)
T cd06617         153 YLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQ----VVE  222 (283)
T ss_pred             cccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHH----HHh
Confidence            654211    1233468889999998864    45688999999999999999999998643211  111111    110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       +     ..+.+..   ....+.+.+++.+|++.+|.+||++.++++
T Consensus       223 -~-----~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 -E-----PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -c-----CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0     1111111   112345778899999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-34  Score=303.90  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..+.||+|+||.||+++..  +..+|+|++.....   .....+..|+.++++++|+|++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667888999999999999875  67899999864422   234578899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ |+|.+.+.....       .++|.++..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++..
T Consensus       106 ~~~-g~l~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         106 YCL-GSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             CCC-CCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            996 577777654332       38999999999999999999999   8999999999999999999999999999875


Q ss_pred             ccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ...       .....++..|+|||++.   .+.++.++|||||||++|||++|+.||.......   .+..+    ...+
T Consensus       175 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~----~~~~  240 (317)
T cd06635         175 ASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI----AQNE  240 (317)
T ss_pred             cCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHH----Hhcc
Confidence            432       22346788999999874   4568999999999999999999999986532211   11111    1111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      .         ...........+.+++.+|++.+|.+||++.++++.+-.....
T Consensus       241 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         241 S---------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             C---------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            0         0111122334578899999999999999999999866544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.7e-35  Score=298.07  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=199.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|+||.||++...  +..+|+|.+....  ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999986  6789999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccCCccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLART  474 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~  474 (644)
                      +++++|.+++......      .+++..+..++.|+++||.|||+   .+++|+||||+||++++++ .+||+|||.+..
T Consensus        81 ~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          81 CDGGDLMKRINRQRGV------LFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             CCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence            9999999998653321      37899999999999999999998   8999999999999999885 469999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......   ......|+..|+|||.+....++.++||||||+++|||++|+.||.....       .+++..... +.. 
T Consensus       152 ~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~-  219 (257)
T cd08225         152 LNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ-GYF-  219 (257)
T ss_pred             ccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc-ccC-
Confidence            643221   12234688999999999888899999999999999999999999865332       112222111 111 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                              ..........+.+++.+|++.+|++||++.++++.
T Consensus       220 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 --------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                    01111223457788899999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=302.49  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |+..+.||+|++|.||+|...  +..|++|++....  ......+.+|+.++++++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999875  7889999987543  223457889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                       +++|.+++.....      ..+++..++.++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||+++...
T Consensus        81 -~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 -DLDLKKYMDSSPL------TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             -CcCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence             5789998864432      138999999999999999999999   899999999999999999999999999997654


Q ss_pred             ccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-------HHHHH
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-------LWELR  548 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-------~~~~~  548 (644)
                      ....   ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.++       .|...
T Consensus       151 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         151 VPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             CCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence            2211   12233568899999987654 5689999999999999999999998764322111111111       00000


Q ss_pred             hcCchhhhhh--cccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAAD--SRLG----GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d--~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .  .+.+...  +...    ..........+.+++.+|+++||++||+++++++
T Consensus       228 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         228 T--SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             h--hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0  0000000  0000    0001112245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=301.46  Aligned_cols=263  Identities=25%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEEEe
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVYE  394 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  394 (644)
                      |+..++||+|++|.||+|+..  +..+|+|++....  ....+.+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556789999999999999886  5789999997653  33346788999999999999999999999988  78999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ ++|.+++.....       .+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..
T Consensus        81 ~~~-~~l~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~  149 (287)
T cd07840          81 YMD-HDLTGLLDSPEV-------KFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP  149 (287)
T ss_pred             ccc-ccHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceee
Confidence            996 588888754422       38899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH----Hh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL----RR  549 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~----~~  549 (644)
                      ......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.....    +.
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         150 YTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             ccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence            653221  11233456888999998764 457899999999999999999999987654322111111110000    00


Q ss_pred             ---------cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 ---------KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ---------~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               ...........+...+...+...+.+++.+|++.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     00000000000001111112456788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-37  Score=291.32  Aligned_cols=250  Identities=27%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeec--ccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +++|+..+.||+|.|+.||+..+.  ++.+|+|.+..  -+..+.+++.+|+.|.+.|+|||||+|.....+.+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356777889999999999998876  77888887643  23446788999999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFG  470 (644)
                      |+|.+++|..-+-+..        ..+....-..+.||++||.|+|.   ++|||||+||.|+||-.   .--+||+|||
T Consensus        90 e~m~G~dl~~eIV~R~--------~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE--------FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ecccchHHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccc
Confidence            9999999876554331        36677778899999999999999   99999999999999943   3458999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +|..+.. +   ......+||++|||||++...+|+..+|||+.||+||-|+.|++||.+.+...    +.    +....
T Consensus       159 vAi~l~~-g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----ly----e~I~~  226 (355)
T KOG0033|consen  159 LAIEVND-G---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LY----EQIKA  226 (355)
T ss_pred             eEEEeCC-c---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----HH----HHHhc
Confidence            9998762 2   22456789999999999999999999999999999999999999998754432    22    22222


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      |.+.  ++++.....    .+...+|+.+|+..||.+|.|+.|.++
T Consensus       227 g~yd--~~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  227 GAYD--YPSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccC--CCCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2211  111111222    334567889999999999999998874

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-34  Score=298.47  Aligned_cols=259  Identities=23%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  393 (644)
                      ++|+..++||.|++|.||++...  +..+|+|.+..... ....++.+|++++++++||||++++++|...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999985  67899999875432 4457789999999999999999999998654  3689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++......    ...++......++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKR----GGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EecCCCCHHHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            999999999887542211    1237888999999999999999999   999999999999999999999999999987


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc-cchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN-SYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~-~~~~~l~~~~~~~~~~~~  552 (644)
                      ......     .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..++..    ..
T Consensus       154 ~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~  224 (287)
T cd06621         154 ELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MP  224 (287)
T ss_pred             cccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CC
Confidence            654221     22345788999999999889999999999999999999999998765321 111122222111    01


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ... .....  .......+.+.+++.+|++.+|++||++.|+++
T Consensus       225 ~~~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 NPE-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             chh-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            111 11111  101123456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=298.68  Aligned_cols=246  Identities=26%  Similarity=0.419  Sum_probs=197.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccC---CCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .|+..+.||+|+||.||+|.+.  +..+++|.+... ......++.+|+.++++++   |||++++++.+..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4667889999999999999985  678999998654 3344567889999999997   999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++...         .+++...+.++.++++||.|||+   .+++||||+|+||+++.++.++|+|||++.
T Consensus        82 e~~~~~~L~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          82 EYAEGGSVRTLMKAG---------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             ecCCCCcHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            999999999988532         38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .......   ......|+..|+|||.+.++ .++.++|||||||++|||++|+.||.......       +... .... 
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~-~~~~-  217 (277)
T cd06917         150 LLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMML-IPKS-  217 (277)
T ss_pred             ecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhc-cccC-
Confidence            7653321   12334688999999998754 46899999999999999999999997543211       1100 0000 


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          ..+.+...   .....+.+++.+|++.||++||++.++++
T Consensus       218 ----~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 ----KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                11111111   13346778889999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-34  Score=295.60  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +|+..+.||+|++|.||+++..  ++.+++|++..... ...+.+.+|+..+.+++|+||+++++.+...+.+++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6788899999999999999987  78899999876544 45678999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++....        .++...++.++.|+++||.|||+.  .+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~~~~L~~~l~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          82 DGGSLADLLKKVG--------KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             CCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999996542        388999999999999999999962  789999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      .....   .....++..|+|||.+....++.++||||||+++|||++|+.|+........ ..+..++.    ...    
T Consensus       152 ~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~----~~~----  219 (264)
T cd06623         152 NTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-FELMQAIC----DGP----  219 (264)
T ss_pred             cCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-HHHHHHHh----cCC----
Confidence            32211   2245678899999999998999999999999999999999999876542111 11222111    110    


Q ss_pred             hhcccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          557 ADSRLGGEFSEK-EMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       557 ~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       .    ...+.. ..+.+.+++.+|++++|++||++.++++.
T Consensus       220 -~----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 -P----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -C----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             0    111222 34578889999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=312.80  Aligned_cols=267  Identities=22%  Similarity=0.284  Sum_probs=197.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----ce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----DF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~  389 (644)
                      +++|+..++||+|+||.||+|+..  +..||+|++.... ......+..|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999875  7889999986432 334567888999999999999999999876543     58


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||++ ++|.+++...         .+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~---------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ---------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcc
Confidence            99999995 5777766322         38899999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++................|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+...    ...+.....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~  226 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVL  226 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHc
Confidence            999876432221111234578999999998754 568999999999999999999999996543211    111111111


Q ss_pred             hcCch---hhhhhc-------ccC--CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCC
Q 006446          549 RKGRI---LDAADS-------RLG--GEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGE  601 (644)
Q Consensus       549 ~~~~~---~~~~d~-------~l~--~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  601 (644)
                      .....   ....+.       ...  ....     ......+.+++.+|++.+|++||++.++++.  ++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            11000   000000       000  0000     1123457889999999999999999999986  5443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-34  Score=290.76  Aligned_cols=246  Identities=29%  Similarity=0.500  Sum_probs=202.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .|+..+.||+|++|.||++...  +..+++|++........+.+.+|+..+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667889999999999999986  67899999977665567889999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....       .+++..+..++.++++||.|||+   .+++||||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          81 GGSLKDLLKSTNQ-------TLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCcHHHHHhhcCC-------CCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999865432       38999999999999999999999   9999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...    .....++..|++||.+....++.++||||||+++|||++|+.|+.......   .+    ..... ..     
T Consensus       151 ~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~-~~-----  213 (253)
T cd05122         151 TKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---AL----FKIAT-NG-----  213 (253)
T ss_pred             ccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HH----HHHHh-cC-----
Confidence            211    234568899999999988889999999999999999999999987543211   11    11110 00     


Q ss_pred             hcccCCCCCHHH--HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          558 DSRLGGEFSEKE--MECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       558 d~~l~~~~~~~~--~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          ........  ...+.+++.+|++.||++||++.++++
T Consensus       214 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 ----PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ----CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                01111111  356788899999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.5e-35  Score=300.20  Aligned_cols=256  Identities=24%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccC-CCceeeEeeeeeec--cceEEEEe
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYER--HDFLLVYE  394 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E  394 (644)
                      |+..++||+|+||.||+|...  +..+|+|+++.... ........|+.++.++. |+|++++++++.+.  +.+++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999875  67899999875422 22334567899999985 99999999999987  88999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ |+|.+++.....       .++|..+..++.|++.||+|||+   .+++||||||+||+++. +.+||+|||+++.
T Consensus        81 ~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~  148 (282)
T cd07831          81 LMD-MNLYELIKGRKR-------PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRG  148 (282)
T ss_pred             cCC-ccHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccc
Confidence            996 688887754322       38999999999999999999999   89999999999999999 9999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc---
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK---  550 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~---  550 (644)
                      ......    .....++..|+|||.+.. +.++.++|||||||++|||++|+.||...+..+    ...+.......   
T Consensus       149 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~~~~~~~~~~  220 (282)
T cd07831         149 IYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLGTPDA  220 (282)
T ss_pred             cccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHHHHHcCCCCH
Confidence            642211    233467889999997654 557899999999999999999999997654322    11211111100   


Q ss_pred             --------CchhhhhhcccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 --------GRILDAADSRLGG----EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 --------~~~~~~~d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                              ........+....    .........+.+++.+|++++|++||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                    0000000000000    001123467888999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-34  Score=295.79  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||+|++|.||++...  +..+++|++.... ....+++.+|+.++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999987  6789999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....       .++......++.|+++||+|||+  ..+++||||||+||++++++.+||+|||.+...
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          81 MDGGSLDKILKEVQG-------RIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             cCCCcHHHHHHHccC-------CCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            999999999865432       37888999999999999999997  368999999999999999999999999998765


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....     .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+.+...... .   
T Consensus       152 ~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~-~---  220 (265)
T cd06605         152 VNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFELLQYIVNE-P---  220 (265)
T ss_pred             HHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHHHHHHhcC-C---
Confidence            4221     112568889999999998899999999999999999999999986543211  1122211111111 0   


Q ss_pred             hhhcccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEK-EMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            ....... ....+.+++.+|++.||++||++.++++
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 ------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                  0111111 3445778899999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.7e-34  Score=298.75  Aligned_cols=251  Identities=29%  Similarity=0.432  Sum_probs=203.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++.|+..+.||+|++|.||++.+.  +..+++|++..... ..+.+..|++.+++++|+|++++++.+......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999997  78899999976554 56778899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++.....       .+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        96 ~~~~~~L~~~l~~~~~-------~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          96 YMDGGSLTDIITQNFV-------RMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             ccCCCcHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999976431       38999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......   ......++..|++||.+.+..++.++|||||||++|||++|+.||.......   ...    ... .....
T Consensus       166 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~----~~~-~~~~~  234 (286)
T cd06614         166 LTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALF----LIT-TKGIP  234 (286)
T ss_pred             hccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHH-hcCCC
Confidence            542211   1233457889999999988889999999999999999999999986533211   111    100 11100


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .     +  .........+.+++.+|++.+|.+||++.++++
T Consensus       235 ~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 P-----L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             C-----C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0     0  011112345778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-34  Score=299.16  Aligned_cols=262  Identities=26%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +|+..++||+|++|.||+|+..  +..||+|+++..... ....+..|+.++++++|+||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999986  678999998765433 3456778999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      + ++|.+++.....     ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        81 ~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          81 D-KDLKKYMDTHGV-----RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             C-ccHHHHHHhcCC-----CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            7 588888754332     1248999999999999999999998   899999999999999999999999999998654


Q ss_pred             ccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-------HHHH
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-------WELR  548 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-------~~~~  548 (644)
                      ....   ......++..|++||.+.+. .++.++|||||||++|||++|+.||......+....+....       ++..
T Consensus       152 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07836         152 IPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI  228 (284)
T ss_pred             CCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence            2211   12334578899999988654 56889999999999999999999997654322211111110       0000


Q ss_pred             hcCchhhhhhcccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLG-------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...   ........       ..+.......+.+++.+|++.||.+||++.++++
T Consensus       229 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         229 SQL---PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcC---chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000   00000000       0011122345678999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=316.59  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=195.1

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeec----ccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc--eEEEEec
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSE----TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEY  395 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~Ey  395 (644)
                      ..+||+|+|-+||||.+.  |-+||--.++.    .+....+.|..|+.+|+.|+|||||+++..+.+...  ..+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            568999999999999987  44555333221    233456889999999999999999999998876554  8899999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEeccCCccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLART  474 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGla~~  474 (644)
                      |..|+|..|+.+.+.        ++.....+++.||+.||.|||+. ..+|+|||||.+||+|+.+ |.|||+|+|||..
T Consensus       125 ~TSGtLr~Y~kk~~~--------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR--------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ccCCcHHHHHHHhcc--------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            999999999977654        77888999999999999999985 4799999999999999876 8899999999998


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....     ...+.|||.|||||++. ..|++..||||||++|+||+|+..||......   ..+..-|    -.|.-.
T Consensus       196 ~r~s~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---AQIYKKV----~SGiKP  262 (632)
T KOG0584|consen  196 LRKSH-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---AQIYKKV----TSGIKP  262 (632)
T ss_pred             hhccc-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---HHHHHHH----HcCCCH
Confidence            75321     44589999999999887 78999999999999999999999999765421   2233222    223222


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ..+.        .-....+.+++.+|+.. .++|||+.|+|+  +|..+
T Consensus       263 ~sl~--------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  263 AALS--------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhh--------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            2221        11123466788899999 999999999995  45543

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-34  Score=301.38  Aligned_cols=264  Identities=24%  Similarity=0.309  Sum_probs=195.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  391 (644)
                      ..+|+..+.||+|+||.||+|+..  +..||+|+++.....  ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888999999999999999986  788999998754322  233567899999999999999999998755  46899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+. ++|.+++.....       .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        86 v~e~~~-~~l~~~l~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~  154 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPT-------PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGL  154 (309)
T ss_pred             EEecCC-CCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccce
Confidence            999995 588888764332       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH------
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL------  544 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~------  544 (644)
                      ++.......   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++.      
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         155 ARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES  231 (309)
T ss_pred             eeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            987653211   1223345788999999865 457899999999999999999999997654322221121110      


Q ss_pred             -HHHHhcCchhhhhhcccCCC-C---C---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 -WELRRKGRILDAADSRLGGE-F---S---EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 -~~~~~~~~~~~~~d~~l~~~-~---~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       |............  .+... +   .   ......+.+++.+|+++||++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         232 IWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hchhhhcccccccc--cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0000000000000  00000 0   0   0113456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=314.59  Aligned_cols=244  Identities=28%  Similarity=0.449  Sum_probs=199.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch---hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +.|...+.||.|+||.||-+++.  ...||||++.-..++   ..++.+.|+..|.+++|||+|.+-|++..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            34666788999999999999886  577999999755443   3467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||| -||-.+.+.-.+.       +|...++..|+.+.++||+|||+   .+.||||||+.||||++.+.|||+|||.|.
T Consensus       106 EYC-lGSAsDlleVhkK-------plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             HHH-hccHHHHHHHHhc-------cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchh
Confidence            999 6777777754433       37888899999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ...+       ....+||+.|||||++.   .|.|+-|+||||+|++..||+-.++|......       +.-+...-..
T Consensus       175 i~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQN  240 (948)
T KOG0577|consen  175 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQN  240 (948)
T ss_pred             hcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhc
Confidence            7653       44578999999999874   68899999999999999999999999665432       1111111111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .      .|.|.   ..+..+.+...+..|++.-|.+|||.+++++
T Consensus       241 e------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 E------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             C------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            1      12222   3355666777888999999999999998875

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-34  Score=291.13  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=204.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVY  393 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  393 (644)
                      +|+..+.||+|++|.||+|+..  +..+++|++.....  ...+.+.+|+.++++++|+||+++++++...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999987  77899999876542  4567889999999999999999999999988  8899999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~  149 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--------KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAK  149 (260)
T ss_pred             EecCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence            9999999999986543        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ........ .......++..|++||.+.....+.++||||||++++||++|+.||.....      .....+....    
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~----  218 (260)
T cd06606         150 RLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGS----  218 (260)
T ss_pred             eccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccc----
Confidence            76533211 112345688899999999888899999999999999999999999876541      1111111111    


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           .......+......+.+++.+|++.+|++||++.++++
T Consensus       219 -----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 -----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                 11112233333567888999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.7e-34  Score=296.74  Aligned_cols=241  Identities=21%  Similarity=0.270  Sum_probs=185.6

Q ss_pred             cccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHH---HhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTT---IGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .||+|+||.||++...  +..+|+|.+.....   .....+..|..+   +...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999885  67899998865321   222334444433   334479999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++....        .+++.....++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++.....
T Consensus        81 ~~~L~~~i~~~~--------~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          81 GGDLHYHLSQHG--------VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999886432        38999999999999999999999   8999999999999999999999999999976542


Q ss_pred             cccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ..     .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||........ ..+    .....       
T Consensus       150 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~----~~~~~-------  212 (279)
T cd05633         150 KK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI----DRMTL-------  212 (279)
T ss_pred             cC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH----HHHhh-------
Confidence            11     223468999999998864 4578999999999999999999999975432211 111    11100       


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                         ......+......+.+++.+|++.||++||     +++++++.
T Consensus       213 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 ---TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               011122223345677888999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1e-34  Score=300.63  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=193.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..++||+|+||.||++...  +..+|+|++.... ......+.+|+.++.++. |+||+++++++...+..++++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445678999999999999886  6789999987543 234567889999999996 99999999999998899999999


Q ss_pred             cCCCccchhh---hccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          396 MPNGSLDKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l---~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      ++ ++|.++.   .....      ..+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||++
T Consensus        85 ~~-~~l~~l~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             cc-CCHHHHHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            85 4555433   21111      248899999999999999999997  248999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccC---CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVG---RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +.......    .....|+..|+|||.+...   .++.++|||||||++|||++|+.||....      ....-+.....
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~  225 (288)
T cd06616         156 GQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK  225 (288)
T ss_pred             HHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC
Confidence            76542211    2334688899999998766   68999999999999999999999986532      11111111110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       +     ..+.+...........+.+++.+|++.+|++||++++|++.
T Consensus       226 -~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 -G-----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -C-----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1     11122222222344567889999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=293.29  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-----cchhhHHHHHHHHHHhccCCCceeeEeeeeeec--cce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-----SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  389 (644)
                      .+|+..+.||+|+||.||+|+..  +..+++|.+...     ..+....+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999875  678999987532     223446788999999999999999999998764  458


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++++||+++++|.+++....        .+++.....++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--------~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--------ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcc
Confidence            89999999999999985432        27788899999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++................++..|+|||++.+..++.++|||||||++|||++|+.||......   ..+.    ....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~  223 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIF----KIAT  223 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHH----HHHc
Confidence            99986542111111123456889999999998888999999999999999999999998653211   1111    1110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               ......++....+.+.+++.+|++ +|.+||+..+++.
T Consensus       224 ---------~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         224 ---------QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---------CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                     111122333444567788889999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-34  Score=300.48  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeecc-------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-------  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-------  387 (644)
                      ++|+..++||+|+||.||++...  +..||+|++.....  .....+.+|+.++++++||||++++++|....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            47888999999999999999986  67899999865432  22345678999999999999999999987654       


Q ss_pred             -ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          388 -DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       388 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                       ..++||||+. ++|.+++.....       .+++.+...++.|++.||.|||+   .+++||||||+||+++.++.+||
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKNV-------KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEE
Confidence             3599999995 578777754322       38899999999999999999999   89999999999999999999999


Q ss_pred             eccCCccccccccccc-ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          467 GDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      +|||++.......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........    ...+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~----~~~~  236 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ----LTLI  236 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHH
Confidence            9999998764322111 112334578899999988654 468899999999999999999999876443211    1111


Q ss_pred             HHHHh--------cCchhhhhhc-ccCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 WELRR--------KGRILDAADS-RLGGEFSE---------KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 ~~~~~--------~~~~~~~~d~-~l~~~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .....        .....+..+. .+......         .+...+.+++.+|++.||.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            11110        0000000000 00000000         01234568999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-34  Score=295.05  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      +|+..+.||+|+||.||++...  +..+++|.+....   ....+.+.+|+.++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999987  7889999987542   2346788999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++....        .+++.....++.|+++||.|||+   .+++|+||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~~L~~~l~~~~--------~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          81 LLLGGDLRYHLSQKV--------KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             CCCCCCHHHHHHhcC--------CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999999986541        38889999999999999999998   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....    ......|+..|+|||.+....++.++|+||||+++|+|++|+.||.......     ..+.......    
T Consensus       150 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~----  216 (258)
T cd05578         150 VTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET----  216 (258)
T ss_pred             cCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc----
Confidence            64321    1234568889999999988889999999999999999999999987654321     1111111110    


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM--KTVL  595 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~--~evl  595 (644)
                            ....++......+.+++.+|++.||.+||++  ++++
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                  1112222334667789999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=294.11  Aligned_cols=252  Identities=23%  Similarity=0.262  Sum_probs=201.9

Q ss_pred             CCCCCCcccccCcEEEEEeeecC--ceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..++||.|.-|+||++.+.+  ..+|+|++.+..   ++...+...|-+||+.+.||.+..|+..+......||+||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34557899999999999999985  679999997754   3444567789999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ||+||+|...+++....      .++......++.+++.||+|||.   .|||.|||||+||||.++|++-|+||.|+..
T Consensus       158 yCpGGdL~~LrqkQp~~------~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGK------RFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cCCCccHHHHHhhCCCC------ccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999988765443      48888889999999999999999   9999999999999999999999999999753


Q ss_pred             cccc--------------------------------cccc---------------------ccccccccCCCccCccccc
Q 006446          475 IQEN--------------------------------LKTH---------------------HSTKEIAGTPGYMAPESFL  501 (644)
Q Consensus       475 ~~~~--------------------------------~~~~---------------------~~~~~~~gt~~y~APE~~~  501 (644)
                      ....                                ....                     ......+||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            3110                                0000                     0012357999999999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhc
Q 006446          502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACC  581 (644)
Q Consensus       502 ~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl  581 (644)
                      +...+.++|+|+|||++|||+.|+.||.+....+....++.   +           +.++.+  .......+.+|+.+.+
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~-----------~l~Fp~--~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---Q-----------PLKFPE--EPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---C-----------CCcCCC--CCcchhHHHHHHHHHh
Confidence            99999999999999999999999999988665433222211   0           111111  1144567788999999


Q ss_pred             CCCCCCCCC----HHHHHH
Q 006446          582 HPNPHLRPS----MKTVLQ  596 (644)
Q Consensus       582 ~~dP~~RPs----~~evl~  596 (644)
                      ..||++|..    +.||-+
T Consensus       373 vKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ccChhhhhccccchHHhhc
Confidence            999999998    667654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=300.86  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=209.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      +-|+..+.||+|.|..|-++++-  |..||||++.+..-+  ....+..|+..|+-++|||||+||.+......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            55777889999999999998764  999999999776433  34678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE-cCCCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-d~~~~vkL~DFGla~  473 (644)
                      .-.+|+|.+|+.+....       +......+++.||..|+.|+|+   ..+|||||||+||.+ .+-|-|||.|||.+.
T Consensus        98 LGD~GDl~DyImKHe~G-------l~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEG-------LNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             ecCCchHHHHHHhhhcc-------ccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccc
Confidence            99999999999776553       8889999999999999999999   899999999999976 556889999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .+.+..+    ....+|...|-|||++.+..|+ ++.||||+||+||.|+||+.||+.....+....+++.         
T Consensus       168 kf~PG~k----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---------  234 (864)
T KOG4717|consen  168 KFQPGKK----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---------  234 (864)
T ss_pred             cCCCcch----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------
Confidence            7764332    4456899999999999999885 7899999999999999999999987665543333331         


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                             +  -..+......+.+|+..|+..||++|.+.+++..
T Consensus       235 -------K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 -------K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -------c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                   1  1344556677889999999999999999999875

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.2e-34  Score=304.29  Aligned_cols=267  Identities=28%  Similarity=0.376  Sum_probs=196.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeec--cceE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER--HDFL  390 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~  390 (644)
                      .++|+..+.||+|+||.||+|.+.  +..+|+|++...  .......+..|+.+++++ +||||++++++|...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888999999999999999885  678999988542  223445677899999999 999999999998653  3689


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|+||++ ++|..++...         .++|..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        86 lv~e~~~-~~L~~~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN---------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             EEecccc-cCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999996 6898887543         27899999999999999999999   899999999999999999999999999


Q ss_pred             Ccccccccccc--cccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH---
Q 006446          471 LARTIQENLKT--HHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL---  544 (644)
Q Consensus       471 la~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~---  544 (644)
                      +++........  ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..+.   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~  232 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP  232 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99876432211  011234568999999998764 457899999999999999999999986543321111111110   


Q ss_pred             ----HHHHhcCchhhhhhcccC------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 ----WELRRKGRILDAADSRLG------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 ----~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                          +.........+..+....      ..........+.+++.+|++.||++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                000000000000100000      00011123567889999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.2e-34  Score=291.74  Aligned_cols=241  Identities=26%  Similarity=0.364  Sum_probs=195.1

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||.|++|.||+++..  +..+++|++....   ....+.+..|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999998  7899999986532   23456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++....        .+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~~l~~~~--------~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          81 WTILRDRG--------LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             HHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            99996543        27889999999999999999999   999999999999999999999999999998765321  


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                        ......++..|++||.+....++.++|+||||+++|||++|..||.....+.  ..+.   ...         .+...
T Consensus       148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~---~~~---------~~~~~  211 (262)
T cd05572         148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIY---NDI---------LKGNG  211 (262)
T ss_pred             --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHH---HHH---------hccCC
Confidence              1233468889999999988889999999999999999999999997654211  1111   111         00011


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                      ...++......+.+++.+||+.+|++||+     ++|+++
T Consensus       212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            12222223456888999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-34  Score=309.47  Aligned_cols=262  Identities=20%  Similarity=0.278  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-C-----CceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-H-----RNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~  390 (644)
                      .+|+..+.||+|+||.|-+|.+.  ++.||||++++.... ..+-..|+.+|..|+ |     -|+|++++++..++++|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            47889999999999999999887  678999999775433 455678999999997 4     48999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC--CcEEEec
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE--FNARLGD  468 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~--~~vkL~D  468 (644)
                      ||+|.+ .-+|.++|..+.-.      .++......++.||+.||..||+   .+|||+||||+||||.+-  ..+||+|
T Consensus       265 iVfELL-~~NLYellK~n~f~------Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFR------GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEe
Confidence            999999 78999999876543      48899999999999999999998   999999999999999654  3699999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-----
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-----  543 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-----  543 (644)
                      ||.++.....      ......+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.+....+++.     
T Consensus       335 FGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  335 FGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             cccccccCCc------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence            9999876532      12456788999999999999999999999999999999998777765543332223221     


Q ss_pred             --HHHHHhc-Cchh-------------h----------------hhhcc-cC-------CCCCHHHHHHHHHHHHHhcCC
Q 006446          544 --LWELRRK-GRIL-------------D----------------AADSR-LG-------GEFSEKEMECVLILGLACCHP  583 (644)
Q Consensus       544 --~~~~~~~-~~~~-------------~----------------~~d~~-l~-------~~~~~~~~~~l~~L~~~Cl~~  583 (644)
                        +.+...+ .+..             +                ..+.. ..       ......+.+.+++++.+|+.+
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence              1111000 0000             0                00110 11       011123455678999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 006446          584 NPHLRPSMKTVLQV  597 (644)
Q Consensus       584 dP~~RPs~~evl~~  597 (644)
                      ||.+|+|..|+++.
T Consensus       489 dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  489 DPAERITPAQALNH  502 (586)
T ss_pred             CchhcCCHHHHhcC
Confidence            99999999999864

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-34  Score=295.55  Aligned_cols=240  Identities=28%  Similarity=0.396  Sum_probs=189.7

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||+||++...  ++.+++|.+....   ....+.+..|+.++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999876  7789999986532   22345677899999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++.....      ..+++..++.++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++......   
T Consensus        81 ~~~l~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---  148 (277)
T cd05577          81 KYHIYNVGE------PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---  148 (277)
T ss_pred             HHHHHHcCc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---
Confidence            999865432      138899999999999999999999   89999999999999999999999999999765421   


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                       .......++..|+|||.+.++.++.++|||||||++|||++|+.||...........+..    .    .. .     .
T Consensus       149 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~----~~-~-----~  213 (277)
T cd05577         149 -KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----R----TL-E-----M  213 (277)
T ss_pred             -CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----c----cc-c-----c
Confidence             112344678899999999888899999999999999999999999976443211111111    0    00 0     0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKT  593 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  593 (644)
                      ...++......+.+++.+|++.||++||+.++
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            11122223456778899999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.8e-34  Score=308.29  Aligned_cols=263  Identities=22%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------  386 (644)
                      ..++|+..+.||+|+||.||+++..  +..||+|++...  .......+..|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875  788999998643  233445678899999999999999999988643      


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ...++|+||+. ++|.+.+..          .++......++.|++.||+|||+   .+++||||||+||+++.++.+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEE
Confidence            35799999994 688777632          16788889999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH----
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH----  542 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~----  542 (644)
                      +|||+++.......    .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..    
T Consensus       160 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  235 (353)
T cd07850         160 LDFGLARTAGTSFM----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT  235 (353)
T ss_pred             ccCccceeCCCCCC----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999986542211    2334678899999999999999999999999999999999999975432111111110    


Q ss_pred             ----HH-------HHHHhcCc------hhhhhhcccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 ----WL-------WELRRKGR------ILDAADSRLG----GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ----~~-------~~~~~~~~------~~~~~d~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                          +.       ........      ..+.....+.    ..........+.+++.+|++.||++||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                00       00000000      0000000000    00011234567889999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-34  Score=299.65  Aligned_cols=263  Identities=26%  Similarity=0.323  Sum_probs=196.4

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeecc----
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----  387 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----  387 (644)
                      ...++|+..+.||+|+||.||+|+..  +..||+|+++....  .....+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34568889999999999999999986  67899999875432  23356778999999999999999999987654    


Q ss_pred             ------ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          388 ------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       388 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                            .+++|+||+++ +|..++.....       .+++..+..++.|++.||+|||+   .+|+||||||+||+++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~  152 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV-------HFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNK  152 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence                  78999999975 67666654322       38999999999999999999999   899999999999999999


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +.+||+|||++........  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+
T Consensus       153 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         153 GQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             CcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999999999987643221  11223456788999998764 45789999999999999999999999764432211111


Q ss_pred             HHHHHHHHhcCch---hhh--------hh------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          541 VHWLWELRRKGRI---LDA--------AD------SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       541 ~~~~~~~~~~~~~---~~~--------~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .........   .+.        .+      .++...+. .....+.+++.+|++.||.+||+++++++
T Consensus       231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 ----SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ----HHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                111110000   000        00      00000010 12346788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.2e-34  Score=290.82  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..++||+|++|.||+++..  +..+++|++....  .....++..|++++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999875  6789999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++......    ...+++.....++.++++||+|||+   .+++||||+|+||++++++.+||+|||+++..
T Consensus        81 ~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          81 APFGDLSKAISKRKKK----RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             cCCCCHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            9999999998653211    1248999999999999999999998   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ...     ......++..|++||.+.+..++.++|+||||+++|||++|+.||...+..    .+..    ....+.   
T Consensus       154 ~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~----~~~~~~---  217 (256)
T cd08530         154 KKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRY----KVQRGK---  217 (256)
T ss_pred             ccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHhcCC---
Confidence            532     122346788999999999888999999999999999999999998764321    1111    111111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ...........+.+++.+|++.+|++||++.++++.
T Consensus       218 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 ------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                  122233445668889999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.4e-34  Score=297.60  Aligned_cols=264  Identities=21%  Similarity=0.239  Sum_probs=193.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccC-CCceeeEeeeeeeccc-----
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHD-----  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----  388 (644)
                      ++|+..+.||+|+||.||+|...  +..||+|++.....  .....+.+|+.++++++ |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999986  67899998765432  23467888999999995 6999999999887665     


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEe
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLG  467 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~  467 (644)
                      .++||||+++ +|.+++......   ....+++.....++.||++||.|||+   .+++||||||+||+++. ++.+||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG---PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEe
Confidence            8999999974 888888643221   11248999999999999999999999   89999999999999999 8999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++.......   ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||...........+...   
T Consensus       154 dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---  227 (295)
T cd07837         154 DLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL---  227 (295)
T ss_pred             ecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH---
Confidence            9999986532211   1223356889999998865 45789999999999999999999998764322111111110   


Q ss_pred             HHhcCc--h----hhhhh----cccC----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGR--I----LDAAD----SRLG----GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~--~----~~~~d----~~l~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       .....  .    ....+    +...    ..........+.+++.+|+++||.+||++.++++
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         228 -LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             -hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00000  0    00000    0000    0000122345778999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-34  Score=322.71  Aligned_cols=270  Identities=20%  Similarity=0.280  Sum_probs=187.1

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecC---ceEEEE------------------EeecccchhhHHHHHHHHHHhccCCCc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRN---KEIAVK------------------RVSETSRQGKQEFIAEVTTIGSLRHRN  375 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~---~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~n  375 (644)
                      ..++|+..++||+|+||+||++.++.   ...+.|                  ++. ........+.+|+.+|++++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            34689999999999999999987641   111111                  111 11223456889999999999999


Q ss_pred             eeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCC
Q 006446          376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       376 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N  455 (644)
                      |+++++++...+..++|+|++ .++|.+++........   ......+...|+.|++.||.|||+   ++|+||||||+|
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~---~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~N  297 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWK---DRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN  297 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhcccccc---ccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence            999999999999999999998 5677777754332111   113345667899999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCccc
Q 006446          456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQN  534 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P-~~~~~~~  534 (644)
                      ||++.++.+||+|||+++.+.....  .......||..|+|||++.+..++.++|||||||++|||++|+.+ +..... 
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-  374 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-  374 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-
Confidence            9999999999999999987643211  112345799999999999999999999999999999999998754 432221 


Q ss_pred             cchhhHHHHHHHHHh-cC-------chhhhhhcc-c---CCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          535 SYNNSIVHWLWELRR-KG-------RILDAADSR-L---GGEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~-~~-------~~~~~~d~~-l---~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .....+.+.+..... ..       ++.+.++.. +   ...+..     .....+.+++.+|++.||++||++.|+++.
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111122221110000 00       000000000 0   000000     011235667889999999999999999863

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-34  Score=299.10  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=193.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|++|.||+|+..  ++.||+|++.....  ...+.+..|+.++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999976  67899999865432  234578899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~  473 (644)
                      |++ ++|.+++.....      ..+++.....++.||+.||+|||+   .+++||||||+||+++. ++.+||+|||++.
T Consensus        82 ~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD------FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             ccc-ccHHHHHHhCCC------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEccccccc
Confidence            995 678777743321      125778888999999999999999   89999999999999985 5679999999997


Q ss_pred             cccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH----HH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE----LR  548 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~----~~  548 (644)
                      ......   .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+..+...    .+
T Consensus       152 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        152 AFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW  228 (294)
T ss_pred             ccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            654221   112334678899999988654 5789999999999999999999999764432111111110000    00


Q ss_pred             hc-Cchhhhh--hcccCCC----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RK-GRILDAA--DSRLGGE----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~-~~~~~~~--d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .. ..+.+..  -+.....    ........+.+++.+|++.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 0000000  0000000    01112344678899999999999999999986

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.4e-34  Score=299.16  Aligned_cols=263  Identities=19%  Similarity=0.239  Sum_probs=195.4

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      ..+.+|.|+++.||++...++.||+|++...  .....+.+..|+.++++++|+||+++++++.+.+..+++|||+++|+
T Consensus         6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            3455677788888888888899999998754  34455788999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK  480 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~  480 (644)
                      |.+++......      .+++.....++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+........
T Consensus        86 l~~~l~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          86 CEDLLKTHFPE------GLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             HHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            99998654221      37888889999999999999999   8999999999999999999999999999876542221


Q ss_pred             c----cccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH----Hhc
Q 006446          481 T----HHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL----RRK  550 (644)
Q Consensus       481 ~----~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~----~~~  550 (644)
                      .    ........++..|+|||.+..  ..++.++|||||||++|||++|+.||.......   .+.+-....    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  233 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDK  233 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCcccccc
Confidence            1    111233457788999999875  357899999999999999999999997643211   111100000    000


Q ss_pred             Cc-------hhh----hhhcc----cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GR-------ILD----AADSR----LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~-------~~~----~~d~~----l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..       ...    ..++.    ............+.+++.+||+.||++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00       000    00000    0011122234567789999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-34  Score=292.63  Aligned_cols=245  Identities=25%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||.||+++..  +..+++|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987  78899999865433   4456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++....        .+++..+..++.|+++||+|||+   .+++||||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~l~~~~--------~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          81 ASLLENVG--------SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             HHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            99986432        38899999999999999999998   89999999999999999999999999998765322110


Q ss_pred             -----cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          482 -----HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       482 -----~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                           ........++..|++||.......+.++||||||+++|||++|+.||......    .+..   .. ..+..   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~---  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQ---NI-LNGKI---  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-hcCCc---
Confidence                 01123456788999999998888999999999999999999999998754421    1111   11 11111   


Q ss_pred             hhcccCCCCCHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEK--EMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~--~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                             .....  ....+..++.+|++.+|.+||++.++.+.|+.
T Consensus       219 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         219 -------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence                   01111  24567789999999999999999777776664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-34  Score=287.66  Aligned_cols=246  Identities=28%  Similarity=0.476  Sum_probs=201.1

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||+|++|.||+++..  +..+++|.+.....  ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999876  67899999876543  4567899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++....        .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~L~~~~~~~~--------~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          81 AENGSLRQIIKKFG--------PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             CCCCcHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999999986442        38999999999999999999998   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ......   .....++..|+|||......++.++||||+|+++|||++|+.|+......     ..  .+... ...   
T Consensus       150 ~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~--~~~~~-~~~---  215 (254)
T cd06627         150 NDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AA--LFRIV-QDD---  215 (254)
T ss_pred             CCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HH--HHHHh-ccC---
Confidence            532211   23346788999999998888899999999999999999999998654311     11  11111 111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            ...++......+.+++.+|++.+|++||++.++++
T Consensus       216 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 ------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                  11122223456778899999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.3e-34  Score=295.89  Aligned_cols=257  Identities=17%  Similarity=0.201  Sum_probs=182.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCc-----eEEEEEeecccchhh-----------HHHHHHHHHHhccCCCceeeEeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNK-----EIAVKRVSETSRQGK-----------QEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~-----~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      ++|+..++||+|+||.||+|...+.     .+++|..........           .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            6788999999999999999987633     456664332221110           112334455667789999999997


Q ss_pred             eeecc----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          383 CYERH----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       383 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +....    ..++++|++. .++.+.+....        ..++.....|+.|++.||+|||+   .+|+||||||+|||+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill  159 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--------CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMV  159 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc--------cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            76543    2467777763 35555543221        14677888999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          459 DSEFNARLGDFGLARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                      +.+++++|+|||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            999999999999998764221110    1122346999999999999999999999999999999999999999765322


Q ss_pred             cchhhH--HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          535 SYNNSI--VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       535 ~~~~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ......  .++.... ..++        +..   ......+.+++..|++.+|++||++.++++.|+
T Consensus       240 ~~~~~~~~~~~~~~~-~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRL-HEGK--------IKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHh-hhhh--------hcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            211000  1111111 1111        100   112355778899999999999999999999874

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.1e-34  Score=287.84  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=203.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..+.||.|+||.||++...  +..+++|++.....  ...+.+..|++++++++|+|++++.+.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999987  78899999876533  4567788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....    ....+++..+..++.++++||.|||+   .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          81 ADGGDLSQKIKKQKK----EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             cCCCcHHHHHHHhhc----cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeec
Confidence            999999999865431    11248999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....   .......|+..|+|||.+....++.++||||+|+++++|++|+.||......    .+..   ... .+.   
T Consensus       154 ~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~~-~~~---  219 (258)
T cd08215         154 SSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELAL---KIL-KGQ---  219 (258)
T ss_pred             ccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHH---HHh-cCC---
Confidence            5322   1123346888999999998888999999999999999999999998654321    1111   111 111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ....+......+.+++.+|++.+|++||++.++++.
T Consensus       220 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 ------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  111222334567789999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=290.62  Aligned_cols=244  Identities=25%  Similarity=0.306  Sum_probs=189.4

Q ss_pred             CcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHH-HhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTT-IGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +.||+|+||.||+|+..  ++.||+|.+.....   .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999885  67899999865432   222334455444 4456899999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++....        .+++..+..++.|+++||.|||+   .+++||||+|+||+++.++.+||+|||+++.... 
T Consensus        82 ~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          82 GDCASLIKTLG--------GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             CCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            99999986432        37888899999999999999999   8999999999999999999999999999875432 


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                            .....++..|+|||.+.+..++.++||||||+++|||++|..||.......    +    +.....+..     
T Consensus       150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~----~~~~~~~~~-----  210 (260)
T cd05611         150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA----V----FDNILSRRI-----  210 (260)
T ss_pred             ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH----H----HHHHHhccc-----
Confidence                  223467889999999988888999999999999999999999996543211    1    111111111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                       .............+.+++.+|++.+|++||++.++.+.|+.
T Consensus       211 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         211 -NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             -CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence             01111112234567889999999999999988777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.6e-34  Score=297.95  Aligned_cols=243  Identities=24%  Similarity=0.370  Sum_probs=195.2

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ..+||+|+||.||++...  +..||+|++..........+..|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999885  678999998765555667789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++...         .+++.....++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......  
T Consensus       105 ~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--  170 (292)
T cd06657         105 TDIVTHT---------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  170 (292)
T ss_pred             HHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--
Confidence            9887432         27889999999999999999999   899999999999999999999999999987654221  


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                       .......|+..|+|||.+....++.++||||||+++|||++|..||.......    .......         ...+.+
T Consensus       171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~----~~~~~~~---------~~~~~~  236 (292)
T cd06657         171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRD---------NLPPKL  236 (292)
T ss_pred             -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh---------hCCccc
Confidence             11233568899999999988889999999999999999999999987543211    1111110         001111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..  .......+.+++.+|++.+|.+||++.++++
T Consensus       237 ~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 KN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            00  0112334667889999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=292.76  Aligned_cols=246  Identities=27%  Similarity=0.421  Sum_probs=207.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      -|+..++||+|.||.||++.++  |..+|+|++...+  ..++...||.+|.+...|++|+++|.+.....+|+|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3666889999999999999987  7889999986544  57899999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      -||+.+.+...+.       +|...++..|+...+.||+|||.   ..-+|||||+.||||+.+|.+||+|||.|-.+.+
T Consensus       112 AGSiSDI~R~R~K-------~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  112 AGSISDIMRARRK-------PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             CCcHHHHHHHhcC-------CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            9999999976554       49999999999999999999999   8889999999999999999999999999987764


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ....   ...+.||+-|||||++..-.|+.++||||+|++..||+-|++||....+-...                . .+
T Consensus       182 TMAK---RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----------------F-MI  241 (502)
T KOG0574|consen  182 TMAK---RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----------------F-MI  241 (502)
T ss_pred             hHHh---hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----------------E-ec
Confidence            4322   34578999999999999999999999999999999999999998764431110                0 00


Q ss_pred             hcccCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          558 DSRLGGE--FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       558 d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...-+..  -+++....+.+.+..|+-.+|++|-++-++++.
T Consensus       242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            0001122  244556678889999999999999999888763

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-34  Score=292.69  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=195.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |+..+.||+|++|.||+|+..  ++.|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            556789999999999999986  67899999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                       +|+|.+++.....      ..+++.++..++.|++.+|.|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        81 -~~~l~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          81 -EGNLYQLMKDRKG------KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             -CCCHHHHHHhccc------ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence             8899988865431      138999999999999999999999   899999999999999999999999999998664


Q ss_pred             ccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH---------HHHH
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH---------WLWE  546 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~---------~~~~  546 (644)
                      ....    .....++..|+|||.+. ...++.++|+||||+++|||++|+.||..............         |...
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd07830         151 SRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG  226 (283)
T ss_pred             CCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence            3211    23456788999999875 45579999999999999999999999865433221111111         1000


Q ss_pred             HHhcCchhhhhhcccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRILDAADSRLGG---EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .................   .........+.+++.+|++.+|++||+++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000000000000   000111356889999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=325.30  Aligned_cols=262  Identities=26%  Similarity=0.443  Sum_probs=208.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ++....+.||+|.||.|++|...         ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44455669999999999999865         23699999986533 4567899999999999 6999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccC-CCCCCC-----c--cccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDE-TNSGPG-----E--VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~~~-----~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      .+++|.||++.|+|.++|..++ ......     .  ..|...+.+.++.|||.|++||++   .++|||||.++|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence            9999999999999999998776 110000     1  248899999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccc--cCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccc
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIA--GTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSY  536 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~  536 (644)
                      ++..+||+|||+|+.........  .+...  -+..|||||.+....++.|||||||||+||||++ |..||......  
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--  528 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--  528 (609)
T ss_pred             CCCEEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence            99999999999999754322211  11122  3557999999999999999999999999999999 88888652211  


Q ss_pred             hhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          537 NNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       537 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       ..+    ++..+.|..+         +.+......+..+++.||+.+|++||+..++.+.++..
T Consensus       529 -~~l----~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 -EEL----LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -HHH----HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             112    2334444432         23334456677899999999999999999999999883

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-34  Score=303.89  Aligned_cols=269  Identities=23%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  388 (644)
                      .++|...+.||+|+||.||+++..  +..||+|++...  .......+..|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999876  688999998653  233345677899999999999999999988654     35


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++|+||+. ++|.+++....        .+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ--------TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECc
Confidence            899999995 78888875432        38899999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH---
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL---  544 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~---  544 (644)
                      ||+++......   .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.......+....   
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         152 FGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             CccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99998664321   11233467889999998765 468999999999999999999999997543211111111100   


Q ss_pred             ----HHHHhcCchhhhhhc---ccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCC
Q 006446          545 ----WELRRKGRILDAADS---RLGG---EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGE  601 (644)
Q Consensus       545 ----~~~~~~~~~~~~~d~---~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  601 (644)
                          +.....+.....+..   ....   .........+.+++.+|++++|++||+++++++.  ++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                000000000000000   0000   0011233557889999999999999999999976  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-34  Score=293.12  Aligned_cols=262  Identities=24%  Similarity=0.314  Sum_probs=197.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |+..+.||+|++|.||++...  +..+++|++......  ....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999886  678999998754332  4567888999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      + ++|.+++.....       .+++..+..++.++++||.|||+   .+++|+||||+||+++.++.+||+|||.+....
T Consensus        81 ~-~~l~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          81 D-TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             C-CCHHHHHHhhcc-------cCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            6 488888765332       38999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-------HHHHH
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-------LWELR  548 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-------~~~~~  548 (644)
                      ...   .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...       .+...
T Consensus       150 ~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (283)
T cd05118         150 SPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF  226 (283)
T ss_pred             CCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence            322   112334678899999998776 7899999999999999999999998654321111111100       00000


Q ss_pred             hc---CchhhhhhcccC--CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RK---GRILDAADSRLG--GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~---~~~~~~~d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..   .......+....  ..........+.+++.+|+++||.+||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00   000000000000  0011223456889999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.4e-34  Score=300.05  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=191.4

Q ss_pred             Cccccc--CcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKG--GFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G--~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ..||+|  +||+||++.+.  ++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999885  7899999986532  23346788999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ++|.+++......      .+++.....++.|++.||+|||+   .+++||||||+|||++.++.+|++||+.+......
T Consensus        84 ~~l~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~  154 (328)
T cd08226          84 GSANSLLKTYFPE------GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN  154 (328)
T ss_pred             CCHHHHHHhhccc------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence            9999988654321      37889999999999999999998   89999999999999999999999999865433211


Q ss_pred             ccccc----cccccccCCCccCccccccC--CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH------
Q 006446          479 LKTHH----STKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE------  546 (644)
Q Consensus       479 ~~~~~----~~~~~~gt~~y~APE~~~~~--~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~------  546 (644)
                      .....    ......++..|+|||++.+.  .++.++|||||||++|||++|+.||........   +......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~  231 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPL  231 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCc
Confidence            11100    01112356679999998764  478999999999999999999999976432111   1110000      


Q ss_pred             ----------HH----------------hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 ----------LR----------------RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ----------~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                                ..                ..+......+..+...........+.+++.+|++.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                      00                000000011111122222344567889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-34  Score=304.13  Aligned_cols=271  Identities=23%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeecc-----ceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-----DFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  390 (644)
                      +|+..+.||+|++|.||+++..  +..+++|++....  ....+.+.+|+.+++.++|+||+++.+++....     .++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999986  6889999987643  344577899999999999999999999998775     789


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ++|||++ ++|.+++....        .+++..+..++.+++.||+|||+   .+|+||||||+|||++.++.++|+|||
T Consensus        81 lv~e~~~-~~l~~~l~~~~--------~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--------PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccC
Confidence            9999997 58888885432        38999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH----
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----  545 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~----  545 (644)
                      ++.................++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.....    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence            998765332111113345678899999999887 789999999999999999999999976543221111111100    


Q ss_pred             ---HHHhcCchhhhhhc-ccCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCC
Q 006446          546 ---ELRRKGRILDAADS-RLGGE-----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEA  602 (644)
Q Consensus       546 ---~~~~~~~~~~~~d~-~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~  602 (644)
                         .........+.+.. .....     ........+.+++.+||+.+|.+||+++++++.  +++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence               00000000000000 00000     011123457789999999999999999999974  55543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-34  Score=293.15  Aligned_cols=259  Identities=24%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhcc---CCCceeeEeeeeeeccc-----
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL---RHRNLVKLIGWCYERHD-----  388 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-----  388 (644)
                      |+..+.||+|+||.||+|+.+  +..+|+|+++....  .....+..|+.+++++   +|+|++++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999986  68899999874322  2234566777777665   59999999999988776     


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .+++|||++ ++|.+++......      .+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.+||+|
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~------~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~d  150 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKP------GLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIAD  150 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEec
Confidence            999999996 5888888653321      38999999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ||++........    .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+   ...
T Consensus       151 fg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~---~~~  223 (287)
T cd07838         151 FGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD---VIG  223 (287)
T ss_pred             cCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH---HcC
Confidence            999987643211    2234578899999999988999999999999999999999999876443221111111   100


Q ss_pred             hcCch---------hhhhhcccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRI---------LDAADSRLGG---EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~---------~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+..         ..........   .........+.+++.+|++.||.+||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000         0000000000   111123456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.1e-34  Score=297.09  Aligned_cols=244  Identities=30%  Similarity=0.456  Sum_probs=192.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..+.||+|+||.||+|+..  +..+++|.+...   .....+++.+|+.++++++|+|++++++++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4666788999999999999985  678999998643   22334578899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+. |+|.+++.....       .+++.++..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~~-~~l~~~~~~~~~-------~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          96 YCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             ccC-CCHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            996 688777654322       37889999999999999999998   8999999999999999999999999999876


Q ss_pred             ccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ...       .....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+.......   .+..    . ..+
T Consensus       165 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~----~-~~~  229 (308)
T cd06634         165 MAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH----I-AQN  229 (308)
T ss_pred             ecC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHH----H-hhc
Confidence            532       22346788999999874   3567889999999999999999999986533211   1111    1 111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..     +..   ........+.+++.+||+.+|++||++.++++.
T Consensus       230 ~~-----~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         230 ES-----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CC-----CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            10     111   111233557789999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.4e-34  Score=303.78  Aligned_cols=268  Identities=22%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeee----ccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~  389 (644)
                      ..+|+..+.||+|+||.||+|+..  +..||+|++....  ....+.+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999876  7889999987542  2345667889999999999999999998763    3468


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++|+||+. ++|.+++....        .+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ--------PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccc
Confidence            99999994 68988875332        38899999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccc-cccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH----
Q 006446          470 GLARTIQENLKTHH-STKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW----  543 (644)
Q Consensus       470 Gla~~~~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~----  543 (644)
                      |+++.......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+...    
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~  231 (334)
T cd07855         152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP  231 (334)
T ss_pred             ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence            99986643221111 1234578899999998765 46899999999999999999999999764322111000000    


Q ss_pred             ---HHHHHhcCchhhhhhcc-cCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          544 ---LWELRRKGRILDAADSR-LGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       544 ---~~~~~~~~~~~~~~d~~-l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                         .++......+....+.. ......     ......+.+++.+|++.+|++||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00000000011111000 001111     1234568889999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=281.02  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             CCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEeccCC
Q 006446          323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ....||.|..|.|++.+.+  +..+|||.+.... .++.++.+..+.++...+ +|.||+.+|++..+...++.||.| .
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence            3677999999999999998  5889999997654 445667777887777664 899999999999999999999999 5


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      ..++++|..-..       .++....=++...+..||.||.+  .++|+|||+||+|||+|+.|++||||||++-.+-+.
T Consensus       175 ~C~ekLlkrik~-------piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  175 TCAEKLLKRIKG-------PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHHhcC-------CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            567777754433       26666677888899999999998  579999999999999999999999999999776543


Q ss_pred             ccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ..    .+..+|.+.|||||.+.   ..+|+.++||||||+.|+||+||+.||.....+-  +.+..          ++.
T Consensus       246 kA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltk----------vln  309 (391)
T KOG0983|consen  246 KA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTK----------VLN  309 (391)
T ss_pred             cc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHH----------HHh
Confidence            22    45678999999999985   4578999999999999999999999998755332  11111          111


Q ss_pred             hhhcccCCC--CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGE--FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      -..+.|++.  |+.    .+.++...|++.|+.+||...++++.
T Consensus       310 ~ePP~L~~~~gFSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 EEPPLLPGHMGFSP----DFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCCCCCCcccCcCH----HHHHHHHHHhhcCcccCcchHHHhcC
Confidence            122444432  343    45567779999999999999999863

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.2e-33  Score=294.93  Aligned_cols=243  Identities=29%  Similarity=0.455  Sum_probs=191.3

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      |...++||+|+||+||+|+..  +..|++|++.....   ...+.+..|+.++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999875  67899999865322   3345688899999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +. |+|.+++.....       .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~~~-------~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            95 677777754332       38999999999999999999998   89999999999999999999999999998643


Q ss_pred             cccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ..       .....|+..|+|||++.   .+.++.++|||||||++|||++|+.|+.......    .   +...... .
T Consensus       172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~---~~~~~~~-~  236 (313)
T cd06633         172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A---LYHIAQN-D  236 (313)
T ss_pred             CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----H---HHHHHhc-C
Confidence            21       22356888999999984   4568899999999999999999999986543211    1   1111111 1


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .     +..   ........+.+++.+|++.+|.+||++.++++.
T Consensus       237 ~-----~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 S-----PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C-----CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     111   111122357788999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.4e-33  Score=287.78  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=188.4

Q ss_pred             HHHHhCCCCCCCcc--cccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          314 LKKATGNFNPKNKL--GKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       314 l~~a~~~f~~~~~L--G~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      .....++|+..+.+  |+|+||.||+++..  +..+|+|.+........     |+.....+ +|+||+++++++...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            33344566666666  99999999999876  67899998865322111     22222212 69999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEe
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLG  467 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~  467 (644)
                      .++||||+++++|.+++....        .++|.+...++.|+++||.|||+   .+++||||||+||+++.++ .++|+
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG--------KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999986543        38999999999999999999999   8999999999999999998 99999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++....       .....++..|+|||++....++.++|||||||++|||++|+.||........  ....+....
T Consensus       153 dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~  223 (267)
T PHA03390        153 DYGLCKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ  223 (267)
T ss_pred             cCccceecCC-------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh
Confidence            9999876542       1234688999999999988899999999999999999999999975432211  112221111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-MKTVLQ  596 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~  596 (644)
                        ..        .  ..........+.+++.+|++++|.+||+ ++++++
T Consensus       224 --~~--------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 --QK--------K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --cc--------c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              00        0  0111133456778889999999999995 688874

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-34  Score=301.58  Aligned_cols=266  Identities=21%  Similarity=0.300  Sum_probs=193.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      .++|...+.||+|+||.||+|+..  +..||+|++....  ......+.+|+.++++++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378989999999999999999875  7889999986432  223456889999999999999999999987543      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++|+||+. .+|..++.   .       .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~-------~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---H-------PLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---C-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEe
Confidence            4699999995 46665541   1       27889999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH---
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW---  543 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~---  543 (644)
                      |||+++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...   
T Consensus       160 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  233 (342)
T cd07879         160 DFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  233 (342)
T ss_pred             eCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999764321      233467889999999876 46889999999999999999999999764321111111100   


Q ss_pred             ----HHHHHhcCchhhhhh--ccc-CCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCC
Q 006446          544 ----LWELRRKGRILDAAD--SRL-GGEFS---EKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEAD  603 (644)
Q Consensus       544 ----~~~~~~~~~~~~~~d--~~l-~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~  603 (644)
                          ..+............  +.. .....   ......+.+++.+|+++||++||++.++++.  +++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                000000000000000  000 00000   0122346789999999999999999999943  665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-33  Score=295.34  Aligned_cols=264  Identities=24%  Similarity=0.304  Sum_probs=192.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      .++|+..++||+|+||.||+|+..  +..+++|++......  ....+.+|++++++++|+||+++++.+.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999986  678999998654322  2346778999999999999999999875433      


Q ss_pred             --ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          388 --DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       388 --~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                        .+++|+||+. ++|...+.....       .+++..+..++.|+++||.|||+   .+++||||||+||++++++.+|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~  155 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSV-------KLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILK  155 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence              4699999995 467666643322       38999999999999999999999   8999999999999999999999


Q ss_pred             EeccCCccccccccccc--------ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccc
Q 006446          466 LGDFGLARTIQENLKTH--------HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSY  536 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~--------~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~  536 (644)
                      |+|||+++.........        .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~  235 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ  235 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999998654322111        111234578889999987654 578999999999999999999999876443221


Q ss_pred             hhhHHHHHHHHHhcC---------chhhhhhcccCCCCC-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          537 NNSIVHWLWELRRKG---------RILDAADSRLGGEFS-------EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       537 ~~~l~~~~~~~~~~~---------~~~~~~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...+    +......         .+....+.......+       ......+.+++.+|++.||++||++.++++
T Consensus       236 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         236 LHLI----FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHH----HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111    1111000         000000000000000       011245778999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-33  Score=294.20  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=192.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+|.+.  +..||||+++... .....++..|+.++.+.. |+||++++++|.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            56778899999999999999997  7889999987543 234456677887777765 9999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ ++|.+++.....       .+++..+..++.+++.||+|||+  ..+|+||||+|+||++++++.+||+|||++..
T Consensus        95 ~~~-~~l~~l~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          95 LMS-TCLDKLLKRIQG-------PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             ccC-cCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            984 577666644222       38999999999999999999996  24899999999999999999999999999976


Q ss_pred             ccccccccccccccccCCCccCccccccCC----CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGR----ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ......    .....++..|+|||.+....    ++.++||||||+++|||++|+.||......  .. ...   .....
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~-~~~---~~~~~  234 (296)
T cd06618         165 LVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FE-VLT---KILQE  234 (296)
T ss_pred             ccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HH-HHH---HHhcC
Confidence            542111    22345788999999987553    789999999999999999999998653211  01 111   11111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .      .+.+..  .....+.+.+++.+|++.||++||++.++++.
T Consensus       235 ~------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 E------PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C------CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0      001110  01123467889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.6e-34  Score=292.40  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|...+.||+|+||.||+++..  +..+++|++...   .....+.+..|+.++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999985  788999998653   2233467888999999998 99999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++++|.+++....        .+++..+..++.|++.||.|||+   .+++|+||||+||+++.+++++|+|||++
T Consensus        81 ~e~~~~~~L~~~l~~~~--------~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--------SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccc
Confidence            99999999999986543        38999999999999999999998   89999999999999999999999999999


Q ss_pred             ccccccccc-----------------cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          473 RTIQENLKT-----------------HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       473 ~~~~~~~~~-----------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      .........                 ........++..|+|||.+....++.++||||||++++|+++|+.||...... 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence            866432211                 01123345789999999998888999999999999999999999998764321 


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM----KTVLQ  596 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~----~evl~  596 (644)
                         .......    .          ....++....+.+.+++.+|++.+|.+||++    +++++
T Consensus       229 ---~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ---LTFQKIL----K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HHHHHHH----h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               1111111    0          1112222334567889999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-33  Score=299.10  Aligned_cols=272  Identities=19%  Similarity=0.262  Sum_probs=200.6

Q ss_pred             cccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeee
Q 006446          307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      ++....++...+++|+..+.||+|+||.||++...  +..||+|++....  ....+.+.+|+.++++++|+||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            34445677788899999999999999999999865  6789999986532  2334667889999999999999999998


Q ss_pred             eeec------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCE
Q 006446          383 CYER------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI  456 (644)
Q Consensus       383 ~~~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI  456 (644)
                      +...      ...+++++++ +++|.+++...         .+++..+..++.|+++||+|||+   .+|+||||||+||
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NI  151 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNL  151 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHE
Confidence            8643      3468888887 88998877432         28899999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          457 MLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       457 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      ++++++.+||+|||+++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus       152 ll~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  225 (345)
T cd07877         152 AVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  225 (345)
T ss_pred             EEcCCCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999998764321      234567889999998866 567899999999999999999999986543221


Q ss_pred             chhhHHHHH-------HHHHhcC---chhhhhhcccCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          536 YNNSIVHWL-------WELRRKG---RILDAADSRLGGEFS---EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       536 ~~~~l~~~~-------~~~~~~~---~~~~~~d~~l~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ....+..+.       .......   ......+......+.   ......+.+++.+|++.||.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111111100       0000000   000000000000000   0123456789999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-33  Score=288.32  Aligned_cols=240  Identities=21%  Similarity=0.282  Sum_probs=185.2

Q ss_pred             cccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHH---HHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEV---TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .||+|+||.||++...  ++.||+|.+.....   .....+..|.   ..++...||||+++++.+...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875  67899999865421   1122333443   34455689999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 g~~L~~~l~~~~--------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          81 GGDLHYHLSQHG--------VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999998885432        38999999999999999999999   8999999999999999999999999999876532


Q ss_pred             cccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ..     .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||......... .    ......      .
T Consensus       150 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~----~~~~~~------~  213 (278)
T cd05606         150 KK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E----IDRMTL------T  213 (278)
T ss_pred             cC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-H----HHHHhh------c
Confidence            11     2234689999999998755 5899999999999999999999999764322111 0    011100      0


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                      ...    ..+......+.+++.+|++.+|.+||     ++.++++
T Consensus       214 ~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 MAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            111    12222235677888999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-33  Score=292.60  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=198.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc----chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS----RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      +|+..+.||+|++|.||+++..     +..+|+|.++...    ....+.+..|+.++.++ +|+||+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667889999999999998753     4679999987532    22345688999999999 599999999999988899


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||+++|+|.+++....        .+++.....++.|+++||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE--------HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC--------CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEEC
Confidence            99999999999999986432        37888999999999999999998   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |+++.......  .......|+..|+|||.+.+..  .+.++||||||+++|||++|..||...........+   ....
T Consensus       150 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~  224 (288)
T cd05583         150 GLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRI  224 (288)
T ss_pred             ccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHH
Confidence            99886543211  1122346889999999987665  788999999999999999999998643221111111   1111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..       ..+.....    ....+.+++.+|++.||++|||++++.+.|+..
T Consensus       225 ~~-------~~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         225 LK-------SKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             Hc-------cCCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            10       01111122    234567788999999999999999998888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.4e-33  Score=290.87  Aligned_cols=250  Identities=22%  Similarity=0.269  Sum_probs=193.6

Q ss_pred             CCCCCCcccccCcEEEEEeee-----cCceEEEEEeecccc----hhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          320 NFNPKNKLGKGGFGTVYKGIW-----RNKEIAVKRVSETSR----QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      +|+..+.||+|+||.||++..     .+..||+|++.....    ...+.+..|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999886     367899999875322    2346678899999999 599999999999988899


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++|+||+++++|.+++....        .+++.....++.|++.||.|||+   .+++||||||+|||++.++.+||+||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--------RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999986532        27888888999999999999999   99999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccC--CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |+++.......  .......|+..|+|||.+...  .++.++||||||+++|||++|+.||........   ...+....
T Consensus       150 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~  224 (290)
T cd05613         150 GLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRRI  224 (290)
T ss_pred             ccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHHHHh
Confidence            99986542211  112345688999999998753  467899999999999999999999864322111   11111111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                      ...           ...++......+.+++.+|++.||++||     +++++++
T Consensus       225 ~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            110           0112222334667889999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-33  Score=296.24  Aligned_cols=266  Identities=21%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             HHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee-cc
Q 006446          313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RH  387 (644)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~  387 (644)
                      ++...+++|+..+.||+|+||.||++...  +..||+|++...  .....+.+..|+.++++++||||+++.+++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34456789999999999999999999876  678999988643  22345678899999999999999999998865 55


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++++||+ +++|.+++...         .+++.....++.|+++||.|||+   .+++||||||+||++++++.+||+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~---------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR---------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeC
Confidence            789999998 67888877432         26778888999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH--
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL--  544 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~--  544 (644)
                      |||+++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++.  
T Consensus       151 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         151 DFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             ccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99998754321      223457889999998766 568999999999999999999999986543211111111110  


Q ss_pred             -----HHHHhcCchhhhhh-cccCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 -----WELRRKGRILDAAD-SRLGGEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 -----~~~~~~~~~~~~~d-~~l~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           .+....+...+... -......+.     .....+.+++.+|++++|++||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000000011100 000111111     123567889999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=333.38  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ..+-++.....||.|.||.||.|...  |.-.|+|.++-..  ....+...+|+.++..++|||+|+++|+=.+++.++|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            34567888999999999999999876  6678999876443  3344667889999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      .||||++|+|.+.+...+.        .+.....-+..|++.|++|||+   .+||||||||.||+||.+|-+|++|||.
T Consensus      1312 FMEyC~~GsLa~ll~~gri--------~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI--------EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHhccCcHHHHHHhcch--------hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccc
Confidence            9999999999999865432        4555556678999999999999   9999999999999999999999999999


Q ss_pred             cccccccccc-cccccccccCCCccCccccccCC---CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          472 ARTIQENLKT-HHSTKEIAGTPGYMAPESFLVGR---ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       472 a~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~---~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |.....+... ........||+.|||||.+.+.+   -..+.||||+|||++||+||++||...+..   ..++.    .
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy----~ 1453 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMY----H 1453 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHh----H
Confidence            9988755311 12235678999999999997543   467899999999999999999999765431   11211    1


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                      ...|..         +.+++.....-.+.+..|++.||++|.++.|+++.=
T Consensus      1454 V~~gh~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1454 VAAGHK---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HhccCC---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            122222         233333444456678899999999999988887754

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=307.77  Aligned_cols=248  Identities=24%  Similarity=0.423  Sum_probs=198.2

Q ss_pred             CCCCCcccccCcEEEEEeeecCc--eEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~~--~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      |++...||.|+||.||++..+..  --|.|.+...+....++|+-||.||..+.||+||+|++.+...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            34466799999999999988743  3577888777778889999999999999999999999999999999999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |-++..+..-..       .|...++.-++++++.||.|||+   ++|||||||+.|||++-+|.++|+|||.+....  
T Consensus       114 GAVDaimlEL~r-------~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--  181 (1187)
T KOG0579|consen  114 GAVDAIMLELGR-------VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--  181 (1187)
T ss_pred             chHhHHHHHhcc-------ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--
Confidence            999988764433       38899999999999999999999   999999999999999999999999999986532  


Q ss_pred             ccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                       ..........||+.|||||+..     ..+|+.++||||||++|.||+.+.+|-....+-   ..++.    .. +.. 
T Consensus       182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllK----ia-KSe-  251 (1187)
T KOG0579|consen  182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLK----IA-KSE-  251 (1187)
T ss_pred             -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHH----Hh-hcC-
Confidence             1222245678999999999875     457899999999999999999999985432210   11111    10 000 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .|.|  --+......+.+++.+|+..||..||++.++++
T Consensus       252 ----PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 ----PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ----CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                1111  112234556778889999999999999999874

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.8e-33  Score=297.90  Aligned_cols=265  Identities=23%  Similarity=0.272  Sum_probs=192.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec----------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER----------  386 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~----------  386 (644)
                      .+|...+.||.|+||.||+|+..  +..||+|++........+.+.+|+.++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999886  678999998776656667889999999999999999999776543          


Q ss_pred             ----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-C
Q 006446          387 ----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-E  461 (644)
Q Consensus       387 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~  461 (644)
                          ...++|+||++ ++|.+++...         .+++.....++.||++||.|||+   .+++||||||+||+++. +
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~  151 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG---------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED  151 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence                35799999996 6888877432         27889999999999999999999   89999999999999974 5


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +.+||+|||+++................++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67899999999865422111111233467889999998754 45788999999999999999999999764432111111


Q ss_pred             HHHHHH--HHhcCchh----hhhh-cccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          541 VHWLWE--LRRKGRIL----DAAD-SRLGGEF-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       541 ~~~~~~--~~~~~~~~----~~~d-~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..-...  ........    .... .......     .......+.+++.+|+++||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            100000  00000000    0000 0000000     0112245678999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=296.92  Aligned_cols=263  Identities=21%  Similarity=0.260  Sum_probs=193.7

Q ss_pred             CCCC-CCCcccccCcEEEEEeeec--CceEEEEEeecccchh--------------hHHHHHHHHHHhccCCCceeeEee
Q 006446          319 GNFN-PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG--------------KQEFIAEVTTIGSLRHRNLVKLIG  381 (644)
Q Consensus       319 ~~f~-~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~g  381 (644)
                      ++|. ..+.||+|+||.||+|...  +..||+|+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3567999999999999876  7889999986543221              124778999999999999999999


Q ss_pred             eeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      ++..++..++||||++ |+|.+++....        .+++.....++.|++.||.|||+   .+++||||||+||+++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--------RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSK  155 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCC
Confidence            9999999999999995 78988885322        37889999999999999999998   899999999999999999


Q ss_pred             CcEEEeccCCccccccccc-----------ccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCC
Q 006446          462 FNARLGDFGLARTIQENLK-----------THHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGN  529 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~  529 (644)
                      +.+||+|||+++.......           .........++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999976541110           00111223467889999998764 46899999999999999999999987


Q ss_pred             CCccccchhhHHHHHHHHHhcCch---hhhhh--------cccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          530 QSEQNSYNNSIVHWLWELRRKGRI---LDAAD--------SRLGGE---FSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d--------~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                      ......    ....+........-   ....+        ......   ........+.+++.+|++.+|++||++++++
T Consensus       236 ~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        236 GENEID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCHHH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            654322    11112221111100   00000        000000   0011234577899999999999999999998


Q ss_pred             HH
Q 006446          596 QV  597 (644)
Q Consensus       596 ~~  597 (644)
                      ..
T Consensus       312 ~~  313 (335)
T PTZ00024        312 KH  313 (335)
T ss_pred             cC
Confidence            63

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=290.72  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |+..++||+|++|.||+|+..  ++.+++|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999987  6889999987653  333467889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      + ++|.+++.....       .+++..+..++.+++.||.|||+   .+++||||+|+||++++++.+||+|||+++...
T Consensus        81 ~-~~l~~~i~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          81 D-MDLKKYLDKRPG-------PLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             C-cCHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            7 689999875432       38999999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-------HHHH
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-------WELR  548 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-------~~~~  548 (644)
                      ....   ......++..|+|||.+... .++.++|||||||++|||++|+.||...........+....       |...
T Consensus       150 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         150 IPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             CCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence            3211   12234567789999998766 78999999999999999999999987654322111111110       0000


Q ss_pred             hcCchhhhhhcccCC-CC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGG-EF---SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~-~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..-...+..-+.... ..   .......+.+++.+|++.||++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000000 00   0011346888999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=293.68  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=200.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +.|..-++||+||||.||-+..+  |+-+|+|++.+.   .+++....+.|-.+|.+++.+.||.+--.+..++.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56778899999999999988765  788999988543   3445566788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ..|.+|+|.-+|+.....      .++....+.++.+|+.||++||+   .+||.|||||+|||||+.|+++|+|+|||.
T Consensus       265 tlMNGGDLkfHiyn~g~~------gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNP------GFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             EeecCCceeEEeeccCCC------CCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEE
Confidence            999999999999765432      48888999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+.....    ....+||.+|||||+++++.|+...|.||+||++|||+.|+.||....+......              
T Consensus       336 ei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE--------------  397 (591)
T KOG0986|consen  336 EIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE--------------  397 (591)
T ss_pred             ecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH--------------
Confidence            8763321    3345899999999999999999999999999999999999999976443221111              


Q ss_pred             hhhhhccc---CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006446          554 LDAADSRL---GGEFSEKEMECVLILGLACCHPNPHLRPSMK  592 (644)
Q Consensus       554 ~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  592 (644)
                         +|.+.   ..++++...+....|....++.||++|..-+
T Consensus       398 ---vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  398 ---VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               11111   1234444455666677788899999997554

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=295.78  Aligned_cols=268  Identities=19%  Similarity=0.282  Sum_probs=197.0

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc---
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH---  387 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~---  387 (644)
                      ....++|+..+.||+|+||.||++...  +..||||++...  .....+.+..|+.++++++|+||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999875  778999998543  2233456889999999999999999999887543   


Q ss_pred             ---ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          388 ---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       388 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                         ..++|+||+ +++|.+++...         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~---------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE---------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCE
Confidence               458999999 77898887432         38899999999999999999999   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++.....      .....++..|+|||.+.+ ..++.++|||||||++|++++|+.||...........+...
T Consensus       158 kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07880         158 KILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV  231 (343)
T ss_pred             EEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999865421      233467889999998875 45889999999999999999999999764321111111100


Q ss_pred             -------HHHHHhcCchhhhhh--cccC-CC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          544 -------LWELRRKGRILDAAD--SRLG-GE---FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       544 -------~~~~~~~~~~~~~~d--~~l~-~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                             ...............  +... ..   ........+.+++.+|++.||++||++.++++  .++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                   000000000000000  0000 00   00112234678999999999999999999983  34443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=308.09  Aligned_cols=202  Identities=31%  Similarity=0.467  Sum_probs=173.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc------ceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------DFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~  390 (644)
                      .+...+.||+|+||.||+|+.+  |..||||.++... ....+....|+++|++|+|+|||++.++=.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4566789999999999999976  8899999997653 344567789999999999999999999866543      579


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc--CCC--cEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD--SEF--NARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~--~vkL  466 (644)
                      +|||||.+|||+..|......     ..|+..+.+.++.+++.||.|||+   ++|+||||||.||++-  .++  .-||
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~-----~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENA-----YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEee
Confidence            999999999999999654433     349999999999999999999998   9999999999999993  223  4699


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      +|||.|+.++++.    .....+||..|++||++. .+.|+..+|.|||||++||++||..||.....
T Consensus       166 tDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  166 TDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9999999887543    256789999999999998 48899999999999999999999999987544

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-33  Score=285.47  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=192.8

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-----cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-----SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +|...++||+|+||.||+++..  +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4777899999999999999876  334555555432     122344567899999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+++++|.+++......    ...+++.+++.++.|+++||.|||+   .+++|+||||+||+++. +.+||+|||++
T Consensus        81 ~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHT----GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhc----ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCce
Confidence            9999999999988643211    1248999999999999999999999   89999999999999976 56999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.......   ......|+..|+|||.+....++.++|+||||+++|+|++|+.||.....       ....... ..+.
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~-~~~~  221 (260)
T cd08222         153 RLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRI-VEGP  221 (260)
T ss_pred             eecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH-HcCC
Confidence            77643211   12334578899999999888889999999999999999999999864321       1111111 1111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               ....+......+.+++.+|++.+|++||++.++++
T Consensus       222 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ---------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                     11223334456788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-34  Score=298.39  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeec--ccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ...|++.++||.||.++||++... .+.+|+|++..  .+.+...-|..|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            456888999999999999999887 46688887754  34556778999999999995 999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||- +-+|.++|.+....      ...| .+..+..|+++|+.++|+   .+|||.||||.|+|+-+ |.+||+|||+|.
T Consensus       440 E~G-d~DL~kiL~k~~~~------~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSI------DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             ecc-cccHHHHHHhccCC------CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            986 67899999765543      2446 667899999999999999   99999999999999865 689999999999


Q ss_pred             cccccccccccccccccCCCccCccccccC-----------CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVG-----------RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      .+..+ .........+||+.||+||.+...           +.++++||||+||+||+|+.|+.||.....        .
T Consensus       508 aI~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~  578 (677)
T KOG0596|consen  508 AIQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------Q  578 (677)
T ss_pred             ccCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------H
Confidence            88643 223334677999999999988422           357899999999999999999999864210        1


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEK-EMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      |       .++..+.++...-+|+.. .-..+.+++..|++.||.+||++.++|+.
T Consensus       579 ~-------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  579 I-------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             H-------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1       123344555443344321 11228889999999999999999999873

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=284.56  Aligned_cols=269  Identities=23%  Similarity=0.365  Sum_probs=219.4

Q ss_pred             HHHHHHHhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeee
Q 006446          311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      .+++.....+++...++-+|.||+||+|.+..       +.|.+|.++.... -....++.|...+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45666666789999999999999999997752       3577787765433 345678899999999999999999999


Q ss_pred             eeecc-ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          383 CYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       383 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      |.+.. ..+.+|.++.-|+|..||...+........++.-.+...++.|++.|++|||+   .+|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence            98764 57999999999999999987666555566778899999999999999999999   999999999999999999


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l  540 (644)
                      ..+||+|=.++|.+.+. ..+...+....+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+...  
T Consensus       433 LqVkltDsaLSRDLFP~-DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPG-DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--  509 (563)
T ss_pred             eeEEeccchhccccCcc-cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence            99999999999988743 33333455567889999999999999999999999999999998 999987766543322  


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                            ....|.       |+..  +..+.+.+..++.-||..+|++||+.+|+++-|.+
T Consensus       510 ------ylkdGy-------RlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  510 ------YLKDGY-------RLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ------HHhccc-------eecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                  122222       2222  22445677888889999999999999999988764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=274.54  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             CHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeec
Q 006446          310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYER  386 (644)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~  386 (644)
                      ++.++.+.|     .+.||+|+++.|-.++.-  +.++|||++.+...+.+....+|++++.+.+ |+||++|++|+.++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            356666665     567999999999887654  8899999999888888889999999999984 99999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---  463 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---  463 (644)
                      ..+|||||.|.+|+|..++++..        .++..+..++.++||.||.+||.   ++|.||||||+|||..+...   
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~--------~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK--------HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh--------hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCc
Confidence            99999999999999999997654        38889999999999999999999   99999999999999976544   


Q ss_pred             EEEeccCCcccccccccc-ccc---ccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          464 ARLGDFGLARTIQENLKT-HHS---TKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~-~~~---~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                      +|||||.+..-...+... ...   ....+|...|||||+..     ...|+.+.|.||+||+||-|++|.+||.+....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            899999998654322111 111   12457888999999863     345789999999999999999999999764332


Q ss_pred             cc--h-----hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHH----HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          535 SY--N-----NSIVHWLWELRRKGRILDAADSRLGGEFSEKEM----ECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       535 ~~--~-----~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~----~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .-  .     ..-.+.+.+-.++|+.          +|++++-    ....+|+...+..|+.+|.++.++++
T Consensus       298 dCGWdrGe~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  298 DCGWDRGEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCccCCCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            11  0     1111122233333332          4444432    33456777777899999999999887

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-32  Score=289.79  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=190.6

Q ss_pred             CCCCCCcccccCcEEEEEeeec----CceEEEEEeecc--cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeec----cc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR----NKEIAVKRVSET--SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER----HD  388 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~  388 (644)
                      +|+..+.||+|+||.||+++..    +..+|+|++...  .....+.+.+|+.+++++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999986    457999998643  222356788899999999 599999999876432    35


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++++||+. ++|.+++....        .+++..+..++.|++.||.|||+   .+++||||||+|||+++++.+||+|
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ--------PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCc
Confidence            788899885 78988885432        38899999999999999999999   8999999999999999999999999


Q ss_pred             cCCccccccccccc-ccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH---
Q 006446          469 FGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW---  543 (644)
Q Consensus       469 FGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~---  543 (644)
                      ||+++......... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...   
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  228 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT  228 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence            99998664322111 11234578999999998765 46899999999999999999999998764422111111110   


Q ss_pred             -----HHHHHhcCchhhh---hhcccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          544 -----LWELRRKGRILDA---ADSRLGGE---FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       544 -----~~~~~~~~~~~~~---~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ....... .....   ....-...   ........+.+++.+|++.||++||++.++++
T Consensus       229 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         229 PDEETLSRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCHHHHHhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0000000 00000   00000000   00112345778999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-33  Score=296.73  Aligned_cols=261  Identities=20%  Similarity=0.300  Sum_probs=195.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc----
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD----  388 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----  388 (644)
                      ..++|+..+.||+|++|.||+|+..  +..||+|++...  .....+.+.+|+.++++++|+||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578889999999999999999986  678999998653  22334667789999999999999999998766554    


Q ss_pred             --eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          389 --FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       389 --~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                        .++|+||+ +++|.+++...         .+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ---------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEE
Confidence              89999998 67998888531         38999999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-  544 (644)
                      +|||++......      .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...........+.+.. 
T Consensus       160 ~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~  233 (343)
T cd07851         160 LDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG  233 (343)
T ss_pred             cccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence            999999865422      233467889999998865 367899999999999999999999997543321111111100 


Q ss_pred             ------HHHHhcC---chhhhhhcccCCCCC---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 ------WELRRKG---RILDAADSRLGGEFS---EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 ------~~~~~~~---~~~~~~d~~l~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            +......   .........-...+.   ......+.+++.+|++++|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                  0000000   000000000000110   012456788999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=280.11  Aligned_cols=263  Identities=26%  Similarity=0.363  Sum_probs=195.9

Q ss_pred             CcccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEee
Q 006446          306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLIG  381 (644)
Q Consensus       306 ~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g  381 (644)
                      ...|+-..|+.       ...||.|+||+|+|-.++  ++..|||+++.... .+.++++.|.+...+- ++||||+++|
T Consensus        58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            45566665554       678999999999999887  78999999986543 5667888888765554 7999999999


Q ss_pred             eeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      .+..++..|+.||.| .-||+.+-..-...   ....++....-+|..-...||.||.+  +..|||||+||+|||||..
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~v---q~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~  204 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSV---QKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRH  204 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHH---HhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecC
Confidence            999999999999999 67887654321100   00126666666777788899999998  5789999999999999999


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                      |.+||||||++-.+.+...    .+.-+|...|||||.+..  ..|+.+|||||+|++|+|++||+.|+....      +
T Consensus       205 G~vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------s  274 (361)
T KOG1006|consen  205 GDVKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------S  274 (361)
T ss_pred             CCEeeecccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------H
Confidence            9999999999987654322    455689999999999863  348999999999999999999999986532      2


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCC-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFS-EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +.+-+.+. ..|..     +.+-.... .+....+...+-.|+..|-+.||+..++.++
T Consensus       275 vfeql~~V-v~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  275 VFEQLCQV-VIGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHH-HcCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22212111 11221     22211111 1223345667778999999999999998753

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=297.82  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=204.0

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      -.+.|.....||+|.|+.|.++++.  +.+||+|.+.+..  ....+.+.+|+.+|..++|||||+++++......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467889999999999999999987  7899999997653  23345688999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+.+|.+.+|+.....        +.......++.|+.+|++|||.   +.|+|||||++||||+.++++||+|||++
T Consensus       134 ~eya~~ge~~~yl~~~gr--------~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR--------MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             EEeccCchhHHHHHhccc--------chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccc
Confidence            999999999999976654        4446677889999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ..+.....    ....+|++.|.|||++.+.++ .+++|+||+|+++|-|++|..||++....+.....           
T Consensus       203 ~~~~~~~~----lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-----------  267 (596)
T KOG0586|consen  203 TFFDYGLM----LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-----------  267 (596)
T ss_pred             eeeccccc----ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh-----------
Confidence            88763221    456789999999999998876 68999999999999999999999875433221111           


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           +-.+++-  +.-....+.+|+.+++-.+|.+|+++.++++.
T Consensus       268 -----l~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  268 -----LRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -----eeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                 1111111  11223345668889999999999999999864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=278.16  Aligned_cols=235  Identities=27%  Similarity=0.357  Sum_probs=191.9

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      ||+|+||.||++...  +..+++|.+.....   .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999986  67899999875432   2456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT  481 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~  481 (644)
                      .+++....        .+++.....++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--  147 (250)
T cd05123          81 FSHLSKEG--------RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--  147 (250)
T ss_pred             HHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--
Confidence            99986543        38899999999999999999999   999999999999999999999999999998764321  


Q ss_pred             cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       482 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                       .......++..|++||...+...+.++|+||||+++||+++|+.||...+.    ..+...+.   . +          
T Consensus       148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~---~-~----------  208 (250)
T cd05123         148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL---K-D----------  208 (250)
T ss_pred             -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh---c-C----------
Confidence             113445688899999999888899999999999999999999999965432    11111111   0 1          


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKT  593 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  593 (644)
                      ...++......+.+++.+|+..||++||++.+
T Consensus       209 ~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            01122222456778999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=274.82  Aligned_cols=239  Identities=25%  Similarity=0.353  Sum_probs=193.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|.||+|-+++-+  ++.+|+|++++..   ++....-+.|-++|...+||.+..|.-.++..+.+|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            67888999999999999998876  7889999998753   333445567899999999999999998899999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||..+|.|.-+|...+        .++......+-..|.+||.|||+   ++||.||||.+|.|||++|++||+|||+++
T Consensus       248 eyanGGeLf~HLsrer--------~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER--------VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEccCceEeeehhhhh--------cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccch
Confidence            9999999999986644        36666677788999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .--   .....++..+||+.|+|||++....|..+.|.|.+||++|||+|||.||...+..    .+.+.+         
T Consensus       317 E~I---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLI---------  380 (516)
T KOG0690|consen  317 EEI---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELI---------  380 (516)
T ss_pred             hcc---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----HHHHHH---------
Confidence            532   2222356789999999999999999999999999999999999999999875432    222211         


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                       -.-|-+++.....+...    |+.-.+..||.+|.
T Consensus       381 -l~ed~kFPr~ls~eAkt----LLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 -LMEDLKFPRTLSPEAKT----LLSGLLKKDPKKRL  411 (516)
T ss_pred             -HhhhccCCccCCHHHHH----HHHHHhhcChHhhc
Confidence             11233344444544333    44456778999995

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.8e-33  Score=313.65  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=188.8

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec------
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------  386 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------  386 (644)
                      .-..+|+..+.||+||||.|||++.+  |..||||++.... ........+|+..+++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34568999999999999999999876  8999999997653 33456678899999999999999997432110      


Q ss_pred             --------------------------------------------------------------------------------
Q 006446          387 --------------------------------------------------------------------------------  386 (644)
Q Consensus       387 --------------------------------------------------------------------------------  386 (644)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH
Q 006446          387 ---------------------------------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       387 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~  433 (644)
                                                       ..+|+=||||+...|.+++.++.-..       .-...++++.+|++
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-------~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-------QRDEAWRLFREILE  708 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-------hhHHHHHHHHHHHH
Confidence                                             01466677777766666665443210       24456789999999


Q ss_pred             HHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc----c-----------cccccccccccccCCCccCcc
Q 006446          434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ----E-----------NLKTHHSTKEIAGTPGYMAPE  498 (644)
Q Consensus       434 aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~----~-----------~~~~~~~~~~~~gt~~y~APE  498 (644)
                      ||+|+|+   ++||||||||.||+||++..|||+|||+|....    .           ........+..+||.-|+|||
T Consensus       709 GLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999   999999999999999999999999999998721    0           011111235678999999999


Q ss_pred             ccccC---CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHH
Q 006446          499 SFLVG---RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLI  575 (644)
Q Consensus       499 ~~~~~---~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  575 (644)
                      ++.+.   +|+.|+|+||+||+++||+.   ||....+   ...+    ....+.+.+...      ..+...++..-..
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~i----L~~LR~g~iP~~------~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---RASI----LTNLRKGSIPEP------ADFFDPEHPEEAS  849 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH---HHHH----HHhcccCCCCCC------cccccccchHHHH
Confidence            99754   49999999999999999985   5543221   1111    112234443222      2344455566678


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 006446          576 LGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       576 L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ++.|++++||.+|||+.|+|+
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=5.4e-32  Score=311.31  Aligned_cols=144  Identities=28%  Similarity=0.442  Sum_probs=129.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...++||+|+||.||+|.+.  ++.||+|+++...   ......+..|+.++..++|+||+++++++.....+++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999987  7889999987542   233467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++...+.|+.||+.||.|||.   .+|+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--------~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--------YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986432        27888899999999999999999   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=8.8e-33  Score=271.21  Aligned_cols=288  Identities=23%  Similarity=0.307  Sum_probs=208.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec------CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeee-ccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~  389 (644)
                      ..|+....||+|.||.||+++-.      ...+|+|+++.+...  -.....+|+.++++++|||++.|..++.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888999999999999999654      236899999765322  23456789999999999999999999887 7789


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC----CcEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNAR  465 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vk  465 (644)
                      +|++||.+. +|.+.++..+....   ..++-.....|+.||+.|+.|||+   +-|+||||||.|||+..+    |.||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~---~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKA---KQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchh---ccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeE
Confidence            999999954 78887765543322   358888999999999999999999   779999999999999887    9999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchh-----h
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN-----S  539 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~-----~  539 (644)
                      |+|+|++|.+......-.....++-|..|.|||++.+. .||.+.|||+.||++.||++-.+-|...+......     .
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999998655544445778889999999998876 58999999999999999999888776644322111     0


Q ss_pred             HHHHHHHHHhcCc------------h---hhhhhcccCCCCCH-H-------HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          540 IVHWLWELRRKGR------------I---LDAADSRLGGEFSE-K-------EMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       540 l~~~~~~~~~~~~------------~---~~~~d~~l~~~~~~-~-------~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      -++-+.++.....            .   +.-+..+......- .       -...-.+|..+++..||.+|.+++|.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            1111112111100            0   00000000000000 0       0012567888999999999999999987


Q ss_pred             HHhC-CCCCCCCCCCCCC
Q 006446          597 VLSG-EADPPVLPPERPS  613 (644)
Q Consensus       597 ~L~~-~~~~~~~p~~~p~  613 (644)
                      .-=. +.+.|..|..+..
T Consensus       337 h~yF~~d~lpp~pt~~~v  354 (438)
T KOG0666|consen  337 HPYFTEDPLPPLPTSDNV  354 (438)
T ss_pred             ccccccCCCCCCccccee
Confidence            6433 2345555555543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=5.2e-32  Score=272.79  Aligned_cols=218  Identities=21%  Similarity=0.169  Sum_probs=174.2

Q ss_pred             cCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccchhhhc
Q 006446          330 GGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY  407 (644)
Q Consensus       330 G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  407 (644)
                      |.+|.||+++..  ++.+|+|+++...     .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999986  6789999987643     233455555666799999999999999999999999999999999864


Q ss_pred             cCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccc
Q 006446          408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE  487 (644)
Q Consensus       408 ~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  487 (644)
                      ..        .+++.....++.|+++||.|||+   .+++||||||+||+++.++.++|+|||.+......      ...
T Consensus        79 ~~--------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~  141 (237)
T cd05576          79 FL--------NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDG  141 (237)
T ss_pred             hc--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc------ccc
Confidence            32        28899999999999999999999   89999999999999999999999999988765422      122


Q ss_pred             cccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCH
Q 006446          488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSE  567 (644)
Q Consensus       488 ~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  567 (644)
                      ..++..|+|||.+....++.++||||+|+++|||++|+.|+.......      .            ....    ...+.
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~------------~~~~----~~~~~  199 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------N------------THTT----LNIPE  199 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c------------cccc----cCCcc
Confidence            345678999999988889999999999999999999998864321100      0            0000    01112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          568 KEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       568 ~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                      .....+.+++.+|++.||++||++
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCC
Confidence            223457788999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=9e-31  Score=294.41  Aligned_cols=264  Identities=21%  Similarity=0.319  Sum_probs=168.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeee------ee
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW------CY  384 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~------~~  384 (644)
                      ..++|+..++||+|+||.||+|++.      +..||+|++......  +.+..|  .+.+..+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999986      458999987643221  111111  1122222222222211      34


Q ss_pred             eccceEEEEeccCCCccchhhhccCCC------------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          385 ERHDFLLVYEYMPNGSLDKFIFYDETN------------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       385 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                      .+.+.++|+||+++++|.+++......            ...............++.|++.||.|||+   .+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            566899999999999999988643210            00001112233456799999999999999   899999999


Q ss_pred             CCCEEEcC-CCcEEEeccCCcccccccccccccccccccCCCccCccccccC----------------------CCCCcc
Q 006446          453 SSNIMLDS-EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG----------------------RATIET  509 (644)
Q Consensus       453 p~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~~s  509 (644)
                      |+|||++. ++.+||+|||+++.+.....  .......+++.|+|||.+...                      .++.++
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            99999986 58999999999986542211  113456789999999965322                      234567


Q ss_pred             chHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh----hhhhcccCCC----C--CHHHHHHHHHHHHH
Q 006446          510 DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL----DAADSRLGGE----F--SEKEMECVLILGLA  579 (644)
Q Consensus       510 DVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~d~~l~~~----~--~~~~~~~l~~L~~~  579 (644)
                      |||||||+||||+++..|....        +..+...+...+.-.    ....++...+    +  .........+|+.+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            9999999999999977664321        111111111111100    0011110000    0  00112234479999


Q ss_pred             hcCCCCCCCCCHHHHHHH
Q 006446          580 CCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       580 Cl~~dP~~RPs~~evl~~  597 (644)
                      |++.||++|||++++++.
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=7.4e-31  Score=262.34  Aligned_cols=237  Identities=27%  Similarity=0.373  Sum_probs=192.2

Q ss_pred             CcEEEEEeeec--CceEEEEEeecccchh-hHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccchhhhc
Q 006446          331 GFGTVYKGIWR--NKEIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY  407 (644)
Q Consensus       331 ~fG~Vy~g~~~--~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  407 (644)
                      +||.||+|+..  +..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987  5889999997665444 68899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccc
Q 006446          408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE  487 (644)
Q Consensus       408 ~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  487 (644)
                      ..        .+++..+..++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......    ....
T Consensus        81 ~~--------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~  145 (244)
T smart00220       81 RG--------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTT  145 (244)
T ss_pred             cc--------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc----cccc
Confidence            32        17889999999999999999999   899999999999999999999999999998765321    1345


Q ss_pred             cccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCH
Q 006446          488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSE  567 (644)
Q Consensus       488 ~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  567 (644)
                      ..++..|++||.+....++.++||||||++++||++|..||.....   ...+.++..    .+....       .....
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~~----~~~~~~-------~~~~~  211 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKIG----KPKPPF-------PPPEW  211 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHh----ccCCCC-------ccccc
Confidence            5688899999999888899999999999999999999999865321   112222111    111000       00000


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          568 KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       568 ~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .....+.+++.+|+..+|++||++.++++
T Consensus       212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            03356778999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=302.69  Aligned_cols=210  Identities=27%  Similarity=0.357  Sum_probs=182.4

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeee
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWC  383 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~  383 (644)
                      -..++++....+|++.++||+|+||.|...+++  ++.||+|++++.   .+....-|..|-.+|..-..+-|+++.-.+
T Consensus        65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            345667777789999999999999999999987  677999999763   334456788899999988899999999999


Q ss_pred             eeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       384 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      .+..++|+|||||+||+|-.+|.+..        .++......++..|..||.-||+   .|+|||||||+|||||..|+
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~--------~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFD--------RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcC--------CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCc
Confidence            99999999999999999999996554        26777777889999999999999   99999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccc----c-CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL----V-GRATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      +||+|||.|-.+...+..  .....+|||.|.+||++.    + +.|.+.+|.||+||++|||++|..||+..
T Consensus       214 ikLADFGsClkm~~dG~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADGTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             EeeccchhHHhcCCCCcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            999999999888644332  245678999999999985    2 67899999999999999999999999764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=8.7e-31  Score=287.90  Aligned_cols=265  Identities=18%  Similarity=0.318  Sum_probs=181.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeee------------------cCceEEEEEeecccchhhHH--------------HHHH
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIW------------------RNKEIAVKRVSETSRQGKQE--------------FIAE  364 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~------------------~~~~vavK~~~~~~~~~~~~--------------~~~E  364 (644)
                      ..++|+..++||+|+||.||+|.+                  .++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                  13579999987544333333              3447


Q ss_pred             HHHHhccCCCce-----eeEeeeeee--------ccceEEEEeccCCCccchhhhccCCC----------------CCCC
Q 006446          365 VTTIGSLRHRNL-----VKLIGWCYE--------RHDFLLVYEYMPNGSLDKFIFYDETN----------------SGPG  415 (644)
Q Consensus       365 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~~----------------~~~~  415 (644)
                      +..+.+++|.++     ++++++|..        ++..+|||||+++|+|.++++.....                ....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778877655     677888753        35689999999999999998743211                0011


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCcc
Q 006446          416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM  495 (644)
Q Consensus       416 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~  495 (644)
                      ...++|..+..++.|++++|.|||+   .+|+||||||+|||++.++.+||+|||+++.......  .......+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCccee
Confidence            2236788999999999999999999   8999999999999999999999999999976542211  1112234578999


Q ss_pred             CccccccCCC----------------------CCccchHHHHHHHHHHHcCCC-CCCCCcccc-----chhhHHHHHHHH
Q 006446          496 APESFLVGRA----------------------TIETDIYAFGVLILEVACGRK-PGNQSEQNS-----YNNSIVHWLWEL  547 (644)
Q Consensus       496 APE~~~~~~~----------------------t~~sDVwSfGvvl~el~tG~~-P~~~~~~~~-----~~~~l~~~~~~~  547 (644)
                      |||.+.....                      ..+.||||+||+++||++|.. |+.......     ....+..|  ..
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RM  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hh
Confidence            9998754321                      235799999999999999875 654321100     00111112  11


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNP---HLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP---~~RPs~~evl~  596 (644)
                      ......        .-.......+...+|+.+|+..+|   .+|+|++|+++
T Consensus       456 ~~~~~~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 YKGQKY--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hcccCC--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111110        001111223456677788888665   78999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=286.32  Aligned_cols=238  Identities=26%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      +..|.....+|.|+|+.|-++.+.  +...+||++.+...    +-.+|+.++... .||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567788888999999999999886  67899999976522    233566555554 79999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE-cCCCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-d~~~~vkL~DFGla~  473 (644)
                      .+.++-|.+.+...+.        .. .++..|+.+|+.|+.|||+   ++||||||||+|||+ +..++++|+|||.++
T Consensus       397 ~l~g~ell~ri~~~~~--------~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--------FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             hccccHHHHHHHhcch--------hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999888777755442        22 6777899999999999999   999999999999999 588999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      ....+-|..|.|||++....+++++|+||||++||||++|+.||.....+   ..+.    ....    
T Consensus       465 ~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~----~~i~----  527 (612)
T KOG0603|consen  465 ELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIH----TRIQ----  527 (612)
T ss_pred             hCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHH----Hhhc----
Confidence            77533      22346688999999999999999999999999999999999999875533   1111    1111    


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                              .+.++....+...+|+.+|++.||.+||+|.++..
T Consensus       528 --------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 --------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                    23344455566778999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=241.47  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=193.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +|+..++||+|.||+||+|+..  .+.||+|+++....+  .-...++||.++++++|+|||++++....+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566789999999999999887  567999998765432  245678999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      | ..+|.+|...-..       .++......++.|+++||.++|+   .+++|||+||.|.||+.+|+.||+|||+++.+
T Consensus        83 c-dqdlkkyfdslng-------~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNG-------DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             h-hHHHHHHHHhcCC-------cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            9 6688887754433       38888899999999999999999   99999999999999999999999999999987


Q ss_pred             cccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHH--HhcC
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWEL--RRKG  551 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~--~~~~  551 (644)
                      .-..+-   ....+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|.+.+.++   ++....|.+  ..+.
T Consensus       152 gipvrc---ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  152 GIPVRC---YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTED  225 (292)
T ss_pred             CCceEe---eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHHHhCCCccc
Confidence            633211   33456789999999988765 7899999999999999998 555566554332   333322221  1111


Q ss_pred             c---hhhhhhcccCCCCCH-----HHHH----HHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 R---ILDAADSRLGGEFSE-----KEME----CVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~---~~~~~d~~l~~~~~~-----~~~~----~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .   +....|-..-..++.     +.+.    .-.+|..+.+.-+|..|.++++.+|.
T Consensus       226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1   111122111111111     0111    11345555666699999999988874

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=260.10  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=197.5

Q ss_pred             hCCCCC-CCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeee----ccce
Q 006446          318 TGNFNP-KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE----RHDF  389 (644)
Q Consensus       318 ~~~f~~-~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~  389 (644)
                      +++|.+ .++||-|-.|.|-.+..+  ++++|+|++...     ....+|++.--+. .|||||++++++.+    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            444544 367999999999999887  778999988543     3345666654333 69999999998764    4568


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARL  466 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL  466 (644)
                      ++|||+|++|.|...+......      .+...+.-.|++||+.|+.|||+   .+|.||||||+|+|...   |-.+||
T Consensus       135 LiVmE~meGGeLfsriq~~g~~------afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQ------AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             EeeeecccchHHHHHHHHcccc------cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence            9999999999999988755432      58899999999999999999999   99999999999999964   456899


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||.|+....+.    .....+-|+.|.|||++...+|+...|+||+||++|-|+||.+||.......    +..-...
T Consensus       206 tDfGFAK~t~~~~----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~  277 (400)
T KOG0604|consen  206 TDFGFAKETQEPG----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKR  277 (400)
T ss_pred             cccccccccCCCc----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHh
Confidence            9999999765322    2445678999999999999999999999999999999999999998754322    1111222


Q ss_pred             HHhcCchhhhhhcccCCCCCHHH----HHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCCCCCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKE----MECVLILGLACCHPNPHLRPSMKTVLQV--LSGEADPPVL  607 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~~  607 (644)
                      ..+.|+          -+|+.+|    .+...+++...+..+|.+|.++.+++..  +.+....|..
T Consensus       278 rI~~gq----------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t  334 (400)
T KOG0604|consen  278 RIRTGQ----------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT  334 (400)
T ss_pred             HhhccC----------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence            222222          1344433    4556789999999999999999999863  4444434433

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=269.02  Aligned_cols=239  Identities=24%  Similarity=0.329  Sum_probs=188.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC--ceEEEEEeecccc---hhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSR---QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .+|....+||+|+||+|.++.-++  +.+|||++++.-.   +..+--+.|-++|.-. +-|.++++..++..-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            578889999999999999998874  5699999876521   1222224455666554 578999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+.+|+|--++++-..        +.......++.+||-||-+||+   ++|+.||||.+|||||.+|++||+|||++
T Consensus       429 MEyvnGGDLMyhiQQ~Gk--------FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK--------FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             EEEecCchhhhHHHHhcc--------cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence            999999999988876543        5556677899999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.-   ......+...+||+.|+|||++..++|....|.|||||+||||+.|.+||++.++++....+.+    .     
T Consensus       498 KEn---i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e----h-----  565 (683)
T KOG0696|consen  498 KEN---IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME----H-----  565 (683)
T ss_pred             ccc---ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----c-----
Confidence            852   2233346678999999999999999999999999999999999999999998776543333322    1     


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                               .-.++.........+....+...|.+|.
T Consensus       566 ---------nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 ---------NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                     1123333334444555666777888873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=290.58  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=190.0

Q ss_pred             CCCCCcccccCcEE-EEEeeecCceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccCC
Q 006446          321 FNPKNKLGKGGFGT-VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       321 f~~~~~LG~G~fG~-Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      |...+.+|.|+-|+ ||+|...++.||||++-...   .....+|+..|..- +|||||++++.-.+++.+|+..|.| .
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            55567889999876 89999999999999985433   23456899999887 6999999999998999999999999 7


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---C--CcEEEeccCCcc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---E--FNARLGDFGLAR  473 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~--~~vkL~DFGla~  473 (644)
                      -+|.+++..... ....   ..-...+.++.|+++||++||+   .+||||||||.||||+.   +  .+++|+|||+++
T Consensus       587 ~sL~dlie~~~~-d~~~---~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  587 CSLQDLIESSGL-DVEM---QSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             hhHHHHHhcccc-chhh---cccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            899999976411 1111   1113446788999999999999   99999999999999976   2  579999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG-RKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG-~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .+......-.......||.+|+|||++....-+.++||||+||++|++++| .+||......+.  .++.-      ...
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~------~~~  731 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTG------NYT  731 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcC------ccc
Confidence            987544433335667899999999999999889999999999999999995 899986443221  11110      000


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                      +.     .+...  .++  ...+|+.+|++++|..||++.+|+
T Consensus       732 L~-----~L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  732 LV-----HLEPL--PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ee-----eeccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            00     01111  111  567899999999999999999997

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=267.60  Aligned_cols=261  Identities=20%  Similarity=0.277  Sum_probs=201.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCC--C----ceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH--R----NLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----nIv~l~g~~~~~~~~  389 (644)
                      +++|....++|+|.||.|-.+.+.  +..||+|+++...+. .+..+-|+.++.++.+  |    -+|++.+|+..+++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999887  568999999766543 4555779999999942  2    388899999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---------
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---------  460 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---------  460 (644)
                      ++|+|.| +-|+.++|..+.-      ..++..+...++.|+++++++||+   .+++|-||||+|||+.+         
T Consensus       167 Civfell-G~S~~dFlk~N~y------~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNY------IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCc------cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence            9999999 7799999966443      258889999999999999999999   99999999999999932         


Q ss_pred             -----------CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 006446          461 -----------EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN  529 (644)
Q Consensus       461 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~  529 (644)
                                 +..+||.|||.|+...++      ....+.|..|.|||++.+-.++..+||||+||+|.|+.+|...|+
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                       345899999999875432      245788999999999999999999999999999999999999988


Q ss_pred             CCccccchhhHHHHH--------------HHHHhcCchh-----------hhhhcc--cC--CCCCHHHHHHHHHHHHHh
Q 006446          530 QSEQNSYNNSIVHWL--------------WELRRKGRIL-----------DAADSR--LG--GEFSEKEMECVLILGLAC  580 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~--------------~~~~~~~~~~-----------~~~d~~--l~--~~~~~~~~~~l~~L~~~C  580 (644)
                      ..+..+.. .+++-+              .+....+++.           ...++.  +.  -.-...+...+.+|+..|
T Consensus       311 tHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  311 THENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             cCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            76532211 111111              0111111100           000000  00  012335666799999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 006446          581 CHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       581 l~~dP~~RPs~~evl~  596 (644)
                      +..||.+|+|++|+++
T Consensus       390 L~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  390 LEFDPARRITLREALS  405 (415)
T ss_pred             HccCccccccHHHHhc
Confidence            9999999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=273.35  Aligned_cols=195  Identities=31%  Similarity=0.484  Sum_probs=168.5

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      .+.||.|.||+||-|+++  |+.||||++.+.  .......+.+|+.||.+++||.||.+.-.|...+..+.|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            688999999999999887  889999999764  3344578899999999999999999999999999999999999 66


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---CcEEEeccCCccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FNARLGDFGLARTIQ  476 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGla~~~~  476 (644)
                      ++.+.+......      .|+...-..++.||+.||.|||.   ++|+|+||||+||||...   -.+||||||.||...
T Consensus       648 DMLEMILSsEkg------RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  648 DMLEMILSSEKG------RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             hHHHHHHHhhcc------cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            665555433322      37777778889999999999999   999999999999999654   469999999999987


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      +...    ...++||+.|+|||++.+..|+..-|+||.||++|--++|..||...+
T Consensus       719 EksF----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  719 EKSF----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             hhhh----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence            5422    456899999999999999999999999999999999999999997643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=245.62  Aligned_cols=204  Identities=25%  Similarity=0.389  Sum_probs=167.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+.......||+|++|.|-+-++.  |.-.|+|++... ..+..++.+.|+.+..+. .+|.+|.++|.....+..++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344455778999999998777765  788999999764 345567788888877665 7999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |.| .-||+.+-.+--..    ...++....=+|+..+..||.|||+  ...++|||+||+|||++.+|++|+||||++-
T Consensus       125 E~M-~tSldkfy~~v~~~----g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKK----GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             HHh-hhhHHHHHHHHHhc----CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999 67888775432211    1247778888999999999999998  5789999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL----VGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      .+.+...    .+...|...|||||.+.    ...|+-|+||||+|+.+.||++++.||+...
T Consensus       198 ~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  198 YLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            7764322    33457889999999875    3368999999999999999999999987643

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.2e-32  Score=257.84  Aligned_cols=267  Identities=22%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chh-hHHHHHHHHHHhccCCCceeeEeeeeeec--------c
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQG-KQEFIAEVTTIGSLRHRNLVKLIGWCYER--------H  387 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--------~  387 (644)
                      .|+...+||+|.||+||+++..  ++.||+|++..+. +.+ -...++|+++|..|+|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4566788999999999999887  6678998764432 222 24568999999999999999999999753        3


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      .++||+++|+ -+|...|.....       .++..++.++++++..||.|+|.   ..|+|||+||.|+||+.++.+||+
T Consensus        98 t~ylVf~~ce-hDLaGlLsn~~v-------r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   98 TFYLVFDFCE-HDLAGLLSNRKV-------RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             eeeeeHHHhh-hhHHHHhcCccc-------cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEee
Confidence            4899999995 477777744322       38889999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccccccccc-ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH--
Q 006446          468 DFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW--  543 (644)
Q Consensus       468 DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~--  543 (644)
                      |||++|.+....... ...+..+-|..|.+||.+.+. .++++.|||+-||++.||++|.+-+.+..+......+...  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999998775332221 123556779999999998765 6899999999999999999999888775543222111111  


Q ss_pred             -----HHHHHhcCchhhhhhcc-cC-CCCC--HHHH------HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          544 -----LWELRRKGRILDAADSR-LG-GEFS--EKEM------ECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       544 -----~~~~~~~~~~~~~~d~~-l~-~~~~--~~~~------~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           +|....+-.+.+.+... +. +.+.  ++.+      ...++|+.+++..||.+||.+.+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                 11111111111111100 11 1110  0111      145678889999999999999999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=264.32  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=194.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEee--cccchhh-----HHHHHHHHHHhccCCCceeeEeeeeee-cc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGK-----QEFIAEVTTIGSLRHRNLVKLIGWCYE-RH  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~--~~~~~~~-----~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~  387 (644)
                      .++|-..++||+|||++||++.+-  .+.||||+-.  +..++.+     +...+|..|-+.|.||.||++++++.- ..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            356667889999999999999876  6678999753  3333322     345789999999999999999999874 45


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcE
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNA  464 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~v  464 (644)
                      .+|-|+|||++.+|+-||..++.        ++..+...|+.||..||.||.+. ..+|||-||||.||||-.   -|.+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl--------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL--------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh--------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence            78999999999999999987664        78899999999999999999874 479999999999999954   4789


Q ss_pred             EEeccCCccccccccccc----ccccccccCCCccCccccccC----CCCCccchHHHHHHHHHHHcCCCCCCCCccccc
Q 006446          465 RLGDFGLARTIQENLKTH----HSTKEIAGTPGYMAPESFLVG----RATIETDIYAFGVLILEVACGRKPGNQSEQNSY  536 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~----~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~  536 (644)
                      ||.|||+++.++.....+    ..+...+||..|++||++.-+    +++.|.||||.||++|.++.|+.||......  
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--  690 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--  690 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--
Confidence            999999999987543221    123556899999999998654    4788999999999999999999999864322  


Q ss_pred             hhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 006446          537 NNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV  594 (644)
Q Consensus       537 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ev  594 (644)
                       ..+++       ...++.+..-.++..  +.........+.+|++.--++|....++
T Consensus       691 -QdILq-------eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  691 -QDILQ-------ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -HHHHh-------hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence             22222       222333322222111  1112234567889999999999765554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=277.26  Aligned_cols=259  Identities=25%  Similarity=0.376  Sum_probs=205.0

Q ss_pred             CHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeee-
Q 006446          310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE-  385 (644)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~-  385 (644)
                      .+..+...+.-|++.+.||+|.+|.||+++..  ++..|+|+..... +..++...|..+++.+ .|||++.++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34444455677888999999999999998765  6778888875543 3346667888998887 69999999999874 


Q ss_pred             ----ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          386 ----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       386 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                          ++++|||||||.+||..+++..-...      .+.|..+..|+..++.||.+||.   ..++|||||-.||||+.+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~------rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e  159 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGN------RLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTEN  159 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhccc------chhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEecc
Confidence                35799999999999999998654422      48999999999999999999999   999999999999999999


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccC-----CCCCccchHHHHHHHHHHHcCCCCCCCCccccc
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-----RATIETDIYAFGVLILEVACGRKPGNQSEQNSY  536 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~  536 (644)
                      +.|||+|||++..++..   ........||+.|||||++...     .|+.++|+||+|++..||.-|.+|+.+..+...
T Consensus       160 ~~VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra  236 (953)
T KOG0587|consen  160 AEVKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA  236 (953)
T ss_pred             CcEEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence            99999999999887632   2224456899999999999754     367899999999999999999999876543110


Q ss_pred             hhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          537 NNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       537 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                             +..      +.....++|  .-+....+.+.+.+..|+..|-++||++.++++
T Consensus       237 -------LF~------IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 -------LFL------IPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -------hcc------CCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                   111      111112222  224456677888999999999999999998874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=270.33  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCce--EEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~--vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+++....||-||||+|=+...++..  +|+|++++.   .....+....|-.+|.+.+.|.||+++-.+.+...+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999999888554  788887653   4445667889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |-|-+|.|...|.....        ++......++..+.+|++|||.   ++||.|||||+|.|||.+|-+||.|||.|+
T Consensus       500 EaClGGElWTiLrdRg~--------Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS--------FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             HhhcCchhhhhhhhcCC--------cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHH
Confidence            99999999999965443        6666777889999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+....+    +-..+||+.|.|||++.+...+.++|.||+|+++|||++|++||...++-.....++.-+         
T Consensus       569 ki~~g~K----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi---------  635 (732)
T KOG0614|consen  569 KIGSGRK----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI---------  635 (732)
T ss_pred             HhccCCc----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---------
Confidence            8874433    556799999999999999999999999999999999999999998876533322222211         


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS  590 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs  590 (644)
                          |.   -+++........+|+.+.|..+|.+|..
T Consensus       636 ----d~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 ----DK---IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----hh---hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                11   1234444455667888999999999976

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-29  Score=267.06  Aligned_cols=242  Identities=22%  Similarity=0.383  Sum_probs=191.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .-|...+.||-|+||+|.++...  ...+|+|.+++.+   +.......+|-.||.+-..+-||+|+-.+.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45778889999999999998765  4568999887643   233456788999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|++-.+|.+...        +.......++.+++.|+++.|.   .++|||||||+|||||.+|++||.|||||.
T Consensus       709 dYIPGGDmMSLLIrmgI--------FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI--------FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             eccCCccHHHHHHHhcc--------CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccc
Confidence            99999999999875542        6777778889999999999999   999999999999999999999999999985


Q ss_pred             ccc---------c--ccc--------------------------c--cccccccccCCCccCccccccCCCCCccchHHH
Q 006446          474 TIQ---------E--NLK--------------------------T--HHSTKEIAGTPGYMAPESFLVGRATIETDIYAF  514 (644)
Q Consensus       474 ~~~---------~--~~~--------------------------~--~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSf  514 (644)
                      -+.         +  +..                          .  .......+||+.|+|||++....++..+|.||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            321         0  000                          0  000122579999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCC
Q 006446          515 GVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN  584 (644)
Q Consensus       515 Gvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~d  584 (644)
                      ||+||||+.|+.||-...+.+....+..|...++          --..+.++.+....+.+   .|+..|
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~----------~~~~~~ls~e~~~li~k---Lc~sad  914 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINWRNFLH----------IPYQGNLSKEALDLIQK---LCCSAD  914 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeehhhccc----------cccccccCHHHHHHHHH---HhcChh
Confidence            9999999999999988877776666777743321          12234555555544444   465443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=248.53  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=195.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..++||+|.|++|-.+++.  .+.+|+|++++.   ..........|-.+..+- +||.+|-+..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367999999999999999999887  567999998764   223344455666666665 79999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |.||+++|+|--++.+.+.        |+.+....+...|..||.|||+   .+|+.||||.+|||||.+|++||.|+|+
T Consensus       329 vieyv~ggdlmfhmqrqrk--------lpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK--------LPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             EEEEecCcceeeehhhhhc--------CcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccch
Confidence            9999999999888765443        8888888899999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++.--..   ...+...+||+.|.|||++.+..|....|.|++||+++||+.||.||+--..+.....--+++.+..-+.
T Consensus       398 cke~l~~---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  398 CKEGLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             hhcCCCC---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            9863322   2235678999999999999999999999999999999999999999976433333333444555443332


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                      ++      ++    +.....+...++..-++.||.+|.
T Consensus       475 qi------ri----prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  475 QI------RI----PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cc------cc----cceeehhhHHHHHHhhcCCcHHhc
Confidence            22      11    111222334466678889999884

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=4.4e-28  Score=235.90  Aligned_cols=210  Identities=35%  Similarity=0.574  Sum_probs=182.7

Q ss_pred             ccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccch
Q 006446          327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDK  403 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  403 (644)
                      ||+|.+|.||++...  +.++++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999998  789999998765432 35678999999999999999999999999899999999999999999


Q ss_pred             hhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCccccccccccc
Q 006446          404 FIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLARTIQENLKTH  482 (644)
Q Consensus       404 ~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~~~~~~~  482 (644)
                      ++....       ..+++..+..++.+++++|.|||+   .+++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        81 ~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          81 LLKENE-------GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             HHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            986542       138899999999999999999999   89999999999999999 89999999999987653221  


Q ss_pred             ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhccc
Q 006446          483 HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL  561 (644)
Q Consensus       483 ~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  561 (644)
                       ......+...|++||..... ..+.++|+|++|+++++|                                        
T Consensus       149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence             12345678899999998877 788999999999999999                                        


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       562 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                               ..+.+++.+|++.+|++||+++++++.|
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                     4566788899999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-29  Score=242.78  Aligned_cols=267  Identities=25%  Similarity=0.333  Sum_probs=194.4

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cceE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HDFL  390 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~  390 (644)
                      +.+..+.||-|+||.||..++.  ++.|+.|++.+.-  -...+.+.+|+++|.-++|.|++..+++..-.     .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4556788999999999999887  7899999986532  23457788999999999999999998876543     3678


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      .+.|.| ..+|.+.+-...        .|+-....-++.||++||+|||+   .+|+||||||.|.|++.|...||||||
T Consensus       134 V~TELm-QSDLHKIIVSPQ--------~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQ--------ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHH-HhhhhheeccCC--------CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccc
Confidence            899999 667877764322        37777777788999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-----
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-----  544 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-----  544 (644)
                      ++|..+.....+  .+..+-|..|.|||++.+. .|+.+.||||.||++.|++..|..|....+-+..+.+.+.+     
T Consensus       202 LARvee~d~~~h--MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  202 LARTWDQRDRLN--MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             cccccchhhhhh--hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            999876433322  3445668899999999865 58999999999999999998888777654433222232221     


Q ss_pred             --HHHHhcCchhhhhhcccC-CC-------CC--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          545 --WELRRKGRILDAADSRLG-GE-------FS--EKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       545 --~~~~~~~~~~~~~d~~l~-~~-------~~--~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        ...--+|.-..++..... ..       -+  ..+.+ -+.+..+++++||..|.+..+.++.+..+
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~he-av~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHE-AVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchH-HHHHHHHHhCCCCcccccHhhhccccccc
Confidence              000001111111111110 00       01  12222 23466688999999999999999877543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-27  Score=244.10  Aligned_cols=275  Identities=23%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             CCcccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-----C---C
Q 006446          305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-----H---R  374 (644)
Q Consensus       305 ~~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~  374 (644)
                      +.+...+.+... .++|...++||.|.|++||++.+.  .+.||+|+.+. ..+-.+..+.||++|++++     |   .
T Consensus        65 GYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   65 GYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             CCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence            444444555443 368889999999999999999987  56799998854 3344566789999999984     3   4


Q ss_pred             ceeeEeeeeeec----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCC
Q 006446          375 NLVKLIGWCYER----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRD  450 (644)
Q Consensus       375 nIv~l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrD  450 (644)
                      .||+|++.|...    .+++||+|++ +-+|..+|.+..-+      .++.....+|+.||+.||.|||++  .+|||-|
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr------Glpl~~VK~I~~qvL~GLdYLH~e--cgIIHTD  213 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR------GLPLSCVKEICRQVLTGLDYLHRE--CGIIHTD  213 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC------CCcHHHHHHHHHHHHHHHHHHHHh--cCccccC
Confidence            699999999854    5899999999 88899988765432      388899999999999999999994  6899999


Q ss_pred             CCCCCEEEcCC-----------C---------------------------------------------------------
Q 006446          451 IKSSNIMLDSE-----------F---------------------------------------------------------  462 (644)
Q Consensus       451 lkp~NILld~~-----------~---------------------------------------------------------  462 (644)
                      |||+|||+..+           +                                                         
T Consensus       214 lKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~  293 (590)
T KOG1290|consen  214 LKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEG  293 (590)
T ss_pred             CCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccc
Confidence            99999999211           0                                                         


Q ss_pred             --------------------------------------------------------------------------------
Q 006446          463 --------------------------------------------------------------------------------  462 (644)
Q Consensus       463 --------------------------------------------------------------------------------  462 (644)
                                                                                                      
T Consensus       294 ~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~  373 (590)
T KOG1290|consen  294 IEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGT  373 (590)
T ss_pred             ccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccc
Confidence                                                                                            


Q ss_pred             ------------------cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcC
Q 006446          463 ------------------NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG  524 (644)
Q Consensus       463 ------------------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG  524 (644)
                                        +|||+|||-|.....+      .+.-..|..|.|||++.+..|++.+||||++|+++||+||
T Consensus       374 ~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh------FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTG  447 (590)
T KOG1290|consen  374 IASNPLVNPDIPLPECDIRVKIADLGNACWVHKH------FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATG  447 (590)
T ss_pred             cccccccCCCCCCCccceeEEEeeccchhhhhhh------hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcC
Confidence                              0233333333322211      2223468899999999999999999999999999999999


Q ss_pred             CCCCCCCccccch---h---hHHHHH----HHHHhcCch-hhhhhcc-----------------c--CCCCCHHHHHHHH
Q 006446          525 RKPGNQSEQNSYN---N---SIVHWL----WELRRKGRI-LDAADSR-----------------L--GGEFSEKEMECVL  574 (644)
Q Consensus       525 ~~P~~~~~~~~~~---~---~l~~~~----~~~~~~~~~-~~~~d~~-----------------l--~~~~~~~~~~~l~  574 (644)
                      ...|+......+.   +   .+++.+    +.+...|+. .+.+..+                 |  .-+++.++...+.
T Consensus       448 DyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fs  527 (590)
T KOG1290|consen  448 DYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFS  527 (590)
T ss_pred             ceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHH
Confidence            9888764332221   1   222221    111122211 1111110                 0  0147788889999


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q 006446          575 ILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       575 ~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.+.-|++.+|++|||+.+.++
T Consensus       528 dFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  528 DFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHHHHhcCccccccHHHHhc
Confidence            9999999999999999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=237.69  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=193.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------c
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------H  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~  387 (644)
                      ..+|.....+|.|.- .|..+.+.  +.+||+|++...  .....+...+|..++..+.|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999998 67767665  789999987543  223345667899999999999999999988743      3


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      +.|+|||+| ..+|...+..          .++-.....|..|++.|++|||+   .+|+||||||+||++..+..+||.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~----------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM----------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH----------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeec
Confidence            689999999 7899888862          26667788999999999999999   999999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+|+..+..    ...+..+.|..|.|||++.+-.+.+.+||||.||++.||++|+.-|.+.+      .+-+|..-.
T Consensus       161 dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~  230 (369)
T KOG0665|consen  161 DFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKII  230 (369)
T ss_pred             cchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHH
Confidence            99999865432    23677889999999999988889999999999999999999998876532      222222111


Q ss_pred             HhcC--------------c-------------hhhh-hhcccCC--CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKG--------------R-------------ILDA-ADSRLGG--EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~--------------~-------------~~~~-~d~~l~~--~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...|              +             ..+. .|..+..  +.+........+++.+|+-.||++|.+++++|+.
T Consensus       231 ~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  231 EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1111              0             0000 0111111  1112233456788999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.2e-26  Score=229.83  Aligned_cols=198  Identities=33%  Similarity=0.526  Sum_probs=171.4

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      |+..+.||+|++|.||++...  +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            456788999999999999987  588999999766544 57788999999999999999999999999899999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++......       +++.....++.+++.+|.|||+   .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       81 GGDLFDYLRKKGGK-------LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CCCHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            99999998654321       7889999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCcccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESF-LVGRATIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~-~~~~~t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      ...  .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       151 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            210  012345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1.4e-27  Score=225.58  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=190.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeee--cCceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeecc--ceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERH--DFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~lV  392 (644)
                      .++|+..+++|+|.+++|+.|..  ++.+++||.++...   .+...+|+.+|..|+ ||||+.|+++..+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46788889999999999999984  47889999997643   567789999999997 999999999988653  57899


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEeccCC
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGL  471 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DFGl  471 (644)
                      +||..+.+....-.           +|+...+..++.+++.||.|+|+   .||+|||+||.|+|||.. ..++|+|+|+
T Consensus       114 FE~v~n~Dfk~ly~-----------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-----------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             hhhhccccHHHHhh-----------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecch
Confidence            99998887765541           37777888899999999999999   999999999999999976 4689999999


Q ss_pred             cccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH---
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL---  547 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~---  547 (644)
                      |..+.+...    ..-.+.+..|--||++.. ..|+..-|+|||||++..|+..+.||-......  ++++..+.-+   
T Consensus       180 AEFYHp~~e----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~--DQLVkIakVLGt~  253 (338)
T KOG0668|consen  180 AEFYHPGKE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVKIAKVLGTD  253 (338)
T ss_pred             HhhcCCCce----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH--HHHHHHHHHhChH
Confidence            988764322    223345667789998865 457889999999999999999999986654332  3343322111   


Q ss_pred             -----HhcCchhhhhhcccCC---C--------C-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 -----RRKGRILDAADSRLGG---E--------F-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 -----~~~~~~~~~~d~~l~~---~--------~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ..+-.+  .+|+++.+   .        |     ..-.....++++.+.+..|-++|||++|.+.
T Consensus       254 el~~Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  254 ELYAYLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 111000  12222211   0        0     0011235667888899999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=250.46  Aligned_cols=196  Identities=24%  Similarity=0.386  Sum_probs=167.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hh-----hHHHHHHHHHHhccC---CCceeeEeeeeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QG-----KQEFIAEVTTIGSLR---HRNLVKLIGWCYE  385 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~-----~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~  385 (644)
                      ..|...+.+|+|+||.|+.+.++  ..+|++|.+.+..-   .+     .-..-.||+||.+++   |+||+++++++.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35788899999999999999998  56899998865421   11     123456999999997   9999999999999


Q ss_pred             ccceEEEEecc-CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          386 RHDFLLVYEYM-PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       386 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      ++.+||++|-. ++-+|.+++..++.        ++..+..-|++||+.|+++||+   ++|||||||-+||.+|.+|-+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~--------m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR--------MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc--------cchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeE
Confidence            99999999986 55688888865543        8888899999999999999999   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCC
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      ||+|||.+.....     ......+||..|.|||++.+.+| ...-|||++|++||-++....||..
T Consensus       710 klidfgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  710 KLIDFGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEeeccchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999977642     22566789999999999998887 5678999999999999999888763

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=3.5e-27  Score=245.21  Aligned_cols=273  Identities=22%  Similarity=0.240  Sum_probs=206.0

Q ss_pred             cccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC------CCceee
Q 006446          307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR------HRNLVK  378 (644)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~  378 (644)
                      .++.+.|+  ...+|......|+|-|++|.+|.+.  +..||||++.+... ..+.=+.|+++|++|.      --|+++
T Consensus       422 Yrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  422 YRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            34444444  4578999999999999999999987  77999999976542 2344568999999995      358999


Q ss_pred             EeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       379 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      |+-.|...+++|||+|-+ ..+|.+.|.+-...     ..|.......++.|+.-||..|..   ++|+|.||||+|||+
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~n-----vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-----VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILV  569 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-----cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEe
Confidence            999999999999999988 78999999765433     237778888999999999999999   999999999999999


Q ss_pred             cCCC-cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccch
Q 006446          459 DSEF-NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~  537 (644)
                      ++.. .+||||||.|....++.     .+...-..-|.|||++.+-.|+...|+||.||+||||.||+..|.+.....+.
T Consensus       570 NE~k~iLKLCDfGSA~~~~ene-----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML  644 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENE-----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML  644 (752)
T ss_pred             ccCcceeeeccCcccccccccc-----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence            9875 57999999998765443     23344566799999999999999999999999999999999988776543332


Q ss_pred             hhHHHHH----HHHHhcCchhhh-hhcc--------------------------------c--CCCCCHH---HHHHHHH
Q 006446          538 NSIVHWL----WELRRKGRILDA-ADSR--------------------------------L--GGEFSEK---EMECVLI  575 (644)
Q Consensus       538 ~~l~~~~----~~~~~~~~~~~~-~d~~--------------------------------l--~~~~~~~---~~~~l~~  575 (644)
                      ...++.-    ..+.++|++.+. +|..                                |  .+.++.+   ....+.+
T Consensus       645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd  724 (752)
T KOG0670|consen  645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD  724 (752)
T ss_pred             HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence            2222110    111222221110 1111                                1  0113333   3455678


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 006446          576 LGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       576 L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      |+..|+..||++|.+..|+|+
T Consensus       725 LLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  725 LLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHhccChhhcCCHHHHhc
Confidence            999999999999999999886

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=4e-27  Score=251.46  Aligned_cols=252  Identities=28%  Similarity=0.381  Sum_probs=199.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+|+...++|.|.+|.|||+++.  ++..|+|.++....+...-...|+-+++..+|+|||.++|.+.....++++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357888999999999999999987  778999999988777777788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |.+|+|.+.-+...        .|+..+...+++...+||+|||+   ++-+|||||-.|||+++.+.+|++|||.+-.+
T Consensus        94 cgggslQdiy~~Tg--------plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG--------PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             cCCCcccceeeecc--------cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhh
Confidence            99999988765332        38888888999999999999999   89999999999999999999999999998776


Q ss_pred             cccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ....   ...+...||+.|||||+..   .+.|..++|||+.|+...|+.--.+|.....+.    +.+.    +..+..
T Consensus       163 tati---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----r~l~----LmTkS~  231 (829)
T KOG0576|consen  163 TATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----RALF----LMTKSG  231 (829)
T ss_pred             hhhh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----HHHH----HhhccC
Confidence            5322   2245678999999999864   567899999999999999998777663322110    1000    000000


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         .-.+.+..  .....+.+..++..|+-.+|++||+++.+++
T Consensus       232 ---~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 ---FQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ---CCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence               00111111  1233456778899999999999999987664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.6e-26  Score=272.09  Aligned_cols=197  Identities=17%  Similarity=0.255  Sum_probs=138.9

Q ss_pred             ccCC-CceeeEeeee-------eeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC
Q 006446          370 SLRH-RNLVKLIGWC-------YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG  441 (644)
Q Consensus       370 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~  441 (644)
                      +++| +||++++++|       .+...+++++||+ +++|.++|.....       .+++.+++.++.||++||.|||+ 
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~-   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR-------SVDAFECFHVFRQIVEIVNAAHS-   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc-------cccHHHHHHHHHHHHHHHHHHHh-
Confidence            4556 6888889887       2334678889988 6799999964322       38999999999999999999999 


Q ss_pred             CCCCeEeCCCCCCCEEEcC-------------------CCcEEEeccCCccccccccc-------c------cccccccc
Q 006446          442 SEKRVLHRDIKSSNIMLDS-------------------EFNARLGDFGLARTIQENLK-------T------HHSTKEIA  489 (644)
Q Consensus       442 ~~~~ivHrDlkp~NILld~-------------------~~~vkL~DFGla~~~~~~~~-------~------~~~~~~~~  489 (644)
                        ++|+||||||+||||+.                   ++.+|++|||+++.......       .      ........
T Consensus        99 --~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (793)
T PLN00181         99 --QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM  176 (793)
T ss_pred             --CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence              99999999999999965                   44556666666654211000       0      00011245


Q ss_pred             cCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHH
Q 006446          490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKE  569 (644)
Q Consensus       490 gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  569 (644)
                      ||+.|||||++.+..++.++|||||||+||||++|..|+....     ..+..+.     ...    ..+..     ...
T Consensus       177 gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~-----~~~----~~~~~-----~~~  237 (793)
T PLN00181        177 EMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLR-----HRV----LPPQI-----LLN  237 (793)
T ss_pred             CCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHH-----Hhh----cChhh-----hhc
Confidence            7889999999999999999999999999999999988754211     1111110     000    01110     011


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          570 MECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       570 ~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ......++.+||+++|.+||+|+|+++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            223456788999999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-26  Score=220.73  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=189.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeee-eeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGW-CYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~  393 (644)
                      .+.|++.+.||+|.||.+-++.++  ++.+++|-+...- -..++|.+|..---.| .|.||+.-++. +...+.++.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            357888999999999999999998  5679999886543 2467888888655555 58999998775 45556788999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE-c-CCCcEEEeccCC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-D-SEFNARLGDFGL  471 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-d-~~~~vkL~DFGl  471 (644)
                      ||+|.|+|..-+...         .+......+++.|+++|+.|+|+   .++||||||.+|||| + +..++||||||+
T Consensus       102 E~aP~gdL~snv~~~---------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA---------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             ccCccchhhhhcCcc---------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence            999999998877432         25666778899999999999999   999999999999999 3 335899999999


Q ss_pred             cccccccccccccccccccCCCccCcccccc---C--CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLV---G--RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~--~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      .+..+..      .....-+..|.+||....   +  ...+.+|||.||++++.+++|+.||+.....    .-..|-|.
T Consensus       170 t~k~g~t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----d~~Y~~~~  239 (378)
T KOG1345|consen  170 TRKVGTT------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----DKPYWEWE  239 (378)
T ss_pred             ccccCce------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc----CchHHHHH
Confidence            8865421      223345667999997642   2  3578899999999999999999999853221    22345566


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      .+..+.....  |+.-..+.+    .++.+-.+-+.+++++|-.+.++.++-.
T Consensus       240 ~w~~rk~~~~--P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  240 QWLKRKNPAL--PKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             HHhcccCccC--chhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            6666665422  222233443    4445566788999999977777766543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.7e-25  Score=229.37  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=194.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~  390 (644)
                      ..+.|...++||+|.|+.||++++.     +..||+|.+...+.  ......|++.|..+. +.||+++.+++..++...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4467888999999999999999875     35799999876553  345789999999994 899999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEecc
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDF  469 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DF  469 (644)
                      +|+||++.....++..           .++..+...++..+..||.++|.   ++||||||||+|+|.+.. ++-.|.||
T Consensus       112 ivlp~~~H~~f~~l~~-----------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR-----------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             EEecccCccCHHHHHh-----------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEec
Confidence            9999999998888874           27788889999999999999999   999999999999999865 66899999


Q ss_pred             CCcccccccc-----cc-------c-----------------------------ccccccccCCCccCccccc-cCCCCC
Q 006446          470 GLARTIQENL-----KT-------H-----------------------------HSTKEIAGTPGYMAPESFL-VGRATI  507 (644)
Q Consensus       470 Gla~~~~~~~-----~~-------~-----------------------------~~~~~~~gt~~y~APE~~~-~~~~t~  507 (644)
                      |+|...+...     ..       .                             ......+||+||.|||++. ....++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9997322100     00       0                             0001256999999999876 456799


Q ss_pred             ccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH--------H-HHhcCc--hhh------hhhc-----cc----
Q 006446          508 ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW--------E-LRRKGR--ILD------AADS-----RL----  561 (644)
Q Consensus       508 ~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~--------~-~~~~~~--~~~------~~d~-----~l----  561 (644)
                      +.||||.||+++-+++++.||.....+-.  .+.+.+.        + ..-.|.  +.+      ..+.     .+    
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~--al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDAD--ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccc--hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            99999999999999999999866543321  1221110        0 000112  111      0000     00    


Q ss_pred             --C--------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          562 --G--------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       562 --~--------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                        .        ....+.....+.++..+|+..||.+|.++++.|+.
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              0        00111122367889999999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.2e-24  Score=206.67  Aligned_cols=166  Identities=23%  Similarity=0.186  Sum_probs=123.9

Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++.....       .++|.+++.|+.|++.||.|||+   .+      ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVRGR-------PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc
Confidence            688888865332       38999999999999999999998   44      999999999999999  9999865421


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                              ...||+.|||||++.+..++.++|||||||++|||++|+.||.......  ..+..+..... ..      +
T Consensus        63 --------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~-~~------~  125 (176)
T smart00750       63 --------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMP-AD------D  125 (176)
T ss_pred             --------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhc-cC------C
Confidence                    1258899999999999999999999999999999999999986543211  11111111110 00      0


Q ss_pred             cccCCCCCHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          559 SRLGGEFSEKEME--CVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       559 ~~l~~~~~~~~~~--~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      +.- .........  .+.+++.+|++.+|.+||++.|+++.+..
T Consensus       126 ~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      126 PRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             ccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            000 011112222  58889999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=209.32  Aligned_cols=248  Identities=19%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCC
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      ....+|.+...|+.|+|++++..+++|++.-.  .....++|..|.-.|+-+.||||+.++|.|....++.++..|||.|
T Consensus       193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            34567889999999999999999999987533  3344578999999999999999999999999999999999999999


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccc
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL  479 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~  479 (644)
                      ||...|+....      ..++-.+..+++.++|+|++|||+.. .-|.---|.+..|++|++.+++|+-=..--.++   
T Consensus       273 slynvlhe~t~------vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---  342 (448)
T KOG0195|consen  273 SLYNVLHEQTS------VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             HHHHHHhcCcc------EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---
Confidence            99999976543      25778889999999999999999843 345555689999999999998875211100111   


Q ss_pred             cccccccccccCCCccCccccccCCC---CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          480 KTHHSTKEIAGTPGYMAPESFLVGRA---TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       480 ~~~~~~~~~~gt~~y~APE~~~~~~~---t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                           .....-.+.||+||.++..+-   -.++|+|||.+++||+.|...||....+-+..                +++
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mki  401 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKI  401 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhh
Confidence                 122344688999999987653   46799999999999999999999765443221                122


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .-+.++..+++.....+.+|+.-|+..||.+||.+.+++-+|++
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            23344555666666778889999999999999999999998875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5e-23  Score=217.61  Aligned_cols=167  Identities=19%  Similarity=0.209  Sum_probs=129.1

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec---CceEEEEEeecc-----cchhhHHHHHHHHHHhccCCCceee-Eeeeeee
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSET-----SRQGKQEFIAEVTTIGSLRHRNLVK-LIGWCYE  385 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~  385 (644)
                      .....+|...++||+|+||+||+|++.   +..+|||++...     .....+.|.+|+++|++++|+|+++ ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345578999999999999999999874   456799987533     1223456899999999999999995 4432   


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC-CCCCEEEcCCCcE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI-KSSNIMLDSEFNA  464 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-kp~NILld~~~~v  464 (644)
                       +..+|||||+++++|....   .         ..   ...++.+++++|.|||+   .+|+|||| ||+|||++.++++
T Consensus        91 -~~~~LVmE~~~G~~L~~~~---~---------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR---P---------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC---c---------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCE
Confidence             4689999999999996221   0         00   13578899999999999   99999999 9999999999999


Q ss_pred             EEeccCCcccccccccccc-----cccccccCCCccCccccccC
Q 006446          465 RLGDFGLARTIQENLKTHH-----STKEIAGTPGYMAPESFLVG  503 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~  503 (644)
                      ||+|||+|+.+........     ..+...+++.|+|||.+...
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999997754321111     01356788999999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=4.2e-21  Score=198.58  Aligned_cols=263  Identities=30%  Similarity=0.432  Sum_probs=197.5

Q ss_pred             CCCCCcccccCcEEEEEeeecCceEEEEEeecccch---hhHHHHHHHHHHhccCCC-ceeeEeeeeeeccceEEEEecc
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHR-NLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      |...+.||.|+||.||++... ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            556788999999999999988 78899998765432   367899999999999988 7999999997777789999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccCCcccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTI  475 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~  475 (644)
                      .++++.+++......     ..+.......++.+++.++.|+|+   .+++|||+||+||+++... .++++|||.++..
T Consensus        81 ~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          81 DGGSLEDLLKKIGRK-----GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             CCCcHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            999999666543311     237888899999999999999999   8899999999999999998 7999999999865


Q ss_pred             ccccccc---ccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          476 QENLKTH---HSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       476 ~~~~~~~---~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      .......   .......|+..|+|||.+..   .......|+||+|++++++++|+.|+.............+.+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            4332211   12356789999999999987   57899999999999999999999996554321001112221111110


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .     .................+.+++..|+..+|..|.++.+....
T Consensus       233 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0     000000011112223567778889999999999999987764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.5e-21  Score=204.23  Aligned_cols=262  Identities=21%  Similarity=0.229  Sum_probs=191.7

Q ss_pred             CCCCCCcccccCcEEEEEeeecC---ceEEEEEeecccchhhHHHHHHHHHHhccCC----CceeeEeeee-eeccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWRN---KEIAVKRVSETSRQGKQEFIAEVTTIGSLRH----RNLVKLIGWC-YERHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~~---~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l  391 (644)
                      +|...++||+|+||.||++....   ..+|+|............+..|+.++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            78999999999999999999874   3688888766543333377788888888863    5888888888 46677899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-----CcEEE
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-----FNARL  466 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-----~~vkL  466 (644)
                      ||+.+ +.+|.++......      ..++-...+.|+.|++.+|++||+   .+++||||||.|+++...     ..+.|
T Consensus        99 VM~l~-G~sL~dl~~~~~~------~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPP------GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             EEecc-CccHHHHHHhCCC------CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEE
Confidence            99988 8999997754431      148889999999999999999999   999999999999999765     46999


Q ss_pred             eccCCcc--ccc-cccc--ccc-c-ccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          467 GDFGLAR--TIQ-ENLK--THH-S-TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       467 ~DFGla~--~~~-~~~~--~~~-~-~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                      .|||+++  .+. .+..  ... . .....||.+|.+++...+...+++.|+||++.++.|+..|..||...........
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~  248 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK  248 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence            9999998  322 1111  111 1 1235699999999999999999999999999999999999999966443222111


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      +...    .....    ...  ......   ..+.++...+-..+..++|....+.+.|+.....
T Consensus       249 ~~~~----~~~~~----~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  249 FEKD----PRKLL----TDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHH----hhhhc----ccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            1111    00000    000  111222   3334444445558999999999999988765443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.9e-21  Score=218.64  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=183.6

Q ss_pred             CCCCcccccCcEEEEEeeec--CceEEEEEee----c-cc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          322 NPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS----E-TS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~----~-~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ...+++|.|++|.|+.....  ....+.|...    . .. ++....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35778999999977766544  2333333322    1 11 111222667888889999999999888888777776679


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++ +|..++....        .+...++..+++|+..|++|+|.   .+|.|||+|++|++++.++.+||+|||.+.
T Consensus       401 E~~~~-Dlf~~~~~~~--------~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG--------KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hcccH-HHHHHHhccc--------ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcce
Confidence            99999 9998886541        26777888999999999999999   999999999999999999999999999998


Q ss_pred             cccccccc-cccccccccCCCccCccccccCCCCC-ccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          474 TIQENLKT-HHSTKEIAGTPGYMAPESFLVGRATI-ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       474 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~-~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      .+.-.... .......+|...|+|||.+....|.+ ..||||.|+++..|++|+.||.........  ..    +....+
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~--~~----~~~~~~  542 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS--FK----TNNYSD  542 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc--hh----hhcccc
Confidence            76532221 13356788999999999999998865 589999999999999999998765433211  00    000000


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .......   ..........+...++.+++++||.+|.+|++|++
T Consensus       543 ~~~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  543 QRNIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000000   00112233445667889999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=1.5e-20  Score=202.40  Aligned_cols=214  Identities=27%  Similarity=0.403  Sum_probs=163.6

Q ss_pred             HhccCCCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCe-
Q 006446          368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRV-  446 (644)
Q Consensus       368 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i-  446 (644)
                      |+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+.....       .++|.-...++++|+.||+|||+   .+| 
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-------~~d~~F~~s~~rdi~~Gl~ylh~---s~i~   70 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-------KLDYFFILSFIRDISKGLAYLHN---SPIG   70 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-------CccHHHHHHHHHHHHHHHHHHhc---Ccce
Confidence            4678999999999999999999999999999999999976443       39999999999999999999998   333 


Q ss_pred             EeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCC-------CCCccchHHHHHHHH
Q 006446          447 LHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR-------ATIETDIYAFGVLIL  519 (644)
Q Consensus       447 vHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~t~~sDVwSfGvvl~  519 (644)
                      .|+.++++|+++|..+.+||+|||+........ .........-..-|.|||.+....       .+.+.||||||++++
T Consensus        71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~  149 (484)
T KOG1023|consen   71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY  149 (484)
T ss_pred             eeeeeccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence            999999999999999999999999987764210 001011222345799999986531       477899999999999


Q ss_pred             HHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCC-H-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          520 EVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFS-E-KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       520 el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-~-~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      |+++.+.||...........++..+..   .+.      +-+++... . +..+.+..++..||..+|.+||++++|-..
T Consensus       150 ei~~r~~~~~~~~~~~~~~eii~~~~~---~~~------~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  150 EILFRSGPFDLRNLVEDPDEIILRVKK---GGS------NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             HHHhccCccccccccCChHHHHHHHHh---cCC------CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            999999999876554443344443322   111      11111111 1 333368889999999999999999999887


Q ss_pred             HhCC
Q 006446          598 LSGE  601 (644)
Q Consensus       598 L~~~  601 (644)
                      ++..
T Consensus       221 ~~~~  224 (484)
T KOG1023|consen  221 LLTI  224 (484)
T ss_pred             hhhh
Confidence            7654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2e-20  Score=184.60  Aligned_cols=171  Identities=13%  Similarity=0.139  Sum_probs=133.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhH---------HHHHHHHHHhccCCCceeeEeeeeeec-
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQ---------EFIAEVTTIGSLRHRNLVKLIGWCYER-  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~---------~~~~Ei~~l~~l~H~nIv~l~g~~~~~-  386 (644)
                      ..++|+..++||.|+||.||+....+..+|+|.+.........         .+.+|+..+.+++|++|..+..++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4689999999999999999997776778999999754332222         267899999999999999998875532 


Q ss_pred             -------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          387 -------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       387 -------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                             +..+|+|||+++.+|.++..            ++.    ....+++++|..+|+   .+++|||+||+||+++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~  169 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE------------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS  169 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh------------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence                   35799999999999977631            221    245689999999999   9999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHH
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA  522 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~  522 (644)
                      .++ ++|+|||..+.......    ..           .++....+..++|+||||+.+.-+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a----~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKA----KD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhh----HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            988 99999998875532111    00           1334445667899999999987653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=2.3e-20  Score=209.46  Aligned_cols=252  Identities=21%  Similarity=0.194  Sum_probs=184.4

Q ss_pred             CCCCCCcccccCcEEEEEeeecCceEEEEEeeccc-chhhHHHH---HHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS-RQGKQEFI---AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~-~~~~~~~~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++...+.||.+.|=+|.+|+++.+.|+||++-+.. .-..+.|.   .|++ ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            56778999999999999999998889999986543 33344444   4455 4556899999999987777788999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      . .-+|.+.|...+        .|...+...|+.|++.||.-+|+   .+|+|||||.+||||+.-.-+.|+||..-+-.
T Consensus       103 v-khnLyDRlSTRP--------FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  103 V-KHNLYDRLSTRP--------FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             H-hhhhhhhhccch--------HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCc
Confidence            8 568888875433        37778888999999999999999   99999999999999999999999999876543


Q ss_pred             cccccccccc----cccccCCCccCccccccC-----------CCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhh
Q 006446          476 QENLKTHHST----KEIAGTPGYMAPESFLVG-----------RATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNS  539 (644)
Q Consensus       476 ~~~~~~~~~~----~~~~gt~~y~APE~~~~~-----------~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~  539 (644)
                      .-........    +....-..|+|||.+...           ..+++.||||+||++.||++ |++||+-       .+
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQ  243 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQ  243 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HH
Confidence            2111111111    122233479999987531           26789999999999999998 6777753       22


Q ss_pred             HHHHHHHHHhcCc--hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          540 IVHWLWELRRKGR--ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       540 l~~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      +..+     +.+.  ..+..-..+       +...+..+++.|++.||++|.++++.|+.-.|...
T Consensus       244 L~aY-----r~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  244 LLAY-----RSGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             HHhH-----hccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence            3221     1111  111111111       11246678899999999999999999998766543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-19  Score=173.05  Aligned_cols=204  Identities=21%  Similarity=0.367  Sum_probs=168.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCC-CceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .+.|...++||.|+||.+|.|..-  +.+||+|.-+...+  ..++..|..+.+.|+| ..|..+..+..++..-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            367889999999999999999875  88999998765543  3567788899999875 567777777888888899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---CcEEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FNARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGl  471 (644)
                      .+ +-||++...-....       ++....+-++-|+..-++|+|.   .+.+||||||+|+|..-+   ..+.|+|||+
T Consensus        92 LL-GPsLEdLfnfC~R~-------ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRR-------FTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             cc-CccHHHHHHHHhhh-------hhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence            98 88999887655443       7888999999999999999999   999999999999999654   4588999999


Q ss_pred             ccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          472 ARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       472 a~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                      |+.+.+.....    .......||.+|.+-....+-.-+.+-|+=|+|.+|....-|..||++....
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            98775322111    1124567999999988777777889999999999999999999999886544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.4e-19  Score=175.97  Aligned_cols=139  Identities=15%  Similarity=0.137  Sum_probs=106.2

Q ss_pred             CCcccccCcEEEEEeeec-CceEEEEEeecccch--h-------hHH-----------------HHHHHHHHhccCCCce
Q 006446          324 KNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQ--G-------KQE-----------------FIAEVTTIGSLRHRNL  376 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~nI  376 (644)
                      ...||+|+||.||+|... ++.||||+++.....  .       ...                 ...|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999986 789999998754211  0       112                 2349999999988776


Q ss_pred             eeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHh-HhCCCCCeEeCCCCCCC
Q 006446          377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL-HNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       377 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDlkp~N  455 (644)
                      ........  ...+|||||++++++...+....        .++......++.|++.+|.|| |+   .+|+||||||+|
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~--------~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~N  148 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA--------PLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYN  148 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHH
Confidence            44332221  23489999998877765432211        378889999999999999999 56   799999999999


Q ss_pred             EEEcCCCcEEEeccCCccccc
Q 006446          456 IMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~~  476 (644)
                      ||++ ++.++|+|||+|....
T Consensus       149 Ili~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEEE-CCcEEEEEccccccCC
Confidence            9998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2.3e-19  Score=182.29  Aligned_cols=232  Identities=22%  Similarity=0.271  Sum_probs=153.0

Q ss_pred             CCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCC----------CceeeEeeeee-
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRH----------RNLVKLIGWCY-  384 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H----------~nIv~l~g~~~-  384 (644)
                      +...+.||.|+++.||.+++.  ++++|+|......   ....+++.+|.-.+..+.+          -.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345788999999999999998  5899999875432   3345677777766665432          22222222221 


Q ss_pred             --------ecc--------ceEEEEeccCCCccchhhhc---cCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 006446          385 --------ERH--------DFLLVYEYMPNGSLDKFIFY---DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR  445 (644)
Q Consensus       385 --------~~~--------~~~lV~Ey~~~gsL~~~l~~---~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  445 (644)
                              ...        ..+++|+-+ .++|.+++..   ....    ...+....|+.+..|+.+.+++||+   .+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~----~~~l~~~arl~lT~Q~I~lvA~Lh~---~G  165 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT----HSPLAFAARLSLTVQMIRLVANLHS---YG  165 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT----SHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc----cchhHHHHHHHHHHHHHHHHHHHhh---cc
Confidence                    111        247788887 7788877542   2211    2236677788899999999999999   99


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccC--------CCCCccchHHHHHH
Q 006446          446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG--------RATIETDIYAFGVL  517 (644)
Q Consensus       446 ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~t~~sDVwSfGvv  517 (644)
                      ++|+||||+|++++.+|.++|+||+.....+...      .....+..|.+||.....        .++.+.|.|++|++
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            9999999999999999999999998877654321      113345789999976442        47899999999999


Q ss_pred             HHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006446          518 ILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR  588 (644)
Q Consensus       518 l~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R  588 (644)
                      +|.|+||+.||..........    |                .+ ..+. +..+.+..|+..++++||++|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~----~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPE----W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSG----G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCcccccc----c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999998754432211    0                11 2233 566788889999999999988

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.80  E-value=1.8e-18  Score=171.83  Aligned_cols=180  Identities=21%  Similarity=0.276  Sum_probs=127.0

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK  118 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~  118 (644)
                      .+..+. +|.+.++.|+||.+..     ++.|+++|+.|+++        .+|+|+|+|.|.+....+||||||++++..
T Consensus        20 ~~w~~~G~a~~~~~~i~LT~~~~-----~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~~~~gdG~af~~~~~~   86 (218)
T cd07308          20 GNWTVGGSTVITKNYIRLTPDVP-----SQSGSLWSRVPIPA--------KDFEIEVEFSIHGGSGLGGDGFAFWYTEEP   86 (218)
T ss_pred             CCeEEcCCeEEeCCEEEeCCCCC-----CCEeEEEeCCCccC--------CCEEEEEEEEEeCCCCCCCCEEEEEEECCC
Confidence            478888 9999999999998765     78999999999998        689999999998755678999999999854


Q ss_pred             CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceee----ecCCcc--------ceeeecCcccccCC
Q 006446          119 DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGL----DVNSVY--------SIRQVPLTRVNLAN  186 (644)
Q Consensus       119 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgi----d~ns~~--------s~~~~~~~~~~l~~  186 (644)
                      .    ..|..+|--       ...+-+||||||+.|.  +-...+|.+    ..++..        +.....+ ... .+
T Consensus        87 ~----~~g~~~G~~-------~~~~Glai~fdt~~n~--~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~-~~~-~~  151 (218)
T cd07308          87 G----SDGPLFGGP-------DKFKGLAIFFDTYDND--GKGFPSISVFLNDGTKSYDYETDGEKLELASCSL-KFR-NS  151 (218)
T ss_pred             C----CCCcccccC-------CCCCEEEEEEEcCCCC--CCCCCeEEEEEeCCCceecccCCCccccccceeE-ecc-cC
Confidence            3    245555531       1234589999999984  222233333    222211        1112222 111 12


Q ss_pred             CceEEEEEEEcCceEEEEEecCC--CCCcccccCccC-cCCCceeeeecccCCCcccccccccccc
Q 006446          187 GTDIKVQVRYDGQNITVFVANME--TPLLSEPIDLSE-YLPEKVFVGFSASTGDDTQLNCVKSWAF  249 (644)
Q Consensus       187 g~~~~~~I~Y~~~~l~v~~~~~~--~~~ls~~~dl~~-~l~~~~~vGfsastg~~~~~~~i~~wsf  249 (644)
                      +.+++++|.|+...|.|.+....  ...+-  .++.. .+|+..|+||||+||...+.|.|++|..
T Consensus       152 ~~~~~~~I~y~~~~l~v~i~~~~~~~~~~c--~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~~  215 (218)
T cd07308         152 NAPTTLRISYLNNTLKVDITYSEGNNWKEC--FTVEDVILPSQGYFGFSAQTGDLSDNHDILSVHT  215 (218)
T ss_pred             CCCeEEEEEEECCEEEEEEeCCCCCCccEE--EEcCCcccCCCCEEEEEeccCCCcCcEEEEEEEe
Confidence            67999999999888998885321  11222  22223 4678899999999999999999999865

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.1e-18  Score=168.82  Aligned_cols=188  Identities=16%  Similarity=0.130  Sum_probs=140.7

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeecccchh----hHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEecc
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQG----KQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~----~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .....|++|+||+||.+...+.+++.+.+.....-.    ...+.+|+++|++|. |+++.+++++    +..+++|||+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456789999999999887778888888776544311    125789999999995 5889999887    3469999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC-CCCCEEEcCCCcEEEeccCCcccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI-KSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl-kp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++.+|.+.+..               ....++.+++++|.++|+   .+|+|||| ||+|||++.++.++|+|||++...
T Consensus        81 ~G~~L~~~~~~---------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         81 AGAAMYQRPPR---------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             cCccHHhhhhh---------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            98888654310               113577899999999999   99999999 799999999999999999999865


Q ss_pred             cccccc----cc------cccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 006446          476 QENLKT----HH------STKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQS  531 (644)
Q Consensus       476 ~~~~~~----~~------~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~  531 (644)
                      ......    ..      .......++.|++|+...-  .+--...+.++-|+-+|.++|++.+.-..
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            432210    00      0011236788888885432  22235678999999999999999885443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=2.3e-18  Score=167.65  Aligned_cols=140  Identities=16%  Similarity=0.131  Sum_probs=108.7

Q ss_pred             CCcccccCcEEEEEeeec-CceEEEEEeecccchh--------------------------hHHHHHHHHHHhccCCCce
Q 006446          324 KNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQG--------------------------KQEFIAEVTTIGSLRHRNL  376 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~nI  376 (644)
                      ...||+|++|.||+|+.. +..||||+++......                          ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999986 8899999987642110                          1123578999999999987


Q ss_pred             eeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCE
Q 006446          377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI  456 (644)
Q Consensus       377 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI  456 (644)
                      .....+...  ..+|||||++++++....... .       .++......++.+++.++.+||+  +.+|+||||||+||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~-------~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NI  149 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-V-------PLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNI  149 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-c-------cCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhE
Confidence            554443332  348999999887654432111 1       26677889999999999999997  36999999999999


Q ss_pred             EEcCCCcEEEeccCCccccc
Q 006446          457 MLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       457 Lld~~~~vkL~DFGla~~~~  476 (644)
                      |++ +++++|+|||+++...
T Consensus       150 ll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEE-CCCEEEEEcccceecC
Confidence            999 8899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.6e-18  Score=172.70  Aligned_cols=202  Identities=21%  Similarity=0.334  Sum_probs=169.2

Q ss_pred             CCCCCCCcccccCcEEEEEeee--cCceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      -.|...++||+|.||+.+.|+.  ++..||||.-...+  ...++..|....+.| ..++|.+.+-+..++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3688899999999999999975  48899999754433  345677788888877 468999998888888888999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-----CcEEEeccC
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-----FNARLGDFG  470 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-----~~vkL~DFG  470 (644)
                      + +-||+++...+...       ++......|+.|+..-++|+|+   +.+|.|||||+|+||..-     ..+.+.|||
T Consensus       106 L-GPSLEDLFD~CgR~-------FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRR-------FSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             h-CcCHHHHHHHhcCc-------ccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEecc
Confidence            8 88999988766553       8889999999999999999999   999999999999999643     348999999


Q ss_pred             Ccccccccccccc----cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          471 LARTIQENLKTHH----STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       471 la~~~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      +|+.+.+.....+    ..+...||.+||+-.-..+..-+.+-|.=|+|-++...+-|..||++...
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            9998764322111    13456799999999988899999999999999999999999999987543

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=5e-18  Score=166.85  Aligned_cols=137  Identities=17%  Similarity=0.248  Sum_probs=106.8

Q ss_pred             CCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhcc-----CCCceeeEeeeeeecc---c-eE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-----RHRNLVKLIGWCYERH---D-FL  390 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~  390 (644)
                      ....++||+|+||.||.  +. ....+||++........+.+.+|+.+++++     .||||++++|++.++.   . +.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34578899999999996  33 333479988765555567899999999999     5799999999998863   3 34


Q ss_pred             EEEec--cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHH-HHhHhCCCCCeEeCCCCCCCEEEcC----CCc
Q 006446          391 LVYEY--MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL-DYLHNGSEKRVLHRDIKSSNIMLDS----EFN  463 (644)
Q Consensus       391 lV~Ey--~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDlkp~NILld~----~~~  463 (644)
                      +|+||  +++|+|.+++....         ++..  ..++.+++.++ +|||+   .+|+||||||+|||++.    +.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~---------~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR---------YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc---------ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCc
Confidence            78999  66899999995421         3333  35577778777 99999   99999999999999974    347


Q ss_pred             EEEeccCCcc
Q 006446          464 ARLGDFGLAR  473 (644)
Q Consensus       464 vkL~DFGla~  473 (644)
                      ++|+||+.+.
T Consensus       148 ~~LiDg~G~~  157 (210)
T PRK10345        148 PVVCDNIGES  157 (210)
T ss_pred             EEEEECCCCc
Confidence            9999955443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.8e-18  Score=186.27  Aligned_cols=233  Identities=22%  Similarity=0.226  Sum_probs=174.0

Q ss_pred             cccccCcEEEEEeee-----cCceEEEEEeecccch--hhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEeccC
Q 006446          326 KLGKGGFGTVYKGIW-----RNKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .+|+|+||.|++..-     .+.-+|+|.+++....  .......|-.++...+ ||.+|++.-.+..+..++++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999986432     2566888877653211  1124556777888886 9999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|.|...+.....        ........+...+|-+++.+|+   .+|+|||+|++||+++.+|.+++.|||+++..-.
T Consensus        81 gg~lft~l~~~~~--------f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM--------FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             cchhhhccccCCc--------hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence            9999888765432        5555566677888999999999   9999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ..       ..+||..|||||++.  ......|.||||++++||++|..||...    ....|..               
T Consensus       150 ~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~Il~---------------  201 (612)
T KOG0603|consen  150 EK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRILK---------------  201 (612)
T ss_pred             hh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHHhh---------------
Confidence            21       128999999999988  5677899999999999999999998761    0011110               


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM--KTVLQVLSG  600 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~--~evl~~L~~  600 (644)
                         ..-.++.+.......+...+...+|..|--.  .-+.++++.
T Consensus       202 ---~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h  243 (612)
T KOG0603|consen  202 ---AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH  243 (612)
T ss_pred             ---hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence               1123344444445556667777788888655  445555443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.2e-17  Score=163.15  Aligned_cols=134  Identities=19%  Similarity=0.304  Sum_probs=114.7

Q ss_pred             CcccccCcEEEEEeeecCceEEEEEeecccch--------hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQ--------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +.||+|++|.||+|...+..+++|+.......        ....+..|+.++..++|+++.....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            57999999999999999899999986543211        1245788999999999999988888877778899999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ++++|.+++..           ..+ .+..++.+++.+|.+||+   .+++|||++|.|||++ ++.++|+|||+++.
T Consensus        82 ~G~~L~~~~~~-----------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINS-----------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHh-----------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999998842           122 788999999999999999   9999999999999999 78999999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=6.7e-17  Score=182.07  Aligned_cols=139  Identities=19%  Similarity=0.300  Sum_probs=115.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--------chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      ....|...++||+|+||.||+|.+.+..+++|+.....        ....+.+..|++++.+++|++++....++.....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34556778999999999999999987776666542211        1123568899999999999999988888887778


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++||||+++++|.+++.                .+..++.+++++|.|||+   .+++||||||+|||+ +++.++|+|
T Consensus       411 ~~lv~E~~~g~~L~~~l~----------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE----------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             CEEEEEecCCCcHHHHHH----------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEe
Confidence            899999999999988873                346789999999999999   999999999999999 678999999


Q ss_pred             cCCcccc
Q 006446          469 FGLARTI  475 (644)
Q Consensus       469 FGla~~~  475 (644)
                      ||+++..
T Consensus       471 FGla~~~  477 (535)
T PRK09605        471 FGLGKYS  477 (535)
T ss_pred             CcccccC
Confidence            9999764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=8.7e-17  Score=157.43  Aligned_cols=131  Identities=19%  Similarity=0.278  Sum_probs=108.2

Q ss_pred             cccccCcEEEEEeeecCceEEEEEeecccc--------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSR--------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .||+|+||.||+|.+.+..+++|+......        .....+.+|+.++..++|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            489999999999998899999998653221        113567789999999999876666556666677899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|.+++....         .      .++.+++.+|.+||+   .+++|||++|.||+++ ++.+++.|||+++..
T Consensus        81 g~~l~~~~~~~~---------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGN---------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcH---------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999988773211         0      789999999999999   9999999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.3e-16  Score=160.48  Aligned_cols=141  Identities=18%  Similarity=0.209  Sum_probs=108.7

Q ss_pred             CCCCCCcccccCcEEEEEee-e--cCceEEEEEeecccch------------------------hhHHHHHHHHHHhccC
Q 006446          320 NFNPKNKLGKGGFGTVYKGI-W--RNKEIAVKRVSETSRQ------------------------GKQEFIAEVTTIGSLR  372 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~-~--~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  372 (644)
                      .|...+.||+|++|.||+|+ .  .+..||+|+++.....                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 3  3789999998753210                        0123567999999997


Q ss_pred             CCc--eeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC-eEeC
Q 006446          373 HRN--LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR-VLHR  449 (644)
Q Consensus       373 H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHr  449 (644)
                      +..  +.+++++    ...++||||+++++|........        .+...+...++.|++.+|.+||+   .+ ++||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~  173 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--------EPEEEEEFELYDDILEEMRKLYK---EGELVHG  173 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--------CcchHHHHHHHHHHHHHHHHHHh---cCCEEeC
Confidence            533  3444443    23589999999988876542221        14455667899999999999999   88 9999


Q ss_pred             CCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          450 DIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       450 Dlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ||||+||+++ +++++|+|||.+....
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999 8899999999987654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.3e-16  Score=162.44  Aligned_cols=199  Identities=20%  Similarity=0.275  Sum_probs=140.3

Q ss_pred             CCCceeeEeeeeeec---------------------------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHH
Q 006446          372 RHRNLVKLIGWCYER---------------------------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR  424 (644)
Q Consensus       372 ~H~nIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~  424 (644)
                      +|||||++.+.+.+.                           ..+|+||.-+ .-+|.+|+..+.         .+...+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---------~s~r~~  343 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---------RSYRTG  343 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---------CchHHH
Confidence            599999999876531                           2479999887 568999886443         566677


Q ss_pred             HHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE--cCCC--cEEEeccCCcccccccccc-cc--cccccccCCCccCc
Q 006446          425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML--DSEF--NARLGDFGLARTIQENLKT-HH--STKEIAGTPGYMAP  497 (644)
Q Consensus       425 ~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl--d~~~--~vkL~DFGla~~~~~~~~~-~~--~~~~~~gt~~y~AP  497 (644)
                      .-|+.|+++|+.|||.   ++|.|||+|++||||  |+|+  ...|+|||++-.-+.++-. ..  ......|...-|||
T Consensus       344 ~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  344 RVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            7789999999999999   999999999999999  4444  4688999998654432211 11  01234577789999


Q ss_pred             cccccCC------CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHH
Q 006446          498 ESFLVGR------ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEME  571 (644)
Q Consensus       498 E~~~~~~------~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  571 (644)
                      |+....+      -..|+|.|+.|.+.||++....||....+.     +++  ...+++.++     +.+..    ....
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----~L~--~r~Yqe~qL-----Palp~----~vpp  484 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----LLD--TRTYQESQL-----PALPS----RVPP  484 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----eec--hhhhhhhhC-----CCCcc----cCCh
Confidence            9876432      246899999999999999999999873321     111  011222222     22222    2334


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          572 CVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       572 ~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      .+.+|+...+++||++||+..-....|+
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            5667778889999999999877766665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=1.8e-16  Score=182.13  Aligned_cols=199  Identities=20%  Similarity=0.236  Sum_probs=155.8

Q ss_pred             HHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccC---CCceeeEeeeeeeccc
Q 006446          313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHD  388 (644)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~  388 (644)
                      +.......|.+.+.||+|+||.||+|... ++.||+|.-+....   -+|.--.+++.||+   -+-|..+.......+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            33444567888999999999999999887 77899998665432   23333334455555   2234444444455667


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc-------CC
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-------SE  461 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-------~~  461 (644)
                      -+||+||.+.|+|.+++...+        .++|...+.++.|++..++.||.   .+|||+||||+|.||.       ++
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~--------~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK--------VMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             ceeeeeccccccHHHhhccCC--------CCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcc
Confidence            899999999999999996322        48999999999999999999999   9999999999999993       23


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCC
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK  526 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~  526 (644)
                      ..++|+|||.+..+..-... .......+|-.+-.+|+..+..++.+.|.|.+..+++-|+.|+.
T Consensus       838 ~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            56899999999876532221 22466788999999999999999999999999999999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=5.9e-16  Score=151.62  Aligned_cols=143  Identities=18%  Similarity=0.213  Sum_probs=110.1

Q ss_pred             HHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccch----------------------hhHHHHHHHHHHh
Q 006446          313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQ----------------------GKQEFIAEVTTIG  369 (644)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~  369 (644)
                      ++.....-|...+.||+|+||.||++... ++.||||++......                      ....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34443334777899999999999999885 789999987643210                      1123567899999


Q ss_pred             ccCCC--ceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeE
Q 006446          370 SLRHR--NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVL  447 (644)
Q Consensus       370 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv  447 (644)
                      .+.|+  .+.+.++.    ...++||||+++++|......              .....++.++++++.++|+   .+++
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------------~~~~~~~~~i~~~l~~lh~---~gi~  147 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------------EDPEEVLDEILEEIVKAYK---HGII  147 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------------ccHHHHHHHHHHHHHHHHH---CCCC
Confidence            99887  44455543    345899999999998765420              2235688899999999999   9999


Q ss_pred             eCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          448 HRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       448 HrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ||||||+||++++++.++|+|||++....
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=5.7e-16  Score=143.11  Aligned_cols=136  Identities=18%  Similarity=0.139  Sum_probs=116.6

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCC--CceeeEeeeeeeccceEEEEeccCCCc
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH--RNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      ..+.||+|.++.||++...+..+++|.......  ...+..|+..++.++|  .++.+++++....+..++++||++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            356799999999999999888999999865543  5678899999999977  589999999888888999999998877


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +..+               ++.....++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus        80 ~~~~---------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV---------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC---------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            7543               44566788999999999999855568999999999999999999999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=8.5e-17  Score=170.38  Aligned_cols=125  Identities=25%  Similarity=0.442  Sum_probs=107.2

Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      .+++.|++|...+|.+||...+...     ..+|...+.++.|++.|+.|      ++.+|||+||.||+...+..+||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e-----~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE-----ERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc-----ccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhh
Confidence            5899999999999999997555432     36788899999999999999      688999999999999999999999


Q ss_pred             ccCCccccccccc---ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc
Q 006446          468 DFGLARTIQENLK---THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC  523 (644)
Q Consensus       468 DFGla~~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t  523 (644)
                      |||+.........   .....+...||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9999987653220   1112456789999999999999999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=6e-16  Score=174.45  Aligned_cols=209  Identities=23%  Similarity=0.306  Sum_probs=138.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+|+..+.|-.|++|.||..+++  .+++|+|. .++.     ...+.  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            468999999999999999999887  67788843 2211     00110  12222233322                  


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                         |+-...+....        .+.-        +++.+++|||+   .+|+|||+||+|.+|+.=|++|+.|||+.+..
T Consensus       136 ---gDc~tllk~~g--------~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG--------PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ---chhhhhcccCC--------CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhh
Confidence               33222232111        1221        22678999999   99999999999999999999999999998643


Q ss_pred             cccc------------cccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH
Q 006446          476 QENL------------KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       476 ~~~~------------~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~  543 (644)
                      ....            ......+.++||+.|.|||++....|...+|+|++|+++||.+-|+.||....+.+....++..
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd  273 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  273 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence            2110            0111134568999999999999999999999999999999999999999887665433332221


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                      ..      ..         .+-++.-.....+++.+.++.+|..|-
T Consensus       274 ~i------~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 DI------EW---------PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hc------cc---------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            10      00         111222223445566777888888885

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=1.9e-14  Score=144.97  Aligned_cols=135  Identities=20%  Similarity=0.207  Sum_probs=106.1

Q ss_pred             CCccc-ccCcEEEEEeeecCceEEEEEeeccc-------------chhhHHHHHHHHHHhccCCCce--eeEeeeeeecc
Q 006446          324 KNKLG-KGGFGTVYKGIWRNKEIAVKRVSETS-------------RQGKQEFIAEVTTIGSLRHRNL--VKLIGWCYERH  387 (644)
Q Consensus       324 ~~~LG-~G~fG~Vy~g~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~~  387 (644)
                      ...|| .||.|+||+....+..++||++....             ......+.+|+.++.+|+|+++  ++.++++..+.
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            45687 89999999998889999999885321             1223567889999999998875  67777654432


Q ss_pred             c----eEEEEeccCC-CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          388 D----FLLVYEYMPN-GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       388 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      .    .++|+||+++ .+|.+++....         ++..    .+.+++++|.+||+   .+|+||||||.|||++.++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~---------l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEAP---------LSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcCC---------CCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCC
Confidence            2    3599999997 68888874321         3332    35689999999999   9999999999999999999


Q ss_pred             cEEEeccCCccc
Q 006446          463 NARLGDFGLART  474 (644)
Q Consensus       463 ~vkL~DFGla~~  474 (644)
                      .++|+|||.++.
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            999999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=2.5e-14  Score=138.51  Aligned_cols=137  Identities=20%  Similarity=0.241  Sum_probs=97.4

Q ss_pred             CCcccccCcEEEEEeeec-CceEEEEEeecccch--hhHHH----------------------HHHHHHHhccCCCc--e
Q 006446          324 KNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQ--GKQEF----------------------IAEVTTIGSLRHRN--L  376 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~n--I  376 (644)
                      .+.||+|+||.||+|... +..||||++......  ....+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988 889999998653211  11111                      34555566554432  3


Q ss_pred             eeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCE
Q 006446          377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI  456 (644)
Q Consensus       377 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI  456 (644)
                      .+.++.    ...++||||++++.+.........        .. .+...++.+++.++.++|.  +.+|+||||||+||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNI  146 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhE
Confidence            344433    246899999998654322111110        11 4567889999999999997  37899999999999


Q ss_pred             EEcCCCcEEEeccCCccccc
Q 006446          457 MLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       457 Lld~~~~vkL~DFGla~~~~  476 (644)
                      +++ ++.++|+|||.+....
T Consensus       147 li~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEE-CCcEEEEECccccccc
Confidence            999 8999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.52  E-value=6.6e-13  Score=133.09  Aligned_cols=183  Identities=21%  Similarity=0.230  Sum_probs=116.0

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-CCCCCCCceEEEEecC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGN  117 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~~~~~g~G~aF~l~~~  117 (644)
                      .+..+. +|.+.++.|+||++..     .+.|++||+.|+++        .+|+|+|+|+|.+ ....+||||||+++..
T Consensus        20 ~~w~~~G~a~v~~~~IrLTp~~~-----~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~   86 (248)
T cd06901          20 PLWDFLGSTMVTSQYIRLTPDHQ-----SKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKE   86 (248)
T ss_pred             CCEEEcceEEEcCCeEEECCCCC-----CCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcC
Confidence            478888 8988888999998865     57999999999999        6799999999997 4457899999999985


Q ss_pred             CCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC--CCCCCce-eeecCCccce------eeecCc--cccc-C
Q 006446          118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ--DINDNHV-GLDVNSVYSI------RQVPLT--RVNL-A  185 (644)
Q Consensus       118 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~--d~~~~Hv-gid~ns~~s~------~~~~~~--~~~l-~  185 (644)
                      ..    ..|..+|--   ...   +. +||-|||+.|.+-  ....+-| ++=.++...-      ....+.  .... .
T Consensus        87 ~~----~~G~~fG~~---~~f---~G-l~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~rn  155 (248)
T cd06901          87 RM----QPGPVFGSK---DNF---HG-LAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPFRN  155 (248)
T ss_pred             CC----ccCcccccC---CCC---ce-EEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeeccC
Confidence            32    334444421   111   12 6999999988431  0111112 1111111110      000111  1111 3


Q ss_pred             CCceEEEEEEEcCceEEEEEecCCCCCcccccCccC-cCCCceeeeecccCCCccccccccc
Q 006446          186 NGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSE-YLPEKVFVGFSASTGDDTQLNCVKS  246 (644)
Q Consensus       186 ~g~~~~~~I~Y~~~~l~v~~~~~~~~~ls~~~dl~~-~l~~~~~vGfsastg~~~~~~~i~~  246 (644)
                      .+.+..++|.|....+.|.+.....-....-..... .||...|+||||+||...+.|.|++
T Consensus       156 ~~~~t~~rI~Y~~~~l~v~vd~~~~~~w~~Cf~~~~v~LP~~~yfGiSA~Tg~~sd~hdIls  217 (248)
T cd06901         156 KDHDTFVAIRYSKGRLTVMTDIDGKNEWKECFDVTGVRLPTGYYFGASAATGDLSDNHDIIS  217 (248)
T ss_pred             CCCCeEEEEEEECCeEEEEEecCCCCceeeeEEeCCeecCCCCEEEEEecCCCCCCcEEEEE
Confidence            445578999999877888775322110000012222 4677899999999999888887765

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4.7e-15  Score=167.10  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=182.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---CceEEEEEeeccc--chhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ..|...+.||+|+|+.|-.....   ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45677788999999999877654   3457777665443  222233344777777776 99999999999999999999


Q ss_pred             EeccCCCccchhhh-ccCCCCCCCccccCHHHHHHHHHHHHHHHHHhH-hCCCCCeEeCCCCCCCEEEcCCC-cEEEecc
Q 006446          393 YEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-NGSEKRVLHRDIKSSNIMLDSEF-NARLGDF  469 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~-~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivHrDlkp~NILld~~~-~vkL~DF  469 (644)
                      .||..++++.+.+. .....       .+-...-.++.|+..++.|+| +   .++.|||+||+|.+++..+ +.+++||
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~-------~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTG-------TSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             cCcccccccccccccCCccC-------CCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCc
Confidence            99999999988873 22211       333344567899999999999 6   8999999999999999999 9999999


Q ss_pred             CCccccccccccccccccccc-CCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAG-TPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~g-t~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |+|..+.............+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......  .....|....
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc
Confidence            999887641222222445677 9999999998874 45778999999999999999999987644322  1111221110


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                         +.        .....-........++..+|+..+|..|.+.+++.
T Consensus       248 ---~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 ---GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ---cc--------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence               00        00111112223445567788889999999988875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=1.6e-12  Score=142.12  Aligned_cols=144  Identities=19%  Similarity=0.257  Sum_probs=101.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhh----------------------------------------
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGK----------------------------------------  358 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~----------------------------------------  358 (644)
                      .|+ .+.||.|++|.||+|++. |+.||||+.+.......                                        
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            454 468999999999999986 88999999865421110                                        


Q ss_pred             HHHHHHHHHHhccC----CCceeeEeeeee-eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH
Q 006446          359 QEFIAEVTTIGSLR----HRNLVKLIGWCY-ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       359 ~~~~~Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~  433 (644)
                      -+|..|...+.+++    |.+-+.+-..+. ..+..+|||||+++++|.++.......       .   .+.+++..++.
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-------~---~~~~ia~~~~~  267 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-------L---DRKALAENLAR  267 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-------C---CHHHHHHHHHH
Confidence            12455666555552    333333333332 234579999999999999876432211       2   23456666665


Q ss_pred             -HHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          434 -ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       434 -aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                       .+..+|.   .+++|+|+||.||++++++++++.|||++..+.+
T Consensus       268 ~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       268 SFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             4677887   8999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=5e-13  Score=133.69  Aligned_cols=204  Identities=24%  Similarity=0.357  Sum_probs=138.6

Q ss_pred             HHHHhccCCCceeeEeeeeeec-----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhH
Q 006446          365 VTTIGSLRHRNLVKLIGWCYER-----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH  439 (644)
Q Consensus       365 i~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH  439 (644)
                      ..-|-++-|.|||++..|+.+.     .+..++.|||..|+|..+|++.+...    ..+......+++.||..||.|||
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~----~a~~~~~wkkw~tqIlsal~yLh  193 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ----KALFQKAWKKWCTQILSALSYLH  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh----hhhhHHHHHHHHHHHHhhhhhhh
Confidence            3445566799999999987654     35789999999999999997654321    23666666789999999999999


Q ss_pred             hCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccc--cccccccccCCCccCccccccCCCCCccchHHHHHH
Q 006446          440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT--HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL  517 (644)
Q Consensus       440 ~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvv  517 (644)
                      + |..+|+|+++..+-|++..++-+|++----..... ....  ...+....+-++|.+||.=...+.+..+|||+||+.
T Consensus       194 s-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~-s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  194 S-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-SVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             c-cCCccccCCcchhheeecCCceEEecccCccccch-hhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            8 66899999999999999999988886422111100 0000  001223456789999998777778889999999999


Q ss_pred             HHHHHcCCCCCCCCccc-cchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          518 ILEVACGRKPGNQSEQN-SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       518 l~el~tG~~P~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                      .+||..+..--...... .....+..         .+...-+. +           =...+..|++..|..||+|++++
T Consensus       272 AlemailEiq~tnseS~~~~ee~ia~---------~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVEVEENIAN---------VIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             HHHHHHheeccCCCcceeehhhhhhh---------heeeccCc-c-----------ccCcCcccccCCCCCCcchhhhh
Confidence            99999876432221110 00000100         00000011 1           01245689999999999999876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=2.9e-12  Score=138.74  Aligned_cols=249  Identities=23%  Similarity=0.298  Sum_probs=175.1

Q ss_pred             CCCCCCCcccc--cCcEEEEEeee--c--CceEEEEEeecccc--hhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGK--GGFGTVYKGIW--R--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~--G~fG~Vy~g~~--~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      ..|...+.+|.  |.+|.||.+..  .  ...+|+|+-+..-.  +....=.+|+..-+.+ .|+|.++....+..++.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667888999  99999999988  3  56789888443222  2223334566666666 499999988888889999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH----HHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ----ALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNA  464 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDlkp~NILld~~-~~v  464 (644)
                      ++-.|++ +.+|..+.+....       .++......+..+..+    ||..+|.   .+++|-|+||.||+...+ ..+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~-------~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCN-------FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             eeeeccc-cchhHHhhhcccc-------cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence            9999998 6788887754332       1444455566666666    9999999   999999999999999999 889


Q ss_pred             EEeccCCcccccccccccc--cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          465 RLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      +++|||+...+........  ......|...|++||.. ++.++...|+|++|.+.+|..++-.+........       
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------  334 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------  334 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------
Confidence            9999999988764331111  11233577889999965 5568899999999999999999876643321111       


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        |...+.+.        +..++.+.-...+..+..++++++|..|++.+.+..
T Consensus       335 --W~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 --WSQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --cccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              22222222        112222222233444778999999999998876653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.4e-11  Score=116.97  Aligned_cols=131  Identities=17%  Similarity=0.107  Sum_probs=97.7

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceee-EeeeeeeccceEEEEeccCCCccc
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK-LIGWCYERHDFLLVYEYMPNGSLD  402 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gsL~  402 (644)
                      .+.|+.|.++.||+....++.+++|....... ....+..|+.+++.+.+.++++ ++.+.  ....++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            35689999999999998899999998755432 2345678999999887655544 44443  23458999999998876


Q ss_pred             hhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC--CCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS--EKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       403 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ...             .   ....++.+++++|+.||...  ..+++|+|++|.||+++ ++.+++.|||.+..
T Consensus        80 ~~~-------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430             0   01245678999999999832  23469999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.27  E-value=2.6e-10  Score=112.94  Aligned_cols=186  Identities=18%  Similarity=0.206  Sum_probs=122.0

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK  118 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~  118 (644)
                      ..-.+. +|.+.++.|+||.+..     ++.|.+|.+.|++.        -+|+..|+|+|......+||||||.+....
T Consensus        22 ~~W~~~G~t~~~~~~IrLTp~~~-----~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~~~~gdG~a~W~t~~~   88 (225)
T cd06902          22 PFWSHGGDAIASLEQVRLTPSLR-----SKKGSVWTKNPFSF--------ENWEVEVTFRVTGRGRIGADGLAIWYTKER   88 (225)
T ss_pred             CceEecccEEecCCEEEECCCCC-----CCEEEEeeCCCcCC--------CCEEEEEEEEEecCCCCCCCEEEEEEECCC
Confidence            356677 7877888999998655     68999999999985        469999999998644467899999999753


Q ss_pred             CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecC-Cccceee------ecCc--cccc-CCCc
Q 006446          119 DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVN-SVYSIRQ------VPLT--RVNL-ANGT  188 (644)
Q Consensus       119 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~n-s~~s~~~------~~~~--~~~l-~~g~  188 (644)
                      .    ..|+.+|--+.   .   +. +||.|||+.|.+ ..+...|-+=+| +...-..      ..+.  .... ....
T Consensus        89 ~----~~G~~~G~~~~---f---~G-l~I~~Dt~~n~~-~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~  156 (225)
T cd06902          89 G----EEGPVFGSSDK---W---NG-VGIFFDSFDNDG-KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFRNKPY  156 (225)
T ss_pred             C----CCCCccCCCCc---c---cE-EEEEEECCCCCC-CCCCcEEEEEECCCCeeccccCCCcccccceEEEeccCCCC
Confidence            2    24555553221   1   12 699999998732 122234422111 1111100      0001  1122 2356


Q ss_pred             eEEEEEEEcCceEEEEEecC---CCCCcccccCccC-cCCCceeeeecccCCCccccccccccccc
Q 006446          189 DIKVQVRYDGQNITVFVANM---ETPLLSEPIDLSE-YLPEKVFVGFSASTGDDTQLNCVKSWAFD  250 (644)
Q Consensus       189 ~~~~~I~Y~~~~l~v~~~~~---~~~~ls~~~dl~~-~l~~~~~vGfsastg~~~~~~~i~~wsf~  250 (644)
                      +.+++|.|....|.|.+...   .......-.++.. .||...|+||||+||...+.|.|++|.+.
T Consensus       157 p~~~rI~Y~~~~l~V~~d~~~~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~  222 (225)
T cd06902         157 PVRAKITYYQNVLTVSINNGFTPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTF  222 (225)
T ss_pred             CeEEEEEEECCeEEEEEeCCcCCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEe
Confidence            78999999998888888532   2111222223333 47888999999999999999999998775

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=1.1e-10  Score=129.60  Aligned_cols=145  Identities=13%  Similarity=0.211  Sum_probs=92.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchh----------------------------------h----
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG----------------------------------K----  358 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~----------------------------------~----  358 (644)
                      ..|+. +.||.|++|.||+|++.  |++||||+.+......                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 78999999999999986  7899999987542110                                  0    


Q ss_pred             --HHHHHHHHHHhccC----CCceeeEeeeeee-ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHH
Q 006446          359 --QEFIAEVTTIGSLR----HRNLVKLIGWCYE-RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT  431 (644)
Q Consensus       359 --~~~~~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i  431 (644)
                        -+|..|+..+.+++    +.+.+.+-.++.+ ..+.+|||||++++.+.++-......       .+.   ..++...
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-------~d~---~~la~~~  268 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-------TDM---KLLAERG  268 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-------CCH---HHHHHHH
Confidence              12444555555542    3333333333322 34678999999999997743211110       111   1122222


Q ss_pred             HH-HHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEEEeccCCcccccc
Q 006446          432 SQ-ALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARLGDFGLARTIQE  477 (644)
Q Consensus       432 a~-aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL~DFGla~~~~~  477 (644)
                      +. -+.-++.   .+++|+|+||.||+++.++    ++++.|||++..+++
T Consensus       269 v~~~~~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            21 1222333   7999999999999999988    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=5.3e-10  Score=122.36  Aligned_cols=163  Identities=18%  Similarity=0.230  Sum_probs=121.3

Q ss_pred             CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCH
Q 006446          342 NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW  421 (644)
Q Consensus       342 ~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~  421 (644)
                      +.+|.|...+...........+-++.|+.+|||||++++......+.+|||+|-+.  -|..++..           +.-
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----------l~~  103 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----------LGK  103 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------hHH
Confidence            67788888766554334456677899999999999999999999999999999873  45555532           223


Q ss_pred             HHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccc
Q 006446          422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL  501 (644)
Q Consensus       422 ~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~  501 (644)
                      ....-.+.||+.||.+||+  +.+++|++|.-+.|++++.|..||++|.++........   ......--..|..|+.+.
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcC
Confidence            3444567899999999997  47899999999999999999999999998865542211   011112223466676543


Q ss_pred             cCCCCCccchHHHHHHHHHHHcC
Q 006446          502 VGRATIETDIYAFGVLILEVACG  524 (644)
Q Consensus       502 ~~~~t~~sDVwSfGvvl~el~tG  524 (644)
                      ...  ...|.|.|||+++|++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            322  346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=9.5e-10  Score=108.95  Aligned_cols=142  Identities=17%  Similarity=0.230  Sum_probs=109.2

Q ss_pred             CCcccccCcEEEEEeeecC-ceEEEEEeecccc-hhhHHHHHHHHHHhccCCC--ceeeEeeeeeecc---ceEEEEecc
Q 006446          324 KNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHR--NLVKLIGWCYERH---DFLLVYEYM  396 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~-~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~~~~---~~~lV~Ey~  396 (644)
                      .+.|+.|..+.||+....+ ..+++|....... .....+..|.++++.+++.  ++.+++.++....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            3568999999999998875 7899998765432 2356788999999999763  4567788776643   568999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC-----------------------------------
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG-----------------------------------  441 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----------------------------------  441 (644)
                      ++.++.+.+..  .       .++..++..++.+++++|.+||+.                                   
T Consensus        83 ~G~~l~~~~~~--~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          83 DGRVLRDRLLR--P-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             CCEecCCCCCC--C-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99888776521  0       256667777788888888888752                                   


Q ss_pred             ------------------CCCCeEeCCCCCCCEEEcC--CCcEEEeccCCccc
Q 006446          442 ------------------SEKRVLHRDIKSSNIMLDS--EFNARLGDFGLART  474 (644)
Q Consensus       442 ------------------~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~  474 (644)
                                        ....++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              1356899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=2.2e-09  Score=104.04  Aligned_cols=137  Identities=13%  Similarity=0.133  Sum_probs=96.2

Q ss_pred             CCcccccCcEEEEEeeecC--------ceEEEEEeeccc----------------------chhhHHH----HHHHHHHh
Q 006446          324 KNKLGKGGFGTVYKGIWRN--------KEIAVKRVSETS----------------------RQGKQEF----IAEVTTIG  369 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~--------~~vavK~~~~~~----------------------~~~~~~~----~~Ei~~l~  369 (644)
                      ...||.|--+.||.|...+        ..+|||..+...                      ....+.+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997652        689999765210                      0011223    37999999


Q ss_pred             ccCC--CceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHh-HhCCCCCe
Q 006446          370 SLRH--RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL-HNGSEKRV  446 (644)
Q Consensus       370 ~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~i  446 (644)
                      ++..  -++.+++++    ..-+|||||+.+..+..-....        ..++..+...+..+++.+|.+| |+   .++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~---~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKE---CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            8853  355555554    4568999999665432211111        0144445667789999999999 77   899


Q ss_pred             EeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          447 LHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       447 vHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      +|+||++.|||++ ++.+.|+|||.+...+
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999999997 4679999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.01  E-value=2.5e-10  Score=123.86  Aligned_cols=249  Identities=20%  Similarity=0.185  Sum_probs=171.6

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec---CceEEEEEeecccchhhHH--HHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSRQGKQE--FIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      ...+.+|.....||.|.|+.|++...+   +..+++|.+.+.......+  -..|+.+...+ .|.+++++...+..-..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            345578999999999999999987755   5678999876654332222  23455555555 48888887666666667


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEe
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLG  467 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~  467 (644)
                      .++=-||++++++...+.-.        ..++...++.+..+++.++.++|+   ..++|+|+||+||++..+ +..+++
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~--------~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTS--------QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             ccCchhhhcCcchhhhhHHH--------HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcc
Confidence            77999999999987665211        136777788999999999999998   999999999999999886 889999


Q ss_pred             ccCCcccccccccccccccccccCCCcc--CccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYM--APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |||++..+.-.      .......-+++  +|+......+..+.|++|||.-+.|.+++..--....         .|  
T Consensus       410 ~~~~~t~~~~~------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~--  472 (524)
T KOG0601|consen  410 DFGCWTRLAFS------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---------QS--  472 (524)
T ss_pred             cccccccccee------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---------cc--
Confidence            99998743211      11112223344  5555566778899999999999999999865322211         11  


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...+.+.+     +++.+..     +.+..+...+..+++..||.+.+.......+
T Consensus       473 ~~i~~~~~-----p~~~~~~-----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  473 LTIRSGDT-----PNLPGLK-----LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             eeeecccc-----cCCCchH-----HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            11111211     1121211     3344566678899999999998887665544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=4.9e-09  Score=98.48  Aligned_cols=132  Identities=20%  Similarity=0.271  Sum_probs=100.9

Q ss_pred             CcccccCcEEEEEeeecCceEEEEEe-ecccch-------hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          325 NKLGKGGFGTVYKGIWRNKEIAVKRV-SETSRQ-------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~~vavK~~-~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ..+++|+-+.+|.+.+.+.++++|.= ++.-+.       ....-..|..+|.+++--.|...+=+..+.....|+|||.
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46889999999999888777777743 222111       1234567999999886555544444555677789999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++..|.+++...               +..++..+-.-+.-||.   .+|+|+||.++||++..+. +.++||||+...
T Consensus        82 ~G~~lkd~l~~~---------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA---------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc---------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            998888888432               35677788888889999   9999999999999998775 999999999753

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=98.95  E-value=2.9e-08  Score=97.55  Aligned_cols=174  Identities=15%  Similarity=0.178  Sum_probs=109.8

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK  118 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~  118 (644)
                      .+-.+. +|.+.++.|+||.+ .     ++.|.+|-+.|+++-+       +|+..|+|+|......+||||||.++...
T Consensus        21 ~~W~~~G~t~v~~~~IrLTp~-~-----s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~~~~gdGla~W~t~~~   87 (215)
T cd06903          21 PNWQTSGNPKLESGRIILTPP-G-----NQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPEGRSGGGLNFWLVKDG   87 (215)
T ss_pred             CCeEEcCcEEeeCCeEEECCC-C-----CceEeEeeCCcCCCCC-------CEEEEEEEEecccCCcCCCEEEEEEECCC
Confidence            356677 88888889999988 5     6899999999998831       79999999998644478999999999754


Q ss_pred             CCCCCCCC-cccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceee-----ecCc--cc-ccCCCce
Q 006446          119 DLPENSEG-QWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQ-----VPLT--RV-NLANGTD  189 (644)
Q Consensus       119 ~~~~~~~g-~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~-----~~~~--~~-~l~~g~~  189 (644)
                      ...   .| ...|-   .....   . +||.|||+.|.  .|  ...++-.++...-..     ..+.  .. ...++.+
T Consensus        88 ~~~---~g~~~fG~---~~~f~---G-l~I~~Dt~~n~--~p--~i~~~~NDGt~~yd~~~d~~~~~g~C~~~~rn~~~p  153 (215)
T cd06903          88 NAD---VGTSSIYG---PSKFD---G-LQLLIDNNGGS--GG--SLRGFLNDGSKDYKNEDVDSLAFGSCLFAYQDSGVP  153 (215)
T ss_pred             ccc---CCccccCC---CCCCc---E-EEEEEECCCCC--Cc--eEEEEECCCCeeccccCCcccccceeeEeccCCCCC
Confidence            321   11 22221   11111   1 69999998872  11  111111111111100     0011  11 1245668


Q ss_pred             EEEEEEEcC--ceEEEEEecCCCCCcccccCccC-cCC-CceeeeecccCCCccccccccc
Q 006446          190 IKVQVRYDG--QNITVFVANMETPLLSEPIDLSE-YLP-EKVFVGFSASTGDDTQLNCVKS  246 (644)
Q Consensus       190 ~~~~I~Y~~--~~l~v~~~~~~~~~ls~~~dl~~-~l~-~~~~vGfsastg~~~~~~~i~~  246 (644)
                      .+++|.|..  ..+.|.+...  ..+    .... .|| ...|+||||+||...+.|.|++
T Consensus       154 ~~iri~Y~~~~~~l~v~vd~~--~Cf----~~~~v~lP~~~y~fGiSAaTg~~~d~hdIl~  208 (215)
T cd06903         154 STIRLSYDALNSLFKVQVDNR--LCF----QTDKVQLPQGGYRFGITAANADNPESFEILK  208 (215)
T ss_pred             EEEEEEEECCCCEEEEEECCC--EEE----ecCCeecCCCCCEEEEEEcCCCCCCcEEEEE
Confidence            899999998  7788887531  111    1112 255 4567999999999888888775

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=98.94  E-value=1.7e-08  Score=100.87  Aligned_cols=182  Identities=19%  Similarity=0.249  Sum_probs=110.0

Q ss_pred             CeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC-CCCCCCceEEEEecCC
Q 006446           41 ELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNK  118 (644)
Q Consensus        41 ~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~-~~~~g~G~aF~l~~~~  118 (644)
                      .-.+. +|.+.++.|+||.+..     ++.|.++.+.|+++        .+|+..|+|.|... ....|+||||.+....
T Consensus        23 ~W~~~G~t~i~~~~IrLTp~~~-----~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~   89 (229)
T PF03388_consen   23 NWDIGGSTVITDNFIRLTPDRQ-----SQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDP   89 (229)
T ss_dssp             TEEEEET-EEESSEEEEE-SST-----TEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSS
T ss_pred             CEEECCeEEecCCEEEECCCcc-----cCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCc
Confidence            56677 8888899999998875     78999999999998        47999999999974 4568999999999743


Q ss_pred             CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCC--CCCCceeeecC-Cccceee------ecCc--cccc-CC
Q 006446          119 DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQD--INDNHVGLDVN-SVYSIRQ------VPLT--RVNL-AN  186 (644)
Q Consensus       119 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d--~~~~Hvgid~n-s~~s~~~------~~~~--~~~l-~~  186 (644)
                      ..    .|..+|--+. -     +. ++|=|||+.|.+-.  -....|.+=+| ...+-..      ..+.  .... ..
T Consensus        90 ~~----~G~~fG~~~~-f-----~G-l~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~  158 (229)
T PF03388_consen   90 GS----DGPVFGGPDK-F-----DG-LGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNS  158 (229)
T ss_dssp             SS----SCSBTTB-SS-------EE-EEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE---BTE
T ss_pred             cc----cccccCCCcc-c-----ce-EEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccceeccCcC
Confidence            22    5555553111 1     12 68999999884311  11223333222 1111000      0011  1122 24


Q ss_pred             CceEEEEEEEcCceEEEEEecCC-CCCcccc--cCccC-cCCCceeeeecccCCCccccccccc
Q 006446          187 GTDIKVQVRYDGQNITVFVANME-TPLLSEP--IDLSE-YLPEKVFVGFSASTGDDTQLNCVKS  246 (644)
Q Consensus       187 g~~~~~~I~Y~~~~l~v~~~~~~-~~~ls~~--~dl~~-~l~~~~~vGfsastg~~~~~~~i~~  246 (644)
                      +.+..++|.|....+.|.+...- +.-....  ..... .||...|+|+||+||.....|.|++
T Consensus       159 ~~p~~~ri~Y~~~~l~v~id~~~~~~~~~~~~Cf~~~~v~LP~~~yfGvSA~Tg~~~d~hdi~s  222 (229)
T PF03388_consen  159 DVPTRIRISYSKNTLTVSIDSNYLKNQDDWELCFTTDGVDLPEGYYFGVSAATGELSDNHDILS  222 (229)
T ss_dssp             SSEEEEEEEEETTEEEEEEETSCCSECCTTEEEEEESTEEGGSSBEEEEEEEESSSGGEEEEEE
T ss_pred             CCCEEEEEEEECCeEEEEEecccccCCcCCcEEEEcCCeecCCCCEEEEEecCCCCCCcEEEEE
Confidence            55779999999988888876321 1101100  01111 3678899999999999888888765

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.91  E-value=1e-08  Score=95.91  Aligned_cols=143  Identities=18%  Similarity=0.245  Sum_probs=105.7

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEe-ecccc-------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRV-SETSR-------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~-~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ....|-+|+-+.|+++.+.++..+||.- .+.-+       -..+.-.+|++.+.+++--.|.-..=++.+...-.|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            5678999999999999999998888853 22211       124566789999999865555444445556666789999


Q ss_pred             ccCC-CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEEeccC
Q 006446          395 YMPN-GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLGDFG  470 (644)
Q Consensus       395 y~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFG  470 (644)
                      |.++ .++.+++.......      ..-.....++..|-+.+.-||.   ..|+|+||..+||+|..++   .+.+.|||
T Consensus        91 ~~~g~~~vk~~i~~~~~~~------~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE------SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             eccchhHHHHHHHHHccCc------ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeec
Confidence            9965 37888886543321      1222236788889999999999   9999999999999996654   46899999


Q ss_pred             Cccc
Q 006446          471 LART  474 (644)
Q Consensus       471 la~~  474 (644)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            9864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.78  E-value=2.2e-09  Score=122.26  Aligned_cols=250  Identities=21%  Similarity=0.207  Sum_probs=156.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ....|...+-+-.|.++.+..+.-.  +...+.|.....   .....+....+-.+.-..+||-++...--+.-....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777778888999998876544  222222322111   11111111112222222344555554444445667899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      +++|..+++|...|+....        ++..-....+..+.++++|||.   ..+.|||++|.|.+...++..+++|||.
T Consensus       882 ~~~~~~~~~~~Skl~~~~~--------~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC--------LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC--------cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccc
Confidence            9999999999988876542        2222223345567789999998   6699999999999999999999999984


Q ss_pred             cccccc------c---------------cccc-------ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc
Q 006446          472 ARTIQE------N---------------LKTH-------HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC  523 (644)
Q Consensus       472 a~~~~~------~---------------~~~~-------~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t  523 (644)
                      ......      .               ....       .......||+.|.+||...+.......|.|+.|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            322110      0               0000       01123568999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006446          524 GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK  592 (644)
Q Consensus       524 G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  592 (644)
                      |..||.........+.+.        .++.   ..    .....+......+++...+..+|.+|-.|.
T Consensus      1031 g~pp~na~tpq~~f~ni~--------~~~~---~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENIL--------NRDI---PW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhccc--------cCCC---CC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999998765433221111        1110   00    112222333444556666778888887766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=7.2e-08  Score=98.52  Aligned_cols=141  Identities=13%  Similarity=0.057  Sum_probs=100.1

Q ss_pred             CcccccCcEEEEEeeecCceEEEEEeecccch-----------hhHHHHHHHHHHhccCCCc--eeeEeeeeee-----c
Q 006446          325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQ-----------GKQEFIAEVTTIGSLRHRN--LVKLIGWCYE-----R  386 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~-----~  386 (644)
                      +.+-......|++..+.|+.+.||+.......           ....+.+|...+.++...+  ..+++++...     .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            44554455567788888899999987433211           1114778888888884333  3334444432     2


Q ss_pred             cceEEEEeccCCC-ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-----
Q 006446          387 HDFLLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-----  460 (644)
Q Consensus       387 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----  460 (644)
                      ..-+||+|++++- +|.+++......      ..+...+..++.+++..+.-||.   .+|+|+|++++|||++.     
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~------~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATN------PPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhccc------CCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCC
Confidence            3578999999875 788887422111      13456677899999999999999   99999999999999985     


Q ss_pred             --CCcEEEeccCCccc
Q 006446          461 --EFNARLGDFGLART  474 (644)
Q Consensus       461 --~~~vkL~DFGla~~  474 (644)
                        +..+.|+||+.++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              47899999998863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=6.1e-08  Score=103.31  Aligned_cols=173  Identities=21%  Similarity=0.301  Sum_probs=128.2

Q ss_pred             cEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceEEEEeccCC-Cccchh
Q 006446          332 FGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFLLVYEYMPN-GSLDKF  404 (644)
Q Consensus       332 fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~  404 (644)
                      -.+.||+...  |..|++||+.-...+....-..-++.++++.|.|+|++..++..    ...+++||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3578998876  78899999943322222234456788999999999999998773    3468999999986 577776


Q ss_pred             hhccCCCC-------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          405 IFYDETNS-------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       405 l~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      -+......       -...........+.++.|+..||.++|+   .|+.-+-|.+++||++.+.+++|+.+|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            65443222       1122336678889999999999999999   8898899999999999999999999998877653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP  527 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P  527 (644)
                      ...                 |-+..   -.+-|.=-||.+++.|+||+.-
T Consensus       446 d~~-----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT-----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC-----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            220                 11111   2346888999999999999644

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.72  E-value=3.9e-07  Score=94.96  Aligned_cols=264  Identities=18%  Similarity=0.165  Sum_probs=158.1

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeee------eeccc-eEEEE
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWC------YERHD-FLLVY  393 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~------~~~~~-~~lV~  393 (644)
                      ...+.||+|+-+.+|.----+. .+.|+..........+..+|+   ... .||-+-.=+.|=      -+++. .-+.|
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~aqk~a~l---a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQAQKVAEL---AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecchhhc-hhheeecCCCchHHHHHHHHh---ccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3477899999999995321122 344766554433333333332   222 455433323321      12223 56677


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      +.+++.-=-..++ +...+.......+|.-.++++..+|.+.+-||+   .+.+-+|+.++|+|+.++..+.|.|=..-.
T Consensus        90 P~v~g~~pI~~~y-~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          90 PKVSGKEPIHMIY-SPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             ccCCCccchhhhc-CchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence            7775542222222 222233344458999999999999999999999   889999999999999999999999855443


Q ss_pred             cccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcC-CCCCCCCccccchhhHHHHHHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACG-RKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG-~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ... ++.   .....+|...|.+||.-.     +..-+...|-|.+||++++++.| ++||.+.........-.+   ..
T Consensus       166 i~~-ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~  238 (637)
T COG4248         166 INA-NGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TD  238 (637)
T ss_pred             ecc-CCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hh
Confidence            322 111   133457889999999754     33457889999999999999886 999876432111100000   01


Q ss_pred             HhcCchhhhhhcccC-----CCCCHH-HHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHhC
Q 006446          548 RRKGRILDAADSRLG-----GEFSEK-EMECVLILGLACCHP--NPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~-----~~~~~~-~~~~l~~L~~~Cl~~--dP~~RPs~~evl~~L~~  600 (644)
                      ...|......+.+-.     .+.+-+ ....+..|-.+|+..  ++.-||+++.++..|..
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            112222222222111     112211 123345566678764  36789999999877754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=4.6e-07  Score=87.45  Aligned_cols=125  Identities=22%  Similarity=0.262  Sum_probs=79.0

Q ss_pred             EEEEeeec-CceEEEEEeeccc--------------c------------hhhHHHHHHHHHHhccCCC--ceeeEeeeee
Q 006446          334 TVYKGIWR-NKEIAVKRVSETS--------------R------------QGKQEFIAEVTTIGSLRHR--NLVKLIGWCY  384 (644)
Q Consensus       334 ~Vy~g~~~-~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~  384 (644)
                      .||.|... +..+|+|..+...              +            .......+|.+.|.++..-  ++.+++.+- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999876 7789999865320              0            0012356799999999765  455555442 


Q ss_pred             eccceEEEEeccC--CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHH-hHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          385 ERHDFLLVYEYMP--NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY-LHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       385 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~ivHrDlkp~NILld~~  461 (644)
                         .-.|||||++  +..+..+.. ..         ++......++.+++..+.. +|.   .+++|+||.+.|||++++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~-~~---------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD-VD---------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH-CG---------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT
T ss_pred             ---CCEEEEEecCCCccchhhHHh-cc---------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc
Confidence               4579999997  444444332 11         1123345667777775555 467   899999999999999988


Q ss_pred             CcEEEeccCCccccc
Q 006446          462 FNARLGDFGLARTIQ  476 (644)
Q Consensus       462 ~~vkL~DFGla~~~~  476 (644)
                       .+.++|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             99999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=7.3e-07  Score=87.87  Aligned_cols=107  Identities=21%  Similarity=0.272  Sum_probs=82.3

Q ss_pred             hHHHHHHHHHHhccCC--CceeeEeeeeeecc----ceEEEEeccCCC-ccchhhhccCCCCCCCccccCHHHHHHHHHH
Q 006446          358 KQEFIAEVTTIGSLRH--RNLVKLIGWCYERH----DFLLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHG  430 (644)
Q Consensus       358 ~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~  430 (644)
                      .....+|...+.+|..  -...+.+++...+.    ..+||+|++++- +|.+++.....        ++-..+..++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--------~~~~~~~~ll~~  126 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--------LDPSQRRELLRA  126 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--------cchhhHHHHHHH
Confidence            3467788888877743  33455566655432    458999999874 78888854221        345567789999


Q ss_pred             HHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEEeccCCcccc
Q 006446          431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLGDFGLARTI  475 (644)
Q Consensus       431 ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~~  475 (644)
                      ++..+.-||+   .+|+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       127 l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  127 LARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   9999999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.46  E-value=2.2e-06  Score=83.50  Aligned_cols=147  Identities=20%  Similarity=0.230  Sum_probs=108.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc------chhhHHHHHHHHHHhccCCC--ceeeEeeeee-ec--
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS------RQGKQEFIAEVTTIGSLRHR--NLVKLIGWCY-ER--  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~--nIv~l~g~~~-~~--  386 (644)
                      ...+-..---|+||-+.|++-.+.+..+-+|+-...-      ..+...|.+|+..|.+|...  .+.+.+ ++. .+  
T Consensus        17 ~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~   95 (216)
T PRK09902         17 EGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE   95 (216)
T ss_pred             CCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence            3344333445779999999988888889999875221      33567899999999998532  344444 332 11  


Q ss_pred             --cceEEEEeccCC-CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          387 --HDFLLVYEYMPN-GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       387 --~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                        ..-+||+|-+++ -+|.+++......      ..+...+..++.++++.+.-||.   .++.|+|+-+.|||++.++.
T Consensus        96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~------~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902         96 GEWRALLVTEDMAGFISIADWYAQHAVS------PYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             CceEEEEEEEeCCCCccHHHHHhcCCcC------CcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCC
Confidence              246899997743 5888887543221      25667788999999999999999   99999999999999986667


Q ss_pred             --EEEeccCCccc
Q 006446          464 --ARLGDFGLART  474 (644)
Q Consensus       464 --vkL~DFGla~~  474 (644)
                        ++++||.-++.
T Consensus       167 ~~v~lIDlEk~r~  179 (216)
T PRK09902        167 AEAGFLDLEKSRR  179 (216)
T ss_pred             eeEEEEEhhccch
Confidence              99999987764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.41  E-value=7.3e-08  Score=106.29  Aligned_cols=154  Identities=18%  Similarity=0.283  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccccc------ccccccccCCCccCccccc
Q 006446          428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH------HSTKEIAGTPGYMAPESFL  501 (644)
Q Consensus       428 ~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~------~~~~~~~gt~~y~APE~~~  501 (644)
                      +.+++.||.|+|.  ...+||++|.|++|.+++++..||+.|+.+..........      ...........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3445689999998  5889999999999999999999999999886544311100      0011223456899999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHcCCCC-CCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHh
Q 006446          502 VGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLAC  580 (644)
Q Consensus       502 ~~~~t~~sDVwSfGvvl~el~tG~~P-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~C  580 (644)
                      ....+.++|+||+||++|-+..|..+ +.........      -.    .+...+.-......+.+.+..+    =+.+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------~~----~~~~~~~~~~~~s~~~p~el~~----~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------SF----SRNLLNAGAFGYSNNLPSELRE----SLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh------hh----hhcccccccccccccCcHHHHH----HHHHH
Confidence            98889999999999999999855544 3332211110      00    0111111111112334444444    44567


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 006446          581 CHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       581 l~~dP~~RPs~~evl~~  597 (644)
                      +..++.-||++.++...
T Consensus       249 l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             hcCCcccCcchhhhhcc
Confidence            88999999988777644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.38  E-value=2.5e-06  Score=85.04  Aligned_cols=135  Identities=20%  Similarity=0.236  Sum_probs=94.0

Q ss_pred             CCCCCcccccCcEEEEEeeec-CceEEEEEeeccc----------c------------hhhHHHHHHHHHHhccCCC--c
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETS----------R------------QGKQEFIAEVTTIGSLRHR--N  375 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~----------~------------~~~~~~~~Ei~~l~~l~H~--n  375 (644)
                      ....++||-|--+.||.|... +.++|||.-+...          .            -......+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345789999999999999998 8899999543210          0            0112356789999998654  6


Q ss_pred             eeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCC
Q 006446          376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN  455 (644)
Q Consensus       376 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~N  455 (644)
                      +.+.++|-    .-.+||||.++--|...-             ++-...-.|+..|++-+.-+-+   .++||+|+.+-|
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r-------------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefN  232 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLR-------------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFN  232 (304)
T ss_pred             CCCccccc----cceeeeehcccceeeccc-------------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchhe
Confidence            66777664    347999999775554432             1112222334444444444434   899999999999


Q ss_pred             EEEcCCCcEEEeccCCcccc
Q 006446          456 IMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       456 ILld~~~~vkL~DFGla~~~  475 (644)
                      |++++|+.+.++||-.+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999877644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=7.9e-06  Score=81.67  Aligned_cols=145  Identities=15%  Similarity=0.219  Sum_probs=85.3

Q ss_pred             CcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCce--eeEeeeeeeccceEEEEeccCCCc-c
Q 006446          325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL--VKLIGWCYERHDFLLVYEYMPNGS-L  401 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gs-L  401 (644)
                      ..||+|..+.||+.  .+..+++|......  ......+|.++++.+..-.+  .+.++++...+...+|||+++|.. +
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            57899999999984  35577888876533  23456789999988864433  567777777777889999998863 2


Q ss_pred             chhhhcc----------------CCCCC-CCccccC-HHHHH-HHH-------HHHHH-HHHHhHhC-CCCCeEeCCCCC
Q 006446          402 DKFIFYD----------------ETNSG-PGEVTLN-WEKRL-SVI-------HGTSQ-ALDYLHNG-SEKRVLHRDIKS  453 (644)
Q Consensus       402 ~~~l~~~----------------~~~~~-~~~~~l~-~~~~~-~i~-------~~ia~-aL~yLH~~-~~~~ivHrDlkp  453 (644)
                      ...+...                ..... .....+. ...++ ..+       ..+.+ ...+|... ....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            2111100                00000 0000010 00000 000       00111 12222211 234678999999


Q ss_pred             CCEEEcCCCcEEEeccCCccc
Q 006446          454 SNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       454 ~NILld~~~~vkL~DFGla~~  474 (644)
                      .||++++++ +.+.||+.+..
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CcEEEcCCC-cEEEechhcCc
Confidence            999999988 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=98.24  E-value=6.2e-05  Score=73.36  Aligned_cols=96  Identities=15%  Similarity=0.157  Sum_probs=70.8

Q ss_pred             ccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCCCC-CCCCCCc
Q 006446           49 VAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDL-PENSEGQ  127 (644)
Q Consensus        49 ~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~~~-~~~~~g~  127 (644)
                      +.+|.|+||++..     +++|-+.|.+++|.-+.      -...+|.+-.......++|||||||+-.... -.+..||
T Consensus        29 i~~g~LRLT~~~~-----nqata~~~~~~FPs~~n------~v~veFd~yayg~~g~GADGia~vLsDasv~p~~G~fGG   97 (255)
T cd06900          29 VVNNRLRLTDASG-----NQATAVTLQRLFPSAGN------YVEVEFDYYAYGSGGNGADGVALVLSDASVTPQAGAFGG   97 (255)
T ss_pred             cccCeEEeccCcc-----CcceeEEEeeeeccCCC------eEEEEEEEEEecCCCCCCceEEEEEeCCCcCCcCCCcCc
Confidence            3489999999876     79999999999987321      2566777766655577899999999963322 3568899


Q ss_pred             ccccccccC-CCCCCccEEEEEEecCCCc
Q 006446          128 WLGIVNGIT-NGTNQSQIVAIEFDTKKSY  155 (644)
Q Consensus       128 ~lGl~~~~~-~~~~~~~~~aVEfDt~~n~  155 (644)
                      -||+--.+. .......-+.|-||-|-|.
T Consensus        98 sLGYa~~~~~~~GfaGGwLGiGlDEyGNF  126 (255)
T cd06900          98 SLGYAQRNDGVPGFAGGWLGIGLDEYGNF  126 (255)
T ss_pred             ccccccccCCCCccccceEEEEEeccccc
Confidence            999976542 2224456789999998883

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.22  E-value=1.7e-05  Score=77.64  Aligned_cols=138  Identities=15%  Similarity=0.148  Sum_probs=95.3

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHH---------HHHHHHHhccC---CCceeeEeeeee
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEF---------IAEVTTIGSLR---HRNLVKLIGWCY  384 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~---H~nIv~l~g~~~  384 (644)
                      ..++|...+++-......|.+-..+++.+++|..+...+...+.|         .+++..+.+++   ....+.++-.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            356788888888888888888888899999999876554333332         23344444443   223333333222


Q ss_pred             -----eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          385 -----ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       385 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                           .....+|+|||++|..|.++..            ++.    .+...+++++.-||.   .|++|+|..|.|++++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED------------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh------------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEE
Confidence                 2235679999999988876541            221    245667788999999   9999999999999999


Q ss_pred             CCCcEEEeccCCccc
Q 006446          460 SEFNARLGDFGLART  474 (644)
Q Consensus       460 ~~~~vkL~DFGla~~  474 (644)
                      +++ +++.||+.-+.
T Consensus       170 ~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  170 NNG-IRIIDTQGKRM  183 (229)
T ss_pred             CCc-EEEEECccccc
Confidence            655 99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.19  E-value=8.2e-06  Score=90.37  Aligned_cols=144  Identities=17%  Similarity=0.235  Sum_probs=94.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhh----------------------------------------
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGK----------------------------------------  358 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~----------------------------------------  358 (644)
                      .|+ .+.|+.++-|.||+|++. |+.||||+.+..-+...                                        
T Consensus       127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E  205 (517)
T COG0661         127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE  205 (517)
T ss_pred             HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence            454 378999999999999998 89999998764321110                                        


Q ss_pred             HHHHHHHHHHhccC----CCceeeEeeeee-eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH
Q 006446          359 QEFIAEVTTIGSLR----HRNLVKLIGWCY-ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       359 ~~~~~Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~  433 (644)
                      -++..|...+.+++    ...-+++=.++. ..+...|+|||++|-.+.+........       .+.   ..|+..+++
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-------~d~---k~ia~~~~~  275 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-------IDR---KELAELLVR  275 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-------CCH---HHHHHHHHH
Confidence            02344555555542    222222223332 245679999999999998885332221       332   233333333


Q ss_pred             H-HHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          434 A-LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       434 a-L~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      + +..+-.   .+++|.|.+|.||+++.++++.+.|||+...+++
T Consensus       276 ~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         276 AFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2 222222   6899999999999999999999999999987654

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=98.13  E-value=0.00012  Score=75.10  Aligned_cols=177  Identities=18%  Similarity=0.273  Sum_probs=109.7

Q ss_pred             cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCCCCCCCCC
Q 006446           46 NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSE  125 (644)
Q Consensus        46 ~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~~~~~~~~  125 (644)
                      ||..+...|+|+.+-.     ++.|-+|-+..++|        --|...-+|.|+.....++|||||--+....    --
T Consensus        61 dAIas~eqvRlaPSmr-----srkGavWtka~~~f--------e~weVev~~rVtGrGRiGAdGlaiWYt~~~G----~~  123 (497)
T KOG3838|consen   61 DAIASSEQVRLAPSMR-----SRKGAVWTKASVPF--------ENWEVEVQFRVTGRGRIGADGLAIWYTRGRG----HV  123 (497)
T ss_pred             cccccccceeeccccc-----cccCceeecccCCc--------ccceEEEEEEecccccccCCceEEEEecCCC----cc
Confidence            5544556788987654     68899987777766        3477889999998777889999999986432    12


Q ss_pred             CcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCC--ccceeeec-----Cc--ccccCC-CceEEEEEE
Q 006446          126 GQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNS--VYSIRQVP-----LT--RVNLAN-GTDIKVQVR  195 (644)
Q Consensus       126 g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns--~~s~~~~~-----~~--~~~l~~-g~~~~~~I~  195 (644)
                      |.-+|-.+      .=|. +++=||.+.|. ---|..-|.+=.|.  +.+.....     +.  -.+..| --+..|+|+
T Consensus       124 GpVfGg~d------~WnG-igiffDSfdnD-~qknnP~Is~~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRarIt  195 (497)
T KOG3838|consen  124 GPVFGGLD------SWNG-IGIFFDSFDND-GQKNNPAISVLLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRARIT  195 (497)
T ss_pred             cccccccc------cccc-eEEEeeccccc-CCcCCccEEEEecCCcccccCCCccHHHHHHHhhHHhccCCCCceEEEE
Confidence            22222111      1122 48899998772 12233344443321  11110000     00  011111 124689999


Q ss_pred             EcCceEEEEEecCCCCCccccc--CccC-cCCCceeeeecccCCCcccccccccc
Q 006446          196 YDGQNITVFVANMETPLLSEPI--DLSE-YLPEKVFVGFSASTGDDTQLNCVKSW  247 (644)
Q Consensus       196 Y~~~~l~v~~~~~~~~~ls~~~--dl~~-~l~~~~~vGfsastg~~~~~~~i~~w  247 (644)
                      |=...|+|.+..--+|.=.|-.  +... .||..-|.|.||+||.....|.+++.
T Consensus       196 Y~~nvLtv~innGmtp~d~yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~F  250 (497)
T KOG3838|consen  196 YYGNVLTVMINNGMTPSDDYEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSF  250 (497)
T ss_pred             EeccEEEEEEcCCCCCCCCcceeEeccceeccCCCeeeeeecccccccccceeee
Confidence            9999999998654444323332  2333 57899999999999999889999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=4.7e-07  Score=98.86  Aligned_cols=184  Identities=19%  Similarity=0.181  Sum_probs=134.7

Q ss_pred             CCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCc-eeeEeeeeeeccceEEEEeccCC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN-LVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      +...+-+++|+.+++||.+-. .+....+.+...     ....-++++|.+++||| .+..++-+..+...++.++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            333456889999999998766 333445555333     33456889999999999 77778888778889999999977


Q ss_pred             C-ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          399 G-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       399 g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      + +...-.       ...+..+...+...+...-+++|+|||+   ..-+|||    ||+..+ ...|.+||+....+.+
T Consensus       319 ~rs~~~~~-------~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  319 GRSSALEM-------TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             CccccccC-------ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCc
Confidence            6 221111       1112234445556666777889999998   4458898    777665 6789999999987764


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      ..    ......+|+.|+|||....+.+..+.|+|+.|+-..++.-|-+|-
T Consensus       384 ~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  384 TM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            33    244567999999999999999999999999998877887777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.09  E-value=2.2e-05  Score=77.98  Aligned_cols=145  Identities=17%  Similarity=0.159  Sum_probs=86.6

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEeeeeee---ccceEEEEeccCC
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIGWCYE---RHDFLLVYEYMPN  398 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~---~~~~~lV~Ey~~~  398 (644)
                      .+.|+.|..+.||+....++.+++|.....  ........|..+++.+....  +.+++.++..   ....+++|+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            356899999999999998889999997554  45567778888888885333  4566664433   2346899999998


Q ss_pred             Cccch----------------hh---hccCCCCCCCccccCHHH---------HHHH------------HHHHHH-HHHH
Q 006446          399 GSLDK----------------FI---FYDETNSGPGEVTLNWEK---------RLSV------------IHGTSQ-ALDY  437 (644)
Q Consensus       399 gsL~~----------------~l---~~~~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-aL~y  437 (644)
                      ..+..                .+   +......    ....+..         ....            ...+.+ .+..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPF----SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC----CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccc----cccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            88777                11   1110000    0011111         0000            111222 2333


Q ss_pred             hHh----CCCCCeEeCCCCCCCEEEc-CCCcEEEeccCCccc
Q 006446          438 LHN----GSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLART  474 (644)
Q Consensus       438 LH~----~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~  474 (644)
                      +++    .....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            332    2457899999999999999 666678999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.06  E-value=3.7e-05  Score=77.70  Aligned_cols=146  Identities=16%  Similarity=0.161  Sum_probs=86.8

Q ss_pred             cccccCc-EEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEeccCCCccch
Q 006446          326 KLGKGGF-GTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDK  403 (644)
Q Consensus       326 ~LG~G~f-G~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  403 (644)
                      .|-.|.. ..||+....+..+++|+.....   ..+..+|+.+++.+. +--+.+++++....+..++|||++++.+|..
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3445555 7899987777788888875443   345677888888874 3345567777766667899999999888764


Q ss_pred             hhhcc--------------CCCCCCC-ccccC--HHHHHHHHH--------------------HHHHHHHHhHh----CC
Q 006446          404 FIFYD--------------ETNSGPG-EVTLN--WEKRLSVIH--------------------GTSQALDYLHN----GS  442 (644)
Q Consensus       404 ~l~~~--------------~~~~~~~-~~~l~--~~~~~~i~~--------------------~ia~aL~yLH~----~~  442 (644)
                      .....              .....+. .....  +..++.-..                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            42100              0000000 00010  001110000                    01112222211    12


Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       443 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ...++|+|+.|.|||++++..+.|.||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            35699999999999999988889999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=1.7e-05  Score=76.80  Aligned_cols=105  Identities=21%  Similarity=0.214  Sum_probs=83.1

Q ss_pred             HHHHHHhccCC-CceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC
Q 006446          363 AEVTTIGSLRH-RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG  441 (644)
Q Consensus       363 ~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~  441 (644)
                      .|..++..+++ +++.+++|.|-    .+++.||.+.+++...-. .    ......-+|..|.+|+.++++.+.+|++.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~----l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-P----LSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-c----cccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            57888888876 69999999994    377999998776642200 0    00001368999999999999999999987


Q ss_pred             CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       442 ~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ....+.-.|++++|+-+++++++|+.|...+...+
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            76679999999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=97.93  E-value=0.00019  Score=72.70  Aligned_cols=176  Identities=19%  Similarity=0.221  Sum_probs=114.2

Q ss_pred             cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-CCCCCCCceEEEEecCCCCCCCC
Q 006446           46 NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENS  124 (644)
Q Consensus        46 ~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~~~~~g~G~aF~l~~~~~~~~~~  124 (644)
                      +..+...-|+||.+..     ++.|.++=..||..        -+|...+.|.|.. ....-|||||+.++-....    
T Consensus        79 stvv~~~~irLT~d~q-----sk~GAv~n~~Pv~s--------~~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q----  141 (351)
T KOG3839|consen   79 STVVTSNYIRLTPDEQ-----SKSGAVWNRQPVFS--------RDWEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ----  141 (351)
T ss_pred             cEEEEeeeeecccccc-----ccccccccCCCccc--------cceeEEEEEEEecCCCcccccceEEEeeccccc----
Confidence            4445566799998876     78899999999986        4599999999997 4567899999999874433    


Q ss_pred             CCcccccccccCCCCCCccEEEEEEecCCCccCCC-----------CCCceeeecCCccceeeecCc--ccccCCCce-E
Q 006446          125 EGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDI-----------NDNHVGLDVNSVYSIRQVPLT--RVNLANGTD-I  190 (644)
Q Consensus       125 ~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~-----------~~~Hvgid~ns~~s~~~~~~~--~~~l~~g~~-~  190 (644)
                      .|.-+|-+..       -+..||=.||+.|.+--+           +++|-++|-.  .+...+.++  ..+.++... .
T Consensus       142 ~GPvFG~~dk-------F~GL~vfidtY~n~~g~~~~v~P~isvmv~~gs~sYD~~--~Dg~~tel~gc~a~~rn~~~dt  212 (351)
T KOG3839|consen  142 PGPVFGSKDK-------FTGLAVFIDTYGNHNGPHEHVFPYISVMVNIGSLSYDHS--KDGTHTELAGCTANFRNLPHDT  212 (351)
T ss_pred             CCCCCCCccc-------ceeEEEEEeccCCcCCCcccceeeEEEEeccCCcccccC--CCCCccccccceeeeccCCCcc
Confidence            3444553221       134799999998843111           1122222210  000011110  112222221 2


Q ss_pred             EEEEEEcCceEEEEEecCCCCCcccccCccCc-CCCceeeeecccCCCcccccccccc
Q 006446          191 KVQVRYDGQNITVFVANMETPLLSEPIDLSEY-LPEKVFVGFSASTGDDTQLNCVKSW  247 (644)
Q Consensus       191 ~~~I~Y~~~~l~v~~~~~~~~~ls~~~dl~~~-l~~~~~vGfsastg~~~~~~~i~~w  247 (644)
                      .+-|.|+.+++++...-..+.....-.++..+ +|.--|+|+||+||+..+.|.+.+-
T Consensus       213 ~~~iry~~~~l~~~~dl~~~~~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~  270 (351)
T KOG3839|consen  213 LVVIRYEKKTLSISIDLEGPNEWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSL  270 (351)
T ss_pred             eeEEEecCCceEEEEecCCCceeeeeeeecceecccceEEeeeeccCccchhhHHHHh
Confidence            57799999888888765455556666777775 7888899999999998888887653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.86  E-value=0.00024  Score=70.43  Aligned_cols=153  Identities=18%  Similarity=0.194  Sum_probs=95.8

Q ss_pred             ccCHHHHHHHhCCCCCCCc---ccccCcEEEEEeeec-CceEEEEEeecccchh-------------------hH-----
Q 006446          308 KFRLKELKKATGNFNPKNK---LGKGGFGTVYKGIWR-NKEIAVKRVSETSRQG-------------------KQ-----  359 (644)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~---LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~-------------------~~-----  359 (644)
                      ..+.+.+.....+..+...   |..|--+.||+|.-. +..+|||+.+......                   .+     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            4556666666666555555   456778889998865 7889999886432111                   01     


Q ss_pred             HHHHHHHHHhccC--CCceeeEeeeeeeccceEEEEeccCCCcc-chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHH
Q 006446          360 EFIAEVTTIGSLR--HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD  436 (644)
Q Consensus       360 ~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~  436 (644)
                      ...+|+.-|.++.  +-.+.+.+++.    +-.|||||+....+ .-.|.         ...+...+...+..++.+.+.
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---------Dv~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---------DVPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---------cCCcCchhHHHHHHHHHHHHH
Confidence            1234666666653  23333334333    34899999954311 11110         111222245556666767666


Q ss_pred             HhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       437 yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      -|-.  ..++||+||..-|||+. ++.+.++|+|.|....
T Consensus       181 ~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         181 RLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHH--hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            6654  37899999999999999 8899999999987655

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.82  E-value=0.00011  Score=81.38  Aligned_cols=145  Identities=17%  Similarity=0.270  Sum_probs=92.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchh-------------------------------------hHHH
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQG-------------------------------------KQEF  361 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~-------------------------------------~~~~  361 (644)
                      .|+ .+.||.-..|.||+|+++ |..||||+-+..-++.                                     .-+|
T Consensus       163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            343 467999999999999998 6789999865432111                                     0134


Q ss_pred             HHHHHHHhcc----CCCce---eeEeeeeee-ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH
Q 006446          362 IAEVTTIGSL----RHRNL---VKLIGWCYE-RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       362 ~~Ei~~l~~l----~H~nI---v~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~  433 (644)
                      ..|.+-..+.    +|-++   |.+=.++.+ .....|+||||+|..+.+.-.-....       ++-..   |+..+.+
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-------i~~~~---i~~~l~~  311 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-------ISPHD---ILNKLVE  311 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-------CCHHH---HHHHHHH
Confidence            5555544443    35551   112222222 24679999999999888765433322       34333   3333333


Q ss_pred             HHHHhHhCCCCCeEeCCCCCCCEEEcC----CCcEEEeccCCcccccc
Q 006446          434 ALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQE  477 (644)
Q Consensus       434 aL~yLH~~~~~~ivHrDlkp~NILld~----~~~vkL~DFGla~~~~~  477 (644)
                      +  |++..-..|++|+|=.|.||+++.    ++.+.+-|||+......
T Consensus       312 ~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  312 A--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             H--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2  222222368999999999999984    67899999999987653

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.0002  Score=85.24  Aligned_cols=153  Identities=14%  Similarity=0.259  Sum_probs=93.8

Q ss_pred             CCcccccCcEEEEEeeecC----ceEEEEEeecccc-hhhHHHHHHHHHHhccC-CCce--eeEeeeeeec---cceEEE
Q 006446          324 KNKLGKGGFGTVYKGIWRN----KEIAVKRVSETSR-QGKQEFIAEVTTIGSLR-HRNL--VKLIGWCYER---HDFLLV  392 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV  392 (644)
                      .+.++.|.+..+|+....+    ..+++|+...... .....+.+|+.+|+.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            5678899999999877663    4678887654321 23456889999999995 6664  7788888764   467899


Q ss_pred             EeccCCCccchh-----------------------hhccCCCC------CCCcc----cc-CHHHHHHH---------HH
Q 006446          393 YEYMPNGSLDKF-----------------------IFYDETNS------GPGEV----TL-NWEKRLSV---------IH  429 (644)
Q Consensus       393 ~Ey~~~gsL~~~-----------------------l~~~~~~~------~~~~~----~l-~~~~~~~i---------~~  429 (644)
                      |||+++..+.+-                       |+.-....      +....    .+ .|...+.-         ..
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999987654321                       11100000      00000    01 12221111         11


Q ss_pred             HHHHHHHHhHhCC--------CCCeEeCCCCCCCEEEcCC-Cc-EEEeccCCccccc
Q 006446          430 GTSQALDYLHNGS--------EKRVLHRDIKSSNIMLDSE-FN-ARLGDFGLARTIQ  476 (644)
Q Consensus       430 ~ia~aL~yLH~~~--------~~~ivHrDlkp~NILld~~-~~-vkL~DFGla~~~~  476 (644)
                      .+.+.+.+|....        ...++|+|+++.|||++.+ .+ +-|.||+++..-+
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            2334456664422        1459999999999999853 33 5799999986543

>PRK10593 hypothetical protein; Provisional

Probab=97.78  E-value=0.00037  Score=72.70  Aligned_cols=79  Identities=8%  Similarity=-0.012  Sum_probs=59.2

Q ss_pred             CCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCC---CceeeEeeeeeec---cceEEEEe
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH---RNLVKLIGWCYER---HDFLLVYE  394 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~E  394 (644)
                      ....+.||.|..+.||+-...+..+++|..+..  .....+..|...|+.|.-   -.+.+++++|...   +..+||||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            344678999999999998776667777875331  123578899999988853   3677888887643   56899999


Q ss_pred             ccCCCcc
Q 006446          395 YMPNGSL  401 (644)
Q Consensus       395 y~~~gsL  401 (644)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9988765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.71  E-value=0.00032  Score=70.49  Aligned_cols=145  Identities=12%  Similarity=0.126  Sum_probs=78.6

Q ss_pred             CcccccCcE-EEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCC---ceeeEeeeeeec---cceEEEEeccC
Q 006446          325 NKLGKGGFG-TVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHR---NLVKLIGWCYER---HDFLLVYEYMP  397 (644)
Q Consensus       325 ~~LG~G~fG-~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~~  397 (644)
                      +.|+.|+.. .||+.   +..+++|..+..  .....+..|.+.+..+...   .+.++++.+...   ...+++||+++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777766 58875   346777765432  2345788899998887532   233344443322   23488999999


Q ss_pred             CCccchhh------------------hccCCCCCCCc--c-------ccCHHHHH--HHH-------HHHHH-HHHH-hH
Q 006446          398 NGSLDKFI------------------FYDETNSGPGE--V-------TLNWEKRL--SVI-------HGTSQ-ALDY-LH  439 (644)
Q Consensus       398 ~gsL~~~l------------------~~~~~~~~~~~--~-------~l~~~~~~--~i~-------~~ia~-aL~y-LH  439 (644)
                      +.++.+..                  +.-........  .       .-.|....  .+.       .+... .++. ++
T Consensus        78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  157 (235)
T cd05155          78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR  157 (235)
T ss_pred             CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence            87775331                  11100000000  0       00122111  000       01111 1111 11


Q ss_pred             h--CCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          440 N--GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       440 ~--~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      .  .....++|+|+.+.|||++++...-|.||+.+..
T Consensus       158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            1  1235699999999999999776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.69  E-value=0.00021  Score=67.15  Aligned_cols=129  Identities=19%  Similarity=0.232  Sum_probs=88.6

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceee-EeeeeeeccceEEEEeccCCCc
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK-LIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      +..+.|++|.+|.||+|.+.+..+|+|.-+.++.  ...+..|.++|..+.--++-+ ++.+-    +-++.|||..+-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            3467899999999999999999999998776653  467888999998887655443 33332    3345599998878


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC-CCCEEEcCCCcEEEeccCCccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK-SSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk-p~NILld~~~~vkL~DFGla~~  474 (644)
                      |.+.-..           .+-    +-+..+++.---|-.   .+|-|+.|. |...+|-.+..+.|+||..|+.
T Consensus        99 L~~~~~~-----------~~r----k~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG-----------GDR----KHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc-----------ccH----HHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            7655421           111    223344555444444   788888886 4444444445999999999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.68  E-value=0.00071  Score=65.97  Aligned_cols=134  Identities=16%  Similarity=0.262  Sum_probs=89.8

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeeccc----------------chhhHHHHHHHHHHhccC------CCceeeE
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS----------------RQGKQEFIAEVTTIGSLR------HRNLVKL  379 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nIv~l  379 (644)
                      +....||+|+.-.||.--. +....||+.....                ....++..+|+....++.      +.+|.++
T Consensus         4 ~~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3467899999999995322 4567888876554                122455666766666655      8899999


Q ss_pred             eeeeeeccceEEEEeccCC--C----ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCC
Q 006446          380 IGWCYERHDFLLVYEYMPN--G----SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKS  453 (644)
Q Consensus       380 ~g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp  453 (644)
                      +|+......+-+|+|...+  |    +|.+++....         ++. ...   ..+-+-..||-+   ..|+.+|++|
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---------~~~-~~~---~~L~~f~~~l~~---~~Iv~~dl~~  146 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---------LTE-ELR---QALDEFKRYLLD---HHIVIRDLNP  146 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---------ccH-HHH---HHHHHHHHHHHH---cCCeecCCCc
Confidence            9999999889999998643  3    3666663322         333 222   223334456666   8899999999


Q ss_pred             CCEEEcCCC----cEEEec-cCCc
Q 006446          454 SNIMLDSEF----NARLGD-FGLA  472 (644)
Q Consensus       454 ~NILld~~~----~vkL~D-FGla  472 (644)
                      .||++....    .+.|+| ||-.
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCc
Confidence            999995432    466776 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.56  E-value=0.00051  Score=69.94  Aligned_cols=141  Identities=13%  Similarity=0.065  Sum_probs=81.8

Q ss_pred             cccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEEeccCCCccchh
Q 006446          326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVYEYMPNGSLDKF  404 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~~~  404 (644)
                      .+..|-...+|+....+..+++|........-.-+..+|..+++.+....++ ++++.+.    -++|+||+++..+..-
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            3566888899998877888999876543322112456788888888643333 3344332    3689999988776532


Q ss_pred             -----------------hhccCCCCCCCccccCHHHHH-HHHHH---------HHHHHHHhHhC-----CCCCeEeCCCC
Q 006446          405 -----------------IFYDETNSGPGEVTLNWEKRL-SVIHG---------TSQALDYLHNG-----SEKRVLHRDIK  452 (644)
Q Consensus       405 -----------------l~~~~~~~~~~~~~l~~~~~~-~i~~~---------ia~aL~yLH~~-----~~~~ivHrDlk  452 (644)
                                       |+.....    ...++...++ .+..+         +...+..+-..     ....++|+|+.
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~----~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRF----GYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence                             1111110    1112222111 11111         11112222111     13579999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccc
Q 006446          453 SSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       453 p~NILld~~~~vkL~DFGla~~~  475 (644)
                      |.||++++++ ++|.||..+..-
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCcC
Confidence            9999999877 789999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.54  E-value=0.00074  Score=65.49  Aligned_cols=125  Identities=25%  Similarity=0.331  Sum_probs=89.8

Q ss_pred             CCCCCCCcccccCc-EEEEEeeecCceEEEEEeec---cc---------c---------hhhHHHHHHHHHHhccC---C
Q 006446          319 GNFNPKNKLGKGGF-GTVYKGIWRNKEIAVKRVSE---TS---------R---------QGKQEFIAEVTTIGSLR---H  373 (644)
Q Consensus       319 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~vavK~~~~---~~---------~---------~~~~~~~~Ei~~l~~l~---H  373 (644)
                      ..++..+.||.|.- |.||+....+..+|+|.++.   ..         .         .-...|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            67888999999999 99999999999999999431   00         0         11235788999988885   4


Q ss_pred             Cce--eeEeeeeeecc------------------ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHH
Q 006446          374 RNL--VKLIGWCYERH------------------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       374 ~nI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~  433 (644)
                      .++  |+.+||..-..                  ...||.||.+...                 .+..    +-+.+|.+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~----~~~~~~~~  175 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQI----RDIPQMLR  175 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccch----hHHHHHHH
Confidence            466  99999974321                  1356677664332                 1222    23445666


Q ss_pred             HHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       434 aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      -|..+|.   .+|+-+|+|+.|..     .-||+|||.+
T Consensus       176 dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            7778898   99999999999975     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.53  E-value=0.00087  Score=67.16  Aligned_cols=73  Identities=18%  Similarity=0.195  Sum_probs=47.3

Q ss_pred             CcccccCcEEEEEeeec---CceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEEeccCCCc
Q 006446          325 NKLGKGGFGTVYKGIWR---NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      +.|..|-...+|+....   ++.+++|....... ...+...|+.++..+...+++ ++++.+.    -.++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            45777888899998766   46788887654322 122334688888888544443 3443332    247999998877


Q ss_pred             cc
Q 006446          401 LD  402 (644)
Q Consensus       401 L~  402 (644)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            64

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.52  E-value=0.0006  Score=79.97  Aligned_cols=196  Identities=20%  Similarity=0.164  Sum_probs=130.7

Q ss_pred             HHHHHHHHhccCCCceeeEeeeeeeccce----EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHH
Q 006446          361 FIAEVTTIGSLRHRNLVKLIGWCYERHDF----LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD  436 (644)
Q Consensus       361 ~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~  436 (644)
                      ...|+..+....|+|++.++.|..++...    .+..|++..-++...+....        .++....+.+..+..+||.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--------~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--------SIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--------ccCHHHHHHHHHHHhhhHH
Confidence            44577888888999999999998765433    34456777777766664332        3677788888899999999


Q ss_pred             HhHhCCCCCeEeCCCCCC---CEEEcCCCcEEEe--ccCCcccccccccccccccccccCCCccCccccccCCCC--Ccc
Q 006446          437 YLHNGSEKRVLHRDIKSS---NIMLDSEFNARLG--DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT--IET  509 (644)
Q Consensus       437 yLH~~~~~~ivHrDlkp~---NILld~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t--~~s  509 (644)
                      |+|+   ....|.-+..+   +...+.++.+..+  ||+..+........    ....-+..|.+||......+.  ...
T Consensus       301 ~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~  373 (1351)
T KOG1035|consen  301 YLHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLT  373 (1351)
T ss_pred             HHHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhh
Confidence            9999   44445444444   4445666777777  88888766533221    122345567888887766554  458


Q ss_pred             chHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 006446          510 DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP  589 (644)
Q Consensus       510 DVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP  589 (644)
                      |+|.+|..+..+..|..+-.....      ..                 +-+......    ...+...+|+..++++|+
T Consensus       374 dL~~lgll~~~~~~~~~i~~~~~~------~~-----------------~~l~~~~~~----~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  374 DLWCLGLLLLQLSQGEDISEKSAV------PV-----------------SLLDVLSTS----ELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             HHHHHHHHHhhhhhcCcccccccc------hh-----------------hhhccccch----hhhhhhhhhcchhhhhcc
Confidence            999999999999988765221110      00                 001111111    344566789999999999


Q ss_pred             CHHHHHHHH
Q 006446          590 SMKTVLQVL  598 (644)
Q Consensus       590 s~~evl~~L  598 (644)
                      +..+++...
T Consensus       427 ~~~~ll~~~  435 (1351)
T KOG1035|consen  427 SALELLTHP  435 (1351)
T ss_pred             chhhhhhch
Confidence            999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.36  E-value=0.0025  Score=66.31  Aligned_cols=148  Identities=15%  Similarity=0.124  Sum_probs=89.4

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEeee------eeeccceEEEEec
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIGW------CYERHDFLLVYEY  395 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~Ey  395 (644)
                      .+.|..|....+|+....++.+++|+...   ........|+.++..+.+..  +.+++..      ....+..++|++|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            45677788889999877777899998764   23345666777777775432  4444432      1223456899999


Q ss_pred             cCCCccchh--------------hhccCCC---CCCCccccCHHHHHH----------HHHHHHHHHHHhHh----CCCC
Q 006446          396 MPNGSLDKF--------------IFYDETN---SGPGEVTLNWEKRLS----------VIHGTSQALDYLHN----GSEK  444 (644)
Q Consensus       396 ~~~gsL~~~--------------l~~~~~~---~~~~~~~l~~~~~~~----------i~~~ia~aL~yLH~----~~~~  444 (644)
                      +++..+...              ++.....   .........|.....          ....+..++.++.+    ....
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            988776431              0110000   001111233433211          11123344555543    2346


Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          445 RVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       445 ~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      +++|+|+.|.|||++++..+.|.||+.+..
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            799999999999999987789999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.34  E-value=0.0058  Score=64.30  Aligned_cols=148  Identities=11%  Similarity=0.116  Sum_probs=79.9

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEee------eeeeccceEEEEec
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIG------WCYERHDFLLVYEY  395 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g------~~~~~~~~~lV~Ey  395 (644)
                      .+.|+.|....+|+....++.+++|+....   ..+....|+..+..|...+  +.+.+.      +....+..++++||
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            355677777899998877778999987521   2233334555555553211  223232      11224567899999


Q ss_pred             cCCCccchh--------------hhccCCC---CCCCccccCH-HHHHHH------------H-HHHHHHHHHhHhC---
Q 006446          396 MPNGSLDKF--------------IFYDETN---SGPGEVTLNW-EKRLSV------------I-HGTSQALDYLHNG---  441 (644)
Q Consensus       396 ~~~gsL~~~--------------l~~~~~~---~~~~~~~l~~-~~~~~i------------~-~~ia~aL~yLH~~---  441 (644)
                      +++..+...              ++.....   .......+.| .....-            + ..+...++.+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            988755321              1111000   0001111223 221111            1 1111222333211   


Q ss_pred             -CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          442 -SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       442 -~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                       ...+++|+|+.|.||+++.+...-|.||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             346899999999999999776668999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.24  E-value=0.005  Score=64.48  Aligned_cols=148  Identities=14%  Similarity=0.108  Sum_probs=84.9

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEeeee------eeccceEEEEec
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIGWC------YERHDFLLVYEY  395 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~------~~~~~~~lV~Ey  395 (644)
                      .+.++.|....+|+....++.+++|+.....  ...+...|+.++..|....  +.+++...      ...+..++++||
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            4567777778999887666788889765422  1234455667776664222  33443321      123567899999


Q ss_pred             cCCCccchh--------------hhccCCC-CCCC---ccccCHHHHHH------------HHHHHHHHHHHhHh----C
Q 006446          396 MPNGSLDKF--------------IFYDETN-SGPG---EVTLNWEKRLS------------VIHGTSQALDYLHN----G  441 (644)
Q Consensus       396 ~~~gsL~~~--------------l~~~~~~-~~~~---~~~l~~~~~~~------------i~~~ia~aL~yLH~----~  441 (644)
                      +++..+...              ++..... ..+.   ...-.|.....            ....+.+.++++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            988654311              1110000 0000   00122322111            11223344555543    2


Q ss_pred             CCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       442 ~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ...+++|+|+.+.||+++.++.+.|.||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            35789999999999999998877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.09  E-value=0.0054  Score=66.25  Aligned_cols=75  Identities=12%  Similarity=0.088  Sum_probs=52.1

Q ss_pred             CCcccccCcEEEEEeeecCc--eEEEEEeeccc-------chhhHHHHHHHHHHhccC---CCceeeEeeeeeeccceEE
Q 006446          324 KNKLGKGGFGTVYKGIWRNK--EIAVKRVSETS-------RQGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~--~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+.||.|.+..||+....++  .++||.-....       .-..+.+..|.+.|..+.   -.++.+++.+.  ....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            45799999999999998753  89999854211       123456677777777762   24566677663  345789


Q ss_pred             EEeccCCCc
Q 006446          392 VYEYMPNGS  400 (644)
Q Consensus       392 V~Ey~~~gs  400 (644)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.05  E-value=0.0035  Score=65.44  Aligned_cols=145  Identities=21%  Similarity=0.221  Sum_probs=82.7

Q ss_pred             CcccccCcEEEEEeeecC--------ceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEEec
Q 006446          325 NKLGKGGFGTVYKGIWRN--------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey  395 (644)
                      +.|..|-...+|+....+        +.+++|+..... ....+...|..++..+....+. ++++.+. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            345667777889887653        678888865543 2234456788888777543333 4455543 2   358999


Q ss_pred             cCCCccchhh-----------------hccCCCC-CCC--ccccCHHHHHH--------------------------HHH
Q 006446          396 MPNGSLDKFI-----------------FYDETNS-GPG--EVTLNWEKRLS--------------------------VIH  429 (644)
Q Consensus       396 ~~~gsL~~~l-----------------~~~~~~~-~~~--~~~l~~~~~~~--------------------------i~~  429 (644)
                      ++|..+....                 +...... ...  ....-|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9887765321                 1111110 000  00111111110                          111


Q ss_pred             HHHHHHHHhHh------CCCCCeEeCCCCCCCEEEcCC----CcEEEeccCCccc
Q 006446          430 GTSQALDYLHN------GSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLART  474 (644)
Q Consensus       430 ~ia~aL~yLH~------~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~  474 (644)
                      .+...+..|..      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      245789999999999999985    8899999988764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=96.55  E-value=0.017  Score=61.57  Aligned_cols=143  Identities=18%  Similarity=0.258  Sum_probs=80.0

Q ss_pred             cccccCcEEEEEeeec------CceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEEeccCC
Q 006446          326 KLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      .|-.|-.-.+|+....      ++.+++|........ .-+-..|..++..+...++. ++++.+.. +   .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            4445667788887653      257888877654322 22236788888888654444 34555432 2   58999987


Q ss_pred             Cccchh-----------------hhccCCCCCCCccccCHHHHHHHHHH-----------------HHHHHHHh----Hh
Q 006446          399 GSLDKF-----------------IFYDETNSGPGEVTLNWEKRLSVIHG-----------------TSQALDYL----HN  440 (644)
Q Consensus       399 gsL~~~-----------------l~~~~~~~~~~~~~l~~~~~~~i~~~-----------------ia~aL~yL----H~  440 (644)
                      .+|...                 +|..... .. .....|.+..++..+                 +...+..|    ..
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~-~~-~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMP-GP-KNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCC-CC-CCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            776522                 1111100 00 001123322222211                 11112222    21


Q ss_pred             -CCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCcccc
Q 006446          441 -GSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLARTI  475 (644)
Q Consensus       441 -~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~  475 (644)
                       .....++|+|+++.|||+++ ++.+++.||..+...
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence             23458999999999999986 468999999888643

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.29  E-value=0.029  Score=58.05  Aligned_cols=148  Identities=21%  Similarity=0.265  Sum_probs=76.3

Q ss_pred             CCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC---CCceeeEeeeeeeccceEEEEeccC
Q 006446          321 FNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .+..+.++.|....+|+....++.+.||.-.   ......|..|..-|+.|.   --.+.+++++...++.-+||+||++
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            3446678999999999988778899999876   334467888888888883   3457788998887777899999997


Q ss_pred             CCcc--ch---------hhhc-cCCC-------------CCCCccccCHHHH-----HHHHHHHH-----------HHHH
Q 006446          398 NGSL--DK---------FIFY-DETN-------------SGPGEVTLNWEKR-----LSVIHGTS-----------QALD  436 (644)
Q Consensus       398 ~gsL--~~---------~l~~-~~~~-------------~~~~~~~l~~~~~-----~~i~~~ia-----------~aL~  436 (644)
                      .+..  ..         .|++ ....             .......-+|..-     +.-..+.+           +.++
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            7611  11         1233 1110             0011112344432     22222111           1112


Q ss_pred             H----hHh-CCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          437 Y----LHN-GSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       437 y----LH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      -    |+. .....++|+||-+.|++.+.++.+.|.|=..
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~  215 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC  215 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence            2    221 1245799999999999999998899988653

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.28  E-value=0.047  Score=57.05  Aligned_cols=148  Identities=13%  Similarity=0.172  Sum_probs=83.1

Q ss_pred             ccCcEEEEEeeecCceEEEEEee-cccchhhHHHHHHHHHHhccCC--CceeeEeeeeeecc--ceEEEEeccCCCccch
Q 006446          329 KGGFGTVYKGIWRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRH--RNLVKLIGWCYERH--DFLLVYEYMPNGSLDK  403 (644)
Q Consensus       329 ~G~fG~Vy~g~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~  403 (644)
                      .|-.-.+|.....++++++.+-. ...........+|+.+|+.+.-  --.-..++.|.++.  ..+.||+|+++..+..
T Consensus        35 ~G~sn~t~~~~~~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~  114 (321)
T COG3173          35 GGWSNDTFRLGDTGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS  114 (321)
T ss_pred             CCcccceEEEecCCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence            34344455555556777777221 1222334555678888887632  23344577787766  6799999998754433


Q ss_pred             hhhccCC---------------------CCC---------CCccccCHHHHHHHHH--------HHHHHHHHhHhC----
Q 006446          404 FIFYDET---------------------NSG---------PGEVTLNWEKRLSVIH--------GTSQALDYLHNG----  441 (644)
Q Consensus       404 ~l~~~~~---------------------~~~---------~~~~~l~~~~~~~i~~--------~ia~aL~yLH~~----  441 (644)
                      .+.....                     ...         ...+.-.|...+..++        ....-..+|+..    
T Consensus       115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~  194 (321)
T COG3173         115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW  194 (321)
T ss_pred             cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence            3211100                     000         0001112322221111        111223444432    


Q ss_pred             -CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          442 -SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       442 -~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                       ....++|+|+.+.|++++.+.-+=+.||+++..-+
T Consensus       195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence             23579999999999999999889999999997654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.18  E-value=0.019  Score=56.17  Aligned_cols=151  Identities=15%  Similarity=0.116  Sum_probs=91.7

Q ss_pred             CcEEEEEeeecCceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCccchhhhccC
Q 006446          331 GFGTVYKGIWRNKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE  409 (644)
Q Consensus       331 ~fG~Vy~g~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~  409 (644)
                      +-.+.-+++.+-++..+|++....-. ...-|..+.+++++++  .|+++..=  ....+-++.|+|-.-..        
T Consensus        74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------  141 (308)
T ss_pred             CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------
Confidence            34444444444456677777544333 3456778888888764  46666521  33356788888832110        


Q ss_pred             CCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccc
Q 006446          410 TNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA  489 (644)
Q Consensus       410 ~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~  489 (644)
                               ..    ..++.-=..+|.-.|++. .+.+|+|..|+|||-|+.|.+||.|-+..-.-              
T Consensus       142 ---------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------  193 (308)
T PF07387_consen  142 ---------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------  193 (308)
T ss_pred             ---------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------
Confidence                     10    112221135778888754 78999999999999999999999997654211              


Q ss_pred             cCCCccCccccccCCCCCccchHHHHHHHHHHHcCC
Q 006446          490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR  525 (644)
Q Consensus       490 gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~  525 (644)
                       +..|.--|   ....|.++.+-+|=.-+++++...
T Consensus       194 -~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  194 -QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             -eeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence             11122211   123466777878777777776643

The function of this family is unknown.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.08  E-value=0.062  Score=55.41  Aligned_cols=33  Identities=21%  Similarity=0.375  Sum_probs=27.1

Q ss_pred             CCeEeCCCCCCCEEEcCCCc-EEEeccCCccccc
Q 006446          444 KRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQ  476 (644)
Q Consensus       444 ~~ivHrDlkp~NILld~~~~-vkL~DFGla~~~~  476 (644)
                      ..++|+|+++.|||++++++ .-|.||+.+..-+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            46999999999999998555 5699999886543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.83  E-value=0.099  Score=55.16  Aligned_cols=144  Identities=19%  Similarity=0.228  Sum_probs=82.7

Q ss_pred             ccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc------eeeEeeee--eecc--ceEEEEecc
Q 006446          327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN------LVKLIGWC--YERH--DFLLVYEYM  396 (644)
Q Consensus       327 LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~--~~~~--~~~lV~Ey~  396 (644)
                      |.+ .-..+|+....++.+++|.....  ....+...|+..|..|.-..      +..+-|-.  .-.+  ..+-+++|+
T Consensus        34 l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 55678988888777788887665  33455666777777663222      22221211  1123  678899999


Q ss_pred             CCCccch-h--------------hhccCC-CC--CC-CccccCHHH-------------HHHHHHHHHHHHHHhHhC---
Q 006446          397 PNGSLDK-F--------------IFYDET-NS--GP-GEVTLNWEK-------------RLSVIHGTSQALDYLHNG---  441 (644)
Q Consensus       397 ~~gsL~~-~--------------l~~~~~-~~--~~-~~~~l~~~~-------------~~~i~~~ia~aL~yLH~~---  441 (644)
                      +|..+.. -              |+.... -.  .+ ......|..             ......++...+..+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988873 1              111000 00  11 111244431             011223333444444432   


Q ss_pred             -CCCC---eEeCCCCCCCEEEcCCCc-EEEeccCCcc
Q 006446          442 -SEKR---VLHRDIKSSNIMLDSEFN-ARLGDFGLAR  473 (644)
Q Consensus       442 -~~~~---ivHrDlkp~NILld~~~~-vkL~DFGla~  473 (644)
                       ....   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             2233   999999999999999985 8999999775

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.83  E-value=0.0022  Score=77.07  Aligned_cols=177  Identities=12%  Similarity=-0.010  Sum_probs=117.4

Q ss_pred             EEEEEeecccchhh-----HHHHHHHHHHhccCCCceeeEeeeeee--ccceEEEEeccCCCccchhhhccCCCCCCCcc
Q 006446          345 IAVKRVSETSRQGK-----QEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV  417 (644)
Q Consensus       345 vavK~~~~~~~~~~-----~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~  417 (644)
                      ..+|+.+...-+..     +..+.|....++..|+++.....=...  ..+.+..++|+..|.+...+.+.-....    
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~---- 1330 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESP---- 1330 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCC----
Confidence            44555544433332     333444445556689888776543332  3356889999999999998865433221    


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhHhC--CCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCcc
Q 006446          418 TLNWEKRLSVIHGTSQALDYLHNG--SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM  495 (644)
Q Consensus       418 ~l~~~~~~~i~~~ia~aL~yLH~~--~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~  495 (644)
                      .++..-......+...+..-.|..  ...-.+|+++|+-|.+|..+.++|++++|+.+...+. .  .......+++-|+
T Consensus      1331 ~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~--sf~Gl~l~sp~~v 1407 (2724)
T KOG1826|consen 1331 DLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-L--SFFGLELCSPIYV 1407 (2724)
T ss_pred             cchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-H--hhhhhhhCCHHHH
Confidence            233222222222324444444432  2346899999999999999999999999999843211 1  1134556788899


Q ss_pred             CccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          496 APESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       496 APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      .|++...-+++.++|+|..|+-+|+...|..++
T Consensus      1408 ~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1408 LQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999988888999999999999999998887664

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.82  E-value=0.078  Score=55.38  Aligned_cols=30  Identities=23%  Similarity=0.309  Sum_probs=26.2

Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       443 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999998 678999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.65  E-value=0.12  Score=54.21  Aligned_cols=104  Identities=23%  Similarity=0.244  Sum_probs=72.1

Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..|++|++. ++++...            ....|.+.+.++.+.+..+.-|..  .-+.=|||+.-.||||+ +|++-|+
T Consensus       300 y~yl~~kdh-gt~is~i------------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLI  363 (488)
T COG5072         300 YLYLHFKDH-GTPISII------------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLI  363 (488)
T ss_pred             EEEEEEecC-Cceeeee------------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEE
Confidence            456777765 5554321            126799999999999988888876  46788999999999999 9999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGV  516 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGv  516 (644)
                      ||-++|.-.....        +--.+.-.|-.+. |.-+.+-|||-+--
T Consensus       364 DfklsRl~~~q~~--------isy~rldhp~lF~-G~dd~QFeIYrlMr  403 (488)
T COG5072         364 DFKLSRLSYSQGI--------ISYNRLDHPDLFN-GVDDYQFEIYRLMR  403 (488)
T ss_pred             EeeeeecccCCce--------eeccccCchhhhc-CccceeeeHHHHHH
Confidence            9999995432211        1112233454444 44577788887433

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.61  E-value=0.14  Score=55.29  Aligned_cols=80  Identities=16%  Similarity=0.159  Sum_probs=53.5

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccc-------hhhHHHHHHHHHHhccC---CCceeeEeeeeeeccceEEEE
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSR-------QGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .+.||.|....||+....++.++||+-....+       .....-..|...|+.+.   ..++.+++.+|.+  .-+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            56789999999999887777899998652111       12333344566665553   3477788888873  467889


Q ss_pred             eccCC--Cccchhh
Q 006446          394 EYMPN--GSLDKFI  405 (644)
Q Consensus       394 Ey~~~--gsL~~~l  405 (644)
                      ||+++  ..+.+.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99966  3444443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.59  E-value=0.055  Score=56.71  Aligned_cols=33  Identities=15%  Similarity=0.172  Sum_probs=29.2

Q ss_pred             CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       442 ~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ...+++|+|+.+.|||+++++.+.+.||..+..
T Consensus       194 ~~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       194 WRTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             cceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            356899999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.58  E-value=0.079  Score=56.15  Aligned_cols=143  Identities=15%  Similarity=0.173  Sum_probs=78.8

Q ss_pred             cccccCcEEEEEeeecC-----ceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEEeccCCC
Q 006446          326 KLGKGGFGTVYKGIWRN-----KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      .|..|=...+|+....+     ..|++|........ .-+-..|..+++.+...++- ++++++. .+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            44446667788876553     27888877554322 22335788888888655554 4555552 22   589999776


Q ss_pred             ccchh-----------------hhccCCCCCCCccccCHHHHHHHHHHH----------------------HHHHHHhHh
Q 006446          400 SLDKF-----------------IFYDETNSGPGEVTLNWEKRLSVIHGT----------------------SQALDYLHN  440 (644)
Q Consensus       400 sL~~~-----------------l~~~~~~~~~~~~~l~~~~~~~i~~~i----------------------a~aL~yLH~  440 (644)
                      .|..-                 +|......  ....--|....++..++                      .+-+..+..
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~--~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPG--SKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCC--CCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            65321                 11111000  00011233222222111                      111111111


Q ss_pred             -----CCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCcccc
Q 006446          441 -----GSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLARTI  475 (644)
Q Consensus       441 -----~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~  475 (644)
                           ..+...+|.|+.+.|||+++ ++.++++||..|..-
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence                 12346899999999999975 578999999988653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	644
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-50
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-38
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-29
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		3e-25
1fat_A	252	Phytohemagglutinin-L Length = 252		4e-25
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		5e-25
1wbf_A	242	Winged Bean Lectin, Saccharide Free Form Length = 2		1e-23
2e7q_A	237	Crystal Structure Of Basic Winged Bean Lectin In Co		1e-23
1wbl_A	241	Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga		1e-23
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-23
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-23
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		8e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-23
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-23
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-22
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-22
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-22
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-22
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-22
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-22
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-22
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-22
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-22
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-22
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-22
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-22
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-22
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		5e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-22
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-22
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-21
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		1e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		2e-21
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		2e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-21
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		4e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-21
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		8e-21
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-21
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-20
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-20
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-20
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		2e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-20
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-20
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-20
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		8e-20
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-19
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-19
1q8o_A	252	Pterocartpus Angolensis Lectin Pal In Complex With		5e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-19
1n3o_A	252	Pterocarcpus Angolensis Lectin In Complex With Alph		6e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-19
1gnz_A	257	Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m		9e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-18
1gsl_A	243	Lectin (Fourth Isolated From (Griffonia Simplicifol		1e-18
1bzw_A	232	Peanut Lectin Complexed With C-Lactose Length = 232		1e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-18
2pel_A	236	Peanut Lectin Length = 236		1e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		1e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		2e-18
1hql_A	257	The Xenograft Antigen In Complex With The B4 Isolec		2e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-18
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		2e-18
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		2e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-18
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		3e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-18
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		4e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-18
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		5e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-18
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		6e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-18
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		7e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-17
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		1e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-14
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		5e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-14
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		6e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-13
1fay_A	238	Winged Bean Acidic Lectin Complexed With Methyl-Alp		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
1fx5_A	242	Crystal Structure Analysis Of Ulex Europaeus Lectin		5e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
1qmo_E	133	Structure Of Fril, A Legume Lectin That Delays Hema		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
3u4x_A	236	Crystal Structure Of A Lectin From Camptosema Pedic		9e-10
3u4x_A	236	Crystal Structure Of A Lectin From Camptosema Pedic		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2d3p_A	236	Cratylia Floribunda Seed Lectin Crystallized At Bas		2e-08
2d3p_A	236	Cratylia Floribunda Seed Lectin Crystallized At Bas		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
1ioa_A	240	Arcelin-5, A Lectin-Like Defense Protein From Phase		3e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-08
1mvq_A	236	Cratylia Mollis Lectin (Isoform 1) In Complex With		5e-08
1mvq_A	236	Cratylia Mollis Lectin (Isoform 1) In Complex With		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
1lgb_A	181	Interaction Of A Legume Lectin With The N2 Fragment		5e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-08
1lgc_A	181	Interaction Of A Legume Lectin With The N2 Fragment		6e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-08
2b7y_A	182	Fava Bean Lectin-Glucose Complex Length = 182		6e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-08
1ofs_A	187	Pea Lectin-sucrose Complex Length = 187		7e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-08
1avb_A	226	Arcelin-1 From Phaseolus Vulgaris L Length = 226		9e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
1wuv_A	237	Crystal Structure Of Native Canavalia Gladiata Lect		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
2ltn_A	181	Design, Expression, And Crystallization Of Recombin		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
1azd_A	237	Concanavalin From Canavalia Brasiliensis Length = 2		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-07
2ow4_A	237	Crystal Structure Of A Lectin From Canavalia Mariti		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
2cwm_A	237	Native Crystal Structure Of No Releasing Inductive		3e-07
1loa_A	181	Three-Dimensional Structures Of Complexes Of Lathyr		3e-07
2ovu_A	237	Crystal Strucure Of A Lectin From Canavalia Gladiat		3e-07
1lof_C	181	X-Ray Structure Of A Biantennary Octasaccharide-Lec		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
1rin_A	180	X-Ray Crystal Structure Of A Pea Lectin-Trimannosid		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-07
2lal_A	181	Crystal Structure Determination And Refinement At 2		6e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-07
2yz4_A	237	The Neutron Structure Of Concanavalin A At 2.2 Angs		8e-07
2ctv_A	237	High Resolution Crystallographic Studies Of Native		8e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-06
2cna_A	237	The Covalent And Three-Dimensional Structure Of Con		3e-06
2cna_A	237	The Covalent And Three-Dimensional Structure Of Con		3e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
1cn1_A	237	Crystal Structure Of Demetallized Concanavalin A. T		3e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
2gdf_A	237	Crystal Structure Of Dioclea Violacea Seed Lectin L		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
3sh3_A	237	Crystal Structure Of A Pro-Inflammatory Lectin From		4e-06
2je9_A	239	Crystal Structure Of Recombinant Dioclea Grandiflor		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-06
2jec_A	239	Crystal Structure Of Recombinant Dioclea Grandiflor		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (505), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 180/299 (60%), Gaps = 9/299 (3%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQ-EFIAE 364
           K+F L+EL+ A+ NF+ KN LG+GGFG VYKG +     +AVKR+ E   QG + +F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V  I    HRNL++L G+C    + LLVY YM NGS+   +     +  P    L+W KR
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP----LDWPKR 141
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +  G+++ L YLH+  + +++HRD+K++NI+LD EF A +GDFGLA+ +  + K  H 
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHV 199
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE-QNSYNNSIVHW 543
              + GT G++APE    G+++ +TD++ +GV++LE+  G++  + +   N  +  ++ W
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA 602
           +  L ++ ++    D  L G + ++E+E ++ + L C   +P  RP M  V+++L G+ 
Sbjct: 260 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  196 bits (498), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 178/299 (59%), Gaps = 9/299 (3%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQ-EFIAE 364
           K+F L+EL+ A+ NF  KN LG+GGFG VYKG +     +AVKR+ E   QG + +F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V  I    HRNL++L G+C    + LLVY YM NGS+   +     +  P    L+W KR
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP----LDWPKR 133
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +  G+++ L YLH+  + +++HRD+K++NI+LD EF A +GDFGLA+ +  + K  H 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHV 191
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE-QNSYNNSIVHW 543
              + G  G++APE    G+++ +TD++ +GV++LE+  G++  + +   N  +  ++ W
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA 602
           +  L ++ ++    D  L G + ++E+E ++ + L C   +P  RP M  V+++L G+ 
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  172 bits (436), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 103/286 (36%), Positives = 163/286 (56%), Gaps = 10/286 (3%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIG 369
           L +L++AT NF+ K  +G G FG VYKG+ R+  ++A+KR +  S QG +EF  E+ T+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
             RH +LV LIG+C ER++ +L+Y+YM NG+L + ++     S    ++++WE+RL +  
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY----GSDLPTMSMSWEQRLEICI 146
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
           G ++ L YLH    + ++HRD+KS NI+LD  F  ++ DFG+++   E L   H    + 
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTE-LDQTHLXXVVK 202
Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GT GY+ PE F+ GR T ++D+Y+FGV++ EV C R    QS      N +  W  E   
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHN 261
Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
            G++    D  L  +   + +       + C   +   RPSM  VL
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  171 bits (434), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 103/286 (36%), Positives = 163/286 (56%), Gaps = 10/286 (3%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIG 369
           L +L++AT NF+ K  +G G FG VYKG+ R+  ++A+KR +  S QG +EF  E+ T+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
             RH +LV LIG+C ER++ +L+Y+YM NG+L + ++     S    ++++WE+RL +  
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY----GSDLPTMSMSWEQRLEICI 146
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
           G ++ L YLH    + ++HRD+KS NI+LD  F  ++ DFG+++   E L   H    + 
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTE-LGQTHLXXVVK 202
Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GT GY+ PE F+ GR T ++D+Y+FGV++ EV C R    QS      N +  W  E   
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHN 261
Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
            G++    D  L  +   + +       + C   +   RPSM  VL
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (427), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 160/300 (53%), Gaps = 23/300 (7%)
Query: 309 FRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIAVKRVSE----TSRQGK 358
           F   ELK  T NF+ +      NK+G+GGFG VYKG   N  +AVK+++     T+ + K
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
           Q+F  E+  +   +H NLV+L+G+  +  D  LVY YMPNGSL      D  +   G   
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-----LDRLSCLDGTPP 129
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L+W  R  +  G +  +++LH   E   +HRDIKS+NI+LD  F A++ DFGLAR  ++ 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN 538
            +T   ++ I GT  YMAPE+ L G  T ++DIY+FGV++LE+  G    ++  +     
Sbjct: 187 AQTVMXSR-IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242
Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            +         +  I D  D ++  +     +E +  +   C H   + RP +K V Q+L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 159/300 (53%), Gaps = 23/300 (7%)
Query: 309 FRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIAVKRVSE----TSRQGK 358
           F   ELK  T NF+ +      NK+G+GGFG VYKG   N  +AVK+++     T+ + K
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
           Q+F  E+  +   +H NLV+L+G+  +  D  LVY YMPNGSL      D  +   G   
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-----LDRLSCLDGTPP 129
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L+W  R  +  G +  +++LH   E   +HRDIKS+NI+LD  F A++ DFGLAR  ++ 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN 538
            +T    + I GT  YMAPE+ L G  T ++DIY+FGV++LE+  G    ++  +     
Sbjct: 187 AQTVMXXR-IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242
Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            +         +  I D  D ++  +     +E +  +   C H   + RP +K V Q+L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 155/300 (51%), Gaps = 23/300 (7%)
Query: 309 FRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIAVKRVSE----TSRQGK 358
           F   ELK  T NF+ +      NK+G+GGFG VYKG   N  +AVK+++     T+ + K
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
           Q+F  E+  +   +H NLV+L+G+  +  D  LVY YMPNGSL      D  +   G   
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL-----LDRLSCLDGTPP 123
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L+W  R  +  G +  +++LH   E   +HRDIKS+NI+LD  F A++ DFGLAR   E 
Sbjct: 124 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA-SEK 179
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN 538
                    I GT  YMAPE+ L G  T ++DIY+FGV++LE+  G    ++  +     
Sbjct: 180 FAQXVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 236
Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            +         +  I D  D ++  +     +E +  +   C H   + RP +K V Q+L
Sbjct: 237 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 102/300 (34%), Positives = 149/300 (49%), Gaps = 23/300 (7%)
Query: 309 FRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIAVKRVSE----TSRQGK 358
           F   ELK  T NF+ +      NK G+GGFG VYKG   N  +AVK+++     T+ + K
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
           Q+F  E+      +H NLV+L+G+  +  D  LVY Y PNGSL      D  +   G   
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL-----LDRLSCLDGTPP 120
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L+W  R  +  G +  +++LH   E   +HRDIKS+NI+LD  F A++ DFGLAR   E 
Sbjct: 121 LSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA-SEK 176
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN 538
                    I GT  Y APE+ L G  T ++DIY+FGV++LE+  G    ++  +     
Sbjct: 177 FAQXVXXSRIVGTTAYXAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 233
Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            +         +  I D  D +   +     +E    +   C H   + RP +K V Q+L
Sbjct: 234 LLDIKEEIEDEEKTIEDYIDKKX-NDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 148/302 (49%), Gaps = 43/302 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQ--EFIAEVTTIGSLRHRNLV 377
           + N K K+G G FGTV++  W   ++AVK + E     ++  EF+ EV  +  LRH N+V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
             +G   +  +  +V EY+  GSL + +      SG  E  L+  +RLS+ +  ++ ++Y
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLH----KSGARE-QLDERRRLSMAYDVAKGMNY 152
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LHN +   ++HR++KS N+++D ++  ++ DFGL+R       T  S+K  AGTP +MAP
Sbjct: 153 LHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAP 208
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDA 556
           E      +  ++D+Y+FGV++ E+A  ++P GN                        L+ 
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN------------------------LNP 244
Query: 557 ADSRLGGEFSEKEMEC-------VLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
           A       F  K +E        V  +   C    P  RPS  T++ +L       V PP
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
Query: 610 ER 611
            R
Sbjct: 305 NR 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 146/302 (48%), Gaps = 43/302 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQ--EFIAEVTTIGSLRHRNLV 377
           + N K K+G G FGTV++  W   ++AVK + E     ++  EF+ EV  +  LRH N+V
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
             +G   +  +  +V EY+  GSL + +      SG  E  L+  +RLS+ +  ++ ++Y
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLH----KSGARE-QLDERRRLSMAYDVAKGMNY 152
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LHN +   ++HRD+KS N+++D ++  ++ DFGL+R           +K  AGTP +MAP
Sbjct: 153 LHNRNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAP 208
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDA 556
           E      +  ++D+Y+FGV++ E+A  ++P GN                        L+ 
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN------------------------LNP 244
Query: 557 ADSRLGGEFSEKEMEC-------VLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP 609
           A       F  K +E        V  +   C    P  RPS  T++ +L       V PP
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
Query: 610 ER 611
            R
Sbjct: 305 NR 306

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 125/234 (53%), Gaps = 20/234 (8%)
Query: 27  LHFNFQSFTEQNRNELSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           ++FNFQ F E N   L  D S  +   +++T  +  G P     GRA Y    Q+W +  
Sbjct: 4   IYFNFQRFNETNL-ILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTT 62
Query: 86  NVKATFSTTFVLNI-LNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQI 144
              A+F+T+F  NI +   A P +GLAF +      P++ +G +LG+ +G     +    
Sbjct: 63  GTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDG---SNSNFHT 118
Query: 145 VAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVF 204
           VA+EFDT  + + D  + H+G+DVN   SIR +  TR +  NG + +V + YD  +  + 
Sbjct: 119 VAVEFDTLYNKDWDPTERHIGIDVN---SIRSIKTTRWDFVNGENAEVLITYD-SSTNLL 174
Query: 205 VANMETP------LLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           VA++  P      ++S+ +DL   LPE V VGFSA+TG    + + N V SW+F
Sbjct: 175 VASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/234 (34%), Positives = 125/234 (53%), Gaps = 20/234 (8%)
Query: 27  LHFNFQSFTEQNRNELSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           ++FNFQ F E N   L  D S  +   +++T  +  G P     GRA Y    Q+W +  
Sbjct: 4   IYFNFQRFNETNL-ILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTT 62
Query: 86  NVKATFSTTFVLNI-LNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQI 144
              A+F+T+F  NI +   A P +GLAF +      P++ +G +LG+ +G     +    
Sbjct: 63  GTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDG---SNSNFHT 118
Query: 145 VAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVF 204
           VA+EFDT  + + D  + H+G+DVN   SIR +  TR +  NG + +V + YD  +  + 
Sbjct: 119 VAVEFDTLYNKDWDPTERHIGIDVN---SIRSIKTTRWDFVNGENAEVLITYD-SSTNLL 174
Query: 205 VANMETP------LLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           VA++  P      ++S+ +DL   LPE V VGFSA+TG    + + N V SW+F
Sbjct: 175 VASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 135/255 (52%), Gaps = 21/255 (8%)
Query: 6   MAKFLILAILMGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVR-GAP 64
           M + ++  IL+  AA   +  + F F+ F E N   +   ++TV+   +++T     G P
Sbjct: 8   MKRIVLFLILLTKAASANL--ISFTFKKFNETNL--ILQRDATVSSGKLRITKAAENGVP 63
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNI-LNQTAQPGEGLAFVIAGNKDLPEN 123
                GRA Y    Q+W +     A+++T+F  N+     A P +GLAF +      P++
Sbjct: 64  TAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPKD 123
Query: 124 SEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVN 183
            +G +LG+ +   N  + +Q VA+EFDT  +   D  + H+G+DVNS+ SI+    T  +
Sbjct: 124 -KGGFLGLFDS-KNYASSNQTVAVEFDTFYNGGWDPTERHIGIDVNSIKSIKT---TSWD 178
Query: 184 LANGTDIKVQVRYDGQNITVFVANMETP------LLSEPIDLSEYLPEKVFVGFSASTGD 237
            ANG + +V + YD  +  + VA++  P      ++SE +DL+  LPE V VGFSA+TG 
Sbjct: 179 FANGENAEVLITYD-SSTNLLVASLVHPSQKTSFIVSERVDLTSVLPEWVSVGFSATTGL 237
Query: 238 D---TQLNCVKSWAF 249
                + N V SW+F
Sbjct: 238 SKGYVETNEVLSWSF 252

>pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 121/246 (49%), Gaps = 28/246 (11%)
Query: 24  VSSLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLW 81
           + ++ FNF  F  QN  +L    D    + S +++T  V G P  N +GRA+Y    Q+W
Sbjct: 1   MKTISFNFNQF-HQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW 59
Query: 82  RDNKNVKATFSTTFVLNILN--QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I        P +GL F IA     P N++    G   GI N  
Sbjct: 60  DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIA-----PPNTQTGEGGGYFGIYNPL 114
Query: 140 NQSQIVAIEFDT-KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
           +    VA+EFDT + +++  I   H+G+DVNSV S + VP T   L NG    V ++YD 
Sbjct: 115 SPYPFVAVEFDTFRNTWDPQI--PHIGIDVNSVISTKTVPFT---LDNGGIANVVIKYDA 169
Query: 199 QN-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-------TQLNCVKS 246
                  + VF +      +++ +DL + LPE V VGFSA+TGD        T+ + + S
Sbjct: 170 STKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILS 229
Query: 247 WAFDGS 252
           W+F  S
Sbjct: 230 WSFSAS 235

>pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 120/244 (49%), Gaps = 28/244 (11%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ FNF  F  QN  +L    D    + S +++T  V G P  N +GRA+Y    Q+W  
Sbjct: 2   TISFNFNQF-HQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDS 60
Query: 84  NKNVKATFSTTFVLNILN--QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                A+F T F  +I        P +GL F IA     P N++    G   GI N  + 
Sbjct: 61  TTGNVASFETRFSFSIRQPFPRPHPADGLVFFIA-----PPNTQTGEGGGYFGIYNPLSP 115
Query: 142 SQIVAIEFDT-KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
              VA+EFDT + +++  I   H+G+DVNSV S + VP T   L NG    V ++YD   
Sbjct: 116 YPFVAVEFDTFRNTWDPQI--PHIGIDVNSVISTKTVPFT---LDNGGIANVVIKYDAST 170
Query: 201 -----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-------TQLNCVKSWA 248
                + VF +      +++ +DL + LPE V VGFSA+TGD        T+ + + SW+
Sbjct: 171 KILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS 230
Query: 249 FDGS 252
           F  S
Sbjct: 231 FSAS 234

>pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 120/244 (49%), Gaps = 28/244 (11%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ FNF  F  QN  +L    D    + S +++T  V G P  N +GRA+Y    Q+W  
Sbjct: 2   TISFNFNQF-HQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDS 60
Query: 84  NKNVKATFSTTFVLNILN--QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                A+F T F  +I        P +GL F IA     P N++    G   GI N  + 
Sbjct: 61  TTGNVASFETRFSFSIRQPFPRPHPADGLVFFIA-----PPNTQTGEGGGYFGIYNPLSP 115
Query: 142 SQIVAIEFDT-KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
              VA+EFDT + +++  I   H+G+DVNSV S + VP T   L NG    V ++YD   
Sbjct: 116 YPFVAVEFDTFRNTWDPQI--PHIGIDVNSVISTKTVPFT---LDNGGIANVVIKYDAST 170
Query: 201 -----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-------TQLNCVKSWA 248
                + VF +      +++ +DL + LPE V VGFSA+TGD        T+ + + SW+
Sbjct: 171 KILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS 230
Query: 249 FDGS 252
           F  S
Sbjct: 231 FSAS 234

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYLE-- 129
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLA 186
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 231
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 232 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLA 190
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 235
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 236 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/237 (35%), Positives = 124/237 (52%), Gaps = 18/237 (7%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWR 82
           SL F+F +F    RN L F  D  T   + +Q+T  D  GAP+ +  GR ++  Q +LW 
Sbjct: 11  SLSFSFINFDRDERN-LIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWE 69
Query: 83  DNKNVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLPENSEGQWLGIVNGITNGTNQ 141
            + N  A   T F   + +  + P +G+AF IA  +  +P  S G  LG+ N  T   N+
Sbjct: 70  KSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRT-ALNE 128
Query: 142 S--QIVAIEFDT---KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRY 196
           S  Q++A+EFDT   + S   D N  H+G+DVN   SIR   + R     G  + V V Y
Sbjct: 129 SANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVN---SIRSSKVVRWERREGKTLNVLVTY 185
Query: 197 DGQNITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           +    T+ V     + +   LS  +DL+  LPE V VGFSA++G+  Q + ++SW+F
Sbjct: 186 NPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSF 242

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYLE-- 133
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 190
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 235
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 236 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 123
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 124 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 179
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 190
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 235
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 236 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 190
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 235
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 236 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 131
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 189
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 234
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 235 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 69  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 120
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 121 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 176
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G FG VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLEK- 127
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 128 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP--IKWTAPESLA 183
Query: 502 VGRATIETDIYAFGVLILEVAC---GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
             + +I++D++AFGVL+ E+A       PG    Q          ++EL  K       D
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------VYELLEK-------D 226
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 227 YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 133
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 190
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 235
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 236 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 271

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 72  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 123
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 124 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 179
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 128
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 94  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 145
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 146 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 201
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 36/280 (12%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 126
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLA 183
Query: 502 VGRATIETDIYAFGVLILEVAC---GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
             + +I++D++AFGVL+ E+A       PG    Q          ++EL  K       D
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------VYELLEK-------D 226
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 227 YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 137/279 (49%), Gaps = 34/279 (12%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 140
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+    A  P  + APES 
Sbjct: 141 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---AKFPIKWTAPESL 197
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS 559
              + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D 
Sbjct: 198 AYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DY 242
Query: 560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 243 RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 279

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 127
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 129
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 187
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 232
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 233 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 268

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 95  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 146
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 147 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 202
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 128
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 128
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLE-- 128
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 129
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 187
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 232
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 233 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 127
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 230
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 231 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET           +K + +   T++ +D
Sbjct: 71  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETK-------FEMKKLIDIARQTARGMD 122
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 123 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 178
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +  +   + ++D+YAFG+++ E+  G+ P
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYL--RECN----RQEVNAVVLLYMATQISSAMEYL--- 373
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HR++ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 374 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 431
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 476
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 477 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 512

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+        +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 67  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T++      H  ++++G+  +MA
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 32/278 (11%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYL--- 334
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HR++ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 392
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
             + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       D R
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK-------DYR 437
Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 438 M--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 110/201 (54%), Gaps = 14/201 (6%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F +V EYMP G+L  ++   E N    EVT      L +    S A++YL   
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYL--RECNR--EEVTAV--VLLYMATQISSAMEYL--- 146
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLA 204
Query: 502 VGRATIETDIYAFGVLILEVA 522
               +I++D++AFGVL+ E+A
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIA 225

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +     L +    S A++YL   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVV----LLYMATQISSAMEYLEK- 127
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +      + APES  
Sbjct: 128 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP--IKWTAPESLA 183
Query: 502 VGRATIETDIYAFGVLILEVAC---GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
             + +I++D++AFGVL+ E+A       PG    Q          ++EL  K       D
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------VYELLEK-------D 226
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
            R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 227 YRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 264

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 123/239 (51%), Gaps = 14/239 (5%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWR 82
           S+ F F  F E  + +L F  D S  +  A+Q+T  D +G P     GRA+Y    +LW+
Sbjct: 3   SVCFTFTDF-ESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQ 61
Query: 83  DNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGIVNGITNGTNQ 141
            +  V A+F TTF  +I   ++ P + L F IA  +  +P  S G+ LG+     N  + 
Sbjct: 62  SSSLV-ASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSD 120
Query: 142 SQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           + +V++EFDT  + +  D N  H+G+DVNS   IR    ++ +  NG      + Y+  +
Sbjct: 121 NGVVSVEFDTYPNTDIGDPNYRHIGIDVNS---IRSKAASKWDWQNGKTATAHISYNSAS 177
Query: 201 ITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDIG 255
             + V     N    ++S  ++L+   P  V VGFSA+TG  TQ N + +W+F  S +G
Sbjct: 178 KRLSVVSSYPNSSPVVVSFDVELNNVXPXWVRVGFSATTGQYTQTNNILAWSFRSSLMG 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 67  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T +      H  ++++G+  +MA
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMA 174
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 87  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 138
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T +      H  ++++G+  +MA
Sbjct: 139 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMA 194
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 95  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 146
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T +      H  ++++G+  +MA
Sbjct: 147 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMA 202
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +      + ++D+YAFG+++ E+  G+ P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+   +    +V ++    SL   +   ET           +K + +   T++ +D
Sbjct: 83  LLFMGYS-TKPQLAIVTQWCEGSSLYHHLHASETK-------FEMKKLIDIARQTARGMD 134
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T +      H  ++++G+  +MA
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMA 190
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +  +   + ++D+YAFG+++ E+  G+ P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 24/214 (11%)
Query: 326 KLGKGGFGTVYKGIWRNKE---IAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +LG G FG VYK   +NKE   +A  +V ET S +  +++I E+  + +  H  +VKL+G
Sbjct: 18  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             Y      ++ E+ P G++D  +   E + G  E  +       V     +AL++LH+ 
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQ-----VVCRQMLEALNFLHS- 127
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             KR++HRD+K+ N+++  E + RL DFG++    +NLKT        GTP +MAPE  +
Sbjct: 128 --KRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 502 VGRAT-----IETDIYAFGVLILEVACGRKPGNQ 530
                      + DI++ G+ ++E+A    P ++
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 24/214 (11%)
Query: 326 KLGKGGFGTVYKGIWRNKE---IAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +LG G FG VYK   +NKE   +A  +V ET S +  +++I E+  + +  H  +VKL+G
Sbjct: 26  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             Y      ++ E+ P G++D  +   E + G  E  +       V     +AL++LH+ 
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQ-----VVCRQMLEALNFLHS- 135
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             KR++HRD+K+ N+++  E + RL DFG++    +NLKT        GTP +MAPE  +
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 502 VGRAT-----IETDIYAFGVLILEVACGRKPGNQ 530
                      + DI++ G+ ++E+A    P ++
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 127/234 (54%), Gaps = 20/234 (8%)
Query: 30  NFQSFTEQNRNELSF---DNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           + QSF+ +N N  SF    ++TV+ S +++T     G P  +  GRA Y    Q++  + 
Sbjct: 2   DIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKST 61
Query: 86  NVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQI 144
              A+++T+F  NI     +   +G+AF +      P+++ G +LG+ +      N +Q 
Sbjct: 62  GAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSG-FLGVFDSDVYD-NSAQT 119
Query: 145 VAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVF 204
           VA+EFDT  + + D    H+G+DVNS+ SIR        LANG + ++ + Y+    ++ 
Sbjct: 120 VAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW---GLANGQNAEILITYNAAT-SLL 175
Query: 205 VANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
           VA++  P      ++SE +D++  LPE V +GFSA+TG     T+ + V SW+F
Sbjct: 176 VASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 48/288 (16%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRV----SETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           +G GGFG VY+  W   E+AVK       E   Q  +    E      L+H N++ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C +  +  LV E+   G L++ +        P ++ +NW  +++      + ++YLH+ +
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIA------RGMNYLHDEA 125
Query: 443 EKRVLHRDIKSSNIMLDSEFN--------ARLGDFGLARTIQENLKTHHSTK-EIAGTPG 493
              ++HRD+KSSNI++  +           ++ DFGLAR      + H +TK   AG   
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYA 179
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWELRRKG 551
           +MAPE       +  +D++++GVL+ E+  G  P  G      +Y               
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-------------- 225
Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                A ++L         E    L   C +P+PH RPS   +L  L+
Sbjct: 226 ----VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYLE-- 129
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP---GYMAPE 498
            +K  +HRD+ + N ++      ++ DFGL+R     L T  +    AG      + APE
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAPAGAKFPIKWTAPE 183
Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           S    + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK------- 228
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           D R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 229 DYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+        +V ++    SL   +   ET           +K + +   T++ +D
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK-------FEMKKLIDIARQTARGMD 134
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA T +      H  ++++G+  +MA
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMA 190
Query: 497 PESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
           PE   +  +   + ++D+YAFG+++ E+  G+ P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+     +AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++   E N       +N    L +    S A++YL   
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYL--RECNRQ----EVNAVVLLYMATQISSAMEYL--- 129
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP---GYMAPE 498
            +K  +HRD+ + N ++      ++ DFGL+R     L T  +    AG      + APE
Sbjct: 130 EKKNFIHRDLAARNCLVGENHLVKVADFGLSR-----LMTGDTYTAPAGAKFPIKWTAPE 184
Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           S    + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K       
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEK------- 229
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           D R+  E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 230 DYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 268

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 119/237 (50%), Gaps = 25/237 (10%)
Query: 29  FNFQSFTEQNRNELSFDNSTVAKSA-IQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNKN 86
           F F  F     N     ++TV  S  +Q+T  D  G P     GRA+Y     +W     
Sbjct: 7   FTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINIWDSKTG 66
Query: 87  VKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIV 145
           V A+F+T+F   I     A   +GLAF +A     P+   G +LG+ +     ++  Q V
Sbjct: 67  VVASFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAG-FLGLFDSAVFNSSY-QTV 124
Query: 146 AIEFDTKKSYEQ----DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNI 201
           A+EFDT   YE     D  D H+G+DVNS+ SI+ V   + +LANG   KV + YD  + 
Sbjct: 125 AVEFDT---YENTVFLDPPDTHIGIDVNSIKSIKTV---KWDLANGEAAKVLITYD-SSA 177
Query: 202 TVFVANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDDT---QLNCVKSWAF 249
            + VA +  P      +LS+ +DL   LPE V +GFSA+TG  +   + + V SW+F
Sbjct: 178 KLLVAALVYPSSKTSFILSDVVDLKSVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 119/237 (50%), Gaps = 25/237 (10%)
Query: 29  FNFQSFTEQNRNELSFDNSTVAKS-AIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNKN 86
           F F  F     N     ++TV  S  +Q+T  D  G P     GRA+Y     +W     
Sbjct: 7   FTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPINIWDSKTG 66
Query: 87  VKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIV 145
           V A+F+T+F   I     A   +GLAF +A     P+   G +LG+ +     ++  Q V
Sbjct: 67  VVASFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAG-FLGLFDSAVFNSSY-QTV 124
Query: 146 AIEFDTKKSYEQ----DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNI 201
           A+EFDT   YE     D  D H+G+DVNS+ SI+ V   + +LANG   KV + YD  + 
Sbjct: 125 AVEFDT---YENTVFLDPPDTHIGIDVNSIKSIKTV---KWDLANGEAAKVLITYD-SSA 177
Query: 202 TVFVANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDDT---QLNCVKSWAF 249
            + VA +  P      +LS+ +DL   LPE V +GFSA+TG  +   + + V SW+F
Sbjct: 178 KLLVAALVYPSSKTSFILSDVVDLKSVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +G+G FG V K  WR K++A+K++   S   ++ FI E+  +  + H N+VKL G C   
Sbjct: 17  VGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRV 446
           +   LV EY   GSL     Y+  +             +S     SQ + YLH+   K +
Sbjct: 73  NPVCLVMEYAEGGSL-----YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 447 LHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA 505
           +HRD+K  N++L +     ++ DFG A  IQ    TH +  +  G+  +MAPE F     
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNK--GSAAWMAPEVFEGSNY 181
Query: 506 TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEF 565
           + + D++++G+++ EV   RKP ++    ++               RI+ A  +      
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------RIMWAVHNGTRPPL 226
Query: 566 SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
            +   + +  L   C   +P  RPSM+ ++++++
Sbjct: 227 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 31/274 (11%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +G+G FG V K  WR K++A+K++   S   ++ FI E+  +  + H N+VKL G C   
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRV 446
           +   LV EY   GSL     Y+  +             +S     SQ + YLH+   K +
Sbjct: 72  NPVCLVMEYAEGGSL-----YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 447 LHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA 505
           +HRD+K  N++L +     ++ DFG A  IQ    TH +  +  G+  +MAPE F     
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNK--GSAAWMAPEVFEGSNY 180
Query: 506 TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEF 565
           + + D++++G+++ EV   RKP ++    ++               RI+ A  +      
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------RIMWAVHNGTRPPL 225
Query: 566 SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
            +   + +  L   C   +P  RPSM+ ++++++
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 119/230 (51%), Gaps = 23/230 (10%)
Query: 306 PKKFRLKEL------KKATGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQG 357
           P + +LK+L      K+    F+   KLG+G +G+VYK I +   + +A+K+V   S   
Sbjct: 10  PPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--D 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            QE I E++ +      ++VK  G  ++  D  +V EY   GS+   I            
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK------- 120
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
           TL  ++  +++  T + L+YLH     R +HRDIK+ NI+L++E +A+L DFG+A  + +
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177
Query: 478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +   +    + GTP +MAPE           DI++ G+  +E+A G+ P
Sbjct: 178 XMAKRNX---VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 134/250 (53%), Gaps = 31/250 (12%)
Query: 30  NFQSFTEQNRNELSF---DNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           N QSF+ +N N  SF    ++TV+   +Q+T     G P  +  GRA Y    Q++  + 
Sbjct: 2   NIQSFSFKNFNSPSFILQGDATVSSGKLQLTKVKENGIPTPSSLGRAFYSSPIQIYDKST 61
Query: 86  NVKATFSTTFVLNILNQT-AQPGEGLAFVIAGNKDLPENSE----GQWLGIVNG-ITNGT 139
              A+++T+F + I   + A   +G+AF +     +P  SE    G +LG+ +  + N  
Sbjct: 62  GAVASWATSFTVKISAPSKASFADGIAFAL-----VPVGSEPRRNGGYLGVFDSDVYN-- 114
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N +Q VA+EFDT  +   D +  H+G+DVNS+ SI  V     +LANG + ++ + Y+  
Sbjct: 115 NSAQTVAVEFDTLSNSGWDPSMKHIGIDVNSIKSIATVSW---DLANGENAEILITYNAA 171
Query: 200 NITVFVANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFD 250
             ++ VA++  P      +LSE +D++  LPE V VGFSA+TG      + + V SW+F 
Sbjct: 172 T-SLLVASLVHPSRRTSYILSERVDITNELPEYVSVGFSATTGLSEGYIETHDVLSWSF- 229
Query: 251 GSDIGGDSKA 260
            S +  DS A
Sbjct: 230 ASKLPDDSTA 239

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 84  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 134
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 191
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 82
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 83  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 133
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 190
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 87
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 88  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 138
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 195
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 78  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 185
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 72
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 73  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 123
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 180
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 127/232 (54%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSETS-RQG 357
           AP + +L+ LK+          LG G FGTVYKGIW  +       +A+K ++ET+  + 
Sbjct: 3   APNQAQLRILKET--ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
             EF+ E   + S+ H +LV+L+G C       LV + MP+G L +++   + N G  ++
Sbjct: 61  NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIG-SQL 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + + YL    E+R++HRD+ + N+++ S  + ++ DFGLAR ++ 
Sbjct: 119 LLNWCVQIA------KGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           + K +++       P  +MA E     + T ++D++++GV I E+   G KP
Sbjct: 170 DEKEYNADG--GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 134/246 (54%), Gaps = 24/246 (9%)
Query: 291 LDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------E 344
           L+ ++   +  +  AP + +L+ LK+          LG G FGTVYKGIW  +       
Sbjct: 12  LETELVEPLTPSGTAPNQAQLRILKET--ELKRVKVLGSGAFGTVYKGIWVPEGETVKIP 69
Query: 345 IAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDK 403
           +A+K ++ET+  +   EF+ E   + S+ H +LV+L+G C       LV + MP+G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLE 128
Query: 404 FIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN 463
           ++   + N G  ++ LNW  +++      + + YL    E+R++HRD+ + N+++ S  +
Sbjct: 129 YVHEHKDNIG-SQLLLNWCVQIA------KGMMYL---EERRLVHRDLAARNVLVKSPNH 178
Query: 464 ARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVA 522
            ++ DFGLAR ++ + K +++  +    P  +MA E     + T ++D++++GV I E+ 
Sbjct: 179 VKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236
Query: 523 C-GRKP 527
             G KP
Sbjct: 237 TFGGKP 242

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 119/236 (50%), Gaps = 17/236 (7%)
Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SL F+F  F       ++  ++ V  + + Q+T  V G P +   GRA+Y   FQ+W   
Sbjct: 3   SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDST 62
Query: 85  KNVKATFSTTFVLNI-LNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIV-NGITNGTNQS 142
               A+F T+F   I     A   +GLAF +A     P +  G  LGI  +G  N +NQ 
Sbjct: 63  TGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGM-LGIFKDGYFNKSNQ- 120
Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ--- 199
            IVA+EFDT  + + D    H+G++VNS+ SI+ VP    N  NG    V + Y+     
Sbjct: 121 -IVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW---NWTNGEVANVFISYEASTKS 176
Query: 200 -NITVFVANMETPLLSEPI-DLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFD 250
              ++   ++ET  + + I D+   LPE V  GFSA+TG D    Q N V SW+F+
Sbjct: 177 LTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFE 232

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 136/289 (47%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV-RWM 199
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 252
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP++RP+   ++ +L  +  P
Sbjct: 253 QPDNC---------PERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 325 NKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQ---EFIAEVTTIGSLRHRNLVKL 379
           +KLG GG  TVY  +    N ++A+K +    R+ ++    F  EV     L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           I    E   + LV EY+   +L ++I     + GP  V        + I+ T+Q LD + 
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVD-------TAINFTNQILDGIK 125
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +  + R++HRDIK  NI++DS    ++ DFG+A+ + E   T   T  + GT  Y +PE 
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSPEQ 183
Query: 500 FLVGRATIE-TDIYAFGVLILEVACGRKPGN 529
              G AT E TDIY+ G+++ E+  G  P N
Sbjct: 184 -AKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 134/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 137 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV-RWM 192
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 245
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           + +L L   C   NP +RPS   ++  +  E +P
Sbjct: 246 KPDNCP---------DMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 86
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 87  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 137
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 194
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 84  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 134
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 191
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV-RWM 199
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 252
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP +RP+   ++ +L  +  P
Sbjct: 253 QPDNC---------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 79
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 80  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 130
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 187
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 85
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 86  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 136
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 193
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV-RWM 196
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 249
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP +RP+   ++ +L  +  P
Sbjct: 250 QPDNC---------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 289

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 78  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 185
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 78  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 185
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV-RWM 201
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 254
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 255 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 111/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 78
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 79  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 129
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++NI++    + ++ DFGLAR I++N     + +E A  P  + APE+   G
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EXTAREGAKFPIKWTAPEAINYG 186
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV-RWM 199
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 252
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP +RP+   ++ +L  +  P
Sbjct: 253 QPDNC---------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +        + ++  TSQ    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL----------QAHAERIDHIKLLQYTSQICKG 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           +     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 188
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           ++G G FGTVYKG W   ++AVK  +V + + +  Q F  EV  +   RH N++  +G+ 
Sbjct: 43  RIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
             + +  +V ++    SL K +   ET            + + +   T+Q +DYLH    
Sbjct: 102 -TKDNLAIVTQWCEGSSLYKHLHVQETK-------FQMFQLIDIARQTAQGMDYLH---A 150
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV- 502
           K ++HRD+KS+NI L      ++GDFGLA T++         ++  G+  +MAPE   + 
Sbjct: 151 KNIIHRDMKSNNIFLHEGLTVKIGDFGLA-TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 503 --GRATIETDIYAFGVLILEVACGRKP 527
                + ++D+Y++G+++ E+  G  P
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/244 (33%), Positives = 120/244 (49%), Gaps = 19/244 (7%)
Query: 29  FNFQSFTEQNRNE-LSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNKN 86
           F F  F     N  L  D        +Q+T  D  G P  +  GRA Y     +W     
Sbjct: 6   FVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATG 65
Query: 87  VKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIV 145
           + A+F+T+F   I     A   +GLAF +A     P+ S G +LG+ +   +G+   Q V
Sbjct: 66  LVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVSGSTY-QTV 123
Query: 146 AIEFDT-KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVF 204
           A+EFDT + +   D    H+G DVNS+ SI+ V   + +LANG   KV + Y+   + + 
Sbjct: 124 AVEFDTYENTVFTDPPYTHIGFDVNSISSIKTV---KWSLANGEAAKVLITYNSA-VKLL 179
Query: 205 VANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGSDIG 255
           VA++  P      +L++ +DLS  LPE V VGFSA+TG      + + V SW+F     G
Sbjct: 180 VASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFASKLAG 239
Query: 256 GDSK 259
             +K
Sbjct: 240 XXTK 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 133
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 134 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 189
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYEL 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 130
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HR++ + NI++++E   ++GDFGL + + ++ K ++  KE   +P +  A
Sbjct: 131 L---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKEPGESPIFWYA 186
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYEL 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 128
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 129 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 184
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYEL 209

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 113/206 (54%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
            +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGME 159
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWY 215
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES    + ++ +D+++FGV++ E+
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYEL 241

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 17/205 (8%)
Query: 326 KLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +LG G FG V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 73
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
            +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E+
Sbjct: 74  TQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 124
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HR+++++NI++    + ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 181
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   GR P
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 132
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 188
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 185
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 113/206 (54%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
            +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGME 126
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWY 182
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES    + ++ +D+++FGV++ E+
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYEL 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 134
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 135 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 190
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYEL 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 135
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 136 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 191
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 185
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 136
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 137 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 192
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYEL 217

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 199
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 252
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP +RP+   ++ +L  +  P
Sbjct: 253 QPDNC---------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 17/207 (8%)
Query: 324 KNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           + KLG G FG V+   + ++ ++AVK +   S    + F+AE   + +L+H  LVKL   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA- 77
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
              +    ++ E+M  GSL  F+  DE +  P            +I  ++Q  + +    
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP---------KLIDFSAQIAEGMAFIE 128
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
           ++  +HRD++++NI++ +    ++ DFGLAR I++N    ++ +E A  P  + APE+  
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAIN 185
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKP 527
            G  TI++D+++FG+L++E+   GR P
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEPGESPIFWYA 185
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 207
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATL---AEQPYQGLSNEQVLRFVME----GGLLD 260
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 261 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++          +  ++  K L       + ++Y
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QKHKERIDHIKLLQYTSQICKGMEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 203
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 113/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ EY+P GSL  ++   +         ++  K L       + ++Y
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-------IDHIKLLQYTSQICKGMEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 203
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 137/310 (44%), Gaps = 30/310 (9%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQ 356
           A   F   E + A        +LG+G FG VY+G+ +          +A+K V+E  S +
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 61
Query: 357 GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGP 414
            + EF+ E + +      ++V+L+G   +    L++ E M  G L  ++     E  + P
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
                +  K + +    +  + YL+     + +HRD+ + N M+  +F  ++GDFG+ R 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
           I E        K +     +M+PES   G  T  +D+++FGV++ E+A       Q  Q 
Sbjct: 179 IYETDYYRKGGKGLLPV-RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQG 234
Query: 535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV 594
             N  ++ ++ E    G +LD  D+     F    M         C   NP +RPS   +
Sbjct: 235 LSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEI 281
Query: 595 LQVLSGEADP 604
           +  +  E +P
Sbjct: 282 ISSIKEEMEP 291

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 174 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 229
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 282
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 283 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 135/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 198
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 251
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP +RP+   ++ +L  +  P
Sbjct: 252 QPDNC---------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 291

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 200
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 253
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 254 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 200
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 253
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 254 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 201
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 254
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 255 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 119/235 (50%), Gaps = 30/235 (12%)
Query: 311 LKELKKATGNFNPKN------KLGKGGFGTVYKGIWRNKEIAV----KRVSETSRQGKQE 360
           +K+ +  T + NP++      +LG G FG VYK   +NKE +V    K +   S +  ++
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELED 80
Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
           ++ E+  + S  H N+VKL+   Y  ++  ++ E+   G++D  +   E      ++ + 
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                 V   T  AL+YLH+    +++HRD+K+ NI+   + + +L DFG++    +N +
Sbjct: 140 ------VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTR 187
Query: 481 THHSTKEIAGTPGYMAPESFLVGRAT-----IETDIYAFGVLILEVACGRKPGNQ 530
           T        GTP +MAPE  +   +       + D+++ G+ ++E+A    P ++
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 114/205 (55%), Gaps = 20/205 (9%)
Query: 326 KLGKGGFGTV----YKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LGKG FG+V    Y  +  N  + +AVK++  ++ +  ++F  E+  + SL+H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 380 IGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G CY   R +  L+ E++P GSL +++          +  ++  K L       + ++Y
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL-------QKHKERIDHIKLLQYTSQICKGMEY 132
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P +  A
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 188
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PES    + ++ +D+++FGV++ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 139 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 194
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 247
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 248 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
            +LG G FG V+ G + N      +  +      Q F+ E   + +L+H  LV+L     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
                 ++ EYM  GSL  F+  DE     G+V L       +I  ++Q  + +     K
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEG----GKVLLP-----KLIDFSAQIAEGMAYIERK 129
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++N+++      ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFG 186
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++D+++FG+L+ E+   G+ P
Sbjct: 187 CFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 17/207 (8%)
Query: 324 KNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           + KLG G FG V+   + ++ ++AVK +   S    + F+AE   + +L+H  LVKL   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
              +    ++ E+M  GSL  F+  DE +  P            +I  ++Q  + +    
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP---------KLIDFSAQIAEGMAFIE 301
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
           ++  +HRD++++NI++ +    ++ DFGLAR I++N    ++ +E A  P  + APE+  
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAIN 358
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKP 527
            G  TI++D+++FG+L++E+   GR P
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 147/311 (47%), Gaps = 52/311 (16%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSETSRQGKQEFIAEVTTIGSLR 372
           N   K +LG+G FG V+     N         +AVK + + S   +++F  E   + +L+
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKR 424
           H ++VK  G C E    ++V+EYM +G L+KF        +   E N  P E+T +  + 
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP-PTELTQS--QM 130
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           L +    +  + YL   + +  +HRD+ + N ++      ++GDFG++R +      ++ 
Sbjct: 131 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST--DYYR 185
Query: 485 TKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVH 542
                  P  +M PES +  + T E+D+++ GV++ E+   G++P  Q      NN ++ 
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----NNEVI- 240
Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMK---TVLQ 596
              E   +GR+L            ++   C   V  L L C    PH+R ++K   T+LQ
Sbjct: 241 ---ECITQGRVL------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285
Query: 597 VLSGEADPPVL 607
            L+ +A P  L
Sbjct: 286 NLA-KASPVYL 295

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 59  DVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGN 117
           D  G P  +  GRA Y     +W     + A+F+T+F   I     A   +GLAF +A  
Sbjct: 38  DSNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPV 97
Query: 118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDT-KKSYEQDINDNHVGLDVNSVYSIRQ 176
              P+ S G +LG+ +     T   Q VA+EFDT + +   D    H+G DVNS+ SI+ 
Sbjct: 98  ASAPD-SGGGFLGLFDSAVGDTTY-QTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKT 155
Query: 177 VPLTRVNLANGTDIKVQVRYDGQNITVFVANMETP------LLSEPIDLSEYLPEKVFVG 230
           V   + +LANG   KV + Y+   + + VA++  P      +L++ +DLS  LPE V VG
Sbjct: 156 V---KWSLANGEAAKVLITYNSA-VKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVG 211
Query: 231 FSASTGDD---TQLNCVKSWAF 249
           FSA+TG      + + V SW+F
Sbjct: 212 FSAATGASKGYIETHDVFSWSF 233

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 136/289 (47%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HR++ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 199
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 252
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP++RP+   ++ +L  +  P
Sbjct: 253 QPDNC---------PERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 136/289 (47%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G  R+         +AVK V+E+ S + + EF+ E + +      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L+V E M +G L  ++     E  + PG      ++ + +    +  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+    K+ +HR++ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 200
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APES   G  T  +D+++FGV++ E+        Q  Q   N  ++ ++ +    G  LD
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEIT---SLAEQPYQGLSNEQVLKFVMD----GGYLD 253
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           E V  L   C   NP++RP+   ++ +L  +  P
Sbjct: 254 QPDNC---------PERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHP 293

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 118/235 (50%), Gaps = 30/235 (12%)
Query: 311 LKELKKATGNFNPKN------KLGKGGFGTVYKGIWRNKEIAV----KRVSETSRQGKQE 360
           +K+ +  T + NP++      +LG G FG VYK   +NKE +V    K +   S +  ++
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELED 80
Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
           ++ E+  + S  H N+VKL+   Y  ++  ++ E+   G++D  +   E      ++ + 
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                 V   T  AL+YLH+    +++HRD+K+ NI+   + + +L DFG++    +N +
Sbjct: 140 ------VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTR 187
Query: 481 THHSTKEIAGTPGYMAPESFLVGRAT-----IETDIYAFGVLILEVACGRKPGNQ 530
                    GTP +MAPE  +   +       + D+++ G+ ++E+A    P ++
Sbjct: 188 XIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++        + P     +  K + +    +  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 207
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATL---AEQPYQGLSNEQVLRFVME----GGLLD 260
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 261 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 133/289 (46%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++     E  + P     +  K + +    +  +
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N  +  +F  ++GDFG+ R I E        K +     +M
Sbjct: 139 AYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 194
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 247
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+           + +L L   C   NP +RPS   ++  +  E +P
Sbjct: 248 KPDNCP---------DMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 118/235 (50%), Gaps = 30/235 (12%)
Query: 311 LKELKKATGNFNPKN------KLGKGGFGTVYKGIWRNKEIAV----KRVSETSRQGKQE 360
           +K+ +  T + NP++      +LG G FG VYK   +NKE +V    K +   S +  ++
Sbjct: 23  MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELED 80
Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
           ++ E+  + S  H N+VKL+   Y  ++  ++ E+   G++D  +   E      ++ + 
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV- 139
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                 V   T  AL+YLH+    +++HRD+K+ NI+   + + +L DFG++    +N +
Sbjct: 140 ------VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTR 187
Query: 481 THHSTKEIAGTPGYMAPESFLVGRAT-----IETDIYAFGVLILEVACGRKPGNQ 530
                    GTP +MAPE  +   +       + D+++ G+ ++E+A    P ++
Sbjct: 188 XIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 242

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
            KLG G FG V+ G + N      +  +      Q F+ E   + +L+H  LV+L     
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           +     ++ E+M  GSL  F+  DE     G+V L       +I  ++Q  + +     K
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEG----GKVLLP-----KLIDFSAQIAEGMAYIERK 128
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVG 503
             +HRD++++N+++      ++ DFGLAR I++N    ++ +E A  P  + APE+   G
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFG 185
Query: 504 RATIETDIYAFGVLILEVAC-GRKP 527
             TI++++++FG+L+ E+   G+ P
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRN----KEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +G G FG VYKG+ +     KE+ V     +   T +Q + +F+ E   +G   H N+++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFSHHNIIR 110
Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L G   +    +++ EYM NG+LDKF+         GE ++   + + ++ G +  + YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL-----REKDGEFSV--LQLVGMLRGIAAGMKYL 163
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
            N      +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T        + APE
Sbjct: 164 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 499 SFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           +    + T  +D+++FG+++ EV   G +P
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 326 KLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLV 377
           +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      ++V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +L+G   +    L++ E M  G L  ++        + P     +  K + +    +  +
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K +     +M
Sbjct: 142 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWM 197
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           +PES   G  T  +D+++FGV++ E+A       Q  Q   N  ++ ++ E    G +LD
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGLSNEQVLRFVME----GGLLD 250
Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
             D+     F    M         C   NP +RPS   ++  +  E +P
Sbjct: 251 KPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 125/236 (52%), Gaps = 24/236 (10%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-T 353
           G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E T
Sbjct: 1   GSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           S +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG 117
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+
Sbjct: 118 -SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
            +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 168 LLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 125/237 (52%), Gaps = 24/237 (10%)
Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE- 352
            G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E 
Sbjct: 23  QGSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 80
Query: 353 TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS 412
           TS +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N 
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNI 139
Query: 413 GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA 472
           G  +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA
Sbjct: 140 G-SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 189
Query: 473 RTIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           + +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 190 KLLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 109/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 138
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++ +T    S   +  +P    PE  +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP----PEVLM 194
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              ++++ EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIYIVI-EYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 78  EPIY-IVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 127
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 184
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 185 FTIKSDVWSFGILLTELTTKGRVP 208

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 251 EPIY-IVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 357
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 125/236 (52%), Gaps = 24/236 (10%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-T 353
           G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E T
Sbjct: 1   GSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           S +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG 117
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+
Sbjct: 118 -SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
            +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 168 LLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 121/234 (51%), Gaps = 13/234 (5%)
Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SL F F +F    +N +   ++ +  +A+Q+T  D  G P+ +  GR ++  Q  LW  +
Sbjct: 3   SLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS 62
Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLP-ENSEGQWLGIVNGITNGTNQS 142
            +  A F + F  ++ +  +   +G+AF IA  +  +P  +  G       G    T+ +
Sbjct: 63  SSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSAN 122
Query: 143 QIVAIEFDT---KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD-- 197
           Q++A+EFDT   + S   D N  H+G+DVNS+ S++ V   R    +G  + V V ++  
Sbjct: 123 QVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDR---RDGQSLNVLVTFNPS 179
Query: 198 GQNITVFVANMETPL--LSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +N+ V     +     +S  +D+   LPE V VGFSA++G+  Q + ++SW+F
Sbjct: 180 TRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSF 233

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 251 EPIY-IVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 357
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 76  EPIY-IVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 125
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 182
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 183 FTIKSDVWSFGILLTELTTKGRVP 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 74  EPIY-IVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 123
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 180
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 181 FTIKSDVWSFGILLTELTTKGRVP 204

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+         GE T  + +   ++  ++Q    +       
Sbjct: 82  EPIY-IVTEYMNKGSLLDFL--------KGE-TGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 188
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 123
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T  S++       +  PE  +  
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSRGSKFPVRWSPPEVLMYS 181
Query: 504 RATIETDIYAFGVLILEV-ACGRKP 527
           + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 121/234 (51%), Gaps = 13/234 (5%)
Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SL F F +F    +N +   ++ +  +A+Q+T  D  G P+ +  GR ++  Q  LW  +
Sbjct: 3   SLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKS 62
Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLP-ENSEGQWLGIVNGITNGTNQS 142
            +  A F + F  ++ +  +   +G+AF IA  +  +P  +  G       G    T+ +
Sbjct: 63  SSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSAN 122
Query: 143 QIVAIEFDT---KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD-- 197
           Q++A+EFDT   + S   D N  H+G+DVNS+ S++ V   R    +G  + V V ++  
Sbjct: 123 QVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDR---RDGQSLNVLVTFNPS 179
Query: 198 GQNITVFVANMETPL--LSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +N+ V     +     +S  +D+   LPE V VGFSA++G+  Q + ++SW+F
Sbjct: 180 TRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSF 233

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIY-IVCEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
                +V EYM  GSL  F+         GE T  + +   ++   +Q    +       
Sbjct: 334 -EPIYIVTEYMSKGSLLDFL--------KGE-TGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 440
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP 464

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 325 NKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G  G V+ G +  + ++AVK + + S      F+AE   +  L+H+ LV+L    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
             +    ++ EYM NGSL  F+        P  + L   K L +    ++ + ++    E
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL------KTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLV 502
           +  +HRD++++NI++    + ++ DFGLAR I++      + +E A  P  + APE+   
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED---AEXTAREGAKFPIKWTAPEAINY 184
Query: 503 GRATIETDIYAFGVLILEVAC-GRKP 527
           G  TI++D+++FG+L+ E+   GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIY-IVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 122
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T    S   +  +P    PE  +
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLM 178
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 179 YSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 143/304 (47%), Gaps = 49/304 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + + +   +++F  E   + +L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF---------IFYD-ETNSGPGEVTLNWEKRLS 426
           VK  G C +    ++V+EYM +G L+KF         I  D +     GE+ L+      
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS-----Q 134
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH---H 483
           ++H  SQ    +   + +  +HRD+ + N ++ +    ++GDFG++R +          H
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVH 542
           +   I     +M PES +  + T E+D+++FGV++ E+   G++P  Q      N  ++ 
Sbjct: 195 TMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS----NTEVI- 245
Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS--G 600
              E   +GR+L+            KE+  V+   L C    P  R ++K + ++L   G
Sbjct: 246 ---ECITQGRVLERP------RVCPKEVYDVM---LGCWQREPQQRLNIKEIYKILHALG 293
Query: 601 EADP 604
           +A P
Sbjct: 294 KATP 297

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T    S   +  +P    PE  +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLM 174
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + E S   +Q+F  E   +  L+H+++
Sbjct: 23  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF---------IFYDETNSGPGEVTLNWEKRLSV 427
           V+  G C E    L+V+EYM +G L++F         +     +  PG + L   + L+V
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAV 140
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
               +  + YL   +    +HRD+ + N ++      ++GDFG++R I          + 
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
           +     +M PES L  + T E+D+++FGV++ E+   G++P  Q                
Sbjct: 198 MLPI-RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------------ 244
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEAD 603
                   +A D    G   E+   C   V  +   C    P  R S+K V   L   A 
Sbjct: 245 --------EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 296
Query: 604 -PPV 606
            PPV
Sbjct: 297 APPV 300

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 251 EPIY-IVGEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 357
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 123
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T    S   +  +P    PE  +
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLM 179
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 7   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 122
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 123 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 173
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 174 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 47/304 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + E S   +Q+F  E   +  L+H+++
Sbjct: 17  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF---------IFYDETNSGPGEVTLNWEKRLSV 427
           V+  G C E    L+V+EYM +G L++F         +     +  PG + L   + L+V
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAV 134
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
               +  + YL   +    +HRD+ + N ++      ++GDFG++R I          + 
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
           +     +M PES L  + T E+D+++FGV++ E+   G++P  Q       + I      
Sbjct: 192 MLPI-RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT----- 245
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEAD 603
              +GR L            E+   C   V  +   C    P  R S+K V   L   A 
Sbjct: 246 ---QGREL------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 290
Query: 604 -PPV 606
            PPV
Sbjct: 291 APPV 294

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 138
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T    S   +  +P    PE  +
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLM 194
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 133/304 (43%), Gaps = 47/304 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + E S   +Q+F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF---------IFYDETNSGPGEVTLNWEKRLSV 427
           V+  G C E    L+V+EYM +G L++F         +     +  PG + L   + L+V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAV 163
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
               +  + YL   +    +HRD+ + N ++      ++GDFG++R I          + 
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
           +     +M PES L  + T E+D+++FGV++ E+   G++P  Q       + I      
Sbjct: 221 MLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT----- 274
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEAD 603
              +GR L            E+   C   V  +   C    P  R S+K V   L   A 
Sbjct: 275 ---QGREL------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
Query: 604 -PPV 606
            PPV
Sbjct: 320 APPV 323

>pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 117/243 (48%), Gaps = 24/243 (9%)
Query: 23  QVSSLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQL 80
           Q  S+ F F +F     + + F  D +T A +      +  G P+   +GRA+Y D  QL
Sbjct: 1   QSDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQL 60
Query: 81  WRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGIT-NGT 139
           W +     A+F T F   +      P +GLAF +A   D      G++LG+ N  T    
Sbjct: 61  WDNKTESVASFYTEFTFFLKITGNGPADGLAFFLAP-PDSDVKDAGEYLGLFNKSTATQP 119
Query: 140 NQSQIVAIEFDT-------KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKV 192
           +++Q+VA+EFDT       + SY       H+G++VNS+ S+        ++ +G     
Sbjct: 120 SKNQVVAVEFDTWTNPNFPEPSYR------HIGINVNSIVSVATKRWEDSDIFSGKIATA 173
Query: 193 QVRYDGQNITVFVANMETP-----LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC-VKS 246
           ++ YDG +  +    +  P     +LS  +D+ + LPE V VG SASTG++  L   + S
Sbjct: 174 RISYDG-SAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILS 232
Query: 247 WAF 249
           W F
Sbjct: 233 WRF 235

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 4   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 119
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 120 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 171 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 6   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 121
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 122 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 173 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++    ++ EYM NG L  ++                ++ L +     +A++YL +   
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL-------REMRHRFQTQQLLEMCKDVCEAMEYLES--- 129
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFL 501
           K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T    S   +  +P    PE  +
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLM 185
Query: 502 VGRATIETDIYAFGVLILEV-ACGRKP 527
             + + ++DI+AFGVL+ E+ + G+ P
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 123/230 (53%), Gaps = 15/230 (6%)
Query: 30  NFQSFTEQNRNELSF-DNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNKNV 87
           +F S++ +N  E++F  ++T    A+Q+T  D  G P+ + +G+A Y +   LW D+   
Sbjct: 10  DFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLW-DSTGK 68
Query: 88  KATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG-TNQSQIVA 146
            A+F T+F   + N  A   +GLAF +A   D      G +LG+    T    +++Q+VA
Sbjct: 69  AASFYTSFTFLLKNYGAPTADGLAFFLA-PVDSSVKDYGGFLGLFRHETAADPSKNQVVA 127
Query: 147 IEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN--I 201
           +EFDT     +D ND    H+G+DVNS+ S+        +    +     + YD ++  +
Sbjct: 128 VEFDTW--INKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYDARSKIL 185
Query: 202 TVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           TV ++  +    +LS  +DL++ LP+KV +GFSA  G D ++  + SW F
Sbjct: 186 TVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGYD-EVTYILSWHF 234

>pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 121/236 (51%), Gaps = 25/236 (10%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ FNF SF+E N   ++F  D + ++   IQ+T   +     N  GR +Y    ++W  
Sbjct: 3   TVSFNFNSFSEGNP-AINFQGDVTVLSNGNIQLTNLNK----VNSVGRVLYAMPVRIWSS 57
Query: 84  NKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSE---GQWLGIVNGITNGT 139
                A+F T+F   + + +   P +G+ F IA     PE+++   G   G   G+++  
Sbjct: 58  ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIA-----PEDTQIPAGSIGGGTLGVSDTK 112
Query: 140 NQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
                V +EFDT  + E  D   +HVG+DVNSV S++ VP    N  +G  +KV V YD 
Sbjct: 113 GAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---NSVSGAVVKVTVIYDS 169
Query: 199 QNITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSASTG-DDTQLNCVKSWAF 249
              T+ VA    N +   +++ +DL   LPE+V  GFSAS      Q++ ++SW+F
Sbjct: 170 STKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              ++++ EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIYIVI-EYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N     + ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EXTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PEL|A Chain A, Peanut Lectin Length = 236

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 121/236 (51%), Gaps = 25/236 (10%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ FNF SF+E N   ++F  D + ++   IQ+T   +     N  GR +Y    ++W  
Sbjct: 3   TVSFNFNSFSEGNP-AINFQGDVTVLSNGNIQLTNLNK----VNSVGRVLYAMPVRIWSS 57
Query: 84  NKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSE---GQWLGIVNGITNGT 139
                A+F T+F   + + +   P +G+ F IA     PE+++   G   G   G+++  
Sbjct: 58  ATGNVASFLTSFSFEMKDIKDYDPADGIIFFIA-----PEDTQIPAGSIGGGTLGVSDTK 112
Query: 140 NQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
                V +EFDT  + E  D   +HVG+DVNSV S++ VP    N  +G  +KV V YD 
Sbjct: 113 GAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---NSVSGAVVKVTVIYDS 169
Query: 199 QNITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSASTG-DDTQLNCVKSWAF 249
              T+ VA    N +   +++ +DL   LPE+V  GFSAS      Q++ ++SW+F
Sbjct: 170 STKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
                +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 75  -EPIXIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 124
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N     + ++ A  P  + APE+ L GR
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EXTARQGAKFPIKWTAPEAALYGR 181
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVP 205

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 9   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 67  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 124
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 125 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 175
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 176 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 4   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIG-SQY 119
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 120 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 171 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 116/242 (47%), Gaps = 19/242 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSA--IQVT-YDVRGAPITNQSGRAIYKDQFQL 80
           V ++ F+F  F E   N+L+   + +   +  +Q+T  +  G P  + +GR +Y     +
Sbjct: 1   VETISFSFSEF-EPGNNDLTLQGAAIITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHI 59
Query: 81  WRDNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG 138
           W       A+F T F  +I     +  P +GL F +   K  P    G +LG+ N  +  
Sbjct: 60  WDMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGVFNN-SKQ 117
Query: 139 TNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
            N  Q +A+EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD 
Sbjct: 118 DNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDA 174
Query: 199 QN-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFD 250
            +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F 
Sbjct: 175 SSKILLAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFH 234
Query: 251 GS 252
            S
Sbjct: 235 AS 236

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 6   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 121
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 122 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 173 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  +RH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              ++ V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIYI-VTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 325 NKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V+ G W  N ++A+K +   +    + F+ E   +  L+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E   ++ V EYM  GSL  F+       G G       K  +++   +Q    +     
Sbjct: 74  SEEPIYI-VTEYMNKGSLLDFL-----KDGEGRAL----KLPNLVDMAAQVAAGMAYIER 123
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLV 502
              +HRD++S+NI++ +    ++ DFGLAR I++N     + ++ A  P  + APE+ L 
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDN---EXTARQGAKFPIKWTAPEAALY 180
Query: 503 GRATIETDIYAFGVLILE-VACGRKP 527
           GR TI++D+++FG+L+ E V  GR P
Sbjct: 181 GRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 6   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 121
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 122 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 173 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIY-IVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ ++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  G L  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIY-IVMEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 10  APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 125
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 126 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 177 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 13  APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 70
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 71  NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG-SQY 128
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 129 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 179
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 180 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 6   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 121
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 122 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 173 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+         GE T  + +   ++  ++Q    +       
Sbjct: 82  EPIY-IVTEYMNKGSLLDFL--------KGE-TGKYLRLPQLVDMSAQIASGMAYVERMN 131
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N     + ++ A  P  + APE+ L GR
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EWTARQGAKFPIKWTAPEAALYGR 188
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGLAR ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 113/241 (46%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      S + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQP--GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +P   +GL F +   K  P    G +LGI N  +   
Sbjct: 61  DMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGIFNN-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q + +EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLGVEFDTFSNQWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAS 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKLLHAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 116/240 (48%), Gaps = 24/240 (10%)
Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           S+ F F +F     + + F  D +T A +      +  G P+   +GRA+Y D  QLW +
Sbjct: 4   SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 63
Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGIT-NGTNQS 142
                A+F T F   +      P +GLAF +A   D      G++LG+ N  T    +++
Sbjct: 64  KTESVASFYTEFTFFLKITGNGPADGLAFFLAP-PDSDVKDAGEYLGLFNKSTATQPSKN 122
Query: 143 QIVAIEFDT-------KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVR 195
           Q+VA+EFDT       + SY       H+G++VNS+ S+        ++ +G     ++ 
Sbjct: 123 QVVAVEFDTWTNPNFPEPSYR------HIGINVNSIVSVATKRWEDSDIFSGKIATARIS 176
Query: 196 YDGQNITVFVANMETP-----LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC-VKSWAF 249
           YDG +  +    +  P     +LS  +D+ + LPE V VG SASTG++  L   + SW F
Sbjct: 177 YDG-SAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF 235

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 123/232 (53%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E +   +++FI E   +  L H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV+E+M +G L  ++    T  G        E  L +     + + YL   S 
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLEEAS- 123
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 179
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 180 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 214

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  G L  F+       G     L   + + +    +  + Y+   +   
Sbjct: 85  EPIY-IVTEYMSKGCLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 134
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGLAR I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGR 191
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 327 LGKGGFGTVYKGIW-----RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G       R   +A+K  +V  T +Q +++F+ E + +G   H N++ L
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIHL 88
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    ++V EYM NGSLD F+   + N G   V     + + ++ G S  + YL 
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVI----QLVGMLRGISAGMKYL- 140
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+       + APE+
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 500 FLVGRATIETDIYAFGVLILEVAC-GRKP 527
               + T  +D++++G+++ EV   G +P
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           KLG+G FG V+ G W        +  +      + F+ E   +  LRH  LV+L     E
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              + +V EYM  GSL  F+       G     L   + + +    +  + Y+   +   
Sbjct: 252 EPIY-IVTEYMSKGSLLDFL------KGEMGKYLRLPQLVDMAAQIASGMAYVERMN--- 301
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD++++NI++      ++ DFGL R I++N    ++ ++ A  P  + APE+ L GR
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLIEDN---EYTARQGAKFPIKWTAPEAALYGR 358
Query: 505 ATIETDIYAFGVLILEVAC-GRKP 527
            TI++D+++FG+L+ E+   GR P
Sbjct: 359 FTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 113/241 (46%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      S + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQP--GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +P   +GL F +   K  P    G +LGI N  +   
Sbjct: 61  DMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGGG-YLGIFNN-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q + +EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLGVEFDTFSNQWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAS 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKILHAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 121/235 (51%), Gaps = 20/235 (8%)
Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSA-IQVT-YDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ F++  F  +  N +   ++ V  S  +Q+   D  G P  +  GRA+Y     +W  
Sbjct: 3   TVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDK 62
Query: 84  NKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
                A+F+ +F        T +  +GLAF +A     P+   G +LG+ N   +G    
Sbjct: 63  ETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQTHAG-YLGLFNENESG---D 118
Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNIT 202
           Q+VA+EFDT ++   D  + H+G++VNS+ SI+    T  +LAN    KV + YD    +
Sbjct: 119 QVVAVEFDTFRN-SWDPPNPHIGINVNSIRSIKT---TSWDLANNKVAKVLITYDAST-S 173
Query: 203 VFVANMETP------LLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAF 249
           + VA++  P      +LS+ +DL   LPE V +GFSA+TG D   + + V SW+F
Sbjct: 174 LLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSF 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 124/236 (52%), Gaps = 24/236 (10%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-T 353
           G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E T
Sbjct: 1   GSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           S +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG 117
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+
Sbjct: 118 -SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
            +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 168 LLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 124/236 (52%), Gaps = 24/236 (10%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-T 353
           G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E T
Sbjct: 1   GSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           S +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIG 117
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+
Sbjct: 118 -SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
            +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 168 LLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 113/241 (46%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      S + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +  P +GL F +   K  P    G +LGI N  +   
Sbjct: 61  DMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGIFNQ-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q + +EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLGVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAS 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKLLHAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E S   + +FI E   +  L H  LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV+E+M +G L  ++    T  G        E  L +     + + YL    E
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLE---E 141
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 199
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 200 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 124/236 (52%), Gaps = 24/236 (10%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-T 353
           G+  AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E T
Sbjct: 1   GSGEAPNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           S +  +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG 117
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             +  LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+
Sbjct: 118 -SQYLLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
            +    K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 168 LLGAEEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E +   +++FI E   +  L H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV+E+M +G L  ++    T  G        E  L +     + + YL    E
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLE---E 119
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 177
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 178 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E +   +++FI E   +  L H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV+E+M +G L  ++    T  G        E  L +     + + YL    E
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLE---E 121
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 179
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 180 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 214

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      + + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +  P +GL F +   K  P    G +LG+ N  +   
Sbjct: 61  DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGVFNN-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q +A+EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAP 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LP+ V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E +   +++FI E   +  L H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV+E+M +G L  ++    T  G        E  L +     + + YL    E
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLE---E 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 182
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 183 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 321 FNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRN 375
           F+   ++G G FG VY  + +  ++ +A+K++S + +Q     Q+ I EV  +  LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 376 LVKLIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGP-GEVTLNWEKRLSVIHGTSQ 433
            ++  G CY R H   LV EY    + D      E +  P  EV +      +V HG  Q
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIA-----AVTHGALQ 126
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L YLH+ +   ++HRD+K+ NI+L      +LGDFG A  +              GTP 
Sbjct: 127 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANXFVGTPY 176
Query: 494 YMAPESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           +MAPE  L    G+   + D+++ G+  +E+A  RKP
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP 212

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 75
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 229
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 230 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 92
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 145
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 246
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 247 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 102
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 155
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 256
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 257 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 321 FNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRN 375
           F+   ++G G FG VY  + +  ++ +A+K++S + +Q     Q+ I EV  +  LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 376 LVKLIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            ++  G CY R H   LV EY    + D      E +  P    L   +  +V HG  Q 
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLL----EVHKKP----LQEVEIAAVTHGALQG 166
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L YLH+ +   ++HRD+K+ NI+L      +LGDFG A  +              GTP +
Sbjct: 167 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANXFVGTPYW 216
Query: 495 MAPESFLV---GRATIETDIYAFGVLILEVACGRKP 527
           MAPE  L    G+   + D+++ G+  +E+A  RKP
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP 251

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 113/241 (46%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      + + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +  P +GL F +   K  P    G +LGI N  +   
Sbjct: 61  DMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGIFNN-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q + +EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLGVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAS 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKILHAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     L  G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 10  APNQALLRILKET--EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 125
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 126 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 177 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 121/239 (50%), Gaps = 23/239 (9%)
Query: 27  LHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           L F   +F   N  +L F  + S  +   +Q+T    G P     GRA+Y    ++W + 
Sbjct: 4   LSFTINNFVP-NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNT 62
Query: 85  KNVKATFSTTFVLNILNQTAQP---GEGLAFVIAG-NKDLPENSEGQWLGIVNGITNGTN 140
               A+FST+F   +  +   P    +GLAF +A  +  +P  S  ++LG+ N   +  +
Sbjct: 63  TGSVASFSTSFTFVV--KAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS-DS 119
Query: 141 QSQIVAIEFDT--KKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
            +QIVA+EFDT    SY+  D N  H+G+DVN + SI+ V   + +  NG      + Y 
Sbjct: 120 SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV---QWDWINGGVAFATITYL 176
Query: 198 GQNIT-----VFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC--VKSWAF 249
             N T     V+ +N  T  ++  +DL E LPE V VGFSA+TG  T++    V SW+F
Sbjct: 177 APNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 34/274 (12%)
Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            +LG G FG V  G W+ + ++AVK + E S   + EF  E  T+  L H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            + +   +V EY+ NG L  ++     + G G   L   + L + +   + + +L +   
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL----RSHGKG---LEPSQLLEMCYDVCEGMAFLES--- 122
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
            + +HRD+ + N ++D +   ++ DFG+ R + ++   + S+        + APE F   
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYF 180
Query: 504 RATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNS-IVHWLWELRRKGRILDAADSRL 561
           + + ++D++AFG+L+ EV + G+ P      + Y NS +V  + +  R  R   A+D+  
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP-----YDLYTNSEVVLKVSQGHRLYRPHLASDT-- 233
Query: 562 GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
                      +  +  +C H  P  RP+ + +L
Sbjct: 234 -----------IYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 138/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V EYM NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 167
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 168 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 223
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 273
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 274 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 311

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRH 373
            NF  + K+G+G F  VY+   +     +A+K+V        + + + I E+  +  L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGT 431
            N++K      E ++  +V E    G L + I  F  +    P      +  +L      
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----- 146
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL+++H+   +RV+HRDIK +N+ + +    +LGD GL R         HS   + GT
Sbjct: 147 -SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGT 199
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YM+PE         ++DI++ G L+ E+A  + P    + N         L+ L +K 
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCKKI 250
Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
              D     L  +   +E+  ++ +   C +P+P  RP +  V  V
Sbjct: 251 EQCDYPP--LPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDV 291

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 7   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIG-SQY 122
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+ +  
Sbjct: 123 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 173
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 174 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 148
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 254
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 255 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 292

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     L  G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 10  APNQALLRILKET--EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 125
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 126 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 177 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     L  G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI-WRNKEIAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLV 377
           F   +++GKG FG VYKGI    KE+   ++ +      +      E+T +       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +  G   +     ++ EY+  GS       D    GP E T       +++    + LDY
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSA-----LDLLKPGPLEETYI----ATILREILKGLDY 131
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH+   +R +HRDIK++N++L  + + +L DFG+A  + +   T        GTP +MAP
Sbjct: 132 LHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAP 185
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P          NS +H    +R    I   +
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGEPP----------NSDLH---PMRVLFLIPKNS 232
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G+ S+   E V     AC + +P  RP+ K +L+
Sbjct: 233 PPTLEGQHSKPFKEFV----EACLNKDPRFRPTAKELLK 267

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+  + E TS + 
Sbjct: 37  APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA 94
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 95  NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG-SQY 152
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +  
Sbjct: 153 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 204 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 121/235 (51%), Gaps = 18/235 (7%)
Query: 27  LHFNFQSFTEQNRNELSFDNSTVAKSAI-QVTYDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           L FNF  F    +N +   +++V+ + + QVT   +  P T   GRA+Y    Q+W    
Sbjct: 6   LSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSK--PTTTSIGRALYAAPIQIWDSIT 63
Query: 86  NVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLPENSEGQWLGIVNGITNGTNQSQI 144
              A+F+T+F   +    +   +GLAF +A  N  +P  S     G+ +  ++  + +QI
Sbjct: 64  GKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFS-SSDSKSSNQI 122
Query: 145 VAIEFDT--KKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANG--TDIKVQVRYDGQ 199
           +A+EFDT   K+Y   D +  H+G+DVNS+ SI+ V   + +  NG   D+ +  R   +
Sbjct: 123 IAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV---KWDWRNGEVADVVITYRAPTK 179
Query: 200 NITV---FVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC--VKSWAF 249
           ++TV   + ++  + +++  +DL   LPE V VGFS   G+  +     V SW F
Sbjct: 180 SLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 168
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 224
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 274
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 275 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 312

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 149
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 205
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 255
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 256 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 293

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 113/241 (46%), Gaps = 17/241 (7%)
Query: 24  VSSLHFNFQSFTEQNRNELSFDNSTVAKSAI-QVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           V ++ F+F  F   N N      + + +S + Q+T  +  G P  + +GR +Y     +W
Sbjct: 1   VETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIW 60
Query: 82  RDNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I     +  P +GL F +   K  P    G +LGI N  +   
Sbjct: 61  DMTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYG-YLGIFNN-SKQD 118
Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
           N  Q + +EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD  
Sbjct: 119 NSYQTLGVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDAS 175
Query: 200 N-----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDG 251
           +     + V+ ++     ++E +D+ + LPE V VG S +TG   D  + + V SW+F  
Sbjct: 176 SKILHAVLVYPSSGAIYTIAEIVDVKQVLPEWVDVGLSGATGAQRDAAETHDVYSWSFQA 235
Query: 252 S 252
           S
Sbjct: 236 S 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 141
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 142 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 197
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 247
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 248 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 285

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 149
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 205
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 255
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 256 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 293

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 147
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 203
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 253
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 254 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 148
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 204
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 254
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 255 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 292

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 115/217 (52%), Gaps = 22/217 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLR 372
            F     LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           + ++ +L+G C       L+ + MP G L  ++   + N G  +  LNW  +++      
Sbjct: 73  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIA------ 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +    K +H+  E    P
Sbjct: 125 EGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVP 179
Query: 493 -GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 3   APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQY 118
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+ +  
Sbjct: 119 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 169
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 170 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 146
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 147 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 202
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 252
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 253 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 290

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 122/232 (52%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQG 357
           AP +  L+ LK+    F     LG G FGTVYKG+W  +       +A+K + E TS + 
Sbjct: 10  APNQALLRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   + S+ + ++ +L+G C       L+ + MP G L  ++   + N G  + 
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG-SQY 125
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + ++YL +   +R++HRD+ + N+++ +  + ++ DFG A+ +  
Sbjct: 126 LLNWCVQIA------KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 176
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             K +H+  E    P  +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 177 EEKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 139/284 (48%), Gaps = 38/284 (13%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + YL 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKYL- 144
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI--QENLKTHHSTKEIAGTP-GYMA 496
             + K+ +HRD+ + N MLD +F  ++ DFGLAR +  +E    H+ T   A  P  +MA
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKLPVKWMA 200
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
            ES    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR       
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR------- 250
Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 251 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 288

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 115/217 (52%), Gaps = 22/217 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLR 372
            F     LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           + ++ +L+G C       L+ + MP G L  ++   + N G  +  LNW  +++      
Sbjct: 70  NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIA------ 121
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           + ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +    K +H+  E    P
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVP 176
Query: 493 -GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
             +MA ES L    T ++D++++GV + E+   G KP
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 115/211 (54%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKE--IAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V +G  +    KE  +A+K +    T RQ ++EF++E + +G   H N+++L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRL 82
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G        +++ E+M NG+LD F+  ++     G+ T+   + + ++ G +  + YL 
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLND-----GQFTVI--QLVGMLRGIASGMRYL- 134
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--YMAP 497
             +E   +HRD+ + NI+++S    ++ DFGL+R ++EN      T  + G     + AP
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 498 ESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           E+    + T  +D +++G+++ EV + G +P
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGK-QEFIAEVTTIGSLRH 373
           ++  F    KLG G + TVYKG+ +     +A+K V   S +G     I E++ +  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+V+L    +  +   LV+E+M N  L K++      + P  + LN  K         Q
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ--WQLLQ 119
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H   E ++LHRD+K  N++++     +LGDFGLAR     + T  S  E+  T  
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS--EVV-TLW 173
Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQSEQ 533
           Y AP+  +  R  +   DI++ G ++ E+  G+   PG   E+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 325 NKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            ++G G FG V+ G W NK+ +A+K + E +   +++FI E   +  L H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E+    LV E+M +G L  ++    T  G        E  L +     + + YL    E
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL---RTQRG----LFAAETLLGMCLDVCEGMAYLE---E 122
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +      + +PE F   
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 180
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           R + ++D+++FGVL+ EV      G    +N  N+ +V
Sbjct: 181 RYSSKSDVWSFGVLMWEVF---SEGKIPYENRSNSEVV 215

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 124/237 (52%), Gaps = 28/237 (11%)
Query: 27  LHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGA----PITNQS-GRAIYKDQFQLW 81
           + FN+  F +        D S + +   ++  D R A    P+ N++   A+Y     +W
Sbjct: 1   VSFNYTRFKD--------DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIW 52
Query: 82  RDNKNVKATFSTTFVLNILN-QTAQPGEGLAFVIAG-NKDLPENSEGQWLGIVNGITNGT 139
                  A+F T+F   + N Q   P +G+ F +A    ++P NS+G +LGI +   +  
Sbjct: 53  DSATGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITD---SSN 109
Query: 140 NQSQIVAIEFDTKKSY--EQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
           +Q+Q VA+EFD+  +    + +  +H+G+DVNS+ S++ V   RV+   G+  K  + YD
Sbjct: 110 SQNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNWNRVS---GSLEKATIIYD 166
Query: 198 GQN--ITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGD-DTQLNCVKSWAF 249
                +TV +   N +   +S+ IDL   LPEKV VGFSA+T + + + + + SW+F
Sbjct: 167 SDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSF 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     ++  +++AVK +    +Q ++    EV  +   +H N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  ++ E++  G+L   +          +V LN E+  +V     QAL YLH    
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV---------SQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    I +++      K + GTP +MAPE     
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KXLVGTPYWMAPEVISRS 216
Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               E DI++ G++++E+  G  P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G   E 
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 387 HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              L +V EYM  GSL  ++         G   L  +  L       +A++YL   +   
Sbjct: 87  KGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 137
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N+++  +  A++ DFGL        K   ST++    P  + APE+    +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKK 190
Query: 505 ATIETDIYAFGVLILEV-ACGRKP 527
            + ++D+++FG+L+ E+ + GR P
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G   E 
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 387 HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              L +V EYM  GSL  ++         G   L  +  L       +A++YL   +   
Sbjct: 72  KGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 122
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N+++  +  A++ DFGL        K   ST++    P  + APE+    +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKK 175
Query: 505 ATIETDIYAFGVLILEV-ACGRKP 527
            + ++D+++FG+L+ E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 115/211 (54%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKE--IAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V +G  +    KE  +A+K +    T RQ ++EF++E + +G   H N+++L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRL 80
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G        +++ E+M NG+LD F+  ++     G+ T+   + + ++ G +  + YL 
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLND-----GQFTVI--QLVGMLRGIASGMRYL- 132
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--YMAP 497
             +E   +HRD+ + NI+++S    ++ DFGL+R ++EN      T  + G     + AP
Sbjct: 133 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 498 ESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           E+    + T  +D +++G+++ EV + G +P
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 208
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 314
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 315 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 352

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 149
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITV--YLLQGRR--------- 255
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 256 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 293

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G   E 
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 387 HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              L +V EYM  GSL  ++         G   L  +  L       +A++YL   +   
Sbjct: 259 KGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 309
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N+++  +  A++ DFGL        K   ST++    P  + APE+    +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREKK 362
Query: 505 ATIETDIYAFGVLILEV-ACGRKP 527
            + ++D+++FG+L+ E+ + GR P
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 138/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V E M NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 147
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 148 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITV--YLLQGRR--------- 253
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 254 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 291

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 150
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 256
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 257 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 154
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 155 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 260
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 261 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 298

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 39  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV-TLNW 421
            E   I  L H+N+V+ IG   +     ++ E M  G L  F+   ET   P +  +L  
Sbjct: 97  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 154
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 155 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 210
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 211 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 149
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 150 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 255
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 256 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 293

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 25  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-VTLNW 421
            E   I  L H+N+V+ IG   +     ++ E M  G L  F+   ET   P +  +L  
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 140
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 141 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 196
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 197 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 23/225 (10%)
Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    +   +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I       
Sbjct: 120 ---AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
               E+ GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 171 SKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G C       L+V  YM +G L  FI  +ET++   +  + +  +++      + + +L 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVA------KGMKFL- 150
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA E
Sbjct: 151 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           S    + T ++D+++FGVL+ E+     P    + N+++ ++  +L + RR         
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-PYPDVNTFDITV--YLLQGRR--------- 256
Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
             L  E+    +  V+   L C HP   +RPS   ++  +S 
Sbjct: 257 -LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISA 294

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 138/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 75
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V E M NGSLD F+   +             + + ++ G +
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 229
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 230 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G   E 
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 387 HDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
              L +V EYM  GSL  ++         G   L  +  L       +A++YL   +   
Sbjct: 78  KGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 128
Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGR 504
            +HRD+ + N+++  +  A++ DFGL        K   ST++    P  + APE+     
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEALREAA 181
Query: 505 ATIETDIYAFGVLILEV-ACGRKP 527
            + ++D+++FG+L+ E+ + GR P
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 138/290 (47%), Gaps = 42/290 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLR 372
           N +    +G G FG V  G  +    KEI+V     +V  T +Q +++F+ E + +G   
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFD 104
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    ++V E M NGSLD F+   +             + + ++ G +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-------FTVIQLVGMLRGIA 157
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL   S+   +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T+      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
            + +PE+    + T  +D++++G+++ EV + G +P                 WE+  + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQD 258
Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            ++ A D    G      M+C   +  L L C   + + RP  + ++ +L
Sbjct: 259 -VIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 327 LGKGGFGTVYKGIWRNK------EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTV+KG+W  +       + +K + + S RQ  Q     +  IGSL H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G C       LV +Y+P GSL   +       GP ++ LNW  ++      ++ + YL 
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP-QLLLNWGVQI------AKGMYYL- 149
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E  ++HR++ + N++L S    ++ DFG+A  +  + K    ++  A TP  +MA E
Sbjct: 150 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIKWMALE 205
Query: 499 SFLVGRATIETDIYAFGVLILEV 521
           S   G+ T ++D++++GV + E+
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 327 LGKGGFGTVYKGIWRNK------EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FGTV+KG+W  +       + +K + + S RQ  Q     +  IGSL H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +G C       LV +Y+P GSL   +       GP ++ LNW  ++      ++ + YL 
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGP-QLLLNWGVQI------AKGMYYL- 131
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E  ++HR++ + N++L S    ++ DFG+A  +  + K    ++  A TP  +MA E
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIKWMALE 187
Query: 499 SFLVGRATIETDIYAFGVLILEV 521
           S   G+ T ++D++++GV + E+
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 115/230 (50%), Gaps = 21/230 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG+G FG+V +G  + ++     +AVK  ++  +S++  +EF++E   +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 380 IGWCYERHDF-----LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +G C E         +++  +M  G L  ++ Y    +GP  + L  +  L  +   +  
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIALG 159
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-G 493
           ++YL N   +  LHRD+ + N ML  +    + DFGL++ I      ++    IA  P  
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG--DYYRQGRIAKMPVK 214
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH 542
           ++A ES      T ++D++AFGV + E+A  G  P    + +   + ++H
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G  +    +EI V     +   T +Q +++F++E + +G   H N++ L
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIHL 95
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ EYM NGSLD F+     N G   V     + + ++ G    + YL 
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI----QLVGMLRGIGSGMKYL- 147
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFG++R ++++ +  ++T+       + APE+
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D++++G+++ EV + G +P
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     ++  K++AVK++    +Q ++    EV  +    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +   N          E+  +V     +AL YLHN   
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNE---------EQIATVCLSVLRALSYLHN--- 159
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L S+   +L DFG    + + +      K + GTP +MAPE     
Sbjct: 160 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKXLVGTPYWMAPEVISRL 216
Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               E DI++ G++++E+  G  P
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 23/225 (10%)
Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    +   +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I    ++ 
Sbjct: 120 ---AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK 172
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            ST  + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 173 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 16  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 73
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 74  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 131
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 132 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 187
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 188 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G  +    +EI V     +   T +Q +++F++E + +G   H N++ L
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIHL 80
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ EYM NGSLD F+     N G   V     + + ++ G    + YL 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI----QLVGMLRGIGSGMKYL- 132
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFG++R ++++ +  ++T+       + APE+
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D++++G+++ EV + G +P
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 24  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 139
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 140 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 195
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 196 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 24  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAM 139
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 140 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 195
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 196 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 39  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSLAM 154
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 155 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 210
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 211 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 41  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 98
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-VTLNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P +  +L  
Sbjct: 99  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 156
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 157 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 212
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 213 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 39  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFL 96
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 154
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 155 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 210
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 211 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 31  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 88
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 89  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 146
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 147 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 202
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 203 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G  +    +EI V     +   T +Q +++F++E + +G   H N++ L
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIHL 74
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G   +    +++ EYM NGSLD F+     N G   V     + + ++ G    + YL 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFL---RKNDGRFTVI----QLVGMLRGIGSGMKYL- 126
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             S+   +HRD+ + NI+++S    ++ DFG++R ++++ +  ++T+       + APE+
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D++++G+++ EV + G +P
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI-WRNKEIAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLV 377
           F    ++GKG FG V+KGI  R +++   ++ +      +      E+T +       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D   +GP     +  +  +++    + LDY
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSA-----LDLLRAGP----FDEFQIATMLKEILKGLDY 135
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L  + + +L DFG+A  + +   T        GTP +MAP
Sbjct: 136 LH--SEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 189
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P          NS +H    +R    I    
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPP----------NSDMH---PMRVLFLIPKNN 236
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G+F++   E +     AC + +P  RP+ K +L+
Sbjct: 237 PPTLVGDFTKSFKEFI----DACLNKDPSFRPTAKELLK 271

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 25  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 140
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 141 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 196
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 197 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 51  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 108
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-VTLNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P +  +L  
Sbjct: 109 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 166
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 167 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 222
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 223 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    +   +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I       
Sbjct: 120 ---AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 171 SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 311 LKELKKATGNFNPKNK------LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK K      +G+G  GTVY    +   +E+A+++++   +  K+  I
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 66
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +   ET    G++     
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA---- 120
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
              +V     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I       
Sbjct: 121 ---AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 171
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 172 SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLV 377
           ++ +G+G FG V K   +      + A+KR+ E  S+   ++F  E+  +  L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYD---ETN-----SGPGEVTLNWEKRLSVIH 429
            L+G C  R    L  EY P+G+L  F+      ET+     +     TL+ ++ L    
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++ +DYL   S+K+ +HRD+ + NI++   + A++ DFGL+R  +  +K     K + 
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMG 191
Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWEL 547
             P  +MA ES      T  +D++++GVL+ E V+ G  P        Y       L+E 
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELYEK 243
Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             +G  L            EK + C   V  L   C    P+ RPS   +L  L+
Sbjct: 244 LPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 286

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 28/219 (12%)
Query: 327 LGKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVK 378
           +G+G FG V++    G+   +    +AVK + E +    Q +F  E   +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETN----------------SGPGEVTLNWE 422
           L+G C       L++EYM  G L++F+     +                S PG   L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           ++L +    +  + YL   SE++ +HRD+ + N ++      ++ DFGL+R I  +   +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY-SADYY 230
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
            +    A    +M PES    R T E+D++A+GV++ E+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLV 377
           ++ +G+G FG V K   +      + A+KR+ E  S+   ++F  E+  +  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYD---ETN-----SGPGEVTLNWEKRLSVIH 429
            L+G C  R    L  EY P+G+L  F+      ET+     +     TL+ ++ L    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++ +DYL   S+K+ +HRD+ + NI++   + A++ DFGL+R  +  +K     K + 
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMG 201
Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWEL 547
             P  +MA ES      T  +D++++GVL+ E V+ G  P        Y       L+E 
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELYEK 253
Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             +G  L            EK + C   V  L   C    P+ RPS   +L  L+
Sbjct: 254 LPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 65  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 180
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 181 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 236
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
              ++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 237 -AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            TG++    K+ +   G +   +W  KE+    ++E     KQ  ++EV  +  L+H N+
Sbjct: 15  GTGSYGRCQKIRRKSDGKIL--VW--KELDYGSMTEAE---KQMLVSEVNLLRELKHPNI 67
Query: 377 VKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           V+      +R +    +V EY   G L   I    T        L+ E  L V+   + A
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVI----TKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 435 LDYLHNGSE--KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           L   H  S+    VLHRD+K +N+ LD + N +LGDFGLAR +  +       KE  GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---EDFAKEFVGTP 180
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            YM+PE         ++DI++ G L+ E+ C   P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSE-TSRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 42  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 99
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 100 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 157
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+AR I   
Sbjct: 158 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 213
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
              ++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 214 -AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL-------QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 510 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 564
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 602

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFL-------QVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 181
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 219

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+   +        +L+    +   +  S AL YL +
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLES 157
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 158 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 212
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 213 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 250

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-------QVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 130 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 184
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+   +        +L+    +   +  S AL YL +
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK-------FSLDLASLILYAYQLSTALAYLES 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++     S  ++     +MAPES 
Sbjct: 130 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK--WMAPESI 184
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+   +        +L+    +   +  S AL YL +
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLES 131
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 132 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 186
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 187 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 104/190 (54%), Gaps = 14/190 (7%)
Query: 341 RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN 398
           R+  +A+K  +   T RQ +++F++E + +G   H N+++L G        ++V EYM N
Sbjct: 76  RDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML 458
           GSLD F+      +  G+ T+   + + ++ G    + YL   S+   +HRD+ + N+++
Sbjct: 135 GSLDTFL-----RTHDGQFTIM--QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLV 184
Query: 459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLI 518
           DS    ++ DFGL+R ++++    ++T        + APE+      +  +D+++FGV++
Sbjct: 185 DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 519 LEV-ACGRKP 527
            EV A G +P
Sbjct: 245 WEVLAYGERP 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+   +        +L+    +   +  S AL YL +
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLES 132
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 133 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 187
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 188 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 225

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 115/237 (48%), Gaps = 28/237 (11%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKN------KLGKGGFGTVYKGIWRN--KEIAVKRVSE 352
           G++++ ++FR   L+      +P++      K+G+G  G V     R+  K +AVK++  
Sbjct: 1   GSHMSHEQFR-AALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL 59
Query: 353 TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS 412
             +Q ++    EV  +   +H N+V++        +  +V E++  G+L   + +   N 
Sbjct: 60  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 119
Query: 413 GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA 472
                    E+  +V     QAL  LH    + V+HRDIKS +I+L  +   +L DFG  
Sbjct: 120 ---------EQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 167
Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI--ETDIYAFGVLILEVACGRKP 527
             + + +      K + GTP +MAPE  L+ R     E DI++ G++++E+  G  P
Sbjct: 168 AQVSKEVPRR---KXLVGTPYWMAPE--LISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-------QVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 130 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 184
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+   +        +L+    +   +  S AL YL +
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLES 134
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 135 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 189
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 227

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D    GP    L+  +  +++    + LDY
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGP----LDETQIATILREILKGLDY 139
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L      +L DFG+A  + +   T        GTP +MAP
Sbjct: 140 LH--SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 193
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P ++             L  ++    I    
Sbjct: 194 EVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------------LHPMKVLFLIPKNN 240
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 241 PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 275

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 117/232 (50%), Gaps = 24/232 (10%)
Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW----RNKEI--AVKRVSE-TSRQG 357
           AP +  L+ LK+          LG G FGTVYKGIW     N +I  A+K + E TS + 
Sbjct: 5   APNQALLRILKET--ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA 62
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV 417
            +E + E   +  +    + +L+G C       LV + MP G L   +  +    G  ++
Sbjct: 63  NKEILDEAYVMAGVGSPYVSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDL 121
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            LNW  +++      + + YL +    R++HRD+ + N+++ S  + ++ DFGLAR +  
Sbjct: 122 -LNWCMQIA------KGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKP 527
           +   +H+       P  +MA ES L  R T ++D++++GV + E+   G KP
Sbjct: 172 DETEYHADG--GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----EVTLNWEKRLS---VIH 429
            L+G C      L++ EY   G L  F+        PG       + N E++LS   ++H
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL---RRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
            +SQ    +   + K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  K  A
Sbjct: 171 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKGNA 228
Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             P  +MAPES      T+++D++++G+L+ E+
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 112/209 (53%), Gaps = 19/209 (9%)
Query: 327 LGKGGFGTVYKGIW-----RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +G G FG V  G       R+  +A+K  +V  T +Q +++F+ E + +G   H N+V L
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPNVVHL 109
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G        ++V E+M NG+LD F+         G+ T+   + + ++ G +  + YL 
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVI--QLVGMLRGIAAGMRYL- 161
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             ++   +HRD+ + NI+++S    ++ DFGL+R I+++ +  ++T        + APE+
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + T  +D++++G+++ EV + G +P
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 326 KLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  GTVY    +   +E+A+++++   +  K+  I E+  +   ++ N+V  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V EY+  GSL   +   ET    G++        +V     QAL++LH+   
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIA-------AVCRECLQALEFLHSN-- 136
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
            +V+HR+IKS NI+L  + + +L DFG    I    ++  ST  + GTP +MAPE     
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST--MVGTPYWMAPEVVTRK 192
Query: 504 RATIETDIYAFGVLILEVACGRKP 527
               + DI++ G++ +E+  G  P
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     R+  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +   N          E+  +V     QAL  LH    
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNE---------EQIAAVCLAVLQALSVLH---A 143
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 144 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPE--LIS 198
Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK-------EIAVKRVSET-SRQGKQEFI 362
           LKE+ +   N      LG G FG VY+G            ++AVK + E  S Q + +F+
Sbjct: 25  LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT-LNW 421
            E   I    H+N+V+ IG   +     ++ E M  G L  F+   ET   P + + L  
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQPSSLAM 140
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQEN 478
              L V    +    YL    E   +HRDI + N +L        A++GDFG+A+ I   
Sbjct: 141 LDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR- 196
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             +++     A  P  +M PE+F+ G  T +TD ++FGVL+ E+
Sbjct: 197 -ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     R+  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +           +N E+  +V     QAL  LH    
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTR---------MNEEQIAAVCLAVLQALSVLH---A 145
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 146 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPE--LIS 200
Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     R+  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +           +N E+  +V     QAL  LH    
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQG- 267
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPE--LIS 320
Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-------QVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ +    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 130 ---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 184
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 324 KNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           + KLG G FG V+   + ++ ++AVK +   S    + F+AE   + +L+H  LVKL   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA- 244
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
              +    ++ E+M  GSL  F+  DE +  P            +I  ++Q  + +    
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP---------KLIDFSAQIAEGMAFIE 295
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
           ++  +HRD++++NI++ +    ++ DFGLAR               A  P  + APE+  
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLARV-------------GAKFPIKWTAPEAIN 342
Query: 502 VGRATIETDIYAFGVLILEVAC-GRKP 527
            G  TI++D+++FG+L++E+   GR P
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     R+  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +   N          E+  +V     QAL  LH    
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNE---------EQIAAVCLAVLQALSVLH---A 134
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPE--LIS 189
Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D    GP    L+  +  +++    + LDY
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGP----LDETQIATILREILKGLDY 134
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L      +L DFG+A  + +   T        GTP +MAP
Sbjct: 135 LH--SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAP 188
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P ++             L  ++    I    
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------------LHPMKVLFLIPKNN 235
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 236 PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 112/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
            E+ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -ELCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E +   ++ E    G L  F+          + +L+    +   +  S AL YL +
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL-------QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              KR +HRDI + N+++ +    +LGDFGL+R ++++  T++   +      +MAPES 
Sbjct: 510 ---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPESI 564
Query: 501 LVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV 541
              R T  +D++ FGV + E+   G KP     Q   NN ++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVI 602

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           K+G+G  G V     R+  K +AVK++    +Q ++    EV  +   +H N+V++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
               +  +V E++  G+L   + +           +N E+  +V     QAL  LH    
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLH---A 188
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + V+HRDIKS +I+L  +   +L DFG    + + +      K + GTP +MAPE  L+ 
Sbjct: 189 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMAPE--LIS 243
Query: 504 RATI--ETDIYAFGVLILEVACGRKP 527
           R     E DI++ G++++E+  G  P
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 103/190 (54%), Gaps = 14/190 (7%)
Query: 341 RNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN 398
           R+  +A+K  +   T RQ +++F++E + +G   H N+++L G        ++V EYM N
Sbjct: 76  RDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML 458
           GSLD F+      +  G+ T+   + + ++ G    + YL   S+   +HRD+ + N+++
Sbjct: 135 GSLDTFL-----RTHDGQFTIM--QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLV 184
Query: 459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLI 518
           DS    ++ DFGL+R ++++     +T        + APE+      +  +D+++FGV++
Sbjct: 185 DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 519 LEV-ACGRKP 527
            EV A G +P
Sbjct: 245 WEVLAYGERP 254

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D    GP    L+  +  +++    + LDY
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGP----LDETQIATILREILKGLDY 119
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L      +L DFG+A  + +   T        GTP +MAP
Sbjct: 120 LH--SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAP 173
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P ++             L  ++    I    
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------------LHPMKVLFLIPKNN 220
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 221 PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 255

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIF------YDETNSGPGEVTLNWEKRLSVIHGT 431
            L+G C      L++ EY   G L  F+        D+ +  P E+         ++H +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR-------DLLHFS 158
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           SQ    +   + K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  K  A  
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKGNARL 216
Query: 492 P-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           P  +MAPES      T+++D++++G+L+ E+
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 321 FNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLV 377
           F    K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           K  G   +     ++ EY+  GS       D    GP    L+  +  +++    + LDY
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSA-----LDLLEPGP----LDETQIATILREILKGLDY 119
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH  SEK++ HRDIK++N++L      +L DFG+A  + +   T        GTP +MAP
Sbjct: 120 LH--SEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAP 173
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E         + DI++ G+  +E+A G  P ++             L  ++    I    
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------------LHPMKVLFLIPKNN 220
Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 221 PPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 255

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 324 KNKLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLV 377
           ++ +G+G FG V K   +      + A+KR+ E  S+   ++F  E+  +  L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYD---ETN-----SGPGEVTLNWEKRLSVIH 429
            L+G C  R    L  EY P+G+L  F+      ET+     +     TL+ ++ L    
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             ++ +DYL   S+K+ +HR++ + NI++   + A++ DFGL+R  +  +K     K + 
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMG 198
Query: 490 GTP-GYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWEL 547
             P  +MA ES      T  +D++++GVL+ E V+ G  P        Y       L+E 
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELYEK 250
Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             +G  L            EK + C   V  L   C    P+ RPS   +L  L+
Sbjct: 251 LPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 293

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 115 GLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIF------YDETNSGPGEVTLNWEKRLSVIHGT 431
            L+G C      L++ EY   G L  F+        D+ +  P E+         ++H +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR-------DLLHFS 166
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           SQ    +   + K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  K  A  
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKGNARL 224
Query: 492 P-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           P  +MAPES      T+++D++++G+L+ E+
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 118/231 (51%), Gaps = 28/231 (12%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVY------KGIWRNKEIAVKRVS-ET 353
            T + P  F  + LK+          LG+G FG V       +G    +++AVK +  E+
Sbjct: 10  ATEVDPTHFEKRFLKRI-------RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVYEYMPNGSLDKFIFYDETN 411
                 +   E+  + +L H N+VK  G C E   +   L+ E++P+GSL +++  ++  
Sbjct: 63  GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 412 SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL 471
                  +N +++L       + +DYL  GS + V HRD+ + N++++SE   ++GDFGL
Sbjct: 123 -------INLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGL 172
Query: 472 ARTIQENLKTHHSTKEIAGTPGY-MAPESFLVGRATIETDIYAFGVLILEV 521
            + I+ + K   + K+   +P +  APE  +  +  I +D+++FGV + E+
Sbjct: 173 TKAIETD-KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 112/210 (53%), Gaps = 19/210 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKEI--AVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G G FG V  G  +    +EI  A+K + S  + + +++F++E + +G   H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   +    +++ E+M NGSLD F+     N G   V     + + ++ G +  + YL  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVI----QLVGMLRGIAAGMKYL-- 151
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--YMAPE 498
            ++   +HRD+ + NI+++S    ++ DFGL+R ++++      T  + G     + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 499 SFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           +    + T  +D++++G+++ EV + G +P
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 168
Query: 494 YMAPESFLVGRATIET--DIYAFGVLILEVACGRK--PGN 529
           Y APE  L+G     T  DI++ G +  E+   R   PG+
Sbjct: 169 YRAPE-ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 115
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 169
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 8   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 118
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 119 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 172
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 11  NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 121
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 122 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 175
Query: 494 YMAPESFLVGR-ATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L  +  +   DI++ G +  E+   R   PG+
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 11  NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 121
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 122 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 175
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 326 KLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNLV 377
           KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L G         +V E  P GSL      D      G   L    R +V    ++ + Y
Sbjct: 79  RLYG-VVLTPPMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMGY 130
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L +   KR +HRD+ + N++L +    ++GDFGL R + +N   H+  +E    P  + A
Sbjct: 131 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCA 186
Query: 497 PESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           PES      +  +D + FGV + E+   G++P
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
            ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H+  +E    P  + 
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWC 181
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 84  IRLYGVVLTP-PMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 135
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H+  +E    P  + 
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWC 191
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 112
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 113 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T     ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 T-----DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 215

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 116
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 117 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 168
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T     ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 169 T-----DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 219

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 142/303 (46%), Gaps = 63/303 (20%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------EVTLNWEKR 424
           ++ L+G C +     ++ EY   G+L +++   +    PG           E  L+ +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I      HH 
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI------HHI 203
Query: 485 TKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNN 538
                 T G     +MAPE+      T ++D+++FGVL+ E+   G  P        Y  
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPG 255
Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVL 595
             V  L++L ++G  +D            K   C   + ++   C H  P  RP+ K ++
Sbjct: 256 VPVEELFKLLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 303
Query: 596 QVL 598
           + L
Sbjct: 304 EDL 306

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 110/205 (53%), Gaps = 21/205 (10%)
Query: 327 LGKGGFGTVY------KGIWRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG+G FG V       +G    +++AVK +  E+      +   E+  + +L H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 380 IGWCYER--HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G C E   +   L+ E++P+GSL +++  ++         +N +++L       + +DY
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-------INLKQQLKYAVQICKGMDY 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-MA 496
           L  GS + V HRD+ + N++++SE   ++GDFGL + I+ + K   + K+   +P +  A
Sbjct: 130 L--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEXXTVKDDRDSPVFWYA 185
Query: 497 PESFLVGRATIETDIYAFGVLILEV 521
           PE  +  +  I +D+++FGV + E+
Sbjct: 186 PECLMQSKFYIASDVWSFGVTLHEL 210

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 78  IRLYGVVLTP-PMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 129
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H+  +E    P  + 
Sbjct: 130 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWC 185
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H+  +E    P  + 
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWC 181
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L+G C      L++ EY   G L  F+             L  +   ++ + T+   D 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR-------VLETDPAFAIANSTASTRDL 166
Query: 438 LHNGSE----------KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           LH  S+          K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  K 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKG 224
Query: 488 IAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
            A  P  +MAPES      T+++D++++G+L+ E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 111
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 112 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 163
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T     ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 164 T-----DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            TG++    K+ +   G +   +W  KE+    ++E     KQ  ++EV  +  L+H N+
Sbjct: 15  GTGSYGRCQKIRRKSDGKIL--VW--KELDYGSMTEAE---KQMLVSEVNLLRELKHPNI 67
Query: 377 VKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           V+      +R +    +V EY   G L   I    T        L+ E  L V+   + A
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVI----TKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 435 LDYLHNGSE--KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           L   H  S+    VLHRD+K +N+ LD + N +LGDFGLAR +  +       K   GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTP 180
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            YM+PE         ++DI++ G L+ E+ C   P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G     L K   +DE  +             
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA------------ 116
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 117 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 169
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 170 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 219

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LGKG FG   K   R   + + +K +     + ++ F+ EV  +  L H N++K IG  Y
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK 444
           +      + EY+  G+L   I   ++          W +R+S     +  + YLH+ +  
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ-------YPWSQRVSFAKDIASGMAYLHSMN-- 128
Query: 445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE---------NLKTHHSTKE--IAGTPG 493
            ++HRD+ S N ++    N  + DFGLAR + +         +LK     K   + G P 
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 494 YMAPESFLVGRATIE-TDIYAFGVLILEV 521
           +MAPE  + GR+  E  D+++FG+++ E+
Sbjct: 188 WMAPE-MINGRSYDEKVDVFSFGIVLCEI 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            TG++    K+ +   G +   +W  KE+    ++E     KQ  ++EV  +  L+H N+
Sbjct: 15  GTGSYGRCQKIRRKSDGKIL--VW--KELDYGSMTEAE---KQMLVSEVNLLRELKHPNI 67
Query: 377 VKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           V+      +R +    +V EY   G L   I    T        L+ E  L V+   + A
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVI----TKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 435 LDYLHNGSE--KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           L   H  S+    VLHRD+K +N+ LD + N +LGDFGLAR +  +       K   GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFVGTP 180
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            YM+PE         ++DI++ G L+ E+ C   P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LG+G FG VY+G++ N +     +AVK    + +   K++F++E   + +L H ++VKLI
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E   ++++ E  P G L  ++          E   N  K L+++  + Q    +  
Sbjct: 92  GIIEEEPTWIIM-ELYPYGELGHYL----------ERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
                 +HRDI   NI++ S    +LGDFGL+R I++      S   +     +M+PES 
Sbjct: 141 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WMSPESI 198
Query: 501 LVGRATIETDIYAFGVLILEV-ACGRKP 527
              R T  +D++ F V + E+ + G++P
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYD----ETNSGPGEVTLNWEKRLSVIHGTSQ 433
            L+G C      L++ EY   G L  F+       ET+            R  ++H +SQ
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR-DLLHFSSQ 172
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP- 492
               +   + K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  K  A  P 
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIVKGNARLPV 230
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEV 521
            +MAPES      T+++D++++G+L+ E+
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------YDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 252
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 304
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 305 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 18/233 (7%)
Query: 320 NFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHR 374
           +F   N LGKG F  VY+   I    E+A+K + + +       Q    EV     L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           ++++L  +  + +   LV E   NG +++++   +    P     +  +    +H     
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKP----FSENEARHFMHQIITG 124
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + YLH+     +LHRD+  SN++L    N ++ DFGLA  ++   + H++   + GTP Y
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNY 178
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           ++PE        +E+D+++ G +   +  GR P +     +  N +V   +E+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 137
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 138 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 190
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 191 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 240

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LG+G FG VY+G++ N +     +AVK    + +   K++F++E   + +L H ++VKLI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E   ++++ E  P G L  ++          E   N  K L+++  + Q    +  
Sbjct: 80  GIIEEEPTWIIM-ELYPYGELGHYL----------ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
                 +HRDI   NI++ S    +LGDFGL+R I++      S   +     +M+PES 
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WMSPESI 186
Query: 501 LVGRATIETDIYAFGVLILEV-ACGRKP 527
              R T  +D++ F V + E+ + G++P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 327 LGKGGFGTVYKGIWRNKE-----IAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LG+G FG VY+G++ N +     +AVK    + +   K++F++E   + +L H ++VKLI
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   E   ++++ E  P G L  ++          E   N  K L+++  + Q    +  
Sbjct: 76  GIIEEEPTWIIM-ELYPYGELGHYL----------ERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
                 +HRDI   NI++ S    +LGDFGL+R I++     +    +   P  +M+PES
Sbjct: 125 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE---DYYKASVTRLPIKWMSPES 181
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               R T  +D++ F V + E+ + G++P
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      R+ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 34/233 (14%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRV--SETSRQG-KQEFIAEVTTIGSL 371
           A  +F     LGKG FG VY    + ++  +A+K +  ++  + G + +   EV     L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRLSV 427
           RH N+++L G+ ++     L+ EY P G+    L K   +DE  +             + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------TY 110
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T      
Sbjct: 111 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----T 162
Query: 488 IAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 163 LCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 114
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 115 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 166
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 167 T-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 116
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 117 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 168
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 169 T-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 219

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 112
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 113 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR 164
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      ++GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 T-----TLSGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 215

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI--------FYDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 203
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 255
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 256 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------YDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 200
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 252
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 253 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------YDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 211
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 264 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 110
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 111 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 163
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 164 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 213

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI--------FYDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 204
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 256
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 257 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 125
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H   +E    P  + 
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWC 181
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 128
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 129 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 181
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 182 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 231

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------YDETNSGPGEVTLNWEKRLSV 427
           ++ L+G C +     ++ EY   G+L +++         Y    S   E  L+ +  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
            +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTN 211
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWE 546
                 +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L++
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELFK 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 264 LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -XLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 115
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 116 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 168
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 169 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 218

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T    
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 325 NKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNL 376
            KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G         +V E  P GSL      D      G   L    R +V    ++ + 
Sbjct: 84  IRLYGVVLT-PPMKMVTELAPLGSL-----LDRLRKHQGHFLLGTLSRYAV--QVAEGMG 135
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL +   KR +HRD+ + N++L +    ++GDFGL R + +N   H   +E    P  + 
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWC 191
Query: 496 APESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           APES      +  +D + FGV + E+   G++P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 114
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 115 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 166
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 167 T-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 116
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 170
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 142/298 (47%), Gaps = 53/298 (17%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------EVTLNWEKR 424
           ++ L+G C +     ++ EY   G+L +++   +    PG           E  L+ +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKK 208
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHW 543
           T        +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 260
Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           L++L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 261 LFKLLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 116
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 170
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           ++LGKG FG+V    Y  +  N    +AVK++  +    +++F  E+  + +L    +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G  Y   R    LV EY+P+G L  F+             L+  + L       + ++
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-------LDASRLLLYSSQICKGME 129
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     +R +HRD+ + NI+++SE + ++ DFGLA+ +  + K ++  +E   +P +  
Sbjct: 130 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWY 185
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES      + ++D+++FGV++ E+
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           ++LGKG FG+V    Y  +  N    +AVK++  +    +++F  E+  + +L    +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G  Y   R    LV EY+P+G L  F+             L+  + L       + ++
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-------LDASRLLLYSSQICKGME 128
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     +R +HRD+ + NI+++SE + ++ DFGLA+ +  + K ++  +E   +P +  
Sbjct: 129 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWY 184
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES      + ++D+++FGV++ E+
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  + +T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKNTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 115
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 169
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 141/295 (47%), Gaps = 47/295 (15%)
Query: 327 LGKGGFGTVYK----GIWRNK-----EIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      G+ ++K     ++AVK + S+ + +   + I+E+  +  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------EVTLNWEKR 424
           ++ L+G C +     ++ EY   G+L +++   +    PG           E  L+ +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I  ++  +  
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKK 193
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHW 543
           T        +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 245
Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           L++L ++G  +D   S    E          ++   C H  P  RP+ K +++ L
Sbjct: 246 LFKLLKEGHRMDKP-SNCTNEL--------YMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 53/297 (17%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 116
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 117 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 168
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 169 T-----TLCGTLDYLPPEX-IEGRXHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 219
Query: 540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
                       RI     SR+   F +   E    L       NP  RP ++ VL+
Sbjct: 220 Y----------KRI-----SRVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 8   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 118
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 119 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 172
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQGKQEFIAEVTTIGSL 371
           G++   + LG G FG V  G  +    ++AVK     ++      GK +   E+  +   
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLF 68
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL        DF +V EY+  G L  +I         G V     +RL      
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRL--FQQI 120
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             A+DY H      V+HRD+K  N++LD+  NA++ DFGL+  + +        ++  G+
Sbjct: 121 LSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRDSCGS 173
Query: 492 PGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           P Y APE  + GR  A  E DI++ GV++  + CG  P
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 116
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 170
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 115
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 169
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+ ++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+ ++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 115
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 169
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           ++LGKG FG+V    Y  +  N    +AVK++  +    +++F  E+  + +L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G  Y   R    LV EY+P+G L  F+             L+  + L       + ++
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-------LDASRLLLYSSQICKGME 141
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     +R +HRD+ + NI+++SE + ++ DFGLA+ +  + K ++  +E   +P +  
Sbjct: 142 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWY 197
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES      + ++D+++FGV++ E+
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQGKQEFIAEVTTIGSLR 372
           +  G +  K +LG GGFG V + I ++  +++A+K+   E S + ++ +  E+  +  L 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 373 HRNLV----------KLIGWCYERHDF-LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
           H N+V          KL       +D  LL  EY   G L K++   E   G  E  +  
Sbjct: 72  HPNVVSAREVPDGLQKLAP-----NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR- 125
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFGLARTIQEN 478
               +++   S AL YLH   E R++HRD+K  NI+L         ++ D G A+ + + 
Sbjct: 126 ----TLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 178
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                   E  GT  Y+APE     + T+  D ++FG L  E   G +P
Sbjct: 179 ----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLL------Q 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 137
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 138 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---- 190
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
            ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 191 -DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 240

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQGKQEFIAEVTTIGSLR 372
           +  G +  K +LG GGFG V + I ++  +++A+K+   E S + ++ +  E+  +  L 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 373 HRNLV----------KLIGWCYERHDF-LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
           H N+V          KL       +D  LL  EY   G L K++   E   G  E  +  
Sbjct: 71  HPNVVSAREVPDGLQKLAP-----NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR- 124
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFGLARTIQEN 478
               +++   S AL YLH   E R++HRD+K  NI+L         ++ D G A+ + + 
Sbjct: 125 ----TLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                   E  GT  Y+APE     + T+  D ++FG L  E   G +P
Sbjct: 178 ----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGS-- 370
           K+    ++PK+ +G+G    V + + R    E AVK +  T+ +   E + EV       
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 371 ---LR----HRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
              LR    H +++ LI   YE   F+ LV++ M  G L  F +  E      +V L+ +
Sbjct: 150 THILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGEL--FDYLTE------KVALSEK 200
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           +  S++    +A+ +LH  +   ++HRD+K  NI+LD     RL DFG +  ++   K  
Sbjct: 201 ETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-- 255
Query: 483 HSTKEIAGTPGYMAPESFLVGRATI------ETDIYAFGVLILEVACGRKP 527
              +E+ GTPGY+APE               E D++A GV++  +  G  P
Sbjct: 256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 110/233 (47%), Gaps = 34/233 (14%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRV--SETSRQG-KQEFIAEVTTIGSL 371
           A  +F     LGKG FG VY    +N +  +A+K +  ++  + G + +   EV     L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRLSV 427
           RH N+++L G+ ++     L+ EY P G+    L K   +DE  +             + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------TY 113
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           I   + AL Y H+   K+V+HRDIK  N++L S    ++ DFG +     + +       
Sbjct: 114 ITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA-----A 165
Query: 488 IAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y ++
Sbjct: 166 LCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQDT 214

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++   S+D   F D   S    + L   K  S +    Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDA--SALTGIPLPLIK--SYLFQLLQ 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 24/217 (11%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V +    G+ +     ++AVK +  T+   ++E  ++E+  +  L +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE-----TNSGPGEVTLNWEKR-------L 425
            L+G C      L++ EY   G L  F+          +  PG+     +K         
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            ++H +SQ    +   + K  +HRD+ + N++L +   A++GDFGLAR I  +  +++  
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND--SNYIV 216
Query: 486 KEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           K  A  P  +MAPES      T+++D++++G+L+ E+
Sbjct: 217 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 5   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLL------Q 115
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 116 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 169
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 6   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++   S+D   F D   S    + L   K  S +    Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDA--SALTGIPLPLIK--SYLFQLLQ 116
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 117 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 170
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQG---KQEFIAEVTTIGSLRHR 374
           +F+    LGKG FG VY    R  +  +A+K + +T  +    + +   EV     LRH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           N+++L G+ ++     L+ EY P G+    L K   +DE  +             + I  
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA------------TYITE 120
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +T      + G
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT-----TLCG 172
Query: 491 TPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKP 527
           T  Y+ PE  + GR   E  D+++ GVL  E   G  P
Sbjct: 173 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 114
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 115 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD---- 167
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
            ++ GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 168 -DLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 41/222 (18%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAE--VTTIGSLRHRNLVKLIGWCY 384
           +G+G +G VYKG    + +AVK  S  +RQ    FI E  +  +  + H N+ + I    
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 385 E-----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
                 R ++LLV EY PNGSL K++            T +W     + H  ++ L YLH
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLH---------TSDWVSSCRLAHSVTRGLAYLH 128
Query: 440 ------NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA------RTIQENLKTHHSTKE 487
                 +  +  + HRD+ S N+++ ++    + DFGL+      R ++   + + +  E
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 488 IAGTPGYMAPESFLVGRATI--------ETDIYAFGVLILEV 521
           + GT  YMAPE  L G   +        + D+YA G++  E+
Sbjct: 189 V-GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 327 LGKGGFGTVYKGIWR---NKEI--AVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G G FG V  G  +    +EI  A+K + S  + + +++F++E + +G   H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G   +    +++ E+M NGSLD F+     N G   V     + + ++ G +  + YL  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL---RQNDGQFTVI----QLVGMLRGIAAGMKYL-- 125
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--YMAPE 498
            ++   +HR + + NI+++S    ++ DFGL+R ++++      T  + G     + APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 499 SFLVGRATIETDIYAFGVLILEV-ACGRKP 527
           +    + T  +D++++G+++ EV + G +P
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQGKQEFIAEVTTIGSL 371
           G++   + LG G FG V  G  +    ++AVK     ++      GK +   E+  +   
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLF 68
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL        DF +V EY+  G L  +I         G V     +RL      
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRL--FQQI 120
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ--ENLKTHHSTKEIA 489
             A+DY H      V+HRD+K  N++LD+  NA++ DFGL+  +   E L+T        
Sbjct: 121 LSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS------C 171
Query: 490 GTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           G+P Y APE  + GR  A  E DI++ GV++  + CG  P
Sbjct: 172 GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 139/296 (46%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+     T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDXXKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIG 381
           LG+GGFG V+    +   K  A K++++   +   G Q  + E   +  +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               + D  LV   M  G +   I+  DE N G  E           I  T+Q +  L +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--------RAIFYTAQIVSGLEH 304
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++ +++RD+K  N++LD + N R+ D GLA  ++        TK  AGTPG+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELL 361
Query: 501 LVGRATIETDIYAFGVLILEVACGRKP 527
           L        D +A GV + E+   R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 3   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L  F+        P  +  ++  +L       Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLL------Q 113
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+  T E+  T  
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVV-TLW 167
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIG 381
           LG+GGFG V+    +   K  A K++++   +   G Q  + E   +  +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               + D  LV   M  G +   I+  DE N G  E           I  T+Q +  L +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--------RAIFYTAQIVSGLEH 304
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++ +++RD+K  N++LD + N R+ D GLA  ++        TK  AGTPG+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELL 361
Query: 501 LVGRATIETDIYAFGVLILEVACGRKP 527
           L        D +A GV + E+   R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L KF+        P  +  ++  +L       Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLL------Q 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFLVGR-ATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L  +  +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIG 381
           LG+GGFG V+    +   K  A K++++   +   G Q  + E   +  +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               + D  LV   M  G +   I+  DE N G  E           I  T+Q +  L +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--------RAIFYTAQIVSGLEH 304
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++ +++RD+K  N++LD + N R+ D GLA  ++        TK  AGTPG+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELL 361
Query: 501 LVGRATIETDIYAFGVLILEVACGRKP 527
           L        D +A GV + E+   R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 138/305 (45%), Gaps = 40/305 (13%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW-------RNKEIAVKRVSETSRQG-K 358
           K+ +LKE+  +   F    +LG+  FG VYKG         + + +A+K + + +    +
Sbjct: 16  KQAKLKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
           +EF  E      L+H N+V L+G   +     +++ Y  +G L +F+     +S  G   
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 419 LNWEKRLSV-----IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
            +   + ++     +H  +Q    +   S   V+H+D+ + N+++  + N ++ D GL R
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 474 TIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
            +      ++     +  P  +MAPE+ + G+ +I++DI+++GV++ EV      G Q  
Sbjct: 194 EVYA--ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---GLQPY 248
Query: 533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRP 589
               N  +V    E+ R  ++L   D            +C   V  L + C +  P  RP
Sbjct: 249 CGYSNQDVV----EMIRNRQVLPCPD------------DCPAWVYALMIECWNEFPSRRP 292
Query: 590 SMKTV 594
             K +
Sbjct: 293 RFKDI 297

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
            ++G+G FG V+ G  R  N  +AVK   ET     K +F+ E   +    H N+V+LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C ++    +V E +  G    F+  +          L  +  L ++   +  ++YL + 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR-------LRVKTLLQMVGDAAAGMEYLES- 231
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
             K  +HRD+ + N ++  +   ++ DFG++R  +E    + ++  +   P  + APE+ 
Sbjct: 232 --KCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 501 LVGRATIETDIYAFGVLILE 520
             GR + E+D+++FG+L+ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G     L K   +DE  +             
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA------------ 116
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 117 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX---- 169
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 170 -XLXGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 219

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIG 381
           LG+GGFG V+    +   K  A K++++   +   G Q  + E   +  +  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               + D  LV   M  G +   I+  DE N G  E           I  T+Q +  L +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--------RAIFYTAQIVSGLEH 304
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++ +++RD+K  N++LD + N R+ D GLA  ++        TK  AGTPG+MAPE  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELL 361
Query: 501 LVGRATIETDIYAFGVLILEVACGRKP 527
           L        D +A GV + E+   R P
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 114
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 115 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA---- 167
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 168 -ALCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -ALCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AVK + +T       Q+   EV  +  L H 
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++           V   W K         Q 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL-----------VAHGWMKEKEARAKFRQI 115
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           +  +    +K ++HRD+K+ N++LD++ N ++ DFG +   T    L T        G+P
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGSP 169
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 113
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 114 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX---- 166
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 167 -XLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 216

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 153
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 154 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 209
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 261
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 262 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 150
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 151 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 206
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 258
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 259 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 113
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ +FG +     + +
Sbjct: 114 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR 165
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 166 T-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 216

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 148
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 149 CTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 204
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 256
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 257 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 114
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 115 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 166
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
                  + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 167 X-----XLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI----------FYDETNSGPGEVTLNWEKRL 425
           ++ L+G C +     ++ EY   G+L +++           YD  N  P E  + ++  +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD-INRVPEE-QMTFKDLV 160
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           S  +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+     T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDXXKKT 216
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWL 544
                   +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEEL 268
Query: 545 WELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           ++L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 269 FKLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 327 LGKGGFGTVYKGIWRNK-----EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +GKG FG VY G + ++     + A+K +S  T  Q  + F+ E   +  L H N++ LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 381 GWCYERHDF-LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           G          ++  YM +G L +FI   + N    ++       +S     ++ ++YL 
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-------ISFGLQVARGMEYL- 140
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
             +E++ +HRD+ + N MLD  F  ++ DFGLAR I +           A  P  + A E
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 499 SFLVGRATIETDIYAFGVLILEV 521
           S    R T ++D+++FGVL+ E+
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWEL 221

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 114
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ +FG +     + +
Sbjct: 115 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR 166
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
           T      + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 167 T-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 217

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIG 369
           A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRL 425
            LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +             
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------ 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
           + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +     
Sbjct: 112 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX---- 164
Query: 486 KEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
             + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 -XLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 214

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 140/296 (47%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++ EY   G+L +++         +  + N  P E  + ++  +S
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 207
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 263
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 315
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 316 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAE 364
           K+ + A  +F     LGKG FG VY  + R K+    +A+K +  ++  + G + +   E
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLN 420
           V     LRH N+++L G+ ++     L+ EY P G+    L K   +DE  +        
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------- 112
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                + I   + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +
Sbjct: 113 -----TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
                  + GT  Y+ PE  + GR   E  D+++ GVL  E   G+ P    E N+Y  +
Sbjct: 165 D-----TLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQET 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 109/230 (47%), Gaps = 27/230 (11%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQG-KQEFIAEVTTIGSLR 372
           +F     LGKG FG VY  + R K+    +A+K +  S+  ++G + +   E+     L 
Sbjct: 24  DFEIGRPLGKGKFGNVY--LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L  + Y+R    L+ EY P G L     Y E        T + ++  +++   +
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGEL-----YKELQKS---CTFDEQRTATIMEELA 133
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            AL Y H    K+V+HRDIK  N++L  +   ++ DFG +     +L+     K + GT 
Sbjct: 134 DALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLR----RKTMCGTL 185
Query: 493 GYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
            Y+ PE  + GR   E  D++  GVL  E+  G  P   +  N     IV
Sbjct: 186 DYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIV 234

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           GN+     LG+G FG V              K I  K ++++  QG+ E   E++ +  L
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 70
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL      + + ++V EY  N   D  +  D+ +    E    +++ +S     
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIIS----- 123
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +     +  K   G+
Sbjct: 124 --AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSCGS 174
Query: 492 PGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           P Y APE  + G+  A  E D+++ GV++  + C R P
Sbjct: 175 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGS 370
            GN+     LG+G FG V              K I  K ++++  QG+ E   E++ +  
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRL 64
Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           LRH +++KL      + + ++V EY  N   D  +  D+ +    E    +++ +S    
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIIS---- 118
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
              A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +     +  K   G
Sbjct: 119 ---AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSCG 168
Query: 491 TPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           +P Y APE  + G+  A  E D+++ GV++  + C R P
Sbjct: 169 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 7   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L  F+        P  +  ++  +L       Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLL------Q 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 118 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 171
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           GN+     LG+G FG V              K I  K ++++  QG+ E   E++ +  L
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 71
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL      + + ++V EY  N   D  +  D+ +    E    +++ +S     
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIIS----- 124
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHHSTKEIA 489
             A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +   LKT        
Sbjct: 125 --AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS------C 173
Query: 490 GTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           G+P Y APE  + G+  A  E D+++ GV++  + C R P
Sbjct: 174 GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRH 373
           NF    K+G+G +G VYK   RNK     +A+K++  +T  +G     I E++ +  L H
Sbjct: 4   NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL+   +  +   LV+E++ +  L  F+        P  +  ++  +L       Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLL------Q 114
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L + H+    RVLHRD+K  N+++++E   +L DFGLAR     ++T+    E+  T  
Sbjct: 115 GLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTY--XHEVV-TLW 168
Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGN 529
           Y APE  L     +   DI++ G +  E+   R   PG+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           GN+     LG+G FG V              K I  K ++++  QG+ E   E++ +  L
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 61
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL      + + ++V EY  N   D  +  D+ +    E    +++ +S     
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ--EARRFFQQIIS----- 114
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +     +  K   G+
Sbjct: 115 --AVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----NFLKTSCGS 165
Query: 492 PGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           P Y APE  + G+  A  E D+++ GV++  + C R P
Sbjct: 166 PNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
            ++G+G FG V+ G  R  N  +AVK   ET     K +F+ E   +    H N+V+LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C ++    +V E +  G    F+  +          L  +  L ++   +  ++YL + 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR-------LRVKTLLQMVGDAAAGMEYLES- 231
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
             K  +HRD+ + N ++  +   ++ DFG++R  +E      ++  +   P  + APE+ 
Sbjct: 232 --KCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 501 LVGRATIETDIYAFGVLILE 520
             GR + E+D+++FG+L+ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGI-WRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   Y+      KE+   +V   S       K++   E+    SL + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E  DF+ +V E     SL +     +  + P       E R   +  T Q + YLHN
Sbjct: 110 F-FEDDDFVYVVLEICRRRSLLELHKRRKAVTEP-------EARY-FMRQTIQGVQYLHN 160
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ + + ++GDFGLA  I+ +       K++ GTP Y+APE  
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD---GERKKDLCGTPNYIAPEVL 214
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E DI++ G ++  +  G+ P   S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 325 NKLGKGGFGTV----YKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           ++LGKG FG+V    Y  +  N    +AVK++  +    +++F  E+  + +L    +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 379 LIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             G  Y   R +  LV EY+P+G L  F+             L+  + L       + ++
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-------LDASRLLLYSSQICKGME 125
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY-M 495
           YL     +R +HRD+ + NI+++SE + ++ DFGLA+ +  + K     +E   +P +  
Sbjct: 126 YL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDXXVVREPGQSPIFWY 181
Query: 496 APESFLVGRATIETDIYAFGVLILEV 521
           APES      + ++D+++FGV++ E+
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGI-WRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   Y+      KE+   +V   S       K++   E+    SL + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E  DF+ +V E     SL +     +  + P       E R   +  T Q + YLHN
Sbjct: 94  F-FEDDDFVYVVLEICRRRSLLELHKRRKAVTEP-------EARY-FMRQTIQGVQYLHN 144
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ + + ++GDFGLA  I+ +       K++ GTP Y+APE  
Sbjct: 145 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD---GERKKDLCGTPNYIAPEVL 198
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E DI++ G ++  +  G+ P   S
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   +E+A+K + +T       Q+   EV  +  L H 
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           L+ EY   G +  ++             +  ++  S       A
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--------AHGRMKEKEARSKFRQIVSA 123
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           + Y H   +KR++HRD+K+ N++LD++ N ++ DFG +   T+   L T        G+P
Sbjct: 124 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT------FCGSP 174
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 175 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQG---KQEFIAEVTTIGSLRHR 374
           +F+    LGKG FG VY    R  +  +A+K + +T  +    + +   EV     LRH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGS----LDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           N+++L G+ ++     L+ EY P G+    L K   +DE  +             + I  
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA------------TYITE 120
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            + AL Y H+   KRV+HRDIK  N++L S    ++ DFG +     + +       + G
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR-----DTLCG 172
Query: 491 TPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKP 527
           T  Y+ PE  + GR   E  D+++ GVL  E   G  P
Sbjct: 173 TLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 139/296 (46%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++  Y   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 325 NKLGKGGFG--TVYKGIWRNKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
            K+G+G FG   + K     ++  +K +  S  S + ++E   EV  + +++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               E     +V +Y   G L K I   +      +  L+W  ++ +      AL ++H+
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL------ALKHVHD 143
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              +++LHRDIKS NI L  +   +LGDFG+AR +   ++     +   GTP Y++PE  
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEIC 197
Query: 501 LVGRATIETDIYAFGVLILEVA 522
                  ++DI+A G ++ E+ 
Sbjct: 198 ENKPYNNKSDIWALGCVLYELC 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 306 PKKFRLKELKKATGNFNPKNK-LGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGK 358
           P++ R KE+         ++K LG G FGTV KG ++         + + +        K
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            E +AE   +  L +  +V++IG C E   ++LV E    G L+K++   + N    +  
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 128
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           +     + ++H  S  + YL    E   +HRD+ + N++L ++  A++ DFGL++ ++ +
Sbjct: 129 I-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 180
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              + +         + APE     + + ++D+++FGVL+ E  + G+KP
Sbjct: 181 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 306 PKKFRLKELKKATGNFNPKNK-LGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGK 358
           P++ R KE+         ++K LG G FGTV KG ++         + + +        K
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            E +AE   +  L +  +V++IG C E   ++LV E    G L+K++   + N    +  
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 128
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           +     + ++H  S  + YL    E   +HRD+ + N++L ++  A++ DFGL++ ++ +
Sbjct: 129 I-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 180
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              + +         + APE     + + ++D+++FGVL+ E  + G+KP
Sbjct: 181 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)
Query: 328 GKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIGWCYER 386
            +G FG V+K    N+ +AVK      +Q  Q E+  EV ++  ++H N+++ IG   E+
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIG--AEK 88
Query: 387 H------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH- 439
                  D  L+  +   GSL  F+  +          ++W +   +    ++ L YLH 
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKAN---------VVSWNELCHIAETMARGLAYLHE 139
Query: 440 ------NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
                 +G +  + HRDIKS N++L +   A + DFGLA   +   K+   T    GT  
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG-KSAGDTHGQVGTRR 198
Query: 494 YMAPESF-----LVGRATIETDIYAFGVLILEVA 522
           YMAPE           A +  D+YA G+++ E+A
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 136/302 (45%), Gaps = 40/302 (13%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIW-------RNKEIAVKRVSETSRQG-KQEF 361
           +LKE+  +   F    +LG+  FG VYKG         + + +A+K + + +    ++EF
Sbjct: 2   KLKEISLSAVRF--MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
             E      L+H N+V L+G   +     +++ Y  +G L +F+     +S  G    + 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 422 EKRLSV-----IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
             + ++     +H  +Q    +   S   V+H+D+ + N+++  + N ++ D GL R + 
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 477 ENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
                ++     +  P  +MAPE+ + G+ +I++DI+++GV++ EV      G Q     
Sbjct: 180 A--ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF---SYGLQPYCGY 234
Query: 536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMK 592
            N  +V    E+ R  ++L   D            +C   V  L + C +  P  RP  K
Sbjct: 235 SNQDVV----EMIRNRQVLPCPD------------DCPAWVYALMIECWNEFPSRRPRFK 278
Query: 593 TV 594
            +
Sbjct: 279 DI 280

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 122/244 (50%), Gaps = 37/244 (15%)
Query: 324 KNKLGKGGFGTVYKG-IWRNKEI-AVKRVSETSRQGK-------QEFIAEVTTIGSLRHR 374
           + ++GKGGFG V+KG + ++K + A+K +     +G+       QEF  EV  + +L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL G  +      +V E++P G L   +  D+ +       + W  +L ++   +  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHP------IKWSVKLRLMLDIALG 134
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFGLARTIQENLKTHHSTKEIA 489
           ++Y+ N +   ++HRD++S NI L S        A++ DFGL++      ++ HS   + 
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 490 GTPGYMAPESFLVGRA--TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           G   +MAPE+        T + D Y+F +++  +  G  P ++     Y+   + ++  +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-----YSYGKIKFINMI 242
Query: 548 RRKG 551
           R +G
Sbjct: 243 REEG 246

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 306 PKKFRLKELKKATGNFNPKNK-LGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGK 358
           P++ R KE+         ++K LG G FGTV KG ++         + + +        K
Sbjct: 11  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 70
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            E +AE   +  L +  +V++IG C E   ++LV E    G L+K++   + N    +  
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 126
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           +     + ++H  S  + YL    E   +HRD+ + N++L ++  A++ DFGL++ ++ +
Sbjct: 127 I-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 178
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              + +         + APE     + + ++D+++FGVL+ E  + G+KP
Sbjct: 179 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGI-WRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   Y+      KE+   +V   S       K++   E+    SL + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E  DF+ +V E     SL +     +  + P       E R   +  T Q + YLHN
Sbjct: 110 F-FEDDDFVYVVLEICRRRSLLELHKRRKAVTEP-------EARY-FMRQTIQGVQYLHN 160
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ + + ++GDFGLA  I+ +       K + GTP Y+APE  
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD---GERKKTLCGTPNYIAPEVL 214
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E DI++ G ++  +  G+ P   S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYKGI-WRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   Y+      KE+   +V   S       K++   E+    SL + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E  DF+ +V E     SL +     +  + P       E R   +  T Q + YLHN
Sbjct: 110 F-FEDDDFVYVVLEICRRRSLLELHKRRKAVTEP-------EARY-FMRQTIQGVQYLHN 160
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ + + ++GDFGLA  I+ +       K + GTP Y+APE  
Sbjct: 161 N---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD---GERKKXLCGTPNYIAPEVL 214
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E DI++ G ++  +  G+ P   S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 139/296 (46%), Gaps = 49/296 (16%)
Query: 327 LGKGGFGTVYK----GIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRN 375
           LG+G FG V      GI ++K      +AVK + +  + +   + ++E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI---------FYDETNSGPGEVTLNWEKRLS 426
           ++ L+G C +     ++  Y   G+L +++         +  + N  P E  + ++  +S
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE-QMTFKDLVS 161
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
             +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I  N+  +  T 
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTT 217
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLW 545
                  +MAPE+      T ++D+++FGVL+ E+   G  P        Y    V  L+
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           +L ++G  +D            K   C   + ++   C H  P  RP+ K +++ L
Sbjct: 270 KLLKEGHRMD------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +LG G FG+V +G++R +    ++A+K + + T +   +E + E   +  L +  +V+LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G C +    +LV E    G L KF+           V         ++H  S  + YL  
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-------ELLHQVSMGMKYLE- 127
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
             EK  +HRD+ + N++L +   A++ DFGL++ +  +  ++++ +     P  + APE 
Sbjct: 128 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 184
Query: 500 FLVGRATIETDIYAFGVLILE-VACGRKP 527
               + +  +D++++GV + E ++ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++         + + +        K E +AE   +  L +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++   + N    +  +     + ++H  S  + YL 
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNI-----IELVHQVSMGMKYL- 127
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE 
Sbjct: 128 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + + ++D+++FGVL+ E  + G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LGKG +G VY G  +     IA+K + E   +  Q    E+     L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGP---GEVTLNWEKRLSVIHGTSQALDYLHNG 441
           E     +  E +P GSL   +    +  GP    E T+ +  +  ++ G    L YLH+ 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTK-QILEG----LKYLHD- 140
Query: 442 SEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              +++HRDIK  N+++++     ++ DFG ++ +      +  T+   GT  YMAPE  
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEII 195
Query: 501 LVGRATI--ETDIYAFGVLILEVACGRKP 527
             G        DI++ G  I+E+A G+ P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AV+ + +T       Q+   EV  +  L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +          +   E  G+P Y
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPPY 178
Query: 495 MAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            APE F   +    E D+++ GV++  +  G  P
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++         + + +        K E +AE   +  L +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++   + N    +  +     + ++H  S  + YL 
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNI-----IELVHQVSMGMKYL- 123
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE 
Sbjct: 124 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + + ++D+++FGVL+ E  + G+KP
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++         + + +        K E +AE   +  L +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++   + N    +  +     + ++H  S  + YL 
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNI-----IELVHQVSMGMKYL- 121
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE 
Sbjct: 122 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + + ++D+++FGVL+ E  + G+KP
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AVK + +T       Q+   EV  +  L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +   T    L T        G+P
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGSP 176
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 114/235 (48%), Gaps = 20/235 (8%)
Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKSA--IQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           S  F+F +F   N+N L      +  SA  +++T    GAP+ +  GRA+Y     +  D
Sbjct: 3   STSFSFTNF-NPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHI-HD 60
Query: 84  NKNVKATFSTTFVLNILNQTAQPG-EGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
           N  + A+F+T+F   +    A    +GLAF +A     P+ + G +LG+     +  +  
Sbjct: 61  NTTL-ASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRAHDASY- 117
Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNIT 202
           Q VA+EFDT  S   D N  H+G+D N + S +  P    ++  G    + + Y      
Sbjct: 118 QTVAVEFDTY-SNAWDPNYTHIGIDTNGIESKKTTPF---DMVYGEKANIVITYQASTKA 173
Query: 203 -----VFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
                VF  +  +  +S  +DL + LPE V VGFSA+TG +    + + + SW+F
Sbjct: 174 LAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSF 228

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AVK + +T       Q+   EV  +  L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +   T    L T        G+P
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGSP 176
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++         + + +        K E +AE   +  L +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++   + N    +  +     + ++H  S  + YL 
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNI-----IELVHQVSMGMKYL- 127
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE 
Sbjct: 128 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + + ++D+++FGVL+ E  + G+KP
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHR 374
           GN+  +  +GKG F  V   + +   +E+AVK + +T       Q+   EV  +  L H 
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 126
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           + Y H   +K ++HRD+K+ N++LD + N ++ DFG +   T+   L T        G+P
Sbjct: 127 VQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT------FCGSP 177
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LGKG +G VY G  +     IA+K + E   +  Q    E+     L+H+N+V+ +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGP---GEVTLNWEKRLSVIHGTSQALDYLHNG 441
           E     +  E +P GSL   +    +  GP    E T+ +  +  ++ G    L YLH+ 
Sbjct: 76  ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTK-QILEG----LKYLHD- 126
Query: 442 SEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              +++HRDIK  N+++++     ++ DFG ++ +      +  T+   GT  YMAPE  
Sbjct: 127 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEII 181
Query: 501 LVGRATI--ETDIYAFGVLILEVACGRKP 527
             G        DI++ G  I+E+A G+ P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSI 540
              K I GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N + 
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 541 VHW 543
           V +
Sbjct: 233 VSY 235

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVKRVSETSRQG------KQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++ K++      +  +        K E +AE   +  L +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++   + N    +  +     + ++H  S  + YL 
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNI-----IELVHQVSMGMKYL- 133
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE 
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 500 FLVGRATIETDIYAFGVLILEV-ACGRKP 527
               + + ++D+++FGVL+ E  + G+KP
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 65  ITNQSGRAIYKDQFQLW-RDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLP 121
           + N  GRA+Y     +W R+  NV A F T  TFV+N  N +    +G  F IA     P
Sbjct: 37  VKNTVGRALYSSPIHIWDRETGNV-ANFVTSFTFVINAPN-SYNVADGFTFFIAPVDTKP 94
Query: 122 ENSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           + + G +LG+ N        +Q VA+EFDT    +++    D H+G+DVNS   I+ V  
Sbjct: 95  Q-TGGGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNS---IKSVNT 149
Query: 180 TRVNLANGTDIKVQVRYDGQNITVFVANMETP-----------LLSEPIDLSEYLPEKVF 228
               L NG +  V + ++     V   ++  P            LS+ + L + +PE V 
Sbjct: 150 KSWKLQNGEEANVVIAFNAAT-NVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVR 208
Query: 229 VGFSASTGDDTQLNCVKSWAF 249
           +GFSA+TG +   + V SW+F
Sbjct: 209 IGFSATTGAEYAAHEVLSWSF 229

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   +E+A+K + +T       Q+   EV  +  L H 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           L+ EY   G +  ++             +  ++  S       A
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--------AHGRMKEKEARSKFRQIVSA 126
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + Y H   +KR++HRD+K+ N++LD++ N ++ DFG +       K         G P Y
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD----AFCGAPPY 179
Query: 495 MAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            APE F   +    E D+++ GV++  +  G  P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LGKG FG V       KE A  R        K+  +A+     +L    +++       R
Sbjct: 16  LGKGTFGKVI----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSR 66
Query: 387 HDFLLVYEYMPNGSLDKFIFYDE-TNSGPGEVTLNWEKRLSV----IHGTS--QALDYLH 439
           H FL   +Y    + D+  F  E  N G     L+ E+  S      +G     ALDYLH
Sbjct: 67  HPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE 
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEV 180
Query: 500 FL---VGRATIETDIYAFGVLILEVACGRKP 527
                 GRA    D +  GV++ E+ CGR P
Sbjct: 181 LEDNDYGRA---VDWWGLGVVMYEMMCGRLP 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LGKG FG V       KE A  R        K+  +A+     +L    +++       R
Sbjct: 156 LGKGTFGKVI----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSR 206
Query: 387 HDFLLVYEYMPNGSLDKFIFYDE-TNSGPGEVTLNWEKRLS----VIHGTS--QALDYLH 439
           H FL   +Y    + D+  F  E  N G     L+ E+  S      +G     ALDYLH
Sbjct: 207 HPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE 
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 320
Query: 500 FL---VGRATIETDIYAFGVLILEVACGRKP 527
                 GRA    D +  GV++ E+ CGR P
Sbjct: 321 LEDNDYGRA---VDWWGLGVVMYEMMCGRLP 348

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LGKG FG V       KE A  R        K+  +A+     +L    +++       R
Sbjct: 17  LGKGTFGKVI----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSR 67
Query: 387 HDFLLVYEYMPNGSLDKFIFYDE-TNSGPGEVTLNWEKRLSV----IHGTS--QALDYLH 439
           H FL   +Y    + D+  F  E  N G     L+ E+  S      +G     ALDYLH
Sbjct: 68  HPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE 
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPEV 181
Query: 500 FL---VGRATIETDIYAFGVLILEVACGRKP 527
                 GRA    D +  GV++ E+ CGR P
Sbjct: 182 LEDNDYGRA---VDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LGKG FG V       KE A  R        K+  +A+     +L    +++       R
Sbjct: 18  LGKGTFGKVI----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSR 68
Query: 387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEV--TLNWEKRLSV----IHGTS--QALDYL 438
           H FL   +Y    + D+  F  E  +G GE+   L+ E+  S      +G     ALDYL
Sbjct: 69  HPFLTALKYSFQ-THDRLCFVMEYANG-GELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H  SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE
Sbjct: 127 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAPE 181
Query: 499 SFL---VGRATIETDIYAFGVLILEVACGRKP 527
                  GRA    D +  GV++ E+ CGR P
Sbjct: 182 VLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 210

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSI 540
              K I GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N + 
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
Query: 541 VHW 543
           V +
Sbjct: 233 VSY 235

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LGKG FG V       KE A  R        K+  +A+     +L    +++       R
Sbjct: 159 LGKGTFGKVI----LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSR 209
Query: 387 HDFLLVYEYMPNGSLDKFIFYDE-TNSGPGEVTLNWEKRLSV----IHGTS--QALDYLH 439
           H FL   +Y    + D+  F  E  N G     L+ E+  S      +G     ALDYLH
Sbjct: 210 HPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             SEK V++RD+K  N+MLD + + ++ DFGL +   E +K   + K   GTP Y+APE 
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 323
Query: 500 FL---VGRATIETDIYAFGVLILEVACGRKP 527
                 GRA    D +  GV++ E+ CGR P
Sbjct: 324 LEDNDYGRA---VDWWGLGVVMYEMMCGRLP 351

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 42/293 (14%)
Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +G+G +G V K   RNK+    +A+K+   S+  +  K+  + E+  +  LRH NLV L+
Sbjct: 33  VGEGSYGMVMK--CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
             C ++  + LV+E++ +  LD    +   N    +V   +     +I+G      + HN
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKY--LFQIINGI--GFCHSHN 144
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
                ++HRDIK  NI++      +L DFG ART+    + +    E+A T  Y APE  
Sbjct: 145 -----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--EVA-TRWYRAPE-L 195
Query: 501 LVGRATI--ETDIYAFGVLILEVACGRK--PGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
           LVG        D++A G L+ E+  G    PG+      Y+  I+  L  L  + + L  
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLGNLIPRHQELFN 253
Query: 557 ADSRLGG----EFSEKE---------MECVLILGLACCHPNPHLRPSMKTVLQ 596
            +    G    E  E+E          E V+ L   C H +P  RP    +L 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 306 PKKFRLKELKKATGNFNPKNK-LGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGK 358
           P++ R KE+         ++K LG G FGTV KG ++         + + +        K
Sbjct: 355 PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 414
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            E +AE   +  L +  +V++IG C E   ++LV E    G L+K++   + N    +  
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 470
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           +     + ++H  S  + YL    E   +HRD+ + N++L ++  A++ DFGL++ ++ +
Sbjct: 471 I-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              + +         + APE     + + ++D+++FGVL+ E  + G+KP
Sbjct: 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSI 540
              K I GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N + 
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 541 VHW 543
           V +
Sbjct: 233 VSY 235

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 113/230 (49%), Gaps = 20/230 (8%)
Query: 306 PKKFRLKELKKATGNFNPKNK-LGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGK 358
           P++ R KE+         ++K LG G FGTV KG ++         + + +        K
Sbjct: 356 PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 415
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            E +AE   +  L +  +V++IG C E   ++LV E    G L+K++   + N    +  
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 471
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           +     + ++H  S  + YL    E   +HRD+ + N++L ++  A++ DFGL++ ++ +
Sbjct: 472 I-----IELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 523
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKP 527
              + +         + APE     + + ++D+++FGVL+ E  + G+KP
Sbjct: 524 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSI 540
              K I GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N + 
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
Query: 541 VHW 543
           V +
Sbjct: 233 VSY 235

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AV+ + +T       Q+   EV  +  L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEIAGTP 492
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +   T    L T        G+P
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT------FCGSP 176
Query: 493 GYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            Y APE F   +    E D+++ GV++  +  G  P
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              K I GTP ++APE        +E D+++ GV+   +  G  P
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 25/239 (10%)
Query: 29  FNFQSFTEQNRNELSFDNSTVAKS--AIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNK 85
           FNF  F E+N  EL+       KS   +++T   + G P+   +GRA+Y +  ++W    
Sbjct: 5   FNFDHF-EENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTT 63
Query: 86  NVKATFSTTFVLNILNQTA--QPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
              A+F T F  NI    A  +P +GL F +    + P+  +G  LG+      G N   
Sbjct: 64  GNVASFETRFSFNITQPYAYPEPADGLTFFMVP-PNSPQGEDGGNLGVFKP-PEGDNA-- 119
Query: 144 IVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN--- 200
             A+EFDT ++   D    H+G+DVNS+ S + +      L NG    V ++YD      
Sbjct: 120 -FAVEFDTFQN-TWDPQVPHIGIDVNSIVSSKTL---HFQLENGGVANVVIKYDSPTKIL 174
Query: 201 --ITVFVANMETPLLSEPIDLSEYLP--EKVFVGFSASTG---DDTQLNCVKSWAFDGS 252
             +  F +      LS  +DL +  P  E V VG SA+TG   +  + + + SW+F  S
Sbjct: 175 NVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 327 LGKGGFGTV-------YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVK 378
           LG+G FG V        KG      +AVK + E +   + ++ ++E   +  + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------------EVTLNW 421
           L G C +    LL+ EY   GSL  F+  +    GPG                 E  L  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLK 480
              +S     SQ + YL   +E +++HRD+ + NI++      ++ DFGL+R + +E+  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
              S   I     +MA ES      T ++D+++FGVL+ E+ 
Sbjct: 207 VKRSQGRIPVK--WMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 121/244 (49%), Gaps = 37/244 (15%)
Query: 324 KNKLGKGGFGTVYKG-IWRNKEI-AVKRVSETSRQGK-------QEFIAEVTTIGSLRHR 374
           + ++GKGGFG V+KG + ++K + A+K +     +G+       QEF  EV  + +L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL G  +      +V E++P G L   +  D+ +       + W  +L ++   +  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHP------IKWSVKLRLMLDIALG 134
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFGLARTIQENLKTHHSTKEIA 489
           ++Y+ N +   ++HRD++S NI L S        A++ DFG ++      ++ HS   + 
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLL 187
Query: 490 GTPGYMAPESFLVGRA--TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           G   +MAPE+        T + D Y+F +++  +  G  P ++     Y+   + ++  +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-----YSYGKIKFINMI 242
Query: 548 RRKG 551
           R +G
Sbjct: 243 REEG 246

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 29/243 (11%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVT 366
           +K    ++   +LG G F  V K      G+    +   KR S  SR+G  ++E   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  + H N++ L      R D +L+ E +  G L  F+   E+        L+ E+  S
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--------LSEEEATS 119
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTH 482
            I      ++YLH    K++ H D+K  NIML D      + +L DFGLA  I++ ++  
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSI 540
              K I GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N + 
Sbjct: 176 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
Query: 541 VHW 543
           V +
Sbjct: 233 VSY 235

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AVK + +T       Q+   EV  +  L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++             +  ++  +       A
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--------AHGRMKEKEARAKFRQIVSA 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +          +      G P Y
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPY 178
Query: 495 MAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            APE F   +    E D+++ GV++  +  G  P
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 112/223 (50%), Gaps = 32/223 (14%)
Query: 324 KNKLGKGGFGTVYKG-IWRNKEI-AVKRVSETSRQGK-------QEFIAEVTTIGSLRHR 374
           + ++GKGGFG V+KG + ++K + A+K +     +G+       QEF  EV  + +L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL G  +      +V E++P G L   +  D+ +       + W  +L ++   +  
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL-DKAHP------IKWSVKLRLMLDIALG 134
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFGLARTIQENLKTHHSTKEIA 489
           ++Y+ N +   ++HRD++S NI L S        A++ DF L++      ++ HS   + 
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 490 GTPGYMAPESFLVGRA--TIETDIYAFGVLILEVACGRKPGNQ 530
           G   +MAPE+        T + D Y+F +++  +  G  P ++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQGKQEFIAEVTTIGSL 371
           G++   + LG G FG V  G       ++AVK     ++      GK     E+  +   
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK--IRREIQNLKLF 73
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           RH +++KL        D  +V EY+  G L  +I  +      G +     +RL      
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN------GRLDEKESRRL--FQQI 125
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
              +DY H      V+HRD+K  N++LD+  NA++ DFGL+  + +        +   G+
Sbjct: 126 LSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRXSCGS 178
Query: 492 PGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           P Y APE  + GR  A  E DI++ GV++  + CG  P
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 326 KLGKGGFGTVYKGIWRNK----EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           +LG G FG+V +G++R +    ++A+K + + T +   +E + E   +  L +  +V+LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G C +    +LV E    G L KF+           V         ++H  S  + YL  
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-------ELLHQVSMGMKYL-- 452
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPES 499
             EK  +HR++ + N++L +   A++ DFGL++ +  +  ++++ +     P  + APE 
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 510
Query: 500 FLVGRATIETDIYAFGVLILE-VACGRKP 527
               + +  +D++++GV + E ++ G+KP
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 30/220 (13%)
Query: 327 LGKGGFGTVYK----GIWRNK---EIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG G FG V      GI +     ++AVK + E +   ++E  ++E+  +  L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 378 KLIGWCYERHDFLLVYEYMPNGSL--------DKF----IFYDETNSGPGEVTLN---WE 422
            L+G C       L++EY   G L        +KF    I Y+       E  LN   +E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
             L   +  ++ +++L     K  +HRD+ + N+++      ++ DFGLAR I  +  ++
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD--SN 227
Query: 483 HSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           +  +  A  P  +MAPES   G  TI++D++++G+L+ E+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 327 LGKGGFGTV-------YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVK 378
           LG+G FG V        KG      +AVK + E +   + ++ ++E   +  + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------------EVTLNW 421
           L G C +    LL+ EY   GSL  F+  +    GPG                 E  L  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLK 480
              +S     SQ + YL   +E +++HRD+ + NI++      ++ DFGL+R + +E+  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
              S   I     +MA ES      T ++D+++FGVL+ E+ 
Sbjct: 207 VKRSQGRIPVK--WMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +F     +G GGFG V+K   R   K   ++RV   + + ++E    V  +  L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 378 KLIGWCYERHDF--------LLVYEYMPNGSLD------KFIFYDETNSGPGEVTLNWEK 423
              G C++  D+        L   +Y P  S +      K +F        G +    EK
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 424 R----------LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
           R          L +    ++ +DY+H+   K+++HRD+K SNI L      ++GDFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
           +++ + K   S     GT  YM+PE         E D+YA G+++ E+
Sbjct: 185 SLKNDGKRTRS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 37/221 (16%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +F     +G GGFG V+K   R   K   +KRV   + + ++E    V  +  L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 378 KLIGWCYERHDF-----------------LLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
              G C++  D+                  +  E+   G+L+++I   E   G     L+
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGE---KLD 120
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
               L +    ++ +DY+H+   K++++RD+K SNI L      ++GDFGL  +++ + K
Sbjct: 121 KVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
              S     GT  YM+PE         E D+YA G+++ E+
Sbjct: 178 RXRS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRV---SETSRQG-KQEFIAEVTTIGSLRHR 374
           +F+    LGKG FG VY    + NK I   +V   S+  ++G + +   E+     LRH 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHG 430
           N++++  + ++R    L+ E+ P G L K +     +DE  S             + +  
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA------------TFMEE 123
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            + AL Y H   E++V+HRDIK  N+++  +   ++ DFG +     +L+     + + G
Sbjct: 124 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLR----RRXMCG 175
Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           T  Y+ PE         + D++  GVL  E   G  P +       +  IV
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIA 363
           +K ++ ELK    +F   ++LG G  G V K   R   + + R     E     + + I 
Sbjct: 6   QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           E+  +       +V   G  Y   +  +  E+M  GSLD+ +   E    P E+    + 
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEIL--GKV 119
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            ++V+ G    L YL    + +++HRD+K SNI+++S    +L DFG++  + +++    
Sbjct: 120 SIAVLRG----LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 169
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                 GT  YMAPE       ++++DI++ G+ ++E+A GR P
Sbjct: 170 -ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRV---SETSRQG-KQEFIAEVTTIGSLRHR 374
           +F+    LGKG FG VY    + NK I   +V   S+  ++G + +   E+     LRH 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHG 430
           N++++  + ++R    L+ E+ P G L K +     +DE  S             + +  
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA------------TFMEE 122
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            + AL Y H   E++V+HRDIK  N+++  +   ++ DFG +     +L+     + + G
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLR----RRXMCG 174
Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           T  Y+ PE         + D++  GVL  E   G  P +       +  IV
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           L ELK    +F   ++LG G  G V+K   +   + + R     E     + + I E+  
Sbjct: 3   LGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
           +       +V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++V
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAV 116
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           I G    L YL    + +++HRD+K SNI+++S    +L DFG++  + + +       E
Sbjct: 117 IKG----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-----ANE 165
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             GT  YM+PE       ++++DI++ G+ ++E+A GR P
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 327 LGKGGFGTV-------YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVK 378
           LG+G FG V        KG      +AVK + E +   + ++ ++E   +  + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG-----------------EVTLNW 421
           L G C +    LL+ EY   GSL  F+  +    GPG                 E  L  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLK 480
              +S     SQ + YL   +E  ++HRD+ + NI++      ++ DFGL+R + +E+  
Sbjct: 150 GDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
              S   I     +MA ES      T ++D+++FGVL+ E+ 
Sbjct: 207 VKRSQGRIPVK--WMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIA 363
           +K ++ ELK    +F   ++LG G  G V+K   +   + + R     E     + + I 
Sbjct: 58  QKQKVGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           E+  +       +V   G  Y   +  +  E+M  GSLD+ +      +G     +  + 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKV 171
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            ++VI G    L YL    + +++HRD+K SNI+++S    +L DFG++  + +++    
Sbjct: 172 SIAVIKG----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 221
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                 GT  YM+PE       ++++DI++ G+ ++E+A GR P
Sbjct: 222 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS--ETSRQGKQEFIAEVTTIGSL 371
           K + N++ K +LGKG F  V + + +    E A K ++  + S +  Q+   E      L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSV 427
           +H N+V+L     E     LV++ +  G L + I    FY E ++               
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------------- 108
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHS 484
            H   Q L+ +       ++HR++K  N++L S+      +L DFGLA  + ++   H  
Sbjct: 109 -HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 165
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
               AGTPGY++PE       +   DI+A GV++  +  G  P    +Q+
Sbjct: 166 --GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 7/191 (3%)
Query: 341 RNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG 399
           + +++A+KR++ E  +    E + E+  +    H N+V        + +  LV + +  G
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
           S+   I +           L+     +++    + L+YLH   +   +HRD+K+ NI+L 
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 150
Query: 460 SEFNARLGDFGLARTIQE--NLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGV 516
            + + ++ DFG++  +    ++  +   K   GTP +MAPE     R    + DI++FG+
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 210
Query: 517 LILEVACGRKP 527
             +E+A G  P
Sbjct: 211 TAIELATGAAP 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 92/191 (48%), Gaps = 7/191 (3%)
Query: 341 RNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNG 399
           + +++A+KR++ E  +    E + E+  +    H N+V        + +  LV + +  G
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
           S+   I +           L+     +++    + L+YLH   +   +HRD+K+ NI+L 
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 155
Query: 460 SEFNARLGDFGLARTIQE--NLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGV 516
            + + ++ DFG++  +    ++  +   K   GTP +MAPE     R    + DI++FG+
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI 215
Query: 517 LILEVACGRKP 527
             +E+A G  P
Sbjct: 216 TAIELATGAAP 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 24/236 (10%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIG- 369
           ++K    +F     LGKG FG V+   ++  N+  A+K + +       +   E T +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEK 69
Query: 370 -----SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
                +  H  L  +      + +   V EY+  G L     Y   +    +++      
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYA 125
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +I G    L +LH+   K +++RD+K  NI+LD + + ++ DFG+ +   EN+     
Sbjct: 126 AEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAK 175
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           T E  GTP Y+APE  L  +     D ++FGVL+ E+  G+ P +  ++    +SI
Sbjct: 176 TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS--ETSRQGKQEFIAEVTTIGSL 371
           K + N++ K +LGKG F  V + + +    E A K ++  + S +  Q+   E      L
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSV 427
           +H N+V+L     E     LV++ +  G L + I    FY E ++               
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------------- 107
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHS 484
            H   Q L+ +       ++HR++K  N++L S+      +L DFGLA  + ++   H  
Sbjct: 108 -HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 164
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
               AGTPGY++PE       +   DI+A GV++  +  G  P    +Q+
Sbjct: 165 --GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 212

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS--ETSRQGKQEFIAEVTTIGSL 371
           K + N++ K +LGKG F  V + + +    E A K ++  + S +  Q+   E      L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSV 427
           +H N+V+L     E     LV++ +  G L + I    FY E ++               
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------------- 108
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHS 484
            H   Q L+ +       ++HR++K  N++L S+      +L DFGLA  + ++   H  
Sbjct: 109 -HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG- 166
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
               AGTPGY++PE       +   DI+A GV++  +  G  P    +Q+
Sbjct: 167 ---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 30/231 (12%)
Query: 308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS--ETSRQGKQEFIA 363
           +F +    K + N++ K +LGKG F  V + + +    E A K ++  + S +  Q+   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTL 419
           E      L+H N+V+L     E     LV++ +  G L + I    FY E ++       
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------ 131
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQ 476
                   I    +++ Y H+     ++HR++K  N++L S+      +L DFGLA  + 
Sbjct: 132 ------HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           ++   H      AGTPGY++PE       +   DI+A GV++  +  G  P
Sbjct: 183 DSEAWHG----FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIA 363
           +K ++ ELK    +F   ++LG G  G V+K   +   + + R     E     + + I 
Sbjct: 23  QKQKVGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           E+  +       +V   G  Y   +  +  E+M  GSLD+ +      +G     +  + 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKV 136
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            ++VI G    L YL    + +++HRD+K SNI+++S    +L DFG++  + +++    
Sbjct: 137 SIAVIKG----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 186
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                 GT  YM+PE       ++++DI++ G+ ++E+A GR P
Sbjct: 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 41/234 (17%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQG--KQEFIAEVTTIGSLR-HRNLVKLI 380
           KLGKG +G V+K I R   + +AVK++ +  +     Q    E+  +  L  H N+V L+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 381 GWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 +D    LV++YM            + ++      L    +  V++   + + YL
Sbjct: 76  NVLRADNDRDVYLVFDYMET----------DLHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--------------TIQENLKTHHS 484
           H+G    +LHRD+K SNI+L++E + ++ DFGL+R              +I EN +    
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 485 TKEI----AGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PGNQS 531
            + I      T  Y APE  L   + T   D+++ G ++ E+ CG+   PG+ +
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 319 GNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V   + I   KE+AVK + +T       Q+   EV     L H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL           LV EY   G +  ++          E    + + +S       A
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLV-AHGRXKEKEARAKFRQIVS-------A 125
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           + Y H   +K ++HRD+K+ N++LD++ N ++ DFG +          +      G P Y
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFS----NEFTFGNKLDAFCGAPPY 178
Query: 495 MAPESFLVGRAT-IETDIYAFGVLILEVACGRKP 527
            APE F   +    E D+++ GV++  +  G  P
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIA 363
           +K ++ ELK    +F   ++LG G  G V+K   +   + + R     E     + + I 
Sbjct: 15  QKQKVGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           E+  +       +V   G  Y   +  +  E+M  GSLD+ +      +G     +  + 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKV 128
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            ++VI G    L YL    + +++HRD+K SNI+++S    +L DFG++  + +++    
Sbjct: 129 SIAVIKG----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 178
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                 GT  YM+PE       ++++DI++ G+ ++E+A GR P
Sbjct: 179 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F   ++LG G  G V+K   +   + + R     E     + + I E+  +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V   G  Y   +  +  E+M  GSLD+ +      +G     +  +  ++VI G    L 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG----LT 118
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YL    + +++HRD+K SNI+++S    +L DFG++  + +++          GT  YM+
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMS 171
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE       ++++DI++ G+ ++E+A GR P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 9   QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 67  DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 118
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 119 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 173
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 105 DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 156
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 157 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 211
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 14  QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 72  DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 123
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 124 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 178
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 34  QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 92  DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 143
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 144 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 198
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 66  DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 117
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 118 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 172
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIG- 381
           +  +GKG FG V++G WR +E+AVK  S  SR+ +  F  AE+     LRH N++  I  
Sbjct: 11  QESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 382 -------WCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                  W        LV +Y  +GSL D    Y  T  G  ++ L+    L+ +H    
Sbjct: 69  DNKDNGTWT----QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH---- 120
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---- 489
            ++ +    +  + HRD+KS NI++       + D GLA  ++ +  T   T +IA    
Sbjct: 121 -MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSAT--DTIDIAPNHR 175
Query: 490 -GTPGYMAPESF--LVGRATIET----DIYAFGVLILEVA 522
            GT  YMAPE     +     E+    DIYA G++  E+A
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 42/235 (17%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           +   +F     LG+G FG V K   RN    +  A+K++  T  +     ++EV  + SL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASL 59
Query: 372 RHRNLVKLIGWCYERHDFL-------------LVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            H+ +V+      ER +F+             +  EY  NG+L   I  +  N    E  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY- 118
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
             W     +     +AL Y+H+     ++HRD+K  NI +D   N ++GDFGLA+ +  +
Sbjct: 119 --WR----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 479 LK-----------THHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEV 521
           L            +  +     GT  Y+A E     G    + D+Y+ G++  E+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 116/261 (44%), Gaps = 35/261 (13%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 63
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 64  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 114
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 115 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 168
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVH 542
              GTP Y+APE       GRA    D +  GV++ E+ CGR P  NQ  +  +   ++ 
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 225
Query: 543 WLWELRRKGRILDAADSRLGG 563
              E+R    +   A S L G
Sbjct: 226 ---EIRFPRTLSPEAKSLLAG 243

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 33/260 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 109
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW 543
              GTP Y+APE       GRA    D +  GV++ E+ CGR P    +       I+  
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-- 218
Query: 544 LWELRRKGRILDAADSRLGG 563
           + E+R    +   A S L G
Sbjct: 219 MEEIRFPRTLSPEAKSLLAG 238

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 29/253 (11%)
Query: 404 FIFYDETNSGPGEVTLNWEKRLSVIHG------TSQALDYLHNGSEKRVLHRDIKSSNIM 457
           F   +  N G     +  +++L   H        S AL+YLH   E+ +++RD+K  N++
Sbjct: 97  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVL 153
Query: 458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
           LDSE + +L D+G+ +   E L+   +T    GTP Y+APE           D +A GVL
Sbjct: 154 LDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVL 210
Query: 518 ILEVACGRKP------GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKE-- 569
           + E+  GR P       +  +QN+ +      L +  R  R +    + +   F  K+  
Sbjct: 211 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLKSFLNKDPK 270
Query: 570 --MECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSFVWPAMPPSFVESD 627
             + C+   G A    +P  R     +++         V+PP +P+        +F +S 
Sbjct: 271 ERLGCLPQTGFADIQGHPFFRNVDWDMME------QKQVVPPFKPNISGEFGLDNF-DSQ 323
Query: 628 YTHTGSQLDPFSD 640
           +T+   QL P  D
Sbjct: 324 FTNERVQLXPDDD 336

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 33/260 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 109
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW 543
              GTP Y+APE       GRA    D +  GV++ E+ CGR P    +       I+  
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-- 218
Query: 544 LWELRRKGRILDAADSRLGG 563
           + E+R    +   A S L G
Sbjct: 219 MEEIRFPRTLSPEAKSLLAG 238

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 116/261 (44%), Gaps = 35/261 (13%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 109
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVH 542
              GTP Y+APE       GRA    D +  GV++ E+ CGR P  NQ  +  +   ++ 
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 543 WLWELRRKGRILDAADSRLGG 563
              E+R    +   A S L G
Sbjct: 221 ---EIRFPRTLSPEAKSLLAG 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 320 NFNPKNKLGKGGFGTVY----KGIWRNKEIAVKRVSETSRQGKQEF-IAEVTTIGSLRHR 374
           +FN    LGKG FG V     KG      I + +     +    E  + E   +  L   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 375 NLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             +  +  C++  D L  V EY+  G L   I        P  V    E         S 
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE--------ISI 131
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L +LH   ++ +++RD+K  N+MLDSE + ++ DFG+ +   E++    +T+E  GTP 
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPD 185
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           Y+APE           D +A+GVL+ E+  G+ P +  +++    SI+
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 33/260 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 109
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW 543
              GTP Y+APE       GRA    D +  GV++ E+ CGR P    +       I+  
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-- 218
Query: 544 LWELRRKGRILDAADSRLGG 563
           + E+R    +   A S L G
Sbjct: 219 MEEIRFPRTLSPEAKSLLAG 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 33/260 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 59  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 109
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 163
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW 543
              GTP Y+APE       GRA    D +  GV++ E+ CGR P    +       I+  
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-- 218
Query: 544 LWELRRKGRILDAADSRLGG 563
           + E+R    +   A S L G
Sbjct: 219 MEEIRFPRTLSPEAKSLLAG 238

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 315 KKATGNFNPKNKLGKGGFGTV-----------YKGIWRNKEIAVKRVSETSRQGKQEFIA 363
           K +  +F     LG G FG V           Y      KEI V R+ +      +  + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLML 60
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
            + T     H  ++++ G   +     ++ +Y+  G L  F    ++   P  V   +  
Sbjct: 61  SIVT-----HPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAA 113
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            + +      AL+YLH+   K +++RD+K  NI+LD   + ++ DFG A+ + +      
Sbjct: 114 EVCL------ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 158
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            T  + GTP Y+APE           D ++FG+LI E+  G  P
Sbjct: 159 VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 114/260 (43%), Gaps = 33/260 (12%)
Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEFIAEVT---T 367
           K    +F+    LGKG FG V   + R K      A+K + +     K E    VT    
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 61
Query: 368 IGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           + + RH  L  L  + ++ HD L  V EY   G L    F+  +     E     E+   
Sbjct: 62  LQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGEL----FFHLSR----ERVFTEERARF 112
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                  AL+YLH+   + V++RDIK  N+MLD + + ++ DFGL +   E +    + K
Sbjct: 113 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMK 166
Query: 487 EIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW 543
              GTP Y+APE       GRA    D +  GV++ E+ CGR P    +       I+  
Sbjct: 167 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-- 221
Query: 544 LWELRRKGRILDAADSRLGG 563
           + E+R    +   A S L G
Sbjct: 222 MEEIRFPRTLSPEAKSLLAG 241

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE--FIAEVTTIGSLRHRNL 376
           +N    LGKG FG V K   R   +E AVK +++ S + K     + EV  +  L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHG 430
           +KL     +   F +V E    G L     +DE         +   KR S      +I  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL-----FDE---------IIKRKRFSEHDAARIIKQ 129
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKE 487
               + Y+H  +   ++HRD+K  NI+L+S   + + ++ DFGL+   Q+N K     K+
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKD 182
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             GT  Y+APE  L G    + D+++ GV++  +  G  P
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 33/226 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV---------SETSRQGKQEFIAEVTTI 368
           N+ PK  LG+G    V + I +   KE AVK +         +E  ++ ++  + EV  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 369 GSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
             +  H N+++L         F LV++ M  G L  F +  E      +VTL+ ++   +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE------KVTLSEKETRKI 129
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +    + +  LH  +   ++HRD+K  NI+LD + N +L DFG +  +    K     +E
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRE 182
Query: 488 IAGTPGYMAPESFLVGRAT------IETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE               E D+++ GV++  +  G  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           ++G+G +G+V K + +   + +AVKR+  T   ++ KQ  +     + S     +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             +   D  +  E M + S DKF  Y    S   +V +  E    +   T +AL++L   
Sbjct: 89  ALFREGDCWICMELM-STSFDKF--YKYVYSVLDDV-IPEEILGKITLATVKALNHLKEN 144
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
              +++HRDIK SNI+LD   N +L DFG++  + +++         AG   YMAPE   
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMAPERID 198
Query: 502 VGRA----TIETDIYAFGVLILEVACGRKP 527
              +     + +D+++ G+ + E+A GR P
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 33/226 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV---------SETSRQGKQEFIAEVTTI 368
           N+ PK  LG+G    V + I +   KE AVK +         +E  ++ ++  + EV  +
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 369 GSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
             +  H N+++L         F LV++ M  G L  F +  E      +VTL+ ++   +
Sbjct: 65  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE------KVTLSEKETRKI 116
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +    + +  LH  +   ++HRD+K  NI+LD + N +L DFG +  +    K     +E
Sbjct: 117 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRE 169
Query: 488 IAGTPGYMAPESFLVGRAT------IETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE               E D+++ GV++  +  G  P
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 404 FIFYDETNSGPGEVTLNWEKRLSVIHG------TSQALDYLHNGSEKRVLHRDIKSSNIM 457
           F   +  N G     +  +++L   H        S AL+YLH   E+ +++RD+K  N++
Sbjct: 86  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVL 142
Query: 458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
           LDSE + +L D+G+ +   E L+   +T    GTP Y+APE           D +A GVL
Sbjct: 143 LDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVL 199
Query: 518 ILEVACGRKP 527
           + E+  GR P
Sbjct: 200 MFEMMAGRSP 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 325 NKLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLI 380
            KLG+G +G VYK I    N+ +A+KR+  E   +G     I EV+ +  L+HRN+++L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
              +  H   L++EY  N  L K++     +  P +V++   K  S ++     +++ H+
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM-----DKNP-DVSMRVIK--SFLYQLINGVNFCHS 150
Query: 441 GSEKRVLHRDIKSSNIMLD----SEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
              +R LHRD+K  N++L     SE    ++GDFGLAR     +     T EI  T  Y 
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEII-TLWYR 204
Query: 496 APESFLVGRATIETDIYAFGVLILEVAC 523
            PE  L  R       Y+  V I  +AC
Sbjct: 205 PPEILLGSRH------YSTSVDIWSIAC 226

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 404 FIFYDETNSGPGEVTLNWEKRLSVIHG------TSQALDYLHNGSEKRVLHRDIKSSNIM 457
           F   +  N G     +  +++L   H        S AL+YLH   E+ +++RD+K  N++
Sbjct: 82  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVL 138
Query: 458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
           LDSE + +L D+G+ +   E L+   +T    GTP Y+APE           D +A GVL
Sbjct: 139 LDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVL 195
Query: 518 ILEVACGRKP 527
           + E+  GR P
Sbjct: 196 MFEMMAGRSP 205

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHR 374
            F     LGKGGFG V     R   K  A K++ +   +   G+   + E   +  +  R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            +V L  + YE  D L +   + NG   KF  Y    +G  E           +   ++ 
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--------RAVFYAAEI 295
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
              L +   +R+++RD+K  NI+LD   + R+ D GLA  + E      + K   GT GY
Sbjct: 296 CCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----QTIKGRVGTVGY 351
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
           MAPE     R T   D +A G L+ E+  G+ P  Q ++ 
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ---GKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGFG V     R   K  A K++ +   +   G+   + E   +  +  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
           + YE  D L +   + NG   KF  Y    +G  E           +   ++    L + 
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--------RAVFYAAEICCGLEDL 302
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             +R+++RD+K  NI+LD   + R+ D GLA  + E      + K   GT GYMAPE   
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----QTIKGRVGTVGYMAPEVVK 358
Query: 502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQN 534
             R T   D +A G L+ E+  G+ P  Q ++ 
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 12/130 (9%)
Query: 404 FIFYDETNSGPGEVTLNWEKRLSVIHG------TSQALDYLHNGSEKRVLHRDIKSSNIM 457
           F   +  N G     +  +++L   H        S AL+YLH   E+ +++RD+K  N++
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVL 185
Query: 458 LDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
           LDSE + +L D+G+ +   E L+   +T    GTP Y+APE           D +A GVL
Sbjct: 186 LDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 518 ILEVACGRKP 527
           + E+  GR P
Sbjct: 243 MFEMMAGRSP 252

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 24/236 (10%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIG- 369
           ++K    +F     LGKG FG V+   ++  N+  A+K + +       +   E T +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEK 68
Query: 370 -----SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
                +  H  L  +      + +   V EY+  G L     Y   +    +++      
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYA 124
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +I G    L +LH+   K +++RD+K  NI+LD + + ++ DFG+ +   EN+     
Sbjct: 125 AEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAK 174
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           T    GTP Y+APE  L  +     D ++FGVL+ E+  G+ P +  ++    +SI
Sbjct: 175 TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNLVKLIG 381
           +KLG+G + TVYKG  +  +  +A+K +     +G     I EV+ +  L+H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             +      LV+EY+ +  L +++  D+  +      +N       +    + L Y H  
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYL--DDCGN-----IINMHNVKLFLFQLLRGLAYCHR- 118
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             ++VLHRD+K  N++++     +L DFGLAR      KT+ +  E+     +  P   L
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--EVVTL--WYRPPDIL 172
Query: 502 VGRATIET--DIYAFGVLILEVACGRK--PGNQSEQN 534
           +G     T  D++  G +  E+A GR   PG+  E+ 
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 326 KLGKGGFGTVYKGI-WRNKEIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+G+G +G VYK    + + +A+KR+  +   +G     I E++ +  L H N+V LI  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            +      LV+E+M    L K +  DE  +G  +  +             Q L  + +  
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIKIY--------LYQLLRGVAHCH 136
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
           + R+LHRD+K  N++++S+   +L DFGLAR     ++++  T E+  T  Y AP+  + 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVV-TLWYRAPDVLMG 193
Query: 503 GRA-TIETDIYAFGVLILEVACGR 525
            +  +   DI++ G +  E+  G+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 326 KLGKGGFGTVYKGI-WRNKEIAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+G+G +G VYK    + + +A+KR+  +   +G     I E++ +  L H N+V LI  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            +      LV+E+M    L K +  DE  +G  +  +             Q L  + +  
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVL--DENKTGLQDSQIKIY--------LYQLLRGVAHCH 136
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
           + R+LHRD+K  N++++S+   +L DFGLAR     ++++  T E+  T  Y AP+  + 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVV-TLWYRAPDVLMG 193
Query: 503 GRA-TIETDIYAFGVLILEVACGR 525
            +  +   DI++ G +  E+  G+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 328 GKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH 387
            +G FG V+K    N  +AVK      +Q  Q    E+ +   ++H NL++ I    +R 
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIA-AEKRG 81
Query: 388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN------- 440
             L V  ++     DK    D          + W +   V    S+ L YLH        
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 441 -GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
            G +  + HRD KS N++L S+  A L DFGLA   +   K    T    GT  YMAPE 
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPG-KPPGDTHGQVGTRRYMAPEV 196
Query: 500 F-----LVGRATIETDIYAFGVLILEVA 522
                     A +  D+YA G+++ E+ 
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRNL 376
           +N    LGKG FG V K   R   +E AVK +++ S + K     + EV  +  L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHG 430
           +KL     +   F +V E    G L     +DE             KR S      +I  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL-----FDEIIK---------RKRFSEHDAARIIKQ 129
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKE 487
               + Y+H  +   ++HRD+K  NI+L+S   + + ++ DFGL+   Q+N K     K+
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKD 182
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             GT  Y+APE  L G    + D+++ GV++  +  G  P
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 326 KLGKGGFGTVYKGIWRNKE-IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+G+G +G VYK      E  A+K++  E   +G     I E++ +  L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            + +   +LV+E++ +  L K +  D    G   VT       S +      + Y H+  
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAK-----SFLLQLLNGIAYCHD-- 118
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
            +RVLHRD+K  N++++ E   ++ DFGLAR     +     T EI  T  Y AP+  + 
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIV-TLWYRAPDVLMG 174
Query: 503 GRATIET-DIYAFGVLILEVACG 524
            +    T DI++ G +  E+  G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHR 374
           +F P   LG+GGFG V++   +NK      A+KR+   +R+  +++ + EV  +  L H 
Sbjct: 6   DFEPIQCLGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 375 NLVKLI-GWCYERHDFLL------VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
            +V+    W  +     L      VY Y+      K    D  N   G  T+   +R   
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN---GRCTIEERERSVC 120
Query: 428 IH---GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA---------RTI 475
           +H     ++A+++LH+   K ++HRD+K SNI    +   ++GDFGL          +T+
Sbjct: 121 LHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
              +  +       GT  YM+PE       + + DI++ G+++ E+
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRNL 376
           +N    LGKG FG V K   R   +E AVK +++ S + K     + EV  +  L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHG 430
           +KL     +   F +V E    G L     +DE             KR S      +I  
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGEL-----FDEIIK---------RKRFSEHDAARIIKQ 129
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKE 487
               + Y+H  +   ++HRD+K  NI+L+S   + + ++ DFGL+   Q+N K     K+
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKD 182
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             GT  Y+APE  L G    + D+++ GV++  +  G  P
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 114/242 (47%), Gaps = 42/242 (17%)
Query: 314 LKKATGNFNPKNK----LGKGGFGTVY--KGIWRNKEIAVKRVSE---TSRQGKQEFIAE 364
           ++ +T  F+ + K    LGKG FG V   K     +E AVK +S+     +  K+  + E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V  +  L H N++KL  +  ++  F LV E    G L     +DE  S          KR
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-----FDEIIS---------RKR 122
Query: 425 LS------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTI 475
            S      +I      + Y+H     +++HRD+K  N++L+S   + N R+ DFGL+   
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
           + + K     K+  GT  Y+APE  L G    + D+++ GV++  +  G  P N +  N 
Sbjct: 180 EASKK----MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA--NE 232
Query: 536 YN 537
           Y+
Sbjct: 233 YD 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 32/242 (13%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVY----KGIWRNKEIAVKRVSETSRQ 356
           G  +  KK  L E+      +    KLG G +G V     K     + I + R +  S  
Sbjct: 25  GMFITSKKGHLSEM------YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS 78
Query: 357 GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPG 415
              + + EV  +  L H N++KL  +  ++ ++ LV E    G L D+ I   + N    
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA 138
Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNA--RLGDFGLA 472
            V +       V+ G +    YLH  +   ++HRD+K  N++L+S E +A  ++ DFGL+
Sbjct: 139 AVIIK-----QVLSGVT----YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQS 531
              +   K     KE  GT  Y+APE  L  +   + D+++ GV++  +  G  P G Q+
Sbjct: 187 AVFENQKK----MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
Query: 532 EQ 533
           +Q
Sbjct: 242 DQ 243

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 326 KLGKGGFGTVYKGIWRNKE-IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+G+G +G VYK      E  A+K++  E   +G     I E++ +  L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            + +   +LV+E++ +  L K +  D    G   VT       S +      + Y H+  
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAK-----SFLLQLLNGIAYCHD-- 118
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
            +RVLHRD+K  N++++ E   ++ DFGLAR     +     T E+  T  Y AP+  + 
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLMG 174
Query: 503 GRATIET-DIYAFGVLILEVACG 524
            +    T DI++ G +  E+  G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 89  F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 139
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 140 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKTLCGTPNYIAPEVL 193
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 194 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 29/234 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRH 373
           T ++    +LGKG F  V + + +   +E A K ++  + S +  Q+   E      L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIH 429
            N+V+L     E     LV++ +  G L + I    +Y E ++               IH
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS------------HCIH 137
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTK 486
              ++++++H   +  ++HRD+K  N++L S+      +L DFGLA  +Q   +      
Sbjct: 138 QILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG-- 192
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
             AGTPGY++PE           DI+A GV++  +  G  P    +Q+     I
Sbjct: 193 -FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 245

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 85  F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 135
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKTLCGTPNYIAPEVL 189
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 85  F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 135
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKTLCGTPNYIAPEVL 189
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 326 KLGKGGFGTVYKGIWRNKE-IAVKRVS-ETSRQG-KQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+G+G +G VYK      E  A+K++  E   +G     I E++ +  L+H N+VKL   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
            + +   +LV+E++ +  L K +  D    G   VT       S +      + Y H+  
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL--DVCEGGLESVTAK-----SFLLQLLNGIAYCHD-- 118
Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
            +RVLHRD+K  N++++ E   ++ DFGLAR     +     T E+  T  Y AP+  + 
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLMG 174
Query: 503 GRATIET-DIYAFGVLILEVACG 524
            +    T DI++ G +  E+  G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 115/242 (47%), Gaps = 42/242 (17%)
Query: 314 LKKATGNFNPKNK----LGKGGFGTVY--KGIWRNKEIAVKRVSE---TSRQGKQEFIAE 364
           ++ +T  F+ + K    LGKG FG V   K     +E AVK +S+     +  K+  + E
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 99
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V  +  L H N++KL  +  ++  F LV E    G L     +DE  S          KR
Sbjct: 100 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-----FDEIIS---------RKR 145
Query: 425 LS------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTI 475
            S      +I      + Y+H   + +++HRD+K  N++L+S   + N R+ DFGL+   
Sbjct: 146 FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 202
Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
           + + K     K+  GT  Y+APE  L G    + D+++ GV++  +  G  P N +  N 
Sbjct: 203 EASKK----MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA--NE 255
Query: 536 YN 537
           Y+
Sbjct: 256 YD 257

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 107 F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 157
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 158 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVL 211
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 212 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKG FG V   K     +E AVK +S+     +  K+  + EV  +  L H N++KL  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGTSQAL 435
           +  ++  F LV E    G L     +DE  S          KR S      +I      +
Sbjct: 118 FFEDKGYFYLVGEVYTGGEL-----FDEIIS---------RKRFSEVDAARIIRQVLSGI 163
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            Y+H   + +++HRD+K  N++L+S   + N R+ DFGL+   + + K     K+  GT 
Sbjct: 164 TYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----MKDKIGTA 216
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN 537
            Y+APE  L G    + D+++ GV++  +  G  P N +  N Y+
Sbjct: 217 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA--NEYD 258

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 325 NKLGKGGFGTVY------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
            KLG G +G V        G  R  +I +K+ S T+       + EV  +  L H N++K
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 379 LIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           L  +  ++ ++ LV E    G L D+ I   + +     V +       V+ GT+    Y
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-----QVLSGTT----Y 119
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           LH  +   ++HRD+K  N++L+S+      ++ DFGL+     + +     KE  GT  Y
Sbjct: 120 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS----AHFEVGGKMKERLGTAYY 172
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQN 534
           +APE  L  +   + D+++ GV++  + CG  P G Q++Q 
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG--- 381
            ++GKG +G V+ G WR +++AVK V  T+ +       E+     +RH N++  I    
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 382 -----WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
                W        L+ +Y  NGSL     YD   S     TL+ +  L + + +   L 
Sbjct: 102 KGTGSWT----QLYLITDYHENGSL-----YDYLKS----TTLDAKSMLKLAYSSVSGLC 148
Query: 437 YLH-----NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA-RTIQENLKTHHSTKEIAG 490
           +LH        +  + HRD+KS NI++       + D GLA + I +  +         G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 491 TPGYMAPESFLVG------RATIETDIYAFGVLILEVA 522
           T  YM PE           ++ I  D+Y+FG+++ EVA
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 378 KLIGWCYERHDFLLV-YEYMPNGSL--------DKFIFYDETNSGPGEVTLNWEKRLSVI 428
            L+G C +    L+V  E+   G+L        ++F+ Y E      +  L  E  +   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGD 211
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 49/257 (19%)
Query: 314 LKKATGNFNPKNK----LGKGGFGTVY--KGIWRNKEIAVKRVSE---TSRQGKQEFIAE 364
           ++ +T  F+ + K    LGKG FG V   K     +E AVK +S+     +  K+  + E
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V  +  L H N++KL  +  ++  F LV E    G L     +DE  S          KR
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-----FDEIIS---------RKR 128
Query: 425 LS------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTI 475
            S      +I      + Y+H     +++HRD+K  N++L+S   + N R+ DFGL+   
Sbjct: 129 FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 185
Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN------ 529
           + + K     K+  GT  Y+APE  L G    + D+++ GV++  +  G  P N      
Sbjct: 186 EASKK----MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 240
Query: 530 ---QSEQNSYNNSIVHW 543
              + E+  Y   +  W
Sbjct: 241 ILKKVEKGKYTFELPQW 257

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 325 NKLGKGGFGTVY------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
            KLG G +G V        G  R  +I +K+ S T+       + EV  +  L H N++K
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 379 LIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           L  +  ++ ++ LV E    G L D+ I   + +     V +       V+ GT+    Y
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-----QVLSGTT----Y 136
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           LH  +   ++HRD+K  N++L+S+      ++ DFGL+     + +     KE  GT  Y
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS----AHFEVGGKMKERLGTAYY 189
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQN 534
           +APE  L  +   + D+++ GV++  + CG  P G Q++Q 
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE 229

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 159
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 160 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVL 213
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 79/332 (23%), Positives = 134/332 (40%), Gaps = 55/332 (16%)
Query: 308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE-----IAVKRVSE--TSRQGKQE 360
           K +L+++      F     LGKG FG+V +   + ++     +AVK +     +    +E
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDF------LLVYEYMPNGSLDKFIFYDETNSGP 414
           F+ E   +    H ++ KL+G              +++  +M +G L  F+        P
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
             + L    R  V    +  ++YL   S +  +HRD+ + N ML  +    + DFGL+R 
Sbjct: 132 FNLPLQTLVRFMV--DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 475 IQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSE 532
           I      ++     +  P  ++A ES      T+ +D++AFGV + E+   G+ P    E
Sbjct: 187 IYSG--DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244
Query: 533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRP 589
               N  I ++L                +GG   ++  EC   V  L   C   +P  RP
Sbjct: 245 ----NAEIYNYL----------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
Query: 590 SMKTV----------LQVLSGEADPPVLPPER 611
           S   +          L VLS   DP  +  ER
Sbjct: 285 SFTCLRMELENILGHLSVLSTSQDPLYINIER 316

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK--QEFIAEVTTIGSLRHRNLVKL-- 379
           LG GG   V+  + +  ++++AVK + ++ +R       F  E     +L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 380 IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G        L  +V EY+   +L   +  +    GP    +  ++ + VI    QAL++
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GP----MTPKRAIEVIADACQALNF 131
Query: 438 LH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
            H NG    ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  + GT  Y++
Sbjct: 132 SHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNN 538
           PE          +D+Y+ G ++ EV  G  P  G+  +  +Y +
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQH 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 327 LGKGGFGTVYK-GIWRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKGGF   ++      KE+   ++   S       +++   E++   SL H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 382 WCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           + +E +DF+ +V E     SL +     +      E    +  R  V+        YLH 
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVL-----GCQYLHR 133
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
               RV+HRD+K  N+ L+ +   ++GDFGLA  ++ +       K + GTP Y+APE  
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVL 187
Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQS 531
                + E D+++ G ++  +  G+ P   S
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           +   +F     LG+G FG V K   RN    +  A+K++  T  +     ++EV  + SL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASL 59
Query: 372 RHRNLVKLIGWCYERHDFL-------------LVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            H+ +V+      ER +F+             +  EY  N +L   I  +  N    E  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY- 118
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
             W     +     +AL Y+H+     ++HRD+K  NI +D   N ++GDFGLA+ +  +
Sbjct: 119 --WR----LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 479 LK-----------THHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEV 521
           L            +  +     GT  Y+A E     G    + D+Y+ G++  E+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV---------SETSRQGKQEFIAEVTTI 368
           N+ PK  LG+G    V + I +   KE AVK +         +E  ++ ++  + EV  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 369 GSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
             +  H N+++L         F LV++ M  G L  F +  E      +VTL+ ++   +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE------KVTLSEKETRKI 129
Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +    + +  LH  +   ++HRD+K  NI+LD + N +L DFG +  +    K     + 
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRS 182
Query: 488 IAGTPGYMAPESFLVGRAT------IETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE               E D+++ GV++  +  G  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 30/226 (13%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRV-SETSRQGK 358
           P  F  + LKK          LG+G FG V    +        + +AVK + ++   Q +
Sbjct: 8   PTVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR 60
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGE 416
             +  E+  + +L H +++K  G C ++ +    LV EY+P GSL  ++           
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---------PR 111
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
            ++   + L       + + YLH+   +  +HR++ + N++LD++   ++GDFGLA+ + 
Sbjct: 112 HSIGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 477 ENLKTHHSTKEIAGTPGY-MAPESFLVGRATIETDIYAFGVLILEV 521
           E    ++  +E   +P +  APE     +    +D+++FGV + E+
Sbjct: 169 EG-HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LG G FG V+K        ++A K +     + K+E   E++ +  L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 385 ERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++D +LV EY+  G L D+ I  DE+ +     T+ + K++       + + ++H   +
Sbjct: 157 SKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQI------CEGIRHMH---Q 205
Query: 444 KRVLHRDIKSSNIML---DSEFNARLGDFGLARTIQ--ENLKTHHSTKEIAGTPGYMAPE 498
             +LH D+K  NI+    D++   ++ DFGLAR  +  E LK +       GTP ++APE
Sbjct: 206 MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF------GTPEFLAPE 258
Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
                  +  TD+++ GV+   +  G  P          N+I+   W+L
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 315 KKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIG 369
           KK   +F     LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   + 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRL 425
            L H   VKL     +         Y  NG L K+I     +DET +           R 
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RF 114
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 S AL+YLH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   + 
Sbjct: 115 YTAEIVS-ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 170
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
               GT  Y++PE      A   +D++A G +I ++  G  P     +      I+   +
Sbjct: 171 X-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 229
Query: 546 -----------ELRRKGRILDAADSRLGGEFSEKEME 571
                      +L  K  +LDA   RLG E    EME
Sbjct: 230 DFPEKFFPKARDLVEKLLVLDAT-KRLGCE----EME 261

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSE----TSRQG--KQEFIAEVTTIGSLRHRNLV 377
           +LG G F  V K   +   KE A K + +    +SR+G  ++E   EV  +  +RH N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L      + D +L+ E +  G L  F F  E  S   +    + K         Q LD 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEATQFLK---------QILDG 120
Query: 438 LHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           +H    KR+ H D+K  NIML D        +L DFG+A  I+      +  K I GTP 
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKNIFGTPE 176
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHW 543
           ++APE        +E D+++ GV+   +  G  P  G   ++   N S V++
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 315 KKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIG 369
           KK   +F     LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   + 
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRL 425
            L H   VKL     +         Y  NG L K+I     +DET +           R 
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RF 113
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 S AL+YLH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   + 
Sbjct: 114 YTAEIVS-ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
               GT  Y++PE      A   +D++A G +I ++  G  P     +      I+   +
Sbjct: 170 X-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 228
Query: 546 -----------ELRRKGRILDAADSRLGGEFSEKEME 571
                      +L  K  +LDA   RLG E    EME
Sbjct: 229 DFPEKFFPKARDLVEKLLVLDAT-KRLGCE----EME 260

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 110/247 (44%), Gaps = 31/247 (12%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSE-TSRQGK 358
           P  F  + LKK          LG+G FG V    +        + +AVK + E    Q +
Sbjct: 2   PTVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR 54
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGE 416
             +  E+  + +L H ++VK  G C ++ +    LV EY+P GSL  ++           
Sbjct: 55  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PR 105
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
             +   + L       + + YLH    +  +HR + + N++LD++   ++GDFGLA+ + 
Sbjct: 106 HCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP 162
Query: 477 ENLKTHHSTKEIAGTPGY-MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
           E    ++  +E   +P +  APE     +    +D+++FGV + E+       NQS    
Sbjct: 163 EG-HEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL-TYCDSNQSPHTK 220
Query: 536 YNNSIVH 542
           +   I H
Sbjct: 221 FTELIGH 227

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 315 KKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIG 369
           KK   +F     LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   + 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRL 425
            L H   VKL     +         Y  NG L K+I     +DET +           R 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RF 112
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 S AL+YLH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   + 
Sbjct: 113 YTAEIVS-ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
               GT  Y++PE      A   +D++A G +I ++  G  P     +      I+   +
Sbjct: 169 X-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227
Query: 546 -----------ELRRKGRILDAADSRLGGEFSEKEME 571
                      +L  K  +LDA   RLG E    EME
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDAT-KRLGCE----EME 259

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSE----TSRQG--KQEFIAEVTTIGSLRHRNLV 377
           +LG G F  V K   +   KE A K + +    +SR+G  ++E   EV  +  +RH N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L      + D +L+ E +  G L  F F  E  S   +    + K         Q LD 
Sbjct: 79  TLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEATQFLK---------QILDG 127
Query: 438 LHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           +H    KR+ H D+K  NIML D        +L DFG+A  I+      +  K I GTP 
Sbjct: 128 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKNIFGTPE 183
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHW 543
           ++APE        +E D+++ GV+   +  G  P  G   ++   N S V++
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 235

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 31/247 (12%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSE-TSRQGK 358
           P  F  + LKK          LG+G FG V    +        + +AVK + E    Q +
Sbjct: 3   PTVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR 55
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGE 416
             +  E+  + +L H ++VK  G C ++ +    LV EY+P GSL  ++       G  +
Sbjct: 56  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQ 113
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
           + L  ++         + + YLH    +  +HR + + N++LD++   ++GDFGLA+ + 
Sbjct: 114 LLLFAQQ-------ICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVP 163
Query: 477 ENLKTHHSTKEIAGTPGY-MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
           E    ++  +E   +P +  APE     +    +D+++FGV + E+       NQS    
Sbjct: 164 EG-HEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL-TYCDSNQSPHTK 221
Query: 536 YNNSIVH 542
           +   I H
Sbjct: 222 FTELIGH 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 315 KKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIG 369
           KK   +F     LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   + 
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRL 425
            L H   VKL     +         Y  NG L K+I     +DET +           R 
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RF 111
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 S AL+YLH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   + 
Sbjct: 112 YTAEIVS-ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
               GT  Y++PE      A   +D++A G +I ++  G  P     +      I+   +
Sbjct: 168 X-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 226
Query: 546 -----------ELRRKGRILDAADSRLGGEFSEKEME 571
                      +L  K  +LDA   RLG E    EME
Sbjct: 227 DFPEKFFPKARDLVEKLLVLDAT-KRLGCE----EME 258

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 28/225 (12%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRV-SETSRQGK 358
           P  F  + LKK          LG+G FG V    +        + +AVK + ++   Q +
Sbjct: 25  PTVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVYEYMPNGSLDKFIFYDETNSGPGE 416
             +  E+  + +L H +++K  G C +       LV EY+P GSL  ++           
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---------PR 128
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
            ++   + L       + + YLH    +  +HRD+ + N++LD++   ++GDFGLA+ + 
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
           E  + +   ++      + APE     +    +D+++FGV + E+
Sbjct: 186 EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 29/232 (12%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRVSE----TSRQG--KQEFIAEVTTIGSLRHRNLV 377
           +LG G F  V K   +   KE A K + +    +SR+G  ++E   EV  +  +RH N++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L      + D +L+ E +  G L  F+   E+ +   E T   ++ L  +H       Y
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLT-EDEATQFLKQILDGVH-------Y 144
Query: 438 LHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           LH+   KR+ H D+K  NIML D        +L DFG+A  I+      +  K I GTP 
Sbjct: 145 LHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKNIFGTPE 197
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHW 543
           ++APE        +E D+++ GV+   +  G  P  G   ++   N S V++
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 249

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 43/266 (16%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 382 WCYERHDFLLV-YEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +C++  + L     Y  NG L K+I     +DET +           R       S AL+
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALE 151
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++
Sbjct: 152 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVS 207
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW----------- 545
           PE      A   +D++A G +I ++  G  P     +      I+   +           
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 267
Query: 546 ELRRKGRILDAADSRLGGEFSEKEME 571
           +L  K  +LDA   RLG E    EME
Sbjct: 268 DLVEKLLVLDAT-KRLGCE----EME 288

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK--QEFIAEVTTIGSLRHRNLVKL-- 379
           LG GG   V+  + +  ++++AVK + ++ +R       F  E     +L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 380 IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G        L  +V EY+   +L   +  +    GP    +  ++ + VI    QAL++
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GP----MTPKRAIEVIADACQALNF 131
Query: 438 LH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
            H NG    ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  + GT  Y++
Sbjct: 132 SHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE          +D+Y+ G ++ EV  G  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 378 KLIGWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +     +++ E+   G+L  ++        P +V         L  E  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGD 209
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 30/226 (13%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRV-SETSRQGK 358
           P  F  + LKK          LG+G FG V    +        + +AVK + ++   Q +
Sbjct: 8   PTVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR 60
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGE 416
             +  E+  + +L H +++K  G C ++ +    LV EY+P GSL  ++           
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---------PR 111
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
            ++   + L       + + YLH    +  +HR++ + N++LD++   ++GDFGLA+ + 
Sbjct: 112 HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 477 ENLKTHHSTKEIAGTPGY-MAPESFLVGRATIETDIYAFGVLILEV 521
           E    ++  +E   +P +  APE     +    +D+++FGV + E+
Sbjct: 169 EG-HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 3/98 (3%)
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           K +++RD+K  N+MLDSE + ++ DFG+ +   EN+    +TK   GTP Y+APE     
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
                 D +AFGVL+ E+  G+ P    +++    SI+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 378 KLIGWCYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +    L+V  E+   G+L  ++        P +V         L  E  +   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGD 246
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK--QEFIAEVTTIGSLRHRNLVKL-- 379
           LG GG   V+  + +  ++++AVK + ++ +R       F  E     +L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 380 IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G        L  +V EY+   +L   +  +    GP    +  ++ + VI    QAL++
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GP----MTPKRAIEVIADACQALNF 131
Query: 438 LH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
            H NG    ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  + GT  Y++
Sbjct: 132 SHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE          +D+Y+ G ++ EV  G  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 315 KKATGNFNPKNKLGKGGFGTV-----YKGIWRNKEIAVKRVSETSRQGKQEFIA---EVT 366
           K+  G +  +  LG+G FG V     YK     +++A+K +S    +     +    E++
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKT---QQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
            +  LRH +++KL        D ++V EY      D  +         G           
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGR---------R 112
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHHS 484
                  A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +   LKT   
Sbjct: 113 FFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 485 TKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
                G+P Y APE  + G+  A  E D+++ G+++  +  GR P
Sbjct: 168 ----CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 116/219 (52%), Gaps = 25/219 (11%)
Query: 320 NFNPKNKLGKGGFGTVYK--GIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRN 375
           +  P  +LG+G +G V K   +   + +AVKR+  T  S++ K+  +    ++ ++    
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            V   G  +   D  +  E M + SLDKF     D+  + P ++      +++V     +
Sbjct: 68  TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDIL----GKIAV--SIVK 120
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-AGTP 492
           AL++LH  S+  V+HRD+K SN+++++    ++ DFG++  + +++      K+I AG  
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----AKDIDAGCK 173
Query: 493 GYMAPESF---LVGRA-TIETDIYAFGVLILEVACGRKP 527
            YMAPE     L  +  ++++DI++ G+ ++E+A  R P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK--QEFIAEVTTIGSLRHRNLVKLIG 381
           LG GG   V+  + +  ++++AVK + ++ +R       F  E     +L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 382 WCYERHDF----LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                        +V EY+   +L   +  +    GP    +  ++ + VI    QAL++
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GP----MTPKRAIEVIADACQALNF 131
Query: 438 LH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
            H NG    ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  + GT  Y++
Sbjct: 132 SHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE          +D+Y+ G ++ EV  G  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 119/257 (46%), Gaps = 43/257 (16%)
Query: 301 GTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETS---- 354
           G  + P  +  K+  K   ++    KLG G +G V     +N   E A+K + ++     
Sbjct: 18  GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 355 ---------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI 405
                     +  +E   E++ + SL H N++KL     ++  F LV E+   G L + I
Sbjct: 78  RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 406 F----YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE 461
                +DE ++             +++      + YLH  +   ++HRDIK  NI+L+++
Sbjct: 138 INRHKFDECDAA------------NIMKQILSGICYLHKHN---IVHRDIKPENILLENK 182
Query: 462 ---FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLI 518
               N ++ DFGL+    ++ K     ++  GT  Y+APE  L  +   + D+++ GV++
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYK----LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
Query: 519 LEVACGRKP-GNQSEQN 534
             + CG  P G Q++Q+
Sbjct: 238 YILLCGYPPFGGQNDQD 254

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 378 KLIGWCYERHDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +    L+V  E+   G+L  ++        P +V         L  E  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGD 200
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 327 LGKGGFGTV-----------YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN 375
           +GKG FG V           Y   + NK+  V+R         +    E+  +  L H  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER------NEVRNVFKELQIMQGLEHPF 76
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           LV L     +  D  +V + +  G L    ++ + N    E T+        I     AL
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLR---YHLQQNVHFKEETVKL-----FICELVMAL 128
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           DYL N   +R++HRD+K  NI+LD   +  + DF +A  +    +T  +T  +AGT  YM
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT--MAGTKPYM 181
Query: 496 APESFLVGRA---TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
           APE F   +    +   D ++ GV   E+  GR+P +     S +  IVH
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVH 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 22/234 (9%)
Query: 304 LAPKKFRLKELKKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK-- 358
           L P+   +      +  +     LG GG   V+  + +  ++++AVK + ++ +R     
Sbjct: 14  LVPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY 73
Query: 359 QEFIAEVTTIGSLRHRNLVKL--IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGP 414
             F  E     +L H  +V +   G        L  +V EY+   +L   +       GP
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGP 129
Query: 415 GEVTLNWEKRLSVIHGTSQALDYLH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
               +  ++ + VI    QAL++ H NG    ++HRD+K +NIM+ +    ++ DFG+AR
Sbjct: 130 ----MTPKRAIEVIADACQALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIAR 181
Query: 474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            I ++  +   T  + GT  Y++PE          +D+Y+ G ++ EV  G  P
Sbjct: 182 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 3/98 (3%)
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           K +++RD+K  N+MLDSE + ++ DFG+ +   EN+    +TK   GTP Y+APE     
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 504 RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
                 D +AFGVL+ E+  G+ P    +++    SI+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 36/217 (16%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           LGKG FG V   K     +E AVK +S+     +  K+  + EV  +  L H N+ KL  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGTSQAL 435
           +  ++  F LV E    G L     +DE  S          KR S      +I      +
Sbjct: 94  FFEDKGYFYLVGEVYTGGEL-----FDEIIS---------RKRFSEVDAARIIRQVLSGI 139
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            Y H     +++HRD+K  N++L+S   + N R+ DFGL+   + + K     K+  GT 
Sbjct: 140 TYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----XKDKIGTA 192
Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN 529
            Y+APE  L G    + D+++ GV++  +  G  P N
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 378 KLIGWCYERHDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +    L+V  E+   G+L  ++        P +V         L  E  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGD 200
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVK----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLI- 380
           ++G+G F TVYKG+     + V     +  + ++  +Q F  E   +  L+H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 381 GW---CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            W      +   +LV E   +G+L  ++          +V  +W +++       + L +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQI------LKGLQF 144
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           LH  +   ++HRD+K  NI +     + ++GD GLA      LK     K + GTP + A
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLA-----TLKRASFAKAVIGTPEFXA 198
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
           PE +   +     D+YAFG   LE A    P ++ +
Sbjct: 199 PEXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQ 233

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 114/265 (43%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A+  +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 378 KLIGWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +     +++ E+   G+L  ++        P +V         L  E  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       K  
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 209
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 324 KNKLGKGGFGTVYKGIWRNK--EIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLI 380
           K KLG G FG V+    R+   E  +K +++   Q   E I AE+  + SL H N++K+ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               + H+  +V E    G L + I   +         L+      ++     AL Y H+
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGK----ALSEGYVAELMKQMMNALAYFHS 142
Query: 441 GSEKRVLHRDIKSSNIML-DSEFNA--RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
              + V+H+D+K  NI+  D+  ++  ++ DFGLA   + +    HST   AGT  YMAP
Sbjct: 143 ---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTN-AAGTALYMAP 195
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKP 527
           E F     T + DI++ GV++  +  G  P
Sbjct: 196 EVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 35/242 (14%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVSETSRQGKQEF---IAEVTTIGSLR 372
           NF     LGKG FG V   + R KE     AVK + +       +    + E   +   R
Sbjct: 24  NFEFIRVLGKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 373 HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           +   +  +  C++  D    V E++  G L   +F+ + +    E    +     +    
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEII---- 134
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL +LH+   K +++RD+K  N++LD E + +L DFG+ +   E +    +T    GT
Sbjct: 135 -SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGT 187
Query: 492 PGYMAPE---SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS-----YNNSIVHW 543
           P Y+APE     L G A    D +A GVL+ E+ CG  P     ++       N+ +V+ 
Sbjct: 188 PDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244
Query: 544 LW 545
            W
Sbjct: 245 TW 246

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 25/230 (10%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW-RNKEIAVKRVSETSRQGKQEFIAEVTTIG 369
           L  L+   G F     +G G +G VYKG   +  ++A  +V + +   ++E   E+  + 
Sbjct: 16  LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK 75
Query: 370 SL-RHRNLVKLIGWCYERH------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
               HRN+    G   +++         LV E+   GS+   I   + N      TL  E
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEE 129
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
               +     + L +LH   + +V+HRDIK  N++L      +L DFG++  +   +   
Sbjct: 130 WIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 483 HSTKEIAGTPGYMAPESFLVGR---AT--IETDIYAFGVLILEVACGRKP 527
           ++     GTP +MAPE         AT   ++D+++ G+  +E+A G  P
Sbjct: 187 NT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 378 KLIGWCYERHDFLLVY-EYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +    L+V  E+   G+L  ++        P +V         L  E  +   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       K  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 200
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 378 KLIGWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +     +++ E+   G+L  ++        P +V         L  E  +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       K  
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDXVRKGD 209
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRV-SETSRQGK--QEFIAEVTTIGSLRHRNLVKL-- 379
           LG GG   V+  + +  ++++AVK + ++ +R       F  E     +L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 380 IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            G        L  +V EY+   +L   +  +    GP    +  ++ + VI    QAL++
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GP----MTPKRAIEVIADACQALNF 131
Query: 438 LH-NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
            H NG    ++HRD+K +NI++ +    ++ DFG+AR I ++  +   T  + GT  Y++
Sbjct: 132 SHQNG----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLS 187
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PE          +D+Y+ G ++ EV  G  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 378 KLIGWCYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVT--------LNWEKRLSVI 428
            L+G C +    L+V  E+   G+L  ++        P +V         L  E  +   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       K  
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGD 200
Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
           A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 14/219 (6%)
Query: 27  LHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           L F F++F+ QN  +LSF  N++V ++ +     V         G A Y     +W  N 
Sbjct: 4   LSFKFKNFS-QNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNT 62
Query: 86  NVKATFSTTFVLNILNQTAQP---GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
              A+F T+F    +  +A P    +GL F +A   D P    G + G+ N  T   +  
Sbjct: 63  GELASFITSFSF-FMETSANPKAATDGLTFFLAP-PDSPLRRAGGYFGLFND-TKCDSSY 119
Query: 143 QIVAIEFDTKKSYEQ--DINDNHVGLDVNSVYSIRQVPLT-RVNLANGTDIKVQVRYDGQ 199
           Q VA+EFDT  S     D    H+G+DVN V SI       R  L N  ++++      +
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIYEASSK 179
Query: 200 NITV---FVANMETPLLSEPIDLSEYLPEKVFVGFSAST 235
            +T    + ++  +  ++  +DL E LPE V VGFS ST
Sbjct: 180 TLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGST 218

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 29/234 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRH 373
           T  +     +GKG F  V + +      E A K ++  + S +  Q+   E      L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIH 429
            N+V+L     E     LV++ +  G L + I    +Y E ++                H
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---------------H 107
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTK 486
              Q L+ + +  +  V+HRD+K  N++L S+      +L DFGLA  +Q + +      
Sbjct: 108 CIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-- 165
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
             AGTPGY++PE           DI+A GV++  +  G  P    +Q+     I
Sbjct: 166 -FAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 218

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 145
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 201
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 262 LVEKLLVLDAT-KRLGCE----EME 281

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 148
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 149 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 204
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 265 LVEKLLVLDAT-KRLGCE----EME 284

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 145
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANA-FVGTAQYVSP 201
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 262 LVEKLLVLDAT-KRLGCE----EME 281

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 148
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 149 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 204
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 264
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 265 LVEKLLVLDAT-KRLGCE----EME 284

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 145
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 201
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 262 LVEKLLVLDAT-KRLGCE----EME 281

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 129
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 130 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 185
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 245
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 246 LVEKLLVLDAT-KRLGCE----EME 265

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 103 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 150
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 151 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 206
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARD 266
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 267 LVEKLLVLDAT-KRLGCE----EME 286

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG 357
           NG + +  K + +++KK    F  K  LG G F  V     +   K  AVK + + + +G
Sbjct: 6   NGESSSSWKKQAEDIKKI---FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKG 62
Query: 358 KQEFIA-EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNS 412
           K+  I  E+  +  ++H N+V L       +   LV + +  G L D+ +   FY E ++
Sbjct: 63  KESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA 122
Query: 413 GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDF 469
                        ++I     A+ YLH      ++HRD+K  N++    D E    + DF
Sbjct: 123 S------------TLIRQVLDAVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDF 167
Query: 470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           GL++   E      ST    GTPGY+APE       +   D ++ GV+   + CG  P
Sbjct: 168 GLSKM--EGKGDVMSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 144
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 145 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 200
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 261 LVEKLLVLDAT-KRLGCE----EME 280

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 113/217 (52%), Gaps = 21/217 (9%)
Query: 320 NFNPKNKLGKGGFGTVYK--GIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRN 375
           +  P  +LG+G +G V K   +   + +AVKR+  T  S++ K+  +    ++ ++    
Sbjct: 52  DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 111
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
            V   G  +   D  +  E M + SLDKF  Y +       +  +   +++V     +AL
Sbjct: 112 TVTFYGALFREGDVWICMELM-DTSLDKF--YKQVIDKGQTIPEDILGKIAV--SIVKAL 166
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-AGTPGY 494
           ++LH  S+  V+HRD+K SN+++++    ++ DFG++  + +++      K I AG   Y
Sbjct: 167 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV-----AKTIDAGCKPY 219
Query: 495 MAPESF---LVGRA-TIETDIYAFGVLILEVACGRKP 527
           MAPE     L  +  ++++DI++ G+ ++E+A  R P
Sbjct: 220 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F F  E  S   E    + K+  +++G  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQ--ILNGVY 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEI 488
               YLH+    ++ H D+K  NIML D        ++ DFGLA  I       +  K I
Sbjct: 129 ----YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 144
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 145 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 200
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 260
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 261 LVEKLLVLDAT-KRLGCE----EME 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F TV   + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 147
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 148 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 203
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARD 263
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 264 LVEKLLVLDAT-KRLGCE----EME 283

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           F  +++LG+G    VY+   +   K  A+K + +T    K+    E+  +  L H N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIK 112
Query: 379 LIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           L        +  LV E +  G L D+ +   +Y E ++               +    +A
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA------------DAVKQILEA 160
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           + YLH   E  ++HRD+K  N++  +   +   ++ DFGL++ ++  +      K + GT
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGT 213
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           PGY APE         E D+++ G++   + CG +P
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFI-----AEV 365
           ++K     +   + LG+G F TVYK   +N    +A+K++    R   ++ I      E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
             +  L H N++ L+     + +  LV+++M    L+  I  +     P  +        
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIK------- 115
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI-QENLKTHHS 484
           + +  T Q L+YLH   +  +LHRD+K +N++LD     +L DFGLA++    N    H 
Sbjct: 116 AYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 485 TKEIAGTPGYMAPESFLVGRAT-IETDIYAFGVLILEV 521
                 T  Y APE     R   +  D++A G ++ E+
Sbjct: 173 VV----TRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 321 FNPKNKLGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL- 371
            N    LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  + 
Sbjct: 30  LNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 89
Query: 372 RHRNLVKLIGWCYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVT-------LNWEK 423
            H N+V L+G C +    L+V  E+   G+L  ++        P +         L  E 
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            +      ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++     
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDX 204
Query: 484 STKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             K  A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           K+G+G +GTV+K   +N+E    +A+KRV   +         + E+  +  L+H+N+V+L
Sbjct: 9   KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
               +      LV+E+  +  L K+  +D  N       L+ E   S +    + L + H
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKY--FDSCNGD-----LDPEIVKSFLFQLLKGLGFCH 118
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +   + VLHRD+K  N++++     +L DFGLAR     ++ +  + E+     +  P  
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTL--WYRPPD 171
Query: 500 FLVGRATIET--DIYAFGVLILEVACGRKP 527
            L G     T  D+++ G +  E+A   +P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 325 NKLGKGGFGTVYK--GIWRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
            +LGKG F  V +   +   +E A K ++  + S +  Q+   E      L+H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
               E     L+++ +  G L + I    +Y E ++                H   Q L+
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------------HCIQQILE 132
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            + +  +  V+HRD+K  N++L S+      +L DFGLA  ++   +        AGTPG
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG---FAGTPG 189
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           Y++PE           D++A GV++  +  G  P    +Q+     I
Sbjct: 190 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 236

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 42/234 (17%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           +   +F     LG+G FG V K   RN    +  A+K++  T  +     ++EV  + SL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASL 59
Query: 372 RHRNLVKLIGWCYERHDFL-------------LVYEYMPNGSLDKFIFYDETNSGPGEVT 418
            H+ +V+      ER +F+             +  EY  N +L   I  +  N    E  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY- 118
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
             W     +     +AL Y+H+     ++HR++K  NI +D   N ++GDFGLA+ +  +
Sbjct: 119 --WR----LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 479 LK-----------THHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILE 520
           L            +  +     GT  Y+A E     G    + D Y+ G++  E
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 321 FNPKNKLGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL- 371
            N    LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 372 RHRNLVKLIGWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGPGEVT----LNWEKRLS 426
            H N+V L+G C +     +++ E+   G+L  ++        P +      L  E  + 
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD--PDYVRK 203
Query: 487 EIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV---ACGRKPGNQSEQNSYNNSIVH 542
             A  P  +MAPE+      TI++D+++FGVL+ E+        PG + ++         
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------- 254
Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
              E  R+   L         +++  EM   +   L C H  P  RP+   +++ L
Sbjct: 255 ---EFXRR---LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 301

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 321 FNPKNKLGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL- 371
            N    LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 372 RHRNLVKLIGWCYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVT----LNWEKRLS 426
            H N+V L+G C +    L+V  E+   G+L  ++        P +      L  E  + 
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
                ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRK 203
Query: 487 EIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
             A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/116 (37%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 142 SQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           S +VA+EFDT  + +  D N  H+G+DVNS   IR     + +  NG      + Y+  +
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNS---IRSKVTAKWDWQNGKIATAHISYNSVS 57
Query: 201 ----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS 252
               +T + A  +   LS  I+L   LPE V VG SASTG D + N V SW+F  S
Sbjct: 58  KRLSVTSYYAGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS 113

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 27/244 (11%)
Query: 294 DIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVS 351
           +I+  +N      KK R  ++K    +++    +G+G FG V   +     K  A+K +S
Sbjct: 52  NIDNFLNRYEKIVKKIRGLQMKAE--DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLS 109
Query: 352 --ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIF-Y 407
             E  ++    F  E   I +  +   V  +   ++   +L +V EYMP G L   +  Y
Sbjct: 110 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY 169
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
           D        V   W K  +       ALD +H+     ++HRD+K  N++LD   + +L 
Sbjct: 170 D--------VPEKWAKFYTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLA 216
Query: 468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVAC 523
           DFG    + E    H  T    GTP Y++PE        G    E D ++ GV + E+  
Sbjct: 217 DFGTCMKMDETGMVHCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274
Query: 524 GRKP 527
           G  P
Sbjct: 275 GDTP 278

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIGW-CY 384
           +GKG +G V++G W+ + +AVK  S  SR  K  F   E+     LRH N++  I     
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 385 ERHD---FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-- 439
            RH      L+  Y   GSL  ++            TL+    L ++   +  L +LH  
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQL---------TTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 440 ---NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-------A 489
                 +  + HRD+KS NI++       + D GLA      +    ST ++        
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA------VMHSQSTNQLDVGNNPRV 207
Query: 490 GTPGYMAPESFLVGRATIE---------TDIYAFGVLILEVA 522
           GT  YMAPE   V   TI+          DI+AFG+++ EVA
Sbjct: 208 GTKRYMAPE---VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F F  E  S   E    + K+  +++G  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQ--ILNGVY 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
               YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 129 ----YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 323 PKNKL------GKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQE-FIAEVTTI 368
           P+N+L      G G FG V +    G+ ++     +AVK +  ++   ++E  ++E+  +
Sbjct: 37  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 96
Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-----FYDETNSGPG-----EV 417
             L  H N+V L+G C      L++ EY   G L  F+      +  + + P      E+
Sbjct: 97  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 156
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            L+ E  LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ 
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILE---VACGRKPGNQSEQ 533
           +  +++  K  A  P  +MAPES      T E+D++++G+ + E   +     PG   + 
Sbjct: 214 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 271
Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
             Y               +++      L  E +  EM  ++     C   +P  RP+ K 
Sbjct: 272 KFY---------------KMIKEGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQ 313
Query: 594 VLQVLSGE 601
           ++Q++  +
Sbjct: 314 IVQLIEKQ 321

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F F  E  S   E    + K+  +++G  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQ--ILNGVY 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEI 488
               YLH+    ++ H D+K  NIML D        ++ DFGLA  I       +  K I
Sbjct: 129 ----YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIGW-CY 384
           +GKG +G V++G W+ + +AVK  S  SR  K  F   E+     LRH N++  I     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 385 ERH---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-- 439
            RH      L+  Y   GSL  ++            TL+    L ++   +  L +LH  
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQL---------TTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 440 ---NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-------A 489
                 +  + HRD+KS NI++       + D GLA      +    ST ++        
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA------VMHSQSTNQLDVGNNPRV 178
Query: 490 GTPGYMAPESFLVGRATIE---------TDIYAFGVLILEVA 522
           GT  YMAPE   V   TI+          DI+AFG+++ EVA
Sbjct: 179 GTKRYMAPE---VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYK--GIWRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRH 373
           T  +    +LGKG F  V +   I   +E A K ++  + S +  Q+   E      L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIH 429
            N+V+L     E     LV++ +  G L + I    +Y E ++                H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---------------H 107
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTK 486
              Q L+ +++     ++HRD+K  N++L S+      +L DFGLA  +Q + +      
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-- 165
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
             AGTPGY++PE           D++A GV++  +  G  P    +Q+     I
Sbjct: 166 -FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI 218

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIGW-CY 384
           +GKG +G V++G W+ + +AVK  S  SR  K  F   E+     LRH N++  I     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 385 ERH---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-- 439
            RH      L+  Y   GSL  ++            TL+    L ++   +  L +LH  
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYL---------QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 440 ---NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-------A 489
                 +  + HRD+KS NI++       + D GLA      +    ST ++        
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA------VMHSQSTNQLDVGNNPRV 178
Query: 490 GTPGYMAPESFLVGRATIE---------TDIYAFGVLILEVA 522
           GT  YMAPE   V   TI+          DI+AFG+++ EVA
Sbjct: 179 GTKRYMAPE---VLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/308 (22%), Positives = 136/308 (44%), Gaps = 52/308 (16%)
Query: 323 PKNKL------GKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQE-FIAEVTTI 368
           P+N+L      G G FG V +    G+ ++     +AVK +  ++   ++E  ++E+  +
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-----FYDETNSGPGEVTLNWE 422
             L  H N+V L+G C      L++ EY   G L  F+      +  + + P  +  +  
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 423 KRL-----SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
                   S  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILE---VACGRKPGNQSEQ 533
           +  +++  K  A  P  +MAPES      T E+D++++G+ + E   +     PG   + 
Sbjct: 198 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
             Y               +++      L  E +  EM  ++     C   +P  RP+ K 
Sbjct: 256 KFY---------------KMIKEGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQ 297
Query: 594 VLQVLSGE 601
           ++Q++  +
Sbjct: 298 IVQLIEKQ 305

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 323 PKNKL------GKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQE-FIAEVTTI 368
           P+N+L      G G FG V +    G+ ++     +AVK +  ++   ++E  ++E+  +
Sbjct: 39  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 98
Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-----FYDETNSGPG-----EV 417
             L  H N+V L+G C      L++ EY   G L  F+      +  + + P      E+
Sbjct: 99  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            L+ E  LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ 
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILE---VACGRKPGNQSEQ 533
           +  +++  K  A  P  +MAPES      T E+D++++G+ + E   +     PG   + 
Sbjct: 216 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 273
Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
             Y               +++      L  E +  EM  ++     C   +P  RP+ K 
Sbjct: 274 KFY---------------KMIKEGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQ 315
Query: 594 VLQVLSGE 601
           ++Q++  +
Sbjct: 316 IVQLIEKQ 323

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 323 PKNKL------GKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQE-FIAEVTTI 368
           P+N+L      G G FG V +    G+ ++     +AVK +  ++   ++E  ++E+  +
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 103
Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-----FYDETNSGPG-----EV 417
             L  H N+V L+G C      L++ EY   G L  F+      +  + + P      E+
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            L+ E  LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILE---VACGRKPGNQSEQ 533
           +  +++  K  A  P  +MAPES      T E+D++++G+ + E   +     PG   + 
Sbjct: 221 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
             Y               +++      L  E +  EM  ++     C   +P  RP+ K 
Sbjct: 279 KFY---------------KMIKEGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQ 320
Query: 594 VLQVLSGE 601
           ++Q++  +
Sbjct: 321 IVQLIEKQ 328

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F F  E  S   E    + K+  +++G  
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEFLKQ--ILNGVY 128
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEI 488
               YLH+    ++ H D+K  NIML D        ++ DFGLA  I       +  K I
Sbjct: 129 ----YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 123
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 176
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 123
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 176
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G F T  + + +  ++E A+K + +    ++ K  ++  E   +  L H   VKL  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 382 WCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              +         Y  NG L K+I     +DET +           R       S AL+Y
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------RFYTAEIVS-ALEY 145
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH    K ++HRD+K  NI+L+ + + ++ DFG A+ +    K   +     GT  Y++P
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX-FVGTAQYVSP 201
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-----------E 546
           E      A   +D++A G +I ++  G  P     +      I+   +           +
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 547 LRRKGRILDAADSRLGGEFSEKEME 571
           L  K  +LDA   RLG E    EME
Sbjct: 262 LVEKLLVLDAT-KRLGCE----EME 281

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 327 LGKGGFGTVYK----GIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSL-RHRNLV 377
           LG+G FG V +    GI +    + +AVK + E +   +    ++E+  +  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 378 KLIGWCYERHDFLLV-YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH------G 430
            L+G C +    L+V  E+   G+L  ++        P +    ++  L++ H       
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       K  A 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD--PDXVRKGDAR 211
Query: 491 TP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
            P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIML-DSEF---NARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML D        ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 140/308 (45%), Gaps = 52/308 (16%)
Query: 323 PKNKL------GKGGFGTVYK----GIWRNKE---IAVKRVSETSRQGKQE-FIAEVTTI 368
           P+N+L      G G FG V +    G+ ++     +AVK +  ++   ++E  ++E+  +
Sbjct: 44  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 103
Query: 369 GSL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-----FYDETNSGPG-----EV 417
             L  H N+V L+G C      L++ EY   G L  F+      +  + + P      E+
Sbjct: 104 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            L+ E  LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 478 NLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILE---VACGRKPGNQSEQ 533
           +  +++  K  A  P  +MAPES      T E+D++++G+ + E   +     PG   + 
Sbjct: 221 D--SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 278
Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
             Y               +++      L  E +  EM  ++     C   +P  RP+ K 
Sbjct: 279 KFY---------------KMIKEGFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQ 320
Query: 594 VLQVLSGE 601
           ++Q++  +
Sbjct: 321 IVQLIEKQ 328

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKL 379
           K+G+G +G V+K   RN++    +A+K+  E+      + IA  E+  +  L+H NLV L
Sbjct: 10  KIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +     +    LV+EY  +  L +   Y          ++ W+        T QA+++ H
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCH 119
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
             +    +HRD+K  NI++      +L DFG AR +     + +   E+A T  Y +PE 
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVA-TRWYRSPE- 172
Query: 500 FLVGRATI--ETDIYAFGVLILEVACG 524
            LVG        D++A G +  E+  G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 29/234 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYK--GIWRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRH 373
           T  +    +LGKG F  V +   I   +E A K ++  + S +  Q+   E      L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIH 429
            N+V+L     E     LV++ +  G L + I    +Y E ++                H
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---------------H 107
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTK 486
              Q L+ +++     ++HRD+K  N++L S+      +L DFGLA  +Q + +      
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-- 165
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
             AGTPGY++PE           D++A GV++  +  G  P    +Q+     I
Sbjct: 166 -FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI 218

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 7   LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 62
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 63  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 120
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 121 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 171
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 172 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 227 IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 265

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 7   LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 62
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 63  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 120
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 121 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 171
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 172 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 227 IPFEHDEE 234

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 8   LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 63
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 121
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 122 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 173 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 266

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 31/247 (12%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 8   LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 63
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 121
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 122 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK 526
            DFG    +++ + T      +   P ++    +  GR+     +++ G+L+ ++ CG  
Sbjct: 173 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDI 228
Query: 527 PGNQSEQ 533
           P    E+
Sbjct: 229 PFEHDEE 235

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 21  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 76
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 134
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 135 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 186 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 241 IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDR 279

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 20  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 75
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 133
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 134 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 185 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 240 IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDR 278

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 21  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 76
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 134
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 135 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 186 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 241 IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDR 279

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVT 366
           R K+ +     ++ ++ LG G F  V     +   K +A+K +++ + +GK+  +  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWE 422
            +  ++H N+V L           L+ + +  G L D+ +   FY E ++          
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM---LDSEFNARLGDFGLARTIQENL 479
               +I     A+ YLH+     ++HRD+K  N++   LD +    + DFGL++   E+ 
Sbjct: 120 ---RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +  ST    GTPGY+APE       +   D ++ GV+   + CG  P
Sbjct: 172 GSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 31/247 (12%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 8   LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 63
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 64  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 121
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 122 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 172
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK 526
            DFG    +++ + T      +   P ++    +  GR+     +++ G+L+ ++ CG  
Sbjct: 173 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDI 228
Query: 527 PGNQSEQ 533
           P    E+
Sbjct: 229 PFEHDEE 235

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 21  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 76
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 134
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 135 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 186 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 241 IPFEHDEE 248

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 20  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 75
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 133
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 134 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 185 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 240 IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 278

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 20  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 75
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 133
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 134 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 185 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 240 IPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDR 278

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 29/240 (12%)
Query: 321 FNPKNKLGKGGFGTVYK------GIWRNKEIAVKRVSETSRQG--KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K      G+    +   KR +++SR+G  +++   EV+ +  ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 124
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDS----EFNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH+    ++ H D+K  NIML      +   ++ DFGLA  I       +  K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNI 177
Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWE 546
            GTP ++APE        +E D+++ GV+   +  G  P  G+  ++   N S V++ +E
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 20  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 75
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 76  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 133
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 134 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 184
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 185 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 240 IPFEHDEE 247

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +++   +LG G FG V++   R      A K V       K+    E+ T+  LRH  LV
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L     + ++ +++YE+M  G L + +  DE N       ++ ++ +  +    + L +
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNK------MSEDEAVEYMRQVCKGLCH 270
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFN--ARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           +H   E   +H D+K  NIM  ++ +   +L DFGL      +L    S K   GT  + 
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSVKVTTGTAEFA 323
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNN 538
           APE          TD+++ GVL   +  G  P G +++  +  N
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 27  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 83  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 140
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 141 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 192 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 247 IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 21  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 76
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 77  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 134
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 135 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 185
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 186 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 241 IPFEHDEE 248

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 35  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 90
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 91  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 148
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 149 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 199
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 200 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 255 IPFEHDEE 262

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIA-EVT 366
           R K+ +     ++ ++ LG G F  V   +     K +A+K +++ + +GK+  +  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWE 422
            +  ++H N+V L           L+ + +  G L D+ +   FY E ++          
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM---LDSEFNARLGDFGLARTIQENL 479
               +I     A+ YLH+     ++HRD+K  N++   LD +    + DFGL++   E+ 
Sbjct: 120 ---RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +  ST    GTPGY+APE       +   D ++ GV+   + CG  P
Sbjct: 172 GSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 40  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 95
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 96  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 153
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 154 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 204
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 205 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259
Query: 526 KPGNQSEQ 533
            P    E+
Sbjct: 260 IPFEHDEE 267

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I  E+     L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIA-EVT 366
           R K+ +     ++ ++ LG G F  V   +     K +A+K +++ + +GK+  +  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWE 422
            +  ++H N+V L           L+ + +  G L D+ +   FY E ++          
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM---LDSEFNARLGDFGLARTIQENL 479
               +I     A+ YLH+     ++HRD+K  N++   LD +    + DFGL++   E+ 
Sbjct: 120 ---RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +  ST    GTPGY+APE       +   D ++ GV+   + CG  P
Sbjct: 172 GSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVK--RVSETSRQGKQEFIAEVTTIGS 370
           AT  + P  ++G G +GTVYK   R+      +A+K  RV      G    I+ V  +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 371 LR------HRNLVKLIGWCY-ERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTL 419
           LR      H N+V+L+  C   R D      LV+E++ +  L  ++        P E   
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +  ++        + LD+LH      ++HRD+K  NI++ S    +L DFGLAR     +
Sbjct: 124 DLMRQFL------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
               +   +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 175 ----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 217

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +++   +LG G FG V++   R      A K V       K+    E+ T+  LRH  LV
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L     + ++ +++YE+M  G L + +  DE N       ++ ++ +  +    + L +
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNK------MSEDEAVEYMRQVCKGLCH 164
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFN--ARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           +H   E   +H D+K  NIM  ++ +   +L DFGL      +L    S K   GT  + 
Sbjct: 165 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSVKVTTGTAEFA 217
Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNN 538
           APE          TD+++ GVL   +  G  P G +++  +  N
Sbjct: 218 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 261

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQ 356
           ++ T LAP K    E +     +     LG GGFG+VY GI    N  +A+K V +    
Sbjct: 35  LHATKLAPGK----EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 90
Query: 357 GKQEFI------AEVTTIGSLRH--RNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFY 407
              E         EV  +  +      +++L+ W +ER D F+L+ E  P    D F F 
Sbjct: 91  DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFI 148
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARL 466
            E  +      L  E   S      +A+ + HN     VLHRDIK  NI++D +    +L
Sbjct: 149 TERGA------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 199
Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
            DFG    +++ + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG 
Sbjct: 200 IDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 526 KPGNQSEQ------------NSYNNSIVHWLWELRRKGR 552
            P    E+            +S    ++ W   LR   R
Sbjct: 255 IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 293

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVT 366
           R K+ +     ++ ++ LG G F  V     +   K +A+K +++ + +GK+  +  E+ 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 367 TIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWE 422
            +  ++H N+V L           L+ + +  G L D+ +   FY E ++          
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--------- 119
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM---LDSEFNARLGDFGLARTIQENL 479
               +I     A+ YLH+     ++HRD+K  N++   LD +    + DFGL++   E+ 
Sbjct: 120 ---RLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +  ST    GTPGY+APE       +   D ++ GV+   + CG  P
Sbjct: 172 GSVLSTA--CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL----- 379
           LG GG G V+  +  +  K +A+K++  T  Q  +  + E+  I  L H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 380 ---------IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
                    +G   E +   +V EYM           +    GP    L    RL  ++ 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD------LANVLEQGP---LLEEHARL-FMYQ 128
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTKEIA 489
             + L Y+H+ +   VLHRD+K +N+ +++E    ++GDFGLAR +  +        E  
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 490 GTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGR 525
            T  Y +P   L     T   D++A G +  E+  G+
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGI-WRN--KEIAVKRVS-ETSRQGKQ-EFIAEVTTI 368
           L +A   +    ++G+G +G V+K    +N  + +A+KRV  +T  +G     I EV  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 369 GSLR---HRNLVKLIGWC-YERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
             L    H N+V+L   C   R D      LV+E++     D   + D+    PG  T  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPE-PGVPT-- 119
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            E    ++    + LD+LH+    RV+HRD+K  NI++ S    +L DFGLAR     + 
Sbjct: 120 -ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM- 174
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +   +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 175 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LG+G FG V+          VK++S +    +Q +  +V    +L+ R+ V+      ER
Sbjct: 32  LGQGSFGKVF---------LVKKISGSD--ARQLYAMKVLKKATLKVRDRVRT---KMER 77
Query: 387 -------HDFL--LVYEYMPNGSLDKFIFYDETNSG------PGEVTLNWEKRLSVIHGT 431
                  H F+  L Y +   G L  ++  D    G        EV    E     +   
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKL--YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           + ALD+LH+     +++RD+K  NI+LD E + +L DFGL++   ++ K  +S     GT
Sbjct: 136 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGT 189
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             YMAPE       T   D ++FGVL+ E+  G  P
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGI-WRN--KEIAVKRVS-ETSRQGKQ-EFIAEVTTI 368
           L +A   +    ++G+G +G V+K    +N  + +A+KRV  +T  +G     I EV  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 369 GSLR---HRNLVKLIGWC-YERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
             L    H N+V+L   C   R D      LV+E++     D   + D+    PG  T  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPE-PGVPT-- 119
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            E    ++    + LD+LH+    RV+HRD+K  NI++ S    +L DFGLAR     + 
Sbjct: 120 -ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM- 174
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +   +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 175 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LG+G FG V+          VK++S +    +Q +  +V    +L+ R+ V+      ER
Sbjct: 33  LGQGSFGKVF---------LVKKISGSD--ARQLYAMKVLKKATLKVRDRVRT---KMER 78
Query: 387 -------HDFL--LVYEYMPNGSLDKFIFYDETNSG------PGEVTLNWEKRLSVIHGT 431
                  H F+  L Y +   G L  ++  D    G        EV    E     +   
Sbjct: 79  DILVEVNHPFIVKLHYAFQTEGKL--YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 136
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           + ALD+LH+     +++RD+K  NI+LD E + +L DFGL++   ++ K  +S     GT
Sbjct: 137 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGT 190
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             YMAPE       T   D ++FGVL+ E+  G  P
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 73  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 123
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 178
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGI-WRN--KEIAVKRVS-ETSRQGKQ-EFIAEVTTI 368
           L +A   +    ++G+G +G V+K    +N  + +A+KRV  +T  +G     I EV  +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 369 GSLR---HRNLVKLIGWC-YERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
             L    H N+V+L   C   R D      LV+E++     D   + D+    PG  T  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPE-PGVPT-- 119
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            E    ++    + LD+LH+    RV+HRD+K  NI++ S    +L DFGLAR     + 
Sbjct: 120 -ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM- 174
Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +   +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 175 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER 386
           LG+G FG V+          VK++S +    +Q +  +V    +L+ R+ V+      ER
Sbjct: 32  LGQGSFGKVF---------LVKKISGSD--ARQLYAMKVLKKATLKVRDRVRT---KMER 77
Query: 387 -------HDFL--LVYEYMPNGSLDKFIFYDETNSG------PGEVTLNWEKRLSVIHGT 431
                  H F+  L Y +   G L  ++  D    G        EV    E     +   
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKL--YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           + ALD+LH+     +++RD+K  NI+LD E + +L DFGL++   ++ K  +S     GT
Sbjct: 136 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGT 189
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             YMAPE       T   D ++FGVL+ E+  G  P
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           K+G+G +GTV+K   +N+E    +A+KRV   +         + E+  +  L+H+N+V+L
Sbjct: 9   KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
               +      LV+E+  +  L K+  +D  N       L+ E   S +    + L + H
Sbjct: 67  HDVLHSDKKLTLVFEFC-DQDLKKY--FDSCNGD-----LDPEIVKSFLFQLLKGLGFCH 118
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           +   + VLHRD+K  N++++     +L +FGLAR     ++ +  + E+     +  P  
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTL--WYRPPD 171
Query: 500 FLVGRATIET--DIYAFGVLILEVA-CGRK--PGN 529
            L G     T  D+++ G +  E+A  GR   PGN
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 125
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAPE--LLK 180
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEF-IAEVTTIGSLR--- 372
           AT  + P  ++G G +GTVYK    +    V   S     G++   I+ V  +  LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 373 ---HRNLVKLIGWCY-ERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
              H N+V+L+  C   R D      LV+E++     D   + D+    PG   L  E  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPP-PG---LPAETI 114
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             ++    + LD+LH      ++HRD+K  NI++ S    +L DFGLAR     +    +
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM----A 167
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 46/286 (16%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIAEVTTIGSL---- 371
           +F   ++LG G +G V+K   R+KE     AVKR S +  +G ++   ++  +GS     
Sbjct: 58  SFQRLSRLGHGSYGEVFK--VRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           +H   V+L    +E    L +   +   SL +       +    +V   W      +  T
Sbjct: 115 QHPCCVRLE-QAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQV---W----GYLRDT 166
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL +LH+   + ++H D+K +NI L      +LGDFGL       L T  + +   G 
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV----ELGTAGAGEVQEGD 219
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YMAPE  L G      D+++ G+ ILEVAC  +  +  E            W+  R+G
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQG 267
Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
            +     + L       E+  VL++ L    P+P LR + + +L +
Sbjct: 268 YLPPEFTAGL-----SSELRSVLVMML---EPDPKLRATAEALLAL 305

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEF-IAEVTTIGSLR--- 372
           AT  + P  ++G G +GTVYK    +    V   S     G++   I+ V  +  LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 373 ---HRNLVKLIGWCY-ERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
              H N+V+L+  C   R D      LV+E++     D   + D+    PG   L  E  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPP-PG---LPAETI 114
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             ++    + LD+LH      ++HRD+K  NI++ S    +L DFGLAR     +    +
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM----A 167
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G +G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 26  SLHFNFQSFTEQNRNE-LSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SLHF F  F++  ++  L  D ST +   +Q+T    G+P +N  GRA+Y     +W D 
Sbjct: 125 SLHFTFNQFSQSPKDLILQGDASTDSDGNLQLTRVSNGSPQSNSVGRALYYAPVHVW-DK 183
Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGI 131
             V A+F  TF   I +  + P +G+AF IA  +  +P  S G+ LG+
Sbjct: 184 SAVVASFDATFTFLIKSPDSDPADGIAFFIANTDSSIPHGSGGRLLGL 231

>pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--GQN 200
           IVA+E DT  + +  D N  H+G+++ S   IR    TR N+ +G      + Y+   + 
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKS---IRSKATTRWNVQDGKVGTAHISYNSVAKR 60
Query: 201 ITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           ++  V+     +  +S  +DL+  LPE V VG SASTG   + N + SW+F
Sbjct: 61  LSAIVSYPGGSSATVSYDVDLNNILPEWVRVGLSASTGVYKETNTILSWSF 111

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 30/246 (12%)
Query: 293 DDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVK 348
           +D EG++    L P  +   E ++       + +LG+G FG V++   ++K+     AVK
Sbjct: 49  EDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVK 103
Query: 349 RVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           +V  E  R      + E+     L    +V L G   E     +  E +  GSL + I  
Sbjct: 104 KVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-- 155
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARL 466
                G     L  ++ L  +    + L+YLH    +R+LH D+K+ N++L S+ + A L
Sbjct: 156 --KQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 206
Query: 467 GDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
            DFG A  +Q +   K+  +   I GT  +MAPE  +      + DI++   ++L +  G
Sbjct: 207 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266
Query: 525 RKPGNQ 530
             P  Q
Sbjct: 267 CHPWTQ 272

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 327 LGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LG G F  V+  K     K  A+K + ++          E+  +  ++H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS-VIHGTSQALDYLHNGSE 443
               + LV + +  G L   I          E  +  EK  S VI     A+ YLH   E
Sbjct: 77  STTHYYLVMQLVSGGELFDRIL---------ERGVYTEKDASLVIQQVLSAVKYLH---E 124
Query: 444 KRVLHRDIKSSNIM-LDSEFNARL--GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             ++HRD+K  N++ L  E N+++   DFGL++  Q  + +        GTPGY+APE  
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-----TACGTPGYVAPEVL 179
Query: 501 LVGRATIETDIYAFGVLILEVACGRKP 527
                +   D ++ GV+   + CG  P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 27/235 (11%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEF------I 362
           +KE +     +     LG GGFG+VY GI    N  +A+K V +       E        
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 363 AEVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTL 419
            EV  +  +      +++L+ W +ER D F+L+ E  P    D F F  E  +      L
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------L 112
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQEN 478
             E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ 
Sbjct: 113 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           + T      +   P ++    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 220

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 35/247 (14%)
Query: 306 PKKFRLKELKKATGNFNPK----NKLGKGGFGTVYKGI--WRNKEIAVKRVS-------- 351
           PK   L+ L    G ++ K    + LG G FG V+  +   +NKE+ VK +         
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 352 --ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE 409
             E  + GK     E+  +  + H N++K++     +  F LV E   +G LD F F D 
Sbjct: 67  WIEDPKLGK--VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDR 123
Query: 410 TNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF 469
                    L+      +      A+ YL     K ++HRDIK  NI++  +F  +L DF
Sbjct: 124 HPR------LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT--IETDIYAFGVLILEVACGRKP 527
           G A  ++   K  ++     GT  Y APE  L+G      E ++++ GV +  +     P
Sbjct: 175 GSAAYLERG-KLFYT---FCGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
Query: 528 GNQSEQN 534
             + E+ 
Sbjct: 230 FCELEET 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 27/235 (11%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEF------I 362
           +KE +     +     LG GGFG+VY GI    N  +A+K V +       E        
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 363 AEVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTL 419
            EV  +  +      +++L+ W +ER D F+L+ E  P    D F F  E  +      L
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------L 112
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQEN 478
             E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ 
Sbjct: 113 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           + T      +   P ++    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 27/235 (11%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEF------I 362
           +KE +     +     LG GGFG+VY GI    N  +A+K V +       E        
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 363 AEVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTL 419
            EV  +  +      +++L+ W +ER D F+L+ E  P    D F F  E  +      L
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------L 112
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQEN 478
             E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ 
Sbjct: 113 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           + T      +   P ++    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQE---FIAEVTTI-GSLRHRNLVKLI 380
           +GKG FG V     + +E+  AVK + + +   K+E    ++E   +  +++H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 381 GWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            + ++  D L  V +Y+  G L    FY           L    R       S AL YLH
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----FYHLQRE---RCFLEPRARFYAAEIAS-ALGYLH 156
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           + +   +++RD+K  NI+LDS+ +  L DFGL +   EN++ + +T    GTP Y+APE 
Sbjct: 157 SLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 500 FLVGRATIETDIYAFGVLILEVACGRKP 527
                     D +  G ++ E+  G  P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 327 LGKGGFGTVYK-----GIWRNKEIAVKRVSETS--RQGKQ--EFIAEVTTIGSLRHRNLV 377
           LGKGG+G V++     G    K  A+K + +    R  K      AE   +  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSL-----DKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
            LI          L+ EY+  G L      + IF ++T                 +   S
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC-------------FYLAEIS 131
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR-TIQENLKTHHSTKEIAGT 491
            AL +LH   +K +++RD+K  NIML+ + + +L DFGL + +I +   TH       GT
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH----TFCGT 184
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             YMAPE  +        D ++ G L+ ++  G  P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 35/216 (16%)
Query: 327 LGKGGFGTVYK-----GIWRNKEIAVKRVSETS--RQGKQ--EFIAEVTTIGSLRHRNLV 377
           LGKGG+G V++     G    K  A+K + +    R  K      AE   +  ++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 378 KLIGWCYERHDFLLVYEYMPNGSL-----DKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
            LI          L+ EY+  G L      + IF ++T                 +   S
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC-------------FYLAEIS 131
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR-TIQENLKTHHSTKEIAGT 491
            AL +LH   +K +++RD+K  NIML+ + + +L DFGL + +I +   TH       GT
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH----XFCGT 184
Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             YMAPE  +        D ++ G L+ ++  G  P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 116/257 (45%), Gaps = 31/257 (12%)
Query: 284 RRYRARELD---DDIEGLINGTNLAPKKFRLKE-LKKATGNFNPKNKLGKGGFGTVYKGI 339
           R  R+RE     +D EG++    L P  +  +E +  AT       +LG+G FG V++  
Sbjct: 58  RGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRME 113
Query: 340 WRNK--EIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM 396
            +    + AVK+V  E  R        E+     L    +V L G   E     +  E +
Sbjct: 114 DKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELL 167
Query: 397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI 456
             GSL + +          +  L  ++ L  +    + L+YLH+   +R+LH D+K+ N+
Sbjct: 168 EGGSLGQLVKE--------QGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNV 216
Query: 457 MLDSE-FNARLGDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYA 513
           +L S+  +A L DFG A  +Q +   K+  +   I GT  +MAPE  L      + D+++
Sbjct: 217 LLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 276
Query: 514 FGVLILEVACGRKPGNQ 530
              ++L +  G  P  Q
Sbjct: 277 SCCMMLHMLNGCHPWTQ 293

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI-AEVTTIGSLRHRNLVKLIGWCYE 385
           +GKG +G V++G+W  + +AVK  S  SR  +  F   E+     LRH N++  I     
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFS--SRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 386 RHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-- 439
             +      L+  Y  +GSL  F+            TL     L +    +  L +LH  
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFL---------QRQTLEPHLALRLAVSAACGLAHLHVE 124
Query: 440 ---NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN---LKTHHSTKEIAGTPG 493
                 +  + HRD KS N+++ S     + D GLA    +    L   ++ +   GT  
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR--VGTKR 182
Query: 494 YMAPESF--LVGRATIE----TDIYAFGVLILEVA 522
           YMAPE     +     E    TDI+AFG+++ E+A
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEF-IAEVTTIGSLR--- 372
           AT  + P  ++G G +GTVYK    +    V   S     G++   I+ V  +  LR   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 373 ---HRNLVKLIGWCY-ERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
              H N+V+L+  C   R D      LV+E++     D   + D+    PG   L  E  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPP-PG---LPAETI 114
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             ++    + LD+LH      ++HRD+K  NI++ S    +L DFGLAR     +    +
Sbjct: 115 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM----A 167
Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +  T  Y APE  L        D+++ G +  E+   RKP
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKP 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEF------I 362
           +KE +     +     LG GGFG+VY GI    N  +A+K V +       E        
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 363 AEVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTL 419
            EV  +  +      +++L+ W +ER D F+L+ E  P    D F F  E  +      L
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------L 134
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQEN 478
             E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ 
Sbjct: 135 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 191
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQSEQ 533
           + T     +  GT  Y  PE     R    +  +++ G+L+ ++ CG  P    E+
Sbjct: 192 VYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 242

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 327 LGKGGFGTVYKGIWRNKE--IAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWC 383
           LG+G  G V   + R  E  +AVK V         E I +   I   L H N+VK  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E +   L  EY   G L     +D      G    + ++     H     + YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL-----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLHGIG- 124
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
             + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+APE  L+ 
Sbjct: 125 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPE--LLK 179
Query: 504 RATIE---TDIYAFGVLILEVACGRKPGNQ 530
           R        D+++ G+++  +  G  P +Q
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------A 363
           KE +     +     LG GGFG+VY GI    N  +A+K V +       E         
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 364 EVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
           EV  +  +      +++L+ W +ER D F+L+ E  P    D F F  E  +      L 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------LQ 112
Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENL 479
            E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ +
Sbjct: 113 EELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 169
Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
            T      +   P ++    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYK--GIWRNKEIA--VKRVSETSRQGKQEFIAEVTTIGSLRH 373
           T  +    +LGKG F  V +   +   +E A  +    + S +  Q+   E      L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIH 429
            N+V+L     E     L+++ +  G L + I    +Y E ++                H
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------------H 114
Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTK 486
              Q L+ + +  +  V+HR++K  N++L S+      +L DFGLA  ++   +      
Sbjct: 115 CIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
             AGTPGY++PE           D++A GV++  +  G  P    +Q+     I
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 30/246 (12%)
Query: 293 DDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVK 348
           +D EG++    L P  +   E ++       + ++G+G FG V++   ++K+     AVK
Sbjct: 35  EDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVK 89
Query: 349 RVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           +V  E  R      + E+     L    +V L G   E     +  E +  GSL + I  
Sbjct: 90  KVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-- 141
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARL 466
                G     L  ++ L  +    + L+YLH    +R+LH D+K+ N++L S+ + A L
Sbjct: 142 --KQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 192
Query: 467 GDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
            DFG A  +Q +   K+  +   I GT  +MAPE  +      + DI++   ++L +  G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 525 RKPGNQ 530
             P  Q
Sbjct: 253 CHPWTQ 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 30/246 (12%)
Query: 293 DDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVK 348
           +D EG++    L P  +   E ++       + ++G+G FG V++   ++K+     AVK
Sbjct: 51  EDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVK 105
Query: 349 RVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFY 407
           +V  E  R      + E+     L    +V L G   E     +  E +  GSL + I  
Sbjct: 106 KVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-- 157
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARL 466
                G     L  ++ L  +    + L+YLH    +R+LH D+K+ N++L S+ + A L
Sbjct: 158 --KQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAAL 208
Query: 467 GDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
            DFG A  +Q +   K+  +   I GT  +MAPE  +      + DI++   ++L +  G
Sbjct: 209 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268
Query: 525 RKPGNQ 530
             P  Q
Sbjct: 269 CHPWTQ 274

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 31/257 (12%)
Query: 284 RRYRARELD---DDIEGLINGTNLAPKKFRLKE-LKKATGNFNPKNKLGKGGFGTVYKGI 339
           R  R+RE     +D EG++    L P  +  +E +  AT       +LG+G FG V++  
Sbjct: 39  RGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRME 94
Query: 340 WRNK--EIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM 396
            +    + AVK+V  E  R        E+     L    +V L G   E     +  E +
Sbjct: 95  DKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELL 148
Query: 397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI 456
             GSL + +          +  L  ++ L  +    + L+YLH+   +R+LH D+K+ N+
Sbjct: 149 EGGSLGQLVKE--------QGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNV 197
Query: 457 MLDSE-FNARLGDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYA 513
           +L S+  +A L DFG A  +Q +   K   +   I GT  +MAPE  L      + D+++
Sbjct: 198 LLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 257
Query: 514 FGVLILEVACGRKPGNQ 530
              ++L +  G  P  Q
Sbjct: 258 SCCMMLHMLNGCHPWTQ 274

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 29/235 (12%)
Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------A 363
           KE +     +     LG GGFG+VY GI    N  +A+K V +       E         
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 364 EVTTIGSLR--HRNLVKLIGWCYERHD-FLLVYEYM-PNGSLDKFIFYDETNSGPGEVTL 419
           EV  +  +      +++L+ W +ER D F+L+ E M P   L  FI    T  G     L
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERMEPVQDLFDFI----TERG----AL 111
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQEN 478
             E   S      +A+ + HN     VLHRDIK  NI++D +    +L DFG    +++ 
Sbjct: 112 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           + T      +   P ++    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 219

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWC 383
           L +GGF  VY+   +   +E A+KR+     +  +  I EV  +  L  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 384 ---YERHD-----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
               E  D     FLL+ E +  G L +F+   E+  GP    L+ +  L + + T +A+
Sbjct: 96  SIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESR-GP----LSCDTVLKIFYQTCRAV 149
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA------ 489
            ++H   +  ++HRD+K  N++L ++   +L DFG A TI        S +  A      
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 490 ---GTPGYMAPE------SFLVGRATIETDIYAFGVLILEVACGRK 526
               TP Y  PE      +F +G    + DI+A G  IL + C R+
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGE---KQDIWALGC-ILYLLCFRQ 250

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 327 LGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------AEVTTIGSLR--HRNL 376
           LG GGFG+VY GI    N  +A+K V +       E         EV  +  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 377 VKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           ++L+ W +ER D F+L+ E  P    D F F  E  +      L  E   S      +A+
Sbjct: 72  IRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------LQEELARSFFWQVLEAV 123
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            + HN     VLHRDIK  NI++D +    +L DFG    +++ + T      +   P +
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           +    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 181 IRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 215

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 29/158 (18%)
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA- 434
           LVKL     +  +  +V EYMP G +    F      G          R S  H    A 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIG----------RFSEPHARFYAA 148
Query: 435 -----LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
                 +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + 
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK------GRTWXLC 199
Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 327 LGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------AEVTTIGSLR--HRNL 376
           LG GGFG+VY GI    N  +A+K V +       E         EV  +  +      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 377 VKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           ++L+ W +ER D F+L+ E  P    D F F  E  +      L  E   S      +A+
Sbjct: 75  IRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------LQEELARSFFWQVLEAV 126
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            + HN     VLHRDIK  NI++D +    +L DFG    +++ + T      +   P +
Sbjct: 127 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 183
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           +    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 184 IRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 218

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 29/158 (18%)
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA- 434
           LVKL     +  +  +V EYMP G +    F      G          R S  H    A 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIG----------RFSEPHARFYAA 148
Query: 435 -----LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
                 +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + 
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK------GRTWXLC 199
Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 327 LGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------AEVTTIGSLR--HRNL 376
           LG GGFG+VY GI    N  +A+K V +       E         EV  +  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 377 VKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           ++L+ W +ER D F+L+ E  P    D F F  E  +      L  E   S      +A+
Sbjct: 72  IRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------LQEELARSFFWQVLEAV 123
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            + HN     VLHRDIK  NI++D +    +L DFG    +++ + T      +   P +
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           +    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 181 IRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 215

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFGLA+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 327 LGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGKQEFI------AEVTTIGSLR--HRNL 376
           LG GGFG+VY GI    N  +A+K V +       E         EV  +  +      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 377 VKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           ++L+ W +ER D F+L+ E  P    D F F  E  +      L  E   S      +A+
Sbjct: 72  IRLLDW-FERPDSFVLILE-RPEPVQDLFDFITERGA------LQEELARSFFWQVLEAV 123
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            + HN     VLHRDIK  NI++D +    +L DFG    +++ + T      +   P +
Sbjct: 124 RHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
           +    +  GR+     +++ G+L+ ++ CG  P    E+
Sbjct: 181 IRYHRYH-GRSAA---VWSLGILLYDMVCGDIPFEHDEE 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 33/241 (13%)
Query: 302 TNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGKQ 359
           T+  P KF  +++ K T        LG+G +  V   +     KE AVK + + +   + 
Sbjct: 3   TDSLPGKF--EDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 360 EFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
               EV T+   + ++N+++LI +  +   F LV+E +  GS+   I          +  
Sbjct: 56  RVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--------QKQKH 107
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTI 475
            N  +   V+   + ALD+LH    K + HRD+K  NI+ +S       ++ DF L   +
Sbjct: 108 FNEREASRVVRDVAAALDFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGM 164
Query: 476 Q-ENLKTHHSTKEI---AGTPGYMAPE--SFLVGRATI---ETDIYAFGVLILEVACGRK 526
           +  N  T  +T E+    G+  YMAPE       +AT      D+++ GV++  +  G  
Sbjct: 165 KLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224
Query: 527 P 527
           P
Sbjct: 225 P 225

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR----------HR 374
           LGKGGFGTV+ G  +    ++A+K +      G       VT    +           H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS---GPGEVTLNWEKRLSVIHGT 431
            +++L+ W   +  F+LV E  P  + D F +  E      GP                 
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFG----------- 146
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQENLKTHHSTKEIAG 490
            Q +  + +   + V+HRDIK  NI++D     A+L DFG    + +   T      +  
Sbjct: 147 -QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205
Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
            P +++   +    AT    +++ G+L+ ++ CG  P  + ++
Sbjct: 206 PPEWISRHQYHALPAT----VWSLGILLYDMVCGDIPFERDQE 244

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFGLA+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 23/227 (10%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVS--ETSRQGKQEFIAEV 365
           ++++L+    ++     +G+G FG V   +     K  A+K +S  E  ++    F  E 
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 366 TTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
             I +  +   V  + + ++   +L +V EYMP G L   +          +V   W + 
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWARF 172
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
            +       ALD +H+      +HRD+K  N++LD   + +L DFG    + +       
Sbjct: 173 YTA--EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 485 TKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVACGRKP 527
           T    GTP Y++PE        G    E D ++ GV + E+  G  P
Sbjct: 228 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 27/229 (11%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEI----AVKRVS--ETSRQGKQEFIA 363
           ++++L+    ++     +G+G FG V   + R+K      A+K +S  E  ++    F  
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 122
Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
           E   I +  +   V  + + ++   +L +V EYMP G L   +          +V   W 
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWA 175
Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           +  +       ALD +H+      +HRD+K  N++LD   + +L DFG    + +     
Sbjct: 176 RFYTA--EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 483 HSTKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVACGRKP 527
             T    GTP Y++PE        G    E D ++ GV + E+  G  P
Sbjct: 231 CDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 320 NFNPKNKLGKGGFGT-VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +F PK+ LG G  GT VY+G++ N+++AVKR+           +  +    S  H N+++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE--SDEHPNVIR 82
Query: 379 LIGWCYER-HDFLLVYEYMPNGSLDKFIFY-DETNSGPGEVTLNWEKRLSVIHGTSQALD 436
              +C E+   F  +   +   +L +++   D  + G   +TL        +  T+  L 
Sbjct: 83  Y--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL--------LQQTTSGLA 132
Query: 437 YLHNGSEKRVLHRDIKSSNIMLD-----SEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           +LH+ +   ++HRD+K  NI++       +  A + DFGL + +     +      + GT
Sbjct: 133 HLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 492 PGYMAPESF---LVGRATIETDIYAFG-VLILEVACGRKPGNQSEQNSYN 537
            G++APE          T   DI++ G V    ++ G  P  +S Q   N
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 23/227 (10%)
Query: 310 RLKELKKATGNFNPKNKLGKGGFGTV--YKGIWRNKEIAVKRVS--ETSRQGKQEFIAEV 365
           ++++L+    ++     +G+G FG V   +     K  A+K +S  E  ++    F  E 
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 366 TTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
             I +  +   V  + + ++   +L +V EYMP G L   +          +V   W + 
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWARF 177
Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
            +       ALD +H+      +HRD+K  N++LD   + +L DFG    + +       
Sbjct: 178 YTA--EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 232
Query: 485 TKEIAGTPGYMAPESFLV----GRATIETDIYAFGVLILEVACGRKP 527
           T    GTP Y++PE        G    E D ++ GV + E+  G  P
Sbjct: 233 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWX 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 105/249 (42%), Gaps = 44/249 (17%)
Query: 298 LINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQG 357
           L N +NL      +KE  K   ++     L +G F  +      NK  A+K+  ++  + 
Sbjct: 10  LSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEK 69
Query: 358 KQEFIA-----------------EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS 400
           K++F                   E+  I  +++   +   G      +  ++YEYM N S
Sbjct: 70  KRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS 129
Query: 401 L---DKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSS 454
           +   D++ F  + N     P +V         +I     +  Y+HN  EK + HRD+K S
Sbjct: 130 ILKFDEYFFVLDKNYTCFIPIQVIK------CIIKSVLNSFSYIHN--EKNICHRDVKPS 181
Query: 455 NIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG---YMAPESFLVGRAT--IET 509
           NI++D     +L DFG +  + +        K+I G+ G   +M PE F    +    + 
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVD--------KKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 510 DIYAFGVLI 518
           DI++ G+ +
Sbjct: 234 DIWSLGICL 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK------GRTWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK------GRTWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK------GRTWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  +AGTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLAGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+M+D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 29/158 (18%)
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA- 434
           LVKL     +  +  +V EY+P G +    F      G          R S  H    A 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFYAA 148
Query: 435 -----LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
                 +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + 
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVK------GRTWXLC 199
Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 200 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           +LG G FG V++ + +   +    K ++      K     E++ +  L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            ++++ +L+ E++  G L   I  ++      EV          I+   QA + L +  E
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV----------INYMRQACEGLKHMHE 167
Query: 444 KRVLHRDIKSSNIMLDSE--FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
             ++H DIK  NIM +++   + ++ DFGLA      L      K    T  + APE  +
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIVKVTTATAEFAAPE--I 221
Query: 502 VGRATI--ETDIYAFGVLILEVACGRKP 527
           V R  +   TD++A GVL   +  G  P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 26  SLHFNFQSFTEQNRNE-LSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SLHF F  F++  ++  L  D ST +   +Q+T    G+P +N  GRA+Y     +W D 
Sbjct: 125 SLHFTFNQFSQNPKDLILQGDASTDSDGNLQLTRVSNGSPQSNSVGRALYYAPVHVW-DK 183
Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGI 131
             V A+F  TF   I +  +   +G+AF IA  +  +P  S G+ LG+
Sbjct: 184 SAVVASFDATFTFLIKSTDSDIADGIAFFIANTDSSIPHGSGGRLLGL 231

>pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--GQN 200
           IVA+E DT  + +  D N  H+G+++ S   IR    TR N+ +G      + Y+   + 
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKS---IRSKATTRWNVQDGKVGTAHISYNSVAKR 60
Query: 201 ITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           ++  V+     +  +S  +DL+  LPE V VG SASTG   + N + SW+F
Sbjct: 61  LSAIVSYPGGSSATVSYDVDLNNILPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 93
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 139
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 140 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWX 190
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 191 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 320 NFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL- 376
           +  P  +LG+G +G V K   +   +  AVKR+  T    +Q+ +     I S R  +  
Sbjct: 35  DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDI-SXRTVDCP 93
Query: 377 --VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
             V   G  +   D  +  E + + SLDKF  Y +       +  +   +++V     +A
Sbjct: 94  FTVTFYGALFREGDVWICXE-LXDTSLDKF--YKQVIDKGQTIPEDILGKIAV--SIVKA 148
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI-AGTPG 493
           L++LH  S+  V+HRD+K SN+++++    +  DFG++  + +++      K+I AG   
Sbjct: 149 LEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV-----AKDIDAGCKP 201
Query: 494 YMAPESF---LVGRA-TIETDIYAFGVLILEVACGRKP 527
           Y APE     L  +  ++++DI++ G+  +E+A  R P
Sbjct: 202 YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWX 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 100
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 146
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 197
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWX 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWX 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE---TSRQG--KQEFIAEVTTIGSLRHRNLVKL 379
           +GKG F  V + I R   ++ AVK V     TS  G   ++   E +    L+H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +          +V+E+M    L  F      ++G       + + ++  H   Q L+ L 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAG-----FVYSEAVAS-HYMRQILEALR 144
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
              +  ++HRD+K  N++L S+ N+   +LGDFG+A  + E+           GTP +MA
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR---VGTPHFMA 201
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           PE           D++  GV++  +  G  P   +++  +   I
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 86
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 132
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 133 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWT 183
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 184 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 101
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 147
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 148 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWT 198
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 327 LGKGGFGTVY-------------KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           LG G FG V              K + + K + +K++  T        + E   + ++  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNF 121
Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             LVKL     +  +  +V EY+P G +    F      G          R S  H    
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIG----------RFSEPHARFY 167
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A       +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  
Sbjct: 168 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWX 218
Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           + GTP Y+APE  L        D +A GVLI E+A G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++       +T  + GTP Y
Sbjct: 175 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GATWTLCGTPEY 225
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 29  FNFQSFTEQNRNELSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNKNV 87
           FNF +F   ++  L  + +  +K  +Q+T       P  +  GRA Y D  Q+ +D+ NV
Sbjct: 6   FNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQI-KDSNNV 64
Query: 88  KATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIV 145
            A+F+T  TF++   NQ+     GLAF +      P+  + ++LGI N   N    ++ V
Sbjct: 65  -ASFNTNFTFIIRAKNQSIS-AYGLAFALVPVNSPPQKKQ-EFLGIFN-TNNPEPNARTV 120
Query: 146 AIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITV-- 203
           A+ F+T K+   D + N +   VN      +         NG    VQ+ YD  N  +  
Sbjct: 121 AVVFNTFKN-RIDFDKNFIKPYVNENCDFHKY--------NGEKTDVQITYDSSNNDLRV 171
Query: 204 ---FVANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
              F  +     +S  + L + + E V VGFS ++G   D T+ + V SW+F
Sbjct: 172 FLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 149 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 199
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 200 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 147 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPEY 197
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
             +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP 
Sbjct: 140 TFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVK------GRTWXLCGTPE 190
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE  L        D +A GVLI E+A G  P
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 114/262 (43%), Gaps = 46/262 (17%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  + + RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 92  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 141
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 142 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           E  L  +  T   DI++ G ++ E+   R   PG             H+L +L     IL
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK------------HYLDQLNHILGIL 246
Query: 555 DAADSRLGGEFSEKEMECVLIL 576
                   G  S++++ C++ L
Sbjct: 247 --------GSPSQEDLNCIINL 260

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 155 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 205
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A+K +S+      ++R+         E+  +  L H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 126
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 127 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 179
Query: 493 GYMAPESFL-VGRATI--ETDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A+K +S+      ++R+         E+  +  L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 127
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 180
Query: 493 GYMAPESFL-VGRATI--ETDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A+K +S+      ++R+         E+  +  L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 127
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 180
Query: 493 GYMAPESFL-VGRATI--ETDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A+K +S+      ++R+         E+  +  L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 127
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 180
Query: 493 GYMAPESFL-VGRATI--ETDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 327 LGKGGFGTVYKGI-WRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           LG+G FG V++ +   +K+  + +  +     +     E++ +   RHRN++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
             + ++++E++    LD F   +  N+   E  LN  + +S +H   +AL +LH+ +   
Sbjct: 73  MEELVMIFEFI--SGLDIF---ERINTSAFE--LNEREIVSYVHQVCEALQFLHSHN--- 122
Query: 446 VLHRDIKSSNIMLDSEFNA--RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           + H DI+  NI+  +  ++  ++ +FG AR     LK   + + +   P Y APE     
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR----QLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 504 RATIETDIYAFGVLILEVACGRKP 527
             +  TD+++ G L+  +  G  P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A+K +S+      ++R+         E+  +  L H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 133
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 134 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 186
Query: 493 GYMAPESFL-VGRATI--ETDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 175 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPEY 225
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLXGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V       R   +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGI---- 106
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV----TLNWEKRLSVIHGTSQALDYLH 439
               D L           D +I  D   +   ++     L+ +     ++   + L Y+H
Sbjct: 107 ---RDILRASTL--EAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
           + +   VLHRD+K SN+++++  + ++ DFGLAR             E   T  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 500 FLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
            L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  LV   M    L K +             L+ +     ++   + L Y
Sbjct: 110 IRAPTIEQMKDVYLVTHLM-GADLYKLL---------KTQHLSNDHICYFLYQILRGLKY 159
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 160 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 26  SLHFNFQSFTEQNRNE-LSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           SLHF F  F++  ++  L  D ST +   +Q+T    G+P ++  GRA+Y     +W D 
Sbjct: 125 SLHFTFNQFSQSPKDLILQGDASTDSDGNLQLTRVSNGSPQSDSVGRALYYAPVHIW-DK 183
Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGI 131
             V A+F  TF   I +   +  +G+AF IA  +  +P  S G+ LG+
Sbjct: 184 SAVVASFDATFTFLIKSPDREIADGIAFFIANTDSSIPHGSGGRLLGL 231

>pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDIND---NHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           IVA+E DT      DI D    H+G+++ S   IR    TR ++ NG      + Y+   
Sbjct: 4   IVAVELDTYP--NTDIGDPSYQHIGINIKS---IRSKATTRWDVQNGKVGTAHISYNSVA 58
Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++  V+     +  +S  +DL+  LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPGGSSATVSYDVDLNNILPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  + + RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 92  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 141
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 142 IHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLPE 122
           + N  GRA+Y     +W       A F T  TFV++  N +    +G  F IA     P+
Sbjct: 37  VRNTVGRALYSSPIHIWDSKTGNVANFVTSFTFVIDAPN-SYNVADGFTFFIAPVDTKPQ 95
Query: 123 NSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLT 180
            + G +LG+ N   +    SQ VA+EFDT    +++    D H+G+DVNS+ SI      
Sbjct: 96  -TGGGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSWA 153
Query: 181 RVNLANGTDIKVQVRYDG 198
              L NG +  V + ++G
Sbjct: 154 ---LQNGKEANVVIAFNG 168

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 139
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 139
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLPE 122
           + N  GRA+Y     +W       A F T  TFV++  N +    +G  F IA     P+
Sbjct: 37  VRNTVGRALYSSPIHIWDSKTGNVANFVTSFTFVIDAPN-SYNVADGFTFFIAPVDTKPQ 95
Query: 123 NSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLT 180
            + G +LG+ N   +    SQ VA+EFDT    +++    D H+G+DVNS+ SI      
Sbjct: 96  -TGGGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW- 152
Query: 181 RVNLANGTDIKVQVRYDG 198
              L NG +  V + ++G
Sbjct: 153 --KLQNGKEANVVIAFNG 168

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGW 382
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI--- 86
Query: 383 CYERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               +D +     E M +  + + +   +         L+ +     ++   + L Y+H+
Sbjct: 87  ----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
            +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 501 LVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 90  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 139
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 140 IHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGW 382
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI--- 88
Query: 383 CYERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               +D +     E M +  + + +   +         L+ +     ++   + L Y+H+
Sbjct: 89  ----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
            +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 501 LVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 202 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 8/137 (5%)
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTA-QPGEGLAFVIAGNKDLPEN 123
           + N  GRA+Y     +W       A F+TTF+  I         +G  F IA     P+ 
Sbjct: 38  VKNTVGRALYSLPIHIWDSETGNVADFTTTFIFVIDAPNGYNVADGFTFFIAPVDTKPQ- 96
Query: 124 SEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLTR 181
           + G +LG+ NG  +    +Q VA+EFDT    +++      H+G+DVN++ SI       
Sbjct: 97  TGGGYLGVFNG-KDYDKTAQTVAVEFDTFYNAAWDPSNGKRHIGIDVNTIKSIST---KS 152
Query: 182 VNLANGTDIKVQVRYDG 198
            NL NG +  V + ++ 
Sbjct: 153 WNLQNGEEAHVAISFNA 169

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G FG V+K   R   +++A+K+V  E  ++G     + E+  +  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 382 WC------YERH--DFLLVYEYMPN---GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
            C      Y R      LV+++  +   G L   +          + TL+  KR  V+  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKR--VMQM 133
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEI 488
               L Y+H     ++LHRD+K++N+++  +   +L DFGLAR  ++ +N + +     +
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 489 AGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
             T  Y  PE  L  R      D++  G ++ E+   R P  Q     +  +++  L
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL 245

>pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 65  ITNQSGRAIYKDQFQLW-RDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLP 121
           + N  GRA+Y     +W R+  NV A F T  TFV+N  N +    +G  F IA     P
Sbjct: 37  VKNTVGRALYSSPIHIWDRETGNV-ANFVTSFTFVINAPN-SYNVADGFTFFIAPVDTKP 94
Query: 122 ENSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           + + G +LG+ N        +Q VA+EFDT    +++    D H+G+DVN   SI+ V  
Sbjct: 95  Q-TGGGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVN---SIKSVNT 149
Query: 180 TRVNLANGTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSE 221
               L NG +  V + ++         N+ T  L+ P  L E
Sbjct: 150 KSWKLQNGEEANVVIAFNA------ATNVLTVSLTYPNSLEE 185

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQG-KQEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 94  IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 143
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G FG V+K   R   +++A+K+V  E  ++G     + E+  +  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 382 WC------YER--HDFLLVYEYMPN---GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
            C      Y R      LV+++  +   G L   +          + TL+  KR  V+  
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKR--VMQM 133
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEI 488
               L Y+H     ++LHRD+K++N+++  +   +L DFGLAR  ++ +N + +     +
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 489 AGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
             T  Y  PE  L  R      D++  G ++ E+   R P  Q     +  +++  L
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGW 382
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI--- 94
Query: 383 CYERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               +D +     E M +  + + +   +         L+ +     ++   + L Y+H+
Sbjct: 95  ----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
            +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  
Sbjct: 151 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 501 LVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 208 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 240

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGW 382
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI--- 86
Query: 383 CYERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
               +D +     E M +  + + +   +         L+ +     ++   + L Y+H+
Sbjct: 87  ----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
            +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 501 LVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G FG V+K   R   +++A+K+V  E  ++G     + E+  +  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 382 WC------YERH--DFLLVYEYMPN---GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
            C      Y R      LV+++  +   G L   +          + TL+  KR  V+  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKR--VMQM 133
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEI 488
               L Y+H     ++LHRD+K++N+++  +   +L DFGLAR  ++ +N + +     +
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 489 AGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
             T  Y  PE  L  R      D++  G ++ E+   R P  Q     +  +++  L
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL 245

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 182
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
           +    T  Y APE  L        DI++ G ++ E+ C +
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL---- 379
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 380 -IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 +  D  +V + M    L K +             L+ +     ++   + L Y+
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKYI 144
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 499 SFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL---- 379
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 380 -IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 +  D  +V + M    L K +             L+ +     ++   + L Y+
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKYI 145
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 499 SFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI ++A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 149 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A++ +S+      ++R+         E+  +  L H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 266
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 267 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 319
Query: 493 GYMAPESFL-VGRATIE--TDIYAFGVLILEVACGRKPGNQ 530
            Y+APE  + VG A      D ++ GV++     G  P ++
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 93  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 149
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 150 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 238

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 84  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 140
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 141 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL--- 379
           +G+G +G V   Y  + + + +A+K++S    Q   Q  + E+  +   RH N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 380 --IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  +  D  +V + M    L K +             L+ +     ++   + L Y
Sbjct: 110 IRAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKY 159
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 160 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  +        D +A GVLI E+A G  P
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 326 KLGKGGFGTVYKGIWRN--KEIAVKRV-SETSRQG-KQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G FG V+K   R   +++A+K+V  E  ++G     + E+  +  L+H N+V LI 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 382 WC------YERH--DFLLVYEYMPN---GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
            C      Y R      LV+++  +   G L   +          + TL+  KR  V+  
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKR--VMQM 132
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR--TIQENLKTHHSTKEI 488
               L Y+H     ++LHRD+K++N+++  +   +L DFGLAR  ++ +N + +     +
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 489 AGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
             T  Y  PE  L  R      D++  G ++ E+   R P  Q     +  +++  L
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKL---- 379
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 380 -IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 +  D  +V + M    L K +             L+ +     ++   + L Y+
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLL---------KTQHLSNDHICYFLYQILRGLKYI 144
Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
           H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 499 SFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE------TSRQGKQEF--IAEVTTIGSLRHRNL 376
           LG G  G V     R   K++A++ +S+      ++R+         E+  +  L H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 377 VKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +K+  + ++  D+ +V E M  G L DK +     N    E T          +    A+
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKL-----YFYQMLLAV 252
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            YLH   E  ++HRD+K  N++L S+      ++ DFG ++ + E        + + GTP
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTP 305
Query: 493 GYMAPESFL-VGRATIE--TDIYAFGVLILEVACGRKP 527
            Y+APE  + VG A      D ++ GV++     G  P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVT----LNWEKRLSVIHGTSQALDY 437
              +D +     E M     D +I  D   +   ++     L+ +     ++   + L Y
Sbjct: 91  ---NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           +H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y AP
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
           E  L  +  T   DI++ G ++ E+   R   PG  
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A+K++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 142 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 316 KATGNFN-----PKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSR--QGKQEFIAEVT 366
           ++  NFN        +LG+G F  V + I ++  +E A K + +  R    + E + E+ 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 367 TIGSLRHRNLVKLIGWCYER-HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
            +   +    V  +   YE   + +L+ EY   G +            P    +  E   
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-------PELAEMVSEN-- 131
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLGDFGLARTIQENLKTH 482
            VI    Q L+ ++   +  ++H D+K  NI+L S +   + ++ DFG++R I    +  
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL- 190
Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL 517
              +EI GTP Y+APE       T  TD++  G++
Sbjct: 191 ---REIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIA-----EVTTIGSLRHRNLVKL 379
           +G G +G+V   I +   +++A+K++S   R  + E  A     E+  +  ++H N++ L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 380 I------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +            +DF LV  +M    L K +           +  + EK   +++   +
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----------GLKFSEEKIQYLVYQMLK 137
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG--- 490
            L Y+H+     V+HRD+K  N+ ++ +   ++ DFGLAR         H+  E+ G   
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVV 185
Query: 491 TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
           T  Y APE  L      +T DI++ G ++ E+  G+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 27/237 (11%)
Query: 29  FNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVK 88
           FN ++F + N   +   ++TV+     +  +V+G    +  GRA Y    Q+     +  
Sbjct: 6   FNVETFNKTNL--ILQGDATVSSEGHLLLTNVKGNE-EDSMGRAFYSAPIQINDRTIDNL 62
Query: 89  ATFSTTFVLNILNQTAQ-PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAI 147
           A+FST F   I  +  +    GLAF +      P+  +G++LG+ N  TN    +  VA+
Sbjct: 63  ASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFN-TTNYDRDAHTVAV 120
Query: 148 EFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLA--NGTDIKVQVRYDGQNITVFV 205
            FDT          N + +DVN   SIR +     N    NG   +V++ YD     + V
Sbjct: 121 VFDTVS--------NRIEIDVN---SIRPIATESCNFGHNNGEKAEVRITYDSPKNDLRV 169
Query: 206 ANM-----ETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDGSDI 254
           + +     E   +S  + L + + + V VGFSA++G   + T+ + V SW+F  + I
Sbjct: 170 SLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNFI 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            LD+LH+     +++RD+K  NI+LD E + +L DFGL++   ++ K  +S     GT  
Sbjct: 142 GLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS---FCGTVE 195
Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           YMAPE       +   D +++GVL+ E+  G  P
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHR 374
           + +F  K+ LG+G +G V     +   + +A+K++    +       + E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 375 NLVKLIGW----CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           N++ +        +E  + + + + +    L + I             L+ +     I+ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---------STQMLSDDHIQYFIYQ 120
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK---- 486
           T +A+  LH  +   V+HRD+K SN++++S  + ++ DFGLAR I E+   +        
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 487 ---EIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGR 525
              E   T  Y APE  L   + +   D+++ G ++ E+   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--GQN 200
           IVA+E DT  + +  D N  H+G+D+ SV   R     + N+ NG      + Y+  G+ 
Sbjct: 4   IVAVELDTYPNTDIGDPNYPHIGIDIKSV---RSKKTAKWNMQNGKVGTAHIIYNSVGKR 60
Query: 201 ITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           ++  V+  N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 61  LSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 325 NKLGKGGFGTV--YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
            KLG+GGF  V   +G+      A+KR+    +Q ++E   E        H N+++L+ +
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 383 CYE----RHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           C      +H+  L+  +   G+L   I    D+ N       L  ++ L ++ G  + L+
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN------FLTEDQILWLLLGICRGLE 148
Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG---LARTIQENLKTHHSTKEIAG--- 490
            +H    K   HRD+K +NI+L  E    L D G    A    E  +   + ++ A    
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 491 TPGYMAPESFLVGRATI---ETDIYAFGVLILEVACGRKP 527
           T  Y APE F V    +    TD+++ G ++  +  G  P
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 43/216 (19%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIA-----EVTTIGSLRHRNLVKL 379
           +G G +G+V   I +   +++A+K++S   R  + E  A     E+  +  ++H N++ L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 106
Query: 380 I------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +            +DF LV  +M    L K +           +  + EK   +++   +
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----------GMEFSEEKIQYLVYQMLK 155
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG--- 490
            L Y+H+     V+HRD+K  N+ ++ +   ++ DFGLAR         H+  E+ G   
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVV 203
Query: 491 TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGR 525
           T  Y APE  L      +T DI++ G ++ E+  G+
Sbjct: 204 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 76  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 123
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 124 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 176
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                T  Y APE  L        D+++ G ++ E+ C +
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 27/230 (11%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +G G FG   + +    N+ +AVK + E   +  +    E+    SLRH N+V+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +V EY   G L    F    N+G     E    +++ +S        + Y H  
Sbjct: 85  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS-------GVSYCH-- 131
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLG--DFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              +V HRD+K  N +LD     RL   DFG +++       H   K   GTP Y+APE 
Sbjct: 132 -AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEV 186
Query: 500 FLVGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
            L      +  D+++ GV +  +  G  P    E+       +H +  ++
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 236

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHR 374
           + +F  K+ LG+G +G V     +   + +A+K++    +       + E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 375 NLVKLIGW----CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           N++ +        +E  + + + + +    L + I             L+ +     I+ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---------STQMLSDDHIQYFIYQ 120
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK-------THH 483
           T +A+  LH  +   V+HRD+K SN++++S  + ++ DFGLAR I E+            
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 484 STKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGR 525
              E   T  Y APE  L   + +   D+++ G ++ E+   R
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/176 (22%), Positives = 85/176 (48%), Gaps = 21/176 (11%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQ--GKQEFIAEVTTIGSL 371
           K   N+  K+ +G+G +G VY    +N  K +A+K+V+         +  + E+T +  L
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGE-----VTLNWEKRLS 426
           +   +++L       HD ++  + +    L  +I  +  +S   +     + L  +   +
Sbjct: 85  KSDYIIRL-------HDLIIPEDLLKFDEL--YIVLEIADSDLKKLFKTPIFLTEQHVKT 135
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           +++       ++H   E  ++HRD+K +N +L+ + + ++ DFGLARTI  +   H
Sbjct: 136 ILYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIH 188

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHR 374
           + +F  K+ LG+G +G V     +   + +A+K++    +       + E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 375 NLVKLIGW----CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           N++ +        +E  + + + + +    L + I             L+ +     I+ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---------STQMLSDDHIQYFIYQ 120
Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK-------THH 483
           T +A+  LH  +   V+HRD+K SN++++S  + ++ DFGLAR I E+            
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 484 STKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGR 525
              E   T  Y APE  L   + +   D+++ G ++ E+   R
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 182
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
           +    T  Y APE  L        D+++ G ++ E+ C +
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGE 416
           ++   E+  +  L H N+VKL+    + ++    +V+E +  G + +          P  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---------PTL 131
Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
             L+ ++         + ++YLH    ++++HRDIK SN+++  + + ++ DFG++   +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIE---TDIYAFGVLILEVACGRKP 527
            +     +T    GTP +MAPES    R        D++A GV +     G+ P
Sbjct: 189 GSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 86
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 87  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 134
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 135 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 187
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                T  Y APE  L        D+++ G ++ E+ C +
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 327 LGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGK-QEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G+G +G V           +A++++S    Q   Q  + E+  +   RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 384 YERHDFLLV--YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +D +     E M +  + + +   +         L+ +     ++   + L Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
           +   VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y APE  L
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 502 VGRA-TIETDIYAFGVLILEVACGRK--PGNQ 530
             +  T   DI++ G ++ E+   R   PG  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNL 376
           +F+    +G+GGFG VY  +     K  A+K + +   + KQ E +A       L  R +
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIM 241
Query: 377 VKLI--GWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           + L+  G C     F++   Y  + + DK  F  D  N G     L+     S       
Sbjct: 242 LSLVSTGDC----PFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 296
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A      L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S   
Sbjct: 297 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV-- 350
Query: 488 IAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQ 530
             GT GYMAPE    G A   + D ++ G ++ ++  G  P  Q
Sbjct: 351 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 392

>pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 65  ITNQSGRAIYKDQFQLW-RDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLP 121
           + N  GRA+Y     +W R+  NV A F T  TFV+N  N +    +G  F IA     P
Sbjct: 37  VKNTVGRALYSSPIHIWDRETGNV-ANFVTSFTFVINAPN-SYNVADGFTFFIAPVDTKP 94
Query: 122 ENSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           + + G +LG+ N        +Q VA+EFDT    +++    D H+G+DVN   SI+ V  
Sbjct: 95  Q-TGGGYLGVFNS-AEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVN---SIKSVNT 149
Query: 180 TRVNLANGTDIKVQVRYDG 198
               L NG +  V + ++ 
Sbjct: 150 KSWKLQNGEEANVVIAFNA 168

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP Y
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEY 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +AP   L        D +A GVLI E+A G  P
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNL 376
           +F+    +G+GGFG VY  +     K  A+K + +   + KQ E +A       L  R +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIM 242
Query: 377 VKLI--GWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           + L+  G C     F++   Y  + + DK  F  D  N G     L+     S       
Sbjct: 243 LSLVSTGDC----PFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A      L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S   
Sbjct: 298 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV-- 351
Query: 488 IAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQ 530
             GT GYMAPE    G A   + D ++ G ++ ++  G  P  Q
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNL 376
           +F+    +G+GGFG VY  +     K  A+K + +   + KQ E +A       L  R +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIM 242
Query: 377 VKLI--GWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           + L+  G C     F++   Y  + + DK  F  D  N G     L+     S       
Sbjct: 243 LSLVSTGDC----PFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A      L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S   
Sbjct: 298 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV-- 351
Query: 488 IAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQ 530
             GT GYMAPE    G A   + D ++ G ++ ++  G  P  Q
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 33/224 (14%)
Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQ-EFIAEVTTIGSLRHRNL 376
           +F+    +G+GGFG VY  +     K  A+K + +   + KQ E +A       L  R +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-------LNERIM 242
Query: 377 VKLI--GWCYERHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           + L+  G C     F++   Y  + + DK  F  D  N G     L+     S       
Sbjct: 243 LSLVSTGDC----PFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 297
Query: 434 A------LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           A      L+++HN   + V++RD+K +NI+LD   + R+ D GLA    +  K H S   
Sbjct: 298 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASV-- 351
Query: 488 IAGTPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRKPGNQ 530
             GT GYMAPE    G A   + D ++ G ++ ++  G  P  Q
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 27/230 (11%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +G G FG   + +    N+ +AVK + E   +       E+    SLRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +V EY   G L    F    N+G     E    +++ +S        + Y H  
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS-------GVSYCH-- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLG--DFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              +V HRD+K  N +LD     RL   DFG +++       H   K   GTP Y+APE 
Sbjct: 133 -AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEV 187
Query: 500 FLVGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
            L      +  D+++ GV +  +  G  P    E+       +H +  ++
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 74
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI----------QMELDHERMSY 123
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 124 LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTSFMMT 176
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1AZD|A Chain A, Concanavalin From Canavalia Brasiliensis Length = 237

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           IVA+E DT      DI D    H+G+D+ SV S +     + N+ NG      + Y+  G
Sbjct: 4   IVAVELDTYP--NTDIGDPSYPHIGIDIKSVRSKKTA---KWNMQNGKVGTAHIIYNSVG 58
Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++  V+  N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/303 (21%), Positives = 123/303 (40%), Gaps = 59/303 (19%)
Query: 327 LGKGGFGTVYKGIWRN---------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           LG+G F  ++KG+ R           E+ +K + +  R   + F    + +  L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              G C+   + +LV E++  GSLD ++           + + W  +L V    + A+ +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL-----KKNKNCINILW--KLEVAKQLAWAMHF 128
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           L    E  ++H ++ + NI+L  E               E+ KT        G P ++  
Sbjct: 129 L---EENTLIHGNVCAKNILLIRE---------------EDRKT--------GNPPFIKL 162
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGN---QSEQNSYNNSIVHWLWELRRKG-RI 553
               +    +  DI    +  +   C   P N    +++ S+  +    LWE+   G + 
Sbjct: 163 SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTT----LWEICSGGDKP 218
Query: 554 LDAADSRLGGEFSE--------KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP 605
           L A DS+   +F E        K  E   ++   C    P  RPS + +++ L+    P 
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNSLFTPD 277
Query: 606 VLP 608
           ++P
Sbjct: 278 LVP 280

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 11/100 (11%)
Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           +AL YL    +  V+HRD+K SNI+LD     +L DFG++  + ++     S    AG  
Sbjct: 135 KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCA 188
Query: 493 GYMAPESFLVGRAT-----IETDIYAFGVLILEVACGRKP 527
            YMAPE       T     I  D+++ G+ ++E+A G+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 32/237 (13%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEV 365
           P   ++K+++    +F     +G+G FG V     +N +    +V       K E +   
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD----KVFAMKILNKWEMLKRA 116
Query: 366 TTIGSLRHRNLVKLIG---WCYERH-------DFLLVYEYMPNGSLDKFIFYDETNSGPG 415
            T    R    V + G   W    H       +  LV +Y   G L   +   E +  P 
Sbjct: 117 ET-ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPE 174
Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
           E+   +   + +      A+D +H   +   +HRDIK  NI++D   + RL DFG    +
Sbjct: 175 EMARFYLAEMVI------AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225
Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKP 527
            E+     S     GTP Y++PE         GR   E D ++ GV + E+  G  P
Sbjct: 226 MEDGTVQSSVA--VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 27/230 (11%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +G G FG   + +    N+ +AVK + E   +  +    E+    SLRH N+V+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +V EY   G L    F    N+G     E    +++ +S        + Y H  
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS-------GVSYAH-- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARL--GDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              +V HRD+K  N +LD     RL   DFG ++        H   K   GTP Y+APE 
Sbjct: 133 -AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA----SVLHSQPKSAVGTPAYIAPEV 187
Query: 500 FLVGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
            L      +  D+++ GV +  +  G  P    E+       +H +  ++
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|2OW4|A Chain A, Crystal Structure Of A Lectin From Canavalia Maritima Seeds (Conm) In Complex With Man1-2man-Ome Length = 237

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           IVA+E DT      DI D    H+G+D+ SV   R     + N+ NG      + Y+  G
Sbjct: 4   IVAVELDTYP--NTDIGDPSYPHIGIDIKSV---RSKKTAKWNMQNGKVGTAHIIYNSVG 58
Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++  V+  N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ GV++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2CWM|A Chain A, Native Crystal Structure Of No Releasing Inductive Lectin From Seeds Of The Canavalia Maritima (Conm) Length = 237

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           IVA+E DT      DI D    H+G+D+ SV   R     + N+ NG      + Y+  G
Sbjct: 4   IVAVELDTYP--NTDIGDPSYPHIGIDIKSV---RSKKTAKWNMQNGKVGTAHIIYNSVG 58
Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++  V+  N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLPE 122
           + N  GRA+Y     +W       A F T  TFV++  N +    +G  F IA     P+
Sbjct: 37  VRNTVGRALYSSPIHIWDSKTGNVANFVTSFTFVIDAPN-SYNVADGFTFFIAPVDTKPQ 95
Query: 123 NSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLT 180
            + G +LG+ N   +    SQ VA+EFDT    +++    D H+G+DVNS+ SI      
Sbjct: 96  -TGGGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSWA 153
Query: 181 RVNLANGTDIKVQVRYDG 198
              L NG +  V + ++ 
Sbjct: 154 ---LQNGKEANVVIAFNA 168

>pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           IVA+E DT      DI D    H+G+D+ SV S +     + N+ NG      + Y+  G
Sbjct: 4   IVAVELDTYP--NTDIGDPDYPHIGIDIKSVRSKKTA---KWNMQNGKVGTAHIIYNSVG 58
Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           + ++  V+  N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 10/138 (7%)
Query: 65  ITNQSGRAIYKDQFQLWRDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLPE 122
           + N  GRA+Y     +W       A F T  TFV++  N +    +G  F IA     P+
Sbjct: 37  VRNTVGRALYSSPIHIWDSKTGNVANFVTSFTFVIDAPN-SYNVADGFTFFIAPVDTKPQ 95
Query: 123 NSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLT 180
            + G +LG+ N   +    SQ VA+EFDT    +++    D H+G+DVNS+ SI      
Sbjct: 96  -TGGGYLGVFNS-KDYDKTSQTVAVEFDTFYNTAWDPSNGDRHIGIDVNSIKSINTKSW- 152
Query: 181 RVNLANGTDIKVQVRYDG 198
              L NG +  V + ++ 
Sbjct: 153 --KLQNGKEANVVIAFNA 168

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 324 KNKLGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLI 380
           ++ LG+G    V   I    ++E AVK + +     +     EV  +   + HRN+++LI
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
            +  E   F LV+E M  GS+   I              N  +   V+   + ALD+LHN
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRR--------HFNELEASVVVQDVASALDFLHN 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHH-STKEI---AGTPG 493
              K + HRD+K  NI+ +        ++ DFGL   I+ N      ST E+    G+  
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 494 YMAPESF--LVGRATI---ETDIYAFGVLILEVACGRKP 527
           YMAPE        A+I     D+++ GV++  +  G  P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
           +E + G  +  +  E  +S     ++ +++L   S ++ +HRD+ + NI+L      ++ 
Sbjct: 185 EEDSDGFYKEPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKIC 241
Query: 468 DFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV---AC 523
           DFGLAR I +N    +  K     P  +MAPES      + ++D++++GVL+ E+     
Sbjct: 242 DFGLARDIYKN--PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGG 299
Query: 524 GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHP 583
              PG Q +++  +           R+G  + A       E+S  E+  ++   L C H 
Sbjct: 300 SPYPGVQMDEDFCSR---------LREGMRMRAP------EYSTPEIYQIM---LDCWHR 341
Query: 584 NPHLRPSMKTVLQVL 598
           +P  RP    +++ L
Sbjct: 342 DPKERPRFAELVEKL 356

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 119
Query: 373 HRNLVKLIG------WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 168
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 169 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 221
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ GV++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART   +      T 
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 184
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
           E+  T  Y APE  L        DI++ G ++ E+  G
Sbjct: 185 EVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 59/104 (56%), Gaps = 6/104 (5%)
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L  E  +      ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
               +  K  A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 254 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 59/104 (56%), Gaps = 6/104 (5%)
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L  E  +      ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
               +  K  A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 247 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 59/104 (56%), Gaps = 6/104 (5%)
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L  E  +      ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
               +  K  A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 252 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 12/139 (8%)
Query: 65  ITNQSGRAIYKDQFQLW-RDNKNVKATFST--TFVLNILNQTAQPGEGLAFVIAGNKDLP 121
           + N  GRA+Y     +W R+  NV A F T  TFV+N  N +    +G  F IA     P
Sbjct: 37  VKNTVGRALYSSPIHIWDRETGNV-ANFVTSFTFVINAPN-SYNVADGFTFFIAPVDTKP 94
Query: 122 ENSEGQWLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPL 179
           + + G +LG+ N        ++ VA+EFDT    +++    D H+G+DVN   SI+ V  
Sbjct: 95  Q-TGGGYLGVFNS-AEYDKTTETVAVEFDTFYNAAWDPSNRDRHIGIDVN---SIKSVNT 149
Query: 180 TRVNLANGTDIKVQVRYDG 198
               L NG +  V + ++ 
Sbjct: 150 KSWKLQNGEEANVVIAFNA 168

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 59/104 (56%), Gaps = 6/104 (5%)
Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L  E  +      ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 479 LKTHHSTKEIAGTP-GYMAPESFLVGRATIETDIYAFGVLILEV 521
               +  K  A  P  +MAPE+      TI++D+++FGVL+ E+
Sbjct: 245 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +G G +G+V   Y    R K +AVK++S    S    +    E+  +  L+H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 382 WCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLS------VIHGTSQ 433
                        + P  S++ F  ++   T  G     +   + LS      +++   +
Sbjct: 95  V------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR 142
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L Y+H+     ++HRD+K SN+ ++ +   R+ DFGLAR   E +  + +T+       
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR------W 193
Query: 494 YMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
           Y APE  L      +T DI++ G ++ E+  G+   PG+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH+     +++RD+K  N+++D +   ++ DFG A+ ++        T  + GTP  
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------GRTWXLCGTPEA 204
Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 47/239 (19%)
Query: 321 FNPKNKLGKGGFGTVYKG-----IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN 375
           F  ++K+G+G F +VY       +   ++IA+K +  TS   +    AE+  +     ++
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAGGQD 80
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
            V  + +C+ ++D +++   MP   L+   F D  NS      L++++    +    +AL
Sbjct: 81  NVMGVKYCFRKNDHVVIA--MPY--LEHESFLDILNS------LSFQEVREYMLNLFKAL 130
Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQEN---------------- 478
             +H      ++HRD+K SN + +       L DFGLA+   +                 
Sbjct: 131 KRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 479 ---------LKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
                    L         AGTPG+ APE        T   D+++ GV+ L +  GR P
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 131
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 132 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 184
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 124
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 125 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 177
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 178 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 131
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 132 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 184
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 80
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 129
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 130 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 182
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 183 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 74
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 123
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 176
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 119
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 168
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 169 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 221
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 75
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 124
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 125 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 177
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 178 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +G G +G+V   Y    R K +AVK++S    S    +    E+  +  L+H N++ L+ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 382 WCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLS------VIHGTSQ 433
                        + P  S++ F  ++   T  G     +   + LS      +++   +
Sbjct: 87  ------------VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 134
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L Y+H+     ++HRD+K SN+ ++ +   R+ DFGLAR   E +  + +T+       
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR------W 185
Query: 494 YMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
           Y APE  L      +T DI++ G ++ E+  G+   PG+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 59/303 (19%)
Query: 327 LGKGGFGTVYKGIWRN---------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           LG+G F  ++KG+ R           E+ +K + +  R   + F    + +  L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
              G C    + +LV E++  GSLD ++           + + W  +L V    + A+ +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-----KKNKNCINILW--KLEVAKQLAAAMHF 128
Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           L    E  ++H ++ + NI+L  E               E+ KT        G P ++  
Sbjct: 129 L---EENTLIHGNVCAKNILLIRE---------------EDRKT--------GNPPFIKL 162
Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGN---QSEQNSYNNSIVHWLWELRRKG-RI 553
               +    +  DI    +  +   C   P N    +++ S+  +    LWE+   G + 
Sbjct: 163 SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTT----LWEICSGGDKP 218
Query: 554 LDAADSRLGGEFSE--------KEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP 605
           L A DS+   +F E        K  E   ++   C    P  RPS + +++ L+    P 
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAPKAAELANLIN-NCMDYEPDHRPSFRAIIRDLNSLFTPD 277
Query: 606 VLP 608
           ++P
Sbjct: 278 LVP 280

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 23/228 (10%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +G G FG   + +    N+ +AVK + E   +  +    E+    SLRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +V EY   G L    F    N+G     E    +++ +S        + Y H  
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS-------GVSYCH-- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
              +V HRD+K  N +LD     RL       +    L  H   K+  GTP Y+APE  L
Sbjct: 133 -AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL--HSQPKDTVGTPAYIAPEVLL 189
Query: 502 VGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
                 +  D+++ GV +  +  G  P    E+       +H +  ++
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 70  GRAIYKDQFQLW-RDNKNVKATFSTTFVLNI-LNQTAQPGEGLAFVIAGNKDLPENSEGQ 127
           GRA+Y     +W RD  NV A F T+F   I    +    +G  F IA     P+ + G 
Sbjct: 42  GRALYSTPIHIWDRDTGNV-ANFVTSFTFVIDAPSSYNVADGFTFFIAPVDTKPQ-TGGG 99
Query: 128 WLGIVNGITNGTNQSQIVAIEFDT--KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLA 185
           +LG+ N        SQ VA+EFDT    +++    + H+G+DVN   SI+ V     NL 
Sbjct: 100 YLGVFNS-KEYDKTSQTVAVEFDTFYNAAWDPSNKERHIGIDVN---SIKSVNTKSWNLQ 155
Query: 186 NGTDIKVQVRYDGQNITVFVANMETPLLSEP 216
           NG    V + ++         N+ T  L+ P
Sbjct: 156 NGERANVVIAFNA------ATNVLTVTLTYP 180

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 46/259 (17%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--------RVSETSRQGKQEFI 362
           L EL+K    ++ K  +G+G +G V   I  N+  A++        ++ + + +  +   
Sbjct: 21  LLELQKK---YHLKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTL-- 419
            EV  +  L H N+ +L     +     LV E    G L DK   + + ++G   + +  
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 420 ---------NWEKRLSVIHGTSQALDY-----------------LHNGSEKRVLHRDIKS 453
                    N E     IHG  ++LD+                 LH    + + HRDIK 
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 454 SNIML--DSEFNARLGDFGLARTIQE-NLKTHHSTKEIAGTPGYMAPESFLVGRATI--E 508
            N +   +  F  +L DFGL++   + N   ++     AGTP ++APE       +   +
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 509 TDIYAFGVLILEVACGRKP 527
            D ++ GVL+  +  G  P
Sbjct: 257 CDAWSAGVLLHLLLMGAVP 275

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI-------FYDETNSGPGEVTLNWEKRL 425
           H+N++ L+              + P  SL++F          D   S   ++ L+ E+  
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 182
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
                T  Y APE  L        DI++ G ++ E+  G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 30/231 (12%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS 370
           +KE++    +F     +G+G FG V     +N E    R+       K E +    T   
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTE----RIYAMKILNKWEMLKRAETACF 137
Query: 371 LRHRNL--------VKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
              R++        +  + + ++  + L LV +Y   G L   +          E  L  
Sbjct: 138 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL-------SKFEDKLPE 190
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
           +     I     A+D +H   +   +HRDIK  N++LD   + RL DFG    + ++   
Sbjct: 191 DMARFYIGEMVLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 247
Query: 482 HHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKP 527
             S     GTP Y++PE        +G+   E D ++ GV + E+  G  P
Sbjct: 248 QSSVA--VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 30/231 (12%)
Query: 311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS 370
           +KE++    +F     +G+G FG V     +N E    R+       K E +    T   
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTE----RIYAMKILNKWEMLKRAETACF 121
Query: 371 LRHRNL--------VKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
              R++        +  + + ++  + L LV +Y   G L   +          E  L  
Sbjct: 122 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL-------SKFEDKLPE 174
Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
           +     I     A+D +H   +   +HRDIK  N++LD   + RL DFG    + ++   
Sbjct: 175 DMARFYIGEMVLAIDSIH---QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 231
Query: 482 HHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKP 527
             S     GTP Y++PE        +G+   E D ++ GV + E+  G  P
Sbjct: 232 QSSVA--VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 326 KLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL-- 379
           K+G+G +G VYK   ++ +     A+K++  T          E+  +  L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 85
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +   +      L+++Y  +       F+  + +    V L      S+++     + YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNAR----LGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
                 VLHRD+K +NI++  E   R    + D G AR     LK       +  T  Y 
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 496 APESFLVGRA-TIETDIYAFGVLILEV 521
           APE  L  R  T   DI+A G +  E+
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAEL 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 327 LGKGGFGTV---YKGIWRNKEIAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +G G +G+V   Y    R K +AVK++S    S    +    E+  +  L+H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 382 WCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLS------VIHGTSQ 433
                        + P  S++ F  ++   T  G     +   + LS      +++   +
Sbjct: 95  V------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 142
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L Y+H+     ++HRD+K SN+ ++ +   R+ DFGLAR   E +  + +T+       
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR------W 193
Query: 494 YMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
           Y APE  L      +T DI++ G ++ E+  G+   PG+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 327 LGKGGFGTVYKG-IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
           +G G FG V++  +  + E+A+K+V +  R   +E   ++  I  ++H N+V L  + Y 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL--QIMRI--VKHPNVVDLKAFFYS 103
Query: 386 RHD-----FL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
             D     FL LV EY+P         Y +       + +        ++   ++L Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-----YMYQLLRSLAYIH 158
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPG----- 493
           +     + HRDIK  N++LD      +L DFG A+ +            IAG P      
Sbjct: 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL------------IAGEPNVSXIC 203
Query: 494 ---YMAPE-SFLVGRATIETDIYAFGVLILEVACGR 525
              Y APE  F     T   DI++ G ++ E+  G+
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 56/113 (49%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           IVA+E DT  +   DI D    H+G+D+ SV   R     + N+ NG      + Y+  +
Sbjct: 4   IVAVELDTYPN--TDIGDPSYPHIGIDIKSV---RSKKTAKWNMQNGKVGTAHIIYNSVD 58
Query: 201 ----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
                 V   N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 55/113 (48%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           IVA+E DT      DI D    H+G+D+ SV   R     + N+ NG      + Y+  +
Sbjct: 4   IVAVELDTYP--NTDIGDPSYPHIGIDIKSV---RSKKTAKWNMQNGKVGTAHIIYNSVD 58
Query: 201 ----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
                 V   N ++  +S  +DL   LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ G ++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  +  ++ +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  LV E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
               T  Y APE  L        DI++ G ++ E+ 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 120 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 172
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S  E   TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 345 IAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW------CYERHDFLLVYEY 395
           +AVK++S   +     K+ +  E+  +  + H+N++ L+          E  D  LV E 
Sbjct: 52  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN 455
           M + +L + I           + L+ E+   +++     + +LH+     ++HRD+K SN
Sbjct: 111 M-DANLCQVI----------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFG 515
           I++ S+   ++ DFGLART   N            T  Y APE  L        DI++ G
Sbjct: 157 IVVKSDCTLKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYAANVDIWSVG 212
Query: 516 VLILEVACG 524
            ++ E+  G
Sbjct: 213 CIMGELVKG 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 23/228 (10%)
Query: 327 LGKGGFGT--VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           +G G FG   + +    N+ +AVK + E   +  +    E+    SLRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHNG 441
                 +V EY   G L    F    N+G     E    +++ +S        + Y H  
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS-------GVSYCH-- 132
Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
              +V HRD+K  N +LD     RL       +    L  H   K   GTP Y+APE  L
Sbjct: 133 -AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL--HSQPKSTVGTPAYIAPEVLL 189
Query: 502 VGRATIET-DIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
                 +  D+++ GV +  +  G  P    E+       +H +  ++
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 83
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----------QMELDHERMSY 132
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 133 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMV 185
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ G ++ E+  G
Sbjct: 186 PFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 82  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 182
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
                T  Y APE  L        DI++ G ++ E+  G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 108/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+AG   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSR-------QGKQEFIAEVTTI 368
           K  G +   + LG+G +G V K +  ++ +  + V    +        G+     E+  +
Sbjct: 2   KLIGKYLMGDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 369 GSLRHRNLVKLIGWCY--ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
             LRH+N+++L+   Y  E+    +V EY   G  +        +S P       EKR  
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML------DSVP-------EKRFP 107
Query: 427 VI--HG----TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
           V   HG        L+YLH+   + ++H+DIK  N++L +    ++   G+A  +     
Sbjct: 108 VCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP-FA 163
Query: 481 THHSTKEIAGTPGYMAPE--SFLVGRATIETDIYAFGVLILEVACGRKP 527
              + +   G+P +  PE  + L   +  + DI++ GV +  +  G  P
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 108/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+AG   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ G ++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVN 82
Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF----IFYDETNSGPGEVT---LNWEKRL 425
           H+N++ L+              + P  SL++F    I  +  ++   +V    L+ E+  
Sbjct: 83  HKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 130
Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T    
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 183
Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
                T  Y APE  L        DI++ G ++ E+  G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/246 (21%), Positives = 106/246 (43%), Gaps = 27/246 (10%)
Query: 299 INGTNLAPKKFRLKELKKATGN-FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-- 353
           +   NLA  K R  ++    G+ +     +G G +G V     R   +++A+K++     
Sbjct: 34  VAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD 93
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDK-FIFYDETNS 412
                +  + E+  +   +H N++ +           ++   +P G     ++  D   S
Sbjct: 94  VVTNAKRTLRELKILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMES 144
Query: 413 GPGEVT-----LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
              ++      L  E     ++   + L Y+H+    +V+HRD+K SN++++     ++G
Sbjct: 145 DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIG 201
Query: 468 DFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGR 525
           DFG+AR +  +   H +   E   T  Y APE  L +   T   D+++ G +  E+   R
Sbjct: 202 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261
Query: 526 K--PGN 529
           +  PG 
Sbjct: 262 QLFPGK 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 327 LGKGGFGTVYKGIWRNK---EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           +G G FG     + R+K   E+   +  E      +    E+    SLRH N+V+     
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSG---PGEVTLNWEKRLSVIHGTSQALDYLHN 440
                  ++ EY   G L + I     N+G     E    +++ LS        + Y H+
Sbjct: 86  LTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLS-------GVSYCHS 134
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLG--DFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
               ++ HRD+K  N +LD     RL   DFG +++       H   K   GTP Y+APE
Sbjct: 135 ---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 187
Query: 499 SFLVGRATIE---TDIYAFGVLILEVACGRKPGNQSEQ-NSYNNSIVHWL 544
             L  R   +    D+++ GV +  +  G  P    E+   Y  +I   L
Sbjct: 188 VLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 101/257 (39%), Gaps = 38/257 (14%)
Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGF-----------GTVYKGIWRNKEIAVKRVSETS 354
           P   RLKE++    +F     +G+G F           G VY     NK   +KR   + 
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 355 RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSG 413
            + +++ +           R  +  + + ++  ++L LV EY   G L   +      S 
Sbjct: 108 FREERDVLVN-------GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL------SK 154
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
            GE       R  +      A+D +H       +HRDIK  NI+LD   + RL DFG   
Sbjct: 155 FGERIPAEMARFYLAE-IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL 210
Query: 474 TIQENLKTHHSTKEIAGTPGYMAPESF-------LVGRATIETDIYAFGVLILEVACGRK 526
            ++ +  T  S   + GTP Y++PE           G    E D +A GV   E+  G+ 
Sbjct: 211 KLRAD-GTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
Query: 527 PGNQSEQNSYNNSIVHW 543
           P            IVH+
Sbjct: 269 PFYADSTAETYGKIVHY 285

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ G ++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           K   N  P     +G     Y  I   + +A+K++S   +     K+ +  E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVN 81
Query: 373 HRNLVKLIGW------CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H+N++ L+          E  D  +V E M + +L + I          ++ L+ E+   
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI----------QMELDHERMSY 130
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++     + +LH+     ++HRD+K SNI++ S+   ++ DFGLART      T     
Sbjct: 131 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA----GTSFMMT 183
Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
               T  Y APE  L        DI++ G ++ E+  G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 108/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 70
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 71  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+AG   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 170 ---HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/246 (21%), Positives = 106/246 (43%), Gaps = 27/246 (10%)
Query: 299 INGTNLAPKKFRLKELKKATGN-FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-- 353
           +   NLA  K R  ++    G+ +     +G G +G V     R   +++A+K++     
Sbjct: 33  VAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD 92
Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDK-FIFYDETNS 412
                +  + E+  +   +H N++ +           ++   +P G     ++  D   S
Sbjct: 93  VVTNAKRTLRELKILKHFKHDNIIAIKD---------ILRPTVPYGEFKSVYVVLDLMES 143
Query: 413 GPGEVT-----LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG 467
              ++      L  E     ++   + L Y+H+    +V+HRD+K SN++++     ++G
Sbjct: 144 DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIG 200
Query: 468 DFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGR 525
           DFG+AR +  +   H +   E   T  Y APE  L +   T   D+++ G +  E+   R
Sbjct: 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260
Query: 526 K--PGN 529
           +  PG 
Sbjct: 261 QLFPGK 266

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 345 IAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW------CYERHDFLLVYEY 395
           +AVK++S   +     K+ +  E+  +  + H+N++ L+          E  D  LV E 
Sbjct: 50  VAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSN 455
           M + +L + I           + L+ E+   +++     + +LH+     ++HRD+K SN
Sbjct: 109 M-DANLCQVI----------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 154
Query: 456 IMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFG 515
           I++ S+   ++ DFGLART   N            T  Y APE  L        DI++ G
Sbjct: 155 IVVKSDCTLKILDFGLARTASTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 210
Query: 516 VLILEVACG 524
            ++ E+  G
Sbjct: 211 CIMGELVKG 219

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE--IAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRN 375
           N+  K+ +G+G +G VY    +N E  +A+K+V+         +  + E+T +  L+   
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 376 LVKLIGWCYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           +++L          + D L +   + +  L K             + L  E   ++++  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF--------KTPIFLTEEHIKTILYNL 138
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI---------------- 475
               +++H   E  ++HRD+K +N +L+ + + ++ DFGLARTI                
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 476 -----QENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEV 521
                 +NLK   ++  +  T  Y APE  L+    T   DI++ G +  E+
Sbjct: 196 EPGPHNKNLKKQLTSHVV--TRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 70
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTL 419
           +  ++H N++ L+              + P  SL++F        +   + N+      L
Sbjct: 71  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
             +    +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 324 KNKLGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLI 380
           ++ LG+G    V   I    ++E AVK + +     +     EV  +   + HRN+++LI
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
            +  E   F LV+E M  GS+   I              N  +   V+   + ALD+LHN
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRR--------HFNELEASVVVQDVASALDFLHN 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHH-STKEI---AGTPG 493
              K + HRD+K  NI+ +        ++ DF L   I+ N      ST E+    G+  
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 494 YMAPESF--LVGRATI---ETDIYAFGVLILEVACGRKP 527
           YMAPE        A+I     D+++ GV++  +  G  P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 48/230 (20%)
Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +G G +G+V     +    +IAVK++S   ++    K+ +  E+  +  ++H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 382 WCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRLS------VIHGTSQ 433
                        + P  SL++F  ++      G     +   ++L+      +I+   +
Sbjct: 118 V------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG--- 490
            L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR         H+  E+ G   
Sbjct: 166 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDDEMTGYVA 213
Query: 491 TPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRK--PG----NQSEQ 533
           T  Y APE  L      +  DI++ G ++ E+  GR   PG    NQ +Q
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQ 263

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE---TSRQG--KQEFIAEVTTIGSLRHRNLVKL 379
           +GKG F  V + I R   ++ AVK V     TS  G   ++   E +    L+H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +          +V+E+M    L  F      ++G       + + ++  H   Q L+ L 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAG-----FVYSEAVAS-HYMRQILEALR 144
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
              +  ++HRD+K   ++L S+ N+   +LG FG+A  + E+           GTP +MA
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR---VGTPHFMA 201
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           PE           D++  GV++  +  G  P   +++  +   I
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 245

>pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)
Query: 23  QVSSLHFNFQSFTEQNRNE-LSFDNSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQL 80
           Q  +LHF F  F++  ++  L  D +T     +++T     G+P  +  GRA++     +
Sbjct: 122 QTDALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPEGSSVGRALFYAPVHI 181
Query: 81  WRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGI 131
           W  +  V A F  TF   I +  + P +G+AF I+  +  +P  S G+ LG+
Sbjct: 182 WESSATVSA-FEATFAFLIKSPDSHPADGIAFFISNIDSSIPSGSTGRLLGL 232

>pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           IVA+E DT  +   DI D    H+G+D+ SV S +     + N+ +G      + Y+  +
Sbjct: 4   IVAVELDTYPN--TDIGDPSYPHIGIDIKSVRSKKTA---KWNMQDGKVGTAHIIYNSVD 58
Query: 201 ----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
                 V   N +   +S  +DL++ LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNADATSVSYDVDLNDVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 39/224 (17%)
Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN 375
           T  +  K  +G G +    + I +  N E AVK + ++ R   +E I  +   G  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEILLRYG--QHPN 77
Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGT 431
           ++ L     +     +V E M  G L DK +   F+ E  +             +V+   
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------------AVLFTI 125
Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARLGDFGLARTIQENLKTHHSTKE 487
           ++ ++YLH    + V+HRD+K SNI+   E     + R+ DFG A+ ++       +   
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-------AENG 175
Query: 488 IAGTPGY----MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +  TP Y    +APE           DI++ GVL+  +  G  P
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 81
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 82  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 81
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 82  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 326 KLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           KL +   G ++KG W+  +I VK  +V + S +  ++F  E   +    H N++ ++G C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 384 YE---RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
                 H  L+ + +MP GSL   + ++ TN       ++  + +      ++ + +LH 
Sbjct: 77  QSPPAPHPTLITH-WMPYGSLYN-VLHEGTN-----FVVDQSQAVKFALDMARGMAFLHT 129
Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
             E  +    + S ++M+D +  AR+    +  + Q   + +         P ++APE+ 
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY--------APAWVAPEAL 180
Query: 501 LVGRATI---ETDIYAFGVLILEVACGRKP 527
                       D+++F VL+ E+     P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 81
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 82  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 12/113 (10%)
Query: 144 IVAIEFDTKKSYEQDINDN---HVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
           IVA+E DT  +   DI D    H+G+D+ SV S +     + N+ +G      + Y+  +
Sbjct: 4   IVAVELDTYPN--TDIGDPSYPHIGIDIKSVRSKKTA---KWNMQDGKVGTAHIIYNSVD 58
Query: 201 ----ITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
                 V   N +   +S  +DL++ LPE V VG SASTG   + N + SW+F
Sbjct: 59  KRLSAVVSYPNADATSVSYDVDLNDVLPEWVRVGLSASTGLYKETNTILSWSF 111

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 327 LGKGGFGTVYKGIWRN--KEIAVKRVSE---TSRQG--KQEFIAEVTTIGSLRHRNLVKL 379
           +GKG F  V + I R   ++ AVK V     TS  G   ++   E +    L+H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           +          +V+E+M    L  F      ++G       + + ++  H   Q L+ L 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAG-----FVYSEAVAS-HYMRQILEALR 146
Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
              +  ++HRD+K   ++L S+ N+   +LG FG+A  + E+           GTP +MA
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR---VGTPHFMA 203
Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
           PE           D++  GV++  +  G  P   +++  +   I
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII 247

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 24  EVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 79
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 80  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR------ 178
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 179 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ--- 199
           IVA+E D+  + +  D N  H+G+D+ S   IR     R N+  G    V + Y+     
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKS---IRSKSTARWNMQTGKVGTVHISYNSVAKR 60
Query: 200 -NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +  V  +   +  +S  +DL+  LPE V VG SA+TG   + N + SW+F
Sbjct: 61  LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSF 111

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 80
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 81  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 179
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PG 528
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG
Sbjct: 180 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 231

>pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ--- 199
           IVA+E D+  + +  D N  H+G+D+ S   IR     R N+  G    V + Y+     
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKS---IRSKSTARWNMQTGKVGTVHISYNSVAKR 60
Query: 200 -NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +  V  +   +  +S  +DL+  LPE V VG SA+TG   + N + SW+F
Sbjct: 61  LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSF 111

>pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ--- 199
           IVA+E D+  + +  D N  H+G+D+ S   IR     R N+  G    V + Y+     
Sbjct: 6   IVAVELDSYPNTDIGDPNYPHIGIDIKS---IRSKSTARWNMQTGKVGTVHISYNSVAKR 62
Query: 200 -NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +  V  +   +  +S  +DL+  LPE V VG SA+TG   + N + SW+F
Sbjct: 63  LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSF 113

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 126 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 178
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S      TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGI--WRNKEIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRL 70
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 71  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2JEC|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Mutant E123a-H131n-K132q Complexed With 5-Bromo-4-Chloro-3- Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 144 IVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ--- 199
           IVA+E D+  + +  D N  H+G+D+ S   IR     R N+  G    V + Y+     
Sbjct: 6   IVAVELDSYPNTDIGDPNYPHIGIDIKS---IRSKSTARWNMQTGKVGTVHISYNSVAKR 62
Query: 200 -NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +  V  +   +  +S  +DL+  LPE V VG SA+TG   + N + SW+F
Sbjct: 63  LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSF 113

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 127 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 179
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S      TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 81
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 82  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 180
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 181 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 128 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 180
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S      TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 16/148 (10%)
Query: 327 LGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQE---FIAEVTTIGSLRHRNLVKLIGWC 383
           +GKG FG VY G W   E+A+ R+ +  R  + +   F  EV      RH N+V  +G C
Sbjct: 41  IGKGRFGQVYHGRWHG-EVAI-RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
                  ++       +L   +          ++ L+  K   +     + + YLH    
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVV-------RDAKIVLDVNKTRQIAQEIVKGMGYLH---A 148
Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGL 471
           K +LH+D+KS N+  D+     + DFGL
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGL 175

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 40/242 (16%)
Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG 357
           +G +L  +    + +  + G +  K  +G G +    + + +  N E AVK + ++ R  
Sbjct: 9   SGVDLGTENLYFQSMVFSDG-YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP 67
Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSG 413
            +E I  +   G  +H N++ L     +     LV E M  G L DK +   F+ E  + 
Sbjct: 68  SEE-IEILLRYG--QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS 124
Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIM-LDSEFNA---RLGDF 469
                        V+H   + ++YLH+   + V+HRD+K SNI+ +D   N    R+ DF
Sbjct: 125 ------------FVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDF 169
Query: 470 GLARTIQENLKTHHSTKEIAGTPGY----MAPESFLVGRATIETDIYAFGVLILEVACGR 525
           G A+ ++       +   +  TP Y    +APE           DI++ G+L+  +  G 
Sbjct: 170 GFAKQLR-------AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY 222
Query: 526 KP 527
            P
Sbjct: 223 TP 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 121 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 173
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S      TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHH 483
           ++    +A+ YLH+ +   + HRD+K  N++  S+  NA  +L DFG A+       +H+
Sbjct: 166 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHN 218
Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           S      TP Y+APE     +     D+++ GV++  + CG  P
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 47/236 (19%)
Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNK--EIAVKRVS---ETSRQGKQEFIAEVTT 367
           E+ +   N +P   +G G +G+V           +AVK++S   ++    K+ +  E+  
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRL 74
Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--IFYDETNSGPGEVTLNWEKRL 425
           +  ++H N++ L+              + P  SL++F  ++      G     +   ++L
Sbjct: 75  LKHMKHENVIGLLD------------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 426 S------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           +      +I+   + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------ 173
Query: 480 KTHHSTKEIAG---TPGYMAPESFLVGRATIET-DIYAFGVLILEVACGRK--PGN 529
              H+  E+ G   T  Y APE  L      +T DI++ G ++ E+  GR   PG 
Sbjct: 174 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 109/249 (43%), Gaps = 39/249 (15%)
Query: 327 LGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEF-IAEVTTIGSLRHRNLVKLIG 381
           LG+G    V++G  R+K+     A+K  +  S     +  + E   +  L H+N+VKL  
Sbjct: 17  LGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 382 WCYE---RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
              E   RH  +L+ E+ P GSL  +   +E ++  G   L   + L V+      +++L
Sbjct: 75  IEEETTTRHK-VLIMEFCPCGSL--YTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHL 128
Query: 439 HNGSEKRVLHRDIKSSNIML----DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
               E  ++HR+IK  NIM     D +   +L DFG AR ++++         + GT  Y
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVXLYGTEEY 181
Query: 495 MAPESFLVGRATIE----------TDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
           + P+ +   RA +            D+++ GV     A G  P    E    N  +++ +
Sbjct: 182 LHPDMY--ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 545 WELRRKGRI 553
              +  G I
Sbjct: 240 ITGKPSGAI 248
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	644
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-124
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-121
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-74
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-60
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-54
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	1e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-53
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	4e-51
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-49
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	3e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-48
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	2e-48
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	5e-48
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	1e-47
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	2e-47
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	3e-47
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	3e-47
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	3e-47
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	4e-47
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	2e-46
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	6e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-45
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	7e-45
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	1e-44
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	2e-44
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	1e-43
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	3e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-42
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	9e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-39
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-38
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	1e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-35
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	8e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-32
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	3e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-27
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	4e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	2e-26
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	6e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-21
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	7e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-12
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	4e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-11
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	2e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	2e-04
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  369 bits (951), Expect = e-124
 Identities = 107/302 (35%), Positives = 180/302 (59%), Gaps = 9/302 (2%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQG-KQEFIA 363
            K+F L+EL+ A+ NF+ KN LG+GGFG VYKG   +   +AVKR+ E   QG + +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           EV  I    HRNL++L G+C    + LLVY YM NGS+   +          +  L+W K
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR----ERPESQPPLDWPK 132

Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
           R  +  G+++ L YLH+  + +++HRD+K++NI+LD EF A +GDFGLA+ +     TH 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHV 191

Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE-QNSYNNSIVH 542
           +T  + GT G++APE    G+++ +TD++ +GV++LE+  G++  + +   N  +  ++ 
Sbjct: 192 TTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA 602
           W+  L ++ ++    D  L G + ++E+E ++ + L C   +P  RP M  V+++L G+ 
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

Query: 603 DP 604
             
Sbjct: 311 LA 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  361 bits (930), Expect = e-121
 Identities = 106/324 (32%), Positives = 165/324 (50%), Gaps = 31/324 (9%)

Query: 293 DDIEGLINGTNLAPKKFRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIA 346
           ++    ++ T      F   ELK  T NF+ +      NK+G+GGFG VYKG   N  +A
Sbjct: 1   ENKSLEVSDTRF--HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVA 58

Query: 347 VKRVSE----TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD 402
           VK+++     T+ + KQ+F  E+  +   +H NLV+L+G+  +  D  LVY YMPNGSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118

Query: 403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF 462
             +         G   L+W  R  +  G +  +++LH   E   +HRDIKS+NI+LD  F
Sbjct: 119 DRLS-----CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAF 170

Query: 463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA 522
            A++ DFGLAR  ++  +T  +++ I GT  YMAPE  L G  T ++DIY+FGV++LE+ 
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

Query: 523 CGRKP--GNQSEQNSYNNSIVHWLWE-LRRKGRILDAADSRLGGEFSEKEMECVLILGLA 579
            G      ++  Q      ++    E    +  I D  D ++        +E +  +   
Sbjct: 229 TGLPAVDEHREPQL-----LLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQ 282

Query: 580 CCHPNPHLRPSMKTVLQVLSGEAD 603
           C H   + RP +K V Q+L     
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  353 bits (907), Expect = e-118
 Identities = 106/295 (35%), Positives = 168/295 (56%), Gaps = 10/295 (3%)

Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEV 365
            +  L +L++AT NF+ K  +G G FG VYKG+ R+  ++A+KR +  S QG +EF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
            T+   RH +LV LIG+C ER++ +L+Y+YM NG+L + ++     S    ++++WE+RL
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY----GSDLPTMSMSWEQRL 142

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            +  G ++ L YLH  +   ++HRD+KS NI+LD  F  ++ DFG+++   E  +TH ST
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
             + GT GY+ PE F+ GR T ++D+Y+FGV++ EV C R    QS      N +  W  
Sbjct: 200 V-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAV 257

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
           E    G++    D  L  +   + +       + C   +   RPSM  VL  L  
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  240 bits (615), Expect = 2e-74
 Identities = 67/313 (21%), Positives = 120/313 (38%), Gaps = 34/313 (10%)

Query: 309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTI 368
              + L   +          +G FG V+K    N+ +AVK      +Q   +   EV ++
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSL 72

Query: 369 GSLRHRNLVKLIGWCYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
             ++H N+++ IG          D  L+  +   GSL  F+  +          ++W + 
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---------VVSWNEL 123

Query: 425 LSVIHGTSQALDYLH-------NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
             +    ++ L YLH       +G +  + HRDIKS N++L +   A + DFGLA   + 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 478 NLKTHHSTKEIAGTPGYMAPE-----SFLVGRATIETDIYAFGVLILEVACGRKPGNQSE 532
             K+   T    GT  YMAPE           A +  D+YA G+++ E+A      +   
Sbjct: 184 G-KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GP 241

Query: 533 QNSYNNSIVHWLW-----ELRRKGRILDAADSRLGGEFSEKEMECVLI-LGLACCHPNPH 586
            + Y       +      E  ++  +       L   + +     +L      C   +  
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 587 LRPSMKTVLQVLS 599
            R S   V + ++
Sbjct: 302 ARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  209 bits (533), Expect = 1e-62
 Identities = 79/297 (26%), Positives = 140/297 (47%), Gaps = 35/297 (11%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K K+G G FGTV++  W   ++AVK     +   +   EF+ EV  +  LRH N+V  +G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
              +  +  +V EY+  GSL + +             L+  +RLS+ +  ++ ++YLHN 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-----QLDERRRLSMAYDVAKGMNYLHN- 155

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL 501
               ++HR++KS N+++D ++  ++ DFGL+R       +  S    AGTP +MAPE   
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA---AGTPEWMAPEVLR 212

Query: 502 VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN-SIVHWLWELRRKGR---ILDAA 557
              +  ++D+Y+FGV++ E+A  ++P        + N +    +  +  K +   I    
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP--------WGNLNPAQVVAAVGFKCKRLEIPRNL 264

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPERPSF 614
           + ++            +I    C    P  RPS  T++ +L       V PP R   
Sbjct: 265 NPQVAA----------II--EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  202 bits (517), Expect = 3e-60
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 41/300 (13%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           +  +G+G FG V K  WR K++A+K++   S   ++ FI E+  +  + H N+VKL G C
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
              +   LV EY   GSL   +   E               +S     SQ + YLH+   
Sbjct: 71  --LNPVCLVMEYAEGGSLYNVLHGAEPLP-----YYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 444 KRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
           K ++HRD+K  N++L +     ++ DFG A  IQ ++  +       G+  +MAPE F  
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN------KGSAAWMAPEVFEG 177

Query: 503 GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR--ILDAADSR 560
              + + D++++G+++ EV   RKP      +         +W +    R  ++      
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232

Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS------GEADPPVLPPERPSF 614
           +            L+    C   +P  RPSM+ ++++++        AD P+  P + S 
Sbjct: 233 IES----------LM--TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (514), Expect = 1e-59
 Identities = 70/326 (21%), Positives = 121/326 (37%), Gaps = 49/326 (15%)

Query: 309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAE--VT 366
               E      N      +G+G +G VYKG    + +AVK  S  +R   Q FI E  + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIY 59

Query: 367 TIGSLRHRNLVKLIGWCYE-----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
            +  + H N+ + I          R ++LLV EY PNGSL K++            T +W
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---------TSDW 110

Query: 422 EKRLSVIHGTSQALDYLHN------GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
                + H  ++ L YLH         +  + HRD+ S N+++ ++    + DFGL+  +
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 476 QENL-----KTHHSTKEIAGTPGYMAPE-------SFLVGRATIETDIYAFGVLILEVAC 523
             N      +  ++     GT  YMAPE             A  + D+YA G++  E+  
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 524 GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS--------RLGGEFSEKEMECVLI 575
                   E  S     + +  E+       D            +    + E  +    +
Sbjct: 231 RCTDLFPGE--SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 576 LGLA--CCHPNPHLRPSMKTVLQVLS 599
                 C   +   R + +   + ++
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMA 314

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (492), Expect = 4e-57
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 44/288 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRV----SETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +  +G GGFG VY+  W   E+AVK       E   Q  +    E      L+H N++ L
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            G C +  +  LV E+   G L++ +             +  +  ++     ++ ++YLH
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR---------IPPDILVNWAVQIARGMNYLH 122

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNAR--------LGDFGLARTIQENLKTHHSTKEIAGT 491
           + +   ++HRD+KSSNI++  +            + DFGLAR      K        AG 
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-----AGA 177

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN-SIVHWLWELRRK 550
             +MAPE       +  +D++++GVL+ E+  G  P        +     +   + +   
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--------FRGIDGLAVAYGVAMN 229

Query: 551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                     L         E    L   C +P+PH RPS   +L  L
Sbjct: 230 KL-------AL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (492), Expect = 1e-56
 Identities = 63/315 (20%), Positives = 109/315 (34%), Gaps = 52/315 (16%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
              LGKG FG   K   R   + + +K +     + ++ F+ EV  +  L H N++K IG
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             Y+      + EY+  G+L   I   ++          W +R+S     +  + YLH  
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGII---KSMDSQ----YPWSQRVSFAKDIASGMAYLH-- 125

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN-----------LKTHHSTKEIAG 490
               ++HRD+ S N ++    N  + DFGLAR + +                     + G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK 550
            P +MAPE         + D+++FG+++ E+          +           +     +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLNVRGFLDR 242

Query: 551 GRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL--------S 599
                                C      + + CC  +P  RPS   +   L         
Sbjct: 243 ----------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286

Query: 600 GEADPPVLPPERPSF 614
                P L      F
Sbjct: 287 HLPLGPQLEQLDRGF 301

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (483), Expect = 9e-56
 Identities = 51/286 (17%), Positives = 107/286 (37%), Gaps = 46/286 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
             KL +   G ++KG W+  +I VK  +V + S +  ++F  E   +    H N++ ++G
Sbjct: 15  LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 382 WCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            C         L+  +MP GSL   +             ++  + +      ++ + +LH
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVL------HEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              E  +    + S ++M+D +  AR+    +  + Q               P ++APE+
Sbjct: 129 T-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAWVAPEA 179

Query: 500 FLVGRATIET---DIYAFGVLILEVACGRKPGNQSEQNSYNN-SIVHWLWELRRKGR--- 552
                        D+++F VL+ E+     P        + + S +    ++  +G    
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--------FADLSNMEIGMKVALEGLRPT 231

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           I       +            L+    C + +P  RP    ++ +L
Sbjct: 232 IPPGISPHV----------SKLM--KICMNEDPAKRPKFDMIVPIL 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (477), Expect = 7e-55
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 46/291 (15%)

Query: 324 KNKLGKGGFGTVYKGIW--RNKEIAVKRVSETSRQGK-------QEFIAEVTTIGSLRHR 374
           + ++GKGGFG V+KG        +A+K +     +G+       QEF  EV  + +L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N+VKL G  +      +V E++P G L   +      + P    + W  +L ++   +  
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRL---LDKAHP----IKWSVKLRLMLDIALG 134

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFGLARTIQENLKTHHSTKEIA 489
           ++Y+ N     ++HRD++S NI L S        A++ DFGL++       + HS   + 
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVSGLL 187

Query: 490 GTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           G   +MAPE+        T + D Y+F +++  +  G  P      + Y+   + ++  +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKFINMI 242

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           R +G        R      E     +  +   C   +P  RP    +++ L
Sbjct: 243 REEGL-------RP--TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  185 bits (471), Expect = 8e-54
 Identities = 74/284 (26%), Positives = 124/284 (43%), Gaps = 38/284 (13%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
             ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N++  +G
Sbjct: 29  GQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
           +        +V ++    SL   +   ET           +K + +   T++ +DYLH  
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASETK-------FEMKKLIDIARQTARGMDYLHA- 138

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE--- 498
             K ++HRD+KS+NI L  +   ++GDFGLA        +H   +  +G+  +MAPE   
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMAPEVIR 195

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN--NSIVHWLWELRRKGRILDA 556
                  + ++D+YAFG+++ E+  G+ P        Y+  N+    +  + R     D 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIEMVGRGSLSPDL 247

Query: 557 ADSRLG--GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +  R               L+    C       RPS   +L  +
Sbjct: 248 SKVRSNCPKRMKR------LM--AECLKKKRDERPSFPRILAEI 283

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  183 bits (465), Expect = 1e-53
 Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 10/236 (4%)

Query: 23  QVSSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQL 80
           +  S+ F F +F     + + F  ++      +Q+    + G P+   +GRA+Y D  QL
Sbjct: 1   ESDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQL 60

Query: 81  WRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG-T 139
           W +     A+F T F   +      P +GLAF +A   D      G++LG+ N  T    
Sbjct: 61  WDNKTESVASFYTEFTFFLKITGNGPADGLAFFLA-PPDSDVKDAGEYLGLFNKSTATQP 119

Query: 140 NQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
           +++Q+VA+EFDT  +    + +  H+G++VNS+ S+        ++ +G     ++ YDG
Sbjct: 120 SKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDG 179

Query: 199 Q----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC-VKSWAF 249
                 + +   +    +LS  +D+ + LPE V VG SASTG++  L   + SW F
Sbjct: 180 SAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF 235

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (469), Expect = 3e-53
 Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 45/290 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
              +GKG FG VY G W   E+A++   +   +    + F  EV      RH N+V  +G
Sbjct: 38  GELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C       ++       +L   +   +         L+  K   +     + + YLH  
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI-------VLDVNKTRQIAQEIVKGMGYLHA- 148

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK--EIAGTPGYMAPES 499
             K +LH+D+KS N+  D      + DFGL              K     G   ++APE 
Sbjct: 149 --KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 500 FLVGRA---------TIETDIYAFGVLILEVACGRKP--GNQSEQNSYNNSIVHWLWELR 548
                          +  +D++A G +  E+     P     +E       I+   W++ 
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------II---WQMG 256

Query: 549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
              +  + +   +G E S+      ++  L C       RP+   ++ +L
Sbjct: 257 TGMK-PNLSQIGMGKEISD------IL--LFCWAFEQEERPTFTKLMDML 297

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  176 bits (446), Expect = 4e-51
 Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 14/236 (5%)

Query: 25  SSLHFNFQSF---TEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQ 79
           ++++F +  F   + +N  E++F  ++T    A+Q+T     G P+ + +G+A Y +   
Sbjct: 2   NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61

Query: 80  LWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITN-G 138
           LW       A+F T+F   + N  A   +GLAF +A   D      G +LG+    T   
Sbjct: 62  LWDSTGKA-ASFYTSFTFLLKNYGAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAAD 119

Query: 139 TNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
            +++Q+VA+EFDT  + +  D    H+G+DVNS+ S+        +    +     + YD
Sbjct: 120 PSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYD 179

Query: 198 GQ----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +     + +   +    +LS  +DL++ LP+KV +GFSA  G   ++  + SW F
Sbjct: 180 ARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHF 234

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  174 bits (441), Expect = 2e-50
 Identities = 76/235 (32%), Positives = 113/235 (48%), Gaps = 15/235 (6%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
            SL F+F  F       ++  ++ V  +  +Q+T  V G P +   GRA+Y   FQ+W  
Sbjct: 2   GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
                A+F T+F   I     A   +GLAF +A   D      G  LGI          +
Sbjct: 62  TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPV-DTQPLDLGGMLGIFKD-GYFNKSN 119

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
           QIVA+EFDT  + + D    H+G++VNS+ SI+ VP    N  NG    V + Y+   ++
Sbjct: 120 QIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW---NWTNGEVANVFISYEASTKS 176

Query: 201 ITVFVANME---TPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
           +T  +       + ++   +D+   LPE V  GFSA+TG D    Q N V SW+F
Sbjct: 177 LTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSF 231

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  174 bits (442), Expect = 1e-49
 Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 48/304 (15%)

Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAE--VTTIGSLRHRNLVKLIGW 382
             +GKG +G V++G W+ + +AVK  S    + ++ +  E  +     LRH N++  I  
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 383 C----YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                +      L+  Y   GSL  ++            TL+    L ++   +  L +L
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL---------QLTTLDTVSCLRIVLSIASGLAHL 121

Query: 439 HNGSEKR-----VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH-STKEIAGTP 492
           H           + HRD+KS NI++       + D GLA    ++            GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 493 GYMAPE------SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN-------SYNNS 539
            YMAPE            +    DI+AFG+++ EVA         E           N+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 540 IVHWLWEL--RRKGR--ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
               + ++    + R  I +   S        K M+        C + NP  R +   + 
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK-------ECWYQNPSARLTALRIK 294

Query: 596 QVLS 599
           + L+
Sbjct: 295 KTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (444), Expect = 2e-49
 Identities = 69/301 (22%), Positives = 112/301 (37%), Gaps = 42/301 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAE--VTTIGSLRHRNLVKLIGW 382
             +GKG FG V++G WR +E+AVK  S    + ++ +  E  +     LRH N++  I  
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 383 CYERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
             + +       LV +Y  +GSL  ++            T+  E  + +   T+  L +L
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL---------NRYTVTVEGMIKLALSTASGLAHL 155

Query: 439 HNGSEKR-----VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH-STKEIAGTP 492
           H           + HRD+KS NI++       + D GLA        T   +     GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 493 GYMAPE------SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE 546
            YMAPE      +     +    DIYA G++  E+A     G   E   Y       +  
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE--DYQLPYYDLVPS 273

Query: 547 LRRKGRILDAA---DSRLGGEFSEKEMECVLILGLA-----CCHPNPHLRPSMKTVLQVL 598
                 +         R       +   C  +  +A     C + N   R +   + + L
Sbjct: 274 DPSVEEMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

Query: 599 S 599
           S
Sbjct: 332 S 332

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  171 bits (435), Expect = 3e-49
 Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 14/248 (5%)

Query: 23  QVSSLHFNFQSFTEQNRNELSFDNSTVAKS-AIQVTYDVR-GAPITNQSGRAIYKDQFQL 80
              SL F+F +F    RN +   ++  +++  +Q+T     GAP+ +  GR ++  Q +L
Sbjct: 8   STDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRL 67

Query: 81  WRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLPENSEGQWLGIVNGITN-G 138
           W  + N  A   T F   + +  + P +G+AF IA  +  +P  S G  LG+ N  T   
Sbjct: 68  WEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALN 127

Query: 139 TNQSQIVAIEFDT---KKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVR 195
            + +Q++A+EFDT   + S   D N  H+G+DVNS+ S + V         G  + V V 
Sbjct: 128 ESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVRW---ERREGKTLNVLVT 184

Query: 196 YDGQ----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDG 251
           Y+      ++     + +   LS  +DL+  LPE V VGFSA++G+  Q + ++SW+F  
Sbjct: 185 YNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFTS 244

Query: 252 SDIGGDSK 259
           + +    K
Sbjct: 245 TLLYTAQK 252

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (437), Expect = 1e-48
 Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 48/304 (15%)

Query: 325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI--AEVTTIGSLRHRNLVKLIGW 382
            ++GKG +G V+ G WR +++AVK         +  +    E+     +RH N++  I  
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 383 CYERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
             +         L+ +Y  NGSL  ++            TL+ +  L + + +   L +L
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL---------KSTTLDAKSMLKLAYSSVSGLCHL 150

Query: 439 HNGSEKR-----VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH-STKEIAGTP 492
           H           + HRD+KS NI++       + D GLA     +            GT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 493 GYMAPE------SFLVGRATIETDIYAFGVLILEVACGRKPGNQSE--QNSYNNSIVH-- 542
            YM PE      +    ++ I  D+Y+FG+++ EVA     G   E  Q  Y++ +    
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 543 -----WLWELRRKGR--ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
                      +K R    +   S        K M         C   NP  R +   V 
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT-------ECWAHNPASRLTALRVK 323

Query: 596 QVLS 599
           + L+
Sbjct: 324 KTLA 327

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  169 bits (428), Expect = 2e-48
 Identities = 74/242 (30%), Positives = 115/242 (47%), Gaps = 26/242 (10%)

Query: 24  VSSLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRGAPITNQSGRAIYKDQFQLW 81
           + ++ FNF  F +     L    ++ + + S +++T  V G P  N +GRA+Y    Q+W
Sbjct: 1   MKTISFNFNQFHQNEEQ-LKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW 59

Query: 82  RDNKNVKATFSTTFVLNILNQ--TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
                  A+F T F  +I        P +GL F IA   +      G +     GI N  
Sbjct: 60  DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIA-PPNTQTGEGGGYF----GIYNPL 114

Query: 140 NQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG- 198
           +    VA+EFDT ++   D    H+G+DVNSV S + VP     L NG    V ++YD  
Sbjct: 115 SPYPFVAVEFDTFRNTW-DPQIPHIGIDVNSVISTKTVPF---TLDNGGIANVVIKYDAS 170

Query: 199 -QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-------TQLNCVKSW 247
            + + V +          +++ +DL + LPE V VGFSA+TGD        T+ + + SW
Sbjct: 171 TKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSW 230

Query: 248 AF 249
           +F
Sbjct: 231 SF 232

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  168 bits (426), Expect = 5e-48
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 20/261 (7%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWR 82
               F+F++F   +        ++TV+ S +++T     G P  +  GRA Y    Q++ 
Sbjct: 2   DIQSFSFKNFNSSS---FILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYD 58

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
            +    A+++T+F  NI     +   +G+AF +      P  S   +LG+ +      N 
Sbjct: 59  KSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVYD-NS 116

Query: 142 SQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
           +Q VA+EFDT  + + D    H+G+DVNS+ SIR        LANG + ++ + Y+    
Sbjct: 117 AQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW---GLANGQNAEILITYNAATS 173

Query: 200 NITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGSD 253
            +   + +       ++SE +D++  LPE V +GFSA+TG     T+ + V SW+F  S 
Sbjct: 174 LLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF-ASK 232

Query: 254 IGGDSKAFRVLIAVLVPAVVL 274
           +  DS    + IA  +   VL
Sbjct: 233 LPDDSTTEPLDIASYLVRNVL 253

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  166 bits (422), Expect = 1e-47
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 19/239 (7%)

Query: 24  VSSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVR-GAPITNQSGRAIYKDQFQL 80
           V ++ F+F  F   N N L+    + + +S  +Q+T   + G P  + +GR +Y     +
Sbjct: 1   VETISFSFSEFEPGNDN-LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHM 59

Query: 81  WRDNKNVKATFSTTFVLNILNQ--TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG 138
           W       A+F T F  +I        P +GL F +   K  P      +LG+ N  +  
Sbjct: 60  WDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFN-NSKQ 117

Query: 139 TNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
            N  Q +A+EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD 
Sbjct: 118 DNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF---QLDNGQVANVVIKYDA 174

Query: 199 --QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
             + + V +    +     ++E +D+ + LP+ V VG S +TG   D  + + V SW+F
Sbjct: 175 PSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSF 233

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  166 bits (421), Expect = 2e-47
 Identities = 70/234 (29%), Positives = 118/234 (50%), Gaps = 14/234 (5%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDV-RGAPITNQSGRAIYKDQFQLW 81
           +S+ F F  F    ++ L F  +++V  + A+Q+T    +G P     GRA+Y    +LW
Sbjct: 2   NSVCFTFTDFESGQQD-LIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60

Query: 82  RDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN-KDLPENSEGQWLGIVNGITNGTN 140
           + +  V A+F TTF  +I   ++ P + L F IA     +P  S G+ LG+     N  +
Sbjct: 61  QSSSLV-ASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGS 119

Query: 141 QSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
            + +V++EFDT  + +  D N  H+G+DVNS+ S         +  NG      + Y+  
Sbjct: 120 DNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW---DWQNGKTATAHISYNSA 176

Query: 200 ----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
               ++     N    ++S  ++L+   P+ V VGFSA+TG  TQ N + +W+F
Sbjct: 177 SKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSF 230

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  166 bits (420), Expect = 3e-47
 Identities = 76/238 (31%), Positives = 116/238 (48%), Gaps = 19/238 (7%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVT-YDVRGAPITNQSGRAIYKDQFQLW 81
               F F  F     N L    ++ V  +  +Q+T  D  G P  +  GRA Y     +W
Sbjct: 2   EETSFVFSKFKPLEPN-LILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60

Query: 82  RDNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
                + A+F+T+F   I     A   +GLAF +A     P +S G +LG+ +   +G +
Sbjct: 61  DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAP-DSGGGFLGLFDSAVSG-S 118

Query: 141 QSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
             Q VA+EFDT ++    D    H+G DVNS+ SI+ V     +LANG   KV + Y+  
Sbjct: 119 TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW---SLANGEAAKVLITYNSA 175

Query: 200 NITVFV-----ANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
              +       ++  + +L++ +DLS  LPE V VGFSA+TG      + + V SW+F
Sbjct: 176 VKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  165 bits (418), Expect = 3e-47
 Identities = 64/238 (26%), Positives = 103/238 (43%), Gaps = 25/238 (10%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           +  F    F+   +N L F  +    K  + +T       + N  GRA+Y     +W   
Sbjct: 3   TTSFLITKFSPDQQN-LIFQGDGYTTKEKLTLTKA-----VKNTVGRALYSSPIHIWDRE 56

Query: 85  KNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
               A F T+F   I    +    +G  F IA   D    + G +LG+ N        +Q
Sbjct: 57  TGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGVFNS-AEYDKTTQ 114

Query: 144 IVAIEFDTKKSYEQ--DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
            VA+EFDT  +        D H+G+DVNS+ S+         L NG +  V + ++    
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW---KLQNGEEANVVIAFNAATN 171

Query: 200 NITVFVA--------NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
            +TV +          + +  LS+ + L + +PE V +GFSA+TG +   + V SW+F
Sbjct: 172 VLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 229

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  165 bits (418), Expect = 3e-47
 Identities = 71/238 (29%), Positives = 116/238 (48%), Gaps = 21/238 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFDN--STVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
            ++ FNF SF+E N   ++F    + ++   IQ+T   +     N  GR +Y    ++W 
Sbjct: 2   ETVSFNFNSFSEGNPA-INFQGDVTVLSNGNIQLTNLNK----VNSVGRVLYAMPVRIWS 56

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKD-LPENSEGQWLGIVNGITNGTN 140
                 A+F T+F   + +     P +G+ F IA     +P  S G       G+++   
Sbjct: 57  SATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGT---LGVSDTKG 113

Query: 141 QSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
               V +EFDT  + E  D   +HVG+DVNSV S++ VP    N  +G  +KV V YD  
Sbjct: 114 AGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---NSVSGAVVKVTVIYDSS 170

Query: 200 ----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAFDGS 252
               ++ V   N +   +++ +DL   LPE+V  GFSAS      Q++ ++SW+F  +
Sbjct: 171 TKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  165 bits (418), Expect = 4e-47
 Identities = 72/239 (30%), Positives = 118/239 (49%), Gaps = 19/239 (7%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
             L F   +F     + L F   ++V+ +  +Q+T    G P     GRA+Y    ++W 
Sbjct: 2   DELSFTINNFVPNEAD-LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIA-GNKDLPENSEGQWLGIVNGITNGTN 140
           +     A+FST+F   +         +GLAF +A  +  +P  S  ++LG+ N  +N  +
Sbjct: 61  NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFN-NSNSDS 119

Query: 141 QSQIVAIEFDTKKSYE---QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
            +QIVA+EFDT  ++     D N  H+G+DVN + SI+     + +  NG      + Y 
Sbjct: 120 SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKT---VQWDWINGGVAFATITYL 176

Query: 198 --GQNITVFV---ANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAF 249
              + +   +   +N  T  ++  +DL E LPE V VGFSA+TG  T  + + V SW+F
Sbjct: 177 APNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  163 bits (414), Expect = 2e-46
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 17/246 (6%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
             L F F++F++  ++ LSF  N++V ++  +Q+       P     G A Y     +W 
Sbjct: 2   DDLSFKFKNFSQNGKD-LSFQGNASVIETGVLQLNKVGNNLP-DETGGIARYIAPIHIWN 59

Query: 83  DNKNVKATFSTTFVLNILNQT--AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
            N    A+F T+F   +          +GL F +A   D P    G + G+ N  T   +
Sbjct: 60  CNTGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFN-DTKCDS 117

Query: 141 QSQIVAIEFDTKKSYEQ--DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
             Q VA+EFDT  S     D    H+G+DVN V SI      +          V++ Y+ 
Sbjct: 118 SYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK-RYGLNNVANVEIIYEA 176

Query: 199 --QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAFDGS 252
             + +T  +    +  +  ++  +DL E LPE V VGFS ST       + V +W F  +
Sbjct: 177 SSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236

Query: 253 DIGGDS 258
            I  +S
Sbjct: 237 FINTNS 242

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  161 bits (409), Expect = 6e-46
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 20/235 (8%)

Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKS--AIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           S  F+F +F     N L      +  S   +++T    GAP+ +  GRA+Y     +   
Sbjct: 3   STSFSFTNFNPNQNN-LILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH-- 59

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
           +    A+F+T+F   +     A   +GLAF +A     P  + G +LG+     +  +  
Sbjct: 60  DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQP-QARGGFLGLFADRAHDAS-Y 117

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
           Q VA+EFDT  +   D N  H+G+D N + S +  P    ++  G    + + Y    + 
Sbjct: 118 QTVAVEFDTYSNAW-DPNYTHIGIDTNGIESKKTTPF---DMVYGEKANIVITYQASTKA 173

Query: 201 ITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
           +   +    +  +  +S  +DL + LPE V VGFSA+TG +    + + + SW+F
Sbjct: 174 LAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSF 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (416), Expect = 4e-45
 Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 50/289 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEI--AVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
             ++G+G FG V+ G  R      AVK   E      K +F+ E   +    H N+V+LI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHN 440
           G C ++    +V E +  G    F+      +    + +  +  L ++   +  ++YL  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-----RTEGARLRV--KTLLQMVGDAAAGMEYLE- 230

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT-HHSTKEIAGTP-GYMAPE 498
              K  +HRD+ + N ++  +   ++ DFG++R   + +       +++   P  + APE
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV---PVKWTAPE 285

Query: 499 SFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGRI 553
           +   GR + E+D+++FG+L+ E    G  P        Y    N     ++     KG  
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASP--------YPNLSNQQTREFV----EKGGR 333

Query: 554 LDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           L                 C   V  L   C    P  RPS  T+ Q L 
Sbjct: 334 L------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  159 bits (403), Expect = 7e-45
 Identities = 79/257 (30%), Positives = 132/257 (51%), Gaps = 23/257 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVT-YDVRGAPITNQSGRAIYKDQFQLW 81
           + ++FNFQ F E N   L    +++V+ S  +++T  +  G P     GRA Y    Q+W
Sbjct: 2   NDIYFNFQRFNETN---LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW 58

Query: 82  RDNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
            +     A+F+T+F  NI     A P +GLAF +      P   +G +LG+ +G     +
Sbjct: 59  DNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDG---SNS 114

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
               VA+EFDT  + + D  + H+G+DVNS+ SI+       +  NG + +V + YD   
Sbjct: 115 NFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW---DFVNGENAEVLITYDSST 171

Query: 199 QNITVFV---ANMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDGS 252
             +   +   +   + ++S+ +DL   LPE V VGFSA+TG    + + N V SW+F  S
Sbjct: 172 NLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF-AS 230

Query: 253 DIGGDSKAFRVLIAVLV 269
            +  ++ +  + +A LV
Sbjct: 231 KLSDETTSEGLNLANLV 247

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  158 bits (401), Expect = 1e-44
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 18/237 (7%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
             L FNF  F    +N + F  +++V+ + +     V   P T   GRA+Y    Q+W  
Sbjct: 4   DDLSFNFDKFVPNQKN-IIFQGDASVSTTGVLQVTKVSK-PTTTSIGRALYAAPIQIWDS 61

Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGTNQS 142
                A+F+T+F   +    +   +GLAF +A     +P  S     G+ +  ++  + +
Sbjct: 62  ITGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSN 120

Query: 143 QIVAIEFDTKKSYE---QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG- 198
           QI+A+EFDT         D +  H+G+DVNS+ SI+ V     +  NG    V + Y   
Sbjct: 121 QIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK---WDWRNGEVADVVITYRAP 177

Query: 199 -QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD--DTQLNCVKSWAF 249
            +++TV ++   +  + +++  +DL   LPE V VGFS   G+  + + + V SW F
Sbjct: 178 TKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  158 bits (400), Expect = 2e-44
 Identities = 69/236 (29%), Positives = 115/236 (48%), Gaps = 20/236 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVT-YDVRGAPITNQSGRAIYKDQFQLW 81
            ++ F++  F  +  N +    ++ V  S  +Q+   D  G P  +  GRA+Y     +W
Sbjct: 2   ETVSFSWNKFVPKQPN-MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60

Query: 82  RDNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
                  A+F+ +F        T +  +GLAF +A   D    +   +LG+ N   +G  
Sbjct: 61  DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPI-DTKPQTHAGYLGLFNENESG-- 117

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
             Q+VA+EFDT ++   D  + H+G++VNS+ SI+       +LAN    KV + YD   
Sbjct: 118 -DQVVAVEFDTFRNSW-DPPNPHIGINVNSIRSIKTTSW---DLANNKVAKVLITYDAST 172

Query: 201 ITVFVA-----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAF 249
             +  +        + +LS+ +DL   LPE V +GFSA+TG D   + + V SW+F
Sbjct: 173 SLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSF 228

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  155 bits (393), Expect = 1e-43
 Identities = 65/234 (27%), Positives = 117/234 (50%), Gaps = 22/234 (9%)

Query: 27  LHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           + FN+  F   +   L F  ++ +     + +        +   +  A+Y     +W   
Sbjct: 1   VSFNYTRFK--DDGSLIFQGDAKIWTDGRLAMP---TDPLVNRTTSHALYATPVPIWDSA 55

Query: 85  KNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAG-NKDLPENSEGQWLGIVNGITNGTNQS 142
               A+F T+F   + N     P +G+ F +A    ++P NS+G +LGI +   +  +Q+
Sbjct: 56  TGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITD---SSNSQN 112

Query: 143 QIVAIEFDTKKSYE--QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
           Q VA+EFD+  +    + +  +H+G+DVNS+ S++ V     N  +G+  K  + YD   
Sbjct: 113 QFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNW---NRVSGSLEKATIIYDSDT 169

Query: 199 QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSAST-GDDTQLNCVKSWAF 249
           + +TV +   N +   +S+ IDL   LPEKV VGFSA+T   + + + + SW+F
Sbjct: 170 KILTVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSF 223

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  154 bits (391), Expect = 3e-43
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 25/239 (10%)

Query: 26  SLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWR 82
           +  FNF  F E ++  L+     S  +   +++T   + G P+   +GRA+Y +  ++W 
Sbjct: 2   TQSFNFDHFEENSKE-LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60

Query: 83  DNKNVKATFSTTFVLNILNQTAQ--PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
                 A+F T F  NI    A   P +GL F +    + P+  +G  L    G+     
Sbjct: 61  STTGNVASFETRFSFNITQPYAYPEPADGLTFFMV-PPNSPQGEDGGNL----GVFKPPE 115

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
                A+EFDT ++   D    H+G+DVNS+ S + +      L NG    V ++YD   
Sbjct: 116 GDNAFAVEFDTFQNTW-DPQVPHIGIDVNSIVSSKTLHF---QLENGGVANVVIKYDSPT 171

Query: 199 QNITVFVA---NMETPLLSEPIDLSEYLP--EKVFVGFSASTG---DDTQLNCVKSWAF 249
           + + V +A         LS  +DL +  P  E V VG SA+TG   +  + + + SW+F
Sbjct: 172 KILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSF 230

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  156 bits (395), Expect = 2e-42
 Identities = 66/301 (21%), Positives = 128/301 (42%), Gaps = 37/301 (12%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSR 355
           +G +L  +    + ++K    +    K+G+G FG           ++  +K +  S  S 
Sbjct: 9   SGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64

Query: 356 QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPG 415
           + ++E   EV  + +++H N+V+      E     +V +Y   G L K I   +      
Sbjct: 65  KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
           +  L+W  ++        AL ++H   ++++LHRDIKS NI L  +   +LGDFG+AR +
Sbjct: 125 DQILDWFVQIC------LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
              ++   +     GTP Y++PE         ++DI+A G ++ E+   +         +
Sbjct: 176 NSTVELARA---CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

Query: 536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
               I+         G         +   +S    +   ++       NP  RPS+ ++L
Sbjct: 233 LVLKII--------SGSF-----PPVSLHYSY---DLRSLV-SQLFKRNPRDRPSVNSIL 275

Query: 596 Q 596
           +
Sbjct: 276 E 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (387), Expect = 4e-42
 Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 59/296 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +F     +G GGFG V+K   R   K   +KRV    +   ++   EV  +  L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67

Query: 378 KLIGWCYERHDFL-----------------LVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
              G C++  D+                  +  E+   G+L+++I           + L 
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
                      ++ +DY+H    K++++RD+K SNI L      ++GDFGL  +++ + K
Sbjct: 127 L------FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
              S     GT  YM+PE         E D+YA G+++ E+        ++ +       
Sbjct: 178 RTRSK----GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------- 226

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
               +   R G I D         F +KE    L+         P  RP+   +L+
Sbjct: 227 ---FFTDLRDGIISD--------IFDKKEKT--LLQK--LLSKKPEDRPNTSEILR 267

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  153 bits (388), Expect = 6e-42
 Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 35/287 (12%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV---SETSRQGKQEFIAEVTTIGSLRH 373
            NF  + K+G+G F  VY+         +A+K+V        + + + I E+  +  L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGT 431
            N++K      E ++  +V E    G L + I  F  +    P      +  +L      
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----- 146

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL+++H    +RV+HRDIK +N+ + +    +LGD GL R          +   + GT
Sbjct: 147 -SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 199

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YM+PE         ++DI++ G L+ E+A  + P    + N         L+ L +K 
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCKK- 249

Query: 552 RILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
            I       L    +SE E+  ++     C +P+P  RP +  V  V
Sbjct: 250 -IEQCDYPPLPSDHYSE-ELRQLV---NMCINPDPEKRPDVTYVYDV 291

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  147 bits (371), Expect = 9e-41
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 25/235 (10%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           +   FN ++F + N   L    ++TV+     +  +V+G    +  GRA Y    Q+   
Sbjct: 2   NDASFNVETFNKTN---LILQGDATVSSEGHLLLTNVKG-NEEDSMGRAFYSAPIQINDR 57

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
             +  A+FST F   I  +       GLAF +      P   +G++LG+ N  TN    +
Sbjct: 58  TIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT-TNYDRDA 115

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
             VA+ FDT          N + +DVNS+  I           NG   +V++ YD    +
Sbjct: 116 HTVAVVFDT--------VSNRIEIDVNSIRPIATESCN-FGHNNGEKAEVRITYDSPKND 166

Query: 201 ITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           + V +    + E   +S  + L + + + V VGFSA++G   + T+ + V SW+F
Sbjct: 167 LRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSF 221

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (379), Expect = 2e-40
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 53/291 (18%)

Query: 325 NKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
             LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L+G C       L+ + MP G L  ++   + N G   + LNW          ++ ++Y
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNW------CVQIAKGMNY 132

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L    ++R++HRD+ + N+++ +  + ++ DFGLA+ +    K +H+       P  +MA
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--GKVPIKWMA 187

Query: 497 PESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKG 551
            ES L    T ++D++++GV + E+   G KP        Y     + I   L     KG
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIPASEISSIL----EKG 235

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                   RL      +   C   V ++   C   +   RP  + ++   S
Sbjct: 236 E-------RL-----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  148 bits (375), Expect = 2e-40
 Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 53/291 (18%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
              LG+G FG VY+G++ N +     +AVK   +  +   K++F++E   + +L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           KLIG   E     ++ E  P G L  ++           + +     +       +A+ Y
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELGHYL-----ERNKNSLKV--LTLVLYSLQICKAMAY 128

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L        +HRDI   NI++ S    +LGDFGL+R I++      S   +   P  +M+
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL---PIKWMS 182

Query: 497 PESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKG 551
           PES    R T  +D++ F V + E+   G++P        +    N  ++  L     KG
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP--------FFWLENKDVIGVL----EKG 230

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             L             K   C   +  L   C   +P  RP    ++  LS
Sbjct: 231 DRL------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  148 bits (376), Expect = 2e-40
 Identities = 56/301 (18%), Positives = 114/301 (37%), Gaps = 51/301 (16%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F P   LG+GGFG V++   +  +   A+KR+        +++ + EV  +  L H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 377 VKLIGWCYERHDFL------------LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V+      E++               +  +     +L  ++    T              
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC----- 120

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           L +    ++A+++LH    K ++HRD+K SNI    +   ++GDFGL   + ++ +    
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 485 TKEIA---------GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS 535
              +          GT  YM+PE       + + DI++ G+++ E+        Q E+  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVR 235

Query: 536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL 595
               +        R  +        L  +    E    ++       P+P  RP    ++
Sbjct: 236 TLTDV--------RNLKF-----PPLFTQKYPCEYV--MV--QDMLSPSPMERPEAINII 278

Query: 596 Q 596
           +
Sbjct: 279 E 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (374), Expect = 3e-40
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 36/287 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRN 375
           ++     +G G +G   K   +   K +  K +     +   KQ  ++EV  +  L+H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 376 LVKLIGWCYERHDFLL--VYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIHGT 431
           +V+      +R +  L  V EY   G L   I            E  L    +L+     
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT----- 121

Query: 432 SQALDYLH--NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             AL   H  +     VLHRD+K +N+ LD + N +LGDFGLAR +  +       K   
Sbjct: 122 -LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFV 177

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GTP YM+PE         ++DI++ G L+ E+     P     Q      I         
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------- 229

Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           +G+       R+   +S+   E   I+     +   + RPS++ +L+
Sbjct: 230 EGKF-----RRIPYRYSD---ELNEIIT-RMLNLKDYHRPSVEEILE 267

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (371), Expect = 4e-40
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 48/293 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
             ++G G FG V+ G W NK ++A+K + E +   +++FI E   +  L H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C E+    LV E+M +G L  ++      +  G      E  L +     + + YL    
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL-----RTQRGLFAA--ETLLGMCLDVCEGMAYL---E 121

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
           E  V+HRD+ + N ++      ++ DFG+ R + ++  T  +  +    P  + +PE F 
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---PVKWASPEVFS 178

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGRILDA 556
             R + ++D+++FGVL+ EV   G+ P        Y    N+ +V  +      G  L  
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP--------YENRSNSEVVEDI----STGFRL-- 224

Query: 557 ADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEADPPV 606
                      K       V  +   C    P  RP+   +L+ L+  A+  +
Sbjct: 225 ----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  148 bits (376), Expect = 5e-40
 Identities = 71/323 (21%), Positives = 137/323 (42%), Gaps = 63/323 (19%)

Query: 324 KNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNL 376
           +  +G G FG VYKG+ +         +A+K +    + + + +F+ E   +G   H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           ++L G   +    +++ EYM NG+LDKF+         GE ++   + + ++ G +  + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-----REKDGEFSV--LQLVGMLRGIAAGMK 161

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG--- 493
           YL   +    +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T       G   
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS------GGKI 212

Query: 494 ---YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY---NNSIVHWLWE 546
              + APE+    + T  +D+++FG+++ EV   G +P        Y   +N  V    +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--------YWELSNHEV---MK 261

Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEAD 603
               G  L               M+C   +  L + C       RP    ++ +L     
Sbjct: 262 AINDGFRL------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

Query: 604 PP----VLPPERPSFVWPAMPPS 622
            P     L    P         S
Sbjct: 310 APDSLKTLADFDPRVSIRLPSTS 332

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 7e-40
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 48/286 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
             +LG G FG V  G W+ + ++AVK + E S   + EF  E  T+  L H  LVK  G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C + +   +V EY+ NG L  ++      S    +     + L + +   + + +L    
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL-----RSHGKGLEP--SQLLEMCYDVCEGMAFL---E 121

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
             + +HRD+ + N ++D +   ++ DFG+ R + ++        +    P  + APE F 
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---PVKWSAPEVFH 178

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGRILDA 556
             + + ++D++AFG+L+ EV   G+ P        Y    N+ +V  +     +G  L  
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP--------YDLYTNSEVVLKV----SQGHRL-- 224

Query: 557 ADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                      +       +  +  +C H  P  RP+ + +L  + 
Sbjct: 225 ----------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  146 bits (371), Expect = 7e-40
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
             +LG G FG V  G WR + ++A+K + E S   + EFI E   + +L H  LV+L G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C ++    ++ EYM NG L  ++                ++ L +     +A++YL    
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL-----REMRHRFQT--QQLLEMCKDVCEAMEYL---E 137

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
            K+ LHRD+ + N +++ +   ++ DFGL+R + ++  T     +    P  +  PE  +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEVLM 194

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKP 527
             + + ++DI+AFGVL+ E+   G+ P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (369), Expect = 1e-39
 Identities = 60/311 (19%), Positives = 114/311 (36%), Gaps = 65/311 (20%)

Query: 324 KNKLGKGGFGTVYKGIWRNK---------EIAVKRVSETSRQGKQEFIAEVTTIGSLRHR 374
              LG+G F  ++KG+ R           E+ +K + +  R   + F    + +  L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +LV   G C    + +LV E++  GSLD ++           + + W+  L V    + A
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-----KKNKNCINILWK--LEVAKQLAAA 125

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR--------LGDFGLARTIQENLKTHHSTK 486
           + +L    E  ++H ++ + NI+L  E + +        L D G++ T+           
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182

Query: 487 EIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSI 540
                  ++ PE     +   + TD ++FG  + E+   G KP             +   
Sbjct: 183 -------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--------LSALDSQRK 227

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVL-ILGLACCHPNPHLRPSMKTVLQVLS 599
           + +          L                   L  L   C    P  RPS + +++ L+
Sbjct: 228 LQFY----EDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

Query: 600 GEADPPVLPPE 610
               P ++P  
Sbjct: 272 SLFTPDLVPRG 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  146 bits (371), Expect = 2e-39
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 42/283 (14%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSL-RHR 374
           +F   ++LG G +G V+K   +   +  AVKR        + +   +AEV +   + +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 375 NLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             V+L    +E    L L  E     SL +    +   +   E  +        +  T  
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQV-----WGYLRDTLL 168

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL +LH    + ++H D+K +NI L      +LGDFGL       L T  + +   G P 
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV----ELGTAGAGEVQEGDPR 221

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           YMAPE  L G      D+++ G+ ILEVAC  +  +  E            W+  R+G +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYL 269

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
                + L  E         +++      P+P LR + + +L 
Sbjct: 270 PPEFTAGLSSELRS------VLVM--MLEPDPKLRATAEALLA 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  145 bits (369), Expect = 3e-39
 Identities = 62/314 (19%), Positives = 117/314 (37%), Gaps = 49/314 (15%)

Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           ++    KLG+GGF  V   +G+      A+KR+    +Q ++E   E        H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 378 KLIGWCYER----HDFLLVYEYMPNGSLDKFIFYDETNSGP---GEVTLNWEKRLSVIHG 430
           +L+ +C       H+  L+  +   G+L   I   +         ++       L ++ G
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-------LWLLLG 142

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA- 489
             + L+ +H    K   HRD+K +NI+L  E    L D G       +++       +  
Sbjct: 143 ICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 490 -----GTPGYMAPESF-LVGRATI--ETDIYAFGVLILEVACGRKP--GNQSEQNSYNNS 539
                 T  Y APE F +     I   TD+++ G ++  +  G  P      + +S   +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

Query: 540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           +         + ++      R      +      L+        +PH RP +  +L  L 
Sbjct: 260 V---------QNQLSIPQSPRHSSALWQ------LLNS--MMTVDPHQRPHIPLLLSQLE 302

Query: 600 GEADPPVLPPERPS 613
               P   P +  +
Sbjct: 303 ALQPP--APGQHTT 314

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (367), Expect = 3e-39
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 48/287 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+KLG G +G VY+G+W+   +  AVK + E + +  +EF+ E   +  ++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
            C     F ++ E+M  G+L  ++          EV+      L +    S A++YL   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSA--VVLLYMATQISSAMEYL--- 127

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESF 500
            +K  +HRD+ + N ++      ++ DFGL+R +  +  T H+  +    P  + APES 
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPESL 184

Query: 501 LVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGRILD 555
              + +I++D++AFGVL+ E+A  G  P        Y     + +   L     K   + 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELL----EKDYRM- 231

Query: 556 AADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                      E+   C   V  L  AC   NP  RPS   + Q   
Sbjct: 232 -----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (366), Expect = 3e-39
 Identities = 70/283 (24%), Positives = 113/283 (39%), Gaps = 45/283 (15%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           ++G+G F TVYKG+      E+A   +   + ++  +Q F  E   +  L+H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 382 ----WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ---A 434
                   +   +LV E M +G+L  ++          +V  +W           Q    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSW---------CRQILKG 141

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           L +LH      ++HRD+K  NI +     + ++GD GLA      LK     K + GTP 
Sbjct: 142 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-----LKRASFAKAVIGTPE 195

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           +MAPE +         D+YAFG+ +LE+A    P ++ +  +     V        K   
Sbjct: 196 FMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----SGVKPAS 250

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            D        E  E            C   N   R S+K +L 
Sbjct: 251 FDKVAIPEVKEIIEG-----------CIRQNKDERYSIKDLLN 282

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  145 bits (368), Expect = 5e-39
 Identities = 71/295 (24%), Positives = 132/295 (44%), Gaps = 58/295 (19%)

Query: 324 KNKLGKGGFGTVYKGIWR---NKEI--AVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
           +  +G G  G V  G  R    +++  A+K +    + + +++F++E + +G   H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L G        ++V EYM NGSLD F+      +  G+ T+   + + ++ G    + Y
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIM--QLVGMLRGVGAGMRY 166

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG---- 493
           L   S+   +HRD+ + N+++DS    ++ DFGL+R ++++    ++T       G    
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT------GGKIP 217

Query: 494 --YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY---NNSIVHWLWEL 547
             + APE+      +  +D+++FGV++ EV   G +P        Y    N  V      
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP--------YWNMTNRDV---ISS 266

Query: 548 RRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
             +G        RL        M C   +  L L C H +   RP    ++ VL 
Sbjct: 267 VEEGY-------RL-----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  145 bits (367), Expect = 7e-39
 Identities = 73/298 (24%), Positives = 122/298 (40%), Gaps = 52/298 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + E S   +Q+F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF-------IFYDETNSGPGEVTLNWEKRLSVIH 429
           V+  G C E    L+V+EYM +G L++F                     L   + L+V  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             +  + YL   +    +HRD+ + N ++      ++GDFG++R I              
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR------V 216

Query: 490 GTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHW 543
           G        +M PES L  + T E+D+++FGV++ E+   G++P        +       
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------WYQLSNTE 268

Query: 544 LWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
             +   +GR L            E+   C   V  +   C    P  R S+K V   L
Sbjct: 269 AIDCITQGREL------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (367), Expect = 8e-39
 Identities = 80/343 (23%), Positives = 140/343 (40%), Gaps = 66/343 (19%)

Query: 324 KNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNL 376
              LG G FGTV+KG+W  +       + +K + + + RQ  Q     +  IGSL H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V+L+G C       LV +Y+P GSL   +       GP  + LNW          ++ + 
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLL-LNW------GVQIAKGMY 129

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL    E  ++HR++ + N++L S    ++ DFG+A  +  + K    ++  A TP  +M
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIKWM 184

Query: 496 APESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRK 550
           A ES   G+ T ++D++++GV + E+   G +P        Y       +   L     K
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------YAGLRLAEVPDLL----EK 232

Query: 551 GRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS-------- 599
           G        RL      +   C   V ++ + C   + ++RP+ K +    +        
Sbjct: 233 GE-------RL-----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280

Query: 600 -----GEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDP 637
                 E+ P + P   P  +                   L+ 
Sbjct: 281 YLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEA 323

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  144 bits (365), Expect = 8e-39
 Identities = 67/299 (22%), Positives = 135/299 (45%), Gaps = 53/299 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           K +LG+G FG V+     N         +AVK + + +   +++F  E   + +L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKRLSVI 428
           VK  G C +    ++V+EYM +G L+KF        +   +      +  L   + L + 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
              +  + YL   + +  +HRD+ + N ++ +    ++GDFG++R +      ++     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST--DYYRVGGH 194

Query: 489 AGTP-GYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVH 542
              P  +M PES +  + T E+D+++FGV++ E+   G++P        +    N  ++ 
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------WFQLSNTEVIE 246

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
            +     +GR+L            E+   C   V  + L C    P  R ++K + ++L
Sbjct: 247 CI----TQGRVL------------ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (362), Expect = 1e-38
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 326 KLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKL 379
            +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG     +   ++ E    G L  F+           + L     +   +  S AL YL 
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFL-----QVRKYSLDL--ASLILYAYQLSTALAYL- 132

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
               KR +HRDI + N+++ S    +LGDFGL+R ++++     S  ++   P  +MAPE
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIKWMAPE 187

Query: 499 SFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           S    R T  +D++ FGV + E+   G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  144 bits (364), Expect = 2e-38
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 53/291 (18%)

Query: 325 NKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
             LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L+G C       L+ + MP G L  ++   + N G   + LNW          ++ ++Y
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNW------CVQIAKGMNY 132

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L    ++R++HRD+ + N+++ +  + ++ DFGLA+ +    K +H+       P  +MA
Sbjct: 133 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--GKVPIKWMA 187

Query: 497 PESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKG 551
            ES L    T ++D++++GV + E+   G KP        Y     + I   L     KG
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------YDGIPASEISSIL----EKG 235

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                   RL      +   C   V ++ + C   +   RP  + ++   S
Sbjct: 236 E-------RL-----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  143 bits (363), Expect = 2e-38
 Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 52/297 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-----IAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
              LG+G FG+V +G  + ++     +AVK  ++  +S++  +EF++E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 377 VKLIGWCYERH-----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           ++L+G C E         +++  +M  G L  ++ Y    +GP  + L  +  L  +   
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDI 156

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           +  ++YL   S +  LHRD+ + N ML  +    + DFGL++ I      ++    IA  
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG--DYYRQGRIAKM 211

Query: 492 P-GYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLW 545
           P  ++A ES      T ++D++AFGV + E+A  G  P        Y    N+ +  +L 
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--------YPGVQNHEMYDYL- 262

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                G  L            ++  +C   +  +  +C   +P  RP+   +   L 
Sbjct: 263 ---LHGHRL------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (374), Expect = 2e-38
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 38/281 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNKEI--AVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           +KLG G +G VY+G+W+   +  AVK + E + +  +EF+ E   +  ++H NLV+L+G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
           C     F ++ E+M  G+L  ++          EV+      L +    S A++YL    
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL----RECNRQEVSA--VVLLYMATQISSAMEYL---E 335

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV 502
           +K  +HR++ + N ++      ++ DFGL+R +  +  T H+  +      + APES   
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAY 393

Query: 503 GRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRL 561
            + +I++D++AFGVL+ E+A  G  P        Y    +  ++EL  K   +       
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP--------YPGIDLSQVYELLEKDYRM------- 438

Query: 562 GGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                E+   C   V  L  AC   NP  RPS   + Q   
Sbjct: 439 -----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  142 bits (359), Expect = 4e-38
 Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 324 KNKLGKGGFGTVYKGIWRNK----EIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVK 378
             +LG G FG+V +G++R +    ++A+K +   T +   +E + E   +  L +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           LIG C +    +LV E    G L KF+             +       ++H  S  + YL
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKRE----EIPVSNVAELLHQVSMGMKYL 126

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAP 497
               EK  +HRD+ + N++L +   A++ DFGL++ +  +  ++++ +     P  + AP
Sbjct: 127 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAP 182

Query: 498 ESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           E     + +  +D++++GV + E    G+KP
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (360), Expect = 4e-38
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 50/292 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
              +GKG FG VY G + ++       A+K +S  T  Q  + F+ E   +  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 378 KLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
            LIG          ++  YM +G L +FI   + N          +  +S     ++ ++
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-------PTVKDLISFGLQVARGME 138

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYM 495
           YL   +E++ +HRD+ + N MLD  F  ++ DFGLAR I +           A  P  + 
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 496 APESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRK 550
           A ES    R T ++D+++FGVL+ E+   G  P        Y       + H+L     +
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--------YRHIDPFDLTHFL----AQ 243

Query: 551 GRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           GR L             +   C   +  +   C   +P +RP+ + ++  + 
Sbjct: 244 GRRL------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (361), Expect = 5e-38
 Identities = 74/326 (22%), Positives = 134/326 (41%), Gaps = 49/326 (15%)

Query: 324 KNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
            ++LGKG FG+V    +          +AVK++  +    +++F  E+  + +L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 378 KLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           K  G  Y   R    LV EY+P+G L  F+           +  +  + L       + +
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDAS--RLLLYSSQICKGM 140

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GY 494
           +YL     +R +HRD+ + NI+++SE + ++ DFGLA+ +  + K ++  +E   +P  +
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFW 196

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVA-CGRKP---------GNQSEQNSYNNSIVHWL 544
            APES      + ++D+++FGV++ E+     K              E++    S +   
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL-- 254

Query: 545 WELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSG- 600
            EL  +G+       RL          C   V  L   C  P+P  RPS   +   L   
Sbjct: 255 -ELLEEGQ-------RL-----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

Query: 601 EADPPVLPPERPSFVWPAMPPSFVES 626
            +          +        S   S
Sbjct: 302 WSGSRGCETHAFTAHPEGKHHSLSFS 327

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (358), Expect = 5e-38
 Identities = 63/207 (30%), Positives = 110/207 (53%), Gaps = 17/207 (8%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
             +LG G FG V+ G +    ++AVK + + S      F+AE   +  L+H+ LV+L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
             +     ++ EYM NGSL  F+   +T SG     L   K L +    ++ + ++    
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL---KTPSGI---KLTINKLLDMAAQIAEGMAFI---E 126

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
           E+  +HRD++++NI++    + ++ DFGLAR I++N  T     +    P  + APE+  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIKWTAPEAIN 183

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKP 527
            G  TI++D+++FG+L+ E+   GR P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (358), Expect = 5e-38
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
              +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G  
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 384 Y-ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
             E+    +V EYM  GSL  ++         G   L  +  L       +A++YL    
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 134

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
               +HRD+ + N+++  +  A++ DFGL +       T  + K     P  + APE+  
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGK----LPVKWTAPEALR 187

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKP 527
             + + ++D+++FG+L+ E+   GR P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  142 bits (360), Expect = 6e-38
 Identities = 74/343 (21%), Positives = 134/343 (39%), Gaps = 85/343 (24%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
             +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFI--FYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +V+L+G   +    L++ E M  G L  ++        + P     +  K + +    + 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            + YL   +  + +HRD+ + N M+  +F  ++GDFG+ R I E                
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--------------D 192

Query: 494 Y-------------MAPESFLVGRATIETDIYAFGVLILEVA-CGRKP--GNQSEQNSYN 537
           Y             M+PES   G  T  +D+++FGV++ E+A    +P  G  +EQ    
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---- 248

Query: 538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTV 594
                 +     +G +L            +K   C   +  L   C   NP +RPS   +
Sbjct: 249 ------VLRFVMEGGLL------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290

Query: 595 LQVLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDP 637
           +  +                    M P F E  + ++     P
Sbjct: 291 ISSIK-----------------EEMEPGFREVSFYYSEENKLP 316

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (358), Expect = 7e-38
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 50/291 (17%)

Query: 325 NKLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVK 378
             +G+G FG VY G   + +      AVK ++  T      +F+ E   +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 379 LIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           L+G C       L+V  YM +G L  FI     N          +  +      ++ + Y
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETH---NPTVKDLIGFGLQVAKGMKY 143

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L   + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 497 PESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSY----NNSIVHWLWELRRKG 551
            ES    + T ++D+++FGVL+ E+   G  P        Y       I  +L     +G
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL----LQG 248

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           R L             +   C   +  + L C HP   +RPS   ++  +S
Sbjct: 249 RRL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  141 bits (357), Expect = 8e-38
 Identities = 57/210 (27%), Positives = 108/210 (51%), Gaps = 21/210 (10%)

Query: 326 KLGKGGFGTVYKGIWRNK----EIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +LG G FGTV KG ++ K     +AVK  +        K E +AE   +  L +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG C E   ++LV E    G L+K++  +          +  +  + ++H  S  + YL 
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRH--------VKDKNIIELVHQVSMGMKYL- 133

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
              E   +HRD+ + N++L ++  A++ DFGL++ ++ + + ++  +     P  + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE 190

Query: 499 SFLVGRATIETDIYAFGVLILEVA-CGRKP 527
                + + ++D+++FGVL+ E    G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (357), Expect = 8e-38
 Identities = 67/290 (23%), Positives = 127/290 (43%), Gaps = 31/290 (10%)

Query: 324 KNKLGKGGFGTVYKGIWR------NKEIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNL 376
              LG+G FG V    +        +++AVK +  E+      +   E+  + +L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 377 VKLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           VK  G C E   +   L+ E++P+GSL +++     N       +N +++L       + 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKN----KINLKQQLKYAVQICKG 138

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-G 493
           +DYL     ++ +HRD+ + N++++SE   ++GDFGL + I+ + K +++ K+   +P  
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEYYTVKDDRDSPVF 194

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
           + APE  +  +  I +D+++FGV + E+        +            H    + R   
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 553 ILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
            L     RL          C   V  L   C    P  R S + +++   
Sbjct: 255 TLK-EGKRL-----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (359), Expect = 9e-38
 Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 55/316 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-----IAVKRVSE--TSRQGKQEFIAEVTTIGSLRHRNL 376
              LGKG FG+V +   + ++     +AVK +     +    +EF+ E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 377 VKLIGWCYER------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
            KL+G              +++  +M +G L  F+        P  + L  +  +  +  
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVRFMVD 145

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
            +  ++YL   S +  +HRD+ + N ML  +    + DFGL+R I      ++     + 
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG--DYYRQGCASK 200

Query: 491 TP-GYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWL 544
            P  ++A ES      T+ +D++AFGV + E+   G+ P        Y    N  I ++L
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--------YAGIENAEIYNYL 252

Query: 545 WELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSG- 600
                 G  L            ++  EC   V  L   C   +P  RPS   +   L   
Sbjct: 253 ----IGGNRL------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

Query: 601 -EADPPVLPPERPSFV 615
                 +   + P ++
Sbjct: 297 LGHLSVLSTSQDPLYI 312

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  139 bits (350), Expect = 1e-37
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 23/235 (9%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRD 83
           +   FNF +F   ++  L  + +  +K  +Q+T       P  +  GRA Y D  Q+   
Sbjct: 2   TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS 61

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
           N    A+F+T F   I  +  +    GLAF +    + P   + ++LGI N   N    +
Sbjct: 62  NNV--ASFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLGIFNT-NNPEPNA 117

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
           + VA+ F+T K+   D + N +   VN             +  NG    VQ+ YD    +
Sbjct: 118 RTVAVVFNTFKNRI-DFDKNFIKPYVNENCDF--------HKYNGEKTDVQITYDSSNND 168

Query: 201 ITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           + VF+    +     +S  + L + + E V VGFS ++G   D T+ + V SW+F
Sbjct: 169 LRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  140 bits (355), Expect = 1e-37
 Identities = 71/296 (23%), Positives = 137/296 (46%), Gaps = 43/296 (14%)

Query: 324 KNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
             +LGKG FG+V    +        + +AVK++  ++ +  ++F  E+  + SL+H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 378 KLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           K  G CY   R +  L+ EY+P GSL  ++   + +       ++  K L       + +
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKE----RIDHIKLLQYTSQICKGM 127

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GY 494
           +YL     KR +HRD+ + NI++++E   ++GDFGL + + ++ K     KE   +P  +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKEPGESPIFW 183

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVA--CGRKPGNQSEQNSYNNSIVHW------LWE 546
            APES    + ++ +D+++FGV++ E+     +     +E      +          L E
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           L +          RL      +   C   + ++   C + N + RPS + +   + 
Sbjct: 244 LLKNNG-------RL-----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (356), Expect = 2e-37
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 33/290 (11%)

Query: 324 KNKLGKGGFGTVYKGIWRNK------EIAVKRV-SETSRQGKQEFIAEVTTIGSLRHRNL 376
              LG+G FG V    +          +AVK + ++   Q +  +  E+  + +L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 377 VKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +K  G C +       LV EY+P GSL  ++     +S      +   + L       + 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS------IGLAQLLLFAQQICEG 146

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-G 493
           + YLH    +  +HRD+ + N++LD++   ++GDFGLA+ + E    ++  +E   +P  
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRVREDGDSPVF 202

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
           + APE     +    +D+++FGV + E+        +   +      I      + R   
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 553 ILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           +L+       GE   +  +C   V  L   C       RP+ + ++ +L 
Sbjct: 263 LLER------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (354), Expect = 2e-37
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 327 LGKGGFGTVYKGI-WRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY 384
           LGKG +G VY G    N+  IA+K + E   +  Q    E+     L+H+N+V+ +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ---ALDYLHNG 441
           E     +  E +P GSL   +    +  GP +     E+ +     T Q    L YLH  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDN---EQTIGFY--TKQILEGLKYLH-- 139

Query: 442 SEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
            + +++HRDIK  N+++++     ++ DFG ++ +        +     GT  YMAPE  
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEII 195

Query: 501 LVGR--ATIETDIYAFGVLILEVACGRKP 527
             G        DI++ G  I+E+A G+ P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 3e-37
 Identities = 51/211 (24%), Positives = 109/211 (51%), Gaps = 17/211 (8%)

Query: 324 KNKLGKGGFGTVYKGIWRNK-----EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLV 377
              +G G FG V  G  +        +A+K +    + + +++F+ E + +G   H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L G   +    ++V EYM NGSLD F+          + T+   + + ++ G +  + Y
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVI--QLVGMLRGIASGMKY 162

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           L   S+   +HRD+ + NI+++S    ++ DFGL R ++++ +  ++T+       + +P
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 498 ESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           E+    + T  +D++++G+++ EV   G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  139 bits (352), Expect = 3e-37
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 326 KLGKGGFGTVYKGIWRNKE-----IAVKRVSE---TSRQGKQEFIAEVTTIGSLRHRNLV 377
           KLG G FG V +G W         +AVK +     +  +   +FI EV  + SL HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L G         +V E  P GSL   +         G   L            ++ + Y
Sbjct: 85  RLYGVV-LTPPMKMVTELAPLGSLLDRL-----RKHQGHFLL--GTLSRYAVQVAEGMGY 136

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L     KR +HRD+ + N++L +    ++GDFGL R + +N   +    E    P  + A
Sbjct: 137 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-EHRKVPFAWCA 192

Query: 497 PESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           PES      +  +D + FGV + E+   G++P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  139 bits (352), Expect = 3e-37
 Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 66/306 (21%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
             +LG+  FG VYKG           + +A+K + +      ++EF  E      L+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKRLSV 427
           +V L+G   +     +++ Y  +G L +F              +    +  L     + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +   +  ++YL   S   V+H+D+ + N+++  + N ++ D GL R +           +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA--------D 182

Query: 488 I--AGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY--- 536
                        +MAPE+ + G+ +I++DI+++GV++ EV   G +P        Y   
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--------YCGY 234

Query: 537 -NNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMK 592
            N  +V  +    R  ++L                +C   V  L + C +  P  RP  K
Sbjct: 235 SNQDVVEMI----RNRQVL------------PCPDDCPAWVYALMIECWNEFPSRRPRFK 278

Query: 593 TVLQVL 598
            +   L
Sbjct: 279 DIHSRL 284

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  140 bits (354), Expect = 4e-37
 Identities = 71/296 (23%), Positives = 139/296 (46%), Gaps = 43/296 (14%)

Query: 324 KNKLGKGGFGTVYKGIWR------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
             +LGKG FG+V    +        + +AVK++  ++ +  ++F  E+  + SL+H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 378 KLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           K  G CY   R +  L+ EY+P GSL  ++   + +       ++  K L       + +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKE----RIDHIKLLQYTSQICKGM 158

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GY 494
           +YL     KR +HRD+ + NI++++E   ++GDFGL + + ++ K ++  KE   +P  +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKEPGESPIFW 214

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVA--CGRKPGNQSEQNSYNNSIVHW------LWE 546
            APES    + ++ +D+++FGV++ E+     +     +E      +          L E
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           L +          RL      +   C   + ++   C + N + RPS + +   + 
Sbjct: 275 LLKNNG-------RL-----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (361), Expect = 5e-37
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 38/280 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            KLG+G FG V+ G W     +A+K +   +    + F+ E   +  LRH  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E     +V EYM  GSL  F+   +  +G     L   + + +    +  + Y+     
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFL---KGETGK---YLRLPQLVDMAAQIASGMAYV---ER 298

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
              +HRD++++NI++      ++ DFGLAR I++N  T     +      + APE+ L G
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--WTAPEAALYG 356

Query: 504 RATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLG 562
           R TI++D+++FG+L+ E+   GR P         N  ++  +     +G        R+ 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQV----ERGY-------RM- 400

Query: 563 GEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                   EC   +  L   C    P  RP+ + +   L 
Sbjct: 401 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (356), Expect = 6e-37
 Identities = 74/291 (25%), Positives = 122/291 (41%), Gaps = 50/291 (17%)

Query: 325 NKLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVK 378
             +G+G FG VY G   + +      AVK ++  T      +F+ E   +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 379 LIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           L+G C       L+V  YM +G L  FI     N          +  +      ++ + +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETH---NPTVKDLIGFGLQVAKGMKF 207

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMA 496
           L   + K+ +HRD+ + N MLD +F  ++ DFGLAR + +        K  A  P  +MA
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 497 PESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSY----NNSIVHWLWELRRKG 551
            ES    + T ++D+++FGVL+ E+   G  P        Y       I  +L     +G
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL----LQG 312

Query: 552 RILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
           R L             +   C   +  + L C HP   +RPS   ++  +S
Sbjct: 313 RRL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (360), Expect = 6e-37
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 52/286 (18%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
              +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L+G  
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 384 -YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS 442
             E+    +V EYM  GSL  ++         G   L  +  L       +A++YL    
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL------RSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306

Query: 443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPESFL 501
               +HRD+ + N+++  +  A++ DFGL +       T  + K     P  + APE+  
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGK----LPVKWTAPEALR 359

Query: 502 VGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY----NNSIVHWLWELRRKGRILDA 556
             + + ++D+++FG+L+ E+   GR P        Y       +V  +     KG     
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP--------YPRIPLKDVVPRV----EKGY---- 403

Query: 557 ADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
              ++     +    C   V  +   C H +   RP+   + + L 
Sbjct: 404 ---KM-----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (353), Expect = 6e-37
 Identities = 79/314 (25%), Positives = 121/314 (38%), Gaps = 43/314 (13%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
              LG G FG VY+G             +AVK + E  S Q + +F+ E   I    H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +V+ IG   +     ++ E M  G L  F+            +L     L V    +   
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGC 153

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARL---GDFGLARTIQENLKTHHSTKEIAGTP 492
            YL    E   +HRDI + N +L      R+   GDFG+AR I     +++     A  P
Sbjct: 154 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--SYYRKGGCAMLP 208

Query: 493 G-YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRK 550
             +M PE+F+ G  T +TD ++FGVL+ E+   G  P        Y +     + E    
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------YPSKSNQEVLEFVTS 260

Query: 551 GRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSG-EADPPV 606
           G  +            +    C   V  +   C    P  RP+   +L+ +     DP V
Sbjct: 261 GGRM------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

Query: 607 LPPERPSFVWPAMP 620
           +    P    P + 
Sbjct: 309 INTALPIEYGPLVE 322

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (359), Expect = 1e-36
 Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 15/205 (7%)

Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            KLG G FG V+   +    ++AVK +   S    + F+AE   + +L+H  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            +     ++ E+M  GSL  F+  DE +           K +      ++ + ++    +
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSK------QPLPKLIDFSAQIAEGMAFI---EQ 302

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
           +  +HRD++++NI++ +    ++ DFGLAR I++N  T     +      + APE+   G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--WTAPEAINFG 360

Query: 504 RATIETDIYAFGVLILEVA-CGRKP 527
             TI++D+++FG+L++E+   GR P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (361), Expect = 2e-36
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 38/280 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNK-EIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
            KLG+G FG V+ G W     +A+K +   +    + F+ E   +  LRH  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSE 443
            E     +V EYM  GSL  F+   +  +G     L   + + +    +  + Y+     
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFL---KGETGK---YLRLPQLVDMAAQIASGMAYV---ER 381

Query: 444 KRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG 503
              +HRD++++NI++      ++ DFGLAR I++N  T     +      + APE+ L G
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--WTAPEAALYG 439

Query: 504 RATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLG 562
           R TI++D+++FG+L+ E+   GR P         N  ++  +     +G        R+ 
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQV----ERGY-------RM- 483

Query: 563 GEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                   EC   +  L   C    P  RP+ + +   L 
Sbjct: 484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  141 bits (356), Expect = 2e-36
 Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 56/296 (18%)

Query: 320 NFNPKNKLGKGGFGT-VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTT-IGSLRHRNLV 377
           +F PK+ LG G  GT VY+G++ N+++AVKR+             EV     S  H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 378 KLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +      +   F  +  E     +L +++  ++ +           + ++++  T+  L 
Sbjct: 82  RYFC-TEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLG-----LEPITLLQQTTSGLA 132

Query: 437 YLHNGSEKRVLHRDIKSSNIML-----DSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           +LH      ++HRD+K  NI++       +  A + DFGL + +     +      + GT
Sbjct: 133 HLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 492 PGYMAPESF---LVGRATIETDIYAFGVLILEVACGRKP--GNQSEQ------NSYNNSI 540
            G++APE          T   DI++ G +   V        G   ++       + +   
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           +H           + A +               LI        +P  RPS K VL+
Sbjct: 250 LHPEKHED-----VIARE---------------LIE--KMIAMDPQKRPSAKHVLK 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (346), Expect = 2e-36
 Identities = 65/303 (21%), Positives = 109/303 (35%), Gaps = 61/303 (20%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSL-RHR 374
            F+   K+G G FG+V+K + R      A+KR          +Q  + EV     L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQ 433
           ++V+      E    L+  EY   GSL   I  +       +     E  L  +     +
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK-----EAELKDLLLQVGR 126

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLD-------------------SEFNARLGDFGLART 474
            L Y+H      ++H DIK SNI +                    ++   ++GD G    
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQ 533
           I     +    +E  G   ++A E          + DI+A  + ++  A         +Q
Sbjct: 184 I-----SSPQVEE--GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT 593
                      W   R+GR+      R+    S +E   +L       HP+P  RPS   
Sbjct: 237 -----------WHEIRQGRL-----PRIPQVLS-QEFTELL---KVMIHPDPERRPSAMA 276

Query: 594 VLQ 596
           +++
Sbjct: 277 LVK 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (347), Expect = 2e-36
 Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 56/305 (18%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +F     LG+G FG V K      ++  A+K++  T  +     ++EV  + SL H+ +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVV 65

Query: 378 KLIG-WCYERHDFL------------LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           +    W   R+               +  EY  NG+L   I           +    ++ 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-------HSENLNQQRDEY 118

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
             +     +AL Y+H    + ++HRD+K  NI +D   N ++GDFGLA+ +  +L     
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 485 TKEIA-----------GTPGYMAPESFLVGRATI--ETDIYAFGVLILEVACGRKPGNQS 531
             +             GT  Y+A E  L G      + D+Y+ G++  E+      G + 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234

Query: 532 EQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM 591
                       + +  R   I             + E +  +I        +P+ RP  
Sbjct: 235 VN----------ILKKLRSVSI--EFPPDFDDNKMKVEKK--II--RLLIDHDPNKRPGA 278

Query: 592 KTVLQ 596
           +T+L 
Sbjct: 279 RTLLN 283

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  142 bits (360), Expect = 4e-36
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEI--AVKRV-SETSRQGKQEFIAEVTTIGSLRHRNLVK 378
             +LG G FG+V +G++R   K+I  A+K +   T +   +E + E   +  L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           LIG C +    +LV E    G L KF+             +       ++H  S  + YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-------IPVSNVAELLHQVSMGMKYL 452

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAP 497
               EK  +HR++ + N++L +   A++ DFGL++ +  +  ++++ +     P  + AP
Sbjct: 453 ---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAP 508

Query: 498 ESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           E     + +  +D++++GV + E    G+KP
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  142 bits (360), Expect = 7e-36
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 51/288 (17%)

Query: 326 KLGKGGFGTVYKGIWRNKE-----IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRNLVKL 379
            +G+G FG V++GI+ + E     +A+K     TS   +++F+ E  T+    H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG     +   ++ E    G L  F+           + L     +   +  S AL YL 
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFL-----QVRKFSLDL--ASLILYAYQLSTALAYL- 507

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP-GYMAPE 498
               KR +HRDI + N+++ S    +LGDFGL+R ++++     S  ++   P  +MAPE
Sbjct: 508 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIKWMAPE 562

Query: 499 SFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSY---NNSIVHWLWELRRKGRIL 554
           S    R T  +D++ FGV + E+   G KP        +    N+ V  +  +    R+ 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP--------FQGVKNNDV--IGRIENGERL- 611

Query: 555 DAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLS 599
                            C   +  L   C   +P  RP    +   LS
Sbjct: 612 ------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (347), Expect = 9e-36
 Identities = 79/318 (24%), Positives = 118/318 (37%), Gaps = 51/318 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSET-SRQGKQEFIAEVTTIGSLRHRN 375
              LG G FG VY+G             +AVK + E  S Q + +F+ E   I    H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +V+ IG   +     ++ E M  G L  F+            +L     L V    +   
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGC 194

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARL---GDFGLARTIQENLKTHHSTKEIAGTP 492
            YL    E   +HRDI + N +L      R+   GDFG+AR I       +  K   G  
Sbjct: 195 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR---AGYYRK---GGC 245

Query: 493 GY-----MAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLWE 546
                  M PE+F+ G  T +TD ++FGVL+ E+   G  P        Y +     + E
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--------YPSKSNQEVLE 297

Query: 547 LRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVLSGEA- 602
               G  +            +    C   V  +   C    P  RP+   +L+ +     
Sbjct: 298 FVTSGGRM------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

Query: 603 DPPVLPPERPSFVWPAMP 620
           DP V+    P    P + 
Sbjct: 346 DPDVINTALPIEYGPLVE 363

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (344), Expect = 1e-35
 Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 30/252 (11%)

Query: 284 RRYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGI-WRN 342
           +  R     +D EG++    L P  +  +E          + ++G+G FG V++    + 
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRGSFGEVHRMKDKQT 82

Query: 343 KE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL 401
               AVK+V       + E   E+     L    +V L G   E     +  E +  GSL
Sbjct: 83  GFQCAVKKVRL--EVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ---ALDYLHNGSEKRVLHRDIKSSNIML 458
            + I       G        E R        Q    L+YLH    +R+LH D+K+ N++L
Sbjct: 138 GQLI----KQMGCLP-----EDRALYY--LGQALEGLEYLH---TRRILHGDVKADNVLL 183

Query: 459 DSE-FNARLGDFGLARTIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFG 515
            S+   A L DFG A  +Q +   K+  +   I GT  +MAPE  +      + DI++  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 516 VLILEVACGRKP 527
            ++L +  G  P
Sbjct: 244 CMMLHMLNGCHP 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (343), Expect = 2e-35
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 51/296 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE----IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHRNLV 377
           ++ +G+G FG V K   +        A+KR+ E  S+   ++F  E+  +  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKRLSVIH 429
            L+G C  R    L  EY P+G+L  F               +     TL+ ++ L    
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS---TK 486
             ++ +DYL   S+K+ +HRD+ + NI++   + A++ DFGL+R  +  +K        +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206

Query: 487 EIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNNSIVHWLW 545
                  +MA ES      T  +D++++GVL+ E+   G  P        Y       L+
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELY 251

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVLQVL 598
           E   +G  L            EK + C   V  L   C    P+ RPS   +L  L
Sbjct: 252 EKLPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  129 bits (325), Expect = 8e-35
 Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 17/186 (9%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           +  F    F+   +N L F  +    K  + +T       + N  GRA+Y     +W   
Sbjct: 3   TTSFLITKFSPDQQN-LIFQGDGYTTKEKLTLTKA-----VKNTVGRALYSSPIHIWDRE 56

Query: 85  KNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
               A F T+F   I    +    +G  F IA   D    + G +LG+ N        +Q
Sbjct: 57  TGNVANFVTSFTFVINAPNSYNVADGFTFFIA-PVDTKPQTGGGYLGVFNS-AEYDKTTQ 114

Query: 144 IVAIEFDTKKSYE--QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
            VA+EFDT  +        D H+G+DVNS+ S+         L NG +  V + ++    
Sbjct: 115 TVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW---KLQNGEEANVVIAFNAATN 171

Query: 200 NITVFV 205
            +TV +
Sbjct: 172 VLTVSL 177

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (338), Expect = 9e-35
 Identities = 73/312 (23%), Positives = 116/312 (37%), Gaps = 70/312 (22%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
              +G+G FG V++              +AVK + E  S   + +F  E   +    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKF----------IFYDETNSGPGEVTLNWEKRL 425
           +VKL+G C       L++EYM  G L++F                 S    V+      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 426 SVIHGTSQALD------YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           S       A        YL   SE++ +HRD+ + N ++      ++ DFGL+R I    
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA- 227

Query: 480 KTHHSTKEI--AGTPGY-----MAPESFLVGRATIETDIYAFGVLILEVA-CGRKP--GN 529
                  +   A          M PES    R T E+D++A+GV++ E+   G +P  G 
Sbjct: 228 -------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280

Query: 530 QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPH 586
             E+          +    R G IL                 C   +  L   C    P 
Sbjct: 281 AHEE----------VIYYVRDGNIL------------ACPENCPLELYNLMRLCWSKLPA 318

Query: 587 LRPSMKTVLQVL 598
            RPS  ++ ++L
Sbjct: 319 DRPSFCSIHRIL 330

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (336), Expect = 2e-34
 Identities = 60/303 (19%), Positives = 113/303 (37%), Gaps = 48/303 (15%)

Query: 325 NKLGKGGFGTVYKGI--WRNKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           ++LG G  G V+K         +A K +    +   +  I  E+  +       +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHN 440
             Y   +  +  E+M  GSLD+     +    P       E+ L  +     + L YL  
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQV--LKKAGRIP-------EQILGKVSIAVIKGLTYLR- 148

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL-KTHHSTKEIAGTPGYMAPES 499
             + +++HRD+K SNI+++S    +L DFG++  + +++  +        GT  YM+PE 
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------VGTRSYMSPER 201

Query: 500 FLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS 559
                 ++++DI++ G+ ++E+A GR P    +           +     +         
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 560 RLGGEFSEKEMECVLILGL--------------------------ACCHPNPHLRPSMKT 593
           R   +F       + I  L                           C   NP  R  +K 
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 594 VLQ 596
           ++ 
Sbjct: 322 LMV 324

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 6e-34
 Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 50/310 (16%)

Query: 326 KLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGW 382
            L +GGF  VY  + +   +E A+KR+     +  +  I EV  +  L  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 383 CYERHD--------FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
                +        FLL+ E      ++     +       +  L         + T +A
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI------FYQTCRA 148

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA----- 489
           + ++H   +  ++HRD+K  N++L ++   +L DFG A TI        S +  A     
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 490 ----GTPGYMAPESF-LVGRATI--ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
                TP Y  PE   L     I  + DI+A G ++  +   + P     +    N    
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA 602
                 +                        LI        NP  R S+  V+  L   A
Sbjct: 268 IPPHDTQYTVFHS------------------LIRA--MLQVNPEERLSIAEVVHQLQEIA 307

Query: 603 DPPVLPPERP 612
               + P+ P
Sbjct: 308 AARNVNPKSP 317

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (328), Expect = 2e-33
 Identities = 65/329 (19%), Positives = 135/329 (41%), Gaps = 77/329 (23%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE---------IAVKRVSE-TSRQGKQEFIAEVTTIGSL-R 372
              LG+G FG V        +         +AVK + +  + +   + ++E+  +  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKR 424
           H+N++ L+G C +     ++ EY   G+L ++        + Y    +   E  + ++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I         
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI------ 210

Query: 485 TKEIAGTPGY-------------MAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQ 530
                    Y             MAPE+      T ++D+++FGVL+ E+   G  P   
Sbjct: 211 --------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--- 259

Query: 531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHL 587
                Y    V  L++L ++G  +            +K   C   + ++   C H  P  
Sbjct: 260 -----YPGIPVEELFKLLKEGHRM------------DKPANCTNELYMMMRDCWHAVPSQ 302

Query: 588 RPSMKTVLQVL----SGEADPPVLPPERP 612
           RP+ K +++ L    +   +   L   +P
Sbjct: 303 RPTFKQLVEDLDRILTLTTNEEYLDLSQP 331

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  128 bits (325), Expect = 2e-33
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 11/209 (5%)

Query: 326 KLGKGGFGTVYKGI--WRNKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
            +G G    V       + +++A+KR++ E  +    E + E+  +    H N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHNG 441
              + +  LV + +  GS+   I +           L+ E  ++ I     + L+YLH  
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLEYLHK- 139

Query: 442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE--IAGTPGYMAPES 499
                +HRD+K+ NI+L  + + ++ DFG++  +        +       GTP +MAPE 
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 500 FLVGRA-TIETDIYAFGVLILEVACGRKP 527
               R    + DI++FG+  +E+A G  P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (326), Expect = 2e-33
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 39/234 (16%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSE-TSRQGKQEFIAEVTTIGSLRHRN 375
              LG+G FG V K    + +       +AVK + E  S    ++ ++E   +  + H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKF----------IFYDETNSGPGEVTLNWEKRL 425
           ++KL G C +    LL+ EY   GSL  F                +     +    E+ L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 426 SVIHGTSQALD------YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
           ++    S A        YL   +E +++HRD+ + NI++      ++ DFGL+R + E  
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 480 KTHHSTKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
                   +  + G     +MA ES      T ++D+++FGVL+ E+   G  P
Sbjct: 205 S------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (322), Expect = 6e-33
 Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 39/276 (14%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW 382
           K+GKG FG V+KGI     K +A+K +  E +    ++   E+T +       + K  G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG- 87

Query: 383 CYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHN 440
            Y +   L ++ EY+  GS       D    GP +     E +++ I     + LDYLH+
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLD-----ETQIATILREILKGLDYLHS 137

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF 500
              ++ +HRDIK++N++L      +L DFG+A  + +     ++     GTP +MAPE  
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVI 191

Query: 501 LVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSR 560
                  + DI++ G+  +E+A G  P          +S +H +  L     I       
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLF---LIPKNNPPT 238

Query: 561 LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           L G +S+   E V     AC +  P  RP+ K +L+
Sbjct: 239 LEGNYSKPLKEFV----EACLNKEPSFRPTAKELLK 270

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (322), Expect = 7e-33
 Identities = 47/248 (18%), Positives = 100/248 (40%), Gaps = 38/248 (15%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEI-AVKRVS--ETSRQ 356
           +G +L  +    + +      ++   ++G GG   V++ +   K+I A+K V+  E   Q
Sbjct: 9   SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ 68

Query: 357 GKQEFIAEVTTIGSLRHRNL--VKLIGWCYERHDFLLVYEYMPNGSLDKFI----FYDET 410
               +  E+  +  L+  +   ++L  +        +V E   N  L+ ++      D  
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPW 127

Query: 411 NSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG 470
                E    W+  L        A+  +H   +  ++H D+K +N ++      +L DFG
Sbjct: 128 -----ERKSYWKNMLE-------AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFG 171

Query: 471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI-----------ETDIYAFGVLIL 519
           +A  +Q +  T        GT  YM PE+     ++            ++D+++ G ++ 
Sbjct: 172 IANQMQPD-TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 520 EVACGRKP 527
            +  G+ P
Sbjct: 231 YMTYGKTP 238

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (326), Expect = 7e-33
 Identities = 64/301 (21%), Positives = 133/301 (44%), Gaps = 53/301 (17%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE---------IAVKRVSE-TSRQGKQEFIAEVTTIGSL-R 372
              LG+G FG V        +         +AVK + +  + +   + ++E+  +  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKR 424
           H+N++ L+G C +     ++ EY   G+L ++        + Y    +   E  + ++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + ++ +HRD+ + N+++      ++ DFGLAR I       ++
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-------NN 255

Query: 485 TKE-IAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN 537
                  T G     +MAPE+      T ++D+++FGVL+ E+   G  P        Y 
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YP 307

Query: 538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV 597
              V  L++L ++G  +D             E+  ++     C H  P  RP+ K +++ 
Sbjct: 308 GIPVEELFKLLKEGHRMDKP------ANCTNELYMMM---RDCWHAVPSQRPTFKQLVED 358

Query: 598 L 598
           L
Sbjct: 359 L 359

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (323), Expect = 9e-33
 Identities = 66/296 (22%), Positives = 122/296 (41%), Gaps = 46/296 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHR 374
              LG G FG V +             ++AVK +        K+  ++E+  +  L +H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKF------IFYDETNSGPGEVTLNWEKRLSVI 428
           N+V L+G C      L++ EY   G L  F      +   +        T +    L   
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN---LKTHHST 485
              +Q + +L   + K  +HRD+ + N++L +   A++GDFGLAR I  +   +   ++ 
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKP--GNQSEQNSYNNSIVH 542
             +     +MAPES      T+++D++++G+L+ E+   G  P  G              
Sbjct: 228 LPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------- 275

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
             ++L + G  +          F+ K +  ++    AC    P  RP+ + +   L
Sbjct: 276 -FYKLVKDGYQMAQP------AFAPKNIYSIM---QACWALEPTHRPTFQQICSFL 321

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (318), Expect = 2e-32
 Identities = 65/286 (22%), Positives = 128/286 (44%), Gaps = 46/286 (16%)

Query: 325 NKLGKGGFGTVYKGI--WRNKEIAVKRV-SETSRQGKQEFIAEVTTI-GSLRHRNLVKLI 380
            +LG+G +G V K       + +AVKR+ +  + Q ++  + ++     ++     V   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLH 439
           G  +   D  +  E M + SLDKF  Y +       +    E  L  I     +AL++LH
Sbjct: 73  GALFREGDVWICMELM-DTSLDKF--YKQVIDKGQTIP---EDILGKIAVSIVKALEHLH 126

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFG----LARTIQENLKTHHSTKEIAGTPGYM 495
             S+  V+HRD+K SN+++++    ++ DFG    L   + +++         AG   YM
Sbjct: 127 --SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--------AGCKPYM 176

Query: 496 APESFLVGRA----TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           APE           ++++DI++ G+ ++E+A  R P        Y++    W    ++  
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP--------YDS----WGTPFQQLK 224

Query: 552 RILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           ++++    +L   +FS + ++        C   N   RP+   ++Q
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFT----SQCLKKNSKERPTYPELMQ 266

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (317), Expect = 2e-32
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 27/227 (11%)

Query: 311 LKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK       K+G+G  GTVY  +     +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
            E+  +   ++ N+V  +   Y   D L +V EY+  GSL      D       +     
Sbjct: 66  NEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLT-----DVVTETCMD----- 114

Query: 422 EKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
           E +++ +     QAL++LH+    +V+HRDIKS NI+L  + + +L DFG    I     
Sbjct: 115 EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              +   + GTP +MAPE         + DI++ G++ +E+  G  P
Sbjct: 172 KRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (322), Expect = 2e-32
 Identities = 68/303 (22%), Positives = 132/303 (43%), Gaps = 57/303 (18%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE---------IAVKRVSE-TSRQGKQEFIAEVTTIGSL-R 372
              LG+G FG V        +         +AVK +    + +   + I+E+  +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKR 424
           H+N++ L+G C +     ++ EY   G+L ++        + Y    S   E  L+ +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
           +S  +  ++ ++YL   + K+ +HRD+ + N+++  +   ++ DFGLAR I         
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247

Query: 485 TKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKPGNQSEQNSYNN 538
                 T G     +MAPE+      T ++D+++FGVL+ E+   G  P        Y  
Sbjct: 248 ---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPG 296

Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMEC---VLILGLACCHPNPHLRPSMKTVL 595
             V  L++L ++G  +            +K   C   + ++   C H  P  RP+ K ++
Sbjct: 297 VPVEELFKLLKEGHRM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344

Query: 596 QVL 598
           + L
Sbjct: 345 EDL 347

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (318), Expect = 3e-32
 Identities = 51/228 (22%), Positives = 102/228 (44%), Gaps = 33/228 (14%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHR 374
              LG+G FG V +            + +AVK + E  +    +  ++E+  +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 375 NLVKLIGWCYERHD-FLLVYEYMPNGSLDKF--------IFYDETNSGPGEVTLNWEKRL 425
           N+V L+G C +     +++ E+   G+L  +        + Y        +  L  E  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 ++ +++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++       
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---PDYV 205

Query: 486 KEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
           +            +MAPE+      TI++D+++FGVL+ E+   G  P
Sbjct: 206 R---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  128 bits (324), Expect = 3e-32
 Identities = 61/312 (19%), Positives = 113/312 (36%), Gaps = 69/312 (22%)

Query: 321 FNPKNKLGKGGFGTV-YKGIWRNKEIAVKRVSETSRQGKQEFIAEVTT-IGSLRHRNLVK 378
              +  LG G  GTV ++G ++ + +AVKR+           + E+     S  H N+++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73

Query: 379 LIGWCYERHDFL-LVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
                     FL +  E   N +L   +      DE      E        +S++   + 
Sbjct: 74  YYC-SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE-----YNPISLLRQIAS 126

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSE-------------FNARLGDFGLARTIQENLK 480
            + +LH     +++HRD+K  NI++ +                  + DFGL + +     
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 481 THHST-KEIAGTPGYMAPE-------SFLVGRATIETDIYAFGVLILEVACGRKP--GNQ 530
           +  +     +GT G+ APE            R T   DI++ G +   +    K   G++
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 531 SEQNS------YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
             + S      ++   +  L +   +  I +A D               LI        +
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHD---RSLIAEATD---------------LI--SQMIDHD 283

Query: 585 PHLRPSMKTVLQ 596
           P  RP+   VL+
Sbjct: 284 PLKRPTAMKVLR 295

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score =  123 bits (309), Expect = 3e-32
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 48/247 (19%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
           +   F   +F + N   L    ++TV+ +  +Q++Y+       +   RA Y    Q+  
Sbjct: 2   TETSFIIDAFNKTN---LILQGDATVSSNGNLQLSYNS-----YDSMSRAFYSAPIQIRD 53

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                 A+F T F +NI     A    GL FV+   +   +                   
Sbjct: 54  STTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKG------------------ 95

Query: 142 SQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
              V +EFDT          + + +DVN+   I+ VP   V+  +G + +V++ Y+   +
Sbjct: 96  -DTVTVEFDTFL--------SRISIDVNNND-IKSVPWD-VHDYDGQNAEVRITYNSSTK 144

Query: 200 NITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDGSD 253
             +V ++N  T     +S  ++L + + + V VGFSA++G      + + V SW+F    
Sbjct: 145 VFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKF 204

Query: 254 IGGDSKA 260
           I    + 
Sbjct: 205 INLKDQK 211

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (316), Expect = 4e-32
 Identities = 62/234 (26%), Positives = 114/234 (48%), Gaps = 32/234 (13%)

Query: 310 RLKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEF 361
           + +E +    + +P        +LG G FG VYK   +      A K +   S +  +++
Sbjct: 4   KSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
           I E+  + +  H  +VKL+G  Y      ++ E+ P G++D              +T   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLT--- 115

Query: 422 EKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
           E ++ V+     +AL++LH+   KR++HRD+K+ N+++  E + RL DFG++    + L+
Sbjct: 116 EPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIE-------TDIYAFGVLILEVACGRKP 527
              S     GTP +MAPE  +V   T++        DI++ G+ ++E+A    P
Sbjct: 173 KRDS---FIGTPYWMAPE--VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (315), Expect = 6e-32
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 27/227 (11%)

Query: 311 LKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFI 362
              L+      +P+       K+G+G  G V     +   +++AVK +    +Q ++   
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
            EV  +   +H N+V++    Y   + L ++ E++  G+L      D  +       LN 
Sbjct: 91  NEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALT-----DIVSQVR----LN- 139

Query: 422 EKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
           E++++ +     QAL YLH    + V+HRDIKS +I+L  +   +L DFG    I +++ 
Sbjct: 140 EEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
              S   + GTP +MAPE         E DI++ G++++E+  G  P
Sbjct: 197 KRKS---LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  123 bits (312), Expect = 1e-31
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 36/230 (15%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHR 374
              LG G FG V +              +AVK +        ++  ++E+  +  L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKF----------IFYDETNSGPGEVTLNWEKR 424
           N+V L+G C      L++ EY   G L  F                     E+ L+ E  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN---LKT 481
           LS  +  ++ + +L   + K  +HRD+ + NI+L      ++ DFGLAR I+ +   +  
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 482 HHS---TKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVA-CGRKP 527
            ++    K       +MAPES      T E+D++++G+ + E+   G  P
Sbjct: 205 GNARLPVK-------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (312), Expect = 3e-31
 Identities = 43/219 (19%), Positives = 92/219 (42%), Gaps = 30/219 (13%)

Query: 325 NKLGKGGFGTVYKGIWRNKEI-AVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNL--VKL 379
            ++G GG   V++ +   K+I A+K V+  E   Q    +  E+  +  L+  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
             +        +V E   N  L+ ++             ++  +R S      +A+  +H
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKS----IDPWERKSYWKNMLEAVHTIH 125

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              +  ++H D+K +N ++      +L DFG+A  +Q +  T        GT  YM PE+
Sbjct: 126 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD-TTSVVKDSQVGTVNYMPPEA 180

Query: 500 FLVGRATI-----------ETDIYAFGVLILEVACGRKP 527
                ++            ++D+++ G ++  +  G+ P
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  123 bits (311), Expect = 3e-31
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 326 KLGKGGFGTVYKGI--WRNKEIAVKRV-SETSRQGKQEFIAEVTTI-GSLRHRNLVKLIG 381
           ++G+G +G+V K +     + +AVKR+ S    + +++ + ++  +  S     +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHN 440
             +   D  +  E M + S DKF  Y    S   +  +  E+ L  I   T +AL++L  
Sbjct: 89  ALFREGDCWICMELM-STSFDKF--YKYVYSVLDD-VIP-EEILGKITLATVKALNHLK- 142

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFG----LARTIQENLKTHHSTKEIAGTPGYMA 496
               +++HRDIK SNI+LD   N +L DFG    L  +I    KT       AG   YMA
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTR-----DAGCRPYMA 193

Query: 497 PESFLVGRA----TIETDIYAFGVLILEVACGRKP 527
           PE      +     + +D+++ G+ + E+A GR P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 4e-31
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 35/233 (15%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSL 371
             +   +   + LG+G    V++G  +      A+K  +  S     +    E   +  L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 372 RHRNLVKLIGWCYERHD---FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
            H+N+VKL     E       +L+ E+ P GSL   +       G  E        L V+
Sbjct: 65  NHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVL 118

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDFGLARTIQEN--LKTH 482
                 +++L    E  ++HR+IK  NIM     D +   +L DFG AR ++++    + 
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS- 174

Query: 483 HSTKEIAGTPGYMAPESFLVGRATI--------ETDIYAFGVLILEVACGRKP 527
                + GT  Y+ P+ +                 D+++ GV     A G  P
Sbjct: 175 -----LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (321), Expect = 5e-31
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 32/229 (13%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWRNK----EIAVKRVSETSRQGKQEFIA-EVTTIG 369
            +  G +  K +LG GGFG V +  W ++    ++A+K+  +      +E    E+  + 
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLR--WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67

Query: 370 SLRHRNLVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
            L H N+V                  LL  EY   G L K++   E   G  E       
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-----GP 122

Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR---LGDFGLARTIQEN-- 478
             +++   S AL YLH   E R++HRD+K  NI+L          + D G A+ + +   
Sbjct: 123 IRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                      GT  Y+APE     + T+  D ++FG L  E   G +P
Sbjct: 180 CTE------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (312), Expect = 6e-31
 Identities = 44/223 (19%), Positives = 90/223 (40%), Gaps = 38/223 (17%)

Query: 325 NKLGKGGFGTVYKGIWRNKEI-AVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNL--VKL 379
            ++G GG   V++ +   K+I A+K V+  E   Q    +  E+  +  L+  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFI----FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
             +        +V E   N  L+ ++      D       E    W+  L        A+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW-----ERKSYWKNMLE-------AV 168

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
             +H   +  ++H D+K +N ++      +L DFG+A  +Q +  T        G   YM
Sbjct: 169 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD-TTSVVKDSQVGAVNYM 223

Query: 496 APESFL-----------VGRATIETDIYAFGVLILEVACGRKP 527
            PE+               + + ++D+++ G ++  +  G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 9e-31
 Identities = 68/309 (22%), Positives = 124/309 (40%), Gaps = 63/309 (20%)

Query: 324 KNKLGKGGFGTVYKGIWRNKE-------IAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHR 374
              LG G FG V                +AVK + E      ++  ++E+  +  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKF------IFYDETNSGPGEVTLNWEKRLSVI 428
           N+V L+G C       L++EY   G L  +       F ++      +  L  E+ L+V+
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 429 HGTSQAL-----------DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
             T + L           ++L     K  +HRD+ + N+++      ++ DFGLAR I  
Sbjct: 170 --TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 478 NLKTHHSTKEIAGTPG-----YMAPESFLVGRATIETDIYAFGVLILEVA-CGRKP--GN 529
           +    +               +MAPES   G  TI++D++++G+L+ E+   G  P  G 
Sbjct: 225 D---SNYVV---RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278

Query: 530 QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP 589
             + N          ++L + G  +D         ++ +E+  ++    +C   +   RP
Sbjct: 279 PVDAN---------FYKLIQNGFKMDQP------FYATEEIYIIM---QSCWAFDSRKRP 320

Query: 590 SMKTVLQVL 598
           S   +   L
Sbjct: 321 SFPNLTSFL 329

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (305), Expect = 5e-30
 Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 35/228 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNL 376
            +   + LG+G    V++G  +      A+K  +  S     +    E   +  L H+N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 377 VKLIGWCYE---RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           VKL     E       +L+ E+ P GSL   +       G  E        L V+     
Sbjct: 70  VKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF-----LIVLRDVVG 123

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDFGLARTIQEN--LKTHHSTKE 487
            +++L    E  ++HR+IK  NIM     D +   +L DFG AR ++++    +      
Sbjct: 124 GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS------ 174

Query: 488 IAGTPGYMAPESFLVGRATI--------ETDIYAFGVLILEVACGRKP 527
           + GT  Y+ P+ +                 D+++ GV     A G  P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 5e-30
 Identities = 55/249 (22%), Positives = 101/249 (40%), Gaps = 30/249 (12%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQ 359
           N +NL      +KE  K   ++     L +G F  +      NK  A+K+  ++  + K+
Sbjct: 12  NYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKR 71

Query: 360 EFIA-----------------EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLD 402
           +F                   E+  I  +++   +   G      +  ++YEYM N S+ 
Sbjct: 72  DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131

Query: 403 KFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF 462
           KF  Y           +  +    +I     +  Y+H  +EK + HRD+K SNI++D   
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNG 189

Query: 463 NARLGDFGLARTIQEN-LKTHHSTKEIAGTPGYMAPESFLVGRATI---ETDIYAFGVLI 518
             +L DFG +  + +  +K         GT  +M PE F    ++    + DI++ G+ +
Sbjct: 190 RVKLSDFGESEYMVDKKIKG------SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICL 242

Query: 519 LEVACGRKP 527
             +     P
Sbjct: 243 YVMFYNVVP 251

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (299), Expect = 7e-30
 Identities = 71/232 (30%), Positives = 120/232 (51%), Gaps = 27/232 (11%)

Query: 306 PKKFRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG 357
           P + +LK+L + +    P+       KLG+G +G+VYK I +   + +A+K+V   S   
Sbjct: 10  PPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-- 67

Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGE 416
            QE I E++ +      ++VK  G  Y ++  L +V EY   GS+   I      +    
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDII---RLRNKT-- 121

Query: 417 VTLNWEKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
             L  E  ++ I   T + L+YLH     R +HRDIK+ NI+L++E +A+L DFG+A  +
Sbjct: 122 --LT-EDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            + +   ++   + GTP +MAPE           DI++ G+  +E+A G+ P
Sbjct: 176 TDTMAKRNT---VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (301), Expect = 1e-29
 Identities = 37/325 (11%), Positives = 73/325 (22%), Gaps = 69/325 (21%)

Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE---FIAEVTT 367
            L +          L  G    V+        ++ A+K  +  +   + E          
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 368 IGSLRHRNLVKLIGWC--------------------------YERHDFLLVYEYMPNGSL 401
              L   +  +                               Y   ++LL+         
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE 461
             F   D      G+  +       +     +    L     K ++H      N+ +  +
Sbjct: 176 LLFSTLDFVYVFRGDEGI--LALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPD 230

Query: 462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA---TIETDIYAFGVLI 518
               LGD      +             +  P   AP  FL       T   + +  G+ I
Sbjct: 231 GRLMLGDVSALWKVGTRGPA-------SSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283

Query: 519 LEVACGRKP---GNQSEQNSYNNSIVHWL----WELRRKGRILDAADSRLGGEFSEKEME 571
             V C   P        + S+    +               + D   +            
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT------------ 331

Query: 572 CVLILGLACCHPNPHLRPSMKTVLQ 596
             LI      + +   R      ++
Sbjct: 332 --LIGRF--LNFDRRRRLLPLEAME 352

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  119 bits (300), Expect = 2e-29
 Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 29/219 (13%)

Query: 325 NKLGKG--GFGTVYKGI--WRNKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVK 378
             +GKG     TV         + + V+R++    S +       E+       H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 379 LIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALD 436
                +   + L +V  +M  GS    I           +    E  ++ I  G  +ALD
Sbjct: 91  YRA-TFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMN---ELAIAYILQGVLKALD 142

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK----THHSTKEIAGTP 492
           Y+H       +HR +K+S+I++  +    L       ++  + +     H   K      
Sbjct: 143 YIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 493 GYMAPESFLVGRATIE----TDIYAFGVLILEVACGRKP 527
            +++PE  ++ +        +DIY+ G+   E+A G  P
Sbjct: 200 PWLSPE--VLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 2e-29
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 33/216 (15%)

Query: 326 KLGKGGFGTVYKGI--WRNKEIAVKRV-SETSRQGKQEFIAEVTTIGSL-RHRNLVKLIG 381
           ++G G  G V+K         IAVK++    +++  +  + ++  +        +V+  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI-HGTSQALDYLHN 440
                 D  +  E M     +K           G +    E+ L  +     +AL YL  
Sbjct: 92  TFITNTDVFIAMELM-GTCAEKLKKRM-----QGPIP---ERILGKMTVAIVKALYYLK- 141

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARLGDFG----LARTIQENLKTHHSTKEIAGTPGYMA 496
             +  V+HRD+K SNI+LD     +L DFG    L     ++          AG   YMA
Sbjct: 142 -EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--------RSAGCAAYMA 192

Query: 497 PESFLVGRA-----TIETDIYAFGVLILEVACGRKP 527
           PE             I  D+++ G+ ++E+A G+ P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 3e-29
 Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 36/238 (15%)

Query: 306 PKKFRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETS 354
               +  ++ +     +P+       ++G G FG VY       ++ +A+K++S   + S
Sbjct: 35  AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 94

Query: 355 RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSG 413
            +  Q+ I EV  +  LRH N ++  G CY R     LV EY    + D      E +  
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGSASD----LLEVHKK 149

Query: 414 PGEVTLNWEKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA 472
           P    L  E  ++ + HG  Q L YLH+     ++HRD+K+ NI+L      +LGDFG A
Sbjct: 150 P----LQ-EVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT---IETDIYAFGVLILEVACGRKP 527
             +              GTP +MAPE  L         + D+++ G+  +E+A  + P
Sbjct: 202 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 4e-29
 Identities = 69/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)

Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAE 364
            +  L  L+   G F     +G G +G VYKG      +  A+K +  T    ++E   E
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQE 70

Query: 365 VTTIGSL-RHRNLVKLIGWCYERHDFL-------LVYEYMPNGSLDKFIFYDETNSGPGE 416
           +  +     HRN+    G  + + +         LV E+   GS+   I    T     +
Sbjct: 71  INMLKKYSHHRNIATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLK 127

Query: 417 VTLNWEKRLSVI-HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
                E+ ++ I     + L +LH   + +V+HRDIK  N++L      +L DFG++  +
Sbjct: 128 -----EEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIET-----DIYAFGVLILEVACGRKPGNQ 530
              +   ++     GTP +MAPE          T     D+++ G+  +E+A G  P   
Sbjct: 180 DRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--- 233

Query: 531 SEQNSYNNSIVHWLWELRRKGRILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRP 589
                     +H +  L     I      RL   ++S+K    +     +C   N   RP
Sbjct: 234 -------LCDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFI----ESCLVKNHSQRP 279

Query: 590 SMKTVLQ 596
           + + +++
Sbjct: 280 ATEQLMK 286

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 1e-28
 Identities = 38/250 (15%), Positives = 76/250 (30%), Gaps = 27/250 (10%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGK 358
           P      E +  +      + LG+G F  VY+    +       ++  +K     +    
Sbjct: 52  PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111

Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVT 418
                 +  +        +K       ++  +LV E    G+L   I          E  
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI---NLYKNTPEKV 168

Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-----------DSEFNARLG 467
           +     +S        ++ +H   +  ++H DIK  N +L           D      L 
Sbjct: 169 MPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRK 526
           D G +  ++   K    T +   T G+   E  L  +    + D +     +  +  G  
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKC-ETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 527 PGNQSEQNSY 536
              ++E    
Sbjct: 284 MKVKNEGGEC 293

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 1e-28
 Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 43/225 (19%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS----ETSRQGKQEFIAEVTTIGS 370
            +F     LGKG FG VY    R K+    +A+K +     E +    Q    EV     
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA--REKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSH 65

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS---- 426
           LRH N+++L G+ ++     L+ EY P G++     Y E         L    +      
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTV-----YRE---------LQKLSKFDEQRT 111

Query: 427 --VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA-RTIQENLKTHH 483
              I   + AL Y H    KRV+HRDIK  N++L S    ++ DFG +            
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-- 166

Query: 484 STKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
               + GT  Y+ PE  + GR    + D+++ GVL  E   G+ P
Sbjct: 167 ----LCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  116 bits (293), Expect = 2e-28
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 32/229 (13%)

Query: 306 PKKFRLKELKKATGNFN------PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG 357
           P  F  + +    G  N          LG G FG V+K        ++A K +     + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 358 KQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVYEYMPNGSL-DKFIFYDETNSGPG 415
           K+E   E++ +  L H NL++L    +E ++D +LV EY+  G L D+ I      +   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT--- 185

Query: 416 EVTLNWEKR-LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLA 472
                 E   +  +    + + ++H   +  +LH D+K  NI+  +    ++   DFGLA
Sbjct: 186 ------ELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236

Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--IL 519
           R  +         K   GTP ++APE       +  TD+++ GV+  +L
Sbjct: 237 RRYKPR----EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYML 281

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  115 bits (289), Expect = 2e-28
 Identities = 55/339 (16%), Positives = 107/339 (31%), Gaps = 82/339 (24%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRNL 376
           +F P   +G+GGFG V++   +  +   A+KR+        +++ + EV  +  L H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           V+     +         E M    L         +S       + + R      T   + 
Sbjct: 67  VRYFN-AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 437 YLHNGSEKRVL------------------------------------------------- 447
            L   S K  L                                                 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 448 -HRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA---------GTPGYMAP 497
            HRD+K SNI    +   ++GDFGL   + ++ +       +          GT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           E       + + DI++ G+++ E+          E+      +        R  +     
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQ--MERVRIITDV--------RNLKF---- 291

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
                 ++ +   E +++       P+P  RP    +++
Sbjct: 292 PLLFTQKYPQ---EHMMV--QDMLSPSPTERPEATDIIE 325

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (292), Expect = 3e-28
 Identities = 42/333 (12%), Positives = 79/333 (23%), Gaps = 64/333 (19%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVS-------ETSRQGKQEFIAE------------- 364
           LG+       +   +   +   V              +Q K+E +               
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 365 -----VTTIGSLRHRNLVKLI--GWCYERHDFLLVYEYMPNGSLDKFIFYDE-TNSGPGE 416
                +     ++     K+I           L  +   P    +   F +   +     
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 417 VTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ 476
            +L    RL +     + L  LH      ++H  ++  +I+LD      L  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRA-----TIETDIYAFGVLILEVACGRKP-GNQ 530
            +  +          P   A      G+      T   D +  G+ I  + C   P  + 
Sbjct: 263 ASAVS--PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS 590
           +             W  R    I     +              L+ G          R  
Sbjct: 321 AALGGSE-------WIFRSCKNIPQPVRA--------------LLEGF--LRYPKEDRLL 357

Query: 591 MKTVLQVLSGEADPPVLPPERPSFVWPAMPPSF 623
               ++    E     L    P +     P   
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGEPTRE 390

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (285), Expect = 4e-28
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA----EVTTIGSLRHRNLVKL 379
           KLG GG  TVY       N ++A+K       + K+E +     EV     L H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           I    E   + LV EY+   +L ++I     + GP    L+ +  ++  +     + + H
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGP----LSVDTAINFTNQILDGIKHAH 128

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
              + R++HRDIK  NI++DS    ++ DFG+A+ + E   T   T  + GT  Y +PE 
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT--QTNHVLGTVQYFSPEQ 183

Query: 500 FLVGRATIETDIYAFGVLILEVACGRKP 527
                    TDIY+ G+++ E+  G  P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (284), Expect = 7e-28
 Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 34/215 (15%)

Query: 326 KLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIA----EVTTIGSLRHRNLVKL 379
            +G+GG G VY+     R + +A+K +   +      F      E  T G L+  ++V +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 380 IGWCYERHDF-------LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
                  HDF        +    +    L   +       GP    L   + ++++    
Sbjct: 100 -------HDFGEIDGQLYVDMRLINGVDLAAML----RRQGP----LAPPRAVAIVRQIG 144

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            ALD  H        HRD+K  NI++ ++  A L DFG+A    +   T        GT 
Sbjct: 145 SALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT--QLGNTVGTL 199

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            YMAPE F    AT   DIYA   ++ E   G  P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (288), Expect = 1e-27
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 30/233 (12%)

Query: 307 KKFRLKELKKATGNFNPK----NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE 360
           KK+  + ++   G+         +LG G FG V++ + +   +    K ++      K  
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94

Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTL 419
              E++ +  L H  L+ L     ++++ +L+ E++  G L D+    D   S       
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS------- 147

Query: 420 NWEKRLS-VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLARTIQ 476
             E  +   +    + L ++H   E  ++H DIK  NIM +++  + +   DFGLA  + 
Sbjct: 148 --EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202

Query: 477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
            +       K    T  + APE          TD++A GVL  +L    G  P
Sbjct: 203 PD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL--LSGLSP 249

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (280), Expect = 1e-27
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 32/227 (14%)

Query: 313 ELKKATGNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS----ETSRQGKQEFIAE 364
            + +   +F   N LGKG F  VY+    +      +A+K +       +   ++    E
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNE 61

Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           V     L+H ++++L  +  + +   LV E   NG +          +     +   E R
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-----NRYLKNRVKPFS-ENEAR 115

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN---LKT 481
              +H     + YLH      +LHRD+  SN++L    N ++ DFGLA  ++       T
Sbjct: 116 -HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171

Query: 482 HHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
                 + GTP Y++PE      A  +E+D+++ G +   +  GR P
Sbjct: 172 ------LCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (294), Expect = 2e-27
 Identities = 70/328 (21%), Positives = 112/328 (34%), Gaps = 62/328 (18%)

Query: 326 KLGKGGFGTVYKGIWRN---KEIAVKRVSETSRQGKQE-FIAEVTTIGSLRHRNLVKL-- 379
            +  GG G +Y  + RN   + + +K +  +     Q   +AE   +  + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 380 IGWCYERHDFLLVY---EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
                +RH   + Y   EY+   SL +               L   + ++ +     AL 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQK----LPVAEAIAYLLEILPALS 196

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH      +++ D+K  NIML  E   +L D G    I            + GTPG+ A
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGY--LYGTPGFQA 245

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
           PE  +    T+ TDIY  G  +  +               N   V  L E     +  D+
Sbjct: 246 PEI-VRTGPTVATDIYTVGRTLAALTLDLPT--------RNGRYVDGLPEDDPVLKTYDS 296

Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS----MKTVLQVLSGE---ADPPVLPP 609
                              L      P+P  R +    M   L  +  E    D  V  P
Sbjct: 297 YGR----------------LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRP 340

Query: 610 ERPSFVWPAMPPSFVESDYTHTGSQLDP 637
              +   P+     V+    HT   LD 
Sbjct: 341 GLSTIFSPSRSTFGVDLLVAHTDVYLDG 368

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  112 bits (283), Expect = 2e-27
 Identities = 74/334 (22%), Positives = 124/334 (37%), Gaps = 68/334 (20%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVS----ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LGKGGF   ++       +  A K V         Q ++    E++   SL H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGTSQA 434
           G+  +     +V E     SL      +              K L+       +      
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL-----LEL---------HKRRKALTEPEARYYLRQIVLG 153

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ---ENLKTHHSTKEIAGT 491
             YLH     RV+HRD+K  N+ L+ +   ++GDFGLA  ++   E  K       + GT
Sbjct: 154 CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGT 204

Query: 492 PGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK 550
           P Y+APE  L  +  + E D+++ G ++  +  G+ P   S              E   +
Sbjct: 205 PNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----------ETYLR 252

Query: 551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ---VLSGEADPPVL 607
             I    +  +    +       LI  +     +P  RP++  +L      SG   P  L
Sbjct: 253 --IK-KNEYSIPKHINPVAAS--LIQKM--LQTDPTARPTINELLNDEFFTSG-YIPARL 304

Query: 608 PPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDL 641
           P    +     +PP F  +  +   S   P + L
Sbjct: 305 PITCLT-----IPPRFSIAPSSLDPSNRKPLTVL 333

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (280), Expect = 3e-27
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 33/215 (15%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
              LG G F  V+    R   K  A+K + ++          E+  +  ++H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 382 WCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                  + LV + +  G L D+ +    Y E ++              VI     A+ Y
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------------LVIQQVLSAVKY 121

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEF-NARL--GDFGLARTIQENLKTHHSTKEIAGTPGY 494
           LH   E  ++HRD+K  N++  +   N+++   DFGL++  Q  +          GTPGY
Sbjct: 122 LH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGTPGY 173

Query: 495 MAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           +APE       +   D ++ GV+  IL   CG  P
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYIL--LCGYPP 206

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 4e-27
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 41/217 (18%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVS----ETSRQGKQEFIAEVTTIGSLRHRNLVKLI 380
           LGKGGF   ++       +  A K V         Q ++    E++   SL H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81

Query: 381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS------VIHGTSQA 434
           G+  +     +V E     SL +                   K L+       +      
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKR--------------RKALTEPEARYYLRQIVLG 127

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ---ENLKTHHSTKEIAGT 491
             YLH     RV+HRD+K  N+ L+ +   ++GDFGLA  ++   E  K       + GT
Sbjct: 128 CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV------LCGT 178

Query: 492 PGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           P Y+APE  L  +  + E D+++ G ++  +  G+ P
Sbjct: 179 PNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  105 bits (264), Expect = 4e-27
 Identities = 42/113 (37%), Positives = 59/113 (52%), Gaps = 8/113 (7%)

Query: 142 SQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ- 199
           S +VA+EFDT  + +  D N  H+G+DVNS+ S         +  NG      + Y+   
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAK---WDWQNGKIATAHISYNSVS 57

Query: 200 ---NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
              ++T + A  +   LS  I+L   LPE V VG SASTG D + N V SW+F
Sbjct: 58  KRLSVTSYYAGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSF 110

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (276), Expect = 1e-26
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA----EVTTIGSLRHRNLVKL 379
            LG GG   V+       ++++AVK V          F      E     +L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 380 --IGWCYERHDFL--LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
              G        L  +V EY+   +L   +       GP    +  ++ + VI    QAL
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGP----MTPKRAIEVIADACQAL 129

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           ++ H   +  ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  + GT  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +PE          +D+Y+ G ++ EV  G  P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (277), Expect = 1e-26
 Identities = 52/272 (19%), Positives = 97/272 (35%), Gaps = 47/272 (17%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSE 352
           + +      F+   L +    ++ K  +G+G +G V   I        A+K     ++ +
Sbjct: 7   HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66

Query: 353 TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFIFYDETN 411
            + +  +    EV  +  L H N+ +L     +     LV E    G L DK   + + +
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 412 SGPGEVTLNWEKRLSVIHGTS-------------------------------QALDYLHN 440
           +G   + +   +                                         AL YLH 
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH- 185

Query: 441 GSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLARTIQENLKTHHST-KEIAGTPGYMAP 497
              + + HRDIK  N +  +  +  +   DFGL++   +     +      AGTP ++AP
Sbjct: 186 --NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 498 E--SFLVGRATIETDIYAFGVLILEVACGRKP 527
           E  +        + D ++ GVL+  +  G  P
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  107 bits (267), Expect = 2e-26
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 8/113 (7%)

Query: 143 QIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ-- 199
            IVA+E DT  + +  D +  H+G+D+ SV S +       N+ NG      + Y+    
Sbjct: 3   TIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW---NMQNGKVGTAHIIYNSVDK 59

Query: 200 --NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFD 250
             +  V   N ++  +S  +DL   LPE V VG SASTG   + N + SW+F 
Sbjct: 60  RLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFT 112

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 73.8 bits (180), Expect = 6e-15
 Identities = 28/109 (25%), Positives = 54/109 (49%), Gaps = 4/109 (3%)

Query: 28  HFNFQSFTEQNRNELSFDNSTVA-KSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWRDNK 85
           HF F  F++  ++ +   ++T      +++T     G+P  +  GRA++     +W  + 
Sbjct: 127 HFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSA 186

Query: 86  NVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGIVN 133
            V A+F  TF   I +  + P +G+AF I+  +  +P  S G+ LG+  
Sbjct: 187 VV-ASFEATFTFLIKSPDSHPADGIAFFISNIDSSIPSGSTGRLLGLFP 234

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 2e-26
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 39/223 (17%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRV--SETSRQGKQEFIA-EVTTIGSL 371
            +F+    LGKG FG VY    R K+    +A+K +  S+  ++G +  +  E+     L
Sbjct: 14  DDFDIGRPLGKGKFGNVYLA--REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS----- 426
           RH N++++  + ++R    L+ E+ P G L     Y E         L    R       
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGEL-----YKE---------LQKHGRFDEQRSA 117

Query: 427 -VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
             +   + AL Y H   E++V+HRDIK  N+++  +   ++ DFG +     +L+    T
Sbjct: 118 TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR--T 171

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
             + GT  Y+ PE  + G+    + D++  GVL  E   G  P
Sbjct: 172 --MCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  107 bits (270), Expect = 5e-26
 Identities = 57/241 (23%), Positives = 92/241 (38%), Gaps = 49/241 (20%)

Query: 315 KKATGNFN----PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTI 368
             +T  F     PK  LG+G    V + I +   KE AVK +  T          +    
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 369 GSLR----------HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGP 414
            +L+          H N+++L         F LV++ M  G L D         E     
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE----- 123

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
                  ++   ++    + +  LH   +  ++HRD+K  NI+LD + N +L DFG +  
Sbjct: 124 -------KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATI------ETDIYAFGVL--ILEVACGRK 526
           +          +E+ GTP Y+APE               E D+++ GV+   L    G  
Sbjct: 174 LDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL--LAGSP 227

Query: 527 P 527
           P
Sbjct: 228 P 228

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (280), Expect = 5e-26
 Identities = 57/237 (24%), Positives = 94/237 (39%), Gaps = 36/237 (15%)

Query: 306 PKKFRLKELKKATGNFNPK----NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQ 359
            K++  + ++    +         +LG G FG V++   R      A K V       K+
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199

Query: 360 EFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-----DKFIFYDETNSGP 414
               E+ T+  LRH  LV L     + ++ +++YE+M  G L     D+     E     
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE----- 254

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLA 472
                  ++ +  +    + L ++H   E   +H D+K  NIM  ++ +  L   DFGL 
Sbjct: 255 -------DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
             +        S K   GT  + APE          TD+++ GVL  IL    G  P
Sbjct: 305 AHLDPK----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL--LSGLSP 355

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 36/222 (16%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRN 375
           N++ K +LGKG F  V + + +    E A K ++      +  Q+   E      L+H N
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGT 431
           +V+L     E     LV++ +  G L +  +   FY E                  I   
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE------------ADASHCIQQI 114

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEI 488
            +++ Y H      ++HR++K  N++L S+      +L DFGLA  + ++     +    
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS----EAWHGF 167

Query: 489 AGTPGYMAPESFLVGRA-TIETDIYAFGVL--ILEVACGRKP 527
           AGTPGY++PE  L     +   DI+A GV+  IL    G  P
Sbjct: 168 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYIL--LVGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (269), Expect = 6e-26
 Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 35/241 (14%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG 357
           +  + +  +  L         +N    LGKG FG V K   R   +E AVK +++ S + 
Sbjct: 3   HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62

Query: 358 KQE--FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETN 411
           K     + EV  +  L H N++KL     +   F +V E    G L D+ I    + E +
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122

Query: 412 SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGD 468
           +              +I      + Y+H   +  ++HRD+K  NI+L+S   + + ++ D
Sbjct: 123 AA------------RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIID 167

Query: 469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRK 526
           FGL+   Q+N       K+  GT  Y+APE  L G    + D+++ GV+  IL    G  
Sbjct: 168 FGLSTCFQQN----TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYIL--LSGTP 220

Query: 527 P 527
           P
Sbjct: 221 P 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (272), Expect = 6e-26
 Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 24/219 (10%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRH 373
           +     +GKG F  V + I R        K + V + + +     ++   E +    L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            ++V+L+          +V+E+M    L     ++           +       +    +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEIAG 490
           AL Y H   +  ++HRD+K   ++L S+ N+   +LG FG+A  + E+           G
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES---GLVAGGRVG 195

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           TP +MAPE           D++  GV+  IL    G  P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFIL--LSGCLP 232

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (268), Expect = 6e-26
 Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)

Query: 316 KATGNFNPK----NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIG 369
              G+ N      N +G+G +G V   + +      A K++ +   +    F  E+  + 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRL 425
           SL H N+++L     +  D  LV E    G L ++ +    + E+++             
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------------ 109

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTH 482
            ++     A+ Y H   +  V HRD+K  N +  +   +   +L DFGLA   +      
Sbjct: 110 RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---- 162

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
              +   GTP Y++P+  L G    E D ++ GV+  +L   CG  P
Sbjct: 163 KMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVL--LCGYPP 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 6e-26
 Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 32/243 (13%)

Query: 297 GLINGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE-- 352
            +++  +  P  F        +  +  +  LGKG FG V     +   +E AVK +S+  
Sbjct: 4   SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63

Query: 353 -TSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FY 407
              +  K+  + EV  +  L H N++KL  +  ++  F LV E    G L D+ I    +
Sbjct: 64  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 123

Query: 408 DETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNA 464
            E ++              +I      + Y+H   + +++HRD+K  N++L+S   + N 
Sbjct: 124 SEVDAA------------RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI 168

Query: 465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG 524
           R+ DFGL+   + +       K+  GT  Y+APE  L G    + D+++ GV++  +  G
Sbjct: 169 RIIDFGLSTHFEAS----KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

Query: 525 RKP 527
             P
Sbjct: 224 CPP 226

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (272), Expect = 8e-26
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 34/235 (14%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEF 361
             +F +    K + N++ K +LGKG F  V + + +    E A K ++      +  Q+ 
Sbjct: 16  GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEV 417
             E      L+H N+V+L     E     LV++ +  G L +  +   FY E ++     
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---- 131

Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLART 474
                     I    +++ Y H      ++HR++K  N++L S+      +L DFGLA  
Sbjct: 132 --------HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           + ++     +    AGTPGY++PE       +   DI+A GV+  IL    G  P
Sbjct: 181 VNDS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL--LVGYPP 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  108 bits (271), Expect = 8e-26
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 39/232 (16%)

Query: 312 KELKKATGNFN----PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEV 365
           ++L + +  F      K  +G G +    + I +  N E AVK + ++ R   +E I  +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEIL 69

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNW 421
                 +H N++ L     +     +V E M  G L DK +   F+ E  +         
Sbjct: 70  LRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-------- 119

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA----RLGDFGLARTIQE 477
               +V+   ++ ++YLH    + V+HRD+K SNI+   E       R+ DFG A+ ++ 
Sbjct: 120 ----AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
               +        T  ++APE           DI++ GVL   +    G  P
Sbjct: 173 E---NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM--LTGYTP 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/313 (23%), Positives = 116/313 (37%), Gaps = 58/313 (18%)

Query: 318 TGNFN-----PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGS 370
           +G F       ++ LG+G    V   I    ++E AVK + +     +     EV  +  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 371 LR-HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRL 425
            + HRN+++LI +  E   F LV+E M  GS+         ++E  +             
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------------ 114

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTH 482
            V+   + ALD+LHN   K + HRD+K  NI+ +        ++ DF L   I+ N    
Sbjct: 115 VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 483 HST----KEIAGTPGYMAPESFLVGRATIET-----DIYAFGVL--ILEVACGRKP--GN 529
             +        G+  YMAPE                D+++ GV+  IL    G  P  G 
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL--LSGYPPFVGR 229

Query: 530 QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECV------LILGLACCHP 583
                 ++        +      I +        EF +K+   +      LI  L     
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGK-----YEFPDKDWAHISCAAKDLISKL--LVR 282

Query: 584 NPHLRPSMKTVLQ 596
           +   R S   VLQ
Sbjct: 283 DAKQRLSAAQVLQ 295

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (267), Expect = 2e-25
 Identities = 46/224 (20%), Positives = 89/224 (39%), Gaps = 33/224 (14%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR 372
           K+    +     LG+G FG V++ +     K    K V       +     E++ +   R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIAR 59

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSL-----DKFIFYDETNSGPGEVTLNWEKRLSV 427
           HRN++ L        + ++++E++    +           +E      E+        S 
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-----EIV-------SY 107

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLARTIQENLKTHHST 485
           +H   +AL +LH      + H DI+  NI+  +  ++ +   +FG AR ++       + 
Sbjct: 108 VHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNF 160

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           + +   P Y APE       +  TD+++ G L  +L    G  P
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL--LSGINP 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 2e-25
 Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 51/272 (18%)

Query: 285 RYRARELDDDIEGLINGTNLAPKKFRLKELKKATGNFNPKN---------KLGKGGFGTV 335
           + + R L+++ E  I  +    K F   +L     +  PK           LG G  G V
Sbjct: 94  KGKRRPLNNNSE--IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151

Query: 336 YKGIWR--NKEIAVKRVS--------ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE 385
                R   K++A++ +S                    E+  +  L H  ++K+  + ++
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FD 210

Query: 386 RHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG 441
             D+ +V E M  G L DK +      E                   +    A+ YLH  
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCK------------LYFYQMLLAVQYLH-- 256

Query: 442 SEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
            E  ++HRD+K  N++L S   +   ++ DFG ++ + E        + + GTP Y+APE
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPE 311

Query: 499 ---SFLVGRATIETDIYAFGVLILEVACGRKP 527
              S          D ++ GV++     G  P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (269), Expect = 2e-25
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 44/231 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTT-----IGSLR 372
            ++PK+ +G+G    V + + R    E AVK +  T+ +   E + EV          LR
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 373 ----HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKR 424
               H +++ LI          LV++ M  G L D         E            ++ 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE------------KET 202

Query: 425 LSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
            S++    +A+ +LH      ++HRD+K  NI+LD     RL DFG +  ++        
Sbjct: 203 RSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG----EK 255

Query: 485 TKEIAGTPGYMAPESFLVGRATI------ETDIYAFGVL--ILEVACGRKP 527
            +E+ GTPGY+APE               E D++A GV+   L    G  P
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL--LAGSPP 304

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  108 bits (272), Expect = 3e-25
 Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 35/229 (15%)

Query: 314 LKKATGNFNPK----NKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEV 365
           +    G+ +       KLG G +G V     +  + E A+K +  +  S     + + EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNW 421
             +  L H N++KL  +  ++ ++ LV E    G L D+ I    ++E ++         
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------- 139

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQEN 478
                +I      + YLH   +  ++HRD+K  N++L+S   +   ++ DFGL+   +  
Sbjct: 140 ----VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                  KE  GT  Y+APE  L  +   + D+++ GV++  +  G  P
Sbjct: 193 ----KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (266), Expect = 4e-25
 Identities = 32/243 (13%), Positives = 64/243 (26%), Gaps = 53/243 (21%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE------------------------ 360
           LG+       +   +   +   V     T R                             
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 361 ----FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE-TNSGPG 415
               FI     +   + + ++++          L  +   P    +   F +   +    
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
             +L    RL +     + L  LH+     ++H  ++  +I+LD      L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLV-----------GRATIETDIYAFGVLILEVACG 524
                        + + G+  PE                  T   D +A G++I  + C 
Sbjct: 257 GA-------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 525 RKP 527
             P
Sbjct: 310 DLP 312

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  104 bits (262), Expect = 5e-25
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 26/214 (12%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLI 380
           K KLG G FG V+    R    E  +K +++   Q   E I  E+  + SL H N++K+ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 381 GWCYERHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKR-LSVIHGTSQALDYL 438
               + H+  +V E    G L ++ +      +    ++   E     ++     AL Y 
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIV---SAQARGKALS---EGYVAELMKQMMNALAYF 140

Query: 439 HNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           H    + V+H+D+K  NI+          ++ DFGLA   + +      +   AGT  YM
Sbjct: 141 H---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD----EHSTNAAGTALYM 193

Query: 496 APESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           APE       T + DI++ GV+   L    G  P
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFL--LTGCLP 224

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (269), Expect = 8e-25
 Identities = 69/327 (21%), Positives = 135/327 (41%), Gaps = 70/327 (21%)

Query: 299 INGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS----- 351
             G  + P  +  K+  K   ++    KLG G +G V     +  + E A+K +      
Sbjct: 16  FQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75

Query: 352 --------ETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-D 402
                   +   +  +E   E++ + SL H N++KL     ++  F LV E+   G L +
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135

Query: 403 KFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
           + I    +DE ++             +++      + YLH   +  ++HRDIK  NI+L+
Sbjct: 136 QIINRHKFDECDAA------------NIMKQILSGICYLH---KHNIVHRDIKPENILLE 180

Query: 460 S---EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGV 516
           +     N ++ DFGL+    ++    +  ++  GT  Y+APE  L  +   + D+++ GV
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235

Query: 517 LILEVACGRKP-GNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECV-- 573
           ++  + CG  P G Q++Q+     +         KG+            F   + + +  
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKK-V--------EKGKY----------YFDFNDWKNISD 276

Query: 574 ----LILGLACCHPNPHLRPSMKTVLQ 596
               LI  +     + + R + +  L 
Sbjct: 277 EAKELIKLMLT--YDYNKRCTAEEALN 301

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 1e-24
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 37/217 (17%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVK------RVSETSRQGKQEFIAEVTTIGSLR 372
           ++   +LG G F  V K   +    E A K        +      ++E   EV+ +  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVI 428
           H N++ L      R D +L+ E +  G L D         E  +             S I
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------------SFI 121

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLARTIQENLKTHHS 484
                 ++YLH    K++ H D+K  NIML  +     + +L DFGLA  I++       
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VE 174

Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--IL 519
            K I GTP ++APE        +E D+++ GV+  IL
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 1e-24
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 37/217 (17%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQG-KQEFIAEVTTIGSLR 372
           ++   +LG G F  V K   ++       K I  ++   + R   ++E   EV+ +  + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVI 428
           H N++ L      R D +L+ E +  G L D         E  +             S I
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------------SFI 121

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLARTIQENLKTHHS 484
                 ++YLH    K++ H D+K  NIML  +     + +L DFGLA  I++ ++    
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---- 174

Query: 485 TKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--IL 519
            K I GTP ++APE        +E D+++ GV+  IL
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (258), Expect = 3e-24
 Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 44/230 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS--------ETSRQGKQEFIAEVTTIG 369
            +     LG G  G V     R   K++A+K +S                    E+  + 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRL 425
            L H  ++K+  + ++  D+ +V E M  G L DK +      E                
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------------ 117

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTH 482
              +    A+ YLH   E  ++HRD+K  N++L S   +   ++ DFG ++ + E     
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---- 170

Query: 483 HSTKEIAGTPGYMAPE---SFLVGRATIETDIYAFGVL--ILEVACGRKP 527
              + + GTP Y+APE   S          D ++ GV+  I     G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC--LSGYPP 218

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  102 bits (257), Expect = 3e-24
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 25/214 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRH 373
            +    K+G+G +G V+K   RN++    +A+K+  E+      + IA  E+  +  L+H
Sbjct: 4   KYEKIGKIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            NLV L+     +    LV+EY  + ++   +  D    G  E  +      S+   T Q
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-----SITWQTLQ 113

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           A+++ H   +   +HRD+K  NI++      +L DFG AR +      +    E+A T  
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVA-TRW 167

Query: 494 YMAPESFLVGRATIET--DIYAFGVLILEVACGR 525
           Y +PE  LVG        D++A G +  E+  G 
Sbjct: 168 YRSPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (255), Expect = 3e-24
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 37/214 (17%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVK------RVSETSRQGKQEFIAEVTTIGSLRHRN 375
             +LG G F  V K   +   KE A K        S      ++E   EV  +  +RH N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGT 431
           ++ L      + D +L+ E +  G L D         E      E T         +   
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-----EAT-------QFLKQI 117

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA----RLGDFGLARTIQENLKTHHSTKE 487
              + YLH    KR+ H D+K  NIML  +       +L DFG+A  I+      +  K 
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKN 170

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVL--IL 519
           I GTP ++APE        +E D+++ GV+  IL
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 5e-24
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 33/221 (14%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRN 375
            +    +LGKG F  V + +     +E A       + S +  Q+   E      L+H N
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGT 431
           +V+L     E     L+++ +  G L +  +   +Y E ++               I   
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS------------HCIQQI 119

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA---RLGDFGLARTIQENLKTHHSTKEI 488
            +A+ + H   +  V+HR++K  N++L S+      +L DFGLA  ++       +    
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE---QQAWFGF 173

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           AGTPGY++PE           D++A GV+  IL    G  P
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL--LVGYPP 212

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (255), Expect = 9e-24
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 34/215 (15%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           +++LG+G    VY+   +   K  A+K +       K+    E+  +  L H N++KL  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 382 WCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
                 +  LV E +  G L D+ +   +Y E ++               +    +A+ Y
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA------------DAVKQILEAVAY 163

Query: 438 LHNGSEKRVLHRDIKSSNIMLDS-EFNARL--GDFGLARTIQENLKTHHSTKEIAGTPGY 494
           LH   E  ++HRD+K  N++  +   +A L   DFGL++ ++         K + GTPGY
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGY 216

Query: 495 MAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
            APE         E D+++ G++  IL   CG +P
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYIL--LCGFEP 249

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (253), Expect = 1e-23
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 40/227 (17%)

Query: 314 LKKATGNFN-----PKNKLGKGGFGTVYKGIWR--NKEIAVK--RVSETSRQGKQEFIAE 364
             ++  NFN        +LG+G F  V + I +   +E A K  +     +  + E + E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78

Query: 365 VTTIGSLRHR-NLVKLIGWCYERHDFLLVYEYMPNGSL------DKFIFYDETNSGPGEV 417
           +  +   +    ++ L        + +L+ EY   G +      +      E      +V
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN-----DV 133

Query: 418 TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARL--GDFGLART 474
                    +I    + + YLH   +  ++H D+K  NI+L S +    +   DFG++R 
Sbjct: 134 I-------RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVL--IL 519
           I          +EI GTP Y+APE       T  TD++  G++  +L
Sbjct: 184 IGHA----CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  100 bits (251), Expect = 1e-23
 Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGS 370
            +    K+G+G +GTV+K   +N+E    +A+KRV  +   +G        + E+  +  
Sbjct: 3   KYEKLEKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKE 57

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           L+H+N+V+L    +      LV+E+     L K+      +S  G++     K  S +  
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-----DSCNGDLDPEIVK--SFLFQ 109

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
             + L + H    + VLHRD+K  N++++     +L +FGLAR     ++ +  + E+  
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVV- 163

Query: 491 TPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           T  Y  P+     +  +   D+++ G +  E+A   +P
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 2e-23
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 39/222 (17%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRV------SETSRQGKQEFIAEVTTIGSLRHRN 375
             +LG G F  V K   +    + A K +      S      +++   EV+ +  ++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGT 431
           ++ L      + D +L+ E +  G L D         E            E+    +   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE------------EEATEFLKQI 123

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA----RLGDFGLARTIQENLKTHHSTKE 487
              + YLH     ++ H D+K  NIML          ++ DFGLA  I       +  K 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKN 176

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           I GTP ++APE        +E D+++ GV+  IL    G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  102 bits (257), Expect = 3e-23
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 63/293 (21%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHRNLVKL 379
              LGKG FG V K   R   +E AVK +++ S + K     + EV  +  L H N++KL
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 380 IGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
                +   F +V E    G L D+ I    + E ++              +I      +
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------------RIIKQVFSGI 134

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
            Y+H   +  ++HRD+K  NI+L+S   + + ++ DFGL+   Q+N       K+  GT 
Sbjct: 135 TYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTA 187

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKP---GNQSEQNSYNNSIVHWLWELRR 549
            Y+APE  L G    + D+++ GV++  +  G  P    N+ +           + +   
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----------ILKRVE 235

Query: 550 KGRILDAADSRLGGEFSEKEMECV------LILGLACCHPNPHLRPSMKTVLQ 596
            G+            F   +   +      LI  +     +P LR +    L+
Sbjct: 236 TGKY----------AFDLPQWRTISDDAKDLIRKMLT--FHPSLRITATQCLE 276

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =   99 bits (250), Expect = 4e-23
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQEFIA--EVTTIGSLRH 373
            +     +G+G +G V K   RNK+    +A+K+  E+      + IA  E+  +  LRH
Sbjct: 26  KYENLGLVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIHGT 431
            NLV L+  C ++  + LV+E++ + ++   +  +   +G     V          +   
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQ-------KYLFQI 133

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
              + + H      ++HRDIK  NI++      +L DFG ART+    + +    E+A T
Sbjct: 134 INGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVA-T 187

Query: 492 PGYMAPESFLVGRATIET--DIYAFGVLILEVACGR 525
             Y APE  LVG        D++A G L+ E+  G 
Sbjct: 188 RWYRAPE-LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.7 bits (247), Expect = 5e-23
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 24/213 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEI-AVKRVS-ETSRQGKQEF----IAEVTTIGSLRH 373
            ++   K+G+G +G VYK      E  A+K++  E   +G        I E++ +  L+H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKH 59

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+VKL    + +   +LV+E++    L K +     +   G +     K  S +     
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-----DVCEGGLESVTAK--SFLLQLLN 111

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            + Y H   ++RVLHRD+K  N++++ E   ++ DFGLAR     ++ +  T EI  T  
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIV-TLW 165

Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
           Y AP+  +  +  +   DI++ G +  E+  G 
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  100 bits (251), Expect = 6e-23
 Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 19/185 (10%)

Query: 326 KLGKGGFGTVYKGIWR----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIG 381
           K+G+G +G VYK   +    +K+ A+K++  T          E+  +  L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 85

Query: 382 WCYERHD--FLLVYEYMPNGSLDKFI-FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
                 D    L+++Y  +  L   I F+  + +    V L      S+++     + YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNAR----LGDFGLARTIQENLKTH-HSTKEIAGTPG 493
           H      VLHRD+K +NI++  E   R    + D G AR     LK        +  T  
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 494 YMAPE 498
           Y APE
Sbjct: 201 YRAPE 205

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEI-AVKRVS-ETSRQGKQEF----IAEVTTIGSLRH 373
            +    K+G+G +G VYK       I A+KR+  +   +G        I E++ +  L H
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG---IPSTAIREISLLKELHH 78

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            N+V LI   +      LV+E+M    L K +  ++T     ++     K    ++   +
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI-----K--IYLYQLLR 130

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            + + H   + R+LHRD+K  N++++S+   +L DFGLAR     ++++  T E+  T  
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVV-TLW 184

Query: 494 YMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
           Y AP+  +  +  +   DI++ G +  E+  G+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 54/292 (18%)

Query: 323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKL 379
               LG+G F    K + +  N+  AVK +S+      Q+   E+T +     H N+VKL
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKL 71

Query: 380 IGWCYERHDFLLVYEYMPNGSL-DKFI---FYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
               +++    LV E +  G L ++      + ET +              ++     A+
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS------------YIMRKLVSAV 119

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHHSTKEIAGTP 492
            ++H   +  V+HRD+K  N++   E  N   ++ DFG AR    +   +   K    T 
Sbjct: 120 SHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---NQPLKTPCFTL 173

Query: 493 GYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK 550
            Y APE           D+++ GV+   +    G+ P  QS   S   +    + +  +K
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP-FQSHDRSLTCTSAVEIMKKIKK 230

Query: 551 GRILDAADSRLGGEFSEKEMECV------LILGLACCHPNPHLRPSMKTVLQ 596
           G             F  +  + V      LI GL     +P+ R  M  +  
Sbjct: 231 GDF----------SFEGEAWKNVSQEAKDLIQGL--LTVDPNKRLKMSGLRY 270

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 63/250 (25%), Positives = 96/250 (38%), Gaps = 57/250 (22%)

Query: 305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQG 357
           A K    KE +     +     LG GGFG+VY GI    N  +A+K     R+S+     
Sbjct: 29  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 88

Query: 358 KQEFIA-EVTTIGSLRHR--NLVKLIGWCYERHDFLLVYEY-MPNGSLDKFIFYDETNSG 413
               +  EV  +  +      +++L+ W      F+L+ E   P   L  FI    T  G
Sbjct: 89  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERG 144

Query: 414 PGEVTLNWEKRLS----------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-F 462
                      L           V+    +A+ + HN     VLHRDIK  NI++D    
Sbjct: 145 ----------ALQEELARSFFWQVL----EAVRHCHN---CGVLHRDIKDENILIDLNRG 187

Query: 463 NARLGDFGLARTIQEN-LKTHHSTKEIAGTPGYMAPESFL----VGRATIETDIYAFGVL 517
             +L DFG    +++             GT  Y  PE        GR      +++ G+L
Sbjct: 188 ELKLIDFGSGALLKDTVYTDF------DGTRVYSPPEWIRYHRYHGR---SAAVWSLGIL 238

Query: 518 ILEVACGRKP 527
           + ++ CG  P
Sbjct: 239 LYDMVCGDIP 248

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 77/344 (22%), Positives = 125/344 (36%), Gaps = 90/344 (26%)

Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQGKQEFIA- 363
           K+ +     +     LGKGGFGTV+ G       ++A+K     RV   S          
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 364 EVTTIGSLR----HRNLVKLIGWCYERHDFLLVYEY-MPNGSLDKFIFYDETNSGPGEVT 418
           EV  +  +     H  +++L+ W   +  F+LV E  +P   L  +I    T  G     
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI----TEKG----- 134

Query: 419 LNWEKRLS----------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLG 467
                 L           V+     A+ + H+   + V+HRDIK  NI++D      +L 
Sbjct: 135 -----PLGEGPSRCFFGQVVA----AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI 182

Query: 468 DFGLARTIQEN-LKTHHSTKEIAGTPGYMAPESFL----VGRATIETDIYAFGVLILEVA 522
           DFG    + +             GT  Y  PE                +++ G+L+ ++ 
Sbjct: 183 DFGSGALLHDEPYTDF------DGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMV 233

Query: 523 CGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECV-LILGLACC 581
           CG  P                 +E  ++  IL+ A+       S    +C  LI    C 
Sbjct: 234 CGDIP-----------------FERDQE--ILE-AELHFPAHVSP---DCCALIRR--CL 268

Query: 582 HPNPHLRPSMKTVLQ---VLSGEADPPVLP--PERPSFVWPAMP 620
            P P  RPS++ +L    + +   D P+ P         W  +P
Sbjct: 269 APKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWSLLP 312

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 25/216 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVSETSRQGKQE-----FIAEVTTIGS 370
            F    KLG G + TVYKG   NK     +A+K V    +   +E      I E++ +  
Sbjct: 6   QFKQLEKLGNGTYATVYKG--LNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKE 59

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           L+H N+V+L    +  +   LV+E+M N  L K++      + P  + LN  K       
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK--YFQWQ 116

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
             Q L + H   E ++LHRD+K  N++++     +LGDFGLAR     + T   + E+  
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVV- 170

Query: 491 TPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
           T  Y AP+  +  R  +   DI++ G ++ E+  G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.1 bits (240), Expect = 5e-22
 Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 43/246 (17%)

Query: 300 NGTNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVK--RVSETSR 355
              +L   +   +  KK   +F     LG+G F TV   + +  ++E A+K        +
Sbjct: 11  GAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK 70

Query: 356 QGKQEFI-AEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFI-------- 405
           + K  ++  E   +  L H   VKL  + ++  + L     Y  NG L K+I        
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 406 ----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE 461
               FY        E+                AL+YLH    K ++HRD+K  NI+L+ +
Sbjct: 130 TCTRFY------TAEIVS--------------ALEYLH---GKGIIHRDLKPENILLNED 166

Query: 462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV 521
            + ++ DFG A+ +              GT  Y++PE      A   +D++A G +I ++
Sbjct: 167 MHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

Query: 522 ACGRKP 527
             G  P
Sbjct: 226 VAGLPP 231

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 62/329 (18%), Positives = 117/329 (35%), Gaps = 76/329 (23%)

Query: 299 INGTNLAPKKFRLKELKKATGNFN-----PKNKLGKGGFGTVYKGIWR--NKEIAVKRVS 351
            +  + +  +   +  +             K  LG G  G V +   R   ++ A+K + 
Sbjct: 4   HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63

Query: 352 ETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE-----RHDFLLVYEYMPNGSL-DKF 404
           ++ +  +     EV          ++V ++   YE     +   L++ E M  G L  + 
Sbjct: 64  DSPKARQ-----EVDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGELFSRI 117

Query: 405 I-----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD 459
                  + E  +              ++     A+ +LH      + HRD+K  N++  
Sbjct: 118 QERGDQAFTEREAA------------EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYT 162

Query: 460 SEF-NA--RLGDFGLARTIQEN-LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFG 515
           S+  +A  +L DFG A+   +N L+T         TP Y+APE     +     D+++ G
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNALQT------PCYTPYYVAPEVLGPEKYDKSCDMWSLG 216

Query: 516 VL--ILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECV 573
           V+  IL   CG  P   +   + +  +   +    R G+            F   E   V
Sbjct: 217 VIMYIL--LCGFPPFYSNTGQAISPGMKRRI----RLGQY----------GFPNPEWSEV 260

Query: 574 ------LILGLACCHPNPHLRPSMKTVLQ 596
                 LI  L     +P  R ++   + 
Sbjct: 261 SEDAKQLIRLLLKT--DPTERLTITQFMN 287

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.1 bits (247), Expect = 6e-22
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 24/230 (10%)

Query: 308 KFRLKELKKATGN-FNPKNKLGKGGFGTVYKGIWRN-KEI-AVKRVSE---TSRQGKQEF 361
           +++  E +    + F     LG+GGFG V+    +   ++ A K++++     R+G Q  
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
           + E   +  +  R +V L  + +E    L LV   M  G +     Y   N         
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI----RYHIYNVDEDNPGFQ 287

Query: 421 WEKRLSVIHGTSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            E R   I  T+Q    L++LH   ++ +++RD+K  N++LD + N R+ D GLA    E
Sbjct: 288 -EPR--AIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV---E 338

Query: 478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
                  TK  AGTPG+MAPE  L        D +A GV + E+   R P
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 49/241 (20%)

Query: 308 KFRLKELKKATGN-FNPKNKLGKGGFGTVYKGIWRN-KEI-AVKRVSE---TSRQGKQEF 361
           +++  E +  T N F     LGKGGFG V     R   ++ A K++ +     R+G+   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL--------------DKFIF 406
           + E   +  +  R +V L  + YE  D L LV   M  G L               + +F
Sbjct: 232 LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290

Query: 407 YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL 466
           Y        E+                 L+ LH    +R+++RD+K  NI+LD   + R+
Sbjct: 291 Y------AAEICC--------------GLEDLH---RERIVYRDLKPENILLDDHGHIRI 327

Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK 526
            D GLA  + E            GT GYMAPE     R T   D +A G L+ E+  G+ 
Sbjct: 328 SDLGLAVHVPEGQTIK----GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

Query: 527 P 527
           P
Sbjct: 384 P 384

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 41/240 (17%)

Query: 305 APKKFRLKELKKATG--NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQG 357
            P    +     AT    +    KLG+G +G VYK    +      +A+KR+  E   +G
Sbjct: 18  GPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEG 75

Query: 358 KQEF----IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
                   I EV+ +  L+HRN+++L    +  H   L++EY  N  L K++   + N  
Sbjct: 76  ---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPD 128

Query: 414 --PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR-----L 466
                +     K  S ++     +++ H    +R LHRD+K  N++L     +      +
Sbjct: 129 VSMRVI-----K--SFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178

Query: 467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
           GDFGLAR     ++    T EI  T  Y  PE  L  R  +   DI++   +  E+    
Sbjct: 179 GDFGLARAFGIPIRQF--THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.8 bits (234), Expect = 5e-21
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE-----FIAEVTTIGSLR 372
            +   +KLG+G + TVYKG  +  +  +A+K +    R   +E      I EV+ +  L+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+V L    +      LV+EY+    L +++     +     + ++  K    +    
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-----DDCGNIINMHNVK--LFLFQLL 110

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
           + L Y H    ++VLHRD+K  N++++     +L DFGLAR      KT+    E+  T 
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVV-TL 164

Query: 493 GYMAPESFLVGRA-TIETDIYAFGVLILEVACGR 525
            Y  P+  L     + + D++  G +  E+A GR
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 87.3 bits (216), Expect = 7e-21
 Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 6/112 (5%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVT-YDVRGAPITNQSGRAIYKDQFQLWR 82
            SL F+F  F     + L F  ++T   + +QVT  D  G P+++ +GR +Y    +LW 
Sbjct: 2   QSLSFSFTKFDPNQED-LIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWE 60

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVN 133
           D+  +  +F T     I    T++  +GLAF IA   D   +  G +LG+  
Sbjct: 61  DSAVL-TSFDTIINFEISTPYTSRIADGLAFFIAPP-DSVISYHGGFLGLFP 110

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 25/188 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGS 370
            +   + LG+G F TVYK   R+K     +A+K++      + K       + E+  +  
Sbjct: 11  RYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           L H N++ L+     + +  LV+++M    L+  I  +     P  +     K  + +  
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI-----K--AYMLM 120

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
           T Q L+YLH   +  +LHRD+K +N++LD     +L DFGLA++     + +  T ++  
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVV- 174

Query: 491 TPGYMAPE 498
           T  Y APE
Sbjct: 175 TRWYRAPE 182

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 51/223 (22%)

Query: 327 LGKGGFGTVYKGIWR-NKEI-AVKRVSET---SRQGKQEFIAE---VTTIGSLRHRNLVK 378
           +G+GGFG VY        ++ A+K + +     +QG+   + E   ++ + +     +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 379 LIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPGEVTLNWEKRL 425
           +  + +   D L  + + M  G L         F      FY        E+ L      
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIIL------ 303

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                    L+++H    + V++RD+K +NI+LD   + R+ D GLA    +        
Sbjct: 304 --------GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KP 347

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
               GT GYMAPE    G A     D ++ G ++ ++  G  P
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 67/347 (19%), Positives = 131/347 (37%), Gaps = 95/347 (27%)

Query: 324 KNKLGKGGFGTVYKGIWRN-------KEIAVKRVSE-TSRQGKQEFIAEVTTIGSL-RHR 374
              LG+G FG V +            + +AVK + E  +    +  ++E+  +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 375 NLVKLIGWC------------YERHDFLLVY----------------------EYMPNGS 400
           N+V L+G C            + +   L  Y                      +Y+    
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 401 LDK-------------------------FIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +D                           +  +E      +  L  E  +      ++ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG-Y 494
           ++L   + ++ +HRD+ + NI+L  +   ++ DFGLAR I ++    +  K  A  P  +
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKW 261

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVAC-GRKP--GNQSEQNSYNNSIVHWLWELRRKG 551
           MAPE+      TI++D+++FGVL+ E+   G  P  G + ++               ++G
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------FCRRLKEG 312

Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
             + A       +++  EM   +   L C H  P  RP+   +++ L
Sbjct: 313 TRMRAP------DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLI 380
              LG G  G V +   +   ++ A+K + +  +  +     EV       +  ++V+++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 121

Query: 381 GWCYE-----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS-VIHGTSQA 434
              YE     R   L+V E +  G L    F    + G    T   E+  S ++    +A
Sbjct: 122 DV-YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFT---EREASEIMKSIGEA 173

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLARTIQENLKTHHSTKEIAGT 491
           + YLH      + HRD+K  N++  S+  NA  +L DFG A+    +    +S      T
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYT 226

Query: 492 PGYMAPESFLVGRATIETDIYAFGVL--ILEVACGRKP 527
           P Y+APE     +     D+++ GV+  IL   CG  P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGYPP 262

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 35/224 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGS 370
            + P  ++G G +GTVYK   R+      +A+K V       G        + EV  +  
Sbjct: 10  RYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 371 LR---HRNLVKLIGWCYERHD-----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
           L    H N+V+L+  C            LV+E++    L  ++   +    PG   L  E
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPG---LPAE 120

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK-T 481
               ++    + LD+LH      ++HRD+K  NI++ S    +L DFGLAR     +  T
Sbjct: 121 TIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                 +  T  Y APE  L        D+++ G +  E+   +
Sbjct: 178 P----VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 51/237 (21%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVK--------RVSETSRQGKQEFIAE 364
            + +  ++  + LG G FG V+  + +  NKE+ VK                   +   E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 365 VTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           +  +  + H N++K++     +  F LV E   +G LD F F D               R
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDR------------HPR 126

Query: 425 LS----------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
           L           ++     A+ YL     K ++HRDIK  NI++  +F  +L DFG A  
Sbjct: 127 LDEPLASYIFRQLV----SAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179

Query: 475 IQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATI--ETDIYAFGVLILEVACGRKP 527
           ++      T        GT  Y APE  + G      E ++++ GV +  +     P
Sbjct: 180 LERGKLFYTF------CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 74/328 (22%), Positives = 129/328 (39%), Gaps = 83/328 (25%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHR 374
           GN+     +GKG F  V         +E+A+K + +T  +    Q+   EV  +  L H 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 375 NLVKLIGWCYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS---- 426
           N+VKL    +E         L+ EY   G +  ++       G          R+     
Sbjct: 75  NIVKL----FEVIETEKTLYLIMEYASGGEVFDYL----VAHG----------RMKEKEA 116

Query: 427 ------VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN-- 478
                 ++     A+ Y H    KR++HRD+K+ N++LD++ N ++ DFG +        
Sbjct: 117 RSKFRQIVS----AVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSY 536
           L          G P Y APE F  G+     E D+++ GV++  +  G  P +   QN  
Sbjct: 170 LDAF------CGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFD--GQN-- 218

Query: 537 NNSIVHWLWELRRKGRILDAADSRLGGEFSEKE---MECV-LILGLACCHPNPHLRPSMK 592
                  L ELR +  +L        G++        +C  L+        NP  R +++
Sbjct: 219 -------LKELRER--VLR-------GKYRIPFYMSTDCENLLKRFLV--LNPIKRGTLE 260

Query: 593 TVLQ---VLSGEADPPVLPPERPSFVWP 617
            +++   + +G  +  + P   P     
Sbjct: 261 QIMKDRWINAGHEEDELKPFVEPELDIS 288

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 53/237 (22%), Positives = 90/237 (37%), Gaps = 79/237 (33%)

Query: 327 LGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEFIA--EVTTIGSLRHRNLVKL 379
           +GKG FG V           K++ A+K ++      KQ+ +   EV  +   +   +++ 
Sbjct: 23  IGKGSFGKVCIVQKND---TKKMYAMKYMN------KQKCVERNEVRNV--FKELQIMQG 71

Query: 380 IGWCYERHDFL--------------LVYEYMPNGSL------------DKFIFYDETNSG 413
           +      H FL              +V + +  G L            +    +      
Sbjct: 72  L-----EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF------ 120

Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
             E+ +              ALDYL     +R++HRD+K  NI+LD   +  + DF +A 
Sbjct: 121 ICELVM--------------ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163

Query: 474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA---TIETDIYAFGVLILEVACGRKP 527
            +            +AGT  YMAPE F   +    +   D ++ GV   E+  GR+P
Sbjct: 164 MLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 36/193 (18%)

Query: 325 NKLGKGGFGTVYKGIWRNKE----IAVKRVS-ETSRQGKQEF----IAEVTTIGSLRHRN 375
            K+G+G FG V+K   R+++    +A+K+V  E  ++G   F    + E+  +  L+H N
Sbjct: 23  AKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHEN 77

Query: 376 LVKLIGWCYERHD--------FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
           +V LI  C  +            LV+++  +  L   +     ++   + TL+  K   V
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-----SNVLVKFTLSEIK--RV 129

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS--T 485
           +      L Y+H     ++LHRD+K++N+++  +   +L DFGLAR       +  +  T
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 486 KEIAGTPGYMAPE 498
             +  T  Y  PE
Sbjct: 187 NRVV-TLWYRPPE 198

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 67/271 (24%), Positives = 102/271 (37%), Gaps = 66/271 (24%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVY----KGIWR-------NKEIAVKRVSETS 354
           P   RLKE++    +F     +G+G F  V     K   +       NK   +KR  E S
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVS 106

Query: 355 RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL--------DKF- 404
                 F  E   + +   R + +L  + ++  ++L LV EY   G L        ++  
Sbjct: 107 C-----FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160

Query: 405 ----IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS 460
                FY        E+ +              A+D +H       +HRDIK  NI+LD 
Sbjct: 161 AEMARFY------LAEIVM--------------AIDSVH---RLGYVHRDIKPDNILLDR 197

Query: 461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIY-------A 513
             + RL DFG    ++ +      +    GTP Y++PE          T  Y       A
Sbjct: 198 CGHIRLADFGSCLKLRADGTVR--SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255

Query: 514 FGVLILEVACGRKP-GNQSEQNSYNNSIVHW 543
            GV   E+  G+ P    S   +Y   IVH+
Sbjct: 256 LGVFAYEMFYGQTPFYADSTAETYGK-IVHY 285

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 33/200 (16%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR 372
           +K    F  +   G+G FGTV  G  +     +A+K+V +  R   +E +  +  +  L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77

Query: 373 HRNLVKL--IGWCYERHDF-----LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
           H N+V+L    +     D       +V EY+P+ +L +                      
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ----------VAP 126

Query: 426 SVIHGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQEN 478
             I          +++  LH  S   V HRDIK  N++++      +L DFG A+ +  +
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 479 LKTHHSTKEIAGTPGYMAPE 498
                +   I  +  Y APE
Sbjct: 186 ---EPNVAYIC-SRYYRAPE 201

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 61/264 (23%), Positives = 103/264 (39%), Gaps = 55/264 (20%)

Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVY----KGIWRNKEI-AVK--RVSETSRQGKQE-F 361
           ++++L+    ++     +G+G FG V     K     +++ A+K     E  ++     F
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-----------DKFIFYDE 409
             E   +       +V+L  + ++   +L +V EYMP G L               FY  
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-- 173

Query: 410 TNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF 469
                 EV L              ALD +H       +HRD+K  N++LD   + +L DF
Sbjct: 174 ----TAEVVL--------------ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212

Query: 470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFL----VGRATIETDIYAFGVLILEVACGR 525
           G     + N +         GTP Y++PE        G    E D ++ GV + E+  G 
Sbjct: 213 GTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 526 KP-GNQSEQNSYNNSIVHWLWELR 548
            P    S   +Y+  I++    L 
Sbjct: 271 TPFYADSLVGTYSK-IMNHKNSLT 293

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 36/192 (18%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           +     +G G FG V++     + E+A+K+V     Q K+    E+  +  ++H N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97

Query: 380 IGWCY---ERHDFL---LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS- 432
             + Y   ++ D +   LV EY+P  ++ +   +                 + ++     
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT----------MPMLLIKLY 146

Query: 433 -----QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTK 486
                ++L Y+H+     + HRDIK  N++LD      +L DFG A+ +   +    +  
Sbjct: 147 MYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVS 200

Query: 487 EIAGTPGYMAPE 498
            I  +  Y APE
Sbjct: 201 YIC-SRYYRAPE 211

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 72/245 (29%), Positives = 101/245 (41%), Gaps = 52/245 (21%)

Query: 320 NFNPKNKLGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEF---IAEVTTIGSL 371
            F     LGKG FG V     K         A+K + +     K E    + E   + + 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205

Query: 372 RHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPGEVT 418
           RH  L  L  + ++ HD L  V EY   G L         F      FY        E+ 
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIV 258

Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
                          ALDYLH  SEK V++RD+K  N+MLD + + ++ DFGL +   E 
Sbjct: 259 S--------------ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EG 299

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYN 537
           +K   + K   GTP Y+APE           D +  GV++ E+ CGR P  NQ  +  + 
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

Query: 538 NSIVH 542
             I+ 
Sbjct: 360 L-ILM 363

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 59/235 (25%)

Query: 320 NFNPKNKLGKGGFGTVY---KGIWRN-----------KEIAVKRVSETSRQGKQEFIAEV 365
            F     LGKGG+G V+   K    N           K + V+   +T+        AE 
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-----KAER 72

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNS 412
             +  ++H  +V LI + ++    L L+ EY+  G L         F      FY     
Sbjct: 73  NILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY----- 126

Query: 413 GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA 472
              E+++              AL +LH   +K +++RD+K  NIML+ + + +L DFGL 
Sbjct: 127 -LAEISM--------------ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

Query: 473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +   E++     T    GT  YMAPE  +        D ++ G L+ ++  G  P
Sbjct: 169 K---ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 66/270 (24%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVY----KGIWR-------NKEIAVKRVSETS 354
           P   ++K+++    +F     +G+G FG V     K   +       NK   +KR +ET+
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETA 119

Query: 355 RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL--------DKF- 404
                 F  E   + +   + +  L  + ++  + L LV +Y   G L        D+  
Sbjct: 120 C-----FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173

Query: 405 ----IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS 460
                FY        E+ +              A+D +H       +HRDIK  NI++D 
Sbjct: 174 EEMARFY------LAEMVI--------------AIDSVHQ---LHYVHRDIKPDNILMDM 210

Query: 461 EFNARLGDFGLA-RTIQENLKTHHSTKEIAGTPGYMAPE-----SFLVGRATIETDIYAF 514
             + RL DFG   + +++       +    GTP Y++PE         GR   E D ++ 
Sbjct: 211 NGHIRLADFGSCLKLMEDGTVQ---SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 515 GVLILEVACGRKP-GNQSEQNSYNNSIVHW 543
           GV + E+  G  P   +S   +Y   I++ 
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGK-IMNH 296

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 35/223 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKG--IWRNKEI-AVKRVS-ETSRQGKQEF----IAEVTTIGSL 371
            +    ++G+G +G V+K   +       A+KRV  +T  +G        I EV  +  L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHL 68

Query: 372 R---HRNLVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
               H N+V+L                LV+E++    L  ++   +    PG   +  E 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPG---VPTET 121

Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK-TH 482
              ++    + LD+LH     RV+HRD+K  NI++ S    +L DFGLAR     +  T 
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                +  T  Y APE  L        D+++ G +  E+   +
Sbjct: 179 ----VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 46/193 (23%), Positives = 87/193 (45%), Gaps = 25/193 (12%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR 372
           +    ++     +G G FG VY+       + +A+K+V     Q K+    E+  +  L 
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 105

Query: 373 HRNLVKLIGWCY---ERHDFL---LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H N+V+L  + Y   E+ D +   LV +Y+P  ++ +       +     + + + K   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYVK--L 160

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHST 485
            ++   ++L Y+H+     + HRDIK  N++LD +    +L DFG A+ +        + 
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNV 214

Query: 486 KEIAGTPGYMAPE 498
             I  +  Y APE
Sbjct: 215 SYIC-SRYYRAPE 226

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 84.1 bits (209), Expect = 6e-18
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 49/229 (21%)

Query: 320 NFNPKNKLGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEF--IAEVTTIGSLR 372
            F     LG+G FG V+          +++ A+K + + + + +       E   +  + 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84

Query: 373 HRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKFI-----FYDETNSGPGEVTL 419
           H  +VKL  + ++    L L+ +++  G L         F      FY        E+ L
Sbjct: 85  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY------LAELAL 137

Query: 420 NWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENL 479
                         ALD+LH      +++RD+K  NI+LD E + +L DFGL++   E++
Sbjct: 138 --------------ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESI 177

Query: 480 KTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
                     GT  YMAPE  +  R  T   D ++FGVL+ E+  G  P
Sbjct: 178 DHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 58/247 (23%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVS------------------------- 351
             +  K+++GKG +G V        N   A+K +S                         
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 352 ETSRQGKQEFIA-EVTTIGSLRHRNLVKLIGWCYE------RHDFLLVYEYMPNGSLDKF 404
               +G  E +  E+  +  L H N+VKL     E           +V+E +  G +   
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV--- 125

Query: 405 IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA 464
              +     P            +I G    ++YLH    ++++HRDIK SN+++  + + 
Sbjct: 126 --MEVPTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHI 176

Query: 465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI---ETDIYAFGVLILEV 521
           ++ DFG++   + +     +T    GTP +MAPES    R        D++A GV  L  
Sbjct: 177 KIADFGVSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGV-TLYC 232

Query: 522 -ACGRKP 527
              G+ P
Sbjct: 233 FVFGQCP 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 61/260 (23%), Positives = 101/260 (38%), Gaps = 49/260 (18%)

Query: 287 RARELDDDIEGLINGTNLAPKKFRLKELKKAT-GNFNPKNKLGKGGFGTVY--KGIWRNK 343
           +  E +   E L        KK+       A    F+    LG G FG V   K      
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67

Query: 344 EIAVKRVSETS--RQGKQEFI-AEVTTIGSLRHRNLVKLIGWCYERHDFL-LVYEYMPNG 399
             A+K + +    +  + E    E   + ++    LVKL  + ++ +  L +V EY+  G
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGG 126

Query: 400 SL-------DKF-----IFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVL 447
            +        +F      FY        ++ L                +YLH      ++
Sbjct: 127 EMFSHLRRIGRFSEPHARFY------AAQIVL--------------TFEYLH---SLDLI 163

Query: 448 HRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI 507
           +RD+K  N+++D +   ++ DFG A+ ++        T  + GTP  +APE  L      
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNK 217

Query: 508 ETDIYAFGVLILEVACGRKP 527
             D +A GVLI E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 67/238 (28%), Positives = 97/238 (40%), Gaps = 53/238 (22%)

Query: 327 LGKGGFGTV----YKGIWRNKEI-AVKRVSETSRQGKQEF---IAEVTTIGSLRHRNLVK 378
           LGKG FG V     K         A+K + +     K E    + E   + + RH  L  
Sbjct: 13  LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 379 LIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPGEVTLNWEKRL 425
           L  + ++ HD L  V EY   G L         F      FY        E+        
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY------GAEIVS------ 116

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                   AL+YLH    + V++RDIK  N+MLD + + ++ DFGL +   E +    + 
Sbjct: 117 --------ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATM 162

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYNNSIVH 542
           K   GTP Y+APE           D +  GV++ E+ CGR P  NQ  +  +   I+ 
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILM 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG G FG V  G  +    ++AVK ++            I  E+  +   RH +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 382 WCYE----RHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
             Y+      DF +V EY+  G L D          G     +   +   +      A+D
Sbjct: 77  --YQVISTPTDFFMVMEYVSGGELFDYIC-----KHGR----VEEMEARRLFQQILSAVD 125

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHHSTKEIAGTPGY 494
           Y H      V+HRD+K  N++LD+  NA++ DFGL+  + +   L+T        G+P Y
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNY 176

Query: 495 MAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
            APE    GR  A  E DI++ GV++  + CG  P
Sbjct: 177 AAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLP 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 44/219 (20%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIGWC 383
           LG+G +G V   + R   + +AVK V         E I  E+     L H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70

Query: 384 YE----RHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKR------LSVIHGTS 432
           Y      +   L  EY   G L    F   E + G  E     + +      ++      
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPE----PDAQRFFHQLMA------ 116

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH--HSTKEIAG 490
             + YLH      + HRDIK  N++LD   N ++ DFGLA   + N +    +      G
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---CG 169

Query: 491 TPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
           T  Y+APE  L  R       D+++ G+++  +  G  P
Sbjct: 170 TLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 46/380 (12%), Positives = 96/380 (25%), Gaps = 103/380 (27%)

Query: 248 AFDGSDIGGDSKAFRVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTNLAPK 307
           AFD         +       LVP   +  G       RYR                    
Sbjct: 2   AFDALREPDRESSAPPDDVQLVPGARIANG-------RYRLLIF---------------- 38

Query: 308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSE---TSRQGKQEFI 362
                               G       ++      ++++A+  V           QE +
Sbjct: 39  -------------------HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL 79

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
           +    +  +    + +++   + R   L+V E++  GSL +     +T+  P        
Sbjct: 80  SRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGA----- 131

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
             +  +   + A D  H      V       S + +  + +  L                
Sbjct: 132 --IRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAY-------------- 172

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
                    P  M         A  + DI   G  +  +   R P     +    + +  
Sbjct: 173 ---------PATMPD-------ANPQDDIRGIGASLYALLVNRWPL---PEAGVRSGLAP 213

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS--MKTVLQVLSG 600
              +   +       D  +  + S         +       +  +R +  +  ++Q  + 
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQISA--------VAARSVQGDGGIRSASTLLNLMQQATA 265

Query: 601 EADPPVLPPERPSFVWPAMP 620
            AD   +          A P
Sbjct: 266 VADRTEVLGPIDEAPVSAAP 285

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 66/245 (26%)

Query: 327 LGKGGFGTV----YKGIWRNKEI-AVKRVSETSRQGKQEFIA--EVTTI--------GSL 371
           LGKG FG V    +K      +  A+K +       K   +   +V            + 
Sbjct: 25  LGKGSFGKVFLAEFKK---TNQFFAIKALK------KDVVLMDDDVECTMVEKRVLSLAW 75

Query: 372 RHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPGEVT 418
            H  L  +    ++  + L  V EY+  G L        KF      FY        E+ 
Sbjct: 76  EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEII 128

Query: 419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
           L               L +LH    K +++RD+K  NI+LD + + ++ DFG+ +   EN
Sbjct: 129 L--------------GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---EN 168

Query: 479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQNSYN 537
           +     T    GTP Y+APE  L  +     D ++FGVL+ E+  G+ P   Q E+  ++
Sbjct: 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

Query: 538 NSIVH 542
           + I  
Sbjct: 229 S-IRM 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 51/226 (22%)

Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIA----EVTTIGSLRHRNLVKLI 380
           LG+G +G V +          AVK + +   +      A    E+  +  LRH+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 381 GWCYE------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS-- 432
               +      +    +V EY   G  +     D             EKR  V       
Sbjct: 72  ---VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVP----------EKRFPVCQAHGYF 115

Query: 433 ----QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN-----LKTHH 483
                 L+YLH+   + ++H+DIK  N++L +    ++   G+A  +         +T  
Sbjct: 116 CQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-- 170

Query: 484 STKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
                 G+P +  PE        +  + DI++ GV +  +  G  P
Sbjct: 171 ----SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 46/220 (20%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIGWC 383
           LG+G +G V   + R   + +AVK V         E I  E+     L H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF---- 70

Query: 384 YE----RHDFLLVYEYMPNGSLDKFIF-YDETNSGPGEVTLNWEKR------LSVIHGTS 432
           Y      +   L  EY   G L    F   E + G  E     + +      ++      
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPE----PDAQRFFHQLMA------ 116

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH--HSTKEIAG 490
             + YLH      + HRDIK  N++LD   N ++ DFGLA   + N +    +      G
Sbjct: 117 -GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---CG 169

Query: 491 TPGYMAPESFLVGR--ATIETDIYAFGVLILEV-ACGRKP 527
           T  Y+APE     R       D+++ G+ +L     G  P
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGI-VLTAMLAGELP 207

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 74/249 (29%)

Query: 327 LGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLI 380
           LGKG FG V     K      ++ AVK +       K++ I +   +      + ++ L 
Sbjct: 31  LGKGSFGKVMLARVKE---TGDLYAVKVL-------KKDVILQDDDVECTMTEKRILSLA 80

Query: 381 GWCYERHDFL--------------LVYEYMPNGSL-------DKF-----IFYDETNSGP 414
                 H FL               V E++  G L        +F      FY       
Sbjct: 81  R----NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------A 130

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
            E+                AL +LH   +K +++RD+K  N++LD E + +L DFG+ + 
Sbjct: 131 AEIIS--------------ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK- 172

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP-GNQSEQ 533
             E +    +T    GTP Y+APE           D +A GVL+ E+ CG  P   ++E 
Sbjct: 173 --EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230

Query: 534 NSYNNSIVH 542
           + +   I++
Sbjct: 231 DLFEA-ILN 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 3e-16
 Identities = 67/236 (28%), Positives = 98/236 (41%), Gaps = 64/236 (27%)

Query: 320 NFNPKNKLGKGGFGTV----YKGIWRNKEI-AVKRVSETSRQGKQEFIA--EVTTI---- 368
           +FN    LGKG FG V     KG     E+ AVK +       K   I   +V       
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILK------KDVVIQDDDVECTMVEK 392

Query: 369 ----GSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETN 411
                  +   L +L   C++  D L  V EY+  G L        +F     +FY    
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY---- 447

Query: 412 SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL 471
               E+ +               L +L     K +++RD+K  N+MLDSE + ++ DFG+
Sbjct: 448 --AAEIAI--------------GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 488

Query: 472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +   EN+    +TK   GTP Y+APE           D +AFGVL+ E+  G+ P
Sbjct: 489 CK---ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 62/265 (23%), Positives = 104/265 (39%), Gaps = 54/265 (20%)

Query: 290 ELDDDIEGLINGTNLAPKKFRLKELKKAT-GNFNPKNKLGKGGFGTVY----KGIWRNKE 344
           +  D  E L+   +           +K    NF     LG G +G V+           +
Sbjct: 24  DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83

Query: 345 I-AVKRVSETSRQGKQEFI----AEVTTIGSLRHRN-LVKLIGWCYERHDFL-LVYEYMP 397
           + A+K + + +   K +       E   +  +R    LV L  + ++    L L+ +Y+ 
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYIN 142

Query: 398 NGSL-------DKFI-----FYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR 445
            G L       ++F       Y       GE+ L              AL++LH   +  
Sbjct: 143 GGELFTHLSQRERFTEHEVQIY------VGEIVL--------------ALEHLH---KLG 179

Query: 446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVGR 504
           +++RDIK  NI+LDS  +  L DFGL++   E +        +  GT  YMAP+    G 
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYDFCGTIEYMAPDIVRGGD 236

Query: 505 A--TIETDIYAFGVLILEVACGRKP 527
           +      D ++ GVL+ E+  G  P
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASP 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 60/232 (25%)

Query: 320 NFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFI---------AEVTTI 368
           +F     LG G FG V+  +     +  A+K +       K+  +          E   +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK------KEIVVRLKQVEHTNDERLML 60

Query: 369 GSLRHRNLVKLIGWCYERHDFL-LVYEYMPNGSL-------DKF-----IFYDETNSGPG 415
             + H  ++++    ++    + ++ +Y+  G L        +F      FY        
Sbjct: 61  SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AA 113

Query: 416 EVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
           EV L              AL+YLH    K +++RD+K  NI+LD   + ++ DFG A+ +
Sbjct: 114 EVCL--------------ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
            +       T  + GTP Y+APE           D ++FG+LI E+  G  P
Sbjct: 157 PD------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.2 bits (198), Expect = 4e-16
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 59/226 (26%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVK-----RVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
           LG G FG V  G       ++AVK     ++      GK     E+  +   RH +++KL
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81

Query: 380 IGWCYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS--------- 426
               Y+      D  +V EY+  G L  +I      +G          RL          
Sbjct: 82  ----YQVISTPSDIFMVMEYVSGGELFDYI----CKNG----------RLDEKESRRLFQ 123

Query: 427 -VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHH 483
            ++      +DY H      V+HRD+K  N++LD+  NA++ DFGL+  + +   L+T  
Sbjct: 124 QIL----SGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-- 174

Query: 484 STKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
                 G+P Y APE    GR  A  E DI++ GV++  + CG  P
Sbjct: 175 ----SCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLP 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 74/247 (29%)

Query: 327 LGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLI 380
           +G+G +  V     K       I A+K V       K+E + +   I  ++  +++ +  
Sbjct: 17  IGRGSYAKVLLVRLKK---TDRIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQA 66

Query: 381 GWCYERHDFL--------------LVYEYMPNGSL-------DKF-----IFYDETNSGP 414
                 H FL               V EY+  G L        K       FY       
Sbjct: 67  S----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------S 116

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
            E++L              AL+YLH   E+ +++RD+K  N++LDSE + +L D+G+ + 
Sbjct: 117 AEISL--------------ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK- 158

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSE 532
             E L+   +T    GTP Y+APE           D +A GVL+ E+  GR P     S 
Sbjct: 159 --EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216

Query: 533 QNSYNNS 539
            N   N+
Sbjct: 217 DNPDQNT 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.2 bits (196), Expect = 5e-16
 Identities = 62/233 (26%), Positives = 96/233 (41%), Gaps = 72/233 (30%)

Query: 327 LGKGGFGTV----YKGIWRNKEI-AVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLI 380
           LGKG FG V     KG     E+ AVK +       K++ + +   +      + ++ L 
Sbjct: 28  LGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALP 77

Query: 381 GWCYERHDFL--------------LVYEYMPNGSL-------DKF-----IFYDETNSGP 414
           G    +  FL               V EY+  G L        +F     +FY       
Sbjct: 78  G----KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------A 127

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
            E+ +               L +L     K +++RD+K  N+MLDSE + ++ DFG+ + 
Sbjct: 128 AEIAI--------------GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK- 169

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
             EN+    +TK   GTP Y+APE           D +AFGVL+ E+  G+ P
Sbjct: 170 --ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 62/247 (25%), Positives = 99/247 (40%), Gaps = 74/247 (29%)

Query: 327 LGKGGFGTVY----KGIWRNKEI-AVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLI 380
           +G+G +  V     K       I A++ V       K+E + +   I  ++  +++ +  
Sbjct: 60  IGRGSYAKVLLVRLKK---TDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQA 109

Query: 381 GWCYERHDFL--------------LVYEYMPNGSL-------DKF-----IFYDETNSGP 414
                 H FL               V EY+  G L        K       FY       
Sbjct: 110 S----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------S 159

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
            E++L              AL+YLH   E+ +++RD+K  N++LDSE + +L D+G+ + 
Sbjct: 160 AEISL--------------ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK- 201

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP--GNQSE 532
             E L+   +T    GTP Y+APE           D +A GVL+ E+  GR P     S 
Sbjct: 202 --EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259

Query: 533 QNSYNNS 539
            N   N+
Sbjct: 260 DNPDQNT 266

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           AL YLH      +++RD+K  NI+LDS+ +  L DFGL +   EN++ + +T    GTP 
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           Y+APE           D +  G ++ E+  G  P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 58/225 (25%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIA-EVTTIGSLRHRNLVKLIG 381
           LG+G FG V         +++A+K +S     +      +  E++ +  LRH +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 382 WCYE----RHDFLLVYEYMPNGSL-DKFIFYDETNSGPGEVTLNWEKRLS---------- 426
             Y+      D ++V EY   G L D                +  +KR++          
Sbjct: 75  --YDVITTPTDIVMVIEYA-GGELFDY---------------IVEKKRMTEDEGRRFFQQ 116

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN--LKTHHS 484
           +I     A++Y H     +++HRD+K  N++LD   N ++ DFGL+  + +   LKT   
Sbjct: 117 IIC----AIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--- 166

Query: 485 TKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKP 527
                G+P Y APE    G+  A  E D+++ G+++  +  GR P
Sbjct: 167 ---SCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 45/221 (20%), Positives = 89/221 (40%), Gaps = 40/221 (18%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNL 376
           ++    KLG+G +  V++ I    N+++ VK +       K++   E+  + +LR   N+
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 93

Query: 377 VKLIGWCYERHDF--LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS-- 432
           + L     +       LV+E++ N    +                   + L+        
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----------------QTLTDYDIRFYM 136

Query: 433 ----QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKE 487
               +ALDY H      ++HRD+K  N+M+D E    RL D+GLA               
Sbjct: 137 YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVR 190

Query: 488 IAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           +A +  +  PE  +  +      D+++ G ++  +   ++P
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 59/225 (26%)

Query: 327 LGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIA-EVTTIGSLRHRNLVKLIGWC 383
           +G G FG           + +AVK +         E +  E+    SLRH N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRF---- 81

Query: 384 YE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS----------VIH 429
            E         ++ EY   G L + I     N+G          R S          ++ 
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERI----CNAG----------RFSEDEARFFFQQLLS 127

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL--GDFGLARTIQEN--LKTHHST 485
                + Y H+    ++ HRD+K  N +LD     RL   DFG +++   +   K+    
Sbjct: 128 ----GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---- 176

Query: 486 KEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEV-ACGRKP 527
               GTP Y+APE  L  +       D+++ GV  L V   G  P
Sbjct: 177 --TVGTPAYIAPEVLL-RQEYDGKIADVWSCGV-TLYVMLVGAYP 217

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 51/260 (19%), Positives = 92/260 (35%), Gaps = 79/260 (30%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE----TSRQGKQEFIAEVTTIGSLRH 373
            ++    LG G FG V +       K  A+K+V +     +R        E+  +  L H
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDIMKVLDH 59

Query: 374 RNLVKLI-----------------------------------GWCYERHDFL---LVYEY 395
            N++KL+                                                ++ EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG---TSQ---ALDYLHNGSEKRVLHR 449
           +P+ +L K +     +             + +        Q   A+ ++H+     + HR
Sbjct: 120 VPD-TLHKVLKSFIRSGRS----------IPMNLISIYIYQLFRAVGFIHSL---GICHR 165

Query: 450 DIKSSNIMLDSEFNA-RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TI 507
           DIK  N++++S+ N  +L DFG A+ +  +     S   I  +  Y APE  L     T 
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYIC-SRFYRAPELMLGATEYTP 221

Query: 508 ETDIYAFGVLILEVACGRKP 527
             D+++ G +  E+    KP
Sbjct: 222 SIDLWSIGCVFGEL-ILGKP 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 50/231 (21%), Positives = 79/231 (34%), Gaps = 46/231 (19%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIA-----------EVTTI 368
           +  +  +  G +G V  G+      +A+KRV  T   G+   I            E+  +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 369 GSLRHRNLVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
               H N++ L            H   LV E M    L + I                  
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI---HDQRIV--------- 130

Query: 424 RLSVIHGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
            +S  H           L  LH      V+HRD+   NI+L    +  + DF LAR    
Sbjct: 131 -ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186

Query: 478 NLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
           +    + T  +     Y APE  +     T   D+++ G ++ E+   RK 
Sbjct: 187 D---ANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKA 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 31/199 (15%), Positives = 72/199 (36%), Gaps = 39/199 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA-----EVTTIGSLR 372
            +  ++ +G G +G V +   +   + +A+K++                  E+  +  L 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED---LIDCKRILREIAILNRLN 110

Query: 373 HRNLVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
           H ++VK++         +  +  +V E   +    K        +            L+ 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF-----RTP---------VYLTE 155

Query: 428 IHGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
           +H  +        + Y+H+     +LHRD+K +N +++ + + ++ DFGLART+      
Sbjct: 156 LHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 482 HHSTKEIAGTPGYMAPESF 500
           +                  
Sbjct: 213 NSQLPISPREDDMNLVTFP 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRN 375
           +     +G G  G V         + +A+K++S   +     K+ +  E+  +  + H+N
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 85

Query: 376 LVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
           ++ L+          E  D  +V E M   +L + I                +  L    
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----------------QMELDHER 128

Query: 430 GTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            +         + +LH+     ++HRD+K SNI++ S+   ++ DFGLART   +     
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 182

Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
            T  +  T  Y APE  L        DI++ G ++ E+  G 
Sbjct: 183 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 42/222 (18%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRN 375
           +     +G G  G V        ++ +A+K++S   +     K+ +  E+  +  + H+N
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 122

Query: 376 LVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
           ++ L+          E  D  LV E M   +L + I                +  L    
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI----------------QMELDHER 165

Query: 430 G---TSQ---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
                 Q    + +LH+     ++HRD+K SNI++ S+   ++ DFGLART   +     
Sbjct: 166 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 219

Query: 484 STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
            T  +  T  Y APE  L        DI++ G ++ E+   +
Sbjct: 220 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 46/226 (20%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHR 374
            +     +G G +G+V   I +   +++A+K++S   ++    K+ +  E+  +  ++H 
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHE 83

Query: 375 NLVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           N++ L+            +DF LV  +M    L K +                  + S  
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----------------GLKFSEE 126

Query: 429 HGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
                     + L Y+H+     V+HRD+K  N+ ++ +   ++ DFGLAR     +   
Sbjct: 127 KIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180

Query: 483 HSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
             T  +  T  Y APE  L         DI++ G ++ E+    K 
Sbjct: 181 --TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKT 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 44/231 (19%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +     LG GG G V+  +    +K +A+K++  T  Q  +  + E+  I  L H N+VK
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 379 LI--------------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR 424
           +               G   E +   +V EYM    L   +       GP          
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-----EQGP---------- 116

Query: 425 LSVIHGTS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTIQE 477
           L   H         + L Y+H+ +   VLHRD+K +N+ +++E    ++GDFGLAR +  
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 478 NLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP 527
           +        E   T  Y +P   L     T   D++A G +  E+    K 
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKT 223

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 70.3 bits (171), Expect = 2e-13
 Identities = 40/264 (15%), Positives = 87/264 (32%), Gaps = 44/264 (16%)

Query: 4   SLMAKFLILAILMGSAAHIQVSSLHFNF---QSFTEQNRNELSF----DNSTVAKSAIQV 56
             M          G+ A +      + +        Q+   + F     N+  +   I++
Sbjct: 7   DGMGGDAAAPGAAGTQAELPHRRFEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRI 66

Query: 57  TYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAG 116
              ++     +Q G         +W   K     +       +  +     +GLA     
Sbjct: 67  APSLK-----SQRGS--------VWTKTKAAFENWEVEVTFRVTGRGRIGADGLAIWYTE 113

Query: 117 NKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQD--------INDNHVGLDV 168
           N+ L     G        + NG      V I FD+  +  +          N+  +  D 
Sbjct: 114 NQGLDGPVFGS-----ADMWNG------VGIFFDSFDNDGKKNNPAIVVVGNNGQINYDH 162

Query: 169 NSVYSIRQVPLTRVNLAN-GTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSE----YL 223
            +  + + +   + +  N    ++ ++ Y  + +TV + N  TP  ++    ++     +
Sbjct: 163 QNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVI 222

Query: 224 PEKVFVGFSASTGDDTQLNCVKSW 247
           P +   G SA+TG     + V S+
Sbjct: 223 PTQGHFGISAATGGLADDHDVLSF 246

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 35/194 (18%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRN 375
            +   + +G+G +G V           +A+K++S  E     ++    E+  +   RH N
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHEN 86

Query: 376 LVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
           ++ +          +  D  +V + M    L K +      +            LS  H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL-----KTQH----------LSNDHI 130

Query: 431 TS------QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS 484
                   + L Y+H+ +   VLHRD+K SN++L++  + ++ DFGLAR    +      
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 485 TKEIAGTPGYMAPE 498
             E   T  Y APE
Sbjct: 188 LTEYVATRWYRAPE 201

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 48/222 (21%), Positives = 93/222 (41%), Gaps = 33/222 (14%)

Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
              +     +G G +G V   +      ++A+K++    ++    K+ +  E+  +  +R
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMR 82

Query: 373 HRNLVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           H N++ L+          +  DF LV  +M    L K +             L  ++   
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHEK----LGEDRIQF 132

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTK 486
           +++   + L Y+H      ++HRD+K  N+ ++ +   ++ DFGLAR     +     T 
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TG 184

Query: 487 EIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
            +  T  Y APE  L   R T   DI++ G ++ E+    K 
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKT 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 39/198 (19%), Positives = 79/198 (39%), Gaps = 39/198 (19%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHR 374
           N+  K+ +G+G +G VY    +   K +A+K+V+   E     K+    E+T +  L+  
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSD 85

Query: 375 NLVKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
            +++L          +  +  +V E   +  L K        +            L+  H
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF-----KTP---------IFLTEEH 130

Query: 430 GTSQ--------ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
              +          +++H      ++HRD+K +N +L+ + + ++ DFGLARTI     T
Sbjct: 131 --IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 482 HHSTKEIAGTPGYMAPES 499
           +               ++
Sbjct: 186 NIVNDLEENEEPGPHNKN 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 38/166 (22%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLI 380
              LG G  G V +   +   ++ A+K + +  +  +     EV       +  ++V+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 77

Query: 381 GWCYE-----RHDFLLVYEYMPNGSL-DKFI-----FYDETNSGPGEVTLNWEKRLSVIH 429
              YE     R   L+V E +  G L  +        + E  +              ++ 
Sbjct: 78  DV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------EIMK 124

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NA--RLGDFGLA 472
              +A+ YLH      + HRD+K  N++  S+  NA  +L DFG A
Sbjct: 125 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 60.2 bits (146), Expect = 4e-12
 Identities = 16/40 (40%), Positives = 26/40 (65%)

Query: 210 TPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           +  LS+ + L + +PE V +GFSA+TG +   + V SW+F
Sbjct: 3   SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 42

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 45/202 (22%), Positives = 81/202 (40%), Gaps = 46/202 (22%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNL 376
           F  K+ LG+G +G V     +   + +A+K++   +      +    E+  +   +H N+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENI 71

Query: 377 VKLI-----GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           + +            ++  ++ E M    L + I      S          + LS  H  
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI------ST---------QMLSDDH-- 113

Query: 432 SQ--------ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH 483
            Q        A+  LH  +   V+HRD+K SN++++S  + ++ DFGLAR I E+   + 
Sbjct: 114 IQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 484 STKEIAG-------TPGYMAPE 498
                         T  Y APE
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPE 192

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 1e-11
 Identities = 38/257 (14%), Positives = 70/257 (27%), Gaps = 75/257 (29%)

Query: 317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRV---SETSRQGKQ-----EFIAEVTTI 368
            T       K+G+G FG V++ I  +  +A+K +         G       E + E+   
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 369 GSL---------RHRNLVKLIGWC------------------------------YERHDF 389
             L         R    + L                                  ++    
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 390 LLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLH 448
            +V E+   G  L++                +     S++H  + +L         R  H
Sbjct: 138 FIVLEFEFGGIDLEQMR----------TKLSSLATAKSILHQLTASLAVAEA--SLRFEH 185

Query: 449 RDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHH----------STKEIAGTPGYM--- 495
           RD+   N++L      +L      ++    + +            S  E  G   +    
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSS--TIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 496 APESFLVGRATIETDIY 512
             E    G    + DIY
Sbjct: 244 MDEDLFTGDGDYQFDIY 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 33/219 (15%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLRHRN 375
           +   + +G G +G+V           +AVK++S   ++    K+ +  E+  +  ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89

Query: 376 LVKLI------GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
           ++ L+          E +D  LV   M    L+  +             L  +    +I+
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-----KCQK----LTDDHVQFLIY 139

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
              + L Y+H+     ++HRD+K SN+ ++ +   ++ DFGLAR   + +     T  +A
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVA 191

Query: 490 GTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKP 527
            T  Y APE  L         DI++ G ++ E+    + 
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRT 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 47/238 (19%), Positives = 88/238 (36%), Gaps = 41/238 (17%)

Query: 326 KLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR----------- 372
           KLG G F TV+    +  N  +A+K V       +     E+  +  +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMG 84

Query: 373 HRNLVKLIGWCYERHDFL----LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
             +++KL+     +        +V+E +   +L   I         G + L + K++S  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK---YEHRG-IPLIYVKQIS-- 137

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE------FNARLGDFGLARTIQENLKTH 482
                 LDY+H      ++H DIK  N++++           ++ D G A    E+    
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK--PGNQSEQNSYNN 538
             T+E      Y +PE  L        DI++   LI E+  G      ++    + ++
Sbjct: 196 IQTRE------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 60.7 bits (146), Expect = 2e-10
 Identities = 34/227 (14%), Positives = 72/227 (31%), Gaps = 28/227 (12%)

Query: 63  APITNQSGRAIYKDQFQ---LWRDNKNVKATFSTTFVLNI--LNQTAQPGEGLAFVIAGN 117
             +T+Q  R    ++ +   +W         +       +    +    G+G+A     +
Sbjct: 33  TILTSQYVRLTPDERSKEGSIWNHQPCFLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRD 92

Query: 118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQD----------INDNHVGLD 167
           +            +   +    +    +AI  DT  + E            +N+  +  D
Sbjct: 93  R-----------LVPGPVFGSKDNFHGLAIFLDTYPNDETTERVFPYISVMVNNGSLSYD 141

Query: 168 VNSVYSIRQVPLTRVNLAN-GTDIKVQVRYDGQNITVFVANMETPLLSEPIDLSE-YLPE 225
            +      ++     +  N   D  + VRY    +TV     +       ID++   LP 
Sbjct: 142 HSKDGRWTELAGCTADFRNRDHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDITGVRLPT 201

Query: 226 KVFVGFSASTGDDTQLNCVKSWAFDGSDIGGDSKAFRVLIAVLVPAV 272
             + G SA TGD +  + + S       +        +    + P+V
Sbjct: 202 GYYFGASAGTGDLSDNHDIISMKLFQLMVEHTPDEENIDWTKIEPSV 248

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 66/374 (17%), Positives = 115/374 (30%), Gaps = 113/374 (30%)

Query: 318 TGNFNPKNKLGKGGFGTVY--KGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN 375
            G ++   KLG G F TV+    I   K +A+K V +++    +  + E+  + S+R+ +
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 376 LVKLIGWCYERH---DFL----------LVYEYMPNG-SLDKFIFYDETNSGPGEVTLNW 421
                          DF           +V+E +  G  L K+I      S    + L  
Sbjct: 95  -PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI----IKSNYQGLPLPC 147

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-------------------- 461
            K+  +I    Q LDYLH  ++ R++H DIK  NI+L                       
Sbjct: 148 VKK--IIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203

Query: 462 -----------------------------FNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
                                           ++ D G A  + +    H +  E   T 
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFT--EDIQTR 257

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH---------- 542
            Y + E  +        DI++   +  E+A G           Y     H          
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317

Query: 543 ----WL--WELRRK-----GRILDAADSRLGG---------EFSEKEMECVLILGLACCH 582
                +   +  ++     G +      +  G         E+S++E        L    
Sbjct: 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377

Query: 583 PNPHLRPSMKTVLQ 596
             P  R +    L+
Sbjct: 378 LIPEKRATAAECLR 391

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 52/202 (25%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE----------TSRQGKQEFIAEVTTI 368
           +    KLGKG +G V+K I R   + +AVK++ +          T R        E+  +
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR--------EIMIL 62

Query: 369 GSLR-HRNLVKLIGWCY--ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
             L  H N+V L+         D  LV++YM    L   I      +            L
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI-----RANI----------L 106

Query: 426 SVIHGTSQ--------ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE 477
             +H   Q         + YLH+G    +LHRD+K SNI+L++E + ++ DFGL+R+   
Sbjct: 107 EPVH--KQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 478 NLKTHHSTKEIAGTPGYMAPES 499
             +  ++             + 
Sbjct: 162 IRRVTNNIPLSINENTENFDDD 183

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 32/216 (14%), Positives = 72/216 (33%), Gaps = 61/216 (28%)

Query: 319 GNFNPKNKLGKGGFGTVYKGI----------WRNKEIAVKRVSETS----------RQGK 358
             +  K+   +   G +Y+             + ++ ++K  ++            R  K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 359 QEFIAEVTTIGSLRHRNLVKLIGWCYERHDF-LLVYEYMPNG-SLDKFIFYDETNSGPGE 416
              + +   + S     +   +G+   +  +  LV   +  G SL   +           
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL----------- 148

Query: 417 VTLNWEKRLS---VIHGTSQALD---YLHNGSEKRVLHRDIKSSNIMLDSEFNAR--LGD 468
             ++ +  LS   V+    + LD   +LH   E   +H ++ + NI +D E  ++  L  
Sbjct: 149 -DVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAG 204

Query: 469 FGLAR---------TIQENLKTHHSTKEIAGTPGYM 495
           +G A             E  ++ H      G   ++
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHE-----GDLEFI 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 40/197 (20%), Positives = 78/197 (39%), Gaps = 41/197 (20%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            ++    ++G+G FG +++G  +  N+++A+K   E  R    +   E  T   L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 377 VKLIGWCYERHDF-LLVYEYMPNG-SL-DKFIFYDETNSGPGEVTLNWEKRLS---VIHG 430
           +  + +  +     +LV + +  G SL D                    ++ S   V   
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG--------------RKFSVKTVAMA 111

Query: 431 TSQALD---YLHNGSEKRVLHRDIKSSNIMLDSEFNAR-----LGDFGLARTIQENLKTH 482
             Q L     +H   EK +++RDIK  N ++    +       + DFG+ +  ++ +   
Sbjct: 112 AKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168

Query: 483 H----STKEIAGTPGYM 495
           H      K ++GT  YM
Sbjct: 169 HIPYREKKNLSGTARYM 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 39/203 (19%), Positives = 68/203 (33%), Gaps = 52/203 (25%)

Query: 326 KLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEF--------IAEVTTIGSLRHRN 375
           K+G GGFG +Y      + ++ A   V    ++    F        +A+   I     R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 376 LVKLIG-----WC----YERHDF-LLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKR 424
            +  +G           ++   +  +V E +  G  L K                     
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI--------------SGQNGT 147

Query: 425 LS---VIHGTSQALD---YLHNGSEKRVLHRDIKSSNIMLDSEFNAR--LGDFGLARTIQ 476
                V+    + LD   Y+H   E   +H DIK++N++L  +   +  L D+GL+    
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204

Query: 477 ENLKTHH----STKEIAGTPGYM 495
            N           K   GT  + 
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFT 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 47/229 (20%), Positives = 80/229 (34%), Gaps = 65/229 (28%)

Query: 302 TNLAPKKFRLKELKKATGNFNPKNKLGKGGFGTVYKG-------IWRNKEIAVKRVSETS 354
           T++A   +++               +G+GGFG +Y         +  +    VK     +
Sbjct: 30  TDMAAAAWKVGL------------PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN 77

Query: 355 RQGKQEF-----IAEVTTIGSLRHRNLVKLIG----WCYERHDF------LLVYEYMPNG 399
                E       A+   I        +K +G    W    HD        ++ +    G
Sbjct: 78  GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--G 135

Query: 400 -SLDKFIFYDETNSGPGEVTLNWEKRLS---VIHGTSQALD---YLHNGSEKRVLHRDIK 452
             L K   Y+              KR S   V+  + + LD   Y+H   E   +H DIK
Sbjct: 136 SDLQKI--YEANA-----------KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIK 179

Query: 453 SSNIMLDSEFNAR--LGDFGLA-RTIQENLKTH---HSTKEIAGTPGYM 495
           +SN++L+ +   +  L D+GLA R   E +         +   GT  + 
Sbjct: 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 45/218 (20%)

Query: 327 LGKGGFGTVYKGI--WRNKEIAVK---RVSETSRQGKQEFIAEVTTIGSLRH-------- 373
           +GKG FG V K      ++ +A+K         RQ  +E       I  L H        
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-------IRILEHLRKQDKDN 157

Query: 374 -RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
             N++ ++     R+   + +E +   S++ +    +       + L       V     
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPL-------VRKFAH 207

Query: 433 Q---ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA--RLGDFGLARTIQENLKTHHSTKE 487
                LD LH   + R++H D+K  NI+L  +  +  ++ DFG +    + + T+  ++ 
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                 Y APE  L  R  +  D+++ G ++ E+  G 
Sbjct: 265 ------YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 25/188 (13%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
             +    K+G G FG +Y G  I   +E+A+K   E  +    +   E      ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVG 66

Query: 377 VKLIGWCYERHDF-LLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +  I WC    D+ ++V E +  G SL+        N    + +L      +V+    Q 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL--GPSLEDLF-----NFCSRKFSLK-----TVLLLADQM 114

Query: 435 LDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGLARTIQENLKTHH----STKE 487
           +  +     K  +HRD+K  N ++          + DFGLA+  ++     H      K 
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174

Query: 488 IAGTPGYM 495
           + GT  Y 
Sbjct: 175 LTGTARYA 182

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 45/197 (22%), Positives = 76/197 (38%), Gaps = 41/197 (20%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            NF    K+G G FG +  G  ++ N+ +A+K   E  +    +   E      L   + 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 377 VKLIGWCYERHDF-LLVYEYMPNG-SL-DKFIFYDETNSGPGEVTLNWEKRLS---VIHG 430
           +  + +      +  +V E +  G SL D F   D              +  S   V+  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD--------------RTFSLKTVLMI 110

Query: 431 TSQALD---YLHNGSEKRVLHRDIKSSNIMLDSEFNAR-----LGDFGLART-IQENLKT 481
             Q +    Y+H+   K +++RD+K  N ++    N       + DF LA+  I    K 
Sbjct: 111 AIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167

Query: 482 HHSTKE---IAGTPGYM 495
           H   +E   + GT  YM
Sbjct: 168 HIPYREHKSLTGTARYM 184

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 37/217 (17%)

Query: 325 NKLGKGGFGTVYKGIW--RNKEIAVK---RVSETSRQGKQEFIAEVTTIGSLRH------ 373
           + +GKG FG V K       + +A+K          Q + E       +  L        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-------VRLLELMNKHDT 112

Query: 374 ---RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
                +V L      R+   LV+E +   S + +     TN     V+LN  ++ +    
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRG--VSLNLTRKFA--QQ 165

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA--RLGDFGLARTIQENLKTHHSTKEI 488
              AL +L    E  ++H D+K  NI+L +   +  ++ DFG +  + + +  +  ++  
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
                Y +PE  L     +  D+++ G +++E+  G 
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 31/191 (16%)

Query: 319 GNFNPKNKLGKGGFGTVYKG--IWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
             F    K+G G FG +Y G  I  N+E+A+K   E  +    + + E      L+    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTG 64

Query: 377 VKLIGWCYERHDF-LLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           +  + W     D+ +LV + +  G SL+        N    +++L      +V+    Q 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL--GPSLEDLF-----NFCSRKLSLK-----TVLMLADQM 112

Query: 435 LD---YLHNGSEKRVLHRDIKSSNIMLDSEFNAR---LGDFGLARTIQENLKTHH----S 484
           ++   ++H    K  LHRDIK  N ++     A    + DFGLA+  ++     H     
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 485 TKEIAGTPGYM 495
            K + GT  Y 
Sbjct: 170 NKNLTGTARYA 180

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 5e-05
 Identities = 72/473 (15%), Positives = 132/473 (27%), Gaps = 130/473 (27%)

Query: 31  FQSFTEQNRNELSFD------NSTVAK---SAIQVTYDVRGAPITNQS-----GRAIYKD 76
             S    +     F          V K     +++ Y    +PI  +         +Y +
Sbjct: 55  IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114

Query: 77  QF-QLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGI 135
           Q  +L+ DN+     F+   V        QP   L       + L E    + + +++G+
Sbjct: 115 QRDRLYNDNQ----VFAKYNV-----SRLQPYLKL------RQALLELRPAKNV-LIDGV 158

Query: 136 TNGTNQSQIVAIEFDTKKSYE-QDINDNHVG-LDVNSVYSIRQVPLTRVNLANGTDIKVQ 193
             G+ ++ +     D   SY+ Q   D  +  L++ +  S   V      L    D    
Sbjct: 159 L-GSGKTWVAL---DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214

Query: 194 VRYDGQNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC------VKSW 247
            R D        +N++  + S   +L   L  K +             NC      V   
Sbjct: 215 SRSDHS------SNIKLRIHSIQAELRRLLKSKPYE------------NCLLVLLNV--Q 254

Query: 248 AFDGSDIGGDSKAF----RVLIAVLVPAVVLLAGVAFYCWRRYRARELDDDIEGLINGTN 303
             +         AF    ++L+      V      A           LD     L     
Sbjct: 255 --NAKAW----NAFNLSCKILLTTRFKQVTDFLSAA-----TTTHISLDHHSMTLTPDEV 303

Query: 304 ---LAPKKF---RLKELKKATGNFNPKNKLGKGGFGTVYK---GIWRN-KEIAVKRVSET 353
              L   K+   R ++L +     NP             +     W N K +   +++  
Sbjct: 304 KSLLL--KYLDCRPQDLPREVLTTNP---RRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 354 SRQGKQEFIAEVTTIGSLRHR--NL------VKL------IGWCY-ERHDFLLVYEYMPN 398
                +  +  +      R     L        +      + W    + D ++V   +  
Sbjct: 359 I----ESSLNVLEP-AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413

Query: 399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI 451
            SL               V    ++    I      L+       +  LHR I
Sbjct: 414 YSL---------------VEKQPKESTISIPS--IYLELKVKLENEYALHRSI 449

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 Length = 256

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 26/198 (13%), Positives = 59/198 (29%), Gaps = 31/198 (15%)

Query: 52  SAIQVTYDVRGAPITNQSGRAIYKDQFQLW-RDNKNVKATFSTTFVLNILNQTAQPGEGL 110
            A      +      N  G         LW +   ++K +F+  +    +  + Q   G+
Sbjct: 38  QASLEEGRIVLTSNQNSKG--------SLWLKQGFDLKDSFTMEWTFRSVGYSGQTDGGI 89

Query: 111 AFVIAGNKDLPE-----NSEGQWLGIVNGI-TNGTNQSQIVAIEFDTKKSYEQDINDNHV 164
           +F    + ++P      N    + G+   +  NG     +     D +K  ++    +  
Sbjct: 90  SFWFVQDSNIPRDKQLYNGPVNYDGLQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQS 149

Query: 165 GLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANM--ETPLLSEPIDLSEY 222
                  Y    VP             ++V YD ++  +    +  +    +  +     
Sbjct: 150 FASCLMGYQDSSVP-----------STIRVTYDLEDDNLLKVQVDNKVCFQTRKVRFP-- 196

Query: 223 LPEKVFVGFSASTGDDTQ 240
                 +G +A  G    
Sbjct: 197 -SGSYRIGVTAQNGAVNN 213

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A Length = 222

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 26/198 (13%), Positives = 59/198 (29%), Gaps = 31/198 (15%)

Query: 52  SAIQVTYDVRGAPITNQSGRAIYKDQFQLW-RDNKNVKATFSTTFVLNILNQTAQPGEGL 110
            A      +      N  G         LW +   ++K +F+  +    +  + Q   G+
Sbjct: 31  QASLEEGRIVLTSNQNSKG--------SLWLKQGFDLKDSFTMEWTFRSVGYSGQTDGGI 82

Query: 111 AFVIAGNKDLPE-----NSEGQWLGIVNGI-TNGTNQSQIVAIEFDTKKSYEQDINDNHV 164
           +F    + ++P      N    + G+   +  NG     +     D +K  ++    +  
Sbjct: 83  SFWFVQDSNIPRDKQLYNGPVNYDGLQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQS 142

Query: 165 GLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFVANM--ETPLLSEPIDLSEY 222
                  Y    VP             ++V YD ++  +    +  +    +  +     
Sbjct: 143 FASCLMGYQDSSVP-----------STIRVTYDLEDDNLLKVQVDNKVCFQTRKVRFP-- 189

Query: 223 LPEKVFVGFSASTGDDTQ 240
                 +G +A  G    
Sbjct: 190 -SGSYRIGVTAQNGAVNN 206

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	644
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.98
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.98
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.96
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.54
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	98.98
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.93
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.36
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.81
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.69
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.46
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.09
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.93
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.93
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.8
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.67
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.29
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.91
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.81
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.58
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.94
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.04

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=1.3e-61  Score=486.77  Aligned_cols=225  Identities=32%  Similarity=0.563  Sum_probs=200.5

Q ss_pred             cccceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEe
Q 006446           23 QVSSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNIL  100 (644)
Q Consensus        23 ~~~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~  100 (644)
                      .+.+++|+|++|..   .+|.++ ||.+.+|.|+||+++. +.+..+++|||+|++||+|||++||+++||+|+|+|.|.
T Consensus        23 sa~~~sF~f~~F~~---~nL~l~GdA~i~~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFsF~I~   99 (281)
T 3ujo_A           23 SANLISFTFKKFNE---TNLILQRDATVSSGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFTFNLQ   99 (281)
T ss_dssp             -CEEEEEEESSCCS---TTEEECSSCCCBTTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEEEECC
T ss_pred             cCCcceEEcCCCCc---cCEEEecceEEeCCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEEEEEe
Confidence            34689999999974   489999 9999999999999875 234456999999999999999999999999999999999


Q ss_pred             c-CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecC
Q 006446          101 N-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       101 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                      + +...+||||||||+|....|. +.||||||+|.+++ +++||+|||||||++|.+|||++|||||||||+.|.++.+|
T Consensus       100 ~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~Dp~~nHVGIDvNSi~S~~t~~~  177 (281)
T 3ujo_A          100 APNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGWDPTERHIGIDVNSIKSIKTTSW  177 (281)
T ss_dssp             CSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSSCCSSSEEEEEESSSCCSCEEEC
T ss_pred             cCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEeccccccCCCCCCeEEEEcCCCCccccccc
Confidence            7 567799999999999766554 78999999998776 77899999999999998899999999999999999999888


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCC---cccccccccccccC
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDG  251 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~s  251 (644)
                         .+.+|+.++|||+||+  ++|+|++..   +.+|+|++.+||+++|||+|||||||+||.   ..+.|+|++|+|++
T Consensus       178 ---~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~IlsWSFss  254 (281)
T 3ujo_A          178 ---DFANGENAEVLITYDSSTNLLVASLVHPSQKTSFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSFAS  254 (281)
T ss_dssp             ---CCCSSCCEEEEEEECTTTCEEEEEEECTTTCCCEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEEEEEEE
T ss_pred             ---cccCCCEEEEEEEEeCCCCEEEEEEecCCCCCCceEEEEechHHhccCcEEEEEEeecCCCCcccceeEEEEEEEEE
Confidence               4679999999999999  888999853   446799999999999999999999999996   58999999999998


Q ss_pred             CccC
Q 006446          252 SDIG  255 (644)
Q Consensus       252 s~~~  255 (644)
                      +...
T Consensus       255 ~l~~  258 (281)
T 3ujo_A          255 KLSI  258 (281)
T ss_dssp             EECS
T ss_pred             EcCC
Confidence            7653

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=1.8e-60  Score=474.86  Aligned_cols=228  Identities=33%  Similarity=0.538  Sum_probs=203.7

Q ss_pred             cccceeEEcCCCCCCCCCCeEEe-cccc-cCCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEE
Q 006446           23 QVSSLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNI   99 (644)
Q Consensus        23 ~~~~~~f~f~~f~~~~~~~l~~~-~a~~-~~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i   99 (644)
                      .+.+++|+|++|.+. ..+|.++ ||.+ .+|.|+||+++. +.+..+++|||+|++||+|||++||+++||+|+|+|.|
T Consensus         8 sa~~~sF~f~~F~~~-~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F~I   86 (261)
T 3zyr_A            8 STDSLSFSFINFDRD-ERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSFFL   86 (261)
T ss_dssp             CCEEEEEEESSCCSC-CTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEEEE
T ss_pred             cCcccEEEcCCCCCC-CCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEEEE
Confidence            346899999999854 4589999 9999 589999999864 33455799999999999999999999999999999999


Q ss_pred             ecCCCCCCCceEEEEecCCC-CCCCCCCcccccccccCCCC-CCccEEEEEEecC---CCccCCCCCCceeeecCCccce
Q 006446          100 LNQTAQPGEGLAFVIAGNKD-LPENSEGQWLGIVNGITNGT-NQSQIVAIEFDTK---KSYEQDINDNHVGLDVNSVYSI  174 (644)
Q Consensus       100 ~~~~~~~g~G~aF~l~~~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~~aVEfDt~---~n~~~d~~~~Hvgid~ns~~s~  174 (644)
                      .+....+||||||||+|... +|.++.||||||+|.+++++ +.||+|||||||+   +|.+|||++|||||||||+.|.
T Consensus        87 ~~~~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~Dp~~nHVGIdvNsi~S~  166 (261)
T 3zyr_A           87 SSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSS  166 (261)
T ss_dssp             ECSSSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCS
T ss_pred             ecCCCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCCCCCCCeEEEEcCCCCcc
Confidence            97666789999999999654 58889999999999887754 5689999999999   9988999999999999999999


Q ss_pred             eeecCcccccCCCceEEEEEEEcC--ceEEEEEecC--CCCCcccccCccCcCCCceeeeecccCCCccccccccccccc
Q 006446          175 RQVPLTRVNLANGTDIKVQVRYDG--QNITVFVANM--ETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFD  250 (644)
Q Consensus       175 ~~~~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~~--~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~  250 (644)
                      ++.+|   .+.+|+.++|||+||+  ++|+|++..+  .+|+|++.+||+++|||+|||||||+||...+.|+|++|+|+
T Consensus       167 ~s~~~---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~  243 (261)
T 3zyr_A          167 KVVRW---ERREGKTLNVLVTYNPSTRTIDVVATYPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFT  243 (261)
T ss_dssp             EEEEC---CCCTTCCEEEEEEEETTTTEEEEEEECTTCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEE
T ss_pred             ccccc---cccCCceEEEEEEEcCCCCEEEEEEEcCCCCCeEEEEEechHHhCcCcEEEEEEecCCCccceEEEEEEEEE
Confidence            99888   4679999999999999  8899998633  367999999999999999999999999999999999999999


Q ss_pred             CCcc
Q 006446          251 GSDI  254 (644)
Q Consensus       251 ss~~  254 (644)
                      ++..
T Consensus       244 s~l~  247 (261)
T 3zyr_A          244 STLL  247 (261)
T ss_dssp             EEEC
T ss_pred             EEcC
Confidence            8764

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=8.8e-60  Score=468.59  Aligned_cols=225  Identities=32%  Similarity=0.514  Sum_probs=200.7

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccc-cCCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~-~~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|.+. ..+|.++ ||.+ .+|.|+||++... .+..+++|||+|++||+|||++||+++||+|+|+|.|.+
T Consensus         2 ~~~sF~f~~F~~~-~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~   80 (251)
T 3ipv_A            2 EETSFVFSKFKPL-EPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYA   80 (251)
T ss_dssp             EEEEEEESSCCSS-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred             cceEEEeCCCCCC-CCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeC
Confidence            4689999999854 4589999 9999 5899999998652 344569999999999999999999999999999999997


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecC
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                       +...+||||||||+|....|. +.||||||+|.+++ ++.||+|||||||++|.+| ||++|||||||||+.|.++.+|
T Consensus        81 ~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~~  158 (251)
T 3ipv_A           81 PNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW  158 (251)
T ss_dssp             SSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCccccccee
Confidence             567789999999999766555 67999999998776 7789999999999999899 9999999999999999999887


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEecC---CCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccC
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVANM---ETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDG  251 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~~---~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~s  251 (644)
                         .+.+|+.++|||+||+  ++|+|++..+   ..|+|++.+||+++|||+|||||||+||..   .+.|+|++|+|++
T Consensus       159 ---~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF~s  235 (251)
T 3ipv_A          159 ---SLANGEAAKVLITYNSAVKLLVASLVYPSSKTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSFAS  235 (251)
T ss_dssp             ---CCCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEE
T ss_pred             ---EecCCCEEEEEEEEeCCCCEEEEEEecCCCCccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEEEE
Confidence               4789999999999999  7899998643   356999999999999999999999999998   8999999999998


Q ss_pred             CccC
Q 006446          252 SDIG  255 (644)
Q Consensus       252 s~~~  255 (644)
                      +...
T Consensus       236 ~l~~  239 (251)
T 3ipv_A          236 KLAG  239 (251)
T ss_dssp             EECC
T ss_pred             ECCC
Confidence            7643

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=7e-59  Score=461.59  Aligned_cols=223  Identities=31%  Similarity=0.515  Sum_probs=198.9

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|... ..+|.++ ||.+. +|.|+||++..+.+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+ 
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~   80 (239)
T 1dbn_A            2 DELSFTINNFVPN-EADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP   80 (239)
T ss_dssp             CEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cceEEEcCCCCCC-CCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence            4689999999864 4589999 99995 899999987632334479999999999999999999999999999999997 


Q ss_pred             CCCCCCCceEEEEecCCC-CCCCCCCcccccccccCCCCCCccEEEEEEecCCC---ccCCCCCCceeeecCCccceeee
Q 006446          102 QTAQPGEGLAFVIAGNKD-LPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKS---YEQDINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n---~~~d~~~~Hvgid~ns~~s~~~~  177 (644)
                      +...+||||||||+|... +|.++.||||||+|.++ +++.||+|||||||++|   .+|||++|||||||||+.|+++.
T Consensus        81 ~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~~Dp~~nHVGIdvNs~~S~~~~  159 (239)
T 1dbn_A           81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccccCCCCCcEEEecCCccccceE
Confidence            566789999999999655 78889999999999764 46789999999999999   77999999999999999999998


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc--cccccccccccc
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD--TQLNCVKSWAFD  250 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~  250 (644)
                      +|   +|.+|+.++|||+||+  ++|+|++..   +..|+|++.+||+++||++|||||||+||..  .+.|+|++|+|+
T Consensus       160 ~~---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~  236 (239)
T 1dbn_A          160 QW---DWINGGVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFT  236 (239)
T ss_dssp             EC---CCCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEE
T ss_pred             cc---cccCCCEEEEEEEEeCCCcEEEEEEccCCCCCcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEEeE
Confidence            88   4889999999999999  789999853   3457999999999999999999999999999  999999999998


Q ss_pred             CC
Q 006446          251 GS  252 (644)
Q Consensus       251 ss  252 (644)
                      ++
T Consensus       237 s~  238 (239)
T 1dbn_A          237 ST  238 (239)
T ss_dssp             EE
T ss_pred             ec
Confidence            64

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=8.6e-59  Score=459.86  Aligned_cols=222  Identities=35%  Similarity=0.526  Sum_probs=195.6

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-C
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-Q  102 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~  102 (644)
                      +++|+|++|... ..+|.++ ||.+. +|.|+||++..+.+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+ +
T Consensus         3 ~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~   81 (237)
T 1fny_A            3 SLSFSFPKFAPN-QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN   81 (237)
T ss_dssp             EEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred             ceEEEcCCCCCC-CCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence            679999999864 4589999 99995 899999987633334579999999999999999999999999999999997 5


Q ss_pred             CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCccc
Q 006446          103 TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRV  182 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~~  182 (644)
                      ...+||||||||+|....| ++.||||||+|.++ +++.||+|||||||++|.+|||++|||||||||+.|.++.+|   
T Consensus        82 ~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~Dp~~nHVGIdvNsi~S~~~~~~---  156 (237)
T 1fny_A           82 PATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW---  156 (237)
T ss_dssp             TTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC---
T ss_pred             CCCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccCcccCCCCCceEEecCCccccccccc---
Confidence            6678999999999976555 48999999999764 577899999999999998899999999999999999999888   


Q ss_pred             ccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCCc
Q 006446          183 NLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGSD  253 (644)
Q Consensus       183 ~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss~  253 (644)
                      +|.+|+.++|||+||+  +.|+|++..   +..|+|++.+||+++||++|||||||+||..   .+.|+|++|+|+++.
T Consensus       157 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~l  235 (237)
T 1fny_A          157 NWTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             CCCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             cccCCCEEEEEEEEeCCCcEEEEEEecCCCCCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEec
Confidence            4889999999999999  789999853   3457999999999999999999999999998   999999999998753

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=7.2e-57  Score=444.66  Aligned_cols=215  Identities=34%  Similarity=0.614  Sum_probs=193.6

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccC-CCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYD-VRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~-~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|... ..+|.++ +|.+. +|.|+||++ ..     +++|||+|++||+|||+.+|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~-----~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~   75 (232)
T 1v6i_A            2 ETVSFNFNSFSEG-NPAINFQGDVTVLSNGNIQLTNLNKV-----NSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKD   75 (232)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEESCEECTTSCEECSCTTST-----TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCCC-CCCeEEcccEEEccCCcEEeCCCCCC-----CceEEEEeCCCEEeecCCCCCccceEEEEEEEEec
Confidence            4689999999864 4589999 99995 899999987 43     79999999999999999999999999999999997


Q ss_pred             -CCCCCCCceEEEEecCC-CCCCCC-CCcccccccccCCCCCCccEEEEEEecCCCcc-CCCCCCceeeecCCccceeee
Q 006446          102 -QTAQPGEGLAFVIAGNK-DLPENS-EGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~-~~~~~~-~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~-~d~~~~Hvgid~ns~~s~~~~  177 (644)
                       +...+||||||||+|.. .+|.++ .||||||+|.    ++.||+|||||||++|.+ |||++|||||||||+.|.++.
T Consensus        76 ~~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~  151 (232)
T 1v6i_A           76 IKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTV  151 (232)
T ss_dssp             CSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEE
T ss_pred             CCCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccc
Confidence             55678999999999965 578888 9999999986    567899999999999988 599999999999999999998


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEec--CCCCCcccccCccCcCCCceeeeecccCCC--cccccccccccccC
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVAN--METPLLSEPIDLSEYLPEKVFVGFSASTGD--DTQLNCVKSWAFDG  251 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~--~~~~~ls~~~dl~~~l~~~~~vGfsastg~--~~~~~~i~~wsf~s  251 (644)
                      +|   +|.+|+.++|||+||+  ++|+|++..  +..|+|++.+||+++||++|||||| +||.  ..+.|+|++|+|++
T Consensus       152 ~~---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s  227 (232)
T 1v6i_A          152 PW---NSVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTS  227 (232)
T ss_dssp             EC---CCCTTCEEEEEEEEETTTTEEEEEEECTTSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEE
T ss_pred             cc---cccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEe
Confidence            88   4889999999999999  789998863  4567999999999999999999999 9998  58999999999987


Q ss_pred             Cc
Q 006446          252 SD  253 (644)
Q Consensus       252 s~  253 (644)
                      +.
T Consensus       228 ~l  229 (232)
T 1v6i_A          228 TL  229 (232)
T ss_dssp             EE
T ss_pred             ec
Confidence            64

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=7e-57  Score=447.22  Aligned_cols=222  Identities=28%  Similarity=0.504  Sum_probs=195.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|.+. ..+|.++ +|.+. +|.|+||++..+. +..+++|||+|++||+|||+.+|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~   80 (239)
T 1gzc_A            2 ETISFSFSEFEPG-NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQ   80 (239)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred             eeEEEEeCCCCCC-CCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeC
Confidence            3689999999864 4589999 99995 8999999876322 33479999999999999999999999999999999997


Q ss_pred             -C-CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeec
Q 006446          102 -Q-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVP  178 (644)
Q Consensus       102 -~-~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~  178 (644)
                       + ...+||||||||+|....| ++.||||||+|.++ +++.||+|||||||++|. | ||++|||||||||+.|.++.+
T Consensus        81 ~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~  157 (239)
T 1gzc_A           81 PYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP  157 (239)
T ss_dssp             CCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCcccccccc
Confidence             4 5678999999999976554 48999999999754 577899999999999997 9 699999999999999999988


Q ss_pred             CcccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCC---ccccccccccccc
Q 006446          179 LTRVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFD  250 (644)
Q Consensus       179 ~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~  250 (644)
                      |   +|.+|+.++|||+||+  +.|+|++..   +..|+|++.+||+.+||++|||||||+||.   ..+.|+|++|+|+
T Consensus       158 ~---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~  234 (239)
T 1gzc_A          158 F---QLDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ  234 (239)
T ss_dssp             C---CCCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEE
T ss_pred             c---cccCCCEEEEEEEEeCCCcEEEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEeE
Confidence            8   4889999999999999  789999853   345799999999999999999999999997   4899999999998


Q ss_pred             CCc
Q 006446          251 GSD  253 (644)
Q Consensus       251 ss~  253 (644)
                      ++.
T Consensus       235 s~l  237 (239)
T 1gzc_A          235 ASL  237 (239)
T ss_dssp             EEE
T ss_pred             Eec
Confidence            753

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=1e-56  Score=446.38  Aligned_cols=221  Identities=31%  Similarity=0.538  Sum_probs=197.2

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      .+++|+|++|... ..+|.++ ||.+. +|.|+||++..  +..+++|||+|++||+|||+.+|+++||+|+|+|+|.+.
T Consensus         4 ~~~~F~f~~F~~~-~~~l~l~G~A~i~~~g~l~LT~~~~--~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~   80 (242)
T 1qnw_A            4 DDLSFNFDKFVPN-QKNIIFQGDASVSTTGVLQVTKVSK--PTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD   80 (242)
T ss_dssp             CSEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCCC----CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS
T ss_pred             cceEEEcCCCCCC-CCCeEEccceEEccCCcEEecCCCC--cccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC
Confidence            5789999999864 4589999 99995 89999998761  234799999999999999999999999999999999865


Q ss_pred             CCCCCCceEEEEecCC-CCCCCCCCcccccccccCCCCCCccEEEEEEecC----CCccCCCCCCceeeecCCccceeee
Q 006446          103 TAQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTK----KSYEQDINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~----~n~~~d~~~~Hvgid~ns~~s~~~~  177 (644)
                      ...+||||||||+|.. .+|.++.||||||+|.++ +++.+|+|||||||+    +|. |||++|||||||||+.|+++.
T Consensus        81 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~-~Dp~~nHVGIdvNs~~S~~~~  158 (242)
T 1qnw_A           81 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP-WDPDFKHIGIDVNSIKSIKTV  158 (242)
T ss_dssp             SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC-CCCCCCcEEEecCCcccccee
Confidence            5568999999999965 478889999999999754 577899999999999    996 999999999999999999998


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc--cccccccccccc
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD--TQLNCVKSWAFD  250 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~  250 (644)
                      +|   +|.+|+.++|||+||+  +.|.|++..   +..|+|++.+||+.+||++|||||||+||..  .+.|+|++|+|+
T Consensus       159 ~~---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~  235 (242)
T 1qnw_A          159 KW---DWRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFT  235 (242)
T ss_dssp             EC---CCCTTCCEEEEEEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEE
T ss_pred             cc---cccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEEeE
Confidence            88   4889999999999999  789999853   4457999999999999999999999999999  999999999998


Q ss_pred             CCc
Q 006446          251 GSD  253 (644)
Q Consensus       251 ss~  253 (644)
                      ++.
T Consensus       236 s~l  238 (242)
T 1qnw_A          236 SNL  238 (242)
T ss_dssp             EEC
T ss_pred             eec
Confidence            764

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=9.5e-57  Score=446.60  Aligned_cols=220  Identities=30%  Similarity=0.458  Sum_probs=195.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEE-EEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGR-AIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~-~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|... ..+|.++ +|.+. +|.|+||++..  +..+++|| |+|++||+|||+.+|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~--~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~   78 (242)
T 1fx5_A            2 DDLSFKFKNFSQN-GKDLSFQGNASVIETGVLQLNKVGN--NLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMET   78 (242)
T ss_dssp             CEEEEEESSCCTT-CSSEEEEETCEECTTSCEESCCCSS--SSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCCC-CCCeEEcccEEeccCCcEEecCCCC--cccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEec
Confidence            4689999999864 4589999 99995 89999998761  23479999 999999999999999999999999999986


Q ss_pred             C--CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCcc--CCCCCCceeeecCCccceeee
Q 006446          102 Q--TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE--QDINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       102 ~--~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~--~d~~~~Hvgid~ns~~s~~~~  177 (644)
                      .  ...+||||||||+|....| ++.||||||+|.++ +++.||+|||||||++|.+  |||++|||||||||+.|.++.
T Consensus        79 ~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~  156 (242)
T 1fx5_A           79 SANPKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE  156 (242)
T ss_dssp             SSCGGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCcccccee
Confidence            3  5568999999999976554 48999999999754 5778999999999999988  799999999999999999998


Q ss_pred             cCcccccCCC--ceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccC--CCccccccccccc
Q 006446          178 PLTRVNLANG--TDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSAST--GDDTQLNCVKSWA  248 (644)
Q Consensus       178 ~~~~~~l~~g--~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsast--g~~~~~~~i~~ws  248 (644)
                      +|   +|.+|  +.++|||+||+  +.|+|++..   +..|+|++.+||+++||++|||||||+|  |.. +.|+|++|+
T Consensus       157 ~~---~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWs  232 (242)
T 1fx5_A          157 RW---NKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWY  232 (242)
T ss_dssp             EC---CCCCSGGGCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEE
T ss_pred             cc---cccCCCceeEEEEEEEeCCCCEEEEEEecCCCCccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEE
Confidence            88   48899  99999999999  789999854   3457999999999999999999999999  999 999999999


Q ss_pred             ccCCc
Q 006446          249 FDGSD  253 (644)
Q Consensus       249 f~ss~  253 (644)
                      |+++.
T Consensus       233 F~s~l  237 (242)
T 1fx5_A          233 FTSTF  237 (242)
T ss_dssp             EEEES
T ss_pred             eEeec
Confidence            98764

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=2.5e-56  Score=446.50  Aligned_cols=222  Identities=30%  Similarity=0.509  Sum_probs=197.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|...   +|.++ ||.+.+|.|+||++..+ .+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+ 
T Consensus         2 ~~~~F~f~~F~~~---~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~   78 (253)
T 1g7y_A            2 DIQSFSFKNFNSS---SFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAP   78 (253)
T ss_dssp             EEEEEEESSCCSS---CEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cceEEEcCCCCcC---CEEEecceEEeCCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecC
Confidence            4689999999853   89999 99999999999987632 133479999999999999999999999999999999987 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      +...+||||||||+|....| ++.||||||+|.++ ++..||+|||||||++|.+|||++|||||||||+.|.++.+|  
T Consensus        79 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~Dp~~nHVGIdvns~~S~~t~~~--  154 (253)
T 1g7y_A           79 NKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--  154 (253)
T ss_dssp             SGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceeccCcCCCCCcEeeccCCccccceecc--
Confidence            45668999999999976555 58899999999764 467899999999999998899999999999999999999888  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCCc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGSD  253 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss~  253 (644)
                       ++.+|+.++|||+||+  ++|+|++..   +..|+|++.+||+.+||++|||||||+||..   .+.|+|++|+|+++.
T Consensus       155 -~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l  233 (253)
T 1g7y_A          155 -GLANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL  233 (253)
T ss_dssp             -CCCTTSEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred             -ccCCCCeEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEEeeC
Confidence             4889999999999999  789999853   3456999999999999999999999999999   999999999998875


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       234 ~  234 (253)
T 1g7y_A          234 P  234 (253)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=2.8e-56  Score=440.55  Aligned_cols=215  Identities=31%  Similarity=0.554  Sum_probs=192.2

Q ss_pred             eeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-CC
Q 006446           27 LHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QT  103 (644)
Q Consensus        27 ~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~~  103 (644)
                      ++|+|++|. . ..+|.++ ||.+. +|.|+||++.   +..+++|||+|++||+|||+.+|+++||+|+|+|+|.+ +.
T Consensus         1 ~sF~f~~F~-~-~~~l~l~G~A~v~~~g~l~LT~~~---~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~   75 (234)
T 2eig_A            1 VSFNYTRFK-D-DGSLIFQGDAKIWTDGRLAMPTDP---LVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQR   75 (234)
T ss_dssp             CEEEESSCC-S-SSSEEEEETCEEEGGGEEESSSCG---GGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTT
T ss_pred             CeEEcCCCC-C-CCCeEEcccEEEcCCCCeeeCCCC---CccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCC
Confidence            479999998 2 3589999 99995 8999999871   12379999999999999999999999999999999997 56


Q ss_pred             CCCCCceEEEEecCC-CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCC---CceeeecCCccceeeecC
Q 006446          104 AQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDIND---NHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       104 ~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~---~Hvgid~ns~~s~~~~~~  179 (644)
                      ..+||||||||+|.. .+|.++.||||||+|.+   ++.||+|||||||++|. |||++   |||||||||+.|.++.+|
T Consensus        76 ~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~-~Dp~~~~~nHVGIdvNsi~S~~~~~~  151 (234)
T 2eig_A           76 YPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV-WDPKSLRSSHIGIDVNSIMSLKAVNW  151 (234)
T ss_dssp             SCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT-TSCTTTCSSEEEEEESSSSCSEEEEC
T ss_pred             CCCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc-cCCCCCCCCceEEecCCccccceecc
Confidence            678999999999965 57888999999999865   66789999999999997 99999   999999999999999888


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEec--CCCCCcccccCccCcCCCceeeeecccC--CCcccccccccccccCCc
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVAN--METPLLSEPIDLSEYLPEKVFVGFSAST--GDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~--~~~~~ls~~~dl~~~l~~~~~vGfsast--g~~~~~~~i~~wsf~ss~  253 (644)
                         +|.+|+.++|||+||+  +.|+|++..  +..|+|++.+||+++||++|||||||+|  |.. +.|+|++|+|+++.
T Consensus       152 ---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l  227 (234)
T 2eig_A          152 ---NRVSGSLEKATIIYDSDTKILTVVMTHQNGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTL  227 (234)
T ss_dssp             ---CCCTTCCEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEEC
T ss_pred             ---cccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEecC
Confidence               4889999999999999  688998863  4567999999999999999999999999  988 99999999998875


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       228 ~  228 (234)
T 2eig_A          228 K  228 (234)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=2.8e-56  Score=447.11  Aligned_cols=228  Identities=29%  Similarity=0.495  Sum_probs=198.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      .+++|+|++|...+..+|.++ ||.+.+|.|+||++..+. +..+++|||+|++||+|||+.+|+++||+|+|+|+|.+.
T Consensus         3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~~   82 (257)
T 1hql_A            3 DSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT   82 (257)
T ss_dssp             -CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCCCCCCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEecC
Confidence            468999999982123589999 999999999999876321 334799999999999999999999999999999999865


Q ss_pred             CCCCCCceEEEEecCCCCCCCCCCcccccccccC-CCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCc
Q 006446          103 TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGIT-NGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                      ...+||||||||+|....| ++.||||||+|.++ +++..||+|||||||++|.+| ||++|||||||||+.|.++.+| 
T Consensus        83 ~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~-  160 (257)
T 1hql_A           83 GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW-  160 (257)
T ss_dssp             SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceecc-
Confidence            5668999999999976544 58899999999765 377889999999999999889 9999999999999999999998 


Q ss_pred             ccc-cCCCceEEEEEEEcC--ceEEEEEecC--CCCCcccccCccCcCCCceeeeecccCC-CcccccccccccccCCcc
Q 006446          181 RVN-LANGTDIKVQVRYDG--QNITVFVANM--ETPLLSEPIDLSEYLPEKVFVGFSASTG-DDTQLNCVKSWAFDGSDI  254 (644)
Q Consensus       181 ~~~-l~~g~~~~~~I~Y~~--~~l~v~~~~~--~~~~ls~~~dl~~~l~~~~~vGfsastg-~~~~~~~i~~wsf~ss~~  254 (644)
                      .+. |.+|+.++|||+||+  ++|+|++..+  ..|+|++.+||+.+||++|||||||+|| ...+.|+|++|+|+++..
T Consensus       161 ~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s~~~  240 (257)
T 1hql_A          161 EDSDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSNLQ  240 (257)
T ss_dssp             CHHHHTSCSCEEEEEEEETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEEC-
T ss_pred             CcccccCCceEEEEEEEeCCCCEEEEEEecCCCCceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEEeEecCC
Confidence            344 667999999999999  7899998543  3579999999999999999999999999 899999999999988753

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=6.3e-56  Score=439.18  Aligned_cols=219  Identities=29%  Similarity=0.516  Sum_probs=194.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|... ..+|.++ ||.+. +|.|+||++..+.+..+++|||+|++||+|||+.+  ++||+|+|+|+|.+ 
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~   78 (233)
T 1n47_A            2 ESTSFSFTNFNPN-QNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAP   78 (233)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCS
T ss_pred             cceEEEcCCCCCC-CCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCC
Confidence            4689999999864 4589999 99995 89999998874444457999999999999999887  99999999999997 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      +...+||||||||+|....|. +.||||||+|.+ +++..||+|||||||++|. |||++||||||+||+.|.++.+|  
T Consensus        79 ~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~n~~vAVEFDT~~N~-~Dp~~nHvGIdvns~~S~~~~~~--  153 (233)
T 1n47_A           79 AAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADR-AHDASYQTVAVEFDTYSNA-WDPNYTHIGIDTNGIESKKTTPF--  153 (233)
T ss_dssp             STTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSS-SCCGGGCCEEEEEECSCCT-TSCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCccCceEEEEeccccCC-CCCCCCcEEEccCCccccccccc--
Confidence            456789999999999766665 899999999976 4577899999999999996 99999999999999999999887  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEecC---CCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCC
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVANM---ETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGS  252 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~~---~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss  252 (644)
                       ++.+|+.++|||+||+  ++|+|++..+   ..|+|++.+||+.+||++|||||||+||..   .+.|+|++|+|+++
T Consensus       154 -~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~  231 (233)
T 1n47_A          154 -DMVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             -CCCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             -cccCCCEEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEee
Confidence             5789999999999999  7899998543   357999999999999999999999999998   99999999999865

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=6.6e-56  Score=442.90  Aligned_cols=221  Identities=29%  Similarity=0.509  Sum_probs=195.9

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|... ..+|.++ ||.+. +|.|+||++..+ .+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~   80 (253)
T 1sbf_A            2 ETVSFSWNKFVPK-QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA   80 (253)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCCC-CCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeC
Confidence            4689999999864 4589999 99995 899999987632 133479999999999999999999999999999999997


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       +...+||||||||+|....| ++.||||||+|.+   ++.||+|||||||++|. |||++|||||||||+.|.++.+| 
T Consensus        81 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~-~Dp~~nHVGIdvNs~~S~~t~~~-  154 (253)
T 1sbf_A           81 PDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS-WDPPNPHIGINVNSIRSIKTTSW-  154 (253)
T ss_dssp             SSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCT-TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccCC-CCCCCCcEEEEcCCccccceecc-
Confidence             46678999999999976555 5899999999865   66789999999999996 99999999999999999999888 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc--ccccccccccccCCc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD--TQLNCVKSWAFDGSD  253 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~ss~  253 (644)
                        ++.+|+.++|||+||+  ++|+|++..   +..|+|++.+||+.+||++|||||||+||..  .+.|+|++|+|+++.
T Consensus       155 --~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~l  232 (253)
T 1sbf_A          155 --DLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL  232 (253)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred             --cccCCCeeEEEEEEeCCCcEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEeec
Confidence              4889999999999999  789999853   3357999999999999999999999999999  999999999998875


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       233 ~  233 (253)
T 1sbf_A          233 P  233 (253)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=2.3e-55  Score=437.48  Aligned_cols=224  Identities=31%  Similarity=0.534  Sum_probs=196.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|... ..+|.++ +|.+. +|.|+||++.. +.+..+++|||+|++||+|||+ +|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~   79 (240)
T 2fmd_A            2 NSVCFTFTDFESG-QQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQ   79 (240)
T ss_dssp             CEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCB
T ss_pred             cceEEEcCCCCCC-CCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEec
Confidence            4689999999864 4589999 99995 79999998764 2234578999999999999999 99999999999999987


Q ss_pred             CCCCCCCceEEEEecCCCCCCC-CCCcccccccccCCCCCCccEEEEEEecCCCcc-CCCCCCceeeecCCccceeeecC
Q 006446          102 QTAQPGEGLAFVIAGNKDLPEN-SEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~-~d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                      ....+||||||+|+|....|.+ +.|+||||+|.+++++..||+|||||||++|.+ |||++||||||+||+.|..+.+|
T Consensus        80 ~~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~  159 (240)
T 2fmd_A           80 GSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW  159 (240)
T ss_dssp             SSSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE
Confidence            5556899999999997666766 899999999987777789999999999999988 69999999999999999998887


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEecC--CCCCcccccCccCcCCCceeeeecccCCCcccccccccccccCCc
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVANM--ETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~~--~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~  253 (644)
                         ++.+|+.++|||+||+  ++|+|++..+  ..|+|++.+||+.+||++|||||||+||...+.|+|++|+|+++.
T Consensus       160 ---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~~  234 (240)
T 2fmd_A          160 ---DWQNGKTATAHISYNSASKRLSVVSSYPNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRSSL  234 (240)
T ss_dssp             ---CCCSSCEEEEEEEEETTTTEEEEEEECTTSCCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEEEE
T ss_pred             ---EeeCCCEEEEEEEEeCCCCEEEEEEecCCCCceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEecC
Confidence               4789999999999999  7899998533  468999999999999999999999999999999999999998764

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=7.6e-56  Score=442.72  Aligned_cols=220  Identities=33%  Similarity=0.574  Sum_probs=195.2

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|...   +|.++ +|.+. +|.|+||++..+ .+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~---~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~   78 (252)
T 1fat_A            2 NDIYFNFQRFNET---NLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQV   78 (252)
T ss_dssp             CCEEEEESSCCGG---GEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCC
T ss_pred             cceEEEcCCCCcC---CEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeC
Confidence            4689999999854   89999 99995 899999987632 233579999999999999999999999999999999997


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       +...+||||||||+|....| ++.||||||+|.+   ++.||+|||||||++|.+|||++|||||||||+.|.++.+| 
T Consensus        79 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~~Dp~~nHVGIdvNs~~S~~~~~~-  153 (252)
T 1fat_A           79 PNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW-  153 (252)
T ss_dssp             CSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCCCCCCCCCeEEEecCCccccceecc-
Confidence             45678999999999976554 5899999999875   66899999999999998899999999999999999999888 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGS  252 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss  252 (644)
                        ++.+|+.++|||+||+  +.|+|++..   +..|+|++.+||+.+||++|||||||+||..   .+.|+|++|+|+++
T Consensus       154 --~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~  231 (252)
T 1fat_A          154 --DFVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK  231 (252)
T ss_dssp             --CCCTTCEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred             --cccCCCEEEEEEEEeCCCCEEEEEEecCCCCCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEEee
Confidence              4889999999999999  789999853   3356999999999999999999999999999   99999999999887


Q ss_pred             cc
Q 006446          253 DI  254 (644)
Q Consensus       253 ~~  254 (644)
                      ..
T Consensus       232 l~  233 (252)
T 1fat_A          232 LS  233 (252)
T ss_dssp             EC
T ss_pred             CC
Confidence            54

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=2.4e-55  Score=436.17  Aligned_cols=217  Identities=30%  Similarity=0.527  Sum_probs=195.4

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-C
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-Q  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~  102 (644)
                      .+++|+|++|... ..+|.++ +|...+|.|+||++..     +++|||+|++||+|||+.+|+++||+|+|+|+|.+ +
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~~~~g~l~LT~~~~-----~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~   75 (234)
T 2bqp_A            2 ETTSFLITKFSPD-QQNLIFQGDGYTTKEKLTLTKAVK-----NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPN   75 (234)
T ss_dssp             EEEEEEESSBCTT-CTTEEEEETCEEETBEEEEECSCT-----TCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSS
T ss_pred             cceEEEcCCCCCC-CCCEEEeeceecCCCEEEeCCCCC-----CCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCC
Confidence            4689999999864 3589999 9996689999998865     78999999999999999999999999999999997 4


Q ss_pred             CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCC--CCceeeecCCccceeeecCc
Q 006446          103 TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDIN--DNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~--~~Hvgid~ns~~s~~~~~~~  180 (644)
                      ...+||||||+|+|....|. +.|+||||+|.+ +++..||+|||||||++|.+|||+  +|||||||||+.|.++.+| 
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~~N~~~Dp~~~~nHVgIdvns~~S~~s~~~-  152 (234)
T 2bqp_A           76 SYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW-  152 (234)
T ss_dssp             TTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCcEEEEEecCCCCCC-CCCCcccccccc-CCCCCCcEEEEEEecccCcccCCCCCCCceeEeeCCccccceEee-
Confidence            56789999999999766666 889999999976 456789999999999999889999  9999999999999999887 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEec--------CCCCCcccccCccCcCCCceeeeecccCCCccccccccccccc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVAN--------METPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFD  250 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~--------~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~  250 (644)
                        ++.+|+.++|||+||+  ++|+|++..        |..|+|++.+||+.+||++|||||||+||...+.|+|++|+|+
T Consensus       153 --~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~  230 (234)
T 2bqp_A          153 --KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFH  230 (234)
T ss_dssp             --CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEE
T ss_pred             --EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEE
Confidence              4789999999999999  789998842        3457999999999999999999999999999999999999998


Q ss_pred             CC
Q 006446          251 GS  252 (644)
Q Consensus       251 ss  252 (644)
                      ++
T Consensus       231 s~  232 (234)
T 2bqp_A          231 SE  232 (234)
T ss_dssp             EE
T ss_pred             ee
Confidence            65

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=7.9e-56  Score=440.73  Aligned_cols=223  Identities=29%  Similarity=0.482  Sum_probs=196.0

Q ss_pred             cceeEEcCCC----CCCCCCCeEEe-cccccCCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEE
Q 006446           25 SSLHFNFQSF----TEQNRNELSFD-NSTVAKSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLN   98 (644)
Q Consensus        25 ~~~~f~f~~f----~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~   98 (644)
                      .+++|+|++|    .+. ..+|.++ +|.+.+|.|+||++..+. +..+++|||+|++||+||| .+|+++||+|+|+|+
T Consensus         2 ~~~~F~f~~F~~~~~~~-~~~l~l~GdA~i~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F~   79 (243)
T 1gsl_A            2 NTVNFTYPDFWSYSLKN-GTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTFL   79 (243)
T ss_dssp             CCCEEEESCCCCTTCCT-TSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEEE
T ss_pred             cceEEEcCCCccccCCC-CCCEEEccceEecCCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEEE
Confidence            3679999999    542 4589999 999999999999876321 3347999999999999999 999999999999999


Q ss_pred             EecCCCCCCCceEEEEecCCCCCCCCCCcccccccccCC-CCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceee
Q 006446           99 ILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITN-GTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQ  176 (644)
Q Consensus        99 i~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~  176 (644)
                      |.+....+||||||||+|....| ++.||||||+|.+++ +++.||+|||||||++|.+| ||++||||||+||+.|.++
T Consensus        80 I~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~  158 (243)
T 1gsl_A           80 LKNYGAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT  158 (243)
T ss_dssp             EEESSSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred             EecCCCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccccce
Confidence            98755568999999999976544 588999999998764 77889999999999999889 9999999999999999999


Q ss_pred             ecCcccccCC---CceEEEEEEEcC--ceEEEEEecC--CCCCcccccCccCcCCCceeeeecccCCCcccccccccccc
Q 006446          177 VPLTRVNLAN---GTDIKVQVRYDG--QNITVFVANM--ETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF  249 (644)
Q Consensus       177 ~~~~~~~l~~---g~~~~~~I~Y~~--~~l~v~~~~~--~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf  249 (644)
                      .+|   ++.+   |+.++|||+||+  +.|+|++..+  ..|+|++.+||+.+||++|||||||+|| ..+.|+|++|+|
T Consensus       159 ~~~---~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~IlsWsF  234 (243)
T 1gsl_A          159 TRW---ENDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHF  234 (243)
T ss_dssp             EEC---CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEEEEEEE
T ss_pred             eee---EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCCCceeEEEEechHHhCCCceEEEEEeccC-CcceeEEEEEEE
Confidence            888   3667   999999999999  7899998533  4579999999999999999999999999 999999999999


Q ss_pred             cCCcc
Q 006446          250 DGSDI  254 (644)
Q Consensus       250 ~ss~~  254 (644)
                      +++..
T Consensus       235 ~s~l~  239 (243)
T 1gsl_A          235 FSTLD  239 (243)
T ss_dssp             EEECT
T ss_pred             Eeecc
Confidence            88753

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=2e-55  Score=437.02  Aligned_cols=219  Identities=34%  Similarity=0.592  Sum_probs=193.2

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      .+++|+|++|... ..+|.++ +|.+. +|.|+||++..+.+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+.
T Consensus         2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~   80 (242)
T 1wbf_A            2 KTISFNFNQFHQN-EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQP   80 (242)
T ss_dssp             CEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cceEEEcCCCCCC-CCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCC
Confidence            3689999999864 4589999 99995 8999999876322334799999999999999999999999999999999863


Q ss_pred             --CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          103 --TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       103 --~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                        ...+||||||||+|....| ++.||||||+|.+    +.||+|||||||++|. |||++|||||||||+.|.++.+| 
T Consensus        81 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~-~Dp~~nHVGIdvNs~~S~~~~~~-  153 (242)
T 1wbf_A           81 FPRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNT-WDPQIPHIGIDVNSVISTKTVPF-  153 (242)
T ss_dssp             CCSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEECSCCT-TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEeccccCC-CCCCCCeEEEECCCccccceeee-
Confidence              5678999999999975544 4889999999864    6789999999999996 99999999999999999999887 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccC----CCc---cccccccccc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSAST----GDD---TQLNCVKSWA  248 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsast----g~~---~~~~~i~~ws  248 (644)
                        ++.+|+.++|||+||+  ++|+|++..   +..|+|++.+||+.+||++|||||||+|    |..   .+.|+|++|+
T Consensus       154 --~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWs  231 (242)
T 1wbf_A          154 --TLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWS  231 (242)
T ss_dssp             --CCCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEE
T ss_pred             --EecCCCEEEEEEEEeCCCCEEEEEEccCCCCCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEEE
Confidence              4889999999999999  789999854   3356999999999999999999999999    888   8999999999


Q ss_pred             ccCCc
Q 006446          249 FDGSD  253 (644)
Q Consensus       249 f~ss~  253 (644)
                      |+++.
T Consensus       232 F~s~l  236 (242)
T 1wbf_A          232 FSASL  236 (242)
T ss_dssp             EEEEC
T ss_pred             eEecC
Confidence            98764

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=6e-55  Score=433.55  Aligned_cols=218  Identities=29%  Similarity=0.519  Sum_probs=192.2

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      +++|+|++|... ..+|.++ +|.+. +|.|+||++..+. +..+++|||+|++||+|||+.+|+++||+|+|+|+|.+.
T Consensus         2 ~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~   80 (238)
T 1f9k_A            2 TQSFNFDHFEEN-SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP   80 (238)
T ss_dssp             EEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred             CeEEEcCCCCCC-CCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecC
Confidence            578999999864 4589999 99995 7999999876311 234789999999999999999999999999999999863


Q ss_pred             --CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          103 --TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       103 --~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                        ...+||||||||+|....| ++.||||||+|.+   ++ +|+|||||||++|. |||++|||||||||+.|.++.+| 
T Consensus        81 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~-~Dp~~nHVgIdvns~~S~~s~~~-  153 (238)
T 1f9k_A           81 YAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT-WDPQVPHIGIDVNSIVSSKTLHF-  153 (238)
T ss_dssp             CSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCT-TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCC-CCCCCCeEEEecCCccccceEee-
Confidence              5678999999999976554 5889999999875   45 89999999999996 99999999999999999999887 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCC--ceeeeecccCCCc---cccccccccccc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPE--KVFVGFSASTGDD---TQLNCVKSWAFD  250 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~--~~~vGfsastg~~---~~~~~i~~wsf~  250 (644)
                        ++.+|+.++|||+||+  ++|+|++..   +..|+|++.+||+.+||+  +|||||||+||..   .+.|+|++|+|+
T Consensus       154 --~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~  231 (238)
T 1f9k_A          154 --QLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT  231 (238)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEE
T ss_pred             --cccCCCEEEEEEEEeCCCCEEEEEEecCCCCCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEeE
Confidence              4889999999999999  789999854   335689999999999999  9999999999999   999999999998


Q ss_pred             CCc
Q 006446          251 GSD  253 (644)
Q Consensus       251 ss~  253 (644)
                      ++.
T Consensus       232 s~~  234 (238)
T 1f9k_A          232 SSL  234 (238)
T ss_dssp             EEC
T ss_pred             eec
Confidence            764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-55  Score=457.51  Aligned_cols=265  Identities=27%  Similarity=0.447  Sum_probs=209.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|...++||+|+||+||+|++.       +..||||+++..+....++|.+|+.+|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35666789999999999999864       46799999988777778899999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCC-------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          392 VYEYMPNGSLDKFIFYDETNS-------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      |||||++|+|.++|+......       ......++|.+++.|+.|||+||+|||+   ++|+||||||+||||++++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            999999999999997643211       1122359999999999999999999999   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......    .+...
T Consensus       198 Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDC  272 (329)
T ss_dssp             EECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHH
T ss_pred             EEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHH
Confidence            9999999997653322 222345689999999999999999999999999999999999 89999764321    22221


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      +    ..+..         .+.+......+.+|+.+||+.||++||||+||++.|+.....
T Consensus       273 i----~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 I----TQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             H----HHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H----HcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1    12211         122223345678899999999999999999999999886543

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=1.4e-54  Score=427.04  Aligned_cols=212  Identities=28%  Similarity=0.454  Sum_probs=189.1

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|...   +|.++ ||.+. +|.|+||++.  .+..+++|||+|++||+|||+.+|+++||+|+|+|+|.+ 
T Consensus         2 ~~~~F~f~~F~~~---~l~l~G~A~v~~~g~l~LT~~~--~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~   76 (226)
T 1avb_A            2 NDASFNVETFNKT---NLILQGDATVSSEGHLLLTNVK--GNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAK   76 (226)
T ss_dssp             EEEEEEESSCCGG---GEEEEETCEECTTSCEECSCSS--SCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEES
T ss_pred             cceEEEcCCCCcc---CEEEeccEEECCCCEEEeCCCC--CCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCC
Confidence            3689999999854   89999 99995 8999999874  123479999999999999999999999999999999997 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      +...+||||||||+|....|. +.||||||+|.+ ++++.||+|||||||+        +|||||||||+.|.++.+| +
T Consensus        77 ~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~--------~nHVGIdvNs~~S~~t~~~-~  145 (226)
T 1avb_A           77 NIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV--------SNRIEIDVNSIRPIATESC-N  145 (226)
T ss_dssp             STTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT--------TTEEEEEESSSSCSEEEEC-C
T ss_pred             CCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc--------CCccceeecCcccCccccC-C
Confidence            556789999999999766666 899999999975 4577899999999998        5899999999999999999 6


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEecC---CCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCC
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVANM---ETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGS  252 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~~---~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss  252 (644)
                      ..|.+|+.++|||+||+  ++|+|++..+   .+|+|++.+||+++||++|||||||+||..   .+.|+|++|+|+++
T Consensus       146 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~  224 (226)
T 1avb_A          146 FGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             SGGGTTCEEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             ccccCCCeEEEEEEEeCCCcEEEEEEeecCCCccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence            78889999999999999  7899998533   357999999999999999999999999999   99999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.4e-55  Score=451.33  Aligned_cols=263  Identities=26%  Similarity=0.482  Sum_probs=213.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|...++||+|+||+||+|++.       +..||||+++..+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            35667889999999999999874       45799999988777778899999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCC-----CCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          392 VYEYMPNGSLDKFIFYDET-----NSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      |||||++|+|.++|.....     ........++|.++++|+.|||+||+|||+   ++|+||||||+||||++++++||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            9999999999999975421     111223359999999999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+|+....... ........||+.|||||++.++.++.++|||||||+||||+| |+.||......    .+...  
T Consensus       170 ~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~--  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC--  242 (299)
T ss_dssp             CCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH--
T ss_pred             CCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH--
Confidence            99999987653322 122344679999999999999999999999999999999998 89999765421    22222  


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                        ...+..         ...+......+.+|+.+||+.||++|||++||++.|+...
T Consensus       243 --i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          243 --ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             --HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              122221         1122233456788999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.2e-54  Score=449.24  Aligned_cols=261  Identities=23%  Similarity=0.423  Sum_probs=212.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      +++..++||+|+||+||+|++.       +..||||+++... ....++|.+|+.++++++|||||+++|+|.+.+.++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3445788999999999999873       4679999997543 3345789999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          392 VYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      |||||++|+|.++|.......        ......++|.++++|+.|||+||+|||+   ++||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            999999999999997543211        1112359999999999999999999999   89999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~  542 (644)
                      +||+|||+++....... ........||++|||||++.++.++.++|||||||+||||+| |+.||.....    ..+..
T Consensus       184 ~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHH
T ss_pred             EEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence            99999999997753322 222455689999999999999999999999999999999998 8999976542    22222


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .    ...+...         ..+......+.+|+.+||+.||++||||+||++.|+.-
T Consensus       259 ~----i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 M----IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H----HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2    2222211         22333445678899999999999999999999999854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=441.88  Aligned_cols=258  Identities=26%  Similarity=0.480  Sum_probs=202.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +++...++||+|+||+||+|++.+ .||||+++..  ..+..+.|.+|+.+|++++|||||+++|+|.+ +.++||||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            567778999999999999998865 6999998643  34456789999999999999999999999865 5789999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.++|.....       .++|.+++.|+.|||+||+|||+   ++||||||||+||||++++++||+|||+|+...
T Consensus       114 ~gGsL~~~l~~~~~-------~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          114 EGSSLYKHLHVQET-------KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SSCBHHHHHHTSCC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             CCCCHHHHHhhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            99999999975543       39999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .... .......+||+.|||||++..   +.++.++|||||||+||||+||+.||.......   .+.    .....+..
T Consensus       184 ~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~----~~~~~~~~  255 (307)
T 3omv_A          184 RWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QII----FMVGRGYA  255 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHH----HHHHTTCC
T ss_pred             cCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHH----HHHhcCCC
Confidence            3222 122455689999999999863   468999999999999999999999997643211   111    11112211


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          .+.+ ..........+.+|+.+||+.||++||||.||++.|+..
T Consensus       256 ----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          256 ----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             ----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1111 112223345677899999999999999999999988754

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=1.2e-53  Score=423.85  Aligned_cols=214  Identities=29%  Similarity=0.425  Sum_probs=189.2

Q ss_pred             cceeEEcCCCCCCCCCC-eEEe-ccccc-CCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEe
Q 006446           25 SSLHFNFQSFTEQNRNE-LSFD-NSTVA-KSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNIL  100 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~-l~~~-~a~~~-~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~  100 (644)
                      .+++|+|++|...   + |.++ ||.+. +|.|+||++.. +.+..+++|||+|++||+|||+.  +++||+|+|+|+|.
T Consensus         2 ~~~~F~f~~F~~~---~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~   76 (240)
T 1ioa_A            2 TETSFNFPNFHTD---DKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIR   76 (240)
T ss_dssp             CCCEEEESSCCTT---SSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECC
T ss_pred             cceEEEcCCCCCC---CcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEe
Confidence            3689999999854   7 9999 99995 89999998764 22345799999999999999986  89999999999999


Q ss_pred             c-CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecC
Q 006446          101 N-QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       101 ~-~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                      + +...+||||||||+|....|. +.||||||+|.+ ++++.||+|||||||+        +|||||||||+.|.++.+|
T Consensus        77 ~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~--------~nHVGIdvNs~~S~~t~~~  146 (240)
T 1ioa_A           77 AKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF--------KNRIDFDKNFIKPYVNENC  146 (240)
T ss_dssp             BSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT--------TTEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc--------CCceeeeeCCccccccccC
Confidence            7 556789999999999766666 899999999975 4577899999999998        5899999999999999999


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccC
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDG  251 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~s  251 (644)
                       +..|.+|+.++|||+||+  +.|+|++..   +.+|+|++.+||+++||++|||||||+||..   .+.|+|++|+|++
T Consensus       147 -~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s  225 (240)
T 1ioa_A          147 -DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSS  225 (240)
T ss_dssp             -CHHHHCSSCEEEEEEEETTTTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEE
T ss_pred             -CccccCCCEEEEEEEEeCCCcEEEEEEecCCCCccceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEe
Confidence             677889999999999999  789999853   3457999999999999999999999999999   9999999999988


Q ss_pred             Ccc
Q 006446          252 SDI  254 (644)
Q Consensus       252 s~~  254 (644)
                      +..
T Consensus       226 ~~~  228 (240)
T 1ioa_A          226 KFR  228 (240)
T ss_dssp             EEC
T ss_pred             eCC
Confidence            753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-52  Score=435.94  Aligned_cols=249  Identities=25%  Similarity=0.395  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++...  .....+.+.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57889999999999999999986  789999999754  33446789999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ||++|+|.++|......      .+++.+.+.|+.||+.||+|||+   ++|+||||||+||||+.++++||+|||+|+.
T Consensus       104 y~~gg~L~~~i~~~~~~------~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGV------LFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             CCTTCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             CCCCCcHHHHHHHcCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEccccccee
Confidence            99999999999654322      37888999999999999999999   9999999999999999999999999999997


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......   .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.......    +.   ... ..+.. 
T Consensus       175 ~~~~~~---~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~---~~i-~~~~~-  242 (350)
T 4b9d_A          175 LNSTVE---LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----LV---LKI-ISGSF-  242 (350)
T ss_dssp             CCHHHH---HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HH---HHH-HHTCC-
T ss_pred             ecCCcc---cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HH---HHH-HcCCC-
Confidence            653211   1345689999999999999999999999999999999999999997654221    11   111 11211 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +.+...++    ..+.+|+.+||+.||++|||++|+++
T Consensus       243 ----~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ----PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11222333    45778899999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-51  Score=431.47  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=207.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +.|+..++||+|+||+||+|++.  ++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999986  7899999998766666778899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++...         .+++.+...++.||+.||+|||+   ++|+||||||+||||+.++++||+|||+|+.+.
T Consensus       154 ~gg~L~~~l~~~---------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          154 EGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             TTEEHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            999999998642         28899999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ....   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......    .+...+    ..+     
T Consensus       222 ~~~~---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i----~~~-----  285 (346)
T 4fih_A          222 KEVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMI----RDN-----  285 (346)
T ss_dssp             SSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHS-----
T ss_pred             CCCC---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHH----HcC-----
Confidence            3221   145678999999999999999999999999999999999999999764321    111111    111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+.+  .........+.+|+.+||+.||++|||++|+++
T Consensus       286 ~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111  111122345778899999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-51  Score=424.20  Aligned_cols=265  Identities=26%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc----ceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----DFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E  394 (644)
                      +++...++||+|+||+||+|+++++.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+    .++||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            35667889999999999999999999999999654322 233456777788899999999999998764    5899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC-----CCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS-----EKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ||++|+|.++|...         .++|..+++++.|+|+||+|||+.+     ..+|+||||||+|||||.++++||+||
T Consensus        82 y~~~gsL~~~l~~~---------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY---------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             CCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CCCCCcHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            99999999999643         2899999999999999999999731     349999999999999999999999999


Q ss_pred             CCccccccccccc-ccccccccCCCccCccccccC------CCCCccchHHHHHHHHHHHcCCCCCCCCccccch-----
Q 006446          470 GLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG------RATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-----  537 (644)
Q Consensus       470 Gla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~------~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-----  537 (644)
                      |+|+......... ......+||+.|||||++.+.      .++.++|||||||+||||+||+.|+.........     
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            9998775332211 112346899999999998654      4678999999999999999998876533221100     


Q ss_pred             --hhHHHHHHHHHhcCchhhhhhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          538 --NSIVHWLWELRRKGRILDAADSRLGGEF-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       538 --~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        ......+....        .+..++..+     +.+..+.+.+|+.+||+.||++||||.||++.|+..
T Consensus       233 ~~~~~~~~~~~~~--------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          233 PSDPSVEEMRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CSSCCHHHHHHHH--------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccchHHHHHHHH--------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              00011111111        112222222     224567788999999999999999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-51  Score=435.23  Aligned_cols=265  Identities=22%  Similarity=0.387  Sum_probs=211.7

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecccc-hhhHHHHHHHHHHhccCC-CceeeEeeeeeec-
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRH-RNLVKLIGWCYER-  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~-  386 (644)
                      ..++|+..++||+|+||+||+|++.+       +.||||++..... ...+.|.+|+.+|.+++| ||||+++|+|.+. 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            45678889999999999999998753       4699999976543 345779999999999965 8999999999765 


Q ss_pred             cceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +.++||||||++|+|.++|+......        ......++|.+++.++.|||+||+|||+   ++||||||||+||||
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence            56899999999999999997543210        1122358999999999999999999999   999999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      ++++++||+|||+|+....... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.......  
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--  295 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--  295 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred             CCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence            9999999999999997653322 222455679999999999999999999999999999999998 999997654321  


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       .+.    .....+..         ...+......+.+++.+||+.||++|||+.||++.|+..
T Consensus       296 -~~~----~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          296 -EFC----RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             -HHH----HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHH----HHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence             121    12222221         122222334677889999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-50  Score=425.85  Aligned_cols=252  Identities=23%  Similarity=0.259  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +.|+..++||+|+||+||+|++.  +..||||+++....     ..+|+.++++++|||||++++++.+++.++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            46777889999999999999987  78999999975432     247999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccCCcccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLARTI  475 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla~~~  475 (644)
                      ++|+|.++|....        .+++.+...++.||++||+|||+   ++|+||||||+||||+.++ ++||+|||+|+.+
T Consensus       133 ~gg~L~~~l~~~~--------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          133 EGGSLGQLIKQMG--------CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             TTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            9999999997543        38999999999999999999999   9999999999999999987 6999999999987


Q ss_pred             ccccccc--ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          476 QENLKTH--HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       476 ~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......  ......+||+.|||||++.+..++.++|||||||++|||+||+.||...........+.       ....-
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~~~~~  274 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-------SEPPP  274 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-------HSCCG
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-------cCCCC
Confidence            5332211  11234679999999999999999999999999999999999999998755443222111       11110


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          ...+...++    ..+.+++.+||+.||++|||+.|+++.|...
T Consensus       275 ----~~~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          275 ----IREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ----GGGSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----chhcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                011223333    4577788999999999999999999887653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-50  Score=416.13  Aligned_cols=243  Identities=26%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             CCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceEEEE
Q 006446          322 NPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFLLVY  393 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  393 (644)
                      +..++||+|+||+||+|++.  +..||+|++...  .....+.|.+|+.+|++++|||||++++++..    ++.++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45668999999999999987  678999999654  33446779999999999999999999999865    34689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEcC-CCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLDS-EFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~-~~~vkL~DFG  470 (644)
                      |||++|+|.+++....        .+++.....++.||++||+|||+   ++  |+||||||+||||+. ++.+||+|||
T Consensus       109 Ey~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK--------VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCc
Confidence            9999999999997543        38999999999999999999998   66  999999999999985 7999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +|+.....     .....+||+.|||||++. ++++.++|||||||+||||+||+.||......   ..+.    .....
T Consensus       178 la~~~~~~-----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~----~~i~~  244 (290)
T 3fpq_A          178 LATLKRAS-----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIY----RRVTS  244 (290)
T ss_dssp             GGGGCCTT-----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHH----HHHTT
T ss_pred             CCEeCCCC-----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HHHH----HHHHc
Confidence            99864321     134568999999999886 46999999999999999999999999754321   1111    11222


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.....    +....+    ..+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~----~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          245 GVKPAS----FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCCCGG----GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCC----CCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211111    111222    34678899999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.1e-51  Score=421.69  Aligned_cols=247  Identities=23%  Similarity=0.296  Sum_probs=206.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||+||+|+..  ++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46889999999999999999986  788999999753   2334567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++|+|.+++....        .++..+...++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+
T Consensus       112 Ey~~gG~L~~~i~~~~--------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999997543        38999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+..... .......+||+.|||||++.+..++.++||||+||++|||+||+.||.......    +..    ....+. 
T Consensus       181 ~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~----~i~~~~-  250 (311)
T 4aw0_A          181 VLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFA----KIIKLE-  250 (311)
T ss_dssp             ECCTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHTC-
T ss_pred             ecCCCCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHcCC-
Confidence            8753222 222456789999999999999999999999999999999999999997654321    211    111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                           ..+...++    ..+.+|+.+|++.||++|||++|++
T Consensus       251 -----~~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -----YDFPEKFF----PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----CCCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----CCCCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence                 11222333    4567899999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=432.85  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=210.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      +.|+..++||+|+||.||+|++.  ++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46888999999999999999987  7899999998776666778999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++...         .+++.+...|+.||++||+|||+   ++|+||||||+||||+.++++||+|||+|+.+.
T Consensus       231 ~gG~L~~~i~~~---------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          231 EGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             TTEEHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             CCCcHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            999999998543         28899999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......    .+...+    ..+     
T Consensus       299 ~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i----~~~-----  362 (423)
T 4fie_A          299 KEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMI----RDN-----  362 (423)
T ss_dssp             SSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHS-----
T ss_pred             CCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHH----HcC-----
Confidence            322   1245678999999999999999999999999999999999999999764321    111111    111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ..+.+.  ........+.+|+.+||+.||++|||++|+++  .+...
T Consensus       363 ~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          363 LPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             CCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            111111  11122345678899999999999999999987  35543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-49  Score=406.52  Aligned_cols=244  Identities=24%  Similarity=0.406  Sum_probs=190.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||+|++....   ....+.+.+|+.++++++|||||++++++.+++.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999886  7899999997542   233567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+ +|+|.+++....        .++..+...++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+
T Consensus        93 Ey~-~g~L~~~l~~~~--------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--------KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             eCC-CCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCe
Confidence            999 789999986543        38999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ......    .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||......    .+..    ....+.
T Consensus       161 ~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~----~i~~~~  228 (275)
T 3hyh_A          161 IMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFK----NISNGV  228 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTC
T ss_pred             ecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCC
Confidence            765321    1345689999999999988776 57999999999999999999999764321    1111    111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            ..+...++    ..+.+|+.+|++.||++|||++|+++
T Consensus       229 ------~~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ------YTLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  11222233    45678899999999999999999987

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=1.7e-49  Score=388.81  Aligned_cols=193  Identities=27%  Similarity=0.467  Sum_probs=167.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|...   +|.++ +|.+. +|.|+||++..     +++|||+|++||+|||+.+|+++||+|+|+|+|.+ 
T Consensus         2 ~~~~F~f~~F~~~---~l~l~G~A~v~~~g~l~LT~~~~-----~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~   73 (223)
T 1dhk_B            2 TETSFIIDAFNKT---NLILQGDATVSSNGNLQLSYNSY-----DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTH   73 (223)
T ss_dssp             CCCEEEESSCCGG---GEEEESSEEECTTSCEEESSSCS-----SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECC
T ss_pred             cceEEEcCCCCcC---CEEEeccEEECCCCEEEcCCCCC-----CCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCC
Confidence            3689999999854   89999 99995 89999997654     79999999999999999999999999999999997 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      +...+||||||||+|....|.                   +++|||||||+        +||||||+||+ |+++.+| .
T Consensus        74 ~~~~~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT~--------~nHVGIdvNsi-S~~~~~~-~  124 (223)
T 1dhk_B           74 RQANSAVGLDFVLVPVQPESK-------------------GDTVTVEFDTF--------LSRISIDVNNN-DIKSVPW-D  124 (223)
T ss_dssp             C---CCSEEEEEEEEC-------------------------CCEEEEEETT--------TTEEEEEETTE-EEEEEEC-C
T ss_pred             CCCCCCCceEEEEecCCCCCC-------------------ccEEEEEecCC--------CCcccccCCcc-ccccccC-C
Confidence            556789999999999654332                   35899999998        58999999999 9999999 7


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCCc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGSD  253 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss~  253 (644)
                      ..|.+|+.++|||+||+  +.|+|++..   +.+|+|++.+||+++||++|||||||+||..   .+.|+|++|+|+++.
T Consensus       125 ~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~  204 (223)
T 1dhk_B          125 VHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKF  204 (223)
T ss_dssp             GGGTTTSCEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC
T ss_pred             ccccCCCEEEEEEEEeCCCCEEEEEEecCCCCccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEecc
Confidence            78889999999999999  689999853   3367999999999999999999999999999   999999999998875


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       205 ~  205 (223)
T 1dhk_B          205 I  205 (223)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8e-50  Score=413.93  Aligned_cols=246  Identities=24%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|+||+||+|+..     ++.||+|+++...  ......+.+|+.+|++++|||||++++++.+.+.++|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888999999999999999863     5679999997542  2234568899999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |||||++|+|.+++....        .+++.+...++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+
T Consensus       104 vmEy~~gg~L~~~l~~~~--------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEcCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999997543        38999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      |+.......   .....+||+.|||||++.+..++.++||||+||++|||+||+.||......+    +...    ...+
T Consensus       173 a~~~~~~~~---~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~----i~~~  241 (304)
T 3ubd_A          173 SKESIDHEK---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTM----ILKA  241 (304)
T ss_dssp             EEC-----C---CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHC
T ss_pred             ceeccCCCc---cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHH----HHcC
Confidence            986543221   1345689999999999999999999999999999999999999997654321    1111    1111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                      .      ..+...+    ...+.+|+.+||+.||++|||     ++|+++
T Consensus       242 ~------~~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          242 K------LGMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C------CCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------CCCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1      1122223    345678899999999999998     466664

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=1.9e-48  Score=368.77  Aligned_cols=173  Identities=28%  Similarity=0.501  Sum_probs=154.7

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-C
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-Q  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~  102 (644)
                      .+++|+|++|... ..+|.++ +|...+|.|+||++..     +++|||+|++||+|||+.+|+++||+|+|+|.|.+ +
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~~~~g~l~LT~~~~-----~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~   75 (181)
T 2ltn_A            2 ETTSFLITKFSPD-QQNLIFQGDGYTTKEKLTLTKAVK-----NTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPN   75 (181)
T ss_dssp             EEEEEEESSCCSS-CTTEEEEETCEECSSSEEEECSCS-----SCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSS
T ss_pred             cceEEEcCCCCCC-CCCEEEeccccCCCCCeEcCCCCC-----CCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCC
Confidence            4689999999864 4589999 9996689999998765     79999999999999999999999999999999997 5


Q ss_pred             CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCC--CCceeeecCCccceeeecCc
Q 006446          103 TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDIN--DNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~--~~Hvgid~ns~~s~~~~~~~  180 (644)
                      ...+||||||||+|....|. +.||||||+|.+ ++++.||+|||||||++|.+|||+  +|||||||||+.|+++.+| 
T Consensus        76 ~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~~Dp~~~~nHVGIdvNs~~S~~t~~~-  152 (181)
T 2ltn_A           76 SYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW-  152 (181)
T ss_dssp             TTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCceEEEEecCCCCCC-CCCccccccccC-CCCccccEEEEEeccccccccCCCCCCCEEEEEcCCccccceecc-
Confidence            66789999999999766666 899999999976 457789999999999999889999  9999999999999999888 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEecC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVANM  208 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~~~  208 (644)
                        ++.+|+.++|||+||+  ++|+|++.-|
T Consensus       153 --~l~~G~~~~v~I~Yd~~~~~L~V~l~~~  180 (181)
T 2ltn_A          153 --KLQNGEEANVVIAFNAATNVLTVSLTYP  180 (181)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred             --ccCCCCEEEEEEEEECCCCEEEEEEecC
Confidence              4789999999999999  7889888543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-47  Score=396.33  Aligned_cols=250  Identities=22%  Similarity=0.416  Sum_probs=187.3

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeecc---------
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH---------  387 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~---------  387 (644)
                      +|+..+.||+|+||+||+|+..  ++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5788899999999999999986  78999999976543 34567899999999999999999999987654         


Q ss_pred             ---ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          388 ---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       388 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                         .+++|||||++|+|.+++.....     ....++...+.|+.||++||+|||+   ++|+||||||+||||+.++.+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCT-----IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCS-----GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCC-----CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcE
Confidence               37999999999999999965432     1135677889999999999999999   999999999999999999999


Q ss_pred             EEeccCCccccccccccc---------ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          465 RLGDFGLARTIQENLKTH---------HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      ||+|||+|+.........         ...+..+||+.|||||++.+..++.++|||||||++|||++   ||....   
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---  231 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---  231 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---
Confidence            999999998875332111         11234579999999999999999999999999999999996   764321   


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        ... ..+. ..........         .......+.+|+.+||+.||++|||+.|+++
T Consensus       232 --~~~-~~~~-~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 --ERV-RTLT-DVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HHH-HHHH-HHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHH-HHHH-HHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111 1111 1111111111         1122234567899999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6e-46  Score=389.55  Aligned_cols=287  Identities=36%  Similarity=0.649  Sum_probs=245.7

Q ss_pred             cccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      .++++.++..++++|+..+.||+|+||.||+|++. +..||+|++........+.+.+|+.++++++||||++++++|.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34556666778899999999999999999999987 78999999887776777889999999999999999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      .+..++||||+++|+|.+++......    ...++|.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLP----TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCC----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEE
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCC----ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999654321    2248999999999999999999999   8999999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+|||+++........ .......||+.|+|||.+.++.++.++|||||||++|||++|+.||........ ..+..|..
T Consensus       180 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~  257 (321)
T 2qkw_B          180 ITDFGISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAV  257 (321)
T ss_dssp             ECCCTTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTH
T ss_pred             Eeeccccccccccccc-ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhh
Confidence            9999999865422211 113445689999999999999999999999999999999999999987554432 34667777


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .....+.+...+++.+......+....+.+++.+||+.||++||+++|+++.|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            777777777777887877888889999999999999999999999999999998653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.6e-46  Score=389.74  Aligned_cols=295  Identities=36%  Similarity=0.669  Sum_probs=249.0

Q ss_pred             CCcccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeee
Q 006446          305 APKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       305 ~~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      ....|++.++..+.++|+..+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3567999999999999999999999999999999876 78899999876532 233478999999999999999999999


Q ss_pred             eeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       383 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      |...+..++||||+++|+|.+++......    ...++|..+..++.|++.||.|||+.+..+|+||||||+|||++.++
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPES----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTT----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            99999999999999999999999765432    22489999999999999999999993333999999999999999999


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc-ccchhhHH
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ-NSYNNSIV  541 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~-~~~~~~l~  541 (644)
                      .+||+|||+++.......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus       172 ~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             CEEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             CEEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            999999999987643221  113445699999999999998999999999999999999999999963211 11223466


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP  605 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  605 (644)
                      +|+.............+..+...+.......+.+++.+|++.||.+|||+++|++.|++.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            7777777777777778888888889999999999999999999999999999999999875443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=397.23  Aligned_cols=266  Identities=20%  Similarity=0.281  Sum_probs=201.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeee------ccc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE------RHD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~  388 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||+++...  ....+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46888999999999999999986  7899999997543  2345678899999999999999999998764      357


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +|||||||+ |+|.+++....        .+++.+...++.||+.||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~--------~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ--------PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEee
Confidence            899999995 78999986543        38999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccccccc-ccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          469 FGLARTIQENLK-THHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       469 FGla~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      ||+|+.+..... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+.    .
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~----~  277 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM----M  277 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH----H
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH----H
Confidence            999987643221 11224567899999999998765 56999999999999999999999998754332222221    1


Q ss_pred             HHhcCc-----------hhhhhhcccCC--CCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          547 LRRKGR-----------ILDAADSRLGG--EFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       547 ~~~~~~-----------~~~~~d~~l~~--~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ......           ..... ..+..  ..+.     .....+.+|+.+||+.||++|||++|+++  .++..
T Consensus       278 ~~g~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          278 VLGTPSPAVIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHCCCCGGGTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hcCCCChHHhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            111100           00000 00000  0000     11235678999999999999999999987  35443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-44  Score=385.79  Aligned_cols=200  Identities=25%  Similarity=0.398  Sum_probs=169.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  390 (644)
                      ..++|+..++||+|+||+||+|+.+     ++.||+|++....  ...++.+|+.+|+.+ +|||||++++++.+.+.++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999864     4679999986543  345678999999998 6999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEecc
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDF  469 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DF  469 (644)
                      +|||||++|+|.+++.           .+++.+...++.|+++||+|||+   ++|+||||||+|||++.+ +.+||+||
T Consensus        97 lvmE~~~g~~L~~~~~-----------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN-----------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEEECCCCCCHHHHHT-----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEeCCCcccHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            9999999999999882           28889999999999999999999   999999999999999887 79999999


Q ss_pred             CCcccccccccc-------------------------cccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHc
Q 006446          470 GLARTIQENLKT-------------------------HHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVAC  523 (644)
Q Consensus       470 Gla~~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~t  523 (644)
                      |+|+........                         .......+||+.|||||++.+. .++.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999865422100                         0112345799999999998775 48999999999999999999


Q ss_pred             CCCCCCCCc
Q 006446          524 GRKPGNQSE  532 (644)
Q Consensus       524 G~~P~~~~~  532 (644)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.5e-45  Score=409.84  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=207.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||+|++........+.+.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57889999999999999999987  7899999998776666778899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC--CcEEEeccCCccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE--FNARLGDFGLART  474 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~--~~vkL~DFGla~~  474 (644)
                      ++|+|.++|.....       .+++.+...++.||++||.|||+   ++|+||||||+|||++.+  +.+||+|||+|+.
T Consensus       237 ~gg~L~~~i~~~~~-------~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          237 SGGELFEKVADEHN-------KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             CCCBHHHHHTCTTS-------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             CCCcHHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999864432       38999999999999999999999   999999999999999864  8999999999998


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      +....    .....+||+.|||||++.+..++.++||||+||++|||++|+.||......+    +..    ....+...
T Consensus       307 ~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~----~i~~~~~~  374 (573)
T 3uto_A          307 LDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLR----NVKSCDWN  374 (573)
T ss_dssp             CCTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH----HHHTTCCC
T ss_pred             ccCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHH----HHHhCCCC
Confidence            75322    1345689999999999999999999999999999999999999997654321    111    11111100


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        ........++    ..+.+|+.+||+.||.+||++.|+++
T Consensus       375 --~~~~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 --MDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --CCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCcccccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0011111222    35678899999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-43  Score=364.73  Aligned_cols=284  Identities=36%  Similarity=0.610  Sum_probs=233.1

Q ss_pred             CCcccCHHHHHHHhCCCCCC------CcccccCcEEEEEeeecCceEEEEEeecc----cchhhHHHHHHHHHHhccCCC
Q 006446          305 APKKFRLKELKKATGNFNPK------NKLGKGGFGTVYKGIWRNKEIAVKRVSET----SRQGKQEFIAEVTTIGSLRHR  374 (644)
Q Consensus       305 ~~~~~~~~~l~~a~~~f~~~------~~LG~G~fG~Vy~g~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~  374 (644)
                      ....|++.++..++++|...      ++||+|+||.||+|+.++..||+|++...    .....+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            35779999999999999988      89999999999999999999999998653    233457789999999999999


Q ss_pred             ceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCC
Q 006446          375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSS  454 (644)
Q Consensus       375 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~  454 (644)
                      ||+++++++.+.+..++||||+++|+|.+++......     ..++|..++.++.|+++||.|||+   .+|+||||||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~  162 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-----PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSA  162 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHH
Confidence            9999999999999999999999999999998643321     248999999999999999999999   89999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          455 NIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       455 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                      |||++.++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             HEEEcCCCcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999999876532211 11344679999999998764 5899999999999999999999999875544


Q ss_pred             cchhhHHHHHHHHHhc-CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          535 SYNNSIVHWLWELRRK-GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       535 ~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .....+   ....... ..+.+.+++.+ ........+.+.+++.+|++.||.+||+++++++.|+...
T Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          241 QLLLDI---KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SBTTHH---HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHH---HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            332222   2222222 22334444443 3456677888999999999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.4e-44  Score=373.95  Aligned_cols=266  Identities=30%  Similarity=0.530  Sum_probs=204.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ..++|+..++||+|+||.||+|+..+..||||++....  ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            34678889999999999999999999999999987653  3345678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |+++|+|.+++.....     ...+++..++.++.|+++||+|||+   .+  |+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGA-----REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CCTTCBHHHHHHSTTH-----HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             cCCCCcHHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            9999999999965321     1238999999999999999999999   77  999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    ....   ......
T Consensus       187 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~---~~~~~~  256 (309)
T 3p86_A          187 RLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAA---VGFKCK  256 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----HHHH---HHHSCC
T ss_pred             ccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH---HHhcCC
Confidence            8654221   11345679999999999999999999999999999999999999997654321    1111   110111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPP  609 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~p~  609 (644)
                               ....+......+.+++.+||+.||++||+++++++.|+.......+|+
T Consensus       257 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          257 ---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             ---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence                     112222233457789999999999999999999999988755444443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-43  Score=397.08  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHH---HHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEF---IAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..++||+|+||+||+++..  ++.||||++.+..   .......   ..++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56888999999999999999987  7889999997532   1222223   34467788889999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ||||||++|+|.++|....        .++......++.||+.||+|||+   ++||||||||+||||+.++++||+|||
T Consensus       269 lVmEy~~GGdL~~~l~~~~--------~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG--------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccc
Confidence            9999999999999997543        38999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +|+.....     .....+||+.|||||++.. ..|+.++||||+||+||||++|+.||........ ..+..    ...
T Consensus       338 lA~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~----~i~  407 (689)
T 3v5w_A          338 LACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR----MTL  407 (689)
T ss_dssp             TCEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHH----HHH
T ss_pred             eeeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH----hhc
Confidence            99876532     1345689999999999975 4799999999999999999999999976443221 11111    111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                      ..      ...+...++    ..+.+|+.+||+.||.+|++     ++||++
T Consensus       408 ~~------~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          408 TM------AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HC------CCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CC------CCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            11      111222333    45678899999999999998     677763

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.8e-43  Score=362.74  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=207.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||.||+|...  ++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            357999999999999999999875  788999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++...         .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++..
T Consensus        99 ~~~~~L~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           99 LAGGSLTDVVTET---------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             CTTCBHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999998643         28899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .   .......+.   
T Consensus       167 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~---~~~~~~~~~---  233 (297)
T 3fxz_A          167 TPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----A---LYLIATNGT---  233 (297)
T ss_dssp             CSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHHHCS---
T ss_pred             CCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHHHhCCC---
Confidence            53221   1345679999999999999999999999999999999999999997643211    1   111111111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         +  ....+......+.+++.+||+.||++|||++|+++
T Consensus       234 ---~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 ---P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               0  01112233455778999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=367.31  Aligned_cols=258  Identities=23%  Similarity=0.433  Sum_probs=210.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|...++||+|+||.||++++.  +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            46778899999999999999986  7789999997777777788999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++.....       .++|.+++.++.|+++||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus        90 ~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           90 KGGTLRGIIKSMDS-------QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             TTCBHHHHHHHCCT-------TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            99999999976433       38999999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccccc-----------cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          477 ENLKTHH-----------STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       477 ~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      .......           ......||+.|+|||.+.+..++.++|||||||++|||++|..|+............     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-----  234 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----  234 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----
Confidence            3221110           011457999999999999999999999999999999999999998654332211000     


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                            ......+......++    ..+.+++.+||+.||++||+++++++.|+..
T Consensus       235 ------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 ------NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ------CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  001111111222222    3467789999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=372.23  Aligned_cols=258  Identities=23%  Similarity=0.436  Sum_probs=208.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..++||+|+||.||+|.+.     +..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45677899999999999999985     345999999765 334567899999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++.....       .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       129 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDG-------QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             EECCTTCBHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eeCCCCCcHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence            999999999999965433       38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +................+|..|+|||++.+..++.++|||||||++|||++ |+.||......    .+..    ....+
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~----~~~~~  270 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVIS----SVEEG  270 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHH----HHHTT
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHH----HHHcC
Confidence            877543322222334456788999999998999999999999999999999 99999764322    1111    11111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                               .....+......+.+|+.+||+.||++||+++++++.|+....
T Consensus       271 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          271 ---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     1112222334567889999999999999999999999988643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-43  Score=372.70  Aligned_cols=265  Identities=23%  Similarity=0.345  Sum_probs=206.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc----ceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----DFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|++.++.||||++..... ....+..|+.++++++||||+++++++....    .+++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            5788899999999999999999999999999965443 3445667999999999999999999998754    3799999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC----------CeEeCCCCCCCEEEcCCCcE
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK----------RVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~----------~ivHrDlkp~NILld~~~~v  464 (644)
                      |+++|+|.+++...         .++|..+..++.|+++||+|||+   .          +|+||||||+|||++.++.+
T Consensus       103 ~~~~g~L~~~l~~~---------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A          103 FHEKGSLSDFLKAN---------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             CCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             cCCCCCHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            99999999999643         28999999999999999999998   6          99999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                      ||+|||+++....... ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||...........
T Consensus       171 kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          171 CIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            9999999987653322 222344679999999999876     3566789999999999999999999976443221110


Q ss_pred             HHHHHHHHHhcCchhhh----hhcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          540 IVHWLWELRRKGRILDA----ADSRLGGEF-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~----~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      . .   .........+.    .........     .......+.+|+.+||+.||++|||+++|++.|+..
T Consensus       250 ~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          250 E-E---EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             H-H---HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h-h---hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0 0   00000000000    011111111     123456688999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-43  Score=377.37  Aligned_cols=257  Identities=22%  Similarity=0.459  Sum_probs=197.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|++.     +..||||+++.. .....++|.+|+.++++++||||++++++|.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999875     456999999765 334567899999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++.....       .+++.+++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       125 ~e~~~~~sL~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDA-------QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             EECCTTCBHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EeCCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999999975432       38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +................++..|+|||++....++.++|||||||++|||++ |+.||......    .+..    ....+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~~----~i~~~  266 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIK----AVDEG  266 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHHH----HHHTT
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcC
Confidence            877533222221233346788999999999999999999999999999998 99998754321    1111    11111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                               .....+......+.+++.+||+.||++||++++|++.|+...
T Consensus       267 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          267 ---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             ---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                     111122233456788999999999999999999999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-42  Score=363.37  Aligned_cols=263  Identities=25%  Similarity=0.378  Sum_probs=213.9

Q ss_pred             CCcccCHHHHHHHhCC----------CCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC
Q 006446          305 APKKFRLKELKKATGN----------FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR  372 (644)
Q Consensus       305 ~~~~~~~~~l~~a~~~----------f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~  372 (644)
                      .+..+++++++.+++.          |+..++||+|+||.||+|+..  ++.||||++........+.+.+|+.++++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            3456888888888764          566779999999999999886  7899999998776666788999999999999


Q ss_pred             CCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       373 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                      ||||+++++++...+..++||||+++|+|.+++...         .+++..+..++.|+++||.|||+   .+|+|||||
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlk  168 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIK  168 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCC
Confidence            999999999999999999999999999999998532         38999999999999999999999   899999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          453 SSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       453 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      |+|||++.++.+||+|||+++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          169 SDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HHHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987653211   1345679999999999999999999999999999999999999997643


Q ss_pred             cccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       533 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..    .....   . ...     ..+.+.  ........+.+++.+|++.||++||+++++++.
T Consensus       246 ~~----~~~~~---~-~~~-----~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          246 PV----QAMKR---L-RDS-----PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HH----HHHHH---H-HHS-----SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HH----HHHHH---H-hcC-----CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            21    11111   1 111     111111  111223457788999999999999999999873

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.7e-43  Score=360.71  Aligned_cols=264  Identities=24%  Similarity=0.435  Sum_probs=205.9

Q ss_pred             CCCCCCCcccccCcEEEEEeee------cCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  390 (644)
                      ++|+..++||+|+||.||++++      .+..||||++........+.+.+|+.++++++||||++++++|...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5678899999999999999984      2678999999877766778899999999999999999999998654  4589


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++|+|.+++.....       .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEeCCCCCHHHHHHhccc-------ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            99999999999999976543       38999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc--------chhhHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNS--------YNNSIVH  542 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~--------~~~~l~~  542 (644)
                      +++................++..|+|||.+.+..++.++||||||+++|||++|..|+.......        .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99877533222222334457788999999999999999999999999999999999976532110        0001111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+...         .........+......+.+++.+||+.||++|||++|+++.|+..
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          240 HLIEL---------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHH---------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH---------HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111         111112222333445688899999999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-42  Score=371.07  Aligned_cols=262  Identities=22%  Similarity=0.410  Sum_probs=210.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ++|+..+.||+|+||.||+|++.         +..||||+++... ....+.+.+|+.+++++ +||||++++++|.+.+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            56788899999999999999863         2469999997653 33457799999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      .+++||||+++|+|.+++.......        ......+++.+++.++.||++||+|||+   .+|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence            9999999999999999997643210        0112348999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999876532211 12344567889999999999999999999999999999999 999987654322   


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       +..    ....+.         ....+......+.+++.+||+.||++||++.|+++.|+..
T Consensus       314 -~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 -LFK----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             -HHH----HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHH----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             221    111111         1122223345677899999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-42  Score=364.06  Aligned_cols=247  Identities=24%  Similarity=0.404  Sum_probs=204.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .++|+..+.||+|+||.||+|++.  ++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467889999999999999999985  789999999754  3344567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.+...++.|+++||+|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        94 e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             CCCTTCBHHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             ECCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999996543        28899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ......    ......||+.|+|||++.+..+. .++|||||||++|||++|+.||.......    +..    ....+.
T Consensus       163 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~----~i~~~~  230 (328)
T 3fe3_A          163 EFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRE----RVLRGK  230 (328)
T ss_dssp             GGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCC
T ss_pred             ecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhCC
Confidence            764321    13456799999999999888765 79999999999999999999997654221    111    111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .      .+..    .....+.+|+.+|++.||.+|||++|+++.
T Consensus       231 ~------~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 Y------RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C------CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C------CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1      1111    223456788999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.2e-43  Score=375.02  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=207.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|...+.||+|+||.||+|++.  +..||||.++... ....++|.+|+.++++++||||++++++|...+..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            56778899999999999999986  7789999987543 33456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       194 ~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGA-------RLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CTTCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999975432       38999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ...... .......++..|+|||.+..+.++.++|||||||++|||++ |+.||......    .+.+    ....+.  
T Consensus       264 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~----~~~~~~--  332 (377)
T 3cbl_A          264 ADGVYA-ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTRE----FVEKGG--  332 (377)
T ss_dssp             TTSEEE-CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHH----HHHTTC--
T ss_pred             CCCcee-ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCC--
Confidence            422111 11122345778999999998999999999999999999998 99998764321    1111    112221  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                             ....+......+.+|+.+||+.||++|||++++++.|+..
T Consensus       333 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          333 -------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                   1112222335677899999999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-42  Score=365.95  Aligned_cols=256  Identities=25%  Similarity=0.441  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..++||+|+||.||+|++.  +.    +||+|.+... .....+++.+|+.++++++||||++++++|.+. ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            46888999999999999999875  33    3688887543 334567899999999999999999999999875 4889


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+
T Consensus        94 v~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD-------NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEecCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcc
Confidence            9999999999999976543       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........+|..|+|||++.+..++.++|||||||++|||++ |+.||.......    +..    ....
T Consensus       164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~----~~~~  234 (327)
T 3poz_A          164 AKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS----ILEK  234 (327)
T ss_dssp             HHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH----HHHT
T ss_pred             eeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHH----HHHc
Confidence            987753322 121334567889999999999999999999999999999999 999997654322    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      +.         ....+......+.+++.+||+.||++||+++++++.|+....
T Consensus       235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 GE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TC---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CC---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11         112222334567789999999999999999999999987543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-42  Score=359.90  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||+|+..  ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            67889999999999999999886  7789999986543 23346788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++....        .+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           87 CSGGELFDRIEPDI--------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CTTEEGGGGSBTTT--------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            99999999985432        38999999999999999999999   99999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ..... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........  ....|.    ......
T Consensus       156 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~----~~~~~~  228 (323)
T 3tki_A          156 RYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKKTYL  228 (323)
T ss_dssp             EETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHH----TTCTTS
T ss_pred             ccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh----cccccC
Confidence            53222 122345689999999999987775 7799999999999999999999976543211  111111    111100


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                               .........+.+|+.+|++.||++|||++|+++.
T Consensus       229 ---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                     0011223456788999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-42  Score=355.14  Aligned_cols=264  Identities=24%  Similarity=0.370  Sum_probs=201.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhc--cCCCceeeEeeeeeec----cceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS--LRHRNLVKLIGWCYER----HDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~l  391 (644)
                      .++|+..++||+|+||.||+|+++++.||||++...   ....+..|.+++..  ++||||+++++++...    ..+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            467889999999999999999999999999998653   33455566666655  8999999999997653    45899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC-----CCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS-----EKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ||||+++|+|.+++...         .+++..++.++.|+++||+|||...     ..+|+||||||+|||++.++.+||
T Consensus        84 v~e~~~~g~L~~~l~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQLT---------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EECCCTTCBHHHHHTTC---------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             ehhhccCCCHHHHHhhc---------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence            99999999999999432         3899999999999999999999210     289999999999999999999999


Q ss_pred             eccCCccccccccccc-ccccccccCCCccCccccccC------CCCCccchHHHHHHHHHHHcC----------CCCCC
Q 006446          467 GDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG------RATIETDIYAFGVLILEVACG----------RKPGN  529 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~------~~t~~sDVwSfGvvl~el~tG----------~~P~~  529 (644)
                      +|||+++......... .......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765322211 112345799999999999876      455799999999999999999          78876


Q ss_pred             CCccccchhhHHHHHHHHHhcCchhhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          530 QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG-EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ...........   .........    ..+.+.. .+.......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       235 ~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          235 DVVPNDPSFED---MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTSCSSCCHHH---HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCcchhh---hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            54332221111   111111110    0111111 1233466788999999999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=355.39  Aligned_cols=273  Identities=21%  Similarity=0.270  Sum_probs=215.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc--ceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--DFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  393 (644)
                      ++|...++||+|+||.||+|+..  ++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999987  7889999997543 334577889999999999999999999998765  789999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----cCCCcEEEecc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDF  469 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DF  469 (644)
                      ||+++|+|.+++......     ..+++.+++.++.|+++||+|||+   .+|+||||||+|||+    +.++.+||+||
T Consensus        89 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNA-----YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             eCCCCCCHHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence            999999999999754332     138999999999999999999999   899999999999999    88888999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccc--------cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFL--------VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      |+++.......    .....||+.|+|||++.        ...++.++|||||||++|||++|+.||...........+.
T Consensus       161 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          161 GAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             CCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            99987653221    33457999999999886        5678999999999999999999999997644332222222


Q ss_pred             HHHHHHHhcCchhhhh-----------hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          542 HWLWELRRKGRILDAA-----------DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      .-+.............           +-.....+.......+.+++.+|++.||++||+++|+++....++-
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            2111111100000000           0011234567778889999999999999999999999999887653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.6e-43  Score=367.36  Aligned_cols=273  Identities=23%  Similarity=0.349  Sum_probs=213.2

Q ss_pred             CCCCCCCcccccCcEEEEEeee------cCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeee--eccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY--ERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~  390 (644)
                      ++|+..+.||+|+||.||++++      .+..||+|++........+.+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5778899999999999999984      26789999998777667788999999999999999999999987  445689


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++++|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA-------RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EEEeecCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccc
Confidence            99999999999999975433       38999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++................||..|+|||.+.+..++.++|||||||++|||++|+.||.........  ...+.......
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~  250 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVPAL  250 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CCHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccccccH
Confidence            9987653322222234456888999999999989999999999999999999999998653211000  00000000000


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      ..+.+..........+......+.+++.+|+++||++||+++++++.|+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11112222222233333445668889999999999999999999999998743

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-42  Score=350.68  Aligned_cols=253  Identities=25%  Similarity=0.467  Sum_probs=207.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||+|++. +..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            46778899999999999999985 77899999976543 34679999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~L~~~l~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           89 HGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             TCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCcHHHHHHhcCc-------ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999965443       38999999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......+|..|+|||.+....++.++||||||+++|||++ |+.||.......    +..   .. ..+     
T Consensus       159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----~~~---~~-~~~-----  223 (269)
T 4hcu_A          159 DQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVE---DI-STG-----  223 (269)
T ss_dssp             HHH--HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHH---HH-HTT-----
T ss_pred             ccc--ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----HHH---HH-hcC-----
Confidence            221  11334567888999999999999999999999999999999 999987643221    111   11 111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          .....+......+.+++.+|++.||++||+++++++.|+..
T Consensus       224 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          224 ----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                11111222234577889999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-42  Score=362.58  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..++||+|+||.||+|++.  +.    +||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46778899999999999999875  33    37888775432 334567889999999999999999999986 567899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+
T Consensus        92 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG-------ALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG-------GSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEeCCCCCHHHHHHHccc-------cCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCc
Confidence            9999999999999975432       38889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........+|..|+|||.+.++.++.++|||||||++|||++ |+.||.......    +..    ....
T Consensus       162 a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~----~~~~  232 (325)
T 3kex_A          162 ADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPD----LLEK  232 (325)
T ss_dssp             GGGSCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHH----HHHT
T ss_pred             ccccCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHH----HHHc
Confidence            998753322 222345678889999999999999999999999999999999 999997654322    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      +..         ...+......+.+++.+||+.||++||+++++++.|+.....
T Consensus       233 ~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          233 GER---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TCB---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCC---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111         011111222456788999999999999999999999876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-42  Score=375.56  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=206.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc-ceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH-DFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~  396 (644)
                      .++|+..++||+|+||.||+|.+.+..||||+++...  ..+.|.+|+.+|++++||||++++++|.+.. .+++|||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            3567788999999999999999999999999997654  4678999999999999999999999987765 799999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++......      .+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       270 ~~g~L~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRS------VLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             TTCBHHHHHHHHCTT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999764321      37899999999999999999999   899999999999999999999999999998543


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ..      .....++..|+|||.+....++.++|||||||++|||++ |+.||......+    +..    ....+.   
T Consensus       341 ~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~~~----~i~~~~---  403 (450)
T 1k9a_A          341 ST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP----RVEKGY---  403 (450)
T ss_dssp             ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----HHH----HHHTTC---
T ss_pred             cc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----HHHcCC---
Confidence            21      122357889999999999999999999999999999998 999997654322    111    111221   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                            +...+......+.+|+.+||+.||++||+++++++.|+..
T Consensus       404 ------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 ------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  1122223345677899999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=373.39  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=210.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..++||+|+||.||+|++.       +..||||+++.. ......++.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56788899999999999999854       457999999654 3445567899999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEEe
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLG  467 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~  467 (644)
                      +||||+++|+|.+++....... .....+++.+++.++.||++||+|||+   .+|+||||||+|||++.++   .+||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCS-SSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeCCCCCHHHHHHhhcccc-CccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999997654321 122348999999999999999999999   8999999999999999554   59999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+...   
T Consensus       227 DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~---  298 (367)
T 3l9p_A          227 DFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF---  298 (367)
T ss_dssp             CCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH---
T ss_pred             CCcccccccccccc-ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---
Confidence            99999876432221 22344568999999999999999999999999999999998 99998764321    12211   


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                       ...+.         ....+......+.+|+.+||+.||++||++.+|++.|+.....
T Consensus       299 -i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          299 -VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -HHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence             11111         1111222334577899999999999999999999999875433

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-41  Score=357.94  Aligned_cols=247  Identities=25%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||+++..  ++.||+|+++..   .......+.+|+.++++++||||+++++++...+.+++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999986  788999999764   2334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|..++....        .+++.....++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        85 E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           85 EYANGGELFFHLSRER--------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            9999999999986543        38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    ....+. 
T Consensus       154 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~----~i~~~~-  221 (337)
T 1o6l_A          154 EGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE----LILMEE-  221 (337)
T ss_dssp             CSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCC-
T ss_pred             hcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHH----HHHcCC-
Confidence            643221   1234568999999999999999999999999999999999999999764321    1111    111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~  597 (644)
                           ..+...+    ...+.+++.+|++.||++||     +++++++.
T Consensus       222 -----~~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -----IRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 1122223    34567888999999999999     89998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-42  Score=376.92  Aligned_cols=264  Identities=22%  Similarity=0.267  Sum_probs=210.1

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeee
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWC  383 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~  383 (644)
                      +.++++....++|+..++||+|+||+||+|++.  ++.||+|++....   ......+.+|..++.+++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            455666667789999999999999999999987  5789999997532   22334588999999999999999999999


Q ss_pred             eeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       384 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      .+.+.+++|||||++|+|.+++.....       .+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~-------~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFED-------RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCC
Confidence            999999999999999999999975332       38999999999999999999999   99999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                      +||+|||+++.......  ......+||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+...
T Consensus       214 vkL~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~  291 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG  291 (437)
T ss_dssp             EEECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEEcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence            99999999987643221  1134468999999999987     5678999999999999999999999998654332222


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQV  597 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~  597 (644)
                      .+..+.    ..-.     -+.....++    ..+.+|+.+|++.+|++  ||+++|+++.
T Consensus       292 ~i~~~~----~~~~-----~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 KIMNHK----ERFQ-----FPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHTHH----HHCC-----CCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhhhcc----cccc-----CCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            222110    0000     011111233    45667888999888888  9999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=356.21  Aligned_cols=254  Identities=28%  Similarity=0.497  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++|+..+.||+|+||.||++++.++.||+|++...  ...+.|.+|+.++++++||||+++++++.+  ..++||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            46778899999999999999999999999998643  345789999999999999999999999874  58999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc-EEEeccCCcccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQE  477 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-vkL~DFGla~~~~~  477 (644)
                      |+|.+++.....     ...+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++....
T Consensus        84 ~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           84 GSLYNVLHGAEP-----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             CBHHHHHHCSSS-----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCHHHHHhccCC-----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            999999975432     123788999999999999999999865578999999999999998886 79999999986542


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      .      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ....+... .+..    
T Consensus       159 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~-~~~~----  222 (307)
T 2eva_A          159 H------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVH-NGTR----  222 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HHHHHHHH-TTCC----
T ss_pred             c------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HHHHHHHh-cCCC----
Confidence            2      233468999999999999999999999999999999999999997543221     11111111 1111    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                       +.+...+    ...+.+++.+|++.||++||+++++++.|+...
T Consensus       223 -~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          223 -PPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             -CCCBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             -CCccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             1111222    345778999999999999999999999998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-41  Score=347.29  Aligned_cols=254  Identities=25%  Similarity=0.457  Sum_probs=207.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||+|.+. +..||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            56788899999999999999888 45799999976543 34678999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           87 NGCLLNYLRSHGK-------GLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             TCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             CCcHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            9999999975432       38999999999999999999999   8999999999999999999999999999987643


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ..   ... ..+.    
T Consensus       157 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~---~~~-~~~~----  222 (268)
T 3sxs_A          157 DQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VV---LKV-SQGH----  222 (268)
T ss_dssp             TCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HH---HHH-HTTC----
T ss_pred             hhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----HH---HHH-HcCC----
Confidence            221  11234456778999999998899999999999999999999 999987643221    11   111 1111    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                           ....+......+.+++.+|++.||++|||++++++.|+...
T Consensus       223 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          223 -----RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             -----CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                 01111112345778999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.2e-42  Score=348.97  Aligned_cols=252  Identities=27%  Similarity=0.471  Sum_probs=195.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccc----hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSR----QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|++.+..||||++.....    ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            5788899999999999999999999999999865432    235678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC--------CCcEEE
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS--------EFNARL  466 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--------~~~vkL  466 (644)
                      |+++++|.+++...         .+++..+..++.|+++||.|||+....+|+||||||+|||++.        ++.+||
T Consensus        87 ~~~~~~L~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           87 FARGGPLNRVLSGK---------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             CCTTEEHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             cCCCCCHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            99999999998432         3889999999999999999999922222999999999999986        778999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||+++......     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .   ...
T Consensus       158 ~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~---~~~  225 (271)
T 3dtc_A          158 TDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA----V---AYG  225 (271)
T ss_dssp             CCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH----H---HHH
T ss_pred             ccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHh
Confidence            9999998664321     234578999999999999999999999999999999999999997643211    1   111


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ...         .......+......+.+++.+|++.||++||+++|+++.|+.
T Consensus       226 ~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          226 VAM---------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHT---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hhc---------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111         111122223334567889999999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.1e-42  Score=365.57  Aligned_cols=273  Identities=21%  Similarity=0.376  Sum_probs=213.1

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeE
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKL  379 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l  379 (644)
                      +...+.....++|+..++||+|+||.||+|++.       ++.||||+++.... ...+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            344555556788999999999999999999843       36799999976533 3456799999999999 79999999


Q ss_pred             eeeeeeccc-eEEEEeccCCCccchhhhccCCCCC---------------------------------------------
Q 006446          380 IGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSG---------------------------------------------  413 (644)
Q Consensus       380 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~~---------------------------------------------  413 (644)
                      +++|.+.+. .++||||+++|+|.+++........                                             
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999976432100                                             


Q ss_pred             -------------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccc
Q 006446          414 -------------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK  480 (644)
Q Consensus       414 -------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~  480 (644)
                                   .....+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                         001228999999999999999999999   8999999999999999999999999999987643222


Q ss_pred             ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       481 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                       ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......   .+.    .....+.       
T Consensus       249 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~-------  313 (359)
T 3vhe_A          249 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC----RRLKEGT-------  313 (359)
T ss_dssp             -CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHH----HHHHHTC-------
T ss_pred             -chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHH----HHHHcCC-------
Confidence             122345678999999999999999999999999999999998 999997654322   111    1111111       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        ....+......+.+++.+|++.||++||+++|+++.|+..
T Consensus       314 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          314 --RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence              1111222234577889999999999999999999999754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-42  Score=360.95  Aligned_cols=267  Identities=25%  Similarity=0.451  Sum_probs=212.6

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH  387 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~  387 (644)
                      ...++|+..+.||+|+||.||+|++.+       ..||+|+++... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999999864       689999997653 334577999999999999999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC----------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS----------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI  451 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl  451 (644)
                      ..++||||+++|+|.+++.......                ......+++.+++.++.||++||.|||+   .+|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence            9999999999999999997542110                0011358999999999999999999999   89999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 006446          452 KSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQ  530 (644)
Q Consensus       452 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~  530 (644)
                      ||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999987653221 111344568899999999999999999999999999999999 9999976


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      ....    .+..    ....+...         ..+......+.+++.+||+.||++||++.++++.|+....
T Consensus       280 ~~~~----~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          280 MAHE----EVIY----YVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SCHH----HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CChH----HHHH----HHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            4321    1111    11222211         1122223467789999999999999999999999998653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.8e-42  Score=354.37  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=203.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--C-------ceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--N-------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      ++|...+.||+|+||.||+|+..  +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            46778899999999999999876  2       46999999877767778899999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc------
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN------  463 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~------  463 (644)
                      ++||||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.      
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKN-------CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             EEEEECCCCCCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence            999999999999999976443       38899999999999999999999   89999999999999999887      


Q ss_pred             --EEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          464 --ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       464 --vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                        +||+|||+++....       .....||..|+|||.+.+ ..++.++|||||||++|||++|..|+.......   ..
T Consensus       158 ~~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~  227 (289)
T 4fvq_A          158 PFIKLSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RK  227 (289)
T ss_dssp             CEEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH
T ss_pred             ceeeeccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HH
Confidence              99999999976532       223457889999999987 678999999999999999999665543322111   11


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVL  607 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~  607 (644)
                      ..    ....       ...+....    ...+.+++.+||+.||++|||++++++.|+....+...
T Consensus       228 ~~----~~~~-------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          228 LQ----FYED-------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             HH----HHHT-------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             HH----Hhhc-------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            11    1111       01111111    23467789999999999999999999999988654443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.2e-42  Score=376.30  Aligned_cols=257  Identities=25%  Similarity=0.456  Sum_probs=209.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..++|+..++||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            4467888999999999999999997 6789999997654 34678999999999999999999999986 5679999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |++|+|.+++.....      ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       264 ~~~g~L~~~l~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEG------SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             CTTCBHHHHHHSHHH------HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             cCCCcHHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            999999999975432      137889999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....  .......+|..|+|||.+..+.++.++|||||||++|||++ |+.||......    .+...    ...+.  
T Consensus       335 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~----i~~~~--  402 (454)
T 1qcf_A          335 EDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRA----LERGY--  402 (454)
T ss_dssp             CCHHH--HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH----HHHTC--
T ss_pred             CCCce--eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCC--
Confidence            43211  11233456789999999999999999999999999999999 99999764321    12211    11111  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                             ....+......+.+|+.+||+.||++||++++|++.|+....
T Consensus       403 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 -------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                   111222334567889999999999999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-41  Score=346.09  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=204.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|++++..||+|++....  ....+.+.+|+.++++++||||+++++++.+.  +..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            468889999999999999999999999999997543  34456799999999999999999999999887  78899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |+++|+|.+++.....      ..+++..++.++.|+++||.|||+   .+  ++||||||+|||++.++.++|+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTN------FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             CCTTCBHHHHHHSCSS------CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             ccCCCcHHHHHhhccc------CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccce
Confidence            9999999999975432      148999999999999999999998   77  999999999999999999999999887


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCC---ccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATI---ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~---~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      ....        .....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||.......    .   ......
T Consensus       161 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~---~~~~~~  225 (271)
T 3kmu_A          161 FSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----I---GMKVAL  225 (271)
T ss_dssp             CTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----H---HHHHHH
T ss_pred             eeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----H---HHHHHh
Confidence            6432        23346899999999998765544   7999999999999999999997643211    1   111111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+         .....+......+.+++.+||+.||++||+++++++.|+..
T Consensus       226 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          226 EG---------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             SC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            11         11122223334678899999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.8e-42  Score=379.59  Aligned_cols=256  Identities=28%  Similarity=0.467  Sum_probs=211.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..+|+..++||+|+||.||+|++.  +..||||+++.... ..++|.+|+.+|++++||||++++++|.+.+.+++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356778899999999999999987  67899999976543 467899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |++|+|.+++......      .+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       298 ~~~g~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             CTTCBHHHHHHHSCTT------TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             cCCCCHHHHHHhcCcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999754321      38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....  .......++..|+|||.+..+.++.++|||||||++|||++ |+.||.......    +...    ...    
T Consensus       369 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~~~~----~~~----  434 (495)
T 1opk_A          369 TGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYEL----LEK----  434 (495)
T ss_dssp             TTCCE--ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHH----HHT----
T ss_pred             cCCce--eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHc----
Confidence            43211  11234456789999999999999999999999999999999 999987654321    2211    111    


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                           ..+...+......+.+|+.+||+.||++||+++++++.|+...
T Consensus       435 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                 1112222333456778999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-41  Score=352.84  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=205.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57888999999999999999876  7789999986532   334567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        91 e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG--------PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             ECCCSCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             eCCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            9999999999996543        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ........ ..
T Consensus       160 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~-~~  229 (294)
T 4eqm_A          160 ALSETSL--TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQD-SV  229 (294)
T ss_dssp             TC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHHHHSS-CC
T ss_pred             ccccccc--cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhhc-cC
Confidence            7653221  11344679999999999999999999999999999999999999997644211       11111111 11


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-SMKTVLQVLSGEA  602 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~~~  602 (644)
                      .. ........+    ...+.+++.+|++.||++|| +++++.+.|+...
T Consensus       230 ~~-~~~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          230 PN-VTTDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CC-HHHHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CC-cchhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            11 111122223    34577889999999999999 9999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=360.32  Aligned_cols=243  Identities=26%  Similarity=0.358  Sum_probs=193.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++....  ......+..|+..+.++ +||||++++++|.+++.+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57899999999999999999986  7889999986543  23344556666666665 8999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+ +++|.+++.....       .++|..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus       137 e~~-~~~L~~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA-------SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             ecc-CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            999 7899998876543       38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......    ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.....           +.....+..
T Consensus       206 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~  269 (311)
T 3p1a_A          206 ELGTAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYL  269 (311)
T ss_dssp             ECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCC
T ss_pred             ecccCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCC
Confidence            764321    1344569999999998875 799999999999999999999877543210           111122221


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .....    ..    ....+.+++.+|+++||++||+++|+++
T Consensus       270 ~~~~~----~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFT----AG----LSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHH----TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Ccccc----cC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111    11    2345778999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-41  Score=348.90  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=205.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .++|+..+.||+|+||.||++.+. +..||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            457788899999999999999988 45799999976543 3467899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....       .+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A          102 ANGCLLNYLREMRH-------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             TTCBHHHHHHCGGG-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCCcHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            99999999976433       38999999999999999999999   899999999999999999999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ...    ....+    
T Consensus       172 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----~~~----~~~~~----  237 (283)
T 3gen_A          172 DDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAE----HIAQG----  237 (283)
T ss_dssp             CHHH--HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHH----HHHTT----
T ss_pred             cccc--ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----HHH----HHhcc----
Confidence            3211  11234457788999999998999999999999999999998 999997654321    111    11111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                           .....+......+.+++.+||+.||++||+++++++.|+..
T Consensus       238 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          238 -----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                 11111122235677899999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=364.53  Aligned_cols=264  Identities=23%  Similarity=0.405  Sum_probs=212.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~  386 (644)
                      .++|...++||+|+||.||+|++.         +..||+|++.... ....+.+.+|+.+++++ +||||++++++|...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888999999999999999864         2469999997653 34457889999999999 999999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +..++||||+++|+|.+++.......        ......+++.+++.++.|+++||.|||+   .+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence            99999999999999999997653211        1112358999999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      +.++.+||+|||+++....... ........+|..|+|||++.+..++.++|||||||++|||++ |+.||......   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             cCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            9999999999999987653221 122344567889999999999999999999999999999999 99998764321   


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                       .+..    ....+.         ....+......+.+++.+||+.||++||+++|+++.|+...
T Consensus       301 -~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          301 -ELFK----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             -HHHH----HHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHH----HHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1211    111211         11122223346778999999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-41  Score=361.79  Aligned_cols=250  Identities=25%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch------hhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      .++|+..+.||+|+||.||+++..  +..||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            357888999999999999999986  778999999764322      246789999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NAR  465 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vk  465 (644)
                      ++||||+++|+|.+++....        .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE--------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS--------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEcCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEE
Confidence            99999999999999995432        38999999999999999999999   8999999999999998877    799


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+|||+++......    ......||+.|+|||++....++.++|||||||++|||++|+.||.......    +..   
T Consensus       160 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~---  228 (361)
T 2yab_A          160 LIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA---  228 (361)
T ss_dssp             ECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---
T ss_pred             EEecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---
Confidence            99999998765321    1345679999999999999899999999999999999999999997654221    111   


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       ....+...  .++......    ...+.+++.+|++.||++|||+.|+++
T Consensus       229 -~i~~~~~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          229 -NITAVSYD--FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -HHHTTCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHhcCCC--CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             11111100  000000111    245678999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=357.31  Aligned_cols=250  Identities=20%  Similarity=0.290  Sum_probs=203.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..+.||+|+||.||+++..  +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            367888999999999999999986  6789999986543 3456788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC--CCcEEEeccCCcc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS--EFNARLGDFGLAR  473 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~  473 (644)
                      +++|+|.+++.....       .+++.++..++.|+++||.|||+   .+|+||||||+|||++.  ++.+||+|||+++
T Consensus        83 ~~g~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           83 ISGLDIFERINTSAF-------ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCBHHHHHTSSSC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999965432       38999999999999999999999   89999999999999987  7899999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   ... .+..
T Consensus       153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~---~i~-~~~~  220 (321)
T 1tki_A          153 QLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIE---NIM-NAEY  220 (321)
T ss_dssp             ECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---HHH-HTCC
T ss_pred             ECCCCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHH---HHH-cCCC
Confidence            765321    1345678999999999998889999999999999999999999997644321    111   111 1110


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .  .+......+    ...+.+++.+|++.||++|||+.|+++
T Consensus       221 ~--~~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          221 T--FDEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  000000112    345778999999999999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=348.83  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--------------------------hhhHHHHHHHHHHhc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--------------------------QGKQEFIAEVTTIGS  370 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~  370 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||+|++.....                          ...+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            67888999999999999999876  67899999865421                          123568899999999


Q ss_pred             cCCCceeeEeeeeee--ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEe
Q 006446          371 LRHRNLVKLIGWCYE--RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLH  448 (644)
Q Consensus       371 l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH  448 (644)
                      ++||||+++++++.+  .+..++||||+++++|.+++...         .+++.++..++.|+++||+|||+   .+|+|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH  160 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---------PLSEDQARFYFQDLIKGIEYLHY---QKIIH  160 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeec
Confidence            999999999999986  56799999999999998875321         38999999999999999999999   89999


Q ss_pred             CCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCC---CCCccchHHHHHHHHHHHcCC
Q 006446          449 RDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR---ATIETDIYAFGVLILEVACGR  525 (644)
Q Consensus       449 rDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~~sDVwSfGvvl~el~tG~  525 (644)
                      |||||+|||++.++++||+|||+++.......   ......||+.|+|||.+....   ++.++|||||||++|||++|+
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            99999999999999999999999987653211   134467999999999987665   378899999999999999999


Q ss_pred             CCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          526 KPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       526 ~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .||......    .+   .... ......    ......+    ...+.+++.+||+.||++||++.|+++
T Consensus       238 ~pf~~~~~~----~~---~~~~-~~~~~~----~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          238 CPFMDERIM----CL---HSKI-KSQALE----FPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSSCCSSHH----HH---HHHH-HHCCCC----CCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCccHH----HH---HHHH-hcccCC----CCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            999754321    11   1111 111100    0001122    345778899999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=359.00  Aligned_cols=257  Identities=23%  Similarity=0.459  Sum_probs=200.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|+||.||+|++..      ..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999998762      249999997643 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++.....       .+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       124 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG-------EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEeCCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCc
Confidence            9999999999999975433       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++................+|..|+|||.+....++.++|||||||++|||++ |+.||......    .+..    ....
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~----~~~~  265 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMK----AIND  265 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HHHT
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHH----HHHC
Confidence            9876533222222233456789999999999999999999999999999999 99998654321    1111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      +.         ....+......+.+++.+||+.||++||++.++++.|+...
T Consensus       266 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          266 GF---------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             TC---------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CC---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11         11112223456788999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=356.27  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=202.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch------hhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|.+......      ..+.+.+|+.++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888999999999999999986  788999998754321      3567899999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL  466 (644)
                      +||||+++|+|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++    .+||
T Consensus        91 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE--------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS--------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEcCCCCCHHHHHHhcC--------CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999995432        38999999999999999999999   9999999999999999887    8999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||+++......    ......||+.|+|||++....++.++|||||||++|||++|+.||.......    ...   .
T Consensus       160 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~---~  228 (326)
T 2y0a_A          160 IDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA---N  228 (326)
T ss_dssp             CCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---H
T ss_pred             EECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHH---H
Confidence            9999998764221    1345679999999999998999999999999999999999999997643211    111   1


Q ss_pred             HHhc-CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRK-GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .... .....    .....    ....+.+++.+|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~----~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSAVNYEFED----EYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHTCCCCCH----HHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCcCc----ccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1110 00000    00011    1245678899999999999999999987

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-41  Score=350.50  Aligned_cols=243  Identities=23%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999986  7889999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        86 e~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             CCCCSCBHHHHHHHTS--------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eCCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999997543        38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ..   .... .+. 
T Consensus       155 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~---~~i~-~~~-  219 (318)
T 1fot_A          155 YVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TY---EKIL-NAE-  219 (318)
T ss_dssp             ECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---HHHH-HCC-
T ss_pred             ecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HH---HHHH-hCC-
Confidence            65421      334679999999999999999999999999999999999999997643211    11   1111 111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                           ..+...+    ...+.+++.+|++.||++||     +++++++
T Consensus       220 -----~~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -----LRFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 1122223    34577888999999999999     8888874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-41  Score=373.27  Aligned_cols=257  Identities=26%  Similarity=0.458  Sum_probs=204.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .++|+..++||+|+||.||+|.+. +..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            356778899999999999999998 4679999997654 235789999999999999999999999976 6789999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++......      .+++.+++.++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~gsL~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          261 SKGSLLDFLKGETGK------YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             TTCBHHHHHSHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             cCCCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999643211      38899999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ....  .......++..|+|||.+..+.++.++|||||||++|||++ |+.||......    .+..    ....+.   
T Consensus       332 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~----~i~~~~---  398 (452)
T 1fmk_A          332 DNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGY---  398 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTC---
T ss_pred             CCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCC---
Confidence            3211  11234457889999999999999999999999999999999 99998764321    1111    111111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                            +...+....+.+.+|+.+||+.||++|||++++++.|+.....
T Consensus       399 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                  1122223345678899999999999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.7e-41  Score=346.10  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=201.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchh-------hHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG-------KQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      .++|+..+.||+|+||.||+|++.  ++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999985  7889999986543221       267899999999999999999999987654 


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEcCCCc---
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLDSEFN---  463 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~---  463 (644)
                       ++||||+++|+|.+++.....       .+++..++.++.|+++||+|||+   .+  |+||||||+|||++.++.   
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH-------PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS-------CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             -eEEEEecCCCCHHHHHhcccC-------CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCc
Confidence             799999999999998865443       38999999999999999999999   77  999999999999988776   


Q ss_pred             --EEEeccCCcccccccccccccccccccCCCccCccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          464 --ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL--VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       464 --vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                        +||+|||+++.....      .....||+.|+|||.+.  ...++.++|||||||++|||++|+.||........  .
T Consensus       166 ~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~  237 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--K  237 (287)
T ss_dssp             CCEEECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--H
T ss_pred             eeEEeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--H
Confidence              999999999754321      34467999999999984  45678999999999999999999999976543211  1


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ...   .....         ......+......+.+++.+||+.||++||+++++++.|+.
T Consensus       238 ~~~---~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          238 FIN---MIREE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHH---HHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHH---HHhcc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111   11111         11222233334567889999999999999999999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-41  Score=355.94  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeecC--c---eEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWRN--K---EIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~~--~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      ...++|+..+.||+|+||.||+|++..  .   .||||++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999998863  2   7999998754  34456789999999999999999999999987765


Q ss_pred             e------EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          389 F------LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       389 ~------~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      .      ++|+||+++|+|.+++.......  ....+++..++.++.|+++||.|||+   .+|+||||||+|||++.++
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGE--NPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccc--cccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence            4      99999999999999996543221  11248999999999999999999999   8999999999999999999


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHH
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~  541 (644)
                      .+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......    +.
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~  249 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IY  249 (323)
T ss_dssp             CEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH
T ss_pred             CEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HH
Confidence            9999999999876532211 11234457889999999999999999999999999999999 899987654322    11


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVL  607 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~  607 (644)
                      ..    ...+.         ....+......+.+++.+|++.||++||++.++++.|+....-|-.
T Consensus       250 ~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          250 NY----LIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             HH----HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HH----HhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            11    11111         1111222335678899999999999999999999999886544433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-41  Score=353.83  Aligned_cols=258  Identities=19%  Similarity=0.237  Sum_probs=206.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||||++.....  .+.+..|+.+++++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            57888999999999999999964  78899999875432  35688999999999 999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc-----EEEeccC
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-----ARLGDFG  470 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-----vkL~DFG  470 (644)
                      + +++|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.     +||+|||
T Consensus        87 ~-~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           87 L-GPSLEDLFDLCDR-------TFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             C-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             C-CCCHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            9 9999999975432       38999999999999999999999   89999999999999999887     9999999


Q ss_pred             Cccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          471 LARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       471 la~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. +..
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~-i~~  234 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK-IGD  234 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH-HHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH-HHh
Confidence            998764322111    012456899999999999999999999999999999999999999987543332221111 111


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ......     ...+...+    . .+.+++.+|++.||.+||++.++.+.|+.
T Consensus       235 ~~~~~~-----~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          235 TKRATP-----IEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHHSC-----HHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hhccCC-----HHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            111000     01111112    1 67788999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3e-41  Score=348.26  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=198.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||+|+.. ++.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999987 78899999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ ++|.+++.....       .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEG-------GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             CS-EEHHHHHHTSTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             cC-CCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            96 599988865433       38899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch-
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI-  553 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~-  553 (644)
                      .....   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........   +.. +......... 
T Consensus       151 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~-~~~~~~~~~~~  223 (288)
T 1ob3_A          151 GIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSK  223 (288)
T ss_dssp             CC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTT
T ss_pred             Ccccc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHHHHCCCChh
Confidence            42211   1334578999999999875 4589999999999999999999999976543221   111 1111111100 


Q ss_pred             -----hh--hhhcccCC-------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 -----LD--AADSRLGG-------EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 -----~~--~~d~~l~~-------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           .+  ..++.+..       .+.......+.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 00  00000000       011122345678999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=362.09  Aligned_cols=246  Identities=23%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             CCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      ..+.||+|+||.||+|+..  +..||+|+++.......+.+.+|+.++++++||||+++++++.+.+.+++||||+++|+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3568999999999999876  77899999987766667889999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE--cCCCcEEEeccCCccccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML--DSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl--d~~~~vkL~DFGla~~~~~~  478 (644)
                      |.+++.....       .+++..+..++.||++||.|||+   .+|+||||||+|||+  +.++.+||+|||+++.....
T Consensus       173 L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          173 LFDRIIDESY-------NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EHHHHHHTGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             HHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9998865432       38999999999999999999999   899999999999999  56789999999999876532


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD  558 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  558 (644)
                      ..    .....||+.|+|||++....++.++|||||||++|||++|+.||........   +    .........  . .
T Consensus       243 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~----~~i~~~~~~--~-~  308 (373)
T 2x4f_A          243 EK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---L----NNILACRWD--L-E  308 (373)
T ss_dssp             CB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H----HHHHHTCCC--S-C
T ss_pred             cc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhccCC--C-C
Confidence            21    3345799999999999988999999999999999999999999976543211   1    111111000  0 0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       559 ~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ......+    ...+.+++.+|++.||++||+++|+++
T Consensus       309 ~~~~~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 DEEFQDI----SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001122    345778999999999999999999997

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-41  Score=361.92  Aligned_cols=252  Identities=19%  Similarity=0.293  Sum_probs=206.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..+.||+|+||.||+|+..  +..+|+|++..........+.+|+.++++++||||+++++++.+...+++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357899999999999999999986  678999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC--CCcEEEeccCCcc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS--EFNARLGDFGLAR  473 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~  473 (644)
                      +++|+|.+++.....       .+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++
T Consensus       130 ~~gg~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          130 LSGGELFDRIAAEDY-------KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             CCCCBHHHHTTCTTC-------CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             CCCCcHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999865432       38999999999999999999999   89999999999999974  4779999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ...   ... ....
T Consensus       200 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~---~i~-~~~~  267 (387)
T 1kob_A          200 KLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQ---NVK-RCDW  267 (387)
T ss_dssp             ECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---HHH-HCCC
T ss_pred             ecCCCc----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----HHH---HHH-hCCC
Confidence            765321    1234579999999999999999999999999999999999999997643211    111   111 1110


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            .............+.+++.+||+.||++||++.|+++.
T Consensus       268 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 ------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                  01111111223457789999999999999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=361.05  Aligned_cols=247  Identities=24%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..++||+|+||.||+++..  ++.||+|+++..   .....+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999986  678999999754   233456678899999988 69999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|..++....        .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+
T Consensus       102 v~E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR--------RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccc
Confidence            999999999999997543        38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++......   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..    ....+
T Consensus       171 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~----~i~~~  239 (353)
T 3txo_A          171 CKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFE----AILND  239 (353)
T ss_dssp             CBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHC
T ss_pred             eeecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHH----HHHcC
Confidence            98643221   12445689999999999998899999999999999999999999997654322    111    11111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM------KTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~------~evl~  596 (644)
                      .          ..++......+.+++.+|++.||++||++      +++++
T Consensus       240 ~----------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 E----------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C----------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1          11222233457788999999999999998      66664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=356.58  Aligned_cols=266  Identities=24%  Similarity=0.398  Sum_probs=209.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ..++|+..+.||+|+||.||+|++.       +..||+|++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3467888999999999999999872       357999999754 233457899999999999 8999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC---------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS---------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~---------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                      ..++||||+++|+|.+++.......               ......+++..++.++.|+++||.|||+   .+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence            9999999999999999997543210               0111248999999999999999999999   899999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 006446          453 SSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQS  531 (644)
Q Consensus       453 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~  531 (644)
                      |+|||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999987653321 112344567889999999999999999999999999999998 99999765


Q ss_pred             ccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          532 EQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       532 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      ....   .+.    .....+         .....+......+.+|+.+||+.||.+||++.++++.|+...
T Consensus       279 ~~~~---~~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          279 PVDA---NFY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CCSH---HHH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CcHH---HHH----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            4322   111    111111         111122223456778999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-40  Score=348.55  Aligned_cols=261  Identities=22%  Similarity=0.279  Sum_probs=200.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..++||+|+||.||+|+.. ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            367888999999999999999986 78899999875432  234678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ |+|.+++.....       .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A          100 FME-KDLKKVLDENKT-------GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             CCS-EEHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCC-CCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence            996 588888865433       38899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.    ........
T Consensus       169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~~~  241 (311)
T 3niz_A          169 FGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF----SILGTPNP  241 (311)
T ss_dssp             TTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH----HHHCCCCT
T ss_pred             cCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----HHHCCCCh
Confidence            642211   1344578999999999876 568999999999999999999999998765443222222    11111100


Q ss_pred             h---------hhhhcccC--CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 L---------DAADSRLG--GEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~---------~~~d~~l~--~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .         ...+....  ....     ......+.+|+.+|++.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0         00000000  0000     011235678999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.3e-41  Score=350.48  Aligned_cols=263  Identities=26%  Similarity=0.407  Sum_probs=210.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      .++|...+.||+|+||.||+++..       +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            457888899999999999999863       3679999997643 34457889999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCC----------------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCC
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNS----------------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKS  453 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp  453 (644)
                      ++||||+++|+|.+++.......                ......+++.+++.++.|+++||.|||+   .+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence            99999999999999997643210                0112348999999999999999999999   8999999999


Q ss_pred             CCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCc
Q 006446          454 SNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSE  532 (644)
Q Consensus       454 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~  532 (644)
                      +|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             heEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987653221 111334567889999999999899999999999999999999 999997654


Q ss_pred             cccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       533 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ...    +..    ....+.         ....+......+.+++.+|++.||++||++.++++.|+..
T Consensus       258 ~~~----~~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          258 PER----LFN----LLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGG----HHH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH----HHH----HhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            322    211    111111         1112222335677899999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-41  Score=346.72  Aligned_cols=260  Identities=28%  Similarity=0.514  Sum_probs=197.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||.||+|++.+ .+|+|+++...  ....+.+.+|+.++++++||||+++++++ .....++||||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            4678899999999999999998765 59999987543  34457799999999999999999999976 45578999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A          101 CEGSSLYHHLHASET-------KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             CCEEEHHHHHTTC----------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             cCCCcHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccc
Confidence            999999999965433       38999999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ..... ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......   ..+..    ....+.
T Consensus       171 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~----~~~~~~  242 (289)
T 3og7_A          171 SRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIE----MVGRGS  242 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHH----HHHHTS
T ss_pred             ccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHH----Hhcccc
Confidence            42211 11234567999999999986   567888999999999999999999999764432   11222    222222


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .....     ..........+.+++.+|++.||.+||+++++++.|+...
T Consensus       243 ~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 LSPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCcch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11110     1111223356788999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-41  Score=350.69  Aligned_cols=264  Identities=24%  Similarity=0.401  Sum_probs=210.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      .++|+..+.||+|+||.||+|++.       +..||+|++..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            357888999999999999999852       46899999976543 3457789999999999 99999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCC----------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS----------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~----------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      .++||||+++|+|.+++.......          ......+++..++.++.|+++||.|||+   .+|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence            999999999999999997643210          0112248999999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      +.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             cCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            9999999999999987653321 111334567889999999999999999999999999999999 9999876543221 


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        +..    ....+         .....+......+.+++.+|++.||.+||+++++++.|+..
T Consensus       257 --~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 --FYK----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             --HHH----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHH----HhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence              111    11111         11111222335677899999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-41  Score=355.92  Aligned_cols=267  Identities=21%  Similarity=0.365  Sum_probs=207.2

Q ss_pred             CCCCCcccccCcEEEEEeee------cCceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cceEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDFLL  391 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  391 (644)
                      |+..++||+|+||.||++.+      .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ..+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            47889999999999988865      26789999997653 34467789999999999999999999999874  56899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++...         .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       113 v~e~~~~~~L~~~l~~~---------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEecccCCcHHHHHhhC---------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccc
Confidence            99999999999999543         28899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++................+|..|+|||.+.+..++.++|||||||++|||++|+.||.......  .....+........
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELIGIAQGQMTVL  258 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHHCSCCHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhhcccccchhHH
Confidence            9877543222222344568889999999999899999999999999999999999986532110  00000000001111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.+..........+......+.+|+.+||+.||++||+++++++.|+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            12222222223333344456788899999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-41  Score=353.06  Aligned_cols=262  Identities=22%  Similarity=0.405  Sum_probs=205.2

Q ss_pred             CCCCCCCcccccCcEEEEEeee------cCceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec--cce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER--HDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  389 (644)
                      ++|+..++||+|+||.||++++      .+..||+|++.... ....+.+.+|+.++++++||||+++++++...  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577889999999999999984      26789999997543 33457889999999999999999999999876  568


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||+++|+|.+++.....       .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN-------KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEEeCCCCcHHHHHHhccc-------cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcc
Confidence            999999999999999965443       38999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc--------ccchhhHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ--------NSYNNSIV  541 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~--------~~~~~~l~  541 (644)
                      |+++................||..|+|||.+.+..++.++||||||+++|||++|+.|+.....        ........
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            9998775433222223456788899999999999999999999999999999999988543210        00000010


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      . .         ............+......+.+|+.+||+.||.+|||++++++.|+.
T Consensus       251 ~-~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          251 R-L---------VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             H-H---------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             H-H---------HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            1 1         11111111222233334567889999999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-41  Score=352.92  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc----
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD----  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----  388 (644)
                      .++|+..++||+|+||.||++++.  ++.||+|++....   ......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            367888999999999999999975  7889999997643   2334678899999999999999999999887654    


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++||||+++|+|.+++....        .+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG--------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECC
T ss_pred             cEEEEecCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEee
Confidence            499999999999999996543        38999999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ||+++................||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ......
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~  232 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHV  232 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHh
Confidence            9999876543322222345679999999999999999999999999999999999999997644211       112222


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhC
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL-QVLSG  600 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl-~~L~~  600 (644)
                      ........   .....+    ...+.+++.+||+.||++||+..+++ +.|..
T Consensus       233 ~~~~~~~~---~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          233 REDPIPPS---ARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HCCCCCHH---HHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCCCcc---cccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            22111110   001122    24577889999999999999766655 44433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=355.97  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..++||+|+||.||+|++.  +.    +|++|.+... .....+.+.+|+.++++++||||++++++|... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            57888999999999999999875  33    3577777543 344567899999999999999999999999875 4889


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        94 v~~~~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD-------NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             EEEecCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            9999999999999976543       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++........ .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.......    +...    ...
T Consensus       164 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~----~~~  234 (327)
T 3lzb_A          164 AKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI----LEK  234 (327)
T ss_dssp             -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHH----HHT
T ss_pred             eeEccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHH----HHc
Confidence            9876533221 11334557889999999999999999999999999999999 999997654332    1111    111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP  604 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~  604 (644)
                      +.         ....+......+.+++.+||+.||.+||+++|+++.|+.....
T Consensus       235 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          235 GE---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11         1112222334577899999999999999999999999987543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-40  Score=356.17  Aligned_cols=266  Identities=17%  Similarity=0.175  Sum_probs=206.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccchh-----------hHHHHHHHHHHhccCCCceee
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQG-----------KQEFIAEVTTIGSLRHRNLVK  378 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~  378 (644)
                      ..++|+..++||+|+||.||+|.+.       +..||||++.......           ...+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            3468899999999999999999885       3579999987654221           123455677788889999999


Q ss_pred             Eeeeeeec----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCC
Q 006446          379 LIGWCYER----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSS  454 (644)
Q Consensus       379 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~  454 (644)
                      +++++...    ...++||||+ +++|.+++.....       .+++..++.|+.||+.||+|||+   .+|+||||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~  181 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-------RFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKAS  181 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHH
Confidence            99999875    4589999999 9999999976433       38999999999999999999999   89999999999


Q ss_pred             CEEEc--CCCcEEEeccCCcccccccccccc----cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          455 NIMLD--SEFNARLGDFGLARTIQENLKTHH----STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       455 NILld--~~~~vkL~DFGla~~~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      |||++  .++.+||+|||+++.+........    ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999  889999999999987653322111    113455999999999999999999999999999999999999999


Q ss_pred             CCCccccchhhHHHHHHHHHhcCchhhhhhcccCC-CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          529 NQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGG-EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       529 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .......   ....+..... ...+.+..++.+.. .++    ..+.+++.+||+.||.+||+++++++.|+..
T Consensus       262 ~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          262 EDNLKDP---KYVRDSKIRY-RENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             GGGTTCH---HHHHHHHHHH-HHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccccCH---HHHHHHHHHh-hhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            7533221   1222222211 22344455554432 223    4567788899999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-41  Score=345.06  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             CCCCCC-cccccCcEEEEEeeec----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKN-KLGKGGFGTVYKGIWR----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +|...+ .||+|+||.||+|++.    +..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            444455 8999999999999863    5679999997653 34567899999999999999999999999 556799999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             ECCTTEEHHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EeCCCCCHHHHHHhCCc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECccccee
Confidence            99999999999964332       38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......    .+...    ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~----i~~~~  230 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAF----IEQGK  230 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHH----HHTTC
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHH----HhcCC
Confidence            76533222222234457889999999998889999999999999999998 99999764432    12211    11111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                               ...++......+.+++.+||+.||++||++.++++.|+...
T Consensus       231 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          231 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     11222233456778999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.1e-41  Score=345.79  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=194.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..+.||+|+||.||+|++.     +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            357888999999999999999875     2459999987543 344567899999999999999999999984 467899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        93 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY-------SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT-------TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEecCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccc
Confidence            9999999999999975432       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++.......  .......+|+.|+|||.+....++.++|||||||++|||++ |+.||.......    +...+    ..
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~~~~i----~~  232 (281)
T 1mp8_A          163 SRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI----EN  232 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH----HT
T ss_pred             ccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----HHHHH----Hc
Confidence            987653221  11234456789999999998899999999999999999996 999997654322    21111    11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +..         ...+......+.+++.+|++.||++||++.++++.|+..
T Consensus       233 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          233 GER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            110         112222335677899999999999999999999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.7e-41  Score=357.75  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .++|+..+.||+|+||.||+++..  +..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999986  7789999997543  334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFG  470 (644)
                      ||+++|+|.+++....        .+++..+..++.||++||.|||+   .+|+||||||+|||++.++   .+||+|||
T Consensus       108 e~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE--------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             CCCCSCBHHHHHTTCS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999886432        38899999999999999999999   8999999999999998654   59999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    ....
T Consensus       177 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~----~i~~  244 (362)
T 2bdw_A          177 LAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYA----QIKA  244 (362)
T ss_dssp             TCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHH
T ss_pred             cceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHh
Confidence            998765321    134567999999999999989999999999999999999999999764321    1111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +...      ............+.+++.+||+.||++||++.++++.
T Consensus       245 ~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          245 GAYD------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TCCC------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCC------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110      0000001123457789999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-41  Score=355.96  Aligned_cols=267  Identities=25%  Similarity=0.395  Sum_probs=210.2

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeee
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE  385 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~  385 (644)
                      ....++|+..+.||+|+||.||+|...+       ..||+|.+.... ....+.+.+|+.+++++ +||||++++++|.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3345788999999999999999998752       369999997653 33457789999999999 89999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCC------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNS------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      .+..++||||+++|+|.+++.......      ......+++..++.++.|++.||.|||+   .+|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence            999999999999999999986532100      0011247999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred             CCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence            999999999999987653221 111334567889999999999999999999999999999998 9999876543221  


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       +..    ....+         .....+......+.+++.+||+.||.+||++.++++.|+..
T Consensus       276 -~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 -FYK----LVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -HHH----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             111    11111         11111112235677899999999999999999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.2e-41  Score=350.23  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=191.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..++||+|+||.||+|+..  +..||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357889999999999999999876  78899999975532 334678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |++ |+|.+++.......  ....+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~-~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGN--TPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSS--CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             ecC-CCHHHHHHhccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            997 69999986543211  11248899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC--
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG--  551 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~--  551 (644)
                      ......   ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........    ...+.......  
T Consensus       158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~  230 (317)
T 2pmi_A          158 FGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIMGTPNE  230 (317)
T ss_dssp             TTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCT
T ss_pred             cCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCh
Confidence            642211   1344578999999999876 4689999999999999999999999976543221    22222211110  


Q ss_pred             c----------------------hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 R----------------------ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~----------------------~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .                      +.+...+.....+    ...+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0                      0001111111122    245778999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.8e-41  Score=345.27  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=199.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||+||+|+..  ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999986  6789999997543  2334778899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++ +|.+++.....       .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~-~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             CCSE-EHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCC-CHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            9964 66666544332       38999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....   .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+......   ......+.........
T Consensus       151 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          151 FGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCT
T ss_pred             cCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCCh
Confidence            64221   1134567899999999997766 799999999999999999998886443221   1122222222111100


Q ss_pred             h------hhhhc---------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 L------DAADS---------RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~------~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .      ...+.         .............+.+++.+|++.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0      00000         0000111123345678999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-40  Score=359.31  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..++||+|+||+||+++..  ++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+.+.+++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57888999999999999999987  6789999997642   23345678899999887 899999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|..++....        .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++++||+|||++
T Consensus       132 ~E~~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR--------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             EECCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEcCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeeccee
Confidence            99999999999987543        38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccch-hhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-NSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-~~l~~~~~~~~~~~  551 (644)
                      +......   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+++.+....+
T Consensus       201 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~  277 (396)
T 4dc2_A          201 KEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  277 (396)
T ss_dssp             BCCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred             eecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence            8633221   1245568999999999999999999999999999999999999999653221110 01111122222111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                      .      .    .++......+.+|+.+||+.||++||++
T Consensus       278 ~------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 Q------I----RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             C------C----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             c------c----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1      1    1222233457788999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-40  Score=346.43  Aligned_cols=269  Identities=24%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             HHHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhc--cCCCceeeEeeeeeec--
Q 006446          311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS--LRHRNLVKLIGWCYER--  386 (644)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~--  386 (644)
                      ........++|+..++||+|+||.||+|++.+..||||++....   ...+..|.+++..  ++||||+++++++...  
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            33334445789999999999999999999999999999986443   2334445555444  5999999999999887  


Q ss_pred             --cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC-----CCCeEeCCCCCCCEEEc
Q 006446          387 --HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS-----EKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       387 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NILld  459 (644)
                        ...++||||+++|+|.+++...         .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST---------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence              6799999999999999999543         2899999999999999999999820     12999999999999999


Q ss_pred             CCCcEEEeccCCccccccccccc-ccccccccCCCccCccccccCCCCCc------cchHHHHHHHHHHHcC--------
Q 006446          460 SEFNARLGDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVGRATIE------TDIYAFGVLILEVACG--------  524 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~------sDVwSfGvvl~el~tG--------  524 (644)
                      .++.+||+|||+++......... .......||+.|+|||++.....+.+      +|||||||++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999999998664322111 11234579999999999987766665      9999999999999999        


Q ss_pred             --CCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          525 --RKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       525 --~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                        +.||..........  .. .......        ..+...++     ......+.+++.+||+.||++||++.++++.
T Consensus       257 ~~~~p~~~~~~~~~~~--~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSY--ED-MREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCCCTTTTTSCSSCCH--HH-HHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccHhhhcCCCCch--hh-hHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence              56665433222111  11 1111111        11122222     2566778999999999999999999999999


Q ss_pred             HhCCC
Q 006446          598 LSGEA  602 (644)
Q Consensus       598 L~~~~  602 (644)
                      |+...
T Consensus       326 L~~l~  330 (337)
T 3mdy_A          326 LAKMS  330 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=364.42  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=202.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .++|+..++||+|+||.||++...  +..+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            457888999999999999999876  7889999987543  334567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc---CCCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFG  470 (644)
                      ||+++|+|.+++....        .+++.....++.||++||.|||+   .+|+||||||+|||++   .++.+||+|||
T Consensus        90 E~~~gg~L~~~i~~~~--------~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           90 DLVTGGELFEDIVARE--------YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             CCCBCCBHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EeCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999986543        38899999999999999999999   8999999999999998   46789999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++.......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......    +..    ....
T Consensus       159 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~----~i~~  227 (444)
T 3soa_A          159 LAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR----LYQ----QIKA  227 (444)
T ss_dssp             SCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH----HHHH
T ss_pred             eeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH----HHH----HHHh
Confidence            9987653221   1345679999999999999899999999999999999999999997644221    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      +...      ............+.+++.+|++.||++||++.|+++.
T Consensus       228 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          228 GAYD------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TCCC------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCC------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1110      0010011223457788999999999999999999873

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-41  Score=340.62  Aligned_cols=253  Identities=25%  Similarity=0.444  Sum_probs=207.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||+++.. +..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46778899999999999999986 67899999976543 34678999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....       .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           87 HGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCcHHHHHhhCcc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            9999999975433       38899999999999999999999   8999999999999999999999999999987642


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||.+....++.++||||||+++|||++ |+.||......    .+..   . ...+.    
T Consensus       157 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~---~-i~~~~----  222 (267)
T 3t9t_A          157 DQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVE---D-ISTGF----  222 (267)
T ss_dssp             HHH--HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH---H-HHTTC----
T ss_pred             ccc--cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHH---H-HhcCC----
Confidence            211  11234567889999999998899999999999999999999 89998764321    1111   1 11111    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                           ....+......+.+++.+|++.||++||+++++++.|+..
T Consensus       223 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          223 -----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 1111122234677899999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-40  Score=343.77  Aligned_cols=262  Identities=17%  Similarity=0.238  Sum_probs=209.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..+.||+|+||.||+|+..  ++.||+|++....  ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            357888999999999999999964  7899999986543  345688999999999 79999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc-----EEEecc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN-----ARLGDF  469 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~-----vkL~DF  469 (644)
                      |+ +++|.+++.....       .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.     +||+||
T Consensus        87 ~~-~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             CC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ec-CCCHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            99 9999999975432       38999999999999999999999   89999999999999988776     999999


Q ss_pred             CCccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          470 GLARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       470 Gla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~  234 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIG  234 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHH
Confidence            9998765332211    11345679999999999999999999999999999999999999998754332222 111111


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      ........     +.+...++    ..+.+++.+|++.||++||++++|++.|+...
T Consensus       235 ~~~~~~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          235 EKKQSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHHHHSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhccCccH-----HHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            11111111     11112233    45778899999999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.4e-41  Score=363.27  Aligned_cols=257  Identities=21%  Similarity=0.284  Sum_probs=206.7

Q ss_pred             HHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      +.++....++|+..++||+|+||+||++++.  +..||+|+++...   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556788999999999999999999987  6789999997532   2234568899999999999999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEE
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      .+.+++||||+++|+|.+++...         .+++.....++.||+.||+|||+   .+|+||||||+|||++.++++|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~---------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY---------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEE
Confidence            99999999999999999998643         27889999999999999999999   8999999999999999999999


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCC----CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR----ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      |+|||+++.......  ......+||+.|+|||++....    ++.++|||||||++|||++|+.||...........+.
T Consensus       209 L~DFG~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          209 LADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             ECCCTTCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EeccceeEeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            999999987653221  1134568999999999997655    7899999999999999999999998654322211121


Q ss_pred             HHHHHHHhcCchhhhhhcccC--CCCCHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLG--GEFSEKEMECVLILGLACCHPNPHL--RPSMKTVLQV  597 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~evl~~  597 (644)
                      .+.    .        .....  ..++    ..+.+|+.+|++.+|.+  ||+++|+++.
T Consensus       287 ~~~----~--------~~~~p~~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 NHK----N--------SLTFPDDNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             THH----H--------HCCCCTTCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             hcc----c--------cccCCCccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            110    0        00111  1222    45677889999999988  9999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.8e-41  Score=352.61  Aligned_cols=272  Identities=24%  Similarity=0.455  Sum_probs=214.2

Q ss_pred             HHHHHHHhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeee
Q 006446          311 LKELKKATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       311 ~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      ..+.....++|+..+.||+|+||.||+|++.       +..||+|++.... ......+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444455678999999999999999999865       4679999997543 3345678999999999999999999999


Q ss_pred             eeeccceEEEEeccCCCccchhhhccCCC--CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          383 CYERHDFLLVYEYMPNGSLDKFIFYDETN--SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       383 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                      +.+.+..++||||+++|+|.+++......  .......+++..++.++.|+++||.|||+   .+|+||||||+|||++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcC
Confidence            99999999999999999999998653210  00011237899999999999999999999   89999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhh
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNS  539 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~  539 (644)
                      ++.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~  248 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----Q  248 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----H
T ss_pred             CCeEEECcCcccccccccccc-ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----H
Confidence            999999999999876533211 11234467889999999999999999999999999999999 88898764321    1


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      +..    ....+...         .........+.+++.+|++.||++||++.++++.|+....
T Consensus       249 ~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLR----FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH----HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111    11111111         1112233457789999999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.9e-41  Score=354.43  Aligned_cols=244  Identities=23%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||+|++.  +..||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57888999999999999999985  7899999987532   223457889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+ +|+|.+++....        .+++.++..++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        89 E~~-~g~l~~~l~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK--------RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             CCC-CEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             ECC-CCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            999 789999886543        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .......    .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...........             
T Consensus       157 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------------  219 (336)
T 3h4j_B          157 IMTDGNF----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------------  219 (336)
T ss_dssp             TTTTSBT----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------------
T ss_pred             eccCCcc----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------------
Confidence            7653221    344579999999999987776 7899999999999999999999976443221100             


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +.. ....++......+.+|+.+|++.||.+|||++|+++
T Consensus       220 ----i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          220 ----VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                000 001112222345678999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4e-41  Score=347.69  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=202.3

Q ss_pred             hCCCCCCC-cccccCcEEEEEeeec----CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          318 TGNFNPKN-KLGKGGFGTVYKGIWR----NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       318 ~~~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      .++|...+ .||+|+||.||+|.+.    +..||||++....  ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35666677 8999999999999653    4679999987543  23357899999999999999999999999 567889


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++++|.+++....        .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        94 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR--------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhCc--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence            9999999999999997543        38899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......    .+..    ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~~~  234 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTA----MLE  234 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHH
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHH
Confidence            99876533222121233456789999999998889999999999999999999 99999764321    1111    111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.         ....+......+.+++.+||+.||++||++.++++.|+..
T Consensus       235 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          235 KGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111         1112223345678899999999999999999999999753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.5e-41  Score=344.97  Aligned_cols=255  Identities=29%  Similarity=0.487  Sum_probs=210.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ..++|+..++||+|+||.||+|.+.  +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3467888999999999999999987  6789999987543 346789999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++......      .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             CCTTEEHHHHHHHCCTT------TSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             cCCCCcHHHHHHhcccC------CccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            99999999999754322      48999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    +...+    ..   
T Consensus       161 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~~~----~~---  227 (288)
T 3kfa_A          161 MTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL----EK---  227 (288)
T ss_dssp             SCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHHH----HT---
T ss_pred             ccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----hc---
Confidence            653221  11334567889999999999999999999999999999999 999987654322    11111    11   


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                            ......+......+.+++.+|++.||.+||+++++++.|+.
T Consensus       228 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          228 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence                  11112222333567889999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-40  Score=358.33  Aligned_cols=271  Identities=20%  Similarity=0.264  Sum_probs=204.1

Q ss_pred             hCCCCCCCccccc--CcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKG--GFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G--~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..++||+|  +||.||+++..  +..||||++....  ....+.+.+|+.++++++|||||++++++.+.+.+++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3578889999999  99999999987  7889999997543  3345678889999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |||||++|+|.+++......      .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMD------GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTT------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEccCCCCHHHHHhhhccc------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999754322      38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccc----cccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          472 ARTIQENLKT----HHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       472 a~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +.........    ........||..|+|||++.+  ..++.++|||||||++|||++|+.||.................
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            8765322111    111233578999999999987  5789999999999999999999999976543322111100000


Q ss_pred             H-HHhc------------------Cchhhhh---hcc------cCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          546 E-LRRK------------------GRILDAA---DSR------LGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       546 ~-~~~~------------------~~~~~~~---d~~------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      . ....                  ....+..   .++      ....+.......+.+|+.+||+.||++|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0 0000                  0000000   000      0001112223457889999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-40  Score=354.23  Aligned_cols=243  Identities=22%  Similarity=0.297  Sum_probs=203.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999986  7889999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       121 e~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG--------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccce
Confidence            9999999999997543        28899999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..    ....+. 
T Consensus       190 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~----~i~~~~-  254 (350)
T 1rdq_E          190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYE----KIVSGK-  254 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCC-
T ss_pred             eccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHH----HHHcCC-
Confidence            76422      334579999999999999999999999999999999999999997643221    111    111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                           ..+...+    ...+.+++.+|++.||.+||+     ++++++
T Consensus       255 -----~~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -----VRFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                 1122223    345778899999999999998     888875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=380.04  Aligned_cols=248  Identities=23%  Similarity=0.417  Sum_probs=198.1

Q ss_pred             cccccCcEEEEEeeec----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          326 KLGKGGFGTVYKGIWR----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      +||+|+||.||+|.+.    +..||||+++... ....++|.+|+.+|++++|||||+++++|.. +.+++|||||++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874    3469999997653 3456789999999999999999999999976 56999999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK  480 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~  480 (644)
                      |.+++.....       .+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       422 L~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          422 LHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             HHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             HHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999965432       38999999999999999999999   8999999999999999999999999999987653222


Q ss_pred             ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhc
Q 006446          481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS  559 (644)
Q Consensus       481 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  559 (644)
                      .........+|+.|+|||++..+.++.++|||||||++|||++ |+.||......+    +..    ....+.       
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~----~i~~~~-------  556 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMA----FIEQGK-------  556 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHH----HHHTTC-------
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHH----HHHcCC-------
Confidence            1111223346789999999999999999999999999999998 999997654321    221    122222       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       560 ~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        +...+......+.+|+.+||+.||++||++++|++.|+..
T Consensus       557 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          557 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             --CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1122233445678899999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.5e-41  Score=356.58  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=202.7

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      ....++|+..+.||+|+||.||+|+..  ++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345578999999999999999999986  6789999997642   23456678899999887 99999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++||||+++|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~D  161 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIAD  161 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeE
Confidence            999999999999999996543        28899999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ||+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..    ..
T Consensus       162 FG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~----~i  230 (345)
T 1xjd_A          162 FGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFH----SI  230 (345)
T ss_dssp             CTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HH
T ss_pred             ChhhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HHH----HH
Confidence            99998643211   12445689999999999999999999999999999999999999997654321    111    11


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK-TVL  595 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl  595 (644)
                      ..+.      ..+...+    ...+.+++.+|++.||++||++. +++
T Consensus       231 ~~~~------~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          231 RMDN------PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHCC------CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HhCC------CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1111      1122222    34577889999999999999997 664

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-40  Score=353.82  Aligned_cols=210  Identities=26%  Similarity=0.312  Sum_probs=182.6

Q ss_pred             CcccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-----CCceee
Q 006446          306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-----HRNLVK  378 (644)
Q Consensus       306 ~~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~  378 (644)
                      ...+++++.....++|+..++||+|+||.||+|++.  +..||||++... ....+.+..|+.++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            345666666667789999999999999999999985  778999998643 234566788999999986     999999


Q ss_pred             EeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       379 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +++++...+..++||||+ +++|.+++......      .+++..+..++.||+.||+|||+   .+|+||||||+|||+
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  170 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN------GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILL  170 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEE
Confidence            999999999999999999 99999999765432      38899999999999999999999   999999999999999


Q ss_pred             cC-------------------------CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHH
Q 006446          459 DS-------------------------EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYA  513 (644)
Q Consensus       459 d~-------------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwS  513 (644)
                      +.                         ++.+||+|||+++.....      .....||+.|+|||++.+..++.++||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHH
Confidence            75                         789999999999864421      33467899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCc
Q 006446          514 FGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       514 fGvvl~el~tG~~P~~~~~  532 (644)
                      |||++|||++|+.||....
T Consensus       245 lG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHCCCCCCCCc
Confidence            9999999999999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-40  Score=353.23  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-----chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ++|+..+.||+|+||.||+++..  ++.||||++....     ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46888999999999999999886  7889999986432     1235778999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---EEEec
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGD  468 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~D  468 (644)
                      ||||+++|+|.+++......    ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.   +||+|
T Consensus       104 v~e~~~g~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADA----GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEeCCCCCCHHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEec
Confidence            99999999998888643221    1137899999999999999999999   89999999999999987655   99999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ||+++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+..    ..
T Consensus       177 fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~----~i  244 (351)
T 3c0i_A          177 FGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFE----GI  244 (351)
T ss_dssp             CTTCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHH----HH
T ss_pred             CcceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHH----HH
Confidence            999987653221   13456799999999999999999999999999999999999999976321     1111    11


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+....  .+.....+    ...+.+|+.+||+.||++||++.++++
T Consensus       245 ~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYKM--NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCCC--CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111100  00000112    245778999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-40  Score=353.55  Aligned_cols=247  Identities=23%  Similarity=0.312  Sum_probs=202.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..+.||+|+||.||+++..  ++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999987  5679999997642   23456788999999988 89999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        99 v~E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG--------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999997543        28899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++......   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +...   .. .+
T Consensus       168 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~---i~-~~  236 (353)
T 2i0e_A          168 CKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS---IM-EH  236 (353)
T ss_dssp             CBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH---HH-HC
T ss_pred             ccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----HHHH---HH-hC
Confidence            98643211   12445689999999999999999999999999999999999999997654321    1111   11 11


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                      .      .    .++......+.+|+.+|++.||++||+     ++++++
T Consensus       237 ~------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          237 N------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             C------C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             C------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1      1    122223345778899999999999995     567664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=354.20  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||++...  ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999887  6789999987542   334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|..++....        .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        95 e~~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV--------HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             CCCTTEEHHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999996532        38999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      .....    .......||+.|+|||++..   ..++.++|||||||++|||++|+.||......... .+..   .. ..
T Consensus       164 ~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~~~---~~-~~  234 (384)
T 4fr4_A          164 MLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-EIVH---TF-ET  234 (384)
T ss_dssp             ECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-HHHH---HH-HH
T ss_pred             eccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-HHHH---HH-hh
Confidence            76422    11445689999999999864   45899999999999999999999999754432211 1111   11 11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-MKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~  596 (644)
                      ..          ..++......+.+|+.+||+.||.+||+ ++++++
T Consensus       235 ~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TV----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cc----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            10          1122223356778999999999999998 777764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-40  Score=349.54  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=192.2

Q ss_pred             CCCCCCCcccccCcEEEEEeee-----cCceEEEEEeeccc----chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW-----RNKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      ++|+..+.||+|+||.||+++.     .++.||+|+++...    ......+.+|+.++++++||||+++++++...+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5788899999999999999987     36789999997542    23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||+++|+|.+++....        .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG--------IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEEEeCCCCCcHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeC
Confidence            99999999999999996543        27889999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   ....
T Consensus       166 g~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~---~i~~  235 (327)
T 3a62_A          166 GLCKESIHDGT---VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TID---KILK  235 (327)
T ss_dssp             SCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH---HHHH
T ss_pred             CcccccccCCc---cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHH---HHHh
Confidence            99986432211   1345679999999999999999999999999999999999999997644221    111   1111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                       +.      ..+...+    ...+.+++.+|++.||++||     +++++++
T Consensus       236 -~~------~~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          236 -CK------LNLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -TC------CCCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CC------CCCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             11      1112222    34577889999999999999     7778775

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-40  Score=351.13  Aligned_cols=249  Identities=23%  Similarity=0.319  Sum_probs=198.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|++....   ....+.+..|..++.++ +||||+++++++.+.+.+++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46888999999999999999987  6789999997642   23456688999999988 899999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++++||+|||++
T Consensus        89 ~e~~~gg~L~~~l~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR--------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EeCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999996543        38899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccch-hhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-NSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-~~l~~~~~~~~~~~  551 (644)
                      +......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+......+
T Consensus       158 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          158 KEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             BCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            8643221   1244568999999999999999999999999999999999999999653221100 00111122221111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM  591 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~  591 (644)
                      .      ..+...+    ...+.+|+.+||+.||++||++
T Consensus       235 ~------~~~p~~~----s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 Q------IRIPRSL----SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C------CCCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             C------CCCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence            1      1122223    3457788999999999999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.5e-40  Score=345.98  Aligned_cols=275  Identities=24%  Similarity=0.345  Sum_probs=211.1

Q ss_pred             ccCHHHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhc--cCCCceeeEeeeeee
Q 006446          308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGS--LRHRNLVKLIGWCYE  385 (644)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~  385 (644)
                      ..+........++|+..+.||+|+||.||+|+.+++.||||++...   ..+.+..|.+++..  ++||||+++++++..
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3444444555678999999999999999999999999999998643   34567788888887  799999999999988


Q ss_pred             cc----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC-----CCCeEeCCCCCCCE
Q 006446          386 RH----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS-----EKRVLHRDIKSSNI  456 (644)
Q Consensus       386 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivHrDlkp~NI  456 (644)
                      ..    ..++||||+++|+|.+++...         .+++.+++.++.|+++||.|||...     ..+|+||||||+||
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  178 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence            76    789999999999999999643         2899999999999999999999210     28999999999999


Q ss_pred             EEcCCCcEEEeccCCccccccccccc-ccccccccCCCccCccccccC------CCCCccchHHHHHHHHHHHcC-----
Q 006446          457 MLDSEFNARLGDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG------RATIETDIYAFGVLILEVACG-----  524 (644)
Q Consensus       457 Lld~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~------~~t~~sDVwSfGvvl~el~tG-----  524 (644)
                      |++.++++||+|||+++......... .......||+.|+|||++...      .++.++|||||||++|||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            99999999999999998765322111 113455799999999998765      234789999999999999999     


Q ss_pred             -----CCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCC-CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          525 -----RKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGE-FSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       525 -----~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                           +.||.........  ...+. ........    .+.+... ...+....+.+|+.+||+.||++||++++|++.|
T Consensus       259 ~~~~~~~p~~~~~~~~~~--~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPS--VEEMR-KVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCC--HHHHH-HHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccccCccccCcCccc--HHHHH-HHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence                 6777654332211  11111 11111111    1111111 1235667889999999999999999999999999


Q ss_pred             hCC
Q 006446          599 SGE  601 (644)
Q Consensus       599 ~~~  601 (644)
                      +..
T Consensus       332 ~~i  334 (342)
T 1b6c_B          332 SQL  334 (342)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=349.01  Aligned_cols=264  Identities=24%  Similarity=0.428  Sum_probs=207.7

Q ss_pred             CCCCCCCcccccCcEEEEEeee------cCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc--ceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW------RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--DFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~  390 (644)
                      ++|+..+.||+|+||.||++++      .+..||+|++........+.+.+|+.++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4678889999999999999984      26789999998776667788999999999999999999999987654  789


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++++|.+++.....       .+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       121 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTT-------SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEECCCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence            99999999999999976543       38999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc--------cchhhHHH
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN--------SYNNSIVH  542 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~--------~~~~~l~~  542 (644)
                      +++................++..|+|||.+.+..++.++|||||||++|||++|+.|+......        ........
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            9987653322111123445778899999999888999999999999999999999987542110        00000111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.+         .+........+......+.+++.+||+.||++||+++++++.|+..
T Consensus       271 ~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          271 HLIE---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH---------HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111         1111111122223345678899999999999999999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-40  Score=337.91  Aligned_cols=245  Identities=22%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||.||+|+..  +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356888999999999999999987  568999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccCCc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla  472 (644)
                      +++++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||+   +.++.+||+|||++
T Consensus        88 ~~~~~L~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           88 CTGGELFERVVHKR--------VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             CCSCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             cCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999886543        38899999999999999999999   899999999999999   88899999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .......    ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......    +.    .....+.
T Consensus       157 ~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~----~~~~~~~  223 (277)
T 3f3z_A          157 ARFKPGK----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VM----LKIREGT  223 (277)
T ss_dssp             EECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH----HHHHHCC
T ss_pred             eeccCcc----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HH----HHHHhCC
Confidence            8765321    1344579999999998765 48999999999999999999999997644221    11    1111111


Q ss_pred             hhhhhhcccCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSE----KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .          .++.    .....+.+++.+|++.||++||++.++++
T Consensus       224 ~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 F----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             C----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1          1111    12345778999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-40  Score=349.24  Aligned_cols=251  Identities=20%  Similarity=0.378  Sum_probs=196.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc--------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--------  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--------  387 (644)
                      ++|+..++||+|+||.||+|++.  +..||||+++... ....+.+.+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46888999999999999999986  7889999997543 335678999999999999999999999986543        


Q ss_pred             -------------------------------------------------ceEEEEeccCCCccchhhhccCCCCCCCccc
Q 006446          388 -------------------------------------------------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVT  418 (644)
Q Consensus       388 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~  418 (644)
                                                                       ..++||||+++|+|.+++.....     ...
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~  160 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-----LED  160 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-----GGG
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-----ccc
Confidence                                                             27999999999999999975432     223


Q ss_pred             cCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccccccc---------ccccccc
Q 006446          419 LNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH---------HSTKEIA  489 (644)
Q Consensus       419 l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~---------~~~~~~~  489 (644)
                      ..+..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.........         .......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            6788899999999999999999   899999999999999999999999999998775332110         1123457


Q ss_pred             cCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHH
Q 006446          490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKE  569 (644)
Q Consensus       490 gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  569 (644)
                      ||+.|+|||.+.+..++.++|||||||++|||++|..|+..         ... .......+....         .....
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~-~~~~~~~~~~~~---------~~~~~  298 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVR-IITDVRNLKFPL---------LFTQK  298 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHH-HHHHHHTTCCCH---------HHHHH
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHH-HHHHhhccCCCc---------ccccC
Confidence            99999999999999999999999999999999998766321         011 111111111111         11122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          570 MECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       570 ~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...+.+++.+|++.||++||+++|+++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            345678999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-40  Score=350.22  Aligned_cols=258  Identities=23%  Similarity=0.283  Sum_probs=182.4

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEeccCCCc
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      .++||+|+||.||++++.  ++.||||++...   ....+.+|+.++++++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999987  778999999653   3466788999999997 9999999999999999999999999999


Q ss_pred             cchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC---cEEEeccCCcccccc
Q 006446          401 LDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF---NARLGDFGLARTIQE  477 (644)
Q Consensus       401 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~---~vkL~DFGla~~~~~  477 (644)
                      |.+++....        .+++.++..++.|+++||+|||+   .+|+||||||+|||++.++   .+||+|||+++....
T Consensus        93 L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           93 LFERIKKKK--------HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             HHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             HHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            999997543        38999999999999999999999   9999999999999997765   899999999986543


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+. ......+...   
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~i~~~~~~---  234 (325)
T 3kn6_A          162 DNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDFS---  234 (325)
T ss_dssp             -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-HHHHTTTCCC---
T ss_pred             CCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-HHHHHcCCCC---
Confidence            211   134557899999999999999999999999999999999999999765432111111111 1111111110   


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCCCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEADPP  605 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~~~  605 (644)
                         ...+........+.+|+.+|++.||++||+++|+++.  +++....+
T Consensus       235 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~  281 (325)
T 3kn6_A          235 ---FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS  281 (325)
T ss_dssp             ---CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred             ---CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence               0000001123567789999999999999999999843  44444333

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-40  Score=354.64  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=193.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||.||+++..  ++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+.+++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467889999999999999999986  77899999975432 346788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc--EEEeccCCcc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN--ARLGDFGLAR  473 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--vkL~DFGla~  473 (644)
                      +++|+|.+++....        .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.  +||+|||+++
T Consensus        98 ~~~~~L~~~l~~~~--------~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           98 ASGGELYERICNAG--------RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             CCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             CCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            99999999986543        28999999999999999999999   99999999999999988765  9999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCc-cchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIE-TDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~-sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ......    ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+..   ..... .
T Consensus       167 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~~-~  238 (361)
T 3uc3_A          167 SSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILSV-K  238 (361)
T ss_dssp             ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHTT-C
T ss_pred             cccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhcC-C
Confidence            543221    1344579999999999988887655 8999999999999999999986544332222211   11111 0


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                            ..+..  .......+.+|+.+||+.||++|||++|+++.
T Consensus       239 ------~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 ------YSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------CCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------CCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  00111  00122456789999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=353.36  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=187.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..+.||+|+||.||+|+..  ++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467888999999999999999987  5689999997543  346788999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEeccCCc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~DFGla  472 (644)
                      +++|+|.+++....        .+++.++..++.|+++||.|||+   .+|+||||||+|||++.   ++.+||+|||++
T Consensus       130 ~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          130 VTGGELFDRIVEKG--------YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             CCSCBHHHHHTTCS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             CCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            99999999986432        38899999999999999999999   89999999999999975   889999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .+.    .....+.
T Consensus       199 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~----~~i~~~~  267 (349)
T 2w4o_A          199 KIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMF----RRILNCE  267 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHH----HHHHTTC
T ss_pred             cccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHH----HHHHhCC
Confidence            8764321    1344679999999999999899999999999999999999999997543221   111    1111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .      .............+.+|+.+|++.||++||++.|+++
T Consensus       268 ~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          268 Y------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      0011111223345778999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=365.00  Aligned_cols=264  Identities=23%  Similarity=0.248  Sum_probs=208.9

Q ss_pred             ccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeee
Q 006446          308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      .+++++.....++|+..++||+|+||+||+++..  ++.||+|++++..   ....+.+.+|..++.+++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3455666667789999999999999999999986  7889999997532   2234568899999999999999999999


Q ss_pred             eeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       383 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      +.+.+.+++||||+++|+|.+++.....       .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKFGE-------RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHSS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTS
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCC
Confidence            9999999999999999999999975432       38899999999999999999999   9999999999999999999


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCccccc-------cCCCCCccchHHHHHHHHHHHcCCCCCCCCcccc
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-------VGRATIETDIYAFGVLILEVACGRKPGNQSEQNS  535 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~  535 (644)
                      ++||+|||+++.......  ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.......
T Consensus       200 ~vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             CEEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CEEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            999999999987643221  1123468999999999987       3568999999999999999999999997654322


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR---PSMKTVLQV  597 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Ps~~evl~~  597 (644)
                      ....+..+.    ..-.     .+.+...+    ...+.+|+.+|++ +|++|   |+++|+++.
T Consensus       278 ~~~~i~~~~----~~~~-----~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          278 TYGKIVHYK----EHLS-----LPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHHTHH----HHCC-----CC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHHhcc----cCcC-----CCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            212221110    0000     01111223    3457778899999 99998   589998753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=346.45  Aligned_cols=264  Identities=23%  Similarity=0.302  Sum_probs=204.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l  391 (644)
                      .++|+..+.||+|+||.||+++..  ++.||+|++........+.+.+|+.++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            357888999999999999999974  78999999987766677889999999999999999999999973    347899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |+||+++|+|.+++......    ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       108 v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDK----GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEeCCCCcHHHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            99999999999998753221    1248999999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccccccc------ccccccccCCCccCccccccCC---CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          472 ARTIQENLKTH------HSTKEIAGTPGYMAPESFLVGR---ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       472 a~~~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~---~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      ++.........      .......||+.|+|||.+....   ++.++|||||||++|||++|+.||........  .+..
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVAL  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhH
Confidence            87653211110      0012345799999999987543   68999999999999999999999853211110  1111


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                          ....         .............+.+++.+||+.||.+||+++++++.|+...+
T Consensus       259 ----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 ----AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                0001         11111111223467789999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-40  Score=353.53  Aligned_cols=244  Identities=29%  Similarity=0.469  Sum_probs=198.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +.|+..+.||+|+||.||+|+..  +..||||++.....   ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45788899999999999999975  78899999975432   33467899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||++ |+|.+++.....       .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       134 e~~~-g~l~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             ECCS-EEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             ecCC-CCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            9996 788888764433       38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ....       .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||......       .........
T Consensus       203 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~  268 (348)
T 1u5q_A          203 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN  268 (348)
T ss_dssp             SSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS
T ss_pred             ecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhc
Confidence            6542       23457999999999984   567899999999999999999999998764321       111122111


Q ss_pred             Cchhhhhhccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          551 GRILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       551 ~~~~~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..      +.+ ...+    .+.+.+++.+||+.||++||+++++++.
T Consensus       269 ~~------~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          269 ES------PALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CC------CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC------CCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11      111 1122    3456788899999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-40  Score=339.96  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=199.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..+.||+|+||.||+|...  +..||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            357888999999999999999887  5679999986532   22346788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||++
T Consensus        88 ~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS--------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             EecCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEecccc
Confidence            99999999999986543        28899999999999999999998   89999999999999999999999999998


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .......     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    ...    ..... 
T Consensus       157 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~-  222 (279)
T 3fdn_A          157 VHAPSSR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYK----RISRV-  222 (279)
T ss_dssp             SCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH----HHHHT-
T ss_pred             ccCCccc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHH----HHHhC-
Confidence            6543221     334578999999999999999999999999999999999999997643221    111    11111 


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           .    ..++......+.+++.+|++.||++||+++|+++.
T Consensus       223 -----~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 -----E----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -----C----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -----C----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 1    11222233456788999999999999999999963

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=352.50  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=196.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecc--cchhhHHHHHHHHHHhccCC--CceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRH--RNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..+.||+|+||.||++... +..||||++...  ..+..+.+.+|+.++.+++|  +||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            356888999999999999999886 678999998754  33445778999999999987  9999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      ||+ .+++|.+++....        .+++.++..++.|+++||.|||+   .+|+||||||+|||++ ++.+||+|||++
T Consensus        88 ~e~-~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK--------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EeC-CCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            995 5899999997543        38899999999999999999999   8999999999999997 578999999999


Q ss_pred             ccccccccccccccccccCCCccCcccccc-----------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLV-----------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      +....... ........||+.|+|||++..           ..++.++|||||||++|||++|+.||......     +.
T Consensus       155 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~  228 (343)
T 3dbq_A          155 NQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS  228 (343)
T ss_dssp             CCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH
T ss_pred             cccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HH
Confidence            87653221 111345679999999999865           67899999999999999999999999753221     11


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      . .         ....++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus       229 ~-~---------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          229 K-L---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             H-H---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H-H---------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1 1         11122222223333333567789999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-40  Score=350.37  Aligned_cols=264  Identities=22%  Similarity=0.404  Sum_probs=209.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec---------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~  386 (644)
                      .++|+..+.||+|+||.||+|++.         +..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888999999999999999863         4579999997653 34457789999999999 899999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCC--------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSG--------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +..++||||+++|+|.+++........        .....+++..++.++.|+++||.|||+   .+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            999999999999999999976542110        012248999999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccch
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYN  537 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~  537 (644)
                      +.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             cCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence            9999999999999987653221 111334567889999999998889999999999999999999 99998764321   


Q ss_pred             hhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          538 NSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       538 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                       .+..    ....+.         ....+......+.+++.+||+.||.+||+++++++.|+...
T Consensus       267 -~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          267 -ELFK----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             -HHHH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHH----HHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1211    111111         11112222345778899999999999999999999998753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.5e-41  Score=375.54  Aligned_cols=257  Identities=26%  Similarity=0.458  Sum_probs=209.1

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..++|+..++||+|+||.||+|++. +..||||+++... ...++|.+|+.+|++++|+||++++++|.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3456788899999999999999998 4679999997654 235789999999999999999999999976 678999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |++|+|.+++......      .+++.+++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       343 ~~~gsL~~~l~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGK------YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             CTTEEHHHHHSHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             hcCCcHHHHHhhcCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            9999999999643211      38899999999999999999999   99999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....  .......++..|+|||.+..+.++.++|||||||+||||++ |+.||......    .+..    ....+.  
T Consensus       414 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~----~i~~~~--  481 (535)
T 2h8h_A          414 EDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGY--  481 (535)
T ss_dssp             CCHHH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHH----HHHTTC--
T ss_pred             CCCce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCC--
Confidence            53211  11234457789999999999999999999999999999999 99998764321    1211    111221  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                             +...+....+.+.+|+.+||+.||++||++++|++.|+....
T Consensus       482 -------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 -------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                   111222334567889999999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-40  Score=341.44  Aligned_cols=254  Identities=27%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|...+.||+|+||.||+|++.+     ..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3578889999999999999998752     24999998765 33456789999999999999999999999865 46789


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++++|.+++.....       .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        90 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN-------SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT-------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             EEecCCCCCHHHHHHhccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCC
Confidence            9999999999999976443       38899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++.......  .......+|..|+|||.+....++.++||||||+++|||++ |+.||.......    +...    ...
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~~----~~~  229 (281)
T 3cc6_A          160 SRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGV----LEK  229 (281)
T ss_dssp             GGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHHH----HHH
T ss_pred             Ccccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHHH----Hhc
Confidence            987653221  11234567889999999998899999999999999999998 999997644322    1111    111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +..         ...+......+.+++.+|++.||++||++.++++.|+..
T Consensus       230 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          230 GDR---------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            110         111112234577899999999999999999999999753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.8e-40  Score=337.77  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=205.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .++|+..+.||+|+||.||+|...  +..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468889999999999999999886  7789999986543  334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---EEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFG  470 (644)
                      ||+++++|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||
T Consensus        85 e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE--------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             CCCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999998886543        38899999999999999999999   89999999999999987665   9999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++........    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    +..    ....
T Consensus       154 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~----~~~~  221 (284)
T 3kk8_A          154 LAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----LYA----QIKA  221 (284)
T ss_dssp             TCEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHH
T ss_pred             eeEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH----HHH----HHHh
Confidence            9986643211    334679999999999999999999999999999999999999997644221    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      +...      ............+.+++.+|+++||++||+++|+++  .+...
T Consensus       222 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          222 GAYD------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             TCCC------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             cccc------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            1110      000011112345778999999999999999999987  34443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.1e-41  Score=342.51  Aligned_cols=250  Identities=26%  Similarity=0.442  Sum_probs=198.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec-cceEEEEecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-HDFLLVYEYM  396 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~  396 (644)
                      .++|+..+.||+|+||.||++...+..||+|+++...  ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            3578889999999999999999999999999987543  457789999999999999999999997654 4789999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++++|.+++.....      ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        98 ~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           98 AKGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             TTEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             CCCCHHHHHHhccc------ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            99999999965421      137899999999999999999999   899999999999999999999999999998654


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ..      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    +..    ....+    
T Consensus       169 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~----~~~~~----  230 (278)
T 1byg_A          169 ST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP----RVEKG----  230 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHH----HHTTT----
T ss_pred             cc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH----HHhcC----
Confidence            22      223357889999999999999999999999999999998 999987654321    111    11111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                           .....+......+.+++.+|++.||++||++.++++.|+..
T Consensus       231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          231 -----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                 11122222345677899999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-40  Score=351.35  Aligned_cols=267  Identities=21%  Similarity=0.231  Sum_probs=202.0

Q ss_pred             HHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-----cchhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          313 ELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-----SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       313 ~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      ++....++|+..+.||+|+||.||+|+..  +..||+|++...     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34455678999999999999999999886  678999998653     23456789999999999999999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCCCC--------------------------------CCccccCHHHHHHHHHHHHH
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETNSG--------------------------------PGEVTLNWEKRLSVIHGTSQ  433 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~--------------------------------~~~~~l~~~~~~~i~~~ia~  433 (644)
                      .+..++||||+++|+|.+++........                                .....+++..+..++.|+++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999853111000                                00122467778899999999


Q ss_pred             HHHHhHhCCCCCeEeCCCCCCCEEEcCCC--cEEEeccCCcccccccccc-cccccccccCCCccCcccccc--CCCCCc
Q 006446          434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEF--NARLGDFGLARTIQENLKT-HHSTKEIAGTPGYMAPESFLV--GRATIE  508 (644)
Q Consensus       434 aL~yLH~~~~~~ivHrDlkp~NILld~~~--~vkL~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~--~~~t~~  508 (644)
                      ||+|||+   .+|+||||||+|||++.++  .+||+|||+++........ ........||+.|+|||.+..  ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  8999999999876432111 111345679999999999875  678999


Q ss_pred             cchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 006446          509 TDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR  588 (644)
Q Consensus       509 sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R  588 (644)
                      +|||||||++|||++|+.||........       ............       ..........+.+++.+|++.||.+|
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999976543211       111111111000       00001123457789999999999999


Q ss_pred             CCHHHHHH
Q 006446          589 PSMKTVLQ  596 (644)
Q Consensus       589 Ps~~evl~  596 (644)
                      |++.++++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-40  Score=379.98  Aligned_cols=247  Identities=25%  Similarity=0.424  Sum_probs=196.8

Q ss_pred             CcccccCcEEEEEeeec----CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR----NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||.||+|.+.    +..||||+++....  ...+++.+|+.+|++++|||||+++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999764    46799999976433  345789999999999999999999999964 568999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .+++..++.|+.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.....
T Consensus       454 g~L~~~l~~~~--------~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          454 GPLNKYLQQNR--------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEHHHHHHHCT--------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCHHHHHhhCC--------CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            99999996543        38999999999999999999999   89999999999999999999999999999877533


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...........+|..|+|||++....++.++|||||||++|||++ |+.||.......    +    ......+.     
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~----~~~i~~~~-----  589 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----V----TAMLEKGE-----  589 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----H----HHHHHTTC-----
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----H----HHHHHcCC-----
Confidence            222222334457889999999999999999999999999999998 999997654321    1    11222221     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          ....+......+.+|+.+||+.||++||++++|++.|+.
T Consensus       590 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          590 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                112222334567889999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=345.36  Aligned_cols=265  Identities=22%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|+..  +..||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999987  78899999865432  335678899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~~~l~~~~~~~~--------~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           83 YCDHTVLHELDRYQR--------GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             CCSEEHHHHHHHTSS--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCCchHHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999998875433        38899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-------HH
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-------WE  546 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-------~~  546 (644)
                      ......   ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....       ..
T Consensus       152 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (311)
T 4agu_A          152 LTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ  228 (311)
T ss_dssp             CC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence            653221   1344578999999999876 668999999999999999999999997654322211111100       00


Q ss_pred             HHhcCchhhhhhcccCCCCC------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFS------EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~------~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ..............-.....      ......+.+++.+|++.||++|||++|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            11111100000000000000      1123357789999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8e-40  Score=346.81  Aligned_cols=264  Identities=18%  Similarity=0.218  Sum_probs=199.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecccch-----------hhHHHHHHHHHHhccCCCceeeEeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETSRQ-----------GKQEFIAEVTTIGSLRHRNLVKLIGW  382 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~g~  382 (644)
                      ++|+..+.||+|+||.||+|+..     +..+|+|+.......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57888999999999999999984     467999998765322           12346788999999999999999999


Q ss_pred             eee----ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          383 CYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       383 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      +..    ....++||||+ +++|.+++....        .+++.+++.++.||++||+|||+   .+|+||||||+|||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  184 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--------TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEE
Confidence            988    67899999999 999999996543        38999999999999999999999   899999999999999


Q ss_pred             cCCC--cEEEeccCCccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          459 DSEF--NARLGDFGLARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       459 d~~~--~vkL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      +.++  .+||+|||+++.........    .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9887  99999999998765332111    11244579999999999999899999999999999999999999996432


Q ss_pred             cccchhhHHHHHHHHHhcCchhhhhhcccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          533 QNSYNNSIVHWLWELRRKGRILDAADSRLG-GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       533 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      ...  ..+.. ...... ..+......... ..+    ...+.+++.+||+.||++||++++|++.|+...
T Consensus       265 ~~~--~~~~~-~~~~~~-~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          265 KDP--VAVQT-AKTNLL-DELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TCH--HHHHH-HHHHHH-HTTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccc--HHHHH-HHHhhc-ccccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            211  11111 111111 111111111111 122    245778889999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-40  Score=348.01  Aligned_cols=260  Identities=20%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             HHHHHHHhCCCCCC-CcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccC-CCceeeEeeeee
Q 006446          311 LKELKKATGNFNPK-NKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCY  384 (644)
Q Consensus       311 ~~~l~~a~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~  384 (644)
                      ++......++|... +.||+|+||.||+|+..  ++.||+|++....  ......+.+|+.++.+++ ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33344445567666 88999999999999887  7899999987543  334578899999999995 699999999999


Q ss_pred             eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---C
Q 006446          385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---E  461 (644)
Q Consensus       385 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~  461 (644)
                      +.+..++||||+++|+|.+++.....      ..+++.+++.++.|++.||+|||+   .+|+||||||+|||++.   +
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELA------EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTB
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCC
Confidence            99999999999999999999854322      148999999999999999999999   89999999999999998   7


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      +.+||+|||+++.......    .....||+.|+|||++....++.++|||||||++|||++|+.||........    .
T Consensus       171 ~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~  242 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET----Y  242 (327)
T ss_dssp             CCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----H
T ss_pred             CcEEEeeCccccccCCccc----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----H
Confidence            8999999999987653211    3446799999999999999999999999999999999999999976543211    1


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .   .... .      ...............+.+++.+|++.||++||+++++++.
T Consensus       243 ~---~i~~-~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          243 L---NISQ-V------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             H---HHHH-T------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             H---HHHh-c------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            1   1110 0      0011111112233457789999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-40  Score=341.80  Aligned_cols=257  Identities=26%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             CCCCC-CCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNP-KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~-~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+. .+.||+|+||.||+++..  +..||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45666 478999999999999875  789999999876666678899999999985 79999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---EEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vkL~DFGl  471 (644)
                      |+++|+|.+++....        .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus        92 ~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR--------HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             CCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             cCCCCcHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999997543        38899999999999999999999   89999999999999998776   99999999


Q ss_pred             cccccccccc----cccccccccCCCccCcccccc-----CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchh----
Q 006446          472 ARTIQENLKT----HHSTKEIAGTPGYMAPESFLV-----GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN----  538 (644)
Q Consensus       472 a~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~----  538 (644)
                      ++........    ........||+.|+|||++..     ..++.++|||||||++|||++|+.||..........    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            9865422111    011223469999999999875     568999999999999999999999997654322100    


Q ss_pred             ---hHHHHHHHHHhcCchhhhhhcccCCCCCHH----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          539 ---SIVHWLWELRRKGRILDAADSRLGGEFSEK----EMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       539 ---~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                         .....+......+..          .++..    ....+.+|+.+|++.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~i~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               000111111111111          11111    2345778999999999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-40  Score=365.42  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..++||+|+||.||+++..  +..||+|++...   .......+.+|+.++++++||||+++++++...+.+++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357888999999999999999876  778999999754   334456788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++....        .+++..+..++.|+++||+|||+  ..+|+||||||+||||+.++.+||+|||++
T Consensus       227 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER--------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             EeeCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            99999999999986543        38999999999999999999995  268999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    ..+.
T Consensus       297 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i----~~~~  365 (446)
T 4ejn_A          297 KEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI----LMEE  365 (446)
T ss_dssp             CTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCC
T ss_pred             eeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH----HhCC
Confidence            8643221   1134568999999999999999999999999999999999999999764432    121111    1111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                            ..+...+    ...+.+|+.+||+.||.+||     +++|+++
T Consensus       366 ------~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ------IRFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  1122223    34577899999999999999     9999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-40  Score=339.38  Aligned_cols=253  Identities=26%  Similarity=0.470  Sum_probs=204.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||.||+|... +..||+|++.... ...+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            56788999999999999999987 4589999987544 345789999999999999999999999864 56899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +++|.+++.....      ..+++..++.++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        91 ~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           91 NGSLVDFLKTPSG------IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             TCBHHHHTTSHHH------HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCHHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999964321      138999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......++..|+|||.+..+.++.++||||||+++|||++ |+.||......    .+..    ....+.    
T Consensus       162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~----~~~~~~----  227 (279)
T 1qpc_A          162 NEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQ----NLERGY----  227 (279)
T ss_dssp             SCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTC----
T ss_pred             ccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHH----HHhccc----
Confidence            221  11234567889999999998889999999999999999999 89998764321    1111    111111    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                           ....+......+.+++.+|++.||++||++.++++.|+..
T Consensus       228 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          228 -----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                 1111222235677899999999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-40  Score=347.76  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch------hhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ------GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|.+......      ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46888999999999999999986  778999998754321      3567899999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL  466 (644)
                      +||||+++++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++    .+||
T Consensus        92 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE--------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS--------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEE
Confidence            9999999999999996432        38899999999999999999999   8999999999999999888    7999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||+++......    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    ...   .
T Consensus       161 ~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~---~  229 (321)
T 2a2a_A          161 IDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA---N  229 (321)
T ss_dssp             CCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---H
T ss_pred             ccCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH----HHH---H
Confidence            9999998765321    1345579999999999999999999999999999999999999997643221    111   1


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      . .....  ..++......    ...+.+++.+|++.||++||+++|+++
T Consensus       230 i-~~~~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 I-TSVSY--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             H-HTTCC--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             H-Hhccc--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1 11110  0000001112    245778999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=343.13  Aligned_cols=262  Identities=25%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-----hhhHHHHHHHHHHhccC---CCceeeEeeeeeec
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-----QGKQEFIAEVTTIGSLR---HRNLVKLIGWCYER  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~  386 (644)
                      ..++|+..++||+|+||.||+|++.  ++.||+|++.....     .....+.+|+.++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999975  78899999874321     12345667777777764   99999999999875


Q ss_pred             c-----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          387 H-----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       387 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      .     ..++||||+. |+|.+++......      .+++..+..++.|+++||+|||+   .+|+||||||+|||++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP------GLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSG  156 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTT
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCC
Confidence            5     4899999995 6999998754322      38999999999999999999999   899999999999999999


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      +.+||+|||+++......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    .
T Consensus       157 ~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~  228 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L  228 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----H
T ss_pred             CCEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            999999999998764221    13456799999999999999999999999999999999999999976543221    1


Q ss_pred             HHHHHHHhcCchhhh------hhcccCC--C-----CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          542 HWLWELRRKGRILDA------ADSRLGG--E-----FSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~------~d~~l~~--~-----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+............      ....+..  .     ...+..+.+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            112221111100000      0000000  0     00112346778999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=357.24  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=211.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc--ceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--DFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  393 (644)
                      ++|...++||+|+||.||+|++.  ++.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            46888999999999999999987  7889999997543 234567889999999999999999999998765  689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----cCCCcEEEecc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGDF  469 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~DF  469 (644)
                      ||+++|+|.+++......     ..+++..++.++.|+++||+|||+   .+|+||||||+|||+    +.++.+||+||
T Consensus        89 e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNA-----YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             ecCCCCCHHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            999999999999654322     138999999999999999999999   899999999999999    78888999999


Q ss_pred             CCcccccccccccccccccccCCCccCcccccc--------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      |+++.......    .....||..|+|||++..        ..++.++|||||||++|||++|+.||...........+.
T Consensus       161 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          161 GAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             GGCEECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             CCceEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            99987653221    334679999999999865        567889999999999999999999997544322222222


Q ss_pred             HHHHHHHhcCchhhhh---------------hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          542 HWLWELRRKGRILDAA---------------DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                         ...... ......               +......+.......+.+++.+|++.||++||++.++++.|+..
T Consensus       237 ---~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          237 ---YKIITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             ---HHHHHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             ---HHHhcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence               111111 100000               00112245577788899999999999999999999999988764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-40  Score=361.83  Aligned_cols=251  Identities=24%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||+|++.  +..||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999986  7899999997542   223467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        96 E~~~gg~L~~~l~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           96 EYVSGGELFDYICKNG--------RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             ECCSSEEHHHHTTSSS--------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             eCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999996432        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......    +..    ....+.
T Consensus       165 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~----~i~~~~  232 (476)
T 2y94_A          165 MMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LFK----KICDGI  232 (476)
T ss_dssp             ECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HHH----HHHTTC
T ss_pred             hccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HHH----HHhcCC
Confidence            765321    1344579999999999988765 689999999999999999999997644321    111    111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGEA  602 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~~  602 (644)
                      .      .....++    ..+.+|+.+|++.||++|||++++++  .+....
T Consensus       233 ~------~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          233 F------YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             C------CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             c------CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            0      1112222    45778899999999999999999997  465543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=351.55  Aligned_cols=268  Identities=24%  Similarity=0.385  Sum_probs=196.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHH--HHHHHHhccCCCceeeEeeeeee-----ccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFI--AEVTTIGSLRHRNLVKLIGWCYE-----RHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~--~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~l  391 (644)
                      ++|+..++||+|+||.||+|+..++.||||++.....   ..+.  .|+..+..++||||+++++++..     ...+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            6788899999999999999999999999999975432   3333  44555566899999999986543     335799


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC------CCCeEeCCCCCCCEEEcCCCcEE
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS------EKRVLHRDIKSSNIMLDSEFNAR  465 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~ivHrDlkp~NILld~~~~vk  465 (644)
                      ||||+++|+|.+++....         .++..+..++.|+++||.|||+..      ..+|+||||||+|||++.++.+|
T Consensus        90 v~e~~~~g~L~~~l~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT---------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEecCCCCcHHHHHhhcc---------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            999999999999995432         688999999999999999999821      11999999999999999999999


Q ss_pred             EeccCCccccccccc-----ccccccccccCCCccCcccccc-------CCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          466 LGDFGLARTIQENLK-----THHSTKEIAGTPGYMAPESFLV-------GRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       466 L~DFGla~~~~~~~~-----~~~~~~~~~gt~~y~APE~~~~-------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      |+|||+++.......     .........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653211     1111234579999999999876       4567899999999999999999877644322


Q ss_pred             ccc-hhhHH---------HHHHHHHhcCchhhhhhcccCCCC--CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          534 NSY-NNSIV---------HWLWELRRKGRILDAADSRLGGEF--SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       534 ~~~-~~~l~---------~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ... ...+.         ...........    ..+.+....  .......+.+|+.+||+.||++|||++|+++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            111 11000         00000110000    011111111  123556789999999999999999999999999875


Q ss_pred             C
Q 006446          602 A  602 (644)
Q Consensus       602 ~  602 (644)
                      .
T Consensus       317 l  317 (336)
T 3g2f_A          317 M  317 (336)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-40  Score=347.04  Aligned_cols=272  Identities=22%  Similarity=0.381  Sum_probs=211.7

Q ss_pred             CHHHHHHHhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEe
Q 006446          310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLI  380 (644)
Q Consensus       310 ~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~  380 (644)
                      ...+.....++|+..+.||+|+||.||+|++.       ++.||+|++..... ...+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            33444445678999999999999999999852       46799999976543 3456789999999999 799999999


Q ss_pred             eeeeecc-ceEEEEeccCCCccchhhhccCCCCCC--------CccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC
Q 006446          381 GWCYERH-DFLLVYEYMPNGSLDKFIFYDETNSGP--------GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI  451 (644)
Q Consensus       381 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl  451 (644)
                      +++...+ ..++||||+++|+|.+++.........        ....+++..++.++.|+++||.|||+   .+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence            9988755 489999999999999999754421000        01237899999999999999999999   89999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 006446          452 KSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQ  530 (644)
Q Consensus       452 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~  530 (644)
                      ||+|||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999999987643221 111344567899999999999999999999999999999998 9999876


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .....   .+.    .....+..     .......    ...+.+++.+||+.||.+||++.++++.|+..
T Consensus       254 ~~~~~---~~~----~~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE---EFC----RRLKEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH---HHH----HHHHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH---HHH----HHhccCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            54321   111    11111111     1111222    34577888999999999999999999999764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.8e-40  Score=346.47  Aligned_cols=251  Identities=23%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||++++.  ++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57888999999999999999987  678999998754   2344577889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       121 e~~~~~~L~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK--------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             CCCTTCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            9999999999886543        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......||..|+|||++.+..++.++|||||||++|||++|+.||.......    .   .... ..+. 
T Consensus       190 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~---~~~~-~~~~-  257 (335)
T 2owb_A          190 KVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----T---YLRI-KKNE-  257 (335)
T ss_dssp             ECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HHHH-HHTC-
T ss_pred             ecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----H---HHHH-hcCC-
Confidence            7642211   1344679999999999999899999999999999999999999997643211    1   1111 1111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                           ..+...++    ..+.+++.+||+.||++||+++|+++  .+...
T Consensus       258 -----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          258 -----YSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             -----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -----CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                 11122232    45677899999999999999999997  45544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=355.97  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=192.3

Q ss_pred             CCCCCcccccCcEEEEEeeec--C---ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEEEE
Q 006446          321 FNPKNKLGKGGFGTVYKGIWR--N---KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVY  393 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~  393 (644)
                      |+..++||+|+||.||+|++.  +   ..||+|.++.. .....++|.+|+.++++++||||++++++|.+ ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            556788999999999999874  2   35899998654 33456789999999999999999999999765 45789999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++.....       .+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       171 e~~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETH-------NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             ECCTTCBHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             ECCCCCCHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccc
Confidence            99999999999965433       37899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccc-cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          474 TIQENLKT-HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       474 ~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ........ ........+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.......    +...    ...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~----~~~~  312 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVY----LLQG  312 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHH----HHTT
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHH----HHcC
Confidence            76432211 111234567889999999999999999999999999999999 667776544322    1111    1111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      ..         ...+......+.+++.+||+.||++||+++++++.|+..
T Consensus       313 ~~---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          313 RR---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11         011112234577889999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-40  Score=339.04  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             CCCCCCcccccCcEEEEEeeec--C---ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccce-EEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--N---KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF-LLV  392 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV  392 (644)
                      .|+..++||+|+||.||+|++.  +   ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3455689999999999999864  2   2699999875433 4457889999999999999999999999876665 999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+.+|+|.+++.....       .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR-------NPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             EecccCCCHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            999999999999965433       38899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccccc-ccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLK-THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +....... .........+|..|+|||.+.+..++.++|||||||++|||++|..|+.......   .+...+    ..+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~----~~~  244 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFL----AQG  244 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHH----HTT
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHh----hcC
Confidence            86643221 1122345578899999999999999999999999999999999666644322211   121111    111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .         ....+......+.+++.+|++.||.+|||++++++.|+..
T Consensus       245 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          245 R---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1         1111222234677899999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.5e-40  Score=340.64  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~l  391 (644)
                      .+|+..++||+|+||.||+|++..     ..+|+|.+.... ....+.+.+|+.++++++||||++++++|.+ ++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457778999999999999998752     248999987543 3445778999999999999999999999754 557899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       105 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETH-------NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             EEeCCCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccc
Confidence            9999999999999965433       37899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccc-cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCccccchhhHHHHHHHHHh
Q 006446          472 ARTIQENLKT-HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG-RKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       472 a~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG-~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      ++........ ........+|+.|+|||.+.+..++.++||||||+++|||++| .+||.......    +....    .
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~----~  246 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL----L  246 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHHHH----H
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHH----h
Confidence            9876532211 1113445678899999999999999999999999999999995 55555433222    11111    1


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.         ....+......+.+++.+|++.||++||+++++++.|+..
T Consensus       247 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          247 QGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111         0111111234577899999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=338.89  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=181.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|+..  +..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            56888999999999999999974  7889999996542   223467899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++.....       .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        91 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVK-------PFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             ECCTTEEHHHHHHTCSS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            99999999999975432       38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........           ... 
T Consensus       161 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----------~~~-  225 (278)
T 3cok_A          161 QLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----------KVV-  225 (278)
T ss_dssp             ECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CC-
T ss_pred             eccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----------HHh-
Confidence            7642211   1234578999999999998889999999999999999999999997644321100           000 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        ..+......+    ...+.+++.+|++.||++||+++++++
T Consensus       226 --~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 --LADYEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --SSCCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --hcccCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              0011111222    345678999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.2e-40  Score=338.57  Aligned_cols=263  Identities=17%  Similarity=0.264  Sum_probs=203.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeee-eeccceEEEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC-YERHDFLLVY  393 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  393 (644)
                      ..++|+..+.||+|+||.||+|+..  ++.||+|++....  ..+.+..|+.++++++|+|++..++++ .+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3478999999999999999999964  7889999875543  234688999999999998888877776 4556789999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFG  470 (644)
                      ||+ +++|.+++.....       .+++..++.++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||
T Consensus        85 e~~-~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             Ecc-CCCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            999 9999999875433       38999999999999999999999   899999999999999   889999999999


Q ss_pred             Cccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          471 LARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       471 la~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+......
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence            998765332211    1124567999999999999999999999999999999999999999875443332222221111


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .. ...     .+.+...++    ..+.+++.+|++.||++||+++++++.|+...
T Consensus       234 ~~-~~~-----~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          234 KM-STP-----IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HH-HSC-----HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             cc-cch-----hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            11 111     011112223    45778999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-40  Score=356.75  Aligned_cols=264  Identities=27%  Similarity=0.381  Sum_probs=191.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccC-CCceeeEeeeeeecc--ce
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERH--DF  389 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~  389 (644)
                      ..++|+..++||+|+||.||+|++.  ++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999876  788999998643  3344567889999999997 999999999997544  68


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++|||||+ |+|.+++...         .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecccC-cCHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCC
Confidence            99999996 7899888643         38899999999999999999999   89999999999999999999999999


Q ss_pred             CCccccccccc------------------ccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 006446          470 GLARTIQENLK------------------THHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       470 Gla~~~~~~~~------------------~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      |+++.......                  ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            99986532110                  0111234679999999999876 6789999999999999999999999977


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhh--------------h-------hcccCCCCC------------HHHHHHHHHHH
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDA--------------A-------DSRLGGEFS------------EKEMECVLILG  577 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~--------------~-------d~~l~~~~~------------~~~~~~l~~L~  577 (644)
                      .........+.    ...........              .       .......++            ......+.+|+
T Consensus       234 ~~~~~~~~~i~----~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          234 SSTMNQLERII----GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             SSHHHHHHHHH----HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             CCHHHHHHHHH----HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence            54322211111    11110000000              0       000000000            01124577899


Q ss_pred             HHhcCCCCCCCCCHHHHHHH
Q 006446          578 LACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       578 ~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .+||+.||++|||++|+++.
T Consensus       310 ~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHCCSSGGGSCCHHHHTTS
T ss_pred             HHhhccCcccCCCHHHHhCC
Confidence            99999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9e-40  Score=334.11  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56888999999999999999886  7889999987543 34457789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++....        .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        87 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           87 CSGGELFDRIEPDI--------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             CTTEEGGGGSBTTT--------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999985432        38899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ..... ........||..|+|||.+.+..+ +.++||||||+++|||++|+.||.......  .....|.    ......
T Consensus       156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----~~~~~~  228 (276)
T 2yex_A          156 RYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWK----EKKTYL  228 (276)
T ss_dssp             EETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHH----TTCTTS
T ss_pred             CCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhh----hccccc
Confidence            43221 111345678999999999987665 789999999999999999999997654322  1121211    111000


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               .........+.+++.+|++.||++||+++|+++
T Consensus       229 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                     001122345678999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-40  Score=356.14  Aligned_cols=250  Identities=20%  Similarity=0.321  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecc--cchhhHHHHHHHHHHhccC--CCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLR--HRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||++... +..||||++...  .....+.+.+|+.++++++  ||||+++++++...+.+++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45888999999999999999887 678999998754  3345578999999999996  599999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      | +.+++|.+++....        .+++.++..++.||++||.|||+   .+|+||||||+|||++ ++.+||+|||+++
T Consensus       136 E-~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK--------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             E-CCSEEHHHHHHHCS--------SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             e-cCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            9 56899999997543        38889999999999999999999   8999999999999995 5789999999998


Q ss_pred             cccccccccccccccccCCCccCcccccc-----------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLV-----------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      ....... ........||+.|+|||++..           ..++.++|||||||++|||++|+.||......     . .
T Consensus       203 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~-~  275 (390)
T 2zmd_A          203 QMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I-S  275 (390)
T ss_dssp             CC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H-H
T ss_pred             cccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H-H
Confidence            7653221 111345679999999999865           46899999999999999999999999754321     0 1


Q ss_pred             HHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ....         ..++.....++......+.+|+.+||+.||++||++.|+++.
T Consensus       276 ~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          276 KLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111         112222222222223467789999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-40  Score=354.72  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHH-HhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTT-IGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|++++..   ......+..|..+ ++.++||||+++++++.+.+.+++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57888999999999999999987  6789999997643   2234456677776 5778999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++....        .+++.....++.||+.||+|||+   .+|+||||||+|||++.++++||+|||++
T Consensus       118 ~E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER--------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             EECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             EeCCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccc
Confidence            99999999999997543        27888999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..   ... .+.
T Consensus       187 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~---~i~-~~~  255 (373)
T 2r5t_A          187 KENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYD---NIL-NKP  255 (373)
T ss_dssp             GGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHH---HHH-HSC
T ss_pred             cccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHH---HHH-hcc
Confidence            8643221   12455689999999999999999999999999999999999999997654321    111   111 111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL  598 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L  598 (644)
                            ..+...++    ..+.+|+.+|++.||.+||++.+.++.+
T Consensus       256 ------~~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          256 ------LQLKPNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             ------CCCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             ------cCCCCCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                  11222233    4577889999999999999986444333

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-40  Score=336.92  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|+..  +..||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999986  5689999986542   223467889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus        94 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG--------RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             CCCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999997543        28899999999999999999999   899999999999999999999999999997


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....     ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......    ..   ... ...  
T Consensus       163 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~~~-~~~--  227 (284)
T 2vgo_A          163 HAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----TH---RRI-VNV--  227 (284)
T ss_dssp             ECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH---HHH-HTT--
T ss_pred             cCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----HH---HHH-hcc--
Confidence            65421     1234578999999999999999999999999999999999999997643211    11   111 111  


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +..+...+    ...+.+++.+|++.||.+||+++++++
T Consensus       228 ----~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ----DLKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----CCCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccCCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                11122222    345678999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-40  Score=345.11  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..+.||+|+||.||+|...  +..||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357888999999999999999875  788999999753   234457789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++++|.+++......    ...+++..++.++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++
T Consensus       111 ~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQ----KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EecCCCCCHHHHHHHhccc----ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            9999999999998643211    1138899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.......   ......|+..|+|||.+....++.++||||||+++|||++|+.||......     ....... ...+.
T Consensus       184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~  254 (310)
T 2wqm_A          184 RFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKK-IEQCD  254 (310)
T ss_dssp             ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHHHHHH-HHTTC
T ss_pred             eeecCCCc---cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHHHHHH-hhccc
Confidence            87643211   123457899999999999999999999999999999999999998754321     1111111 11111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP  605 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  605 (644)
                      ..     .+.   .......+.+++.+||+.||++||+++++++.|+...+..
T Consensus       255 ~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          255 YP-----PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             SC-----CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC-----CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            11     011   1122345778899999999999999999999998864433

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-40  Score=347.05  Aligned_cols=264  Identities=26%  Similarity=0.407  Sum_probs=206.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  389 (644)
                      .++|+..+.||+|+||.||+|++.       +..||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            367888999999999999999853       457999999754 334566789999999999999999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEE
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARL  466 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL  466 (644)
                      ++||||+++|+|.+++....... .....+++..++.++.|+++||.|||+   .+|+||||||+|||++.   +..+||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCS-SSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             EEEEecCCCCcHHHHHHhhcccc-cccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999997654221 122348999999999999999999999   89999999999999984   456999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...  
T Consensus       185 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~--  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF--  257 (327)
T ss_dssp             CCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH--
T ss_pred             Ccccccccccccccc-ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHH--
Confidence            999999866432211 11334567899999999999999999999999999999998 99998764321    12221  


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                        ...+..         ..........+.+++.+||+.||.+||++.++++.|+....
T Consensus       258 --~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          258 --VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             --HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence              111111         11122223467789999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.8e-40  Score=337.60  Aligned_cols=251  Identities=23%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||++...  ++.+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56788999999999999999987  6789999986542   334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++.++..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        95 e~~~~~~L~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK--------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             ECCTTCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999886543        38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......    .   .... ..+. 
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~---~~~~-~~~~-  231 (294)
T 2rku_A          164 KVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----T---YLRI-KKNE-  231 (294)
T ss_dssp             ECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HHHH-HTTC-
T ss_pred             ecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HHHH-hhcc-
Confidence            7642211   1344678999999999998889999999999999999999999997643211    1   1111 1111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                           ..+...+    ...+.+++.+|++.||++||+++++++  .+...
T Consensus       232 -----~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          232 -----YSIPKHI----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             -----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -----CCCcccc----CHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence                 1112222    345778899999999999999999997  34443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-39  Score=336.19  Aligned_cols=268  Identities=17%  Similarity=0.259  Sum_probs=208.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeee-eccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY-ERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E  394 (644)
                      .++|+..+.||+|+||.||+|+..  ++.||+|++.....  .+++.+|+.++++++|++++..++++. +....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            468899999999999999999964  78999999865442  356889999999999988777777664 5567899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGl  471 (644)
                      |+ +++|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||+   +.++.+||+|||+
T Consensus        86 ~~-~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             CC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             ec-CCCHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            99 9999999964433       38999999999999999999999   899999999999999   5889999999999


Q ss_pred             ccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          472 ARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       472 a~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence            98765332211    11245679999999999999999999999999999999999999998654332222222211111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLP  608 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~p  608 (644)
                      .. ..     .+.+...++    ..+.+++.+||+.||++||+++++++.|+........+
T Consensus       235 ~~-~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          235 MS-TP-----IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HH-SC-----HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cC-Cc-----hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            11 00     111122233    45778899999999999999999999998754433333

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=350.05  Aligned_cols=264  Identities=25%  Similarity=0.340  Sum_probs=190.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeee--------ec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCY--------ER  386 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~--------~~  386 (644)
                      ..+|+..++||+|+||.||++++.  ++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357888999999999999999985  7899999997776666788999999999996 999999999984        33


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEcCCCcE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld~~~~v  464 (644)
                      ..+++|+||+ +|+|.+++......     ..+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.+
T Consensus       107 ~~~~lv~e~~-~g~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          107 AEFLLLTELC-KGQLVEFLKKMESR-----GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             EEEEEEEECC-SEEHHHHHHHHHTT-----CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ceEEEEEEec-CCCHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCE
Confidence            4589999999 58999988653221     138999999999999999999998   77  9999999999999999999


Q ss_pred             EEeccCCccccccccccc---------ccccccccCCCccCcccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          465 RLGDFGLARTIQENLKTH---------HSTKEIAGTPGYMAPESF---LVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~APE~~---~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      ||+|||+++.........         .......||+.|+|||++   .+..++.++|||||||++|||++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998765322111         001244689999999998   56678999999999999999999999986533


Q ss_pred             cccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Q 006446          533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVLPPE  610 (644)
Q Consensus       533 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~p~~  610 (644)
                      ...    +..                ..............+.+++.+||+.||++||++.|+++.|+........++.
T Consensus       258 ~~~----~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~  315 (337)
T 3ll6_A          258 KLR----IVN----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK  315 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred             HHH----hhc----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence            211    100                0000011111123366789999999999999999999999887544443333

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=349.90  Aligned_cols=241  Identities=23%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--------hhhHHHHHHHHHHhccCCCceeeEeeeeeecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~  387 (644)
                      .++|+..+.||+|+||.||+|+..  +..||||++.....        ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            457899999999999999999875  78899999976431        23456788999999999999999999999999


Q ss_pred             ceEEEEeccCCC-ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          388 DFLLVYEYMPNG-SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       388 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      ..++||||+.+| +|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP--------RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEE
Confidence            999999999777 9999986543        38999999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++......    ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........         
T Consensus       172 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------  238 (335)
T 3dls_A          172 IDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------  238 (335)
T ss_dssp             CCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------
T ss_pred             eecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------
Confidence            9999998765321    1334679999999999988776 7899999999999999999999865221000         


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           ..      ......+    ...+.+|+.+|+++||++||+++++++.
T Consensus       239 -----~~------~~~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 -----AA------IHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TC------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----hc------cCCCccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00      0001112    2457788999999999999999999984

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.6e-40  Score=345.04  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc--eEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK--EIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|+..  +.  .+++|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999876  44  3599988753 334456789999999999 899999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          393 YEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      |||+++|+|.+++.......        ......+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999997543000        0011248999999999999999999999   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++......    ......++..|+|||.+....++.++|||||||++|||++ |+.||.......    +.  
T Consensus       182 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~--  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LY--  251 (327)
T ss_dssp             EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HH--
T ss_pred             EEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH----HH--
Confidence            999999997543211    1233457889999999998889999999999999999998 999997643211    11  


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                        .....+         .....+......+.+++.+|++.||.+||+++++++.|+..
T Consensus       252 --~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          252 --EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             --HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              111111         11112222335677899999999999999999999998864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-40  Score=341.11  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|++....  ....+.+.+|+.++++++||||+++++++..  .+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            57888999999999999999986  7789999997543  3445778999999999999999999998854  5678999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC-----eEeCCCCCCCEEEcCCCcEEEe
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR-----VLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----ivHrDlkp~NILld~~~~vkL~  467 (644)
                      |||+++++|.+++......    ...+++..++.++.|+++||+|||+   .+     |+||||||+|||++.++.+||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKE----RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EeCCCCCCHHHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            9999999999999754321    1138999999999999999999999   66     9999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++.......   ......||..|+|||.+.+..++.++||||||+++|||++|+.||......    .+..    .
T Consensus       159 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~  227 (279)
T 2w5a_A          159 DFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----K  227 (279)
T ss_dssp             CCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----H
T ss_pred             cCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHH----H
Confidence            9999987643211   123457899999999999989999999999999999999999999765321    1111    1


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      ...+..     +.+...    ....+.+++.+||+.||++||+++|+++.+...++
T Consensus       228 i~~~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          228 IREGKF-----RRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHTCC-----CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             Hhhccc-----ccCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            112221     111222    23467789999999999999999999997765543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=334.71  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc----chhhHHHHHHHHHHhccCCCceeeEeeeee--eccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS----RQGKQEFIAEVTTIGSLRHRNLVKLIGWCY--ERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~  389 (644)
                      .++|+..+.||+|+||.||++...  +..||+|++....    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999986  6789999997542    234578999999999999999999999984  45678


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||++++ |.+++......      .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEK------RFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCC-HHHHHHhCccc------ccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecc
Confidence            9999999766 76766543221      38999999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |++........ ........||..|+|||.+.+..  ++.++||||||+++|||++|+.||......    .+.    ..
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~----~~  224 (305)
T 2wtk_C          154 GVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLF----EN  224 (305)
T ss_dssp             TTCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHH----HH
T ss_pred             ccccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHH----HH
Confidence            99987643221 11134556899999999987644  478999999999999999999999764321    111    11


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGEA  602 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~~  602 (644)
                      ...+.      ..+...+    ...+.+++.+|++.||++||+++|+++  .+....
T Consensus       225 i~~~~------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          225 IGKGS------YAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             HHHCC------CCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             HhcCC------CCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            11111      1122223    345678899999999999999999996  455543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=336.09  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=198.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      +|.....||+|+||.||+|+..  +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4556679999999999999985  67899999987766667889999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-CCcEEEeccCCccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-EFNARLGDFGLARTIQ  476 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-~~~vkL~DFGla~~~~  476 (644)
                      +++|.+++......     ..+++..+..++.|++.||.|||+   .+|+||||||+|||++. ++.+||+|||+++...
T Consensus       103 ~~~L~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          103 GGSLSALLRSKWGP-----LKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEHHHHHHHTTCC-----CTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CCCHHHHHHhhccC-----CCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999754321     236788999999999999999999   89999999999999998 8999999999998764


Q ss_pred             ccccccccccccccCCCccCccccccCC--CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGR--ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ....   ......||+.|+|||.+..+.  ++.++||||||+++|||++|+.||.......  ...    ......    
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~~~~~----  241 (295)
T 2clq_A          175 GINP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAM----FKVGMF----  241 (295)
T ss_dssp             C--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHH----HHHHHH----
T ss_pred             CCCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHH----Hhhccc----
Confidence            2211   133457899999999987654  7899999999999999999999986432211  001    010000    


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           .....++......+.+++.+||+.||++||++.++++
T Consensus       242 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 -----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 1111222233346778899999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.1e-40  Score=341.76  Aligned_cols=262  Identities=24%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc--
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH--  387 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--  387 (644)
                      ..++|...+.||+|+||.||+|++..     ..||+|++...  .....+.+.+|+.++++++||||+++++++.+..  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45678889999999999999998752     37999998754  3344577899999999999999999999998765  


Q ss_pred             ---ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          388 ---DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       388 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                         ..++|+||+++|+|.+++.......  ....+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTT--SCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhc--CCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence               3599999999999999986433211  12248999999999999999999999   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......    +...
T Consensus       187 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MYDY  261 (313)
T ss_dssp             EECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHHH
T ss_pred             EEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHH
Confidence            9999999987653221 111334567889999999999999999999999999999999 888987654322    2111


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +    ..+.         ....+......+.+++.+|++.||.+||+++++++.|+..
T Consensus       262 ~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 L----LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             H----HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1    1111         1111222334678899999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=350.99  Aligned_cols=276  Identities=16%  Similarity=0.136  Sum_probs=211.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec----------CceEEEEEeecccchhhHHHHHHHHHHhccCCCceee----------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR----------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK----------  378 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~----------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~----------  378 (644)
                      ++|+..+.||+|+||.||+|+..          +..||+|++...     +.+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            67888999999999999999885          467999998654     46889999999999999998          


Q ss_pred             -----Eeeeeee-ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          379 -----LIGWCYE-RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       379 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                           +++++.. .+..++||||+ +++|.+++.....      ..+++..++.++.||++||.|||+   .+|+|||||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik  186 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT  186 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence                 5677766 67889999999 9999999975421      148999999999999999999999   899999999


Q ss_pred             CCCEEEcCCC--cEEEeccCCccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCC
Q 006446          453 SSNIMLDSEF--NARLGDFGLARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK  526 (644)
Q Consensus       453 p~NILld~~~--~vkL~DFGla~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~  526 (644)
                      |+|||++.++  .+||+|||+++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  99999999998765332211    11234579999999999999899999999999999999999999


Q ss_pred             CCCCCccccchhhHHHHHHHHHhcCchhhhhhcccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Q 006446          527 PGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLG-GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP  605 (644)
Q Consensus       527 P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  605 (644)
                      ||.......  ..+...........  ....+.... ..+    ...+.+++.+|++.||++||+++++++.|+......
T Consensus       267 pf~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          267 PWTNCLPNT--EDIMKQKQKFVDKP--GPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TTGGGTTCH--HHHHHHHHHHHHSC--CCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CcccCCcCH--HHHHHHHHhccCCh--hhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            997643221  22222222211111  011110000 112    245778899999999999999999999998865444


Q ss_pred             CCCCCCCCcccCC
Q 006446          606 VLPPERPSFVWPA  618 (644)
Q Consensus       606 ~~p~~~p~~~~~~  618 (644)
                      ......| +.|+.
T Consensus       339 ~~~~~~~-~dw~~  350 (352)
T 2jii_A          339 RVSPYDP-IGLPM  350 (352)
T ss_dssp             TCCTTSC-CCCCC
T ss_pred             CCCcCcc-ccCcC
Confidence            4444434 55544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.4e-40  Score=338.44  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee----------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----------  385 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----------  385 (644)
                      .++|+..+.||+|+||.||+|++.  ++.||+|++....    +.+.+|+.++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            357888999999999999999986  7899999997543    456789999999999999999998864          


Q ss_pred             ------ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          386 ------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       386 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                            ...+++||||+++|+|.+++......      .+++..++.++.|+++||.|||+   .+|+||||||+|||++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE------KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV  156 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence                  44589999999999999999754321      38999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS  539 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~  539 (644)
                      .++.+||+|||+++.......    .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...        
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------  224 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------  224 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------
T ss_pred             CCCCEEECcchhheecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------
Confidence            999999999999987653221    33457899999999999999999999999999999999999885321        


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPPVL  607 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~  607 (644)
                       ..+ ......+        .+...++    ..+.+++.+|++.||++||++.|+++.|......++.
T Consensus       225 -~~~-~~~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          225 -SKF-FTDLRDG--------IISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             -HHH-HHHHHTT--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             -HHH-HHHhhcc--------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence             011 1111111        1222333    3466788999999999999999999999877655443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-40  Score=338.08  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+++..  ++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999987  78999999875422      13577899999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL  466 (644)
                      +||||+++++|.+++....        .+++..+..++.|+++||.|||+   .+++||||||+||+++.++    .+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE--------SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEeecCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999996543        38999999999999999999999   8999999999999998877    8999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||+++......    ......|++.|+|||.+....++.++||||||+++|||++|+.||.......    ...   .
T Consensus       154 ~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~---~  222 (283)
T 3bhy_A          154 IDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE----TLT---N  222 (283)
T ss_dssp             CCCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H
T ss_pred             EecccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH----HHH---H
Confidence            9999998764321    1334578999999999999999999999999999999999999997643211    111   1


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       .......  ........    ....+.+++.+|++.||++||++.++++
T Consensus       223 -~~~~~~~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 -ISAVNYD--FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -HHTTCCC--CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hHhcccC--Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             1111100  00000011    1345778999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.3e-40  Score=367.03  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..++||+|+||.||+++..  ++.||+|++....   ......+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999986  7899999997542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++......      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       263 mEy~~gg~L~~~l~~~~~~------~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQA------GFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEcCCCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccc
Confidence            9999999999998754321      38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+.    .. 
T Consensus       334 ~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~-  404 (576)
T 2acx_A          334 VHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EV-  404 (576)
T ss_dssp             EECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HC-
T ss_pred             eecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----cc-
Confidence            8764321    13345899999999999998999999999999999999999999987543322222222111    11 


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                               ...++......+.+|+.+|++.||.+||     +++|+++
T Consensus       405 ---------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ---------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                     1122222334677889999999999999     7888874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.3e-40  Score=340.40  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|...+.||+|+||.||+++..  ++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            57888999999999999999986  7889999998765555677899999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccCCcc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGLAR  473 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla~  473 (644)
                      ++++|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+||++   +.++.+||+|||+++
T Consensus        89 ~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           89 SGGELFDRILERG--------VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             CSCBHHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CCccHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999986543        38899999999999999999999   899999999999999   788999999999997


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......    .+..    ....+..
T Consensus       158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~----~i~~~~~  224 (304)
T 2jam_A          158 MEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFE----KIKEGYY  224 (304)
T ss_dssp             CCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH----HHHHCCC
T ss_pred             ecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCC
Confidence            64321     133456899999999999999999999999999999999999999764321    1111    1111111


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                            .............+.+++.+|++.||++||+++|+++  .+++.
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          225 ------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                  0111111223356778999999999999999999986  45554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-39  Score=352.63  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=190.2

Q ss_pred             CCCCCC-CcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhc-cCCCceeeEeeeeee----ccceE
Q 006446          319 GNFNPK-NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGS-LRHRNLVKLIGWCYE----RHDFL  390 (644)
Q Consensus       319 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~  390 (644)
                      ++|... ++||+|+||+||++++.  +..||||++..     ...+.+|+.++.+ .+||||+++++++..    ...++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            345554 68999999999999986  67899999863     2456778888744 589999999999875    56789


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEe
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLG  467 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~  467 (644)
                      +||||+++|+|.+++.....      ..+++..+..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEeCCCCcHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence            99999999999999975432      148999999999999999999999   89999999999999998   7899999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++......    ......||+.|+|||++....++.++|||||||++|||++|+.||...........+...    
T Consensus       207 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----  278 (400)
T 1nxk_A          207 DFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----  278 (400)
T ss_dssp             CCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----
T ss_pred             ecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----
Confidence            999998654221    134567899999999999999999999999999999999999999765433221112111    


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ...+...      +...........+.+|+.+||+.||++|||+.|+++.
T Consensus       279 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          279 IRMGQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHTCCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHcCccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111110      0000001223457789999999999999999999974

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-39  Score=358.37  Aligned_cols=262  Identities=21%  Similarity=0.247  Sum_probs=194.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------c
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------H  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~  387 (644)
                      .++|+..++||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999876  788999999754  334457788999999999999999999999754      3


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      .+++|||||++ +|.+.+..          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~----------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEEeCCCC-CHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEE
Confidence            57999999965 56666531          28899999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH---
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL---  544 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~---  544 (644)
                      |||+++.....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+..   
T Consensus       207 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          207 DFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             CCCCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEEeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999876532    11345689999999999999999999999999999999999999997754322211121110   


Q ss_pred             ------------HHHHhc-C-----chhhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 ------------WELRRK-G-----RILDAADSRLGGEF---SEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 ------------~~~~~~-~-----~~~~~~d~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                  ...... .     .........+....   .......+.+|+.+||+.||++|||++|+++.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        000000 0     00000000000000   01124568899999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-40  Score=338.41  Aligned_cols=251  Identities=26%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|...++||+|+||.||++...  +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46888999999999999999986  6789999987653 33467889999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccCCc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGla  472 (644)
                      +++|+|.+++......    ...+++..+..++.|+++||+|||+   .+|+||||||+|||+   +.++.+||+|||++
T Consensus       102 ~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          102 CEGGELLERIVSAQAR----GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CSCCBHHHHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             CCCCcHHHHHHhhhhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999998643211    0138999999999999999999999   899999999999999   45688999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......    ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.......    +..   .......
T Consensus       175 ~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~----~~~---~~~~~~~  242 (285)
T 3is5_A          175 ELFKSDE----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE----VQQ---KATYKEP  242 (285)
T ss_dssp             CC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHHHCCC
T ss_pred             eecCCcc----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH----HHh---hhccCCc
Confidence            8765321    134567899999999875 568999999999999999999999997643211    111   1110000


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..    ......+    ...+.+++.+|++.||++||+++|+++
T Consensus       243 ~~----~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NY----AVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC----CC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc----ccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00    0000112    245668899999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-40  Score=342.24  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---Cc--eEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---NK--EIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+|++.   +.  .||+|+++..   .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888999999999999999864   22  5899998754   2345678999999999999999999999998764 89


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|+||+++++|.+++.....       .+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQG-------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-------GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeEecccCCCHHHHHHhccC-------CcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccc
Confidence            99999999999999975432       38899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++................+|..|+|||.+....++.++||||||+++|||++ |+.||......    .+..   ....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~---~~~~  239 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILH---KIDK  239 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH---HHHT
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHH---HHHc
Confidence            99876533222222334567889999999998889999999999999999999 99999764321    1111   1111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .+.         ...........+.+++.+|++.||++||++.++++.|+...
T Consensus       240 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          240 EGE---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             SCC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCC---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            111         01111223356778999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6e-40  Score=349.48  Aligned_cols=262  Identities=23%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||.||++.+.  +..||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57888999999999999999987  7789999987653 34457789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      +++++|.+++....        .+++..+..++.+++.||.|||+   . +|+||||||+|||++.++++||+|||+++.
T Consensus       113 ~~~~~L~~~l~~~~--------~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG--------RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             CTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             CCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            99999999997543        28899999999999999999998   5 899999999999999999999999999976


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH-------------
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV-------------  541 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~-------------  541 (644)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.             
T Consensus       182 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          182 LIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHHHC---------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ccccc-----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            54221     334579999999999999999999999999999999999999997644321110000             


Q ss_pred             ---------HHHHHHHhcCchhhhhhccc---CCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          542 ---------HWLWELRRKGRILDAADSRL---GGEF-SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       542 ---------~~~~~~~~~~~~~~~~d~~l---~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               .+...........+..+...   .... .......+.+++.+|++.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                     00000000000111111100   0011 1112345778999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-40  Score=349.38  Aligned_cols=253  Identities=22%  Similarity=0.286  Sum_probs=202.2

Q ss_pred             CCCCCCCcccccCcEEEEEeee-----cCceEEEEEeeccc----chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIW-----RNKEIAVKRVSETS----RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~-----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  388 (644)
                      ++|+..++||+|+||.||+++.     .++.||||+++...    ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788899999999999999987     37889999986532    23446677899999999 69999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++||||+++|+|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++++||+|
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE--------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             EEEEeecCCCCCHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEee
Confidence            999999999999999997543        28899999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      ||+++.......  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+..   .
T Consensus       203 fG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~  277 (355)
T 1vzo_A          203 FGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---R  277 (355)
T ss_dssp             SSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---H
T ss_pred             CCCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---H
Confidence            999987642211  11345679999999999985  3478999999999999999999999976543322222221   1


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQVL  598 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~~L  598 (644)
                      ....       .    ..++......+.+|+.+||+.||++||     +++++++..
T Consensus       278 ~~~~-------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          278 ILKS-------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHC-------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             Hhcc-------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1110       1    122223334577899999999999999     999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.3e-40  Score=341.21  Aligned_cols=259  Identities=22%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..+.||+|+||.||+++..  ++.||+|++.....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999976  77899999875432   2346789999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      +||+++++|.+++....        .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       113 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG--------PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EECCCCEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             EEecCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999997543        38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ........  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......    .    .........
T Consensus       182 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~----~~~~~~~~~  251 (309)
T 2h34_A          182 SATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----V----MGAHINQAI  251 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----H----HHHHHHSCC
T ss_pred             cccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----H----HHHHhccCC
Confidence            87653211  1133457899999999999999999999999999999999999999764321    1    111111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-SMKTVLQVLSGEADP  604 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~~~~~  604 (644)
                      . .  .......++    ..+.+++.+||+.||++|| +++++++.|+.....
T Consensus       252 ~-~--~~~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          252 P-R--PSTVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             C-C--GGGTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             C-C--ccccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0 0  011112222    3577789999999999999 999999999976543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-39  Score=337.81  Aligned_cols=247  Identities=26%  Similarity=0.472  Sum_probs=204.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +.|+..+.||+|+||.||+|+..  +..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999876  7789999997553 34567899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++...         .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++++||+|||++...
T Consensus       102 ~~~~~L~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          102 LGGGSALDLLEPG---------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             CTTEEHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999998532         38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......    .....   . ..+.   
T Consensus       170 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~---~-~~~~---  235 (303)
T 3a7i_A          170 TDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFL---I-PKNN---  235 (303)
T ss_dssp             BTTBC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH---H-HHSC---
T ss_pred             Ccccc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHH---h-hcCC---
Confidence            53221   134457899999999999999999999999999999999999998754321    11111   1 1111   


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                        .+.+...++    ..+.+++.+||+.||++||++.++++.
T Consensus       236 --~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 --PPTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --CCCCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --CCCCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              112223333    457789999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-40  Score=347.04  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ...++|+..++||+|+||.||+|+..  ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34568999999999999999999876  78899999975432  234567899999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE-----cCCCcEEE
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML-----DSEFNARL  466 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl-----d~~~~vkL  466 (644)
                      ||||++ |+|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||+     +.++.+||
T Consensus       111 v~e~~~-~~L~~~~~~~~--------~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP--------DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT--------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             EEecCC-CCHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEE
Confidence            999996 69999986543        28899999999999999999999   899999999999999     45566999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+++.......   ......||..|+|||++.+. .++.++|||||||++|||++|+.||.......   .+... .
T Consensus       179 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~-~  251 (329)
T 3gbz_A          179 GDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKI-F  251 (329)
T ss_dssp             CCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-H
T ss_pred             CcCCCccccCCccc---ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHH-H
Confidence            99999987642211   13445789999999999875 48999999999999999999999997654322   11111 1


Q ss_pred             HHHhcCchhh--hh---------hcccCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRILD--AA---------DSRLGGEF-----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~~~--~~---------d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..........  ..         .+......     .......+.+|+.+|++.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111000000  00         00000000     0012245678999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=344.62  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|...++||+|+||.||+|+..  +..||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999986  678999998654322 223556799999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++ |+|.+++.....       .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN-------IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             CS-EEHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             cc-cCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            96 699998865433       38899999999999999999999   89999999999999999999999999999865


Q ss_pred             cccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc--
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR--  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~--  552 (644)
                      ....   .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......    ....+........  
T Consensus       151 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          151 SIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEE  223 (324)
T ss_dssp             ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTT
T ss_pred             cCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChH
Confidence            4221   11334578999999999876 568999999999999999999999997754322    2222222211110  


Q ss_pred             -hhhhhh---------cccCCCC----CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          553 -ILDAAD---------SRLGGEF----SEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       553 -~~~~~d---------~~l~~~~----~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                       ......         +......    .......+.+|+.+|++.||++|||++|+++  .+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence             000000         0000000    0011245678999999999999999999987  34443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.8e-39  Score=360.04  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=204.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||+++..  ++.||+|++....   ....+.+..|+.++++++||||+++++++...+.+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999986  7889999997542   233567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++......    ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus       265 E~~~gg~L~~~l~~~~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDED----NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTT----SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EeccCCCHHHHHHHhhcc----cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceee
Confidence            999999999998654321    1248999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+   . .+. 
T Consensus       338 ~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~-~~~-  409 (543)
T 3c4z_A          338 ELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---L-EQA-  409 (543)
T ss_dssp             ECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---H-HCC-
T ss_pred             eccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---h-hcc-
Confidence            7653211   1334589999999999999999999999999999999999999998754322222222211   1 111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM-----KTVL  595 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl  595 (644)
                           .    .++......+.+|+.+|++.||++||++     ++++
T Consensus       410 -----~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          410 -----V----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             -----C----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             -----c----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence                 1    1222233456778999999999999975     5565

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-39  Score=354.73  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=190.8

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--------chhhHHHHHHHHHHhccCCCceeeEeeeeeec
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER  386 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~  386 (644)
                      ..++|...++||+|+||.||+|...  ++.||+|++....        ......+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            4578999999999999999999886  6789999987532        122345889999999999999999999975 4


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---Cc
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FN  463 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~  463 (644)
                      +..++||||+++|+|.+++....        .+++..+..++.|+++||+|||+   .+|+||||||+|||++.+   ..
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCC
T ss_pred             CceEEEEEcCCCCcHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcce
Confidence            56899999999999999886432        38999999999999999999999   899999999999999654   45


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +||+|||+++......    ......||+.|+|||++.   ...++.++|||||||++|||++|+.||........   +
T Consensus       281 ~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~  353 (419)
T 3i6u_A          281 IKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---L  353 (419)
T ss_dssp             EEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC---H
T ss_pred             EEEeecccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH---H
Confidence            9999999998765321    134567999999999985   35678899999999999999999999976443221   1


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..    ....+.....  +.....    ....+.+++.+|++.||++||+++|+++
T Consensus       354 ~~----~i~~~~~~~~--~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KD----QITSGKYNFI--PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HH----HHHTTCCCCC--HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH----HHhcCCCCCC--chhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11    1111111000  000011    2345778999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.3e-39  Score=334.10  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=195.6

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l  391 (644)
                      .|...+.||+|+||.||+|...  +..||+|++...  .....+.+.+|+.++++++||||+++++++..    +..+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3666778999999999999886  567999998754  33456778999999999999999999999875    356899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEc-CCCcEEEec
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLD-SEFNARLGD  468 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld-~~~~vkL~D  468 (644)
                      ||||+++|+|.+++....        .+++..+..++.|++.||.|||+   .+  |+||||||+|||++ .++.+||+|
T Consensus       107 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK--------VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEecCCCCHHHHHHHcc--------CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            999999999999996543        38899999999999999999998   77  99999999999998 789999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ||++......     ......||+.|+|||.+. +.++.++|||||||++|||++|+.||......   ..+.    ...
T Consensus       176 fg~~~~~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~----~~~  242 (290)
T 1t4h_A          176 LGLATLKRAS-----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIY----RRV  242 (290)
T ss_dssp             TTGGGGCCTT-----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHH----HHH
T ss_pred             CCCccccccc-----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---HHHH----HHH
Confidence            9999754422     133457999999999876 56999999999999999999999999764321   1111    111


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+......+    ...    ...+.+++.+||+.||.+||+++++++
T Consensus       243 ~~~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          243 TSGVKPASFD----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCCCGGGG----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccCCccccC----CCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111111111    112    245778999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.3e-41  Score=358.84  Aligned_cols=245  Identities=15%  Similarity=0.113  Sum_probs=189.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHH---HHHhccCCCceeeEe-------ee
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEV---TTIGSLRHRNLVKLI-------GW  382 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------g~  382 (644)
                      .++|+..+.||+|+||.||+|++.  ++.||||++...   .....+.+.+|+   .++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            356778899999999999999975  789999999743   334567889999   556666899999998       55


Q ss_pred             eeecc-----------------ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC
Q 006446          383 CYERH-----------------DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR  445 (644)
Q Consensus       383 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~  445 (644)
                      +...+                 ..++||||+ +|+|.+++...... ......++|..++.|+.||++||+|||+   .+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-SSTHKSLVHHARLQLTLQVIRLLASLHH---YG  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT-TTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc-ccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            55443                 279999999 78999999754321 1112346689999999999999999999   89


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccC-----------CCCCccchHHH
Q 006446          446 VLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-----------RATIETDIYAF  514 (644)
Q Consensus       446 ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~~sDVwSf  514 (644)
                      |+||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++.+.           .++.++|||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence            999999999999999999999999999864321      334567 999999999887           89999999999


Q ss_pred             HHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 006446          515 GVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV  594 (644)
Q Consensus       515 Gvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ev  594 (644)
                      ||++|||++|+.||..........                 ..... ...++    ..+.+|+.+||+.||++||++.|+
T Consensus       300 G~il~elltg~~Pf~~~~~~~~~~-----------------~~~~~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAALGGSE-----------------WIFRS-CKNIP----QPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHHSSCCC------CCSG-----------------GGGSS-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHHHCCCCCcccccccchh-----------------hhhhh-ccCCC----HHHHHHHHHHcCCCchhCCCHHHH
Confidence            999999999999996543221111                 00000 12233    457778899999999999999999


Q ss_pred             HH
Q 006446          595 LQ  596 (644)
Q Consensus       595 l~  596 (644)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.3e-40  Score=346.18  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=198.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..+.||+|+||.||+++..  +..||+|++.....    ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            357888999999999999999986  77899999976532    345688888888 79999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC----CcEEEeccC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNARLGDFG  470 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~----~~vkL~DFG  470 (644)
                      |+++|+|.+++....        .+++.....++.||+.||+|||+   .+|+||||||+|||+.++    +.+||+|||
T Consensus        97 ~~~gg~L~~~i~~~~--------~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           97 LMKGGELLDKILRQK--------FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             CCCSCBHHHHHHTCT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             CCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999986543        38999999999999999999999   899999999999998543    359999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++.......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.    .....
T Consensus       166 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~----~~i~~  237 (342)
T 2qr7_A          166 FAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEIL----ARIGS  237 (342)
T ss_dssp             TCEECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-HHHH----HHHHH
T ss_pred             CcccCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-HHHH----HHHcc
Confidence            9987643221   13456789999999999888899999999999999999999999976432211 1122    11222


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +...      +...........+.+|+.+|++.||++||++.++++
T Consensus       238 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          238 GKFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2211      111111223345778899999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-38  Score=340.87  Aligned_cols=263  Identities=22%  Similarity=0.270  Sum_probs=202.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  389 (644)
                      .++|+..++||+|+||.||+++..  +..||+|++.... ....+.+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468889999999999999999876  6789999997543 33447789999999999999999999998765     368


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++|+||+. |+|.+++...         .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEcccC-cCHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeC
Confidence            99999996 6999988542         28899999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..    ..
T Consensus       173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~  248 (364)
T 3qyz_A          173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG----IL  248 (364)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH----HH
T ss_pred             cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH----Hh
Confidence            999877543322222345689999999998764 4589999999999999999999999987654332222221    11


Q ss_pred             hcCchh-----------hhhhcc-cCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          549 RKGRIL-----------DAADSR-LGGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       549 ~~~~~~-----------~~~d~~-l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ......           ...... .....+     ......+.+|+.+|++.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            100000           000000 000011     1112457789999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-40  Score=341.83  Aligned_cols=266  Identities=20%  Similarity=0.367  Sum_probs=187.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ..++|+..+.||+|+||.||+|+..  +..||+|++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3478999999999999999999875  7889999986543 334567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++.............+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864221111122348999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccc--cccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          474 TIQENLKT--HHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       474 ~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ........  ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||........   + .   .....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~-~---~~~~~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L-M---LTLQN  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H-H---HHHTS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H-H---HHhcc
Confidence            66432111  111234578999999999875 5689999999999999999999999976543221   1 1   11111


Q ss_pred             Cc--h-hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GR--I-LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~--~-~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..  . ....++.....++    ..+.+++.+||+.||.+||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00  0 0011111122232    45778899999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-39  Score=342.00  Aligned_cols=264  Identities=24%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+++..  +..||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888999999999999999987  77899999865433  334668899999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A          105 FVDHTILDDLELFPN--------GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             CCSEEHHHHHHHSTT--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             cCCcchHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            999999988765432        28999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH-------HHH
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW-------LWE  546 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~-------~~~  546 (644)
                      ......   ......||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+...       ...
T Consensus       174 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          174 LAAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ecCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            643221   13445789999999998775 7899999999999999999999999775432211111110       001


Q ss_pred             HHhcCchh-hhhhcccCCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRIL-DAADSRLGGEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~-~~~d~~l~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ........ ....+.+......     ...+.+.+|+.+||+.||++||+++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11111100 0000111111111     12356788999999999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.9e-40  Score=339.22  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=198.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..+.||+|+||.||+|+..  +..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            357888999999999999999987  678999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++++|.+++.....       .+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           98 CPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CTTEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             CCCCcHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            999999999865433       38999999999999999999999   89999999999999999999999999998654


Q ss_pred             cccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      .....   ......||..|+|||++.     ...++.++||||||+++|||++|+.||.......    .   .......
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~~~~~~  237 (302)
T 2j7t_A          168 LKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----V---LLKIAKS  237 (302)
T ss_dssp             HHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHHS
T ss_pred             ccccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----H---HHHHhcc
Confidence            32111   123457899999999983     5678999999999999999999999987643211    1   1111111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .. .     .+  ..+......+.+++.+|++.||++||++.++++
T Consensus       238 ~~-~-----~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 DP-P-----TL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CC-C-----CC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CC-c-----cc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10 0     00  011122345778999999999999999999876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.9e-40  Score=347.92  Aligned_cols=270  Identities=22%  Similarity=0.245  Sum_probs=200.8

Q ss_pred             cCHHHHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccch-----------hhHHHHHHHHHHhccCCCce
Q 006446          309 FRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQ-----------GKQEFIAEVTTIGSLRHRNL  376 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nI  376 (644)
                      ....++....++|+..+.||+|+||.||+|... +..||||++......           ..+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            446778888999999999999999999999876 788999998653221           23678999999999999999


Q ss_pred             eeEeeeeeec-----cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCC
Q 006446          377 VKLIGWCYER-----HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDI  451 (644)
Q Consensus       377 v~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDl  451 (644)
                      +++++++...     ..+++||||++ |+|.+++.....       .+++..+..++.|++.||.|||+   .+|+||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl  160 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-------VISPQHIQYFMYHILLGLHVLHE---AGVVHRDL  160 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHH---CcCEecCC
Confidence            9999998543     35899999996 788888865432       38999999999999999999999   89999999


Q ss_pred             CCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 006446          452 KSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       452 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      ||+|||++.++.+||+|||+++......    ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ChHHEEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999998554221    1345678999999999876 6789999999999999999999999987


Q ss_pred             CccccchhhHHHHHHHHHhcCchh-----------hhhhcccCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRIL-----------DAADSRLGGE-------FSEKEMECVLILGLACCHPNPHLRPSMK  592 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~-----------~~~d~~l~~~-------~~~~~~~~l~~L~~~Cl~~dP~~RPs~~  592 (644)
                      .........+..    ........           +.....+...       ........+.+|+.+|++.||++|||++
T Consensus       237 ~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  312 (362)
T 3pg1_A          237 STFYNQLNKIVE----VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE  312 (362)
T ss_dssp             SSHHHHHHHHHH----HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHH----HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence            543322222211    11111110           0000000000       0011234577899999999999999999


Q ss_pred             HHHHH
Q 006446          593 TVLQV  597 (644)
Q Consensus       593 evl~~  597 (644)
                      |+++.
T Consensus       313 ell~h  317 (362)
T 3pg1_A          313 QALRH  317 (362)
T ss_dssp             HHHTS
T ss_pred             HHHcC
Confidence            99863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-39  Score=357.55  Aligned_cols=260  Identities=19%  Similarity=0.293  Sum_probs=204.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCC-CceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..++||+|+||.||+|++.  +..||||++.....  ..++..|+.+++.++| +++..+..++.+....+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            368899999999999999999975  78999998765443  3468899999999987 455566666677778899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFGl  471 (644)
                      |+ +++|.+++.....       .+++..++.|+.||+.||.|||+   .+|+||||||+||||   +.++.+||+|||+
T Consensus        84 ~~-g~sL~~ll~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR-------KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             CC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             CC-CCCHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            99 9999999975433       38999999999999999999999   899999999999999   6889999999999


Q ss_pred             ccccccccccc----ccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          472 ARTIQENLKTH----HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       472 a~~~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ++.........    .......||..|+|||.+.+..++.++|||||||+||||++|+.||...........+.. +...
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-i~~~  231 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-ISEK  231 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH-HHHH
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH-Hhhc
Confidence            98765332211    112356799999999999999999999999999999999999999987554332222221 1111


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .....+..     +...++    ..+.+++.+||+.||++||++.+|++.|+.
T Consensus       232 ~~~~~~~~-----l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          232 KVATSIEA-----LCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHSCHHH-----HHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cccccHHH-----HhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11111111     111222    457789999999999999999999998865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.1e-39  Score=331.57  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=196.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|...+.||+|+||.||+|++.  ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999986  7899999987542   233567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++....        .+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        91 e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG--------RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             ECCCSCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             eccCCCcHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999996543        28899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      .......    .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......    .+..    ....+.
T Consensus       160 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~~~~~  227 (276)
T 2h6d_A          160 MMSDGEF----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFK----KIRGGV  227 (276)
T ss_dssp             CCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCC
T ss_pred             ccCCCcc----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHH----HhhcCc
Confidence            7643211    234578999999999987765 68999999999999999999999764321    1111    111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGE  601 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  601 (644)
                            ..+...+    ...+.+++.+|++.||++||+++++++.  ++..
T Consensus       228 ------~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 ------FYIPEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ------CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ------ccCchhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                  0111222    3457788999999999999999999973  4443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-39  Score=332.78  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      .++|+..+.||+|+||.||+|+..  ++.||+|++...  ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357888999999999999999986  789999998754  334467788999999999 999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC------------
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS------------  460 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~------------  460 (644)
                      |||+++++|.+++.......    ..+++..+..++.|+++||.|||+   .+|+||||||+|||++.            
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIM----SYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-------------
T ss_pred             EEecCCCcHHHHHHhhcccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999997542110    138999999999999999999999   89999999999999984            


Q ss_pred             -------CCcEEEeccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          461 -------EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       461 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                             ...+||+|||++.....       .....||+.|+|||.+.+. .++.++|||||||++|||++|++++....
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             -------CCCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             cccccCCceEEEEcccccccccCC-------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                   44799999999987643       2234589999999998766 56789999999999999999988764321


Q ss_pred             cccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          533 QNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       533 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                            .     +.....+..     +.+...+    ...+.+++.+|++.||++||++.++++
T Consensus       236 ------~-----~~~~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ------Q-----WHEIRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------H-----HHHHHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------H-----HHHHHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  1     111112211     1222233    345778899999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.4e-39  Score=346.33  Aligned_cols=260  Identities=24%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC--------CCceeeEeeeee---
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR--------HRNLVKLIGWCY---  384 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~g~~~---  384 (644)
                      .++|+..++||+|+||.||+|+..  ++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999876  678999999654 334567889999999996        788999999988   


Q ss_pred             -eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCC
Q 006446          385 -ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       385 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~  462 (644)
                       .....++||||+ +++|.+++......      .+++..+..++.||++||.|||+   + +|+||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQ------GLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence             556799999999 66776666543211      38999999999999999999999   7 999999999999999775


Q ss_pred             -------------------------------------------------cEEEeccCCcccccccccccccccccccCCC
Q 006446          463 -------------------------------------------------NARLGDFGLARTIQENLKTHHSTKEIAGTPG  493 (644)
Q Consensus       463 -------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~  493 (644)
                                                                       .+||+|||+++.....      .....||+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~  258 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQ  258 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCc
Confidence                                                             7999999999876432      334578999


Q ss_pred             ccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhh--HHHHHHHHHhc--------Cchh---------
Q 006446          494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS--IVHWLWELRRK--------GRIL---------  554 (644)
Q Consensus       494 y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~--l~~~~~~~~~~--------~~~~---------  554 (644)
                      |+|||++.+..++.++|||||||++|||++|+.||...........  ....+......        +...         
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            9999999999999999999999999999999999976543322111  11111111111        0000         


Q ss_pred             -------------hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 -------------DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 -------------~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                                   +....  ....+......+.+|+.+||+.||++|||++|+++
T Consensus       339 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                         00000  11345667778999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.2e-39  Score=342.39  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=202.9

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--------hhhHHHHHHHHHHhcc-CCCceeeEeee
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--------QGKQEFIAEVTTIGSL-RHRNLVKLIGW  382 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~nIv~l~g~  382 (644)
                      .....++|+..+.||+|+||.||+|++.  ++.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445567999999999999999999986  78999999875431        1245678899999999 79999999999


Q ss_pred             eeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          383 CYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       383 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                      +...+..++||||+++++|.+++....        .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--------~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV--------ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence            999999999999999999999996542        38999999999999999999999   8999999999999999999


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCcccccc------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccc
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSY  536 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~  536 (644)
                      .+||+|||++.......    ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......  
T Consensus       238 ~ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--  311 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--  311 (365)
T ss_dssp             CEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CEEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--
Confidence            99999999998765322    1345679999999999863      35889999999999999999999999764321  


Q ss_pred             hhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          537 NNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       537 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        .....    ...+.... ..+.. ...    ...+.+++.+|++.||++||+++++++
T Consensus       312 --~~~~~----i~~~~~~~-~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 --LMLRM----IMEGQYQF-SSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHHHH----HHHTCCCC-CHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHH----HHhCCCCC-CCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11111    11111100 00000 111    245778999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-39  Score=342.88  Aligned_cols=264  Identities=23%  Similarity=0.292  Sum_probs=196.5

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch-----hhHHHHHHHHHHhccCCCceeeEeeeeeeccc
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-----GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD  388 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~  388 (644)
                      ...++|+..+.||+|+||.||+|+..  +..||+|++......     ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999986  778999998753221     13568899999999999999999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++||||+++ +|.+++.....       .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCS-------SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEe
Confidence            9999999964 88888865432       37888999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+++.......   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......   .+ ..+...
T Consensus       156 fg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~-~~i~~~  228 (346)
T 1ua2_A          156 FGLAKSFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QL-TRIFET  228 (346)
T ss_dssp             CGGGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-HHHHHH
T ss_pred             cccceeccCCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HH-HHHHHH
Confidence            999987643221   13456789999999998754 58999999999999999999999987654321   11 111211


Q ss_pred             HhcCchhhh------hhccc---CCCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGRILDA------ADSRL---GGEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~~~~~------~d~~l---~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .........      .+...   ....+     ......+.+|+.+|++.||++|||++|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            111100000      00000   00011     1123567889999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=344.29  Aligned_cols=255  Identities=16%  Similarity=0.148  Sum_probs=201.9

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeee-------cCceEEEEEeecccchhhHHHHHHHHHHhccC---CCceeeEeeeee
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIW-------RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR---HRNLVKLIGWCY  384 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~  384 (644)
                      ....++|...++||+|+||.||+|++       .++.||+|++....   ..++..|+.++++++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            33457788899999999999999942       26789999997543   456777777777776   999999999999


Q ss_pred             eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC----
Q 006446          385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS----  460 (644)
Q Consensus       385 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~----  460 (644)
                      ..+..++||||+++|+|.+++......   ....++|..++.|+.||++||+|||+   .+|+||||||+|||++.    
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNT---PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTS---TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            999999999999999999999753221   11249999999999999999999999   89999999999999998    


Q ss_pred             -------CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          461 -------EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       461 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                             ++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             ccccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                   89999999999986542211 1224556799999999999999999999999999999999999999854332


Q ss_pred             ccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCC
Q 006446          534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLR-PSMKTVLQVLSGE  601 (644)
Q Consensus       534 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-Ps~~evl~~L~~~  601 (644)
                      ....                   ....+....   ..+.+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       291 ~~~~-------------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          291 GECK-------------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             TEEE-------------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             Ccee-------------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            1110                   011111111   23456678889999999998 5788887777653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=337.76  Aligned_cols=268  Identities=23%  Similarity=0.276  Sum_probs=196.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeee------------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCY------------  384 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~------------  384 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||+|++........+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            67888999999999999999987  7889999998777667788999999999999999999999874            


Q ss_pred             --eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc-CC
Q 006446          385 --ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SE  461 (644)
Q Consensus       385 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~  461 (644)
                        +....++||||++ |+|.+++...         .+++..+..++.|+++||+|||+   .+|+||||||+|||++ ++
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQG---------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhcC---------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCC
Confidence              3467899999997 7999998532         38899999999999999999999   8999999999999997 56


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +.+||+|||+++................+|..|+|||.+.. ..++.++|||||||++|||++|+.||...........+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            79999999999876532222222344567999999998865 67899999999999999999999999865432211111


Q ss_pred             HHH--------HHHHHhcCchhhhhhcccC-CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          541 VHW--------LWELRRKGRILDAADSRLG-GEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       541 ~~~--------~~~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ...        ..+..  ..+......... ...+     ......+.+++.+|++.||++||+++|+++  .++..
T Consensus       238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELL--SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHH--TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhh--hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            110        00000  000000000000 0000     112345778999999999999999999987  45544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-39  Score=353.07  Aligned_cols=195  Identities=21%  Similarity=0.371  Sum_probs=154.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  388 (644)
                      .++|+..++||+|+||.||+|++.  ++.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999876  788999998653  333457789999999999999999999999543     56


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++||||+ +|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV--------YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEecc-ccchhhhcccCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecc
Confidence            89999998 689999886432        38999999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccc------------------------cccccccccCCCccCcccc-ccCCCCCccchHHHHHHHHHHHc
Q 006446          469 FGLARTIQENLKT------------------------HHSTKEIAGTPGYMAPESF-LVGRATIETDIYAFGVLILEVAC  523 (644)
Q Consensus       469 FGla~~~~~~~~~------------------------~~~~~~~~gt~~y~APE~~-~~~~~t~~sDVwSfGvvl~el~t  523 (644)
                      ||+++........                        .......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999876422110                        0113456789999999976 45679999999999999999999


Q ss_pred             C
Q 006446          524 G  524 (644)
Q Consensus       524 G  524 (644)
                      |
T Consensus       280 g  280 (458)
T 3rp9_A          280 M  280 (458)
T ss_dssp             T
T ss_pred             h
Confidence            4

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=334.57  Aligned_cols=250  Identities=28%  Similarity=0.467  Sum_probs=199.2

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ..++|+..+.||+|+||.||+|+..  +..||+|++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467889999999999999999987  7889999997643  35678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+++++|.+++.....       .+++..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus       105 ~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          105 YCGAGSVSDIIRLRNK-------TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             CCTTEEHHHHHHHHTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            9999999999864332       38999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ......   ......||..|+|||.+.+..++.++||||||+++|||++|+.||.......    .   .........  
T Consensus       175 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~~~~~~~~--  242 (314)
T 3com_A          175 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR----A---IFMIPTNPP--  242 (314)
T ss_dssp             CBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHHSCC--
T ss_pred             hhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH----H---HHHHhcCCC--
Confidence            653211   1334578999999999999899999999999999999999999997543211    1   111111100  


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          +.+  ..+......+.+++.+|++.||.+||++.++++
T Consensus       243 ----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 ----PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                000  111122346778999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.6e-39  Score=332.17  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---------chhhHHHHHHHHHHhccC-CCceeeEeeeee
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---------RQGKQEFIAEVTTIGSLR-HRNLVKLIGWCY  384 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~  384 (644)
                      ..++|+..+.||+|+||.||+|+..  ++.||+|++....         ....+.+.+|+.++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3468999999999999999999986  6789999987543         123456889999999996 999999999999


Q ss_pred             eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          385 ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       385 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      ..+..++||||+++++|.+++....        .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV--------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcE
Confidence            9999999999999999999996543        38999999999999999999999   899999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccc------cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL------VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                      ||+|||+++......    ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.......   
T Consensus       164 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---  236 (298)
T 1phk_A          164 KLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---  236 (298)
T ss_dssp             EECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             EEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---
Confidence            999999998765321    134457899999999885      4568899999999999999999999997643211   


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       ...    ....+..      .............+.+++.+|++.||++||++.++++
T Consensus       237 -~~~----~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 -MLR----MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHH----HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHH----HHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             111    1111110      0001111123356788999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-39  Score=344.73  Aligned_cols=261  Identities=20%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      .++|+..+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999986  788999998653  2334567889999999999999999999998653      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      .+++||||+ +++|.+++...         .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecC-CCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEE
Confidence            469999999 88999998642         28899999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++.....      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+..    
T Consensus       171 Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~----  240 (367)
T 1cm8_A          171 DFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK----  240 (367)
T ss_dssp             CCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred             eeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----
Confidence            99999875421      344678999999999877 6799999999999999999999999986543221111111    


Q ss_pred             HHhcCc--------------hhhhhhcccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          547 LRRKGR--------------ILDAADSRLGG---EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       547 ~~~~~~--------------~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ......              ........-..   .........+.+|+.+|++.||++|||++|+++  .++..
T Consensus       241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            100000              00000000000   011122345778999999999999999999998  35544

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.7e-39  Score=358.46  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=196.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+|+..  +..||+|++....  ......+.+|+.++++++||||++++++|.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999986  6789999987643  3346778999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---CcEEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FNARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DFGl  471 (644)
                      |+++|+|.+++....        .+++..+..++.||++||.|||+   .+|+||||||+|||++.+   +.+||+|||+
T Consensus       117 ~~~~g~L~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          117 CYKGGELFDEIIHRM--------KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             CCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             cCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            999999999886543        28899999999999999999999   899999999999999764   5599999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++......    ......||+.|+|||++. +.++.++||||+||++|||++|+.||.......    +..    ....+
T Consensus       186 a~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~----~i~~~  252 (494)
T 3lij_A          186 SAVFENQK----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILR----KVEKG  252 (494)
T ss_dssp             CEECBTTB----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHT
T ss_pred             CeECCCCc----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhC
Confidence            98765322    134567999999999876 569999999999999999999999997654321    111    11111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .... ..+. ...+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       253 ~~~~-~~~~-~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          253 KYTF-DSPE-WKNV----SEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCCC-CSGG-GTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC-Cchh-cccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1100 0000 0112    245778899999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-39  Score=334.71  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=184.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      .++|+..++||+|+||.||+++..  ++.||+|++.....  ...+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            357888999999999999999984  78899999976432  22334455566688899999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      ||++ |+|.+++......    ...+++..+..++.|++.||.|||+   . +|+||||||+|||++.++++||+|||++
T Consensus        86 e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDK----GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             ehhc-cchHHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence            9996 6888877542111    1148999999999999999999998   7 9999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCcccc----ccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESF----LVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      +.......    .....||+.|+|||.+    ....++.++|||||||++|||++|+.||.......  ..+    ....
T Consensus       158 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~  227 (290)
T 3fme_A          158 GYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQL----KQVV  227 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHH----HHHH
T ss_pred             cccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHH----HHHh
Confidence            87653211    2344799999999996    56678999999999999999999999997532211  111    1111


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ....      +..   ........+.+++.+|++.||++|||+.|+++
T Consensus       228 ~~~~------~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPS------PQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCC------CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCC------CCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111      111   11122345778899999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-39  Score=338.28  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=198.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeee--ccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYE--RHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||+|+..  ++.||+|++...   ..+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            57888999999999999999875  789999998643   3467889999999997 9999999999987  56789999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccCCc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLA  472 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla  472 (644)
                      ||+++++|.+++.           .+++..+..++.|+++||+|||+   .+|+||||||+|||++.++ .+||+|||++
T Consensus       113 e~~~~~~l~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             ECCCCCCHHHHGG-----------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eccCchhHHHHHH-----------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            9999999999873           27889999999999999999999   8999999999999999776 8999999999


Q ss_pred             ccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +.......    .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ..+.... ......
T Consensus       179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~-~~~~~~  251 (330)
T 3nsz_A          179 EFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIA-KVLGTE  251 (330)
T ss_dssp             EECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHH-HHHCHH
T ss_pred             eEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHH-HhcCCc
Confidence            87643221    344578999999999877 678999999999999999999999986543221  1111111 110000


Q ss_pred             chhhhhh-----------------------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          552 RILDAAD-----------------------SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       552 ~~~~~~d-----------------------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...+.++                       ..............+.+++.+|++.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0101000                       00111111123456788999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-38  Score=347.96  Aligned_cols=199  Identities=22%  Similarity=0.328  Sum_probs=172.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc------CCCceeeEeeeeeeccce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL------RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~  389 (644)
                      ..+|+..++||+|+||.||+|+..  +..||||++.... ...+.+.+|+.+++.+      +|+||+++++++...+.+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357888999999999999999886  6789999997543 3346677888888877      577999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc--EEEe
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN--ARLG  467 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~--vkL~  467 (644)
                      ++||||+. ++|.+++......      .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.  +||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQ------GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             EEEEeccC-CCHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence            99999995 7999998765432      38999999999999999999999   89999999999999999987  9999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      |||+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       245 DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          245 DFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999764321      3345789999999999999999999999999999999999999977543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.7e-39  Score=340.72  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=199.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc--hhhHHHHHHHHHHhccCCCceeeEeeeeee--------c
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR--QGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--------R  386 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~  386 (644)
                      ++|+..++||+|+||.||+|+..  ++.||+|++.....  .....+.+|+.++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57888999999999999999985  78999999865432  234678899999999999999999999987        3


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      +.+++||||++ |+|.+.+.....       .+++.++..++.|+++||.|||+   .+|+||||||+|||++.++.+||
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVLV-------KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             ceEEEEEeccC-CCHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEE
Confidence            46899999996 577777754433       38999999999999999999999   89999999999999999999999


Q ss_pred             eccCCcccccccccc-cccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          467 GDFGLARTIQENLKT-HHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      +|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........    ...+
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i  241 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALI  241 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHH
Confidence            999999876422111 112345678999999998876 4579999999999999999999999987543221    1112


Q ss_pred             HHHHhcCc--hhhhhh-----ccc---C-CCCC-HHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 WELRRKGR--ILDAAD-----SRL---G-GEFS-EKE------MECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 ~~~~~~~~--~~~~~d-----~~l---~-~~~~-~~~------~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ........  .....+     ..+   . .... .+.      ...+.+|+.+|++.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11111100  000000     000   0 0000 011      2347789999999999999999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-38  Score=348.03  Aligned_cols=200  Identities=24%  Similarity=0.382  Sum_probs=166.4

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  388 (644)
                      .++|+..+.||+|+||.||+|++.  +..||||++...  .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999886  678999999753  333457889999999999999999999999876     56


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++||||+. |+|.+++....        .+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~--------~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI--------FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEecCC-cCHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEcc
Confidence            899999995 69999986432        38999999999999999999999   8999999999999999999999999


Q ss_pred             cCCccccccccccc-------------------ccccccccCCCccCcccc-ccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          469 FGLARTIQENLKTH-------------------HSTKEIAGTPGYMAPESF-LVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       469 FGla~~~~~~~~~~-------------------~~~~~~~gt~~y~APE~~-~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      ||+++.........                   ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            99998765322110                   113556899999999986 5667999999999999999999865554


Q ss_pred             C
Q 006446          529 N  529 (644)
Q Consensus       529 ~  529 (644)
                      .
T Consensus       253 ~  253 (432)
T 3n9x_A          253 I  253 (432)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-38  Score=355.63  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-------------hhhHHHHHHHHHHhccCCCceeeEee
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-------------QGKQEFIAEVTTIGSLRHRNLVKLIG  381 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~g  381 (644)
                      ..++|...++||+|+||.||+|+..  +..||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999986  67899999875421             23567889999999999999999999


Q ss_pred             eeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      ++.+...+++||||+++|+|.+++....        .+++..+..++.||+.||.|||+   .+|+||||||+|||++.+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH--------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENK  182 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESST
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecC
Confidence            9999999999999999999999986543        38999999999999999999999   899999999999999877


Q ss_pred             C---cEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          462 F---NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       462 ~---~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                      +   .+||+|||+++......    ......||+.|+|||++. +.++.++||||+||++|||++|+.||.......   
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---  254 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---  254 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             CCCccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            6   69999999998765321    134567999999999876 569999999999999999999999997654321   


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       +..    ....+.......  ....+    ...+.+++.+|+++||.+|||++|+++
T Consensus       255 -~~~----~i~~~~~~~~~~--~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 -IIK----KVEKGKYYFDFN--DWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -HHH----HHHHCCCCCCHH--HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHH----HHHcCCCCCCcc--ccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             111    111121100000  00112    245778999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-38  Score=341.05  Aligned_cols=262  Identities=21%  Similarity=0.240  Sum_probs=191.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      .++|+..+.||+|+||.||+|+..  +..||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368889999999999999999876  778999999753  2334567889999999999999999999997654      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++||||++ |+|.+++..          .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEEcCC-CCHHHHHhh----------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEE
Confidence            6899999996 678887742          27899999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH-----
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH-----  542 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~-----  542 (644)
                      |||+++......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..     
T Consensus       170 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          170 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             CCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             Eeeccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998764321    13446789999999999999999999999999999999999999976543211111100     


Q ss_pred             ----------HHHHHHhcC------chhhhhhcccCCCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 ----------WLWELRRKG------RILDAADSRLGGEF---SEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ----------~~~~~~~~~------~~~~~~d~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                .+.......      ..............   .......+.+|+.+|++.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                      000000000      00000000000000   11235678899999999999999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=339.68  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=198.4

Q ss_pred             ccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeee
Q 006446          308 KFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCY  384 (644)
Q Consensus       308 ~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~  384 (644)
                      .+.+.++....++|+..+.||+|+||.||+|++.  +..||+|++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3444455556788999999999999999999984  7889999987543 3457889999999999 8999999999998


Q ss_pred             e------ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE
Q 006446          385 E------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML  458 (644)
Q Consensus       385 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl  458 (644)
                      .      .+..++||||+++|+|.+++.....      ..+++..+..++.|++.||.|||+   .+|+||||||+|||+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~  162 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG------NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLL  162 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEE
Confidence            7      4578999999999999999975432      148899999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeccCCcccccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          459 DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       459 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      +.++.+||+|||++........   ......||+.|+|||.+.     ...++.++|||||||++|||++|+.||.....
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             CTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             cCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence            9999999999999987643211   123457899999999987     56789999999999999999999999965432


Q ss_pred             ccchhhHHHHHHHHHhcCchhhhhhccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          534 NSYNNSIVHWLWELRRKGRILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       534 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..    ..   ...... .     .+.+ ...+    ...+.+++.+||+.||.+||+++++++
T Consensus       240 ~~----~~---~~~~~~-~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 MR----AL---FLIPRN-P-----APRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HH----HH---HHHHHS-C-----CCCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH----HH---HHhhcC-c-----cccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11    11   111111 1     0111 1222    245778899999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-39  Score=348.62  Aligned_cols=252  Identities=11%  Similarity=0.030  Sum_probs=179.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhcc--CCCceeeEe-------eeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSL--RHRNLVKLI-------GWCY  384 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------g~~~  384 (644)
                      .+|+..++||+|+||.||+|++.  ++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788999999999999999976  77899999987542   3345677785444444  699988855       3433


Q ss_pred             ec-----------------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHH------HHHHHHHHHHHHHhHhC
Q 006446          385 ER-----------------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKR------LSVIHGTSQALDYLHNG  441 (644)
Q Consensus       385 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~  441 (644)
                      ..                 ..+++|||||+ |+|.+++......       +.+..+      +.++.||++||+|||+ 
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~vk~~i~~qi~~aL~~LH~-  212 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-------YVFRGDEGILALHILTAQLIRLAANLQS-  212 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-------cchhhhhhhhhHHHHHHHHHHHHHHHHH-
Confidence            22                 34899999998 9999999764321       444555      7888999999999999 


Q ss_pred             CCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCcccccc--CCCCCccchHHHHHHHH
Q 006446          442 SEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLIL  519 (644)
Q Consensus       442 ~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~  519 (644)
                        .+|+||||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+  ..++.++|||||||++|
T Consensus       213 --~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          213 --KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             --TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             --CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence              99999999999999999999999999999866421      224457799999999987  67999999999999999


Q ss_pred             HHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          520 EVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       520 el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ||++|+.||.........         .+............+...........+.+|+.+||+.||++||++.++++
T Consensus       285 elltg~~Pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTT---------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHhCCCCCCCcCccccc---------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999765332110         00000000000111111111123456778999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.6e-39  Score=336.68  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=194.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--------chhhHHHHHHHHHHhccCCCceeeEeeeeeecc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--------RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~  387 (644)
                      .++|...+.||+|+||.||+|+..  ++.||||++....        ......+.+|+.++++++||||+++++++..+ 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            357888999999999999999886  6789999986432        12234688999999999999999999998765 


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---E
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---A  464 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---v  464 (644)
                      ..++||||+++++|.+++....        .+++.....++.|+++||.|||+   .+|+||||||+|||++.++.   +
T Consensus        88 ~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           88 DYYIVLELMEGGELFDKVVGNK--------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             SEEEEEECCTTEETHHHHSTTC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCE
T ss_pred             ceEEEEecCCCCcHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeE
Confidence            4899999999999999886432        38899999999999999999999   89999999999999987664   9


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      ||+|||+++......    ......||+.|+|||++.   ...++.++|||||||++|||++|+.||........   +.
T Consensus       157 kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~  229 (322)
T 2ycf_A          157 KITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LK  229 (322)
T ss_dssp             EECCCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HH
T ss_pred             EEccCccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HH
Confidence            999999998764321    123457899999999974   56789999999999999999999999976443221   11


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ..+    ..+....  .+.....+    ...+.+++.+|++.||++||++.++++
T Consensus       230 ~~~----~~~~~~~--~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQI----TSGKYNF--IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHH----HHTCCCC--CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH----HhCcccc--Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            111    1111100  00000112    345778999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.1e-39  Score=368.93  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=203.9

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  390 (644)
                      ..++|+..++||+|+||.||+++..  ++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467899999999999999999987  567999999754   233456788899999988 7999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      |||||+++|+|.+++....        .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++++||+|||
T Consensus       419 lV~E~~~gg~L~~~l~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG--------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecc
Confidence            9999999999999997543        28999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +..    ....
T Consensus       488 la~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~----~i~~  556 (674)
T 3pfq_A          488 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ----SIME  556 (674)
T ss_dssp             TCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHS
T ss_pred             eeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHH----HHHh
Confidence            998643221   12455789999999999999999999999999999999999999998654321    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM-----KTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~-----~evl~  596 (644)
                      +.          ..++......+.+|+.+||+.||++||++     +||++
T Consensus       557 ~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          557 HN----------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             SC----------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CC----------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            11          12222334567789999999999999997     66663

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-39  Score=358.46  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..++||+|+||.||+++..  +..||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999986  7889999986542   334678899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE---cCCCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl---d~~~~vkL~DFG  470 (644)
                      ||+++|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||+   +.++.+||+|||
T Consensus       106 e~~~~~~L~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK--------RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             CCCCSCBHHHHHHTCS--------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             ecCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            9999999999886543        38999999999999999999999   899999999999999   567899999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +++......    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.......    +..    ....
T Consensus       175 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~----~i~~  241 (484)
T 3nyv_A          175 LSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD----ILK----KVEK  241 (484)
T ss_dssp             HHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHH
T ss_pred             eeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHH----HHHc
Confidence            998765321    1344579999999998865 69999999999999999999999997654321    111    1111


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +....      ...........+.+++.+|++.||++|||++|+++
T Consensus       242 ~~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYTF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            21100      00000122345778999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.3e-39  Score=355.36  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=200.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||.||+++..  +..||||++....  ......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            57888999999999999999986  7889999986532  3345778999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc---CCCcEEEeccCC
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFGL  471 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGl  471 (644)
                      |+++|+|.+++....        .+++..+..++.|++.||.|||+   .+|+||||||+|||++   .++.+||+|||+
T Consensus       102 ~~~~~~L~~~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             CCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             cCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999886543        38999999999999999999999   8999999999999995   456799999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++......    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.......    +..    ....+
T Consensus       171 a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~----~i~~~  237 (486)
T 3mwu_A          171 STCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----RVETG  237 (486)
T ss_dssp             TTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHT
T ss_pred             CeECCCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhC
Confidence            98765321    1345579999999999865 59999999999999999999999997654321    111    11111


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ....      ...........+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 KYAF------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCCS------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCC------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1100      000001123457789999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-38  Score=341.99  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=194.1

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec------
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------  386 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------  386 (644)
                      ....++|+..++||+|+||.||+|++.  +..||+|++.....    ...+|+.++++++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999875  78999999865432    234799999999999999999998543      


Q ss_pred             --------------------------------cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHH
Q 006446          387 --------------------------------HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA  434 (644)
Q Consensus       387 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~a  434 (644)
                                                      ..+++||||++ |+|.+.+......    ...+++..+..++.|+++|
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~a  153 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS----GRSIPMNLISIYIYQLFRA  153 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc----CCCCCHHHHHHHHHHHHHH
Confidence                                            23889999997 6888777532111    1148999999999999999


Q ss_pred             HHHhHhCCCCCeEeCCCCCCCEEEc-CCCcEEEeccCCcccccccccccccccccccCCCccCccccccC-CCCCccchH
Q 006446          435 LDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIY  512 (644)
Q Consensus       435 L~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVw  512 (644)
                      |.|||+   .+|+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||.+.+. .++.++|||
T Consensus       154 L~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          154 VGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            999998   9999999999999998 689999999999987643221    3445789999999998765 489999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh--hhc--------ccC-----CCCCHHHHHHHHHHH
Q 006446          513 AFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA--ADS--------RLG-----GEFSEKEMECVLILG  577 (644)
Q Consensus       513 SfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d~--------~l~-----~~~~~~~~~~l~~L~  577 (644)
                      |+||++|||++|+.||......+....+..    ..........  .++        .+.     ..++......+.+|+
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~----~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQ----IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHH----HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            999999999999999987543222111111    1111000000  000        000     001122334578899


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 006446          578 LACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       578 ~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+|++.||++|||+.|+++
T Consensus       303 ~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.2e-38  Score=337.11  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-----------CCceeeEeeeeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-----------HRNLVKLIGWCYE  385 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~  385 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||||++.... ...+.+.+|+.++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57888999999999999999975  7889999987432 34567888999999886           8999999999986


Q ss_pred             cc----ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEc-
Q 006446          386 RH----DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLD-  459 (644)
Q Consensus       386 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld-  459 (644)
                      .+    .+++||||+ +++|.+++......      .+++..+..++.||+.||+|||+   . +|+||||||+|||++ 
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHR------GIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhcc------CCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence            54    789999999 99999998754322      38899999999999999999999   7 999999999999994 


Q ss_pred             -----CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccc
Q 006446          460 -----SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQN  534 (644)
Q Consensus       460 -----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~  534 (644)
                           ..+.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             cCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                 4458999999999876432      33457899999999999999999999999999999999999999765422


Q ss_pred             cch---hhHHHHHHHHHh--------cCch----------------------hhhhhcccCCCCCHHHHHHHHHHHHHhc
Q 006446          535 SYN---NSIVHWLWELRR--------KGRI----------------------LDAADSRLGGEFSEKEMECVLILGLACC  581 (644)
Q Consensus       535 ~~~---~~l~~~~~~~~~--------~~~~----------------------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl  581 (644)
                      ...   ..+.. +.....        .+..                      .+....  ...++......+.+|+.+||
T Consensus       242 ~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          242 SYTKDDDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             ---CHHHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGG
T ss_pred             ccCChHHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHh
Confidence            111   11111 111110        0000                      000000  12355677788999999999


Q ss_pred             CCCCCCCCCHHHHHH--HHhCC
Q 006446          582 HPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       582 ~~dP~~RPs~~evl~--~L~~~  601 (644)
                      +.||++|||++|+++  .+.+.
T Consensus       319 ~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          319 QLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             CSSTTTCBCHHHHHTCGGGTTC
T ss_pred             ccCccccCCHHHHhhChhhhcc
Confidence            999999999999987  34443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=339.38  Aligned_cols=261  Identities=21%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             HHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          316 KATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       316 ~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ...++|+..+.||+|+||.||+|+..+ .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            345788899999999999999998875 59999986542  233466888999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++ ++.+||+|||+++
T Consensus       109 e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKI-------VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             BCCCSEEHHHHTTSSCC-------CCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ecccCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            99999999999965432       38899999999999999999999   8999999999999998 6799999999987


Q ss_pred             ccccccc--ccccccccccCCCccCcccccc---------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHH
Q 006446          474 TIQENLK--THHSTKEIAGTPGYMAPESFLV---------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH  542 (644)
Q Consensus       474 ~~~~~~~--~~~~~~~~~gt~~y~APE~~~~---------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~  542 (644)
                      .......  .........||..|+|||.+..         ..++.++|||||||++|||++|+.||.......    +. 
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~-  252 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----II-  252 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----HH-
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH-
Confidence            6532111  1111234568999999999864         457889999999999999999999997643211    11 


Q ss_pred             HHHHHHhcCchhhhhhcccC-CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Q 006446          543 WLWELRRKGRILDAADSRLG-GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP  605 (644)
Q Consensus       543 ~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  605 (644)
                        +.. ..+..     +.+. ..+    ...+.+++.+||+.||++||+++++++.|+......
T Consensus       253 --~~~-~~~~~-----~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          253 --WQM-GTGMK-----PNLSQIGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             --HHH-HTTCC-----CCCCCSSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             --HHh-ccCCC-----CCCCcCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence              111 11111     1111 112    234678899999999999999999999999876543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.5e-39  Score=343.02  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=182.8

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeec------c
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------H  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~  387 (644)
                      .++|+..+.||+|+||.||+|+..  +..||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468889999999999999999875  788999998653  233456788999999999999999999998754      5


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ..++|+||+ +++|.+++...         .+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ---------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             CCEEEEECC-CEECC-----C---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEeccc-CCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEe
Confidence            689999999 79999988532         38999999999999999999999   999999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.    .
T Consensus       175 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~----~  244 (367)
T 2fst_X          175 DFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL----R  244 (367)
T ss_dssp             C---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----H
T ss_pred             ecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----H
Confidence            99999875421      344678999999999876 678999999999999999999999997654322111111    1


Q ss_pred             HHhcCc-----------hhhhhhcccC--CCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          547 LRRKGR-----------ILDAADSRLG--GEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       547 ~~~~~~-----------~~~~~d~~l~--~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ......           ..... ..+.  .....     .....+.+|+.+|++.||++|||++|+++.
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHH-HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHHhhhHHHHHHH-hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            111100           00000 0000  00110     112457789999999999999999999873

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-39  Score=337.33  Aligned_cols=261  Identities=19%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             cccCHHHHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecc--cchhhHHHHHHHHHHhccC--CCceeeEee
Q 006446          307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLR--HRNLVKLIG  381 (644)
Q Consensus       307 ~~~~~~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g  381 (644)
                      ..+.+..+....++|+..+.||+|+||.||+++.. +..||+|++...  .....+.+.+|+.++.+++  |+||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            33444444445677999999999999999999887 678999998654  3345678899999999997  599999999


Q ss_pred             eeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC
Q 006446          382 WCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE  461 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~  461 (644)
                      ++...+..++||| +.+++|.+++....        .+++..+..++.|+++||.|||+   .+|+||||||+|||+++ 
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKKK--------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-  162 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHCS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-
Confidence            9999999999999 56899999997543        38899999999999999999999   89999999999999965 


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCcccccc-----------CCCCCccchHHHHHHHHHHHcCCCCCCC
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-----------GRATIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      +.+||+|||+++....... ........||+.|+|||.+..           ..++.++|||||||++|||++|+.||..
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CeEEEeeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            8999999999987653221 111234578999999999865           4688899999999999999999999975


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ....     . .....         ..++.....++......+.+++.+||+.||++||+++++++
T Consensus       242 ~~~~-----~-~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          242 IINQ-----I-SKLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCSH-----H-HHHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHH-----H-HHHHH---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            4321     1 11111         11111112222222356778899999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.9e-38  Score=332.05  Aligned_cols=256  Identities=20%  Similarity=0.276  Sum_probs=202.1

Q ss_pred             hCCCCCCCcccccCcEEEEEeee---cCceEEEEEeecccchhhHHHHHHHHHHhccCCCc------eeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIW---RNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN------LVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~  388 (644)
                      .++|+..+.||+|+||.||++..   .+..||+|+++... ...+.+.+|+.+++.++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35788999999999999999987   26789999986543 34567889999999997765      9999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC--------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS--------  460 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--------  460 (644)
                      .++||||+ +++|.+++......      .+++..+..++.|+++||+|||+   .+|+||||||+|||++.        
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFL------PFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCC------CCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccC
Confidence            99999999 89999998654321      38899999999999999999999   89999999999999987        


Q ss_pred             -----------CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 006446          461 -----------EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN  529 (644)
Q Consensus       461 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~  529 (644)
                                 ++.+||+|||+++.....      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                       678999999999865421      334578999999999999999999999999999999999999997


Q ss_pred             CCccccchhhHHHHHHHHHhcCchhhhh------------------------------hccc--CCCCCHHHHHHHHHHH
Q 006446          530 QSEQNSYNNSIVHWLWELRRKGRILDAA------------------------------DSRL--GGEFSEKEMECVLILG  577 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~------------------------------d~~l--~~~~~~~~~~~l~~L~  577 (644)
                      ..........    +....  +......                              ...+  .........+.+.+|+
T Consensus       236 ~~~~~~~~~~----~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  309 (339)
T 1z57_A          236 THDSKEHLAM----MERIL--GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI  309 (339)
T ss_dssp             CSCHHHHHHH----HHHHH--CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCChHHHHHH----HHHHh--CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence            6543221111    11111  0000000                              0000  0112234567788999


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 006446          578 LACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       578 ~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+|++.||++|||++|+++
T Consensus       310 ~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          310 QKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHhCcCcccccCHHHHhc
Confidence            9999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.1e-39  Score=338.26  Aligned_cols=265  Identities=22%  Similarity=0.254  Sum_probs=203.7

Q ss_pred             hCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchh-----------------hHHHHHHHHHHhccCCCceeeEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQG-----------------KQEFIAEVTTIGSLRHRNLVKLI  380 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~H~nIv~l~  380 (644)
                      .++|+..+.||+|+||.||+|...+..||+|++.......                 .+.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3688999999999999999999988999999987542211                 17899999999999999999999


Q ss_pred             eeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          381 GWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       381 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                      +++.+.+..++||||+++|+|.+++.....-.......+++..+..++.|+++||.|||+  ..+|+||||||+|||++.
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence            999999999999999999999999422111111112248999999999999999999996  378999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCccccccC-CCCC-ccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATI-ETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~-~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                      ++.+||+|||+++.....     ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||......   .
T Consensus       188 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~  259 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---V  259 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---H
T ss_pred             CCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---H
Confidence            999999999999876432     13456789999999999877 5666 999999999999999999999765431   1


Q ss_pred             hHHHHHHHHHhcCchhhhhh--cc---c----CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          539 SIVHWLWELRRKGRILDAAD--SR---L----GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d--~~---l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+..    ....+......+  ..   +    ...........+.+++.+|++.||.+||+++|+++
T Consensus       260 ~~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ELFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    111111100000  00   0    00000223356778999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-38  Score=336.28  Aligned_cols=273  Identities=22%  Similarity=0.259  Sum_probs=191.0

Q ss_pred             HHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc-
Q 006446          312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD-  388 (644)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-  388 (644)
                      .+.....++|+..++||+|+||.||+|++.  +..||||++.... .....+.+|+..++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999986  7789999986543 234566788888999999999999999976543 


Q ss_pred             ------eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhH--hCCCCCeEeCCCCCCCEEEcC
Q 006446          389 ------FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH--NGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       389 ------~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivHrDlkp~NILld~  460 (644)
                            +++||||+++ +|...+......    ...+++..+..++.|++.||.|||  +   .+|+||||||+|||++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRR----QVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNE  166 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEET
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeC
Confidence                  8999999975 554444321111    113889999999999999999999  6   89999999999999997


Q ss_pred             -CCcEEEeccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          461 -EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       461 -~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                       ++.+||+|||+++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence             89999999999987653221    3345789999999998655 48999999999999999999999998754332222


Q ss_pred             hHHHHH-------HHHH-hcCchhhhhh------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          539 SIVHWL-------WELR-RKGRILDAAD------SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       539 ~l~~~~-------~~~~-~~~~~~~~~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .+....       +... ......+..+      ..............+.+|+.+|++.||.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            121110       0000 0000000000      000011112245678899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.5e-38  Score=333.59  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=200.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cce
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HDF  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  389 (644)
                      .++|+..+.||+|+||.||+|+..  +..||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468888999999999999999987  7889999996543 33456788999999999999999999998764     678


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++|+||+. |+|.+++...         .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        90 ~lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ---------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEeccC-ccHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEec
Confidence            99999996 7999988642         38899999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccccccccc-------cccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          470 GLARTIQENLKTHH-------STKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       470 Gla~~~~~~~~~~~-------~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      |+++..........       ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||........    .
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~  232 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----L  232 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----H
Confidence            99987653211110       1223578999999998764 6789999999999999999999999976543211    1


Q ss_pred             HHHHHHHhcCch------------hhhhhcccC--CCCC-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhC
Q 006446          542 HWLWELRRKGRI------------LDAADSRLG--GEFS-----EKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSG  600 (644)
Q Consensus       542 ~~~~~~~~~~~~------------~~~~d~~l~--~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~  600 (644)
                      ..+.........            .+... .+.  ....     ......+.+++.+|++.||++||+++|+++  .++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          233 LLIFGIIGTPHSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             HHHHHHHCCCCSTTTTTTCCCHHHHHHHH-TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHhCCCchhccccccccchhhHHhh-cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            111111111000            00000 000  0000     112345678999999999999999999987  3444


Q ss_pred             C
Q 006446          601 E  601 (644)
Q Consensus       601 ~  601 (644)
                      .
T Consensus       312 ~  312 (353)
T 2b9h_A          312 Y  312 (353)
T ss_dssp             T
T ss_pred             c
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.8e-38  Score=336.76  Aligned_cols=207  Identities=21%  Similarity=0.292  Sum_probs=173.9

Q ss_pred             HHHHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CC-----ceeeEeeee
Q 006446          312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HR-----NLVKLIGWC  383 (644)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~  383 (644)
                      +......++|+..++||+|+||.||+|+..  ++.||||+++... ...+++..|+.+++.++ |+     +|+++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            333445678999999999999999999886  6789999997532 33566778888888885 44     499999999


Q ss_pred             eeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc--CC
Q 006446          384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD--SE  461 (644)
Q Consensus       384 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~  461 (644)
                      ...+..++||||++ |+|.+++......      .+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .+
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFR------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTS------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcC------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence            99999999999995 6999998754322      389999999999999999999941 27899999999999994  57


Q ss_pred             CcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCcc
Q 006446          462 FNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQ  533 (644)
Q Consensus       462 ~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~  533 (644)
                      +.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       198 ~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CcEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            88999999999876422      3346789999999999999999999999999999999999999987543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-38  Score=327.44  Aligned_cols=252  Identities=25%  Similarity=0.456  Sum_probs=193.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee----------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----------  385 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----------  385 (644)
                      .++|+..+.||+|+||.||+|+..  +..||+|++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            357888999999999999999975  788999999653 3345778999999999999999999998865          


Q ss_pred             ---ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC
Q 006446          386 ---RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF  462 (644)
Q Consensus       386 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~  462 (644)
                         .+..++||||+++|+|.+++.....       .+++..++.++.|+++||+|||+   .+|+||||||+|||++.++
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENL-------NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCG-------GGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcccc-------ccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence               4568999999999999999975432       37889999999999999999999   8999999999999999999


Q ss_pred             cEEEeccCCccccccccc-----------ccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCC
Q 006446          463 NARLGDFGLARTIQENLK-----------THHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQ  530 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~  530 (644)
                      .+||+|||+++.......           .........||+.|+|||.+.+. .++.++|||||||++|||++   |+..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            999999999987642210           01112345789999999998754 68999999999999999998   4432


Q ss_pred             CccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       531 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...      ........ ..      ....+...+.......+.+++.+|++.||.+||+++++++
T Consensus       231 ~~~------~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 GME------RVNILKKL-RS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH------HHHHHHHH-HS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chh------HHHHHHhc-cc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            110      11111111 11      1112233344445566788999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.7e-39  Score=335.48  Aligned_cols=262  Identities=25%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec---CceEEEEEeecccc--hhhHHHHHHHHHHhcc---CCCceeeEeeeee----
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL---RHRNLVKLIGWCY----  384 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~----  384 (644)
                      +.++|+..+.||+|+||.||+|+..   +..||+|++.....  .....+.+|+.+++.+   +||||++++++|.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999873   57899999865432  2234567787777766   8999999999987    


Q ss_pred             -eccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          385 -ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       385 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                       .....++||||++ |+|.+++......      .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~  158 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP------GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQ  158 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCC
Confidence             5567899999996 7999998654322      38899999999999999999999   89999999999999999999


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~  543 (644)
                      +||+|||+++......    ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......    ....
T Consensus       159 ~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~  230 (326)
T 1blx_A          159 IKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGK  230 (326)
T ss_dssp             EEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH
T ss_pred             EEEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHH
Confidence            9999999998764321    1345678999999999999999999999999999999999999998654322    1111


Q ss_pred             HHHHHhcCchhhhh------hcccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          544 LWELRRKGRILDAA------DSRLG-------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       544 ~~~~~~~~~~~~~~------d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +.............      ...+.       ..+.......+.+++.+|++.||++||++.++++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111110000000      00000       0111122345778999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-38  Score=338.62  Aligned_cols=256  Identities=20%  Similarity=0.277  Sum_probs=195.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccce----
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDF----  389 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----  389 (644)
                      .++|...+.||+|+||.||+|+..  ++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468888999999999999999876  7899999997643  33457788999999999999999999999877654    


Q ss_pred             --EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          390 --LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       390 --~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                        ++||||+. ++|.+++..          .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM----------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEcccc-ccHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEE
Confidence              99999996 788877721          28899999999999999999999   899999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      |||+++.....      .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..    
T Consensus       187 Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----  256 (371)
T 4exu_A          187 DFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK----  256 (371)
T ss_dssp             STTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----
T ss_pred             ecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----
Confidence            99999865422      334578999999999877 6789999999999999999999999986543221111111    


Q ss_pred             HHhcCc----------hhhhhhcccC----CCC---CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          547 LRRKGR----------ILDAADSRLG----GEF---SEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       547 ~~~~~~----------~~~~~d~~l~----~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      ......          ........+.    ..+   .......+.+|+.+|++.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            100000          0000000000    000   01123567889999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=343.84  Aligned_cols=271  Identities=22%  Similarity=0.282  Sum_probs=181.5

Q ss_pred             CCC-CCcccccCcEEEEEeeec----CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEEE
Q 006446          321 FNP-KNKLGKGGFGTVYKGIWR----NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLVY  393 (644)
Q Consensus       321 f~~-~~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  393 (644)
                      |+. .++||+|+||.||+|++.    +..||+|++....  ....+.+|+.++++++||||+++++++..  ...+++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            443 568999999999999965    5689999996543  23568899999999999999999999954  66799999


Q ss_pred             eccCCCccchhhhccCCC-CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----cCCCcEEEec
Q 006446          394 EYMPNGSLDKFIFYDETN-SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----DSEFNARLGD  468 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----d~~~~vkL~D  468 (644)
                      ||++ |+|.+++...... .......+++..+..|+.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9995 6888877533211 11112248999999999999999999999   899999999999999    7789999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccc-----hhhHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSY-----NNSIVH  542 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~-----~~~l~~  542 (644)
                      ||+++................||+.|+|||++.+. .++.++|||||||++|||++|+.||........     ....+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            99998775332222223456899999999998874 589999999999999999999999976443210     011111


Q ss_pred             HHHHHHhcCchh------------hhhhc---ccCCCCCH---------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          543 WLWELRRKGRIL------------DAADS---RLGGEFSE---------KEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       543 ~~~~~~~~~~~~------------~~~d~---~l~~~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .+..........            .....   ........         .....+.+|+.+||+.||.+|||++|+++.
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111111100000            00000   00000000         012356789999999999999999999974

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-38  Score=344.97  Aligned_cols=258  Identities=21%  Similarity=0.266  Sum_probs=191.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc------ceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------DFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~  390 (644)
                      .+|+..++||+|+||.||+|++.  +..||||++....    ....+|+.++++++||||+++++++...+      .++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35778899999999999999986  7889999986543    22347999999999999999999986532      378


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEEecc
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDF  469 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL~DF  469 (644)
                      +||||+++ +|.+.+......    ...+++..+..++.||++||+|||+   .+|+||||||+|||++.+ +.+||+||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eehhcccc-cHHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccc
Confidence            99999965 666655421111    1148999999999999999999999   999999999999999965 56899999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      |+++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......   ..+...+..+ 
T Consensus       202 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~l-  273 (420)
T 1j1b_A          202 GSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVL-  273 (420)
T ss_dssp             TTCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH-
T ss_pred             hhhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh-
Confidence            99987643211    3345789999999998764 7899999999999999999999999875432   2222222111 


Q ss_pred             hcCch--hhhhhccc--------CC-----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRI--LDAADSRL--------GG-----EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~--~~~~d~~l--------~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .....  .....+..        ..     .+.......+.+|+.+||+.||.+||++.|+++
T Consensus       274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00000  00001100        00     011122356788999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.9e-39  Score=346.63  Aligned_cols=259  Identities=22%  Similarity=0.269  Sum_probs=191.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccc------eEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD------FLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~l  391 (644)
                      .+|+..++||+|+||.||+|++. +..+|+|++......    ..+|+.+++.++||||+++++++...+.      +++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888999999999999999986 567999998654322    2369999999999999999999976543      889


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc-CCCcEEEeccC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFG  470 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~~vkL~DFG  470 (644)
                      ||||++++.+..........     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++ .++.+||+|||
T Consensus       116 v~e~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLK-----QTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EeeccCccHHHHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            99999765444333211111     138899999999999999999999   8999999999999999 79999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........   +...+. ...
T Consensus       188 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~-~~g  259 (394)
T 4e7w_A          188 SAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIK-VLG  259 (394)
T ss_dssp             TCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH-HHC
T ss_pred             CcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH-HhC
Confidence            9987643211    3345789999999998764 589999999999999999999999987543221   222111 110


Q ss_pred             cCchh--hhhhc-----ccCC--------CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          550 KGRIL--DAADS-----RLGG--------EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       550 ~~~~~--~~~d~-----~l~~--------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .....  ....+     .+..        .+.......+.+|+.+||+.||++|||+.|+++.
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00000  00000     0000        0111123467889999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-38  Score=364.54  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=201.5

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec-----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .++|+..+.||+|+||.||+|++.     +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            456777889999999999999875     3469999987543 334578999999999999999999999985 457899


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ||||+++|+|.+++.....       .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       468 v~E~~~~g~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKF-------SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTT-------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             EEEcCCCCcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCC
Confidence            9999999999999975432       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++.......  .......+|+.|+|||.+....++.++|||||||++|||++ |+.||......    .+...+    ..
T Consensus       538 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~~~i----~~  607 (656)
T 2j0j_A          538 SRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRI----EN  607 (656)
T ss_dssp             CCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH----HH
T ss_pred             CeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH----Hc
Confidence            987653221  11234457789999999998999999999999999999997 99998764322    121111    11


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +.         ....+......+.+++.+||+.||++||++.++++.|+..
T Consensus       608 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          608 GE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11         1112222335677899999999999999999999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-38  Score=331.27  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=177.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHH-HHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVT-TIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+|...  ++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999987  7889999997653 233455666665 7778899999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |++ |+|.+++......   ....+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSV---LDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             CCS-EEHHHHHHHHHHT---TCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             ecC-CChHHHHHHHHhh---hcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            996 5888777531110   01138899999999999999999999   7 99999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCcccc----ccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESF----LVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~----~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      .......    .....||+.|+|||.+    ....++.++|||||||++|||++|+.||.......      +..     
T Consensus       175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-----  239 (327)
T 3aln_A          175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQL-----  239 (327)
T ss_dssp             C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred             ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HHH-----
Confidence            7643211    2334789999999998    45678999999999999999999999987532110      000     


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       ........+.+...........+.+++.+||+.||++||+++++++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 -TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             0111111111111111123346778999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=331.59  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=194.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc------
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD------  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------  388 (644)
                      ++|...+.||+|+||.||+|++.  +..||||++....  ....+.+.+|+.++++++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999886  7899999996542  3335678899999999999999999999987654      


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .++||||++ ++|.+++..          .+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       104 ~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL----------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             EEEEecccc-CCHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEee
Confidence            499999996 788887731          28899999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+++.....      .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+    ...
T Consensus       170 fg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i----~~~  239 (353)
T 3coi_A          170 FGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI----LKV  239 (353)
T ss_dssp             TTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH----HHH
T ss_pred             cccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHH
Confidence            9999865422      234578999999999876 67899999999999999999999999765432111111    111


Q ss_pred             HhcCc--------------hhhhhhcccCC---CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          548 RRKGR--------------ILDAADSRLGG---EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       548 ~~~~~--------------~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .....              ...........   .........+.+++.+|++.||++||+++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000              00000000000   1112234567889999999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-38  Score=324.72  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             HhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          317 ATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       317 a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ..++|+..++||+|+||.||+++..  ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999999986  7889999987543  23467889999999999999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC---CcEEEecc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE---FNARLGDF  469 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~---~~vkL~DF  469 (644)
                      +||+++++|.+++....        .+++..+..++.|++.||.|||+   .+++||||||+||+++.+   +.+||+||
T Consensus       100 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             EEccCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence            99999999999886543        28899999999999999999999   899999999999999764   47999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++.......    .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......    .+.    ....
T Consensus       169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~----~~~~  235 (287)
T 2wei_A          169 GLSTCFQQNTK----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DIL----KRVE  235 (287)
T ss_dssp             TGGGTBCCCSS----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH----HHHH
T ss_pred             CcceeecCCCc----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHH----HHHH
Confidence            99987643211    234468899999998765 5899999999999999999999999764321    111    1111


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+...... +. ...+    ...+.+++.+|++.||++||++.++++
T Consensus       236 ~~~~~~~~-~~-~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          236 TGKYAFDL-PQ-WRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HCCCCCCS-GG-GTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCc-hh-hhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            12110000 00 0122    245778999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-37  Score=328.98  Aligned_cols=256  Identities=18%  Similarity=0.243  Sum_probs=200.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--C-ceEEEEEeecccchhhHHHHHHHHHHhccCCCc------eeeEeeeeeeccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--N-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN------LVKLIGWCYERHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~  388 (644)
                      .++|+..+.||+|+||.||+++..  + ..||+|+++... ...+.+..|+.++++++|+|      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999875  3 579999986543 34567888999999998776      9999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEE----------
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIML----------  458 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILl----------  458 (644)
                      .++||||+ +++|.+++......      .+++.++..++.||+.||.|||+   .+|+||||||+|||+          
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~------~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQ------PYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             EEEEEecc-CCChHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccc
Confidence            99999999 67777777554321      38999999999999999999999   899999999999999          


Q ss_pred             ---------cCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 006446          459 ---------DSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGN  529 (644)
Q Consensus       459 ---------d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~  529 (644)
                               +.++.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                     67889999999999864321      334579999999999999999999999999999999999999998


Q ss_pred             CCccccchhhHHHHHHHHHhcCchhhhhh------------------------------ccc--CCCCCHHHHHHHHHHH
Q 006446          530 QSEQNSYNNSIVHWLWELRRKGRILDAAD------------------------------SRL--GGEFSEKEMECVLILG  577 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------------------------------~~l--~~~~~~~~~~~l~~L~  577 (644)
                      ........    ..+....  +.......                              +.+  ...........+.+|+
T Consensus       241 ~~~~~~~~----~~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          241 THENREHL----VMMEKIL--GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             CSSHHHHH----HHHHHHH--CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCHHHHH----HHHHHHc--CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            65432211    1111111  11000000                              000  0011223455788999


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 006446          578 LACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       578 ~~Cl~~dP~~RPs~~evl~  596 (644)
                      .+||+.||++|||++|+++
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHhcCChhhCcCHHHHhc
Confidence            9999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-38  Score=331.81  Aligned_cols=257  Identities=19%  Similarity=0.272  Sum_probs=173.5

Q ss_pred             hCCCCCC-CcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceE
Q 006446          318 TGNFNPK-NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFL  390 (644)
Q Consensus       318 ~~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~  390 (644)
                      .++|... +.||+|+||.||+|++.  ++.||+|++.....    ...+....++.++||||+++++++..    +..++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4578774 46999999999999987  78999999865321    11222334566799999999999876    44589


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEe
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLG  467 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~  467 (644)
                      +||||+++|+|.+++.....      ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD------QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C------CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEeccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence            99999999999999975432      148999999999999999999999   89999999999999976   4559999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++......     .....||+.|+|||++....++.++|||||||++|||++|+.||..............    .
T Consensus       174 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~  244 (336)
T 3fhr_A          174 DFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----R  244 (336)
T ss_dssp             CCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ccccceeccccc-----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----h
Confidence            999998654221     3345789999999999888899999999999999999999999976443221111110    0


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGEA  602 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~~  602 (644)
                      ...+.      ..+...........+.+|+.+|++.||++|||++|+++  .++...
T Consensus       245 ~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          245 IRLGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hhccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            00000      01111111122345778999999999999999999998  555543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=331.57  Aligned_cols=244  Identities=25%  Similarity=0.425  Sum_probs=190.4

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc------hhhHHHHHHHHHHhcc----CCCceeeEee
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR------QGKQEFIAEVTTIGSL----RHRNLVKLIG  381 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l----~H~nIv~l~g  381 (644)
                      .....++|+..+.||+|+||.||+|+..  +..||+|++.....      .....+..|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999885  67899999965432      1234566799999998    8999999999


Q ss_pred             eeeeccceEEEEec-cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc-
Q 006446          382 WCYERHDFLLVYEY-MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-  459 (644)
Q Consensus       382 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-  459 (644)
                      ++...+..++|+|| +++++|.+++....        .+++..++.++.|+++||.|||+   .+|+||||||+||+++ 
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG--------PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDL  174 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEET
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeC
Confidence            99999999999999 78999999997543        38999999999999999999999   8999999999999999 


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRAT-IETDIYAFGVLILEVACGRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++......     .....||..|+|||++....+. .++|||||||++|||++|+.||....      
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------  243 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------  243 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred             CCCeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------
Confidence            88999999999998765321     3445689999999998877664 58999999999999999999986421      


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                      .+.       . .      ...+...+    ...+.+++.+|++.||++||+++|+++.
T Consensus       244 ~~~-------~-~------~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 EIL-------E-A------ELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHH-------H-T------CCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHh-------h-h------ccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            110       0 0      01112222    3457788999999999999999999983

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-38  Score=331.16  Aligned_cols=242  Identities=26%  Similarity=0.423  Sum_probs=198.2

Q ss_pred             HHHhCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch------hhHHHHHHHHHHhccC--CCceeeEeeeee
Q 006446          315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ------GKQEFIAEVTTIGSLR--HRNLVKLIGWCY  384 (644)
Q Consensus       315 ~~a~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~  384 (644)
                      ....++|+..+.||+|+||.||+|+..  +..||||++......      ..+.+..|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344578999999999999999999875  788999999754321      2356778999999996  599999999999


Q ss_pred             eccceEEEEeccCC-CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc-CCC
Q 006446          385 ERHDFLLVYEYMPN-GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEF  462 (644)
Q Consensus       385 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld-~~~  462 (644)
                      ..+..++|+||+.+ ++|.+++....        .+++..+..++.|+++||+|||+   .+|+||||||+|||++ +++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG--------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTT
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCC
Confidence            99999999999976 89999986543        38899999999999999999999   9999999999999999 789


Q ss_pred             cEEEeccCCcccccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHH
Q 006446          463 NARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV  541 (644)
Q Consensus       463 ~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~  541 (644)
                      .+||+|||+++......     .....||+.|+|||++....+ +.++|||||||++|||++|+.||....      .+.
T Consensus       188 ~~kL~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~  256 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII  256 (320)
T ss_dssp             EEEECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH
T ss_pred             CEEEeeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhh
Confidence            99999999998765321     334579999999999987766 688999999999999999999986421      010


Q ss_pred             HHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       542 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                              .+.      ..+...++    ..+.+++.+||+.||++||+++++++
T Consensus       257 --------~~~------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 --------RGQ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --------HCC------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------ccc------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    011      01122333    45778899999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=340.33  Aligned_cols=249  Identities=26%  Similarity=0.385  Sum_probs=185.3

Q ss_pred             CCCCCCCcccccCcEE-EEEeeecCceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGT-VYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~-Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      .+|+..++||+|+||+ ||++...++.||||++.....   ..+.+|+.+++++ +|||||++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4688889999999998 566777799999999965432   3456899999999 7999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-----CCcEEEeccCC
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFGL  471 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFGl  471 (644)
                      + |+|.+++......       +.+.....++.||++||.|||+   .+|+||||||+|||++.     ...+||+|||+
T Consensus       101 ~-g~L~~~l~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A          101 A-ATLQEYVEQKDFA-------HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             S-EEHHHHHHSSSCC-------CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             C-CCHHHHHHhcCCC-------ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            5 7999999755432       3334557899999999999999   89999999999999943     34688999999


Q ss_pred             cccccccccccccccccccCCCccCccccc---cCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHH
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFL---VGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ++................||+.|+|||++.   ...++.++|||||||++|||++ |+.||.......     ..   ..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~---~~  241 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----AN---IL  241 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HH---HH
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HH---HH
Confidence            987653322222234567999999999987   4567889999999999999999 899985432211     10   01


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...... .    ..  .........+.+|+.+||+.||++||+++++++
T Consensus       242 ~~~~~~-~----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 LGACSL-D----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTCCCC-T----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccCCc-c----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            111000 0    00  111233445678999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=321.72  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=176.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccch--hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ--GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..+.||+|+||.||+|++.  +..||||++......  ..+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            56788899999999999999986  789999999765322  22344455567888899999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCC-CeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK-RVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |+ ++.+..+......       .+++..+..++.|+++||.|||+   . +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~-~~~~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQG-------PIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             CC-SEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cc-CCcHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            99 4555444433222       38899999999999999999998   6 89999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      ......    ......||+.|+|||.+.     ...++.++|||||||++|||++|+.||......   ...   .....
T Consensus       174 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~~~~  243 (318)
T 2dyl_A          174 RLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEV---LTKVL  243 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHH---HHHHH
T ss_pred             hccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHH---HHHHh
Confidence            664321    133457899999999984     556889999999999999999999999763321   111   11111


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ...      .+.+...  ......+.+++.+||+.||.+||+++++++
T Consensus       244 ~~~------~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          244 QEE------PPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HSC------CCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccC------CCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111      0111110  012245778889999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.8e-37  Score=336.69  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=184.8

Q ss_pred             CCCCCCcccccCcEEEEE-eeecCceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEEEeccC
Q 006446          320 NFNPKNKLGKGGFGTVYK-GIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~-g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .|...+.||+|+||+||. +...++.||||++....   .+.+.+|+.++.++ +||||+++++++.+++.+++||||+ 
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-
Confidence            344467899999999964 45558999999986532   35678899999886 8999999999999999999999999 


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-------------CcE
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-------------FNA  464 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-------------~~v  464 (644)
                      +|+|.+++........ ......+..++.++.||+.||+|||+   .+|+||||||+|||++.+             +.+
T Consensus        92 ~gsL~~~l~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 NLNLQDLVESKNVSDE-NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             SEEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             CCCHHHHHhccCCCch-hhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            4799999975432211 00112344567899999999999999   899999999999999754             489


Q ss_pred             EEeccCCccccccccccc-ccccccccCCCccCcccccc-------CCCCCccchHHHHHHHHHHHc-CCCCCCCCcccc
Q 006446          465 RLGDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLV-------GRATIETDIYAFGVLILEVAC-GRKPGNQSEQNS  535 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-------~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~  535 (644)
                      ||+|||+++......... .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998775322111 11234579999999999865       568999999999999999999 999986543211


Q ss_pred             chhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          536 YNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       536 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        ..+.       . +...   .+.+...........+.+++.+|++.||++||++.++++
T Consensus       248 --~~i~-------~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 --SNII-------R-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHH-------H-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHh-------c-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              1111       0 1000   011111223455677889999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.9e-37  Score=348.52  Aligned_cols=258  Identities=26%  Similarity=0.371  Sum_probs=197.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeee------ccc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE------RHD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~  388 (644)
                      .++|+..++||+|+||.||+|.+.  +..||||++... .....+.+.+|+.++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999885  778999998764 34456779999999999999999999999765      667


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc---EE
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN---AR  465 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~---vk  465 (644)
                      .++||||+++|+|.+++......     ..+++..+..++.+++.||.|||+   .+|+||||||+|||++.++.   +|
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~-----~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENC-----CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCT-----TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             EEEEEEeCCCCCHHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEE
Confidence            89999999999999999754321     137888999999999999999999   89999999999999997665   99


Q ss_pred             EeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       466 L~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      |+|||+++......    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ...|..
T Consensus       165 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~  234 (676)
T 3qa8_A          165 IIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHG  234 (676)
T ss_dssp             ECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSST
T ss_pred             Eccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhh
Confidence            99999998765322    13456799999999999999999999999999999999999999975421      111111


Q ss_pred             HHHhcCc----hhhhhh------c--ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 006446          546 ELRRKGR----ILDAAD------S--RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKT  593 (644)
Q Consensus       546 ~~~~~~~----~~~~~d------~--~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~e  593 (644)
                      .......    ..+...      .  .....+.......+.+++.+|+++||++||++++
T Consensus       235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000000    000000      0  0112344456778899999999999999999966

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-36  Score=311.17  Aligned_cols=230  Identities=14%  Similarity=0.132  Sum_probs=181.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|++.  ++.||+|++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67899999999999999999987  78999999976532   33478899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++...          ....+..+|+.|+++||+|||+   .+|+||||||+|||++.++.+||++++   
T Consensus       111 e~~~g~~L~~~l~~~----------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS----------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC----------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EecCCCCHHHHHhcC----------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            999999999998421          2445678899999999999999   899999999999999999999998543   


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                                          |++|       ++.++|||||||++|||++|+.||..............     ...+..
T Consensus       175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~  222 (286)
T 3uqc_A          175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-----DTAGQP  222 (286)
T ss_dssp             --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-----CTTSCB
T ss_pred             --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-----HhccCC
Confidence                                3333       68899999999999999999999987543221100000     000000


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      .  ....+...++    ..+.+++.+||+.||++| |+.|+++.|+....
T Consensus       223 ~--~~~~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          223 I--EPADIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             C--CHHHHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             C--ChhhcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0  0001112232    457789999999999999 99999999987543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-36  Score=345.27  Aligned_cols=236  Identities=24%  Similarity=0.359  Sum_probs=190.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec---CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccc-----e
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHD-----F  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~  389 (644)
                      ++|+..++||+|+||.||+|++.   ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68899999999999999999874   6789999986543 3445678999999999999999999999988766     7


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      +|||||+++++|.+++..          .++|.+++.++.||++||.|||+   .+|+||||||+|||++.+ .+||+||
T Consensus       160 ~lv~E~~~g~~L~~~~~~----------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEECCCCEECC----C----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCC
T ss_pred             EEEEEeCCCCcHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEec
Confidence            999999999999987642          28999999999999999999999   899999999999999986 8999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |+++....       .....||+.|+|||++.++. +.++|||||||++|||++|..|+..........           
T Consensus       226 G~a~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~-----------  286 (681)
T 2pzi_A          226 GAVSRINS-------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE-----------  286 (681)
T ss_dssp             TTCEETTC-------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT-----------
T ss_pred             ccchhccc-------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccc-----------
Confidence            99987642       23457999999999987654 899999999999999999998876432111000           


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-MKTVLQVLSG  600 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~evl~~L~~  600 (644)
                                   ..........+.+++.+|++.||++||+ ++++.+.|.+
T Consensus       287 -------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 -------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                         0000112245778999999999999995 6666655543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-36  Score=328.46  Aligned_cols=243  Identities=16%  Similarity=0.124  Sum_probs=180.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCC-CceeeEe---------ee-
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRH-RNLVKLI---------GW-  382 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~nIv~l~---------g~-  382 (644)
                      +.|...++||+|+||.||+|++.  ++.||||++.....   ...+.+.+|+.+++.++| +|.....         .. 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45667889999999999999987  88999999874332   235789999999999987 3221111         11 


Q ss_pred             -----------eee-----ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCe
Q 006446          383 -----------CYE-----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRV  446 (644)
Q Consensus       383 -----------~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i  446 (644)
                                 +..     ....+++|+++ +++|.+++....... .....++|..++.++.|+++||+|||+   ++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  232 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-STHKSLVHHARLQLTLQVIRLLASLHH---YGL  232 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence                       111     12467777766 789998884221100 012248899999999999999999999   999


Q ss_pred             EeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCcccc----------ccCCCCCccchHHHHH
Q 006446          447 LHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESF----------LVGRATIETDIYAFGV  516 (644)
Q Consensus       447 vHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~t~~sDVwSfGv  516 (644)
                      +||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          ....++.++|||||||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            99999999999999999999999999875432      334567 999999999          5556889999999999


Q ss_pred             HHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          517 LILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       517 vl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                      ++|||++|+.||...........                ...  ....++    +.+.+|+.+||+.||++||++.+++
T Consensus       306 il~elltg~~Pf~~~~~~~~~~~----------------~~~--~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSEW----------------IFR--SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSGG----------------GGS--SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHCCCCCCCcchhhhHHH----------------HHh--hcccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999976543221110                010  011233    4577889999999999999977664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-35  Score=305.15  Aligned_cols=231  Identities=19%  Similarity=0.286  Sum_probs=177.6

Q ss_pred             CCCCCC-CcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHH-hccCCCceeeEeeeeee----ccceE
Q 006446          319 GNFNPK-NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTI-GSLRHRNLVKLIGWCYE----RHDFL  390 (644)
Q Consensus       319 ~~f~~~-~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~  390 (644)
                      ++|... +.||+|+||.||++...  +..||+|++..     ...+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456555 77999999999999885  77899999864     24567888887 55699999999999987    67799


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEe
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLG  467 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~  467 (644)
                      +||||+++|+|.+++......      .+++..+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQ------AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEeecCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence            999999999999999764321      38999999999999999999999   99999999999999998   7899999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+++...                         +..++.++|||||||++|||++|+.||..........         
T Consensus       163 Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---------  208 (299)
T 3m2w_A          163 DFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------  208 (299)
T ss_dssp             CCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C---------
T ss_pred             ccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH---------
Confidence            999986532                         1346778999999999999999999997543211000         


Q ss_pred             HhcCchhhhhhcccCCCCCH----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCCC
Q 006446          548 RRKGRILDAADSRLGGEFSE----KEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGEA  602 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~~  602 (644)
                          ........ ....++.    .....+.+++.+|++.||++||+++|+++  .+....
T Consensus       209 ----~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          209 ----GMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ----CSCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ----HHHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                00000000 0001111    12346778999999999999999999997  355443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.8e-36  Score=313.98  Aligned_cols=239  Identities=17%  Similarity=0.203  Sum_probs=181.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeeccc--------chhhHHHHHHHHHHhccC---------CCceeeEee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETS--------RQGKQEFIAEVTTIGSLR---------HRNLVKLIG  381 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~l~g  381 (644)
                      ++|+..++||+|+||+||+|+.+++.||||++....        ....+.+.+|+.++++++         ||||+++.+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            467789999999999999999999999999997653        223377889999998886         666666666


Q ss_pred             ee-----------------ee-------------ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHH
Q 006446          382 WC-----------------YE-------------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT  431 (644)
Q Consensus       382 ~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i  431 (644)
                      .+                 .+             .+.+++||||+++|++.+.+...         .+++..+..++.||
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~---------~~~~~~~~~i~~qi  170 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---------LSSLATAKSILHQL  170 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT---------CCCHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc---------CCCHHHHHHHHHHH
Confidence            53                 32             67899999999999877766331         37899999999999


Q ss_pred             HHHHHHhH-hCCCCCeEeCCCCCCCEEEcCCC--------------------cEEEeccCCccccccccccccccccccc
Q 006446          432 SQALDYLH-NGSEKRVLHRDIKSSNIMLDSEF--------------------NARLGDFGLARTIQENLKTHHSTKEIAG  490 (644)
Q Consensus       432 a~aL~yLH-~~~~~~ivHrDlkp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~g  490 (644)
                      +.||.||| +   .+|+||||||+|||++.++                    .+||+|||+|+....        ....|
T Consensus       171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~g  239 (336)
T 2vuw_A          171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVF  239 (336)
T ss_dssp             HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEEC
T ss_pred             HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEE
Confidence            99999999 8   8999999999999999887                    899999999987642        23479


Q ss_pred             CCCccCccccccCCCCCccchHHHHHH-HHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh--hcccCCCCCH
Q 006446          491 TPGYMAPESFLVGRATIETDIYAFGVL-ILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA--DSRLGGEFSE  567 (644)
Q Consensus       491 t~~y~APE~~~~~~~t~~sDVwSfGvv-l~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d~~l~~~~~~  567 (644)
                      |+.|+|||++.+.. +.++||||+|++ .+++++|..||...          .|......  .+....  ..........
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~--~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTD--KMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHH--HHHHTCCCSSCCCSHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHH--hhhhhhccCcccchhhhh
Confidence            99999999998665 889999998777 77788898886321          11111100  000000  0000111123


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 006446          568 KEMECVLILGLACCHPNPHLRPSMKTVL  595 (644)
Q Consensus       568 ~~~~~l~~L~~~Cl~~dP~~RPs~~evl  595 (644)
                      .....+.+|+.+|++.|     |++|++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            45667889999999976     899888

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=8.5e-34  Score=252.93  Aligned_cols=109  Identities=39%  Similarity=0.521  Sum_probs=100.6

Q ss_pred             ccEEEEEEecCCCcc-CCCCCCceeeecCCccceeeecCcccccCCCceEEEEEEEcC--ceEEEEEec--CCCCCcccc
Q 006446          142 SQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QNITVFVAN--METPLLSEP  216 (644)
Q Consensus       142 ~~~~aVEfDt~~n~~-~d~~~~Hvgid~ns~~s~~~~~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~--~~~~~ls~~  216 (644)
                      ||+|||||||++|.+ |||++|||||||||+.|.++.+|   ++.+|+.++|||+||+  +.|+|++..  ...|+|++.
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~---~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~~~p~ls~~   77 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW---DWQNGKIATAHISYNSVSKRLSVTSYYAGSKPATLSYD   77 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC---CCCTTSCEEEEEEEETTTTEEEEEEECSSSCCEEEEEE
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee---EEcCCCEEEEEEEEeCCCcEEEEEEccCCCccceEEEe
Confidence            689999999999988 59999999999999999999888   4789999999999999  788998853  247899999


Q ss_pred             cCccCcCCCceeeeecccCCCcccccccccccccCCc
Q 006446          217 IDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       217 ~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~  253 (644)
                      +||+++||++|||||||+||...+.|+|++|+|+++.
T Consensus        78 vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l  114 (133)
T 1qmo_E           78 IELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL  114 (133)
T ss_dssp             CCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             echHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence            9999999999999999999999999999999998865

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.98  E-value=1.7e-32  Score=276.87  Aligned_cols=200  Identities=15%  Similarity=0.217  Sum_probs=154.9

Q ss_pred             ceeEEcCCCCCC--CCCCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           26 SLHFNFQSFTEQ--NRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        26 ~~~f~f~~f~~~--~~~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      ..||..|.....  ...++.++ +|.+.++.|+||++..     ++.||+||+.|+++        +||+|+|+|.|.+.
T Consensus        33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i~~~~IrLT~~~~-----~~~G~~w~~~p~~~--------~sF~t~F~F~I~~~   99 (260)
T 1gv9_A           33 KYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLK-----SQRGSVWTKTKAAF--------ENWEVEVTFRVTGR   99 (260)
T ss_dssp             GGCEECSSCSCTTSCBTTEEEEETCEECSSCEEEECSST-----TCEEEEEESSCBCC--------SSEEEEEEEEEECS
T ss_pred             ceeEcCccccCCCCccCCeEEcccEEeeCCEEEeCCCCC-----CCEEEEEECCCccc--------cCEEEEEEEEEecC
Confidence            345655555432  23589999 9999999999998765     68999999999954        89999999999974


Q ss_pred             CCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC--CC------CCCceeeecCC-ccc
Q 006446          103 TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ--DI------NDNHVGLDVNS-VYS  173 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~--d~------~~~Hvgid~ns-~~s  173 (644)
                      ...+||||||+|+|...    ..|++||+.       ..++.|||||||+.|.++  +|      |++|+|||+|+ +.|
T Consensus       100 ~~~~gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s  168 (260)
T 1gv9_A          100 GRIGADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGAT  168 (260)
T ss_dssp             SSCCCCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHH
T ss_pred             CCCCCCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCccc
Confidence            34789999999999543    358899983       235779999999999654  33      57899999986 655


Q ss_pred             eeeecCccccc-CCCceEEEEEEEcCceEEEEEec---CCCC--CcccccCccCcCCCceeeeecccCCCcccccccccc
Q 006446          174 IRQVPLTRVNL-ANGTDIKVQVRYDGQNITVFVAN---METP--LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSW  247 (644)
Q Consensus       174 ~~~~~~~~~~l-~~g~~~~~~I~Y~~~~l~v~~~~---~~~~--~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~w  247 (644)
                      .....+ ...+ .+|++++|||+|++..|+|.+..   +..+  .++..+| ..+||+++||||||+||...+.|+|++|
T Consensus       169 ~~~~~c-~~~~~n~g~~~~~~I~Y~~~~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~e~hdIlsw  246 (260)
T 1gv9_A          169 QALASC-QRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSF  246 (260)
T ss_dssp             HCSEEE-CCCCBSCSSCEEEEEEEETTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEE
T ss_pred             ceeecc-ChhhccCCCcEEEEEEEECCEEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCcceEEEEEE
Confidence            444443 2334 35999999999999989998863   3332  5677788 6789999999999999999999999999


Q ss_pred             cccC
Q 006446          248 AFDG  251 (644)
Q Consensus       248 sf~s  251 (644)
                      +|..
T Consensus       247 ~~~~  250 (260)
T 1gv9_A          247 LTFQ  250 (260)
T ss_dssp             EEEE
T ss_pred             EEEE
Confidence            9864

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.98  E-value=2.5e-32  Score=274.88  Aligned_cols=185  Identities=18%  Similarity=0.199  Sum_probs=143.9

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-CC-CCCCCceEEEEec
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-QT-AQPGEGLAFVIAG  116 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-~~-~~~g~G~aF~l~~  116 (644)
                      .++.++ +|.+.+|.|+||++..     ++.|||||+.|+++        +||+|+|+|+|.+ .. ..+||||||+|+|
T Consensus        25 ~~~~l~G~a~i~~g~l~LT~~~~-----~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~   91 (253)
T 2dur_A           25 PLWDFQGSTILTSQYVRLTPDER-----SKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTR   91 (253)
T ss_dssp             CSEEEEETCEECSSCEEEECSSS-----SEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEES
T ss_pred             CCEEEccceEEECCEEEECCCCC-----CCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEEC
Confidence            589999 9999999999998865     78999999999997        6899999999997 34 5689999999999


Q ss_pred             CCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc-------------ccc
Q 006446          117 NKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT-------------RVN  183 (644)
Q Consensus       117 ~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~-------------~~~  183 (644)
                      ...    ..|++||+.+       .++.|||||||++|.++ ++  |+++|||++.+..+..+.             ...
T Consensus        92 ~~~----~~G~~lG~~~-------~~~gvAVefDT~~n~~~-~~--~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~  157 (253)
T 2dur_A           92 DRL----VPGPVFGSKD-------NFHGLAIFLDTYPNDET-TE--RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTAD  157 (253)
T ss_dssp             CCS----CEETBTEECS-------SCEEEEEEEECSCCCTT-CC--SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECC
T ss_pred             CCC----CCCcccCcCC-------CCCEEEEEEECCCCCCC-CC--CCCcEEEEEecCCceeeeccCCCcccccccccHh
Confidence            543    3589999632       25789999999999544 32  667777766665444431             113


Q ss_pred             c-CCCceEEEEEEEcCceEEEEEecCCC-C-CcccccCccCcCCCceeeeecccCCCcccccccccccccCC
Q 006446          184 L-ANGTDIKVQVRYDGQNITVFVANMET-P-LLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS  252 (644)
Q Consensus       184 l-~~g~~~~~~I~Y~~~~l~v~~~~~~~-~-~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss  252 (644)
                      + .+|++++|||+|++..|+|.+..+.. + .+...++ ..+||+++||||||+||...+.|+|++|+|.+-
T Consensus       158 ~~n~g~~~~v~I~Y~~~~L~V~l~~~~~~~~~~~~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          158 FRNRDHDTFLAVRYSRGRLTVMTDLEDKNEWKNCIDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             CBTCSSCEEEEEEEETTEEEEEEECSSSSCCEEEEEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             hccCCCCeEEEEEEECCEEEEEEeCCCCCCceEEEEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence            3 34889999999999989999863322 1 1222333 335999999999999999999999999999753

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.96  E-value=9.2e-31  Score=258.18  Aligned_cols=111  Identities=32%  Similarity=0.471  Sum_probs=102.4

Q ss_pred             CccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCcccccCCCceEEEEEEEcC--ceEEEEEecC--CCCCccc
Q 006446          141 QSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QNITVFVANM--ETPLLSE  215 (644)
Q Consensus       141 ~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~~~--~~~~ls~  215 (644)
                      +||+|||||||++|.+| ||++|||||||||+.|.++.+|   ++.+|+.++|||+||+  +.|+|++..+  ..|+|++
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~---~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~   77 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW---NMQNGKVGTAHIIYNSVDKRLSAVVSYPNADSATVSY   77 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC---CCCTTCEEEEEEEEETTTTEEEEEEECTTSCCEEEEE
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc---cccCCCEEEEEEEEeCCCCEEEEEEecCCCCcceEEE
Confidence            47999999999999989 9999999999999999999888   4789999999999999  7899998633  5789999


Q ss_pred             ccCccCcCCCceeeeecccCCCcccccccccccccCCcc
Q 006446          216 PIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDI  254 (644)
Q Consensus       216 ~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~~  254 (644)
                      .+||+++|+|+|||||||+||...+.|+|++|+|+++..
T Consensus        78 ~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~  116 (237)
T 1nls_A           78 DVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             ECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             eeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence            999999999999999999999999999999999987653

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.96  E-value=1.1e-28  Score=214.83  Aligned_cols=108  Identities=31%  Similarity=0.575  Sum_probs=94.1

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|... ..+|.++ ||.+.+|.|+||+++. +.+..+++|||+|++||+|||+ +|+|+||+|+|+|.|.+ 
T Consensus         2 ~~~~F~f~~F~~~-~~nl~l~G~A~v~~g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~~   79 (113)
T 1qmo_A            2 QSLSFSFTKFDPN-QEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEISTP   79 (113)
T ss_dssp             EEEEEEESSCCSS-CTTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEECS
T ss_pred             cceEEEcCCCCCC-CCCeEEecceEcCCCceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEecC
Confidence            4689999999864 4589999 9999889999998764 2234579999999999999999 99999999999999997 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCccccccccc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGI  135 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~  135 (644)
                      +...+||||||||+|....|. +.||||||+|.+
T Consensus        80 ~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           80 YTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA  112 (113)
T ss_dssp             SSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred             CCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence            566789999999999766777 999999999864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=4.7e-29  Score=280.96  Aligned_cols=184  Identities=16%  Similarity=0.122  Sum_probs=129.5

Q ss_pred             cccccCcEEEEEeeec--CceEEEEEeeccc----------chhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          326 KLGKGGFGTVYKGIWR--NKEIAVKRVSETS----------RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       326 ~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ..+.|+.|.+..++..  ++.++||.+....          ....++|.+|+++|+++ .|+||+++++++.+++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3556677766655443  8899999986531          23346799999999999 799999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||++|++|.++|....        .++..   +|+.||++||+|||+   ++||||||||+||||++++++||+|||+|
T Consensus       321 MEyv~G~~L~d~i~~~~--------~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE--------EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             EECCCSEEHHHHHHTTC--------CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             EecCCCCcHHHHHHhCC--------CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccC
Confidence            99999999999996543        24443   589999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP  527 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P  527 (644)
                      +......   ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       387 r~~~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eeCCCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            8765322   12345689999999998864 567889999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=7.7e-27  Score=261.45  Aligned_cols=187  Identities=14%  Similarity=0.159  Sum_probs=148.2

Q ss_pred             CCCCcccccCcEEEEEeeecCceEEEEEeecccc--------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          322 NPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSR--------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ...++||+|+||.||+|...+..+++|+......        ...+.+.+|+.++++++||||+++..++...++.+|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            4467899999999999988899999998643211        12355899999999999999997777777888889999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++++|.+++..                ++.++.|+++||.|||+   ++|+||||||+|||++.  ++||+|||+++
T Consensus       419 E~~~ggsL~~~l~~----------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          419 SYINGKLAKDVIED----------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             ECCCSEEHHHHSTT----------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             ECCCCCCHHHHHHH----------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCE
Confidence            99999999999853                35789999999999999   99999999999999999  99999999999


Q ss_pred             cccccccccc----cccccccCCCccCcccccc--CCCCCccchHHHHHHHHHHHcCCCCCC
Q 006446          474 TIQENLKTHH----STKEIAGTPGYMAPESFLV--GRATIETDIYAFGVLILEVACGRKPGN  529 (644)
Q Consensus       474 ~~~~~~~~~~----~~~~~~gt~~y~APE~~~~--~~~t~~sDVwSfGvvl~el~tG~~P~~  529 (644)
                      ..........    ......||+.|||||++..  ..|+..+|+|+..+-.++-+-++.+|.
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            8753221110    1235679999999999976  568888999999999999888777653

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.91  E-value=1.2e-24  Score=214.43  Aligned_cols=109  Identities=28%  Similarity=0.607  Sum_probs=94.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCC-CCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~-~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      ..++|+|++|... ..+|.++ +|.+. +|.|+||+++. +.+..+++|||+|++||+|||+ +|+|+||+|+|+|.|.+
T Consensus       124 ~~~~F~~~~F~~~-~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~~  201 (237)
T 1nls_A          124 NALHFMFNQFSKD-QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIKS  201 (237)
T ss_dssp             EEEEEEESCCCTT-CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECCC
T ss_pred             ccchhhhcccccc-CCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEec
Confidence            4579999999874 4589999 99995 89999999864 2234578999999999999997 88999999999999997


Q ss_pred             CCCCCCCceEEEEecCC-CCCCCCCCccccccccc
Q 006446          102 QTAQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGI  135 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~  135 (644)
                      ....+||||||||+|.. .+|.++.||||||||.+
T Consensus       202 ~~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          202 PDSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             SSSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             CCCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence            54568999999999966 68999999999999865

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=2e-22  Score=207.16  Aligned_cols=151  Identities=13%  Similarity=0.084  Sum_probs=120.2

Q ss_pred             HHHHHHhCCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccc------------------hhhHHHHHHHHHHhccC
Q 006446          312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR------------------QGKQEFIAEVTTIGSLR  372 (644)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~  372 (644)
                      ..+......|...+.||+|+||.||+|.+. +..||+|.++....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344444556777799999999999999985 77899999864321                  13456889999999999


Q ss_pred             CCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       373 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                        | +++.+++. .+..++||||+++|+|.+ +..              .....++.|+++||.|||+   .+|+|||||
T Consensus       163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------------~~~~~i~~qi~~~l~~lH~---~giiHrDlk  220 (282)
T 1zar_A          163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------------ENPDEVLDMILEEVAKFYH---RGIVHGDLS  220 (282)
T ss_dssp             --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------------SCHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred             --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCC
Confidence              5 67777553 456799999999999988 421              1134699999999999999   999999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccc
Q 006446          453 SSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFL  501 (644)
Q Consensus       453 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~  501 (644)
                      |+|||++ ++.+||+|||+++..                ..++|||++.
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~~----------------~~~~a~e~l~  252 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVEV----------------GEEGWREILE  252 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEET----------------TSTTHHHHHH
T ss_pred             HHHEEEE-CCcEEEEECCCCeEC----------------CCCCHHHHHH
Confidence            9999999 999999999998743                2468898774

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.87  E-value=1.1e-21  Score=196.80  Aligned_cols=186  Identities=17%  Similarity=0.275  Sum_probs=139.6

Q ss_pred             CCCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecC
Q 006446           39 RNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGN  117 (644)
Q Consensus        39 ~~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~  117 (644)
                      ..+..+. +|.+.++.|+||++ .     ++.|++|.+.|+.+       +++|+|+|+|.|......+||||||++++.
T Consensus        30 i~~w~~~G~a~v~~~~IrLTp~-~-----~s~G~iW~~~p~~~-------~~~f~~~f~FrI~g~~~~~gdGlAfwlt~~   96 (256)
T 2a6y_A           30 PNNWQTGEQASLEEGRIVLTSN-Q-----NSKGSLWLKQGFDL-------KDSFTMEWTFRSVGYSGQTDGGISFWFVQD   96 (256)
T ss_dssp             CTTEEEEETCEEETBEEECCCS-T-----TCEEEEEESSCEEE-------SSCEEEEEEEEEESCCSCCSCEEEEEEEEC
T ss_pred             cCCeEEccceEEeCCEEEECCC-C-----CceEEEeeCCCCcc-------cCCEEEEEEEEEecCCCCCCCeEEEEEeCC
Confidence            3578899 99999999999987 3     57899888888874       478999999999874445899999999995


Q ss_pred             CCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCcc-C---CCCCCceeeecCCccceeeecCccccc-CCCceEEE
Q 006446          118 KDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-Q---DINDNHVGLDVNSVYSIRQVPLTRVNL-ANGTDIKV  192 (644)
Q Consensus       118 ~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~-~---d~~~~Hvgid~ns~~s~~~~~~~~~~l-~~g~~~~~  192 (644)
                      ...|  ..|+.+|..+       ...-+||||||+.|.. +   ..|+.|+++|.+++.+.....+ .... .+|.+.++
T Consensus        97 ~~~~--~~g~~~G~~~-------~f~GlaV~fDT~~n~~p~i~~~~Ndg~~~~d~~~~~~~~~~~c-~~~~rn~~~~~~v  166 (256)
T 2a6y_A           97 SNIP--RDKQLYNGPV-------NYDGLQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASC-LMGYQDSSVPSTI  166 (256)
T ss_dssp             SSSC--CCCTBTTBCT-------TCEEEEEEEESCSTTCSEEEEEEEESSSCCCGGGHHHHCSEEE-ECCCTTCSSCEEE
T ss_pred             CCcc--cCCcccCcCC-------CCCEEEEEEECCCCCCceEEEEECCCceecccCCCcccceecc-eeecccCCCcEEE
Confidence            4333  5788888753       1234899999998731 1   2347899999887544443333 1222 47889999


Q ss_pred             EEEEc-C--ceEEEEEecCCCCCcccccCccCc-CCCce-eeeecccCC---CcccccccccccccCCc
Q 006446          193 QVRYD-G--QNITVFVANMETPLLSEPIDLSEY-LPEKV-FVGFSASTG---DDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       193 ~I~Y~-~--~~l~v~~~~~~~~~ls~~~dl~~~-l~~~~-~vGfsastg---~~~~~~~i~~wsf~ss~  253 (644)
                      ||+|+ +  +.|+|.+..  .    .-.++..+ ||+.+ ||||||+||   ...+.|.|++|+|....
T Consensus       167 ~I~Y~~~~~~~L~V~i~~--~----~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~~  229 (256)
T 2a6y_A          167 RVTYDLEDDNLLKVQVDN--K----VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNGV  229 (256)
T ss_dssp             EEEEEGGGTSEEEEEETT--E----EEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEESC
T ss_pred             EEEEecCCCcEEEEEEcC--E----EEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEecc
Confidence            99998 3  778888754  1    22344455 89998 699999999   78899999999998743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=2e-19  Score=182.29  Aligned_cols=135  Identities=16%  Similarity=0.124  Sum_probs=103.8

Q ss_pred             CCCCCcccccCcEEEEEeee--cCce--EEEEEeecccch------------------------hhHHHHHHHHHHhccC
Q 006446          321 FNPKNKLGKGGFGTVYKGIW--RNKE--IAVKRVSETSRQ------------------------GKQEFIAEVTTIGSLR  372 (644)
Q Consensus       321 f~~~~~LG~G~fG~Vy~g~~--~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~  372 (644)
                      |+..+.||+|+||.||+|..  .+..  ||||+++.....                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999998  4788  999987543111                        1136788999999998


Q ss_pred             CCce--eeEeeeeeeccceEEEEeccC-CC----ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhH-hCCCC
Q 006446          373 HRNL--VKLIGWCYERHDFLLVYEYMP-NG----SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH-NGSEK  444 (644)
Q Consensus       373 H~nI--v~l~g~~~~~~~~~lV~Ey~~-~g----sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~  444 (644)
                      |+++  ..++++    ...+|||||+. +|    +|.++...           .++.....++.|+++||.||| +   .
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----------~~~~~~~~i~~qi~~~l~~lH~~---~  190 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----------LKELDVEGIFNDVVENVKRLYQE---A  190 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----------GGGSCHHHHHHHHHHHHHHHHHT---S
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----------cChHHHHHHHHHHHHHHHHHHHH---C
Confidence            8764  334432    36789999994 25    45444321           223456789999999999999 7   8


Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       445 ~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +|+||||||+|||++.  .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=4.9e-16  Score=164.66  Aligned_cols=138  Identities=12%  Similarity=0.094  Sum_probs=96.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccc--------------hhhHHH--------HHHHHHHhccCCCce
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR--------------QGKQEF--------IAEVTTIGSLRHRNL  376 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~--------------~~~~~~--------~~Ei~~l~~l~H~nI  376 (644)
                      -|+..++||.|++|.||+|... |+.||||+++....              ......        ..|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3888999999999999999886 78999998753210              001112        234555555543332


Q ss_pred             eeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCE
Q 006446          377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNI  456 (644)
Q Consensus       377 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NI  456 (644)
                      ....-+.  ....+|||||+++++|.++...              .....++.|++.+|.|||+   .+||||||||.||
T Consensus       176 ~vp~p~~--~~~~~LVME~i~G~~L~~l~~~--------------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NI  236 (397)
T 4gyi_A          176 PVPEPIA--QSRHTIVMSLVDALPMRQVSSV--------------PDPASLYADLIALILRLAK---HGLIHGDFNEFNI  236 (397)
T ss_dssp             SCCCEEE--EETTEEEEECCSCEEGGGCCCC--------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSE
T ss_pred             CCCeeee--ccCceEEEEecCCccHhhhccc--------------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHE
Confidence            2111111  1234799999998888765421              1124678999999999999   8999999999999


Q ss_pred             EEcCCC----------cEEEeccCCccccc
Q 006446          457 MLDSEF----------NARLGDFGLARTIQ  476 (644)
Q Consensus       457 Lld~~~----------~vkL~DFGla~~~~  476 (644)
                      |+++++          .+.|+||+.+....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCC
Confidence            998876          48999999886543

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.54  E-value=2.6e-14  Score=140.16  Aligned_cols=181  Identities=17%  Similarity=0.298  Sum_probs=119.7

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK  118 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~  118 (644)
                      ....+. +|.+.++.|+||.+ .     ++.|.+|.+.|+++.       .+|++.|+|+|......+||||||.+++..
T Consensus        24 ~~W~~~G~a~i~~~~IrLTp~-~-----~~~G~iWs~~p~~~~-------~~weie~~Fri~g~~~~~gdGlA~W~t~~~   90 (222)
T 2a6z_A           24 NNWQTGEQASLEEGRIVLTSN-Q-----NSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYSGQTDGGISFWFVQDS   90 (222)
T ss_dssp             TTEEEEETCEEETTEEESCCS-T-----TCEEEEEESSCEECC-------SCEEEEEEEEEESCCSCCSCEEEEEEEECS
T ss_pred             CCcEEcccEEEcCCEEEECCC-C-----CCeEEEEeCCCCCCC-------CCEEEEEEEEEeCCCCCCCCEEEEEEECCC
Confidence            467788 88888999999988 3     468999999999863       479999999998744458999999999854


Q ss_pred             CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCcc-C---CCCCCceeeecCCcc--ceeeecCcccccCCCceEEE
Q 006446          119 DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-Q---DINDNHVGLDVNSVY--SIRQVPLTRVNLANGTDIKV  192 (644)
Q Consensus       119 ~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~-~---d~~~~Hvgid~ns~~--s~~~~~~~~~~l~~g~~~~~  192 (644)
                      ..+  ..|..+|.-+.   .   +. +||+|||+.|.. +   ..|+.|...|.++..  +.....+ .+ ..++.+.++
T Consensus        91 ~~~--~~g~~~G~~~~---f---~G-L~I~~Dt~~n~~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~-~~-rn~~~~~~~  159 (222)
T 2a6z_A           91 NIP--RDKQLYNGPVN---Y---DG-LQLLVDNNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLM-GY-QDSSVPSTI  159 (222)
T ss_dssp             SSC--CCCTBTTBCTT---C---EE-EEEEEESCSTTSSEEEEEEEESSSCCCGGGHHHHCSEEEEC-CC-TTEEEEEEE
T ss_pred             ccc--CCCcccCCCCC---C---CE-EEEEEECCCCCCceEEEEECCCCeeeccCCCccccccccce-ec-cCCCCcEEE
Confidence            311  34444553221   1   12 599999998731 0   233444444444211  1111112 11 135678899


Q ss_pred             EEEEc---CceEEEEEecCCCCCcc-cccCccCcCCCc-eeeeecccCC---Cccccccccccccc
Q 006446          193 QVRYD---GQNITVFVANMETPLLS-EPIDLSEYLPEK-VFVGFSASTG---DDTQLNCVKSWAFD  250 (644)
Q Consensus       193 ~I~Y~---~~~l~v~~~~~~~~~ls-~~~dl~~~l~~~-~~vGfsastg---~~~~~~~i~~wsf~  250 (644)
                      +|.|+   ...+.|.+..  ...+. ..|+    ||+. .|+||||+||   +..+.|.|++|++.
T Consensus       160 rI~Y~~~~~~~l~v~id~--~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~  219 (222)
T 2a6z_A          160 RVTYDLEDDNLLKVQVDN--KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF  219 (222)
T ss_dssp             EEEEEGGGTSEEEEEETT--EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred             EEEEEcCCCcEEEEEEcC--eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence            99997   3677887753  11111 1233    5666 4799999999   77888999988764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=3.4e-12  Score=128.76  Aligned_cols=148  Identities=15%  Similarity=0.071  Sum_probs=116.7

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEE
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV  392 (644)
                      +.....+|+....++.|+.+.||+....++.+++|+...........+.+|+.+++.+. |.++.++++++...+..++|
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34445678778888889999999998778899999987543233456889999999984 67788899999888889999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC-------------------------------
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG-------------------------------  441 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------  441 (644)
                      |||+++.+|.+.+.             +......++.+++++|..||+.                               
T Consensus        89 ~e~i~G~~l~~~~~-------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EECCSSEEHHHHCC-------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             EEecCCeehhhccC-------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            99999999877631             1112346788999999999981                               


Q ss_pred             -------------------------CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          442 -------------------------SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       442 -------------------------~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                                               ....++|+|++|.|||++++..+.|.||+.+..
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                     114599999999999998766678999998754

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.17  E-value=1.4e-12  Score=95.83  Aligned_cols=44  Identities=36%  Similarity=0.570  Sum_probs=41.3

Q ss_pred             CCCcccccCccCcCCCceeeeecccCCCcccccccccccccCCc
Q 006446          210 TPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       210 ~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~  253 (644)
                      +|+|++.+||+++|+|+|||||||+||...+.|+|++|+|+++.
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~   46 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL   46 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence            47899999999999999999999999999999999999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1e-10  Score=117.04  Aligned_cols=136  Identities=16%  Similarity=0.081  Sum_probs=98.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEeeeeeeccceEEEEecc
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++......+.|..+.||+.... +..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            4443333345666999998765 567999987543   2356788999999986555  455888888777899999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC----------------------------------
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS----------------------------------  442 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------  442 (644)
                      ++.+|.  ...           .+   ...++.++++.|..||+..                                  
T Consensus        98 ~G~~l~--~~~-----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           98 PGQDLL--SSH-----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             SSEETT--TSC-----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             CCcccC--cCc-----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            998884  210           11   1256677777888888632                                  


Q ss_pred             ---------------------CCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          443 ---------------------EKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       443 ---------------------~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                                           ...++|+|++|.|||++++..+.|.||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 12399999999999998876678999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=5.7e-10  Score=117.93  Aligned_cols=143  Identities=11%  Similarity=0.183  Sum_probs=109.6

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEee--ccc-chhhHHHHHHHHHHhccC--CCceeeEeeeeeec---cceEEEEe
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRVS--ETS-RQGKQEFIAEVTTIGSLR--HRNLVKLIGWCYER---HDFLLVYE  394 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~E  394 (644)
                      ..+.|+.|.++.||+....+..+++|+..  ... ......+.+|+.+++.+.  +.++.+++.++.+.   +..++|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            35678999999999998888889999876  332 123457788999999987  45678899998876   45899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC--------------------------------
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS--------------------------------  442 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------  442 (644)
                      |+++..+.+...          ..++..++..++.++++.|..||...                                
T Consensus       122 ~v~G~~l~~~~~----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          122 FVSGRVLWDQSL----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             CCCCBCCCCTTC----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             ecCCeecCCCcc----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            999888754221          12678888999999999999999731                                


Q ss_pred             -----------------------CCCeEeCCCCCCCEEEcCCCc--EEEeccCCcccc
Q 006446          443 -----------------------EKRVLHRDIKSSNIMLDSEFN--ARLGDFGLARTI  475 (644)
Q Consensus       443 -----------------------~~~ivHrDlkp~NILld~~~~--vkL~DFGla~~~  475 (644)
                                             ...++|+|+++.|||++.++.  +.|.||+.+..-
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                   257999999999999997753  689999998754

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=98.98  E-value=1.3e-08  Score=99.41  Aligned_cols=173  Identities=10%  Similarity=0.139  Sum_probs=108.7

Q ss_pred             CeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCCC
Q 006446           41 ELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKD  119 (644)
Q Consensus        41 ~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~~  119 (644)
                      .-.+. +|.+.++.|+||.+ .     ++.|.+|-+.|+.+       -.+|+.+|+|+|......+||||||.++....
T Consensus        28 ~W~~~G~t~v~~~~IrLTp~-~-----s~~G~lWs~~p~~~-------~~~weiev~Fri~G~~~~~gdGlA~Wyt~~~~   94 (226)
T 2a6v_A           28 QWTLGDKVKLEEGRFVLTPG-K-----NTKGSLWLKPEYSI-------KDAMTIEWTFRSFGFRGSTKGGLAFWLKQGNE   94 (226)
T ss_dssp             TEEEEETCEEETTEEESCCS-T-----TCEEEEEESSCBCC-------SSCEEEEEEEEEESCCSCCSCEEEEEEECSCC
T ss_pred             CcEEcCCeEEeCCEEEECCC-C-----CceEEEeeCCCCCC-------CCCeEEEEEEEEecCCCCCCCEEEEEEECCCC
Confidence            45677 88888889999998 5     78999999999985       14699999999987444479999999997432


Q ss_pred             CCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceee-ecCCcc--------ceeeecCcccccCCCceE
Q 006446          120 LPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGL-DVNSVY--------SIRQVPLTRVNLANGTDI  190 (644)
Q Consensus       120 ~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgi-d~ns~~--------s~~~~~~~~~~l~~g~~~  190 (644)
                      .   ..|...|-..  ...   +. +||.|||+.|.     ...|-+ --|+..        +.....+ . ....+.+.
T Consensus        95 ~---~~g~vfGg~~--d~f---~G-lgI~~Dt~~n~-----~p~i~~~~NDGt~~yd~~~~~~~g~C~~-~-~rn~~~~t  158 (226)
T 2a6v_A           95 G---DSTELFGGSS--KKF---NG-LMILLRLDDKL-----GESVTAYLNDGTKDLDIESSPYFASCLF-Q-YQDSMVPS  158 (226)
T ss_dssp             C---CCCTBTTTBC--SSC---EE-EEEEEEEETTT-----EEEEEEEEEESSSCCCTTTSCCSEEEEC-C-CSSCSSCE
T ss_pred             C---CCcccccccC--CCc---cE-EEEEEECCCCC-----CceEEEEECCCCcccCCCCCcccceEeE-e-ccCCCCCE
Confidence            1   1222222100  001   11 69999998772     011111 111111        1111111 1 12456788


Q ss_pred             EEEEEEc---CceEEEEEecCCCCCcc-cccCccCcCCCce--eeeecccCCCccccccccccc
Q 006446          191 KVQVRYD---GQNITVFVANMETPLLS-EPIDLSEYLPEKV--FVGFSASTGDDTQLNCVKSWA  248 (644)
Q Consensus       191 ~~~I~Y~---~~~l~v~~~~~~~~~ls-~~~dl~~~l~~~~--~vGfsastg~~~~~~~i~~ws  248 (644)
                      ++.|.|.   .+.+.|.+..  +..+. ..|+    ||..-  |+||||+||+..+.|.|++-.
T Consensus       159 ~~ri~Y~~~~~~~l~v~id~--~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~  216 (226)
T 2a6v_A          159 TLRLTYNPLDNHLLKLQMDN--RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMK  216 (226)
T ss_dssp             EEEEEEEGGGTSEEEEEETT--EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEcC--CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEE
Confidence            9999996   5788888753  11111 1122    44444  999999999988888887643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.93  E-value=1.2e-09  Score=112.77  Aligned_cols=188  Identities=14%  Similarity=0.147  Sum_probs=121.6

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC-CCc--eeeEeeeeeecc---ceEEEEeccC
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRN--LVKLIGWCYERH---DFLLVYEYMP  397 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~~  397 (644)
                      .+.++.|....||+..   ..+++|+....  .....+.+|..+++.+. +..  +.+++..+...+   ..++|||+++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999864   67889986432  34567889999998883 332  334555544333   3488999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC------------------------------------
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG------------------------------------  441 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------  441 (644)
                      +.+|......          .++..++..++.++++.|..||+.                                    
T Consensus       100 G~~l~~~~~~----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A          100 GVPLTPLLLN----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             CEECCHHHHH----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             CeECCccccc----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            9888754321          256677777888888888888851                                    


Q ss_pred             -------------------CCCCeEeCCCCCCCEEEcC--CCcEEEeccCCcccccccccccccccc-----------cc
Q 006446          442 -------------------SEKRVLHRDIKSSNIMLDS--EFNARLGDFGLARTIQENLKTHHSTKE-----------IA  489 (644)
Q Consensus       442 -------------------~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~-----------~~  489 (644)
                                         ....++|+|++|.||++++  +..+.|.||+.+...+...........           ..
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                               1246899999999999998  556889999998754321110000000           00


Q ss_pred             cCCCccC-ccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 006446          490 GTPGYMA-PESFLVGRATIETDIYAFGVLILEVACGRKPG  528 (644)
Q Consensus       490 gt~~y~A-PE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~  528 (644)
                      ...+... |+....  .....+.|+++.++|++.+|+.++
T Consensus       250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0001111 221111  122358899999999999998664

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.36  E-value=2.9e-06  Score=87.45  Aligned_cols=138  Identities=15%  Similarity=0.122  Sum_probs=93.5

Q ss_pred             CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCC---ceeeEeeeee-eccceEEEEeccCCC
Q 006446          324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHR---NLVKLIGWCY-ERHDFLLVYEYMPNG  399 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~g  399 (644)
                      .+.++.|....||+.   +..+++|+...  ......+..|..+|+.+.+.   .+.+.+.++. ..+..++||||+++.
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456888999999987   67889998532  23456788999999999753   3455666664 345578999999998


Q ss_pred             ccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC--------------------------------------
Q 006446          400 SLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG--------------------------------------  441 (644)
Q Consensus       400 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------  441 (644)
                      +|......          .++..++..++.++++.|..||+.                                      
T Consensus        99 ~l~~~~~~----------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           99 ILGEDGMA----------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             ECHHHHHT----------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             ECchhhhh----------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            88763211          123333444444444444444431                                      


Q ss_pred             -------------------CCCCeEeCCCCCCCEEEcC---CCc-EEEeccCCccccc
Q 006446          442 -------------------SEKRVLHRDIKSSNIMLDS---EFN-ARLGDFGLARTIQ  476 (644)
Q Consensus       442 -------------------~~~~ivHrDlkp~NILld~---~~~-vkL~DFGla~~~~  476 (644)
                                         ....++|+|+++.|||++.   ++. +.|.||+.+..-+
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               2346799999999999987   455 5899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.27  E-value=3.5e-06  Score=84.68  Aligned_cols=134  Identities=16%  Similarity=0.152  Sum_probs=93.6

Q ss_pred             cccccCcE-EEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          326 KLGKGGFG-TVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       326 ~LG~G~fG-~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      .+..|..| .||+-...  +..+++|+-...   ...++.+|...|+.+. +--+-++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68987654  457899986543   3456788999988874 33466788999888899999999998887


Q ss_pred             chhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC----------------------------------------
Q 006446          402 DKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG----------------------------------------  441 (644)
Q Consensus       402 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------  441 (644)
                      .+.....            ...+..+..+++..|.-||..                                        
T Consensus       108 ~~~~~~~------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          108 FQVLEEY------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             HHHHHHC------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             cccccCC------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            6654211            112234455555555555531                                        


Q ss_pred             ---------------CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          442 ---------------SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       442 ---------------~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                                     ....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                           112489999999999999887778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=2.3e-06  Score=89.92  Aligned_cols=80  Identities=5%  Similarity=-0.029  Sum_probs=57.0

Q ss_pred             CCcc-cccCcEEEEEeeec--------CceEEEEEeeccc---chhhHHHHHHHHHHhccCC---CceeeEeeeeeec--
Q 006446          324 KNKL-GKGGFGTVYKGIWR--------NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRH---RNLVKLIGWCYER--  386 (644)
Q Consensus       324 ~~~L-G~G~fG~Vy~g~~~--------~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~--  386 (644)
                      .+.| +.|....+|+....        +..+++|+.....   ......+..|+.+++.+..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998765        6678888865432   1123567788888888843   3566788887665  


Q ss_pred             -cceEEEEeccCCCccch
Q 006446          387 -HDFLLVYEYMPNGSLDK  403 (644)
Q Consensus       387 -~~~~lV~Ey~~~gsL~~  403 (644)
                       +..++||||+++..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999998877764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=5.2e-05  Score=78.55  Aligned_cols=146  Identities=12%  Similarity=0.177  Sum_probs=82.6

Q ss_pred             CcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC-----CCceeeEe-e--eeeeccceEEEEecc
Q 006446          325 NKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-----HRNLVKLI-G--WCYERHDFLLVYEYM  396 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~-g--~~~~~~~~~lV~Ey~  396 (644)
                      +.|+.|..+.||+....++.+++|+....    ..+...|..+++.|.     .|.++... |  +....+..++++||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            44666778999999887778999998652    123334555555443     24333311 1  122456689999999


Q ss_pred             CCCccch--------------hhhccCCCCC-C-----CccccCHHHHH-------------------------------
Q 006446          397 PNGSLDK--------------FIFYDETNSG-P-----GEVTLNWEKRL-------------------------------  425 (644)
Q Consensus       397 ~~gsL~~--------------~l~~~~~~~~-~-----~~~~l~~~~~~-------------------------------  425 (644)
                      ++..+..              .++....... +     ....-.|...+                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            9876531              1121111000 0     01112343211                               


Q ss_pred             HHHHHHHHHHHHhHh----------CCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          426 SVIHGTSQALDYLHN----------GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       426 ~i~~~ia~aL~yLH~----------~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            011123345666653          1247899999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.81  E-value=4.6e-05  Score=81.20  Aligned_cols=74  Identities=11%  Similarity=0.121  Sum_probs=49.1

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeecccc-------hhhHHHHHHHHHHhccCC--Cce-eeEeeeeeeccceEE
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-------QGKQEFIAEVTTIGSLRH--RNL-VKLIGWCYERHDFLL  391 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~nI-v~l~g~~~~~~~~~l  391 (644)
                      .+.||.|..+.||++...  ++.+++|......+       .....+..|..+++.+..  +.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999654  57899998653221       123456778888887742  333 345544  3445689


Q ss_pred             EEeccCCC
Q 006446          392 VYEYMPNG  399 (644)
Q Consensus       392 V~Ey~~~g  399 (644)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.69  E-value=0.0002  Score=73.72  Aligned_cols=144  Identities=16%  Similarity=0.145  Sum_probs=95.8

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC---CCceeeEeeeeeeccceEEEEeccCCC
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR---HRNLVKLIGWCYERHDFLLVYEYMPNG  399 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~g  399 (644)
                      ..+.|+.|....+|+....++.+++|+....   ....+..|...|+.|.   ...+.+++.++...+..++||||+++.
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            4567899999999998887889999987543   3566888988888884   356888899888878899999999988


Q ss_pred             ccch-----------hhhccCC-CC--C-----------CCccccCHHHHH---HHH--HH--------------HHHH-
Q 006446          400 SLDK-----------FIFYDET-NS--G-----------PGEVTLNWEKRL---SVI--HG--------------TSQA-  434 (644)
Q Consensus       400 sL~~-----------~l~~~~~-~~--~-----------~~~~~l~~~~~~---~i~--~~--------------ia~a-  434 (644)
                      .+..           .|+.... ..  .           .....-+|...+   ++.  .+              +.+. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7632           1222111 00  0           011123565432   111  11              1111 


Q ss_pred             HHHhHh-CCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          435 LDYLHN-GSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       435 L~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ...|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            123321 2357899999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.00022  Score=76.67  Aligned_cols=80  Identities=10%  Similarity=0.037  Sum_probs=48.6

Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccC---CCCCccchHHHHHHHH
Q 006446          443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG---RATIETDIYAFGVLIL  519 (644)
Q Consensus       443 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~t~~sDVwSfGvvl~  519 (644)
                      ...++|+|+++.|||++.++ ++|.||+.+..-........  ....-...|.+|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA--YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH--HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH--HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            47899999999999999876 99999999875432111000  000011345666554311   1122345567788888


Q ss_pred             HHHcCC
Q 006446          520 EVACGR  525 (644)
Q Consensus       520 el~tG~  525 (644)
                      +..+++
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            876653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.46  E-value=0.00035  Score=71.85  Aligned_cols=164  Identities=12%  Similarity=0.064  Sum_probs=91.3

Q ss_pred             cCHHHHHHHhCCCCC-----CCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEee
Q 006446          309 FRLKELKKATGNFNP-----KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIG  381 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~-----~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g  381 (644)
                      ++.+++.....+|..     .+.|+.|....+|+....++.+++|.....  ....++..|+.++..+....  +.+++.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            445556555555654     234667888999998877778999988652  12234556777776664222  223332


Q ss_pred             e------eeeccceEEEEeccCCCccchh--------------hhccCCC-CCCC---ccccCHHHHHHH----------
Q 006446          382 W------CYERHDFLLVYEYMPNGSLDKF--------------IFYDETN-SGPG---EVTLNWEKRLSV----------  427 (644)
Q Consensus       382 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~~-~~~~---~~~l~~~~~~~i----------  427 (644)
                      .      ....+..+++++|+++..+...              ++..... ..+.   .....|...+.-          
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      1223567899999988665321              1211100 0000   011234432111          


Q ss_pred             --HHHHHHHHHHhHhC----CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          428 --IHGTSQALDYLHNG----SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       428 --~~~ia~aL~yLH~~----~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                        ...+...++.+++.    ....++|+|+.+.|||++++..+.|.||+.+..
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              11234455566532    246799999999999999876668999987753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.00066  Score=68.74  Aligned_cols=79  Identities=16%  Similarity=0.198  Sum_probs=56.9

Q ss_pred             CCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCC---CceeeEeeeeeeccceEEEEec
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH---RNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .+...+.+|.|..+.||+.++. |+.+++|+...........|..|...|+.|.-   -.+.+++++.    .-++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            4555678999999999999987 67899998765544444568889999888842   1244455543    34789999


Q ss_pred             cCCCccc
Q 006446          396 MPNGSLD  402 (644)
Q Consensus       396 ~~~gsL~  402 (644)
                      ++.+...
T Consensus        92 l~~~~~~   98 (288)
T 3f7w_A           92 VDERPPT   98 (288)
T ss_dssp             CCCCCCC
T ss_pred             ecccCCC
Confidence            9876643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.0015  Score=66.60  Aligned_cols=142  Identities=8%  Similarity=0.006  Sum_probs=77.8

Q ss_pred             CCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEEEecc-CCCc
Q 006446          323 PKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLVYEYM-PNGS  400 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs  400 (644)
                      ..+.|+.|....+|+.    ..+++|+....... ......|..+++.+....+ .++++.+  ...-++++||+ ++.+
T Consensus        22 ~i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             SCEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             ceeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            3678999999999998    67888887643211 1223467777776643233 3555544  33357899999 6655


Q ss_pred             cchh------------------hhccCCCCCCCccccCHHHH-HHHHH--------------HHHHHH----HHhHh-CC
Q 006446          401 LDKF------------------IFYDETNSGPGEVTLNWEKR-LSVIH--------------GTSQAL----DYLHN-GS  442 (644)
Q Consensus       401 L~~~------------------l~~~~~~~~~~~~~l~~~~~-~~i~~--------------~ia~aL----~yLH~-~~  442 (644)
                      |...                  ++.....   .........+ ..+..              .+...+    ..|.. ..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAV---FPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCC---CSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            5421                  1111100   0000111111 11100              011111    11211 23


Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       443 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ...++|+|+.+.||+ ..++.+.|.||..+..-
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            456999999999999 66677899999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.09  E-value=0.0011  Score=71.53  Aligned_cols=73  Identities=18%  Similarity=0.236  Sum_probs=49.5

Q ss_pred             CCcccccCcEEEEEeeec---------CceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEEE
Q 006446          324 KNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLVY  393 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~  393 (644)
                      .+.|+.|-...+|+....         +..+++|+.....  ....+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            356788888999998865         3678888874321  11456678888888854444 456666542    3899


Q ss_pred             eccCCCccc
Q 006446          394 EYMPNGSLD  402 (644)
Q Consensus       394 Ey~~~gsL~  402 (644)
                      ||+++.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999865654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.93  E-value=0.0038  Score=67.72  Aligned_cols=74  Identities=12%  Similarity=0.015  Sum_probs=48.6

Q ss_pred             CCcccccCcEEEEEeeecC--ceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEEEeccCCCc
Q 006446          324 KNKLGKGGFGTVYKGIWRN--KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      .+.|+.|-...+|+....+  ..+++|+....... .-+...|..++..|...++ .++++.+. .   .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            4568888899999998876  78888887443211 1122578888888865555 45677663 2   25999998766


Q ss_pred             cc
Q 006446          401 LD  402 (644)
Q Consensus       401 L~  402 (644)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.93  E-value=0.0047  Score=63.73  Aligned_cols=146  Identities=16%  Similarity=0.084  Sum_probs=73.1

Q ss_pred             CcccccCcEE-EEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCC--CceeeEeeeeeeccceEEEEeccCCCc
Q 006446          325 NKLGKGGFGT-VYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH--RNLVKLIGWCYERHDFLLVYEYMPNGS  400 (644)
Q Consensus       325 ~~LG~G~fG~-Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gs  400 (644)
                      +.|+.|+... +|+.... ++.+++|.......   .++..|+.+++.+..  -.+.+++.++.+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566665555 6677664 66777776543221   334456666666632  23455666654433  78999997766


Q ss_pred             cchhhhccCC------------------CCCCCccccCHH----------HH-----H-----HHHHHHHHHHHHhH---
Q 006446          401 LDKFIFYDET------------------NSGPGEVTLNWE----------KR-----L-----SVIHGTSQALDYLH---  439 (644)
Q Consensus       401 L~~~l~~~~~------------------~~~~~~~~l~~~----------~~-----~-----~i~~~ia~aL~yLH---  439 (644)
                      +.+++.....                  ........++..          ..     +     .....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6543321100                  000000011110          00     0     00011112222221   


Q ss_pred             hCCCCCeEeCCCCCCCEEEcCC----CcEEEeccCCcccc
Q 006446          440 NGSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLARTI  475 (644)
Q Consensus       440 ~~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~~  475 (644)
                      ......++|||+.+.|||++.+    ..+.|.||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1234689999999999999875    68999999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.80  E-value=0.0034  Score=66.34  Aligned_cols=145  Identities=20%  Similarity=0.194  Sum_probs=82.6

Q ss_pred             CcccccCcEEEEEeeec---------CceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEEEe
Q 006446          325 NKLGKGGFGTVYKGIWR---------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  394 (644)
                      +.|..|-...+|+....         +..+++|+..... .......+|..+++.|.-.++ .++++.+.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45667778888988764         3678888863322 234556689888888743222 456666643    28999


Q ss_pred             ccCCCccchh-----------------hhccCCCCCCCccccCHHHHHHHHHHHHH-------------------HHHHh
Q 006446          395 YMPNGSLDKF-----------------IFYDETNSGPGEVTLNWEKRLSVIHGTSQ-------------------ALDYL  438 (644)
Q Consensus       395 y~~~gsL~~~-----------------l~~~~~~~~~~~~~l~~~~~~~i~~~ia~-------------------aL~yL  438 (644)
                      |+++..|..-                 |+...... ......-|.+..++..++..                   .+..|
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~-~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPF-TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSS-CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCC-CCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998776421                 11111110 11111123444444433321                   22333


Q ss_pred             H----h-CCCCCeEeCCCCCCCEEEcCC----CcEEEeccCCcccc
Q 006446          439 H----N-GSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLARTI  475 (644)
Q Consensus       439 H----~-~~~~~ivHrDlkp~NILld~~----~~vkL~DFGla~~~  475 (644)
                      .    . .....++|+|+.+.|||++.+    +.+.|.||..+..-
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            2    2 234679999999999999877    78999999988643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.76  E-value=0.01  Score=60.79  Aligned_cols=146  Identities=12%  Similarity=0.105  Sum_probs=81.3

Q ss_pred             CcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCc--eeeEeee-----eeeccceEEEEecc
Q 006446          325 NKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN--LVKLIGW-----CYERHDFLLVYEYM  396 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~-----~~~~~~~~lV~Ey~  396 (644)
                      ..|+ |....||+.... ++.+++|...... .....+..|..++..+....  +.+++..     ....+..++++||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 888899988765 4579999986432 12445667777777774222  3444432     12244568899999


Q ss_pred             CCCccch----h----------hhccCCC-CCCCccccCHHHH----HHH---------------HHHHHHHHHHhHh--
Q 006446          397 PNGSLDK----F----------IFYDETN-SGPGEVTLNWEKR----LSV---------------IHGTSQALDYLHN--  440 (644)
Q Consensus       397 ~~gsL~~----~----------l~~~~~~-~~~~~~~l~~~~~----~~i---------------~~~ia~aL~yLH~--  440 (644)
                      ++..+..    .          ++..... ........++...    ..+               ...+...++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8766531    0          1111000 0000111222211    001               1111122333322  


Q ss_pred             --CCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          441 --GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       441 --~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                        .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1346789999999999999 4 899999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.67  E-value=0.0037  Score=65.55  Aligned_cols=73  Identities=8%  Similarity=0.074  Sum_probs=43.4

Q ss_pred             CCcccccCcEEEEEeeecC----------ceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEE
Q 006446          324 KNKLGKGGFGTVYKGIWRN----------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLV  392 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~----------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV  392 (644)
                      .+.|+.|....+|+....+          ..+++|+...... ...+...|..+++.+...++ .++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3457778888999987653          5788887654322 12234577888877753343 3555443  2  3689


Q ss_pred             EeccCCCcc
Q 006446          393 YEYMPNGSL  401 (644)
Q Consensus       393 ~Ey~~~gsL  401 (644)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.29  E-value=0.03  Score=57.95  Aligned_cols=34  Identities=18%  Similarity=0.244  Sum_probs=29.6

Q ss_pred             CCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          443 EKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       443 ~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ...++|+|+.+.||++++++.+.|.||+.+..-.
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            3679999999999999988889999998886543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.91  E-value=0.033  Score=53.54  Aligned_cols=103  Identities=17%  Similarity=0.094  Sum_probs=66.3

Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      -||.+.|.....       +++.++.+.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|+|...+ ..+.     
T Consensus        33 vSL~eIL~~~~~-------PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----   97 (229)
T 2yle_A           33 LSLEEILRLYNQ-------PINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----   97 (229)
T ss_dssp             EEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred             ccHHHHHHHcCC-------CcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----
Confidence            468888865554       4999999999999999887662100 11 1333457999999999988875 1111     


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP  527 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P  527 (644)
                                .....+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                      0112355788653 3456788999999999999875444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.58  E-value=0.051  Score=58.07  Aligned_cols=145  Identities=12%  Similarity=0.097  Sum_probs=83.5

Q ss_pred             CCcccccCcEEEEEeeec---------CceEEEEEeecccchhhHHHHHHHHHHhccCCCce-eeEeeeeeeccceEEEE
Q 006446          324 KNKLGKGGFGTVYKGIWR---------NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-VKLIGWCYERHDFLLVY  393 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~  393 (644)
                      .+.|..|-...+|+....         +..+++|+...... ..-+..+|..+++.+.-.++ .++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            345677888899998876         57788888654321 12233567787777743333 3455433  2  37899


Q ss_pred             eccCCCccchh-----------------hhccCC-----CC-CCCccccCHHHHHHHHHHH-------------------
Q 006446          394 EYMPNGSLDKF-----------------IFYDET-----NS-GPGEVTLNWEKRLSVIHGT-------------------  431 (644)
Q Consensus       394 Ey~~~gsL~~~-----------------l~~~~~-----~~-~~~~~~l~~~~~~~i~~~i-------------------  431 (644)
                      ||+++..|..-                 |+....     .. .... ..-|.+..++..++                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~-p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKE-PILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCS-CCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCC-CcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99998765321                 111100     00 0011 11233333332221                   


Q ss_pred             HHHHHHhHh---------------------CCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          432 SQALDYLHN---------------------GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       432 a~aL~yLH~---------------------~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ...+..|.+                     .....++|+|+.+.||+ +.++.+.|.||..+..-
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            122233321                     12357999999999999 88889999999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=86.94  E-value=0.39  Score=50.76  Aligned_cols=31  Identities=26%  Similarity=0.292  Sum_probs=26.0

Q ss_pred             CeEeCCCCCCCEEE------cCCCcEEEeccCCcccc
Q 006446          445 RVLHRDIKSSNIML------DSEFNARLGDFGLARTI  475 (644)
Q Consensus       445 ~ivHrDlkp~NILl------d~~~~vkL~DFGla~~~  475 (644)
                      .++|+|+.+.|||+      +++..+++.||..|..-
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            46799999999999      45677999999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.04  E-value=0.19  Score=54.29  Aligned_cols=61  Identities=8%  Similarity=0.061  Sum_probs=18.5

Q ss_pred             CCCCcccccCcEEEEEeeecC--ceEEE------EEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          322 NPKNKLGKGGFGTVYKGIWRN--KEIAV------KRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~~--~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      ...++||   ||.||+|.+.+  .+||+      |..+..  +++....|.+|..++..++|+|+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456676   99999999974  47888      766542  23344678899999999999999999887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	644
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-69
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-56
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	4e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-52
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	8e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-50
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	5e-50
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	2e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-49
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	3e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-47
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	2e-47
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	3e-47
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	4e-47
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	7e-47
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-46
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	8e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-45
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	5e-45
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	3e-44
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	4e-44
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	7e-44
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	4e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-40
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	2e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	7e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	1e-31
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	5e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-30
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	6e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-26
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	2e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	5e-11
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	3e-09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 5e-69
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 30/285 (10%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRNL 376
           G      ++G G FGTVYKG W   ++AVK   V+  + Q  Q F  EV  +   RH N+
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  +G+        +V ++    SL   +   ET            K + +   T+Q +D
Sbjct: 67  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTAQGMD 118

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           YLH    K ++HRD+KS+NI L  +   ++GDFGLA          H  ++++G+  +MA
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMA 174

Query: 497 PESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           PE   +      + ++D+YAFG+++ E+  G+ P        Y+N               
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIFMVGRGY 226

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           L    S++     +     +  L   C       RP    +L  +
Sbjct: 227 LSPDLSKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASI 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 3e-64
 Identities = 71/296 (23%), Positives = 113/296 (38%), Gaps = 30/296 (10%)

Query: 324 KNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWC 383
           +  +GKG FG V++G WR +E+AVK  S    +      AE+     LRH N++  I   
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 66

Query: 384 YERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
            + +       LV +Y  +GSL  ++            T+  E  + +   T+  L +LH
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN---------RYTVTVEGMIKLALSTASGLAHLH 117

Query: 440 N-----GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT-HHSTKEIAGTPG 493
                   +  + HRD+KS NI++       + D GLA        T   +     GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 494 YMAPESFL------VGRATIETDIYAFGVLILEVACGRKPGNQSEQNS---YNNSIVHWL 544
           YMAPE            +    DIYA G++  E+A     G   E      Y+       
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 545 WELRRKGRILDAADSRLGGEFSEKE-MECVLILGLACCHPNPHLRPSMKTVLQVLS 599
            E  RK          +   +   E +  +  +   C + N   R +   + + LS
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 9e-63
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 30/281 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKE-IAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
                 ++G G FG V+ G W NK+ +A+K + E     +++FI E   +  L H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L G C E+    LV+E+M +G L  ++                E  L +     + + YL
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-------AAETLLGMCLDVCEGMAYL 117

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
               E  V+HRD+ + N ++      ++ DFG+ R + ++   + S+        + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPE 172

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
            F   R + ++D+++FGVL+ EV    K      +N  N+ +V  +    R         
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRL-------- 221

Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                         V  +   C    P  RP+   +L+ L+
Sbjct: 222 -----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 4e-62
 Identities = 59/308 (19%), Positives = 132/308 (42%), Gaps = 45/308 (14%)

Query: 309 FRLKELKKATGNFNPK---------NKLGKGGFGTVYKGIWR-----NKEIAVKRV-SET 353
           F  ++  +A   F  +           +G G FG V  G  +        +A+K + S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 354 SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG 413
           + + +++F++E + +G   H N++ L G   +    +++ E+M NGSLD F+  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 414 PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR 473
                    + + ++ G +  + YL +      +HRD+ + NI+++S    ++ DFGL+R
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 474 TIQEN--LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQ 530
            ++++    T+ S         + APE+    + T  +D++++G+++ E ++ G +P   
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--- 233

Query: 531 SEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS 590
                         +       +++A +              +  L L C   + + RP 
Sbjct: 234 --------------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279

Query: 591 MKTVLQVL 598
              ++  L
Sbjct: 280 FGQIVNTL 287

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 7e-62
 Identities = 65/280 (23%), Positives = 124/280 (44%), Gaps = 30/280 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
                 +LG G FG V+ G +  + ++AVK + +        F+AE   +  L+H+ LV+
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L     +     ++ EYM NGSL  F+        P  + L   K L +    ++ + ++
Sbjct: 73  LYAVVTQEP-IYIITEYMENGSLVDFLK------TPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
               E+  +HRD++++NI++    + ++ DFGLAR I++N   + + +       + APE
Sbjct: 126 E---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           +   G  TI++D+++FG+L+ E+    +         Y       + +   +G  +    
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRM---- 229

Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                   +   E +  L   C    P  RP+   +  VL
Sbjct: 230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-61
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 32/281 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +     +LG G FG V  G WR   ++A+K + E     + EFI E   + +L H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L G C ++    ++ EYM NG L  ++                ++ L +     +A++YL
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-------RFQTQQLLEMCKDVCEAMEYL 116

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
            +   K+ LHRD+ + N +++ +   ++ DFGL+R + ++   + S+        +  PE
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 171

Query: 499 SFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
             +  + + ++DI+AFGVL+ E+ + G+ P                 +E        +  
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-----------------YERFTNSETAEHI 214

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
              L         E V  +  +C H     RP+ K +L  +
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-61
 Identities = 63/294 (21%), Positives = 123/294 (41%), Gaps = 35/294 (11%)

Query: 312 KELKKATGNFNPKN-KLGKGGFGTVYKGIWRNK----EIAVKRVSETSRQG-KQEFIAEV 365
           K+L     N    + +LG G FG+V +G++R +    ++A+K + + + +   +E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 366 TTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRL 425
             +  L +  +V+LIG C +    +LV E    G L KF+             +      
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-------IPVSNVA 112

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
            ++H  S  + YL     K  +HRD+ + N++L +   A++ DFGL++ +  +   + + 
Sbjct: 113 ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEV-ACGRKPGNQSEQNSYNNSIVHWL 544
                   + APE     + +  +D++++GV + E  + G+KP        Y       +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------YKKMKGPEV 221

Query: 545 WELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                +G+ +         E   +    +  L   C       RP   TV Q +
Sbjct: 222 MAFIEQGKRM---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-61
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 34/280 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
                  +GKG FG V  G +R  ++AVK +   +    Q F+AE + +  LRH NLV+L
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 380 IGWCYERHDFL-LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           +G   E    L +V EYM  GSL  ++         G   L  +  L       +A++YL
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLR------SRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
                   +HRD+ + N+++  +  A++ DFGL +       T            + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPVKWTAPE 170

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           +    + + ++D+++FG+L+ E+    +         Y    +  +     KG  +D   
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMD--- 220

Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                   +     V  +   C H +  +RPS   + + L
Sbjct: 221 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 5e-61
 Identities = 58/312 (18%), Positives = 118/312 (37%), Gaps = 44/312 (14%)

Query: 314 LKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG-KQEFIAEVTTIGS 370
           ++    +F   ++LG G  G V+K   +     +A K +    +   + + I E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 371 LRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHG 430
                +V   G  Y   +  +  E+M  GSLD+ +             +  +    V   
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--------RIPEQILGKVSIA 112

Query: 431 TSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAG 490
             + L YL    + +++HRD+K SNI+++S    +L DFG++  + +++          G
Sbjct: 113 VIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VG 165

Query: 491 TPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKP----------------------G 528
           T  YM+PE       ++++DI++ G+ ++E+A GR P                       
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

Query: 529 NQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGL----ACCHPN 584
                 +    +  +  + R    I +  D  +     +       +        C   N
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285

Query: 585 PHLRPSMKTVLQ 596
           P  R  +K ++ 
Sbjct: 286 PAERADLKQLMV 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-60
 Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 33/295 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVK 378
           +   + KLG+G FG V+ G W     +A+K +        + F+ E   +  LRH  LV+
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           L           +V EYM  GSL  F+  +              + + +    +  + Y+
Sbjct: 77  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL------RLPQLVDMAAQIASGMAYV 129

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
                   +HRD++++NI++      ++ DFGLAR I++N   + + +       + APE
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPE 184

Query: 499 SFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAAD 558
           + L GR TI++D+++FG+L+ E+    +       N                  +LD  +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVE 228

Query: 559 SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG---EADPPVLPPE 610
                    +  E +  L   C    P  RP+ + +   L       +P   P E
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (511), Expect = 4e-60
 Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 44/313 (14%)

Query: 310 RLKELKKATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVS-ETSRQGKQEF 361
           +L  L+    N      +G+G FG V++              +AVK +  E S   + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------------- 406
             E   +    + N+VKL+G C       L++EYM  G L++F+                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 407 -YDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR 465
                 S PG   L+  ++L +    +  + YL    E++ +HRD+ + N ++      +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180

Query: 466 LGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR 525
           + DFGL+R I             A    +M PES    R T E+D++A+GV++ E+    
Sbjct: 181 IADFGLSRNIYSADYYKADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 526 KPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNP 585
                     Y       +    R G IL            E     +  L   C    P
Sbjct: 240 LQ-------PYYGMAHEEVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLP 283

Query: 586 HLRPSMKTVLQVL 598
             RPS  ++ ++L
Sbjct: 284 ADRPSFCSIHRIL 296

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 8e-60
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 32/285 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRN 375
           ++     +G G +G   K   +   K +  K +     +   KQ  ++EV  +  L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 376 LVKLIGWCYERHD--FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
           +V+      +R +    +V EY   G L   I             L+ E  L V+   + 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY----LDEEFVLRVMTQLTL 120

Query: 434 ALDYLH--NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           AL   H  +     VLHRD+K +N+ LD + N +LGDFGLAR +  +       K   GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGT 177

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG 551
           P YM+PE         ++DI++ G L+ E+     P     Q            EL  K 
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----------ELAGK- 225

Query: 552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            I +    R+   +S++  E +        +   + RPS++ +L+
Sbjct: 226 -IREGKFRRIPYRYSDELNEII----TRMLNLKDYHRPSVEEILE 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-59
 Identities = 64/281 (22%), Positives = 120/281 (42%), Gaps = 36/281 (12%)

Query: 325 NKLGKGGFGTVYKGIWRNK----EIAVKRVSETSRQG--KQEFIAEVTTIGSLRHRNLVK 378
            +LG G FGTV KG ++ K     +AVK +   +     K E +AE   +  L +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 379 LIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYL 438
           +IG C E   ++LV E    G L+K++  +          +  +  + ++H  S  + YL
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--------VKDKNIIELVHQVSMGMKYL 123

Query: 439 HNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPE 498
                   +HRD+ + N++L ++  A++ DFGL++ ++ +   + +         + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 499 SFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
                + + ++D+++FGVL+ E  + G+KP        Y       +  +  KG  +   
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP--------YRGMKGSEVTAMLEKGERM--- 229

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
                          +  L   C   +   RP    V   L
Sbjct: 230 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-59
 Identities = 61/293 (20%), Positives = 125/293 (42%), Gaps = 33/293 (11%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSETSRQG-KQEFIAEVTTIGSLR 372
               +  +G G FG VYKG+ +         +A+K +     +  + +F+ E   +G   
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N+++L G   +    +++ EYM NG+LDKF+   +          +  + + ++ G +
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-------FSVLQLVGMLRGIA 120

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTP 492
             + YL N      +HRD+ + NI+++S    ++ DFGL+R ++++ +  ++T       
Sbjct: 121 AGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 493 GYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
            + APE+    + T  +D+++FG+++ EV    +                  WEL     
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNH-E 221

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP 605
           ++ A +              +  L + C       RP    ++ +L      P
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (500), Expect = 1e-58
 Identities = 71/281 (25%), Positives = 128/281 (45%), Gaps = 30/281 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +   K+KLG G +G VY+G+W+  +  +AVK + E + +  +EF+ E   +  ++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
           +L+G C     F ++ E+M  G+L  ++             ++    L +    S A++Y
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRE------CNRQEVSAVVLLYMATQISSAMEY 130

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           L    +K  +HRD+ + N ++      ++ DFGL+R +  +  T+ +         + AP
Sbjct: 131 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAP 185

Query: 498 ESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA 557
           ES    + +I++D++AFGVL+ E+A                      +      ++ +  
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQVYELL 229

Query: 558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           +     E  E   E V  L  AC   NP  RPS   + Q  
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 1e-58
 Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 44/299 (14%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK---QEFIAEVTTIGSLRHRN 375
           F+   ++G G FG VY       ++ +A+K++S + +Q     Q+ I EV  +  LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
            ++  G     H   LV EY    + D    + +         L   +  +V HG  Q L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGL 128

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YLH      ++HRD+K+ NI+L      +LGDFG A  +              GTP +M
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWM 178

Query: 496 APESFL---VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR 552
           APE  L    G+   + D+++ G+  +E+A  + P       S    I        + G 
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGEADPPVLPP 609
             +   +                   +C    P  RP+ + +L+   +  E  P V+  
Sbjct: 239 WSEYFRN----------------FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-58
 Identities = 61/301 (20%), Positives = 119/301 (39%), Gaps = 38/301 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQG-KQEFIAEVTTIGSL 371
             +    LG G FG V +              +AVK +  ++    ++  ++E+  +  L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 372 -RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIF----------YDETNSGPGEVTLN 420
             H N+V L+G C      L++ EY   G L  F+                    E+ L+
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            E  LS  +  ++ + +L     K  +HRD+ + NI+L      ++ DFGLAR I+ +  
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-S 199

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
            +           +MAPES      T E+D++++G+ + E+                  +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------PYPGMPV 253

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG 600
               +++ ++G  +            E     +  +   C   +P  RP+ K ++Q++  
Sbjct: 254 DSKFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 601 E 601
           +
Sbjct: 305 Q 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 5e-58
 Identities = 65/307 (21%), Positives = 120/307 (39%), Gaps = 45/307 (14%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSRQG-KQEFIAEVTTIGSL 371
           N      LG G FG V               ++AVK + E +    ++  ++E+  +  L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 372 -RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEV------------- 417
             H N+V L+G C       L++EY   G L  ++          E+             
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 418 --TLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI 475
              L +E  L   +  ++ +++L     K  +HRD+ + N+++      ++ DFGLAR I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQN 534
             +   +           +MAPES   G  TI++D++++G+L+ E  + G  P       
Sbjct: 215 MSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266

Query: 535 SYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTV 594
                +    ++L + G  +D               E + I+  +C   +   RPS   +
Sbjct: 267 YPGIPVDANFYKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

Query: 595 LQVLSGE 601
              L  +
Sbjct: 318 TSFLGCQ 324

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-57
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 34/286 (11%)

Query: 322 NPKNKLGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGK-QEFIAEVTTIGSLRHRN 375
           +    +G+G FG VY G   + +      AVK ++  +  G+  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 376 LVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           ++ L+G C       L+V  YM +G L  FI  +  N          +  +      ++ 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-------PTVKDLIGFGLQVAKG 142

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN-LKTHHSTKEIAGTPG 493
           + +L +   K+ +HRD+ + N MLD +F  ++ DFGLAR + +    + H+         
Sbjct: 143 MKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           +MA ES    + T ++D+++FGVL+ E+     P         + +       L +  R+
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL 253

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           L            E   + +  + L C HP   +RPS   ++  +S
Sbjct: 254 LQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 4e-57
 Identities = 71/294 (24%), Positives = 125/294 (42%), Gaps = 37/294 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN----KEIAVKRVSET-SRQGKQEFIAEVTTIGSL-RH 373
           +   ++ +G+G FG V K   +      + A+KR+ E  S+   ++F  E+  +  L  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDE--------TNSGPGEVTLNWEKRL 425
            N++ L+G C  R    L  EY P+G+L  F+              +     TL+ ++ L
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 426 SVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHST 485
                 ++ +DYL    +K+ +HRD+ + NI++   + A++ DFGL+R  +  +K     
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
                   +MA ES      T  +D++++GVL+ E+              Y       L+
Sbjct: 188 ----LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAELY 236

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           E   +G  L         E      + V  L   C    P+ RPS   +L  L+
Sbjct: 237 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 3e-56
 Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 39/282 (13%)

Query: 324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGKQEFIAEVTTIGSLRHRNLVKL 379
             ++G+G F TVYKG+      E+A   +   + ++  +Q F  E   +  L+H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 380 IGWCYE----RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
                     +   +LV E M +G+L  ++             +  +   S      + L
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKVMKIKVLRSWCRQILKGL 125

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +LH  +   ++HRD+K  NI +     + ++GD GLA      LK     K + GTP +
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-----LKRASFAKAVIGTPEF 179

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           MAPE     +     D+YAFG+ +LE+A    P ++ +           ++     G   
Sbjct: 180 MAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKP 231

Query: 555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            + D     E  E        +   C   N   R S+K +L 
Sbjct: 232 ASFDKVAIPEVKE--------IIEGCIRQNKDERYSIKDLLN 265

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  188 bits (478), Expect = 4e-56
 Identities = 69/233 (29%), Positives = 119/233 (51%), Gaps = 10/233 (4%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRD 83
           S+ F F +F     + + F  ++      +Q+    + G P+   +GRA+Y D  QLW +
Sbjct: 1   SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 60

Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG-TNQS 142
                A+F T F   +      P +GLAF +A   D      G++LG+ N  T    +++
Sbjct: 61  KTESVASFYTEFTFFLKITGNGPADGLAFFLAPP-DSDVKDAGEYLGLFNKSTATQPSKN 119

Query: 143 QIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
           Q+VA+EFDT  +    + +  H+G++VNS+ S+        ++ +G     ++ YDG  +
Sbjct: 120 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDGSAE 179

Query: 200 NITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNC-VKSWAF 249
            +TV ++  +    +LS  +D+ + LPE V VG SASTG++  L   + SW F
Sbjct: 180 ILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRF 232

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-56
 Identities = 68/295 (23%), Positives = 126/295 (42%), Gaps = 30/295 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSE-TSRQGKQEFIAEVTTIGSL 371
                 +LG+G FG VY+G+ +          +A+K V+E  S + + EF+ E + +   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSG--PGEVTLNWEKRLSVIH 429
              ++V+L+G   +    L++ E M  G L  ++          P     +  K + +  
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
             +  + YL+     + +HRD+ + N M+  +F  ++GDFG+ R I E        K   
Sbjct: 141 EIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-GL 196

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
               +M+PES   G  T  +D+++FGV++ E+A   +   Q   N         +     
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLRFVM 249

Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADP 604
           +G +LD           +   + +  L   C   NP +RPS   ++  +  E +P
Sbjct: 250 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 6e-56
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 36/288 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIW-----RNKEIAVKRVSE---TSRQGKQEFIAEVTTIGSL 371
           +     KLG G FG V +G W     +   +AVK +     +  +   +FI EV  + SL
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
            HRNL++L G         +V E  P GSL   +   + +                    
Sbjct: 69  DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH-------FLLGTLSRYAVQV 120

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
           ++ + YL     KR +HRD+ + N++L +    ++GDFGL R + +N   +   +     
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 492 PGYMAPESFLVGRATIETDIYAFGVLILE-VACGRKPGNQSEQNSYNNSIVHWLWELRRK 550
             + APES      +  +D + FGV + E    G++P           +    L ++ ++
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGSQILHKIDKE 230

Query: 551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
           G  L            E   + +  + + C    P  RP+   +   L
Sbjct: 231 GERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 8e-56
 Identities = 66/290 (22%), Positives = 125/290 (43%), Gaps = 41/290 (14%)

Query: 320 NFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL 371
           + NP+       +LG G FG VYK   +  +   A K +   S +  ++++ E+  + S 
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC 66

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
            H N+VKL+   Y  ++  ++ E+   G++D  +   E         L   +   V   T
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-------PLTESQIQVVCKQT 119

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
             AL+YLH   + +++HRD+K+ NI+   + + +L DFG++       +T        GT
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT---RTIQRRDSFIGT 173

Query: 492 PGYMAPESFLVGRA-----TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE 546
           P +MAPE  +   +       + D+++ G+ ++E+A    P        +  + +  L +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-------HHELNPMRVLLK 226

Query: 547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           + +      A  SR    F +       +    C   N   R +   +LQ
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKD------FLKK--CLEKNVDARWTTSQLLQ 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 3e-55
 Identities = 70/294 (23%), Positives = 126/294 (42%), Gaps = 38/294 (12%)

Query: 311 LKELKKATGNFNPK------NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFI 362
           L++L+      +PK       K+G+G  GTVY  +     +E+A+++++   +  K+  I
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 363 AEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWE 422
            E+  +   ++ N+V  +       +  +V EY+  GSL   +          E  ++  
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---------ETCMDEG 116

Query: 423 KRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTH 482
           +  +V     QAL++LH     +V+HRDIKS NI+L  + + +L DFG    I       
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170

Query: 483 HSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH 542
                + GTP +MAPE         + DI++ G++ +E+  G  P         N + + 
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-------YLNENPLR 223

Query: 543 WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            L+ +   G        +L   F +       +    C   +   R S K +LQ
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRD------FLNR--CLDMDVEKRGSAKELLQ 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 5e-55
 Identities = 63/317 (19%), Positives = 131/317 (41%), Gaps = 39/317 (12%)

Query: 321 FNPKNKLGKGGFGTVYKGIWRNK------EIAVKRVSE-TSRQGKQEFIAEVTTIGSLRH 373
           F     LG G FGTVYKG+W  +       +A+K + E TS +  +E + E   + S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
            ++ +L+G C       L+ + MP G L  ++   + N G        +  L+     ++
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG-------SQYLLNWCVQIAK 122

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            ++YL +   +R++HRD+ + N+++ +  + ++ DFGLA+ +    +  +  +       
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIK 178

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           +MA ES L    T ++D++++GV + E+                       ++      I
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASEI 222

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEADPP----VLPP 609
               +              V ++ + C   +   RP  + ++   S  A  P    V+  
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 610 ERPSFVWPAMPPSFVES 626
           +    +      +F  +
Sbjct: 283 DERMHLPSPTDSNFYRA 299

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 7e-55
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 46/295 (15%)

Query: 307 KKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEF 361
           +++ L+       +F     LGKG FG VY    +     +A+K + +        + + 
Sbjct: 1   RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 362 IAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNW 421
             EV     LRH N+++L G+ ++     L+ EY P G++ + +              + 
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--------FDE 105

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
           ++  + I   + AL Y H    KRV+HRDIK  N++L S    ++ DFG +     +   
Sbjct: 106 QRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
                 + GT  Y+ PE         + D+++ GVL  E   G+ P        +  +  
Sbjct: 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------FEANTY 209

Query: 542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              ++   +              F +   E    L       NP  RP ++ VL+
Sbjct: 210 QETYKRISRVEF----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-54
 Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 31/282 (10%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS-ETSRQGKQEFIAEVTTIGSLRHRN 375
            +++    LG+G +G V   + R   + +AVK V  + +    +    E+     L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +VK  G   E +   L  EY   G L   I          ++ +         H     +
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPEPDAQRFFHQLMAGV 116

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            YLH      + HRDIK  N++LD   N ++ DFGLA   + N +     K + GT  Y+
Sbjct: 117 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYV 172

Query: 496 APESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           APE            D+++ G+++  +  G  P +Q   +           + + K   L
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYL 226

Query: 555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           +        +     +  +          NP  R ++  + +
Sbjct: 227 NPWK-----KIDSAPLALL----HKILVENPSARITIPDIKK 259

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-53
 Identities = 65/299 (21%), Positives = 129/299 (43%), Gaps = 39/299 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWRN---------KEIAVKRV-SETSRQGKQEFIAEVTTIG 369
                  LG+G FG V                 ++AVK + S+ + +   + I+E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 370 SL-RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIF--------YDETNSGPGEVTLN 420
            + +H+N++ L+G C +     ++ EY   G+L +++         Y    S   E  L+
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            +  +S  +  ++ ++YL     K+ +HRD+ + N+++  +   ++ DFGLAR I     
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-D 189

Query: 481 THHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI 540
            +  T        +MAPE+      T ++D+++FGVL+ E+              Y    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------PYPGVP 242

Query: 541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
           V  L++L ++G  +D                 + ++   C H  P  RP+ K +++ L 
Sbjct: 243 VEELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  182 bits (464), Expect = 1e-52
 Identities = 60/303 (19%), Positives = 113/303 (37%), Gaps = 37/303 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           +++   +LG G FG V++   R      A K V       K+    E+ T+  LRH  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L     + ++ +++YE+M  G L + +             ++ ++ +  +    + L +
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNK----MSEDEAVEYMRQVCKGLCH 139

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNAR--LGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
           +H   E   +H D+K  NIM  ++ +    L DFGL   +        +T    GT  + 
Sbjct: 140 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFA 192

Query: 496 APESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD 555
           APE          TD+++ GVL   +  G  P      +    ++    W +        
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-------- 244

Query: 556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ-----VLSGEADPPVLPPE 610
             D       SE   + +          +P+ R ++   L+       +       +P  
Sbjct: 245 --DDSAFSGISEDGKDFI----RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 298

Query: 611 RPS 613
           R +
Sbjct: 299 RYT 301

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  178 bits (453), Expect = 2e-52
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 19/239 (7%)

Query: 24  VSSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVR-GAPITNQSGRAIYKDQFQL 80
           V ++ F+F  F   N N L+    + + +S  +Q+T   + G P  + +GR +Y     +
Sbjct: 1   VETISFSFSEFEPGNDN-LTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHM 59

Query: 81  WRDNKNVKATFSTTFVLNILNQTAQPG--EGLAFVIAGNKDLPENSEGQWLGIVNGITNG 138
           W       A+F T F  +I     +P   +GL F +   K  P      +LG+ N     
Sbjct: 60  WDSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQG-YGYLGVFNNSKQD 118

Query: 139 TNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
            N  Q +A+EFDT  +        H+G+DVNS+ SI+  P     L NG    V ++YD 
Sbjct: 119 -NSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQP---FQLDNGQVANVVIKYDA 174

Query: 199 --QNITVFVANMET---PLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
             + + V +    +     ++E +D+ + LP+ V VG S +TG   D  + + V SW+F
Sbjct: 175 PSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSF 233

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 35/280 (12%)

Query: 326 KLGKGGFGTVYKGIWRNKE-----IAVKRVSETSRQGKQE-FIAEVTTIGSLRHRNLVKL 379
            +G+G FG V++GI+ + E     +A+K     +    +E F+ E  T+    H ++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 380 IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
           IG   E     ++ E    G L  F+   +        +L+    +   +  S AL YL 
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVRKY-------SLDLASLILYAYQLSTALAYLE 125

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPES 499
               KR +HRDI + N+++ S    +LGDFGL+R ++++  T++   +      +MAPES
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWMAPES 180

Query: 500 FLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADS 559
               R T  +D++ FGV + E+        Q  +N       + +      G  L     
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGERL----- 228

Query: 560 RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                        +  L   C   +P  RP    +   LS
Sbjct: 229 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  174 bits (441), Expect = 8e-51
 Identities = 66/236 (27%), Positives = 119/236 (50%), Gaps = 14/236 (5%)

Query: 25  SSLHFNFQSF---TEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQ 79
           ++++F +  F   + +N  E++F  ++T    A+Q+T     G P+ + +G+A Y +   
Sbjct: 2   NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61

Query: 80  LWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT 139
           LW       A+F T+F   + N  A   +GLAF +A   D      G +LG+    T   
Sbjct: 62  LWDSTGKA-ASFYTSFTFLLKNYGAPTADGLAFFLA-PVDSSVKDYGGFLGLFRHETAAD 119

Query: 140 N-QSQIVAIEFDTKKSYEQD-INDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
             ++Q+VA+EFDT  + + +     H+G+DVNS+ S+        +    +     + YD
Sbjct: 120 PSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYD 179

Query: 198 G--QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
              + +TV ++  +    +LS  +DL++ LP+KV +GFSA  G   ++  + SW F
Sbjct: 180 ARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHF 234

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-50
 Identities = 59/298 (19%), Positives = 118/298 (39%), Gaps = 37/298 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSRQG-KQEFIAEVTTIGS- 370
                  LG+G FG V +            + +AVK + E +     +  ++E+  +   
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 371 LRHRNLVKLIGWCYERHD-FLLVYEYMPNGSLDKFIFYDETNSGPGEV--------TLNW 421
             H N+V L+G C +     +++ E+   G+L  ++        P +V         L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 422 EKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKT 481
           E  +      ++ +++L     ++ +HRD+ + NI+L  +   ++ DFGLAR I ++   
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PD 189

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           +    +      +MAPE+      TI++D+++FGVL+ E+                  I 
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKID 243

Query: 542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
                  ++G  +            +     +    L C H  P  RP+   +++ L 
Sbjct: 244 EEFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (448), Expect = 2e-50
 Identities = 56/295 (18%), Positives = 111/295 (37%), Gaps = 33/295 (11%)

Query: 306 PKKFRLKELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIA 363
           P+   +K+       ++   +LG G FG V++ + +   +    K ++      K     
Sbjct: 17  PQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75

Query: 364 EVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEK 423
           E++ +  L H  L+ L     ++++ +L+ E++  G L   I             ++  +
Sbjct: 76  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYK----MSEAE 128

Query: 424 RLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR--LGDFGLARTIQENLKT 481
            ++ +    + L ++H   E  ++H DIK  NIM +++  +   + DFGLA  +  +   
Sbjct: 129 VINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185

Query: 482 HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
             +T     T  + APE          TD++A GVL   +  G  P    +      ++ 
Sbjct: 186 KVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241

Query: 542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              WE                  FS    E    +        P  R ++   L+
Sbjct: 242 RCDWEFDED-------------AFSSVSPEAKDFI-KNLLQKEPRKRLTVHDALE 282

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  171 bits (435), Expect = 5e-50
 Identities = 67/240 (27%), Positives = 125/240 (52%), Gaps = 15/240 (6%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRD 83
           SL F F +F   ++  L F  ++ +  +A+Q+T     G P+ +  GR ++  Q  LW  
Sbjct: 3   SLSFGFPTFP-SDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEK 61

Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGIVN-GITNGTNQ 141
           + +  A F + F  ++ +  +   +G+AF IA  +  +P  S G  LG+   G    T+ 
Sbjct: 62  SSSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSA 121

Query: 142 SQIVAIEFDTKKSYE---QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG 198
           +Q++A+EFDT  + +    D N  H+G+DVNS+ S++ V     +  +G  + V V ++ 
Sbjct: 122 NQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKW---DRRDGQSLNVLVTFNP 178

Query: 199 Q----NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDI 254
                ++    ++     +S  +D+   LPE V VGFSA++G+  Q + ++SW+F  + +
Sbjct: 179 STRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTSTLL 238

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  170 bits (431), Expect = 2e-49
 Identities = 78/240 (32%), Positives = 119/240 (49%), Gaps = 26/240 (10%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           ++ FNF  F  QN  +L    ++ + + S +++T  V G P  N +GRA+Y    Q+W  
Sbjct: 2   TISFNFNQFH-QNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDS 60

Query: 84  NKNVKATFSTTFVLNILNQTAQPG--EGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                A+F T F  +I     +P   +GL F IA     P N++    G   GI N  + 
Sbjct: 61  TTGNVASFETRFSFSIRQPFPRPHPADGLVFFIA-----PPNTQTGEGGGYFGIYNPLSP 115

Query: 142 SQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
              VA+EFDT ++   D    H+G+DVNSV S + VP     L NG    V ++YD   +
Sbjct: 116 YPFVAVEFDTFRNTW-DPQIPHIGIDVNSVISTKTVPF---TLDNGGIANVVIKYDASTK 171

Query: 200 NITVFVANMET---PLLSEPIDLSEYLPEKVFVGFSASTGDD-------TQLNCVKSWAF 249
            + V +          +++ +DL + LPE V VGFSA+TGD        T+ + + SW+F
Sbjct: 172 ILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 231

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 9e-49
 Identities = 56/287 (19%), Positives = 98/287 (34%), Gaps = 35/287 (12%)

Query: 315 KKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTIG 369
           KK   +F     LG+G F TV        ++E A+K + +              E   + 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
            L H   VKL     +         Y  NG L K+I    +         +         
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--------FDETC---TRF 112

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
            T++ +  L     K ++HRD+K  NI+L+ + + ++ DFG A+ +              
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-SKQARANSFV 171

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GT  Y++PE      A   +D++A G +I ++  G  P     +      I+   ++   
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231

Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
           K              F  K  + V          +   R   + +  
Sbjct: 232 K--------------FFPKARDLV----EKLLVLDATKRLGCEEMEG 260

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  167 bits (423), Expect = 3e-48
 Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 18/236 (7%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
            L FNF  F   N+  + F  +++V+ +  +QVT      P T   GRA+Y    Q+W  
Sbjct: 3   DLSFNFDKFV-PNQKNIIFQGDASVSTTGVLQVTKV--SKPTTTSIGRALYAAPIQIWDS 59

Query: 84  NKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQ 143
                A+F+T+F   +    +   +GLAF +A       +     +  +   ++  + +Q
Sbjct: 60  ITGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQ 119

Query: 144 IVAIEFDTKKSYEQ---DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
           I+A+EFDT         D +  H+G+DVNS+ SI+ V     +  NG    V + Y    
Sbjct: 120 IIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW---DWRNGEVADVVITYRAPT 176

Query: 199 QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAF 249
           +++TV ++   +  + +++  +DL   LPE V VGFS   G+    + + V SW F
Sbjct: 177 KSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 232

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  166 bits (421), Expect = 2e-47
 Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 47/295 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---------ETSRQGKQEFIAEVTTI 368
           N+ PK  LG+G    V + I +   KE AVK +          E  ++ ++  + EV  +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 369 GSLR-HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
             +  H N+++L         F LV++ M  G L  ++          +VTL+ ++   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--------TEKVTLSEKETRKI 115

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +    + +  LH   +  ++HRD+K  NI+LD + N +L DFG +  +          +E
Sbjct: 116 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----EKLRE 168

Query: 488 IAGTPGYMAPESFLVGRA------TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIV 541
           + GTP Y+APE               E D+++ GV++  +  G  P    +Q      I+
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228

Query: 542 HWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
              ++            S    ++S+   + V           P  R + +  L 
Sbjct: 229 SGNYQF----------GSPEWDDYSDTVKDLV----SRFLVVQPQKRYTAEEALA 269

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  164 bits (417), Expect = 2e-47
 Identities = 69/239 (28%), Positives = 107/239 (44%), Gaps = 25/239 (10%)

Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKS--AIQVTYDVR-GAPITNQSGRAIYKDQFQLWR 82
           +  FNF  F E ++  L+       KS   +++T   + G P+   +GRA+Y +  ++W 
Sbjct: 2   TQSFNFDHFEENSKE-LNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60

Query: 83  DNKNVKATFSTTFVLNILNQTAQP--GEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
                 A+F T F  NI    A P   +GL F +      P NS     G   G+     
Sbjct: 61  STTGNVASFETRFSFNITQPYAYPEPADGLTFFMV-----PPNSPQGEDGGNLGVFKPPE 115

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
                A+EFDT ++   D    H+G+DVNS+ S + +      L NG    V ++YD   
Sbjct: 116 GDNAFAVEFDTFQNTW-DPQVPHIGIDVNSIVSSKTLHF---QLENGGVANVVIKYDSPT 171

Query: 199 QNITVFVA---NMETPLLSEPIDLSEYLP--EKVFVGFSASTGDD---TQLNCVKSWAF 249
           + + V +A         LS  +DL +  P  E V VG SA+TG      + + + SW+F
Sbjct: 172 KILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSF 230

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 22/237 (9%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYD-VRGAPITNQSGRAIYKDQFQLW 81
           + ++FNFQ F E N   L    +++V+ S  +++T     G P     GRA Y    Q+W
Sbjct: 2   NDIYFNFQRFNETN---LILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW 58

Query: 82  RDNKNVKATFSTTFVLNILNQT-AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
            +     A+F+T+F  NI     A P +GLAF +      P   +G +LG+ +G  +   
Sbjct: 59  DNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGSNS--- 114

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
               VA+EFDT  + + D  + H+G+DVNS+ SI+       +  NG + +V + YD   
Sbjct: 115 NFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW---DFVNGENAEVLITYDSST 171

Query: 201 ITVFVA-----NMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
             +  +        + ++S+ +DL   LPE V VGFSA+TG    + + N V SW+F
Sbjct: 172 NLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 75/235 (31%), Positives = 112/235 (47%), Gaps = 15/235 (6%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
            SL F+F  F       ++  ++ V  +  +Q+T  V G P +   GRA+Y   FQ+W  
Sbjct: 2   GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
                A+F T+F   I     A   +GLAF +A     P +  G  LGI          +
Sbjct: 62  TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDL-GGMLGIFKD-GYFNKSN 119

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNIT 202
           QIVA+EFDT  + + D    H+G++VNS+ SI+ VP    N  NG    V + Y+    +
Sbjct: 120 QIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW---NWTNGEVANVFISYEASTKS 176

Query: 203 VFVA-----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
           +  +        + ++   +D+   LPE V  GFSA+TG D    Q N V SW+F
Sbjct: 177 LTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSF 231

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  163 bits (414), Expect = 7e-47
 Identities = 67/236 (28%), Positives = 117/236 (49%), Gaps = 19/236 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWR 82
               F+F++F   +        ++TV+ S +++T     G P  +  GRA Y    Q++ 
Sbjct: 2   DIQSFSFKNFNSSS---FILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYD 58

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
            +    A+++T+F  NI     +   +G+AF +      P  S   +LG+ +      N 
Sbjct: 59  KSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDS-DVYDNS 116

Query: 142 SQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--Q 199
           +Q VA+EFDT  + + D    H+G+DVNS+ SIR        LANG + ++ + Y+    
Sbjct: 117 AQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTAS---WGLANGQNAEILITYNAATS 173

Query: 200 NITVFVANMET---PLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
            +   + +       ++SE +D++  LPE V +GFSA+TG     T+ + V SW+F
Sbjct: 174 LLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 2e-46
 Identities = 62/317 (19%), Positives = 114/317 (35%), Gaps = 43/317 (13%)

Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE-FIAEVTTI 368
           K+ +     ++ ++ LG G F  V     +   K +A+K +++ + +GK+     E+  +
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 369 GSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
             ++H N+V L           L+ + +  G L   I       G             +I
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGF----YTERDASRLI 113

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIML---DSEFNARLGDFGLARTIQENLKTHHST 485
                A+ YLH   +  ++HRD+K  N++    D +    + DFGL++            
Sbjct: 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVL 166

Query: 486 KEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW 545
               GTPGY+APE       +   D ++ GV+   + CG  P            I+   +
Sbjct: 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 226

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--------V 597
           E           DS    + S+   + +          +P  R + +  LQ         
Sbjct: 227 EF----------DSPYWDDISDSAKDFI----RHLMEKDPEKRFTCEQALQHPWIAGDTA 272

Query: 598 LSGEADPPVLPPERPSF 614
           L       V    + +F
Sbjct: 273 LDKNIHQSVSEQIKKNF 289

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (411), Expect = 4e-46
 Identities = 61/291 (20%), Positives = 111/291 (38%), Gaps = 35/291 (12%)

Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS---ETSRQGKQEFIAEVTTIGSLR 372
           +  +     LG GG   V+       ++++AVK +             F  E     +L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 373 HRNLVKLIGWCYERHD----FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           H  +V +               +V EY+   +L   +  +          +  ++ + VI
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--------MTPKRAIEVI 117

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
               QAL++ H   +  ++HRD+K +NIM+ +    ++ DFG+AR I ++  +   T  +
Sbjct: 118 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
            GT  Y++PE          +D+Y+ G ++ EV  G  P          +S V   ++  
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-------FTGDSPVSVAYQHV 227

Query: 549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-SMKTVLQVL 598
           R+  I  +A        S      V    L     NP  R  +   +   L
Sbjct: 228 REDPIPPSARHE---GLSADLDAVV----LKALAKNPENRYQTAAEMRADL 271

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  161 bits (407), Expect = 8e-46
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 20/236 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVT-YDVRGAPITNQSGRAIYKDQFQLW 81
            ++ F++  F  +  N +    ++ V  S  +Q+   D  G P  +  GRA+Y     +W
Sbjct: 2   ETVSFSWNKFVPKQPN-MILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60

Query: 82  RDNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTN 140
                  A+F+ +F        T +  +GLAF +A     P  +   +LG+ N   +G  
Sbjct: 61  DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNENESGDQ 119

Query: 141 QSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
              +VA+EFDT ++   D  + H+G++VNS+ SI+       +LAN    KV + YD   
Sbjct: 120 ---VVAVEFDTFRNSW-DPPNPHIGINVNSIRSIKTTSW---DLANNKVAKVLITYDAST 172

Query: 199 QNITVFVANMET---PLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAF 249
             +   +         +LS+ +DL   LPE V +GFSA+TG D   + + V SW+F
Sbjct: 173 SLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSF 228

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 62/316 (19%), Positives = 109/316 (34%), Gaps = 27/316 (8%)

Query: 318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQG-KQEFIAEVTTIGSLRHR 374
              +   + +G+G +G V           +A+K++S    Q   Q  + E+  +   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           N++ +           +   Y+    +   ++     +      L+ +     ++   + 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQH----LSNDHICYFLYQILRG 121

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           L Y+H      VLHRD+K SN++L++  + ++ DFGLAR    +        E   T  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 495 MAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
            APE  L  +  T   DI++ G ++ E+   R            N I+  L    ++   
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 554 LDAADSRLGGEFSEKEMECVLI-------------LGLACCHPNPHLRPSMKTVLQ--VL 598
                       S      V               L       NPH R  ++  L    L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 599 SGEADPPVLPPERPSF 614
               DP   P     F
Sbjct: 299 EQYYDPSDEPIAEAPF 314

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 36/289 (12%)

Query: 312 KELKKATGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIG 369
           KEL      +     LG+G FG V++ +     K    K V       +     E++ + 
Sbjct: 1   KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56

Query: 370 SLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
             RHRN++ L        + ++++E++    + + I    T++      LN  + +S +H
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAFE----LNEREIVSYVH 109

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNAR--LGDFGLARTIQENLKTHHSTKE 487
              +AL +LH      + H DI+  NI+  +  ++   + +FG AR     LK   + + 
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR----QLKPGDNFRL 162

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           +   P Y APE       +  TD+++ G L+  +  G  P           +I++  +  
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
                     D     E S + M+ V              R +    LQ
Sbjct: 223 ----------DEEAFKEISIEAMDFV----DRLLVKERKSRMTASEALQ 257

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  157 bits (399), Expect = 5e-45
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 20/235 (8%)

Query: 26  SLHFNFQSFTEQNRNELSFDNSTVAKS--AIQVTYDVRGAPITNQSGRAIYKDQFQLWRD 83
           S  F+F +F   N+N L      +  S   +++T    GAP+ +  GRA+Y     +   
Sbjct: 3   STSFSFTNFN-PNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH-- 59

Query: 84  NKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
           +    A+F+T+F   +     A   +GLAF +A     P  + G +LG+           
Sbjct: 60  DNTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQP-QARGGFLGLFAD-RAHDASY 117

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
           Q VA+EFDT  +   D N  H+G+D N + S +  P    ++  G    + + Y    + 
Sbjct: 118 QTVAVEFDTYSNAW-DPNYTHIGIDTNGIESKKTTPF---DMVYGEKANIVITYQASTKA 173

Query: 201 ITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
           +   +    +  +  +S  +DL + LPE V VGFSA+TG +    + + + SW+F
Sbjct: 174 LAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSF 228

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  156 bits (394), Expect = 3e-44
 Identities = 72/239 (30%), Positives = 116/239 (48%), Gaps = 19/239 (7%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTVAKS-AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
             L F   +F     + L F   ++V+ +  +Q+T    G P     GRA+Y    ++W 
Sbjct: 2   DELSFTINNFVPNEAD-LLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60

Query: 83  DNKNVKATFSTTFVLNILNQTAQ-PGEGLAFVIAG-NKDLPENSEGQWLGIVNGITNGTN 140
           +     A+FST+F   +         +GLAF +A  +  +P  S  ++LG+ N   N  +
Sbjct: 61  NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS-NSDS 119

Query: 141 QSQIVAIEFDTKKSYEQ---DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD 197
            +QIVA+EFDT  ++     D N  H+G+DVN + SI+ V     +  NG      + Y 
Sbjct: 120 SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW---DWINGGVAFATITYL 176

Query: 198 --GQNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD--DTQLNCVKSWAF 249
              + +   +    N  T  ++  +DL E LPE V VGFSA+TG   + + + V SW+F
Sbjct: 177 APNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  155 bits (393), Expect = 4e-44
 Identities = 73/234 (31%), Positives = 115/234 (49%), Gaps = 19/234 (8%)

Query: 25  SSLHFNFQSFTEQNRNELSF--DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
            ++ FNF SF+E N   ++F  D + ++   IQ+T   +     N  GR +Y    ++W 
Sbjct: 2   ETVSFNFNSFSEGNPA-INFQGDVTVLSNGNIQLTNLNK----VNSVGRVLYAMPVRIWS 56

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                 A+F T+F   + +     P +G+ F IA          G   G   G+++    
Sbjct: 57  SATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQI--PAGSIGGGTLGVSDTKGA 114

Query: 142 SQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQN 200
              V +EFDT  + E  D   +HVG+DVNSV S++ VP    N  +G  +KV V YD   
Sbjct: 115 GHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---NSVSGAVVKVTVIYDSST 171

Query: 201 ITVFVA----NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAF 249
            T+ VA    N +   +++ +DL   LPE+V  GFSAS      Q++ ++SW+F
Sbjct: 172 KTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSF 225

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  155 bits (392), Expect = 7e-44
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 15/235 (6%)

Query: 26  SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
            L F F++F++  ++ LSF  N++V ++ +     V         G A Y     +W  N
Sbjct: 3   DLSFKFKNFSQNGKD-LSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN 61

Query: 85  KNVKATFSTTFVLNILNQT--AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
               A+F T+F   +          +GL F +A   D P    G + G+ N  T   +  
Sbjct: 62  TGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFND-TKCDSSY 119

Query: 143 QIVAIEFDTKKSYEQ--DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYD--G 198
           Q VA+EFDT  S     D    H+G+DVN V SI      +          V++ Y+   
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNK-RYGLNNVANVEIIYEASS 178

Query: 199 QNITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAF 249
           + +T  +          ++  +DL E LPE V VGFS ST       + V +W F
Sbjct: 179 KTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYF 233

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (392), Expect = 5e-43
 Identities = 65/341 (19%), Positives = 122/341 (35%), Gaps = 52/341 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHR 374
           +F     LG G FG V+    R   +  A+K + +      +  +    E   +  + H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            ++++ G   +     ++ +Y+  G L   +   +          N   +        + 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-------NPVAKFYAA----EV 113

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
              L     K +++RD+K  NI+LD   + ++ DFG A+ + +   T      + GTP Y
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGTPDY 167

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           +APE           D ++FG+LI E+  G  P   S        I++            
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF---- 223

Query: 555 DAADSRLGGEFSEKEMECVLILGLACCHPN---PHLRPSMKTVLQ-----------VLSG 600
                     F+E   +  L+  L     +    +L+   + V             +LS 
Sbjct: 224 ----------FNEDVKD--LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR 271

Query: 601 EADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDL 641
             + P  PP +      +    + E D  +     DP++DL
Sbjct: 272 NIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADL 312

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  154 bits (391), Expect = 2e-42
 Identities = 63/347 (18%), Positives = 115/347 (33%), Gaps = 56/347 (16%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTI---GSL 371
           +F+    +G+GGFG VY        K  A+K + +     +QG+   + E   +    + 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 372 RHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
               +V +    +       + + M  G L   +              +           
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--------SEADMRFYAAEI 116

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGT 491
              L+++H    + V++RD+K +NI+LD   + R+ D GLA    +            GT
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGT 168

Query: 492 PGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK 550
            GYMAPE    G A     D ++ G ++ ++  G  P  Q           H +  +   
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-----KTKDKHEIDRMTLT 223

Query: 551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM-----KTVLQ--------- 596
             +          E  +     +  L       + + R        + V +         
Sbjct: 224 MAV----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273

Query: 597 --VLSGEADPPVLPPERPSFVWPAMPPSFVESDYTHTGSQLDPFSDL 641
             V   +  PP++PP        A      + + T     LD   +L
Sbjct: 274 QMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQEL 320

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-42
 Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 26/298 (8%)

Query: 316 KATGNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSRQGKQE-----FIAEVTT 367
           +A   +    ++G+G +G V+K        + +A+KRV   + +          +A +  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 368 IGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSV 427
           + +  H N+V+L   C            +    +D+ +             +  E    +
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDM 121

Query: 428 IHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKE 487
           +    + LD+LH     RV+HRD+K  NI++ S    +L DFGLAR          +   
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF----QMALTS 174

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVH----- 542
           +  T  Y APE  L        D+++ G +  E+   +     S        I+      
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234

Query: 543 ----WLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
               W  ++    +   +  ++   +F     E    L L C   NP  R S  + L 
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 60/292 (20%), Positives = 112/292 (38%), Gaps = 29/292 (9%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRNL 376
            ++   K+G+G +G VYK      +  A+K++   +         I E++ +  L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           VKL    + +   +LV+E++                   E  L      S +      + 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--------EGGLESVTAKSFLLQLLNGIA 114

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
           Y H   ++RVLHRD+K  N++++ E   ++ DFGLAR     ++ +        T  Y A
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWYRA 168

Query: 497 PESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW---------- 545
           P+  +   + +   DI++ G +  E+  G        +      I   L           
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 546 -ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            EL +        +      F +   E  + L       +P+ R + K  L+
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 44/289 (15%), Positives = 95/289 (32%), Gaps = 31/289 (10%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
             +    K+G G FG +Y G      +E+A+K     ++    +   E      ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  I WC    D+ ++   +   SL+    +            + +  L +       ++
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-------FSLKTVLLLADQMISRIE 117

Query: 437 YLHNGSEKRVLHRDIKSSNIM---LDSEFNARLGDFGLARTIQEN----LKTHHSTKEIA 489
           Y+H    K  +HRD+K  N +           + DFGLA+  ++        +   K + 
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 490 GTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR 549
           GT  Y +  + L    +   D+ + G +++    G  P    +  +              
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------ 228

Query: 550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVL 598
             + +      L   +  +    +      C       +P    + Q+ 
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-41
 Identities = 61/291 (20%), Positives = 109/291 (37%), Gaps = 34/291 (11%)

Query: 325 NKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE-----FIAEVTTIGSLRHRNLV 377
           + LG+G F TVYK   +  N+ +A+K++    R   ++      + E+  +  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 378 KLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDY 437
            L+     + +  LV+++M                    + L      + +  T Q L+Y
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD--------NSLVLTPSHIKAYMLMTLQGLEY 115

Query: 438 LHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAP 497
           LH   +  +LHRD+K +N++LD     +L DFGLA++     + +        T  Y AP
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ---VVTRWYRAP 169

Query: 498 ESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-----------W 545
           E     R   +  D++A G ++ E+                  I   L            
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            L             L   FS    + + ++       NP  R +    L+
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI-QGLFLFNPCARITATQALK 279

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 8e-41
 Identities = 60/307 (19%), Positives = 110/307 (35%), Gaps = 50/307 (16%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTIG-SLRH 373
           +F     LGKG FG V+   ++  N+  A+K + +         +  + E   +  +  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 374 RNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQ 433
             L  +      + +   V EY+  G L   I              +  +          
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--------SCHKFDLSRATFYAAEIIL 114

Query: 434 ALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
            L +LH    K +++RD+K  NI+LD + + ++ DFG+ +         ++     GTP 
Sbjct: 115 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPD 168

Query: 494 YMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI 553
           Y+APE  L  +     D ++FGVL+ E+  G+ P        ++      L+   R    
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--------FHGQDEEELFHSIRMDNP 220

Query: 554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL------------QVLSGE 601
                      +     +    L +      P  R  ++  +            ++   E
Sbjct: 221 ----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKE 270

Query: 602 ADPPVLP 608
            DPP  P
Sbjct: 271 IDPPFRP 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-40
 Identities = 67/293 (22%), Positives = 111/293 (37%), Gaps = 29/293 (9%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVK--RVSETSRQGKQEFIAEVTTIGSLRHRN 375
           NF    K+G+G +G VYK   +   + +A+K  R+   +       I E++ +  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +VKL+   +  +   LV+E++         F D +        +      S +    Q L
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTG----IPLPLIKSYLFQLLQGL 115

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            + H     RVLHRD+K  N+++++E   +L DFGLAR     ++T+        T  Y 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE---VVTLWYR 169

Query: 496 APESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL 554
           APE  L     +   DI++ G +  E+   R       +      I   L          
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 555 DAADSRLGGEFSEKEMECV-----------LILGLACCHPNPHLRPSMKTVLQ 596
             +       F +   +               L     H +P+ R S K  L 
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-40
 Identities = 55/306 (17%), Positives = 107/306 (34%), Gaps = 39/306 (12%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGK--QEFIAEVTTIGSLRHR 374
             +    K+G+G FG V+K   R   +++A+K+V   + +       + E+  +  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 375 NLVKLIGWCYE--------RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLS 426
           N+V LI  C          +    LV+++  +                  V     +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--------LVKFTLSEIKR 121

Query: 427 VIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHS-T 485
           V+      L+ L+     ++LHRD+K++N+++  +   +L DFGLAR       +  +  
Sbjct: 122 VMQ---MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 486 KEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL 544
                T  Y  PE  L  R      D++  G ++ E+         + +      I    
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 545 -------------WELRRKGRILDAADSRLGGEFSEKEMECVLI-LGLACCHPNPHLRPS 590
                        +EL  K  ++     ++         +   + L       +P  R  
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 591 MKTVLQ 596
               L 
Sbjct: 299 SDDALN 304

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 29/237 (12%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKS--AIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
           +   FN ++F + N   L         S   + +T         +  GRA Y    Q+  
Sbjct: 2   NDASFNVETFNKTN---LILQGDATVSSEGHLLLTNV--KGNEEDSMGRAFYSAPIQIND 56

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
              +  A+FST F   I  +       GLAF +      P   +G++LG+ N        
Sbjct: 57  RTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT------- 108

Query: 142 SQIVAIEFDTKKSY-EQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
                 + D        D   N + +DVNS+  I           NG   +V++ YD   
Sbjct: 109 ---TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNF-GHNNGEKAEVRITYDSPK 164

Query: 199 QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAF 249
            ++ V +    + E   +S  + L + + + V VGFSA++G     T+ + V SW+F
Sbjct: 165 NDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSF 221

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-40
 Identities = 62/308 (20%), Positives = 111/308 (36%), Gaps = 52/308 (16%)

Query: 321 FNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV------SETSRQGKQEFIAEVTTIGSLR 372
           ++   +LG G F  V K   +    + A K +      S      +++   EV+ +  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTS 432
           H N++ L      + D +L+ E +  G L  F+   E+        L  E+    +    
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--------LTEEEATEFLKQIL 123

Query: 433 QALDYLHNGSEKRVLHRDIKSSNIMLDSE----FNARLGDFGLARTIQENLKTHHSTKEI 488
             + YLH     ++ H D+K  NIML          ++ DFGLA  I    +  +    I
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----I 176

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR 548
            GTP ++APE        +E D+++ GV+   +  G  P     +     ++    +E  
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVL-----------QV 597
            +              FS         +       +P  R +++  L           Q 
Sbjct: 237 DE-------------YFSNTSALAKDFI-RRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282

Query: 598 LSGEADPP 605
           LS     P
Sbjct: 283 LSSAWSHP 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 59/317 (18%), Positives = 107/317 (33%), Gaps = 39/317 (12%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV 377
           ++     +G G FG VY+       + +A+K+V     Q K+    E+  +  L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76

Query: 378 KLIGWCYERHD------FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGT 431
           +L  + Y   +        LV +Y+P         Y        + TL        ++  
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-----AKQTLPVIYVKLYMYQL 131

Query: 432 SQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTKEIAG 490
            ++L Y+H      + HRDIK  N++LD +    +L DFG A+ +               
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---- 184

Query: 491 TPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKP---GNQSEQ--------NSYNN 538
           +  Y APE        T   D+++ G ++ E+  G+      +  +Q         +   
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244

Query: 539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ-- 596
             +  +     + +            F  +     + L        P  R +        
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304

Query: 597 VLSGEADPPVLPPERPS 613
                 DP V  P    
Sbjct: 305 FFDELRDPNVKLPNGRD 321

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 38/280 (13%)

Query: 327 LGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWC 383
           LG G  G V +   +   ++ A+K + +       +   EV       +  ++V+++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 384 Y----ERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLH 439
                 R   L+V E +  G L   I         G+      +   ++    +A+ YLH
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 440 NGSEKRVLHRDIKSSNIMLDSEFN---ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMA 496
                 + HRD+K  N++  S+      +L DFG A+        H+S      TP Y+A
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS----HNSLTTPCYTPYYVA 181

Query: 497 PESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA 556
           PE     +     D+++ GV++  + CG  P      +++  +I   +    R G+    
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQY--E 235

Query: 557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
             +    E SE   E  +++        P  R ++   + 
Sbjct: 236 FPNPEWSEVSE---EVKMLI-RNLLKTEPTQRMTITEFMN 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 8e-39
 Identities = 63/290 (21%), Positives = 104/290 (35%), Gaps = 51/290 (17%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQE------FIAEVTTIGS 370
             +     LG GGFG+VY GI    N  +A+K V +       E         EV  +  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 371 LR--HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           +      +++L+ W      F+L+ E             +          L  E   S  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFF 116

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLD-SEFNARLGDFGLARTIQENLKTHHSTKE 487
               +A+ + H      VLHRDIK  NI++D +    +L DFG    +++ + T      
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----- 168

Query: 488 IAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE 546
             GT  Y  PE     R       +++ G+L+ ++ CG  P    E+      I+     
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVF 222

Query: 547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ 596
            R++               S    EC  ++   C    P  RP+ + +  
Sbjct: 223 FRQR--------------VSS---ECQHLI-RWCLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 43/292 (14%), Positives = 96/292 (32%), Gaps = 33/292 (11%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
            ++    ++G+G FG +++G     N+++A+K      R    +   E  T   L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALD 436
           +  + +  +     ++   +   SL+  +              + +            + 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQ 115

Query: 437 YLHNGSEKRVLHRDIKSSNIMLDSEFN-----ARLGDFGLARTIQENLKT----HHSTKE 487
            +H   EK +++RDIK  N ++    +       + DFG+ +  ++ +      +   K 
Sbjct: 116 SIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           ++GT  YM+  + L    +   D+ A G + +    G  P    +  +            
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE------ 226

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS 599
               RI +   S    E      E          +      P    +  + S
Sbjct: 227 ----RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  138 bits (348), Expect = 7e-38
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 23/235 (9%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVR-GAPITNQSGRAIYKDQFQLWRD 83
           +   FNF +F   ++  L  + +  +K  +Q+T       P  +  GRA Y D  Q+   
Sbjct: 2   TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS 61

Query: 84  NKNVKATFSTTFVLNILNQTAQ-PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQS 142
           N    A+F+T F   I  +       GLAF +    + P   + ++LGI N   N    +
Sbjct: 62  NNV--ASFNTNFTFIIRAKNQSISAYGLAFALV-PVNSPPQKKQEFLGIFNT-NNPEPNA 117

Query: 143 QIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QN 200
           + VA+ F+T K+   D + N +   VN             +  NG    VQ+ YD    +
Sbjct: 118 RTVAVVFNTFKNR-IDFDKNFIKPYVNE--------NCDFHKYNGEKTDVQITYDSSNND 168

Query: 201 ITVFVANM---ETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           + VF+          +S  + L + + E V VGFS ++G   D T+ + V SW+F
Sbjct: 169 LRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSF 223

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 57/333 (17%), Positives = 112/333 (33%), Gaps = 40/333 (12%)

Query: 309 FRLKELKKATGNFNPK----NKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQE 360
           F  +E+ K              +G G +G V   +      ++A+K++     S    + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 361 FIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLN 420
              E+  +  +RH N++ L+             ++                       L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LG 119

Query: 421 WEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLK 480
            ++   +++   + L Y+H      ++HRD+K  N+ ++ +   ++ DFGLAR     + 
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176

Query: 481 THHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNS 539
            +        T  Y APE  L   R T   DI++ G ++ E+  G+     S+       
Sbjct: 177 GYV------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230

Query: 540 IVHWL-----WELRRKGRILDAADSRLGGEFSEKEMECVLI--------LGLACCHPNPH 586
           I+          ++R          +   E  +K+   +L         L       +  
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290

Query: 587 LRPSMKTVL-----QVLSGEADPPVLPPERPSF 614
            R +    L     + L    D P +     SF
Sbjct: 291 QRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 323

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 19/213 (8%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHR 374
           +F+    LGKG FG V     +   +  A+K + +    ++      + E   + + RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            L  L            V EY   G L   +             +  E+R       ++ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---------RERVFTEERARFY--GAEI 114

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
           +  L     + V++RDIK  N+MLD + + ++ DFGL +    +     + K   GTP Y
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTPEY 171

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE           D +  GV++ E+ CGR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 57/294 (19%), Positives = 112/294 (38%), Gaps = 31/294 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRV--SETSRQGKQEFIAEVTTIGSLRHRN 375
            +    K+G+G +GTV+K   R  ++ +A+KRV   +         + E+  +  L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 376 LVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQAL 435
           +V+L    +      LV+E+        F   +           + E   S +    + L
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--------DPEIVKSFLFQLLKGL 114

Query: 436 DYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYM 495
            + H+   + VLHRD+K  N++++     +L +FGLAR     ++ +        T  Y 
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS---AEVVTLWYR 168

Query: 496 APESFLVGRA-TIETDIYAFGVLILEVACGRKP---GNQSEQNSYNNSIVHWLWELRRKG 551
            P+     +  +   D+++ G +  E+A   +P   GN  +        +       +  
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 552 RILDAADSRLGGEFSEKEMECVLILGL---------ACCHPNPHLRPSMKTVLQ 596
            +    D +    +        ++  L              NP  R S +  LQ
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (328), Expect = 5e-34
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 22/213 (10%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSE---TSRQGKQEFIAEVTTIGSLRHR 374
            F+    LG G FG V     +      A+K + +      +  +  + E   + ++   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
            LVKL     +  +  +V EY+  G +   +       G      +              
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGR----FSEPHARFYAAQIVLT 153

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGY 494
            +YLH      +++RD+K  N+++D +   ++ DFG A+ ++    T        GTP  
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTPEA 204

Query: 495 MAPESFLVGRATIETDIYAFGVLILEVACGRKP 527
           +APE  L        D +A GVLI E+A G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 58/335 (17%), Positives = 112/335 (33%), Gaps = 57/335 (17%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHR 374
             +     +G G  G V        ++ +A+K++S    ++   +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 375 NLVKLIGWC------YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVI 428
           N++ L+          E  D  LV E M                       + E+   ++
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLL 125

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEI 488
           +     + +LH      ++HRD+K SNI++ S+   ++ DFGLART   +          
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP----Y 178

Query: 489 AGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL---- 544
             T  Y APE  L        DI++ G ++ E+   +      +     N ++  L    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 545 --------------------WELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPN 584
                               +      ++   +      E ++ +      L       +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 585 PHLRPSMKTVLQ-----VLSGEADPPVLPPERPSF 614
           P  R S+   LQ     V    A+    PP+    
Sbjct: 299 PAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDK 333

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 53/304 (17%), Positives = 110/304 (36%), Gaps = 48/304 (15%)

Query: 320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNL 376
           ++    KLG+G +  V++ I    N+++ VK +       K++   E+  + +LR   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92

Query: 377 VKLIGWCYER--HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQA 434
           + L     +       LV+E++ N    +              TL        ++   +A
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----------TLTDYDIRFYMYEILKA 141

Query: 435 LDYLHNGSEKRVLHRDIKSSNIMLDSEFN-ARLGDFGLARTIQENLKTHHSTKEIAGTPG 493
           LDY H      ++HRD+K  N+M+D E    RL D+GLA       + +        +  
Sbjct: 142 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVASRY 194

Query: 494 YMAPESFL-VGRATIETDIYAFGVLILEVACGRKP-------GNQSEQNSYNNSIVHWLW 545
           +  PE  +         D+++ G ++  +   ++P        +Q  + +          
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLA-------------CCHPNPHLRPSMK 592
            + +    LD   + + G  S K  E  +                      +   R + +
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 593 TVLQ 596
             ++
Sbjct: 315 EAME 318

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  120 bits (303), Expect = 1e-31
 Identities = 37/115 (32%), Positives = 56/115 (48%), Gaps = 8/115 (6%)

Query: 143 QIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ-- 199
            IVA+E DT  + +  D +  H+G+D+ SV S +       N+ NG      + Y+    
Sbjct: 3   TIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW---NMQNGKVGTAHIIYNSVDK 59

Query: 200 --NITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS 252
             +  V   N ++  +S  +DL   LPE V VG SASTG   + N + SW+F   
Sbjct: 60  RLSAVVSYPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 87.3 bits (216), Expect = 5e-20
 Identities = 30/121 (24%), Positives = 61/121 (50%), Gaps = 4/121 (3%)

Query: 16  MGSAAHIQVSSLHFNFQSFTEQNRNELSFDNSTVA-KSAIQVT-YDVRGAPITNQSGRAI 73
           + S +  + ++LHF F  F++  ++ +   ++T      +++T     G+P  +  GRA+
Sbjct: 115 LKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRAL 174

Query: 74  YKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAG-NKDLPENSEGQWLGIV 132
           +     +W  +  V A+F  TF   I +  + P +G+AF I+  +  +P  S G+ LG+ 
Sbjct: 175 FYAPVHIWESSAVV-ASFEATFTFLIKSPDSHPADGIAFFISNIDSSIPSGSTGRLLGLF 233

Query: 133 N 133
            
Sbjct: 234 P 234

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-31
 Identities = 63/340 (18%), Positives = 119/340 (35%), Gaps = 52/340 (15%)

Query: 308 KFRLKELKKA----TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVS--ETSRQGKQ 359
            F  +EL K        +   + +G G +G+V           +AVK++S    S    +
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 360 EFIAEVTTIGSLRHRNLVKLIGWCYERHDF-----LLVYEYMPNGSLDKFIFYDETNSGP 414
               E+  +  ++H N++ L+              + +  ++    L+  +   +     
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----- 117

Query: 415 GEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART 474
               L  +    +I+   + L Y+H      ++HRD+K SN+ ++ +   ++ DFGLAR 
Sbjct: 118 ----LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170

Query: 475 IQENLKTHHSTKEIAGTPGYMAPESFL-VGRATIETDIYAFGVLILEVACGRKPGNQSEQ 533
             + +  + +      T  Y APE  L         DI++ G ++ E+  GR     ++ 
Sbjct: 171 TDDEMTGYVA------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

Query: 534 NSYNNSIVHWLW----ELRRKGRILDAAD----------SRLGGEFSEKEMECVLILGLA 579
                 I+  +     EL +K     A +                F       V +L   
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL-EK 283

Query: 580 CCHPNPHLRPSMKTVLQ-----VLSGEADPPVLPPERPSF 614
               +   R +    L            D PV  P   SF
Sbjct: 284 MLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSF 323

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 55/294 (18%), Positives = 101/294 (34%), Gaps = 41/294 (13%)

Query: 320 NFNPKNKLGKGGFGTVYKGI-----WRNKEIAVKRVSETS----RQGKQEFIAEVTTIGS 370
           NF     LG G +G V+           K  A+K + + +     +  +    E   +  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 371 LRHR-NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
           +R    LV L           L+ +Y+  G L   +   E  +              V  
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----------EVQI 133

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIA 489
              + +  L +  +  +++RDIK  NI+LDS  +  L DFGL++    +        +  
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFC 191

Query: 490 GTPGYMAPESFLVGRATI--ETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
           GT  YMAP+    G +      D ++ GVL+ E+  G  P     + +    I   + + 
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 250

Query: 548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSM--KTVLQVLS 599
                    ++     E S    + +          +P  R     +   ++  
Sbjct: 251 ---------SEPPYPQEMSALAKDLI----QRLLMKDPKKRLGCGPRDADEIKE 291

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  114 bits (287), Expect = 6e-30
 Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 50/237 (21%)

Query: 25  SSLHFNFQSFTEQNRNELSFD-NSTV-AKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWR 82
           +   F   +F + N   L    ++TV +   +Q++Y+       +   RA Y    Q+  
Sbjct: 2   TETSFIIDAFNKTN---LILQGDATVSSNGNLQLSYNSY-----DSMSRAFYSAPIQIRD 53

Query: 83  DNKNVKATFSTTFVLNILNQ-TAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQ 141
                 A+F T F +NI     A    GL FV+   +   +                   
Sbjct: 54  STTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESKG------------------ 95

Query: 142 SQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG-- 198
              V +EFDT  S    D+N+N +      V+             +G + +V++ Y+   
Sbjct: 96  -DTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDY-----------DGQNAEVRITYNSST 143

Query: 199 QNITVFVANMETP---LLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAF 249
           +  +V ++N  T     +S  ++L + + + V VGFSA++G      + + V SW+F
Sbjct: 144 KVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 9e-26
 Identities = 43/246 (17%), Positives = 73/246 (29%), Gaps = 15/246 (6%)

Query: 319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL 376
             +    KLG G F TV+       N  +A+K V    +   +    E+  +  +   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADN 71

Query: 377 VKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGP--------GEVTLNWEKRLSVI 428
            K           LL +      +    +   E                 +       + 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 429 HGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARLGDFGLARTIQENLKTHHSTKE 487
                 LDY+H      ++H DIK  N++++       L    +A               
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHYTN 188

Query: 488 IAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL 547
              T  Y +PE  L        DI++   LI E+  G       E +SY     H    +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 548 RRKGRI 553
              G +
Sbjct: 249 ELLGEL 254

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.6 bits (219), Expect = 2e-20
 Identities = 35/238 (14%), Positives = 78/238 (32%), Gaps = 42/238 (17%)

Query: 29  FNFQSFTEQNRNELSF----DNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
           F       Q+   + F     N+  +   I++   ++     +Q G    K +       
Sbjct: 11  FKG-PHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLK-----SQRGSVWTKTKAAF---- 60

Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQI 144
                 +       +  +     +GLA     N+      +G   G         +    
Sbjct: 61  ----ENWEVEVTFRVTGRGRIGADGLAIWYTENQ----GLDGPVFG-------SADMWNG 105

Query: 145 VAIEFDTKKSYEQ--------DINDNHVGLDVNSVYSIRQVPLTRVNLAN-GTDIKVQVR 195
           V I FD+  +  +          N+  +  D  +  + + +   + +  N    ++ ++ 
Sbjct: 106 VGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKIT 165

Query: 196 YDGQNITVFVANMETPLLSEPI----DLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           Y  + +TV + N  TP  ++        +  +P +   G SA+TG     + V S+  
Sbjct: 166 YYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.6 bits (198), Expect = 4e-18
 Identities = 26/169 (15%), Positives = 50/169 (29%), Gaps = 34/169 (20%)

Query: 325 NKLGKGGFGTVYKGI-WRNKEIAVK----------RVSETSRQGKQEFIAEVTTIGSLRH 373
             +G+G    V+     +  E  VK          +V E    G   F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 374 RNLVKL----IGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIH 429
           R L KL    +   Y      ++ E +    L +                  E    V+ 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------------RVENPDEVLD 110

Query: 430 GTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN 478
              + +   +    + ++H D+   N+++  E    + DF  +  + E 
Sbjct: 111 MILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE 155

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 26/214 (12%), Positives = 58/214 (27%), Gaps = 25/214 (11%)

Query: 33  SFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFS 92
           S  +        +N    + A      +      N  G    K  F L          F+
Sbjct: 11  SLPDLINTRKVPNNWQTGEQASLEEGRIVLTSNQNSKGSLWLKQGFDLKDS-------FT 63

Query: 93  TTFVLNILNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTK 152
             +    +  + Q   G++F    + ++P + +           NG      + +  D  
Sbjct: 64  MEWTFRSVGYSGQTDGGISFWFVQDSNIPRDKQL---------YNGPVNYDGLQLLVDNN 114

Query: 153 KSYEQDI----NDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQNITVFV--A 206
                 +    ND    +D   +Y             +     ++V YD ++  +     
Sbjct: 115 GPLGPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQV 174

Query: 207 NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQ 240
           + +    +  +           +G +A  G    
Sbjct: 175 DNKVCFQTRKVRFP---SGSYRIGVTAQNGAVNN 205

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 25/232 (10%), Positives = 56/232 (24%), Gaps = 28/232 (12%)

Query: 25  SSLHFNFQSFTEQNRNELSFDNSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDN 84
            +  ++  +  E    +      T+              P  N  G    K ++ +    
Sbjct: 2   WNKGYSLPNLLEVTDQQKELSQWTLGDKVKLEEGRFVLTPGKNTKGSLWLKPEYSIKDA- 60

Query: 85  KNVKATFSTTFVLNILNQTAQPGEGLAFVIA-GNKDLPENSEGQWLGIVNGITNGTNQSQ 143
                  +  +             GLAF +  GN+       G      NG+        
Sbjct: 61  ------MTIEWTFRSFGFRGSTKGGLAFWLKQGNEGDSTELFGGSSKKFNGL-------- 106

Query: 144 IVAIEFDTKKSYEQDI----NDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDGQ 199
              I         + +    ND    LD+ S            +  +     +++ Y+  
Sbjct: 107 --MILLRLDDKLGESVTAYLNDGTKDLDIESSPYFASCLFQYQD--SMVPSTLRLTYNPL 162

Query: 200 NITVF--VANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF 249
           +  +     +      +  +           +G SA      +   +     
Sbjct: 163 DNHLLKLQMDNRVCFQTRKVKFM--GSSPFRIGTSAINDASKESFEILKMKL 212

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	644
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.94
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.92
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.7
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.67
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.72
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.19
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.03

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=7.7e-55  Score=431.14  Aligned_cols=226  Identities=29%  Similarity=0.520  Sum_probs=200.1

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCC
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQT  103 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~  103 (644)
                      +++|+|++|+.....+|.++ ||.+.+|.|+||+.... .+...++|||+|++||+|||+.+|+++||+|+|+|.|.++.
T Consensus         1 ~~sF~f~~F~~~~~~~l~l~G~A~~~~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~~   80 (236)
T d1hqla_           1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKITG   80 (236)
T ss_dssp             CCEEEESCSCSCGGGTEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEECS
T ss_pred             CEEEEeCCCCCCCcCCEEEeccEEecCCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCCC
Confidence            47999999987656689999 99999999999986542 23457899999999999999999999999999999999766


Q ss_pred             CCCCCceEEEEecCCCCCCCCCCcccccccccCCC-CCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCcc
Q 006446          104 AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNG-TNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       104 ~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      ..+||||||||+|... +.++.|++|||+|..+++ .+.+++|||||||++|.++ ||++||||||+||+.|..+.++..
T Consensus        81 ~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~~~  159 (236)
T d1hqla_          81 NGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWED  159 (236)
T ss_dssp             SCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEECCH
T ss_pred             CCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCccccccccccc
Confidence            6789999999999643 445789999999987654 4578999999999999887 999999999999999999988877


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEe--cCCCCCcccccCccCcCCCceeeeecccCCCc-ccccccccccccCC
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAFDGS  252 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~--~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~-~~~~~i~~wsf~ss  252 (644)
                      .++.+|+.++|||+||+  ++|+|++.  ++..|+|++.|||+++|+++|||||||+||.. .+.|+|++|+|+++
T Consensus       160 ~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~  235 (236)
T d1hqla_         160 SDIFSGKIATARISYDGSAEILTVVLSYPDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN  235 (236)
T ss_dssp             HHHTSCSCEEEEEEEETTTTEEEEEEEETTTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred             ccccCCCEEEEEEEEeCCCcEEEEEEecCCCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeEec
Confidence            88999999999999998  88999885  55667999999999999999999999999975 46689999999875

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=7.1e-54  Score=425.66  Aligned_cols=227  Identities=28%  Similarity=0.466  Sum_probs=200.3

Q ss_pred             cceeEEcCCCCCCC---CCCeEEe-cccccCCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEE
Q 006446           25 SSLHFNFQSFTEQN---RNELSFD-NSTVAKSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNI   99 (644)
Q Consensus        25 ~~~~f~f~~f~~~~---~~~l~~~-~a~~~~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i   99 (644)
                      .+++|+|++|+...   ..+|.++ +|.+.+|.|+||+...+ ++..+++|||+|++||+||++ |++++||+|+|+|.|
T Consensus         2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~i   80 (243)
T d1leda_           2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFLL   80 (243)
T ss_dssp             CCCEEEESCBCCTTSCTTTSEEEEETCEEETBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEEE
T ss_pred             CceEEEcCCCCCCCCCCCCcEEEeeeeEEcCCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEEc
Confidence            47899999998642   4689999 99999999999987653 345579999999999999995 899999999999988


Q ss_pred             ecCCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCC-CCccEEEEEEecCCCccC-CCCCCceeeecCCccceeee
Q 006446          100 LNQTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGT-NQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       100 ~~~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~  177 (644)
                      .+....+||||||||+|... +.+..|++|||++..++++ +.+|+|||||||++|.++ ||++||||||+|++.|..+.
T Consensus        81 ~~~~~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~~  159 (243)
T d1leda_          81 KNYGAPTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATT  159 (243)
T ss_dssp             EESSSSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCccccccc
Confidence            87666789999999999653 4567899999999877654 578999999999999887 99999999999999999999


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEe--cCCCCCcccccCccCcCCCceeeeecccCCCcccccccccccccCCc
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~--~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~  253 (644)
                      ++...++.+|+.++|||+||+  ++|+|++.  ++..|+|++.|||+++|+++||||||||||. .+.|+|++|+|+++.
T Consensus       160 ~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~h~I~sWsF~s~l  238 (243)
T d1leda_         160 RWENDDAYGSSIATAHITYDARSKILTVLLSYEHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSWHFFSTL  238 (243)
T ss_dssp             ECCHHHHTSCCEEEEEEEEETTTTEEEEEEEETTSCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEEEEEEEEEEEEEC
T ss_pred             ccccCCcccCceeEEEEEEECCCCEEEEEEeeCCCCCceEEEecCHHHhcCCcEEEEEEcccCC-cceeeEEEEEEEeeC
Confidence            987778999999999999999  88998884  6778899999999999999999999999995 599999999999876


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       239 ~  239 (243)
T d1leda_         239 D  239 (243)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=2.2e-51  Score=408.69  Aligned_cols=224  Identities=28%  Similarity=0.416  Sum_probs=194.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|+.. ..+|.++ ||.+. +|.|+||+...+ ....++|||+|++||+|||+.+++++||+|+|+|.|.. 
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~~~~~g~l~LT~~~~~-~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~   79 (240)
T d1fx5a_           2 DDLSFKFKNFSQN-GKDLSFQGNASVIETGVLQLNKVGNN-LPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETS   79 (240)
T ss_dssp             CEEEEEESSCCTT-CSSEEEEETCEECTTSCEESCCCSSS-SCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEES
T ss_pred             CceEEECCCCCCC-CCCEEEeeeeEecCCCEEEccCCCCC-CccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCC
Confidence            4789999999864 4689999 99875 789999987642 22468899999999999999999999999999999975 


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCc-cC-CCCCCceeeecCCccceeeec
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSY-EQ-DINDNHVGLDVNSVYSIRQVP  178 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~-~~-d~~~~Hvgid~ns~~s~~~~~  178 (644)
                       +...+||||||+|+|.. .|.++.|++|||+|..+ ++..+++|||||||++|. ++ ||++||||||+||+.|..+.+
T Consensus        80 ~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~  157 (240)
T d1fx5a_          80 ANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER  157 (240)
T ss_dssp             SCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCcccccccc
Confidence             34568999999999964 57789999999998644 456789999999999984 44 999999999999999998888


Q ss_pred             CcccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCC-cccccccccccccCC
Q 006446          179 LTRVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD-DTQLNCVKSWAFDGS  252 (644)
Q Consensus       179 ~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~-~~~~~~i~~wsf~ss  252 (644)
                      + ...+.+|+.++|||+||+  ++|.|++.   ++..|.|+..|||+.+|+++|||||||+||. ..+.|+|++|+|+++
T Consensus       158 ~-~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst  236 (240)
T d1fx5a_         158 W-NKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST  236 (240)
T ss_dssp             C-CCCCSGGGCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEEEE
T ss_pred             c-ccccCCCCeEEEEEEEcCCCCEEEEEEecCCCceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeEEe
Confidence            8 678889999999999998  78999986   4455689999999999999999999999995 568999999999887


Q ss_pred             c
Q 006446          253 D  253 (644)
Q Consensus       253 ~  253 (644)
                      .
T Consensus       237 ~  237 (240)
T d1fx5a_         237 F  237 (240)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-51  Score=425.87  Aligned_cols=267  Identities=21%  Similarity=0.436  Sum_probs=203.1

Q ss_pred             ccCHHHHHHHhCC---------CCCCCcccccCcEEEEEeeec--Cc---eEEEEEeecc-cchhhHHHHHHHHHHhccC
Q 006446          308 KFRLKELKKATGN---------FNPKNKLGKGGFGTVYKGIWR--NK---EIAVKRVSET-SRQGKQEFIAEVTTIGSLR  372 (644)
Q Consensus       308 ~~~~~~l~~a~~~---------f~~~~~LG~G~fG~Vy~g~~~--~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~  372 (644)
                      .++|+++..++.+         |+..++||+|+||+||+|++.  ++   .||||++... .....++|.+|+.+|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            3455566555544         444678999999999999985  22   4889988654 3445678999999999999


Q ss_pred             CCceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCC
Q 006446          373 HRNLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIK  452 (644)
Q Consensus       373 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlk  452 (644)
                      |||||+++|+|.+.+.+++|||||++|+|.+++.....       .++|.+++.++.|||+||+|||+   ++|+|||||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-------~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlK  155 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-------QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLA  155 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-------CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccc
Confidence            99999999999999999999999999999998875443       38999999999999999999999   999999999


Q ss_pred             CCCEEEcCCCcEEEeccCCcccccccccccc--cccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 006446          453 SSNIMLDSEFNARLGDFGLARTIQENLKTHH--STKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGN  529 (644)
Q Consensus       453 p~NILld~~~~vkL~DFGla~~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~  529 (644)
                      |+||||+.++++||+|||+++..........  ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.
T Consensus       156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            9999999999999999999997753322111  1223467999999999999999999999999999999998 899987


Q ss_pred             CCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          530 QSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       530 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .....    .+...+    ..+         .+...+......+.+|+.+||+.||++|||++||++.|+..
T Consensus       236 ~~~~~----~~~~~i----~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         236 DMTNQ----DVINAI----EQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             TCCHH----HHHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCHH----HHHHHH----HcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            64321    222211    111         11122233445678899999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=418.93  Aligned_cols=259  Identities=29%  Similarity=0.511  Sum_probs=203.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..++||+|+||+||+|++++ .||||+++..  ..+..+.|.+|+.++++++|||||+++|++.+ +++++|||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~   85 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC   85 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence            578889999999999999998765 5999998654  34556789999999999999999999999865 5689999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++.....       .++|.+++.++.|||+||+|||+   ++|+||||||+||||+.++++||+|||+|+...
T Consensus        86 ~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          86 EGSSLYHHLHIIET-------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             CEEEHHHHHHTSCC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             CCCCHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            99999999975543       38999999999999999999999   899999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .... ........||+.|||||++..   +.++.++|||||||++|||+||+.||.......   .+.    .....+..
T Consensus       156 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~----~~~~~~~~  227 (276)
T d1uwha_         156 RWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QII----FMVGRGYL  227 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHH----HHHHHTSC
T ss_pred             ccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHH----HHHhcCCC
Confidence            3222 222456689999999999864   358999999999999999999999997644321   111    11122211


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      .... ......+    .+.+.+|+.+||+.||++|||++||++.|+...
T Consensus       228 ~p~~-~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         228 SPDL-SKVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CCCG-GGSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcc-hhccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1100 1122223    346778899999999999999999999998653

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=7.3e-51  Score=404.40  Aligned_cols=222  Identities=31%  Similarity=0.554  Sum_probs=193.3

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      .+++|+|++|.+. ..+|.++ ||.+. +|.|+||+.+.  +...++|||+|++||+||++.+++++||+|+|+|.|.++
T Consensus         2 ~~lsF~f~~F~~~-~~~l~l~GdA~i~~~g~l~LT~~~~--~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~   78 (237)
T d1qnwa_           2 DDLSFNFDKFVPN-QKNIIFQGDASVSTTGVLQVTKVSK--PTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD   78 (237)
T ss_dssp             CSEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCCC----CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS
T ss_pred             CcEEEEcCCCCCC-CCCEEEeeceEEcCCCeEEeccCCC--CccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecC
Confidence            4789999999875 4689999 99875 78999998643  234689999999999999999999999999999999876


Q ss_pred             CCCCCCceEEEEecCC-CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC---CCCCCceeeecCCccceeeec
Q 006446          103 TAQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ---DINDNHVGLDVNSVYSIRQVP  178 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~---d~~~~Hvgid~ns~~s~~~~~  178 (644)
                      ...+||||||+|+|.. ..|.++.|+++|++|. .+..+.+++|||||||++|.++   ||++||||||+|++.|..+.+
T Consensus        79 ~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~-~~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~  157 (237)
T d1qnwa_          79 KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSS-SDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK  157 (237)
T ss_dssp             SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSS-SSCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE
T ss_pred             CCCCcceeEEEEeCCCCCCCCCCccccccccCC-CCCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCcccccc
Confidence            6778999999999954 4677889999999885 4456778999999999999764   699999999999999987776


Q ss_pred             CcccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCCcc--cccccccccccC
Q 006446          179 LTRVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAFDG  251 (644)
Q Consensus       179 ~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~--~~~~i~~wsf~s  251 (644)
                      +   ++.+|+.++|||+||+  ++|+|++.   +|..|+|++.|||+++|+++|||||||+||...  |.|+|++|+|++
T Consensus       158 ~---~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s  234 (237)
T d1qnwa_         158 W---DWRNGEVADVVITYRAPTKSLTVCLSYPSDGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS  234 (237)
T ss_dssp             C---CCCTTCCEEEEEEEEGGGTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEE
T ss_pred             c---ccCCCcEEEEEEEEcCCCcEEEEEEecCCCCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEE
Confidence            6   6789999999999999  88999985   556679999999999999999999999999864  789999999987


Q ss_pred             Cc
Q 006446          252 SD  253 (644)
Q Consensus       252 s~  253 (644)
                      +.
T Consensus       235 ~l  236 (237)
T d1qnwa_         235 NL  236 (237)
T ss_dssp             EC
T ss_pred             ec
Confidence            53

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=415.81  Aligned_cols=254  Identities=25%  Similarity=0.436  Sum_probs=197.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||+||+|++. +..||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            46777899999999999999987 5679999997644 345789999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....       .++|..++.++.|||+||.|||+   .+|+||||||+|||+|+++++||+|||+++....
T Consensus        84 ~g~L~~~l~~~~~-------~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          84 HGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             TCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             CCcHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccC
Confidence            9999999865443       38999999999999999999999   9999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||+|+..|+.....   ...+...+    ..+.     
T Consensus       154 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i----~~~~-----  219 (263)
T d1sm2a_         154 DQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDI----STGF-----  219 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHH----HHTC-----
T ss_pred             CCc--eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HhcC-----
Confidence            322  113446789999999999999999999999999999999996544433221   11222211    1111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          ....+......+.+|+.+||+.||++||||+||++.|+..
T Consensus       220 ----~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         220 ----RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                1112222335678899999999999999999999999864

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=2.3e-50  Score=400.25  Aligned_cols=219  Identities=34%  Similarity=0.595  Sum_probs=189.7

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec--
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN--  101 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~--  101 (644)
                      +++|+|++|..+ ..+|.+. ||.+. +|.|+||+...+.+..+++|||+|++||+|||+.+++++||+|+|+|.|..  
T Consensus         2 t~sF~f~~F~~~-~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~   80 (237)
T d2d3sa1           2 TISFNFNQFHQN-EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF   80 (237)
T ss_dssp             EEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred             eEEEEeCCCCCC-CCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCC
Confidence            689999999865 4689999 99986 679999987654444579999999999999999999999999999999975  


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      ....+||||||+|+|.. .+.++.|++||+++..    ..+++|||||||++| .+||++||||||+|++.|.+...+  
T Consensus        81 ~~~~g~dGlaFvl~p~~-~~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n-~~d~~~nHvgI~vns~~s~~~~~~--  152 (237)
T d2d3sa1          81 PRPHPADGLVFFIAPPN-TQTGEGGGYFGIYNPL----SPYPFVAVEFDTFRN-TWDPQIPHIGIDVNSVISTKTVPF--  152 (237)
T ss_dssp             CSSCCCEEEEEEEECSS-CCCCBCGGGTTTBCTT----SCCCCEEEEEECSCC-TTCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCeEEEEeCCCC-ccCCccccccccccCC----CcCceEEEEEEeecC-CCCCCCCcEEEEcCCCccccccce--
Confidence            44568899999999854 4556889999998753    457899999999999 579999999999999999877665  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCC-------cccccccccccc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGD-------DTQLNCVKSWAF  249 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~-------~~~~~~i~~wsf  249 (644)
                       ++.+|+.++|||+||+  ++|.|++..   +..|+++..+||+.+|+++|||||||+||.       ..|.|+|++|+|
T Consensus       153 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsF  231 (237)
T d2d3sa1         153 -TLDNGGIANVVIKYDASTKILHVVLVFPSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF  231 (237)
T ss_dssp             -CCCTTCEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEE
T ss_pred             -eecCCCEEEEEEEEECCCCEEEEEEEcCCCCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEeEe
Confidence             6889999999999999  889998853   445689999999999999999999999995       458899999999


Q ss_pred             cCCcc
Q 006446          250 DGSDI  254 (644)
Q Consensus       250 ~ss~~  254 (644)
                      +++.+
T Consensus       232 ss~lp  236 (237)
T d2d3sa1         232 SASLP  236 (237)
T ss_dssp             EEECC
T ss_pred             EeeCC
Confidence            98765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-51  Score=417.70  Aligned_cols=259  Identities=22%  Similarity=0.425  Sum_probs=202.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC------ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN------KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      ..|+..++||+|+||.||+|++++      ..||||+++... .....+|.+|+.++++++|||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            457778999999999999998863      369999997543 3345679999999999999999999999999999999


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      |||||.+|+|.+++.....       .++|.++++++.||+.||+|||+   ++|+||||||+||||+.++++||+|||+
T Consensus        87 v~e~~~~~~l~~~~~~~~~-------~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG-------EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEecccCcchhhhhcccc-------cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccch
Confidence            9999999999988865543       39999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ++................||+.|||||++.++.++.++|||||||++|||++|..|+......   ..+...    ..  
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~----i~--  227 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKA----IN--  227 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH----HH--
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHHH----Hh--
Confidence            998754333222234567899999999999999999999999999999999976665443211   122221    11  


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                             ...+...+......+.+|+.+||+.||++||+|+||++.|+....
T Consensus       228 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         228 -------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                   122223333445668889999999999999999999999987543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-51  Score=420.60  Aligned_cols=257  Identities=28%  Similarity=0.451  Sum_probs=211.6

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      .++|+..++||+|+||+||+|++.  +..||||+++... ...++|.+|+.+|++++|||||+++|+|.+++.+++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            357888899999999999999986  6789999987654 3467899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      |++|+|.+++......      .++|..++.|+.|||+||+|||+   ++|+||||||+||||++++++||+|||+|+..
T Consensus        95 ~~~g~l~~~l~~~~~~------~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          95 MTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             CTTCBHHHHHHHSCTT------TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             ccCcchHHHhhhcccc------chHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999754322      48999999999999999999999   89999999999999999999999999999976


Q ss_pred             cccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      .....  .......||+.|+|||++.++.++.++|||||||++|||++|..|+......   ..+.+    ....+    
T Consensus       166 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~~~----~i~~~----  232 (287)
T d1opja_         166 TGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYE----LLEKD----  232 (287)
T ss_dssp             CSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH----HHHTT----
T ss_pred             CCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HHHHH----HHhcC----
Confidence            53221  2234456899999999999999999999999999999999987776443221   11211    11111    


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                           .....+....+.+.+|+.+||+.||++|||++||++.|+...
T Consensus       233 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 122233333456788999999999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=414.23  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=205.8

Q ss_pred             CCCCCC-cccccCcEEEEEeeec----CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          320 NFNPKN-KLGKGGFGTVYKGIWR----NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       320 ~f~~~~-~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      +|...+ +||+|+||+||+|++.    +..||||+++... ....++|.+|+.+|++++|||||+++|+|.. +.++|||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            444555 4999999999999875    3469999997653 3456789999999999999999999999865 5689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++|+|.+++.....       .+++.+++.++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+++
T Consensus        88 E~~~~g~L~~~l~~~~~-------~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             ECCTTEEHHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EeCCCCcHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhh
Confidence            99999999999864433       38999999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ................||+.|||||++..+.++.++|||||||++|||+| |+.||......    .+..    ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~----~i~~~~  229 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQGK  229 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH----HHHTTC
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCC
Confidence            87643333232345678999999999999999999999999999999998 99999765422    1221    222222


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .         .+.+......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       230 ~---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         230 R---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             C---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1         12222333567789999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=412.66  Aligned_cols=253  Identities=25%  Similarity=0.456  Sum_probs=204.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||+||+|+++ +..||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +.+++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            46777899999999999999997 5689999997644 345789999999999999999999998865 56899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....      ..++|.++++|+.|||+||.|||+   ++|+||||||+||||++++.+||+|||+|+....
T Consensus        91 ~g~L~~~~~~~~~------~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          91 NGSLVDFLKTPSG------IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             TCBHHHHTTSHHH------HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCcHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence            9999998754432      138999999999999999999999   9999999999999999999999999999998753


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ..  ........||+.|||||++.++.++.++|||||||++|||+||..|+......   ..+...    ...+.     
T Consensus       162 ~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---~~~~~~----i~~~~-----  227 (272)
T d1qpca_         162 NE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQN----LERGY-----  227 (272)
T ss_dssp             SC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHH----HHTTC-----
T ss_pred             Cc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHhcC-----
Confidence            22  12234567899999999999999999999999999999999976665432211   112221    11111     


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                          +...+....+.+.+|+.+||+.||++||||++|++.|+.
T Consensus       228 ----~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                111122233457789999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=411.66  Aligned_cols=247  Identities=25%  Similarity=0.424  Sum_probs=198.7

Q ss_pred             CcccccCcEEEEEeeec----CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccCC
Q 006446          325 NKLGKGGFGTVYKGIWR----NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMPN  398 (644)
Q Consensus       325 ~~LG~G~fG~Vy~g~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  398 (644)
                      ++||+|+||+||+|.+.    ++.||||+++...  ....++|.+|+.+|++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999875    3579999986542  3345789999999999999999999999964 568999999999


Q ss_pred             CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccccc
Q 006446          399 GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQEN  478 (644)
Q Consensus       399 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~  478 (644)
                      |+|.+++....        .++|.+++.++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus        92 g~L~~~l~~~~--------~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          92 GPLNKYLQQNR--------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             EEHHHHHHHCT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcHHHHHhhcc--------CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            99999987543        38999999999999999999999   89999999999999999999999999999877543


Q ss_pred             ccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          479 LKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       479 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...........||+.|||||.+.++.++.++|||||||++|||+| |+.||......    .+..    ....+..    
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~----~i~~~~~----  228 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTA----MLEKGER----  228 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCC----
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHH----HHHcCCC----
Confidence            332232345679999999999999999999999999999999998 89999764321    1222    1222221    


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           ...+......+.+|+.+||+.||++|||+++|++.|+.
T Consensus       229 -----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         229 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                 12222333567789999999999999999999988864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-50  Score=403.47  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=211.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||+||+|+++ +..||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            67889999999999999999997 55899999986543 45789999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|..++.....       .+++..+.+++.|+|+||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        83 ~g~l~~~~~~~~~-------~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          83 NGCLLNYLREMRH-------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             TEEHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             CCcHHHhhhcccc-------CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            9999999866544       38899999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...  .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+    +..    ....+.    
T Consensus       153 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~~----~i~~~~----  218 (258)
T d1k2pa_         153 DEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAE----HIAQGL----  218 (258)
T ss_dssp             SSC--CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHH----HHHTTC----
T ss_pred             CCc--eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HHH----HHHhCC----
Confidence            322  22345679999999999999999999999999999999998 899997654321    211    111221    


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                           +...+....+.+.+|+.+||+.||++|||++++++.|..
T Consensus       219 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         219 -----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 112222333567889999999999999999999999865

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=6.4e-50  Score=397.78  Aligned_cols=224  Identities=28%  Similarity=0.492  Sum_probs=191.8

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|+.. ..||.++ +|.+. +|.|+||+.... .+..+++|||+|++||+||++.+++++||+|+|+|.|..
T Consensus         2 ~~~sF~f~~F~~~-~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~   80 (239)
T d1gzca_           2 ETISFSFSEFEPG-NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQ   80 (239)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred             eeEEEEeCCCCCC-CCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEec
Confidence            4799999999865 4579999 99875 789999987642 234578999999999999999999999999999999975


Q ss_pred             --CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecC
Q 006446          102 --QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPL  179 (644)
Q Consensus       102 --~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~  179 (644)
                        ....+||||||+|+|... +.+..||+||+++..+. ...++.|||||||++|..+||++||||||+|++.|..+.++
T Consensus        81 ~~~~~~g~dG~aF~l~p~~~-~~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~HvgI~vn~~~s~~t~~~  158 (239)
T d1gzca_          81 PYTRPLPADGLVFFMGPTKS-KPAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF  158 (239)
T ss_dssp             CCSSSCCCEEEEEEEECSSC-CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTSCSSSSEEEEEESSSSCSEEEEC
T ss_pred             CCCCCCCCCeEEEEECCCCC-CCCCCcccccccccCCC-CCccceEEEEEEccccCCCCCCCCEEEEEECCccccccCCc
Confidence              445689999999999654 34568899999876544 35678999999999994349999999999999999888766


Q ss_pred             cccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCC---cccccccccccccC
Q 006446          180 TRVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDG  251 (644)
Q Consensus       180 ~~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~s  251 (644)
                         ++.+|+.++|||+||+  ++|+|++.   ++..|.|++.|||+++|+++|||||||+||.   ..|.|+|++|+|++
T Consensus       159 ---~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF~s  235 (239)
T d1gzca_         159 ---QLDNGQVANVVIKYDAPSKILHVVLVYPSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQA  235 (239)
T ss_dssp             ---CCCTTCEEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEE
T ss_pred             ---cccCCCEEEEEEEEeCCCcEEEEEEecCCCCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEeEe
Confidence               6889999999999999  78889885   4456689999999999999999999999995   45889999999998


Q ss_pred             Ccc
Q 006446          252 SDI  254 (644)
Q Consensus       252 s~~  254 (644)
                      +++
T Consensus       236 ~lp  238 (239)
T d1gzca_         236 SLP  238 (239)
T ss_dssp             EEC
T ss_pred             eCC
Confidence            753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=408.97  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++.... .+..+.+.+|+.++++++|||||++++++.+++.+++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56888999999999999999986  7789999997543 33456789999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +++|+|.+++....        .+++.+...++.||++||+|||+   ++|+||||||+|||+++++++||+|||+|+..
T Consensus        85 ~~gg~L~~~l~~~~--------~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          85 CSGGELFDRIEPDI--------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             CTTEEGGGGSBTTT--------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999995432        38999999999999999999999   99999999999999999999999999999977


Q ss_pred             cccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      ..... .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........  ...    .........
T Consensus       154 ~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~----~~~~~~~~~  226 (271)
T d1nvra_         154 RYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYS----DWKEKKTYL  226 (271)
T ss_dssp             EETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHH----HHHTTCTTS
T ss_pred             ccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHH----HHhcCCCCC
Confidence            53322 222455789999999999988776 5789999999999999999999976443211  111    111111110


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                               .........+.+|+.+||+.||++|||++|+++
T Consensus       227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     001112245667899999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=409.88  Aligned_cols=248  Identities=26%  Similarity=0.395  Sum_probs=207.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..++||+|+||+||+|+..  ++.||||++........+.+.+|+.++++++|||||++++++.+.+.+++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999976  7899999998766566778999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++...         .++..+...++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+|+...
T Consensus       100 ~gg~L~~~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1         100 AGGSLTDVVTET---------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             TTCBHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCcHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            999999987543         28899999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          477 ENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       477 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .   .......+..   
T Consensus       168 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~---~~~~~~~~~~---  234 (293)
T d1yhwa1         168 PEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----A---LYLIATNGTP---  234 (293)
T ss_dssp             STT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHHHCSC---
T ss_pred             ccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----H---HHHHHhCCCC---
Confidence            322   11345689999999999999999999999999999999999999997643211    1   1111111110   


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ....+......+.+++.+||++||++|||++|+++
T Consensus       235 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 -----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 01112223356778999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=405.22  Aligned_cols=244  Identities=26%  Similarity=0.386  Sum_probs=204.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||+|++.  ++.||+|++....   ....+.+.+|+.++++++|||||++++++.+++.+++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            35888899999999999999986  6789999987532   234567889999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++|+|.+++....        .+++.+...++.||++||+|||+   ++|+||||||+|||++.++++||+|||+|+
T Consensus        86 Ey~~~g~L~~~l~~~~--------~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             eecCCCcHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceee
Confidence            9999999999997543        38999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....     ......||+.|||||++.+..++.++|||||||++|||++|+.||.......    +.    .....+. 
T Consensus       155 ~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~----~~i~~~~-  220 (263)
T d2j4za1         155 HAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TY----KRISRVE-  220 (263)
T ss_dssp             CCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH----HHHHTTC-
T ss_pred             ecCCC-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----HH----HHHHcCC-
Confidence            65422     1345679999999999999999999999999999999999999997643221    11    1111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ..++..+    .+.+.+|+.+||++||++|||++|+++
T Consensus       221 -----~~~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 -----FTFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                 1122223    345677899999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=408.56  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      .|+..++||+|+||+||+|++.  +..||||++........+.+.+|+++|++++|||||++++++.+.+.+++|||||+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            5778899999999999999986  67899999987777777899999999999999999999999999999999999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.+++.....       .+++.++..++.||++||.|||+   ++|+||||||+|||++.++++||+|||+|+....
T Consensus        93 ~g~L~~~~~~~~~-------~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          93 GGAVDAVMLELER-------PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            9999999865433       38999999999999999999999   9999999999999999999999999999986643


Q ss_pred             cccccccccccccCCCccCccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFL-----VGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      ...   ......||+.|||||++.     ...++.++|||||||++|||++|+.||......+.   +..    .. .+.
T Consensus       163 ~~~---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~----i~-~~~  231 (288)
T d2jfla1         163 TIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLK----IA-KSE  231 (288)
T ss_dssp             HHH---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH----HH-HSC
T ss_pred             Ccc---cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHH----HH-cCC
Confidence            211   134568999999999984     45689999999999999999999999976543221   111    11 111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      .     +.+  ..+......+.+|+.+||+.||++|||++|+++
T Consensus       232 ~-----~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 P-----PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C-----CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C-----CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     011  111223346778899999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=414.17  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  389 (644)
                      ++|+..++||+|+||+||+|++.+       ..||+|++... .......+.+|+.+|.++ +|||||+++|+|.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578889999999999999998752       25999998654 334456789999999998 899999999999999999


Q ss_pred             EEEEeccCCCccchhhhccCCCCC---------------CCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCC
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSG---------------PGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSS  454 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~  454 (644)
                      ++|||||++|+|.++|........               .....++|..++.++.||++||+|||+   ++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence            999999999999999976532110               112348999999999999999999999   89999999999


Q ss_pred             CEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCcc
Q 006446          455 NIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQ  533 (644)
Q Consensus       455 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~  533 (644)
                      |||++.++++||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987653322 122345678999999999999999999999999999999997 8999976543


Q ss_pred             ccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 006446          534 NSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLS  599 (644)
Q Consensus       534 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~  599 (644)
                      ..   .+..    ....+         .+.+.+....+.+.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~~---~~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA---NFYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH---HHHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH---HHHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22   1211    11121         112222333456788999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=406.44  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=192.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeee--ccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--RHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV  392 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||+|++....  ....+.+.+|+.++++++|||||++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46888999999999999999886  7789999987643  3345678999999999999999999999865  4568999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCC--CCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGS--EKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ||||++|+|.+++.......    ..+++..++.++.|+++||.|||+..  ..+|+||||||+||||+.++++||+|||
T Consensus        84 mEy~~~g~L~~~i~~~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          84 MEYCEGGDLASVITKGTKER----QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EecCCCCcHHHHHHhccccC----CCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            99999999999986432111    13899999999999999999999832  2359999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +|+.......   ......||+.|||||++.+..++.++|||||||++|||++|+.||......    .+..    ....
T Consensus       160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~----~i~~  228 (269)
T d2java1         160 LARILNHDTS---FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----KIRE  228 (269)
T ss_dssp             HHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH----HHHH
T ss_pred             ceeecccCCC---ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHH----HHHc
Confidence            9998753221   134578999999999999999999999999999999999999999764322    1111    1122


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +..     +.+...++    +.+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~-----~~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 GKF-----RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TCC-----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC-----CCCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            221     11223333    45778899999999999999999975

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=7.5e-49  Score=388.81  Aligned_cols=217  Identities=30%  Similarity=0.548  Sum_probs=186.1

Q ss_pred             ceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           26 SLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        26 ~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      ++||+|++|..+ ..+|.++ ||.+. +|.|+||+..... +...++|||+|++||+||++.+++++||+|+|+|.|.+ 
T Consensus         2 ~~SF~f~~F~~~-~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~   80 (234)
T d1f9ka_           2 TQSFNFDHFEEN-SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP   80 (234)
T ss_dssp             EEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred             ceEEEeCCCCCC-CCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECC
Confidence            689999999864 4689999 99975 7899999876422 34578999999999999999999999999999999985 


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       ....+||||||+|+|.. .|.++.|+++|+++..    ..++.|||||||++| .+||++||||||+|++.|.+..++ 
T Consensus        81 ~~~~~g~dG~aF~i~p~~-~~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n-~~Dp~~nHvgi~~ns~~s~~~~~~-  153 (234)
T d1f9ka_          81 YAYPEPADGLTFFMVPPN-SPQGEDGGNLGVFKPP----EGDNAFAVEFDTFQN-TWDPQVPHIGIDVNSIVSSKTLHF-  153 (234)
T ss_dssp             CSSSCCCEEEEEEEECTT-CCCCCSGGGTTTCCSS----CCSCCEEEEEECSCC-TTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCccceEEEEECCCC-CCcccccccccccCCC----CccceEEEEEecccc-CCCCCCCcEeEecCCccccccccc-
Confidence             34567899999999854 4677899999997753    456789999999999 479999999999999998877665 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCC--CceeeeecccCCC---ccccccccccccc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLP--EKVFVGFSASTGD---DTQLNCVKSWAFD  250 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~--~~~~vGfsastg~---~~~~~~i~~wsf~  250 (644)
                        ++.+|+.++|||+||+  ++|.|++.   ++..|.|++.|||+.+|+  ++|||||||+||.   ..|.|+|++|+|+
T Consensus       154 --~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~  231 (234)
T d1f9ka_         154 --QLENGGVANVVIKYDSPTKILNVVLAFHSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT  231 (234)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEE
T ss_pred             --cccCCCEEEEEEEEcCCCcEEEEEEEeCCCCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEeE
Confidence              6889999999999999  88888885   344568999999999997  5699999999994   4578999999998


Q ss_pred             CC
Q 006446          251 GS  252 (644)
Q Consensus       251 ss  252 (644)
                      ++
T Consensus       232 s~  233 (234)
T d1f9ka_         232 SS  233 (234)
T ss_dssp             EE
T ss_pred             Ee
Confidence            75

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=404.79  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=202.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  397 (644)
                      ++|+..+.||+|+||+||+|+++ +..||||+++... ...+.|.+|+.++++++|||||+++|+|.+ ++.++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            46888999999999999999997 5679999997543 345789999999999999999999999954 56899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|..++......      .++|.+++.|+.|||+||+|||+   ++|+||||||+|||||.++++||+|||+++....
T Consensus        95 ~g~l~~~~~~~~~~------~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          95 KGSLLDFLKGETGK------YLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             TCBHHHHHSHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             CCchhhhhhhcccc------cchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            99999988654322      38999999999999999999999   8999999999999999999999999999987653


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILDAA  557 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  557 (644)
                      ...  .......||+.|+|||++..+.++.++|||||||++|||++|..|+......   ..+...+    ..+      
T Consensus       166 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~~i----~~~------  230 (285)
T d1fmka3         166 NEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV----ERG------  230 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH----HTT------
T ss_pred             CCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHH----Hhc------
Confidence            221  1234567899999999999999999999999999999999977775543321   2222221    111      


Q ss_pred             hcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          558 DSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       558 d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                         .....+....+.+.+++.+||+.||++||+|++|+++|+....
T Consensus       231 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         231 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence               1122233334567889999999999999999999999998653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=411.97  Aligned_cols=200  Identities=25%  Similarity=0.426  Sum_probs=177.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .++|+..++||+|+||+||+|++.  +..||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.+++++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457888999999999999999986  7789999997643 3345678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ||++|+|.+++.+..        .+++..+..++.|+++||.|||+  .++|+||||||+|||+++++++||+|||+|+.
T Consensus        85 y~~gg~L~~~l~~~~--------~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG--------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             CCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             cCCCCcHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            999999999997543        28999999999999999999997  13899999999999999999999999999997


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCc
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSE  532 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~  532 (644)
                      .....     ....+||+.|||||++.+..++.++||||+||++|||++|+.||....
T Consensus       155 ~~~~~-----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         155 LIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHT-----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             cCCCc-----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            65321     345689999999999999999999999999999999999999997654

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=1.5e-48  Score=390.66  Aligned_cols=221  Identities=29%  Similarity=0.506  Sum_probs=184.6

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|+.+ ..+|.++ +|.+. +|.|+||+++.. .+...++|||+|++||+||++.++++++|+|+|+|.|..
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~   80 (251)
T d1g9fa_           2 ETVSFSWNKFVPK-QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA   80 (251)
T ss_dssp             EEEEEEESSCCC--CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred             ceEEEEeCCCCCC-CCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence            5799999999865 4579999 99985 789999987642 234578999999999999999999999999999999986


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       ....+||||||+|+|... +.+..||+||+++..   ...++.|||||||++| .+||++||||||+|++.|..+..+ 
T Consensus        81 ~~~~~~gDGlAFvl~p~~~-~~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n-~~D~~~~Hvgi~~n~~~s~~~~~~-  154 (251)
T d1g9fa_          81 PDTKRLADGLAFFLAPIDT-KPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRN-SWDPPNPHIGINVNSIRSIKTTSW-  154 (251)
T ss_dssp             SCC--CCEEEEEEEEETTC-CCCCCGGGTTTCCTT---SCCCSCEEEEEECC-C-TTSCSSSEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCceEEEEecCCC-CCCCccCccCccccc---CCCcceEEEEEecccC-CCCCCCCcEeEEecCcccccccce-
Confidence             566789999999999654 446789999998753   3446889999999999 579999999999999999877666 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCCcc--cccccccccccCCc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDT--QLNCVKSWAFDGSD  253 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~--~~~~i~~wsf~ss~  253 (644)
                        ++.+|+.++|||+||+  ++|.|++.   ++..|+++..|||+.+++++|||||||+||...  |.|+|++|+|+++.
T Consensus       155 --~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s~~  232 (251)
T d1g9fa_         155 --DLANNKVAKVLITYDASTSLLVASLVYPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASNL  232 (251)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEEGGGTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred             --EecCCCEEEEEEEEECCccEEEEEEecCCCCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeECCC
Confidence              6889999999999998  78888874   556679999999999999999999999999765  78999999998865


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      .
T Consensus       233 ~  233 (251)
T d1g9fa_         233 P  233 (251)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=397.49  Aligned_cols=243  Identities=26%  Similarity=0.418  Sum_probs=194.4

Q ss_pred             CCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee----ccceEEEE
Q 006446          322 NPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE----RHDFLLVY  393 (644)
Q Consensus       322 ~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  393 (644)
                      +..++||+|+||+||+|++.  +..||+|++...  .....+.|.+|+++|++++|||||++++++..    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999987  668999998754  33445679999999999999999999999865    34689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCC--eEeCCCCCCCEEEc-CCCcEEEeccC
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKR--VLHRDIKSSNIMLD-SEFNARLGDFG  470 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--ivHrDlkp~NILld-~~~~vkL~DFG  470 (644)
                      ||+++|+|.+++....        .+++..+..++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||
T Consensus        92 E~~~~g~L~~~l~~~~--------~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK--------VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             ECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCcHHHHHhccc--------cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            9999999999997543        38999999999999999999998   66  99999999999996 57899999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      +|+.....     ......||+.|||||++.+ +++.++|||||||++|||++|+.||......   ..+.    .....
T Consensus       161 la~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~----~~i~~  227 (270)
T d1t4ha_         161 LATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIY----RRVTS  227 (270)
T ss_dssp             GGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHH----HHHTT
T ss_pred             cceeccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HHHH----HHHHc
Confidence            99864321     1345689999999998864 6999999999999999999999999754321   1111    11122


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      +....    .+....+    ..+.+|+.+||++||++|||++|+++
T Consensus       228 ~~~~~----~~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         228 GVKPA----SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TCCCG----GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCc----ccCccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            21111    1111222    34678899999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-49  Score=407.25  Aligned_cols=268  Identities=25%  Similarity=0.437  Sum_probs=212.5

Q ss_pred             HHHHhCCCCCCCcccccCcEEEEEeeecC-------ceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeee
Q 006446          314 LKKATGNFNPKNKLGKGGFGTVYKGIWRN-------KEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYE  385 (644)
Q Consensus       314 l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~  385 (644)
                      ++...++|+..+.||+|+||+||+|++.+       ..||||+++.... +..++|.+|+.++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            33345689999999999999999998753       5799999976543 345679999999999999999999999999


Q ss_pred             ccceEEEEeccCCCccchhhhccCCC----------------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeC
Q 006446          386 RHDFLLVYEYMPNGSLDKFIFYDETN----------------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHR  449 (644)
Q Consensus       386 ~~~~~lV~Ey~~~gsL~~~l~~~~~~----------------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHr  449 (644)
                      .+..+++|||+++|+|.+++......                .......++|..++.|+.|+|.||+|||+   ++|+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence            99999999999999999999653321                11122348999999999999999999999   999999


Q ss_pred             CCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCC-CCC
Q 006446          450 DIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR-KPG  528 (644)
Q Consensus       450 Dlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~-~P~  528 (644)
                      ||||+|||||.++++||+|||+|+....... ........||+.|+|||.+....++.++|||||||++|||++|. +||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999987653322 22234567899999999999999999999999999999999986 566


Q ss_pred             CCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Q 006446          529 NQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEA  602 (644)
Q Consensus       529 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~  602 (644)
                      ......    .+...    ...+..         .+.+......+.+|+.+||+.||++||||.||+++|++..
T Consensus       244 ~~~~~~----e~~~~----v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHE----EVIYY----VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHH----HHHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHH----HHHHH----HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            554321    22221    122221         1122233346788999999999999999999999998753

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=4.3e-48  Score=388.63  Aligned_cols=222  Identities=30%  Similarity=0.511  Sum_probs=192.2

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      +..+|+|++|+..   +|.++ ||.+.++.|+||++..+. +...++|||+|++||+|||+.+++++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~f~~F~~~---~l~l~GdA~~~~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~   78 (253)
T d1g7ya_           2 DIQSFSFKNFNSS---SFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAP   78 (253)
T ss_dssp             EEEEEEESSCCSS---CEEEEETCEEETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             cccEEecCCCCcc---cEEEEeeeEEcCCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecC
Confidence            5789999999875   79999 999999999999876432 34578999999999999999999999999999999986 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      ....+||||||+|+|....+ +..||+||+++..+. ...++.+||||||++|.++||++||||||+|++.|..+.++  
T Consensus        79 ~~~~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~Hvgi~~ns~~s~~~~~~--  154 (253)
T d1g7ya_          79 NKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--  154 (253)
T ss_dssp             SGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEeceecCCCCCCCCcEEEeeCCcccccccCC--
Confidence            45578999999999966544 467899999986543 35578899999999998889999999999999999887766  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCC---cccccccccccccCCc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDGSD  253 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~ss~  253 (644)
                       .+.+|+.++|||+||+  ++|.|++..   |..|++++.+||+.+||++|||||||+||.   ..+.|+|++|+|+++.
T Consensus       155 -~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~l  233 (253)
T d1g7ya_         155 -GLANGQNAEILITYNAATSLLVASLVHPSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASKL  233 (253)
T ss_dssp             -CCCTTSEEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred             -CccCCCEEEEEEEEeCCcEEEEEEEecCCCCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEeEEeC
Confidence             6889999999999998  788888864   444689999999999999999999999994   5688999999998865


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      +
T Consensus       234 p  234 (253)
T d1g7ya_         234 P  234 (253)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=2e-48  Score=388.61  Aligned_cols=223  Identities=32%  Similarity=0.532  Sum_probs=192.7

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|.++ ..||.++ ||.+. +|.|+||++..+....+++|||+|++||+||++.+++++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~   80 (239)
T d1dbna_           2 DELSFTINNFVPN-EADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP   80 (239)
T ss_dssp             CEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             CceEEEeCCCCCC-CCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence            5799999999875 3579999 99876 789999987654445578999999999999999999999999999999986 


Q ss_pred             CCCCCCCceEEEEecCC-CCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC---CCCCCceeeecCCccceeee
Q 006446          102 QTAQPGEGLAFVIAGNK-DLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ---DINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~-~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~---d~~~~Hvgid~ns~~s~~~~  177 (644)
                      ....+||||||+|+|.. ..+.++.|++||+++.. +.++.++.+||||||++|.++   ||+.+|||||+|++.|..+.
T Consensus        81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~-~~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~  159 (239)
T d1dbna_          81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNS-NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV  159 (239)
T ss_dssp             STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSS-CCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCCCEEEEEeCCCccCCcccCcccccccccc-CCCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc
Confidence            55678999999999944 46778899999999864 355678999999999999653   88999999999999988776


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCCc--cccccccccccc
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD--TQLNCVKSWAFD  250 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~  250 (644)
                      ..   .+.+|+.++|||+|++  +.|.|++.   ++..|.|++.+||+++|+++||||||||||..  .|.|+|++|+|+
T Consensus       160 ~~---~~~~g~~~~~~i~y~~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWsFs  236 (239)
T d1dbna_         160 QW---DWINGGVAFATITYLAPNKTLIASLVYPSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFT  236 (239)
T ss_dssp             EC---CCCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEE
T ss_pred             cc---eEeCCceeEEEEEEcCCCCEEEEEEEecCCCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEEeE
Confidence            65   5678999999999998  78888875   44556899999999999999999999999975  468999999998


Q ss_pred             CC
Q 006446          251 GS  252 (644)
Q Consensus       251 ss  252 (644)
                      ++
T Consensus       237 s~  238 (239)
T d1dbna_         237 ST  238 (239)
T ss_dssp             EE
T ss_pred             Ee
Confidence            75

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=398.38  Aligned_cols=249  Identities=27%  Similarity=0.453  Sum_probs=198.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEEEEeccC
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVYEYMP  397 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~  397 (644)
                      ++|+..++||+|+||.||+|++++..||||+++...  ..+.|.+|++++++++|||||+++|+|.+ .+.+++||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            356678899999999999999999999999996543  45789999999999999999999999965 456899999999


Q ss_pred             CCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccccc
Q 006446          398 NGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQE  477 (644)
Q Consensus       398 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~  477 (644)
                      +|+|.++|.....      ..++|..+++|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          85 KGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             TEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999975432      148999999999999999999999   8999999999999999999999999999987543


Q ss_pred             cccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcCchhhh
Q 006446          478 NLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKGRILDA  556 (644)
Q Consensus       478 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  556 (644)
                      .      .....+|..|+|||++.++.++.++|||||||++|||+| |+.|+......    .+..++    ..+     
T Consensus       156 ~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~i----~~~-----  216 (262)
T d1byga_         156 T------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKG-----  216 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHH----TTT-----
T ss_pred             C------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HcC-----
Confidence            2      233467899999999999999999999999999999998 67777654332    233322    111     


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          557 ADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       557 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                          .+.+++......+.+|+.+||+.||.+|||+++++++|+..
T Consensus       217 ----~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         217 ----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                12223333345677899999999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=404.73  Aligned_cols=248  Identities=23%  Similarity=0.298  Sum_probs=202.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||||++....   ....+.+.+|+.++++++|||||++++++.+++.+++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            45888999999999999999986  7789999997532   234567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+++|+|.+++....        .+++.....++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+
T Consensus        88 Ey~~gg~L~~~~~~~~--------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EccCCCCHHHhhhccC--------CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccce
Confidence            9999999999987554        38999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||.......    +.    .....+. 
T Consensus       157 ~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~----~~i~~~~-  226 (288)
T d1uu3a_         157 VLSPESKQ-ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IF----QKIIKLE-  226 (288)
T ss_dssp             ECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH----HHHHTTC-
T ss_pred             ecccCCcc-cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HH----HHHHcCC-
Confidence            77532221 22345689999999999999999999999999999999999999998654221    11    1111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           ..+...+    ...+.+|+.+||+.||++|||++|+++
T Consensus       227 -----~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -----YDFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -----CCCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -----CCCCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                 1122233    345778999999999999999998743

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-48  Score=408.53  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=207.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..++||+|+||.||+|+..  +..||||++........+.+.+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999986  7899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC--CCcEEEeccCCccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS--EFNARLGDFGLART  474 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~--~~~vkL~DFGla~~  474 (644)
                      ++|+|.+++.....       .+++.++..|+.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.
T Consensus       106 ~gg~L~~~l~~~~~-------~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         106 SGGELFEKVADEHN-------KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             CSCBHHHHHTCTTS-------CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CCCCHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999864433       38999999999999999999999   99999999999999964  57899999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....    ......||+.|||||++.+..++.++|||||||++|||++|+.||......+    +..   ... .+.. 
T Consensus       176 ~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~---~i~-~~~~-  242 (350)
T d1koaa2         176 LDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLR---NVK-SCDW-  242 (350)
T ss_dssp             CCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---HHH-HTCC-
T ss_pred             ccccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHH---HHH-hCCC-
Confidence            65321    1345689999999999999999999999999999999999999997653221    111   111 1110 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                           ...........+.+.+|+.+||+.||++|||++|+++.
T Consensus       243 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 -----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00111111123457788999999999999999999884

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-48  Score=402.96  Aligned_cols=247  Identities=29%  Similarity=0.467  Sum_probs=201.5

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      .|+..+.||+|+||+||+|+..  +..||||++.....   ...+.+.+|+.+|++++|||||++++++.+.+.+++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888899999999999999876  67899999976432   334678999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ||++|+|..++....        .+++.++..++.||++||.|||+   ++|+||||||+||||+.++++||+|||+|+.
T Consensus        96 ~~~~g~l~~~~~~~~--------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             CCSEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             ecCCCchHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999987665432        38999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccccccccccccccccCCCccCcccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLV---GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      ...       .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.......    .   ...... +
T Consensus       165 ~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~---~~~i~~-~  229 (309)
T d1u5ra_         165 MAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A---LYHIAQ-N  229 (309)
T ss_dssp             SSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHHH-S
T ss_pred             cCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----H---HHHHHh-C
Confidence            542       234579999999999853   468999999999999999999999997643211    1   111111 1


Q ss_pred             chhhhhhccc-CCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          552 RILDAADSRL-GGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       552 ~~~~~~d~~l-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      ..     +.+ ...+    .+.+.+|+.+||+.||++|||++|+++  .+...
T Consensus       230 ~~-----~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         230 ES-----PALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CC-----CCCSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CC-----CCCCCCCC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            11     111 1122    345778899999999999999999987  45544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=402.78  Aligned_cols=254  Identities=24%  Similarity=0.442  Sum_probs=202.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc----eEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK----EIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  391 (644)
                      .+|+..++||+|+||+||+|++.  ++    +||+|+++.. +.+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35888999999999999999876  32    5899988653 344567899999999999999999999999865 6788


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGL  471 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGl  471 (644)
                      ++||+.+|+|.+++.....       .+++..+++++.|||+||+|||+   ++|+||||||+||||+.++++||+|||+
T Consensus        88 v~e~~~~~~l~~~~~~~~~-------~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD-------NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS-------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             EEEeccCCccccccccccc-------CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeecccc
Confidence            8999999999998876544       38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhc
Q 006446          472 ARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRK  550 (644)
Q Consensus       472 a~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~  550 (644)
                      ++....... ........||+.|||||.+.++.++.++|||||||++|||+| |+.||......+    +..    ....
T Consensus       158 a~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~----~i~~  228 (317)
T d1xkka_         158 AKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS----ILEK  228 (317)
T ss_dssp             HHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHH----HHHH
T ss_pred             ceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHH----HHHc
Confidence            998753322 222345578999999999999999999999999999999998 788887654322    221    1112


Q ss_pred             CchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          551 GRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       551 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +.         +...+......+.+|+.+||+.||++|||++|+++.|+..
T Consensus       229 ~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         229 GE---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            21         1122233345678899999999999999999999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-48  Score=402.83  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=190.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc-hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR-QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      +.|+..+.||+|+||+||+|++.  ++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++.+++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888999999999999999986  67899999975432 3345678999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc---CCCcEEEeccCCc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla  472 (644)
                      |++|+|.+++....        .+++.+...++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|
T Consensus        89 ~~gg~L~~~l~~~~--------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          89 VSGGELFDRIVEKG--------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             CCSCBHHHHHHTCS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             cCCCcHHHhhhccc--------CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence            99999999996543        38999999999999999999999   9999999999999994   5789999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +.......    ....+||+.|||||++.+..++.++|||||||++|||++|+.||.......    +..    ....+.
T Consensus       158 ~~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~----~i~~~~  225 (307)
T d1a06a_         158 KMEDPGSV----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFE----QILKAE  225 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH----HHHTTC
T ss_pred             EEccCCCe----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHH----HHhccC
Confidence            87653221    345679999999999999999999999999999999999999997643221    111    111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                      .      .............+.+|+.+||+.||++|||++|+++  .+.+.
T Consensus       226 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         226 Y------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             C------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            1      1111111222345778999999999999999999998  35443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=398.40  Aligned_cols=255  Identities=26%  Similarity=0.401  Sum_probs=198.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||.||+|++..     ..||||+++..   ..+..++|.+|+.+|++++|||||+++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            467888999999999999998752     36899998653   33445789999999999999999999999975 4788


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +||||+++|+|.+++.....       .+++..++.++.|+|.||.|||+   ++|+||||||+||||+.++++||+|||
T Consensus        87 lv~e~~~~~~l~~~~~~~~~-------~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG-------HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-------GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeeeeecCcchhhhhhcccC-------CCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccch
Confidence            99999999999998876543       39999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++................||..|+|||.+.+..++.++|||||||++|||+| |+.||......    .+..+   ...
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~---i~~  229 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHK---IDK  229 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH---HHT
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHH---HHh
Confidence            99987644333333455678899999999999999999999999999999998 89999764322    22222   222


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      .+..         .+.+......+.+|+.+||+.||++|||++||++.|++
T Consensus       230 ~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         230 EGER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             SCCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2211         11222223467789999999999999999999999975

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.1e-47  Score=380.50  Aligned_cols=219  Identities=32%  Similarity=0.572  Sum_probs=189.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      .+++|+|++|+..   +|.+. ||.+. +|.|+||+.... .+...++|||+|++||+||++.++.++||+|+|+|.|.+
T Consensus         2 ~~~sF~f~~F~~~---nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~   78 (233)
T d1g8wa_           2 NDIYFNFQRFNET---NLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQV   78 (233)
T ss_dssp             EEEEEEESSCCGG---GEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCC
T ss_pred             CceEEECCCCCcC---cEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEec
Confidence            5799999999875   79999 99875 889999986542 244578999999999999999999999999999999986


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       ....+||||||+|+|... +.++.|++||+++..   ...++.|||||||++|.++||++||||||+|++.|..+..+ 
T Consensus        79 ~~~~~~gDGlAF~l~~~~~-~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~d~~~~Hvgi~~n~~~s~~~~~~-  153 (233)
T d1g8wa_          79 PNNAGPADGLAFALVPVGS-QPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW-  153 (233)
T ss_dssp             CSSCBCCEEEEEEEEETTC-CCCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCCCeEEEEEecCCC-CCCcccccCCccccC---CCcccEEEEEeecccCCCCCCCCCeEEEECCCcceeeeccc-
Confidence             555789999999999765 446789999998753   34568899999999998899999999999999998877665 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCC---cccccccccccccCC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDGS  252 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~ss  252 (644)
                        ++.+|+.++|||+||+  +.|.|++.   ++..|+++..+||+.+||++|||||||+||.   ..|.|+|++|+|+++
T Consensus       154 --~~~~g~~~~~~I~yd~~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsFss~  231 (233)
T d1g8wa_         154 --DFVNGENAEVLITYDSSTNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK  231 (233)
T ss_dssp             --CCCTTCCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred             --cccCCcEEEEEEEEeCCCcEEEEEEEeCCCCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEEEEE
Confidence              6889999999999998  78888884   4455689999999999999999999999995   457799999999876


Q ss_pred             c
Q 006446          253 D  253 (644)
Q Consensus       253 ~  253 (644)
                      .
T Consensus       232 l  232 (233)
T d1g8wa_         232 L  232 (233)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=1.2e-47  Score=382.69  Aligned_cols=224  Identities=33%  Similarity=0.498  Sum_probs=192.0

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .++||+|++|..+ ..+|.++ ||.+. +|.|+||++..+.+..+++|||+|++||+||++.+++++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~   80 (237)
T d1fnya_           2 GSLSFSFPKFAPN-QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAP   80 (237)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred             ceEEEEeCCCCCC-CCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecC
Confidence            3789999999864 5689999 99876 789999987654445579999999999999999999999999999999986 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      ....+||||||+|+|.... .+..||+||+++..+ .+..++.+||||||++|.++||+++|||||+|++.|..+.+.  
T Consensus        81 ~~~~~gDG~AF~l~~~~~~-~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~d~~~~Higi~~n~~~s~~~~~~--  156 (237)
T d1fnya_          81 NPATTADGLAFFLAPVDTQ-PLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW--  156 (237)
T ss_dssp             STTSCCEEEEEEEEETTCC-CCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCeeEEEEcCCCCC-cccccCcccccCCCC-ccCccceEEEEeccccccCCCCCCceEEEecCCCcccccccc--
Confidence            5667899999999996543 457889999987533 345678999999999998899999999999999998877655  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCC---CcccccccccccccCCc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf~ss~  253 (644)
                       ++.+|+.++|||+||+  ++|.|++.   ++..|+++..+||+.++|++|||||||+||   ...|.|+|++|+|+++.
T Consensus       157 -~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~l  235 (237)
T d1fnya_         157 -NWTNGEVANVFISYEASTKSLTASLVYPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             -CCCTTCCEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             -cccCCcEEEEEEEEeCCccEEEEEEEeCCCCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEEeC
Confidence             6789999999999998  77888774   445668999999999999999999999999   45578999999999876


Q ss_pred             c
Q 006446          254 I  254 (644)
Q Consensus       254 ~  254 (644)
                      +
T Consensus       236 p  236 (237)
T d1fnya_         236 P  236 (237)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-47  Score=404.52  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=209.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||.||+|+..  +..||||+++.......+.+.+|+.+|++++|||||++++++.+++.+++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46889999999999999999986  7889999998766666678889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc--CCCcEEEeccCCccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD--SEFNARLGDFGLART  474 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld--~~~~vkL~DFGla~~  474 (644)
                      ++|+|.+++.....       .+++.+...|+.||+.||+|||+   ++|+||||||+||||+  .++.+||+|||+|+.
T Consensus       109 ~gg~L~~~~~~~~~-------~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         109 SGGELFDRIAAEDY-------KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             CCCBHHHHTTCTTC-------CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CCChHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence            99999888754432       38999999999999999999999   9999999999999998  678999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....    ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......    +..   . ...+.. 
T Consensus       179 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~---~-i~~~~~-  245 (352)
T d1koba_         179 LNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQ---N-VKRCDW-  245 (352)
T ss_dssp             CCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH---H-HHHCCC-
T ss_pred             cCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHH---H-HHhCCC-
Confidence            75321    1345679999999999999999999999999999999999999997644221    111   1 111111 


Q ss_pred             hhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCC
Q 006446          555 DAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGE  601 (644)
Q Consensus       555 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  601 (644)
                           .............+.+|+.+||+.||.+|||++|+++.  +++.
T Consensus       246 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         246 -----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                 11111112223456789999999999999999999873  5543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=395.39  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc------hhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR------QGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..+.||+|+||+||+|++.  ++.||||+++....      ...+.+.+|+.+|++++|||||++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57888999999999999999986  77999999865321      23577999999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC----cEEE
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF----NARL  466 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~----~vkL  466 (644)
                      ||||||++|+|.+++....        .+++.....++.|+++||+|||+   .+|+||||||+|||++.++    .+||
T Consensus        90 iv~E~~~gg~L~~~i~~~~--------~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE--------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEcCCCccccchhcccc--------ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEe
Confidence            9999999999999997543        38999999999999999999999   9999999999999998776    5999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|||+++.......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+    ...   .
T Consensus       159 ~DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~---~  227 (293)
T d1jksa_         159 IDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA---N  227 (293)
T ss_dssp             CCCTTCEECTTSCB----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H
T ss_pred             cchhhhhhcCCCcc----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHH---H
Confidence            99999987653221    345678999999999999999999999999999999999999997654321    111   1


Q ss_pred             HHhcCch--hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          547 LRRKGRI--LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~--~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       ...+..  .....    ..    ....+.+|+.+||+.||++|||++|+++
T Consensus       228 -i~~~~~~~~~~~~----~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         228 -VSAVNYEFEDEYF----SN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -HHTTCCCCCHHHH----TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHhcCCCCCchhc----CC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111110  00000    11    2245678999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=391.62  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=195.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC-----ceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN-----KEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||.||+|++..     ..||||.++... ....+.|.+|+.++++++|||||+++|+|. .+.+++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            467888999999999999998752     358899886543 334577999999999999999999999996 4678999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      |||+++|+|.+++.....       .+++..++.++.||++||.|||+   ++|+||||||+|||++.++++||+|||+|
T Consensus        86 ~E~~~~g~l~~~~~~~~~-------~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKY-------SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             EECCTTEEHHHHHHHTTT-------TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEeccCCcHHhhhhccCC-------CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhh
Confidence            999999999998765443       38999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchhhHHHHHHHHHhcC
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNNSIVHWLWELRRKG  551 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~~l~~~~~~~~~~~  551 (644)
                      +.......  .......||+.|+|||.+.++.++.++|||||||++|||++ |++||......+    +...+    ..+
T Consensus       156 ~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~i----~~~  225 (273)
T d1mp8a_         156 RYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI----ENG  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHH----HTT
T ss_pred             eeccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HHHHH----HcC
Confidence            87653221  22345678999999999999999999999999999999998 888987654322    22211    122


Q ss_pred             chhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          552 RILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       552 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                      ..         ...+......+.+|+.+||+.||++|||++||++.|+.
T Consensus       226 ~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         226 ER---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11         11222233567889999999999999999999998875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=395.16  Aligned_cols=268  Identities=25%  Similarity=0.352  Sum_probs=201.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeecc----ceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----DFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E  394 (644)
                      ++|...++||+|+||.||+|++++..||||+++.... ....+..|+..+.+++|||||+++|+|.+.+    .+++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            3456678999999999999999999999999865432 2223345666777889999999999998764    5899999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC-----CCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG-----SEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ||++|+|.++|...         .++|.++++++.|+|.||+|||+.     ..++|+||||||+||||+.++++||+||
T Consensus        82 y~~~g~L~~~l~~~---------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          82 YHEHGSLFDYLNRY---------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             CCTTCBHHHHHHHC---------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            99999999999653         289999999999999999999973     2479999999999999999999999999


Q ss_pred             CCccccccccccc-ccccccccCCCccCccccccC------CCCCccchHHHHHHHHHHHcCCCCCCCCccccch-----
Q 006446          470 GLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG------RATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-----  537 (644)
Q Consensus       470 Gla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~------~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-----  537 (644)
                      |+++......... .......||+.|+|||++...      .++.++|||||||+||||+||+.|+.........     
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            9998775332211 123457899999999998654      2577999999999999999999887543221110     


Q ss_pred             --hhHHHHHHHHHhcCchhhhhhcccCCCC-CHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          538 --NSIVHWLWELRRKGRILDAADSRLGGEF-SEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       538 --~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                        .............+..    ++.+.... +.+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence              0011112222111111    11111111 22355678899999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=393.21  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=202.0

Q ss_pred             CCcccccCcEEEEEeeecC-----ceEEEEEeecc-cchhhHHHHHHHHHHhccCCCceeeEeeeeee-ccceEEEEecc
Q 006446          324 KNKLGKGGFGTVYKGIWRN-----KEIAVKRVSET-SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE-RHDFLLVYEYM  396 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~  396 (644)
                      .++||+|+||+||+|++..     ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5689999999999999852     25899999753 44556789999999999999999999999876 45799999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTIQ  476 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~~  476 (644)
                      ++|+|.+++.....       .+++..+++++.|+|.||.|||+   .+|+||||||+|||||+++.+||+|||+++...
T Consensus       112 ~~g~l~~~~~~~~~-------~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         112 KHGDLRNFIRNETH-------NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             TTCBHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             ecCchhhhhccccc-------cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            99999999875543       37889999999999999999999   999999999999999999999999999998765


Q ss_pred             ccccc-cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchhh
Q 006446          477 ENLKT-HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRILD  555 (644)
Q Consensus       477 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~  555 (644)
                      ..... ........||+.|+|||.+..+.++.++||||||+++|||+||+.||......   ..+..++    ..+..  
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i----~~g~~--  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQGRR--  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH----HTTCC--
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCC--
Confidence            33221 11234467899999999999999999999999999999999988887653221   1122211    12221  


Q ss_pred             hhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          556 AADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       556 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                             ...+....+.+.+|+.+||+.||++||+|+||++.|+..
T Consensus       253 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         253 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   111122234577899999999999999999999999876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-46  Score=390.95  Aligned_cols=243  Identities=24%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||||+++..   .....+.+.+|+.++++++|||||++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46888999999999999999986  788999999753   2334577899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++|+|..++.....        +++.....++.||+.||+|||+   ++|+||||||+||||+.++++||+|||+|+
T Consensus        84 E~~~gg~l~~~~~~~~~--------~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR--------FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS--------CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eecCCcccccccccccc--------ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccce
Confidence            99999999998865543        7888889999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....||+.|||||++.+..++.++|||||||++|||++|+.||.......    +.    .....+. 
T Consensus       153 ~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~----~~i~~~~-  217 (316)
T d1fota_         153 YVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TY----EKILNAE-  217 (316)
T ss_dssp             ECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HH----HHHHHCC-
T ss_pred             Eeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HH----HHHHcCC-
Confidence            76532      345689999999999999999999999999999999999999997654321    11    1111111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                           ..+...++    ..+.+++.+|++.||.+||     +++++++
T Consensus       218 -----~~~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -----LRFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -----CCCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                 11222233    4577889999999999996     8999885

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=1.1e-46  Score=373.81  Aligned_cols=219  Identities=33%  Similarity=0.557  Sum_probs=183.5

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|++. ..+|.++ ||.+. +|.|+||++..    .+++|||+|++||+||++.++.++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~~~~F~~~-~~~l~l~GdA~i~~~g~l~LT~~~~----~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~   76 (232)
T d1v6ia_           2 ETVSFNFNSFSEG-NPAINFQGDVTVLSNGNIQLTNLNK----VNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDI   76 (232)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEESCEECTTSCEECSCTTS----TTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred             ccEEEECCCCCCC-CCCEEEeeeeEEcCCCEEEeCCCCC----CCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccC
Confidence            5799999999886 3479999 99875 78999998643    268999999999999999999999999999999997 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                      ....+||||||+|+|.....+.  +++.|++....+....++.|||||||++|.++ ||+++|||||+|++.+...... 
T Consensus        77 ~~~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~~-  153 (232)
T d1v6ia_          77 KDYDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW-  153 (232)
T ss_dssp             SSSBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC-
T ss_pred             CCCCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccccccc-
Confidence            5667899999999995533222  22223332223445677999999999999776 9999999999999988776554 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe--cCCCCCcccccCccCcCCCceeeeecccCCCc-ccccccccccccCCc
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD-TQLNCVKSWAFDGSD  253 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~--~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~-~~~~~i~~wsf~ss~  253 (644)
                        ++.+|+.++|||+||+  +.|.|++.  ++..|.++..+||+.+||++|||||||+||.. .+.|+|++|+|+++.
T Consensus       154 --~~~~g~~~~v~I~Yd~~~~~L~V~~~~~~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~l  229 (232)
T d1v6ia_         154 --NSVSGAVVKVTVIYDSSTKTLSVAVTNDNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTL  229 (232)
T ss_dssp             --CCCTTCEEEEEEEEETTTTEEEEEEECTTSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEEE
T ss_pred             --ccCCCCEEEEEEEEeCCceEEEEEEecCCCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEee
Confidence              6889999999999998  78888885  56667899999999999999999999999975 589999999999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=393.91  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=205.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc---cchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET---SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|+..  ++.||||++++.   .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46888999999999999999986  789999999754   2334577899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      |||++|+|.+++.....        ++......++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        85 ey~~gg~L~~~~~~~~~--------~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          85 EYANGGELFFHLSRERV--------FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eccCCCchhhhhhcccC--------CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccc
Confidence            99999999999876542        7888899999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    +..    ....+. 
T Consensus       154 ~~~~~~~---~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~----~i~~~~-  221 (337)
T d1o6la_         154 EGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFE----LILMEE-  221 (337)
T ss_dssp             CSCCTTC---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCC-
T ss_pred             ccccCCc---ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHH----HHhcCC-
Confidence            6543221   2445789999999999999999999999999999999999999998754321    211    111221 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                           ..+...++    ..+.+|+.+||+.||.+||+     ++|+++
T Consensus       222 -----~~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -----IRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 11223333    34678899999999999995     788875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=394.98  Aligned_cols=264  Identities=24%  Similarity=0.459  Sum_probs=211.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..++||+|+||+||+|++.       +..||||+++... .+....|.+|+.++++++|||||+++|+|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            56777899999999999999875       3579999997543 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCC--CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          391 LVYEYMPNGSLDKFIFYDETN--SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +|||||++|+|.+++......  .......++|..+.+++.|+|+||.|||+   ++|+||||||+|||+|+++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence            999999999999998643210  11122247999999999999999999999   8999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCccccchhhHHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR-KPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~-~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      ||+++....... ........||+.|+|||.+.++.++.++|||||||++|||++|+ .||......    .+...    
T Consensus       177 FGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----~~~~~----  247 (308)
T d1p4oa_         177 FGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRF----  247 (308)
T ss_dssp             TTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHH----
T ss_pred             cccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----HHHHH----
Confidence            999997764332 22234557899999999999999999999999999999999985 566543321    12211    


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGEAD  603 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~~~  603 (644)
                      ...+...         ..+......+.+|+.+||+.||++||||++|++.|+...+
T Consensus       248 i~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1122211         1122233568889999999999999999999999998754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=392.61  Aligned_cols=262  Identities=23%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeecC---------ceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCCceeeEeeeeeecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWRN---------KEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERH  387 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~  387 (644)
                      ++|+..++||+|+||.||+|+..+         ..||||+++.... ....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            467778999999999999998642         3699999976543 4457889999999888 8999999999999999


Q ss_pred             ceEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD  459 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld  459 (644)
                      ..++|||||++|+|.+++.......        ......+++.+++.++.||++||+|||+   .+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence            9999999999999999997553211        1123358999999999999999999999   9999999999999999


Q ss_pred             CCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCccccchh
Q 006446          460 SEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVAC-GRKPGNQSEQNSYNN  538 (644)
Q Consensus       460 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~t-G~~P~~~~~~~~~~~  538 (644)
                      .++.+||+|||+++....... ........||+.|+|||.+.++.++.++|||||||++|||++ |+.||......    
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             CCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence            999999999999998764322 222455678999999999999999999999999999999998 68887654321    


Q ss_pred             hHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          539 SIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       539 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .+.    .....+.         ....+......+.+|+.+||+.||++|||+.||++.|++.
T Consensus       245 ~~~----~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 ELF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHH----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH----HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            122    2222222         1122223345688899999999999999999999999864

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=2e-46  Score=372.10  Aligned_cols=220  Identities=29%  Similarity=0.505  Sum_probs=188.1

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|.+. ..+|.++ ||.+. +|.|+||++.......+++|||+|++||+||+..  .++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~   78 (233)
T d1n47a_           2 ESTSFSFTNFNPN-QNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAP   78 (233)
T ss_dssp             EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCS
T ss_pred             CceEEEeCCCCCC-CCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCC
Confidence            3789999999865 4589999 99986 7799999887655556799999999999999864  589999999999986 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      ....+||||||+|+|... +.++.||+|||++..+. +..++.|||||||++| .+||++||||||+|++.|..+.++  
T Consensus        79 ~~~~~gDGlAF~l~~~~~-~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n-~~d~~~~higi~~n~~~s~~~~~~--  153 (233)
T d1n47a_          79 AAAAVADGLAFFLAPPDT-QPQARGGFLGLFADRAH-DASYQTVAVEFDTYSN-AWDPNYTHIGIDTNGIESKKTTPF--  153 (233)
T ss_dssp             STTSCCEEEEEEEECTTC-CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC-TTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred             CCCCCCCceEEEECCCCC-CCCCCCCccccccccCC-CCcCceEEEEEEeeec-CCCCCCCceeEccCCccccccccc--
Confidence            566789999999999654 34578899999976544 4567889999999999 479999999999999998877665  


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCC---cccccccccccccCCc
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGD---DTQLNCVKSWAFDGSD  253 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~ss~  253 (644)
                       .+.+|+.++|||+||+  +.+.|++.   ++..|.|+..+||+.+||++|||||||+||.   ..+.|+|++|+|+++.
T Consensus       154 -~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~l  232 (233)
T d1n47a_         154 -DMVYGEKANIVITYQASTKALAASLVFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL  232 (233)
T ss_dssp             -CCCTTSCEEEEEEEETTTTEEEEEEEETTTTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             -eecCCCEEEEEEEEcCCCeEEEEEEEeCCCCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEEc
Confidence             6889999999999999  77888875   4455689999999999999999999999994   5678999999998763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=393.86  Aligned_cols=259  Identities=27%  Similarity=0.418  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--Cc--eEEEEEeecc-cchhhHHHHHHHHHHhcc-CCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NK--EIAVKRVSET-SRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..++||+|+||+||+|++.  +.  .||||+++.. .....+.|.+|+.+|.++ +|||||+++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56778899999999999999986  32  5788888644 344567899999999999 799999999999999999999


Q ss_pred             EeccCCCccchhhhccCCC--------CCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          393 YEYMPNGSLDKFIFYDETN--------SGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                      |||+++|+|.++|+.....        .......++|.++++++.|||.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999754210        00112249999999999999999999999   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCC-CCCCCccccchhhHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRK-PGNQSEQNSYNNSIVHW  543 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~-P~~~~~~~~~~~~l~~~  543 (644)
                      ||+|||+++.......    .....||..|+|||.+..+.++.++|||||||++|||++|.. ||.....    ..+.+.
T Consensus       167 kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHH
T ss_pred             EEcccccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence            9999999986543221    334568999999999999999999999999999999999765 5654332    122221


Q ss_pred             HHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          544 LWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       544 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +    ..+.         +.+.+....+.+.+|+.+||+.||++||||+||++.|+..
T Consensus       239 i----~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         239 L----PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             G----GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1    1111         1222333345688899999999999999999999998775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.7e-47  Score=387.26  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeecc----ce
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----DF  389 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~  389 (644)
                      ++|+..+.||+|+||+||+|++.  ++.||||+++...   ....+.|.+|+.++++++|||||++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57889999999999999999976  7899999997543   233567899999999999999999999998654    37


Q ss_pred             EEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEecc
Q 006446          390 LLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDF  469 (644)
Q Consensus       390 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DF  469 (644)
                      ++||||+++|+|.+++....        .+++.+.+.++.||++||+|||+   ++|+||||||+|||++.++..+|+||
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~--------~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG--------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEECCCCCEehhhhcccC--------CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehh
Confidence            99999999999999886553        38999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          470 GLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       470 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      |.++................||+.|||||++.+..++.++|||||||++|||+||+.||......+       .......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~  228 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVR  228 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHH
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHh
Confidence            999866433332233456689999999999999999999999999999999999999997643221       1122222


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhC
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-SMKTVLQVLSG  600 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-s~~evl~~L~~  600 (644)
                      .+....   ......++    +.+.+++.+|+++||++|| |++++++.|.+
T Consensus       229 ~~~~~~---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         229 EDPIPP---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCCCCG---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCCC---chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            222110   11112233    4577888999999999999 89999888764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-47  Score=392.37  Aligned_cols=263  Identities=22%  Similarity=0.375  Sum_probs=197.7

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-------CceEEEEEeeccc-chhhHHHHHHHHHHhcc-CCCceeeEeeeeeec-cc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETS-RQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYER-HD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  388 (644)
                      ++|+..++||+|+||.||+|++.       ++.||||+++... ....+.+..|...+.++ +|+|||++++++.+. ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56888999999999999999874       2579999987543 34456788888888887 689999999998765 46


Q ss_pred             eEEEEeccCCCccchhhhccCCCC--------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNS--------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS  460 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~  460 (644)
                      +++|||||++|+|.+++.......        ......++|.+++.++.||++||.|||+   ++|+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence            899999999999999997543211        0112348999999999999999999999   99999999999999999


Q ss_pred             CCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCccccchhh
Q 006446          461 EFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGR-KPGNQSEQNSYNNS  539 (644)
Q Consensus       461 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~-~P~~~~~~~~~~~~  539 (644)
                      ++++||+|||+|+....... ........||+.|||||.+.++.++.++|||||||++|||++|. .||.......   .
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~  245 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---E  245 (299)
T ss_dssp             GGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---H
T ss_pred             CCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            99999999999987653322 22245568999999999999999999999999999999999975 5676543221   1


Q ss_pred             HHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          540 IVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       540 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      +    ......+..         ...+......+.+++.+||+.||++|||++|+++.|+..
T Consensus       246 ~----~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 F----CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             H----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1    112222221         122222334577899999999999999999999999753

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=4.5e-46  Score=372.10  Aligned_cols=225  Identities=30%  Similarity=0.551  Sum_probs=196.7

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-cccccCCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecC
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVAKSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQ  102 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~  102 (644)
                      .+++|+|++|.++ ..+|.+. ||.+.++.|+||++..+ .....++|||+|++||+||++.++++++|+|+|+|.|...
T Consensus         2 ~~~sF~f~~F~~~-~~~l~l~G~A~i~~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~   80 (241)
T d1ukga_           2 DSLSFGFPTFPSD-QKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSP   80 (241)
T ss_dssp             CEEEEEESSCCSC-CSSEEEEETCEEETTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECS
T ss_pred             ccEEEEeCCCCCC-CCCEEEeeeEEEeCCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecC
Confidence            3789999999765 4589999 99999999999987653 2356899999999999999999999999999999999876


Q ss_pred             CCCCCCceEEEEecC-CCCCCCCCCcccccccccCC-CCCCccEEEEEEecCCCccC---CCCCCceeeecCCccceeee
Q 006446          103 TAQPGEGLAFVIAGN-KDLPENSEGQWLGIVNGITN-GTNQSQIVAIEFDTKKSYEQ---DINDNHVGLDVNSVYSIRQV  177 (644)
Q Consensus       103 ~~~~g~G~aF~l~~~-~~~~~~~~g~~lGl~~~~~~-~~~~~~~~aVEfDt~~n~~~---d~~~~Hvgid~ns~~s~~~~  177 (644)
                      ...+|||||||+.+. ...|....|+++|+++.... +...|+.+||||||++|.++   ||++||||||+|++.|.+..
T Consensus        81 ~~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~~  160 (241)
T d1ukga_          81 LSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTV  160 (241)
T ss_dssp             SSSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred             CCCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccccccc
Confidence            667899999999984 45678888999999876554 45678999999999998653   68999999999999998776


Q ss_pred             cCcccccCCCceEEEEEEEcC--ceEEEEEe--cCCCCCcccccCccCcCCCceeeeecccCCCcccccccccccccCCc
Q 006446          178 PLTRVNLANGTDIKVQVRYDG--QNITVFVA--NMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSD  253 (644)
Q Consensus       178 ~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~--~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~  253 (644)
                      .+   ++.+|+.++|||+||+  ++|.|++.  ++..|.+++.+||+.+++++|||||||+||...+.|+|++|+|+++.
T Consensus       161 ~~---~~~~g~~~~v~I~Yd~~~~~L~v~~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsFss~l  237 (241)
T d1ukga_         161 KW---DRRDGQSLNVLVTFNPSTRNLDVVATYSDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTSTL  237 (241)
T ss_dssp             EC---CCCTTCCEEEEEEEETTTTEEEEEEEETTCCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred             cc---ccCCCcEEEEEEEEeCCCcEEEEEEccCCCCceEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEEEEEe
Confidence            55   6789999999999998  78888774  67778999999999999999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-47  Score=392.72  Aligned_cols=277  Identities=23%  Similarity=0.375  Sum_probs=216.2

Q ss_pred             CCcccCHHHHH-HHhCCCCCCCcccccCcEEEEEeeec-------CceEEEEEeecccc-hhhHHHHHHHHHHhcc-CCC
Q 006446          305 APKKFRLKELK-KATGNFNPKNKLGKGGFGTVYKGIWR-------NKEIAVKRVSETSR-QGKQEFIAEVTTIGSL-RHR  374 (644)
Q Consensus       305 ~~~~~~~~~l~-~a~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~  374 (644)
                      .|.+++++... ...++|+..++||+|+||.||+|++.       ++.||||+++.... ....+|.+|+.+++++ +||
T Consensus         8 ~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hp   87 (311)
T d1t46a_           8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM   87 (311)
T ss_dssp             CTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCC
Confidence            35555553322 12367888999999999999999863       35799999976543 3456789999999999 699


Q ss_pred             ceeeEeeeeeeccceEEEEeccCCCccchhhhccCCCC----------CCCccccCHHHHHHHHHHHHHHHHHhHhCCCC
Q 006446          375 NLVKLIGWCYERHDFLLVYEYMPNGSLDKFIFYDETNS----------GPGEVTLNWEKRLSVIHGTSQALDYLHNGSEK  444 (644)
Q Consensus       375 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~----------~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~  444 (644)
                      |||+++|+|.+...+++|||||++|+|.+++.......          ......+++..++.++.||++||+|||+   +
T Consensus        88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~  164 (311)
T d1t46a_          88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---K  164 (311)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence            99999999999999999999999999999997654211          1123358999999999999999999999   9


Q ss_pred             CeEeCCCCCCCEEEcCCCcEEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcC
Q 006446          445 RVLHRDIKSSNIMLDSEFNARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACG  524 (644)
Q Consensus       445 ~ivHrDlkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG  524 (644)
                      +++||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+.++.++.++|||||||++|||+|+
T Consensus       165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~  243 (311)
T d1t46a_         165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL  243 (311)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CeeecccccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence            999999999999999999999999999997753322 2224567899999999999999999999999999999999995


Q ss_pred             -CCCCCCCccccchhhHHHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          525 -RKPGNQSEQNSYNNSIVHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       525 -~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                       .+|+......+   .+..    ....+         .+...+......+.+|+.+||++||++||||.||+++|++.
T Consensus       244 g~p~~~~~~~~~---~~~~----~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         244 GSSPYPGMPVDS---KFYK----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             TCCSSTTCCSSH---HHHH----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHH---HHHH----HHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             44454433221   1111    11111         12222333345688899999999999999999999999853

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-46  Score=380.43  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=202.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc---------hhhHHHHHHHHHHhccC-CCceeeEeeeeeec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR---------QGKQEFIAEVTTIGSLR-HRNLVKLIGWCYER  386 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~  386 (644)
                      ++|+..+.||+|+||+||+|+..  ++.||||+++....         ...+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57888999999999999999985  78999999875431         12346889999999997 99999999999999


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      +.++||||||++|+|.+++....        .+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--------~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEE
Confidence            99999999999999999996543        38999999999999999999999   99999999999999999999999


Q ss_pred             eccCCcccccccccccccccccccCCCccCcccccc------CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLV------GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSI  540 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l  540 (644)
                      +|||+++......    ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.......    +
T Consensus       152 ~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~  223 (277)
T d1phka_         152 TDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----M  223 (277)
T ss_dssp             CCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H
T ss_pred             ccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----H
Confidence            9999998775322    1345689999999999853      346889999999999999999999998654321    1


Q ss_pred             HHHHHHHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          541 VHWLWELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       541 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          ......+..      ...........+.+.+|+.+||++||++|||++|+++
T Consensus       224 ----~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 ----LRMIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----HHHHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                111111111      0111111122346778999999999999999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-46  Score=383.56  Aligned_cols=260  Identities=23%  Similarity=0.257  Sum_probs=195.1

Q ss_pred             CCCcccccCcEEEEEeeec--CceEEEEEeecccch-----hhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          323 PKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQ-----GKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ..++||+|+||+||+|++.  ++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999986  778999998654322     235688999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      ++++++..+.....        .+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~~~~~~~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          82 METDLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             CSEEHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             hcchHHhhhhhccc--------CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCcccccc
Confidence            98887766553222        37888899999999999999999   99999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCchh
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRIL  554 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~~  554 (644)
                      .....   .....+||+.|+|||++... .++.++|||||||++|||++|+.||......+    ....+.+........
T Consensus       151 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         151 GSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEE  223 (299)
T ss_dssp             TSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTT
T ss_pred             CCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChh
Confidence            53221   13446799999999998754 57999999999999999999999997654322    111122211110000


Q ss_pred             hhh------hcc-c--CCCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhC
Q 006446          555 DAA------DSR-L--GGEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSG  600 (644)
Q Consensus       555 ~~~------d~~-l--~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~  600 (644)
                      ...      ... .  ....+.     ...+.+.+|+.+|++.||++|||++|+++  .++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            000      000 0  000111     12345788999999999999999999987  4553

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-46  Score=390.43  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=203.4

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  393 (644)
                      ++|+..+.||+|+||.||+|++.  ++.||||++....   ....+.+.+|+.+|++++|||||++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47888999999999999999986  7899999986532   234567899999999999999999999999999999999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLAR  473 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~  473 (644)
                      ||+.+|+|..++....        .+++.....++.||+.||.|||+   ++|+||||||+||||+.++++||+|||+|+
T Consensus       121 e~~~~g~l~~~l~~~~--------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccccccchhhhHhhcC--------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeee
Confidence            9999999999997554        28999999999999999999999   999999999999999999999999999998


Q ss_pred             cccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCch
Q 006446          474 TIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGRI  553 (644)
Q Consensus       474 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~~  553 (644)
                      .....      .....||+.|||||++.+..++.++|||||||++|||++|+.||......    .+..   . ...+. 
T Consensus       190 ~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~---~-i~~~~-  254 (350)
T d1rdqe_         190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYE---K-IVSGK-  254 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH---H-HHHCC-
T ss_pred             ecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHH---H-HhcCC-
Confidence            76532      33467999999999999999999999999999999999999999764321    1111   1 11111 


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRP-----SMKTVLQ  596 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----s~~evl~  596 (644)
                           ......++    ..+.+++.+||+.||.+|+     +++++++
T Consensus       255 -----~~~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -----VRFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 11122333    4567889999999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-45  Score=388.35  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=197.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHH---HHHHHHHhccCCCceeeEeeeeeeccceE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEF---IAEVTTIGSLRHRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  390 (644)
                      ++|+..++||+|+||.||+|+..  +..||||++....   ......+   ..|+.+++.++|||||++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57888999999999999999986  7889999986432   1222333   34577888889999999999999999999


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      +|||||++|+|.+++....        .+++.....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        84 ivmE~~~gg~L~~~l~~~~--------~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEecCCCcHHHHHHhcc--------cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999997543        27889999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +|+.....     ......||+.|+|||++..+ .++.++|||||||++|||++|+.||.........    . +.....
T Consensus       153 la~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~-~~~~~~  222 (364)
T d1omwa3         153 LACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----E-IDRMTL  222 (364)
T ss_dssp             TCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----H-HHHHSS
T ss_pred             eeeecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----H-HHHhcc
Confidence            99876532     13456899999999999754 6899999999999999999999999765433211    0 111100


Q ss_pred             cCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          550 KGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       550 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                      .      ....+...++    ..+.+|+.+||+.||++|||     ++|+++
T Consensus       223 ~------~~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 T------MAVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             S------CCCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             c------CCCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0      0111122233    45778899999999999999     688874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=385.15  Aligned_cols=246  Identities=23%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc---chhhHHHHHHHHHHh-ccCCCceeeEeeeeeeccceEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS---RQGKQEFIAEVTTIG-SLRHRNLVKLIGWCYERHDFLLV  392 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV  392 (644)
                      ++|+..+.||+|+||+||+|++.  ++.||||+++...   ....+.+..|..++. .++|||||++++++.+++.+++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46888999999999999999986  7889999997532   234456777777765 68999999999999999999999


Q ss_pred             EeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCc
Q 006446          393 YEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLA  472 (644)
Q Consensus       393 ~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla  472 (644)
                      ||||++|+|.+++.....        ++..+...++.||+.||+|||+   ++|+||||||+|||+++++++||+|||++
T Consensus        82 mEy~~~g~L~~~i~~~~~--------~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK--------FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeecCCCcHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchh
Confidence            999999999999975542        7889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR  552 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~  552 (644)
                      +......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +    +.....+.
T Consensus       151 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~----~~~i~~~~  219 (320)
T d1xjda_         151 KENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----L----FHSIRMDN  219 (320)
T ss_dssp             BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H----HHHHHHCC
T ss_pred             hhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----H----HHHHHcCC
Confidence            8654221   22445689999999999999999999999999999999999999997654321    1    11111111


Q ss_pred             hhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 006446          553 ILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMK-TVLQ  596 (644)
Q Consensus       553 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~-evl~  596 (644)
                            +.+...+    ...+.+|+.+||+.||++||+++ ++++
T Consensus       220 ------~~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 ------PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ------CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                  1122223    34577899999999999999996 6753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-46  Score=385.75  Aligned_cols=252  Identities=21%  Similarity=0.287  Sum_probs=204.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEecc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEYM  396 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  396 (644)
                      ++|+..+.||+|+||+||+|++.  ++.||||.++.... ....+.+|+.+|++++|||||++++++.+.+.+++|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            57888999999999999999986  67899999976543 3456889999999999999999999999999999999999


Q ss_pred             CCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC--CcEEEeccCCccc
Q 006446          397 PNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE--FNARLGDFGLART  474 (644)
Q Consensus       397 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~--~~vkL~DFGla~~  474 (644)
                      ++|+|.+++.....       .+++.+...++.||++||+|||+   .+|+||||||+|||++.+  ..+||+|||+++.
T Consensus        84 ~gg~L~~~i~~~~~-------~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          84 SGLDIFERINTSAF-------ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             CCCBHHHHHTSSSC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999999965432       38999999999999999999999   999999999999999854  5899999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhc-Cch
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRK-GRI  553 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~-~~~  553 (644)
                      .....    ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.......    +..   ..... ...
T Consensus       154 ~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~---~i~~~~~~~  222 (321)
T d1tkia_         154 LKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIE---NIMNAEYTF  222 (321)
T ss_dssp             CCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---HHHHTCCCC
T ss_pred             cccCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----HHH---HHHhCCCCC
Confidence            64321    1344678999999999999999999999999999999999999997654321    111   11111 011


Q ss_pred             hhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhC
Q 006446          554 LDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSG  600 (644)
Q Consensus       554 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~  600 (644)
                      .....    ..+    ...+.+|+.+|++.||++|||++|+++  .+++
T Consensus       223 ~~~~~----~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         223 DEEAF----KEI----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CHHHH----TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             Chhhc----cCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            11110    112    234678999999999999999999997  3544

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=385.43  Aligned_cols=260  Identities=20%  Similarity=0.281  Sum_probs=199.3

Q ss_pred             CCCCCCC-cccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhcc-CCCceeeEeeeeee----ccceE
Q 006446          319 GNFNPKN-KLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSL-RHRNLVKLIGWCYE----RHDFL  390 (644)
Q Consensus       319 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~  390 (644)
                      ++|...+ .||+|+||+||+|++.  ++.||||+++.     ...+.+|+.++.++ +|||||++++++.+    +..++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            4677664 5999999999999976  78999999864     34567899987655 89999999999865    45789


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC---CCcEEEe
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS---EFNARLG  467 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~---~~~vkL~  467 (644)
                      +|||||++|+|.+++.....      ..+++.+...|+.||+.||+|||+   ++|+||||||+|||++.   ++.+||+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~------~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC------CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEECCCCCcHHHHHHhcCC------CCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence            99999999999999965322      148999999999999999999999   99999999999999986   4679999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHH
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWEL  547 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~  547 (644)
                      |||+|+......    ......||+.|||||++.+..++.++|||||||++|||+||+.||...........+    ...
T Consensus       157 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~  228 (335)
T d2ozaa1         157 DFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTR  228 (335)
T ss_dssp             CCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------C
T ss_pred             ccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHH
Confidence            999998765322    134568999999999999999999999999999999999999999764432211111    110


Q ss_pred             HhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCCCCC
Q 006446          548 RRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEADPPV  606 (644)
Q Consensus       548 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~~~~  606 (644)
                      ...+..      .+...........+.+|+.+|++.||++|||++|+++.  +......|.
T Consensus       229 i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  283 (335)
T d2ozaa1         229 IRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  283 (335)
T ss_dssp             CCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred             HhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence            000110      00011111223567889999999999999999999983  544443333

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=376.51  Aligned_cols=266  Identities=24%  Similarity=0.344  Sum_probs=199.5

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47888999999999999999986  7889999996543  2335788999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      |+.+ ++..++......      .+++.++..++.|++.||+|||+   ++|+||||||+|||++.++++||+|||+|+.
T Consensus        82 ~~~~-~~~~~~~~~~~~------~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             CCSE-EHHHHHHHTTTT------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             ecCC-chhhhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCccee
Confidence            9965 444454333221      38999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc-
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR-  552 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~-  552 (644)
                      .....   .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.......   .+.. +........ 
T Consensus       152 ~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~-i~~~~~~~~~  224 (298)
T d1gz8a_         152 FGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFR-IFRTLGTPDE  224 (298)
T ss_dssp             HCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCT
T ss_pred             ccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHH-HHHhcCCCch
Confidence            64322   2244568999999999877655 5889999999999999999999997654221   1111 111111100 


Q ss_pred             -hhhhh--hcccCCCC------C-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCC
Q 006446          553 -ILDAA--DSRLGGEF------S-----EKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGE  601 (644)
Q Consensus       553 -~~~~~--d~~l~~~~------~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~  601 (644)
                       .....  .+.....+      +     ......+.+|+.+|++.||++|||++|+++.  ++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence             00000  00000000      0     0112456788999999999999999999984  5543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-44  Score=371.32  Aligned_cols=260  Identities=22%  Similarity=0.341  Sum_probs=197.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||+||+|+++ ++.||||+++...  ....+.+.+|+.+|++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            47888999999999999999987 7889999996543  23357899999999999999999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCcccc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLARTI  475 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~~  475 (644)
                      +.++.+..+.....        .++......++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~~~~~~~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             CSEEHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             ehhhhHHHHHhhcC--------CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            97776666653322        38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc--
Q 006446          476 QENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR--  552 (644)
Q Consensus       476 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~--  552 (644)
                      .....   ......+++.|+|||.+... .++.++|||||||++|||++|+.||........   +.. +........  
T Consensus       151 ~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~-i~~~~~~~~~~  223 (286)
T d1ob3a_         151 GIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSK  223 (286)
T ss_dssp             CC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTT
T ss_pred             ccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHH-HHHhhCCCChh
Confidence            53221   13445789999999998754 568999999999999999999999976543221   111 111111100  


Q ss_pred             ----hhhhh--hcccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 ----ILDAA--DSRLG-------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 ----~~~~~--d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .....  +....       ..+.......+.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000  00000       0011112345778999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=374.98  Aligned_cols=261  Identities=25%  Similarity=0.307  Sum_probs=196.0

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec---CceEEEEEeecccc--hhhHHHHHHHHHHhcc---CCCceeeEeeeeee----
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR---NKEIAVKRVSETSR--QGKQEFIAEVTTIGSL---RHRNLVKLIGWCYE----  385 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~----  385 (644)
                      .++|+..++||+|+||+||+|++.   ++.||||+++....  .....+.+|+.+++.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974   44689999865432  2234566777777666   79999999999863    


Q ss_pred             -ccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcE
Q 006446          386 -RHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNA  464 (644)
Q Consensus       386 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~v  464 (644)
                       ...+++++||+.++++.........       .+++.....++.|+++||+|||+   ++|+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~  155 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQI  155 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCE
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCe
Confidence             3468999999988877655443322       38899999999999999999999   999999999999999999999


Q ss_pred             EEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          465 RLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       465 kL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      ||+|||+++......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.   
T Consensus       156 kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---  228 (305)
T d1blxa_         156 KLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---  228 (305)
T ss_dssp             EECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---
T ss_pred             eecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH---
Confidence            999999998654221    2455689999999999999999999999999999999999999998654322111111   


Q ss_pred             HHHHhcCchhhh------hhcccC-------CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 WELRRKGRILDA------ADSRLG-------GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 ~~~~~~~~~~~~------~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                       ...........      ......       ..+.....+.+.+|+.+|+++||++|||++|+++
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         229 -DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             -HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             11110000000      000000       0011122345677899999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=371.04  Aligned_cols=238  Identities=27%  Similarity=0.424  Sum_probs=194.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccc------hhhHHHHHHHHHHhccC--CCceeeEeeeeeeccc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSR------QGKQEFIAEVTTIGSLR--HRNLVKLIGWCYERHD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~  388 (644)
                      ++|+..++||+|+||+||+|+..  +..||||++.....      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57889999999999999999986  78899999875321      12345678999999986  8999999999999999


Q ss_pred             eEEEEeccCC-CccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCC-CcEEE
Q 006446          389 FLLVYEYMPN-GSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSE-FNARL  466 (644)
Q Consensus       389 ~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~-~~vkL  466 (644)
                      .++||||+.+ +++.+++....        .+++.+...++.|+++||+|||+   ++|+||||||+|||++.+ +.+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~--------~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG--------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEEEEEeccCcchHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEE
Confidence            9999999976 56777775443        38999999999999999999999   999999999999999855 79999


Q ss_pred             eccCCcccccccccccccccccccCCCccCccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH
Q 006446          467 GDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRA-TIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW  545 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~  545 (644)
                      +|||+|+.....     ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||....      .+.    
T Consensus       153 ~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~----  217 (273)
T d1xwsa_         153 IDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII----  217 (273)
T ss_dssp             CCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH----
T ss_pred             Cccccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh----
Confidence            999999865422     1345679999999999987765 577999999999999999999996421      111    


Q ss_pred             HHHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                          .+.      ..++..++    ..+.+|+.+|++.||++|||++|+++
T Consensus       218 ----~~~------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 ----RGQ------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----HCC------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----hcc------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                111      11223343    45678899999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=365.01  Aligned_cols=270  Identities=22%  Similarity=0.245  Sum_probs=199.2

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc-chhhHHHHHHHHHHhccCCCceeeEeeeeeecc----ceE
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH----DFL  390 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~  390 (644)
                      +.+|+..++||+|+||+||+|+..  ++.||||++.... ....+.+++|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            356888999999999999999876  7889999997543 334567899999999999999999999997653    234


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccC
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFG  470 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFG  470 (644)
                      ++++|+.+|+|.+++...         .+++.....++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        87 ~l~~~~~~g~L~~~l~~~---------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeecCCchhhhhhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccC
Confidence            555667799999999643         28999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHh
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRR  549 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~  549 (644)
                      +++................||+.|+|||++.. ..++.++||||+||++|||++|+.||............    .....
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~----~~~~~  230 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI----LGILG  230 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHHHC
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH----hhhcc
Confidence            99876543333333456779999999999854 45789999999999999999999999765432111111    11000


Q ss_pred             cCchh--------hhh--hcccC--CCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCCC
Q 006446          550 KGRIL--------DAA--DSRLG--GEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEAD  603 (644)
Q Consensus       550 ~~~~~--------~~~--d~~l~--~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~~  603 (644)
                      .....        ...  .....  ...+.     .....+.+|+.+|++.||++|||++|+++.  |+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence            00000        000  00000  00111     111346789999999999999999999974  554433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-42  Score=357.69  Aligned_cols=259  Identities=17%  Similarity=0.257  Sum_probs=196.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeee-eeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGW-CYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~-~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++....  ..+++..|++++++++|+|++..++. ..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46889999999999999999986  7899999987643  23568899999999988776665554 5666778999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEc---CCCcEEEeccCCc
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLD---SEFNARLGDFGLA  472 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld---~~~~vkL~DFGla  472 (644)
                      + +++|...+.....       .+++..++.++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|
T Consensus        85 ~-~~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          85 L-GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             C-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             c-CCchhhhhhhccC-------CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence            9 6677666654333       38999999999999999999999   9999999999999985   4567999999999


Q ss_pred             ccccccccc----cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHH
Q 006446          473 RTIQENLKT----HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELR  548 (644)
Q Consensus       473 ~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~  548 (644)
                      +........    ........||+.|||||.+.+..++.++|||||||++|||++|+.||...........+..+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            987533211    1123456799999999999999999999999999999999999999976544332222221111100


Q ss_pred             hcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Q 006446          549 RKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSG  600 (644)
Q Consensus       549 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~  600 (644)
                            ....+.+...++    ..+.+++.+|++.||++||+++++.+.|+.
T Consensus       234 ------~~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         234 ------STPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ------HSCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ------CCChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                  001111222333    356778899999999999999999888865

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=2.7e-42  Score=341.49  Aligned_cols=213  Identities=31%  Similarity=0.474  Sum_probs=178.4

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCC-CCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGA-PITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~-~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~  101 (644)
                      +.++|+|++|+..  .+|.++ ||.+. +|.|+||++.... ....++|||+|++||+||+  +++++||+|+|+|.|.+
T Consensus         2 ~~~sF~f~~F~~~--~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~~   77 (228)
T d1ioaa_           2 TETSFNFPNFHTD--DKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIRA   77 (228)
T ss_dssp             CCCEEEESSCCTT--SSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECCB
T ss_pred             ccceEEcCCCCCC--CcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEec
Confidence            5789999999864  369999 99875 7899999875422 2346899999999999998  57899999999999987


Q ss_pred             -CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCc
Q 006446          102 -QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 -~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                       +...+||||||+|+|... +.+..|++|||++.+ .++..++.|||||||++| .+|++.+|+|+++++..        
T Consensus        78 ~~~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~-~~~~~~~~vave~dt~~n-~~~~~~~~~~~~~~~~~--------  146 (228)
T d1ioaa_          78 KNQSISAYGLAFALVPVNS-PPQKKQEFLGIFNTN-NPEPNARTVAVVFNTFKN-RIDFDKNFIKPYVNENC--------  146 (228)
T ss_dssp             SCTTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCS-SCCGGGCCEEEEEETTTT-EEEEEESSSSCSEEEEC--------
T ss_pred             CCCCCCCCEEEEEEeCCCC-CCCCCcccccccccc-CCCCcceeEEEEecCccc-cccCCCCccceeccccc--------
Confidence             556789999999999654 456789999999864 445678899999999998 35888888888876432        


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCC---CcccccccccccccCC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTG---DDTQLNCVKSWAFDGS  252 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf~ss  252 (644)
                      ...+.+|+.++|||+||+  ++|.|++.   ++..|.|++.+||+++|+++|||||||+||   ...|.|+|++|+|+++
T Consensus       147 ~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFss~  226 (228)
T d1ioaa_         147 DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK  226 (228)
T ss_dssp             CHHHHCSSCEEEEEEEETTTTEEEEEEEETTTCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred             ccccccCcEEEEEEEEcCCCCEEEEEEEeCCCCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeEEe
Confidence            456779999999999998  78888884   556678999999999999999999999999   4558899999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-43  Score=368.08  Aligned_cols=260  Identities=21%  Similarity=0.258  Sum_probs=189.7

Q ss_pred             CCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCCCceeeEeeeeeec------cceEE
Q 006446          320 NFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------HDFLL  391 (644)
Q Consensus       320 ~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l  391 (644)
                      +|+..++||+|+||+||+|++.  ++.||||++.....    ...+|+.+|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4667889999999999999986  78899999976432    234799999999999999999998643      24799


Q ss_pred             EEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccC
Q 006446          392 VYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFG  470 (644)
Q Consensus       392 V~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFG  470 (644)
                      |||||+++.+.........     ...+++.++..++.||++||+|||+   ++|+||||||+|||++.++ .+||+|||
T Consensus        97 v~Ey~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EEeccCCccHHHHHhhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEeccc
Confidence            9999976644443322111     1148999999999999999999999   9999999999999999775 89999999


Q ss_pred             CcccccccccccccccccccCCCccCcccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH-----
Q 006446          471 LARTIQENLKTHHSTKEIAGTPGYMAPESFLV-GRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL-----  544 (644)
Q Consensus       471 la~~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~-----  544 (644)
                      +++.......    .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+....     
T Consensus       169 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         169 SAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  244 (350)
T ss_dssp             TCEECCTTSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhhccCCcc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence            9987653221    344679999999998765 568999999999999999999999997654322111111100     


Q ss_pred             --HHHHhcCchhhhhhcccC-----CCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          545 --WELRRKGRILDAADSRLG-----GEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       545 --~~~~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                        +.... ....+..-+...     ..........+.+|+.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHC-C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhhhhhc-cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000 000000000000     0011122345778899999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=357.99  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=193.6

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeee--------c
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYE--------R  386 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~  386 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++...  .....+.+.+|+.+|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67888999999999999999986  788999998644  23345678999999999999999999999865        3


Q ss_pred             cceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEE
Q 006446          387 HDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARL  466 (644)
Q Consensus       387 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL  466 (644)
                      +.+++||||+.++.+..+.....        .++......++.|+++||.|||+   ++|+||||||+|||++.++.+||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~--------~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEeccCCCccchhhhccc--------ccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEe
Confidence            46899999998777665443221        37788889999999999999999   99999999999999999999999


Q ss_pred             eccCCccccccccccc-ccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH
Q 006446          467 GDFGLARTIQENLKTH-HSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL  544 (644)
Q Consensus       467 ~DFGla~~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~  544 (644)
                      +|||+++......... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.   
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~---  235 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---  235 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH---
Confidence            9999998765322111 112345799999999998765 68999999999999999999999997654322211111   


Q ss_pred             HHHHhcCchhhhhhccc-------------CCCCCH-H------HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 WELRRKGRILDAADSRL-------------GGEFSE-K------EMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 ~~~~~~~~~~~~~d~~l-------------~~~~~~-~------~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                       ...  +..........             ...... +      ....+.+|+.+||++||++|||++|+++.
T Consensus       236 -~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         236 -QLC--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             -HHH--CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -Hhc--CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             111  11000000000             000001 0      12245678999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=361.05  Aligned_cols=266  Identities=20%  Similarity=0.282  Sum_probs=194.3

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeecc--cchhhHHHHHHHHHHhccCCCceeeEeeeeeecc------
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSET--SRQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERH------  387 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------  387 (644)
                      .++|+..++||+|+||+||+|++.  ++.||||+++..  .....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357888999999999999999986  788999999753  2334567889999999999999999999998654      


Q ss_pred             ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEe
Q 006446          388 DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLG  467 (644)
Q Consensus       388 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~  467 (644)
                      ++++||||+ +.+|..++...         .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecc-cccHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccc
Confidence            579999999 66777766432         28999999999999999999999   999999999999999999999999


Q ss_pred             ccCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH-
Q 006446          468 DFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW-  545 (644)
Q Consensus       468 DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~-  545 (644)
                      |||+|+.....      .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||................. 
T Consensus       164 Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         164 DFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             CCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence            99999876532      3456799999999998764 568999999999999999999999976543221111110000 


Q ss_pred             ---HHHhcCc--hhhhhh---cccCC----CCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhCCC
Q 006446          546 ---ELRRKGR--ILDAAD---SRLGG----EFSEKEMECVLILGLACCHPNPHLRPSMKTVLQV--LSGEA  602 (644)
Q Consensus       546 ---~~~~~~~--~~~~~d---~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~--L~~~~  602 (644)
                         +......  ......   +....    .........+.+|+.+|++.||++|||++|+++.  ++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence               0000000  000000   00000    0111122346688999999999999999999984  66544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-42  Score=353.53  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=201.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeeccceEEEEe
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYERHDFLLVYE  394 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  394 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||+++...  ....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47888999999999999999986  6789999986543  2345788999999999999999999999999999999999


Q ss_pred             ccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          395 YMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       395 y~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ++.+++|..++....        .+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||.++.
T Consensus        82 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          82 FCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             CCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ecccccccccccccc--------ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhc
Confidence            999998887775433        37889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccccccccccccccccCCCccCccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHHHHhcCc-
Q 006446          475 IQENLKTHHSTKEIAGTPGYMAPESFLVGR-ATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWELRRKGR-  552 (644)
Q Consensus       475 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~~~~~~~-  552 (644)
                      ......   ......++..|+|||.+.... ++.++||||+||++|||++|+.||.......   ....-+........ 
T Consensus       151 ~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~~~  224 (292)
T d1unla_         151 FGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCT
T ss_pred             ccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH---HHHHHHHhhcCCCCh
Confidence            653222   133456788899999987665 6899999999999999999999975433211   11111111111100 


Q ss_pred             -----hhhhhhc---------ccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          553 -----ILDAADS---------RLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       553 -----~~~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                           .....+.         .-...........+.+|+.+|+++||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000000         0000111222345678899999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-42  Score=358.32  Aligned_cols=251  Identities=23%  Similarity=0.282  Sum_probs=200.3

Q ss_pred             CCCCCCCcccccCcEEEEEeeec-----CceEEEEEeecc----cchhhHHHHHHHHHHhccCC-CceeeEeeeeeeccc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR-----NKEIAVKRVSET----SRQGKQEFIAEVTTIGSLRH-RNLVKLIGWCYERHD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~  388 (644)
                      ++|+..+.||+|+||+||+|+..     ++.||||+++..    .....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            46888999999999999999762     578999998643    22345678899999999977 899999999999999


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +++++||+.+|+|.+++.....        +.......++.|++.||+|||+   ++|+||||||+|||++.++.+||+|
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~--------~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER--------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             eeeeeecccccHHHHHHHhccc--------ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEee
Confidence            9999999999999999876543        6677888899999999999999   9999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccC--CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG--RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      ||+++.+.....  .......|++.|+|||.+...  .++.++|||||||+||||++|+.||...........+..-   
T Consensus       173 FG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~---  247 (322)
T d1vzoa_         173 FGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---  247 (322)
T ss_dssp             SSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---
T ss_pred             ccchhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---
Confidence            999987653222  113456799999999998754  4688999999999999999999999876544332222211   


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPS-----MKTVLQ  596 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-----~~evl~  596 (644)
                       ....          ...++......+.+++.+||++||++|||     ++|+++
T Consensus       248 -~~~~----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         248 -ILKS----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -HHHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -cccC----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             1111          11122233456777899999999999994     788875

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.1e-42  Score=343.93  Aligned_cols=212  Identities=26%  Similarity=0.412  Sum_probs=183.0

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      .+++|+|++|+..   ||.+. ||.+. +|.|+||+...  +...++|||+|++||+|||+.++.++||+|+|+|.|.+ 
T Consensus         2 ~~~sf~f~~F~~~---nl~l~GdA~v~~~g~i~LT~~~~--~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~   76 (226)
T d1avba_           2 NDASFNVETFNKT---NLILQGDATVSSEGHLLLTNVKG--NEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAK   76 (226)
T ss_dssp             EEEEEEESSCCGG---GEEEEETCEECTTSCEECSCSSS--CCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEES
T ss_pred             CceEEECCCCCcc---ceeEecceEECCCCeEEccCCCC--CCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecC
Confidence            5789999999875   89999 99886 67999997643  22368999999999999999999999999999999987 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCcc-CCCCCCceeeecCCccceeeecCc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYE-QDINDNHVGLDVNSVYSIRQVPLT  180 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~-~d~~~~Hvgid~ns~~s~~~~~~~  180 (644)
                      ....+||||||+|+|....+ +..||++||++.          ++|||||+.|.. +|+.+||||||+|+..+..+.+. 
T Consensus        77 ~~~~~gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~-  144 (226)
T d1avba_          77 NIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESC-  144 (226)
T ss_dssp             STTSCCEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC-
T ss_pred             CCCCCCceEEEEEccCCCCC-CCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCcccccccc-
Confidence            56678999999999966443 568889999763          369999999854 59999999999999999888887 


Q ss_pred             ccccCCCceEEEEEEEcC--ceEEEEEe---cCCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCC
Q 006446          181 RVNLANGTDIKVQVRYDG--QNITVFVA---NMETPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGS  252 (644)
Q Consensus       181 ~~~l~~g~~~~~~I~Y~~--~~l~v~~~---~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss  252 (644)
                      ...+.+|+.++|||+||+  ++|+|++.   ++..|.++..+||+.+||++|||||||+||..   .|.|+|++|+|+++
T Consensus       145 ~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~  224 (226)
T d1avba_         145 NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTTTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             ccccCCCeEEEEEEEEcCCCcEEEEEEEeCCCCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEe
Confidence            678999999999999999  78888885   34455889999999999999999999999963   56899999999876


Q ss_pred             c
Q 006446          253 D  253 (644)
Q Consensus       253 ~  253 (644)
                      .
T Consensus       225 ~  225 (226)
T d1avba_         225 F  225 (226)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-41  Score=350.91  Aligned_cols=260  Identities=17%  Similarity=0.239  Sum_probs=205.2

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccCC-CceeeEeeeeeeccceEEEEec
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRH-RNLVKLIGWCYERHDFLLVYEY  395 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey  395 (644)
                      ++|+..++||+|+||+||+|++.  ++.||||++....  ....+.+|++.++.++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57889999999999999999976  7889999886543  23567788999999975 8999999999999999999999


Q ss_pred             cCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcC-----CCcEEEeccC
Q 006446          396 MPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDS-----EFNARLGDFG  470 (644)
Q Consensus       396 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~-----~~~vkL~DFG  470 (644)
                      + +++|.+++.....       .+++..+..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||
T Consensus        83 ~-~~~l~~~~~~~~~-------~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          83 L-GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             C-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             c-CCCHHHHHHhhcc-------chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence            9 7999998865443       38999999999999999999999   99999999999999974     5789999999


Q ss_pred             Ccccccccccc----cccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHHH
Q 006446          471 LARTIQENLKT----HHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLWE  546 (644)
Q Consensus       471 la~~~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~~  546 (644)
                      +|+........    ........||+.|||||++.+..++.++|||||||++|||++|+.||............ ..+..
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~  230 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGE  230 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHh
Confidence            99876532211    11234567999999999999999999999999999999999999999865443322211 11111


Q ss_pred             HHhcCchhhhhhcccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Q 006446          547 LRRKGRILDAADSRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQVLSGE  601 (644)
Q Consensus       547 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~L~~~  601 (644)
                      .......     +.+...++    +.+.+++..|++.+|++||+++.+.+.|+..
T Consensus       231 ~~~~~~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         231 KKQSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCCCh-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1111111     11223333    3467788899999999999999988877653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-41  Score=354.81  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=194.9

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeec--cceEEEE
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYER--HDFLLVY  393 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~  393 (644)
                      ++|+..++||+|+||+||+|+..  ++.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ..+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            47888999999999999999986  7889999986543   467889999999995 99999999998744  4689999


Q ss_pred             eccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCC-cEEEeccCCc
Q 006446          394 EYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEF-NARLGDFGLA  472 (644)
Q Consensus       394 Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~-~vkL~DFGla  472 (644)
                      |||++++|..+..           .++......++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|
T Consensus       112 e~~~~~~L~~~~~-----------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-----------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             ECCCSCBGGGTTT-----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             eecCCCcHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccc
Confidence            9999999977641           38899999999999999999999   9999999999999998655 6999999999


Q ss_pred             ccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccch-hhHHHH-----HH
Q 006446          473 RTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYN-NSIVHW-----LW  545 (644)
Q Consensus       473 ~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~-~~l~~~-----~~  545 (644)
                      +......    ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+...     ..
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~  253 (328)
T d3bqca1         178 EFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY  253 (328)
T ss_dssp             EECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred             eeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence            8765322    13456789999999998765 4799999999999999999999998765432111 111110     00


Q ss_pred             HHHhcCch--hhhhh------------cccCCCCCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 006446          546 ELRRKGRI--LDAAD------------SRLGGEFSEKEMECVLILGLACCHPNPHLRPSMKTVLQ  596 (644)
Q Consensus       546 ~~~~~~~~--~~~~d------------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~  596 (644)
                      ........  .....            ..............+.+|+.+|++.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01110000  00000            00001111122345678999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=356.35  Aligned_cols=261  Identities=21%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec------cc
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER------HD  388 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~  388 (644)
                      ++|+..++||+|+||+||+|++.  +..||||++....  ....+.+.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67899999999999999999986  7899999997543  33456788999999999999999999998643      57


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      +|+||||+.++.+ +.+..          .+++.....++.||+.||.|||+   ++|+||||||+|||++.++.+|++|
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~----------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM----------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEeccchHHH-Hhhhc----------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeec
Confidence            8999999965544 44421          27899999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHH----
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWL----  544 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~----  544 (644)
                      ||+++......    ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||...........+..-.    
T Consensus       163 f~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         163 FGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_dssp             CCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhhhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence            99998765322    2455679999999999999999999999999999999999999997654322111111100    


Q ss_pred             -----------HHHHhcC-c-----hhhhhhcccCCC---CCHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 006446          545 -----------WELRRKG-R-----ILDAADSRLGGE---FSEKEMECVLILGLACCHPNPHLRPSMKTVLQV  597 (644)
Q Consensus       545 -----------~~~~~~~-~-----~~~~~d~~l~~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~evl~~  597 (644)
                                 ....... .     ............   ........+.+|+.+|++.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                       0000000 0     000000011111   112345567889999999999999999999854

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-41  Score=352.17  Aligned_cols=266  Identities=19%  Similarity=0.244  Sum_probs=195.9

Q ss_pred             hCCCCCCCcccccCcEEEEEeeec--CceEEEEEeeccc--chhhHHHHHHHHHHhccCCCceeeEeeeeeec-----cc
Q 006446          318 TGNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS--RQGKQEFIAEVTTIGSLRHRNLVKLIGWCYER-----HD  388 (644)
Q Consensus       318 ~~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  388 (644)
                      .++|+..++||+|+||+||+|++.  ++.||||+++...  ....+.+.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467889999999999999999876  7899999997543  33456788999999999999999999998643     34


Q ss_pred             eEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCcEEEec
Q 006446          389 FLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFNARLGD  468 (644)
Q Consensus       389 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~vkL~D  468 (644)
                      .+++++|+.+|+|.+++...         .+++.+...++.||+.||+|||+   ++|+||||||+|||++.++.+|++|
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEeecCCchhhhcccc---------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccc
Confidence            56677888899999998532         28999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccccccccccccccccCCCccCccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCccccchhhHHHHHH--
Q 006446          469 FGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVG-RATIETDIYAFGVLILEVACGRKPGNQSEQNSYNNSIVHWLW--  545 (644)
Q Consensus       469 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~~~l~~~~~--  545 (644)
                      ||++......      .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.....  
T Consensus       165 fg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         165 FGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             C----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999765422      3445789999999987665 468999999999999999999999976543222221211100  


Q ss_pred             --HHHhcCch--hhhhhcccC--CCCCH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCC
Q 006446          546 --ELRRKGRI--LDAADSRLG--GEFSE-----KEMECVLILGLACCHPNPHLRPSMKTVLQ--VLSGE  601 (644)
Q Consensus       546 --~~~~~~~~--~~~~d~~l~--~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~evl~--~L~~~  601 (644)
                        +.......  .......+.  .....     .....+.+|+.+|++.||++|||++|+++  .+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence              00000000  000000000  00000     11234678999999999999999999997  45543

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.5e-40  Score=321.59  Aligned_cols=191  Identities=27%  Similarity=0.461  Sum_probs=157.0

Q ss_pred             cceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEec-
Q 006446           25 SSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILN-  101 (644)
Q Consensus        25 ~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~-  101 (644)
                      +.++|+|++|+..   +|.++ ||.+. +|.|+||++..     +++|||+|++||+||++.+++++||+|+|+|.|.+ 
T Consensus         2 ~~~sF~~~~F~~~---~l~l~GdA~v~~~g~i~LT~~~~-----~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~   73 (204)
T d1dhkb_           2 TETSFIIDAFNKT---NLILQGDATVSSNGNLQLSYNSY-----DSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTH   73 (204)
T ss_dssp             CCCEEEESSCCGG---GEEEESSEEECTTSCEEESSSCS-----SEEEEEEESSCEESEETTTTEECEEEEEEEEEEECC
T ss_pred             ccceEECCCCCcc---CeeEecceEEcCCCeEEeCCCCC-----CCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecC
Confidence            5789999999775   89999 99985 78999998765     79999999999999999999999999999999987 


Q ss_pred             CCCCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeecCcc
Q 006446          102 QTAQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVPLTR  181 (644)
Q Consensus       102 ~~~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~~~~  181 (644)
                      +...+||||||+++|...                   ...++.+||||||+.|        |+++|+|+.... ...+ .
T Consensus        74 ~~~~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt~~n--------~~~~d~~~~~~~-~~~~-~  124 (204)
T d1dhkb_          74 RQANSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDTFLS--------RISIDVNNNDIK-SVPW-D  124 (204)
T ss_dssp             C---CCSEEEEEEEEC-------------------------CCEEEEEETTTT--------EEEEEETTEEEE-EEEC-C
T ss_pred             CCCCCCceEEEEecCCCC-------------------CCCCcEeeEeeEcccc--------cccCcccccccc-cccc-c
Confidence            555689999999998431                   2335789999999876        677777664432 2233 5


Q ss_pred             cccCCCceEEEEEEEcC--ceEEEEEec---CCCCCcccccCccCcCCCceeeeecccCCCc---ccccccccccccCC
Q 006446          182 VNLANGTDIKVQVRYDG--QNITVFVAN---METPLLSEPIDLSEYLPEKVFVGFSASTGDD---TQLNCVKSWAFDGS  252 (644)
Q Consensus       182 ~~l~~g~~~~~~I~Y~~--~~l~v~~~~---~~~~~ls~~~dl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ss  252 (644)
                      ..+.+|+.++|||+||+  ++|.|++..   +..+.|++.+||+.++|++|||||||+||..   .|.|+|++|+|+++
T Consensus       125 ~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss~  203 (204)
T d1dhkb_         125 VHDYDGQNAEVRITYNSSTKVFSVSLSNPSTGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK  203 (204)
T ss_dssp             GGGTTTSCEEEEEEEETTTTEEEEEEECTTTCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred             cEecCCCEEEEEEEEcCCCEEEEEEEecCCCCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEec
Confidence            67889999999999999  788998853   3445899999999999999999999999964   57899999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-36  Score=322.29  Aligned_cols=265  Identities=20%  Similarity=0.214  Sum_probs=189.8

Q ss_pred             CCCCCCCcccccCcEEEEEeeec--CceEEEEEeecccchhhHHHHHHHHHHhccC-----------CCceeeEeeeeee
Q 006446          319 GNFNPKNKLGKGGFGTVYKGIWR--NKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-----------HRNLVKLIGWCYE  385 (644)
Q Consensus       319 ~~f~~~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~  385 (644)
                      ++|+..++||+|+||+||+|+..  ++.||||+++.... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35888999999999999999875  78899999975432 3456788998888875           5789999998875


Q ss_pred             cc--ceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          386 RH--DFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       386 ~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                      ..  ..+++++++..+...........     ...+.......++.||+.||+|||+  ..+|+||||||+||||+.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEET
T ss_pred             ccccceeeeeeeccccccccccccccc-----ccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCc
Confidence            43  45666666655543333222111     1237888999999999999999997  368999999999999987653


Q ss_pred             ------EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCccccch
Q 006446          464 ------ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLILEVACGRKPGNQSEQNSYN  537 (644)
Q Consensus       464 ------vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~el~tG~~P~~~~~~~~~~  537 (644)
                            +|++|||.+......      .....||+.|+|||.+....++.++||||+||+++||++|+.||.........
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence                  999999999865422      34567999999999999999999999999999999999999999754322111


Q ss_pred             ---hhHHHHHHHH-------HhcCchh-hhhh-------------------cccCCCCCHHHHHHHHHHHHHhcCCCCCC
Q 006446          538 ---NSIVHWLWEL-------RRKGRIL-DAAD-------------------SRLGGEFSEKEMECVLILGLACCHPNPHL  587 (644)
Q Consensus       538 ---~~l~~~~~~~-------~~~~~~~-~~~d-------------------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~  587 (644)
                         ..+...++.+       ...+... ...+                   ......+.......+.+|+.+|++.||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence               1122211111       0000000 0000                   00122345667788999999999999999


Q ss_pred             CCCHHHHHHH
Q 006446          588 RPSMKTVLQV  597 (644)
Q Consensus       588 RPs~~evl~~  597 (644)
                      |||++|+++.
T Consensus       319 Rpta~e~L~H  328 (362)
T d1q8ya_         319 RADAGGLVNH  328 (362)
T ss_dssp             CBCHHHHHTC
T ss_pred             CcCHHHHhcC
Confidence            9999999873

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.94  E-value=3.6e-28  Score=237.03  Aligned_cols=111  Identities=33%  Similarity=0.492  Sum_probs=101.8

Q ss_pred             CccEEEEEEecCCCccC-CCCCCceeeecCCccceeeecCcccccCCCceEEEEEEEcC--ceEEEEEe--cCCCCCccc
Q 006446          141 QSQIVAIEFDTKKSYEQ-DINDNHVGLDVNSVYSIRQVPLTRVNLANGTDIKVQVRYDG--QNITVFVA--NMETPLLSE  215 (644)
Q Consensus       141 ~~~~~aVEfDt~~n~~~-d~~~~Hvgid~ns~~s~~~~~~~~~~l~~g~~~~~~I~Y~~--~~l~v~~~--~~~~~~ls~  215 (644)
                      .|++|||||||++|.++ ||++||||||+|++.|.++.++   ++.+|+.++|||+||+  ++|.|++.  ++..|.|++
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~---~l~~G~~~~v~I~Yd~~~~~L~V~~~~~~~~~~~ls~   77 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW---NMQNGKVGTAHIIYNSVDKRLSAVVSYPNADSATVSY   77 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC---CCCTTCEEEEEEEEETTTTEEEEEEECTTSCCEEEEE
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc---cccCCCEEEEEEEEecCCcEEEEEEecCCCCCeEEEE
Confidence            47999999999999775 9999999999999999887766   6889999999999998  78888885  667789999


Q ss_pred             ccCccCcCCCceeeeecccCCCcccccccccccccCCcc
Q 006446          216 PIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGSDI  254 (644)
Q Consensus       216 ~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss~~  254 (644)
                      .+||+.+|+++||||||||||...+.|+|++|+|+++..
T Consensus        78 ~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~  116 (237)
T d1nlsa_          78 DVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK  116 (237)
T ss_dssp             ECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred             EEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeecc
Confidence            999999999999999999999999999999999988653

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.92  E-value=2.2e-25  Score=217.24  Aligned_cols=111  Identities=26%  Similarity=0.592  Sum_probs=96.3

Q ss_pred             ccceeEEcCCCCCCCCCCeEEe-ccccc-CCceEeccCCCC-CCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEe
Q 006446           24 VSSLHFNFQSFTEQNRNELSFD-NSTVA-KSAIQVTYDVRG-APITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNIL  100 (644)
Q Consensus        24 ~~~~~f~f~~f~~~~~~~l~~~-~a~~~-~~~~~Lt~~~~~-~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~  100 (644)
                      +.+++|+|++|++. ..||.++ +|.+. +|.|+||+.+.+ .+...++|||+|++||||||+ ||+++||+|+|+|.|.
T Consensus       123 sn~~~F~f~~F~~~-~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~I~  200 (237)
T d1nlsa_         123 TNALHFMFNQFSKD-QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIK  200 (237)
T ss_dssp             EEEEEEEESCCCTT-CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECC
T ss_pred             cccceEEeeecCCC-CCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEEEe
Confidence            35799999999875 5689999 99985 899999987643 345688999999999999996 8999999999999999


Q ss_pred             cCCCCCCCceEEEEec-CCCCCCCCCCcccccccccC
Q 006446          101 NQTAQPGEGLAFVIAG-NKDLPENSEGQWLGIVNGIT  136 (644)
Q Consensus       101 ~~~~~~g~G~aF~l~~-~~~~~~~~~g~~lGl~~~~~  136 (644)
                      +....+||||||||+| ...+|.++.||||||||.++
T Consensus       201 ~~~~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n  237 (237)
T d1nlsa_         201 SPDSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN  237 (237)
T ss_dssp             CSSSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred             cCCCCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence            7555689999999999 45789999999999998753

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=3.2e-24  Score=211.21  Aligned_cols=198  Identities=16%  Similarity=0.158  Sum_probs=138.8

Q ss_pred             eeEEcCCCCCCCC--CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCC
Q 006446           27 LHFNFQSFTEQNR--NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQT  103 (644)
Q Consensus        27 ~~f~f~~f~~~~~--~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~  103 (644)
                      .+|+.|.+..++.  .+..+. +|.+.++.|+||++..     +++|+++|++|+++        .+|+|+|+|.+....
T Consensus         9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~~~~i~LT~~~~-----~~~G~v~~~~p~~~--------~~F~~~f~f~~~~~~   75 (228)
T d1gv9a_           9 YSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLK-----SQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG   75 (228)
T ss_dssp             GCEECSSCSCTTSCBTTEEEEETCEECSSCEEEECSST-----TCEEEEEESSCBCC--------SSEEEEEEEEEECSS
T ss_pred             eccCCCcccCCCCCccceEEeeeEEEECCEEEECCCCC-----CCEEEEEeCCCccc--------cCcEEEEEEeccCCC
Confidence            4566565544321  345788 9999999999998776     79999999999988        469999999998655


Q ss_pred             CCCCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceeeec-----
Q 006446          104 AQPGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQVP-----  178 (644)
Q Consensus       104 ~~~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~~~-----  178 (644)
                      ..+||||||+|++..    +..|+.+|..       ...+-+||||||+.| .+|++.+|+.+++|.........     
T Consensus        76 ~~ggdG~aF~i~~~~----~~~g~~~G~~-------~~~~glaVefDt~~n-~~~~~~~~~~~~~n~~~~~~~~~~~~~~  143 (228)
T d1gv9a_          76 RIGADGLAIWYTENQ----GLDGPVFGSA-------DMWNGVGIFFDSFDN-DGKKNNPAIVVVGNNGQINYDHQNDGAT  143 (228)
T ss_dssp             SCCCCEEEEEEESSC----CCEEEETTEC-------SCCEEEEEEEECCCC------CCEEEEEEEESCCCCCHHHHHHH
T ss_pred             CCCCCEEEEEEecCC----CCCCCccCcC-------CCCceEEEEEEcccc-cCCCCCCcEEEEecCCcceeeecCCCcc
Confidence            678999999999853    2456666652       223458999999999 56788888888776432111100     


Q ss_pred             --Cc--cc-ccCCCceEEEEEEEcCceEEEEEecCC----CCCcccccCccCcCCCceeeeecccCCCcccccccccccc
Q 006446          179 --LT--RV-NLANGTDIKVQVRYDGQNITVFVANME----TPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAF  249 (644)
Q Consensus       179 --~~--~~-~l~~g~~~~~~I~Y~~~~l~v~~~~~~----~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf  249 (644)
                        ..  .. ...++..+++|++|+.+.++|++....    .+.+.........+++.+||||||+||...+.|.|++|.+
T Consensus       144 ~~~~~~~~~~~~~~~~~~i~~~~~~~~l~v~i~~~~~~~~~~~~~~~~~~~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~  223 (228)
T d1gv9a_         144 QALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT  223 (228)
T ss_dssp             HCSEEECCCCBSCSSCEEEEEEEETTEEEEEEECSSCCCTTCCEEEEEETTCCCCSSBEEEEEEECCSSCCEEEEEEEEE
T ss_pred             ccccceeeeecCCceEEEEEEEecCCEEEEEEeccccCCCcceeEEEEecccccCCCEEEEEEEeCCCCcCeEEEEEEEE
Confidence              00  11 123566788999999999999985322    2222222223456899999999999999999999998865

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=6.6e-23  Score=195.97  Aligned_cols=168  Identities=15%  Similarity=0.122  Sum_probs=117.8

Q ss_pred             CCCcccccCcEEEEEeeec-CceEEEEEeecccc------------------hhhHHHHHHHHHHhccCCCceeeEeeee
Q 006446          323 PKNKLGKGGFGTVYKGIWR-NKEIAVKRVSETSR------------------QGKQEFIAEVTTIGSLRHRNLVKLIGWC  383 (644)
Q Consensus       323 ~~~~LG~G~fG~Vy~g~~~-~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~  383 (644)
                      ..++||+|+||+||+|+.. ++.||||+++....                  ........|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4688999999999999876 78999998753210                  0112345688899999999999887653


Q ss_pred             eeccceEEEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhCCCCCeEeCCCCCCCEEEcCCCc
Q 006446          384 YERHDFLLVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNGSEKRVLHRDIKSSNIMLDSEFN  463 (644)
Q Consensus       384 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDlkp~NILld~~~~  463 (644)
                          ..+++|||+++..+.++               +......++.|++++|.|||+   ++|+||||||+|||++++ .
T Consensus        84 ----~~~lvme~~~~~~~~~l---------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          84 ----GNAVLMELIDAKELYRV---------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             ----TTEEEEECCCCEEGGGC---------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-E
T ss_pred             ----CCEEEEEeeccccccch---------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-C
Confidence                23799999987655432               223345789999999999999   999999999999999965 5


Q ss_pred             EEEeccCCcccccccccccccccccccCCCccCccccccCCCCCccchHHHHHHHH
Q 006446          464 ARLGDFGLARTIQENLKTHHSTKEIAGTPGYMAPESFLVGRATIETDIYAFGVLIL  519 (644)
Q Consensus       464 vkL~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDVwSfGvvl~  519 (644)
                      ++|+|||+|+.......... ....+.   . -.|. ...+|..++|+||..--++
T Consensus       141 ~~liDFG~a~~~~~~~~~~~-l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWREI-LERDVR---N-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EEECCCTTCEETTSTTHHHH-HHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHHH-HHHHHH---H-HHHH-HcCCCCCcccHHHHHHHHh
Confidence            89999999986642211000 000000   0 0111 2356788999999765443

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.70  E-value=1e-16  Score=155.79  Aligned_cols=188  Identities=13%  Similarity=0.162  Sum_probs=119.9

Q ss_pred             EEcCCCCCCC--CCCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCC
Q 006446           29 FNFQSFTEQN--RNELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQ  105 (644)
Q Consensus        29 f~f~~f~~~~--~~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~  105 (644)
                      |++|++-..+  ..+..+. +|.+.++.|+||.+ .     ++.|.+++..|+++++       +|+++|.|.|......
T Consensus        10 ~s~p~~~~~~~~~~~W~~~g~a~~~~~~i~LTp~-~-----~~~G~~w~~~~i~~~~-------~f~~~~~F~i~g~~~~   76 (221)
T d2a6za1          10 YSLPDLINTRKVPNNWQTGEQASLEEGRIVLTSN-Q-----NSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYSGQ   76 (221)
T ss_dssp             GCBCCCTTCCSCCTTEEEEETCEEETTEEESCCS-T-----TCEEEEEESSCEECCS-------CEEEEEEEEEESCCSC
T ss_pred             ccCCCccccccCCCccEEcceeEEECCEEEECCC-C-----CCceEEEECCccccCC-------CeEEEEEEEEeCCCCC
Confidence            6667664332  2467788 99999999999975 2     5789999999999965       5999999999875667


Q ss_pred             CCCceEEEEecCCCCCCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccceee----ecCc-
Q 006446          106 PGEGLAFVIAGNKDLPENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSIRQ----VPLT-  180 (644)
Q Consensus       106 ~g~G~aF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~~~----~~~~-  180 (644)
                      +||||||++++....  ...|+++|..+       ...=+||||||+.|.   ....|+.++.++......    .... 
T Consensus        77 ggdG~af~~~~~~~~--~~~g~~~G~~~-------~~~GlaV~fDt~~n~---~~~~~~~~ndgt~~~~~~~~~~~~~~~  144 (221)
T d2a6za1          77 TDGGISFWFVQDSNI--PRDKQLYNGPV-------NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFAS  144 (221)
T ss_dssp             CSCEEEEEEEECSSS--CCCCTBTTBCT-------TCEEEEEEEESCSTT---SSEEEEEEEESSSCCCGGGHHHHCSEE
T ss_pred             CCCcEEEEEEcCCCc--cccccccccCC-------CCceEEEEEECCCCC---CCceEEEecCCCccccccCCcccccce
Confidence            899999999974422  23455555321       123379999999882   222233333333221110    0111 


Q ss_pred             -ccc-cCCCceEEEEEEEcC---ceEEEEEecCCCCCcccccCccCcCCCceeeeecccCCCcccccccc
Q 006446          181 -RVN-LANGTDIKVQVRYDG---QNITVFVANMETPLLSEPIDLSEYLPEKVFVGFSASTGDDTQLNCVK  245 (644)
Q Consensus       181 -~~~-l~~g~~~~~~I~Y~~---~~l~v~~~~~~~~~ls~~~dl~~~l~~~~~vGfsastg~~~~~~~i~  245 (644)
                       ... ..++...+++|.|+.   ..+.|.+....  .+.  ++--.+-++..|+||||+||...+.|.+.
T Consensus       145 ~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~~--c~~--~~~v~lp~~~~~fG~SA~TG~~~~~hd~~  210 (221)
T d2a6za1         145 CLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNKV--CFQ--TRKVRFPSGSYRIGVTAQNGAVNNNAESF  210 (221)
T ss_dssp             EECCCTTEEEEEEEEEEEEGGGTSEEEEEETTEE--EEE--ESCCCCCSSEEEEEEEEECCSGGGCCCEE
T ss_pred             eeecccCCCCCEEEEEEEecCccceEEEEecCcE--eEE--ECCeecCCCCEEEEEEEccCCccCCCceE
Confidence             112 346677899999987   33667664211  111  11111224668999999999988777643

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.67  E-value=4.3e-16  Score=150.81  Aligned_cols=181  Identities=10%  Similarity=0.095  Sum_probs=122.5

Q ss_pred             CCeEEe-cccccCCceEeccCCCCCCCCCceEEEEeCCceeeccCCCCceeeEEEEEEEEEecCCCCCCCceEEEEecCC
Q 006446           40 NELSFD-NSTVAKSAIQVTYDVRGAPITNQSGRAIYKDQFQLWRDNKNVKATFSTTFVLNILNQTAQPGEGLAFVIAGNK  118 (644)
Q Consensus        40 ~~l~~~-~a~~~~~~~~Lt~~~~~~~~~~~~G~~~y~~p~~~~~~~~~~~~sFst~F~f~i~~~~~~~g~G~aF~l~~~~  118 (644)
                      .+..+. +|.+.++.|+||.+.      ++.|++|+..|+++++       +|+++|+|.|......+||||||.+.+..
T Consensus        22 ~~W~~~G~~~~~~~~i~LTp~~------~~~G~~w~~~~i~~~~-------~f~i~~~F~i~g~~~~~~dG~afw~~~~~   88 (218)
T d2a6va1          22 SQWTLGDKVKLEEGRFVLTPGK------NTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFRGSTKGGLAFWLKQGN   88 (218)
T ss_dssp             TTEEEEETCEEETTEEESCCST------TCEEEEEESSCBCCSS-------CEEEEEEEEEESCCSCCSCEEEEEEECSC
T ss_pred             CccEECCCEEEECCEEEECCCC------CCeeEEEeCCcccccc-------cceEEEEEEEeCCCCCCCCcEEEEEEcCC
Confidence            467888 898999999999763      4689999999999975       59999999998755678999999999843


Q ss_pred             CC-CCCCCCcccccccccCCCCCCccEEEEEEecCCCccCCCCCCceeeecCCccce----eeecCcc---cccCCCceE
Q 006446          119 DL-PENSEGQWLGIVNGITNGTNQSQIVAIEFDTKKSYEQDINDNHVGLDVNSVYSI----RQVPLTR---VNLANGTDI  190 (644)
Q Consensus       119 ~~-~~~~~g~~lGl~~~~~~~~~~~~~~aVEfDt~~n~~~d~~~~Hvgid~ns~~s~----~~~~~~~---~~l~~g~~~  190 (644)
                      .. +.+..+|..+.++         . +||||||+.|.     .+||.+-+|.=...    ....+..   -...++.+.
T Consensus        89 ~~~~~~~~~G~~~~f~---------G-laV~fDt~~n~-----~~~i~~~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~  153 (218)
T d2a6va1          89 EGDSTELFGGSSKKFN---------G-LMILLRLDDKL-----GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPS  153 (218)
T ss_dssp             CCCCCTBTTTBCSSCE---------E-EEEEEEEETTT-----EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCE
T ss_pred             cccCCCcccccCCCcc---------e-EEEEEECCCCC-----CCeEEEEeCCCCccccccCCcccceEEecccCCCCcE
Confidence            32 1112233333322         2 69999998773     35777755421100    0001111   123467788


Q ss_pred             EEEEEEcC---ceEEEEEecCCCCCc-ccccCccCcCCCceeeeecccCCCcccccccccccccCC
Q 006446          191 KVQVRYDG---QNITVFVANMETPLL-SEPIDLSEYLPEKVFVGFSASTGDDTQLNCVKSWAFDGS  252 (644)
Q Consensus       191 ~~~I~Y~~---~~l~v~~~~~~~~~l-s~~~dl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ss  252 (644)
                      .++|.|+.   ..+.|.+..  +..+ ...|+|  ..++.+|+||||+||...+.|.|++|.+-..
T Consensus       154 ~~~i~Y~~~~~~~l~v~id~--~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~~~  215 (218)
T d2a6va1         154 TLRLTYNPLDNHLLKLQMDN--RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLYDG  215 (218)
T ss_dssp             EEEEEEEGGGTSEEEEEETT--EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEESS
T ss_pred             EEEEEEECcccceEEEEeCC--cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEEec
Confidence            99999987   235666532  1111 222333  3456799999999999999999999987654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=1.3e-07  Score=92.32  Aligned_cols=150  Identities=15%  Similarity=0.074  Sum_probs=103.8

Q ss_pred             HHHHHHhCCCCCCCcccccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccC-CCceeeEeeeeeeccceE
Q 006446          312 KELKKATGNFNPKNKLGKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLR-HRNLVKLIGWCYERHDFL  390 (644)
Q Consensus       312 ~~l~~a~~~f~~~~~LG~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~  390 (644)
                      .+++.....|+..+..+.++...||+....++.+++|+...........+.+|...+..+. +--+.+++.++...+..+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3556666677666555555567899988788889999987666555666788888887764 333566788888888899


Q ss_pred             EEEeccCCCccchhhhccCCCCCCCccccCHHHHHHHHHHHHHHHHHhHhC-----------------------------
Q 006446          391 LVYEYMPNGSLDKFIFYDETNSGPGEVTLNWEKRLSVIHGTSQALDYLHNG-----------------------------  441 (644)
Q Consensus       391 lV~Ey~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----------------------------  441 (644)
                      +||+++++.++.+.....          .   ....++.++++.|..||+.                             
T Consensus        87 lv~~~l~G~~~~~~~~~~----------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE----------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC----------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             EEEEeccccccccccccc----------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            999999988775543111          0   1122344444445555521                             


Q ss_pred             ---------------------------CCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          442 ---------------------------SEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       442 ---------------------------~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                                                 ....++|+|+.|.|||++++..+-|.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                       112489999999999999877678999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.72  E-value=0.00012  Score=70.19  Aligned_cols=75  Identities=15%  Similarity=0.068  Sum_probs=51.7

Q ss_pred             cccccCc-EEEEEeeecC-ceEEEEEeecccchhhHHHHHHHHHHhccCC--CceeeEeeeeeeccceEEEEeccCCCcc
Q 006446          326 KLGKGGF-GTVYKGIWRN-KEIAVKRVSETSRQGKQEFIAEVTTIGSLRH--RNLVKLIGWCYERHDFLLVYEYMPNGSL  401 (644)
Q Consensus       326 ~LG~G~f-G~Vy~g~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  401 (644)
                      .+..|.. +.||+....+ ..+++|......   ...+..|...++.+..  -.+.++++++.+.+..++||+|+++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445543 6799988774 457888765433   3356677777777643  3356678888888889999999988776


Q ss_pred             ch
Q 006446          402 DK  403 (644)
Q Consensus       402 ~~  403 (644)
                      .+
T Consensus        94 ~~   95 (255)
T d1nd4a_          94 LS   95 (255)
T ss_dssp             TT
T ss_pred             cc
Confidence            44

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.19  E-value=0.00072  Score=69.36  Aligned_cols=76  Identities=11%  Similarity=0.117  Sum_probs=47.7

Q ss_pred             CCcccccCcEEEEEeeec--CceEEEEEeeccc-------chhhHHHHHHHHHHhccC-C--CceeeEeeeeeeccceEE
Q 006446          324 KNKLGKGGFGTVYKGIWR--NKEIAVKRVSETS-------RQGKQEFIAEVTTIGSLR-H--RNLVKLIGWCYERHDFLL  391 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~--~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~l  391 (644)
                      .+.||.|....||+....  ++.++||.-....       .........|...|+.+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            346899999999998765  5679999754311       112233456777776652 2  345556554  3445689


Q ss_pred             EEeccCCCcc
Q 006446          392 VYEYMPNGSL  401 (644)
Q Consensus       392 V~Ey~~~gsL  401 (644)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.47  E-value=0.0037  Score=61.98  Aligned_cols=140  Identities=14%  Similarity=0.114  Sum_probs=76.8

Q ss_pred             cEEEEEeeec-CceEEEEEeecccchhhHHHHHHHHHHhccCCCce-----eeEe--eeeeeccceEEEEeccCCCccch
Q 006446          332 FGTVYKGIWR-NKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNL-----VKLI--GWCYERHDFLLVYEYMPNGSLDK  403 (644)
Q Consensus       332 fG~Vy~g~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l~--g~~~~~~~~~lV~Ey~~~gsL~~  403 (644)
                      --.||+.+.. |..+++|..+.. ....+++..|...+..|....+     +..-  .....++..+.+++++++..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            3589999886 667999987654 2345667788888877743222     1111  12234456788999997654421


Q ss_pred             h--------------hhcc-CCCCCCCccccCHHH-------------------HHHHHHHHHHHHHHhH----hCCCCC
Q 006446          404 F--------------IFYD-ETNSGPGEVTLNWEK-------------------RLSVIHGTSQALDYLH----NGSEKR  445 (644)
Q Consensus       404 ~--------------l~~~-~~~~~~~~~~l~~~~-------------------~~~i~~~ia~aL~yLH----~~~~~~  445 (644)
                      .              ++.. ..........+++..                   +-.+...+...++.+.    +....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence            1              0100 000000111122111                   1111122222333332    223467


Q ss_pred             eEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          446 VLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       446 ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      ++|+|+.+.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.21  E-value=0.013  Score=57.40  Aligned_cols=164  Identities=12%  Similarity=0.012  Sum_probs=85.8

Q ss_pred             cCHHHHHHHhCCCCCCCcc-----cccCcEEEEEeeecCceEEEEEeecccchhhHHHHHHHHHHhccCCCc-----eee
Q 006446          309 FRLKELKKATGNFNPKNKL-----GKGGFGTVYKGIWRNKEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRN-----LVK  378 (644)
Q Consensus       309 ~~~~~l~~a~~~f~~~~~L-----G~G~fG~Vy~g~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-----Iv~  378 (644)
                      .+.+|+.....+|...+..     ..|---+.|+.+.+++++++|+.....  ..++...|+.++..|...+     .+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            4567777777888775544     355567789988888889999985432  2334455666666664322     222


Q ss_pred             Ee-e--eeeeccceEEEEeccCCCccchhh--------------hcc-CCCCCC--CccccCHH----------------
Q 006446          379 LI-G--WCYERHDFLLVYEYMPNGSLDKFI--------------FYD-ETNSGP--GEVTLNWE----------------  422 (644)
Q Consensus       379 l~-g--~~~~~~~~~lV~Ey~~~gsL~~~l--------------~~~-~~~~~~--~~~~l~~~----------------  422 (644)
                      .. |  +...++....++.+..+......-              +.. ......  ......|.                
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            11 1  112234556667776554332110              000 000000  00000010                


Q ss_pred             HHHHHHHHHHHHHHHhHh-CCCCCeEeCCCCCCCEEEcCCCcEEEeccCCccc
Q 006446          423 KRLSVIHGTSQALDYLHN-GSEKRVLHRDIKSSNIMLDSEFNARLGDFGLART  474 (644)
Q Consensus       423 ~~~~i~~~ia~aL~yLH~-~~~~~ivHrDlkp~NILld~~~~vkL~DFGla~~  474 (644)
                      .....+..+...+.-.+. ....++||+|+.++||+++.+...-|.||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            011112222222222221 2356899999999999999988788999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.03  E-value=0.0074  Score=61.46  Aligned_cols=73  Identities=18%  Similarity=0.244  Sum_probs=47.7

Q ss_pred             CCcccccCcEEEEEeeecC---------ceEEEEEeecccchhhHHHHHHHHHHhccCCCcee-eEeeeeeeccceEEEE
Q 006446          324 KNKLGKGGFGTVYKGIWRN---------KEIAVKRVSETSRQGKQEFIAEVTTIGSLRHRNLV-KLIGWCYERHDFLLVY  393 (644)
Q Consensus       324 ~~~LG~G~fG~Vy~g~~~~---------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~  393 (644)
                      .+.|+.|-.-.+|+.....         ..|.+++.. .. .......+|..+++.+.-.++. ++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568888889999987642         345555544 22 2234456788888887544544 67777643    6899


Q ss_pred             eccCCCccc
Q 006446          394 EYMPNGSLD  402 (644)
Q Consensus       394 Ey~~~gsL~  402 (644)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876554